PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Roux, D; Cywes-Bentley, C; Zhang, YF; Pons, S; Konkol, M; Kearns, DB; Little, DJ; Howell, PL; Skurnik, D; Pier, GB				Roux, Damien; Cywes-Bentley, Colette; Zhang, Yi-Fan; Pons, Stephanie; Konkol, Melissa; Kearns, Daniel B.; Little, Dustin J.; Howell, P. Lynne; Skurnik, David; Pier, Gerald B.			Identification of Poly-N-acetylglucosamine as a Major Polysaccharide Component of the Bacillus subtilis Biofilm Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; STAPHYLOCOCCUS-EPIDERMIDIS; PSEUDOMONAS-AERUGINOSA; SURFACE POLYSACCHARIDE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; EXOPOLYSACCHARIDE PRODUCTION; CAPSULAR POLYSACCHARIDES; INTERCELLULAR-ADHESION; ANTIBIOTIC-RESISTANCE	Bacillus subtilis is intensively studied as a model organism for the development of bacterial biofilms or pellicles. A key component is currently undefined exopolysaccharides produced from proteins encoded by genes within the eps locus. Within this locus are four genes, epsHIJK, known to be essential for pellicle formation. We show they encode proteins synthesizing the broadly expressed microbial carbohydrate poly-N-acetylglucosamine (PNAG). PNAG was present in both pellicle and planktonic wild-type B. subtilis cells and in strains with deletions in the epsA-G and -L-O genes but not in strains deleted for epsH-K. Cloning of the B. subtilis epsH-K genes into Escherichia coli with in-frame deletions in the PNAG biosynthetic genes pgaA-D, respectively, restored PNAG production in E. coli. Cloning the entire B. subtilis epsHIJK locus into pga-deleted E. coli, Klebsiella pneumoniae, or alginate-negative Pseudomonas aeruginosa restored or conferred PNAG production. Bioinformatic and structural predictions of the EpsHIJK proteins suggest EpsH and EpsJ are glycosyltransferases (GT) with a GT-A fold; EpsI is a GT with a GT-B fold, and EpsK is an alpha-helical membrane transporter. B. subtilis, E. coli, and pga-deleted E. coli carrying the epsHIJK genes on a plasmid were all susceptible to opsonic killing by antibodies to PNAG. The immunochemical and genetic data identify the genes and proteins used by B. subtilis to produce PNAG as a significant carbohydrate factor essential for pellicle formation.	[Roux, Damien; Cywes-Bentley, Colette; Zhang, Yi-Fan; Pons, Stephanie; Skurnik, David; Pier, Gerald B.] Harvard Univ, Sch Med, Div Infect Dis,Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Zhang, Yi-Fan] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Konkol, Melissa; Kearns, Daniel B.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Little, Dustin J.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Little, Dustin J.; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Indiana University System; Indiana University Bloomington; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Skurnik, D (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 181 Longwood Ave, Boston, MA 02115 USA.	dskurnik@rics.bwh.harvard.edu; gpier@rics.bwh.harvard.edu	Roux, Damien/C-5618-2014; Pier, Gerald/AAO-2692-2021; Regan, Clinton/E-6250-2012; Roux, Damien/L-3671-2014	Roux, Damien/0000-0002-6103-6416; Pier, Gerald/0000-0002-9112-2331; Roux, Damien/0000-0002-6103-6416; Cywes Bentley, Colette/0000-0002-6301-0930; Skurnik, David/0000-0002-4205-9639; Zhang, Yifan/0000-0002-2414-2703; Pons, Stephanie/0000-0002-7372-3563	National Institutes of Health [EY016104, AI057159, U54A1057159, GM093030]; AXA Research Fund; Fondation pour la Recherche Medicale; William Randolph Hearst Fund; Hood Foundation; Seedlings Foundation; Canadian Institutes of Health Research [43998]; Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC; Brigham and Women's Hospital from Alopexx Vaccine, LLC; University of Toronto; Ontario Graduate Scholarship Program; Canadian Institutes of Health Research; NATIONAL EYE INSTITUTE [R01EY016144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AXA Research Fund(AXA Research Fund); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); William Randolph Hearst Fund; Hood Foundation; Seedlings Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC; Brigham and Women's Hospital from Alopexx Vaccine, LLC; University of Toronto(University of Toronto); Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016104 and AI057159 (a component of Award U54A1057159) (to G. B. P.) and Grant GM093030 (to D. B. K.). This work was also supported by the AXA Research Fund and the Fondation pour la Recherche Medicale (to D. R.), awards from the William Randolph Hearst Fund (to D. R.) and the Hood Foundation (to D. S.) and the Seedlings Foundation (to D. S. and C. C.-B.), and Grant 43998 from the Canadian Institutes of Health Research (to P. L. H.). G. B. P. is an inventor of intellectual properties (human monoclonal antibody to PNAG and PNAG vaccines) that are licensed by Brigham and Women's Hospital to Alopexx Vaccine, LLC, and Alopexx Pharmaceuticals, LLC, entities in which G. B. P. also holds equity. As an inventor of intellectual properties, G. B. P. also has the right to receive a share of licensing-related income (royalties, fees) through Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC, and Alopexx Vaccine, LLC. G. B. P.'s interests were reviewed and are managed by the Brigham and Women's Hospital and Partners Healthcare in accordance with their conflict of interest policies. C. C.-B. and D. S. are inventors of intellectual properties (use of human monoclonal antibody to PNAG and use of PNAG vaccines) that are licensed by Brigham and Women's Hospital to Alopexx Vaccine, LLC, and Alopexx Pharmaceuticals, LLC. As inventors of intellectual properties, C. C.-B. and D. S. also have the right to receive a share of licensing-related income (royalties, fees) through Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC, and Alopexx Vaccine, LLC.; Supported in part by graduate scholarships from the University of Toronto, the Ontario Graduate Scholarship Program, and Canadian Institutes of Health Research.	Alibert-Franco S, 2009, CURR MED CHEM, V16, P301, DOI 10.2174/092986709787002619; Bakaletz LO, 2012, PAEDIATR RESPIR REV, V13, P154, DOI 10.1016/j.prrv.2012.03.001; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Chuang CH, 2014, GUT, V63, P736, DOI 10.1136/gutjnl-2013-304786; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; Doublet B, 2008, J MICROBIOL METH, V75, P359, DOI 10.1016/j.mimet.2008.06.010; Elsholz AKW, 2014, GENE DEV, V28, P1710, DOI 10.1101/gad.246397.114; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Foulston L, 2014, MBIO, V5, DOI 10.1128/mBio.01667-14; FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057, DOI 10.1128/JB.175.16.5057-5065.1993; Gening ML, 2007, CARBOHYD RES, V342, P567, DOI 10.1016/j.carres.2006.08.010; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Guttenplan SB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001243; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Herriott MM, 2011, TRENDS MICROBIOL, V19, P557, DOI 10.1016/j.tim.2011.07.004; Hsieh PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033155; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konkol MA, 2013, J BACTERIOL, V195, P4085, DOI 10.1128/JB.00696-13; Little DJ, 2014, J BIOL CHEM, V289, P35907, DOI 10.1074/jbc.M114.611400; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Lu X, 2014, MBIO, V5, DOI 10.1128/mBio.00974-14; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Mack D, 2009, TOP CURR CHEM, V288, P157, DOI 10.1007/128_2008_19; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; Martinez A, 1997, APPL MICROBIOL BIOT, V47, P40, DOI 10.1007/s002530050885; Marvasi M, 2010, FEMS MICROBIOL LETT, V313, P1, DOI 10.1111/j.1574-6968.2010.02085.x; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nagorska K, 2010, J APPL GENET, V51, P369, DOI 10.1007/BF03208867; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pozsgai ER, 2012, APPL ENVIRON MICROB, V78, P778, DOI 10.1128/AEM.07098-11; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Romero D, 2013, RES MICROBIOL, V164, P788, DOI 10.1016/j.resmic.2013.06.004; Romero-Steiner S, 2006, CLIN VACCINE IMMUNOL, V13, P165, DOI 10.1128/CVI.13.2.165-169.2006; Shank EA, 2011, CURR OPIN MICROBIOL, V14, P741, DOI 10.1016/j.mib.2011.09.016; SIMON R, 1986, METHOD ENZYMOL, V118, P640; Skurnik D, 2013, P NATL ACAD SCI USA, V110, P20747, DOI 10.1073/pnas.1221552110; Skurnik D, 2012, J INFECT DIS, V205, P1709, DOI 10.1093/infdis/jis254; SMITH RL, 1979, ANAL BIOCHEM, V98, P478, DOI 10.1016/0003-2697(79)90170-2; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Valvano MA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P729, DOI 10.1134/S0006297911070029; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; YASBIN RE, 1974, J VIROL, V14, P1343, DOI 10.1128/JVI.14.6.1343-1348.1974; Ye LB, 2014, GLYCOBIOLOGY, V24, P351, DOI 10.1093/glycob/cwu001	64	67	68	5	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19261	19272		10.1074/jbc.M115.648709	http://dx.doi.org/10.1074/jbc.M115.648709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26078454	hybrid, Green Published			2022-12-26	WOS:000358781100039
J	Cao, ZX; Yu, WM; Li, W; Cheng, F; Rao, T; Yao, XB; Zhang, XB; Larre, SP				Cao, Zhixiu; Yu, Weimin; Li, Wei; Cheng, Fan; Rao, Ting; Yao, Xiaobing; Zhang, Xiaobin; Larre, Stephane			Oxidative Damage and Mitochondrial Injuries Are Induced by Various Irrigation Pressures in Rabbit Models of Mild and Severe Hydronephrosis	PLOS ONE			English	Article							INVASIVE PERCUTANEOUS NEPHROLITHOTOMY; PELVIC PRESSURE; RENAL-FUNCTION; NITRIC-OXIDE; OBSTRUCTION; STRESS; KIDNEY; JC-1; FLOW; NEPHROSCOPY	Objective We aimed to study whether tolerance to irrigation pressure could be modified by evaluating the oxidative damage of obstructed kidneys based on rabbit models experiencing different degrees of hydronephrosis. Methods A total of 66 rabbits were randomly divided into two experimental groups and a control group. In the experimental groups, the rabbits underwent a surgical procedure inducing mild (group M, n=24) or severe (group S, n=24) hydronephrosis. In each experimental group, the rabbits were then randomly divided into 4 subgroups (M0-M3 and S0-S3) consisting of 6 rabbits each. Group 0 received no perfusion. Groups 1 through 3 were perfused with 20, 60 and 100 mmHg fluid, respectively. For the control group, after a sham operation was performed, the rabbits were divided into 4 subgroups and were perfused with fluid at 0, 20, 60 or 100 mmHg of pressure. Kidney injuries was evaluated by neutrophil gelatinase associated lipocalin (NGAL). Oxidative damage was assessed by analyzing superoxide dismutase (Mn-SOD) activity, malondialdehyde (MDA) levels, glutathione reductase (GR), catalase (CAT) and peroxide (H2O2) levels, mitochondrial injuries was assessed by mitochondrial membrane potential (MMP), the mitochondrial ultrastructure and tubular cell apoptosis. Results In the experimental groups, all results were similar for groups 0 and 1. In group 2, abnormalities were observed in the S group only, and the kidneys of rabbits in group 3 suffered oxidative damage and mitochondrial injuries with increased NGAL, decreased Mn-SOD, GR and CAT, increased MDA and H2O2, lower levels of MMP, mitochondrial vacuolization and an increased apoptotic index. Conclusion In rabbits, severely obstructed kidneys were more susceptible to oxidative damage and mitochondrial injury than mildly obstructed kidneys when subjected to higher degrees of kidney perfusion pressure.	[Cao, Zhixiu; Yu, Weimin; Cheng, Fan; Rao, Ting; Yao, Xiaobing; Zhang, Xiaobin] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Hunan, Peoples R China; [Li, Wei] Wuhan Univ, Renmin Hosp, Dept Anesthesiol, Wuhan, Hunan, Peoples R China; [Cao, Zhixiu] Wuhan 1 Hosp, Dept Urol, Wuhan, Hunan, Peoples R China; [Larre, Stephane] Univ Reims, Dept Urol, Robert Debre Teaching Hosp, Reims, France	Wuhan University; Wuhan University; CHU de Reims; Universite de Reims Champagne-Ardenne	Cheng, F (corresponding author), Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Hunan, Peoples R China.	urology1969@aliyun.com			National Science Fund Project of China [81200501]; Wuhan University of China [2012302020203]	National Science Fund Project of China; Wuhan University of China	This study was supported by a grant from the National Science Fund Project of China (NO: 81200501) and Dr Research Fund Project of Wuhan University of China (NO: 2012302020203). Weimin Yu received the funding.	Ahmad ST, 2012, TOXICOL LETT, V208, P149, DOI 10.1016/j.toxlet.2011.10.023; Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; Brooks MM, 2013, MOL VIS, V19, P1406; COHEN HJ, 1987, BLOOD, V69, P493; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; de Geus HRH, 2013, BIOMARK MED, V7, P415, DOI [10.2217/BMM.13.5, 10.2217/bmm.13.5]; Dissing TH, 2001, J UROLOGY, V166, P2354, DOI 10.1016/S0022-5347(05)65588-7; Elashry OM, 2008, BJU INT, V102, P1010, DOI 10.1111/j.1464-410X.2008.07747.x; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Guohua Z, 2007, SURG LAPARO ENDO PER, V17, P307, DOI 10.1097/SLE.0b013e31806e61f4; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hervouet E, 2007, BIOCHIMIE, V89, P1080, DOI 10.1016/j.biochi.2007.03.010; Jassem W, 2002, TRANSPLANTATION, V73, P493, DOI 10.1097/00007890-200202270-00001; Joles JA, 2009, J AM COLL CARDIOL, V54, P1632, DOI 10.1016/j.jacc.2009.05.068; Kawakami T, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/740203; Khattab MM, 2005, KIDNEY BLOOD PRESS R, V28, P243, DOI 10.1159/000088829; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kukreja R, 2003, J ENDOUROL, V17, P875, DOI 10.1089/089277903772036181; Landman J, 2002, UROLOGY, V60, P584, DOI 10.1016/S0090-4295(02)01861-7; Li X, 2012, AM J PHYSIOL-RENAL, V302, pF519, DOI 10.1152/ajprenal.00011.2011; Long JG, 2006, LIFE SCI, V79, P1466, DOI 10.1016/j.lfs.2006.04.024; Low RK, 1999, J ENDOUROL, V13, P205, DOI 10.1089/end.1999.13.205; Maneiro E, 2005, ANN RHEUM DIS, V64, P388, DOI 10.1136/ard.2004.022152; Mehaney DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099286; Mortensen J, 2011, INFLAMM RES, V60, P299, DOI 10.1007/s00011-010-0268-3; Park Y, 2008, SURGERY, V143, P243, DOI 10.1016/j.surg.2007.07.041; Perelman A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.171; Reddi AR, 2009, FREE RADICAL BIO MED, V46, P154, DOI 10.1016/j.freeradbiomed.2008.09.032; Rehman J, 2003, UROLOGY, V61, P713, DOI 10.1016/S0090-4295(02)02440-8; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Serel TA, 2004, UROL RES, V32, P69, DOI 10.1007/s00240-003-0397-z; Shao Y, 2012, MINIM INVASIV THER, V21, P302, DOI 10.3109/13645706.2011.595419; Wahlin N, 2001, J UROLOGY, V165, P1696, DOI 10.1016/S0022-5347(05)66396-3; Wen JG, 1998, J UROLOGY, V160, P1567, DOI 10.1016/S0022-5347(01)62614-4; Wen JG, 2002, NEUROUROL URODYNAM, V21, P231, DOI 10.1002/nau.10006; Worcester EM, 2006, J UROLOGY, V176, P600, DOI 10.1016/j.juro.2006.03.095; Wu WQ, 2014, J ENDOUROL, V28, P926, DOI 10.1089/end.2013.0760; Yilmaz HR, 2004, J BIOCHEM MOL TOXIC, V18, P234, DOI 10.1002/jbt.20028; Zhu Xiongwei, 2004, Am J Alzheimers Dis Other Demen, V19, P345, DOI 10.1177/153331750401900611	39	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0127143	10.1371/journal.pone.0127143	http://dx.doi.org/10.1371/journal.pone.0127143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090815	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000008
J	Haile, D; Lakew, Y				Haile, Demewoz; Lakew, Yihunie			Khat Chewing Practice and Associated Factors among Adults in Ethiopia: Further Analysis Using the 2011 Demographic and Health Survey	PLOS ONE			English	Article							RISK	Background Khat chewing has become a highly prevalent practice and a growing public health concern in Ethiopia. Although there have been many small scale studies, very limited national information has been available in the general population. This study aimed to identify factors associated with khat chewing practice among Ethiopian adults. Methods The study used the 2011 Ethiopian demographic and health survey data. The survey was cross-sectional by design and used a multistage cluster sampling procedure. Bivariate and multivariable logistic regression models with adjusted odds ratio (AOR) and their 95% confidence intervals (CI) were used to quantify the predictors. Results The overall khat chewing prevalence was 15.3% (95% CI: 14.90-15.71). Regional variation was observed with the highest in Harari [(53.2% (95% CI: 43.04-63.28)] and lowest in Tigray regional state [(1.1% (95% CI: 0.72-1.66)]. Multivariable analysis showed that Islam followers were 23.8 times more likely to chew khat as compared to Orthodox followers. Being a resident in Oromiya, South Nation, Nationalities and People (SNNP), Gambella, Harari and Dire Dawa regions had 1.9, 1.6, 3.1, 5.2 and 3.5 times higher odds of chewing khat as compared to Addis Ababa residents, respectively. Adults in the age group 45-49 years were 3.6 times more likely to chew khat as compared to 15-19 years. The middle and richest wealth quintiles were 1.3 and 1.5 times more likely to chew khat, respectively, as compared to the poorest category. Rural residents had 1.3 odds of chewing khat than urban residents. Those individuals who had occupation in sales, agriculture, service sector, skilled and unskilled manual workers were 1.6, 1.3, 2.4, 1.7 and 2.3 times more likely to chew khat, respectively, as compared to those who have no occupation. Females were 77% less likely to chew khat as compared to males. Formerly married and those experienced in child death had 1.4 and 1.2 times higher odds to chew khat as compared with those never married and never had child death, respectively. Those who attended mass media were 1.4 times more likely to chew khat compared with not attended. Conclusion Khat chewing is a public health concern in Ethiopia. The highest wealth quintiles, older age group, rural residence, child death, formerly married, males, regions of Oromiya, SNNP, Gambella, Harari and Dire Dawa and Islamic followers had statistically significant association with khat chewing. Due attention needs to be given for these factors in any intervention procedures.	[Haile, Demewoz] Madawalabu Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Bale Robe, Ethiopia; [Lakew, Yihunie] Ethiopian Publ Hlth Assoc, Addis Ababa, Ethiopia	University of Gondar	Haile, D (corresponding author), Madawalabu Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Bale Robe, Ethiopia.	demewozhaile@yahoo.com		Haile, Demewoz/0000-0003-0047-4276	Measure DHS	Measure DHS	The authors acknowledge Measure DHS for granting the data for this study. We appreciate Lianna Tadar, Kissito Healthcare International, Country Representative in Ethiopia for her language editing.	Aden A, 2006, East Afr Med J, V83, P69; Ageely HMA, 2008, J FAM COMMUNITY MED, V15, P3; Al-Motarreb A, 2002, PHYTOTHER RES, V16, P403, DOI 10.1002/ptr.1106; Al-Mugahed L, 2008, B WORLD HEALTH ORGAN, V86, P741, DOI 10.2471/BLT.08.011008; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P84, DOI 10.1111/j.1600-0447.1999.tb10699.x; Ali WM, 2010, MAYO CLIN PROC, V85, P974, DOI 10.4065/mcp.2010.0398; Ambaye GG, 2012, ADV AGR SCI ENG RES, V2; Andualem M., 2002, ETHIOP J HLTH SCI, V12, P69; [Anonymous], ETHIOP SCI J PUBLIC, DOI DOI 10.11648/j.sjph.20130105.14; Armstrong EG, 2008, J DRUG ISSUES, V38, P631, DOI 10.1177/002204260803800212; Austin PC, 2004, J CLIN EPIDEMIOL, V57, P1138, DOI 10.1016/j.jclinepi.2004.04.003; Ayana AM, 2004, ETHIOPIAN MED J, V42, P125; Baasher T., 1980, WHO PUBLIC HLTH PAPE, V73; Belew M, 2000, ETHIOPIAN MED J, V38, P11; Berhanu Megerssa, 2014, Discourse Journal of Agriculture and Food Sciences, V2, P21; BRENNEISEN R, 1990, BRIT J CLIN PHARMACO, V30, P825, DOI 10.1111/j.1365-2125.1990.tb05447.x; Central Statistical Agency (CSA), 2011, DEM HLTH SURV 2011; Central Statistical Agency (CSA), 2005, DEM HLTH SURV 2005; Central Statistics Agency (Ethiopia), 2007, SUMM STAT REP 2007 P; Cox G, 2003, ADV PSYCHIAT TREAT, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; Damena T, 2011, ETHIOP J HEALTH SCI, V21, P37; Feyisa TH, 2003, MT RES DEV, V23, P185, DOI 10.1659/0276-4741(2003)023[0185:KEITEH]2.0.CO;2; Gebissa, 2004, LEAF ALLAH KHAT AGR; Gebissa E, 2010, J ETHNOPHARMACOL, V132, P607, DOI 10.1016/j.jep.2010.01.063; Gelaw Y, 2004, ETHIOP J HEALTH DEV, V18, P179; Getahun W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-390; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ihunwo A O, 2004, East Afr Med J, V81, P468; KALIX P, 1984, B WORLD HEALTH ORGAN, V62, P681; Kasule H., 2011, PREVALENCE FACTORS A; Kebede D, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-109; Kedir H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078601; Lakew Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-330; MahiTigani El, 1962, EMMENT294 WHO; Malaju MT, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-10; Manghi RA, 2009, J PSYCHOACTIVE DRUGS, V41, P1, DOI 10.1080/02791072.2009.10400669; Nigussie T, 2013, ETHIOP J HEALTH SCI, V23, P123; Odenwald M, 2010, J ETHNOPHARMACOL, V132, P537, DOI 10.1016/j.jep.2010.11.012; Rashad E., 2011, EUROPEAN J SCI RES, V63, P122; Reda AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033946; Stefan J, 2005, AUST NZ J PSYCHIAT, V39, P842; Tesfaye F, 2006, PREVENTION CHRONIC D; Vijai-basker G., 2013, INT J PHARM PHARM SC, V5, P74; World Health Organization, 2003, WHO TECH REP SER, V916; World Health Organization (WHO), 2006, WHO TECH REP SER; Yigzaw Kebede, 2002, Ethiopian Journal of Health Development, V16, P9; Zeleke A., 2013, OPEN J EPIDEMIOL, V3, P160, DOI [10.4236/ojepi.2013.34024, DOI 10.4236/OJEPI.2013.34024]	48	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130460	10.1371/journal.pone.0130460	http://dx.doi.org/10.1371/journal.pone.0130460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26090658	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000119
J	Qin, J; Ma, X; Qi, HY; Song, B; Wang, YL; Wen, XJ; Wang, QM; Sun, SL; Li, YS; Zhang, R; Liu, XJ; Hou, HM; Gong, GM; Xu, YM				Qin, Jie; Ma, Xun; Qi, Haiyun; Song, Bo; Wang, Yanlin; Wen, Xuejun; Wang, Qing Mei; Sun, Shilei; Li, Yusheng; Zhang, Rui; Liu, Xinjing; Hou, Haiman; Gong, Guangming; Xu, Yuming			Transplantation of Induced Pluripotent Stem Cells Alleviates Cerebral Inflammation and Neural Damage in Hemorrhagic Stroke	PLOS ONE			English	Article							EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; ISCHEMIC-STROKE; FUNCTIONAL RECOVERY; BRAIN; INJURY; RATS; THERAPY; MECHANISMS; NEURONS; MODELS	Background Little is known about the effects of induced pluripotent stem cell (iPSC) treatment on acute cerebral inflammation and injuries after intracerebral hemorrhage (ICH), though they have shown promising therapeutic potentials in ischemic stoke. Methods An ICH model was established by stereotactic injection of collagenase VII into the left striatum of male Sprague-Dawley (SD) rats. Six hours later, ICH rats were randomly divided into two groups and received intracerebrally 10 mu l of PBS with or without 1x10(6) of iPSCs. Subsequently, neural function of all ICH rats was assessed at days 1, 3, 7, 14, 28 and 42 after ICH. Inflammatory cells, cytokines and neural apoptosis in the rats' perihematomal regions, and brain water content were determined on day 2 or 3 post ICH. iPSC differentiation was determined on day 28 post ICH. Nissl(+) cells and glial fibrillary acidic protein (GFAP)(+) cells in the perihematoma and the survival rates of rats in two groups were determined on post-ICH day 42. Results Compared with control animals, iPSCs treatment not only improved neurological function and survival rate, but also resulted in fewer intracephalic infiltrations of neutrophils and microglia, along with decreased interleukin (IL)-1 beta, IL-6 and tumour necrosis factor-alpha (TNF-alpha), and increased IL-10 in the perihematomal tissues of ICH rats. Furthermore, brain oedema formation, apoptosis, injured neurons and glial scar formation were decreased in iPSCs-transplanted rats. Conclusions Our findings indicate that iPSCs transplantation attenuate cerebral inflammatory reactions and neural injuries after ICH, and suggests that multiple mechanisms including inflammation modulation, neuroprotection and functional recovery might be involved simultaneously in the therapeutic benefit of iPSC treatment against hemorrhagic stroke.	[Qin, Jie; Ma, Xun; Qi, Haiyun; Song, Bo; Wang, Yanlin; Sun, Shilei; Li, Yusheng; Zhang, Rui; Liu, Xinjing; Hou, Haiman; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol 3, Zhengzhou 450052, Henan, Peoples R China; [Qin, Jie; Ma, Xun; Qi, Haiyun; Song, Bo; Wang, Yanlin; Sun, Shilei; Li, Yusheng; Zhang, Rui; Liu, Xinjing; Hou, Haiman; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Key Disciplines Lab Clin Med Henan Prov, Zhengzhou 450052, Henan, Peoples R China; [Wen, Xuejun] Virginia Commonwealth Univ, Inst Engn & Med, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA; [Wang, Qing Mei] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Gong, Guangming] Zhengzhou Univ, Coll Basic Med Sci, Dept Microbiol & Immunol, Zhengzhou 450001, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Virginia Commonwealth University; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Zhengzhou University	Gong, GM (corresponding author), Zhengzhou Univ, Coll Basic Med Sci, Dept Microbiol & Immunol, Zhengzhou 450001, Henan, Peoples R China.	gmgong@zzu.edu.cn; xuyuming@zzu.edu.cn			Natural Science Foundation of China [81301007, 81070920, 81471158]; First Affiliated Hospital of Zhengzhou University; Key Projects for Medical Science and Technology Development of Henan Province, China [201002003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); First Affiliated Hospital of Zhengzhou University; Key Projects for Medical Science and Technology Development of Henan Province, China	This study was supported by grants from Natural Science Foundation of China (81301007 to Jie Qin; 81070920 and 81471158 to Yuming Xu), and supported by the youth innovation fund of the First Affiliated Hospital of Zhengzhou University (to Jie Qin) and the Key Projects for Medical Science and Technology Development of Henan Province, China (No. 201002003, to Guangming Gong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Azevedo-Pereira RL, 2013, METHODS MOL BIOL, V1059, P157, DOI 10.1007/978-1-62703-574-3_14; Chang DJ, 2013, CELL TRANSPLANT, V22, P1427, DOI 10.3727/096368912X657314; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Ding DC, 2013, CELL TRANSPLANT, V22, P619, DOI 10.3727/096368912X655091; Frantzias J, 2011, ANN NEUROL, V69, P389, DOI 10.1002/ana.22243; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Hwang BY, 2011, CEREBROVASC DIS, V31, P211, DOI 10.1159/000321870; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jiang Y, 2011, NEUROSCIENCE, V172, P398, DOI 10.1016/j.neuroscience.2010.10.054; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Lee PY, 2012, CELL TRANSPLANT, V21, P2569, DOI 10.3727/096368912X636902; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Leong WK, 2013, STEM CELLS, V31, P1040, DOI 10.1002/stem.1348; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt326; Liu SP, 2013, CELL TRANSPLANT, V22, P631, DOI 10.3727/096368912X655145; Liu XF, 2014, PROG NEUROBIOL, V115, P92, DOI 10.1016/j.pneurobio.2013.11.007; Mine Y, 2013, NEUROBIOL DIS, V52, P191, DOI 10.1016/j.nbd.2012.12.006; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Qin J, 2013, NEUROSCI LETT, V554, P70, DOI 10.1016/j.neulet.2013.08.047; Qin J, 2013, NEUROSCI LETT, V548, P95, DOI 10.1016/j.neulet.2013.05.007; Rosado-de-Castro PH, 2013, STEM CELLS DEV, V22, P2095, DOI 10.1089/scd.2013.0089; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnabel LV, 2014, REGEN MED, V9, P621, DOI [10.2217/RME.14.29, 10.2217/rme.14.29]; Shi LJ, 2015, NEUROSCI LETT, V591, P115, DOI 10.1016/j.neulet.2015.02.042; Shichita T, 2012, J NEUROCHEM, V123, P29, DOI 10.1111/j.1471-4159.2012.07941.x; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yang KY, 2011, CHEST, V140, P1243, DOI 10.1378/chest.11-0539; Yoo SW, 2013, NEUROBIOL DIS, V58, P249, DOI 10.1016/j.nbd.2013.06.001; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003; Zhu Y, 2012, REV NEUROSCIENCE, V23, P393, DOI 10.1515/revneuro-2012-0042; Ziai WC, 2013, STROKE, V44, pS74, DOI 10.1161/STROKEAHA.111.000662	38	39	41	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129881	10.1371/journal.pone.0129881	http://dx.doi.org/10.1371/journal.pone.0129881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086994	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500068
J	Rojas, AMT; Romero, AM; Pagonabarraga, I; Travasso, RDM; Poire, EC				Rojas, Aimee M. Torres; Romero, Alejandro Meza; Pagonabarraga, Ignacio; Travasso, Rui D. M.; Poire, Eugenia Corvera			Obstructions in Vascular Networks: Relation Between Network Morphology and Blood Supply	PLOS ONE			English	Article							DIRECT NUMERICAL-SIMULATION; RETINAL ARTERY-OCCLUSION; MURRAYS LAW; COMPUTER-SIMULATION; STENOTIC FLOWS; PULSATILE FLOW; BIFURCATION; VESSELS; PLANTS	We relate vascular network structure to hemodynamics after vessel obstructions. We consider tree-like networks with a viscoelastic fluid with the rheological characteristics of blood. We analyze the network hemodynamic response, which is a function of the frequencies involved in the driving, and a measurement of the resistance to flow. This response function allows the study of the hemodynamics of the system, without the knowledge of a particular pressure gradient. We find analytical expressions for the network response, which explicitly show the roles played by the network structure, the degree of obstruction, and the geometrical place in which obstructions occur. Notably, we find that the sequence of resistances of the network without occlusions strongly determines the tendencies that the response function has with the anatomical place where obstructions are located. We identify anatomical sites in a network that are critical for its overall capacity to supply blood to a tissue after obstructions. We demonstrate that relatively small obstructions in such critical sites are able to cause a much larger decrease on flow than larger obstructions placed in non-critical sites. Our results indicate that, to a large extent, the response of the network is determined locally. That is, it depends on the structure that the vasculature has around the place where occlusions are found. This result is manifest in a network that follows Murray's law, which is in reasonable agreement with several mammalian vasculatures. For this one, occlusions in early generation vessels have a radically different effect than occlusions in late generation vessels occluding the same percentage of area available to flow. This locality implies that whenever there is a tissue irrigated by a tree-like in vivo vasculature, our model is able to interpret how important obstructions are for the irrigation of such tissue.	[Rojas, Aimee M. Torres; Romero, Alejandro Meza; Poire, Eugenia Corvera] Univ Nacl Autonoma Mexico, Fac Quim, Dept Fis & Quim Teor, Mexico City 04510, DF, Mexico; [Pagonabarraga, Ignacio; Poire, Eugenia Corvera] Univ Barcelona, Dept Fis Fonamental, Barcelona, Spain; [Travasso, Rui D. M.] Univ Coimbra, Fac Ciencias & Tecnol, Ctr Fis, Dept Fis, Coimbra, Portugal	Universidad Nacional Autonoma de Mexico; University of Barcelona; Universidade de Coimbra	Poire, EC (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Fis & Quim Teor, Mexico City 04510, DF, Mexico.	eugenia.corvera@gmail.com	Poire, Eugenia Corvera/Y-6404-2019; Travasso, Rui/B-8342-2018; Torres Rojas, Aimee M./M-4193-2019; Poire, Eugenia Corvera/B-1119-2008; Pagonabarraga, Ignacio/A-8867-2010	Poire, Eugenia Corvera/0000-0002-4688-6922; Travasso, Rui/0000-0001-6078-0721; Torres Rojas, Aimee M./0000-0002-8430-0996; Poire, Eugenia Corvera/0000-0002-4688-6922; Pagonabarraga, Ignacio/0000-0002-6187-5025	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [245675, 219584]; Ministerio de Economia y Competitividad (MINECO) [FIS2011-22603]; Departament d'Universitats Recerca i Societat de la Informacio (DURSI) [2009SGR-634]; Fondo Europeo de Desarrollo Regional (FEDER) through COMPETE program; FCT [FCOMP-01-0124-FEDER-015708]; European Union [301214]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministerio de Economia y Competitividad (MINECO); Departament d'Universitats Recerca i Societat de la Informacio (DURSI); Fondo Europeo de Desarrollo Regional (FEDER) through COMPETE program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union(European Commission)	AMTR acknowledges financial support from Consejo Nacional de Ciencia y Tecnologia (CONACYT) through fellowship 245675 (http://www.conacyt.mx/). IP acknowledges financial support from Ministerio de Economia y Competitividad (MINECO) under Project No. FIS2011-22603 (http://www.mineco.gob.es/portal/site/mineco/). IP also acknowledges financial support from Departament d'Universitats Recerca i Societat de la Informacio (DURSI) under Project No. 2009SGR-634 (http://web.gencat.cat/ca/inici/index.html). RDMT acknowledges financial support from Fondo Europeo de Desarrollo Regional (FEDER) through COMPETE program and by FCT through project FCOMP-01-0124-FEDER-015708 (http://ec.europa.eu/regional_policy/thefunds/regional/index_es.cfm). ECP declares that the research leading to these results has received funding from the European Union Seventh Framework Programme (FP7-PEOPLE-2011-IIF) under grant agreement no. 301214 (http://ec.europa.eu/research/fp7/index_en.cfm). ECP also acknowledges financial support from Consejo Nacional de Ciencia y Tecnologia (CONACYT) through project 219584 (http://www.conacyt.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastruey J, 2007, J BIOMECH, V40, P1794, DOI 10.1016/j.jbiomech.2006.07.008; Botnar R, 2000, J BIOMECH, V33, P137, DOI 10.1016/S0021-9290(99)00164-5; Bravo-Gutierrez ME, 2011, LANGMUIR, V27, P2075, DOI 10.1021/la103520a; Collepardo-Guevara R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026301; Flores J, 2010, J THEOR BIOL, V265, P599, DOI 10.1016/j.jtbi.2010.06.003; Flores J, 2013, J THEOR BIOL, V317, P257, DOI 10.1016/j.jtbi.2012.10.005; Formaggia Luca, 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P273, DOI 10.1080/10255840600857767; Frauenfelder T, 2007, EUR RADIOL, V17, P1291, DOI 10.1007/s00330-006-0465-1; Grasman J, 2003, J THEOR BIOL, V220, P75, DOI 10.1006/jtbi.2003.3151; HAYREH SS, 1980, OPHTHALMOLOGY, V87, P75, DOI 10.1016/s0161-6420(80)35283-4; Hayreh SS, 2000, AM J OPHTHALMOL, V129, P786, DOI 10.1016/S0002-9394(00)00384-6; Kern T S, 1989, J Diabet Complications, V3, P158, DOI 10.1016/0891-6632(89)90039-1; Lee SE, 2008, J BIOMECH, V41, P2551, DOI 10.1016/j.jbiomech.2008.03.038; Long Q, 2001, J BIOMECH, V34, P1229, DOI 10.1016/S0021-9290(01)00100-2; McCulloh KA, 2004, FUNCT ECOL, V18, P931, DOI 10.1111/j.0269-8463.2004.00913.x; McCulloh KA, 2005, AM J BOT, V92, P985, DOI 10.3732/ajb.92.6.985; McCulloh KA, 2003, NATURE, V421, P939, DOI 10.1038/nature01444; Morrison F.A., 2001, UNDERSTANDING RHEOLO; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Nichols W, 1998, MCDONALDS BLOOD FLOW; SCHWARTZ CJ, 1975, CIRCULATION, V52, P18; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; STERGIOPULOS N, 1992, J BIOMECH, V25, P1477, DOI 10.1016/0021-9290(92)90060-E; Stroud JS, 2000, J BIOMECH, V33, P443, DOI 10.1016/S0021-9290(99)00207-9; SUDA M, 1993, COMPUT METH PROG BIO, V41, P77, DOI 10.1016/0169-2607(93)90067-U; Taber LA, 2001, J BIOMECH, V34, P121, DOI 10.1016/S0021-9290(00)00173-1; Thurston GB, 2006, BIORHEOLOGY, V43, P729; Varghese SS, 2007, J FLUID MECH, V582, P253, DOI 10.1017/S0022112007005848; Varghese SS, 2007, J FLUID MECH, V582, P281, DOI 10.1017/S0022112007005836; Williams HR, 2008, J R SOC INTERFACE, V5, P55, DOI 10.1098/rsif.2007.1022; Zhang L, 2011, EUR J RADIOL, V80, P158, DOI 10.1016/j.ejrad.2010.08.019	31	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128111	10.1371/journal.pone.0128111	http://dx.doi.org/10.1371/journal.pone.0128111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086774	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500013
J	Tsuchida, E; Kaida, A; Pratama, E; Ikeda, MA; Suzuki, K; Harada, K; Miura, M				Tsuchida, Eri; Kaida, Atsushi; Pratama, Endrawan; Ikeda, Masa-Aki; Suzuki, Keiji; Harada, Kiyoshi; Miura, Masahiko			Effect of X-Irradiation at Different Stages in the Cell Cycle on Individual Cell-Based Kinetics in an Asynchronous Cell Population	PLOS ONE			English	Article							HELA-CELLS; IONIZING-RADIATION; S-PHASE; FLUORESCENCE KINETICS; LICENSING FACTOR; DNA-DAMAGE; CHECKPOINTS; REPLICATION; RESPONSES; ARREST	Using an asynchronously growing cell population, we investigated how X-irradiation at different stages of the cell cycle influences individual cell-based kinetics. To visualize the cell-cycle phase, we employed the fluorescent ubiquitination-based cell cycle indicator (Fucci). After 5 Gy irradiation, HeLa cells no longer entered M phase in an order determined by their previous stage of the cell cycle, primarily because green phase (S and G2) was less prolonged in cells irradiated during the red phase (G1) than in those irradiated during the green phase. Furthermore, prolongation of the green phase in cells irradiated during the red phase gradually increased as the irradiation timing approached late G1 phase. The results revealed that endoreduplication rarely occurs in this cell line under the conditions we studied. We next established a method for classifying the green phase into early S, mid S, late S, and G2 phases at the time of irradiation, and then attempted to estimate the duration of G2 arrest based on certain assumptions. The value was the largest when cells were irradiated in mid or late S phase and the smallest when they were irradiated in G1 phase. In this study, by closely following individual cells irradiated at different cell-cycle phases, we revealed for the first time the unique cell-cycle kinetics in HeLa cells that follow irradiation.	[Tsuchida, Eri; Kaida, Atsushi; Miura, Masahiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Sect Oral Radiat Oncol,Bunkyo Ku, Tokyo 1138549, Japan; [Tsuchida, Eri; Harada, Kiyoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial & Neck Reconstruct, Sect Maxillofacial Surg,Bunkyo Ku, Tokyo 1138549, Japan; [Pratama, Endrawan; Ikeda, Masa-Aki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Mol Craniofacial Embryol, Bunkyo Ku, Tokyo 1138549, Japan; [Suzuki, Keiji] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 8528523, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Nagasaki University	Miura, M (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Sect Oral Radiat Oncol,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	masa.mdth@tmd.ac.jp			MEXT [26861569, 26293399, 25670796]; Radiation Effect Association	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Radiation Effect Association	This work was supported by Grants-in-Aid from MEXT (26861569, 26293399, and 25670796) to A.K. and M.M., and by Grants-in-Aid for Scientific Research from the Radiation Effect Association to A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; Choudhury A, 2006, SEMIN RADIAT ONCOL, V16, P51, DOI 10.1016/j.semradonc.2005.08.007; Crissman H A, 1975, Methods Cell Biol, V9, P179, DOI 10.1016/S0091-679X(08)60076-X; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; ENOCH T, 1995, TRENDS BIOCHEM SCI, V20, P426, DOI 10.1016/S0968-0004(00)89093-3; Erenpreisa J, 2010, ONCOGENE, V29, P5447, DOI 10.1038/onc.2010.310; Erenpreisa J, 2008, CELL BIOL INT, V32, P1044, DOI 10.1016/j.cellbi.2008.06.003; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; GRAY JW, 1986, INT J RADIAT BIOL, V49, P237, DOI 10.1080/09553008514552531; Gupta A, 2014, RADIAT RES, V181, P1, DOI 10.1667/RR13572.1; Hall E. J, 2012, RADIOBIOLOGY RADIOLO, P372; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hirai T, 2012, CANCER SCI, V103, P1045, DOI 10.1111/j.1349-7006.2012.02268.x; Howard A, 1953, HEREDITY           S, V6, P261; Kaida A, 2012, EXP CELL RES, V318, P288, DOI 10.1016/j.yexcr.2011.10.016; Kaida A, 2011, CELL BIOL INT, V35, P359, DOI 10.1042/CBI20100643; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Kreis N-N, 2014, ONCOGENE IN PRESS; Labib K, 2011, PHILOS T R SOC B, V366, P3554, DOI 10.1098/rstb.2011.0071; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; Ma KW, 2003, MOL CANCER RES, V1, P438; MAITY A, 1994, RADIOTHER ONCOL, V31, P1, DOI 10.1016/0167-8140(94)90408-1; Mirzayans R, 2013, INT J MOL SCI, V14, P22409, DOI 10.3390/ijms141122409; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; OConnor PM, 1997, CANCER SURV, V29, P151; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sakaue-Sawano A, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-2; STEEL GG, 1971, CELL TISSUE KINET, V4, P93, DOI 10.1111/j.1365-2184.1971.tb01520.x; Suzuki M, 2012, INT J RADIAT ONCOL, V83, pE241, DOI 10.1016/j.ijrobp.2011.12.003; TERASIMA T, 1961, NATURE, V190, P1210, DOI 10.1038/1901210a0; TERASIMA T, 1963, BIOPHYS J, V3, P11, DOI 10.1016/S0006-3495(63)86801-0; Unno J, 2013, CANCER SCI, V104, P703, DOI 10.1111/cas.12144; WATANABE I, 1967, J CELL BIOL, V32, P309, DOI 10.1083/jcb.32.2.309; Yamauchi M, 2011, BIOCHEM BIOPH RES CO, V416, P111, DOI 10.1016/j.bbrc.2011.11.006	38	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128090	10.1371/journal.pone.0128090	http://dx.doi.org/10.1371/journal.pone.0128090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086724	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500012
J	Zhang, JH; Li, H; Shen, HH; Chen, YH; Fang, JY; Tang, ZY				Zhang, Jianhua; Li, He; Shen, Haihua; Chen, Yahan; Fang, Jingyun; Tang, Zhiyao			Effects of Nitrogen Addition on Nitrogen Resorption in Temperate Shrublands in Northern China	PLOS ONE			English	Article							NUTRIENT RESORPTION; PHOSPHORUS RESORPTION; SEMIARID GRASSLAND; LONG-TERM; LITTER DECOMPOSITION; SENESCING LEAVES; LEAF NUTRIENTS; INNER-MONGOLIA; LIFE-SPAN; PLANT	Nutrient resorption from senescing leaves is a key mechanism of nutrient conservation for plants. The nutrient resorption efficiency is highly dependent on leaf nutrient status, species identity and soil nutrient availability. Nitrogen is a limiting nutrient in most ecosystems, it is widely reported that nitrogen resorption efficiency (NRE) was highly dependent on the soil nitrogen availability and vary with N deposition. The effects of nitrogen deposition on NRE and nitrogen concentration in green and senescing leaves have been well established for forests and grasslands; in contrast, little is known on how plants in shrublands respond to nitrogen deposition across the world. In this study, we conducted a two-year nitrogen addition manipulation experiment to explore the responses of nitrogen concentration in green and senescing leaves, and NRE of seven dominant species, namely, Vitex negundo, Wikstroemia chamaedaphne, Carex rigescens and Cleistogenes chinensis from the Vitex negundo community, and Spirea trilobata, Armeniaca sibirica, V. negundo, C. rigescens and Spodiopogon sibiricus from the Spirea trilobata community, to nitrogen deposition in two typical shrub communities of Mt. Dongling in northern China. Results showed that NRE varied remarkably among different life forms, which was lowest in shrubs, highest in grasses, and intermediate in forbs, implying that shrubs may be most capable of obtaining nitrogen from soil, grasses may conserve more nitrogen by absorption from senescing leaves, whereas forbs may adopt both mechanisms to compete for limited nitrogen supply from the habitats. As the N addition rate increases, N concentration in senescing leaves ([N](s)) increased consistent from all species from both communities, that in green leaves ([N](g)) increased for all species from the Vitex negundo community, while no significant responses were found for all species from the Spirea trilobata community; NRE decreased for all species except A. sibirica from the Vitex community and W. chamaedaphn from the Spirea community. Given the substantial interspecific variations in nutrient concentration, resorption and the potentially changing community composition, and the increased soil nutrient availability due to fertilization may indirectly impact nutrient cycling in this region.	[Zhang, Jianhua; Li, He; Shen, Haihua; Chen, Yahan; Fang, Jingyun] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhang, Jianhua; Li, He] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tang, Zhiyao] Peking Univ, Minist Educ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Tang, Zhiyao] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Peking University	Tang, ZY (corresponding author), Peking Univ, Minist Educ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.	zytang@urban.pku.edu.cn	Tang, Zhiyao/B-8795-2008		National Basic Research Program of China on Global Change [2014CB954004]; National Natural Science Foundation of China [31321061, 31330012]; "Strategic Priority Research Program" of CAS [XDA05050300]	National Basic Research Program of China on Global Change(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of CAS	This research was financially supported by National Basic Research Program of China on Global Change (#2014CB954004), National Natural Science Foundation of China (#31321061 & 31330012) and the "Strategic Priority Research Program" of CAS (#XDA05050300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; Carrera AL, 2000, PLANT SOIL, V224, P185, DOI 10.1023/A:1004841917272; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; Cote B, 2002, ANN FOR SCI, V59, P275, DOI 10.1051/forest:2002023; Du EZ, 2013, J PLANT ECOL, V6, P428, DOI 10.1093/jpe/rtt008; Gorissen A, 2004, ECOSYSTEMS, V7, P650, DOI 10.1007/s10021-004-0218-4; Han WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083366; Huang JY, 2012, J ARID ENVIRON, V76, P1, DOI 10.1016/j.jaridenv.2011.08.018; Huang JY, 2008, PLANT SOIL, V306, P149, DOI 10.1007/s11104-008-9565-9; Jiang CM, 2012, ECOL ENG, V44, P1, DOI 10.1016/j.ecoleng.2012.04.006; JOHN MK, 1970, SOIL SCI, V109, P214, DOI 10.1097/00010694-197004000-00002; Killingbeck KT, 1996, ECOLOGY, V77, P1716, DOI 10.2307/2265777; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Kobe RK, 2005, ECOLOGY, V86, P2780, DOI 10.1890/04-1830; Kozovits AR, 2007, FUNCT ECOL, V21, P1034, DOI 10.1111/j.1365-2435.2007.01325.x; Lang SI, 2014, ECOL EVOL, V4, P2217, DOI 10.1002/ece3.1079; Li LJ, 2012, PLANT SOIL ENVIRON, V58, P446, DOI 10.17221/6339-PSE; Li LJ, 2011, J ARID ENVIRON, V75, P787, DOI 10.1016/j.jaridenv.2011.04.009; Li XF, 2010, CAN J FOREST RES, V40, P2256, DOI 10.1139/X10-167; Liu XZ, 2010, SCI CHINA EARTH SCI, V53, P128, DOI 10.1007/s11430-009-0175-z; Lu XT, 2013, GLOBAL CHANGE BIOL, V19, P2775, DOI 10.1111/gcb.12235; Lu XT, 2011, ECOL ENG, V37, P534, DOI 10.1016/j.ecoleng.2010.12.013; Lu XT, 2010, PLANT SOIL, V327, P481, DOI 10.1007/s11104-009-0078-y; Mayor JR, 2014, J ECOL, V102, P36, DOI 10.1111/1365-2745.12190; Norris MD, 2009, PLANT SOIL, V316, P193, DOI 10.1007/s11104-008-9770-6; Norusis M.J., 2009, SPSS17 0 GUIDE DATA; Ostertag R, 2010, PLANT SOIL, V334, P85, DOI 10.1007/s11104-010-0281-x; Quested HM, 2003, ECOLOGY, V84, P3209, DOI 10.1890/02-0426; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; [任丽昀 Ren Liyun], 2005, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V25, P497; Richardson SJ, 2005, ECOLOGY, V86, P20, DOI 10.1890/04-0524; Sirulnik AG, 2007, APPL SOIL ECOL, V36, P1, DOI 10.1016/j.apsoil.2006.11.004; Soudzilovskaia NA, 2007, J VEG SCI, V18, P755, DOI 10.1111/j.1654-1103.2007.tb02591.x; Tang LY, 2013, J PLANT ECOL, V6, P408, DOI 10.1093/jpe/rtt013; van de Weg MJ, 2013, PLANT ECOL, V214, P1273, DOI 10.1007/s11258-013-0250-6; van Heerwaarden LM, 2003, J ECOL, V91, P1060, DOI 10.1046/j.1365-2745.2003.00828.x; Vergutz L, 2012, ECOL MONOGR, V82, P205, DOI 10.1890/11-0416.1; Vourlitis GL, 2007, SOIL SCI SOC AM J, V71, P836, DOI 10.2136/sssaj2006.0339; Wang M, 2014, OECOLOGIA, V174, P365, DOI 10.1007/s00442-013-2784-7; Wessel WW, 2004, ECOSYSTEMS, V7, P662, DOI 10.1007/s10021-004-0219-3; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Yan ZB, 2015, PLANT SOIL, V388, P147, DOI 10.1007/s11104-014-2316-1; Yuan ZY, 2009, GLOBAL ECOL BIOGEOGR, V18, P11, DOI 10.1111/j.1466-8238.2008.00425.x; Yuan ZY, 2005, J ARID ENVIRON, V63, P191, DOI 10.1016/j.jaridenv.2005.01.023; Zeng DH, 2010, BIOGEOCHEMISTRY, V98, P185, DOI 10.1007/s10533-009-9385-x	51	9	12	6	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130434	10.1371/journal.pone.0130434	http://dx.doi.org/10.1371/journal.pone.0130434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086737	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500104
J	Carrillo, JM; Overstreet, RM; Raga, JA; Aznar, FJ				Carrillo, Juan M.; Overstreet, Robin M.; Raga, Juan A.; Aznar, Francisco J.			Living on the Edge: Settlement Patterns by the Symbiotic Barnacle Xenobalanus globicipitis on Small Cetaceans	PLOS ONE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; CHELONIBIA-TESTUDINARIA; WHALE BARNACLES; GREEN TURTLES; ASSOCIATION; RECRUITMENT; ATTACHMENT; MORPHOLOGY; PHYSIOLOGY; CYPRIDS	The highly specialized coronulid barnacle Xenobalanus globicipitis attaches exclusively on cetaceans worldwide, but little is known about the factors that drive the microhabitat patterns on its hosts. We investigate this issue based on data on occurrence, abundance, distribution, orientation, and size of X. globicipitis collected from 242 striped dolphins (Stenella coeruleoalba) that were stranded along the Mediterranean coast of Spain. Barnacles exclusively infested the fins, particularly along the trailing edge. Occurrence, abundance, and density of X. globicipitis were significantly higher, and barnacles were significantly larger, on the caudal fin than on the flippers and dorsal fin. Barnacles were found more frequently and in greater numbers on the dorsal rather than ventral side of the caudal fin and on the central third of dorsal and ventral fluke surfaces. Nearly all examined individuals attached with their cirral fan oriented opposite to the fluke edge. We suggest that X. globicipitis may chemically recognize dolphins as a substratum, but fins, particularly the flukes, are passively selected because of creation of vortices that increase contact of cyprids with skin and early survival of these larvae at the corresponding sites. Cyprids could actively select the trailing edge and orient with the cirri facing the main direction of flow. Attachment on the dorsal side of the flukes is likely associated with asymmetrical oscillation of the caudal fin, and the main presence on the central segment of the flukes could be related to suitable water flow conditions generated by fluke performance for both settlement and nutrient filtration.	[Carrillo, Juan M.; Overstreet, Robin M.] Univ So Mississippi, Dept Coastal Sci, Ocean Springs, MS USA; [Raga, Juan A.; Aznar, Francisco J.] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain	University of Southern Mississippi; University of Valencia	Aznar, FJ (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Sci Pk, Valencia, Spain.	Francisco.Aznar@uv.es	Raga, Juan Antonio/L-7669-2014; Aznar, Francisco Javier/S-3427-2018	Raga, Juan Antonio/0000-0003-2687-2539; Aznar, Francisco Javier/0000-0002-1316-1175	Ministry of Economy and Competitiveness of Spain [CGL2012-39545]; Generalitat Valenciana, Spain [PROMETEOII/2015/018]; US Fish and Wildlife Service/Mississippi Department of Marine Resources [M10AF20151]	Ministry of Economy and Competitiveness of Spain(Spanish Government); Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); US Fish and Wildlife Service/Mississippi Department of Marine Resources	This study was supported by project CGL2012-39545 from the Ministry of Economy and Competitiveness of Spain, and project PROMETEOII/2015/018 from the Generalitat Valenciana, Spain. JMC was funded by the US Fish and Wildlife Service/Mississippi Department of Marine Resources MSCIAP MS.R.798 Award M10AF20151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.T., 1994, BARNACLES STRUCTURE; Anderson MJ, 2008, PERMANOVA P FOR PRIM; Ashraf MA, 2011, J FLUID STRUCT, V27, P145, DOI 10.1016/j.jfluidstructs.2010.11.010; Aznar FJ, 2006, PARASITOLOGY, V133, P369, DOI 10.1017/S0031182006000321; Aznar FJ, 2005, DIS AQUAT ORGAN, V67, P239, DOI 10.3354/dao067239; AZNAR FJ, 1994, DIS AQUAT ORGAN, V18, P159, DOI 10.3354/dao018159; Bearzi Maddalena, 2010, Bulletin Southern California Academy of Sciences, V109, P37, DOI 10.3160/0038-3872-109.2.37; BENZ GW, 1984, CAN J ZOOL, V62, P741, DOI 10.1139/z84-104; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; CRISP DJ, 1955, J EXP BIOL, V32, P569; CRISP DJ, 1957, J ANIM ECOL, V26, P179, DOI 10.2307/1788; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Felts W.J.L., 1966, WHALES DOLPHINS PORP, P255; Fish F. E., 1999, TECHNICAL REPORT; Fish FE, 2006, ANNU REV FLUID MECH, V38, P193, DOI 10.1146/annurev.fluid.38.050304.092201; Fish FE, 2003, MAR MAMMAL SCI, V19, P515, DOI 10.1111/j.1748-7692.2003.tb01318.x; Fish FE, 1998, ADV VERT PALEOBIOL, P303; FISH FE, 1995, J MORPHOL, V225, P51, DOI 10.1002/jmor.1052250105; Fish FE, 2006, BIOINSPIR BIOMIM, V1, pS42, DOI 10.1088/1748-3182/1/4/S06; Fish FE, 2008, INTEGR COMP BIOL, V48, P788, DOI 10.1093/icb/icn029; Frick MG, 2013, CRC MAR BIOL SER, P399; Geraci J.R., 1986, P3; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gotelli N. J., 2009, ECOSIM NULL MODELS S; Jenkins SR, 2005, J ANIM ECOL, V74, P893, DOI 10.1111/j.1365-2656.2005.00985.x; Jonsson PR, 2004, ECOLOGY, V85, P2850, DOI 10.1890/03-0565; Kane EA, 2008, FISH B-NOAA, V106, P395; Kasuya T, 1970, Scient. Rep. Whales Res. Inst., Tokyo, VNo. 22, P39; Larsson AI, 2006, ECOLOGY, V87, P1960, DOI 10.1890/0012-9658(2006)87[1960:BLASFE]2.0.CO;2; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; Moriarty Julia E., 2008, Marine Turtle Newsletter, P1; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; MULLINEAUX LS, 1993, MAR BIOL, V116, P667, DOI 10.1007/BF00355484; MULLINEAUX LS, 1991, MAR BIOL, V110, P93, DOI 10.1007/BF01313096; Najera-Hillman E, 2012, REV MEX BIODIVERS, V83, P1171, DOI 10.7550/rmb.27444; Nogata Y, 2006, BIOL LETTERS, V2, P92, DOI 10.1098/rsbl.2005.0409; Overstreet R, 1978, MASGP 78 021; PARRY DA, 1949, J EXP BIOL, V26, P24; Paterson S, 2003, TRENDS PARASITOL, V19, P370, DOI 10.1016/S1471-4922(03)00149-1; Pavlov VV, 2003, J MORPHOL, V258, P284, DOI 10.1002/jmor.10135; PFALLER J.B., 2006, CARETTA CARETTA MARI, V1, pe36, DOI DOI 10.1017/S1755267206003812; Pugliese MC, 2012, J MORPHOL, V273, P453, DOI 10.1002/jmor.20006; Raga JA, 2008, EMERG INFECT DIS, V14, P471, DOI 10.3201/eid1403.071230; RAJAGURU A, 1992, FISH B-NOAA, V90, P197; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; Reiczigel J., 2005, QUANTITATIVE PARASIT; Reidenerg JS, 2007, ANAT REC, V290, P507, DOI 10.1002/ar.20541; Ridgway SH, 1997, B MAR SCI, V61, P377; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; SAMARAS WF, 1989, MAR MAMMAL SCI, V5, P84, DOI 10.1111/j.1748-7692.1989.tb00216.x; Seilacher A, 2005, PALEOBIOLOGY, V31, P27, DOI 10.1666/0094-8373(2005)031[0027:WBEATA]2.0.CO;2; Skrovan RC, 1999, J EXP BIOL, V202, P2749; Sun Q., 2011, J BIOMECHANICAL SCI, V6, P15; Ungerechts B. E., 1998, J SWIMMING RES, V13, P1; VIDELER J, 1985, J EXP BIOL, V119, P265; Wahl M, 1999, MAR ECOL PROG SER, V187, P59, DOI 10.3354/meps187059; Weber PW, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/4/046001; Wilcox C.D., 2002, UTHSCSA IMAGE TOOL V	58	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127367	10.1371/journal.pone.0127367	http://dx.doi.org/10.1371/journal.pone.0127367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083019	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400011
J	Choueiri, MB; Shen, JP; Gross, AM; Huang, JK; Ideker, T; Fanta, P				Choueiri, Michel B.; Shen, John Paul; Gross, Andrew M.; Huang, Justin K.; Ideker, Trey; Fanta, Paul			ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer	PLOS ONE			English	Article							ADVANCED COLORECTAL-CANCER; THYMIDYLATE SYNTHASE EXPRESSION; MESSENGER-RNA LEVELS; RECTAL-CANCER; MICROSATELLITE INSTABILITY; FLUOROURACIL CHEMOTHERAPY; GASTRIC-CANCER; SURVIVAL; GENE; KRAS	In patients with metastatic colon cancer, response to first line chemotherapy is a strong predictor of overall survival (OS). Currently, oncologists lack diagnostic tests to determine which chemotherapy regimen offers the greatest chance for response in an individual patient. Here we present the results of gene expression analysis for two genes, ERCC1 and TS, measured with the commercially available ResponseDX: Colon assay (Response Genetics, Los Angeles, CA) in 41 patients with de novo metastatic colon cancer diagnosed between July 2008 and August 2013 at the University of California, San Diego. In addition ERCC1 and TS expression levels as determined by RNAseq and survival data for patients in TCGA were downloaded from the TCGA data portal. We found that patients with low expression of ERCC1 (n = 33) had significantly longer median OS (36.0 vs. 10.1 mo, HR 0.29, 95% CI.095 to .84, log-rank p = 9.0x10(-6)) and median time to treatment to failure (TTF) following first line chemotherapy (14.1 vs. 2.4 mo, HR 0.17, 95% CI 0.048 to 0.58, log-rank p = 5.3x10(-4)) relative to those with high expression (n = 4). After accounting for the covariates age, sex, tumor grade and ECOG performance status in a Cox proportional hazard model the association of low ERCC1 with longer OS (HR 0.18, 95% CI 0.14 to 0.26, p = 0.0448) and TTF (HR 0.16, 95% CI 0.14 to 0.21, p = 0.0053) remained significant. Patients with low TS expression (n = 29) had significantly longer median OS (36.0 vs. 14.8 mo, HR 0.25, 95% CI 0.074 to 0.82, log-rank p = 0.022) relative to those with high expression (n = 12). The combined low expression of ERCC1/TS was predictive of response in patients treated with FOLFOX (40% vs. 91%, RR 2.3, Fisher's exact test p = 0.03, n = 27), but not with FOLFIRI (71% vs. 71%, RR 1.0, Fisher's exact test p = 1, n = 14). Overall, these findings suggest that measurement of ERCC1 and TS expression has potential clinical utility in managing patients with metastatic colorectal cancer.	[Choueiri, Michel B.; Shen, John Paul; Ideker, Trey; Fanta, Paul] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Gross, Andrew M.; Huang, Justin K.; Ideker, Trey] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Choueiri, Michel B.; Shen, John Paul; Ideker, Trey; Fanta, Paul] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Fanta, P (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	pfanta@ucsd.edu		Shen, John Paul/0000-0003-4588-2775; Ideker, Trey/0000-0002-1708-8454	American Society of Clinical Oncology; Marsha Rivkin Center for Ovarian Cancer Research; United States National Institutes of Health [R01 ES014811, U24 CA184427]; NATIONAL CANCER INSTITUTE [U24CA184427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008806] Funding Source: NIH RePORTER	American Society of Clinical Oncology; Marsha Rivkin Center for Ovarian Cancer Research; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	American Society of Clinical Oncology: www.asco.org, Young Investigator Award to J.P.S., Marsha Rivkin Center for Ovarian Cancer Research: www.marsharivkin.org, Scientific Scholar Award to J.P.S., United States National Institutes of Health: www.nih.gov, R01 ES014811 to T.I., U24 CA184427 to T.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Basso M, 2013, BRIT J CANCER, V108, P115, DOI 10.1038/bjc.2012.526; Bertagnolli MM, 2011, J CLIN ONCOL, V29, P3153, DOI 10.1200/JCO.2010.33.0092; Buyse M, 2000, LANCET, V356, P373, DOI 10.1016/S0140-6736(00)02528-9; Colucci G, 2005, J CLIN ONCOL, V23, P4866, DOI 10.1200/JCO.2005.07.113; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Etienne MC, 2002, J CLIN ONCOL, V20, P2832, DOI 10.1200/JCO.2002.09.091; Giralt J, 2005, RADIOTHER ONCOL, V74, P101, DOI 10.1016/j.radonc.2004.12.021; Grimminger PP, 2012, PHARMACOGENOMICS J, V12, P404, DOI 10.1038/tpj.2011.29; Iacopetta B, 2001, BRIT J CANCER, V85, P827, DOI 10.1054/bjoc.2001.2007; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Kohonen-Corish MRJ, 2005, J CLIN ONCOL, V23, P2318, DOI 10.1200/JCO.2005.00.109; Kwon HC, 2007, ANN ONCOL, V18, P504, DOI 10.1093/annonc/mdl430; Leichman CG, 1997, J CLIN ONCOL, V15, P3223, DOI 10.1200/JCO.1997.15.10.3223; Lenz HJ, 1998, CLIN CANCER RES, V4, P1227; Li P, 2013, BRIT J CANCER, V108, P1238, DOI 10.1038/bjc.2013.83; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; MCILWRATH AJ, 1994, CANCER RES, V54, P3718; Metzger R, 1998, J CLIN ONCOL, V16, P309, DOI 10.1200/JCO.1998.16.1.309; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Saw RPM, 2003, DIS COLON RECTUM, V46, P192, DOI 10.1007/s10350-004-6524-2; Shirota Y, 2001, J CLIN ONCOL, V19, P4298, DOI 10.1200/JCO.2001.19.23.4298; Sotelo MJ, 2014, WORLD J GASTROENTERO, V20, P4208, DOI 10.3748/wjg.v20.i15.4208; Stoehlmacher J, 2008, CANCER LETT, V272, P221, DOI 10.1016/j.canlet.2008.07.008; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260	31	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0126898	10.1371/journal.pone.0126898	http://dx.doi.org/10.1371/journal.pone.0126898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083491	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400007
J	Jang, DR; Jung, DC; Oh, YT; Noh, S; Han, K; Kim, K; Rha, KH; Choi, YD; Hong, SJ				Jang, Dong Ryul; Jung, Dae Chul; Oh, Young Taik; Noh, Songmi; Han, Kyunghwa; Kim, Kiwook; Rha, Koon-Ho; Choi, Young Deuk; Hong, Sung Joon			Repeat Targeted Prostate Biopsy under Guidance of Multiparametric MRI-Correlated Real-Time Contrast-Enhanced Ultrasound for Patients with Previous Negative Biopsy and Elevated Prostate-Specific Antigen: A Prospective Study	PLOS ONE			English	Article							CANCER-DETECTION; DIAGNOSTIC-ACCURACY; SATURATION BIOPSY; GUIDED BIOPSIES; MEN; ULTRASONOGRAPHY	Objectives To prospectively determine whether multi-parametric MRI (mpMRI) -contrast-enhanced ultrasound (CEUS) correlated, imaging-guided target biopsy (TB) method could improve the detection of prostate cancer in re-biopsy setting of patients with prior negative biopsy. Methods From 2012 to 2014, a total of 42 Korean men with a negative result from previous systematic biopsy (SB) and elevated prostate-specific antigen underwent 3T mpMRI and real-time CEUS guided TB. Target lesions were determined by fusion of mpMRI and CEUS. Subsequently, 12-core SB was performed by a different radiologist. We compared core-based cancer detection rates (CaDR) using the generalized linear mixed model (GLIMMIX) for each biopsy method. Results Core-based CaDR was higher in TB (17.92%, 38 of 212 cores) than in SB (6.15%, 31 of 504 cores) (p < 0.0001; GLIMMIX). In the cancer-positive TB cores, CaDR with suspicious lesions by mpMRI was higher than that by CEUS (86.8% vs. 60.5%, p=0.02; paired t-test) and concordant rate between mpMRI and CEUS was significantly different with discordant rate (48% vs. 52%, p=0.04; McNemar's test). Conclusion The mpMRI-CEUS correlated TB technique for the repeat prostate biopsy of patients with prior negative biopsy can improve CaDR based on the number of cores taken.	[Jang, Dong Ryul; Jung, Dae Chul; Oh, Young Taik; Kim, Kiwook] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea; [Noh, Songmi] Gang Nam Cha Hosp, Cha Med Coll, Dept Pathol, Seoul, South Korea; [Han, Kyunghwa] Yonsei Univ, Coll Med, Avison Biomed Res Ctr, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea; [Rha, Koon-Ho; Choi, Young Deuk; Hong, Sung Joon] Yonsei Univ, Severance Hosp, Coll Med, Dept Urol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jung, DC (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea.	daechul@yuhs.ac		Rha, Koon Ho/0000-0001-8588-7584; Hong, Sung Joon/0000-0001-9869-065X; Jung, Dae Chul/0000-0001-5769-5083; Oh, Young Taik/0000-0002-4438-8890; Han, Kyunghwa/0000-0002-5687-7237; Choi, Young Deuk/0000-0002-8545-5797	"Guerbet Korea" Faculty Research Assistance Program of Dept. Radiology, Yonsei University College of Medicine [4-2012-0091]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2012R1A1A1042668]	"Guerbet Korea" Faculty Research Assistance Program of Dept. Radiology, Yonsei University College of Medicine; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This study was financially supported by the "Guerbet Korea" Faculty Research Assistance Program of Dept. Radiology, Yonsei University College of Medicine for 2012 (4-2012-0091) and the corresponding author of this research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (grant number: NRF-2012R1A1A1042668).	Ahmed HU, 2011, J UROLOGY, V186, P458, DOI 10.1016/j.juro.2011.03.147; Aigner F, 2009, BJU INT, V103, P458, DOI 10.1111/j.1464-410X.2008.08038.x; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Cornelis F, 2013, RADIOLOGY, V269, P159, DOI 10.1148/radiol.13122393; Dang QY, 2008, COMPUT METH PROG BIO, V91, P122, DOI 10.1016/j.cmpb.2008.03.001; Halpern EJ, 2005, CANCER, V104, P2373, DOI 10.1002/cncr.21440; Heijmink SWTPJ, 2006, EUR RADIOL, V16, P927, DOI 10.1007/s00330-005-0035-y; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kundavaram CR, 2012, CURR OPIN UROL, V22, P303, DOI 10.1097/MOU.0b013e328354831f; Kuru TH, 2013, BJU INT, V112, P1080, DOI 10.1111/bju.12259; Mian BM, 2002, UROLOGY, V60, P836, DOI 10.1016/S0090-4295(02)01950-7; Mitterberger M, 2007, PROSTATE, V67, P1537, DOI 10.1002/pros.20639; Patel AR, 2004, UROLOGY, V63, P87, DOI 10.1016/j.urology.2003.08.040; Pepe P, 2013, ANTICANCER RES, V33, P1195; Philip J, 2006, BJU INT, V98, P559, DOI 10.1111/j.1464-410X.2006.06325.x; Pokorny MR, 2014, EUR UROL, V66, P22, DOI 10.1016/j.eururo.2014.03.002; Pondman KM, 2008, EUR UROL, V54, P517, DOI 10.1016/j.eururo.2008.06.001; Portalez D, 2012, EUR UROL, V62, P986, DOI 10.1016/j.eururo.2012.06.044; Puech P, 2013, RADIOLOGY, V268, P461, DOI 10.1148/radiol.13121501; Rabets JC, 2004, J UROLOGY, V172, P94, DOI 10.1097/01.ju.0000132134.10470.75; Scattoni V, 2007, EUR UROL, V52, P1309, DOI 10.1016/j.eururo.2007.08.006; Sonn GA, 2014, EUR UROL, V65, P809, DOI 10.1016/j.eururo.2013.03.025; Strazdina A, 2011, ANTICANCER RES, V31, P1421; Taira AV, 2010, PROSTATE CANCER P D, V13, P71, DOI 10.1038/pcan.2009.42; Taverna G, 2011, BJU INT, V108, P1723, DOI 10.1111/j.1464-410X.2011.10199.x; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Walz J, 2006, EUR UROL, V50, P498, DOI 10.1016/j.eururo.2006.03.026; Zackrisson B, 2004, J UROLOGY, V171, P1500, DOI 10.1097/01.ju.0000118052.59597.83	29	2	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130671	10.1371/journal.pone.0130671	http://dx.doi.org/10.1371/journal.pone.0130671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083348	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400153
J	Lombardi, F; Nakamura, KJ; Chen, T; Sobrera, ER; Tobin, NH; Aldrovandi, GM				Lombardi, Francesca; Nakamura, Kyle J.; Chen, Thomas; Sobrera, Edwin R.; Tobin, Nicole H.; Aldrovandi, Grace M.			A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FUSION INHIBITOR T-20; CORECEPTOR USAGE; GLYCOSYLATION PROFILES; CHEMOKINE RECEPTOR; SEQUENCE VARIATION; ENTRY INHIBITORS; HIGHLY POTENT; TYPE-1; CCR5	Nearly all persons newly infected with HIV-1 harbor exclusively CCR5-using virus. CXCR4-using variants eventually arise in up to 50% of patients infected with subtypes B or D. This transition to efficient CXCR4 utilization is often co-incident with progression to AIDS. The basis for HIV-1's initial dependence on CCR5, the selective force(s) that drive CXCR4-utilization, and the evolutionary pathways by which it occurs are incompletely understood. Greater knowledge of these processes will inform interventions at all stages, from vaccination to cure. The determinants of co-receptor use map primarily, though not exclusively, to the V3 loop of gp120. In this study, we describe five clonal variants with identical V3 loops but divergent CXCR4 use. Mutagenesis revealed two residues controlling this phenotypic switch: a rare polymorphism in C1 and a highly conserved N-glycan in C2. To our knowledge, this is the first description of co-receptor usage regulated by the Nglycan at position 262.	[Lombardi, Francesca; Nakamura, Kyle J.; Chen, Thomas; Sobrera, Edwin R.; Tobin, Nicole H.; Aldrovandi, Grace M.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles	Aldrovandi, GM (corresponding author), Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA.	GAldrovandi@chla.usc.edu	Lombardi, Francesca/ABC-7379-2020	Lombardi, Francesca/0000-0001-5757-8346	National Institute of Child Health and Development [R01 HD 39611, R01 HD 40777, R01 HD 57617]; International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) [U01 AI 68632]; National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI 68632]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH) [AI 68632]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039611, R01HD057617, R01HD040777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068632, U01AI068632] Funding Source: NIH RePORTER	National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Child Health and Development (R01 HD 39611, R01 HD 40777, R01 HD 57617 to Grace M. Aldrovandi) and the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) U01 AI 68632 to Grace M. Aldrovandi. Grace M. Aldrovandi is an Elizabeth Glaser Pediatric AIDS Foundation Scientist. Overall support for IMPAACT was provided by the National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI 68632], the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Mental Health (NIMH) [AI 68632] to Grace M. Aldrovandi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; BRIDGER GJ, 1995, J MED CHEM, V38, P366, DOI 10.1021/jm00002a019; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Cashin K, 2011, J VIROL, V85, P10699, DOI 10.1128/JVI.05510-11; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Ghaffari G, 2005, J VIROL, V79, P13250, DOI 10.1128/JVI.79.21.13250-13261.2005; Go EP, 2013, J PROTEOME RES, V12, P1223, DOI 10.1021/pr300870t; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hoxie JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007179; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiser JJ, 2011, AIDS, V25, P1489, DOI 10.1097/QAD.0b013e328348fc41; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; LEE WR, 1992, P NATL ACAD SCI USA, V89, P2213, DOI 10.1073/pnas.89.6.2213; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Morner A, 1999, J VIROL, V73, P2343; Nakamura KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009786; Neff CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015257; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sanchez V, 2010, J CLIN MICROBIOL, V48, P4135, DOI 10.1128/JCM.01204-10; Schnur E, 2011, J MOL BIOL, V410, P778, DOI 10.1016/j.jmb.2011.04.023; Su ZH, 2009, J INFECT DIS, V200, P1724, DOI 10.1086/648090; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Thielen A, 2011, ANTIVIR THER, V16, P319, DOI 10.3851/IMP1769; Thielen A, 2010, J INFECT DIS, V202, P1435, DOI 10.1086/656600; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; WILEN CB, 2012, CSH PERSPECT MED, V2, P8191, DOI DOI 10.1101/CSHPERSPECT.A006866	62	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128116	10.1371/journal.pone.0128116	http://dx.doi.org/10.1371/journal.pone.0128116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083631	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400028
J	Watson, SA				Watson, Sue-Ann			Giant Clams and Rising CO2: Light May Ameliorate Effects of Ocean Acidification on a Solar-Powered Animal	PLOS ONE			English	Article							OYSTER SACCOSTREA-GLOMERATA; TRIDACNA-SQUAMOSA; CARBON-DIOXIDE; CORAL-REEFS; GROWTH; SURVIVAL; TEMPERATURE; IMPACTS; CROCEA; SIZE	Global climate change and ocean acidification pose a serious threat to marine life. Marine invertebrates are particularly susceptible to ocean acidification, especially highly calcareous taxa such as molluscs, echinoderms and corals. The largest of all bivalve molluscs, giant clams, are already threatened by a variety of local pressures, including overharvesting, and are in decline worldwide. Several giant clam species are listed as 'Vulnerable' on the IUCN Red List of Threatened Species and now climate change and ocean acidification pose an additional threat to their conservation. Unlike most other molluscs, giant clams are 'solar-powered' animals containing photosynthetic algal symbionts suggesting that light could influence the effects of ocean acidification on these vulnerable animals. In this study, juvenile fluted giant clams Tridacna squamosa were exposed to three levels of carbon dioxide (CO2) (control similar to 400, mid similar to 650 and high similar to 950 mu atm) and light (photosynthetically active radiation 35, 65 and 304 mu mol photons m(-2) s(-1)). Elevated CO2 projected for the end of this century (similar to 650 and similar to 950 mu atm) reduced giant clam survival and growth at mid-light levels. However, effects of CO2 on survival were absent at high-light, with 100% survival across all CO2 levels. Effects of CO2 on growth of surviving clams were lessened, but not removed, at high-light levels. Shell growth and total animal mass gain were still reduced at high-CO2. This study demonstrates the potential for light to alleviate effects of ocean acidification on survival and growth in a threatened calcareous marine invertebrate. Managing water quality (e.g. turbidity and sedimentation) in coastal areas to maintain water clarity may help ameliorate some negative effects of ocean acidification on giant clams and potentially other solar-powered calcifiers, such as hard corals.	[Watson, Sue-Ann] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Watson, Sue-Ann] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Watson, SA (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	sueann.watson@my.jcu.edu.au	Watson, Sue-Ann/C-3172-2013; /AAL-3738-2021	Watson, Sue-Ann/0000-0002-9818-7429; 	Ian Potter Foundation [20130107]; Malacological Society of Australasia; Save Our Seas Foundation [273]; Australian Research Council Centre of Excellence for Coral Reef Studies	Ian Potter Foundation; Malacological Society of Australasia; Save Our Seas Foundation; Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	Funding support for this project was provided by the Ian Potter Foundation (20130107, http://www.ianpotter.org.au/), the Malacological Society of Australasia (http://www.malsocaus.org/) and the Save Our Seas Foundation (273, http://saveourseas.com/). Watson S-A was supported by the Australian Research Council Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AL, 2013, AQUACULT INT, V21, P1311, DOI 10.1007/s10499-013-9634-9; Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; Blackford JC, 2007, J MARINE SYST, V64, P229, DOI 10.1016/j.jmarsys.2006.03.016; Bressan M, 2014, MAR ENVIRON RES, V99, P136, DOI 10.1016/j.marenvres.2014.04.009; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Cox L. R., 1969, pN2; DeBoer TS, 2008, CONSERV BIOL, V22, P1255, DOI 10.1111/j.1523-1739.2008.00983.x; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dufault AM, 2013, J EXP BIOL, V216, P1570, DOI 10.1242/jeb.080549; Elfwing T, 2001, MAR FRESHW BEHAV PHY, V34, P239, DOI 10.1080/10236240109379077; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Foyle TP, 1997, AQUACULTURE, V148, P85, DOI 10.1016/S0044-8486(96)01402-0; Gattuso J.-P., 2010, GUIDE BEST PRACTICES, P41, DOI DOI 10.1016/J.JOMS.2003.10.009; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Gilbert A, 2007, CORAL REEFS, V26, P229, DOI 10.1007/s00338-007-0218-x; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Guest JR, 2008, AQUAT CONSERV, V18, P570, DOI 10.1002/aqc.888; Han L, 2008, J EXP MAR BIOL ECOL, V359, P77, DOI 10.1016/j.jembe.2008.02.021; Hean RL, 2003, ECOL MODEL, V163, P87, DOI 10.1016/S0304-3800(02)00400-3; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Hoogenboom MO, 2009, ECOLOGY, V90, P767, DOI 10.1890/07-2010.1; JUINIO MAR, 1989, J MOLLUS STUD, V55, P431, DOI 10.1093/mollus/55.4.431; Kerney R, 2011, P NATL ACAD SCI USA, V108, P6497, DOI 10.1073/pnas.1018259108; KINZIE RA, 1973, B MAR SCI, V23, P93; KIRK JTO, 1977, AUST J MAR FRESH RES, V28, P497, DOI 10.1071/MF9770497; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KLEYPAS JA, 2006, IMPACTS OCEAN ACIDIF; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lucas JS, 2014, CURR BIOL, V24, pR183, DOI 10.1016/j.cub.2013.11.062; LUCAS JS, 1988, GIANT CLAMS ASIA PAC, P21; Manriquez PH, 2014, MAR ECOL PROG SER, V502, P157, DOI 10.3354/meps10703; Manriquez PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068643; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Neo ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058819; Neo ML, 2012, AQUAT BIOL, V14, P265, DOI 10.3354/ab00400; Newman W, 2007, CORAL REEFS, V26, P909, DOI 10.1007/s00338-007-0327-6; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pickering T. D., 2011, VULNERABILITY TROPIC, P647; Pollock FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102498; ROSEWATER JOSEPH, 1965, INDO PACIFIC MOLLUSCA, V1, P347; Rumpho ME, 2011, J EXP BIOL, V214, P303, DOI 10.1242/jeb.046540; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sato Y, 2011, CORAL REEFS, V30, P753, DOI 10.1007/s00338-011-0751-5; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Suggett DJ, 2013, CORAL REEFS, V32, P327, DOI 10.1007/s00338-012-0996-7; Suggett DJ, 2012, GLOBAL CHANGE BIOL, V18, P3015, DOI 10.1111/j.1365-2486.2012.02767.x; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; The Royal Society, 2005, 1205 ROYAL SOC; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Todd PA, 2004, MAR ECOL PROG SER, V271, P167, DOI 10.3354/meps271167; Toonen RJ, 2012, J MAR BIOL ASSOC UK, V92, P731, DOI 10.1017/S0025315411000762; Wallace D, 2006, MS EXCEL PROGRAM DEV; Watson SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2377; Watson SA, 2012, MOLLUSCAN RES, V32, P177; Watson SA, 2012, GLOBAL CHANGE BIOL, V18, P3026, DOI 10.1111/j.1365-2486.2012.02755.x; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Wells S, 1996, TRIDACNA SPP IUCN RE; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124	68	15	16	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128405	10.1371/journal.pone.0128405	http://dx.doi.org/10.1371/journal.pone.0128405			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083404	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000356567400046
J	Heng, S; Paule, SG; Li, Y; Rombauts, LJ; Vollenhoven, B; Salamonsen, LA; Nie, GY				Heng, Sophea; Paule, Sarah G.; Li, Ying; Rombauts, Luk J.; Vollenhoven, Beverley; Salamonsen, Lois A.; Nie, Guiying			Posttranslational removal of alpha-dystroglycan N terminus by PC5/6 cleavage is important for uterine preparation for embryo implantation in women	FASEB JOURNAL			English	Article						endometrium; receptivity; biomarker; glycoprotein; adhesion molecule	DYSTROPHIN-GLYCOPROTEIN COMPLEX; PROPROTEIN CONVERTASE 5/6; PRO-PROTEIN CONVERTASES; BETA-DYSTROGLYCAN; PROHORMONE CONVERTASES; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISM; SKELETAL-MUSCLE; IN-VITRO; MUCIN	Embryo implantation requires a healthy embryo and a receptive endometrium (inner lining of the uterus); endometrial receptivity acquisition involves considerable epithelial surface remodeling. Dystroglycan (DG), a large cell surface glycoprotein, consists of alpha- and beta-subunits; beta-DG anchors within the plasma membrane whereas alpha-DG attaches extracellularly to beta-DG. The glycosylated central alpha-DG mediates adhesion, but it is obstructed by its large N terminus (alpha-DG-N); alpha-DG-N removal enables DG's adhesive function. We demonstrate here that full-length alpha-DG in the human endometrial epithelium is a barrier for embryo attachment and that removal of alpha-DG-N by proprotein convertase 5/6 (PC6; a protease critical for implantation) regulates receptivity. This was evidenced by: 1) alpha-DG contains a PC6-cleavage site near alpha-DG-N, and PC6 cleaves a peptide harboring such a site; 2) PC6 knockdown reduces alpha-DG-N removal from endometrial epithelial cell surface and blastocyst adhesion; 3) mutating the PC6-cleavage site prevents alpha-DG-N removal, causing cell surface retention of full-length alpha-DG and loss of adhesiveness; 4) alpha-DG-N is removed from endometrial tissue in vivo for receptivity and uterine fluid alpha-DG-N reflects tissue removal and receptivity. We thus identified alpha-DGN removal as an important posttranslational control of endometrial receptivity and uterine fluid alpha-DG-N as a potential biomarker for receptivity in women.	[Heng, Sophea; Paule, Sarah G.; Li, Ying; Salamonsen, Lois A.; Nie, Guiying] Hudson Inst Med Res, Ctr Reprod Hlth, Implantat & Placental Dev Lab, Clayton, Vic 3168, Australia; [Heng, Sophea; Paule, Sarah G.; Li, Ying; Salamonsen, Lois A.; Nie, Guiying] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [Rombauts, Luk J.; Vollenhoven, Beverley] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Rombauts, Luk J.; Vollenhoven, Beverley] Monash Hlth, Womens & Childrens Programme, Clayton, Vic, Australia; [Rombauts, Luk J.; Vollenhoven, Beverley] Monash IVF, Clayton, Vic, Australia	Hudson Institute of Medical Research; Monash University; Monash University	Nie, GY (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	guiying.nie@hudson.org.au	Salamonsen, Lois/J-9822-2019	Salamonsen, Lois/0000-0003-0558-7325; Rombauts, Luk/0000-0003-2656-2792; Nie, Guiying/0000-0001-9641-087X	National Health and Medical Research Council of Australia [1044182, 1041835, 388901]; Monash IVF; Victorian Government Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash IVF; Victorian Government Operational Infrastructure Support Program	This work was supported by the National Health and Medical Research Council of Australia (Project Grant No. 1044182 and Fellowship No. 1041835 to G.N., and Fellowship No. 388901 to L.A.S.), Monash IVF, and the Victorian Government Operational Infrastructure Support Program. The authors thank Professor Masato Nishida (National Hospital Organization, Kasumigaura Medical Center, Ibaraki-ken, Japan) for providing the Ishikawa cells, and Professor Carlos Simon (Department of Obstetrics and Gynaecology, University of Valencia, Valencia, Spain) for providing the PC6 knockdown HEC-1A cells. The authors are grateful to their colleagues Drs. Andrew N. Stephens and Adam Rainczuk, for their expert assistance with the SELDI mass spectrometry analysis, Dr. Kelly Walton for her help with generating the Mut DG construct, Dr. Maree Bilandzic for the methylcellulose method of forming BeWo spheroids, and research nurse, Judi Hocking for collecting clinical materials. The authors also thank the patients who kindly donated endometrial tissues and uterine lavage fluids for this study.	Aplin JD, 2006, REPROD BIOMED ONLINE, V13, P833, DOI 10.1016/S1472-6483(10)61032-2; Bilandzic M, 2014, JOVE-J VIS EXP, DOI 10.3791/51655; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Carson DD, 1998, BIOESSAYS, V20, P577, DOI 10.1002/(SICI)1521-1878(199807)20:7<577::AID-BIES9>3.0.CO;2-H; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chen YJ, 2003, BIOCHEM J, V375, P329, DOI 10.1042/BJ20030808; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Freyer C, 2007, REPRODUCTION, V133, P1189, DOI 10.1530/REP-06-0285; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Heng S, 2011, ENDOCRINOLOGY, V152, P5041, DOI 10.1210/en.2011-1273; Heng S, 2011, HUM REPROD, V26, P840, DOI 10.1093/humrep/der002; Heng S, 2010, ENDOCRINOLOGY, V151, P3909, DOI 10.1210/en.2010-0326; Hesse C, 2011, BIOCHEM BIOPH RES CO, V412, P494, DOI 10.1016/j.bbrc.2011.07.129; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; James M, 1996, CELL MOTIL CYTOSKEL, V33, P163, DOI 10.1002/(SICI)1097-0169(1996)33:3<163::AID-CM1>3.0.CO;2-C; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kilpatrick LM, 2009, J PROTEOME RES, V8, P4983, DOI 10.1021/pr900381a; Lei CX, 2009, HUM REPROD, V24, P2879, DOI 10.1093/humrep/dep250; Meseguer M, 1998, MOL HUM REPROD, V4, P1089, DOI 10.1093/molehr/4.12.1089; Meseguer M, 2001, BIOL REPROD, V64, P590, DOI 10.1095/biolreprod64.2.590; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Nie GY, 2005, BIOL REPROD, V72, P1029, DOI 10.1095/biolreprod.104.036889; Nie GY, 2003, BIOL REPROD, V68, P439, DOI 10.1095/biolreprod.102.006676; Nie GY, 2002, REPRODUCTION, V124, P209, DOI 10.1530/reprod/124.2.209; Niklaus AL, 1999, ANAT REC, V255, P241; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Okada H, 2005, J CLIN ENDOCR METAB, V90, P1028, DOI 10.1210/jc.2004-0904; Paule S, 2012, HUM REPROD, V27, P2766, DOI 10.1093/humrep/des203; Paule S, 2011, J MOL HISTOL, V42, P161, DOI 10.1007/s10735-011-9319-5; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Saito F, 2008, FEBS LETT, V582, P439, DOI 10.1016/j.febslet.2008.01.006; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Thompson O, 2010, J CELL SCI, V123, P118, DOI 10.1242/jcs.047902; Toledo AG, 2012, GLYCOBIOLOGY, V22, P1413, DOI 10.1093/glycob/cws109; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831	48	16	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4011	4022		10.1096/fj.14-269456	http://dx.doi.org/10.1096/fj.14-269456			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26077903				2022-12-26	WOS:000359915600035
J	Daher, JPL; Abdelmotilib, HA; Hu, XZ; Volpicelli-Daley, LA; Moehle, MS; Fraser, KB; Needle, E; Chen, Y; Steyn, SJ; Galatsis, P; Hirst, WD; West, AB				Daher, Joao P. L.; Abdelmotilib, Hisham A.; Hu, Xianzhen; Volpicelli-Daley, Laura A.; Moehle, Mark S.; Fraser, Kyle B.; Needle, Elie; Chen, Yi; Steyn, Stefanus J.; Galatsis, Paul; Hirst, Warren D.; West, Andrew B.			Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates alpha-Synuclein Gene-induced Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSON-LIKE NEURODEGENERATION; VECTOR-MEDIATED OVEREXPRESSION; SUBSTANTIA-NIGRA; RAT MODEL; DISEASE	Therapeutic approaches to slow or block the progression of Parkinson disease (PD) do not exist. Genetic and biochemical studies implicate alpha-synuclein and leucine-rich repeat kinase 2 (LRRK2) in late-onset PD. LRRK2 kinase activity has been linked to neurodegenerative pathways. However, the therapeutic potential of LRRK2 kinase inhibitors is not clear because significant toxicities have been associated with one class of LRRK2 kinase inhibitors. Furthermore, LRRK2 kinase inhibitors have not been tested previously for efficacy in models of alpha-synuclein-induced neurodegeneration. To better understand the therapeutic potential of LRRK2 kinase inhibition in PD, we evaluated the tolerability and efficacy of a LRRK2 kinase inhibitor, PF-06447475, in preventing alpha-synuclein-induced neurodegeneration in rats. Both wild-type rats as well as transgenic G2019S-LRRK2 rats were injected intracranially with adeno-associated viral vectors expressing human alpha-synuclein in the substantia nigra. Rats were treated with PF-06447475 or a control compound for 4 weeks post-viral transduction. We found that rats expressing G2019S-LRRK2 have exacerbated dopaminergic neurodegeneration and inflammation in response to the overexpression of alpha-synuclein. Both neurodegeneration and neuro-inflammation associated with G2019S-LRRK2 expression were mitigated by LRRK2 kinase inhibition. Furthermore, PF-06447475 provided neuroprotection in wild-type rats. We could not detect adverse pathological indications in the lung, kidney, or liver of rats treated with PF-06447475. These results demonstrate that pharmacological inhibition of LRRK2 is well tolerated for a 4-week period of time in rats and can counteract dopaminergic neurodegeneration caused by acute alpha-synuclein overexpression.	[Daher, Joao P. L.; Abdelmotilib, Hisham A.; Hu, Xianzhen; Volpicelli-Daley, Laura A.; Moehle, Mark S.; Fraser, Kyle B.; West, Andrew B.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Needle, Elie; Chen, Yi; Hirst, Warren D.] Pfizer Neurosci Res Unit, Cambridge, MA USA; [Steyn, Stefanus J.] Pfizer Pharmacokinet Dynam & Metab Cambridge, Cambridge, MA 02139 USA; [Galatsis, Paul] Pfizer Worldwide Med Chem, Cambridge, MA 02139 USA	University of Alabama System; University of Alabama Birmingham; Pfizer; Pfizer; Pfizer	West, AB (corresponding author), 1719 6th Ave S, Birmingham, AL 35294 USA.	abwest@uab.edu	Abdelmotilib, Hisham/AAT-1452-2020; Moehle, Mark/GNH-1825-2022	Moehle, Mark/0000-0002-8023-1313; West, Andrew/0000-0002-3034-4061; Hirst, Warren/0000-0003-0389-8891	NINDS/National Institutes of Health [F31 NS081963, T32 GM00811127, R01 NS064934]; Michael J. Fox Foundation for Parkinson's Disease Research; American Parkinson's Disease Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS081963, R01NS064934] Funding Source: NIH RePORTER	NINDS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation for Parkinson's Disease Research; American Parkinson's Disease Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS/National Institutes of Health Grants F31 NS081963 (to M. S. M.), T32 GM00811127 (to K. B. F.), and R01 NS064934 (to A. B. W.). This work was also supported by the Michael J. Fox Foundation for Parkinson's Disease Research (to A. B. W. and W. D. H.) and the American Parkinson's Disease Association (to J. P. L. D. and L. A. V.). E. N., Y. C., S. J. S., P. G., and W. D. H. are employees of Pfizer Inc., which holds patent rights to PF-06447475.	Baptista MAS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080705; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cao SW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-259; Chakrabarty P, 2011, NAT NEUROSCI, V14, P694, DOI 10.1038/nn.2829; Cherra SJ, 2013, AM J PATHOL, V182, P474, DOI 10.1016/j.ajpath.2012.10.027; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Daher JPL, 2014, P NATL ACAD SCI USA, V111, P9289, DOI 10.1073/pnas.1403215111; Daher JPL, 2012, HUM MOL GENET, V21, P2420, DOI 10.1093/hmg/dds057; Fabbro D, 2015, MOL PHARMACOL, V87, P766, DOI 10.1124/mol.114.095489; Fuji RN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3634; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Harms AS, 2011, MOL THER, V19, P46, DOI 10.1038/mt.2010.217; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Henderson JL, 2015, J MED CHEM, V58, P419, DOI 10.1021/jm5014055; Herzig MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036581; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Lee JW, 2015, NEUROBIOL AGING, V36, P505, DOI 10.1016/j.neurobiolaging.2014.07.011; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Moehle MS, 2015, HUM MOL GENET, V24, P4250, DOI 10.1093/hmg/ddv157; Moloney TC, 2014, CNS NEUROSCI THER, V20, P50, DOI 10.1111/cns.12200; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Ness D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066164; Oliveras-Salva M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-44; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Puccini JM, 2015, J NEUROSCI, V35, P5271, DOI 10.1523/JNEUROSCI.0650-14.2015; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Van der Perren A, 2015, NEUROBIOL AGING, V36, P1543, DOI 10.1016/j.neurobiolaging.2014.11.015; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2015, MOVEMENT DISORD, V30, P180, DOI 10.1002/mds.26075; West AB, 2014, J COMP NEUROL, V522, P2465, DOI 10.1002/cne.23583	40	128	133	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19433	19444		10.1074/jbc.M115.660001	http://dx.doi.org/10.1074/jbc.M115.660001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26078453	Green Published, hybrid			2022-12-26	WOS:000359364600004
J	Zhang, JF; Ranheim, EA; Du, J; Liu, YG; Wang, JY; Kong, GY; Zhang, J				Zhang, Jingfang; Ranheim, Erik A.; Du, Juan; Liu, Yangang; Wang, Jinyong; Kong, Guangyao; Zhang, Jing			Deficiency of beta Common Receptor Moderately Attenuates the Progression of Myeloproliferative Neoplasm in Nras(G12D/+) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; JUVENILE MYELOMONOCYTIC LEUKEMIA; FACTOR GM-CSF; HEMATOPOIETIC STEM; ONCOGENIC NRAS; SIGNALING PATHWAY; MURINE MODEL; CELLS; NF1; ACTIVATION	Activating Ras signaling is a major driver in juvenile and the myeloproliferative variant of chronic myelomonocytic leukemia (JMML/MP-CMML). Numerous studies suggest that GM-CSF signaling plays a central role in establishing and maintaining JMML/MP-CMML phenotypes in human and mouse. However, it remains elusive how GM-CSF signaling impacts on JMML/MP-CMML initiation and progression. Here, we investigate this issue in a well characterized MP-CMML model induced by endogenous Nras(G12D/+) mutation. In this model, Nras(G12D/+) hematopoietic stem cells (HSCs) are required to initiate and maintain CMML phenotypes and serve as CMML-initiating cells. We show that the common beta chain of the GM-CSF receptor (beta c) is dispensable for Nras(G12D/+) HSC function; loss of beta c does not affect the expansion, increased self-renewal, or myeloid differentiation bias in Nras(G12D/+) HSCs. Therefore, beta c(-/-) does not abrogate CMML in Nras(G12D/+) mice. However, beta c deficiency indeed significantly reduces Nras(G12D/+)-induced splenomegaly and spontaneous colony formation and prolongs the survival of CMML-bearing mice, suggesting that GM-CSF signaling plays an important role in promoting CMML progression. Together, our results suggest that inhibiting GM-CSF signaling in JMML/MP-CMML patients might alleviate disease symptoms but would not eradicate the disease.	[Zhang, Jingfang; Du, Juan; Liu, Yangang; Wang, Jinyong; Kong, Guangyao; Zhang, Jing] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53705 USA; [Ranheim, Erik A.] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, J (corresponding author), Univ Wisconsin, McArdle Lab, Room 7453,1111 Highland Ave, Madison, WI 53705 USA.	zhang@oncology.wisc.edu	Regan, Clinton/E-6250-2012; Kong, Guangyao/L-2162-2013; Ranheim, Erik/AAY-6505-2021		National Institutes of Health [R01 CA152108, HL113066]; Leukemia & Lymphoma Society; National Institutes of Health NCI through the University of Wisconsin Comprehensive Cancer Center [P30 CA014520]; NATIONAL CANCER INSTITUTE [R01CA152108, P30CA014520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health NCI through the University of Wisconsin Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 CA152108 and HL113066 and a Scholar Award from the Leukemia & Lymphoma Society (to J. Z.). This work was also supported in part by National Institutes of Health NCI Grant P30 CA014520 through the University of Wisconsin Comprehensive Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article.	Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Bowen DT, 2005, HEMATOL ONCOL, V23, P26, DOI 10.1002/hon.745; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Cambier N, 1997, HEMATOL CELL THER, V39, P41, DOI 10.1007/s00282-997-0041-4; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Du J, 2013, LEUKEMIA, V27, P754, DOI 10.1038/leu.2012.251; Elliot MA, 2006, BEST PRACT RES CL HA, V19, P571, DOI 10.1016/j.beha.2005.07.012; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; EMANUEL PD, 1991, BLOOD, V77, P925; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Iversen PO, 1997, BLOOD, V90, P4910, DOI 10.1182/blood.V90.12.4910.4910_4910_4917; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim A, 2007, BLOOD, V109, P1687, DOI 10.1182/blood-2006-05-025395; Kong GY, 2014, J CLIN INVEST, V124, P2762, DOI 10.1172/JCI74182; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; Li Q, 2013, NATURE, V504, P143, DOI 10.1038/nature12830; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Matsuura S, 2012, BLOOD, V119, P3155, DOI 10.1182/blood-2011-04-350694; Nicola NA, 1997, CIBA F SYMP, V204, P19; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; Okuda K, 1999, ANN NY ACAD SCI, V872, P305, DOI 10.1111/j.1749-6632.1999.tb08474.x; Onida Francesco, 2004, Curr Hematol Rep, V3, P218; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Wang JY, 2013, BLOOD, V121, P5203, DOI 10.1182/blood-2012-12-475863; Wang JY, 2011, BLOOD, V118, P368, DOI 10.1182/blood-2010-12-326058; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; Woodcock JM, 1997, BLOOD, V90, P3005, DOI 10.1182/blood.V90.8.3005; Yoshida N, 2009, PEDIATR RES, V65, P334, DOI 10.1203/PDR.0b013e3181961d2a; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262	35	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19093	19103		10.1074/jbc.M115.653154	http://dx.doi.org/10.1074/jbc.M115.653154			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26082490	Green Published, hybrid			2022-12-26	WOS:000358781100026
J	Chen, R; Huang, YR; Cai, XB; Xie, LP; He, DL; Zhou, LQ; Xu, CL; Gao, X; Ren, SC; Wang, FB; Ma, LL; Wei, Q; Yin, CJ; Tian, Y; Sun, ZQ; Fu, Q; Ding, Q; Zheng, JH; Ye, ZQ; Ye, DW; Xu, DF; Hou, JQ; Xu, KX; Yuan, JL; Gao, X; Liu, CX; Pan, TJ; Sun, YH				Chen, Rui; Huang, Yiran; Cai, Xiaobing; Xie, Liping; He, Dalin; Zhou, Liqun; Xu, Chuanliang; Gao, Xu; Ren, Shancheng; Wang, Fubo; Ma, Lulin; Wei, Qiang; Yin, Changjun; Tian, Ye; Sun, Zhongquan; Fu, Qiang; Ding, Qiang; Zheng, Junhua; Ye, Zhangqun; Ye, Dingwei; Xu, Danfeng; Hou, Jianquan; Xu, Kexin; Yuan, Jianlin; Gao, Xin; Liu, Chunxiao; Pan, Tiejun; Sun, Yinghao		Chinese Prostate Canc Consortium	Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml	PLOS ONE			English	Article							COMMUNITY-BASED POPULATION; GENOME-WIDE ASSOCIATION; CANCER; BIOPSY; RISK	Objective The influence of age on the performance of percent free prostate-specific antigen (%fPSA) in diagnosing prostate cancer (PCa) in East Asians is controversial. We tested the diagnostic performance of %fPSA in a multi-center biopsy cohort in China and identified the proper age-specific cutoff values to avoid unnecessary biopsies. Methods Consecutive patients with a prostate-specific antigen (PSA) level of 4.0-10.0 ng/ml or 10.1-20.0 ng/ml who underwent transrectal ultrasound-guided or transperineal prostate biopsy were enrolled from 22 Chinese medical centers from Jan 1, 2010 to Dec 31, 2013. The diagnostic accuracy of PSA and %fPSA was determined using the area under the receiver operating characteristic (ROC) curve (AUC). Age-specific cutoff values were calculated using ROC curve analysis. Results The median %fPSA was much lower in younger patients compared with older patients with a PSA level of 4.0-10.0 ng/ml or 10.1-20.0 ng/ml. The AUC of %fPSA was higher than PSA only in older patients. In patients aged 50 to 59 years, %fPSA failed to improve the diagnosis compared with PSA in these two PSA ranges. Age-specific cutoff values were 24%, 27% and 32% for patients aged 60-69, 70-79 and >= 80 years, respectively, to reduce unnecessary biopsies in men with PSA levels of 4.0-10.0 ng/ml to detect 90% of all PCa. Conclusions The effectiveness of %fPSA is correlated with age in the Chinese population. Age-specific cutoff values would help avoid unnecessary biopsies in the Chinese population.	[Chen, Rui; Xu, Chuanliang; Gao, Xu; Ren, Shancheng; Wang, Fubo; Sun, Yinghao] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, 168 Changhai Rd, Shanghai 200433, Peoples R China; [Huang, Yiran] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai 200127, Peoples R China; [Cai, Xiaobing] PLA Headquarters Gen Staff Guard Bur, Dept Hlth Care, Beijing 100017, Peoples R China; [Xie, Liping] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [He, Dalin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Urol, Xian 710061, Peoples R China; [Zhou, Liqun] Peking Univ, Hosp 1, Natl Urol Canc Ctr, Inst Urol,Dept Urol, Beijing 100034, Peoples R China; [Ma, Lulin] Peking Univ, Hosp 3, Dept Urol, Beijing, Peoples R China; [Wei, Qiang] Sichuan Univ, West China Hosp, Dept Urol, Chengdu, Sichuan, Peoples R China; [Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Tian, Ye] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing 100050, Peoples R China; [Sun, Zhongquan] Fudan Univ, Huadong Hosp, Dept Urol, Shanghai 20040, Peoples R China; [Fu, Qiang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Ding, Qiang] Fudan Univ, Huashan Hosp, Shanghai 200040, Peoples R China; [Zheng, Junhua] Tongji Univ, Peoples Hosp 10, Dept Urol, Shanghai 200092, Peoples R China; [Ye, Zhangqun] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Urol, Wuhan 430030, Peoples R China; [Ye, Dingwei] Fudan Univ, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Ye, Dingwei] Dept Oncol, Shanghai 200032, Peoples R China; [Xu, Danfeng] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Hou, Jianquan] Soochow Univ, Affiliated Hosp 1, Suzhou 215006, Peoples R China; [Xu, Kexin] Peking Univ, Peoples Hosp, Beijing 100044, Peoples R China; [Yuan, Jianlin] Fourth Mil Med Univ, Dept Urol, Xian 710032, Peoples R China; [Gao, Xin] Sun Yat Sen Univ, Hosp 3, Dept Urol, Guangzhou 510630, Guangdong, Peoples R China; [Liu, Chunxiao] Southern Med Univ, Zhujiang Hosp, Dept Urol, Guangzhou 510282, Guangdong, Peoples R China; [Pan, Tiejun] Wuhan Gen Hosp, Guangzhou Mil Command, Dept Urol, Wuhan 430070, Hubei, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; Zhejiang University; Xi'an Jiaotong University; Peking University; Peking University; Sichuan University; Nanjing Medical University; Nanjing Medical University; Capital Medical University; Fudan University; Shanghai Jiao Tong University; Fudan University; Tongji University; Huazhong University of Science & Technology; Fudan University; Naval Medical University; Soochow University - China; Peking University; Air Force Military Medical University; Sun Yat Sen University; Southern Medical University - China	Sun, YH (corresponding author), Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, 168 Changhai Rd, Shanghai 200433, Peoples R China.	sunyh@medmail.com.cn	wang, fubo/I-4093-2014; Xie, li/HGE-6052-2022; Zhou, Li/GSE-4531-2022; Wei, Li/AAE-9938-2020; wang, fubo/GPF-4834-2022; wei, li/GSD-3630-2022	wang, fubo/0000-0002-2209-9932; Liqun, Zhou/0000-0003-2795-9038	Program for Changjiang Scholars and Innovative Research Team in University scheme of the Ministry of Education of China [IRT1111]; National Basic Research Program of China [2012CB518300, 2012CB518306]	Program for Changjiang Scholars and Innovative Research Team in University scheme of the Ministry of Education of China; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in University scheme of the Ministry of Education of China (NO. IRT1111, http://www.moe.gov.cn/, Yinghao Sun) and the National Basic Research Program of China (2012CB518300, 2012CB518306, www.nsfc.gov.cn, Yinghao Sun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger AP, 2003, UROLOGY, V62, P840, DOI 10.1016/S0090-4295(03)00671-X; Catalona WJ, 2014, ASIAN J UROL, V1, P12, DOI 10.1016/j.ajur.2014.09.008; Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542; Catalona WJ, 2000, UROLOGY, V55, P372, DOI 10.1016/S0090-4295(99)00547-6; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chen R, 2015, ASIAN J UROL, V2, P107, DOI 10.1016/j.ajur.2015.04.022; Chen R, 2014, ASIAN J UROL, V1, P15, DOI 10.1016/j.ajur.2014.08.007; Erol B, 2014, KAOHSIUNG J MED SCI, V30, P545, DOI 10.1016/j.kjms.2014.03.008; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; He J. CW., 2013, CHINESE CANC REGISTR; Huang MP, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0925-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong IG, 2008, J UROLOGY, V179, P111, DOI 10.1016/j.juro.2007.08.153; Liu ZY, 2009, ASIAN J ANDROL, V11, P100, DOI 10.1038/aja.2008.17; OESTERLING JE, 1995, BRIT J UROL, V75, P347, DOI 10.1111/j.1464-410X.1995.tb07347.x; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun JL, 2013, HUM GENET, V132, P423, DOI 10.1007/s00439-012-1254-3; Tang P, 2013, ASIAN J ANDROL, V15, P129, DOI 10.1038/aja.2012.111; Terao C, 2014, J MED GENET, V51, P530, DOI 10.1136/jmedgenet-2014-102423; Vickers AJ, 2010, CLIN CANCER RES, V16, P4374, DOI 10.1158/1078-0432.CCR-10-1328; Xu JF, 2014, ASIAN J ANDROL, V16, P536, DOI 10.4103/1008-682X.125907; Zhao P, 2004, CHINESE CANC REGISTR	23	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130308	10.1371/journal.pone.0130308	http://dx.doi.org/10.1371/journal.pone.0130308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091007	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835000101
J	Meirelles, PM; Amado, GM; Pereira, GH; Pinheiro, HT; de Moura, RL; Joyeux, JC; Mazzei, EF; Bastos, AC; Edwards, RA; Dinsdale, E; Paranhos, R; Santos, EO; Iida, T; Gotoh, K; Nakamura, S; Sawabe, T; Rezende, CE; Gadelha, LMR; Francini, RB; Thompson, C; Thompson, FL				Meirelles, Pedro M.; Amado-Filho, Gilberto M.; Pereira-Filho, Guilherme H.; Pinheiro, Hudson T.; de Moura, Rodrigo L.; Joyeux, Jean-Christophe; Mazzei, Eric F.; Bastos, Alex C.; Edwards, Robert A.; Dinsdale, Elizabeth; Paranhos, Rodolfo; Santos, Eidy O.; Iida, Tetsuya; Gotoh, Kazuyoshi; Nakamura, Shota; Sawabe, Tomoo; Rezende, Carlos E.; Gadelha, Luiz M. R., Jr.; Francini-Filho, Ronaldo B.; Thompson, Cristiane; Thompson, Fabiano L.			Baseline Assessment of Mesophotic Reefs of the Vitoria-Trindade Seamount Chain Based on Water Quality, Microbial Diversity, Benthic Cover and Fish Biomass Data	PLOS ONE			English	Article							BLACK BAND DISEASE; ATLANTIC-OCEAN; SOUTH ATLANTIC; CORAL-REEFS; SOUTHWESTERN ATLANTIC; HABITAT COMPLEXITY; ABROLHOS BANK; SHORE FISHES; COMMUNITIES; ISLAND	Seamounts are considered important sources of biodiversity and minerals. However, their biodiversity and health status are not well understood; therefore, potential conservation problems are unknown. The mesophotic reefs of the Vitoria-Trindade Seamount Chain (VTC) were investigated via benthic community and fish surveys, metagenomic and water chemistry analyses, and water microbial abundance estimations. The VTC is a mosaic of reef systems and includes fleshy algae dominated rhodolith beds, crustose coralline algae (CCA) reefs, and turf algae dominated rocky reefs of varying health levels. Macro-carnivores and larger fish presented higher biomass at the CCA reefs (4.4 kg per frame) than in the rhodolith beds and rocky reefs (0.0 to 0.1 kg per frame). A larger number of metagenomic sequences identified as primary producers (e.g., Chlorophyta and Streptophyta) were found at the CCA reefs. However, the rocky reefs contained more diseased corals (>90%) than the CCA reefs (similar to 40%) and rhodolith beds (similar to 10%). Metagenomic analyses indicated a heterotrophic and fast-growing microbiome in rocky reef corals that may possibly lead to unhealthy conditions possibly enhanced by environmental features (e.g. light stress and high loads of labile dissolved organic carbon). VTC mounts represent important hotspots of biodiversity that deserve further conservation actions.	[Meirelles, Pedro M.; de Moura, Rodrigo L.; Edwards, Robert A.; Dinsdale, Elizabeth; Paranhos, Rodolfo; Thompson, Cristiane; Thompson, Fabiano L.] Fed Univ Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, Brazil; [Meirelles, Pedro M.; de Moura, Rodrigo L.; Edwards, Robert A.; Dinsdale, Elizabeth; Paranhos, Rodolfo; Thompson, Cristiane; Thompson, Fabiano L.] Fed Univ Rio de Janeiro UFRJ, SAGE COPPE, Rio De Janeiro, Brazil; [Amado-Filho, Gilberto M.] Rio de Janeiro Bot Garden Res Inst IP JBRJ, Rio De Janeiro, Brazil; [Pereira-Filho, Guilherme H.] Fed Univ Sao Paulo UNIFESP, Inst Marine Sci, Santos, Brazil; [Pinheiro, Hudson T.] Calif Acad Sci, Dept Ichthyol, San Francisco, CA 94118 USA; [Pinheiro, Hudson T.] Univ Calif Santa Cruz, Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Pinheiro, Hudson T.; Joyeux, Jean-Christophe; Mazzei, Eric F.; Bastos, Alex C.] Univ Fed Espirito Santo, Dept Oceanog & Ecol, Vitoria, ES, Brazil; [Pinheiro, Hudson T.; Mazzei, Eric F.] Assoc Ambiental Voz Nat, BR-29050780 Vitoria, ES, Brazil; [Santos, Eidy O.] Natl Inst Technol Qual & Metrol INMETRO, Div Metrol Appl Life Sci DIMAV, Rio De Janeiro, Brazil; [Iida, Tetsuya] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Genom Res Pathogen Bacteria, Suita, Osaka 565, Japan; [Gotoh, Kazuyoshi; Nakamura, Shota] Osaka Univ, Microbial Dis Res Inst, Genome Informat Res Ctr, Dept Infect Metagen, Suita, Osaka 565, Japan; [Sawabe, Tomoo] Hokkaido Univ, Fac Fisheries Sci, Microbiol Lab, Hakodate, Hokkaido 041, Japan; [Rezende, Carlos E.] Univ Estadual N Fluminen, Environm Sci Lab LCA, Campos dos Goytacazes, Brazil; [Gadelha, Luiz M. R., Jr.] Natl Lab Sci Comp LNCC, Petropolis, RJ, Brazil; [Francini-Filho, Ronaldo B.] Univ Fed Paraiba, Dept Environm & Engn, Rio Tinto, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); California Academy of Sciences; University of California System; University of California Santa Cruz; Universidade Federal do Espirito Santo; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Osaka University; Osaka University; Hokkaido University; Laboratorio Nacional de Computacao Cientifica (LNCC); Universidade Federal da Paraiba	Thompson, FL (corresponding author), Fed Univ Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, Brazil.	fabianothompson1@gmail.com	de Rezende, Carlos E/I-1893-2015; Thompson, Cristiane C/I-5783-2016; Edwards, Robert/Q-1691-2019; Francini-Filho, Ronaldo/I-5708-2012; Meirelles, Pedro/AAL-4542-2020; Nakamura, Shota/E-3033-2010; Pereira-Filho, Guilherme-Henrique/I-2946-2013; Meirelles, Pedro/AAK-5942-2021; Gadelha, Luiz/N-1566-2019; de Moura, Rodrigo Leao/AAL-5781-2020; Gadelha, Luiz/F-8264-2012; Meirelles, Pedro/GRY-0806-2022; Pinheiro, Hudson/A-4065-2019	Edwards, Robert/0000-0001-8383-8949; Francini-Filho, Ronaldo/0000-0002-7678-6797; Nakamura, Shota/0000-0003-2058-5942; Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241; Meirelles, Pedro/0000-0002-1306-0331; Gadelha, Luiz/0000-0002-8122-9522; de Moura, Rodrigo Leao/0000-0002-5597-6196; Gadelha, Luiz/0000-0002-8122-9522; Pinheiro, Hudson/0000-0002-3143-1474; de Rezende, Carlos/0000-0003-2804-8930; dinsdale, elizabeth/0000-0002-2177-203X; Thompson, Fabiano/0000-0002-7562-1683	International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Japan (Ministry of Education, Science, Sports, Culture, and Technology); National Council for Scientific and Technological Development (CNPq) Universal and Oceanic Islands [04678-2011]; CNPq; CAPES [140869/2012-3, 4848-14-9]; CNPq (Ciencia sem Fronteiras) [GDE 202475/2011-5]; Direct For Biological Sciences [1330800] Funding Source: National Science Foundation; Direct For Computer & Info Scie & Enginr [1305112] Funding Source: National Science Foundation; Division Of Undergraduate Education [1323809] Funding Source: National Science Foundation	International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Japan (Ministry of Education, Science, Sports, Culture, and Technology); National Council for Scientific and Technological Development (CNPq) Universal and Oceanic Islands(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Ciencia sem Fronteiras)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	The authors acknowledge support from the International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Japan (Ministry of Education, Science, Sports, Culture, and Technology) as well as the National Council for Scientific and Technological Development (CNPq) Universal and Oceanic Islands (04678-2011). The authors also thank Ricardo Bahia and Arthur Guth for their support in the field. PMM thanks CNPq and CAPES for the PhD scholarships (140869/2012-3 and 4848-14-9). HTP thanks CNPq (Ciencia sem Fronteiras) for the PhD scholarship (GDE 202475/2011-5).	Andrade L, 2004, HYDROBIOLOGIA, V511, P103, DOI 10.1023/B:HYDR.0000014033.81848.48; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; [Anonymous], [No title captured]; Barott KL, 2012, NATURAL HIST CORAL A; Barott KL, 2011, P ROYAL SOC B; Bongaerts P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-303; Boyett HV, 2007, MAR BIOL, V151, P1711, DOI 10.1007/s00227-006-0603-y; Brazeau DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065845; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Calado L, 2010, CONT SHELF RES, V30, P1181, DOI 10.1016/j.csr.2010.03.007; Campos EJD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026997; Cavalcanti GS, 2013, CONT SHELF RES, V70, P126, DOI 10.1016/j.csr.2013.05.011; Cavalcanti GS, 2014, ISME J, V8, P52, DOI 10.1038/ismej.2013.133; Clark MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029232; Emerson D, 2010, OCEANOGRAPHY, V23, P148, DOI 10.5670/oceanog.2010.67; Etnoyer PJ, 2010, OCEANOGRAPHY, V23, P206, DOI 10.5670/oceanog.2010.96; Foster MS, 2001, J PHYCOL, V37, P659, DOI 10.1046/j.1529-8817.2001.00195.x; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Froese R., 2014, FISHBASE; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Gasparini JL, 2001, J NAT HIST, V35, P1639, DOI 10.1080/002229301317092379; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Grasshoff K., 2009, METHODS SEAWATER ANA; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Gregg AK, 2013, PEERJ, V1, DOI 10.7717/peerj.107; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; LEAL JH, 1991, J MAR BIOL ASSOC UK, V71, P11, DOI 10.1017/S0025315400037358; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Memery L, 2000, PROG OCEANOGR, V47, P69, DOI 10.1016/S0079-6611(00)00032-X; Mendonca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029526; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morato T, 2006, J FISH BIOL, V68, P209, DOI 10.1111/j.0022-1112.2006.00894.x; Muller EM, 2009, CORAL REEFS, V28, P757, DOI 10.1007/s00338-009-0504-x; Nunes F, 2009, MOL ECOL, V18, P4283, DOI 10.1111/j.1365-294X.2009.04347.x; Nunes FLD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022298; Nunes JDCC, 2013, MAR BIOL, V160, P2383, DOI 10.1007/s00227-013-2233-5; Oksanen J., 2005, VEGAN R FUNCTIONS VE; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pereira GH, 2012, J COASTAL RES, V28, P261, DOI 10.2112/11T-00007.1; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Pinheiro HT, 2014, CORAL REEFS, V33, P1113, DOI 10.1007/s00338-014-1211-9; Pinheiro HT, 2011, J FISH BIOL, V79, P1984, DOI 10.1111/j.1095-8649.2011.03138.x; Pinheiro HT, 2010, BRAZ ARCH BIOL TECHN, V53, P1417, DOI 10.1590/S1516-89132010000600018; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Randall J.E., 1967, FOOD HABITS REEF FIS; Rezende CE, 2010, ESTUAR COAST SHELF S, V87, P479, DOI 10.1016/j.ecss.2010.02.008; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sato Y, 2011, CORAL REEFS, V30, P753, DOI 10.1007/s00338-011-0751-5; SCHMID C, 1995, J PHYS OCEANOGR, V25, P2532, DOI 10.1175/1520-0485(1995)025<2532:TVEAIR>2.0.CO;2; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shank TM, 2010, OCEANOGRAPHY, V23, P108, DOI 10.5670/oceanog.2010.65; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; Simon T, 2013, J FISH BIOL, V82, P2113, DOI 10.1111/jfb.12126; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Suzuki MS, ESTUARINE COASTAL SH; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x	68	45	45	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130084	10.1371/journal.pone.0130084	http://dx.doi.org/10.1371/journal.pone.0130084			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090804	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835000085
J	Magnavita, N				Magnavita, Nicola			Work-Related Psychological Injury Is Associated with Metabolic Syndrome Components in Apparently Healthy Workers	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; JOB STRAIN; PSYCHOSOCIAL FACTORS; CARDIOVASCULAR RISK; HYPERTENSION; JAPANESE; METAANALYSIS; POPULATION; DEPRESSION	Objective The aim of this study was to evaluate the association between psychological damage caused by common occupational trauma and metabolic syndrome (MES). Method 571 workers from 20 small Italian companies were invited to fill in the Psychological Injury Risk Indicator (PIRI) during their routine medical examination at the workplace. Results Compared to workers with no psychological injury, workers with a high PIRI score had a significantly increased risk of having at least one metabolic syndrome component (adjusted hazards ratio, 1.8; 95% confidence interval, 1.2 to 2.6). There was a significant increase in the risk of hypertriglyceridemia in male workers (OR 2.53 CI95% 1.03-6.22), and of hypertension in female workers (OR 2.45 CI95% 1.29-4.66). Conclusion Psychological injury related to common occupational trauma may be a modifiable risk factor for metabolic syndrome.	Univ Cattolica Sacro Cuore, Dept Publ Hlth, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Magnavita, N (corresponding author), Univ Cattolica Sacro Cuore, Dept Publ Hlth, Rome, Italy.	nicolamagnavita@gmail.com	Magnavita, Nicola/J-6074-2014	Magnavita, Nicola/0000-0002-0988-7344	Universita Cattolica del Sacro Cuore D1 funds	Universita Cattolica del Sacro Cuore D1 funds	The author received no specific funding for this work. Publication fees will be paid with Universita Cattolica del Sacro Cuore D1 funds.	Babu GR, 2014, OCCUP ENVIRON MED, V71, P220, DOI 10.1136/oemed-2013-101396; Bartoli F, 2013, METAB SYNDR RELAT D, V11, P301, DOI 10.1089/met.2013.0010; Bergmann N, 2014, ENDOCR CONNECT, V3, pR55, DOI 10.1530/EC-14-0031; Buckley TC, 2001, PSYCHOSOM MED, V63, P585, DOI 10.1097/00006842-200107000-00011; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Cherpitel CJ, 2002, ALCOHOL CLIN EXP RES, V26, P1686, DOI 10.1097/01.ALC.0000036300.26619.78; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Edwards EM, 2012, J OCCUP ENVIRON MED, V54, P1447, DOI 10.1097/JOM.0b013e3182783f27; Federation ID, 2006, IDF CONS WORLDW DEF; Garbarino S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097188; Gilbert-Ouimet M, 2012, J PSYCHOSOM RES, V72, P26, DOI 10.1016/j.jpsychores.2011.07.002; Gimeno D, 2010, OCCUP ENVIRON MED, V67, P256, DOI 10.1136/oem.2009.047324; Heslop P, 2002, SOC SCI MED, V54, P1589, DOI 10.1016/S0277-9536(01)00138-1; Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003; Kaur H, 2014, AM J IND MED, V57, P1011, DOI 10.1002/ajim.22345; Kibler JL, 2014, WORLD J CARDIOL, V6, P455, DOI 10.4330/wjc.v6.i6.455; Kiecolt-Glaser JK, 2015, PSYCHONEUROENDOCRINO, V52, P239, DOI 10.1016/j.psyneuen.2014.11.018; Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229; Levenstein S, 2001, ARCH INTERN MED, V161, P1341, DOI 10.1001/archinte.161.10.1341; Magnavita N, 1986, DIFESA SOCIALE, V65, P17; Magnavita Nicola, 2015, ScientificWorldJournal, V2015, P720193, DOI 10.1155/2015/720193; Magnavita N, 2014, RADIOL MED, V119, P142, DOI 10.1007/s11547-013-0329-0; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nishina M, 2011, J ATHEROSCLER THROMB, V18, P396, DOI 10.5551/jat.6692; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Puustinen PJ, 2011, PSYCHOSOM MED, V73, P158, DOI 10.1097/PSY.0b013e3182037315; Raikkonen K, 2007, DIABETES CARE, V30, P872, DOI 10.2337/dc06-1857; Taylor V, 2006, J CLIN PSYCHIAT, V67, P1034, DOI 10.4088/JCP.v67n0704; Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x; Troxel WM, 2005, ARCH INTERN MED, V165, P1022, DOI 10.1001/archinte.165.9.1022; WARNICK GR, 1995, CLIN CHEM, V41, P1427; Weiss T, 2011, GEN HOSP PSYCHIAT, V33, P135, DOI 10.1016/j.genhosppsych.2011.01.002; Whisman MA, 2012, HEALTH PSYCHOL, V31, P80, DOI 10.1037/a0025671; Winwood P., 2009, PSYCHOL INJURY RISK; Winwood PC, 2009, J OCCUP ENVIRON MED, V51, P1057, DOI 10.1097/JOM.0b013e3181b2f3d8	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130944	10.1371/journal.pone.0130944	http://dx.doi.org/10.1371/journal.pone.0130944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NT	26086387	gold, Green Submitted, Green Published			2022-12-26	WOS:000356567500139
J	Roy, CN; Khandaker, I; Oshitani, H				Roy, Chandra Nath; Khandaker, Irona; Oshitani, Hitoshi			Evolutionary Dynamics of Tat in HIV-1 Subtypes B and C	PLOS ONE			English	Article							SUBSTITUTION; EPIDEMIC; HISTORY; ORIGIN	Evolutionary characteristics of HIV-1 have mostly studied focusing its structural genes, Gag, Pol and Env. However, regarding the process of HIV-1's evolution, few studies emphasize on genetic changes in regulatory proteins. Here we investigate the evolutionary dynamics of HIV-1, targeting one of its important regulatory proteins, Tat. We performed a phylogenetic analysis and employed a Bayesian coalescent-based approach using the BEAST package to investigate the evolutionary changes in Tat over time in the process of HIV-1 evolution. HIV-1 sequences of subtypes B and C from different parts of the world were obtained from the Los Alamos database. The mean estimated nucleotide substitution rates for Tat in HIV-1 subtypes B and C were 1.53 x 10(-3) (95% highest probability density-HPD Interval: 1.09 x 10(-3) to 2.08 x 10(-3)) and 2.14 x 10(-3) (95% HPD Interval: 1.35 x 10(-3) to 2.91 x 10(-3)) per site per year, respectively, which is relatively low compared to structural proteins. The median times of the most recent common ancestors (tMRCA) were estimated to be around 1933 (95% HPD, 1907-1952) and 1956 (95% HPD, 1934-1970) for subtypes B and C, respectively. Our analysis shows that subtype C appeared in the global population two decades after the introduction of subtype B. A Gaussian Markov random field (GMRF) skyride coalescent analysis demonstrates that the early expansion rate of subtype B was quite high, rapidly progressing during the 1960s and 1970s to the early 1990s, after which the rate increased up to the 2010s. In contrast, HIV-1 subtype C exhibited a relatively slow occurrence rate until the late 1980s when there was a sharp increase up to the end of 1990s; thereafter, the rate of occurrence gradually slowed. Our study highlights the importance of examining the internal/regulatory genes of HIV-1 to understand its complete evolutionary dynamics. The study results will therefore contribute to better understanding of HIV-1 evolution.	[Roy, Chandra Nath; Khandaker, Irona; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Aoba Ku, Sendai, Miyagi, Japan	Tohoku University	Roy, CN (corresponding author), Tohoku Univ, Grad Sch Med, Dept Virol, Aoba Ku, 2-1 Seiryou Machi, Sendai, Miyagi, Japan.	chandranath@med.tohoku.ac.jp	Roy, Chandra Nath/X-5769-2019; Oshitani, Hitoshi/AAE-4349-2019	Roy, Chandra Nath/0000-0001-6667-1550; Khandaker, Irona/0000-0002-9661-4810				Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; [Anonymous], 2003, SCI HIV AIDS VACC IN, P12; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Berry IM, 2007, J VIROL, V81, P10625, DOI 10.1128/JVI.00985-07; Bontell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079193; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Deng XT, 2008, ALGORITHMICA, V52, P1, DOI 10.1007/s00453-007-9001-1; DOUGHERTY JP, 1988, J VIROL, V62, P2817, DOI 10.1128/JVI.62.8.2817-2822.1988; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HAYNES BF, 1993, SCIENCE, V260, P1279, DOI 10.1126/science.8493572; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Heyndrickx L, 2000, J VIROL, V74, P363, DOI 10.1128/JVI.74.1.363-370.2000; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HOTH DF, 1994, ANN INTERN MED, V121, P603, DOI 10.7326/0003-4819-121-8-199410150-00008; Hutto C, 1996, J VIROL, V70, P3589, DOI 10.1128/JVI.70.6.3589-3598.1996; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Jung M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033579; Kim GJ, 2012, AIDS RES HUM RETROV, V28, P880, DOI [10.1089/aid.2011.0267, 10.1089/AID.2011.0267]; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Raftery AE, 2007, ESTIMATING INTEGRATE; Rambaut A., 2007, FIGTREE V1; Recombinant Identification Program, LOS AL NAT LAB LANL; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Roy CN, 2015, AIDS RES HUM RETROV, V31, P641, DOI [10.1089/aid.2014.0346, 10.1089/AID.2014.0346]; Roy CN, 2015, BIOINFORMATION, V11, P151, DOI 10.6026/97320630011151; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011; Xia X, 2009, PHYLOGENETIC HDB PRA, V2, P611, DOI [10.1017/CBO9780511819049.022, DOI 10.1017/CBO9780511819049.022]; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129896	10.1371/journal.pone.0129896	http://dx.doi.org/10.1371/journal.pone.0129896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087118	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500069
J	Kim, JK; Kwon, YJ; Song, YR; Kim, YS; Kim, HJ; Kim, SG; Ju, YS				Kim, Jwa-Kyung; Kwon, Young-Jun; Song, Young Rim; Kim, Young-Su; Kim, Hyung Jik; Kim, Sung Gyun; Ju, Young-Su			Four-Year Changes in Visceral Fat Mass and the Risk of Developing Proteinuria in the General Population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; METABOLIC SYNDROME; INTRAABDOMINAL FAT; OBESITY; ASSOCIATION; MEN; ACCUMULATION; NONOBESE; WOMEN; MICROALBUMINURIA	Background Previous cross-sectional studies demonstrated the close relationship between visceral obesity and the increased prevalence of proteinuria. But, little is known about the role of changes in visceral fat mass (Delta VFM) over several years in the development of proteinuria. In this longitudinal cohort study with the general population, the changes in Delta VFM as well as baseline VFM on proteinuria development were evaluated. Methods Healthy individuals (n = 2393) who participated in two health screening exams were analyzed. Subjects were divided into three groups based on gender-specific tertiles of baseline VFM and Delta VFM. Each patient was tested for proteinuria using a dipstick, and proteinuria was defined as 1+ or greater. Results The mean age was 51.9 +/- 7.7 years, and the incidence of proteinuria was 3.9% (n = 93). During the 4 years, 52.5% of the subjects experienced a decline in Delta VFM. However, subjects who developed proteinuria exhibited a significant increase in Delta VFM. Even after adjustment for age, smoking, systolic and diastolic BP, serum creatinine, and hs-CRP levels, the highest tertiles for baseline VFM [men, odds ratio (OR) 3.43, 95% confidence interval (CI) 1.229.67; women, OR 2.01, 95% CI 1.05-4.15] and Delta VFM (men, OR 2.92, 95% CI 1.22-6.99; women, OR 3.16, 95% CI 1.56-6.39) were independent predictors of proteinuria development. Following adjustment of both parameters, subjects in the highest baseline VFM and.VFM tertiles exhibited the greatest risk of proteinuria development, which suggested the additive harmful effects of the two factors. Conclusions Baseline VFM and greater increase in Delta VFM were both important risk factors for developing proteinuria in the general population. Appropriate education and interventions to prevent accumulation of VFM should be the major focus of preemptive strategies.	[Kim, Jwa-Kyung; Song, Young Rim; Kim, Young-Su; Kim, Hyung Jik; Kim, Sung Gyun] Hallym Univ, Sacred Heart Hosp, Kidney Res Inst, Dept Internal Med, Anyang, South Korea; [Kwon, Young-Jun; Ju, Young-Su] Hallym Univ, Sacred Heart Hosp, Dept Occupat & Environm Med, Anyang, South Korea	Hallym University; Hallym University	Kim, SG (corresponding author), Hallym Univ, Sacred Heart Hosp, Kidney Res Inst, Dept Internal Med, Anyang, South Korea.	imnksk@gmail.com; zorro@hallym.or.kr			Genomic Cohort of Healthy Populations with Regular Health Check-up at Large Hospitals; Korea Centers for Disease Control and Prevention; Hallym University Research Fund [HURF-2013-35]	Genomic Cohort of Healthy Populations with Regular Health Check-up at Large Hospitals; Korea Centers for Disease Control and Prevention; Hallym University Research Fund	This study was supported by a grant from the Genomic Cohort of Healthy Populations with Regular Health Check-up at Large Hospitals, funded by the Korea Centers for Disease Control and Prevention (2012) and Hallym University Research Fund 2013 (HURF-2013-35).	Bays H, 2014, CURR OPIN ENDOCRINOL, V21, P345, DOI 10.1097/MED.0000000000000093; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Choi ME, 2011, J AM SOC NEPHROL, V22, P990, DOI 10.1681/ASN.2011040423; De Larochelliere E, 2014, ATHEROSCLEROSIS, V234, P23, DOI 10.1016/j.atherosclerosis.2014.01.053; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; Foster MC, 2011, OBESITY, V19, P1284, DOI 10.1038/oby.2010.308; Funahashi T, 1999, INTERNAL MED, V38, P202, DOI 10.2169/internalmedicine.38.202; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Hairston KG, 2009, DIABETES CARE, V32, P1553, DOI 10.2337/dc09-0336; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Hanai K, 2010, CLIN EXP NEPHROL, V14, P132, DOI 10.1007/s10157-009-0245-8; He HB, 2010, TRANSL RES, V155, P71, DOI 10.1016/j.trsl.2009.08.003; Hyun YJ, 2008, CIRC J, V72, P1308, DOI 10.1253/circj.72.1308; Ishizaka Y, 2009, KIDNEY BLOOD PRESS R, V32, P141, DOI 10.1159/000215739; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kanai H, 1996, HYPERTENSION, V27, P125, DOI 10.1161/01.HYP.27.1.125; KANAI H, 1990, HYPERTENSION, V16, P484, DOI 10.1161/01.HYP.16.5.484; Kim H, 2014, HYPERTENS RES, V37, P679, DOI 10.1038/hr.2014.47; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629, DOI 10.5551/jat.7922; Nagase M, 2006, J AM SOC NEPHROL, V17, P3438, DOI 10.1681/ASN.2006080944; NAKAMURA T, 1994, ATHEROSCLEROSIS, V107, P239, DOI 10.1016/0021-9150(94)90025-6; Navarro-Diaz M, 2006, J AM SOC NEPHROL, V17, pS213, DOI 10.1681/ASN.2006080917; Okauchi Y, 2007, DIABETES CARE, V30, P2392, DOI 10.2337/dc07-0218; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Ross WR, 2006, ADV CHRONIC KIDNEY D, V13, P325, DOI 10.1053/j.ackd.2006.07.012; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Sibley SD, 2007, DIABETES CARE, V30, P1898, DOI 10.2337/dc06-2345; WEISINGE.JR, 1974, ANN INTERN MED, V81, P440, DOI 10.7326/0003-4819-81-4-440; Yoon YS, 2007, INT J OBESITY, V31, P528, DOI 10.1038/sj.ijo.0803442	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0131119	10.1371/journal.pone.0131119	http://dx.doi.org/10.1371/journal.pone.0131119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083499	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400167
J	Oliver, TA; Oleson, KLL; Ratsimbazafy, H; Raberinary, D; Benbow, S; Harris, A				Oliver, Thomas A.; Oleson, Kirsten L. L.; Ratsimbazafy, Hajanaina; Raberinary, Daniel; Benbow, Sophie; Harris, Alasdair			Positive Catch & Economic Benefits of Periodic Octopus Fishery Closures: Do Effective, Narrowly Targeted Actions 'Catalyze' Broader Management?	PLOS ONE			English	Article							MARINE RESOURCE-MANAGEMENT; SMALL-SCALE FISHERIES; COMANAGEMENT; SEA; MADAGASCAR; CYANEA; CONSERVATION; DYNAMICS; LESSONS; MODEL	Overview Eight years of octopus fishery records from southwest Madagascar reveal significant positive impacts from 36 periodic closures on: (a) fishery catches and (b) village fishery income, such that (c) economic benefits from increased landings outweigh costs of foregone catch. Closures covered similar to 20% of a village's fished area and lasted 2-7 months. Fishery Catches from Each Closed Site Octopus landings and catch per unit effort (CPUE) significantly increased in the 30 days following a closure's reopening, relative to the 30 days before a closure (landings: +718%, p<0.0001; CPUE: +87%, p<0.0001; n = 36). Open-access control sites showed no before/after change when they occurred independently of other management ("no ban", n = 17/36). On the other hand, open-access control sites showed modest catch increases when they extended a 6-week seasonal fishery shutdown ("ban", n = 19/36). The seasonal fishery shutdown affects the entire region, so confound all potential control sites. Fishery Income in Implementing Villages In villages implementing a closure, octopus fishery income doubled in the 30 days after a closure, relative to 30 days before (+132%, p<0.001, n = 28). Control villages not implementing a closure showed no increase in income after "no ban" closures and modest increases after "ban" closures. Villages did not show a significant decline in income during closure events. Net Economic Benefits from Each Closed Site Landings in closure sites generated more revenue than simulated landings assuming continued open-access fishing at that site (27/36 show positive net earnings; mean +$305/closure; mean +57.7% monthly). Benefits accrued faster than local fishers' time preferences during 17-27 of the 36 closures. High reported rates of illegal fishing during closures correlated with poor economic performance. Broader Co-Management We discuss the implications of our findings for broader co-management arrangements, particularly for catalyzing more comprehensive management.	[Oliver, Thomas A.; Oleson, Kirsten L. L.; Ratsimbazafy, Hajanaina; Raberinary, Daniel; Benbow, Sophie; Harris, Alasdair] Blue Ventures Conservat, London N7 9DP, England; [Oliver, Thomas A.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Oleson, Kirsten L. L.] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Harris, Alasdair] Univ Oxford, Environm Change Inst, Oxford OX1 3QY, England	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Oxford	Oliver, TA (corresponding author), Blue Ventures Conservat, 39-41 North Rd, London N7 9DP, England.	tom.andrew.oliver@gmail.com	Oleson, Kirsten/M-7741-2015; Ratsimbazafy, Hajaniaina/AAH-9653-2020	Oleson, Kirsten/0000-0002-7992-5051; Ratsimbazafy, Hajaniaina/0000-0002-6744-9123	Waterloo Foundation; John D. and Catherine T. MacArthur Foundation; US NSF [OISE 0853086]; Network for Social Change	Waterloo Foundation; John D. and Catherine T. MacArthur Foundation; US NSF(National Science Foundation (NSF)); Network for Social Change	Funding for this study was provided by the Waterloo Foundation, the John D. and Catherine T. MacArthur Foundation, the US NSF OISE 0853086, and the Network for Social Change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson JM, 2006, ANNU REV ANTHROPOL, V35, P117, DOI 10.1146/annurev.anthro.35.081705.123238; Allison E. H., 2001, Journal of International Development, V13, P933, DOI 10.1002/jid.834; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; Andriamalala G, 2010, TROP CONSERV SCI, V3, P447, DOI 10.1177/194008291000300409; [Anonymous], 2013, AFR DEV IND 2012 201; [Anonymous], 2003, SURVEY HDB, DOI DOI 10.4135/9781412986328; [Anonymous], 2009, BLUE VENTURES CONSER; Astuti R, 1995, PEOPLE OF THE SEA; Barnes DKA, 2009, J MAR BIOL ASSOC UK, V89, P1589, DOI 10.1017/S0025315409000113; Barnes-Mauthe M, 2015, ECOSYST SERV, V16, P283, DOI 10.1016/j.ecoser.2014.10.009; Barnes-Mauthe M, 2013, FISH RES, V147, P175, DOI 10.1016/j.fishres.2013.05.011; Barrett CB, 2011, P NATL ACAD SCI USA, V108, P13907, DOI 10.1073/pnas.1011521108; Bartlett CY, 2009, CONSERV BIOL, V23, P1475, DOI 10.1111/j.1523-1739.2009.01293.x; Benbow S, 2014, AFR J MAR SCI, V36, P31, DOI 10.2989/1814232X.2014.893256; Berkes F, 2006, ECOL SOC, V11; BLUMBERG RL, 1988, J FAM ISSUES, V9, P51, DOI 10.1177/019251388009001004; Burke L., 2011, REEFS RISK REVISITED; Caddy JF, 1998, SPECIAL PUBLICATION, V125, P359; Cesar H., 2003, EC WORLDWIDE CORAL R; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; Cinner JE, 2012, GLOBAL ENVIRON CHANG, V22, P651, DOI 10.1016/j.gloenvcha.2012.03.002; Cinner J, 2006, ECOL SOC, V11; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; CLARK C, 1973, J FISH RES BOARD CAN, V30, P1629, DOI 10.1139/f73-262; Clark C.W., 2010, MATH BIOECONOMICS MA, V91; Cohen PJ, 2013, GLOBAL ENVIRON CHANG, V23, P1702, DOI 10.1016/j.gloenvcha.2013.08.010; Cohen PJ, 2013, MAR POLICY, V37, P278, DOI 10.1016/j.marpol.2012.05.010; Cohen PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073383; Cooke A., 2003, P179; COSTANZA R, 1992, CONSERV BIOL, V6, P37, DOI 10.1046/j.1523-1739.1992.610037.x; Da Rocha JM, 2013, ENVIRON RESOUR ECON, V54, P139, DOI 10.1007/s10640-012-9585-z; Da-Rocha JM, 2012, FISH RES, V121, P51, DOI 10.1016/j.fishres.2012.01.009; Diekert FK, 2010, RESOUR ENERGY ECON, V32, P78, DOI 10.1016/j.reseneeco.2009.09.002; Evans L, 2011, J ENVIRON MANAGE, V92, P1938, DOI 10.1016/j.jenvman.2011.03.010; Foale S, 1998, OCEAN COAST MANAGE, V40, P187, DOI 10.1016/S0964-5691(98)00044-1; Guard M, 2002, AMBIO, V31, P528, DOI 10.1639/0044-7447(2002)031[0528:TAFFOC]2.0.CO;2; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; HANNESSON R, 1975, CAN J ECON, V8, P151, DOI 10.2307/134113; Hardisty DJ, 2009, J EXP PSYCHOL GEN, V138, P329, DOI 10.1037/a0016433; Harkes I, 2002, OCEAN COAST MANAGE, V45, P237, DOI 10.1016/S0964-5691(02)00057-1; Harris A., 2011, MADAGASCAR CONSERV D, V6; Harris A, 2007, MADAG CONSERV DEV, V2; Harrison GW, 2005, RES EXP ECO, V10, P125; Hart DR, 2003, FISH B-NOAA, V101, P44; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Holden S. T., 1998, Environment and Development Economics, V3, P105, DOI 10.1017/S1355770X98000060; Hviding E, 1996, GUARDIANS MAROVO LAG; INSTAT, 2012, PAUVR MAD, DOI [10.1111/cars.12058, DOI 10.1111/CARS.12058]; Johannes RE, 2002, ANNU REV ECOL SYST, V33, P317, DOI 10.1146/annurev.ecolsys.33.010802.150524; JOHANNES RE, 1978, ANNU REV ECOL SYST, V9, P349, DOI 10.1146/annurev.es.09.110178.002025; Johannes RE, 1998, OCEAN COAST MANAGE, V40, P165, DOI 10.1016/S0964-5691(98)00046-5; Johannes RE, 1982, TRADITIONAL CONSERVA; Jokiel P.L., 2011, J MAR BIOL, V2011, DOI [10.1155/2011/151682, DOI 10.1155/2011/151682]; Jupiter SD, 2012, CORAL REEFS, V31, P321, DOI 10.1007/s00338-012-0888-x; Kent G, 1997, FOOD POLICY, V22, P393, DOI 10.1016/S0306-9192(97)00030-4; Malleret-King D, 2006, SOCIO EC MONITORING; Nash W, 1995, AITUTAKI TROCHUS FIS; Oleson KLL, 2015, ECOL EC IN PRESS; Ostrom, 1990, GOVERNING COMMONS; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15176, DOI 10.1073/pnas.0701886104; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Otero J, 2005, SCI MAR, V69, P577, DOI 10.3989/scimar.2005.69n4577; Pfister CA, 1996, ECOL APPL, V6, P298, DOI 10.2307/2269573; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P683, DOI 10.1016/S0964-5691(01)00075-8; Quetglas A, 1998, FISH RES, V36, P237, DOI 10.1016/S0165-7836(98)00093-9; R Core Team, 2021, R LANGUAGE ENV STAT; Raberinary D, 2012, FISH RES, V125, P190, DOI 10.1016/j.fishres.2012.02.025; Ratsimbazafy H, 2010, THESIS I HALIEUTIQUE; Rcpp, 2013, PACKAGE LME4; Ribot JC, 2003, RURAL SOCIOL, V68, P153, DOI 10.1111/j.1549-0831.2003.tb00133.x; Roper, 1984, FAO FISH SYNOPSES, V125, P1; Ruttan LM, 1998, HUM ECOL, V26, P43, DOI 10.1023/A:1018744816814; SLUCZANOWSKI PR, 1984, CAN J FISH AQUAT SCI, V41, P1008, DOI 10.1139/f84-117; Teh LSL, 2014, MAR POLICY, V44, P222, DOI 10.1016/j.marpol.2013.08.028; Tucker B, 2012, CURR ANTHROPOL, P1; Valderrama D, 2007, LAND ECON, V83, P86, DOI 10.3368/le.83.1.86; Van Heukelem WF, 1976, GROWTH BIOENERGETICS; VANHEUKE.WF, 1973, J ZOOL, V169, P299; Wamukota AW, 2012, MAR POLICY, V36, P481, DOI 10.1016/j.marpol.2011.09.001; Williams ID, 2006, MAR ECOL PROG SER, V310, P139, DOI 10.3354/meps310139	82	41	46	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129075	10.1371/journal.pone.0129075	http://dx.doi.org/10.1371/journal.pone.0129075			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NS	26083862	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400080
J	He, ZQ; Zhang, HL; Olk, DC				He, Zhongqi; Zhang, Hailin; Olk, Dan C.			Chemical Composition of Defatted Cottonseed and Soy Meal Products	PLOS ONE			English	Article							PROTEIN ADHESIVES; AMINO-COMPOUNDS; SOILS; DIGESTIBILITY; MANAGEMENT; FRACTIONS; IMPROVE; MAPLE; WATER; ACID	Chemical composition is critical information for product quality and exploration of new use. Hence defatted cottonseed meals from both glanded (with gossypol) and glandless (without gossypol) cotton seeds were separated into water soluble and insoluble fractions, or water soluble, alkali soluble as well as total protein isolates. The contents of gossypol, total protein and amino acids, fiber and carbohydrates, and selected macro and trace elements in these products were determined and compared with each other and with those of soy meal products. Data reported in this work improved our understanding on the chemical composition of different cottonseed meal products that is helpful for more economical utilization of these products. These data would also provide a basic reference for product standards and quality control when the production of the cottonseed meal products comes to pilot and industrial scales.	[He, Zhongqi] USDA ARS, So Reg Res Ctr, New Orleans, LA 70122 USA; [Zhang, Hailin] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Olk, Dan C.] USDA ARS, Natl Lab Agr & Environm, Ames, IA USA	United States Department of Agriculture (USDA); Oklahoma State University System; Oklahoma State University - Stillwater; United States Department of Agriculture (USDA)	He, ZQ (corresponding author), USDA ARS, So Reg Res Ctr, New Orleans, LA 70122 USA.	Zhongqi.He@ars.usda.gov		zhang, hailin/0000-0002-8545-1032				[Anonymous], 1969, FOOD TECHNOL-CHICAGO; Bellaloui N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00516; Bertrand JA, 2005, J DAIRY SCI, V88, P1470, DOI 10.3168/jds.S0022-0302(05)72815-0; Broderick GA, 2013, J DAIRY SCI, V96, P2374, DOI 10.3168/jds.2012-5723; Campbell BT, 2014, CSSA SPEC PUBL, V33, P13, DOI 10.2135/cssaspecpub33.c2; Chen MZ, 2015, BIORESOURCES, V10, P41; Cheng HN, 2013, IND CROP PROD, V46, P399, DOI 10.1016/j.indcrop.2013.02.021; Dowd M.K., 2010, COTTON TECHNOLOGY 21, P437; Gao DD, 2010, J SCI FOOD AGR, V90, P1855, DOI 10.1002/jsfa.4024; HAN YW, 1988, J AGR FOOD CHEM, V36, P1181, DOI 10.1021/jf00084a014; He Z., 2012, CAPILLARY ELECTROPHO, P131; He Z, 2011, ENV CHEM ANIMAL MANU, P179; He Z, 2015, JOVE-J VIS EXP, V97, DOI DOI 10.3791/52557; He Z. Q., 2014, Modern Applied Science, V8, P97; He ZQ, 2014, PEDOSPHERE, V24, P178, DOI 10.1016/S1002-0160(14)60004-7; He ZQ, 2014, IND CROP PROD, V61, P398, DOI 10.1016/j.indcrop.2014.07.031; He ZQ, 2014, J AM OIL CHEM SOC, V91, P1489, DOI 10.1007/s11746-014-2495-1; He ZQ, 2014, INT J ADHES ADHES, V50, P102, DOI 10.1016/j.ijadhadh.2014.01.019; He ZQ, 2014, J AM OIL CHEM SOC, V91, P151, DOI 10.1007/s11746-013-2349-2; He ZhongQi, 2013, Modern Applied Science, V7, P79; He ZQ, 2013, AGRON J, V105, P341, DOI 10.2134/agronj2012.0351; Hettiarachchy NS, 1995, J AM OIL CHEM SOC, V72, P1461, DOI 10.1007/BF02577838; KING EE, 1980, PHYTOCHEMISTRY, V19, P1647, DOI 10.1016/S0031-9422(00)83786-3; Li JT, 2012, ASIAN AUSTRAL J ANIM, V25, P1430, DOI 10.5713/ajas.2012.12201; Martens DA, 2002, SOIL BIOL BIOCHEM, V34, P1393, DOI 10.1016/S0038-0717(02)00082-2; MARTENS DA, 1990, CHROMATOGRAPHIA, V29, P7, DOI 10.1007/BF02261130; MARTINEZ WH, 1970, J AGR FOOD CHEM, V18, P961, DOI 10.1021/jf60172a039; Nida DL, 1996, J AGR FOOD CHEM, V44, P1967, DOI 10.1021/jf950565s; Nordqvist P, 2012, J APPL POLYM SCI, V123, P1530, DOI 10.1002/app.34312; Olk DC, 2008, SOIL SCI SOC AM J, V72, P1672, DOI 10.2136/sssaj2007.0406; Perez PG, 2015, J SOIL SEDIMENT, V15, P890, DOI 10.1007/s11368-014-1049-3; Pettigrew WT, 2014, J COTTON SCI, V18, P410; Pettigrew WT, 2011, CROP SCI, V51, P2155, DOI 10.2135/cropsci2011.02.0085; Qi GY, 2013, J AM OIL CHEM SOC, V90, P1917, DOI 10.1007/s11746-013-2343-8; Singh VK, 2014, J BIOBASED MATER BIO, V8, P338, DOI 10.1166/jbmb.2014.1445; Tazisong IA, 2013, SOIL SCI, V178, P231, DOI 10.1097/SS.0b013e31829cf464; Tong XJ, 2015, IND CROP PROD, V67, P11, DOI 10.1016/j.indcrop.2014.12.063; Voet D, 1990, BIOCHEMISTRY-US, P59; Wanapat M, 2013, ASIAN AUSTRAL J ANIM, V26, P529, DOI 10.5713/ajas.2012.12607; Wolfrum EJ, 2009, CELLULOSE, V16, P577, DOI 10.1007/s10570-009-9318-9; Yue HB, 2012, GREEN CHEM, V14, P2009, DOI 10.1039/c2gc35509d; Zhang BuNing, 2009, Modern Applied Science, V3, P77; Zhang BN, 2010, INT J POLYM MATER, V59, P1018, DOI 10.1080/00914031003760709; [No title captured]	44	55	56	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129933	10.1371/journal.pone.0129933	http://dx.doi.org/10.1371/journal.pone.0129933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079931	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300036
J	Hu, QD; Tan, HR; Irwin, DM				Hu, Qingda; Tan, Huanran; Irwin, David M.			Evolution of the Vertebrate Resistin Gene Family	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INSULIN-RESISTANCE; DEATH EVOLUTION; MOLECULE-BETA; WEB SERVER; MOUSE; IDENTIFICATION; PHYLOGENOMICS; INFLAMMATION; EXPRESSION	Resistin (encoded by Retn) was previously identified in rodents as a hormone associated with diabetes; however human resistin is instead linked to inflammation. Resistin is a member of a small gene family that includes the resistin-like peptides (encoded by Retnl genes) in mammals. Genomic searches of available genome sequences of diverse vertebrates and phylogenetic analyses were conducted to determine the size and origin of the resistin-like gene family. Genes encoding peptides similar to resistin were found in Mammalia, Sauria, Amphibia, and Actinistia (coelacanth, a lobe-finned fish), but not in Aves or fish from Actinopterygii, Chondrichthyes, or Agnatha. Retnl originated by duplication and transposition from Retn on the early mammalian lineage after divergence of the platypus, but before the placental and marsupial mammal divergence. The resistin-like gene family illustrates an instance where the locus of origin of duplicated genes can be identified, with Retn continuing to reside at this location. Mammalian species typically have a single copy Retn gene, but are much more variable in their numbers of Retnl genes, ranging from 0 to 9. Since Retn is located at the locus of origin, thus likely retained the ancestral expression pattern, largely maintained its copy number, and did not display accelerated evolution, we suggest that it is more likely to have maintained an ancestral function, while Retnl, which transposed to a new location, displays accelerated evolution, and shows greater variability in gene number, including gene loss, likely evolved new, but potentially lineage-specific, functions.	[Hu, Qingda; Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Tan, Huanran; Irwin, David M.] Peking Univ, Dept Pharmacol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON, Canada	University of Toronto; Peking University; University of Toronto	Irwin, DM (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	david.irwin@utoronto.ca		Irwin, David/0000-0001-6131-4933	National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research [CCI 109605]	National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research	This work was funded by a National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number CCI 109605 to DMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; Benomar Y, 2013, DIABETES, V62, P102, DOI 10.2337/db12-0237; Chumakov AM, 2004, ONCOGENE, V23, P3414, DOI 10.1038/sj.onc.1207126; Codoner-Franch P, 2015, CLIN CHIM ACTA, V438, P46, DOI 10.1016/j.cca.2014.07.043; Dakovic N, 2014, MOL BIOL EVOL, V31, P2637, DOI 10.1093/molbev/msu208; Dalamaga M, 2014, BIOMARK MED, V8, P107, DOI 10.2217/bmm.13.99; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Ding QX, 2011, TRENDS CARDIOVAS MED, V21, P20, DOI 10.1016/j.tcm.2012.01.004; Eirin-Lopez JM, 2012, GENOME DYNAM, V7, P170, DOI 10.1159/000337119; Fan C, 2015, AM J RESP C IN PRESS; Fang C, 2012, EUR RESPIR J, V39, P458, DOI 10.1183/09031936.00107811; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Ghosh S, 2003, GENE, V305, P27, DOI 10.1016/S0378-1119(02)01213-1; GORR T, 1991, NATURE, V351, P394, DOI 10.1038/351394a0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Irwin DM, 2006, COMP BIOCHEM PHYS D, V1, P385, DOI 10.1016/j.cbd.2006.09.001; Irwin DM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0188-x; Irwin DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-166; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim KH, 2000, J BIOL CHEM, V276, P11252; Krimi RB, 2008, INFLAMM BOWEL DIS, V14, P931, DOI 10.1002/ibd.20420; Kurokawa T, 2005, PEPTIDES, V26, P745, DOI 10.1016/j.peptides.2004.12.017; Kushiyama A, 2013, ARTERIOSCL THROM VAS, V33, P1986, DOI 10.1161/ATVBAHA.113.301546; Lee MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5410; Lee Sang Eun, 2012, Journal of Smooth Muscle Research, V48, P27; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; MEYER A, 1990, J MOL EVOL, V31, P359, DOI 10.1007/BF02106050; Morgan CC, 2013, MOL BIOL EVOL, V30, P2145, DOI 10.1093/molbev/mst117; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Osborne LC, 2013, J IMMUNOL, V190, P2292, DOI 10.4049/jimmunol.1200706; Park HK, 2013, DIABETES METAB J, V37, P404, DOI [10.4093/dmj.2013.37.6.404, 10.4093/dmj.2013.37.2.113]; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Pegueroles C, 2013, MOL BIOL EVOL, V30, P1830, DOI 10.1093/molbev/mst083; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Romiguier J, 2013, MOL BIOL EVOL, V30, P2134, DOI 10.1093/molbev/mst116; Sanchez-Solana B, 2012, MOL ENDOCRINOL, V26, P110, DOI 10.1210/me.2011-1027; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Smit A, 1996, REPEATMASKER OPEN 30; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060896; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093	50	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130188	10.1371/journal.pone.0130188	http://dx.doi.org/10.1371/journal.pone.0130188			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076481	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900152
J	Schell, C; Kretz, O; Bregenzer, A; Rogg, M; Helmstadter, M; Lisewski, U; Gotthardt, M; Tharaux, PL; Huber, TB; Grahammer, F				Schell, Christoph; Kretz, Oliver; Bregenzer, Andreas; Rogg, Manuel; Helmstaedter, Martin; Lisewski, Ulrike; Gotthardt, Michael; Tharaux, Pierre-Louis; Huber, Tobias B.; Grahammer, Florian			Podocyte-Specific Deletion of Murine CXADR Does Not Impair Podocyte Development, Function or Stress Response	PLOS ONE			English	Article							ADENOVIRUS RECEPTOR CAR; CONGENITAL NEPHROTIC SYNDROME; TIGHT JUNCTION; GLOMERULAR PROTEIN; ADHESION MOLECULE; TRANSGENIC MICE; FOOT PROCESSES; CELL-ADHESION; SESTRIN 2; COXSACKIEVIRUS	The coxsackie-and adenovirus receptor (CXADR) is a member of the immunoglobulin protein superfamily, present in various epithelial cells including glomerular epithelial cells. Beside its known function as a virus receptor, it also constitutes an integral part of cell-junctions. Previous studies in the zebrafish pronephros postulated a potential role of CXADR for the terminal differentiation of glomerular podocytes and correct patterning of the elaborated foot process architecture. However, due to early embryonic lethality of constitutive Cxadr knockout mice, mammalian data on kidney epithelial cells have been lacking. Interestingly, Cxadr is robustly expressed during podocyte development and in adulthood in response to glomerular injury. We therefore used a conditional transgenic approach to elucidate the function of Cxadr for podocyte development and stress response. Surprisingly, we could not discern a developmental phenotype in podocyte specific Cxadr knock-out mice. In addition, despite a significant up regulation of CXADR during toxic, genetic and immunologic podocyte injury, we could not detect any impact of Cxadr on these injury models. Thus these data indicate that in contrast to lower vertebrate models, mammalian podocytes have acquired molecular programs to compensate for the loss of Cxadr.	[Schell, Christoph; Kretz, Oliver; Bregenzer, Andreas; Rogg, Manuel; Helmstaedter, Martin; Huber, Tobias B.; Grahammer, Florian] Univ Med Ctr Freiburg, Div Renal, Freiburg, Germany; [Schell, Christoph; Huber, Tobias B.] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Schell, Christoph] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Kretz, Oliver] Univ Freiburg, Dept Neuroanat, D-79106 Freiburg, Germany; [Lisewski, Ulrike; Gotthardt, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Tharaux, Pierre-Louis] INSERM, Paris Ctr Rech Cardiovasc, Paris, France; [Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Freiburg	Huber, TB (corresponding author), Univ Med Ctr Freiburg, Div Renal, Freiburg, Germany.	tobias.huber@uniklinik-freiburg.de	Grahammer, Florian/ABB-7775-2021; Tharaux, Pierre-Louis/A-9155-2009; Gotthardt, Michael/ABE-8274-2021	Tharaux, Pierre-Louis/0000-0002-6062-5905; Gotthardt, Michael/0000-0003-1788-3172; Huber, Tobias B./0000-0001-7175-5062; Rogg, Manuel/0000-0002-6658-9159; Kretz, Oliver/0000-0003-1152-5956	German Research Foundation (DFG) [CRC 1140, CRC 992]; Else Kroner Stiftung; Fritz-Thyssen-Stiftung; European Research Council (ERC); BMBF-Joint transnational Grant; Excellence Initiative of the German Federal and State Governments [EXC 294]	German Research Foundation (DFG)(German Research Foundation (DFG)); Else Kroner Stiftung; Fritz-Thyssen-Stiftung; European Research Council (ERC)(European Research Council (ERC)); BMBF-Joint transnational Grant; Excellence Initiative of the German Federal and State Governments	This study was supported by the German Research Foundation (DFG): CRC 1140 (to FG, TBH), Heisenberg program and CRC 992 (to TBH); by the Else Kroner Stiftung (to FG and TBH); by the Fritz-Thyssen-Stiftung (to FG and TBH); by the European Research Council (ERC grant to TBH); by the BMBF-Joint transnational Grant (TBH) and by the Excellence Initiative of the German Federal and State Governments (EXC 294 to TBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechtel W, 2013, J AM SOC NEPHROL, V24, P727, DOI 10.1681/ASN.2012070700; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; BRAY DF, 1993, MICROSC RES TECHNIQ, V26, P489, DOI 10.1002/jemt.1070260603; Carson SD, 1997, BIOCHEM BIOPH RES CO, V233, P325, DOI 10.1006/bbrc.1997.6449; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Dorner AA, 2005, J CELL SCI, V118, P3509, DOI 10.1242/jcs.02476; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Fechner H, 2003, CIRCULATION, V107, P876, DOI 10.1161/01.CIR.0000050150.27478.C5; Fukasawa H, 2009, J AM SOC NEPHROL, V20, P1491, DOI 10.1681/ASN.2008101117; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Grahammer F, 2013, NAT REV NEPHROL, V9, P587, DOI 10.1038/nrneph.2013.169; Hamatani H, 2014, AM J PHYSIOL-RENAL, V307, pF708, DOI 10.1152/ajprenal.00625.2013; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Ito M, 2000, CIRC RES, V86, P275, DOI 10.1161/01.RES.86.3.275; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Nagai M, 2003, LAB INVEST, V83, P901, DOI 10.1097/01.LAB.0000073307.82991.CC; Noutsias M, 2001, CIRCULATION, V104, P275; Papeta N, 2010, J CLIN INVEST, V120, P4055, DOI 10.1172/JCI43721; Raschperger E, 2008, DEV BIOL, V313, P455, DOI 10.1016/j.ydbio.2007.10.049; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Schell C, 2013, J AM SOC NEPHROL, V24, P713, DOI 10.1681/ASN.2012080844; Schreiber Jadwiga, 2014, Adv Neurobiol, V8, P21; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Shono A, 2007, J AM SOC NEPHROL, V18, P2525, DOI 10.1681/ASN.2006101084; Smeets B, 2014, AM J PHYSIOL-RENAL, V307, pF798, DOI 10.1152/ajprenal.00435.2014; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129424	10.1371/journal.pone.0129424	http://dx.doi.org/10.1371/journal.pone.0129424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076477	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000356329900071
J	Chumjan, W; Winterhalter, M; Schulte, A; Benz, R; Suginta, W				Chumjan, Watcharin; Winterhalter, Mathias; Schulte, Albert; Benz, Roland; Suginta, Wipa			Chitoporin from the Marine Bacterium Vibrio harveyi PROBING THE ESSENTIAL ROLES OF TRP136 AT THE SURFACE OF THE CONSTRICTION ZONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BASS LATES-CALCARIFER; ESCHERICHIA-COLI; OUTER-MEMBRANE; ION-TRANSPORT; CURRENT NOISE; PSEUDOMONAS-AERUGINOSA; MALTOPORIN CHANNELS; KLEBSIELLA-OXYTOCA; CHITIN UTILIZATION	VhChiP is a sugar-specific porin present in the outer membrane of the marine bacterium Vibrio harveyi. VhChiP is responsible for the uptake of chitin oligosaccharides, with particular selectivity for chitohexaose. In this study, we employed electrophysiological and biochemical approaches to demonstrate that Trp(136), located at the mouth of the VhChiP pore, plays an essential role in controlling the channel's ion conductivity, chitin affinity, and permeability. Kinetic analysis of sugar translocation obtained from single channel recordings indicated that the Trp(136) mutations W136A, W136D, W136R, and W136F considerably reduce the binding affinity of the protein channel for its best substrate, chitohexaose. Liposome swelling assays confirmed that the Trp(136) mutations decreased the rate of bulk chitohexaose permeation through the VhChiP channel. Notably, all of the mutants show increases in the off-rate for chitohexaose of up to 20-fold compared with that of the native channel. Furthermore, the cation/anion permeability ratio P-c/P-a is decreased in the W136R mutant and increased in the W136D mutant. This demonstrates that the negatively charged surface at the interior of the protein lumen preferentially attracts cationic species, leading to the cation selectivity of this trimeric channel.	[Chumjan, Watcharin; Schulte, Albert; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand; [Chumjan, Watcharin; Suginta, Wipa] Suranaree Univ Technol, Sch Biochem, Nakhon Ratchasima 30000, Thailand; [Schulte, Albert] Suranaree Univ Technol, Sch Chem, Nakhon Ratchasima 30000, Thailand; [Winterhalter, Mathias; Benz, Roland] Jacobs Univ Bremen, Dept Life Sci & Chem, D-28759 Bremen, Germany	Suranaree University of Technology; Suranaree University of Technology; Suranaree University of Technology; Jacobs University	Winterhalter, M (corresponding author), Jacobs Univ Bremen, Dept Life Sci & Chem, D-28759 Bremen, Germany.	m.winterhalter@jacobs-university.de		Winterhalter, Mathias/0000-0002-1604-3318	CHE-PhD-SW Scholarship from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand) [60/2550]; Thailand Research Fund Basic Research Grant [BRG578001]; Suranaree University of Technology [SUT1-102-57-36-18, SUT1-102-56-12-30]	CHE-PhD-SW Scholarship from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand); Thailand Research Fund Basic Research Grant(Thailand Research Fund (TRF)); Suranaree University of Technology	Supported by CHE-PhD-SW Scholarship Contract 60/2550 from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand). This author's 15-month research visit in Germany was supported through the Deutscher Akademischer Austausch Dienst.; Supported by Thailand Research Fund Basic Research Grant BRG578001 and Suranaree University of Technology Grants SUT1-102-57-36-18 and SUT1-102-56-12-30.	Abraham TJ, 2004, AQUACULTURE, V232, P81, DOI 10.1016/S0044-8486(03)00485-X; Andersen C, 1998, J MEMBRANE BIOL, V164, P263, DOI 10.1007/s002329900411; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Aunkham A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095918; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; BENZ R, 1987, J GEN PHYSIOL, V89, P275, DOI 10.1085/jgp.89.2.275; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37; Haldar S, 2010, MICROBIOL RES, V165, P639, DOI 10.1016/j.micres.2009.12.001; Hilty C, 2001, PHYS REV LETT, V86, P5624, DOI 10.1103/PhysRevLett.86.5624; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Jung B. O., 2008, VIBRIOS MACROMOL RES, DOI [10.1007/BF03218953, DOI 10.1007/BF03218953]; Kim BH, 2002, J MEMBRANE BIOL, V187, P239, DOI 10.1007/s00232-001-0167-1; Kullman L, 2002, BIOPHYS J, V82, P803, DOI 10.1016/S0006-3495(02)75442-8; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; LUGTENBERG B, 1983, BIOCHIM BIOPHYS ACTA, V737, P51, DOI 10.1016/0304-4157(83)90014-X; Mahendran KR, 2009, EUR BIOPHYS J BIOPHY, V38, P1141, DOI 10.1007/s00249-009-0495-0; Neves P, 2005, BIOPHYS CHEM, V113, P123, DOI 10.1016/j.bpc.2004.08.004; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; Orlik F, 2003, BIOPHYS J, V85, P876, DOI 10.1016/S0006-3495(03)74527-5; Orlik F, 2002, BIOPHYS J, V82, P2466, DOI 10.1016/S0006-3495(02)75589-6; Pajatsch M, 1999, J BIOL CHEM, V274, P25159, DOI 10.1074/jbc.274.35.25159; Pezeshki S, 2009, BIOPHYS J, V97, P1898, DOI 10.1016/j.bpj.2009.07.018; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Ransangan J, 2009, J AQUAT ANIM HEALTH, V21, P150, DOI 10.1577/H09-002.1; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; SARAVOLAC EG, 1991, J BACTERIOL, V173, P4970, DOI 10.1128/jb.173.16.4970-4976.1991; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schulte A, 2009, J MEMBRANE BIOL, V230, P101, DOI 10.1007/s00232-009-9194-0; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Srivastava DB, 2006, J STRUCT BIOL, V156, P505, DOI 10.1016/j.jsb.2006.05.008; Suginta W, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.238102; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Tendencia EA, 2002, AQUAC RES, V33, P455, DOI 10.1046/j.1365-2109.2002.00688.x; Ulmke C, 1999, J BACTERIOL, V181, P1920, DOI 10.1128/JB.181.6.1920-1923.1999; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; World Health Organization, 1995, CDRGPV951 WHO; WYLIE JL, 1993, J BIOENERG BIOMEMBR, V25, P547, DOI 10.1007/BF01108411; Zachariae U, 2006, J BIOL CHEM, V281, P7413, DOI 10.1074/jbc.M510939200; Zeth K, 2000, STRUCTURE, V8, P981, DOI 10.1016/S0969-2126(00)00189-1	43	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19184	19196		10.1074/jbc.M115.660530	http://dx.doi.org/10.1074/jbc.M115.660530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26082491	Green Published, hybrid			2022-12-26	WOS:000358781100033
J	Clementino, MA; Gomes, MC; Pinto-Sarmento, TCD; Martins, CC; Granville-Garcia, AF; Paiva, SM				Clementino, Marayza Alves; Gomes, Monalisa Cesarino; de Almeida Pinto-Sarmento, Tassia Cristina; Martins, Carolina Castro; Granville-Garcia, Ana Flavia; Paiva, Saul Martins			Perceived Impact of Dental Pain on the Quality of Life of Preschool Children and Their Families	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; LANGUAGE VERSION; HEALTH; PREVALENCE; VALIDATION	The aim of the present study was to evaluate the perceived impact of dental caries and dental pain on oral health-related quality of life (OHRQoL) among preschool children and their families. A cross-sectional study was conduct with 843 preschool children in Campina Grande, Brazil. Parents/caregivers answered a questionnaire on socio-demographic information, their child's general/oral health and history of dental pain. The Brazilian version of the Early Childhood Oral Health Impact Scale was administered to determine the perceived impact of caries and dental pain on OHRQoL. The children underwent an oral examination. Logistic regression for complex sample was used to determine associations between the dependent and independent variables (OR: Odds ratio, alpha = 5%). The independents variables that had a p-value <0.20 in the bivariate analysis were selected for the multivariate model. The prevalence of dental caries and dental pain was 66.3% and 9.4%, respectively. Order of birth of the child, being the middle child (OR: 10.107, 95%CI: 2.008-50.869) and youngest child (OR: 3.276, 95%CI: 1.048-10.284) and dental pain (OR: 84.477, 95%CI: 33.076-215.759) were significant predictors of the perceived impact on OHRQOL for children. Poor perception of oral health was significant predictor of the perceived impact on OHRQOL for family (OR=7.397, 95%CI: 2.190-24.987). Dental caries was not associated with a perceived impact on the ORHQoL of either the children or their families. However, order of child birth and dental pain were indicators of impact of OHRQoL on preschool children and poor perception of oral health was indicators of impact on families.	[Clementino, Marayza Alves; Gomes, Monalisa Cesarino; de Almeida Pinto-Sarmento, Tassia Cristina; Granville-Garcia, Ana Flavia] State Univ Paraiba, Dept Dent, Campina Grande, Brazil; [Martins, Carolina Castro; Paiva, Saul Martins] Univ Fed Minas Gerais, Sch Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil	Universidade Estadual da Paraiba; Universidade Federal de Minas Gerais	Granville-Garcia, AF (corresponding author), State Univ Paraiba, Dept Dent, Campina Grande, Brazil.	anaflaviagg@hotmail.com	Paiva, Saul Martins/H-5757-2012; Granville-Garcia, Ana Flávia/Q-9297-2019; Martins, Carolina Castro/O-2514-2014; Granville-Garcia, Ana F/L-6980-2013; Clementino, Maysa/C-1944-2009; Martins, Carolina/AFD-8433-2022	Paiva, Saul Martins/0000-0002-3968-1638; Martins, Carolina Castro/0000-0001-9072-3226; Granville-Garcia, Ana F/0000-0002-6054-8372; Martins, Carolina/0000-0001-9072-3226	State University of Paraiba; Brazilian fostering agency: Coordination of Higher Education (CAPES, Ministry of Education); Brazilian fostering agency: Research Foundation of the State of Minas Gerais (FAPEMIG); Brazilian fostering agency: National Council for Scientific and Technological Development (CNPq)	State University of Paraiba; Brazilian fostering agency: Coordination of Higher Education (CAPES, Ministry of Education); Brazilian fostering agency: Research Foundation of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian fostering agency: National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the State University of Paraiba and the following Brazilian fostering agencies: Coordination of Higher Education (CAPES, Ministry of Education), the Research Foundation of the State of Minas Gerais (FAPEMIG) and the National Council for Scientific and Technological Development (CNPq).	Aldrigui JM, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-78; Alkarimi HA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-706; Altman DG, 2006, PRACTICAL STAT MED R; Andreasen JO, 2007, TXB COLOR ATLAS TRAU, DOI [10.1111/j.1600-9657.2009.00792.x, DOI 10.1111/J.1600-9657.2009.00792.X]; Arora A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-28; Barbosa T S, 2008, Int J Dent Hyg, V6, P100, DOI 10.1111/j.1601-5037.2008.00293.x; Bianco A, 2010, EUR J PUBLIC HEALTH, V20, P595, DOI 10.1093/eurpub/ckp179; Boeira GF, 2012, CARIES RES, V46, P488, DOI 10.1159/000339491; Cadavid Alexandra Saldarriaga, 2010, Braz. oral res., V24, P211, DOI 10.1590/S1806-83242010000200014; Campus G, CARIES RES, V20092, P155; Cleaton-Jones P, 2008, COMMUNITY DENT HLTH, V25, P79, DOI 10.1922/CDH_2166CleatonJones05; David J, 2009, DENT TRAUMATOL, V25, P500, DOI 10.1111/j.1600-9657.2009.00807.x; de Amorim RG, 2012, CLIN ORAL INVEST, V16, P513, DOI 10.1007/s00784-011-0528-9; Easton JA, 2008, COMMUNITY DENT ORAL, V36, P434, DOI 10.1111/j.1600-0528.2007.00417.x; Foster TD, 1969, BRIT DENT J, V126, P76; Grabowski R, 2007, J OROFAC ORTHOP, V68, P26, DOI 10.1007/s00056-007-1606-0; Hallett KB, 2006, COMMUNITY DENT ORAL, V34, P25, DOI 10.1111/j.1600-0528.2006.00246.x; Heaton TB, 2005, SOC SCI MED, V60, P97, DOI 10.1016/j.socscimed.2004.04.029; Hertwig R, 2002, PSYCHOL BULL, V128, P728, DOI 10.1037//0033-2909.128.5.728; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2010, PRIM RES CENSO2010; Ismail AI, 2007, COMMUNITY DENT ORAL, V35, P170, DOI 10.1111/j.1600-0528.2007.00347.x; Camargo MBJ, 2012, REV SAUDE PUBL, V46, P87, DOI 10.1590/S0034-89102012005000004; Kosmala-Anderson J, 2006, J PUBLIC HEALTH-UK, V28, P183, DOI 10.1093/pubmed/fdl012; Leal SC, 2012, CARIES RES, V46, P102, DOI 10.1159/000336387; Lee GHM, 2010, COMMUNITY DENT ORAL, V38, P333, DOI 10.1111/j.1600-0528.2010.00543.x; Lee GHM, 2009, INT J PAEDIATR DENT, V19, P399, DOI 10.1111/j.1365-263X.2009.01000.x; Li S, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-9; Martins PA, 2013, CARIES RES, V47, P211, DOI 10.1159/000345534; Moura-Leite FR, 2011, EUR ARCH PAEDIATR DE, V12, P293, DOI 10.1007/BF03262826; Pahel BT, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-6; Piovesan C, 2011, COMMUNITY DENT ORAL, V39, P260, DOI 10.1111/j.1600-0528.2010.00598.x; Pitts NB, 2007, COMMUNITY DENT HLTH, V24, P59; Scarpelli AC, 2013, COMMUNITY DENT ORAL, V41, P336, DOI 10.1111/cdoe.12022; Shang XH, 2008, CHINESE MED J-PEKING, V121, P2246, DOI 10.1097/00029330-200811020-00007; Simratvir M, 2009, J Indian Soc Pedod Prev Dent, V27, P164, DOI 10.4103/0970-4388.57097; Talekar BS, 2005, J AM DENT ASSOC, V136, P364, DOI 10.14219/jada.archive.2005.0179; Tesch FC, 2008, CAD SAUDE PUBLICA, V24, P1897, DOI 10.1590/S0102-311X2008000800018; Thikkurissy S, 2012, PEDIATR DENT, V34, P289; Wandera M, 2009, INT J PAEDIATR DENT, V19, P251, DOI 10.1111/j.1365-263X.2009.00969.x; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	41	45	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130602	10.1371/journal.pone.0130602	http://dx.doi.org/10.1371/journal.pone.0130602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26090927	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835000135
J	Yong, HS; Lim, PE; Tan, J; Song, SL; Suana, IW; Eamsobhana, P				Yong, Hoi-Sen; Lim, Phaik-Eem; Tan, Ji; Song, Sze-Looi; Suana, I. Wayan; Eamsobhana, Praphathip			Multigene Phylogeography of Bactrocera caudata (Insecta: Tephritidae): Distinct Genetic Lineages in Northern and Southern Hemispheres	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCES; OXIDASE-I GENE; MOLECULAR PHYLOGENY; SPECIES DIPTERA; COI SEQUENCES; FRUIT-FLIES; CHINA; FLY; PRIMERS; COMPLEX	Bactrocera caudata is a pest of pumpkin flower. Specimens of B. caudata from the northern hemisphere (mainland Asia) and southern hemisphere (Indonesia) were analysed using the partial DNA sequences of the nuclear 28S rRNA and internal transcribed spacer region 2 (ITS-2) genes, and the mitochondrial cytochrome c oxidase subunit I (COI), cytochrome c oxidase subunit II (COII) and 16S rRNA genes. The COI, COII, 16S rDNA and concatenated COI+COII+16S and COI+COII+16S+28S+ITS-2 nucleotide sequences revealed that B. caudata from the northern hemisphere (Peninsular Malaysia, East Malaysia, Thailand) was distinctly different from the southern hemisphere (Indonesia: Java, Bali and Lombok), without common haplotype between them. Phylogenetic analysis revealed two distinct clades (northern and southern hemispheres), indicating distinct genetic lineage. The uncorrected 'p' distance for the concatenated COI+COII+16S nucleotide sequences between the taxa from the northern and southern hemispheres ('p' = 4.46-4.94%) was several folds higher than the 'p' distance for the taxa in the northern hemisphere ('p' = 0.00-0.77%) and the southern hemisphere ('p' = 0.00%). This distinct difference was also reflected by concatenated COI+COII+16S+28S+ITS-2 nucleotide sequences with an uncorrected 'p' distance of 2.34-2.69% between the taxa of northern and southern hemispheres. In accordance with the type locality the Indonesian taxa belong to the nominal species. Thus the taxa from the northern hemisphere, if they were to constitute a cryptic species of the B. caudata species complex based on molecular data, need to be formally described as a new species. The Thailand and Malaysian B. caudata populations in the northern hemisphere showed distinct genetic structure and phylogeographic pattern.	[Yong, Hoi-Sen; Lim, Phaik-Eem] Univ Malaya, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Yong, Hoi-Sen; Song, Sze-Looi] Univ Malaya, Chancellory High Impact Res, Kuala Lumpur 50603, Malaysia; [Lim, Phaik-Eem; Tan, Ji] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur 50603, Malaysia; [Tan, Ji] Univ Tunku Abdul Rahman, Fac Sci, Dept Agr & Food Sci, Kampar 31900, Perak, Malaysia; [Suana, I. Wayan] Mataram Univ, Fac Sci & Math, Mataram, Indonesia; [Eamsobhana, Praphathip] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok 10700, Thailand	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Tunku Abdul Rahman (UTAR); Universitas Mataram; Mahidol University	Yong, HS (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.	yong@um.edu.my; phaikeem@um.edu.my	Eamsobhana, Praphathip/H-3343-2012; Tan, Ji/J-1653-2017; LIM, Phaik Eem/B-5331-2010; Song, Sze-Looi/E-7939-2015; Yong, Hoi Sen/C-1548-2010; song, sl/GRS-1884-2022; Suana, I Wayan/J-2665-2012	LIM, Phaik Eem/0000-0001-9186-1487; Yong, Hoi Sen/0000-0002-9832-8826; Suana, I Wayan/0000-0003-1443-9017; Song, Sze Looi/0000-0002-1188-9728; Tan, Ji/0000-0002-1264-5442	MoHE-HIR Grant [H-50001-00-A000025]; University of Malaya [H-5620009]	MoHE-HIR Grant; University of Malaya(Universiti Malaya)	This study was funded in part by MoHE-HIR Grant (H-50001-00-A000025) and the University of Malaya (H-5620009).	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Baimai V, 2000, BIOL J LINN SOC, V69, P399, DOI 10.1111/j.1095-8312.2000.tb01213.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boykin LM, 2014, J APPL ENTOMOL, V138, P235, DOI 10.1111/jen.12047; Carroll LE, 2019, PEST FRUIT FLIES WOR; DREW R A I, 1989, Memoirs of the Queensland Museum, V26, P1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; Hasegawa E, 2006, ENTOMOL SCI, V9, P55, DOI 10.1111/j.1479-8298.2006.00154.x; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jamnongluk W, 2003, GENOME, V46, P112, DOI 10.1139/G02-113; Jamnongluk W, 2003, GENETICA, V119, P19, DOI 10.1023/A:1024481032579; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Krosch MN, 2012, MOL PHYLOGENET EVOL, V64, P513, DOI 10.1016/j.ympev.2012.05.006; Lim PE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02977; Lim PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037276; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Meeyen K, 2014, ENTOMOL SCI, V17, P219, DOI 10.1111/ens.12049; Mun J, 2003, MOL ECOL, V12, P2941, DOI 10.1046/j.1365-294X.2003.01978.x; Saelee Anchalee, 2006, Songklanakarin Journal of Science and Technology, V28, P249; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shi W, 2005, ENVIRON ENTOMOL, V34, P977, DOI 10.1603/0046-225X-34.4.977; Smith PT, 2003, MOL PHYLOGENET EVOL, V26, P8, DOI 10.1016/S1055-7903(02)00293-2; Song ZK, 2008, FORENSIC SCI INT, V175, P17, DOI 10.1016/j.forsciint.2007.04.227; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Virgilio M, 2015, MOL PHYLOGENET EVOL, V85, P171, DOI 10.1016/j.ympev.2015.01.007; Yong HS, 1992, P NATIONAL IRPA SEMI, V1, P233; Zhang B, 2010, FLA ENTOMOL, V93, P369, DOI 10.1653/024.093.0308	32	6	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129455	10.1371/journal.pone.0129455	http://dx.doi.org/10.1371/journal.pone.0129455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090853	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000044
J	Chen, HF; Lan, CY				Chen, Hsueh-Fen; Lan, Chung-Yu			Role of SFP1 in the Regulation of Candida albicans Biofilm Formation	PLOS ONE			English	Article							GENE-EXPRESSION; FILAMENTATION PATHWAY; DRUG-RESISTANCE; ADHESIN; INFECTIONS; PROTEIN; HWP1; MORPHOGENESIS; EPIDEMIOLOGY; SURFACES	Candida albicans is a major human fungal pathogen. One of the important features of C. albicans pathogenicity is the ability to form biofilms on mucosal surfaces and indwelling medical devices. Biofilm formation involves complex processes in C. albicans, including cell adhesion, filamentous growth, extracellular matrix secretion and cell dispersion. In this work, we characterized the role of the transcription factor Sfp1, particularly with respect to its function in the regulation of biofilm formation. The deletion of the SFP1 gene enhanced cell adhesion and biofilm formation in comparison to the wild-type strain. Interestingly, the sfp1-deleted mutant also exhibited an increase in the expression of the ALS1, ALS3 and HWP1 genes, which encode adhesin proteins. In addition, Sfp1 was demonstrated to function downstream of the Rhb1-TOR signaling pathway. Bcr1 and Efg1 are transcription factors that are critical for controlling biofilm formation, and Efg1 is also required for hyphal growth. Deleting either the BCR1 or EFG1 gene in the sfp1-null background led to reduced adhesin gene expression. As a result, the bcr1/sfp1 or efg1/sfp1 double deletion mutants exhibited dramatically reduced biofilm formation. The results indicated that Sfp1 negatively regulates the ALS1, ALS3 and HWP1 adhesin genes and that the repression of these genes is mediated by the inhibition of Bcr1 and Efg1.	[Chen, Hsueh-Fen; Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 30013, Taiwan; [Lan, Chung-Yu] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University	Lan, CY (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 30013, Taiwan.	cylan@life.nthu.edu.tw		Lan, Chung-Yu/0000-0002-1533-3049	National Science Council (Taiwan) [NSC101-2311-B-007-010-MY3, NSC100-2627-B-007-002]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by grants NSC101-2311-B-007-010-MY3 and NSC100-2627-B-007-002 (to CYL) from the National Science Council (Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; Argimon S, 2007, EUKARYOT CELL, V6, P682, DOI 10.1128/EC.00340-06; Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671; Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chen YT, 2012, EUKARYOT CELL, V11, P168, DOI 10.1128/EC.05200-11; Crump JA, 2000, EUR J CLIN MICROBIOL, V19, P1, DOI 10.1007/s100960050001; Daniels KJ, 2013, EUKARYOT CELL, V12, P1389, DOI 10.1128/EC.00127-13; Douglas L. Julia, 2002, Revista Iberoamericana de Micologia, V19, P139; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Fan Y, 2013, MYCOPATHOLOGIA, V176, P329, DOI 10.1007/s11046-013-9684-6; Fingerman I, 2003, EUKARYOT CELL, V2, P1061, DOI 10.1128/EC.2.5.1061-1068.2003; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x; Green CB, 2005, INFECT IMMUN, V73, P1852, DOI 10.1128/IAI.73.3.1852-1855.2005; Hajjeh RA, 2004, J CLIN MICROBIOL, V42, P1519, DOI 10.1128/JCM.42.4.1519-1527.2004; Hsu PC, 2013, EUKARYOT CELL, V12, P804, DOI 10.1128/EC.00014-13; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kucharikova S, 2011, J MED MICROBIOL, V60, P1261, DOI 10.1099/jmm.0.032037-0; Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034; Lin CH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003305; Loza L, 2004, YEAST, V21, P473, DOI 10.1002/yea.1111; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nett J, 2006, CURR OPIN MICROBIOL, V9, P340, DOI 10.1016/j.mib.2006.06.007; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Russell CL, 2005, FUNGAL GENET BIOL, V42, P676, DOI 10.1016/j.fgb.2005.04.008; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Staab JF, 1996, J BIOL CHEM, V271, P6298, DOI 10.1074/jbc.271.11.6298; Stichternoth C, 2009, APPL ENVIRON MICROB, V75, P3663, DOI 10.1128/AEM.00098-09; Stoldt Volker R., 1997, EMBO (European Molecular Biology Organization) Journal, V16, P1982, DOI 10.1093/emboj/16.8.1982; Tsai PW, 2014, MOL GENET GENOMICS, V289, P807, DOI 10.1007/s00438-014-0846-0; Tsao CC, 2009, FUNGAL GENET BIOL, V46, P126, DOI 10.1016/j.fgb.2008.11.008; Tumbarello M, 2007, J CLIN MICROBIOL, V45, P1843, DOI 10.1128/JCM.00131-07; Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1; Wang YC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-53; Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0	55	128	136	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129903	10.1371/journal.pone.0129903	http://dx.doi.org/10.1371/journal.pone.0129903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087243	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500070
J	Wan, JZ; Meng, D; Long, T; Ying, RR; Ye, M; Zhang, ST; Li, Q; Zhou, Y; Lin, YS				Wan, Jinzhong; Meng, Die; Long, Tao; Ying, Rongrong; Ye, Mao; Zhang, Shengtian; Li, Qun; Zhou, Yan; Lin, Yusuo			Simultaneous Removal of Lindane, Lead and Cadmium from Soils by Rhamnolipids Combined with Citric Acid	PLOS ONE			English	Article							CHAIN ORGANIC-ACIDS; CONTAMINATED SOILS; ENVIRONMENTAL APPLICATIONS; ENHANCED DESORPTION; HEAVY-METALS; BIOSURFACTANT; PHENANTHRENE; CYCLODEXTRIN; REMEDIATION; SURFACTANT	This study investigated the performance of rhamnolipids-citric acid mixed agents in simultaneous desorption of lindane and heavy metals from soils. The capacity of the mixed agents to solubilize lindane, lead and cadmium in aqueous solution was also explored. The results showed that the presence of citric acid greatly enhanced the solubilization of lindane and cadmium by rhamnolipids. A combined effect of the mixed agents on lindane and heavy metals removal from soils was observed. The maximum desorption ratios for lindane, cadmium and lead were 85.4%, 76.4% and 28.1%, respectively, for the mixed agents containing 1% rhamnolipidsand 0.1 mol/L citric acid. The results also suggest that the removal efficiencies of lead and cadmium were strongly related to their speciations in soils, and metals in the exchangeable and carbonate forms were easier to be removed. Our study suggests that the combining use of rhamnolipids and citric acid is a promising alternative to simultaneously remove organochlorine pesticides and heavy metals from soils.	[Wan, Jinzhong; Meng, Die; Long, Tao; Ying, Rongrong; Zhang, Shengtian; Li, Qun; Zhou, Yan; Lin, Yusuo] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Wan, Jinzhong; Meng, Die; Long, Tao; Ying, Rongrong; Zhang, Shengtian; Li, Qun; Zhou, Yan; Lin, Yusuo] State Environm Protect Key Lab Soil Environm Mana, Nanjing, Jiangsu, Peoples R China; [Ye, Mao] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS	Zhang, ST (corresponding author), Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China.	zst@nies.org; lys@nies.org			National Natural Science Foundation of China [41201311]; Environmental Research Projects of Jiangsu Province [2013026]; National High-Tech Research and Development (863) Programme [2009AA063103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environmental Research Projects of Jiangsu Province; National High-Tech Research and Development (863) Programme(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (No. 41201311, http://www.nsfc.gov.cn/, JZW), Environmental Research Projects of Jiangsu Province (2013026, http://www.jshb.gov.cn/jshbw/gsgg/ggtz/201303/t20130326_230602.html, JZW), the National High-Tech Research and Development (863) Programme (2009AA063103, http://program.most.gov.cn/, YSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CJ, 2011, WATER RES, V45, P5501, DOI 10.1016/j.watres.2011.08.011; An CJ, 2010, CHEMOSPHERE, V81, P1423, DOI 10.1016/j.chemosphere.2010.09.012; [Anonymous], 2004, CLEANING UP THE NATI; Bassi R, 2000, ENVIRON PROG, V19, P275, DOI 10.1002/ep.670190415; Cao MH, 2013, ENVIRON POLLUT, V174, P93, DOI 10.1016/j.envpol.2012.11.015; Ehsan S, 2006, J ENVIRON QUAL, V35, P2084, DOI 10.2134/jeq2005.0475; Feng XJ, 2006, ENVIRON SCI TECHNOL, V40, P3260, DOI 10.1021/es0521472; Gao YZ, 2010, SOIL SCI SOC AM J, V74, P51, DOI 10.2136/sssaj2009.0105; Gao YZ, 2003, ENVIRON INT, V29, P613, DOI 10.1016/S0160-4120(03)00048-5; Gusiatin ZM, 2014, J ENVIRON SCI, V26, P855, DOI 10.1016/S1001-0742(13)60534-3; HERMAN DC, 1995, ENVIRON SCI TECHNOL, V29, P2280, DOI 10.1021/es00009a019; Kawano S, 2014, ENVIRON SCI TECHNOL, V48, P8094, DOI 10.1021/es501243v; Lima TMS, 2011, BIODEGRADATION, V22, P1007, DOI 10.1007/s10532-011-9459-z; Ling WT, 2009, SOIL BIOL BIOCHEM, V41, P2187, DOI 10.1016/j.soilbio.2009.08.003; Liu CC, 2013, ENVIRON POLLUT, V178, P97, DOI 10.1016/j.envpol.2013.02.034; Mousset E, 2014, WATER RES, V48, P306, DOI 10.1016/j.watres.2013.09.044; Mulligan CN, 2005, ENVIRON POLLUT, V133, P183, DOI 10.1016/j.envpol.2004.06.009; Mulligan CN, 2001, J HAZARD MATER, V85, P111, DOI 10.1016/S0304-3894(01)00224-2; Ochoa-Loza FJ, 2001, J ENVIRON QUAL, V30, P479, DOI 10.2134/jeq2001.302479x; Ochoa-Loza FJ, 2007, CHEMOSPHERE, V66, P1634, DOI 10.1016/j.chemosphere.2006.07.068; Pacwa-Plociniczak M, 2011, INT J MOL SCI, V12, P633, DOI 10.3390/ijms12010633; Parthasarathi R, 2011, SOIL SEDIMENT CONTAM, V20, P892, DOI 10.1080/15320383.2011.620043; Shin KH, 2004, APPL MICROBIOL BIOT, V65, P336, DOI 10.1007/s00253-004-1561-2; Shin KH, 2008, J ENVIRON QUAL, V37, P509, DOI 10.2134/jeq2007.0258; Slizovskiy IB, 2011, ENVIRON TOXICOL CHEM, V30, P112, DOI 10.1002/etc.357; Song DD, 2013, COLLOID SURFACE A, V436, P201, DOI 10.1016/j.colsurfa.2013.06.011; Sun YY, 2009, J ENVIRON QUAL, V38, P1591, DOI 10.2134/jeq2008.0374; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Ullmann A, 2013, J HAZARD MATER, V260, P676, DOI 10.1016/j.jhazmat.2013.06.027; Wan JZ, 2011, J HAZARD MATER, V189, P458, DOI 10.1016/j.jhazmat.2011.02.055; Wan JZ, 2009, CHEMOSPHERE, V75, P759, DOI 10.1016/j.chemosphere.2009.01.024; Wang GY, 2014, CHEMOSPHERE, V117, P617, DOI 10.1016/j.chemosphere.2014.09.081; Ye M, 2015, ENVIRON SCI POLLUT R, V22, P2687, DOI 10.1007/s11356-014-3518-z; Yuan SH, 2010, GEODERMA, V156, P119, DOI 10.1016/j.geoderma.2010.02.006; Zhang YM, 1997, ENVIRON SCI TECHNOL, V31, P2211, DOI 10.1021/es960687g; Zheng GY, 2012, ENVIRON SCI TECHNOL, V46, P12062, DOI 10.1021/es302832z; Zhou WJ, 2011, ENVIRON POLLUT, V159, P1198, DOI 10.1016/j.envpol.2011.02.001	38	28	31	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129978	10.1371/journal.pone.0129978	http://dx.doi.org/10.1371/journal.pone.0129978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087302	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500071
J	Martini, X; Hoffmann, M; Coy, MR; Stelinski, LL; Pelz-Stelinski, KS				Martini, Xavier; Hoffmann, Mark; Coy, Monique R.; Stelinski, Lukasz L.; Pelz-Stelinski, Kirsten S.			Infection of an Insect Vector with a Bacterial Plant Pathogen Increases Its Propensity for Dispersal	PLOS ONE			English	Article							DIAPHORINA-CITRI HEMIPTERA; CANDIDATUS LIBERIBACTER ASIATICUS; ABDOMINAL COLOR; HOST; VIRUS; BIOLOGY; MANIPULATION; PSYLLIDAE; HOMOPTERA; MOVEMENT	The spread of vector-transmitted pathogens relies on complex interactions between host, vector and pathogen. In sessile plant pathosystems, the spread of a pathogen highly depends on the movement and mobility of the vector. However, questions remain as to whether and how pathogen-induced vector manipulations may affect the spread of a plant pathogen. Here we report for the first time that infection with a bacterial plant pathogen increases the probability of vector dispersal, and that such movement of vectors is likely manipulated by a bacterial plant pathogen. We investigated how Candidatus Liberibacter asiaticus (CLas) affects dispersal behavior, flight capacity, and the sexual attraction of its vector, the Asian citrus psyllid (Diaphorina citri Kuwayama). CLas is the putative causal agent of huanglongbing (HLB), which is a disease that threatens the viability of commercial citrus production worldwide. When D. citri developed on CLas-infected plants, short distance dispersal of male D. citri was greater compared to counterparts reared on uninfected plants. Flight by CLas-infected D. citri was initiated earlier and long flight events were more common than by uninfected psyllids, as measured by a flight mill apparatus. Additionally, CLas titers were higher among psyllids that performed long flights than psyllid that performed short flights. Finally, attractiveness of female D. citri that developed on infected plants to male conspecifics increased proportionally with increasing CLas bacterial titers measured within female psyllids. Our study indicates that the phytopathogen, CLas, may manipulate movement and mate selection behavior of their vectors, which is a possible evolved mechanism to promote their own spread. These results have global implications for both current HLB models of disease spread and control strategies.	[Martini, Xavier; Hoffmann, Mark; Coy, Monique R.; Stelinski, Lukasz L.; Pelz-Stelinski, Kirsten S.] Univ Florida, Ctr Citrus Res & Educ, Dept Entomol & Nematol, Lake Alfred, FL 33850 USA	State University System of Florida; University of Florida	Pelz-Stelinski, KS (corresponding author), Univ Florida, Ctr Citrus Res & Educ, Dept Entomol & Nematol, Lake Alfred, FL 33850 USA.	pelzstelinski@ufl.edu			Citrus Research and Development Foundation [600]	Citrus Research and Development Foundation	This work was supported by the Citrus Research and Development Foundation Grant #600. (http://citrusrdf.org) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa Kenryo, 2007, Research Bulletin of the Plant Protection Service Japan, V43, P23; BAILEY SM, 1995, ENVIRON ENTOMOL, V24, P24, DOI 10.1093/ee/24.1.24; Biere A, 2013, FUNCT ECOL, V27, P567, DOI 10.1111/1365-2435.12100; Boina DR, 2009, ENVIRON ENTOMOL, V38, P1250, DOI 10.1603/022.038.0436; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brodersen C, 2014, HORTSCIENCE, V49, P59, DOI 10.21273/HORTSCI.49.1.59; Cen YJ, 2012, ENTOMOL EXP APPL, V143, P13, DOI 10.1111/j.1570-7458.2012.01222.x; Christiansen-Weniger P, 1998, ENTOMOL EXP APPL, V86, P205, DOI 10.1023/A:1003132403595; Coy MR, 2014, J MICROBIOL METH, V102, P15, DOI 10.1016/j.mimet.2014.04.007; Davis TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049330; DENNO RF, 1992, ECOLOGY, V73, P1323, DOI 10.2307/1940679; DOBSON AP, 1988, Q REV BIOL, V63, P139, DOI 10.1086/415837; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Gharaei AM, 2014, J APPL ENTOMOL, V138, P500, DOI 10.1111/jen.12107; Gonzalez P, 2012, PHYSIOL MOL PLANT P, V79, P71, DOI 10.1016/j.pmpp.2012.05.002; Goulson D, 1997, OECOLOGIA, V109, P219, DOI 10.1007/s004420050076; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Hall DG, 2007, HORTSCIENCE, V42, P364, DOI 10.21273/HORTSCI.42.2.364; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hodge S, 2008, OECOLOGIA, V157, P387, DOI 10.1007/s00442-008-1083-1; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Lafferty KD, 2012, HOST MANIPULATION BY PARASITES, P158; Lefevre T, 2009, TRENDS ECOL EVOL, V24, P41, DOI 10.1016/j.tree.2008.08.007; Lefevre T, 2008, INFECT GENET EVOL, V8, P504, DOI 10.1016/j.meegid.2007.05.008; Lewis-Rosenblum H, 2015, J EC ENTOMO IN PRESS; Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690; Lombaert E, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-75; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Mann RS, 2011, B ENTOMOL RES, V101, P89, DOI 10.1017/S0007485310000222; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Mann RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029197; Martini X, 2014, ARTHROPOD-PLANT INTE, V8, P453, DOI 10.1007/s11829-014-9326-z; Martini X, 2014, ANN ENTOMOL SOC AM, V107, P842, DOI 10.1603/AN14028; Martini X, 2013, FLA ENTOMOL, V96, P658, DOI 10.1653/024.096.0240; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Mitchell PL, 2004, NEOTROP ENTOMOL, V33, P519, DOI 10.1590/S1519-566X2004000500001; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Price P. W., 1980, EVOLUTIONARY BIOL PA; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shapiro L, 2012, ECOL LETT, V15, P1430, DOI 10.1111/ele.12001; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; STINNER RE, 1983, ANNU REV ENTOMOL, V28, P319, DOI 10.1146/annurev.en.28.010183.001535; Tian SK, 2014, J EXP BOT, V65, P953, DOI 10.1093/jxb/ert450; Tiwari S, 2010, J ECON ENTOMOL, V103, P1972, DOI 10.1603/EC10149; Tsai JH, 2000, J ECON ENTOMOL, V93, P1721, DOI 10.1603/0022-0493-93.6.1721; Wenninger EJ, 2008, ENTOMOL EXP APPL, V128, P450, DOI 10.1111/j.1570-7458.2008.00738.x; Wenninger EJ, 2007, FLA ENTOMOL, V90, P715, DOI 10.1653/0015-4040(2007)90[715:DTOMAA]2.0.CO;2; Wenninger EJ, 2009, ANN ENTOMOL SOC AM, V102, P476, DOI 10.1603/008.102.0318	53	63	66	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129373	10.1371/journal.pone.0129373	http://dx.doi.org/10.1371/journal.pone.0129373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083763	gold, Green Published			2022-12-26	WOS:000356567400090
J	Gall, A; Fero, J; Mccoy, C; Claywell, BC; Sanchez, CA; Blount, PL; Li, XH; Vaughan, TL; Matsen, FA; Reid, BJ; Salama, NR				Gall, Alevtina; Fero, Jutta; Mccoy, Connor; Claywell, Brian C.; Sanchez, Carissa A.; Blount, Patricia L.; Li, Xiaohong; Vaughan, Thomas L.; Matsen, Frederick A.; Reid, Brian J.; Salama, Nina R.			Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; DISTAL ESOPHAGUS; MOLECULAR ANALYSIS; FECAL MICROBIOTA; GASTRIC ATROPHY; GUT MICROBIOTA; RISK; ADENOCARCINOMA; INFLAMMATION; PROGRESSION	Background The incidence of esophageal adenocarcinoma (EAC) has increased nearly five-fold over the last four decades in the United States. Barrett's esophagus, the replacement of the normal squamous epithelial lining with a mucus-secreting columnar epithelium, is the only known precursor to EAC. Like other parts of the gastrointestinal (GI) tract, the esophagus hosts a variety of bacteria and comparisons among published studies suggest bacterial communities in the stomach and esophagus differ. Chronic infection with Helicobacter pylori in the stomach has been inversely associated with development of EAC, but the mechanisms underlying this association remain unclear. Methodology The bacterial composition in the upper GI tract was characterized in a subset of participants (n=12) of the Seattle Barrett's Esophagus Research cohort using broad-range 16S PCR and pyrosequencing of biopsy and brush samples collected from squamous esophagus, Barrett's esophagus, stomach corpus and stomach antrum. Three of the individuals were sampled at two separate time points. Prevalence of H. pylori infection and subsequent development of aneuploidy (n=339) and EAC (n=433) was examined in a larger subset of this cohort. Results/Significance Within individuals, bacterial communities of the stomach and esophagus showed overlapping community membership. Despite closer proximity, the stomach antrum and corpus communities were less similar than the antrum and esophageal samples. Re-sampling of study participants revealed similar upper GI community membership in two of three cases. In this Barrett's esophagus cohort, Streptococcus and Prevotella species dominate the upper GI and the ratio of these two species is associated with waist-to-hip ratio and hiatal hernia length, two known EAC risk factors in Barrett's esophagus. H. pylori-positive individuals had a significantly decreased incidence of aneuploidy and a non-significant trend toward lower incidence of EAC.	[Gall, Alevtina] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Gall, Alevtina; Fero, Jutta; Sanchez, Carissa A.; Li, Xiaohong; Reid, Brian J.; Salama, Nina R.] Fred Hutchinson Canc Res Ctr, Human Biol, Seattle, WA 98104 USA; [Mccoy, Connor; Claywell, Brian C.; Blount, Patricia L.; Li, Xiaohong; Vaughan, Thomas L.; Matsen, Frederick A.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Vaughan, Thomas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Salama, Nina R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Blount, Patricia L.; Reid, Brian J.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Mccoy, Connor; Claywell, Brian C.; Matsen, Frederick A.] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98104 USA; [Reid, Brian J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Salama, NR (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	nsalama@fhcrc.org	Salama, Nina Reda/AAG-2437-2019	Salama, Nina Reda/0000-0003-2762-1424; Gall, Alevtina/0000-0001-6386-7566	US National Institutes of Health [P30 CA015704, R01 CA179949, P01 CA 91955, R01 HG005966, K05 CA124911, R01 CA136725]; US National Science Foundation [1223057]; NATIONAL CANCER INSTITUTE [R01CA136725, P30CA015704, P01CA091955, K05CA124911, R01CA179949] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work came from the US National Institutes of Health under award numbers P30 CA015704 (NRS), R01 CA179949 (BJR, TLV), P01 CA 91955 (BJR, TLV), R01 HG005966 (FAM), K05 CA124911 (TLV), R01 CA136725 (TLV), and the US National Science Foundation Award 1223057 (FAM).	Amir I, 2014, ENVIRON MICROBIOL, V16, P2905, DOI 10.1111/1462-2920.12285; Anaparthy R, 2013, CLIN GASTROENTEROL H, V11, P1430, DOI 10.1016/j.cgh.2013.05.007; Anderson LA, 2008, GUT, V57, P734, DOI 10.1136/gut.2007.132662; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Andrici J, 2013, J GASTROEN HEPATOL, V28, P415, DOI 10.1111/j.1440-1746.2012.07199.x; [Anonymous], 2014, R LANG ENV STAT COMP; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Chow WH, 1998, CANCER RES, V58, P588; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Corley DA, 2008, GUT, V57, P727, DOI 10.1136/gut.2007.132068; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; FORMAN D, 1993, GUT, V34, P1672, DOI 10.1136/gut.34.12.1672; Gevers D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002779; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hardikar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052192; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Jones AD, 2003, J GASTROINTEST SURG, V7, P68, DOI 10.1016/S1091-255X(02)00129-4; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lao-Sirieix P, 2008, DIS ESOPHAGUS, V21, P529, DOI 10.1111/j.1442-2050.2007.00807.x; Leibowitz MS, 2013, CLIN CANCER RES, V19, P798, DOI 10.1158/1078-0432.CCR-12-1517; Levine DS, 2000, AM J GASTROENTEROL, V95, P1152; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063139; Liu N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-130; Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069621; Matsen FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056859; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Maukonen J, 2008, J MED MICROBIOL, V57, P1560, DOI 10.1099/jmm.0.47352-0; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; REID BJ, 1992, GASTROENTEROLOGY, V102, P1212; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rudney JD, 2003, ARCH ORAL BIOL, V48, P475, DOI 10.1016/S0003-9969(03)00043-8; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van Tongeren SP, 2005, APPL ENVIRON MICROB, V71, P6438, DOI 10.1128/AEM.71.10.6438-6442.2005; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046	57	77	83	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129055	10.1371/journal.pone.0129055	http://dx.doi.org/10.1371/journal.pone.0129055			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076489	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900044
J	Tatsumi, N; Hojo, N; Sakamoto, H; Inaba, R; Moriguchi, N; Matsuno, K; Fukuda, M; Matsumura, A; Hayashi, S; Morimoto, S; Nakata, J; Fujiki, F; Nishida, S; Nakajima, H; Tsuboi, A; Oka, Y; Hosen, N; Sugiyama, H; Oji, Y				Tatsumi, Naoya; Hojo, Nozomi; Sakamoto, Hiroyuki; Inaba, Rena; Moriguchi, Nahoko; Matsuno, Keiko; Fukuda, Mari; Matsumura, Akihide; Hayashi, Seiji; Morimoto, Soyoko; Nakata, Jun; Fujiki, Fumihiro; Nishida, Sumiyuki; Nakajima, Hiroko; Tsuboi, Akihiro; Oka, Yoshihiro; Hosen, Naoki; Sugiyama, Haruo; Oji, Yusuke			Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms	PLOS ONE			English	Article							TUMOR GENE WT1; LEUKEMIA CELL-LINE; WILMS-TUMORS; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; NONSENSE CODONS; SOLID TUMORS; IN-VITRO; PROTEIN; APOPTOSIS	The Wilms' tumor gene WT1 consists of 10 exons and encodes a zinc finger transcription factor. There are four major WT1 isoforms resulting from alternative splicing at two sites, exon 5 (17AA) and exon 9 (KTS). All major WT1 isoforms are overexpressed in leukemia and solid tumors and play oncogenic roles such as inhibition of apoptosis, and promotion of cell proliferation, migration and invasion. In the present study, a novel alternatively spliced WT1 isoform that had an extended exon 4 (designated as exon 4a) with an additional 153 bp (designated as 4a sequence) at the 3' end was identified and designated as an Ex4a(+) WT1 isoform. The insertion of exon 4a resulted in the introduction of premature translational stop codons in the reading frame in exon 4a and production of C-terminal truncated WT1 proteins lacking zinc finger DNA-binding domain. Overexpression of the truncated Ex4a(+) WT1 isoform inhibited the major WT1-mediated transcriptional activation of anti-apoptotic Bcl-xL gene promoter and induced mitochondrial damage and apoptosis. Conversely, suppression of the Ex4a(+) WT1 isoform by Ex4a-specific siRNA attenuated apoptosis. These results indicated that the Ex4a(+) WT1 isoform exerted dominant negative effects on anti-apoptotic function of major WT1 isoforms. Ex4a(+) WT1 isoform was endogenously expressed as a minor isoform in myeloid leukemia and solid tumor cells and increased regardless of decrease in major WT1 isoforms during apoptosis, suggesting the dominant negative effects on anti-apoptotic function of major WT1 isoforms. These results indicated that Ex4a(+) WT1 isoform had an important physiological function that regulated oncogenic function of major WT1 isoforms.	[Tatsumi, Naoya; Hojo, Nozomi; Sakamoto, Hiroyuki; Inaba, Rena; Moriguchi, Nahoko; Matsuno, Keiko; Fukuda, Mari; Sugiyama, Haruo] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Osaka, Japan; [Matsumura, Akihide] Natl Hosp Org, Dept Surg, Kinki Chuo Chest Med Ctr, Osaka, Japan; [Hayashi, Seiji] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Osaka, Japan; [Morimoto, Soyoko; Fujiki, Fumihiro; Nakajima, Hiroko; Oka, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Canc Immunol, Osaka, Japan; [Nakata, Jun; Tsuboi, Akihiro] Osaka Univ, Grad Sch Med, Dept Canc Immunotherapy, Osaka, Japan; [Nishida, Sumiyuki] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Osaka, Japan; [Hosen, Naoki; Oji, Yusuke] Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Tatsumi, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Osaka, Japan.	tatsumi@cit.med.osaka-u.ac.jp		Nakata, Jun/0000-0002-7494-1204	Ministry of Health, Labour, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science (JSPS); ARK Real Estate co., Ltd; AXE Real Estate co., Ltd.	Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ARK Real Estate co., Ltd; AXE Real Estate co., Ltd.	This work was supported by a Grant-in-Aid from the Ministry of Health, Labour, and Welfare, Japan, the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and the Japan Society for the Promotion of Science (JSPS), and also supported by a donation from ARK Real Estate co., Ltd, and AXE Real Estate co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASOU H, 1991, BLOOD, V77, P2031; Bansal H, 2012, J BIOL CHEM, V287, P32875, DOI 10.1074/jbc.C112.366559; Bardeesy N, 1998, NUCLEIC ACIDS RES, V26, P1784, DOI 10.1093/nar/26.7.1784; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bruening W, 1996, J BIOL CHEM, V271, P8646, DOI 10.1074/jbc.271.15.8646; Caldas H, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-11; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; CASCINO I, 1995, J IMMUNOL, V154, P2706; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Dallosso AR, 2004, HUM MOL GENET, V13, P405, DOI 10.1093/hmg/ddh038; Dechsukhum C, 2000, MOL DIAGN, V5, P117, DOI 10.1016/S1084-8592(00)80029-6; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Han YQ, 2004, ONCOGENE, V23, P6933, DOI 10.1038/sj.onc.1207609; Hossain A, 2006, J BIOL CHEM, V281, P28122, DOI 10.1074/jbc.M512391200; Iben S, 1999, ONCOGENE, V18, P2533, DOI 10.1038/sj.onc.1202618; Ito K, 2006, ONCOGENE, V25, P4217, DOI 10.1038/sj.onc.1209455; Jomgeow T, 2006, CANCER SCI, V97, P259, DOI 10.1111/j.1349-7006.2006.00169.x; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; KAMEI H, 1989, CELL BIOL INT REP, V13, P291, DOI 10.1016/0309-1651(89)90152-5; Kennedy D, 1996, NAT GENET, V12, P329, DOI 10.1038/ng0396-329; KENT J, 1995, ONCOGENE, V11, P1781; Lamba JK, 2003, HUM MOL GENET, V12, P99, DOI 10.1093/hmg/ddg011; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Mayo MW, 1999, EMBO J, V18, P3990, DOI 10.1093/emboj/18.14.3990; Miles C, 1998, P NATL ACAD SCI USA, V95, P13068, DOI 10.1073/pnas.95.22.13068; Miles CG, 2003, MOL CELL BIOL, V23, P2608, DOI 10.1128/MCB.23.7.2608-2613.2003; MOFFETT P, 1995, P NATL ACAD SCI USA, V92, P11105, DOI 10.1073/pnas.92.24.11105; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; Natoli TA, 2002, MOL CELL BIOL, V22, P4433, DOI 10.1128/MCB.22.12.4433-4438.2002; Oji Y, 1999, JPN J CANCER RES, V90, P194, DOI 10.1111/j.1349-7006.1999.tb00733.x; Oji Y, 2002, INT J CANCER, V100, P297, DOI 10.1002/ijc.10476; Oji Y, 2004, CANCER SCI, V95, P583, DOI 10.1111/j.1349-7006.2004.tb02490.x; Oji Y, 2003, CANCER SCI, V94, P712, DOI 10.1111/j.1349-7006.2003.tb01507.x; Panda AC, 2010, FEBS LETT, V584, P1169, DOI 10.1016/j.febslet.2010.02.020; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; REDDY JC, 1995, J BIOL CHEM, V270, P10878, DOI 10.1074/jbc.270.18.10878; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Scharnhorst V, 1999, J BIOL CHEM, V274, P23456, DOI 10.1074/jbc.274.33.23456; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; Simpson LA, 2006, BLOOD, V107, P4695, DOI 10.1182/blood-2005-10-4025; Srinivasula SM, 1999, CANCER RES, V59, P999; Sugiyama H, 2010, JPN J CLIN ONCOL, V40, P377, DOI 10.1093/jjco/hyp194; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Tatsumi N, 2008, INT J ONCOL, V32, P701; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; WANG ZY, 1993, P NATL ACAD SCI USA, V90, P8896, DOI 10.1073/pnas.90.19.8896	53	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130578	10.1371/journal.pone.0130578	http://dx.doi.org/10.1371/journal.pone.0130578			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090994	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000129
J	Enoki, Y; Ishima, Y; Tanaka, R; Sato, K; Kimachi, K; Shirai, T; Watanabe, H; Chuang, VTG; Fujiwara, Y; Takeya, M; Otagiri, M; Maruyama, T				Enoki, Yuki; Ishima, Yu; Tanaka, Ryota; Sato, Keizo; Kimachi, Kazuhiko; Shirai, Tatsuya; Watanabe, Hiroshi; Chuang, Victor T. G.; Fujiwara, Yukio; Takeya, Motohiro; Otagiri, Masaki; Maruyama, Toru			Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury	PLOS ONE			English	Article							INTERFERON-GAMMA; PNEUMOCOCCAL PNEUMONIA; NITRIC-OXIDE; ERYTHROMYCIN; CELLS; INFECTION; PATHOGENESIS; MECHANISM	Reactive oxygen species (ROS) and nitric oxide (NO) are major pathogenic molecules produced during viral lung infections, including influenza. While fluoroquinolones are widely used as antimicrobial agents for treating a variety of bacterial infections, including secondary infections associated with the influenza virus, it has been reported that they also function as anti-oxidants against ROS and as a NO regulator. Therefore, we hypothesized that levo-floxacin (LVFX), one of the most frequently used fluoroquinolone derivatives, may attenuate pulmonary injuries associated with influenza virus infections by inhibiting the production of ROS species such as hydroxyl radicals and neutrophil-derived NO that is produced during an influenza viral infection. The therapeutic impact of LVFX was examined in a PR8 (H1N1) influenza virus-induced lung injury mouse model. ESR spin-trapping experiments indicated that LVFX showed scavenging activity against neutrophil-derived hydroxyl radicals. LVFX markedly improved the survival rate of mice that were infected with the influenza virus in a dose-dependent manner. In addition, the LVFX treatment resulted in a dose-dependent decrease in the level of 8-hydroxy-2'-deoxyguanosine (a marker of oxidative stress) and nitrotyrosine (a nitrative marker) in the lungs of virus-infected mice, and the nitrite/nitrate ratio (NO metabolites) and IFN-gamma in BALF. These results indicate that LVFX may be of substantial benefit in the treatment of various acute inflammatory disorders such as influenza virus-induced pneumonia, by inhibiting inflammatory cell responses and suppressing the overproduction of NO in the lungs.	[Enoki, Yuki; Ishima, Yu; Tanaka, Ryota; Watanabe, Hiroshi; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, Kumamoto 8620973, Japan; [Ishima, Yu; Watanabe, Hiroshi; Maruyama, Toru] Kumamoto Univ, Sch Pharm, Ctr Clin Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan; [Sato, Keizo] Kyushu Univ Hlth & Welf, Sch Pharmaceut Sci, Dept Clin Biochem, Nobeoka, Japan; [Kimachi, Kazuhiko; Shirai, Tatsuya] Chemo Sero Therapeut Res Inst KAKETSUKEN, Kita Ku, Kumamoto, Kumamoto 8608566, Japan; [Chuang, Victor T. G.] Curtin Univ, Fac Hlth Sci, Sch Pharm, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia; [Chuang, Victor T. G.; Fujiwara, Yukio] Kumamoto Univ, Fac Life Sci, Grad Sch Med Sci, Chuo Ku, Kumamoto 8600811, Japan; [Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto 8600082, Japan; [Otagiri, Masaki] Sojo Univ, DDS Res Inst, Nishi Ku, Kumamoto 8600082, Japan	Kumamoto University; Kumamoto University; Curtin University; Kumamoto University; Sojo University; Sojo University	Maruyama, T (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	tomaru@gpo.kumamoto-u.ac.jp	Chuang, Victor/A-3644-2011; Chuang, Victor/A-3644-2011	Chuang, Victor/0000-0002-2141-630X; Chuang, Victor/0000-0003-4543-2256	Japan Society for the Promotion of Science (JSPS) [KAKENHI 21390177, 23390142, 25860118]; Japan Science and Technology Agency (JST) [10801043]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This research was supported [in part] by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) (KAKENHI 21390177, 23390142, 25860118) and by Japan Science and Technology Agency (JST), A-step feasibility study program (10801043).	Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Akamatsu H, 1996, J INT MED RES, V24, P345, DOI 10.1177/030006059602400405; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Dalhoff A, 2005, INFECTION, V33, P55, DOI 10.1007/s15010-005-8209-8; Dalhoff A, 2003, LANCET INFECT DIS, V3, P359, DOI 10.1016/S1473-3099(03)00658-3; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201; Hayashi K, 2006, ANTIMICROB AGENTS CH, V50, P748, DOI 10.1128/AAC.50.2.748-751.2006; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; KADOTA J, 1993, AM REV RESPIR DIS, V147, P153, DOI 10.1164/ajrccm/147.1.153; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kash JC, 2014, FREE RADICAL BIO MED, V67, P235, DOI 10.1016/j.freeradbiomed.2013.10.014; LABRO MT, 1991, EUR J CLIN MICROBIOL, V10, P124, DOI 10.1007/BF01964424; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107966; Matsushita T, 2005, JPN RESP SOC PRESS; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; ODA H, 1994, CHEST, V106, P1116, DOI 10.1378/chest.106.4.1116; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sato E, 2008, CHEM PHARM BULL, V56, P1194, DOI 10.1248/cpb.56.1194; Sato K, 1998, AM J RESP CRIT CARE, V157, P853, DOI 10.1164/ajrccm.157.3.9703098; SICA A, 1992, P NATL ACAD SCI USA, V89, P1740, DOI 10.1073/pnas.89.5.1740; Suliman HB, 2001, AM J PHYSIOL-LUNG C, V280, pL69, DOI 10.1152/ajplung.2001.280.1.L69; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; TAMAOKI J, 1992, EUR RESPIR J, V5, P234; Tanaka K, 1997, J CLIN INVEST, V100, P1822, DOI 10.1172/JCI119710; Tazi KA, 2005, GASTROENTEROLOGY, V129, P303, DOI 10.1053/j.gastro.2005.04.016; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; Visseren FLJ, 2002, EUR J CLIN INVEST, V32, P84, DOI 10.1046/j.1365-2362.2002.0320s1084.x; Vlahos R, 2012, TRENDS PHARMACOL SCI, V33, P3, DOI 10.1016/j.tips.2011.09.001; Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271; Wiley JA, 2001, AM J PATHOL, V158, P119, DOI 10.1016/S0002-9440(10)63950-8; Xu T, 2009, EUR RESPIR J, V33, P852, DOI 10.1183/09031936.00130507; Yashiro M, 2013, CRIT CARE MED, V41, P171, DOI 10.1097/CCM.0b013e3182676352	35	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130248	10.1371/journal.pone.0130248	http://dx.doi.org/10.1371/journal.pone.0130248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086073	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500085
J	Haass, W; Kleiner, H; Weiss, C; Haferlach, C; Schlegelberger, B; Muller, MC; Hehlmann, R; Hofmann, WK; Fabarius, A; Seifarth, W				Haass, Wiltrud; Kleiner, Helga; Weiss, Christel; Haferlach, Claudia; Schlegelberger, Brigitte; Mueller, Martin C.; Hehlmann, Ruediger; Hofmann, Wolf-Karsten; Fabarius, Alice; Seifarth, Wolfgang		SAKK; German Cml Study Grp	Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITORS; CHROMOSOMAL INSTABILITY; CENTROSOME ABERRATIONS; EXPRESSION LEVELS; RANDOMIZED CML; HUMAN CANCERS; CELL-LINE; PHASE CML	Unbalanced (major route) additional cytogenetic aberrations (ACA) at diagnosis of chronic myeloid leukemia (CML) indicate an increased risk of progression and shorter survival. Moreover, newly arising ACA under imatinib treatment and clonal evolution are considered features of acceleration and define failure of therapy according to the European Leukemia-Net (ELN) recommendations. On the basis of 1151 Philadelphia chromosome positive chronic phase patients of the randomized CML-study IV, we examined the incidence of newly arising ACA under imatinib treatment with regard to the p210BCR-ABL breakpoint variants b2a2 and b3a2. We found a preferential acquisition of unbalanced ACA in patients with b3a2 vs. b2a2 fusion type (ratio: 6.3 vs. 1.6, p = 0.0246) concurring with a faster progress to blast crisis for b3a2 patients (p = 0.0124). ESPL1/Separase, a cysteine endopeptidase, is a key player in chromosomal segregation during mitosis. Separase overexpression and/or hyperactivity has been reported from a wide range of cancers and cause defective mitotic spindles, chromosome missegregation and aneuploidy. We investigated the influence of p210BCR-ABL breakpoint variants and imatinib treatment on expression and proteolytic activity of Separase as measured with a specific fluorogenic assay on CML cell lines (b2a2: KCL-22, BV-173; b3a2: K562, LAMA-84). Despite a drop in Separase protein levels an up to 5.4-fold increase of Separase activity under imatinib treatment was observed exclusively in b3a2 but not in b2a2 cell lines. Mimicking the influence of imatinib on BV-173 and LAMA-84 cells by ESPL1 silencing stimulated Separase proteolytic activity in both b3a2 and b2a2 cell lines. Our data suggest the existence of a fusion type-related feedback mechanism that posttranslationally stimulates Separase proteolytic activity after therapy-induced decreases in Separase protein levels. This could render b3a2 CML cells more prone to aneuploidy and clonal evolution than b2a2 progenitors and may therefore explain the cytogenetic results of CML patients.	[Haass, Wiltrud; Kleiner, Helga; Mueller, Martin C.; Hehlmann, Ruediger; Hofmann, Wolf-Karsten; Fabarius, Alice; Seifarth, Wolfgang] Heidelberg Univ, Med Fak Mannheim, Med Univ Klin Hematol & Onkol 3, Mannheim, Germany; [Weiss, Christel] Heidelberg Univ, Med Fak Mannheim, Abt Med Stat & Biomath, Mannheim, Germany; [Haferlach, Claudia] MLL Munchner Leukamielab, Munich, Germany; [Schlegelberger, Brigitte] Hannover Med Sch, Inst Zell & Mol Pathol, D-30623 Hannover, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; MLL Munich Leukemia Laboratory; Hannover Medical School	Seifarth, W (corresponding author), Heidelberg Univ, Med Fak Mannheim, Med Univ Klin Hematol & Onkol 3, Mannheim, Germany.	wolfgang.seifarth@medma.uni-heidelberg.de	Laemmle, Bernhard/AAJ-1216-2020; Hüttmann, Andreas/W-6106-2019; Ottmann, Oliver/D-5007-2016	Laemmle, Bernhard/0000-0003-4538-5154; Hüttmann, Andreas/0000-0003-2230-3873; Ottmann, Oliver/0000-0001-9559-1330; La Rosee, Paul/0000-0002-6758-7809; Oppliger Leibundgut, Elisabeth/0000-0002-6652-4160; Koschmieder, Steffen/0000-0002-1011-8171; Serve, Hubert/0000-0001-8472-5516; Waller, Cornelius/0000-0002-5777-0212	Deutsche Krebshilfe [110625, 106642]; Bundesministerium fur Bildung und Forschung [BMBF 01GI0270]; Deutsche Jose-Carreras Leukamiestiftung [DJCLS H09/01f, H06/04v, H03/01, R05/23]; European Community [LSHC-CT-2004-503216]; Novartis [CSTI571ADE22]; Ruprecht-Karls-Universitat Heidelberg	Deutsche Krebshilfe(Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Jose-Carreras Leukamiestiftung; European Community(European Commission); Novartis(Novartis); Ruprecht-Karls-Universitat Heidelberg	WS received a grant from the Deutsche Krebshilfe (www.krebshilfe.de, 110625), RH obtained grants from Deutsche Krebshilfe (www.krebshilfe.de, 106642), Bundesministerium fur Bildung und Forschung (www.bmbf.de, BMBF 01GI0270), Deutsche Jose-Carreras Leukamiestiftung (www.carreras-stiftung.de, DJCLS H09/01f, H06/04v, H03/01, R05/23), European Community (ec.europa.eu, LSHC-CT-2004-503216). Novartis (www.novartis.de, CSTI571ADE22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge financial support by the Open Access Publishing funding programme of the Ruprecht-Karls-Universitat Heidelberg.	Baccarani M, 2009, ANN ONCOL, V20, P105, DOI 10.1093/annonc/mdp143; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Bacher U, 2005, CANCER GENET CYTOGEN, V157, P53, DOI 10.1016/j.cancergencyto.2004.06.011; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Basu D, 2009, ANAL BIOCHEM, V392, P133, DOI 10.1016/j.ab.2009.05.046; Bolton-Gillespie E, 2013, BLOOD, V121, P4175, DOI 10.1182/blood-2012-11-466938; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Cortes J, 2004, HEMATOL ONCOL CLIN N, V18, P671, DOI 10.1016/j.hoc.2004.03.012; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Di Gion P, 2011, CLIN PHARMACOKINET, V50, P551, DOI 10.2165/11593320-000000000-00000; Fabarius A, 2005, LEUKEMIA, V19, P1573, DOI 10.1038/sj.leu.2403861; Fabarius A, 2008, HAEMATOL-HEMATOL J, V93, P1145, DOI 10.3324/haematol.12793; Fabarius A, 2011, BLOOD, V118, P6760, DOI 10.1182/blood-2011-08-373902; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Giehl M, 2007, LEUKEMIA, V21, P1971, DOI 10.1038/sj.leu.2404834; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; Giehl M, 2010, EUR J HAEMATOL, V85, P139, DOI [10.1111/j.1600-0609.2010.01459.x, 10.1111/j.1600-0609.2010.1459.x]; Haass W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042863; Hanfstein B, 2014, HAEMATOLOGICA, V99, P1441, DOI 10.3324/haematol.2013.096537; Hehlmann R, 2014, J CLIN ONCOL, V32, P415, DOI 10.1200/JCO.2013.49.9020; Hellmuth S, 2014, EMBO J, V33, P1134, DOI 10.1002/embj.201488098; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Jabbour E, 2006, LEUKEMIA, V20, P1767, DOI 10.1038/sj.leu.2404318; Kovacs LAS, 2010, CELL CYCLE, V9, P1750, DOI 10.4161/cc.9.9.11792; Kumari A, 2012, BLOOD, V119, P530, DOI 10.1182/blood-2010-08-303495; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer R, 2009, CLIN CANCER RES, V15, P2703, DOI 10.1158/1078-0432.CCR-08-2454; MITELMAN F, 1976, INT J CANCER, V18, P24, DOI 10.1002/ijc.2910180105; Mukherjee M, 2014, ONCOGENE, V33, P5511, DOI 10.1038/onc.2013.493; Mukherjee M, 2014, J NEURO-ONCOL, V119, P27, DOI 10.1007/s11060-014-1458-6; Nakamura A, 2009, J CELL BIOL, V187, P607, DOI 10.1083/jcb.200906019; Nicholson JM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00148; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; O'Dwyer ME, 2004, BLOOD, V103, P451, DOI 10.1182/blood-2003-02-0371; O'Dwyer ME, 2002, BLOOD, V100, P1628, DOI 10.1182/blood-2002-03-0777; Patel H, 2009, BRIT J HAEMATOL, V146, P408, DOI 10.1111/j.1365-2141.2009.07772.x; Perego RA, 2000, EUR J CANCER, V36, P1395, DOI 10.1016/S0959-8049(00)00128-3; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Pihan GA, 2003, CANCER RES, V63, P1398; Rosenhahn J, 2007, INT J ONCOL, V31, P121; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schnittger S, 2010, GENE CHROMOSOME CANC, V49, P910, DOI 10.1002/gcc.20801; Schoch C, 2003, LEUKEMIA, V17, P461, DOI 10.1038/sj.leu.2402813; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; Terre C, 2004, LEUKEMIA, V18, P1340, DOI 10.1038/sj.leu.2403399; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Verma D, 2010, CANCER-AM CANCER SOC, V116, P2673, DOI 10.1002/cncr.25015; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Zhang NG, 2014, J BIOMOL SCREEN, V19, P878, DOI 10.1177/1087057114520972	55	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129648	10.1371/journal.pone.0129648	http://dx.doi.org/10.1371/journal.pone.0129648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087013	Green Accepted, Green Published, gold			2022-12-26	WOS:000356567500055
J	Holland, BW; Berry, MD; Gray, CG; Tomberli, B				Holland, Bryan W.; Berry, Mark D.; Gray, C. G.; Tomberli, Bruno			A Permeability Study of O-2 and the Trace Amine p-Tyramine through Model Phosphatidylcholine Bilayers	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; LIPID-BILAYERS; FREE-ENERGY; DIFFUSION-COEFFICIENTS; DISSOCIATION-CONSTANTS; BETA-PHENYLETHYLAMINE; COMPUTER-SIMULATION; FORCE-FIELD; PERMEATION; MEMBRANE	We study here the permeability of the hydrophobic O-2 molecule through a model DPPC bilayer at 323K and 350K, and of the trace amine p-tyramine through PC bilayers at 310K. The tyramine results are compared to previous experimental work at 298K. Nonequilibrium work methods were used in conjunction to simultaneously obtain both the potential of mean force (PMF) and the position dependent transmembrane diffusion coefficient, D(z), from the simulations. These in turn were used to calculate the permeability coefficient, P, through the inhomogeneous solubility-diffusion model. The results for O-2 are consistent with previous simulations, and agree with experimentally measured P values for PC bilayers. A temperature dependence in the permeability of O-2 through DPPC was obtained, with P decreasing at higher temperatures. Two relevant species of p-tyramine were simulated, from which the PMF and D(z) were calculated. The charged species had a large energetic barrier to crossing the bilayer of similar to 21 kcal/mol, while the uncharged, deprotonated species had a much lower barrier of similar to 7 kcal/mol. The effective in silico permeability for p-tyramine was calculated by applying three approximations, all of which gave nearly identical results (presented here as a function of the pK(a)). As the permeability value calculated from simulation was highly dependent on the pK(a) of the amine group, a further pK(a) study was performed that also varied the fraction of the uncharged and zwitterionic p-tyramine species. Using the experimental P value together with the simulated results, we were able to label the phenolic group as responsible for the pK(a1) and the amine for the pK(a2), that together represent all of the experimentally measured pK(a) values for p-tyramine. This agrees with older experimental results, in contrast to more recent work that has suggested there is a strong ambiguity in the pK(a) values.	[Holland, Bryan W.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Berry, Mark D.] Brandon Univ, Dept Chem, Brandon, MB R7A 6A9, Canada; [Holland, Bryan W.; Gray, C. G.; Tomberli, Bruno] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Tomberli, Bruno] Capilano Univ, Dept Phys, N Vancouver, BC, Canada	University of Calgary; Brandon University; University of Guelph; Capilano University	Tomberli, B (corresponding author), Capilano Univ, Dept Phys, N Vancouver, BC, Canada.	brunotomberli@capilanou.ca		Berry, Mark/0000-0003-0172-0803	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this work was provided through various grants of the Natural Sciences and Engineering Research Council of Canada, held by MDB, CGG and BT. The computational resources were provided by Brandon University, Brandon, Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG J, 1976, BRIT J PHARMACOL, V57, P501, DOI 10.1111/j.1476-5381.1976.tb10377.x; Asthagiri D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2944252; Balaz S, 2009, CHEM REV, V109, P1793, DOI 10.1021/cr030440j; Bemporad D, 2004, BIOPHYS J, V87, P1, DOI 10.1529/biophysj.103.030601; Berry MD, 2007, REV RECENT CLIN TRIA, V2, P3, DOI 10.2174/157488707779318107; Berry MD, 2013, SYNAPSE, V67, P656, DOI 10.1002/syn.21670; Berry MD, 2011, J NEURAL TRANSM, V118, P1119, DOI 10.1007/s00702-010-0569-2; Berry MD, 2004, J NEUROCHEM, V90, P257, DOI 10.1111/j.1471-4159.2004.02501.x; Born M, 1920, Z PHYS, V1, P45, DOI 10.1007/BF01881023; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Chain Association A, 2005, STAND HDB CHAINS; Chen LY, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2992153; Comer J, 2014, J CHEM THEORY COMPUT, V10, P554, DOI 10.1021/ct400925s; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; DEAMER DW, 1986, CHEM PHYS LIPIDS, V40, P167, DOI 10.1016/0009-3084(86)90069-1; DYCK LE, 1989, LIFE SCI, V44, P1149, DOI 10.1016/0024-3205(89)90309-3; DYCK LE, 1983, J NEUROSCI RES, V10, P211, DOI 10.1002/jnr.490100209; Emsley J., 2011, NATURES BUILDING BLO; EVANS DF, 1979, J SOLUTION CHEM, V8, P461; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Ghaemi Z, 2012, J PHYS CHEM B, V116, P8714, DOI 10.1021/jp301083h; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; HAUSER H, 1972, NATURE, V239, P342, DOI 10.1038/239342a0; HAYDUK W, 1976, J CHEM ENG DATA, V21, P255, DOI 10.1021/je60070a034; HAYDUK W, 1972, CHEM ENG SCI, V27, P1997, DOI 10.1016/0009-2509(72)87058-1; Herzberg G, 1950, MOLECULAR SPECTRA AN; Holland BW, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036707; Holland BW, 2012, J COMPUT PHYS, V231, P4355, DOI 10.1016/j.jcp.2012.02.018; Holland BW, 2012, THESIS U GUELPH; Hummer G, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/034; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JUORIO AV, 1988, N-S ARCH PHARMACOL, V338, P644, DOI 10.1007/BF00165628; KAPPE T, 1965, J MED CHEM, V8, P368, DOI 10.1021/jm00327a018; Kessel A, 2001, BIOPHYS J, V80, P2536, DOI 10.1016/S0006-3495(01)76225-X; Khavrutskii IV, 2009, J AM CHEM SOC, V131, P1706, DOI 10.1021/ja8081704; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kosztin I, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166379; KOZAKI T, 1989, J AM CHEM SOC, V111, P1547, DOI 10.1021/ja00187a002; Latimer WM, 1939, J CHEM PHYS, V7, P108, DOI 10.1063/1.1750387; LEWIS GP, 1954, BRIT J PHARM CHEMOTH, V9, P488, DOI 10.1111/j.1476-5381.1954.tb00866.x; LIEB WR, 1969, NATURE, V224, P240, DOI 10.1038/224240a0; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; MACK F, 1979, N-S ARCH PHARMACOL, V310, P1, DOI 10.1007/BF00499868; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; MARRINK SJ, 1994, J PHYS CHEM-US, V98, P4155, DOI 10.1021/j100066a040; Marrink SJ, 1996, J PHYS CHEM-US, V100, P16729, DOI 10.1021/jp952956f; Miller GM, 2005, J PHARMACOL EXP THER, V313, P983, DOI 10.1124/jpet.105.084459; Miller GM, 2012, J MED CHEM, V55, P1809, DOI 10.1021/jm201437t; NategholEslam M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021114; OPDENKAMP JAF, 1975, BIOCHIM BIOPHYS ACTA, V406, P169, DOI 10.1016/0005-2736(75)90001-2; OWEN BB, 1961, J PHYS CHEM-US, V65, P2065, DOI 10.1021/j100828a035; Partilla JS, 2006, J PHARMACOL EXP THER, V319, P237, DOI 10.1124/jpet.106.103622; PATERSON IA, 1990, J NEUROCHEM, V55, P1827, DOI 10.1111/j.1471-4159.1990.tb05764.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pohorille A, 2007, SPRINGER SERIES CHEM; Revel FG, 2012, BIOL PSYCHIAT, V72, P934, DOI 10.1016/j.biopsych.2012.05.014; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Schubert T, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3615937; Shi Y, 2011, J COMPUT CHEM, V32, P967, DOI 10.1002/jcc.21681; SHIMAMURA M, 1993, NEUROCHEM RES, V18, P727, DOI 10.1007/BF00966788; Shinoda W, 2004, J PHYS CHEM B, V108, P9346, DOI 10.1021/jp035998+; Shoemaker SD, 2003, BIOPHYS J, V84, P998, DOI 10.1016/S0006-3495(03)74916-9; Silvius J. IL, 1982, THERMOTROPIC PHASE T; Sugii T, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2102900; Svetlovics JA, 2012, BIOPHYS J, V102, P2526, DOI 10.1016/j.bpj.2012.04.017; Tepper HL, 2006, J PHYS CHEM B, V110, P21327, DOI 10.1021/jp064192h; Timko J, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3360310; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Ulander J, 2003, BIOPHYS J, V85, P3475, DOI 10.1016/S0006-3495(03)74768-7; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Wei CY, 2009, J AM CHEM SOC, V131, P10237, DOI 10.1021/ja902531k; Widom B, 2003, PHYS CHEM CHEM PHYS, V5, P3085, DOI 10.1039/b304038k; Widomska J, 2007, BBA-BIOMEMBRANES, V1768, P2635, DOI 10.1016/j.bbamem.2007.06.018; WILKE CR, 1955, AICHE J, V1, P264, DOI 10.1002/aic.690010222; Wilson MA, 1996, J AM CHEM SOC, V118, P6580, DOI 10.1021/ja9540381; WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030; WOLYNES PG, 1980, ANNU REV PHYS CHEM, V31, P345, DOI 10.1146/annurev.pc.31.100180.002021; XIANG TX, 1994, J MEMBRANE BIOL, V140, P111; XIANG TX, 1993, BIOPHYS J, V65, P1108, DOI 10.1016/S0006-3495(93)81156-1; Zocher F, 2013, BIOPHYS J, V105, P2760, DOI 10.1016/j.bpj.2013.11.003	86	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0122468	10.1371/journal.pone.0122468	http://dx.doi.org/10.1371/journal.pone.0122468			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086933	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500003
J	Matsumoto, S; Yamaoka, K; Inoue, M; Inoue, M; Muto, S				Matsumoto, Shoko; Yamaoka, Kazue; Inoue, Machiko; Inoue, Mariko; Muto, Shinsuke		Teikyo Ishinomaki Research Grp	Implications for Social Support on Prolonged Sleep Difficulties among a Disaster-Affected Population: Second Report from a Cross-Sectional Survey in Ishinomaki, Japan	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; HEALTH BEHAVIORS; INSOMNIA; STRESS; DISTURBANCE; SYMPTOMS; DISEASE; EVENTS; MODELS; ADULTS	Study Objectives This study aimed to investigate the role of social factors, especially social support for sleep, among victims living at home around 1-2 years after the Great East Japan Earthquake and tsunami. Design A cross-sectional household survey was conducted between May and December 2012 (14-21 months after the disaster) in the Ishinomaki area, Japan. Univariate and multivariate logistic regression models were used to examine the association between social factors, including social support, and prolonged sleep difficulties (persisting over 1 month). Social support was divided into three functions: emotional, informational, and instrumental support. Participants Data were obtained on 2,593 individuals who were living at home after the disaster. Results The prevalence of prolonged sleep difficulties was 6.9% (5.8% male, 7.7% female). This study showed that lack of social support has a stronger association with prolonged sleep difficulties than non-modifiable or hardly modifiable consequences caused directly by the disaster, i.e., severity of home damage, change in family structure and income. Among the three dimensions of social support, lack of emotional support showed the strongest association with prolonged sleep difficulties. Conclusions Social support, especially emotional support, may positively affect sleep among victims living at home around 1-2 years after a disaster.	[Matsumoto, Shoko; Yamaoka, Kazue; Inoue, Mariko] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 173, Japan; [Inoue, Machiko] Hamamatsu Univ, Sch Med, Dept Family & Community Med, Shizuoka, Japan; [Inoue, Mariko; Teikyo Ishinomaki Research Grp] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Muto, Shinsuke] RCI, Hlth & Life Revival Council, Ishinomaki, Miyagi, Japan	Teikyo University; Hamamatsu University School of Medicine; Teikyo University	Matsumoto, S (corresponding author), Teikyo Univ, Grad Sch Publ Hlth, Tokyo 173, Japan.	shoko27@med.teikyo-u.ac.jp	Inoue, Machiko/T-4884-2019	Inoue, Machiko/0000-0002-0799-5894	Japan Public Health Society through a Special Grant for public health in the Great East Japan Earthquake	Japan Public Health Society through a Special Grant for public health in the Great East Japan Earthquake	This study was supported financially by the Japan Public Health Society through a Special Grant for public health in the Great East Japan Earthquake in 2012 (http://www.jsph.jp/news.php?no=129 only in Japanese). The Teikyo Ishinomaki Research Group received the funding, and SM1 KY1 MI1 MI2 were the group members. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], STAT DOCUMENTATION B; [Anonymous], REP DIS VOL CTR GREA; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Chouinard MC, 2007, EUR J CARDIOV PREV R, V14, P51, DOI 10.1097/HJR.0b013e328014027b; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; Daley M, 2009, SLEEP, V32, P55; DAVIDSON LM, 1987, J HUM STRESS, V13, P75, DOI 10.1080/0097840X.1987.9936798; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Emmons KM, 2007, HEALTH EDUC BEHAV, V34, P315, DOI 10.1177/1090198106288011; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Geng FL, 2013, J CLIN PSYCHIAT, V74, P69, DOI 10.4088/JCP.12m07872; Godet-Cayre V, 2006, SLEEP, V29, P179, DOI 10.1093/sleep/29.2.179; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; HEALEY ES, 1981, PSYCHOSOM MED, V43, P439; HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293, DOI 10.1146/annurev.so.14.080188.001453; House JS, 1981, WORK STRESS SOCIAL S; Japan Society of Family Sociology, NAT FAM RES JAP; Kaniasty K., 2004, BIOTERRORISM PSYCHOL, P200, DOI DOI 10.1056/NEJM200506163522421; Kim J, 2010, J HEALTH PSYCHOL, V15, P543, DOI 10.1177/1359105309355338; Koyama S, 2014, TOHOKU J EXP MED, V234, P241, DOI 10.1620/tjem.234.241; Langford CP, 1997, ADV NURS, V25, P95; LIN N, 1979, J HEALTH SOC BEHAV, V20, P108, DOI 10.2307/2136433; Matsumoto S, 2014, SLEEP, V37, P137, DOI 10.5665/sleep.3324; MCCOLL MA, 1995, SOC SCI MED, V41, P395, DOI 10.1016/0277-9536(94)00338-T; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/sim.6008, DOI 10.1002/SIM.6008]; Sateia MJ, 2000, SLEEP, V23, P243; Semmer NK, 2008, INT J STRESS MANAGE, V15, P235, DOI 10.1037/1072-5245.15.3.235; Shakespeare-Finch J., 2013, NATONAL EMERG RESPON, V26, P14, DOI [10.3316/informit.429790671056517, DOI 10.3316/INFORMIT.429790671056517]; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020; Stansfeld SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081115; TARDY CH, 1985, AM J COMMUN PSYCHOL, V13, P187, DOI 10.1007/BF00905728; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; Tempesta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055936; Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x; UMBERSON D, 1987, J HEALTH SOC BEHAV, V28, P306, DOI 10.2307/2136848; Usami M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065398; Van den Berg B, 2008, PSYCHOL MED, V38, P499, DOI 10.1017/S003329170700133X; von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972; Wu ZH, 2015, SLEEP; Yamaoka K, 2010, STUDY STAT SCI HLTH	44	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130615	10.1371/journal.pone.0130615	http://dx.doi.org/10.1371/journal.pone.0130615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NT	26087305	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500123
J	Roiz, D; Ruiz, S; Soriguer, R; Figuerola, J				Roiz, David; Ruiz, Santiago; Soriguer, Ramon; Figuerola, Jordi			Landscape Effects on the Presence, Abundance and Diversity of Mosquitoes in Mediterranean Wetlands	PLOS ONE			English	Article							WEST-NILE-VIRUS; NEUTRALIZING ANTIBODIES; LANDSAT TM; RISK; TRANSMISSION; VECTORS; EPIDEMIOLOGY; MODELS; IMPACT; PREVALENCE	Environment determines the distribution of mosquito-borne diseases in that it influences the vector-host-pathogen transmission cycle, including vector distribution, abundance and diversity. In this study, we analyse the relationship between environmental variables estimated by remote sensing and the spatial distribution (presence, abundance and diversity) of seven mosquito species vectors of West Nile and other pathogens (Usutu, avian malaria and dirofilariasis) in the Donana Natural Park, Spain. Traps were distributed over an area of 54,984 ha divided into six ecological units: marshland, sand dunes, scrubland, ricefields, crops and fishponds. We collected mosquitoes once a month from up to 112 locations using BG-Sentinel traps baited with BG-lure and CO2 during March-November 2010. Hydroperiod, NDVI and Inundation surface were estimated at several resolution scales (100, 250, 500, 1000 and 2000 metres) from corrected and normalized Landsat Images. We sampled 972,346 female mosquitoes, the most abundant species being Culex theileri, Ochlerotatus caspius, Culex modestus, Culex perexiguus, Culex pipiens, Anopheles atroparvus and Ochlerotatus detritus. Our results suggest that: (1) hydroperiod, inundation surface and NDVI are strongly related to the spatial distribution of mosquitoes; (2) the spatial scales used to measure these variables affected quantification of these relationships, the larger scale being more informative; (3) these relationships are species-specific; (4) hydroperiod is negatively related to mosquito presence and richness; (5) Culex abundance is positively related to hydroperiod; (6) NDVI is positively related to mosquito diversity, presence and abundance, except in the case of the two salt marsh species (Oc. caspius and Oc. detritus); and (7) inundation surfaces positively condition the abundance and richness of most species except the salt marsh mosquitoes. Remote sensing data provided reliable information for monitoring mosquito populations. Landscape significantly affected mosquito distribution and abundance, and as a result may alter disease risk. These results suggest that while environmental conditions affect the distribution and abundance of mosquitoes, other factors such as human modification of landscapes may give rise to significant changes in mosquito populations and consequently disease risk.	[Roiz, David; Soriguer, Ramon; Figuerola, Jordi] CSIC, Estn Biol Donana, Seville 41092, Spain; [Ruiz, Santiago] Serv Control Mosquitos, Area Medio Ambiente, Huelva, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Roiz, D (corresponding author), IRD, MIVEGEC Infect Dis & Vectors Ecol Genet Evolut &, UMR IRD224 CNRS5290 UM, 911 Ave Agropolis,BP 64501, F-34394 Montpellier 5, France.	davidroiz@gmail.com	Roiz, David/F-2082-2011; Figuerola, Jordi/B-7917-2008; Ruíz, Santiago/HGU-6016-2022; Casimiro-Soriguer, Ramon/J-1494-2014	Roiz, David/0000-0002-5819-3648; Figuerola, Jordi/0000-0002-4664-9011; Casimiro-Soriguer, Ramon/0000-0002-9165-7766	Junta de Andalucia [P07-RNM-02511, RNM118, RNM157]; European Commission EuroWestNile EU grant [261391, HEALTH.2010.2.3.3-3]; EDENext FP7 project [EDENext 344]	Junta de Andalucia(Junta de Andalucia); European Commission EuroWestNile EU grant; EDENext FP7 project	This work was partially supported by the Junta de Andalucia projects P07-RNM-02511, RNM118, RNM157, and European Commission EuroWestNile EU grant HEALTH. 2010.2.3.3-3 Project 261391, and the EDENext FP7 project, publication number EDENext 344.	Jimenez-Clavero MA, 2007, VET REC, V161, P212, DOI 10.1136/vr.161.6.212; Arav D, 2006, J MED ENTOMOL, V43, P493, DOI 10.1603/0022-2585(2006)43[493:EOPDAR]2.0.CO;2; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Brown H, 2008, VECTOR-BORNE ZOONOT, V8, P197, DOI 10.1089/vbz.2007.0154; Brownstein JS, 2002, VECTOR-BORNE ZOONOT, V2, P157, DOI 10.1089/15303660260613729; Bustamante J, 2009, J ENVIRON MANAGE, V90, P2219, DOI 10.1016/j.jenvman.2007.08.021; Cleckner HL, 2011, REMOTE SENS-BASEL, V3, P2663, DOI 10.3390/rs3122663; Corti D, 1997, OECOLOGIA, V109, P154, DOI 10.1007/s004420050070; Crawley M. J, 2002, STAT COMPUTING INTRO; Crowder DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055006; Danis K, 2011, EUROSURVEILLANCE, V16, P2752; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; Ezenwa VO, 2007, VECTOR-BORNE ZOONOT, V7, P173, DOI 10.1089/vbz.2006.0584; Figuerola J, 2008, VET MICROBIOL, V132, P39, DOI 10.1016/j.vetmic.2008.04.023; Figuerola J, 2007, AVIAN PATHOL, V36, P209, DOI 10.1080/03079450701332329; Garcia-Bocanegra I, 2011, EMERG INFECT DIS, V17, P2397, DOI 10.3201/eid1712.110651; Gomez-Rodriguez C, 2010, REMOTE SENS-BASEL, V2, P1439, DOI 10.3390/rs2061439; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Harbach R. E., 1999, EUR MOSQ B, V4; Hay SI, 1997, INT J REMOTE SENS, V18, P2899, DOI 10.1080/014311697217125; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kitron U, 1998, J MED ENTOMOL, V35, P435, DOI 10.1093/jmedent/35.4.435; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; McAlpine CA, 2008, J APPL ECOL, V45, P558, DOI 10.1111/j.1365-2664.2007.01431.x; Munoz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039549; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; Reisen WK, 1999, J AM MOSQUITO CONTR, V15, P105; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Roche B, 2013, AM NAT, V181, P1, DOI 10.1086/668591; Roiz D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-333; Roiz D, 2012, AM J TROP MED HYG, V86, P642, DOI 10.4269/ajtmh.2012.11-0326; Schafer ML, 2004, MED VET ENTOMOL, V18, P256, DOI 10.1111/j.0269-283X.2004.00504.x; Schaffner F, 2011, MOUSTIQUES EUROPE MO; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Silberbush A, 2011, FUNCT ECOL, V25, P1091, DOI 10.1111/j.1365-2435.2011.01873.x; Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Vazquez A, 2011, EUROSURVEILLANCE, V16, P1; Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687; Vazquez A, 2011, AM J TROP MED HYG, V85, P178, DOI 10.4269/ajtmh.2011.11-0042; Vazquez A, 2010, EMERG INFECT DIS, V16, P549, DOI 10.3201/eid1603.091033; Walsh MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030620; Winters AM, 2008, AM J TROP MED HYG, V79, P581, DOI 10.4269/ajtmh.2008.79.581; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	49	52	53	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128112	10.1371/journal.pone.0128112	http://dx.doi.org/10.1371/journal.pone.0128112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086804	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500014
J	Assefa, D; Klinkenberg, E; Yosef, G				Assefa, Dawit; Klinkenberg, Eveline; Yosef, Genet			Cross Sectional Study Evaluating Routine Contact Investigation in Addis Ababa, Ethiopia: A Missed Opportunity to Prevent Tuberculosis in Children	PLOS ONE			English	Article							CHILDHOOD TUBERCULOSIS; CHALLENGES; BURDEN	The 2013 global roadmap for childhood tuberculosis calls for countries to implement contact screening and provide preventive therapy to children younger than 5 years. Therefore, this study designed to evaluate the implementation status of child contact screening and management in the health facilities of Addis Ababa, Ethiopia. Smear positive TB patients living with children attending daily observed treatment at the TB clinic and health care workers providing service were approached to address the study objective. Structured questionnaires were administered to smear positive index cases living with children whether they were requested to bring children age five year and below for TB screening and to health care providers in HIV, TB and child health clinics to assess their knowledge and practice on contact screening and management. Double data entry and analysis was done using EpiData software 3.1. In 27 health centres, 688 smear-positive index tuberculosis patients were approached of whom 203 (29.5%) reported to have children five years and below in their household. A total of 48 (23.6%) index cases had been requested by the health care workers to bring their children for tuberculosis screening and 45 (93.8%) had complied with this request. Of 230 children living with index smear positive tuberculosis patient, 152 (66.1%) were not screened for tuberculosis, 78 (33.9%) children screened, 2 had tuberculosis, 76 screened negative of which 3 (3.8%) received preventive treatment. None of the health care workers indicated to routinely record and report on child contact management. Household child contact screening and preventive intervention was sub-optimal in Addis Ababa. An important opportunity lost to prevent tuberculosis in young children. Training of health care workers, availing simple symptom based screening tool, and proper documentation could improve implementation.	[Assefa, Dawit] KNCV TB Fdn, Monitoring & Evaluat Unit, TB CARE Country Off 1, Addis Ababa, Ethiopia; [Klinkenberg, Eveline] KNCV TB Fdn, Res Unit, The Hague, Netherlands; [Klinkenberg, Eveline] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Yosef, Genet] Addis Ababa City Adm Hlth Bur, Fed Minist Hlth, TB HIV Control Dept, Addis Ababa, Ethiopia	KNCV Tuberculosis Foundation; KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam; Federal Ministry of Health - Ethiopia (FMOH)	Assefa, D (corresponding author), KNCV TB Fdn, Monitoring & Evaluat Unit, TB CARE Country Off 1, Addis Ababa, Ethiopia.	dawita8246@gmail.com			United States Agency for International Development under USAID Tuberculosis CARE I [AID-OAA-A-10-000020]	United States Agency for International Development under USAID Tuberculosis CARE I(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development under the USAID Tuberculosis CARE I, Cooperative Agreement No. AID-OAA-A-10-000020. The contents of this paper herein expressed are those of the authors and do not necessarily reflect the views of the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, DESK GUID DIAGN MAN; [Anonymous], 2014, WHOHTM201408, P131; Bickenbach J, 2013, INTERNATIONAL PERSPECTIVES ON SPINAL CORD INJURY, P11; Claessens NJM, 2002, INT J TUBERC LUNG D, V6, P362; Detjen A., 2013, FRAMEWORK INTEGRATIN; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Federal Democratic Republic of Ethiopia Ministry of Health, 2013, GUID CLIN PROGR MAN, P44; Fitbomb, 2012, NO MOR SUG; Graham S., 2012, WHAT SILENT EPIDEMIC, P5; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hill PC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001105; Lobato MN, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.6.e75; Marais BJ, 2007, J INFECT DIS, V196, pS76, DOI 10.1086/518659; Marais BJ, 2010, INFECT DIS CLIN N AM, V24, P727, DOI 10.1016/j.idc.2010.04.004; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Nyirenda M, 2006, INT J TUBERC LUNG D, V10, P585; Pothukuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022500; Rekha B, 2013, INT J TUBERC LUNG D, V17, P163, DOI 10.5588/ijtld.12.0415; Schaaf HS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-140; Tornee Songpol, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P331; van Soelen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080803; van Wyk SS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-544; WHO, 2014, WORLD HLTH STAT, P45	23	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129135	10.1371/journal.pone.0129135	http://dx.doi.org/10.1371/journal.pone.0129135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083244	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400082
J	Ge, HF; Gardner, J; Wu, XS; Rulifson, I; Wang, JH; Xiong, YM; Ye, JJ; Belouski, E; Cao, P; Tang, J; Lee, KJ; Coberly, S; Wu, XL; Gupte, J; Miao, L; Yang, L; Nguyen, N; Shan, B; Yeh, WC; Veniant, MM; Li, Y; Baribault, H				Ge, Hongfei; Gardner, Jonitha; Wu, Xiaosu; Rulifson, Ingrid; Wang, Jinghong; Xiong, Yumei; Ye, Jingjing; Belouski, Edward; Cao, Ping; Tang, Jie; Lee, Ki Jeong; Coberly, Suzanne; Wu, Xinle; Gupte, Jamila; Miao, Lynn; Yang, Li; Nguyen, Natalie; Shan, Bei; Yeh, Wen-Chen; Veniant, Murielle M.; Li, Yang; Baribault, Helene			Trefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous Metaplasia	PLOS ONE			English	Article							HIGH-FAT DIET; GASTRIC-CANCER; DIABETES-MELLITUS; EPITHELIAL-CELLS; EXPRESSION; MICE; PEPTIDES; MIGRATION; OBESITY; CHROMOSOME-17	Trefoil factor 3 (TFF3), also called intestinal trefoil factor or Itf, is a 59 amino acid peptide found as a homodimer predominantly along the gastrointestinal tract and in serum. TFF3 expression is elevated during gastrointestinal adenoma progression and has been shown to promote mucosal wound healing. Here we show that in contrast to other trefoil factor family members, TFF1 and TFF2, TFF3 is highly expressed in mouse duodenum, jejunum and ileum and that its expression is regulated by food intake. Overexpression of TFF3 using a recombinant adeno-associated virus (AAV) vector, or daily administration of recombinant TFF3 protein in vivo improved glucose tolerance in a diet-induced obesity mouse model. Body weight, fasting insulin, triglyceride, cholesterol and leptin levels were not affected by TFF3 treatment. Induction of mucinous metaplasia was observed in mice with AAV-mediated TFF3 overexpression, however, no such adverse histological effect was seen after the administration of recombinant TFF3 protein. Altogether these results suggest that the therapeutic potential of targeting TFF3 to treat T2D may be limited.	[Ge, Hongfei; Gardner, Jonitha; Wu, Xiaosu; Rulifson, Ingrid; Wang, Jinghong; Xiong, Yumei; Wu, Xinle; Gupte, Jamila; Miao, Lynn; Yang, Li; Nguyen, Natalie; Shan, Bei; Yeh, Wen-Chen; Li, Yang; Baribault, Helene] Amgen Inc, Metab Disorders, San Francisco, CA 94080 USA; [Veniant, Murielle M.] Amgen Inc, Metab Disorders, Thousand Oaks, CA USA; [Ye, Jingjing; Belouski, Edward; Cao, Ping; Tang, Jie] Amgen Inc, Prot Technol, San Francisco, CA USA; [Lee, Ki Jeong] Amgen Inc, Lead Discovery, Thousand Oaks, CA USA; [Coberly, Suzanne] Amgen Inc, Pathol, San Francisco, CA USA	Amgen; Amgen; Amgen; Amgen; Amgen	Baribault, H (corresponding author), Amgen Inc, Metab Disorders, San Francisco, CA 94080 USA.	baribaulth@gmail.com		, Ki Jeong/0000-0002-8039-7436				Baribault H, 2010, METHODS MOL BIOL, V602, P135, DOI 10.1007/978-1-60761-058-8_9; Brown AC, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-12; De Giorgio MR, 2013, OBESITY, V21, P1389, DOI 10.1002/oby.20165; Ding AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082136; Du TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080271; Durer U, 2007, CELL PHYSIOL BIOCHEM, V20, P329, DOI 10.1159/000107519; Fineman MS, 2012, DIABETES OBES METAB, V14, P546, DOI 10.1111/j.1463-1326.2012.01561.x; Fueger PT, 2008, MOL ENDOCRINOL, V22, P1251, DOI 10.1210/me.2007-0500; Gomez Justin M, 2014, Gastroenterol Hepatol (N Y), V10, P369; Im S, 2013, INT J MED SCI, V10, P133, DOI 10.7150/ijms.5500; Jagla W, 2000, FASEB J, V14, P1126, DOI 10.1096/fasebj.14.9.1126; Jiang GX, 2010, MOL BIOL REP, V37, P3813, DOI 10.1007/s11033-010-0036-z; Karasawa H, 2009, METABOLISM, V58, P296, DOI 10.1016/j.metabol.2008.09.028; Kirikoshi H, 2002, INT J ONCOL, V21, P655; Kumar KG, 2008, J NUTRIGENET NUTRIGE, V1, P155, DOI 10.1159/000113657; Lowrance WT, 2014, J AM SOC NEPHROL, V25, P2327, DOI 10.1681/ASN.2013060604; Ma J, 1982, CANCER, V49, P1664; Mahmood A, 2005, ALIMENT PHARM THER, V21, P1357, DOI 10.1111/j.1365-2036.2005.02436.x; Marathe CS, 2013, PEPTIDES, V44, P75, DOI 10.1016/j.peptides.2013.01.014; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Meng JR, 2013, CLIN EXP MED, V13, P297, DOI 10.1007/s10238-012-0210-9; Neff KJ, 2013, CURR DIABETES REV, V9, P93, DOI 10.2174/1573399811309020001; Nozaki I, 2004, AM J PATHOL, V165, P1907, DOI 10.1016/S0002-9440(10)63243-9; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Paulsen FP, 2008, J BIOL CHEM, V283, P13418, DOI 10.1074/jbc.M800177200; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sasaki M, 2007, PROG HISTOCHEM CYTO, V42, P61, DOI 10.1016/j.proghi.2007.02.001; Shah AA, 2011, RNA BIOL, V8, P77, DOI 10.4161/rna.8.1.13687; Shi HS, 2012, BEHAV BRAIN RES, V227, P265, DOI 10.1016/j.bbr.2011.10.051; Shi Lei, 2014, Int J Pept, V2014, P634135, DOI 10.1155/2014/634135; Srivatsa G, 2002, HISTOPATHOLOGY, V40, P261, DOI 10.1046/j.1365-2559.2002.01347.x; Tan XD, 1997, BIOCHEM BIOPH RES CO, V237, P673, DOI 10.1006/bbrc.1997.7144; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Thim L, 2000, REGUL PEPTIDES, V90, P61, DOI 10.1016/S0167-0115(00)00110-5; TOMITA M, 1995, BIOCHEM J, V311, P293, DOI 10.1042/bj3110293; Vandenbroucke K, 2004, GASTROENTEROLOGY, V127, P502, DOI 10.1053/j.gastro.2004.05.020; Vestergaard EM, 2006, CLIN CANCER RES, V12, P807, DOI 10.1158/1078-0432.CCR-05-1545; Vestergaard EM, 2002, CLIN CHEM, V48, P1689; Wright NA, 1997, FEBS LETT, V408, P121, DOI 10.1016/S0014-5793(97)00424-9; Xiao L, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-26; Xu CC, 2013, PATHOL RES PRACT, V209, P479, DOI 10.1016/j.prp.2013.04.017; Xu Q, 2013, GENE, V529, P104, DOI 10.1016/j.gene.2013.07.070; Xue Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075240; YONG Z, 2013, PLOS ONE, V0008; Yue L, 2014, APMIS, V122, P628, DOI 10.1111/apm.12203	45	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0126924	10.1371/journal.pone.0126924	http://dx.doi.org/10.1371/journal.pone.0126924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083576	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400008
J	Sadeh, S; Clopath, C; Rotter, S				Sadeh, Sadra; Clopath, Claudia; Rotter, Stefan			Processing of Feature Selectivity in Cortical Networks with Specific Connectivity	PLOS ONE			English	Article							INHIBITORY SPIKING NEURONS; PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; RECEPTIVE-FIELDS; SIMPLE CELLS; LAMINAR DEPENDENCE; THALAMIC INPUT; MECHANISMS; EXCITATION	Although non-specific at the onset of eye opening, networks in rodent visual cortex attain a non-random structure after eye opening, with a specific bias for connections between neurons of similar preferred orientations. As orientation selectivity is already present at eye opening, it remains unclear how this specificity in network wiring contributes to feature selectivity. Using large-scale inhibition-dominated spiking networks as a model, we show that feature-specific connectivity leads to a linear amplification of feedforward tuning, consistent with recent electrophysiological single-neuron recordings in rodent neocortex. Our results show that optimal amplification is achieved at an intermediate regime of specific connectivity. In this configuration a moderate increase of pairwise correlations is observed, consistent with recent experimental findings. Furthermore, we observed that feature-specific connectivity leads to the emergence of orientation-selective reverberating activity, and entails pattern completion in network responses. Our theoretical analysis provides a mechanistic understanding of subnetworks' responses to visual stimuli, and casts light on the regime of operation of sensory cortices in the presence of specific connectivity.	[Sadeh, Sadra; Rotter, Stefan] Univ Freiburg, Bernstein Ctr Freiburg, Feiburg, Germany; [Sadeh, Sadra; Rotter, Stefan] Univ Freiburg, Fac Biol, Feiburg, Germany; [Sadeh, Sadra; Clopath, Claudia] Univ London Imperial Coll Sci Technol & Med, Bioengn Dept, London, England	University of Freiburg; University of Freiburg; Imperial College London	Sadeh, S (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	s.sadeh@ucl.ac.uk		Sadeh, Sadra/0000-0001-8159-5461	German Ministry of Education and Research (BMBF) [BFNT 01GQ0830]; German Research Foundation (DFG) [EXC 1086]; EPSRC [EP/M019780/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M019780/1] Funding Source: researchfish	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding by the German Ministry of Education and Research (BMBF, grant BFNT 01GQ0830) and the German Research Foundation (DFG, grant EXC 1086) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batschelet E, 1981, CIRCULAR STAT BIOL; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Cai D, 2005, P NATL ACAD SCI USA, V102, P5868, DOI 10.1073/pnas.0501913102; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Denman DJ, 2013, CEREBRAL CORTEX; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Goldberg JA, 2004, NEURON, V42, P489, DOI 10.1016/S0896-6273(04)00197-7; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Hansen BJ, 2012, NEURON, V76, P590, DOI 10.1016/j.neuron.2012.08.029; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Ko H, 2014, J NEUROSCI, V34, P9812, DOI 10.1523/JNEUROSCI.0875-14.2014; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Miller JEK, 2014, P NATL ACAD SCI USA, V111, pE4053, DOI 10.1073/pnas.1406077111; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Ostojic S, 2014, NAT NEUROSCI, V17, P594, DOI 10.1038/nn.3658; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Pehlevan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089992; Pernice V, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.031916; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; Ricciardi L.M., 1977, DIFFUSION PROCESSES, V14; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Sadeh S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004045; Sadeh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114237; Sadeh S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-148; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Smith MA, 2013, J NEUROPHYSIOL, V109, P940, DOI 10.1152/jn.00846.2012; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005	50	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127547	10.1371/journal.pone.0127547	http://dx.doi.org/10.1371/journal.pone.0127547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083363	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400014
J	Zeng, SG; Liu, L; Shi, Y; Qiu, JQ; Fang, W; Rong, MD; Guo, ZH; Gao, WF				Zeng, Shuguang; Liu, Lei; Shi, Yong; Qiu, Junqi; Fang, Wei; Rong, Mingdeng; Guo, Zehong; Gao, Wenfeng			Characterization of Silk Fibroin/Chitosan 3D Porous Scaffold and In Vitro Cytology	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CHITOSAN NANOFIBROUS SCAFFOLDS; FIBROIN; BONE; DIFFERENTIATION; DEGRADATION; FOAMS	Bone tissue engineering is a powerful tool to treat bone defects caused by trauma, infection, tumors and other factors. Both silk fibroin (SF) and chitosan (CS) are non-toxic and have good biocompatibility, but are poor biological scaffolds when used alone. In this study, the microscopic structure and related properties of SF/CS composite scaffolds with different component ratios were examined. The scaffold material most suitable for osteoblast growth was determined, and these results offer an experimental basis for the future reconstruction of bone defects. First, via freeze-drying and chemical crosslinking methods, SF/CS composites with different component ratios were prepared and their structure was characterized. Changes in the internal structure of the SF and CS mixture were observed, confirming that the mutual modification between the two components was complete and stable. The internal structure of the composite material was porous and three-dimensional with a porosity above 90%. We next studied the pore size, swelling ratio, water absorption ratio, degradation and in vitro cell proliferation. For the 40% SF-60% CS group, the pore size of the scaffold was suitable for the growth of osteoblasts, and the rate of degradation was steady. This favors the early adhesion, growth and proliferation of MG-63 cells. In addition to good biocompatibility and satisfactory cell affinity, this material promotes the secretion of extracellular matrix materials by osteoblasts. Thus, 40% SF-60% CS is a good material for bone tissue engineering.	[Zeng, Shuguang; Liu, Lei; Shi, Yong; Qiu, Junqi; Fang, Wei; Rong, Mingdeng; Guo, Zehong; Gao, Wenfeng] Southern Med Univ, Guangdong Prov Stomatol Hosp, Dept Oral & Maxillofacial Surg, Guangzhou 510280, Guangdong, Peoples R China; [Liu, Lei] Sun Yat Sen Univ, Affiliated Zhongshan Hosp, Branch Hosp Stomatol, Dept Children Stomatol, Zhongshan 528403, Guangdong, Peoples R China	Southern Medical University - China; Sun Yat Sen University	Zeng, SG (corresponding author), Southern Med Univ, Guangdong Prov Stomatol Hosp, Dept Oral & Maxillofacial Surg, Guangzhou 510280, Guangdong, Peoples R China.	sunrisezdoctor@163.com	rong, mingdeng/GRJ-8507-2022		Guangdong Provincial Science and Technology Project [2011B031300022]	Guangdong Provincial Science and Technology Project	This study was supported by a grant from Guangdong Provincial Science and Technology Project (2011B031300022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Boudriot U, 2006, ARTIF ORGANS, V30, P785, DOI 10.1111/j.1525-1594.2006.00301.x; Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170; Collignon H, 1997, ARCH PHYSIOL BIOCHEM, V105, P158, DOI 10.1076/apab.105.2.158.12924; Deng J, 2013, J MATER SCI-MATER M, V24, P2037, DOI 10.1007/s10856-013-4944-z; Dunne LW, 2014, ACTA BIOMATER, V10, P3630, DOI 10.1016/j.actbio.2014.05.005; ELLIOTT A, 1950, NATURE, V165, P921, DOI 10.1038/165921a0; Errico JA, 1997, BONE, V20, P117; Gercek I, 2008, J BIOMED MATER RES A, V86A, P1012, DOI 10.1002/jbm.a.31723; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; Gu Y, 2014, BIOMATERIALS, V35, P2253, DOI 10.1016/j.biomaterials.2013.11.087; Guan L, 2013, CELLS TISSUES ORGANS, V198, P190, DOI 10.1159/000355944; Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.3.CO;2-P; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020; Ji WC, 2013, EXP THER MED, V6, P513, DOI 10.3892/etm.2013.1185; Kang YQ, 2009, MED ENG PHYS, V31, P589, DOI 10.1016/j.medengphy.2008.11.014; Kim TK, 2006, BIOMATERIALS, V27, P152, DOI 10.1016/j.biomaterials.2005.05.081; Lahiji A, 2000, J BIOMED MATER RES, V51, P586; Lai GJ, 2015, INT J NANOMED, V10, P567, DOI 10.2147/IJN.S73780; Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094; Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002; Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115; Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010; MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8; MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X; Mittal A, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045001; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073; PEARSON FG, 1960, J POLYM SCI, V43, P101, DOI 10.1002/pol.1960.1204314109; Qazvini NT, 2011, J MATER SCI-MATER M, V22, P63, DOI 10.1007/s10856-010-4178-2; She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y; Singh L, 2004, BIOMATERIALS, V25, P2611, DOI 10.1016/j.biomaterials.2003.09.040; Sun Kai, 2015, Eur J Orthop Surg Traumatol, V25, P243, DOI 10.1007/s00590-014-1515-z; Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006; Wang SD, 2011, INT J BIOL MACROMOL, V48, P345, DOI 10.1016/j.ijbiomac.2010.12.008; Yang F, 2006, POLYM DEGRAD STABIL, V91, P3065, DOI 10.1016/j.polymdegradstab.2006.08.008; Yang MC, 2009, BIOMATERIALS, V30, P3757, DOI 10.1016/j.biomaterials.2009.03.057; Zhang KH, 2011, J BIOMAT SCI-POLYM E, V22, P1069, DOI 10.1163/092050610X498204; Zhang KH, 2010, J BIOMED MATER RES A, V95A, P870, DOI 10.1002/jbm.a.32895	41	50	54	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128658	10.1371/journal.pone.0128658	http://dx.doi.org/10.1371/journal.pone.0128658			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083846	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400060
J	Park, SH; Chen, WC; Durmus, N; Bleck, B; Reibman, J; Riemekasten, G; Grunig, G				Park, Sung-Hyun; Chen, Wen-Chi; Durmus, Nedim; Bleck, Bertram; Reibman, Joan; Riemekasten, Gabriela; Grunig, Gabriele			The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution	PLOS ONE			English	Article							RESISTIN-LIKE-MOLECULE; INDUCED MITOGENIC FACTOR; SMOOTH-MUSCLE-CELLS; FC-GAMMA RECEPTOR; ARTERIAL-HYPERTENSION; MATRIX METALLOPROTEINASES; ANTIINFLAMMATORY ACTIVITY; SERUM CONCENTRATIONS; DENDRITIC CELLS; TISSUE	Air pollution is known to exacerbate chronic inflammatory conditions of the lungs including pulmonary hypertension, cardiovascular diseases and autoimmune diseases. Directly pathogenic antibodies bind pro-inflammatory cell receptors and cause or exacerbate inflammation. In contrast, anti-inflammatory antibody isotypes (e.g. mouse immunoglobulin G1, IgG1) bind inhibitory cell receptors and can inhibit inflammation. Our previous studies showed that co-exposure to antigen and urban ambient particulate matter (PM2.5) induced severe pulmonary arterial thickening and increased right ventricular systolic pressures in mice via T-cell produced cytokines, Interleukin (IL)-13 and IL-17A. The aim of the current study was to understand how B cell and antibody responses integrate into this T cell cytokine network for the pulmonary hypertension phenotype. Special focus was on antigen-specific IgG1 that is the predominant antibody in the experimental response to antigen and urban ambient PM2.5. Wild type and B cell-deficient mice were primed with antigen and then challenged with antigen and urban particulate matter and injected with antibodies as appropriate. Our data surprisingly showed that B cells were necessary for the development of increased right ventricular pressures and molecular changes in the right heart in response to sensitization and intranasal challenge with antigen and PM2.5. Further, our studies showed that both, the increase in right ventricular systolic pressure and right ventricular molecular changes were restored by reconstituting the B cell KO mice with antigen specific IgG1. In addition, our studies identified a critical, non-redundant role of B cells for the IL-17A-directed inflammation in response to exposure with antigen and PM2.5, which was not corrected with antigen-specific IgG1. In contrast, IL-13-directed inflammatory markers, as well as severe pulmonary arterial remodeling induced by challenge with antigen and PM2.5 were similar in B cell-deficient and wild type mice. Our studies have identified B cells and antigen specific IgG1 as potential therapeutic targets for pulmonary hypertension associated with immune dysfunction and environmental exposures.	[Park, Sung-Hyun; Chen, Wen-Chi; Durmus, Nedim; Reibman, Joan; Grunig, Gabriele] NYU, Langone Med Ctr, Dept Environm Med, Tuxedo Pk, NY 10987 USA; [Bleck, Bertram; Reibman, Joan; Grunig, Gabriele] NYU, Dept Med, Div Pulm Med, Langone Med Ctr, New York, NY 10016 USA; [Riemekasten, Gabriela] Med Univ Lubeck, Clin Rheumatol, D-23538 Lubeck, Germany	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Lubeck	Grunig, G (corresponding author), NYU, Langone Med Ctr, Dept Environm Med, Tuxedo Pk, NY 10987 USA.	ggrunig1@earthlink.net	Riemekasten, Gabriela/B-5019-2017	Reibman, Joan/0000-0001-7878-1511	National Institutes of Health [1R21HL092370-01, 1R01 HL095764-01]; American Heart Association [0855943D]; Stony Wold - Herbert Fund, New York; Hacettepe University grant [014G602002]; Scientific and Technological Research Council of Turkey grant [1059B191401602]; NIEHS center grant [ES00260]; NCI Cancer center grant [5P30CA16087-33]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095764, R21HL092370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Stony Wold - Herbert Fund, New York; Hacettepe University grant(Hacettepe University); Scientific and Technological Research Council of Turkey grant(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NIEHS center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI Cancer center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was funded in part by the National Institutes of Health 1R21HL092370-01 (GG), 1R01 HL095764-01 (GG); American Heart Association, Founders affiliate 0855943D, (GG); Stony Wold - Herbert Fund, New York (SHP); Hacettepe University grant 014G602002 (ND), Scientific and Technological Research Council of Turkey grant 1059B191401602 (ND); core support was by NIEHS center grant (ES00260) and NCI Cancer center grant (5P30CA16087-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DJ, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-1; Arends SJ, 2013, CLIN EXP IMMUNOL, V174, P433, DOI 10.1111/cei.12166; Arends SJ, 2010, EUR RESPIR J, V35, P923, DOI 10.1183/09031936.00164209; Arends SJ, 2013, AUTOIMMUNITY, V46, P463, DOI 10.3109/08916934.2013.812080; Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Baumann U, 2001, J IMMUNOL, V167, P1022, DOI 10.4049/jimmunol.167.2.1022; Becker MO, 2014, AM J RESP CRIT CARE, V190, P808, DOI 10.1164/rccm.201403-0442OC; Biasin V, 2014, J PATHOL, V233, P7, DOI 10.1002/path.4303; Bloomfield GS, 2012, GLOB HEART, V7, P249, DOI 10.1016/j.gheart.2012.06.015; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Bussone G, 2012, ANN RHEUM DIS, V71, P596, DOI 10.1136/annrheumdis-2011-200195; Bussone G, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3336; Chaisson NF, 2013, CHEST, V144, P1346, DOI 10.1378/chest.12-2396; Chelladurai P, 2012, EUR RESPIR J, V40, P766, DOI 10.1183/09031936.00209911; Chen WC, 2013, JOVE-J VIS EXP, DOI 10.3791/50023; Colvin KL, 2013, AM J RESP CRIT CARE, V188, P1126, DOI 10.1164/rccm.201302-0403OC; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Desai DD, 2007, J IMMUNOL, V178, P6217, DOI 10.4049/jimmunol.178.10.6217; Dib H, 2012, EUR RESPIR J, V39, P1405, DOI 10.1183/09031936.00181410; Esmaeil N, 2014, AM J CLIN EXP IMMUNO, V3, P20; Faquim-Mauro EL, 1999, J IMMUNOL, V163, P3572; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Ford JG, 2001, J IMMUNOL, V167, P1769, DOI 10.4049/jimmunol.167.3.1769; Fritz JS, 2013, CHEST, V143, P315, DOI 10.1378/chest.12-0270; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Gilmour MI, 2007, INHAL TOXICOL, V19, P7, DOI 10.1080/08958370701490379; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Grunig G, 2014, PULM CIRC, V4, P25, DOI 10.1086/674902; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Hoffman C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027629; Holguin F, 2014, AM J RESP CRIT CARE, V189, P1018, DOI 10.1164/rccm.201404-0613ED; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Ishikawa Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-42; Jin S, 2014, EXP DERMATOL, V23, P938, DOI 10.1111/exd.12563; Johnson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020828; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kill A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4457; Kim YM, 2011, AM J PATHOL, V179, P1560, DOI 10.1016/j.ajpath.2011.05.051; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Leary PJ, 2014, AM J RESP CRIT CARE, V189, P1093, DOI 10.1164/rccm.201312-2298OC; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Li FB, 2014, J IMMUNOL, V192, P3021, DOI 10.4049/jimmunol.1302934; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Makellar A, 1846, INVESTIGATION NATURE; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; Medesan C, 1997, J IMMUNOL, V158, P2211; Michelakis ED, 2008, CIRCULATION, V118, P1486, DOI 10.1161/CIRCULATIONAHA.106.673988; Miller FW, 2012, J AUTOIMMUN, V39, P259, DOI 10.1016/j.jaut.2012.05.002; Mishra A, 2007, AM J PHYSIOL-LUNG C, V293, pL305, DOI 10.1152/ajplung.00147.2007; Morse JH, 2000, SCAND J IMMUNOL, V51, P607; Munitz A, 2009, J IMMUNOL, V182, P2357, DOI 10.4049/jimmunol.0803130; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Padilla J, 2005, J IMMUNOL, V174, P8097, DOI 10.4049/jimmunol.174.12.8097; Park K, 2012, J LEUKOCYTE BIOL, V91, P245, DOI 10.1189/jlb.0111020; Park SH, 2014, PULM CIRC, V4, P654, DOI 10.1086/678511; Park SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055180; Parks CG, 2014, INT J MOL SCI, V15, P14269, DOI 10.3390/ijms150814269; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Renigunta A, 2006, FEBS LETT, V580, P900, DOI 10.1016/j.febslet.2006.01.012; Riemekasten G, 2011, ANN RHEUM DIS, V70, P530, DOI 10.1136/ard.2010.135772; Said SI, 2010, EUR RESPIR J, V35, P730, DOI 10.1183/09031936.00097109; Sanchez O, 2006, CHEST, V130, P182, DOI 10.1378/chest.130.1.182; SCANO G, 1980, ARCH ENVIRON HEALTH, V35, P360; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Shojima N, 2005, DIABETOLOGIA, V48, P984, DOI 10.1007/s00125-005-1735-1; Su Q, 2007, FASEB J OFFICIAL PUB; Teng XW, 2003, CIRC RES, V92, P1065, DOI 10.1161/01.RES.0000073999.07698.33; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Ulrich S, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-20; WHO, 2000, SIL; Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005; Yamaji-Kegan K, 2014, AM J PHYSIOL-LUNG C, V306, pL1090, DOI 10.1152/ajplung.00279.2013; Zaidi SHE, 2002, CIRCULATION, V105, P516, DOI 10.1161/hc0402.102866	81	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129910	10.1371/journal.pone.0129910	http://dx.doi.org/10.1371/journal.pone.0129910			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079807	Green Published, Green Submitted, gold			2022-12-26	WOS:000356542300035
J	Ruiz, FM; Santillana, E; Spinola-Amilibia, M; Torreira, E; Culebras, E; Romero, A				Ruiz, Federico M.; Santillana, Elena; Spinola-Amilibia, Mercedes; Torreira, Eva; Culebras, Esther; Romero, Antonio			Crystal Structure of Hcp from Acinetobacter baumannii: A Component of the Type VI Secretion System	PLOS ONE			English	Article							SEDIMENTATION-VELOCITY; PROTEIN; ULTRACENTRIFUGATION; EXPRESSION; RESISTANT; LOCUS	The type VI secretion system (T6SS) is a bacterial macromolecular machine widely distributed in Gram-negative bacteria, which transports effector proteins into eukaryotic host cells or other bacteria. Membrane complexes and a central tubular structure, which resembles the tail of contractile bacteriophages, compose the T6SS. One of the proteins forming this tube is the hemolysin co-regulated protein (Hcp), which acts as virulence factor, as transporter of effectors and as a chaperone. In this study, we present the structure of Hcp from Acinetobacter baumannii, together with functional and oligomerization studies. The structure of this protein exhibits a tight beta barrel formed by two beta sheets and flanked at one side by a short a-helix. Six Hcp molecules associate to form a donut-shaped hexamer, as observed in both the crystal structure and solution. These results emphasize the importance of this oligomerization state in this family of proteins, despite the low similarity of sequence among them. The structure presented in this study is the first one for a protein forming part of a functional T6SS from A. baumannii. These results will help us to understand the mechanism and function of this secretion system in this opportunistic nosocomial pathogen.	[Ruiz, Federico M.; Santillana, Elena; Spinola-Amilibia, Mercedes; Torreira, Eva; Romero, Antonio] CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain; [Culebras, Esther] Hosp Clin San Carlos, Dept Clin Microbiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Clinico San Carlos	Ruiz, FM (corresponding author), CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain.	fruiz@cib.csic.es; romero@cib.csic.es	Romero, Antonio/K-5754-2014; Culebras, ESTHER/AAA-3865-2019; Ruiz, Federico M./AAO-9600-2021	Romero, Antonio/0000-0002-6990-6973; Ruiz, Federico M./0000-0002-0385-7777; Culebras, Esther/0000-0001-7395-2684; Santillana Heras, Elena/0000-0002-6227-1725				Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Brunet YR, 2014, EMBO REP, V15, P315, DOI 10.1002/embr.201337936; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W., THE PYMOL MOLECULAR; Douzi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086918; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Filloux Alain, 2013, F1000Prime Rep, V5, P52, DOI 10.12703/P5-52; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Osipiuk Jerzy, 2011, Journal of Structural and Functional Genomics, V12, P21, DOI 10.1007/s10969-011-9107-1; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Vila J, 2008, EXPERT OPIN PHARMACO, V9, P587, DOI 10.1517/14656566.9.4.587; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018	40	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129691	10.1371/journal.pone.0129691	http://dx.doi.org/10.1371/journal.pone.0129691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079269	Green Published, Green Submitted, gold			2022-12-26	WOS:000356542300030
J	Velsko, IM; Chukkapalli, SS; Rivera-Kweh, MF; Chen, H; Zheng, DH; Bhattacharyya, I; Gangula, PR; Lucas, AR; Kesavalu, L				Velsko, Irina M.; Chukkapalli, Sasanka S.; Rivera-Kweh, Mercedes. F.; Chen, Hao; Zheng, Donghang; Bhattacharyya, Indraneel; Gangula, Pandu R.; Lucas, Alexandra R.; Kesavalu, Lakshmyya			Fusobacterium nucleatum Alters Atherosclerosis Risk Factors and Enhances Inflammatory Markers with an Atheroprotective Immune Response in ApoE(null) Mice	PLOS ONE			English	Article							ALVEOLAR BONE-RESORPTION; SITU HYBRIDIZATION FISH; PERIODONTAL PATHOGENS; PORPHYROMONAS-GINGIVALIS; DIRECT VISUALIZATION; RAT MODEL; BACTERIA; INFECTION; IDENTIFICATION; LESIONS	The American Heart Association supports an association between periodontal disease (PD) and atherosclerotic vascular disease (ASVD) but does not as of yet support a causal relationship. Recently, we have shown that major periodontal pathogens Porphyromonas gingivalis and Treponema denticola are causally associated with acceleration of aortic atherosclerosis in ApoE(null) hyperlipidemic mice. The aim of this study was to determine if oral infection with another significant periodontal pathogen Fusobacterium nucleatum can accelerate aortic inflammation and atherosclerosis in the aortic artery of ApoEnull mice. ApoEnull mice (n = 23) were orally infected with F. nucleatum ATCC 49256 and euthanized at 12 and 24 weeks. Periodontal disease assessments including F. nucleatum oral colonization, gingival inflammation, immune response, intrabony defects, and alveolar bone resorption were evaluated. Systemic organs were evaluated for infection, aortic sections were examined for atherosclerosis, and inflammatory markers were measured. Chronic oral infection established F. nucleatum colonization in the oral cavity, induced significant humoral IgG (P=0.0001) and IgM (P=0.001) antibody response (12 and 24 weeks), and resulted in significant (P=0.0001) alveolar bone resorption and intrabony defects. F. nucleatum genomic DNA was detected in systemic organs (heart, aorta, liver, kidney, lung) indicating bacteremia. Aortic atherosclerotic plaque area was measured and showed a local inflammatory infiltrate revealed the presence of F4/80(+) macrophages and CD3(+) T cells. Vascular inflammation was detected by enhanced systemic cytokines (CD30L, IL-4, IL-12), oxidized LDL and serum amyloid A, as well as altered serum lipid profile (cholesterol, triglycerides, chylomicrons, VLDL, LDL, HDL), in infected mice and altered aortic gene expression in infected mice. Despite evidence for systemic infection in several organs and modulation of known atherosclerosis risk factors, aortic atherosclerotic lesions were significantly reduced after F. nucleatum infection suggesting a potential protective function for this member of the oral microbiota.	[Velsko, Irina M.; Chukkapalli, Sasanka S.; Rivera-Kweh, Mercedes. F.; Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32611 USA; [Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Chen, Hao; Zheng, Donghang; Lucas, Alexandra R.] Univ Florida, Coll Med, Cardiovasc Med & Mol Genet & Microbiol, Gainesville, FL USA; [Bhattacharyya, Indraneel] Univ Florida, Coll Dent, Oral Diagnost Sci, Gainesville, FL USA; [Gangula, Pandu R.] CWHR Meharry Med Coll, Dept Oral Biol & Res, Nashville, TN USA; [Gangula, Pandu R.] CWHR Meharry Med Coll, Dept Physiol, Nashville, TN USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Meharry Medical College; Meharry Medical College	Kesavalu, L (corresponding author), Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32611 USA.	Kesavalu@dental.ufl.edu	Chukkapalli, sasanka/AAS-8080-2021		NIH National Institute for Dental and Craniofacial Research [R01DE020820]; NIH National Center for Research Resources [1U54RR026140-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020820] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	NIH National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by the NIH National Institute for Dental and Craniofacial Research (R01DE020820; Dr. Kesavalu) and the NIH National Center for Research Resources (1U54RR026140-01; Dr. Gangula).	Bahrani-Mougeot FK, 2008, J CLIN MICROBIOL, V46, P2129, DOI 10.1128/JCM.02004-07; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; Bolstad AI, 1996, CLIN MICROBIOL REV, V9, P55, DOI 10.1128/CMR.9.1.55; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chukkapalli SS, 2014, INFECT IMMUN, V82, P1959, DOI 10.1128/IAI.01511-14; Ebersole JL, 1997, MICROB PATHOGENESIS, V23, P23, DOI 10.1006/mpat.1996.0129; Elkaim R, 2008, J PERIODONTAL RES, V43, P224, DOI 10.1111/j.1600-0765.2007.01018.x; Fardini Y, 2011, MOL MICROBIOL, V82, P1468, DOI 10.1111/j.1365-2958.2011.07905.x; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; Feuille F, 1996, INFECT IMMUN, V64, P2095, DOI 10.1128/IAI.64.6.2094-2100.1996; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Figuero E, 2011, J PERIODONTOL, V82, P1469, DOI 10.1902/jop.2011.100719; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Guo M, 2000, ORAL MICROBIOL IMMUN, V15, P119, DOI 10.1034/j.1399-302x.2000.150208.x; Han YW, 2013, J DENT RES, V92, P485, DOI 10.1177/0022034513487559; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Jewett A, 2000, INFECT IMMUN, V68, P1893, DOI 10.1128/IAI.68.4.1893-1898.2000; Kesavalu L, 2012, J DENT RES, V91, P255, DOI 10.1177/0022034511435101; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuo LE, 2007, PEPTIDES, V28, P435, DOI 10.1016/j.peptides.2006.08.035; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lee HR, 2012, MOL ORAL MICROBIOL, V27, P109, DOI 10.1111/j.2041-1014.2011.00636.x; Lee JA, 2011, SEMIN THROMB HEMOST, V37, P395, DOI 10.1055/s-0031-1276589; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; MANGAN DF, 1983, INFECT IMMUN, V40, P1104, DOI 10.1128/IAI.40.3.1104-1111.1983; Matthys KE, 1997, MEDIAT INFLAMM, V6, P3, DOI 10.1080/09629359791875; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Norata GD, 2011, CURR OPIN LIPIDOL, V22, P410, DOI 10.1097/MOL.0b013e32834adac3; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Renckens R, 2007, BLOOD, V109, P1593, DOI 10.1182/blood-2006-05-025197; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Saito A, 2009, MICROB PATHOGENESIS, V47, P329, DOI 10.1016/j.micpath.2009.09.012; Settem RP, 2012, INFECT IMMUN, V80, P2436, DOI 10.1128/IAI.06276-11; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stein PS, 2012, ALZHEIMERS DEMENT, V8, P196, DOI 10.1016/j.jalz.2011.04.006; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Tateishi F, 2012, J CLIN PERIODONTOL, V39, P417, DOI 10.1111/j.1600-051X.2012.01855.x; Toussi DN, 2012, CLIN VACCINE IMMUNOL, V19, P1093, DOI 10.1128/CVI.00236-12; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Verma RK, 2010, ORAL DIS, V16, P686, DOI 10.1111/j.1601-0825.2010.01678.x; Zhang YM, 2008, CHINESE MED J-PEKING, V121, P1595, DOI 10.1097/00029330-200808020-00018	53	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129795	10.1371/journal.pone.0129795	http://dx.doi.org/10.1371/journal.pone.0129795			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079509	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300032
J	Baralla, A; Sotgiu, E; Deiana, M; Pasella, S; Pinna, S; Mannu, A; Canu, E; Sotgiu, G; Ganau, A; Zinellu, A; Sotgia, S; Carru, C; Deiana, L				Baralla, Angela; Sotgiu, Elisabetta; Deiana, Marta; Pasella, Sara; Pinna, Sara; Mannu, Andrea; Canu, Elisabetta; Sotgiu, Giovanni; Ganau, Antonello; Zinellu, Angelo; Sotgia, Salvatore; Carru, Ciriaco; Deiana, Luca			Plasma Clusterin and Lipid Profile: A Link with Aging and Cardiovascular Diseases in a Population with a Consistent Number of Centenarians	PLOS ONE			English	Article							BIOMARKER CLUSTERIN/APOLIPOPROTEIN-J; CORONARY-HEART-DISEASE; SERUM APOLIPOPROTEIN-J; HEALTHY CENTENARIANS; NUCLEAR CLUSTERIN; ADVANCED CANCER; SHOCK PROTEINS; CHOLESTEROL; GENE; ATHEROSCLEROSIS	The role of Clusterin in attenuation of inflammation and reverse cholesterol transfer makes this molecule a potential candidate as a marker for cancer, cardiovascular disease, diabetes mellitus, and metabolic syndrome. In elderly subjects cardiovascular diseases represent the primary cause of death and different clinical studies have shown a positive correlation of these diseases with changes in the lipid pattern. This work aimed at evaluating the relationship between circulating clusterin and the biochemical parameters that characterize the lipid profile of a Sardinian population divided into five age groups including centenarians; the high frequency in Sardinia of these long-lived individuals gave us the opportunity to extend the range of the age groups to be analyzed to older ages and to better evaluate the changes in the lipid balance during ageing and its relationship with clusterin concentration in plasma. Our results showed that Clusterin concentration values of the youngest group were more similar with the centenarian's group compared to the other age groups, and a positive correlation arises with LDL. Furthermore given the high prevalence of cardiovascular diseases in the population examined and the association of Clusterin with these pathologies we evaluated Clusterin concentration variation in two groups with or without cardiovascular diseases. In presence of cardiovascular disease, Clusterin is significantly related to the most atherogenic components of lipid profile (total cholesterol and LDL), especially in women, suggesting its potential role in modulating cardiovascular metabolic risk factors.	[Baralla, Angela; Sotgiu, Elisabetta; Pasella, Sara; Pinna, Sara; Mannu, Andrea; Canu, Elisabetta; Sotgiu, Giovanni; Zinellu, Angelo; Sotgia, Salvatore; Carru, Ciriaco; Deiana, Luca] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Deiana, Marta; Deiana, Luca] Assoc LIsola Centenari, Sassari, Italy; [Deiana, Marta; Ganau, Antonello] Univ Sassari, Dept Clin & Expt Med, Cardiol Unit, I-07100 Sassari, Italy	University of Sassari; University of Sassari	Deiana, L (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	proflucadeiana@gmail.com	Sotgiu, Giovanni/N-1032-2017; Carru, Ciriaco/AAI-9996-2021; Ganau, Antonello/D-6899-2012; Sotgia, Salvatore/T-6598-2019	Sotgiu, Giovanni/0000-0002-1600-4474; Zinellu, Angelo/0000-0002-8396-0968; Sotgiu, Elisabetta/0000-0001-8053-1247; Sotgia, Salvatore/0000-0002-3717-3437; Baralla, Angela/0000-0002-5022-0285; Carru, Ciriaco/0000-0002-6985-4907; GANAU, Antonello/0000-0002-7053-293X	Regione Autonoma della Sardegna [L.R.7/2007]; Fondazione Banco di Sardegna [Prot. 998/2007.0729, Prot. 906/2012-1046]	Regione Autonoma della Sardegna(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	LD was funded by Regione Autonoma della Sardegna, grant number L.R.7/2007, http://www.regione.sardegna.it/. Funding provided to the institution Associazione L'Isola dei Centenari by Fondazione Banco di Sardegna, grant numbers Prot. 998/2007.0729, Prot. 906/2012-1046, http://www.fondazionebancodisardegna.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, EXECUTIVE SUMMARY 3, V285, P2486; Arai Yasumichi, 2004, J Atheroscler Thromb, V11, P246; Aronis KN, 2011, J CLIN ENDOCR METAB, V96, pE1871, DOI 10.1210/jc.2011-1555; Baggio G, 1998, FASEB J, V12, P433, DOI 10.1096/fasebj.12.6.433; Banfi C, 2009, PROTEOMICS, V9, P1344, DOI 10.1002/pmic.200800566; BERNS MAM, 1988, INT J EPIDEMIOL, V17, P789, DOI 10.1093/ije/17.4.789; Bettuzzi S, 2009, ADV CANCER RES, V105, P133, DOI 10.1016/S0065-230X(09)05008-8; BLATTER MC, 1993, EUR J BIOCHEM, V211, P871, DOI 10.1111/j.1432-1033.1993.tb17620.x; Caccamo AE, 2005, CELL DEATH DIFFER, V12, P101, DOI 10.1038/sj.cdd.4401491; Chi KN, 2008, CLIN CANCER RES, V14, P833, DOI 10.1158/1078-0432.CCR-07-1310; ChoiMiura NH, 1996, NEUROBIOL AGING, V17, P717; Deiana L, 2002, J AM GERIATR SOC, V50, P2098, DOI 10.1046/j.1532-5415.2002.50630.x; Deiana L, 1999, AGING CLIN EXP RES, V11, P142, DOI 10.1007/BF03399655; Franceschi C, 2003, BIOCHEM SOC T, V31, P457, DOI 10.1042/BST0310457; Gelissen IC, 1998, BIOCHEM J, V331, P231, DOI 10.1042/bj3310231; GILLUM RF, 1982, J CHRON DIS, V35, P635, DOI 10.1016/0021-9681(82)90015-7; Gobal Freij A, 2010, Ther Adv Cardiovasc Dis, V4, P375, DOI 10.1177/1753944710385048; Holliday R, 1998, ANN NY ACAD SCI, V854, P61, DOI 10.1111/j.1749-6632.1998.tb09892.x; Hui-Hui Liu J-JL, 2014, AGEING RES REV, V19, P43, DOI [10.1016/j.arr.2014.12.001, DOI 10.1016/J.ARR.2014.12.001]; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Zhao Dong, 2006, Legal Medicine, V8, P258, DOI 10.1016/j.legalmed.2006.05.004; Ishikawa Y, 1998, ARTERIOSCL THROM VAS, V18, P665, DOI 10.1161/01.ATV.18.4.665; Ishikawa Y, 2001, ATHEROSCLEROSIS, V156, P29, DOI 10.1016/S0021-9150(00)00610-9; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; JORDANSTARCK TC, 1994, J LIPID RES, V35, P194; Karlsson H, 2005, PROTEOMICS, V5, P551, DOI 10.1002/pmic.200300938; Kolovou G, 2011, CURR OPIN CARDIOL, V26, P348, DOI 10.1097/HCO.0b013e32834659d4; Kujiraoka T, 2006, J ATHEROSCLER THROMB, V13, P314, DOI 10.5551/jat.13.314; Lau KM, 2003, LAB INVEST, V83, P743, DOI 10.1097/01.LAB.0000069519.06988.24; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Mackness B, 1997, ARTERIOSCL THROM VAS, V17, P1233, DOI 10.1161/01.ATV.17.7.1233; Malaguarnera M, 1998, Eur Rev Med Pharmacol Sci, V2, P75; Martinez-Bujidos M, 2014, FASEB J; Michel D, 1997, BIOCHEM J, V328, P45, DOI 10.1042/bj3280045; Miwa Y, 2005, BIOCHEM BIOPH RES CO, V331, P1587, DOI 10.1016/j.bbrc.2005.04.069; Nago N, 2011, J EPIDEMIOL, V21, P67, DOI 10.2188/jea.JE20100065; Okamura T, 2003, J INTERN MED, V253, P169, DOI 10.1046/j.1365-2796.2003.01080.x; Patel NV, 2004, NEUROSCI LETT, V371, P199, DOI 10.1016/j.neulet.2004.08.076; Poulakou MV, 2008, ANGIOLOGY, V59, P137, DOI 10.1177/0003319707311722; Pucci S, 2004, ONCOGENE, V23, P2298, DOI 10.1038/sj.onc.1207404; Redondo M, 2000, AM J PATHOL, V157, P393, DOI 10.1016/S0002-9440(10)64552-X; Schwarz M, 2008, THROMB HAEMOSTASIS, V100, P110, DOI 10.1160/TH07-12-0737; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; STUART WD, 1992, BIOCHEMISTRY-US, V31, P8552, DOI 10.1021/bi00151a024; Sun HY, 2010, CLIN CHIM ACTA, V411, P336, DOI 10.1016/j.cca.2009.11.023; Suzuki M, 2001, ASIA PAC J CLIN NUTR, V10, P165, DOI 10.1046/j.1440-6047.2001.00219.x; Trougakos IP, 2006, ANN NY ACAD SCI, V1067, P294, DOI 10.1196/annals.1354.039; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Walter M, 2009, ARTERIOSCL THROM VAS, V29, P1244, DOI 10.1161/ATVBAHA.108.181438; Won JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103351; WONG P, 1994, EUR J BIOCHEM, V221, P917, DOI 10.1111/j.1432-1033.1994.tb18807.x; Zoubeidi A, 2010, CLIN CANCER RES, V16, P1088, DOI 10.1158/1078-0432.CCR-09-2917	54	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128029	10.1371/journal.pone.0128029	http://dx.doi.org/10.1371/journal.pone.0128029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076476	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900017
J	Tian, B; Harrison, R; Morton, J; Deb-Choudhury, S				Tian, Bin; Harrison, Roland; Morton, James; Deb-Choudhury, Santanu			Proteomic Analysis of Sauvignon Blanc Grape Skin, Pulp and Seed and Relative Quantification of Pathogenesis-Related Proteins	PLOS ONE			English	Article							HAZE FORMATION; WHITE WINES; BERRY; BENTONITE; SEQUENCE; IDENTIFICATION; CHITINASES; STRESS; GENOME; WELL	Thaumatin-like proteins (TLPs) and chitinases are the main constituents of so-called protein hazes which can form in finished white wine and which is a great concern of winemakers. These soluble pathogenesis-related (PR) proteins are extracted from grape berries. However, their distribution in different grape tissues is not well documented. In this study, proteins were first separately extracted from the skin, pulp and seed of Sauvignon Blanc grapes, followed by trypsin digestion and analysis by liquid chromatography-electrospray ionization- tandem mass spectrometry (LC-ESI-MS/MS). Proteins identified included 75 proteins from Sauvignon Blanc grape skin, 63 from grape pulp and 35 from grape seed, mostly functionally classified as associated with metabolism and energy. Some were present exclusively in specific grape tissues; for example, proteins involved in photosynthesis were only detected in grape skin and proteins found in alcoholic fermentation were only detected in grape pulp. Moreover, proteins identified in grape seed were less diverse than those identified in grape skin and pulp. TLPs and chitinases were identified in both Sauvignon Blanc grape skin and pulp, but not in the seed. To relatively quantify the PR proteins, the protein extracts of grape tissues were seperated by HPLC first and then analysed by SDS-PAGE. The results showed that the protein fractions eluted at 9.3 min and 19.2 min under the chromatographic conditions of this study confirmed that these corresponded to TLPs and chitinases seperately. Thus, the relative quantification of TLPs and chitinases in protein extracts was carried out by comparing the area of corresponding peaks against the area of a thamautin standard. The results presented in this study clearly demonstrated the distribution of haze-forming PR proteins in grape berries, and the relative quantification of TLPs and chitinases could be applied in fast tracking of changes in PR proteins during grape growth and determination of PR proteins in berries at harvest.	[Tian, Bin; Harrison, Roland; Morton, James] Lincoln Univ, Dept Wine Food & Mol Biosci, Canterbury 7647, New Zealand; [Deb-Choudhury, Santanu] Lincoln Res Ctr, AgRes, Canterbury 8140, New Zealand	Lincoln University - New Zealand; AgResearch - New Zealand	Tian, B (corresponding author), Lincoln Univ, Dept Wine Food & Mol Biosci, Canterbury 7647, New Zealand.	tianbin0201@gmail.com	Harrison, Roland/S-9718-2018; Tian, Bin/X-7123-2018; Morton, James/C-6149-2012	Harrison, Roland/0000-0001-5879-2221; Tian, Bin/0000-0002-2700-7945; Morton, James/0000-0001-9645-5568	New Zealand Winegrowers; Agresearch, Lincoln Research Centre	New Zealand Winegrowers; Agresearch, Lincoln Research Centre	This research was funded by the New Zealand Winegrowers. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The coauthor, Santanu Deb-choudhury, is employed by a commercial company Agresearch, Lincoln Research Centre. Agresearch, Lincoln Research Centre provided support in the form of salary for author SD-C, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BLADE WH, 1988, AM J ENOL VITICULT, V39, P193; Colas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043681; DATTA SK, 1999, PATHOGENESIS RELATED; Deytieux C, 2007, J EXP BOT, V58, P1851, DOI 10.1093/jxb/erm049; Ferreira RB, 2001, TRENDS FOOD SCI TECH, V12, P230, DOI 10.1016/S0924-2244(01)00080-2; Giribaldi M, 2007, PROTEOMICS, V7, P3154, DOI 10.1002/pmic.200600974; Giribaldi M, 2010, J PROTEOMICS, V73, P1647, DOI 10.1016/j.jprot.2010.05.002; Grimplet J, 2009, PROTEOMICS, V9, P2503, DOI 10.1002/pmic.200800158; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jellouli N, 2008, J PLANT PHYSIOL, V165, P471, DOI 10.1016/j.jplph.2007.02.009; Lambri M, 2010, AM J ENOL VITICULT, V61, P225; Le Bourse D, 2011, ANAL BIOANAL CHEM, V401, P1541, DOI 10.1007/s00216-011-4912-8; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Marangon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113757; Marangon M, 2011, J AGR FOOD CHEM, V59, P733, DOI 10.1021/jf1038234; Marangon M, 2009, J AGR FOOD CHEM, V57, P4415, DOI 10.1021/jf9000742; Monteiro S, 2007, PHYTOCHEMISTRY, V68, P416, DOI 10.1016/j.phytochem.2006.11.014; Moser C., 2005, Functional & Integrative Genomics, V5, P208, DOI 10.1007/s10142-005-0143-4; Okuda T, 2006, FOOD SCI TECHNOL RES, V12, P131, DOI 10.3136/fstr.12.131; Peng ZK, 1997, J AGR FOOD CHEM, V45, P4639, DOI 10.1021/jf970194a; Pocock KF, 2006, AUST J GRAPE WINE R, V12, P212, DOI 10.1111/j.1755-0238.2006.tb00061.x; Pocock K. F., 1998, Australian Journal of Grape and Wine Research, V4, P23, DOI 10.1111/j.1755-0238.1998.tb00131.x; Pocock KF, 2000, J AGR FOOD CHEM, V48, P1637, DOI 10.1021/jf9905626; Robinson S. P., 2000, Australian Journal of Grape and Wine Research, V6, P175, DOI 10.1111/j.1755-0238.2000.tb00177.x; Robinson SP, 1997, PLANT PHYSIOL, V114, P771, DOI 10.1104/pp.114.3.771; Salazar FN, 2012, EUR FOOD RES TECHNOL, V234, P509, DOI 10.1007/s00217-012-1659-1; Sarry JE, 2004, PROTEOMICS, V4, P201, DOI 10.1002/pmic.200300499; Sauvage FX, 2010, FOOD CHEM, V118, P26, DOI 10.1016/j.foodchem.2009.02.080; Tattersall DB, 1997, PLANT PHYSIOL, V114, P759, DOI 10.1104/pp.114.3.759; Tattersall DB, 2001, MOLECULAR BIOLOGY & BIOTECHNOLOGY OF THE GRAPEVINE, P183; Tian B, 2015, AUST J GRAPE WINE R, V21, P417, DOI 10.1111/ajgw.12135; Van Sluyter SC, 2009, J AGR FOOD CHEM, V57, P11376, DOI 10.1021/jf902365r; VANLOON LC, 1970, VIROLOGY, V40, P199, DOI 10.1016/0042-6822(70)90395-8; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vincent D, 2006, ELECTROPHORESIS, V27, P1853, DOI 10.1002/elps.200500698; Wang W, 2009, ACTA PHYSIOL PLANT, V31, P597, DOI 10.1007/s11738-008-0269-9; Waters EJ, 1996, J AGR FOOD CHEM, V44, P3, DOI 10.1021/jf9505584; Waters EJ, 1998, J AGR FOOD CHEM, V46, P4950, DOI 10.1021/jf980421o	38	6	8	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130132	10.1371/journal.pone.0130132	http://dx.doi.org/10.1371/journal.pone.0130132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076362	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900141
J	Yan, F; Shen, N; Pang, JX; Molina, JR; Yang, P; Liu, SJ				Yan, Fei; Shen, Na; Pang, Jiuxia; Molina, Julian R.; Yang, Ping; Liu, Shujun			The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2 '-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; IN-VITRO; PHASE-I; C-KIT; MYELODYSPLASTIC SYNDROME; POOR-PROGNOSIS; MAST-CELLS; EXPRESSION; INHIBITOR; MECHANISMS	Lung cancer cells are sensitive to 5-aza-2'-deoxycytidine (decitabine) or midostaurin (PKC412), because decitabine restores the expression of methylation-silenced tumor suppressor genes, whereas PKC412 inhibits hyperactive kinase signaling, which is essential for cancer cell growth. Here, we demonstrated that resistance to decitabine (decitabine(R)) or PKC412 (PKC412(R)) eventually results from simultaneously remethylated DNA and reactivated kinase cascades. Indeed, both decitabine(R) and PKC412(R) displayed the up-regulation of DNA methyltransferase DNMT1 and tyrosine-protein kinase KIT, the enhanced phosphorylation of KIT and its downstream effectors, and the increased global and gene-specific DNA methylation with the down-regulation of tumor suppressor gene epithelial cadherin CDH1. Interestingly, decitabine(R) and PKC412(R) had higher capability of colony formation and wound healing than parental cells in vitro, which were attributed to the hyperactive DNMT1 or KIT, because inactivation of KIT or DNMT1 reciprocally blocked decitabine(R) or PKC412(R) cell proliferation. Further, DNMT1 knockdown sensitized PKC412(R) cells to PKC412; conversely, KIT depletion synergized with decitabine in eliminating decitabine(R). Importantly, when engrafted into nude mice, decitabine(R) and PKC412(R) had faster proliferation with stronger tumorigenicity that was caused by the reactivated KIT kinase signaling and further CDH1 silencing. These findings identify functional cross-talk between KIT and DNMT1 in the development of drug resistance, implying the reciprocal targeting of protein kinases and DNA methyltransferases as an essential strategy for durable responses in lung cancer.	[Yan, Fei; Shen, Na; Pang, Jiuxia; Liu, Shujun] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Molina, Julian R.] Mayo Clin, Dept Med Oncol, Rochester, MN 55905 USA; [Yang, Ping] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA	University of Minnesota System; Mayo Clinic; Mayo Clinic	Liu, SJ (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	sliu@hi.umn.edu	Regan, Clinton/E-6250-2012; Yan, Fei/G-4941-2016	Yan, Fei/0000-0003-4750-1200	National Institutes of Health [R01CA149623, R21CA155915]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R21CA155915, R01CA149623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA149623 and R21CA155915 (to S. L.). This work was also supported in part by funds from the Hormel Foundation (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; Ansari J, 2009, ANTI-CANCER AGENT ME, V9, P569, DOI 10.2174/187152009788451879; Blum W, 2010, P NATL ACAD SCI USA, V107, P7473, DOI 10.1073/pnas.1002650107; Boldrini L, 2004, CLIN CANCER RES, V10, P4101, DOI 10.1158/1078-0432.CCR-03-0664; Brognard J, 2001, CANCER RES, V61, P3986; Carlomagno F, 2005, CURR MED CHEM, V12, P1773, DOI 10.2174/0929867054367266; COURAGE C, 1995, BRIT J CANCER, V71, P697, DOI 10.1038/bjc.1995.137; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Ding WJ, 2008, DIGEST DIS SCI, V53, P2083, DOI 10.1007/s10620-007-0145-2; Dufies M, 2011, ONCOTARGET, V2, P874, DOI 10.18632/oncotarget.360; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fabbro D, 2000, ANTI-CANCER DRUG DES, V15, P17; Fabbro D, 1999, PHARMACOL THERAPEUT, V82, P293, DOI 10.1016/S0163-7258(99)00005-4; Fischer B, 2007, CANCER TREAT REV, V33, P391, DOI 10.1016/j.ctrv.2007.01.006; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Garcia-Manero G, 2011, J CLIN ONCOL, V29, P2521, DOI 10.1200/JCO.2010.34.4226; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Girault I, 2003, CLIN CANCER RES, V9, P4415; Gleixner KV, 2006, BLOOD, V107, P752, DOI 10.1182/blood-2005-07-3022; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Hopfer O, 2007, EXP HEMATOL, V35, P712, DOI 10.1016/j.exphem.2007.01.054; Ikegami Y, 1996, ARZNEIMITTEL-FORSCH, V46, P201; Iliopoulos D, 2005, ONCOGENE, V24, P1625, DOI 10.1038/sj.onc.1208398; Jafri Nazia F., 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P147, DOI 10.1615/JEnvPathToxOncol.v22.i3.10; Jelinek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022110; Jiang L, 2012, BIOCHEM BIOPH RES CO, V422, P739, DOI 10.1016/j.bbrc.2012.05.072; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kandasamy K, 2002, CANCER RES, V62, P4929; Kim HJ, 2006, CANCER, V107, P1042, DOI 10.1002/cncr.22087; Kurakawa E, 2001, INT J ONCOL, V19, P277; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Liu ZF, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1156; Lockwood WW, 2007, INT J CANCER, V120, P436, DOI 10.1002/ijc.22335; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mishra MV, 2008, MOL CANCER RES, V6, P243, DOI 10.1158/1541-7786.MCR-07-0373; Momparler RL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00188; Monnerat C, 2004, ANN ONCOL, V15, P316, DOI 10.1093/annonc/mdh052; Muller CI, 2006, CURR PHARM BIOTECHNO, V7, P315, DOI 10.2174/138920106778521523; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Propper DJ, 2001, J CLIN ONCOL, V19, P1485, DOI 10.1200/JCO.2001.19.5.1485; Rossi Antonio, 2009, Curr Drug Discov Technol, V6, P91; Saito Y, 2003, INT J CANCER, V105, P527, DOI 10.1002/ijc.11127; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Shen N, 2014, ONCOTARGET, V5, P5494, DOI 10.18632/oncotarget.2131; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Stolzel F, 2010, ANN HEMATOL, V89, P653, DOI 10.1007/s00277-009-0889-1; Tenzer A, 2001, CANCER RES, V61, P8203; TSUURA Y, 1994, VIRCHOWS ARCH, V424, P135; Wang Q, 2012, INT J ONCOL, V40, P418, DOI 10.3892/ijo.2011.1233; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Weisberg E, 2008, BLOOD, V112, P5161, DOI 10.1182/blood-2008-02-138065; Went PT, 2004, J CLIN ONCOL, V22, P4514, DOI 10.1200/JCO.2004.10.125; Wu JJ, 2005, FEBS LETT, V579, P1940, DOI 10.1016/j.febslet.2005.02.041; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.380	64	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18480	18494		10.1074/jbc.M114.633693	http://dx.doi.org/10.1074/jbc.M114.633693			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26085088	Green Published, hybrid			2022-12-26	WOS:000358512100021
J	Abe, K; Takamatsu, N; Ishikawa, K; Tsurumi, T; Tanimoto, S; Sakurai, Y; Lisse, T; Imai, K; Serikawa, T; Mashimo, T				Abe, Koichiro; Takamatsu, Nobuhiko; Ishikawa, Kumiko; Tsurumi, Toshiko; Tanimoto, Sho; Sakurai, Yukina; Lisse, Thomas; Imai, Kenji; Serikawa, Tadao; Mashimo, Tomoji			Novel ENU-Induced Mutation in Tbx6 Causes Dominant Spondylocostal Dysostosis-Like Vertebral Malformations in the Rat	PLOS ONE			English	Article							T-BOX PROTEIN; TRANSCRIPTION FACTOR; MESODERM FORMATION; PARAXIAL MESODERM; MOUSE EMBRYOS; GENE; SOMITE; EXPRESSION; SEGMENTATION; ZEBRAFISH	Congenital vertebral malformations caused by embryonic segmentation defects are relatively common in humans and domestic animals. Although reverse genetics approaches in mice have provided information on the molecular mechanisms of embryonic somite segmentation, hypothesis-driven approaches cannot adequately reflect human dysmorphology within the population. In a N-ethyl-N-nitrosourea (ENU) mutagenesis project in Kyoto, the Oune mutant rat strain was isolated due to a short and kinked caudal vertebra phenotype. Skeletal staining of heterozygous rats showed partial loss of the cervical vertebrae as well as hemivertebrae and fused vertebral blocks in lumbar and sacral vertebrae. In homozygous embryos, severe displacement of the whole vertebrae was observed. The Oune locus was genetically mapped to rat chromosome 1 using 202 backcross animals and 50 genome-wide microsatellite markers. Subsequently, a miss-sense mutation in the Tbx6 gene was identified in the critical region. Although the mutation is located within the T-box domain near a predicted dimmer-interface, in vitro experiments revealed that the Tbx6 variant retains normal DNA binding ability and translational efficiency. However, the variant has decreased transcriptional activation potential in response to Notch-mediated signaling. Recently, it was reported that a dominant type of familial spondylocostal dysostosis is caused by a stoploss mutation in TBX6. Thus, we propose that partial dysfunction of Tbx6 leads to similar congenital vertebral malformations in both humans and rats. The Oune strain could be a unique animal model for dominant spondylocostal dysostosis and is useful for molecular dissection of the pathology of congenital vertebral malformations in humans.	[Abe, Koichiro; Ishikawa, Kumiko; Tanimoto, Sho; Imai, Kenji] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Takamatsu, Nobuhiko; Sakurai, Yukina] Kitasato Univ, Sch Sci, Dept Biosci, Sagamihara, Kanagawa 228, Japan; [Tsurumi, Toshiko; Serikawa, Tadao; Mashimo, Tomoji] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan; [Lisse, Thomas] Davis Ctr Regenerat Biol & Med, MDI Biol Lab, Bar Harbor, ME USA	Tokai University; Kitasato University; Kyoto University	Abe, K (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan.	abeko@is.icc.u-tokai.ac.jp	lisse, thomas/B-4847-2019		Japanese Ministry of Education, Science, Culture, Sports, Science and Technology [22930009]; Grants-in-Aid for Scientific Research [26290033] Funding Source: KAKEN	Japanese Ministry of Education, Science, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in Aid from the Japanese Ministry of Education, Science, Culture, Sports, Science and Technology (Grant Number 22930009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2012, GENESIS, V50, P758, DOI 10.1002/dvg.22035; AGULNIK SI, 1995, GENOMICS, V25, P214, DOI 10.1016/0888-7543(95)80128-9; Ahn D, 2012, MOL BIOL EVOL, V29, P3959, DOI 10.1093/molbev/mss199; Beckers J, 2000, MECH DEVELOP, V95, P35, DOI 10.1016/S0925-4773(00)00323-3; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chen YL, 2009, J BIOL CHEM, V284, P23481, DOI 10.1074/jbc.M109.007864; Christ B, 2004, ANAT EMBRYOL, V208, P333, DOI 10.1007/s00429-004-0408-z; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Fuchs H, 2006, SCREENING BONE CARTI; Grunerberg H, 1963, PATHOLOGY DEV; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kojima M, 2000, EUR J BIOCHEM, V267, P4635, DOI 10.1046/j.1432-1327.2000.01499.x; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Mansouri A, 2000, DEVELOPMENT, V127, P2251; Mashimo T, 2008, NAT GENET, V40, P514, DOI 10.1038/ng0508-514; Mashimo T, 2014, DEV GROWTH DIFFER, V56, P46, DOI 10.1111/dgd.12110; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Nacke S, 2000, DEV DYNAM, V219, P192, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1046>3.0.CO;2-9; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Nikaido M, 2002, NAT GENET, V31, P195, DOI 10.1038/ng899; Offiah A, 2010, AM J MED GENET A, V152A, P1357, DOI 10.1002/ajmg.a.33361; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; RIMOIN DL, 1968, AM J MED, V45, P948, DOI 10.1016/0002-9343(68)90193-9; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Sparrow DB, 2013, HUM MOL GENET, V22, P1625, DOI 10.1093/hmg/ddt012; Sparrow DB, 2011, MAMM GENOME, V22, P362, DOI 10.1007/s00335-011-9335-5; Taniguchi Y, 2011, J ANAT, V219, P589, DOI 10.1111/j.1469-7580.2011.01425.x; Turnpenny PD, 2007, DEV DYNAM, V236, P1456, DOI 10.1002/dvdy.21182; Watabe-Rudolph M, 2002, MECH DEVELOP, V119, P251, DOI 10.1016/S0925-4773(02)00394-5; White PH, 2005, GENESIS, V42, P193, DOI 10.1002/gene.20140; White PH, 2003, DEVELOPMENT, V130, P1681, DOI 10.1242/dev.00367; Windner SE, 2012, BIOL OPEN, V1, P806, DOI 10.1242/bio.20121958; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Yasuhiko Y, 2008, DEVELOPMENT, V135, P3511, DOI 10.1242/dev.027144	39	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130231	10.1371/journal.pone.0130231	http://dx.doi.org/10.1371/journal.pone.0130231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090680	Green Published, gold			2022-12-26	WOS:000356835000098
J	Jiang, Y; Zhang, Y; Jin, MM; Gu, ZY; Pei, Y; Meng, P				Jiang, Ying; Zhang, Ying; Jin, Mengmeng; Gu, Zhaoyan; Pei, Yu; Meng, Ping			Aged-Related Changes in Body Composition and Association between Body Composition with Bone Mass Density by Body Mass Index in Chinese Han Men over 50-year-old	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; MINERAL DENSITY; FAT MASS; ADIPOSE-TISSUE; LEAN MASS; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; RISK-FACTORS; ELDERLY-MEN; MUSCLE MASS	Objectives Aging, body composition, and body mass index (BMI) are important factors in bone mineral density (BMD). Although several studies have investigated the various parameters and factors that differentially influence BMD, the results have been inconsistent. Thus, the primary goal of the present study was to further characterize the relationships of aging, body composition parameters, and BMI with BMD in Chinese Han males older than 50 years. Methods The present study was a retrospective analysis of the body composition, BMI, and BMD of 358 Chinese male outpatients between 50 and 89 years of age that were recruited from our hospital between 2009 and 2011. Qualified subjects were stratified according to age and BMI as follows: 50-59 (n = 35), 60-69 (n = 123), 70-79 (n = 93), and 80-89 (n = 107) years of age and low weight (BMI: < 20 kg/m(2); n = 21), medium weight (20 <= BMI < 24 kg/m(2); n = 118), overweight (24 <= BMI < 28 kg/m(2); n = 178), and obese (BMI >= 28 kg/m(2); n = 41). Dual-energy X-ray absorptiometry (DEXA) was used to assess bone mineral content (BMC), lean mass (LM), fat mass (FM), fat-free mass (FFM), lumbar spine (L1-L4) BMD, femoral neck BMD, and total hip BMD. Additionally, the FM index (FMI; FM/height(2)), LM index (LMI; LM/height(2)), FFM index (FFMI; [BMC+LM]/height(2)), percentage of BMC (%BMC; BMC/[BMC+FM+LM] x 100%), percentage of FM (%FM; FM/[BMC+FM+LM] x 100%), and percentage of LM (%LM; LM/(BMC+FM+LM) x 100%) were calculated. Osteopenia or osteoporosis was identified using the criteria and T-score of the World Health Organization. Results Although there were no significant differences in BMI among the age groups, there was a significant decline in height and weight according to age (p < 0.0001 and p = 0.0002, respectively). The LMI and FFMI also declined with age (both p < 0.0001) whereas the FMI exhibited a significant increase that peaked in the 80-89-years group (p = 0.0145). Although the absolute values of BMC and LM declined with age (p = 0.0031 and p < 0.0001, respectively), there was no significant difference in FM. In terms of body composition, there were no significant differences in %BMC but there was an increase in %FM (p < 0.0001) and a decrease in %LM (p < 0.0001) with age. The femoral neck and total hip BMD significantly declined with age (p < 0.0001 and p = 0.0027, respectively) but there were no differences in L1-L4. BMD increased at all sites (all p < 0.01) as BMI increased but there were declines in the detection rates of osteoporosis and osteopenia (both p < 0.001). A logistic regression revealed that when the medium weight group was given a BMI value of 1, a decline in BMI was an independent risk factor of osteoporosis or osteopenia, while an increase in BMI was a protective factor for BMD. At the same time, BMD in L1-L4 exhibited a significant positive association with FMI (p = 0.0003) and the femoral neck and total hip BMDs had significant positive associations with FFMI and LMI, respectively (both p < 0.0001). Conclusions These data indicate that LMI and FFMI exhibited significant negative associations with aging in Chinese Han males older than 50 years, whereas FMI had a positive association. BMD in the femoral neck and total hip declined with age but an increased BMI was protective for BMD. LMI and FFMI were protective for BMD in the femoral neck and total hip.	[Jiang, Ying; Jin, Mengmeng] Peoples Liberat Army Gen Hosp, Dept Geriatr Endocrinol, Beijing, Peoples R China; [Zhang, Ying] Peoples Liberat Army Gen Hosp, Dept Geriatr Nephrol, Beijing, Peoples R China; [Pei, Yu] Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Jin, Mengmeng; Gu, Zhaoyan] Peoples Liberat Army Gen Hosp, Hlth Care Dept, Hainan Branch, Sanya, Peoples R China; [Pei, Yu] Peoples Liberat Army Gen Hosp, Dept Endocrinol, Hainan Branch, Sanya, Peoples R China; [Meng, Ping] Peoples Liberat Army Gen Hosp, Hlth Care Dept, Beijing, Peoples R China; [Jiang, Ying] Peoples Liberat Army Gen Hosp, Dept Nursing, Hainan Branch, Sanya, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Pei, Y (corresponding author), Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China.	baby.toe@163.com; mengping303@163.com	Souza, Ramon S/B-1185-2017	Souza, Ramon S/0000-0002-9501-8435	PLA general hospital, the Department of Geriatric Endocrinology	PLA general hospital, the Department of Geriatric Endocrinology	We are grateful to Mrs Yu Pei and Ping Meng for their excellent suggestions as reviewers of this manuscript. We would like to thank Mrs Mengmeng Jin and Zhaoyan Gu for their unrestricted support of this work. We are also grateful to the PLA general hospital, the Department of Geriatric Endocrinology for supporting this study.	ABATE N, 1994, J LIPID RES, V35, P1490; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Biasioli S, 1993, ASAIO J, V39, pM596; BISHOP CW, 1981, AM J CLIN NUTR, V34, P2530, DOI 10.1093/ajcn/34.11.2530; Bredella MA, 2011, BONE, V48, P748, DOI 10.1016/j.bone.2010.12.011; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chumlea WC, 1999, KIDNEY INT, V56, P244, DOI 10.1046/j.1523-1755.1999.00532.x; Coin A, 2000, OSTEOPOROSIS INT, V11, P1043, DOI 10.1007/s001980070026; Cui LH, 2007, J BONE MINER METAB, V25, P165, DOI 10.1007/s00774-006-0747-3; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Douchi T, 2003, J BONE MINER METAB, V21, P17, DOI 10.1007/s007740300003; EDELSTEIN SL, 1993, AM J EPIDEMIOL, V138, P160, DOI 10.1093/oxfordjournals.aje.a116842; El Hage R, 2009, J BONE MINER METAB, V27, P629, DOI 10.1007/s00774-009-0074-6; Elia M, 2000, ANN NY ACAD SCI, V904, P298; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Fuller NJ, 1999, INT J OBESITY, V23, P1295, DOI 10.1038/sj.ijo.0801070; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Ichikawa S, 2005, J CLIN ENDOCR METAB, V90, P5921, DOI 10.1210/jc.2004-2253; JONES G, 1995, J RHEUMATOL, V22, P932; Karabulut O, 2010, FOLIA MORPHOL, V69, P170; Kim JH, 2012, OSTEOPOROSIS INT, V23, P2009, DOI 10.1007/s00198-011-1808-6; Kim J, 2006, AM J CLIN NUTR, V84, P1014, DOI 10.1093/ajcn/84.5.1014; Kyle UG, 2001, NUTRITION, V17, P534, DOI 10.1016/S0899-9007(01)00555-X; Lane JT, 2005, ENDOCRINE, V27, P295, DOI 10.1385/ENDO:27:3:295; Lee KG, 2012, XENOTRANSPLANTATION, V19, P186, DOI 10.1111/j.1399-3089.2012.00704.x; Lekamwasam S, 2009, J BONE MINER METAB, V27, P83, DOI 10.1007/s00774-008-0006-x; Leslie WD, 2007, APPL PHYSIOL NUTR ME, V32, P1065, DOI 10.1139/H07-068; Levine JA, 2000, J APPL PHYSIOL, V88, P452, DOI 10.1152/jappl.2000.88.2.452; Lim S, 2004, BONE, V35, P792, DOI 10.1016/j.bone.2004.05.016; Liu MY, 2014, AGING MALE, V17, P166, DOI 10.3109/13685538.2014.940308; Liu SP, 2011, ARCH GERONTOL GERIAT, V53, pE192, DOI 10.1016/j.archger.2010.09.002; LUKASKI HC, 1987, AM J CLIN NUTR, V46, P537, DOI 10.1093/ajcn/46.4.537; Makovey J, 2005, OSTEOPOROSIS INT, V16, P1495, DOI 10.1007/s00198-005-1841-4; Mattsson S, 2006, PHYS MED BIOL, V51, pR203, DOI 10.1088/0031-9155/51/13/R13; MAZARIEGOS M, 1994, J GERONTOL, V49, pM201, DOI 10.1093/geronj/49.5.M201; Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217; Moseley KF, 2011, CLIN ENDOCRINOL, V74, P565, DOI 10.1111/j.1365-2265.2010.03965.x; Mott JW, 1999, AM J CLIN NUTR, V69, P1007; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; Napoli N, 2007, CALCIFIED TISSUE INT, V80, P227, DOI 10.1007/s00223-007-9014-4; Nguyen TV, 2000, J BONE MINER RES, V15, P322, DOI 10.1359/jbmr.2000.15.2.322; Paniagua MA, 2006, CLIN INTERV AGING, V1, P283, DOI 10.2147/ciia.2006.1.3.283; Park JJ, 2010, EUR SPINE J, V19, P1942, DOI 10.1007/s00586-010-1559-7; Park JH, 2012, BONE, V50, P1006, DOI 10.1016/j.bone.2012.01.015; Pluijm SMF, 2001, J BONE MINER RES, V16, P2142, DOI 10.1359/jbmr.2001.16.11.2142; Porthouse J, 2004, QJM-INT J MED, V97, P569, DOI 10.1093/qjmed/hch097; REID IR, 1992, J CLIN ENDOCR METAB, V75, P779, DOI 10.1210/jc.75.3.779; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; REID IR, 1992, J CLIN ENDOCR METAB, V75, P45, DOI 10.1210/jc.75.1.45; RISSANEN A, 1988, INT J OBESITY, V12, P391; ROSSNER S, 1990, INT J OBESITY, V14, P893; Salamat MR, 2013, J OSTEOPOROS, V2013, DOI 10.1155/2013/205963; Skrzek A, 2014, HOMO, V65, P232, DOI 10.1016/j.jchb.2014.01.003; Thomas T, 2001, BONE, V29, P114, DOI 10.1016/S8756-3282(01)00487-2; van den Beld AW, 2000, J CLIN ENDOCR METAB, V85, P3276, DOI 10.1210/jc.85.9.3276; Visser M, 1998, APPL RADIAT ISOTOPES, V49, P745, DOI 10.1016/S0969-8043(97)00101-2; Visser M, 1999, J APPL PHYSIOL, V87, P1513, DOI 10.1152/jappl.1999.87.4.1513; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Watts NB, 2012, J CLIN ENDOCR METAB, V97, P1802, DOI 10.1210/jc.2011-3045; Wilsgaard T, 2009, AM J EPIDEMIOL, V169, P877, DOI 10.1093/aje/kwn407; Zhang HB, 2013, ENDOCRINE, V43, P643, DOI 10.1007/s12020-012-9833-6; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	64	26	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130400	10.1371/journal.pone.0130400	http://dx.doi.org/10.1371/journal.pone.0130400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090818	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000113
J	Turnipseed, R; Ugine, TA; Losey, JE				Turnipseed, Rakim; Ugine, Todd A.; Losey, John E.			Egg Predation by the Introduced Lady Beetle, Coccinella septempunctata (Coleoptera: Coccinellidae), Lowers Mortality but Raises Relative Risk for the Native Lady Beetle, Coccinella novemnotata	PLOS ONE			English	Article							HARMONIA-AXYRIDIS COLEOPTERA; LARVAL COLEOMEGILLA-MACULATA; INTRAGUILD PREDATION; INTERSPECIFIC PREDATION; LADYBEETLES COLEOPTERA; ACALYPHA-OSTRYAEFOLIA; BODY-SIZE; CANNIBALISM; PREY; INVASION	Populations of the native ninespotted lady beetle, Coccinella novemnotata Herbst, have undergone precipitous declines in North America following the establishment of the exotic sevenspotted lady beetle, Coccinella septempunctata L. Recent volunteer efforts have made it possible to establish colonies of the now-rare C. novemnotata and test mechanisms contributing to its decline. We evaluated the relative frequencies of intraguild predation and cannibalism of eggs between these two species. A single C. novemnotata or C. septempunctata adult was exposed to conspecific and heterospecific eggs in either the presence or absence of pea aphids. The study revealed two expected results: 1) eggs of C. novemnotata were consumed more frequently than eggs of C. septempunctata by both species, and 2) egg consumption was higher when aphids were absent, independent of predator and egg species. There were also two unexpected results from the study: 1) the asymmetry between egg predation rates was higher when aphids were present, and 2) higher predation rates on C. novemnotata eggs in the absence of alternate prey was due to a relatively higher rate of intraspecific cannibalism. This implies that C. novemnotata would have suffered higher egg mortality rates before the invasion of C. septempunctata, but even though the aggregate rate of egg predation on C. novemnotata eggs is lower post-invasion, it is still significantly higher than the aggregate rate of predation of C. septempunctata eggs. This differential pattern of asymmetric predation could contribute to habitat compression and the overall decline of C. novemnotata.	[Turnipseed, Rakim] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Turnipseed, Rakim; Ugine, Todd A.; Losey, John E.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	University of California System; University of California Berkeley; Cornell University	Losey, JE (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	jel27@cornell.edu			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This project was funded by a grant from the Informal Science Education Program of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWALA BK, 1992, ECOL ENTOMOL, V17, P303, DOI 10.1111/j.1365-2311.1992.tb01062.x; Alyokhin A, 2004, BIOL INVASIONS, V6, P463, DOI 10.1023/B:BINV.0000041554.14539.74; Cottrell TE, 2004, BIOL CONTROL, V31, P362, DOI 10.1016/j.biocontrol.2004.06.004; Cottrell TE, 1998, ENVIRON ENTOMOL, V27, P1375, DOI 10.1093/ee/27.6.1375; Cottrell TE, 2005, BIOL CONTROL, V34, P159, DOI 10.1016/j.biocontrol.2005.04.008; Cottrell TE, 1999, ENTOMOL EXP APPL, V90, P313, DOI 10.1023/A:1026429217088; Cunningham AA, 2003, J PARASITOL, V89, P78; Dixon A.F.G., 2000, INSECT PREDATOR PREY; Elliott N, 1996, OECOLOGIA, V105, P537, DOI 10.1007/BF00330017; EVANS EW, 1991, OECOLOGIA, V87, P401, DOI 10.1007/BF00634598; Gardiner MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023576; Grange LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077917, 10.1371/journal.pone.0084448]; Harmon JP, 2007, J INSECT CONSERV, V11, P85, DOI 10.1007/s10841-006-9021-1; Hemptinne JL, 2000, CHEMOECOLOGY, V10, P123, DOI 10.1007/PL00001813; Hemptinne JL, 2000, EUR J ENTOMOL, V97, P559, DOI 10.14411/eje.2000.087; Hironori Y, 1997, ENTOMOPHAGA, V42, P153, DOI 10.1007/BF02769893; Jafari R., 2013, J BIOL CHEM RES, V30, P152; Kajita Y, 2000, APPL ENTOMOL ZOOL, V35, P473, DOI 10.1303/aez.2000.473; Kajita Y, 2010, ANN ENTOMOL SOC AM, V103, P750, DOI 10.1603/AN10071; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Losey J, 2012, BIOL CONTROL, V61, P98, DOI 10.1016/j.biocontrol.2011.12.009; Michaud JP, 2002, ENVIRON ENTOMOL, V31, P827, DOI 10.1603/0046-225X-31.5.827; Michaud JP, 2000, BIOL CONTROL, V18, P287, DOI 10.1006/bcon.2000.0833; Musser FR, 2003, ENVIRON ENTOMOL, V32, P575, DOI 10.1603/0046-225X-32.3.575; New TR., 2009, INSECT CONSERVATION; Obrycki JJ, 1998, ENVIRON ENTOMOL, V27, P1280, DOI 10.1093/ee/27.5.1280; Obrycki JJ, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P127; Obrycki JJ, 2001, FLA ENTOMOL, V84, P55, DOI 10.2307/3496663; Osawa Naoya, 1992, Japanese Journal of Entomology, V60, P575; Perry JC, 2005, BEHAV ECOL SOCIOBIOL, V58, P578, DOI 10.1007/s00265-005-0947-1; POLIS GA, 1992, TRENDS ECOL EVOL, V7, P151, DOI 10.1016/0169-5347(92)90208-S; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; SAS Institute Inc, 2011, JMP VERS 9 0 2; Sato S, 2003, ECOL ENTOMOL, V28, P628, DOI 10.1046/j.1365-2311.2003.00542.x; Sato S, 2008, APPL ENTOMOL ZOOL, V43, P143, DOI 10.1303/aez.2008.143; Schellhorn NA, 1999, ENVIRON ENTOMOL, V28, P1092, DOI 10.1093/ee/28.6.1092; Snyder WE, 2004, OECOLOGIA, V140, P559, DOI 10.1007/s00442-004-1612-5; Snyder WE, 2000, ENVIRON ENTOMOL, V29, P1173, DOI 10.1603/0046-225X-29.6.1173; STAINES CL, 1990, P ENTOMOL SOC WASH, V92, P310; Turnipseed RK, 2014, ENVIRON ENTOMOL, V43, P969, DOI 10.1603/EN14043; Ugine TA, 2014, ENVIRON ENTOMOL, V43, P1067, DOI 10.1603/EN14053; WHEELER AG, 1995, P ENTOMOL SOC WASH, V97, P701	42	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0118493	10.1371/journal.pone.0118493	http://dx.doi.org/10.1371/journal.pone.0118493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090935	Green Published, gold			2022-12-26	WOS:000356835000002
J	Cordova-Palomera, A; Fatjo-Vilas, M; Falcon, C; Bargallo, N; Alemany, S; Crespo-Facorro, B; Nenadic, I; Fananas, L				Cordova-Palomera, Aldo; Fatjo-Vilas, Mar; Falcon, Carles; Bargallo, Nuria; Alemany, Silvia; Crespo-Facorro, Benedicto; Nenadic, Igor; Fananas, Lourdes			Birth Weight and Adult IQ, but Not Anxious-Depressive Psychopathology, Are Associated with Cortical Surface Area: A Study in Twins	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; BRAIN VOLUME; ANXIETY DISORDERS; SEGMENTATION; THICKNESS; BEHAVIOR; MODELS; GROWTH; YOUNG; SCHIZOPHRENIA	Background Previous research suggests that low birth weight (BW) induces reduced brain cortical surface area (SA) which would persist until at least early adulthood. Moreover, low BW has been linked to psychiatric disorders such as depression and psychological distress, and to altered neurocognitive profiles. Aims We present novel findings obtained by analysing high-resolution structural MRI scans of 48 twins; specifically, we aimed: i) to test the BW-SA association in a middle-aged adult sample; and ii) to assess whether either depression/anxiety disorders or intellectual quotient (IQ) influence the BW-SA link, using a monozygotic (MZ) twin design to separate environmental and genetic effects. Results Both lower BW and decreased IQ were associated with smaller total and regional cortical SA in adulthood. Within a twin pair, lower BW was related to smaller total cortical and regional SA. In contrast, MZ twin differences in SA were not related to differences in either IQ or depression/anxiety disorders. Conclusion The present study supports findings indicating that i) BW has a long-lasting effect on cortical SA, where some familial and environmental influences alter both foetal growth and brain morphology; ii) uniquely environmental factors affecting BW also alter SA; iii) higher IQ correlates with larger SA; and iv) these effects are not modified by internalizing psychopathology.	[Cordova-Palomera, Aldo; Fatjo-Vilas, Mar; Alemany, Silvia; Fananas, Lourdes] Univ Barcelona, Fac Biol, Dept Biol Anim, Unidad Antropol, E-08028 Barcelona, Spain; [Cordova-Palomera, Aldo; Fatjo-Vilas, Mar; Alemany, Silvia; Fananas, Lourdes] Univ Barcelona, Inst Biomed IBUB, E-08028 Barcelona, Spain; [Cordova-Palomera, Aldo; Fatjo-Vilas, Mar; Bargallo, Nuria; Alemany, Silvia; Crespo-Facorro, Benedicto; Fananas, Lourdes] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid 28007, Spain; [Falcon, Carles; Bargallo, Nuria] Inst Invest Biomed August Pi I Sunyer IDIBAPS, Med Image Core Facil, Barcelona 08036, Spain; [Falcon, Carles] Ctr Invest Biomed Red Bioingn Biomed & Nanomed CI, Zaragoza 50018, Spain; [Bargallo, Nuria] Hosp Clin Barcelona, Ctr Diagnost Imagen, E-08036 Barcelona, Spain; [Crespo-Facorro, Benedicto] Univ Cantabria, Sch Med, Dept Psychiat, Univ Hosp Marques Valdecilla, Santander 39008, Cantabria, Spain; [Crespo-Facorro, Benedicto] Inst Formac Invest Marques Valdecilla, IFIMAV, Santander 39008, Cantabria, Spain; [Nenadic, Igor] Univ Jena, Jena Univ Hosp, Dept Psychiat & Psychotherapy, D-07743 Jena, Germany	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Friedrich Schiller University of Jena	Fananas, L (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Anim, Unidad Antropol, Av Diagonal 643, E-08028 Barcelona, Spain.	lfananas@ub.edu	Crespo-Facorro, BENEDICTO/AAY-2238-2021; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Fatjó-Vilas, Mar/AAA-8779-2020; Cordova-Palomera, Aldo/K-5479-2019; Saura, Lourdes Fañanás/C-7586-2017; Sierra, Silvia Alemany/J-7419-2013; Bargallo, Nuria/G-6854-2016	Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Fatjó-Vilas, Mar/0000-0001-9963-6241; Saura, Lourdes Fañanás/0000-0001-6266-7706; Sierra, Silvia Alemany/0000-0002-7925-6767; falcon, carles/0000-0001-5564-2025; Bargallo, Nuria/0000-0001-6284-5402	European Twins Study Network on Schizophrenia Research Training Network [MRTN-CT-2006-035987, EUTwinsS]; ERA-NET NEURON [PIM2010-ERN-00642]; National Council for Science and Technology (CONACyT, Mexico);  [SAF2008-05674];  [2014SGR1636]	European Twins Study Network on Schizophrenia Research Training Network; ERA-NET NEURON; National Council for Science and Technology (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ; 	This work was supported by the Spanish SAF2008-05674, European Twins Study Network on Schizophrenia Research Training Network (grant number EUTwinsS; MRTN-CT-2006-035987), the Catalan 2014SGR1636 and the PIM2010-ERN-00642 in frame of ERA-NET NEURON. A. Cordova-Palomera was funded by The National Council for Science and Technology (CONACyT, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany S, 2013, J AFFECT DISORDERS, V149, P175, DOI 10.1016/j.jad.2013.01.019; Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; Bigos KL, 2010, NEUROIMAGE, V53, P804, DOI 10.1016/j.neuroimage.2010.01.035; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Bjuland KJ, 2013, EARLY HUM DEV, V89, P371, DOI 10.1016/j.earlhumdev.2012.12.003; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Cordova-Palomera A, 2014, PSYCHOL MED, V44, P1117, DOI 10.1017/S0033291713002754; Cordova-Palomera A, 2015, MZTWINREG REGRESSION; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; Draisma H. H. M., 2011, ANAL METABOLOMICS DA; Fatjo-Vilas M, 2012, BIOL PSYCHIAT, V72, P758, DOI 10.1016/j.biopsych.2012.04.035; First M. B., 1997, STRUCTURED CLIN INTE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Glinianaia SV, 2000, ACTA OBSTET GYN SCAN, V79, P450, DOI 10.1034/j.1600-0412.2000.079006450.x; Guilherme R, 2009, HUM REPROD, V24, P100, DOI 10.1093/humrep/den364; Haukvik UK, 2014, SCHIZOPHRENIA BULL, V40, P410, DOI 10.1093/schbul/sbt005; Haukvik UK, 2009, J PSYCHIATR RES, V43, P1287, DOI 10.1016/j.jpsychires.2009.05.001; Hu FB, 1998, STAT MED, V17, P957, DOI 10.1002/(SICI)1097-0258(19980515)17:9<957::AID-SIM791>3.3.CO;2-F; Huang C, 2013, INT J EPIDEMIOL, V42, P160, DOI 10.1093/ije/dys207; Jaffee SR, 2013, DEV PSYCHOPATHOL, V25, P1225, DOI 10.1017/S0954579413000588; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kroes MCW, 2011, J PSYCHIATR NEUROSCI, V36, P256, DOI 10.1503/jpn.100077; Lewis S, 1989, OBSTET COMPLICATIONS; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; Mosing MA, 2009, DEPRESS ANXIETY, V26, P1004, DOI 10.1002/da.20611; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Odlaug BL, 2014, J PSYCHIAT RES; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pinheiro J, 2015, NLME LINEAR NONLINEA; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132; Rajput S, 2011, EUR PSYCHIAT, V26, P390, DOI 10.1016/j.eurpsy.2010.07.002; Raznahan A, 2012, P NATL ACAD SCI USA, V109, P11366, DOI 10.1073/pnas.1203350109; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Sattler, 2018, ASSESSMENT CHILDREN; Skranes J, 2013, CORTEX, V49, P2264, DOI 10.1016/j.cortex.2013.06.001; Takei Y, 2013, J PSYCHIATR RES, V47, P1581, DOI 10.1016/j.jpsychires.2013.07.029; Tamnes CK, 2013, NEUROIMAGE, V68, P63, DOI 10.1016/j.neuroimage.2012.11.039; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; van Tol MJ, 2010, ARCH GEN PSYCHIAT, V67, P1002, DOI 10.1001/archgenpsychiatry.2010.121; Venkatasubramanian G, 2012, J PSYCHIATR RES, V46, P1161, DOI 10.1016/j.jpsychires.2012.06.003; Viding E, 2012, DEV PSYCHOPATHOL, V24, P969, DOI 10.1017/S095457941200048X; Visscher PM, 2004, TWIN RES, V7, P670, DOI 10.1375/1369052042663742; Vuoksimaa E, 2014, CEREB CORTEX; Wagner G, 2012, J PSYCHIATR RES, V46, P1449, DOI 10.1016/j.jpsychires.2012.07.013; Walhovd KB, 2012, P NATL ACAD SCI USA, V109, P20089, DOI 10.1073/pnas.1208180109; Walshe M, 2011, PSYCHIAT RES, V187, P335, DOI 10.1016/j.psychres.2011.01.013; Wechsler D., 1997, WAIS ESCALA INTELIGE; Wheeler B, 2010, LMPERM PERMUTATION T; Winkler AM, 2012, NEUROIMAGE, V61, P1428, DOI 10.1016/j.neuroimage.2012.03.026; Wittchen HU, 2008, PSYCHOTHER PSYCHOSOM, V77, P147, DOI 10.1159/000116608; Wojcik W, 2013, PSYCHOL MED, V43, P1, DOI 10.1017/S0033291712000682; Yaghootkar H, 2012, CURR OPIN CLIN NUTR, V15, P258, DOI 10.1097/MCO.0b013e328351f543; Yoon S, 2013, J PSYCHIATR RES, V47, P1446, DOI 10.1016/j.jpsychires.2013.06.015; Zbozinek TD, 2012, DEPRESS ANXIETY, V29, P1065, DOI 10.1002/da.22026; Zubiaurre-Elorza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042148	64	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129616	10.1371/journal.pone.0129616	http://dx.doi.org/10.1371/journal.pone.0129616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086820	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500053
J	Hecht, M; Erber, S; Harrer, T; Klinker, H; Roth, T; Parsch, H; Fiebig, N; Fietkau, R; Distel, LV				Hecht, Markus; Erber, Sonja; Harrer, Thomas; Klinker, Hartwig; Roth, Thomas; Parsch, Hans; Fiebig, Nora; Fietkau, Rainer; Distel, Luitpold V.			Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells	PLOS ONE			English	Article							HUMAN HEPATIC CELLS; ACTIVE ANTIRETROVIRAL THERAPY; DIFFERENTIATED THYROID-TUMOR; HIV-INFECTED PATIENTS; PHARMACOKINETIC INTERACTION; LINE-1 RETROTRANSPOSITION; HIV-1-INFECTED SUBJECTS; HEALTHY-VOLUNTEERS; PROSTATE-CANCER; I-131 UPTAKE	Background Cancer prevention and therapy in HIV-1-infected patients will play an important role in future. The non-nucleoside reverse transcriptase inhibitors (NNRTI) Efavirenz and Nevirapine are cytotoxic against cancer cells in vitro. As other NNRTIs have not been studied so far, all clinically used NNRTIs were tested and the in vitro toxic concentrations were compared to drug levels in patients to predict possible anti-cancer effects in vivo. Methods Cytotoxicity was studied by Annexin-V-APC/7AAD staining and flow cytometry in the pancreatic cancer cell lines BxPC-3 and Panc-1 and confirmed by colony formation assays. The 50% effective cytotoxic concentrations (EC50) were calculated and compared to the blood levels in our patients and published data. Results The in vitro EC50 of the different drugs in the BxPC-3 pancreatic cancer cells were: Efavirenz 31.5 mu mol/l (= 9944ng/ml), Nevirapine 239 mu mol/l (= 63786ng/ml), Etravirine 89.0 mu mol/l (= 38740ng/ml), Lersivirine 543 mu mol/l (= 168523ng/ml), Delavirdine 171 mu mol/l (= 78072ng/ml), Rilpivirine 24.4 mu mol/l (= 8941ng/ml). As Efavirenz and Rilpivirine had the highest cytotoxic potential and Nevirapine is frequently used in HIV-1 positive patients, the results of these three drugs were further studied in Panc-1 pancreatic cancer cells and confirmed with colony formation assays. 205 patient blood levels of Efavirenz, 127 of Rilpivirine and 31 of Nevirapine were analyzed. The mean blood level of Efavirenz was 3587ng/ml (range 162-15363ng/ml), of Rilpivirine 144ng/ml (range 0-572ng/ml) and of Nevirapine 4955ng/ml (range 1856-8697ng/ml). Blood levels from our patients and from published data had comparable Efavirenz levels to the in vitro toxic EC50 in about 1 to 5% of all patients. Conclusion All studied NNRTIs were toxic against cancer cells. A low percentage of patients taking Efavirenz reached in vitro cytotoxic blood levels. It can be speculated that in HIV-1 positive patients having high Efavirenz blood levels pancreatic cancer incidence might be reduced. Efavirenz might be a new option in the treatment of cancer.	[Hecht, Markus; Erber, Sonja; Fiebig, Nora; Fietkau, Rainer; Distel, Luitpold V.] Univ Hosp Erlangen, Dept Radiat Oncol, Erlangen, Germany; [Harrer, Thomas] Univ Hosp Erlangen, Dept Internal Med 3, Erlangen, Germany; [Klinker, Hartwig] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Roth, Thomas; Parsch, Hans] Univ Hosp Erlangen, Cent Lab, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Wurzburg; University of Erlangen Nuremberg	Hecht, M (corresponding author), Univ Hosp Erlangen, Dept Radiat Oncol, Erlangen, Germany.	Markus.Hecht@uk-erlangen.de	Hecht, Markus/AAX-1792-2020; Fietkau, Rainer/A-9632-2017; Distel, Luitpold/ABD-9880-2020; Klinker, Hartwig/AAC-1134-2021	Hecht, Markus/0000-0003-2082-216X; Distel, Luitpold/0000-0002-8040-3226; 	Interdisciplinary Center for Clinical Research (IZKF) Erlangen	Interdisciplinary Center for Clinical Research (IZKF) Erlangen	Funding for this work was provided by Interdisciplinary Center for Clinical Research (IZKF) Erlangen: rotation-programme for medical doctors (Markus Hecht). (www.izkf.uk-erlangen.de) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DH, 2012, AIDS; Amengual JE, 2008, BLOOD, V112, P4359, DOI 10.1182/blood-2008-06-162289; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Apostolova N, 2013, J HEPATOL, V59, P780, DOI 10.1016/j.jhep.2013.06.005; Azijn H, 2010, ANTIMICROB AGENTS CH, V54, P718, DOI 10.1128/AAC.00986-09; Bonnet F, 2009, CLIN INFECT DIS, V48, P633, DOI 10.1086/596766; Burgi A, 2005, CANCER-AM CANCER SOC, V104, P1505, DOI 10.1002/cncr.21334; Chao C, 2012, AIDS, V26, P2223, DOI 10.1097/QAD.0b013e32835935b3; Cheng CL, 1997, CLIN PHARMACOL THER, V61, P531, DOI 10.1016/S0009-9236(97)90133-8; Corbau R, 2010, ANTIMICROB AGENTS CH, V54, P4451, DOI 10.1128/AAC.01455-09; Dai LX, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-18; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; DeJesus E, 2010, ANTIVIR THER, V15, P711, DOI 10.3851/IMP1562; Ford SL, 2013, ANTIMICROB AGENTS CH, V57, P5472, DOI 10.1128/AAC.01235-13; Girard T, 2005, EUR J HAEMATOL, V74, P70, DOI 10.1111/j.1600-0609.2004.00339.x; Goebel F, 2006, AIDS, V20, P1721, DOI 10.1097/01.aids.0000242818.65215.bd; Gomez-Sucerquia LJ, 2012, ANTIVIR RES, V94, P232, DOI 10.1016/j.antiviral.2012.04.003; Grupp K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-145; Gruzdev B, 2003, AIDS, V17, P2487, DOI 10.1097/00002030-200311210-00011; Gutierrez F, 2005, CLIN INFECT DIS, V41, P1648, DOI 10.1086/497835; Hecht M, 2013, AIDS, V27, P2031, DOI 10.1097/QAD.0b013e3283625444; Houede N, 2014, ONCOLOGIST, V19, P1227, DOI 10.1634/theoncologist.2014-0345; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Justesen US, 2004, J ANTIMICROB CHEMOTH, V54, P206, DOI 10.1093/jac/dkh252; Kakuda TN, 2009, HIV MED, V10, P173, DOI 10.1111/j.1468-1293.2008.00668.x; Kato T, 2005, JPN J CLIN ONCOL, V35, P349, DOI 10.1093/jjco/hyi093; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Landriscina M, 2005, J CLIN ENDOCR METAB, V90, P5663, DOI 10.1210/jc.2005-0367; Landriscina M, 2006, LANCET ONCOL, V7, P877, DOI 10.1016/S1470-2045(06)70908-1; Lopez-Cortes LF, 2005, JAIDS-J ACQ IMM DEF, V39, P551; Mangiacasale R, 2003, ONCOGENE, V22, P2750, DOI 10.1038/sj.onc.1206354; Manosuthi W, 2005, AIDS, V19, P1481, DOI 10.1097/01.aids.0000183630.27665.30; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Modoni S, 2007, CANCER BIOTHER RADIO, V22, P289, DOI 10.1089/cbr.2006.316; Nafrialdi, 2012, Acta Med Indones, V44, P135; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Omar T, 2011, AIDS, V25, P87, DOI 10.1097/QAD.0b013e328340fd99; Pedersen OS, 1999, ANTIVIR CHEM CHEMOTH, V10, P285, DOI 10.1177/095632029901000601; Piasecka A, 1998, INT J RADIAT BIOL, V74, P139, DOI 10.1080/095530098141807; Pittoggi C, 2008, INT BRAZ J UROL, V34, P492, DOI 10.1590/S1677-55382008000400012; Ratanasuwan Winai, 2012, Open AIDS J, V6, P266, DOI 10.2174/1874613601206010266; Sciamanna E, 2005, ONCOGENE, V24, P3923, DOI 10.1038/sj.onc.1208562; Sciamanna I, 2013, ONCOTARGET, V4, P2271, DOI 10.18632/oncotarget.1403; Sinibaldi-Vallebona P, 2006, GENE CHROMOSOME CANC, V45, P1, DOI 10.1002/gcc.20266; Stefanidis K, 2008, GYNECOL ONCOL, V111, P344, DOI 10.1016/j.ygyno.2008.08.006; van Leeuwen MT, 2009, AIDS, V23, P2183, DOI 10.1097/QAD.0b013e328331d384; Vourvahis M, 2010, ANTIMICROB AGENTS CH, V54, P2209, DOI 10.1128/AAC.01110-09; Vourvahis M, 2012, ANTIMICROB AGENTS CH, V56, P2408, DOI 10.1128/AAC.05194-11; Vourvahis M, 2012, ANTIMICROB AGENTS CH, V56, P887, DOI 10.1128/AAC.00572-11; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026739	50	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130277	10.1371/journal.pone.0130277	http://dx.doi.org/10.1371/journal.pone.0130277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086472	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500088
J	Li, Q; Liu, S; Li, J; Bai, O				Li, Qi; Liu, Shuai; Li, Jian; Bai, Ou			Use of a Green Familiar Faces Paradigm Improves P300-Speller Brain-Computer Interface Performance	PLOS ONE			English	Article							P300; COMMUNICATION; BCI; POTENTIALS; CLASSIFICATION; RECOGNITION; PERCEPTION; INTERVAL; AROUSAL; ERPS	Background A recent study showed improved performance of the P300-speller when the flashing row or column was overlaid with translucent pictures of familiar faces (FF spelling paradigm). However, the performance of the P300-speller is not yet satisfactory due to its low classification accuracy and information transfer rate. Objective To investigate whether P300-speller performance is further improved when the chromatic property and the FF spelling paradigm are combined. Methods We proposed a new spelling paradigm in which the flashing row or column is overlaid with translucent green pictures of familiar faces (GFF spelling paradigm). We analyzed the ERP waveforms elicited by the FF and proposed GFF spelling paradigms and compared P300-speller performance between the two paradigms. Results Significant differences in the amplitudes of four ERP components (N170, VPP, P300, and P600f) were observed between both spelling paradigms. Compared to the FF spelling paradigm, the GFF spelling paradigm elicited ERP waveforms of higher amplitudes and resulted in improved P300-speller performance. Conclusions Combining the chromatic property (green color) and the FF spelling paradigm led to better classification accuracy and an increased information transfer rate. These findings demonstrate a promising new approach for improving the performance of the P300-speller.	[Li, Qi; Liu, Shuai; Li, Jian] Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun, Peoples R China; [Liu, Shuai] Yellow River Conservancy Commiss, Hequ Hydrol Stn, Middle Reaches Hydrol & Water Resources Bur, Jinzhong, Peoples R China; [Bai, Ou] Virginia Commonwealth Univ, Sch Engn, Richmond, VA 23284 USA	Changchun University of Science & Technology; Virginia Commonwealth University	Li, Q (corresponding author), Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun, Peoples R China.	liqi@cust.edu.cn			National Natural Science Foundation of China [61203362]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The study was financially supported by the National Natural Science Foundation of China (61203362, http://www.nsfc.gov.cn/) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (44 Batch, http://fund.cscse.edu.cn/Login.aspx).	Allison BZ, 2006, INT J PSYCHOPHYSIOL, V59, P127, DOI 10.1016/j.ijpsycho.2005.02.007; Allison BZ, 2003, IEEE T NEUR SYS REH, V11, P110, DOI 10.1109/TNSRE.2003.814448; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bernat E, 2001, CLIN NEUROPHYSIOL, V112, P159, DOI 10.1016/S1388-2457(00)00445-4; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blau VC, 2007, BEHAV BRAIN FUNCT, V3; Curran T, 2007, NEUROIMAGE, V36, P464, DOI 10.1016/j.neuroimage.2006.12.016; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Freeman JB, 2010, NEUROREPORT, V21, P24, DOI 10.1097/WNR.0b013e3283320d54; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Jin J, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500270; Jin J, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036004; Jin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049688; Jin J, 2012, MED BIOL ENG COMPUT, V50, P289, DOI 10.1007/s11517-012-0868-x; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Kleih SC, 2010, CLIN NEUROPHYSIOL, V121, P1023, DOI 10.1016/j.clinph.2010.01.034; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kubler A, 2005, PROG BRAIN RES, V150, P513, DOI 10.1016/S0079-6123(05)50035-9; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; McFarland DJ, 2003, BIOL PSYCHOL, V63, P237, DOI 10.1016/S0301-0511(03)00073-5; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Polich J, 1996, INT J PSYCHOPHYSIOL, V23, P55, DOI 10.1016/0167-8760(96)00028-1; Rossion B, 2002, COGNITION, V85, P189, DOI 10.1016/S0010-0277(02)00101-4; Rozenkrants B, 2008, CLIN NEUROPHYSIOL, V119, P2260, DOI 10.1016/j.clinph.2008.07.213; Salvaris M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046011; Scherer R, 2004, IEEE T BIO-MED ENG, V51, P979, DOI 10.1109/TBME.2004.827062; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Takano K, 2009, CLIN NEUROPHYSIOL, V120, P1562, DOI 10.1016/j.clinph.2009.06.002; Touryan J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00042; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zhang Y, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026018	41	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130325	10.1371/journal.pone.0130325	http://dx.doi.org/10.1371/journal.pone.0130325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087308	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500097
J	Zhang, JY; Wang, JHC				Zhang, Jianying; Wang, James H-C.			Moderate Exercise Mitigates the Detrimental Effects of Aging on Tendon Stem Cells	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; ACHILLES-TENDON; SELF-RENEWAL; RAT TENDON; COLLAGEN; PROLIFERATION; HOMEOSTASIS; EXPRESSION; CITED2; MOUSE	Aging is known to cause tendon degeneration whereas moderate exercise imparts beneficial effects on tendons. Since stem cells play a vital role in maintaining tissue integrity, in this study we aimed to define the effects of aging and moderate exercise on tendon stem/progenitor cells (TSCs) using in vitro and in vivo models. TSCs derived from aging mice (9 and 24 months) proliferated significantly slower than TSCs obtained from young mice (2.5 and 5 months). In addition, expression of the stem cell markers Oct-4, nucleostemin (NS), Sca-1 and SSEA-1 in TSCs decreased in an age-dependent manner. Interestingly, moderate mechanical stretching (4%) of aging TSCs in vitro significantly increased the expression of the stem cell marker, NS, but 8% stretching decreased NS expression. Similarly, 4% mechanical stretching increased the expression of Nanog, another stem cell marker, and the tenocyte-related genes, collagen I and tenomodulin. However, 8% stretching increased expression of the non-tenocyte-related genes, LPL, Sox-9 and Runx-2, while 4% stretching had minimal effects on the expression of these genes. In the in vivo study, moderate treadmill running (MTR) of aging mice (9 months) resulted in the increased proliferation rate of aging TSCs in culture, decreased lipid deposition, proteoglycan accumulation and calcification, and increased the expression of NS in the patellar tendons. These findings indicate that while aging impairs the proliferative ability of TSCs and reduces their stemness, moderate exercise can mitigate the deleterious effects of aging on TSCs and therefore may be responsible for decreased aging-induced tendon degeneration.	[Zhang, Jianying; Wang, James H-C.] Univ Pittsburgh, MechanoBiol Lab, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Wang, James H-C.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Wang, James H-C.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA USA; [Wang, James H-C.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, JHC (corresponding author), Univ Pittsburgh, MechanoBiol Lab, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA.	wanghc@pitt.edu			NIH/NIAMS [AR061395, AR060920, AR065949]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060920, R01AR061395, R01AR065949] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The funding support for this study was provided by NIH/NIAMS under award numbers AR061395, AR060920, and AR065949. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; ELLIOTT DH, 1965, BIOL REV, V40, P392, DOI 10.1111/j.1469-185X.1965.tb00808.x; Endo T, 2010, MOL ENDOCRINOL, V24, P1267, DOI 10.1210/me.2010-0056; Hess Gregory William, 2010, Foot Ankle Spec, V3, P29, DOI 10.1177/1938640009355191; IPPOLITO E, 1980, J BONE JOINT SURG AM, V62, P583, DOI 10.2106/00004623-198062040-00014; Jiang DP, 2013, HISTOL HISTOPATHOL, V28, P1537, DOI 10.14670/HH-28.1537; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Kohler J, 2013, AGING CELL, V12, P988, DOI 10.1111/acel.12124; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Langberg H, 2001, J PHYSIOL-LONDON, V534, P297, DOI 10.1111/j.1469-7793.2001.00297.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; MICHNA H, 1989, INT ORTHOP, V13, P161, DOI 10.1007/BF00268040; MICHNA H, 1984, CELL TISSUE RES, V236, P465; MOORE MJ, 1987, J ANAT, V153, P163; Nishioka T, 2007, J CARDIOVASC PHARM, V49, P261, DOI 10.1097/FJC.0b013e318033dfd4; Nourissat Geoffroy, 2013, Front Biosci (Elite Ed), V5, P911; Ruge T, 2004, AM J PHYSIOL-RENAL, V287, pF1131, DOI 10.1152/ajprenal.00089.2004; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Ruzzini L, 2013, KNEE SURG SPORT TR A, P1, DOI [10.1007/s00167-012-2175-3, DOI 10.1007/S00167-012-2175-3]; Sharir A, 2011, CURR BIOL, V21, pR472, DOI 10.1016/j.cub.2011.05.025; Torricelli P, 2013, AGE, V35, P2125, DOI 10.1007/s11357-012-9500-0; Tsai WC, 2011, J ORTHOP RES, V29, P1598, DOI 10.1002/jor.21418; Tuite DJ, 1997, SCAND J MED SCI SPOR, V7, P72; Viidik A, 1967, Scand J Plast Reconstr Surg, V1, P141; VIIDIK A, 1969, ACTA ORTHOP SCAND, V40, P261, DOI 10.3109/17453676908989506; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Wood LK, 2015, J ORTHOP RES, V31, P22824; Yang YF, 2013, ANN BIOMED ENG, V41, P2109, DOI 10.1007/s10439-013-0802-x; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Zhang J, 2015, ANN ORS M; Zhang JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087706; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071740; Zhang JY, 2010, J ORTHOP RES, V28, P639, DOI 10.1002/jor.21046; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhou ZP, 2010, AGING CELL, V9, P911, DOI 10.1111/j.1474-9726.2010.00598.x	40	36	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130454	10.1371/journal.pone.0130454	http://dx.doi.org/10.1371/journal.pone.0130454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086850	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000356567500106
J	Ambrosio, JR; Valverde-Islas, L; Nava-Castro, KE; Palacios-Arreola, MI; Ostoa-Saloma, P; Reynoso-Ducoing, O; Escobedo, G; Ruiz-Rosado, A; Dominguez-Ramirez, L; Morales-Montor, J				Ambrosio, Javier R.; Valverde-Islas, Laura; Nava-Castro, Karen E.; Isabel Palacios-Arreola, M.; Ostoa-Saloma, Pedro; Reynoso-Ducoing, Olivia; Escobedo, Galileo; Ruiz-Rosado, Azucena; Dominguez-Ramirez, Lenin; Morales-Montor, Jorge			Androgens Exert a Cysticidal Effect upon Taenia crassiceps by Disrupting Flame Cell Morphology and Function	PLOS ONE			English	Article							HOST-PARASITE RELATIONSHIP; MURINE CYSTICERCOSIS; SEX-HORMONES; ALBINO MICE; PROGESTERONE; INFECTIONS; GROWTH; SOLIUM; CESTODA; GONADECTOMY	The effects of testosterone (T-4) and dihydrotestosterone (DHT) on the survival of the helminth cestode parasite Taenia crassiceps, as well as their effects on actin, tubulin and myosin expression and their assembly into the excretory system of flame cells are described in this paper. In vitro evaluations on parasite viability, flow cytometry, confocal microscopy, video-microscopy of live flame cells, and docking experiments of androgens interacting with actin, tubulin, and myosin were conducted. Our results show that T-4 and DHT reduce T. crassiceps viability in a dose-and time-dependent fashion, reaching 90% of mortality at the highest dose used (40 ng/ml) and time exposed (10 days) in culture. Androgen treatment does not induce differences in the specific expression pattern of actin, tubulin, and myosin isoforms as compared with control parasites. Confocal microscopy demonstrated a strong disruption of the parasite tegument, with reduced assembly, shape, and motion of flame cells. Docking experiments show that androgens are capable of affecting parasite survival and flame cell morphology by directly interacting with actin, tubulin and myosin without altering their protein expression pattern. We show that both T-4 and DHT are able to bind actin, tubulin, and myosin affecting their assembly and causing parasite intoxication due to impairment of flame cell function. Live flame cell video microscopy showing a reduced motion as well changes in the shape of flame cells are also shown. In summary, T-4 and DHT directly act on T. crassiceps cysticerci through altering parasite survival as well as the assembly and function of flame cells.	[Ambrosio, Javier R.; Valverde-Islas, Laura; Reynoso-Ducoing, Olivia] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Nava-Castro, Karen E.] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Dept Ciencias Ambientales, Mexico City 04510, DF, Mexico; [Isabel Palacios-Arreola, M.; Ostoa-Saloma, Pedro; Ruiz-Rosado, Azucena; Morales-Montor, Jorge] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Escobedo, Galileo] Univ Nacl Autonoma Mexico, Fac Med, Unidad Med Expt, Mexico City 04510, DF, Mexico; [Ruiz-Rosado, Azucena] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Ruiz-Rosado, Azucena] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Segar Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Dominguez-Ramirez, Lenin] Univ Amer Puebla, Escuela Ciencias, Dept Ciencias Quim Biol, Santa Catarina Martir Ch, Puebla, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; McGill University; Lady Davis Institute; McGill University; Universidad Americas Puebla (UDLAP)	Morales-Montor, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico.	jmontor66@biomedicas.unam.mx	Montor, Jorge/B-1224-2012; Dominguez-Ramirez, Lenin/AAG-9864-2020; Ambrosio, Javier R/A-6099-2008; Nava-Castro, Karen E/V-4161-2018; Ostoa-Saloma, Pedro/V-3226-2019	Montor, Jorge/0000-0002-9461-610X; Dominguez-Ramirez, Lenin/0000-0002-3483-4658; Ambrosio, Javier R/0000-0001-7441-0609; Nava-Castro, Karen E/0000-0003-2223-6703; Palacios-Arreola, Margarita Isabel/0000-0001-8882-7544; Ostoa-Saloma, Pedro/0000-0003-2066-8019	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) from Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (U.N.A.M.) [IN-216213, IN-201510]; Programa de Fondos Sectoriales CB-SEP, Consejo Nacional de Ciencia y Tecnologia (CONACyT) [176803]; CONACyT [151747]; Pew Latin American Fellows Program in the Biomedical Sciences; CONACyT	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) from Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (U.N.A.M.); Programa de Fondos Sectoriales CB-SEP, Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Pew Latin American Fellows Program in the Biomedical Sciences; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants # IN-216213 and # IN-201510 to Javier Ambrosio, obtained from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) from Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (U.N.A.M.), and Grant 176803, from Programa de Fondos Sectoriales CB-SEP, Consejo Nacional de Ciencia y Tecnologia (CONACyT) to Jorge Morales Montor, and Grant 151747 to Pedro Ostoa-Saloma, also from CONACyT. Lenin Dominguez-Ramirez was in part funded by the Pew Latin American Fellows Program in the Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Karen Nava-Castro has a postdoctoral fellowship from CONACyT. M. Isabel Palacios-Arreola is a PhD student at Programa de Doctorado en Ciencias Biomedicas, UNAM, and has a scholarship from CONACyT.	Alvarez LI, 2007, TRENDS PARASITOL, V23, P97, DOI 10.1016/j.pt.2007.01.003; Ambrosio JR, 2014, INT J PARASITOL, V44, P687, DOI 10.1016/j.ijpara.2014.04.004; Barnes D, 1987, ZOOLOGIA INVERTEBRAD, P179; BHAI I, 1982, INT J PARASITOL, V12, P589, DOI 10.1016/0020-7519(82)90057-1; Bottasso O, 2009, NEUROIMMUNOMODULAT, V16, P65, DOI 10.1159/000180260; Chen LF, 2002, J STRUCT BIOL, V138, P92, DOI 10.1016/S1047-8477(02)00013-8; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coil W.H., 1991, P211; Cruz-Rivera M, 2006, CELL BIOL INT, V30, P598, DOI 10.1016/j.cellbi.2006.02.010; CULBRETH KL, 1972, EXP PARASITOL, V32, P272, DOI 10.1016/0014-4894(72)90034-3; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; DOBSON C, 1961, PARASITOLOGY, V51, P499, DOI 10.1017/S0031182000070748; DORAIS FJ, 1969, EXP PARASITOL, V25, P395, DOI 10.1016/0014-4894(69)90086-1; Durrant JD, 2011, J CHEM INF MODEL, V51, P2897, DOI 10.1021/ci2003889; Escobedo G, 2005, TRENDS PARASITOL, V21, P588, DOI 10.1016/j.pt.2005.09.013; Escobedo G, 2004, J PARASITOL, V90, P1235, DOI 10.1645/GE-297R; Escobedo G, 2011, INT J BIOL SCI, V7, P1443, DOI 10.7150/ijbs.7.1443; Escobedo G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/591079; FRAYHA GJ, 1971, EXP PARASITOL, V29, P255, DOI 10.1016/0014-4894(71)90032-4; Ibarra-Coronado EG, 2011, STEROIDS, V76, P1149, DOI 10.1016/j.steroids.2011.05.003; Hernandez-Bello R, 2010, PARASITE IMMUNOL, V32, P633, DOI 10.1111/j.1365-3024.2010.01232.x; Hernandez-Bello R, 2012, MINIREVIEWS MED CHEM; Hernandez-Bello R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/625380; Kumar D, 2003, PARASITOLOGY, V127, P457, DOI 10.1017/S0031182003003925; LARRALDE C, 1995, J STEROID BIOCHEM, V52, P575, DOI 10.1016/0960-0760(95)00062-5; MOCK BA, 1988, INFECT IMMUN, V56, P3316, DOI 10.1128/IAI.56.12.3316-3319.1988; Morales-Montor J, 2008, CURR TOP MED CHEM, V8, P400, DOI 10.2174/156802608783790866; Morales-Montor J, 2002, EXP PARASITOL, V100, P209, DOI 10.1016/S0014-4894(02)00028-0; Nava-Castro K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/257060; NOVAK M, 1975, INT J PARASITOL, V5, P269, DOI 10.1016/0020-7519(75)90072-7; Palomares F, 2006, J ANTIMICROB CHEMOTH, V57, P482, DOI 10.1093/jac/dki484; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Ricardo PU, 2012, EXP PARASITOL, V130, P32, DOI 10.1016/j.exppara.2011.10.002; ROHDE K, 1992, INT J PARASITOL, V22, P443, DOI 10.1016/0020-7519(92)90145-B; Sciutto E, 2011, PARASITE IMMUNOL, V33, P79, DOI 10.1111/j.1365-3024.2010.01257.x; SCIUTTO E, 1990, PARASITE IMMUNOL, V12, P687, DOI 10.1111/j.1365-3024.1990.tb00997.x; SOLOMON GB, 1966, EXP PARASITOL, V18, P374, DOI 10.1016/0014-4894(66)90039-7; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Valverde-Islas LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014754; Vargas-Villavicencio JA, 2006, PARASITE IMMUNOL, V28, P667, DOI 10.1111/j.1365-3024.2006.00906.x; Vargas-Villavicencio JA, 2005, MICROBES INFECT, V7, P485, DOI 10.1016/j.micinf.2004.12.015; VOGE M, 1963, J PARASITOL, V49, P85, DOI 10.2307/3275681; Yang LJ, 2006, J PHYS CHEM B, V110, P13166, DOI 10.1021/jp060163v	43	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127928	10.1371/journal.pone.0127928	http://dx.doi.org/10.1371/journal.pone.0127928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076446	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900016
J	Jeronimus, BF; Stavrakakis, N; Veenstra, R; Oldehinkel, AJ				Jeronimus, Bertus F.; Stavrakakis, Nikolaos; Veenstra, Rene; Oldehinkel, Albertine J.			Relative Age Effects in Dutch Adolescents: Concurrent and Prospective Analyses	PLOS ONE			English	Article							INDIVIDUAL-LIVES SURVEY; SELF-ESTEEM; INTERNATIONAL EVIDENCE; ANXIETY PROBLEMS; YOUNG ADULTHOOD; BIRTH; CHILDREN; OUTCOMES; DEPRESSION; SCHOOL	The literature on relative age position effects is rather inconsistent. In this study we examined intra-classroom age position (or relative age) effects on Dutch adolescents' school progress and performance (as rated by teachers), physical development, temperamental development (fear and frustration), and depressive symptoms, all adjusted for age at the time of measurement. Data were derived from three waves of Tracking Adolescents' Individuals Lives Survey (TRAILS) of 2230 Dutch adolescents (baseline mean age 11.1, SD = 0.6, 51% girls). Albeit relative age predicted school progress (grade retention ORs = 0.83 for each month, skipped grade OR = 1.47, both p<.001), our key observation is the absence of substantial developmental differences as a result of relative age position in Dutch adolescents with a normative school trajectory, in contrast to most literature. For adolescents who had repeated a grade inverse relative age effects were observed, in terms of physical development and school performance, as well as on depressive symptoms, favoring the relatively young. Cross-cultural differences in relative age effect may be partly explained by the decision threshold for grade retention.	[Jeronimus, Bertus F.; Stavrakakis, Nikolaos; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Veenstra, Rene] Univ Groningen, Dept Sociol, Groningen, Netherlands; [Veenstra, Rene] Univ Groningen, Interuniv Ctr Social Sci Theory & Methodol ICS, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Jeronimus, BF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	B.F.Jeronimus@umcg.nl	Jeronimus, Bertus F/AAC-2877-2020; Veenstra, René/G-6696-2011	Veenstra, René/0000-0001-6686-6307; Jeronimus, Bertus/0000-0003-2826-4537	Alzheimer Forschung Initiative e.V. (AFI) [05825]; AiF/IGF grant of the Bundesministerium fur Wirtschaft [15727 N/1]; Ernst Schering Foundation; Massachusetts Alzheimer Disease Research Center (MADRC) (National Institute on Aging (NIA) grant [P50 AG005134]; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	Alzheimer Forschung Initiative e.V. (AFI); AiF/IGF grant of the Bundesministerium fur Wirtschaft; Ernst Schering Foundation; Massachusetts Alzheimer Disease Research Center (MADRC) (National Institute on Aging (NIA) grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants to C. A. F. v. A from the Alzheimer Forschung Initiative e.V. (AFI) (grant number 05825), from an AiF/IGF grant (grant number 15727 N/1) of the Bundesministerium fur Wirtschaft, a Doctoral Fellowship to A. W. from the Ernst Schering Foundation, and from the Massachusetts Alzheimer Disease Research Center (MADRC) (National Institute on Aging (NIA) grant award number P50 AG005134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela JRZ, 2012, J CLIN CHILD ADOLESC, V41, P391, DOI 10.1080/15374416.2012.654463; Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Achenbach TM, 2003, MANUAL ASEBA ADULT F; Allen J., 2008, J SOCIO-ECON, V37, P343; Beam CR, 2013, DEV PSYCHOPATHOL, V25, P7, DOI 10.1017/S0954579412000867; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1162/qjec.121.4.1437; BELL JF, 1990, OXFORD REV EDUC, V16, P67, DOI 10.1080/0305498900160106; Bobak M, 2001, HUM REPROD, V16, P1512, DOI 10.1093/humrep/16.7.1512; Borenstein M, 2009, INTRO META ANAL; Boyce WT, 2012, P NATL ACAD SCI USA, V109, P17168, DOI 10.1073/pnas.1201730109; Buckles KS, 2013, REV ECON STAT, V95, P711, DOI 10.1162/REST_a_00314; Cascio E, 2007, NBER WORKING PAPER N; Caspi A., 2006, HDB CHILD PSYCHOL, V3, P300, DOI DOI 10.1002/9780470147658.CHPSY0306; Collins WA, 2009, ANNU REV PSYCHOL, V60, P631, DOI 10.1146/annurev.psych.60.110707.163459; Cyranowski JM, 2000, ARCH GEN PSYCHIAT, V57, P21, DOI 10.1001/archpsyc.57.1.21; Dalton B, 2012, COMP EDUC REV, V56, P125, DOI 10.1086/660745; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Deardorff J, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-27; Denessen EJPG, 2010, J EDUC RES, V4; Dhuey E, 2008, ECON EDUC REV, V27, P173, DOI 10.1016/j.econedurev.2006.08.005; Dijkstra JK, 2013, DEV PSYCHOL, V49, P1242, DOI 10.1037/a0030098; Doornbos K, 1971, THESIS RIJKSUNIVERSI; Eaves L, 2004, TWIN RES, V7, P471, DOI 10.1375/1369052042335278; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fenzel L, 1992, J EARLY ADOLESC, V12, P253, DOI DOI 10.1177/0272431692012003002; Ferdinand RF, 2008, J ANXIETY DISORD, V22, P126, DOI 10.1016/j.janxdis.2007.01.008; Flynn J. R., 2009, WHAT IS INT BEYOND; Fraley RC, 2002, PERS SOC PSYCHOL REV, V6, P123, DOI 10.1207/S15327957PSPR0602_03; Gladwell Malcolm, 2008, OUTLIERS; GLEDHILL J, 2002, RES EDUC, V68, P41, DOI DOI 10.7227/RIE.68.4; Goodman R, 2003, BMJ-BRIT MED J, V327, P472, DOI 10.1136/bmj.327.7413.472; Graue ME, 2000, AM EDUC RES J, V37, P509, DOI 10.3102/00028312037002509; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Harris J. R., 2009, NURTURE ASSUMPTION W; HARRIS JR, 1995, PSYCHOL REV, V102, P458, DOI 10.1037/0033-295X.102.3.458; HARTMAN CA, 2000, DUTCH TRANSLATION EA; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Hutchison D, 2013, BRIT ED RES ASS C SE; Janssens KAM, 2011, PEDIATRICS, V128, P553, DOI 10.1542/peds.2010-2364; Jeronimus BF, 2014, J PERS SOC PSYCHOL, V107, P751, DOI 10.1037/a0037009; Koenig MA, 2011, CHILD DEV, V82, P1634, DOI 10.1111/j.1467-8624.2011.01618.x; Laceulle OM, 2015, EUR J PERSONALITY, V29, P125, DOI 10.1002/per.1989; Laurence Stephen, 2006, INNATE MIND CULTURE, V2; Lawlor DA, 2006, BRIT J EDUC PSYCHOL, V76, P481, DOI 10.1348/000709905X49700; Li X, 2012, INVEST OPHTH VIS SCI, V53, P3082, DOI 10.1167/iovs.12-9967; Martin R., 2013, WE DO IT EVOLUTION F; Martin RP, 2004, J LEARN DISABIL-US, V37, P307, DOI 10.1177/00222194040370040301; McDonald G., 2001, COMPARE, V31, P381; Morrow RL, 2012, CAN MED ASSOC J, V184, P755, DOI 10.1503/cmaj.111619; Muhlenweg AM, 2010, ECON LETT, V109, P157, DOI 10.1016/j.econlet.2010.08.032; Musch J, 2001, DEV REV, V21, P147, DOI 10.1006/drev.2000.0516; NEWCOMB AF, 1993, PSYCHOL BULL, V113, P99, DOI 10.1037/0033-2909.113.1.99; Neyer FJ, 2014, J PERS, V82, P539, DOI 10.1111/jopy.12063; Oldehinkel AJ, 1999, PSYCHOL MED, V29, P655, DOI 10.1017/S0033291799008454; Oldehinkel AJ, 2004, DEV PSYCHOPATHOL, V16, P421, DOI 10.1017/S0954579404044591; Oldehinkel AJ, 2007, J ABNORM CHILD PSYCH, V35, P417, DOI 10.1007/s10802-007-9100-0; Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004; Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695; Persico N, 2004, NATL BUREAU EC RES W, V10522; Peterson RA, 2005, J APPL PSYCHOL, V90, P175, DOI 10.1037/0021-9010.90.1.175; Pierson K, 2014, J SPORT SCI, V32, P776, DOI 10.1080/02640414.2013.855804; Putnam SP., 2001, ADV RES TEMPERAMENT, P165; Rothbart M.K., 2011, BECOMING WHO WE ARE; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Sandercock GRH, 2013, J STRENGTH COND RES, V27, P3293, DOI 10.1519/JSC.0b013e318291b28d; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Sukhnandan L., 1998, STREAMING SETTING GR; Thompson AH, 2004, EDUC RES-UK, V46, P313, DOI 10.1080/0013188042000277368; Thompson AH, 1999, CAN J PSYCHIAT, V44, P82, DOI 10.1177/070674379904400111; van Lang NDJ, 2005, BEHAV RES THER, V43, P1485, DOI 10.1016/j.brat.2004.11.005; Verachtert P, 2010, OXFORD REV EDUC, V36, P285, DOI 10.1080/03054981003629896; Wu W, 2010, J EDUC PSYCHOL, V102, P135, DOI 10.1037/a0016664	73	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128856	10.1371/journal.pone.0128856	http://dx.doi.org/10.1371/journal.pone.0128856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076384	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900033
J	Lourenco, S; Carnide, F; Benavides, FG; Lucas, R				Lourenco, Sara; Carnide, Filomena; Benavides, Fernando G.; Lucas, Raquel			Psychosocial Work Environment and Musculoskeletal Symptoms among 21-Year-Old Workers: A Population-Based Investigation (2011-2013)	PLOS ONE			English	Article							LOW-BACK-PAIN; SOCIAL SUPPORT; JOB STRAIN; HEART-DISEASE; RISK-FACTORS; HEALTH; ONSET; METAANALYSIS; PREDICTORS; DISORDERS	Background The current labour market is becoming more flexible and informal, with job insecurity selectively affecting young workers. However, the role of these increasing adverse psychosocial working conditions on health outcomes remains little known among newly employed workers. Objective To estimate the associations between psychosocial work environment and musculoskeletal outcomes (widespread pain syndrome features and regional pain) in a population-based sample of young workers. Methods Cross-sectional data from workers aged 21 years were collected during the third wave of the EPITeen cohort study (2011-2013; n=650). The Job Content Questionnaire was used to characterize the psychosocial work environment according to the demand-control-support model. Data on pain and non-pain dimensions of the widespread pain syndrome (Fibromyalgia Survey Questionnaire) as well as on regional musculoskeletal pain (Nordic Musculoskeletal Questionnaire) were also collected. Crude and adjusted odds ratios (OR) with 95% confidence intervals (95% CI) were computed using logistic regression and all estimates were adjusted for sex, education and occupational biomechanical demands. Results Job insecurity was significantly associated to the non-pain dimension of the widespread pain syndrome (adjusted OR [95% CI]=1.51 [1.08, 2.12]). Young workers with strain jobs were significantly more likely to report high levels of non-pain symptoms when compared with those with no-strain jobs and this effect was even stronger when social support was added to the main exposure: workers with strain jobs and low social support had twice the odds of reporting high levels of non-pain features than those with high strain but high social support jobs (adjusted OR=1.86, 95% CI: 1.04, 3.31). These significant associations were not observed when widespread pain or multisite regional pain were the outcomes. Conclusion In the beginning of professional life, high strain jobs were associated to non-pain complaints, especially when the work environment provided also low social support.	[Lourenco, Sara; Lucas, Raquel] Univ Porto, Inst Publ Hlth, EPIUnit, P-4100 Oporto, Portugal; [Carnide, Filomena] Univ Lisbon, Fac Human Kinet, Cruz Quebrada Dafundo, Portugal; [Benavides, Fernando G.] Pompeu Fabra Univ, Res Ctr Occupat Hlth, Barcelona, Spain; [Lucas, Raquel] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal	Universidade do Porto; Universidade de Lisboa; Pompeu Fabra University; Universidade do Porto	Lourenco, S (corresponding author), Univ Porto, Inst Publ Hlth, EPIUnit, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	slourenco@med.up.pt	Carnide, Filomena/K-5603-2013	Carnide, Filomena/0000-0002-0580-8637; Lucas, Raquel/0000-0002-4408-8134	Portuguese Foundation for Science and Technology (FCT) [FCOMP-01-0124-FEDER-015750, FCT - PTDC/SAU-EPI/115254/2009, SFRH/BD/77965/2011]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This study was supported by the Portuguese Foundation for Science and Technology (FCT, references: FCOMP-01-0124-FEDER-015750, FCT - PTDC/SAU-EPI/115254/2009). Sara Lourenco gratefully acknowledges a doctoral grant from the Portuguese Foundation for Science and Technology (FCT; reference SFRH/BD/77965/2011). The funder (FCT) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AhlbergHulten GK, 1995, SCAND J WORK ENV HEA, V21, P435, DOI 10.5271/sjweh.59; Alves L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037158; Alves Márcia Guimarães de Mello, 2013, Rev. bras. epidemiol., V16, P125, DOI 10.1590/S1415-790X2013000100012; [Anonymous], 2014, GLOB EMPL TRENDS 201; [Anonymous], 2013, IMP CRIS WORK COND E; Astell-Burt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056674; Barbe MF, 2006, BRAIN BEHAV IMMUN, V20, P423, DOI 10.1016/j.bbi.2006.03.001; da Costa BR, 2010, AM J IND MED, V53, P285, DOI 10.1002/ajim.20750; Descatha A, 2012, SCAND J WORK ENV HEA, V38, P568, DOI 10.5271/sjweh.3300; Eriksen W, 2004, OCCUP ENVIRON MED, V61, P398, DOI 10.1136/oem.2003.008482; Eurofound and EU-OSHA, 2014, PSYCH RISKS EUR PREV; European Commission, 2012, NEW SKILLS JOBS EUR; Ferguson E, 2006, J PSYCHOSOM RES, V60, P45, DOI 10.1016/j.jpsychores.2005.06.076; Fingerhut Marilyn, 2006, Med Lav, V97, P313; GANSTER DC, 1986, J APPL PSYCHOL, V71, P102, DOI 10.1037/0021-9010.71.1.102; Hauser W, 2009, J RHEUMATOL, V36, P2806, DOI 10.3899/jrheum.090579; Harkness EF, 2004, ARTHRITIS RHEUM-US, V50, P1655, DOI 10.1002/art.20258; Hartvigsen J, 2004, OCCUP ENVIRON MED, V61; Hoozemans MJM, 2014, OCCUP ENVIRON MED, V71, P788, DOI 10.1136/oemed-2013-101837; International Labour Office, 2012, ISCO88 INT LAB OFF; International Labour Organisation, 2013, PROT WORKPL SAF HLTH; JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kerr MS, 2001, AM J PUBLIC HEALTH, V91, P1069, DOI 10.2105/AJPH.91.7.1069; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lang J, 2012, SOC SCI MED, V75, P1163, DOI 10.1016/j.socscimed.2012.04.015; Lariviere M, 2007, CLIN J PAIN, V23, P506, DOI 10.1097/AJP.0b013e31806a23e8; Lourenco S, 2015, SCAND J WOR IN PRESS; Lourenco S, 2015, RHEUMATOLOG IN PRESS; McBeth J, 2001, ARTHRITIS RHEUM, V44, P940, DOI 10.1002/1529-0131(200104)44:4<940::AID-ANR151>3.0.CO;2-S; Nahit ES, 2003, ANN RHEUM DIS, V62, P755, DOI 10.1136/ard.62.8.755; Nahit ES, 2001, OCCUP ENVIRON MED, V58, P374, DOI 10.1136/oem.58.6.374; Nahit ES, 2001, J RHEUMATOL, V28, P1378; National Research Council, 2001, MUSC DIS WORKPL LOW; Organisation for Economic Co-operation and Development, 2012, LAB FORC STAT SEX AG; Otobe N., 2011, GLOBAL EC CRISIS GEN; Park KO, 2004, AM J HEALTH BEHAV, V28, P444; Pulvers K, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0330-2; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Ramos E, 2007, ACTA PAEDIATR, V96, P281, DOI 10.1111/j.1651-2227.2007.00107.x; Roquelaure Y, 2012, OCCUP MED-OXFORD, V62, P514, DOI 10.1093/occmed/kqs004; Rugulies R, 2008, J EPIDEMIOL COMMUN H, V62, P245, DOI 10.1136/jech.2006.059113; Sanderson K, 2006, CAN J PSYCHIAT, V51, P63, DOI 10.1177/070674370605100202; Soderberg M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1102; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Tennant C, 2001, J PSYCHOSOM RES, V51, P697, DOI 10.1016/S0022-3999(01)00255-0; Waddell G., 2006, IS WORK GOOD YOUR HL; Wilson HD, 2009, ARTHRIT RHEUM-ARTHR, V61, P527, DOI 10.1002/art.24163; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594	51	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130010	10.1371/journal.pone.0130010	http://dx.doi.org/10.1371/journal.pone.0130010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076365	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900123
J	Lange, C; Kiesel, S; Peters, S; Virus, S; Scheer, H; Jahn, D; Moser, J				Lange, Christiane; Kiesel, Svenja; Peters, Sabine; Virus, Simone; Scheer, Hugo; Jahn, Dieter; Moser, Juergen			Broadened Substrate Specificity of 3-Hydroxyethyl Bacteriochlorophyllide a Dehydrogenase (BchC) Indicates a New Route for the Biosynthesis of Bacteriochlorophyll a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATIVE PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; PHOTOSYNTHETIC GENE-CLUSTER; L-THREONINE DEHYDROGENASE; COMPLETE GENOME SEQUENCE; GREEN-SULFUR BACTERIUM; RHODOBACTER-CAPSULATUS; RHODOPSEUDOMONAS SPHEROIDES; CHLOROBIUM-TEPIDUM; ROSEOBACTER-DENITRIFICANS; MDR SUPERFAMILY	Bacteriochlorophyll a biosynthesis requires formation of a 3-hydroxyethyl group on pyrrole ring A that gets subsequently converted into a 3-acetyl group by 3-vinyl bacteriochlorophyllide a hydratase (BchF) followed by 3-hydroxyethyl bacteriochlorophyllide a dehydrogenase (BchC). Heterologous overproduction of Chlorobaculum tepidum BchF revealed an integral transmembrane protein that was efficiently isolated by detergent solubilization. Recombinant C. tepidum BchC was purified as a soluble protein-NAD(+) complex. Substrate recognition of BchC was investigated using six artificial substrate molecules. Modification of the isocyclic E ring, omission of the central magnesium ion, zinc as an alternative metal ion, and a non-reduced B ring system were tolerated by BchC. According to this broadened in vitro activity, the chlorin 3-hydroxyethyl chlorophyllide a was newly identified as a natural substrate of BchC in a reconstituted pathway consisting of dark-operative protochlorophyllide oxidoreductase, BchF, and BchC. The established reaction sequence would allow for an additional new branching point for the synthesis of bacteriochlorophyll a. Biochemical and site-directed mutagenesis analyses revealed, in contrast to theoretical predictions, a zinc-independent BchC catalysis that requires NAD(+) as a cofactor. Based on these results, we are designating a new medium-chain dehydrogenase/reductase family (MDR057 BchC) as theoretically proposed from a recent bioinformatics analysis.	[Lange, Christiane; Kiesel, Svenja; Peters, Sabine; Virus, Simone; Jahn, Dieter; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Scheer, Hugo] Univ Munich, Dept Biol 1, Bot, D-80638 Munich, Germany	Braunschweig University of Technology; University of Munich	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de		Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft [JA 470/9-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant JA 470/9-2. The authors declare that they have no conflicts of interest with the contents of this article.	Addlesee HA, 2000, J BACTERIOL, V182, P3175, DOI 10.1128/JB.182.11.3175-3182.2000; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bashir Q, 2009, J BIOCHEM, V146, P95, DOI 10.1093/jb/mvp051; BOLLIVAR DW, 1994, BIOCHEMISTRY-US, V33, P12763, DOI 10.1021/bi00209a006; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Brocker MJ, 2008, J BIOL CHEM, V283, P29873, DOI 10.1074/jbc.M805206200; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; Brocker MJ, 2012, HANDB PORPHYR SCI, V20, P1; BROUERS M, 1983, PHOTOSYNTH RES, V4, P265, DOI [10.1007/BF00052130, 10.1007/BF00041822]; BURKE DH, 1993, J BACTERIOL, V175, P2414, DOI 10.1128/JB.175.8.2414-2422.1993; Chew AGM, 2007, J BACTERIOL, V189, P6176, DOI 10.1128/JB.00519-07; COOMBER SA, 1990, MOL MICROBIOL, V4, P977, DOI 10.1111/j.1365-2958.1990.tb00670.x; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; Ganapathy S, 2012, BIOCHEMISTRY-US, V51, P4488, DOI 10.1021/bi201817x; Ganapathy S, 2009, P NATL ACAD SCI USA, V106, P8525, DOI 10.1073/pnas.0903534106; Gough SP, 2007, PLANT PHYSIOL BIOCH, V45, P932, DOI 10.1016/j.plaphy.2007.09.001; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRIFFITHS WT, 1980, BIOCHEM J, V186, P267, DOI 10.1042/bj1860267; Harada J, 2014, J BIOL CHEM, V289, P12716, DOI 10.1074/jbc.M113.546739; Hartwich G, 1998, J AM CHEM SOC, V120, P3675, DOI 10.1021/ja970874u; Hebecker S, 2011, MOL MICROBIOL, V80, P935, DOI 10.1111/j.1365-2958.2011.07621.x; Hedlund J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-534; Helfrich M, 1996, J AM CHEM SOC, V118, P2606, DOI 10.1021/ja953440c; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; HUNTER CN, 1988, J GEN MICROBIOL, V134, P1491; JONES OTG, 1964, BIOCHEM J, V91, P572, DOI 10.1042/bj0910572; Kiesel S, 2015, J BIOL CHEM, V290, P1141, DOI 10.1074/jbc.M114.617761; Kim EJ, 2008, J BIOL CHEM, V283, P3718, DOI 10.1074/jbc.M707774200; Klement H, 1999, EUR J BIOCHEM, V265, P862, DOI 10.1046/j.1432-1327.1999.00627.x; LASCELLES J, 1966, BIOCHEM J, V100, P175, DOI 10.1042/bj1000175; Liu Z., 2012, HDB PORPHYRIN SCI CH, P107; Liu ZF, 2011, J BIOL CHEM, V286, P22393, DOI 10.1074/jbc.M111.249433; Machielsen R, 2006, FEBS J, V273, P2722, DOI 10.1111/j.1742-4658.2006.05290.x; MAGONET E, 1992, BIOCHEM J, V287, P361, DOI 10.1042/bj2870361; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; MCGLYNN P, 1993, MOL GEN GENET, V236, P227, DOI 10.1007/BF00277117; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Moser J, 2013, P NATL ACAD SCI USA, V110, P2094, DOI 10.1073/pnas.1218303110; Muller AH, 2011, ANAL BIOCHEM, V419, P271, DOI 10.1016/j.ab.2011.08.028; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Orf GS, 2013, PHOTOSYNTH RES, V116, P315, DOI 10.1007/s11120-013-9869-3; Oster U, 1997, J BIOL CHEM, V272, P9671; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; PUDEK MR, 1975, BIOCHEMISTRY-US, V14, P3132, DOI 10.1021/bi00685a015; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; RICHARDS WR, 1969, BIOCHEMISTRY-US, V8, P3473, DOI 10.1021/bi00836a051; Riveros-Rosas H, 2003, EUR J BIOCHEM, V270, P3309, DOI 10.1046/j.1432-1033.2003.03704.x; Scheer Hugo, 2006, V25, P1; Schiefner A, 2013, J BIOL CHEM, V288, P16815, DOI 10.1074/jbc.M113.453852; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH JRL, 1966, J AM CHEM SOC, V88, P4500, DOI 10.1021/ja00971a036; STRUCK A, 1992, BIOCHIM BIOPHYS ACTA, V1101, P321, DOI 10.1016/0167-4838(92)90559-V; TAYLOR DP, 1983, J BACTERIOL, V154, P580, DOI 10.1128/JB.154.2.580-590.1983; Tsukatani Y, 2013, BBA-BIOENERGETICS, V1827, P1200, DOI 10.1016/j.bbabio.2013.06.007; Watzlich D, 2009, J BIOL CHEM, V284, P15530, DOI 10.1074/jbc.M901331200; WELLINGTON CL, 1989, GENE, V83, P251, DOI 10.1016/0378-1119(89)90111-X; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; YANG ZM, 1990, J BACTERIOL, V172, P5001, DOI 10.1128/jb.172.9.5001-5010.1990; YOUNG DA, 1989, MOL GEN GENET, V218, P1, DOI 10.1007/BF00330558; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; ZSEBO KM, 1984, CELL, V37, P937, DOI 10.1016/0092-8674(84)90428-8	68	9	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19697	19709		10.1074/jbc.M115.660555	http://dx.doi.org/10.1074/jbc.M115.660555			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088139	hybrid, Green Published			2022-12-26	WOS:000359364600029
J	Franco, MC; Ricart, KC; Gonzalez, AS; Dennys, CN; Nelson, PA; Janes, MS; Mehl, RA; Landar, A; Estevez, AG				Franco, Maria C.; Ricart, Karina C.; Gonzalez, Analia S.; Dennys, Cassandra N.; Nelson, Pascal A.; Janes, Michael S.; Mehl, Ryan A.; Landar, Aimee; Estevez, Alvaro G.			Nitration of Hsp90 on Tyrosine 33 Regulates Mitochondrial Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXYNITRITE-INDUCED APOPTOSIS; CYTOCHROME-C-OXIDASE; NITRIC-OXIDE; CHAPERONE MACHINERY; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ATP HYDROLYSIS; GROWTH-FACTOR; PC12 CELLS; PHOSPHORYLATION	Peroxynitrite production and tyrosine nitration are present in several pathological conditions, including neurodegeneration, stroke, aging, and cancer. Nitration of the pro-survival chaperone heat shock protein 90 (Hsp90) in position 33 and 56 induces motor neuron death through a toxic gain-of-function. Here we show that nitrated Hsp90 regulates mitochondrial metabolism independently of the induction of cell death. In PC12 cells, a small fraction of nitrated Hsp90 was located on the mitochondrial outer membrane and down-regulated mitochondrial membrane potential, oxygen consumption, and ATP production. Neither endogenous Hsp90 present in the homogenate nor unmodified and fully active recombinant Hsp90 was able to compete with the nitrated protein for the binding to mitochondria. Moreover, endogenous or recombinant Hsp90 did not prevent the decrease in mitochondrial activity but supported nitrated Hsp90 mitochondrial gain-of-function. Nitrotyrosine in position 33, but not in any of the other four tyrosine residues prone to nitration in Hsp90, was sufficient to down-regulate mitochondrial activity. Thus, in addition to induction of cell death, nitrated Hsp90 can also regulate mitochondrial metabolism, suggesting that depending on the cell type, distinct Hsp90 nitration states regulate different aspects of cellular metabolism. This regulation of mitochondrial homeostasis by nitrated Hsp90 could be of particular relevance in cancer cells.	[Franco, Maria C.; Dennys, Cassandra N.; Nelson, Pascal A.; Estevez, Alvaro G.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Ricart, Karina C.; Landar, Aimee] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Gonzalez, Analia S.] Univ Buenos Aires, Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina; [Janes, Michael S.] ThermoFisher Sci, Eugene, OR 97402 USA; [Mehl, Ryan A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	State University System of Florida; University of Central Florida; University of Alabama System; University of Alabama Birmingham; University of Buenos Aires; Oregon State University	Franco, MC (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA.	mariaclara.franco@ucf.edu	Franco, Maria/O-7862-2015		 [P30 ES00210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036761] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Sarah B. Gitto and Jonathan Virgilio for technical assistance and Victor Darley-Usmar and Paul S. Brookes for constructive criticism on the manuscript. The Oregon State University Cell Imaging and Analysis Facilities of the Environmental Health Sciences Center is supported by Grant P30 ES00210 (to R. A. M.).	Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Alvarez B, 1996, CHEM RES TOXICOL, V9, P390, DOI 10.1021/tx950133b; Arnold S, 2012, MITOCHONDRION, V12, P46, DOI 10.1016/j.mito.2011.05.003; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Borutaite V, 1999, BBA-MOL BASIS DIS, V1453, P41, DOI 10.1016/S0925-4439(98)00082-9; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brookes PS, 1998, J NEUROCHEM, V70, P2195; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Cobbs CS, 2001, ARCH BIOCHEM BIOPHYS, V394, P167, DOI 10.1006/abbi.2001.2540; Cooley RB, 2014, BIOCHEMISTRY-US, V53, P1916, DOI 10.1021/bi5001239; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Flynn JM, 2015, J MOL BIOL, V427, P2904, DOI 10.1016/j.jmb.2015.03.017; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Franco MC, 2006, J BIOL CHEM, V281, P4779, DOI 10.1074/jbc.M512080200; Gadelha FR, 1997, ARCH BIOCHEM BIOPHYS, V345, P243, DOI 10.1006/abbi.1997.0259; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kawasaki H, 2011, FREE RADICAL BIO MED, V50, P419, DOI 10.1016/j.freeradbiomed.2010.10.688; MacMillan-Crow LA, 2000, ARCH BIOCHEM BIOPHYS, V377, P350, DOI 10.1006/abbi.2000.1799; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; Nakamura Y, 2006, CLIN CANCER RES, V12, P1201, DOI 10.1158/1078-0432.CCR-05-1269; Neumann H, 2008, J AM CHEM SOC, V130, P4028, DOI 10.1021/ja710100d; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; Reardon DA, 2012, J NEURO-ONCOL, V107, P213, DOI 10.1007/s11060-011-0740-0; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Robinson KM, 2005, METHOD ENZYMOL, V396, P207, DOI 10.1016/S0076-6879(05)96019-9; Sahawneh MA, 2010, J BIOL CHEM, V285, P33885, DOI 10.1074/jbc.M110.118901; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1506, DOI 10.1038/sj.cdd.4401831; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Sreedhar AS, 2004, FEBS LETT, V562, P11; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Viera L, 2013, FREE RADICAL BIO MED, V55, P101, DOI 10.1016/j.freeradbiomed.2012.10.535; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Xu WP, 2012, MOL CELL, V47, P434, DOI 10.1016/j.molcel.2012.05.015; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	54	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19055	19066		10.1074/jbc.M115.663278	http://dx.doi.org/10.1074/jbc.M115.663278			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085096	Green Published, hybrid			2022-12-26	WOS:000358781100023
J	Kim, J; Shin, H; Kim, J; Kim, J; Park, J				Kim, Jongmin; Shin, Hyunwoo; Kim, Jiyoon; Kim, Junho; Park, Jaesung			Isolation of High-Purity Extracellular Vesicles by Extracting Proteins Using Aqueous Two-Phase System	PLOS ONE			English	Article							MEMBRANE-VESICLES; PLASMA-MEMBRANES; MESSENGER-RNA; INSIDE-OUT; EXOSOMES; SEPARATION; CELL	We present a simple and rapid method to isolate extracellular vesicles (EVs) by using a polyethylene glycol/dextran aqueous two-phase system (ATPS). This system isolated more than similar to 75% of melanoma-derived EVs from a mixture of EVs and serum proteins. To increase the purity of EVs, a batch procedure was combined as additional steps to remove protein contaminants, and removed more than similar to 95% of the protein contaminants. We also performed RT-PCR and western blotting to verify the diagnostic applicability of the isolated EVs, and detected mRNA derived from melanoma cells and CD81 in isolated EVs.	[Kim, Jongmin; Shin, Hyunwoo; Park, Jaesung] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, Gyeong Buk, South Korea; [Kim, Jiyoon; Kim, Junho; Park, Jaesung] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeong Buk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Park, J (corresponding author), Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, Gyeong Buk, South Korea.	jpark@postech.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [2011-0030075, 2011-0028845]; Korea Institute of Science and Technology (KIST) [2E23880-13-072]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korea Institute of Science and Technology (KIST)(Korea Institute of Science & Technology (KIST))	This work was supported by a National Research Foundation of Korea (NRF) grant funded by Korean government (MSIP) (No. 2011-0030075 and 2011-0028845) and Korea Institute of Science and Technology (KIST) institutional program (2E23880-13-072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson, 1986, PARTITION CELL PARTI; Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; ANDREASSON E, 1988, BIOCHIM BIOPHYS ACTA, V936, P339, DOI 10.1016/0005-2728(88)90010-2; ATHA DH, 1981, J BIOL CHEM, V256, P2108; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chen C, 2010, LAB CHIP, V10, P505, DOI 10.1039/b916199f; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; Gromov P, 2013, BBA-PROTEINS PROTEOM, V1834, P2259, DOI 10.1016/j.bbapap.2013.01.013; Hasselmann DO, 2001, CLIN CHEM, V47, P1488; Hatti-Kaul R., 2000, METHODS PROTOCOL, V11; LARSSON C, 1994, METHOD ENZYMOL, V228, P451; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; LOPEZPEREZ MJ, 1981, BIOCHIM BIOPHYS ACTA, V635, P359, DOI 10.1016/0005-2728(81)90034-7; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Nitsawang S, 2006, ENZYME MICROB TECH, V39, P1103, DOI 10.1016/j.enzmictec.2006.02.013; PALMGREN MG, 1990, PLANT PHYSIOL, V92, P871, DOI 10.1104/pp.92.4.871; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raj DAA, 2012, KIDNEY INT, V81, P1263, DOI 10.1038/ki.2012.25; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; SooHoo JR, 2009, BIOMED MICRODEVICES, V11, P323, DOI 10.1007/s10544-008-9238-8; Szajnik M, 2013, GYNECOLOGY OBSTET SU, P003; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; UEMURA M, 1983, PLANT PHYSIOL, V73, P586, DOI 10.1104/pp.73.3.586; WALTER H, 1994, METHOD ENZYMOL, V228, P42; Walter H., 1986, PARTITIONING AQUEOUS; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; WIDELL S, 1982, PLANT PHYSIOL, V70, P1429, DOI 10.1104/pp.70.5.1429; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Zaslavsky BY., 1994, AQUEOUS 2 PHASE PART	31	42	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129760	10.1371/journal.pone.0129760	http://dx.doi.org/10.1371/journal.pone.0129760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090684	gold, Green Published			2022-12-26	WOS:000356835000056
J	Reinhardt, R; Pohlmann, S; Kleinertz, H; Hepner-Schefczyk, M; Paul, A; Flohe, SB				Reinhardt, Renate; Pohlmann, Stephanie; Kleinertz, Holger; Hepner-Schefczyk, Monika; Paul, Andreas; Flohe, Stefanie B.			Invasive Surgery Impairs the Regulatory Function of Human CD56(bright) Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-gamma Synthesis	PLOS ONE			English	Article							HUMAN NK CELLS; DENDRITIC CELLS; IN-VITRO; ACTIVATION; MONOCYTES; CYTOTOXICITY; NKG2D; INTERLEUKIN-12; EXPRESSION; RECEPTORS	Major surgery increases the risk for infectious complications due to the development of immunosuppression. CD56(bright) NK cells play a key role in the defense against bacterial infections through the release of Interferon (IFN) gamma upon stimulation with monocyte-derived Interleukin (IL) 12. We investigated whether invasive visceral surgery interferes with the IFN-gamma synthesis of human NK cells in response to Staphylococcus aureus. In a prospective pilot study, peripheral blood mononuclear cells (PBMC) were isolated from 53 patients before and 1 to 7 d after elective visceral surgery. The release of IL-12 and IFN-gamma from PBMC upon exposure to S. aureus in vitro was quantified. The expression of the IL-12 receptor beta 1 chain on the surface, the phosphorylation of signal transducer and activator of transcription (STAT) 4, and the synthesis of IFN-gamma on/in individual CD56(bright) NK cells were investigated using flow cytometry. The modulatory effect of IL-12 on the S. aureus-induced IFN-gamma production in CD56(bright) NK cells was analyzed. The IFN-gamma secretion from purified CD56(bright) NK cells was quantified after stimulation with IL-12 and IL-18. After surgery, CD56(bright) NK cells among total PBMC were impaired in the release of IFN-gamma for at least 5 d. Likewise, the IL-12-induced release of IFN-gamma from purified CD56(bright) NK cells was abolished. Upon stimulation with S. aureus, PBMC secreted less IL-12 but supplementation with recombinant IL-12 did not restore the capacity of CD56(bright) NK cells to produce IFN-gamma. CD56(bright) NK cells displayed reduced levels of the IL-12R beta 1 chain whereas the phosphorylation of STAT4, the key transcription factor for the Ifng gene was not diminished. In summary, after invasive visceral surgery, CD56(bright) NK cells are impaired in S. aureus-induced IFN-gamma production and might contribute to the enhanced susceptibility to opportunistic infections.	[Reinhardt, Renate; Paul, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany; [Pohlmann, Stephanie; Kleinertz, Holger; Hepner-Schefczyk, Monika; Flohe, Stefanie B.] Univ Duisburg Essen, Univ Hosp Essen, Dept Trauma Surg, Surg Res, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Flohe, SB (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Trauma Surg, Surg Res, Essen, Germany.	stefanie.flohe@uk-essen.de	Kleinertz, Holger/AAL-3899-2021; Flohe, Stefanie/F-9473-2010	Kleinertz, Holger/0000-0002-1494-4913; Flohe, Stefanie/0000-0001-7032-3380	Interne Forschungsforderung Essen (IFORES)	Interne Forschungsforderung Essen (IFORES)	R. Reinhardt was supported by intramural funding of the Interne Forschungsforderung Essen (IFORES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2004, EUR J IMMUNOL, V34, P961, DOI 10.1002/eji.200324705; Austermann J, 2014, CELL REP, V9, P2112, DOI 10.1016/j.celrep.2014.11.020; Barkhausen T, 2008, SHOCK, V30, P401, DOI 10.1097/SHK.0b013e31816e2cda; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Ertel W, 1997, BLOOD, V89, P1612, DOI 10.1182/blood.V89.5.1612.1612_1612_1620; Etogo AO, 2008, J IMMUNOL, V180, P6334, DOI 10.4049/jimmunol.180.9.6334; Flohe SB, 2007, SHOCK, V27, P494, DOI 10.1097/SHK.0b013e31802dec51; Franke A, 2009, J SURG RES, V154, P91, DOI 10.1016/j.jss.2008.06.003; Girart MV, 2007, J IMMUNOL, V179, P3472, DOI 10.4049/jimmunol.179.6.3472; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Haller D, 2002, CLIN DIAGN LAB IMMUN, V9, P649, DOI 10.1128/CDLI.9.3.649-657.2002; Kimura F, 2010, SURG TODAY, V40, P793, DOI 10.1007/s00595-010-4323-z; Kloss M, 2008, J IMMUNOL, V181, P6711, DOI 10.4049/jimmunol.181.10.6711; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Michel T, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00403; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Schinkel C, 2001, J TRAUMA, V50, P321, DOI 10.1097/00005373-200102000-00020; Scott MJ, 2006, CYTOKINE, V33, P79, DOI 10.1016/j.cyto.2005.12.002; Shen H, 2013, J IMMUNOL, V191, P2857, DOI 10.4049/jimmunol.1301539; Souza-Fonseca-Guimaraes F, 2012, CRIT CARE, V16, DOI 10.1186/cc11838; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tai LH, 2013, CANCER RES, V73, P97, DOI 10.1158/0008-5472.CAN-12-1993; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; Wirsdorfer F, 2015, CLIN SCI LOND; Yadavalli GK, 2005, SHOCK, V24, P26, DOI 10.1097/01.shk.0000167110.73129.a8; Zhang SM, 2000, J IMMUNOL, V165, P1374, DOI 10.4049/jimmunol.165.3.1374	32	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130155	10.1371/journal.pone.0130155	http://dx.doi.org/10.1371/journal.pone.0130155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090673	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835000091
J	Suman, DS; Wang, Y; Gaugler, R				Suman, Devi S.; Wang, Yi; Gaugler, Randy			The Insect Growth Regulator Pyriproxyfen Terminates Egg Diapause in the Asian Tiger Mosquito, Aedes albopictus	PLOS ONE			English	Article							DIPTERA-CULICIDAE; JUVENILE-HORMONE; SURVIVAL; DESICCATION; RESISTANCE; INDUCTION; EFFICACY	The Asian tiger mosquito, Aedes albopictus, is a highly invasive mosquito species that transmits chikungunya and dengue. This species overwinters as diapausing eggs in temperate climates. Early diapause termination may be a beneficial strategy for winter mosquito control; however, a mechanism to terminate the diapause process using chemicals is not known. We tested the hypothesis that a hormonal imbalance caused by the administration of juvenile hormone analog would terminate egg diapause in A. albopictus. We tested the insect growth regulator pyriproxyfen on all developmental stages to identify a susceptible stage for diapause termination. We found that pyriproxyfen treatment of mosquito eggs terminated embryonic diapause. The highest rates of diapause termination were recorded in newly deposited (78.9%) and fully embryonated (74.7%) eggs at 0.1 and 1 ppm, respectively. Hatching was completed earlier in newly deposited eggs (25-30 days) compared to fully embryonated eggs (71-80 days). The combined mortality from premature diapause termination and ovicidal activity was 98.2% in newly deposited and >98.9% in fully embryonated eggs at 1 ppm. The control diapause eggs did not hatch under diapausing conditions. Pyriproxyfen exposure to larvae, pupae and adults did not prevent the females from ovipositing diapausing eggs. There was no effect of pyriproxyfen on diapausing egg embryonic developmental time. We also observed mortality in diapausing eggs laid by females exposed to pyriproxyfen immediately after blood feeding. There was no mortality in eggs laid by females that survived larval and pupal exposures. In conclusion, diapausing eggs were the more susceptible to pyriproxyfen diapause termination compared to other life stages. This is the first report of diapause termination in A. albopictuswith a juvenile hormone analog. We believe our findings will be useful in developing a new control strategy against overwintering mosquito populations.	[Suman, Devi S.; Wang, Yi; Gaugler, Randy] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Suman, DS (corresponding author), Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA.	dssuman@rci.rutgers.edu			Deployed War-Fighter Protection (DWFP) Research Program - US Department of Defense through the Armed Forces Pest Management Board (AFPMB); National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant	Deployed War-Fighter Protection (DWFP) Research Program - US Department of Defense through the Armed Forces Pest Management Board (AFPMB); National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant	Funding was provided by the Deployed War-Fighter Protection (DWFP) Research Program, funded by the US Department of Defense through the Armed Forces Pest Management Board (AFPMB) to RG, and the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER EM, 1992, DEV BIOL, V151, P410, DOI 10.1016/0012-1606(92)90181-F; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; DENLINGER DL, 1980, PHYSIOL ENTOMOL, V5, P7, DOI 10.1111/j.1365-3032.1980.tb00207.x; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Gaugler R, 2012, MED VET ENTOMOL, V26, P37, DOI 10.1111/j.1365-2915.2011.00970.x; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192; Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Hoffmann J.A., 1985, P435; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Kidokoro K, 2006, J INSECT PHYSIOL, V52, P473, DOI 10.1016/j.jinsphys.2006.01.001; Lee KY, 1997, J INSECT PHYSIOL, V43, P289, DOI 10.1016/S0022-1910(96)00082-0; Luque G, 2014, BIOL INVASIONS, V16, P981, DOI 10.1007/s10530-013-0561-5; MORI A, 1981, Tropical Medicine, V23, P79; Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006; Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Pumpuni CB, 1989, THESIS U NOTRE DAME; Reynolds JA, 2012, J INSECT PHYSIOL, V58, P966, DOI 10.1016/j.jinsphys.2012.04.013; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rochlin I, 2013, BIOL INVASIONS, V15, P991, DOI 10.1007/s10530-012-0345-3; SOTA T, 1992, ENTOMOL EXP APPL, V63, P155, DOI 10.1007/BF00343575; SPIELMAN A, 1974, J MED ENTOMOL, V11, P223, DOI 10.1093/jmedent/11.2.223; SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217; Suman DS, 2013, ACTA TROP, V128, P103, DOI 10.1016/j.actatropica.2013.06.025; Suman DS, 2013, J MED ENTOMOL, V50, P1261, DOI 10.1603/ME13068; Suman DS, 2011, ARTHROPOD STRUCT DEV, V40, P479, DOI 10.1016/j.asd.2011.04.003; Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Urbanski JM, 2010, P ROY SOC B-BIOL SCI, V277, P2683, DOI 10.1098/rspb.2010.0362; Zhang QR, 2011, P NATL ACAD SCI USA, V108, P16922, DOI 10.1073/pnas.1113863108	34	11	12	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130499	10.1371/journal.pone.0130499	http://dx.doi.org/10.1371/journal.pone.0130499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090954	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000122
J	Goss, LB; Ortiz, JR; Okamura, DM; Hayward, K; Goss, CH				Goss, Louisa B.; Ortiz, Justin R.; Okamura, Daryl M.; Hayward, Kristen; Goss, Christopher H.			Significant Reductions in Mortality in Hospitalized Patients with Systemic Lupus Erythematosus in Washington State from 2003 to 2011	PLOS ONE			English	Article							ADMINISTRATIVE DATA; NEPHRITIS; CYCLOPHOSPHAMIDE; ICD-9-CM; TRENDS; COHORT; INDEX	Background Systemic lupus erythematosus (SLE or lupus) is an autoimmune multisystem disease. While a complete understanding of lupus' origins, mechanisms, and progression is not yet available, a number of studies have demonstrated correlations between disease prevalence and severity, gender, and race. There have been few population based studies in the United States Objectives To assess temporal changes in demographics and hospital mortality of patients with lupus in Washington State from 2003 to 2011 Study Design This study used data from the Healthcare Cost and Utilization Project (HCUP), a patient information database, and data from the Washington State census to study a group of patients in the state. Lupus hospitalizations were defined as any hospitalization with an ICD-9-CM diagnosis code for systemic lupus erythematosus. Regression analysis was used to assess the effect of calendar time on demographics and hospital outcomes. Results There were a total of 18,905 patients in this study with a diagnostic code for lupus. The mean age of the group was 51.5 years (95% CI: 50.6-52.3) in 2003 and 51.3 years (95% CI: 50.6-52.0) in 2011. The population was 88.6% female. Blacks were 2.8 times more likely to have a lupus hospitalization than whites when compared to the Washington population. While hospital mortality decreased during this eight year period (3.12% in 2003 to 1.28% in 2011, p=0.001) hospital length of stay remained statistically unchanged at an average of 4.9 days during that eight year period. We found a significant decrease in annual hospital mortality over the study period [odds ratio(OR): 0.92 per year, 95% CI 0.88-0.96, P<0.001]. Hospital mortality was higher in males (2.6% male death to 1.8% female death) Conclusions In this large group of hospitalized lupus patients in Washington, hospital length of stay remained relatively stable over time but hospital mortality decreased by over 50% over the eight year study period.	[Goss, Louisa B.; Ortiz, Justin R.; Goss, Christopher H.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ortiz, Justin R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Okamura, Daryl M.] Univ Washington, Dept Pediat, Div Nephrol, Seattle, WA 98195 USA; [Okamura, Daryl M.; Hayward, Kristen] Seattle Childrens Res Inst, Seattle, WA USA; [Hayward, Kristen; Goss, Christopher H.] Univ Washington, Dept Pediat, Div Rheumatol, Seattle, WA 98195 USA; [Goss, Christopher H.] Univ Washington, Dept Pediat, Div Pulm, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Goss, CH (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	goss@u.washington.edu		Goss, Christopher/0000-0001-8602-0309; Ortiz, Justin/0000-0002-3138-5965	Robert Wood Johnson Harold Amos Medical Faculty Development Program; Cystic Fibrosis Foundation; NIH [R01HL103965, R01HL113382, R01AI101307, U M1HL119073, P30DK089507]; FDA [R01FD003704]; FOOD AND DRUG ADMINISTRATION [R01FD003704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103965, R01HL113382, UM1HL119073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER; FDA [5R01FD003704-05] Funding Source: Federal RePORTER	Robert Wood Johnson Harold Amos Medical Faculty Development Program(Robert Wood Johnson Foundation (RWJF)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA(United States Department of Health & Human Services); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FDA(United States Department of Health & Human Services)	Dr. Ortiz receives funding from the Robert Wood Johnson Harold Amos Medical Faculty Development Program (http://www.amfdp.org/). Dr. Goss receives funding from the Cystic Fibrosis Foundation, the NIH (R01HL103965, R01HL113382, R01AI101307, U M1HL119073, P30DK089507) (http://grants.nih.gov/grants/oer.htm) and the FDA (R01FD003704)(http://www.fda.gov/forindustry/developingproductsforrarediseasesconditions/whomtocontactaboutorphanproductdevelopment/default.htm). The authors received no specific funding for this work.	[Anonymous], STAT DAT DAT US AGR; Appel GB, 2009, J AM SOC NEPHROL, V20, P1103, DOI 10.1681/ASN.2008101028; Askanase A, 2012, SOC WORK HEALTH CARE, V51, P576, DOI 10.1080/00981389.2012.683369; Atisha-Fregoso Y, 2011, AUTOIMMUNITY, V44, P555, DOI 10.3109/08916934.2011.592882; Belmont HM, 2013, BULL HOSP JT DIS, V71, P208; Centers for Disease Control and Prevention, INT CLASS DIS 9 REV; Chan P-C, J MICROBIOLOGY IMMUN; Chibnik LB, 2010, LUPUS, V19, P741, DOI 10.1177/0961203309356289; Choi J, 2012, CURR OPIN IMMUNOL, V24, P651, DOI 10.1016/j.coi.2012.10.004; Danila MI, 2009, RHEUMATOLOGY, V48, P542, DOI 10.1093/rheumatology/kep012; De Coster C, 2008, MED CARE, V46, P627, DOI 10.1097/MLR.0b013e3181649439; Feldman CH, 2013, ARTHRITIS RHEUM-US, V65, P753, DOI 10.1002/art.37795; Frieri M, 2013, ANN ALLERG ASTHMA IM, V110, P228, DOI 10.1016/j.anai.2012.12.010; Grootscholten C, 2006, KIDNEY INT, V70, P732, DOI 10.1038/sj.ki.5001630; Hiraki LT, 2012, ARTHRITIS RHEUM-US, V64, P2669, DOI 10.1002/art.34472; Jiang Z, 2013, RHEUMATOL INT, V33, P1541, DOI 10.1007/s00296-012-2605-z; Knight AM, 2014, J RHEUMATOL, V41, P539, DOI 10.3899/jrheum.130592; Lee J, 2013, LUPUS, V22, P1341, DOI 10.1177/0961203313505689; Lee J, 2013, RHEUMATOLOGY, V52, P905, DOI 10.1093/rheumatology/kes391; Merrill JT, 2012, BULL HOSP JT DIS, V70, P172; Moores KG, 2013, VACCINE, V31, pK62, DOI 10.1016/j.vaccine.2013.06.104; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Ruiz E, 2014, LUPUS, V23, P431, DOI 10.1177/0961203313517015; Rullo OJ, 2013, ANN RHEUM DIS, V72, P56, DOI 10.1136/annrheumdis-2012-202351; Schwartzman-Morris J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/604892; Shah M, 2013, CLIN THER, V35, P486, DOI 10.1016/j.clinthera.2013.03.001; Son MBF, 2014, PEDIATRICS, V133, pE106, DOI 10.1542/peds.2013-1640; StataCorp LP, STAT DAT AN STAT SOF; Umiker BR, 2014, EUR J IMMUNOL, V44, P1503, DOI 10.1002/eji.201344283; Widdifield J, 2015, ARTHRITIS CARE RES H; Wong EB, 2012, J IMMUNOL, V189, P5667, DOI 10.4049/jimmunol.1201661	32	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128920	10.1371/journal.pone.0128920	http://dx.doi.org/10.1371/journal.pone.0128920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087254	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500031
J	Imamura, Y; Yu, FF; Nakamura, M; Chihara, Y; Okane, K; Sato, M; Kanai, M; Hamada, R; Ueno, M; Yukawa, M; Tsuchiya, E				Imamura, Yuko; Yu, Feifei; Nakamura, Misaki; Chihara, Yuhki; Okane, Kyo; Sato, Masahiro; Kanai, Muneyoshi; Hamada, Ryoko; Ueno, Masaru; Yukawa, Masashi; Tsuchiya, Eiko			RSC Chromatin-Remodeling Complex Is Important for Mitochondrial Function in Saccharomyces cerevisiae	PLOS ONE			English	Article							GENE; EXPRESSION; TRANSCRIPTION; COMPONENTS; NUCLEAR; ROLES; CELLS	RSC (Remodel the Structure of Chromatin) is an ATP-dependent chromatin remodeling complex essential for the growth of Saccharomyces cerevisiae. RSC exists as two distinct isoforms that share core subunits including the ATPase subunit Nps1/Sth1 but contain either Rsc1 or Rsc2. Using the synthetic genetic array (SGA) of the non-essential null mutation method, we screened for mutations exhibiting synthetic growth defects in combination with the temperature-sensitive mutant, nps1-105, and found connections between mitochondrial function and RSC. rsc mutants, including rsc1 Delta, rsc2 Delta, and nps1-13, another temperature-sensitive nps1 mutant, exhibited defective respiratory growth; in addition, rsc2 Delta and nps1-13 contained aggregated mitochondria. The rsc2 Delta phenotypes were relieved by RSC1 overexpression, indicating that the isoforms play a redundant role in respiratory growth. Genome-wide expression analysis in nps1-13 under respiratory conditions suggested that RSC regulates the transcription of some target genes of the HAP complex, a transcriptional activator of respiratory gene expression. Nps1 physically interacted with Hap4, the transcriptional activator moiety of the HAP complex, and overexpression of HAP4 alleviated respiratory defects in nps1-13, suggesting that RSC plays pivotal roles in mitochondrial gene expression and shares a set of target genes with the HAP complex.	[Imamura, Yuko; Yu, Feifei; Nakamura, Misaki; Chihara, Yuhki; Okane, Kyo; Sato, Masahiro; Ueno, Masaru; Yukawa, Masashi; Tsuchiya, Eiko] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima, Hiroshima 7398530, Japan; [Kanai, Muneyoshi; Hamada, Ryoko] Natl Res Inst Brewing, Higashihiroshima, Hiroshima 7390046, Japan	Hiroshima University	Tsuchiya, E (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398530, Japan.	yukoima@hiroshima-u.ac.jp	Ueno, Masaru/G-3990-2019		Ministry of Education, Culture, Sports, Science and Technology of Japan [22580086, 19780076]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to ET (22580086), and MY (19780076); URL: http://www.jsps.go.jp/j-grantsinaid/index.html.	Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Chambers AL, 2012, PROG MOL BIOL TRANSL, V110, P229, DOI 10.1016/B978-0-12-387665-2.00009-2; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Inai T, 2007, MOL CELL BIOL, V27, P1254, DOI 10.1128/MCB.01661-06; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Koyama H, 2004, BIOSCI BIOTECH BIOCH, V68, P909, DOI 10.1271/bbb.68.909; Koyama H, 2002, FEBS LETT, V531, P215, DOI 10.1016/S0014-5793(02)03504-4; Kumar Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-402; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Soutourina J, 2006, MOL CELL BIOL, V26, P4920, DOI 10.1128/MCB.00415-06; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsuchiya E, 1998, NUCLEIC ACIDS RES, V26, P3286, DOI 10.1093/nar/26.13.3286; TSUCHIYA E, 1992, EMBO J, V11, P4017, DOI 10.1002/j.1460-2075.1992.tb05495.x; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wilson B, 2006, GENETICS, V172, P795, DOI 10.1534/genetics.105.047589; Wu H, 2006, APPL ENVIRON MICROB, V72, P7353, DOI 10.1128/AEM.01097-06; Yaniv M, 2014, CANCER GENET-NY, V207, P352, DOI 10.1016/j.cancergen.2014.03.006; Yoboue ED, 2012, J BIOL CHEM, V287, P14569, DOI 10.1074/jbc.M111.302786; Yukawa M, 1999, GENES CELLS, V4, P99, DOI 10.1046/j.1365-2443.1999.00242.x; Yukawa M, 2002, FEMS YEAST RES, V2, P87, DOI 10.1111/j.1567-1364.2002.tb00073.x	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130397	10.1371/journal.pone.0130397	http://dx.doi.org/10.1371/journal.pone.0130397			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086550	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500102
J	Tomasdottir, MO; Sigurdsson, JA; Petursson, H; Kirkengen, AL; Krokstad, S; McEwen, B; Hetlevik, I; Getz, L				Tomasdottir, Margret Olafia; Sigurdsson, Johann Agust; Petursson, Halfdan; Kirkengen, Anna Luise; Krokstad, Steinar; McEwen, Bruce; Hetlevik, Irene; Getz, Linn			Self Reported Childhood Difficulties, Adult Multimorbidity and Allostatic Load. A Cross-Sectional Analysis of the Norwegian HUNT Study	PLOS ONE			English	Article							LEUKOCYTE TELOMERE LENGTH; HEALTH DISPARITIES; METABOLIC SYNDROME; TOXIC STRESS; LIFE STRESS; EXPERIENCES; ADVERSITY; DISEASE; ABUSE; WOMEN	Background Multimorbidity receives increasing scientific attention. So does the detrimental health impact of adverse childhood experiences (ACE). Aetiological pathways from ACE to complex disease burdens are under investigation. In this context, the concept of allostatic overload is relevant, denoting the link between chronic detrimental stress, widespread biological perturbations and disease development. This study aimed to explore associations between self-reported childhood quality, biological perturbations and multimorbidity in adulthood. Materials and Methods We included 37 612 participants, 30-69 years, from the Nord-Trondelag Health Study, HUNT3 (2006-8). Twenty one chronic diseases, twelve biological parameters associated with allostatic load and four behavioural factors were analysed. Participants were categorised according to the self-reported quality of their childhood, as reflected in one question, alternatives ranging from 'very good' to 'very difficult'. The association between childhood quality, behavioural patterns, allostatic load and multimorbidity was compared between groups. Results Overall, 85.4% of participants reported a 'good' or 'very good' childhood; 10.6% average, 3.3% 'difficult' and 0.8% 'very difficult'. Childhood difficulties were reported more often among women, smokers, individuals with sleep problems, less physical activity and lower education. In total, 44.8% of participants with a very good childhood had multimorbidity compared to 77.1% of those with a very difficult childhood (Odds ratio: 5.08; 95% CI: 3.63-7.11). Prevalences of individual diseases also differed significantly according to childhood quality; all but two ( cancer and hypertension) showed a significantly higher prevalence (p < 0.05) as childhood was categorised as more difficult. Eight of the 12 allostatic parameters differed significantly between childhood groups. Conclusions We found a general, graded association between self-reported childhood difficulties on the one hand and multimorbidity, individual disease burden and biological perturbations on the other. The finding is in accordance with previous research which conceptualises allostatic overload as an important route by which childhood adversities become biologically embodied.	[Tomasdottir, Margret Olafia; Sigurdsson, Johann Agust] Univ Iceland, Dept Family Med, Reykjavik, Iceland; [Tomasdottir, Margret Olafia; Sigurdsson, Johann Agust] Primary Hlth Care Capital Area, Reykjavik, Iceland; [Tomasdottir, Margret Olafia; Sigurdsson, Johann Agust; Petursson, Halfdan; Kirkengen, Anna Luise; Hetlevik, Irene; Getz, Linn] Norwegian Univ Sci & Technol NTNU, Dept Publ Hlth & Gen Practice, Gen Practice Res Unit, Trondheim, Norway; [Kirkengen, Anna Luise] UiT Arct Univ, Dept Gen Practice, Tromso, Norway; [Krokstad, Steinar] Norwegian Univ Sci & Technol NTNU, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Levanger, Norway; [McEwen, Bruce] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA	University of Iceland; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); Rockefeller University	Tomasdottir, MO (corresponding author), Univ Iceland, Dept Family Med, Reykjavik, Iceland.	margretolafia@gmail.com	McEwen, Bruce/Z-1630-2019	Krokstad, Steinar/0000-0002-2932-6675; Tomasdottir, Margret/0000-0003-4675-5532	Norwegian Ministry of Health; Norwegian University of Science and Technology; Norwegian Research Council (the FUGE program); Nord-Trondelag County Council; Norwegian Institute of Public Health; Icelandic College of Family Physicians; Central Norway Regional Health Authority	Norwegian Ministry of Health; Norwegian University of Science and Technology; Norwegian Research Council (the FUGE program); Nord-Trondelag County Council; Norwegian Institute of Public Health; Icelandic College of Family Physicians; Central Norway Regional Health Authority	The HUNT3 Survey was mainly funded by the Norwegian Ministry of Health, the Norwegian University of Science and Technology, the Norwegian Research Council (the FUGE program), Central Norway Regional Health Authority, the Nord-Trondelag County Council and the Norwegian Institute of Public Health. The present analysis received support from the Research Fund of the Icelandic College of Family Physicians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACE, ADV CHILDH EXP STUD; Barnes PJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000220; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Beckie TM, 2012, BIOL RES NURS, V14, P311, DOI 10.1177/1099800412455688; Blackburn EH, 2012, NATURE, V490, P169, DOI 10.1038/490169a; Blair C, 2011, DEV PSYCHOPATHOL, V23, P845, DOI 10.1017/S0954579411000344; Boer-Martins L, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-24; Boyce WT, 2010, SOC SCI MED, V71, P1644, DOI 10.1016/j.socscimed.2010.07.045; Brent DA, 2013, JAMA-J AM MED ASSOC, V309, P1777, DOI 10.1001/jama.2013.4220; Carlsson E, 2014, J IMMUNOL, V192, P2071, DOI 10.4049/jimmunol.1301713; Chaloner A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00013; Chapman DP, 2011, SLEEP MED, V12, P773, DOI 10.1016/j.sleep.2011.03.013; Cuijpers P, 2011, CHILD ABUSE NEGLECT, V35, P937, DOI 10.1016/j.chiabu.2011.06.005; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Das-Munshi J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001335; Ehlert U, 2013, PSYCHONEUROENDOCRINO, V38, P1850, DOI 10.1016/j.psyneuen.2013.06.007; Emin O, 2012, RESP PHYSIOL NEUROBI, V183, P206, DOI 10.1016/j.resp.2012.07.002; Feinberg Andrew P, 2013, Trans Am Clin Climatol Assoc, V124, P84; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Forsdahl A, 2002, INT J EPIDEMIOL, V31, P302, DOI 10.1093/ije/31.2.302; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Fryers Tom, 2013, Clin Pract Epidemiol Ment Health, V9, P1, DOI 10.2174/1745017901309010001; Garner AS, 2012, PEDIATRICS, V129, pE224, DOI 10.1542/peds.2011-2662; Gonzalez A, 2012, J PSYCHIATR RES, V46, P1475, DOI 10.1016/j.jpsychires.2012.08.004; Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037; Halaris A, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0400-5; Hardt J, 2010, PSYCHOL REP, V107, P425, DOI 10.2466/02.04.09.10.16.21.PR0.107.5.425-440; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Institute of Medicine, 2012, LIV WELL CHRON ILLN; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Karatsoreos IN, 2013, J CHILD PSYCHOL PSYC, V54, P337, DOI 10.1111/jcpp.12054; Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9; Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003; Kirkengen AL, 2010, LIVED EXPERIENCE VIO; Korkeila J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001625; Krieger N, 2005, J EPIDEMIOL COMMUN H, V59, P350, DOI 10.1136/jech.2004.024562; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Lee C, 2014, SOC SCI MED, V105, P122, DOI 10.1016/j.socscimed.2014.01.017; Lovallo WR, 2012, BIOL PSYCHIAT, V71, P344, DOI 10.1016/j.biopsych.2011.10.018; Mangin D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3526; Mason SM, 2013, OBESITY, V21, pE775, DOI 10.1002/oby.20500; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; McEwen BS, 2015, METABOLISM, V64, pS2, DOI 10.1016/j.metabol.2014.10.029; McEwen BS, 2013, METABOLISM, V62, pS20, DOI 10.1016/j.metabol.2012.08.020; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McGowan PO, 2010, NEUROBIOL DIS, V39, P66, DOI 10.1016/j.nbd.2009.12.026; Mercer SW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4152; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; Miles A., 2011, INT J PERSON CTR MED, V1, P207, DOI [https://doi.org/10.5750/ijpcm.v1i2.61, DOI 10.5750/IJPCM.V1I2.61]; Miller GE, 2012, BIOL PSYCHIAT, V72, P34, DOI 10.1016/j.biopsych.2012.02.034; Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Pesonen AK, 2010, PSYCHONEUROENDOCRINO, V35, P758, DOI 10.1016/j.psyneuen.2009.10.017; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Rich-Edwards JW, 2012, CIRCULATION, V126, P920, DOI 10.1161/CIRCULATIONAHA.111.076877; Rich-Edwards JW, 2010, AM J PREV MED, V39, P529, DOI 10.1016/j.amepre.2010.09.007; Riley EH, 2010, J EPIDEMIOL COMMUN H, V64, P413, DOI 10.1136/jech.2009.095109; Sachs-Ericsson N, 2009, J TRAUMA DISSOCIATIO, V10, P170, DOI 10.1080/15299730802624585; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Savolainen K, 2014, BIOL PSYCHOL, V97, P35, DOI 10.1016/j.biopsycho.2014.02.002; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; Schnittker J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084933; Sethi D., 2013, EUROPEAN REPORT PREV; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Solis CB, 2015, P NATL ACAD SCI USA, V112, pE738, DOI 10.1073/pnas.1417325112; Starfield Barbara, 2011, Perm J, V15, P63; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Starkweather AR, 2014, NURS RES, V63, P36, DOI 10.1097/NNR.0000000000000009; Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001; Sturmberg JP, 2012, J EVAL CLIN PRACT, V18, P1220, DOI 10.1111/j.1365-2753.2012.01882.x; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Tomasdottir MO., 2014, EUR J PERS CENT HEAL, V2, P335, DOI [10.5750/ejpch.v2i3.734, DOI 10.5750/EJPCH.V2I3.734]; Tucker-Seeley RD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-313; Tyrka AR, 2012, HORM METAB RES, V44, P543, DOI 10.1055/s-0032-1306342; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; Vie TL, 2014, SOC SCI MED, V117, P1, DOI 10.1016/j.socscimed.2014.07.019; Vikum E, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-48; Vinik AI, 2011, DIABETIC MED, V28, P643, DOI 10.1111/j.1464-5491.2010.03184.x; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203; WHO, 2008, THE WORLD HEALTH REP; Widom CS, 2015, CHILD ABUSE NEGL; Wirtz PH, 2007, PSYCHONEUROENDOCRINO, V32, P430, DOI 10.1016/j.psyneuen.2007.02.006	90	69	69	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130591	10.1371/journal.pone.0130591	http://dx.doi.org/10.1371/journal.pone.0130591			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NT	26086816	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500118
J	Zhang, CX; Tian, Y; Cong, PH				Zhang, Cai-xia; Tian, Yi; Cong, Pei-hua			Proteome Analysis of Pathogen-Responsive Proteins from Apple Leaves Induced by the Alternaria Blotch Alternaria alternata	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; BACTERIAL DISEASE; AM-TOXIN; PATHOTYPE; RESISTANCE; PLANTS; STRESS; FRUIT; INFECTION; SEQUENCE	Understanding the defence mechanisms used by apple leaves against Alternaria alternate pathogen infection is important for breeding purposes. To investigate the ultrastructural differences between leaf tissues of susceptible and resistant seedlings, in vitro inoculation assays and transmission electron microscopy (TEM) analysis were conducted with two different inoculation assays. The results indicated that the resistant leaves may have certain antifungal activity against A. alternate that is lacking in susceptible leaves. To elucidate the two different host responses to A. alternate infection in apples, the proteomes of susceptible and resistant apple leaves that had or had not been infected with pathogen were characterised using two-dimensional electrophoresis (2-DE) and matrix-assisted laser desorption/ionisation time-of-flight tandem mass spectrometry (MALDI-TOF-TOF MS). MS identified 43 differentially expressed proteins in two different inoculation assays. The known proteins were categorised into 5 classes, among these proteins, some pathogenesis-related (PR) proteins, such as beta-1,3-glucanase, ascorbate peroxidase (APX), glutathione peroxidase (GPX) and mal d1, were identified in susceptible and resistant hosts and were associated with disease resistance of the apple host. In addition, the different levels of mal d1 in susceptible and resistant hosts may contribute to the outstanding anti-disease properties of resistant leaves against A. alternate. Taken together, the resistance mechanisms of the apple host against A. alternate may be a result of the PR proteins and other defence-related proteins. Given the complexity of the biology involved in the interaction between apple leaves and the A. alternate pathogen, further investigation will yield more valuable insights into the molecular mechanisms of suppression of the A. alternate pathogen. Overall, we outline several novel insights into the response of apple leaves to pathogen attacks. These findings increase our knowledge of pathogen resistance mechanisms, and the data will also promote further investigation into the regulation of the expression of these target proteins.	[Zhang, Cai-xia; Tian, Yi; Cong, Pei-hua] Minist Agr, Key Lab Hort Crops Germplasm Resources Utilizat, Xingcheng, Liaoning, Peoples R China; [Zhang, Cai-xia; Tian, Yi; Cong, Pei-hua] Chinese Acad Agr Sci, Res Inst Pomol, Beijing, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Pomology, CAAS	Cong, PH (corresponding author), Minist Agr, Key Lab Hort Crops Germplasm Resources Utilizat, Xingcheng, Liaoning, Peoples R China.	congph@163.com			National Natural Science Foundation of China [30900968, 31201602]; earmarked fund for the China Agriculture Research System [CARS-28]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the China Agriculture Research System	This research was supported by the National Natural Science Foundation of China (30900968; 31201602) and the earmarked fund for the China Agriculture Research System (CARS-28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, PLANT BREEDING, V129, P208, DOI 10.1111/j.1439-0523.2009.01672.x; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; BEVAN M, 1998, NATURE, V391, P485; Biton E, 2014, POSTHARVEST BIOL TEC, V94, P74, DOI 10.1016/j.postharvbio.2014.03.008; Breiteneder H, 2000, J ALLERGY CLIN IMMUN, V106, P27, DOI 10.1067/mai.2000.106929; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Chen Y, 2012, AUSTRALAS PLANT PATH, V41, P247, DOI 10.1007/s13313-012-0128-4; Choi HW, 2008, PLANT PHYSIOL, V148, P383, DOI 10.1104/pp.108.119461; Dangl J, 1998, NATURE, V394, P525, DOI 10.1038/28958; Faize M, 2012, PLANT PATHOL, V61, P858, DOI 10.1111/j.1365-3059.2011.02570.x; Fan HK, 2011, J PLANT BIOL, V54, P150, DOI 10.1007/s12374-011-9151-1; Fang XP, 2012, J PROTEOMICS, V75, P4074, DOI 10.1016/j.jprot.2012.05.022; FILAJDIC N, 1995, PLANT DIS, V79, P695, DOI 10.1094/PD-79-0695; Gonzalez-Teuber M, 2009, PLANT J, V58, P464, DOI 10.1111/j.1365-313X.2009.03790.x; Han YP, 2008, PLANT MOL BIOL, V67, P581, DOI 10.1007/s11103-008-9321-9; Harimoto Y, 2008, J GEN PLANT PATHOL, V74, P222, DOI 10.1007/s10327-008-0089-1; Harteveld DOC, 2014, CROP PROT, V59, P35, DOI 10.1016/j.cropro.2014.01.011; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; IZHAKI A, 1995, PLANT PHYSIOL, V108, P841, DOI 10.1104/pp.108.2.841; Johnson RD, 2000, MOL PLANT MICROBE IN, V13, P742, DOI 10.1094/MPMI.2000.13.7.742; Jung KH, 2007, BIOTECHNOL BIOPROC E, V12, P318, DOI 10.1007/BF02931111; Lee J, 2006, MOL PLANT PATHOL, V7, P405, DOI 10.1111/j.1364-3703.2006.00350.x; Li Y, 2011, J AM SOC HORTIC SCI, V136, P109, DOI 10.21273/JASHS.136.2.109; Li ZT, 2011, PLANT CELL REP, V30, P1, DOI 10.1007/s00299-010-0934-5; Liao M, 2009, PROTEOMICS, V9, P2809, DOI 10.1002/pmic.200800192; Marsh E, 2010, PROTEOMICS, V10, P2057, DOI 10.1002/pmic.200900712; MAUCH F, 1988, PLANT PHYSIOL, V88, P936, DOI 10.1104/pp.88.3.936; Mayer M, 2011, EUR J PLANT PATHOL, V131, P1, DOI 10.1007/s10658-011-9784-4; Mehta A, 2008, FEBS J, V275, P3731, DOI 10.1111/j.1742-4658.2008.06528.x; Montesinos E., 2002, International Microbiology, V5, P169, DOI 10.1007/s10123-002-0085-9; Norelli JL, 2009, TREE GENET GENOMES, V5, P27, DOI 10.1007/s11295-008-0164-y; Ntasiou P, 2015, INT J FOOD MICROBIOL, V197, P22, DOI 10.1016/j.ijfoodmicro.2014.12.008; Rampitsch C, 2012, PROTEOMICS, V12, P673, DOI 10.1002/pmic.201100359; Samuilov VD, 2003, BIOCHEMISTRY-MOSCOW+, V68, P912, DOI 10.1023/A:1025707200663; Shen SH, 2003, PROTEOMICS, V3, P527, DOI 10.1002/pmic.200390066; Shi HY, 2012, MOL BIOL REP, V39, P9509, DOI 10.1007/s11033-012-1815-5; SHIMOMURA N, 1991, Annals of the Phytopathological Society of Japan, V57, P247, DOI 10.3186/jjphytopath.57.247; Sinha R, 2013, J PROTEOMICS, V93, P117, DOI 10.1016/j.jprot.2013.01.020; Soh HC, 2012, EUR J PLANT PATHOL, V132, P37, DOI 10.1007/s10658-011-9846-7; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Venisse JS, 2002, MOL PLANT MICROBE IN, V15, P1204, DOI 10.1094/MPMI.2002.15.12.1204; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang XQ, 2008, PLANTA, V228, P167, DOI 10.1007/s00425-008-0727-z; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1; Zhang CaiXia, 2012, Acta Botanica Boreali-Occidentalia Sinica, V32, P106; Zhuang J, 2011, PLANT MOL BIOL REP, V29, P209, DOI 10.1007/s11105-010-0227-8	49	25	28	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0122233	10.1371/journal.pone.0122233	http://dx.doi.org/10.1371/journal.pone.0122233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086845	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500002
J	Camargos, TS; Bosmans, F; Rego, SC; Mourao, CBF; Schwartz, EF				Camargos, Thalita S.; Bosmans, Frank; Rego, Solange C.; Mourao, Caroline B. F.; Schwartz, Elisabeth F.			The Scorpion Toxin Tf2 from Tityus fasciolatus Promotes Na(v)1.3 Opening	PLOS ONE			English	Article							CHANNEL VOLTAGE-SENSOR; GATED SODIUM-CHANNELS; ALPHA-SCORPION; BETA-TOXIN; DOMAIN IV; CENTRUROIDES-NOXIUS; INTERACTION SITE; MOLECULAR-BASIS; NEUROTOXIN TS1; RECEPTOR-SITE	We identified Tf2, the first beta-scorpion toxin from the venom of the Brazilian scorpion Tityus fasciolatus. Tf2 is identical to Tb2-II found in Tityus bahiensis. We found that Tf2 selectively activates human (h)Na(v)1.3, a neuronal voltage-gated sodium (Na-v) subtype implicated in epilepsy and nociception. Tf2 shifts hNa(v)1.3 activation voltage to more negative values, thereby opening the channel at resting membrane potentials. Seven other tested mammalian Na-v channels (Na(v)1.1-1.2; Na(v)1.4-1.8) expressed in Xenopus oocytes are insensitive upon application of 1 mu M Tf2. Therefore, the identification of Tf2 represents a unique addition to the repertoire of animal toxins that can be used to investigate Na-v channel function.	[Camargos, Thalita S.; Rego, Solange C.; Mourao, Caroline B. F.; Schwartz, Elisabeth F.] Univ Brasilia, Dept Ciencias Fisiol, Lab Toxinol, Brasilia, DF, Brazil; [Bosmans, Frank] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Bosmans, Frank] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	Universidade de Brasilia; Johns Hopkins University; Johns Hopkins University	Schwartz, EF (corresponding author), Univ Brasilia, Dept Ciencias Fisiol, Lab Toxinol, Brasilia, DF, Brazil.	efschwa@unb.br	Mourao, Caroline B F/A-2277-2013; Schwartz, Elisabeth Ferroni/AGE-4234-2022; Bosmans, Frank/T-5589-2017; Schwartz, Elisabeth/G-4531-2012	Mourao, Caroline B F/0000-0003-3795-6025; Schwartz, Elisabeth Ferroni/0000-0001-8239-4055; Bosmans, Frank/0000-0002-6476-235X; Schwartz, Elisabeth/0000-0001-8239-4055; Bosmans, Frank/0000-0002-0451-6050	National Institute of Neurological Disorders and Stroke (NINDS) of National Institutes of Health (NIH) [R00NS073797]; CNPq/FAPDF (INOVATOXIN project) [564.223/2010-7, 193.000.471/2011]; CAPES Foundation; CNPq; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS073797] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS) of National Institutes of Health (NIH); CNPq/FAPDF (INOVATOXIN project); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Parts of the research in this publication were supported by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under award number R00NS073797 (F.B.) and by CNPq (564.223/2010-7)/FAPDF (193.000.471/2011) (INOVATOXIN project) (E.F.S). T.S.C. is a graduate student financed by CNPq and CAPES Foundation. S.C.R. and C.B.F.M. are graduate students supported by CNPq. E.F.S. receives support from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, BIOCHEM J, V375, P551, DOI 10.1042/BJ20030688; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bende NS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5350; Benzinger GR, 1998, J BIOL CHEM, V273, P80, DOI 10.1074/jbc.273.1.80; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Campos FV, 2004, BRIT J PHARMACOL, V142, P1115, DOI 10.1038/sj.bjp.0705793; Capes DL, 2012, P NATL ACAD SCI USA, V109, P2648, DOI 10.1073/pnas.1115575109; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Coelho VA, 2014, TOXICON, V83, P15, DOI 10.1016/j.toxicon.2014.02.010; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cologna CT, 2012, FEBS J, V279, P1495, DOI 10.1111/j.1742-4658.2012.08545.x; DARBON H, 1983, BIOCHEM BIOPH RES CO, V115, P415, DOI 10.1016/S0006-291X(83)80160-0; ELAYEB M, 1986, BIOCHEMISTRY-US, V25, P6671, DOI 10.1021/bi00369a052; Estacion M, 2010, EXP NEUROL, V224, P362, DOI 10.1016/j.expneurol.2010.04.012; Estrada G, 2007, BBA-GEN SUBJECTS, V1770, P1161, DOI 10.1016/j.bbagen.2007.04.006; Estrada G, 2011, PEPTIDES, V32, P75, DOI 10.1016/j.peptides.2010.11.001; Felix JP, 2004, ASSAY DRUG DEV TECHN, V2, P260, DOI 10.1089/1540658041410696; Gilchrist John, 2014, Handb Exp Pharmacol, V221, P203, DOI 10.1007/978-3-642-41588-3_10; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Goodstadt L, 2001, BIOINFORMATICS, V17, P845, DOI 10.1093/bioinformatics/17.9.845; Guerrero-Vargas JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030478; Guimaraes PTC, 2009, CARACTERIZACAO MOLEC, DOI [10.1080/713663671, DOI 10.1080/713663671]; Gur M, 2011, J BIOL CHEM, V286, P35209, DOI 10.1074/jbc.M111.259507; Hains BC, 2007, PROG BRAIN RES, V161, P195, DOI 10.1016/S0079-6123(06)61013-3; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; HOUSSET D, 1994, J MOL BIOL, V238, P88, DOI 10.1006/jmbi.1994.1270; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kalia J, 2014, J MOL BIOL; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; Karbat I, 2010, J BIOL CHEM, V285, P30531, DOI 10.1074/jbc.M110.150888; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KHARRAT R, 1990, TOXICON, V28, P509, DOI 10.1016/0041-0101(90)90295-I; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Leipold E, 2012, J GEN PHYSIOL, V139, P305, DOI 10.1085/jgp.201110720; Lourenco W.R., 1996, Journal of Venomous Animals and Toxins, V2, P121; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; Martin-Eauclaire MF, 2015, J GEN PHYSIOL, V145, P155, DOI 10.1085/jgp.201411268; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mihailescu M, 2014, P NATL ACAD SCI USA, V111, pE5463, DOI 10.1073/pnas.1415324111; Escalona MP, 2013, FRONT BIOSCI-LANDMRK, V18, P572, DOI 10.2741/4121; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pimenta AMC, 2001, TOXICON, V39, P1009, DOI 10.1016/S0041-0101(00)00240-3; Pinheiro CB, 2003, ACTA CRYSTALLOGR D, V59, P405, DOI 10.1107/S090744490202111X; Pintar A, 1999, J MOL BIOL, V287, P359, DOI 10.1006/jmbi.1999.2611; Polikarpov I, 1999, J MOL BIOL, V290, P175, DOI 10.1006/jmbi.1999.2868; POSSANI LD, 1985, BIOCHEM J, V229, P739, DOI 10.1042/bj2290739; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; SAMPAIO SV, 1991, TOXICON, V29, P663, DOI 10.1016/0041-0101(91)90058-Y; Saucedo AL, 2012, BBA-PROTEINS PROTEOM, V1824, P478, DOI 10.1016/j.bbapap.2012.01.003; Sheets MF, 2000, J GEN PHYSIOL, V115, P609, DOI 10.1085/jgp.115.5.609; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Vanoye CG, 2014, NEUROBIOL DIS, V62, P313, DOI 10.1016/j.nbd.2013.10.015; Wagner S, 2003, TOXICON, V41, P737, DOI 10.1016/S0041-0101(03)00008-4; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742	64	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128578	10.1371/journal.pone.0128578	http://dx.doi.org/10.1371/journal.pone.0128578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083731	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400059
J	Nascimento, SL; Surita, FG; Godoy, AC; Kasawara, KT; Morais, SS				Nascimento, Simony Lira; Surita, Fernanda Garanhani; Godoy, Ana Carolina; Kasawara, Karina Tamy; Morais, Sirlei Siani			Physical Activity Patterns and Factors Related to Exercise during Pregnancy: A Cross Sectional Study	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; DIABETES-MELLITUS; WOMEN; INTERVENTION; PROGRAM; SAFETY; IMPACT	Objective To assess the physical activity levels of pregnant women and to examine the characteristics associated with the practice of exercise and the activities of daily living during pregnancy. Methods For this cross-sectional study, 1,279 women were recruited within 72 hours postpartum. They were interviewed about their socio-demographic data and obstetric history and were administered self-report questionnaires about exercise and daily physical activities during pregnancy. Data on the current pregnancy, labor, delivery, and newborn outcomes were collected from participants' medical records. To analyze factors related to the practice of exercise, we used the student t-test, X-2, and odds ratio (OR), with a corresponding 95% confident interval (CI), followed by a multiple logistic regression. The significance level was 5%. Results Compared to the pre-pregnancy period, the prevalence of physical activity among participants was lower throughout pregnancy (20.1%) (p = 0.01). Half of the women interrupted practicing physical exercise due to pregnancy. The lowest prevalence of exercise was observed in the first (13.6%) and third trimesters (13.4%). Less than half of women received exercise guidance during prenatal care meetings (47.4%). Walking was the most commonly reported exercise, followed by water aerobics. Factors positively associated with exercise practice were higher educational level (OR=1.82; CI 95% 1.28-2.60), primiparity (OR=1.49; CI 95% 1.07-2.07), exercising before pregnancy (OR=6.45; CI 95% 4.64-8.96), and exercise guidance during prenatal care (OR=2.54; CI 95% 1.80-3.57). Mildly intense exercise and domestic activities were most frequently reported among pregnant women. There were no differences in maternal and perinatal outcomes between active and sedentary pregnant women. Conclusion The findings indicate that promoting physical activity remains a priority in public health policy, and women of childbearing age, especially those planning a pregnancy, should be encouraged to adopt an exercise routine or maintain an active lifestyle during pregnancy in order to avoid sedentary- and obesity-associated risks.	[Nascimento, Simony Lira; Surita, Fernanda Garanhani; Godoy, Ana Carolina; Kasawara, Karina Tamy; Morais, Sirlei Siani] Univ Campinas UNICAMP, Fac Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil; [Nascimento, Simony Lira] Univ Fed Ceara, Dept Physiotherapy, Fortaleza, CE, Brazil	Universidade Estadual de Campinas; Universidade Federal do Ceara	Surita, FG (corresponding author), Univ Campinas UNICAMP, Fac Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.	surita@unicamp.br	Surita, Fernanda Garanhani/H-9575-2012; Kasawara, Karina T/M-1004-2017	Surita, Fernanda Garanhani/0000-0003-4335-0337; Kasawara, Karina T/0000-0003-1388-2615; Lira do Nascimento, Simony/0000-0001-6248-5590	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/09474-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The publication costs were supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), process number: 2015/09474-0. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, OBSTET GYNECOL, V99, P171; Borg G A, 1974, Exerc Sport Sci Rev, V2, P131; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cavalcante Sergio R, 2009, Reprod Health, V6, P1, DOI 10.1186/1742-4755-6-1; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Cramp AG, 2009, ANN BEHAV MED, V37, P325, DOI 10.1007/s12160-009-9102-y; Davenport MH, 2008, APPL PHYSIOL NUTR ME, V33, P511, DOI 10.1139/H08-018; Melo ASD, 2012, OBSTET GYNECOL, V120, P302, DOI 10.1097/AOG.0b013e31825de592; Dempsey JC, 2005, EXERC SPORT SCI REV, V33, P141; Domenjoz I, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.030; Domingues MR, 2007, REV SAUDE PUBL, V41, P173, DOI 10.1590/s0034-89102007000200002; Duncombe D, 2009, MIDWIFERY, V25, P430, DOI 10.1016/j.midw.2007.03.002; Evenson KR, 2009, MATERN CHILD HLTH J, V13, P364, DOI 10.1007/s10995-008-0359-8; Evenson KR, 2004, PAEDIATR PERINAT EP, V18, P400, DOI 10.1111/j.1365-3016.2004.00595.x; Fell DB, 2009, MATERN CHILD HLTH J, V13, P597, DOI 10.1007/s10995-008-0404-7; Gaston A, 2011, J SCI MED SPORT, V14, P299, DOI 10.1016/j.jsams.2011.02.006; Guelinckx I, 2010, AM J CLIN NUTR, V91, P373, DOI 10.3945/ajcn.2009.28166; Haakstad LAH, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-66; Hegaard HK, 2007, ACTA OBSTET GYN SCAN, V86, P1290, DOI 10.1080/00016340701647341; Hegaard HK, 2011, MATERN CHILD HLTH J, V15, P806, DOI 10.1007/s10995-010-0647-y; Liu JH, 2011, EUR J EPIDEMIOL, V26, P237, DOI 10.1007/s10654-010-9538-1; Lynch KE, 2012, AM J PREV MED, V43, P434, DOI 10.1016/j.amepre.2012.06.020; Melzer K, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.876; Miquelutti MA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-154; Mudd LM, 2009, PREV MED, V49, P194, DOI 10.1016/j.ypmed.2009.06.004; Nascimento SL, 2012, CURR OPIN OBSTET GYN, V24, P387, DOI 10.1097/GCO.0b013e328359f131; Owe KM, 2009, SCAND J MED SCI SPOR, V19, P637, DOI 10.1111/j.1600-0838.2008.00840.x; Ribeiro CP, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-31; Ronnberg AK, 2010, BJOG-INT J OBSTET GY, V117, P1327, DOI 10.1111/j.1471-0528.2010.02619.x; Ruchat SM, 2012, INT J SPORTS MED, V33, P661, DOI 10.1055/s-0032-1304635; Shimidt MD, 2006, MED SCI SPORTS EXERC, V38, P42; Silva Francisco Trindade, 2007, Rev. Bras. Ginecol. Obstet., V29, P490, DOI 10.1590/S0100-72032007000900009; Streuling I, 2011, BJOG-INT J OBSTET GY, V118, P278, DOI 10.1111/j.1471-0528.2010.02801.x; Takito MY, 2008, REV BRAS MED ESPORTE, V14, P132, DOI 10.1590/S1517-86922008000200010; Tavares Jousilene de Sales, 2009, Rev. bras. epidemiol., V12, P10, DOI 10.1590/S1415-790X2009000100002; USA Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Vallim AL, 2011, REPROD HLTH, V16, P8; Walsh JM, 2011, INT J GYNECOL OBSTET, V114, P154, DOI 10.1016/j.ijgo.2011.02.016; Weissgerber TL, 2006, APPL PHYSIOL NUTR ME, V31, P661, DOI [10.1139/H06-060, 10.1139/h06-060]; Wells C, 2012, COMPLEMENT THER MED, V20, P253, DOI 10.1016/j.ctim.2012.02.005; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wolfe LA, 2003, CLIN OBSTET GYNECOL, V46, P488, DOI 10.1097/00003081-200306000-00027; World Health Organization (WHO), 1996, CAR NORM BIRTH PRACT; Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104; Zhang J, 1996, ANN EPIDEMIOL, V6, P53, DOI 10.1016/1047-2797(95)00093-3	45	84	85	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128953	10.1371/journal.pone.0128953	http://dx.doi.org/10.1371/journal.pone.0128953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083416	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400075
J	Sakai, O; Uchida, T; Roggia, MF; Imai, H; Ueta, T; Amano, S				Sakai, Osamu; Uchida, Takatoshi; Roggia, Murilo F.; Imai, Hirotaka; Ueta, Takashi; Amano, Shiro			Role of Glutathione Peroxidase 4 in Glutamate-Induced Oxytosis in the Retina	PLOS ONE			English	Article							OXIDATIVE STRESS MARKERS; GANGLION-CELLS; AQUEOUS-HUMOR; IN-VITRO; GLAUCOMA; EXPRESSION; TOXICITY; ACID	Purpose The purpose of the present study was to investigate the role of glutathione peroxidase 4 (GPx4) in glutamate-induced oxytosis in the retina. Methods For in vitro studies, an immortalized rat retinal precursor cell line R28 was used. Cells were transfected with siRNA specifically silencing GPx4 or with scrambled control siRNA. Lipid peroxidation was evaluated by 4-hydroxy-2-nonenal (4-HNE) immunostaining. Cytotoxicity and cell death were evaluated using an LDH activity assay and annexin V staining, respectively. Cells transfected with GPx4 siRNA or control siRNA were treated with glutamate (1 or 2 mM), and the cytotoxicity was evaluated using the LDH activity assay. For in vivo studies, retinal ganglion cell damage was induced by intravitreal injection of 25-mM N-methyl-D-aspartate (NMDA, 2 mu L/eye) in GPx4(+/+) and GPx(4+/-) mice. The evaluation of lipid peroxidation (4-HNE immunostaining), apoptosis (TUNEL staining), and cell density in the ganglion cell layer (GCL) were performed at 12 h, 1 day, and 7 days after the NMDA injection. Results GPx4 knockdown significantly increased LDH activity by 13.9-fold (P < 0.01) and increased peroxidized lipid levels by 3.2-fold in R28 cells (P < 0.01). In cells transfected with scrambled control siRNA, treatment with glutamate at 1 or 2 mM did not increase LDH activity; whereas, in cells transfected with GPx4 siRNA, glutamate treatment significantly increased LDH activity (1.52-fold, P < 0.01). GPx(4+/-) mice exhibited higher levels of lipid peroxidation in retinas treated with NMDA than GPx4(+/+) mice (1.26-fold, P < 0.05). GPx4(+/-) mice had more TUNEL-positive cells induced by NMDA in GCL (1.45-fold, P < 0.05). In addition, the cell density in GCL of GPx4(+/-) mice was 19% lower than that in GPx4(+/+) mice after treatment with NMDA (P < 0.05). Conclusion These results suggest that defective GPx4 expression is associated with enhanced cytotoxicity by glutamate-induced oxytosis in the retina.	[Sakai, Osamu; Uchida, Takatoshi; Roggia, Murilo F.; Ueta, Takashi] Tokyo Med Univ, Dept Ophthalmol, Tokyo, Japan; [Sakai, Osamu; Uchida, Takatoshi] Senju Pharmaceut Co Ltd, Senju Lab Ocular Sci, Kobe, Hyogo, Japan; [Imai, Hirotaka] Kitasato Univ, Sch Pharmaceut Sci, Tokyo 108, Japan; [Amano, Shiro] Inouye Eye Hosp, Tokyo, Japan; [Amano, Shiro] Miyata Eye Hosp, Miyazaki, Japan	Tokyo Medical University; Senju Pharmaceutical Co. Ltd.; Kitasato University	Amano, S (corresponding author), Inouye Eye Hosp, Tokyo, Japan.	amanoshiro1126@gmail.com						Aihara M, 2014, MOL VIS, V20, P606; Ambati J, 1997, ARCH OPHTHALMOL-CHIC, V115, P1161, DOI 10.1001/archopht.1997.01100160331011; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299, DOI 10.1001/archopht.1996.01100130295012; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Goyal A, 2014, CURR EYE RES, V39, P823, DOI 10.3109/02713683.2011.556299; Honkanen RA, 2003, ARCH OPHTHALMOL-CHIC, V121, P183; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Inman DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065389; Kang YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4672; Kesavulu MM, 2000, DIABETES METAB, V26, P387; Kowluru RA, 2001, NEUROCHEM INT, V38, P385, DOI 10.1016/S0197-0186(00)00112-1; Kumar B, 2014, EXP EYE RES, V125, P193, DOI 10.1016/j.exer.2014.06.009; Lee D, 2014, INVEST OPHTH VIS SCI, V55, P993, DOI 10.1167/iovs.13-12564; Majsterek I, 2011, EXP MOL PATHOL, V90, P231, DOI 10.1016/j.yexmp.2011.01.001; Munemasa Y, 2009, GENE THER, V16, P17, DOI 10.1038/gt.2008.126; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Nakajima Y, 2008, J PHARM PHARMACOL, V60, P1365, DOI 10.1211/jpp/60.10.0013; Nakajima Y, 2008, BRAIN RES, V1226, P226, DOI 10.1016/j.brainres.2008.06.026; Pulido JE, 2007, EXP DIABETES RES, DOI 10.1155/2007/36150; Roggia MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098864; Sakai O, 2015, INVEST OPHTH VIS SCI, V56, P538, DOI 10.1167/iovs.14-15463; Seigel G M, 1996, Mol Vis, V2, P2; Seigel GM, 2014, MOL VIS, V20, P301; Seigel GM, 1996, IN VITRO CELL DEV-AN, V32, P66; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Simo R, 2014, TRENDS ENDOCRIN MET, V25, P23, DOI 10.1016/j.tem.2013.09.005; THOMAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1045, P252, DOI 10.1016/0005-2760(90)90128-K; Ueta T, 2012, J BIOL CHEM, V287, P7675, DOI 10.1074/jbc.M111.335174; Wang DY, 2010, INVEST OPHTH VIS SCI, V51, P4084, DOI 10.1167/iovs.09-4864; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Wortmann M, 2013, CIRC RES, V113, P408, DOI 10.1161/CIRCRESAHA.113.279984; Yuki K, 2013, EXP EYE RES, V115, P230, DOI 10.1016/j.exer.2013.07.002	33	17	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130467	10.1371/journal.pone.0130467	http://dx.doi.org/10.1371/journal.pone.0130467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083388	gold, Green Submitted, Green Published			2022-12-26	WOS:000356567400145
J	Yumerefendi, H; Dickinson, DJ; Wang, H; Zimmerman, SP; Bear, JE; Goldstein, B; Hahn, K; Kuhlman, B				Yumerefendi, Hayretin; Dickinson, Daniel J.; Wang, Hui; Zimmerman, Seth P.; Bear, James E.; Goldstein, Bob; Hahn, Klaus; Kuhlman, Brian			Control of Protein Activity and Cell Fate Specification via Light-Mediated Nuclear Translocation	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; SPATIOTEMPORAL CONTROL; GENE-EXPRESSION; NEURAL ACTIVITY; EXPORT SIGNAL; C-ELEGANS; LOCALIZATION; DOMAIN; LINEAGES; DYNAMICS	Light-activatable proteins allow precise spatial and temporal control of biological processes in living cells and animals. Several approaches have been developed for controlling protein localization with light, including the conditional inhibition of a nuclear localization signal (NLS) with the Light Oxygen Voltage (AsLOV2) domain of phototropin 1 from Avena sativa. In the dark, the switch adopts a closed conformation that sterically blocks the NLS motif. Upon activation with blue light the C-terminus of the protein unfolds, freeing the NLS to direct the protein to the nucleus. A previous study showed that this approach can be used to control the localization and activity of proteins in mammalian tissue culture cells. Here, we extend this result by characterizing the binding properties of a LOV/NLS switch and demonstrating that it can be used to control gene transcription in yeast. Additionally, we show that the switch, referred to as LANS (light-activated nuclear shuttle), functions in the C. elegans embryo and allows for control of nuclear localization in individual cells. By inserting LANS into the C. elegans lin-1 locus using Cas9-triggered homologous recombination, we demonstrated control of cell fate via light-dependent manipulation of a native transcription factor. We conclude that LANS can be a valuable experimental method for spatial and temporal control of nuclear localization in vivo.	[Yumerefendi, Hayretin; Zimmerman, Seth P.; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Wang, Hui; Hahn, Klaus] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27514 USA; [Dickinson, Daniel J.; Goldstein, Bob] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Bear, James E.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Dickinson, Daniel J.; Bear, James E.; Goldstein, Bob; Hahn, Klaus; Kuhlman, Brian] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hahn, K (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27514 USA.	khahn@med.unc.edu; bkuhlman@email.unc.edu		Goldstein, Bob/0000-0001-6961-675X; Dickinson, Daniel J./0000-0003-2651-2584; Hahn, Klaus/0000-0002-1970-7562	NIH [R01 GM093208, R01 DA036877, R01 GM083071, R01 GM102924, T32 CA009156]; Howard Hughes postdoctoral fellowship from Helen Hay Whitney Foundation; Arthritis Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA009156, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102924, R01GM083071, R01GM093208, P01GM103723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036877] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes postdoctoral fellowship from Helen Hay Whitney Foundation; Arthritis Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01 GM093208 (B.K.), R01 DA036877 (B.K, K.H), R01 GM083071 (B.G.), R01 GM102924 (K.H.), and T32 CA009156 (D.J.D.); and by Howard Hughes postdoctoral fellowship from the Helen Hay Whitney Foundation (D.J.D.); H.W. is a recipient of an Arthritis Foundation Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Broitman-Maduro G, 2009, DEVELOPMENT, V136, P2735, DOI 10.1242/dev.038307; Cartwright P, 2000, CELL MOL LIFE SCI, V57, P1193, DOI 10.1007/PL00000759; Del Bene F, 2012, DEV NEUROBIOL, V72, P404, DOI 10.1002/dneu.20914; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Engelke H, 2014, ACS SYNTH BIOL; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FERGUSON EL, 1985, GENETICS, V110, P17; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Holt JE, 2007, CURR GENOMICS, V8, P323, DOI 10.2174/138920207782446151; Jacobs D, 1998, GENETICS, V149, P1809; Jang BC, 2003, J BIOL CHEM, V278, P2773, DOI 10.1074/jbc.C200620200; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050738; Lungu OI, 2012, CHEM BIOL, V19, P507, DOI 10.1016/j.chembiol.2012.02.006; Marshall KS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-6; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Niopek D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5404; Ooi SL, 2006, PLOS GENET, V2, P883, DOI 10.1371/journal.pgen.0020097; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Watanabe M, 2000, EMBO REP, V1, P176, DOI 10.1093/embo-reports/kvd029; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wu MC, 2014, P NATL ACAD SCI USA, V111, P5367, DOI 10.1073/pnas.1400997111; Yang XJ, 2013, MOL BIOL CELL, V24, P2419, DOI 10.1091/mbc.E13-03-0126; Yi JJ, 2014, ACS SYNTH BIOL	48	70	72	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128443	10.1371/journal.pone.0128443	http://dx.doi.org/10.1371/journal.pone.0128443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083500	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400048
J	Cui, XJ; McAllister, R; Boregowda, R; Sohn, JA; Ledesma, FC; Caldecott, KW; Seeger, C; Hu, JM				Cui, Xiuji; McAllister, Rebecca; Boregowda, Rajeev; Sohn, Ji A.; Cortes Ledesma, Felipe; Caldecott, Keith W.; Seeger, Christoph; Hu, Jianming			Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair?	PLOS ONE			English	Article							CLOSED CIRCULAR DNA; HEPADNAVIRUS REVERSE-TRANSCRIPTASE; ENVELOPE PROTEINS; COVALENT COMPLEXES; VIRAL-DNA; IN-VITRO; CELLS; TDP2; REPLICATION; POLYMERASE	Hepatitis B virus (HBV) replication and persistence are sustained by a nuclear episome, the covalently closed circular (CCC) DNA, which serves as the transcriptional template for all viral RNAs. CCC DNA is converted from a relaxed circular (RC) DNA in the virion early during infection as well as from RC DNA in intracellular progeny nucleocapsids via an intracellular amplification pathway. Current antiviral therapies suppress viral replication but cannot eliminate CCC DNA. Thus, persistence of CCC DNA remains an obstacle toward curing chronic HBV infection. Unfortunately, very little is known about how CCC DNA is formed. CCC DNA formation requires removal of the virally encoded reverse transcriptase (RT) protein from the 5' end of the minus strand of RC DNA. Tyrosyl DNA phosphodiesterase-2 (Tdp2) was recently identified as the enzyme responsible for cleavage of tyrosyl-5' DNA linkages formed between topoisomerase II and cellular DNA. Because the RT-DNA linkage is also a 5' DNA-phosphotyrosyl bond, it has been hypothesized that Tdp2 might be one of several elusive host factors required for CCC DNA formation. Therefore, we examined the role of Tdp2 in RC DNA deproteination and CCC DNA formation. We demonstrated Tdp2 can cleave the tyrosyl-minus strand DNA linkage using authentic HBV RC DNA isolated from nucleocapsids and using RT covalently linked to short minus strand DNA produced in vitro. On the other hand, our results showed that Tdp2 gene knockout did not block CCC DNA formation during HBV infection of permissive human hepatoma cells and did not prevent intracellular amplification of duck hepatitis B virus CCC DNA. These results indicate that although Tdp2 can remove the RT covalently linked to the 5' end of the HBV minus strand DNA in vitro, this protein might not be required for CCC DNA formation in vivo.	[Cui, Xiuji; McAllister, Rebecca; Boregowda, Rajeev; Hu, Jianming] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Sohn, Ji A.; Seeger, Christoph] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Cortes Ledesma, Felipe] CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain; [Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Fox Chase Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sussex	Hu, JM (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA.	juh13@psu.edu	Ledesma, Felipe Cortés/F-4803-2014; Caldecott, Keith/S-4245-2019	Ledesma, Felipe Cortés/0000-0002-0440-6783; Caldecott, Keith/0000-0003-4255-9016	National Institutes of Health [R01 AI074982, R21 AI101558, T32 CA060395]; NATIONAL CANCER INSTITUTE [T32CA060395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074982, R21AI119433, R21AI101558] Funding Source: NIH RePORTER; Cancer Research UK [16771] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research UK(Cancer Research UK)	Funding for this work came from the National Institutes of Health, http://www.nih.gov, R01 AI074982 to JH, R21 AI101558 to CS, and T32 CA060395 to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boregowda RK, 2011, J VIROL, V85, P7754, DOI 10.1128/JVI.00483-11; Gao R, 2014, J BIOL CHEM, V289, P17960, DOI 10.1074/jbc.M114.565374; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Hu J, 2015, COLD SPRING HARB PER; Jones SA, 2013, J VIROL, V87, P2563, DOI 10.1128/JVI.02786-12; Jones SA, 2012, J VIROL, V86, P5134, DOI 10.1128/JVI.07137-11; Kock J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001082; Koniger C, 2014, P NATL ACAD SCI USA, V111, pE4244, DOI 10.1073/pnas.1409986111; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lentz TB, 2011, J VIROL, V85, P11916, DOI 10.1128/JVI.05373-11; Lin CP, 2009, J BIOL CHEM, V284, P28084, DOI 10.1074/jbc.M109.030601; Lin L, 2008, J VIROL, V82, P2305, DOI 10.1128/JVI.02147-07; Litwin S, 2005, J CLIN VIROL, V34, pS96, DOI 10.1016/S1386-6532(05)80018-6; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Ning XJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002255; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Raney AK, 2001, J VIROL, V75, P2900, DOI 10.1128/JVI.75.6.2900-2911.2001; Schellenberg MJ, 2012, NAT STRUCT MOL BIOL, V19, P1363, DOI 10.1038/nsmb.2418; Seeger C., 2013, FIELDS VIROLOGY, P2185; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Shi K, 2012, NAT STRUCT MOL BIOL, V19, P1372, DOI 10.1038/nsmb.2423; Sohn JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008093; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; SUMMERS J, 1991, J VIROL, V65, P1310, DOI 10.1128/JVI.65.3.1310-1317.1991; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; WANG GH, 1992, CELL, V71, P663, DOI 10.1016/0092-8674(92)90599-8; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XT, 2003, J VIROL, V77, P4471, DOI 10.1128/JVI.77.8.4471-4480.2003; WEBER M, 1994, J VIROL, V68, P2994, DOI 10.1128/JVI.68.5.2994-2999.1994; WU TT, 1990, VIROLOGY, V175, P255, DOI 10.1016/0042-6822(90)90206-7; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; Zhang YZ, 2003, P NATL ACAD SCI USA, V100, P12372, DOI 10.1073/pnas.2033898100; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994	41	59	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0128401	10.1371/journal.pone.0128401	http://dx.doi.org/10.1371/journal.pone.0128401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079492	Green Published, gold			2022-12-26	WOS:000356542300010
J	Matsumoto-Takahashi, ELA; Tongol-Rivera, P; Villacorte, EA; Angluben, RU; Jimba, M; Kano, S				Matsumoto-Takahashi, Emilie Louise Akiko; Tongol-Rivera, Pilarita; Villacorte, Elena A.; Angluben, Ray U.; Jimba, Masamine; Kano, Shigeyuki			Patient Knowledge on Malaria Symptoms Is a Key to Promoting Universal Access of Patients to Effective Malaria Treatment in Palawan, the Philippines	PLOS ONE			English	Article							AWARENESS-RAISING ACTIVITIES; COMMUNITY-HEALTH WORKERS; RURAL BURKINA-FASO; SEEKING BEHAVIOR; DRUG-RESISTANCE; PREVENTION; MORTALITY; ILLNESS	Introduction Palawan, where health care facilities are still limited, is one of the most malaria endemic provinces in the Philippines. Since 1999, microscopists (community health workers) have been trained in malaria diagnosis and feasibility of early diagnosis and treatments have been enhanced throughout the province. To accelerate the universal access of malaria patients to diagnostic testing in Palawan, positive health seeking behavior should be encouraged when malaria infection is suspected. Methods In this cross-sectional study, structured interviews were carried out with residents (N = 218) of 20 remote malaria-endemic villages throughout Palawan with a history of suspected malaria from January to February in 2012. Structural equation modeling (SEM) was conducted to determine factors associated with appropriate treatment, which included: (1) socio-demo-graphic characteristics; (2) proximity to a health facility; (3) health seeking behavior; (4) knowledge on malaria; (5) participation in community awareness-raising activities. Results Three factors independently associated with appropriate treatment were identified by SEM (CMIN = 10.5, df = 11, CFI = 1.000, RMSEA = .000): "living near microscopist" (p < 0.001), "not living near private pharmacy" (p < 0.01), and "having severe symptoms" (p < 0.01). "Severe symptoms" were positively correlated with more "knowledge on malaria symptoms" (p < 0.001). This knowledge was significantly increased by attending "community awareness-raising activities by microscopists" (p < 0.001). Conclusions In the resource-limited settings, microscopists played a significant role in providing appropriate treatment to all participants with severe malaria symptoms. However, it was considered that knowledge on malaria symptoms made participants more aware of their symptoms, and further progressed self-triage. Strengthening this recognition sensitivity and making residents aware of nearby microscopists may be the keys to accelerating universal access to effective malaria treatment in Palawan.	[Matsumoto-Takahashi, Emilie Louise Akiko; Kano, Shigeyuki] Natl Ctr Global Hlth & Med, Res Inst, Dept Trop Med & Malaria, Tokyo, Japan; [Matsumoto-Takahashi, Emilie Louise Akiko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Tongol-Rivera, Pilarita; Villacorte, Elena A.] Univ Philippines, Coll Publ Hlth, Dept Parasitol, Manila, Philippines; [Angluben, Ray U.] Kilusan Ligtas Malaria Pilipinas Shell Fdn Inc, SPS Govt Ctr, Palawan City, Philippines	National Center for Global Health & Medicine - Japan; University of Tokyo; University of the Philippines System; University of the Philippines Manila	Kano, S (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Trop Med & Malaria, Tokyo, Japan.	kano@ri.ncgm.go.jp	Jimba, Masamine/AAF-5630-2020	Kano, Shigeyuki/0000-0001-9050-4955	Japanese Ministry of Health, Labour and Welfare [H21-Chikyukibo-Ippan-006]; National Center for Global Health and Medicine [25A-2]	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	The present study was supported by a grant from the Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp) (grant number: H21-Chikyukibo-Ippan-006) and by a Grant from the National Center for Global Health and Medicine ( http://www.ncgm.go.jp/) (grant number: 25A-2). SK received both funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abubakar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071998; Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; Akogun OB, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-13; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; Angluben R. U., 2008, Tropical Medicine and Health, V36, P45, DOI 10.2149/tmh.36.45; [Anonymous], PROV HLTH REP 2005; [Anonymous], PROV HLTH REP 1995; [Anonymous], POP PHIL CENS YEARS; [Anonymous], PROV HLTH REP 2000; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Chibwana AI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-219; Delacollette C, 1996, B WORLD HEALTH ORGAN, V74, P423; Deressa W, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-259; Feyisetan B J, 1997, Health Transit Rev, V7, P221; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hazel E, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001384, 10.1371/journal.pmed.1001416]; Hwang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011692; Kelesidis T, 2007, J ANTIMICROB CHEMOTH, V60, P214, DOI 10.1093/jac/dkm109; Makemba AM, 1996, TROP MED INT HEALTH, V1, P305; Matsumoto-Takahashi ELA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-384; Matsumoto-Takahashi ELA, 2014, PARASITOL INT, V63, P519, DOI 10.1016/j.parint.2014.01.008; Mita T, 2012, JPN J INFECT DIS, V65, P465, DOI 10.7883/yoken.65.465; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Mwangome M, 2010, J HEALTH POPUL NUTR, V28, P167; Ndiaye Y, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-240; Parija SC, 2011, INDIAN J MED MICROBI, V29, P243, DOI 10.4103/0255-0857.83906; Provincial Health Office of Palawan, 2010, PROV HLTH REP 2010; Provincial Health Office of Palawan, 2012, PROV HLTH REP 2012; Santos G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059968; Satterfield D., 2002, HEALTH PROMOT PRACT, V3, P166, DOI [10.1177/152483990200300212, DOI 10.1177/152483990200300212]; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Sumba PO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-245; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yasuoka J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-109	37	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0127858	10.1371/journal.pone.0127858	http://dx.doi.org/10.1371/journal.pone.0127858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079135	Green Published, Green Submitted, gold			2022-12-26	WOS:000356542300007
J	Juan, CK; Chen, HJ; Shen, JL; Kao, CH				Juan, Chao-Kuei; Chen, Hsuan-Ju; Shen, Jui-Lung; Kao, Chia-Hung			Lichen Simplex Chronicus Associated With Erectile Dysfunction: A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; PREVALENCE; DISEASE; HYPERTENSION; DEPRESSION; ANXIETY; RISK; MEN	Background An association between lichen simplex chronicus (LSC) and sexual dysfunction was explored. However, no data are available from investigations into the relationship between erectile dysfunction (ED) and LSC. Objectives This retrospective population-based cohort study aimed to clarify the risk of ED associated with LSC. Methods By using the Taiwan National Health Insurance Research dataset, we identified 5611 male patients who had been newly diagnosed with LSC from 2000 to 2004. The date of diagnosis was identified as the index date. LSC patients with incomplete demographic information or with a history of ED before the index date were excluded. In total, 22444 age-matched patients without LSC were randomly selected as the non-LSC group based on a 1: 4 ratio. Subsequence occurrence of ED was measured until 2011. The association between LSC and the risk of developing ED was estimated using Cox proportional hazard regression model. Results After adjusting for age and comorbidities, patients with LSC had a 1.74-fold greater risk of developing ED compared with those without LSC (95% confidence interval= 1.44-2.10). LSC patients with comorbidities including diabetes, hyperlipidemia, hypertension, cardiovascular disease, peripheral arterial disease, chronic obstructive pulmonary disease, chronic kidney disease, depression, and anxiety were at a higher risk of ED compared with the non-LSC patients without comorbidities. Conclusions LSC confers a greater risk in the development of ED. Physicians should be aware of the potential of ED occurrence in LSC patients.	[Juan, Chao-Kuei; Shen, Jui-Lung] Taichung Vet Gen Hosp, Dept Dermatol, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo Kiyo Aoshima Memorial Funds, Japan; Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence, Taiwan [MOHW104-TDU-B212-124-002]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo Kiyo Aoshima Memorial Funds, Japan; Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW104-TDU-B212-124-002, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	An JG, 2013, INT J MED SCI, V10, P593, DOI 10.7150/ijms.5624; [Anonymous], 1993, Int J Impot Res, V5, P181; Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; Aversa A, 2008, INT J IMPOT RES, V20, P566, DOI 10.1038/ijir.2008.43; Ayyar K S, 1986, Indian J Psychiatry, V28, P155; Bhatia M S, 1996, J Indian Med Assoc, V94, P445; Burgin S, 2012, FITZPATRICKS DERMATO, P182; Cheng JYW, 2007, INT J IMPOT RES, V19, P229, DOI 10.1038/sj.ijir.3901517; Ermertcan AT, 2011, J ANDROL, V32, P165, DOI 10.2164/jandrol.110.010959; HALE VE, 1990, ARCH SEX BEHAV, V19, P569, DOI 10.1007/BF01542466; Javaroni V, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/627278; Kahraman H, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-66; Kennedy SH, 1999, J AFFECT DISORDERS, V56, P201, DOI 10.1016/S0165-0327(99)00050-6; Konuk N, 2007, GEN HOSP PSYCHIAT, V29, P232, DOI 10.1016/j.genhosppsych.2007.01.006; Koseoglu N, 2005, J UROLOGY, V174, P249, DOI 10.1097/01.ju.0000163259.33846.74; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Ley HL, 2013, CLIN DERMATOL, V31, P31, DOI 10.1016/j.clindermatol.2011.11.004; Liao YH, 2014, BRIT J DERMATOL, V170, P890, DOI 10.1111/bjd.12811; Lotti T, 2008, DERMATOL THER, V21, P42, DOI 10.1111/j.1529-8019.2008.00168.x; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; Meller SM, 2013, J INVASIVE CARDIOL, V25, P313; Mercan S, 2008, J SEX MARITAL THER, V34, P160, DOI 10.1080/00926230701267951; Mittawae B, 2006, UROLOGY, V67, P575, DOI 10.1016/j.urology.2005.09.040; Navaneethan SD, 2010, AM J KIDNEY DIS, V56, P670, DOI 10.1053/j.ajkd.2010.06.016; Niemeier V, 1997, HAUTARZT, V48, P629, DOI 10.1007/s001050050635; Polonsky TS, 2009, ATHEROSCLEROSIS, V207, P440, DOI 10.1016/j.atherosclerosis.2009.05.005; Quek KF, 2008, J SEX MED, V5, P70, DOI 10.1111/j.1743-6109.2006.00423.x; Ryu JK, 2009, J SEX MED, V6, P1893, DOI 10.1111/j.1743-6109.2009.01275.x; Seftel AD, 2004, J UROLOGY, V171, P2341, DOI 10.1097/01.ju.0000125198.32936.38; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; van Dorssen I E, 1992, Ned Tijdschr Geneeskd, V136, P2175	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128869	10.1371/journal.pone.0128869	http://dx.doi.org/10.1371/journal.pone.0128869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076496	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900035
J	Lin, WL; Guu, SY; Tsai, CC; Prakash, E; Viswaraman, M; Chen, HB; Chang, CF				Lin, Wei-Ling; Guu, Shih-Yun; Tsai, Chan-Chuan; Prakash, Ekambaranellore; Viswaraman, Mohan; Chen, Hsing-Bao; Chang, Chuan-Fa			Derivation of Cinnamon Blocks Leukocyte Attachment by Interacting with Sialosides	PLOS ONE			English	Article							P-SELECTIN; WATER EXTRACT; SIALIC-ACID; IN-VIVO; INFLUENZA-VIRUSES; BLOOD-GLUCOSE; INFLAMMATION; INHIBITOR; RECEPTOR; BINDING	Molecules derived from cinnamon have demonstrated diverse pharmacological activities against infectious pathogens, diabetes and inflammatory diseases. This study aims to evaluate the effect of the cinnamon-derived molecule IND02 on the adhesion of leukocytes to host cells. The anti-inflammatory ability of IND02, a pentameric procyanidin type A polyphenol polymer isolated from cinnamon alcohol extract, was examined. Pretreatment with IND02 significantly reduced the attachment of THP-1 cells or neutrophils to TNF-alpha-activated HUVECs or E-selectin/ICAM-1, respectively. IND02 also reduced the binding of E-, L- and P-selectins with sialosides. Furthermore, IND02 could agglutinate human red blood cells (RBC), and the agglutination could be disrupted by sialylated glycoprotein. Our findings demonstrate that IND02, a cinnamon-derived compound, can interact with sialosides and block the binding of selectins and leukocytes with sialic acids.	[Guu, Shih-Yun; Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Lin, Wei-Ling] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Coll Med, Tainan 70101, Taiwan; [Tsai, Chan-Chuan] Pingtung Christian Hosp, Dept Pathol, Pingtung 900, Taiwan; [Prakash, Ekambaranellore; Viswaraman, Mohan] Ind Biotech Private Ltd, Pune 411048, Maharashtra, India; [Chen, Hsing-Bao] E DA Hosp, Dept Surg, Div Colorectal Surg, Kaohsiung 82445, Taiwan; [Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; E-Da Hospital; National Cheng Kung University; National Cheng Kung University	Chang, CF (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan.	affa@mail.ncku.edu.tw	Lin, Wei-Ling/GQP-6706-2022; Chang, Chuan-Fa/F-8660-2011; Lin, Wei-Ling/AAH-2429-2019	Chang, Chuan-Fa/0000-0003-2404-1248; Ekambaranellore, Prakash/0000-0003-3128-9524	Center of Infectious Disease and Signaling Research of NCKU; Ministry of Science and Technology of Taiwan [NSC 102-2321-B-006-006]; Indus Biotech Private Limited	Center of Infectious Disease and Signaling Research of NCKU; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Indus Biotech Private Limited	This work was supported by the Center of Infectious Disease and Signaling Research of NCKU and the Ministry of Science and Technology of Taiwan (NSC 102-2321-B-006-006, http://www.most.gov.tw/). Indus Biotech Private Limited provided support in the form of salaries for authors Ekambaranellore Prakash and Mohan Viswaraman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	AYMARD M, 1982, J BIOL STAND, V10, P125, DOI 10.1016/S0092-1157(82)80035-8; Beauharnois ME, 2005, BIOCHEMISTRY-US, V44, P9507, DOI 10.1021/bi0507130; Bedard PW, 2010, EXPERT OPIN THER PAT, V20, P781, DOI 10.1517/13543771003767468; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Cao HP, 2010, PHYTOMEDICINE, V17, P1027, DOI 10.1016/j.phymed.2010.03.023; Carvalho ACS, 2014, PANCREAS, V43, P82, DOI 10.1097/MPA.0b013e3182a63b9d; Chang CF, 2011, GLYCOBIOLOGY, V21, P895, DOI 10.1093/glycob/cwr021; Chu A, 1999, J IMMUNOL, V163, P5086; CUMMING DA, 1989, BIOCHEMISTRY-US, V28, P6500, DOI 10.1021/bi00441a051; Endemann G, 1997, J IMMUNOL, V158, P4879; Etzioni A, 1993, Immunodeficiency, V4, P307; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Geng JG, 2004, CURR MED CHEM, V11, P2153, DOI 10.2174/0929867043364720; Hagenlocher Y, 2013, ALLERGY, V68, P490, DOI 10.1111/all.12122; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hong JW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-237; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; Japp AG, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.006007; Jiao LH, 2013, FOOD CHEM TOXICOL, V56, P398, DOI 10.1016/j.fct.2013.02.049; Kandhare AD, 2013, BIOMED AGING PATHOL, V3, P23; Kim SH, 2006, J ETHNOPHARMACOL, V104, P119, DOI 10.1016/j.jep.2005.08.059; Kleinhans H, 2009, HISTOL HISTOPATHOL, V24, P551, DOI 10.14670/HH-24.551; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Kurosawa S, 2000, J IMMUNOL, V165, P4697, DOI 10.4049/jimmunol.165.8.4697; Kwon HK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-392; Kwon HK, 2009, CANCER LETT, V278, P174, DOI 10.1016/j.canlet.2009.01.015; Lee BJ, 2011, IMMUNOPHARM IMMUNOT, V33, P714, DOI 10.3109/08923973.2011.564185; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Lu JM, 2010, CARCINOGENESIS, V31, P481, DOI 10.1093/carcin/bgp292; Lu T, 2012, NUTR RES, V32, P408, DOI 10.1016/j.nutres.2012.05.003; MARTENS CL, 1995, J BIOL CHEM, V270, P21129, DOI 10.1074/jbc.270.36.21129; Mau JL, 2001, J AGR FOOD CHEM, V49, P183, DOI 10.1021/jf000263c; Morokutti A, 2013, J CLIN VIROL, V56, P323, DOI 10.1016/j.jcv.2012.12.002; Myers DD, 2006, J VASC SURG, V44, P625, DOI 10.1016/j.jvs.2006.05.021; Papp I, 2008, CHEM COMMUN, P5851, DOI 10.1039/b813414f; Park IY, 1998, TRANSPLANT P, V30, P2927, DOI 10.1016/S0041-1345(98)00872-0; Pavlovic D, 2002, J IMMUNOL METHODS, V264, P53, DOI 10.1016/S0022-1759(02)00079-0; Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6; Rathi Badal, 2013, Sci Pharm, V81, P567, DOI 10.3797/scipharm.1301-16; Rosenkranz AR, 1999, J CLIN INVEST, V103, P649, DOI 10.1172/JCI5183; Sartorius T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092358; Schon Michael P, 2005, Ther Clin Risk Manag, V1, P201; Shamay Y, 2009, J MED CHEM, V52, P5906, DOI 10.1021/jm900308r; Shan B, 2007, J AGR FOOD CHEM, V55, P5484, DOI 10.1021/jf070424d; Shen Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095786, 10.1371/journal.pone.0087894]; Shihabudeen HMS, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-46; Sperandio M, 2006, FEBS J, V273, P4377, DOI 10.1111/j.1742-4658.2006.05437.x; Stevenson JL, 2007, THROMB RES, V120, pS107, DOI 10.1016/S0049-3848(07)70138-X; Vetal S, 2013, FOOD SCI HUM WELL, V2, P59, DOI [10.1016/j.fshw.2013.03.003, DOI 10.1016/J.FSHW.2013.03.003]; Watz H, 2013, PULM PHARMACOL THER, V26, P265, DOI 10.1016/j.pupt.2012.12.003; Woodhall T, 2005, ORG BIOMOL CHEM, V3, P1795, DOI 10.1039/b501503k; Wynn TA, 2004, HEPATOLOGY, V39, P676, DOI 10.1002/hep.20102	53	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130389	10.1371/journal.pone.0130389	http://dx.doi.org/10.1371/journal.pone.0130389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076445	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900169
J	Noubissi, FK; Harkness, T; Alexander, CM; Ogle, BM				Noubissi, Felicite K.; Harkness, Ty; Alexander, Caroline M.; Ogle, Brenda M.			Apoptosis-induced cancer cell fusion: a mechanism of breast cancer metastasis	FASEB JOURNAL			English	Article						hybrid; hypoxia; migration; mesenchymal stem cell; bimolecular fluorescence complementation	MESENCHYMAL STEM-CELLS; MARROW-DERIVED CELLS; ENDOTHELIAL-CELLS; MACROPHAGE FUSION; CARCINOMA CELLS; TUMOR; BONE; HYBRIDS; HYPOXIA; MEMBRANE	Although cancer cell fusion has been suggested as a mechanism of cancer metastasis, the underlying mechanisms defining this process are poorly understood. In a recent study, apoptotic cells were newly identified as a type of cue that induces signaling via phosphatidylserine receptors to promote fusion of myoblasts. The microenvironment of breast tumors is often hypoxic, and because apoptosis is greatly increased in hypoxic conditions, we decided to investigate whether the mechanism of breast cancer cell fusion with mesenchymal stem/multipotent stromal cells (MSCs) involves apoptosis. We used a powerful tool for identification and tracking of hybrids based on bimolecular fluorescence complementation (BiFC) and found that breast cancer cells fused spontaneously with MSCs. This fusion was significantly enhanced with hypoxia and signaling associated with apoptotic cells, especially between nonmetastatic breast cancer cells and MSCs. In addition, the hybrids showed a significantly higher migratory capacity than did the parent cells. Taken together, these findings describe a mechanism by which hypoxia-induced apoptosis stimulates fusion between MSCs and breast tumor cells resulting in hybrids with an enhanced migratory capacity that may enable their dissemination to distant sites or metastases. In the long run, this study may provide new strategies for developing novel drugs for preventing cancer metastasis.	[Noubissi, Felicite K.; Ogle, Brenda M.] Univ Minnesota Twin Cities, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota Twin Cities, Stem Cell Inst, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota Twin Cities, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Noubissi, Felicite K.; Ogle, Brenda M.] Univ Minnesota Twin Cities, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Harkness, Ty; Alexander, Caroline M.; Ogle, Brenda M.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Alexander, Caroline M.] Univ Wisconsin, Dept Oncol, Madison, WI USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ogle, BM (corresponding author), Univ Minnesota Twin Cities, 312 Church St SE, Minneapolis, MN 55455 USA.	ogle@umn.edu			U.S. Department of Defense, Idea Award [11-1-0205]	U.S. Department of Defense, Idea Award(United States Department of Defense)	The authors thank Dr. Peiman Hematti (Division of Hematology and Oncology, University of Wisconsin, Madison, WI, USA) for the gift of MSCs, Dr. Thomas Kerppola (Professor of Biological Chemistry, University of Michigan, Ann Arbor, MI, USA) for the gift of BiFC constructs, Louis Prahl (University of Minnesota, Minneapolis, MN, USA) for help with the time-lapse microscopy, Dr. Philip Jung (University of Minnesota, Minneapolis, MN, USA) for help with ANOVA with Tukey's HSD post hoc test, and Brian Freeman (University of Minnesota, Minneapolis, MN, USA) for help with the coculture analyses. This work was supported by U.S. Department of Defense, Idea Award 11-1-0205. F.N.K. participated in the study design, performed all the experiments, analyzed the data, and participated in writing the manuscript. T.H. developed molecular tools and protocols for coculture studies and helped to edit the manuscript. C.A. participated in study design, offered helpful consultation in the course of the studies, and helped to edit the manuscript. B.O. participated in study design, offered helpful consultation in the course of the studies and participated in writing the manuscript. All authors read and approved the final manuscript. The authors declare no conflicts of interest.	Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Aichel O., 1911, VORTRAGE AUFSATZE EN, P92; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Berndt B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063711; Berndt Benjamin, 2013, Critical Reviews in Oncogenesis, V18, P97; Chakraborty A, 2004, BONE MARROW TRANSPL, V34, P183, DOI 10.1038/sj.bmt.1704547; Chakraborty AK, 2001, CELL GROWTH DIFFER, V12, P623; Chakraborty AK, 2000, CANCER RES, V60, P2512; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; DEFENDI V, 1967, P NATL ACAD SCI USA, V57, P299, DOI 10.1073/pnas.57.2.299; Dittmar T, 2011, CLIN EXP METASTAS, V28, P75, DOI 10.1007/s10585-010-9359-3; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; ERIKSON J, 1981, NATURE, V294, P173, DOI 10.1038/294173a0; Fan H, 2014, NEOPLASMA, V61, P540, DOI [10.4149/neo_2014066, 10.4149/neo_2014_066]; GOLDENBERG DM, 1968, KLIN WOCHENSCHR, V46, P898, DOI 10.1007/BF01746251; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hafez IM, 2000, BIOPHYS J, V79, P1438, DOI 10.1016/S0006-3495(00)76395-8; HARRIS H, 1988, CANCER RES, V48, P3302; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Jegou A, 2011, P NATL ACAD SCI USA, V108, P10946, DOI 10.1073/pnas.1017400108; Jezkova J, 2002, MOL CELL BIOCHEM, V232, P49; Kaji K, 2002, DEV BIOL, V247, P327, DOI 10.1006/dbio.2002.0694; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kemp K, 2014, ACTA NEUROPATHOL, V128, P629, DOI 10.1007/s00401-014-1303-1; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Lazova R, 2011, ADV EXP MED BIOL, V714, P151, DOI 10.1007/978-94-007-0782-5_8; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; McDonald DM, 2000, CANCER METAST REV, V19, P109, DOI 10.1023/A:1026529222845; Mekler L B, 1971, Vestn Akad Med Nauk SSSR, V26, P80; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Mortensen K, 2004, CELL MOL LIFE SCI, V61, P2125, DOI 10.1007/s00018-004-4200-2; Ozel C, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-10; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Paltsyn AA, 2014, EXP BIOL MED, V239, P595, DOI 10.1177/1535370214523898; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Ramakrishnan M, 2013, CANCER RES, V73, P5360, DOI 10.1158/0008-5472.CAN-13-0896; Rappa G, 2012, AM J PATHOL, V180, P2504, DOI 10.1016/j.ajpath.2012.02.020; Roy SM, 2011, J LIPIDS, V2011, DOI 10.1155/2011/528784; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; STANBRIDGE EJ, 1976, NATURE, V260, P17, DOI 10.1038/260017a0; Trivedi P, 2007, EXP HEMATOL, V35, P146, DOI 10.1016/j.exphem.2006.09.003; VANBLITTERSWIJK WJ, 1987, LIPIDS, V22, P820, DOI 10.1007/BF02535537; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Vignery A, 2005, TRENDS CELL BIOL, V15, P188, DOI 10.1016/j.tcb.2005.02.008; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; Xu MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087893; Yang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-388; Yang Johnny J, 2010, Drug Metab Lett, V4, P201; Yilmaz Y, 2005, BONE MARROW TRANSPL, V35, P1021, DOI 10.1038/sj.bmt.1704939; Zhao M, 2012, CANCER BIOL THER, V13, P782, DOI 10.4161/cbt.20561	59	59	61	4	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4036	4045		10.1096/fj.15-271098	http://dx.doi.org/10.1096/fj.15-271098			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26085132	Bronze			2022-12-26	WOS:000359915600037
J	Neal, SE; Dabir, DV; Tienson, HL; Horn, DM; Glaeser, K; Loo, RRO; Barrientos, A; Koehler, CM				Neal, Sonya E.; Dabir, Deepa V.; Tienson, Heather L.; Horn, Darryl M.; Glaeser, Kathrin; Loo, Rachel R. Ogozalek; Barrientos, Antoni; Koehler, Carla M.			Mia40 Protein Serves as an Electron Sink in the Mia40-Erv1 Import Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL INTERMEMBRANE SPACE; DISULFIDE RELAY SYSTEM; SMALL-MOLECULE INHIBITOR; C-OXIDASE BIOGENESIS; CYTOCHROME-C; SULFHYDRYL OXIDASE; RESPIRATORY-CHAIN; MEMBRANE-PROTEINS; SUBSTRATE; ERV1	A redox-regulated import pathway consisting of Mia40 and Erv1 mediates the import of cysteine-rich proteins into the mitochondrial intermembrane space. Mia40 is the oxidoreductase that inserts two disulfide bonds into the substrate simultaneously. However, Mia40 has one redox-active cysteine pair, resulting in ambiguity about how Mia40 accepts numerous electrons during substrate oxidation. In this study, we have addressed the oxidation of Tim13 in vitro and in organello. Reductants such as glutathione and ascorbate inhibited both the oxidation of the substrate Tim13 in vitro and the import of Tim13 and Cmc1 into isolated mitochondria. In addition, a ternary complex consisting of Erv1, Mia40, and substrate, linked by disulfide bonds, was not detected in vitro. Instead, Mia40 accepted six electrons from substrates, and this fully reduced Mia40 was sensitive to protease, indicative of conformational changes in the structure. Mia40 in mitochondria from the erv1-101 mutant was also trapped in a completely reduced state, demonstrating that Mia40 can accept up to six electrons as substrates are imported. Therefore, these studies support that Mia40 functions as an electron sink to facilitate the insertion of two disulfide bonds into substrates.	[Neal, Sonya E.; Tienson, Heather L.; Glaeser, Kathrin; Loo, Rachel R. Ogozalek; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Neal, Sonya E.; Tienson, Heather L.; Glaeser, Kathrin; Loo, Rachel R. Ogozalek; Koehler, Carla M.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Dabir, Deepa V.] Loyola Marymount Univ, Dept Biol, Los Angeles, CA 90045 USA; [Horn, Darryl M.; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol & Biochem & Mol Biol, Miami, FL 33136 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Loyola Marymount University; University of Miami	Koehler, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Box 951569, Los Angeles, CA 90095 USA.	koehler@chem.ucla.edu	Regan, Clinton/E-6250-2012		National Institutes of Health Ruth L. Kirschstein National Research Service Awards [GM871082, GM007185]; National Institutes of Health [R01 GM061721, R01 GM071775]; UCLA Cota-Robles Fellowship; American Heart Association [0640076N]; Muscular Dystrophy Association [022398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM105781, R01GM071775, R01GM061721] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Cota-Robles Fellowship; American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Awards GM871082 (to S. E. N.) and GM007185 (to H. L. T.) and National Institutes of Health Grants R01 GM061721 and R01 GM071775 (to A. B.). This work was also supported by the UCLA Cota-Robles Fellowship, American Heart Association Grant 0640076N (to C. M. K.), and Muscular Dystrophy Association Grant 022398. The authors declare that they have no conflicts of interest with the contents of this article.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Banci L, 2011, CHEM BIOL, V18, P794, DOI 10.1016/j.chembiol.2011.03.015; Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Beverly KN, 2008, J MOL BIOL, V382, P1144, DOI 10.1016/j.jmb.2008.07.069; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Bottinger L, 2012, MOL BIOL CELL, V23, P3957, DOI 10.1091/mbc.E12-05-0358; Bourens M, 2012, J BIOL CHEM, V287, P31258, DOI 10.1074/jbc.M112.383562; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Dabir DV, 2013, DEV CELL, V25, P81, DOI 10.1016/j.devcel.2013.03.006; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gross DP, 2011, MOL BIOL CELL, V22, P3758, DOI 10.1091/mbc.E11-04-0296; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Hasson SA, 2010, P NATL ACAD SCI USA, V107, P9578, DOI 10.1073/pnas.0914387107; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Kawano S, 2009, P NATL ACAD SCI USA, V106, P14403, DOI 10.1073/pnas.0901793106; Koehler CM, 2009, BBA-MOL CELL RES, V1793, P139, DOI 10.1016/j.bbamcr.2008.08.002; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; Lionaki E, 2010, ANTIOXID REDOX SIGN, V13, P1327, DOI 10.1089/ars.2010.3200; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Spiller MP, 2013, BIOCHEM J, V455, P27, DOI 10.1042/BJ20130442; Stojanovski D, 2008, J CELL BIOL, V183, P195, DOI 10.1083/jcb.200804095; Stojanovski D, 2012, BBA-MOL CELL RES, V1823, P1142, DOI 10.1016/j.bbamcr.2012.04.014; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Terziyska N, 2009, J BIOL CHEM, V284, P1353, DOI 10.1074/jbc.M805035200; Tienson HL, 2009, MOL BIOL CELL, V20, P3481, DOI 10.1091/mbc.E08-10-1062	39	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20804	20814		10.1074/jbc.M115.669440	http://dx.doi.org/10.1074/jbc.M115.669440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26085103	Green Published, hybrid			2022-12-26	WOS:000360011800018
J	Martinez-Rodriguez, L; Erdogan, O; Jimenez-Rodriguez, M; Gonzalez-Rivera, K; Williams, T; Li, L; Weinreb, V; Collier, M; Chandrasekaran, SN; Ambroggio, X; Kuhlman, B; Carter, CW				Martinez-Rodriguez, Luis; Erdogan, Ozguen; Jimenez-Rodriguez, Mariel; Gonzalez-Rivera, Katiria; Williams, Tishan; Li, Li; Weinreb, Violetta; Collier, Martha; Chandrasekaran, Srinivas Niranj; Ambroggio, Xavier; Kuhlman, Brian; Carter, Charles W., Jr.			Functional Class I and II Amino Acid-activating Enzymes Can Be Coded by Opposite Strands of the Same Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; RODIN-OHNO HYPOTHESIS; ATP-BINDING PEPTIDE; CIRCULAR-DICHROISM; SUBSTRATE-BINDING; ADENYLATE KINASE; DOMAIN MOTION; ATOMIC-LEVEL; EVOLUTION; SEQUENCE	Aminoacyl-tRNA synthetases (aaRS) catalyze both chemical steps that translate the universal genetic code. Rodin and Ohno offered an explanation for the existence of two aaRS classes, observing that codons for the most highly conserved Class I active-site residues are anticodons for corresponding Class II active-site residues. They proposed that the two classes arose simultaneously, by translation of opposite strands from the same gene. We have characterized wild-type 46-residue peptides containing ATP-binding sites of Class I and II synthetases and those coded by a gene designed by Rosetta to encode the corresponding peptides on opposite strands. Catalysis by WT and designed peptides is saturable, and the designed peptides are sensitive to active-site residue mutation. All have comparable apparent second-order rate constants 2.9-7.0E-3 M-1 s(-1) or similar to 750,000-1,300,000 times the uncatalyzed rate. The activities of the two complementary peptides demonstrate that the unique information in a gene can have two functional interpretations, one from each complementary strand. The peptides contain phylogenetic signatures of longer, more sophisticated catalysts we call Urzymes and are short enough to bridge the gap between them and simpler uncoded peptides. Thus, they directly substantiate the sense/antisense coding ancestry of Class I and II aaRS. Furthermore, designed 46-mers achieve similar catalytic proficiency to wild-type 46-mers by significant increases in both k(cat) and K-m values, supporting suggestions that the earliest peptide catalysts activated ATP for biosynthetic purposes.	[Martinez-Rodriguez, Luis; Erdogan, Ozguen; Jimenez-Rodriguez, Mariel; Gonzalez-Rivera, Katiria; Williams, Tishan; Li, Li; Weinreb, Violetta; Collier, Martha; Chandrasekaran, Srinivas Niranj; Ambroggio, Xavier; Kuhlman, Brian; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Carter, CW (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	carter@med.unc.edu	Chandrasekaran, Srinivas Niranj/J-8262-2019	Chandrasekaran, Srinivas Niranj/0000-0001-8874-9988; Gonzalez Rivera, Alba Katiria/0000-0001-7029-0240; Le Roux, Ozgun/0000-0002-9885-6872	American Biophysical Society Summer Course; University of North Carolina at Chapel Hill Post-baccalaureate Research Education and Summer Undergraduate Research Experience programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM089569, R01GM078227, R01GM073960] Funding Source: NIH RePORTER	American Biophysical Society Summer Course; University of North Carolina at Chapel Hill Post-baccalaureate Research Education and Summer Undergraduate Research Experience programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hermans for advice on the fluorescence experiments and R. Wolfenden, T. Traut, and C. Lewis for assistance with the manuscript. Completion of this work would not have been possible without the encouragement and support of L. Parise, the American Biophysical Society Summer Course, and the University of North Carolina at Chapel Hill Post-baccalaureate Research Education and Summer Undergraduate Research Experience programs.	Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Arnez JG, 1997, P NATL ACAD SCI USA, V94, P7144, DOI 10.1073/pnas.94.14.7144; Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; BELRHALI H, 1995, STRUCTURE, V3, P341, DOI 10.1016/S0969-2126(01)00166-6; Belrhali H, 1996, THESIS EUROPEAN SYNC; Box GE., 1978, STAT EXPT; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; Carter Charles W. Jr., 2015, Life-Basel, V5, P294, DOI 10.3390/life5010294; Carter CW, 2014, J BIOL CHEM, V289, P30213, DOI 10.1074/jbc.R114.567495; Carter CW, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-11; Carter CW, 2002, MOL CELL, V10, P705, DOI 10.1016/S1097-2765(02)00688-3; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; CHAN KW, 1994, BBA-PROTEIN STRUCT M, V1205, P223, DOI 10.1016/0167-4838(94)90237-2; Chandrasekaran SN, 2013, MOL BIOL EVOL, V30, P1588, DOI 10.1093/molbev/mst070; CHUANG WJ, 1992, BIOCHEMISTRY-US, V31, P7915, DOI 10.1021/bi00149a024; CHUANG WJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P110, DOI 10.1006/abbi.1995.1272; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fersht A. R., 1999, STRUCTURE MECH PROTE, P89; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P8031, DOI 10.1021/bi00399a001; FRY DC, 1985, BIOCHEMISTRY-US, V24, P4680, DOI 10.1021/bi00338a030; FRY DC, 1988, BIOCHEMISTRY-US, V27, P3588, DOI 10.1021/bi00410a009; HARDIN RH, 1993, J STAT PLAN INFER, V37, P339, DOI 10.1016/0378-3758(93)90112-J; HARTLEIN M, 1995, J MOL EVOL, V40, P519; Hu H, 2014, SCI CHINA CHEM, V57, P156, DOI 10.1007/s11426-013-5021-7; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; KIRBY AJ, 1970, J CHEM SOC B, P1165, DOI 10.1039/j29700001165; Kuhlman B, 2004, CURR OPIN STRUC BIOL, V14, P89, DOI 10.1016/j.sbi.2004.01.002; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leaver-Fay A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020937; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Li L, 2013, J BIOL CHEM, V288, P34736, DOI 10.1074/jbc.M113.510958; Li L, 2013, J BIOL CHEM, V288, P26856, DOI 10.1074/jbc.M113.496125; Li L, 2011, J BIOL CHEM, V286, P10387, DOI 10.1074/jbc.M110.198929; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; MULLEN GP, 1993, ARCH BIOCHEM BIOPHYS, V301, P174, DOI 10.1006/abbi.1993.1130; Pervushin K, 2007, NAT STRUCT MOL BIOL, V14, P1202, DOI 10.1038/nsmb1325; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Rodin AS, 2009, J MOL EVOL, V69, P555, DOI 10.1007/s00239-009-9288-4; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; SAS Institute, 2007, JMP STAT GRAPH GUID; Schroeder GK, 2007, BIOCHEMISTRY-US, V46, P4037, DOI 10.1021/bi602600p; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Weinreb V, 2014, J BIOL CHEM, V289, P4367, DOI 10.1074/jbc.M113.538660; Weinreb V, 2012, STRUCTURE, V20, P128, DOI 10.1016/j.str.2011.10.020; Wolfenden R, 2011, ANNU REV BIOCHEM, V80, P645, DOI 10.1146/annurev-biochem-060409-093051	58	35	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19710	19725		10.1074/jbc.M115.642876	http://dx.doi.org/10.1074/jbc.M115.642876			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088142	Green Published, hybrid			2022-12-26	WOS:000359364600030
J	Aleem, SU; Craddock, BP; Miller, WT				Aleem, Saadat U.; Craddock, Barbara P.; Miller, W. Todd			Constitutive Activity in an Ancestral Form of Abl Tyrosine Kinase	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; SUBSTRATE RECOGNITION; MONOSIGA-BREVICOLLIS; NEGATIVE REGULATION; SRC KINASE; EVOLUTION; DOMAIN; SH2; PHOSPHORYLATION	The c-abl proto-oncogene encodes a nonreceptor tyrosine kinase that is found in all metazoans, and is ubiquitously expressed in mammalian tissues. The Abl tyrosine kinase plays important roles in the regulation of mammalian cell physiology. Abl-like kinases have been identified in the genomes of unicellular choanoflagellates, the closest relatives to the Metazoa, and in related unicellular organisms. Here, we have carried out the first characterization of a premetazoan Abl kinase, MbAbl2, from the choanoflagellate Monosiga brevicollis. The enzyme possesses SH3, SH2, and kinase domains in a similar arrangement to its mammalian counterparts, and is an active tyrosine kinase. MbAbl2 lacks the N-terminal myristoylation and cap sequences that are critical regulators of mammalian Abl kinase activity, and we show that MbAbl2 is constitutively active. When expressed in mammalian cells, MbAbl2 strongly phosphorylates cellular proteins on tyrosine, and transforms cells much more potently than mammalian Abl kinase. Thus, MbAbl2 appears to lack the autoinhibitory mechanism that tightly constrains the activity of mammalian Abl kinases, suggesting that this regulatory apparatus arose more recently in metazoan evolution.	[Aleem, Saadat U.; Craddock, Barbara P.; Miller, W. Todd] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Miller, WT (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	todd.miller@stonybrook.edu			National Institutes of Health/National Cancer Institute [R01 CA58530]; NATIONAL CANCER INSTITUTE [R01CA058530] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01 CA58530 from the National Institutes of Health/National Cancer Institute to WTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey FP, 2014, METHOD ENZYMOL, V548, P117, DOI 10.1016/B978-0-12-397918-6.00005-7; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Cao XQ, 2008, J BIOL CHEM, V283, P31401, DOI 10.1074/jbc.M804002200; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; Georghiou G, 2012, NAT CHEM BIOL, V8, P366, DOI [10.1038/nchembio.792, 10.1038/NCHEMBIO.792]; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; King N, 2001, P NATL ACAD SCI USA, V98, P15032, DOI 10.1073/pnas.261477698; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Li WQ, 2008, J BIOL CHEM, V283, P15491, DOI 10.1074/jbc.M800002200; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Mayer BJ, 1998, CURR TOP MICROBIOL, V228, P1; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; Miller WT, 2012, BBA-MOL CELL RES, V1823, P1053, DOI 10.1016/j.bbamcr.2012.03.009; Miller WT, 2003, ACCOUNTS CHEM RES, V36, P393, DOI 10.1021/ar020116v; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005; Pellicena P, 1998, J BIOL CHEM, V273, P15325, DOI 10.1074/jbc.273.25.15325; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Reddy E Premkumar, 2012, Genes Cancer, V3, P447, DOI 10.1177/1947601912462126; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schultheiss KP, 2014, BIOCHEMISTRY-US, V53, P1320, DOI 10.1021/bi4016499; Schultheiss KP, 2012, BIOCHEMISTRY-US, V51, P8267, DOI 10.1021/bi300965h; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Segawa Y, 2006, P NATL ACAD SCI USA, V103, P12021, DOI 10.1073/pnas.0600021103; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Suga H, 2014, MOL BIOL EVOL, V31, P517, DOI 10.1093/molbev/mst241; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Suga H, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002733; Watari A, 2010, ONCOGENE, V29, P3815, DOI 10.1038/onc.2010.148; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Yadav SS, 2008, BIOCHEMISTRY-US, V47, P10871, DOI 10.1021/bi800930e; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0131062	10.1371/journal.pone.0131062	http://dx.doi.org/10.1371/journal.pone.0131062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090675	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835000166
J	Johansson, U; Ria, M; Avall, K; Shalaly, ND; Zaitsev, SV; Berggren, PO; Hedhammar, M				Johansson, Ulrika; Ria, Massimiliano; Avall, Karin; Shalaly, Nancy Dekki; Zaitsev, Sergei V.; Berggren, Per-Olof; Hedhammar, My			Pancreatic Islet Survival and Engraftment Is Promoted by Culture on Functionalized Spider Silk Matrices	PLOS ONE			English	Article							BETA-CELL FUNCTION; POSITRON-EMISSION-TOMOGRAPHY; CYTOPLASMIC FREE CA2+; EXTRACELLULAR-MATRIX; IN-VITRO; BASEMENT-MEMBRANE; INSULIN-SECRETION; RAT; TRANSPLANTATION; INTEGRIN	Transplantation of pancreatic islets is one approach for treatment of diabetes, however, hampered by the low availability of viable islets. Islet isolation leads to disruption of the environment surrounding the endocrine cells, which contributes to eventual cell death. The reestablishment of this environment is vital, why we herein investigated the possibility of using recombinant spider silk to support islets in vitro after isolation. The spider silk protein 4RepCT was formulated into three different formats; 2D-film, fiber mesh and 3D-foam, in order to provide a matrix that can give the islets physical support in vitro. Moreover, cell-binding motifs from laminin were incorporated into the silk protein in order to create matrices that mimic the natural cell environment. Pancreatic mouse islets were thoroughly analyzed for adherence, necrosis and function after in vitro maintenance on the silk matrices. To investigate their suitability for transplantation, we utilized an eye model which allows in vivo imaging of engraftment. Interestingly, islets that had been maintained on silk foam during in vitro culture showed improved revascularization. This coincided with the observation of preserved islet architecture with endothelial cells present after in vitro culture on silk foam. Selected matrices were further evaluated for long-term preservation of human islets. Matrices with the cell-binding motif RGD improved human islet maintenance (from 36% to 79%) with preserved islets architecture and function for over 3 months in vitro. The islets established cell-matrix contacts and formed vessel-like structures along the silk. Moreover, RGD matrices promoted formation of new, insulin-positive islet-like clusters that were connected to the original islets via endothelial cells. On silk matrices with islets from younger donors (<35 year), the amount of newly formed islet-like clusters found after 1 month in culture were almost double compared to the initial number of islets added.	[Johansson, Ulrika; Hedhammar, My] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, S-75007 Uppsala, Sweden; [Johansson, Ulrika; Ria, Massimiliano; Avall, Karin; Zaitsev, Sergei V.; Berggren, Per-Olof] Karolinska Univ Hosp, Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, S-17176 Stockholm, Sweden; [Shalaly, Nancy Dekki; Hedhammar, My] KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, S-10691 Stockholm, Sweden	Swedish University of Agricultural Sciences; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Zaitsev, SV (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, S-17176 Stockholm, Sweden.	Sergei.Zaitsev@ki.se; My.Hedhammar@slu.se		Berggren, Per-Olof/0000-0001-8991-413X	Skandia Insurance Company Ltd.; JDRF award [31-2008-416]	Skandia Insurance Company Ltd.; JDRF award	This work was funded by The Skandia Insurance Company Ltd. MH has shares in Spiber Technologies AB. POB is a founder and board member of Biocrine AB. POB and MH are members of the board of Betamatrix. The authors also thank the Nordic Network for Clinical Islet Transplantation from where the human islets were provided through the JDRF award 31-2008-416 (ECIT Islet for Basic Research program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Agudelo CA, 2008, BIOMATERIALS, V29, P1167, DOI 10.1016/j.biomaterials.2007.11.027; Banerjee M, 2012, MOL CELL ENDOCRINOL, V355, P78, DOI 10.1016/j.mce.2012.01.020; Beattie GM, 2002, DIABETES, V51, P3435, DOI 10.2337/diabetes.51.12.3435; BERGSTEN P, 1995, AM J PHYSIOL-ENDOC M, V268, pE282, DOI 10.1152/ajpendo.1995.268.2.E282; Bloch K, 2011, BIOMATERIALS, V32, P1816, DOI 10.1016/j.biomaterials.2010.11.018; Bohman S, 2007, CELL TRANSPLANT, V16, P15, DOI 10.3727/000000007783464452; Bosco D, 2001, DIABETES, V50, P1039, DOI 10.2337/diabetes.50.5.1039; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cirulli V, 2000, J CELL BIOL, V150, P1445, DOI 10.1083/jcb.150.6.1445; Cornolti R, 2009, CELL TRANSPLANT, V18, P195, DOI 10.3727/096368909788341252; Daoud J, 2010, CELL TRANSPLANT, V19, P1523, DOI 10.3727/096368910X515872; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Daoud JT, 2011, BIOMATERIALS, V32, P1536, DOI 10.1016/j.biomaterials.2010.10.036; Davis NE, 2012, BIOMATERIALS, V33, P6691, DOI 10.1016/j.biomaterials.2012.06.015; Eich T, 2007, TRANSPLANTATION, V84, P893, DOI 10.1097/01.tp.0000284730.86567.9f; Eich T, 2007, NEW ENGL J MED, V356, P2754, DOI 10.1056/NEJMc070201; Fredriksson C, 2009, MATERIALS, V2, P1908, DOI 10.3390/ma2041908; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y; Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039; Johansson U, 2005, AM J TRANSPLANT, V5, P2632, DOI 10.1111/j.1600-6143.2005.01076.x; Kaido T, 2004, J BIOL CHEM, V279, P17731, DOI 10.1074/jbc.M308425200; Kaido T, 2006, DIABETES, V55, P2723, DOI 10.2337/db06-0120; Kantengwa S, 1997, EXP CELL RES, V237, P394, DOI 10.1006/excr.1997.3803; Kilkenny DM, 2008, MOL ENDOCRINOL, V22, P196, DOI 10.1210/me.2007-0241; KINDMARK H, 1992, FEBS LETT, V303, P85, DOI 10.1016/0014-5793(92)80483-W; Koivunen E, 1999, METH MOL B, V129, P3; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; Luan NM, 2010, BIOMATERIALS, V31, P8847, DOI 10.1016/j.biomaterials.2010.08.004; LUCASCLERC C, 1993, MOL CELL ENDOCRINOL, V94, P9, DOI 10.1016/0303-7207(93)90046-M; METRAKOS P, 1993, SURGERY, V114, P423; Nagata N, 2002, J BIOMAT SCI-POLYM E, V13, P579, DOI 10.1163/15685620260178418; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; ORCI L, 1975, LANCET, V2, P1243, DOI 10.1016/S0140-6736(75)92078-4; Otonkoski T, 2008, DIABETES OBES METAB, V10, P119, DOI 10.1111/j.1463-1326.2008.00955.x; Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195; Ris F, 2002, DIABETOLOGIA, V45, P841, DOI 10.1007/s00125-002-0840-7; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sakata Naoaki, 2012, World J Gastrointest Pathophysiol, V3, P19, DOI 10.4291/wjgp.v3.i1.19; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Song HJ, 2009, TRANSPL P, V41, P4302, DOI 10.1016/j.transproceed.2009.09.071; Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118; Stahle M, 2013, TRANSPLANTATION, V96, pE91, DOI [10.1097/01.tp.0000437562.31212.d5, 10.1097/01.TP.0000437562.31212.d5]; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Su J, 2010, BIOMATERIALS, V31, P308, DOI 10.1016/j.biomaterials.2009.09.045; Teramura Y, 2009, BIOMATERIALS, V30, P2270, DOI 10.1016/j.biomaterials.2009.01.036; Vaithilingam V, 2010, AM J TRANSPLANT, V10, P1961, DOI 10.1111/j.1600-6143.2010.03209.x; Vaithilingam Vijayaganapathy, 2011, Rev Diabet Stud, V8, P51, DOI 10.1900/RDS.2011.8.51; van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x; VANDEIJNEN JHM, 1992, CELL TISSUE RES, V267, P139, DOI 10.1007/BF00318700; Virtanen I, 2008, DIABETOLOGIA, V51, P1181, DOI 10.1007/s00125-008-0997-9; Vollrath F, 2002, IN VIVO, V16, P229; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005; Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238; Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061; Zaitsev S, 1997, BIOCHEM BIOPH RES CO, V239, P129, DOI 10.1006/bbrc.1997.7441; ZAITSEV SV, 1995, P NATL ACAD SCI USA, V92, P9712, DOI 10.1073/pnas.92.21.9712; Zhao Y, 2010, TRANSPL P, V42, P4638, DOI 10.1016/j.transproceed.2010.09.154	65	30	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130169	10.1371/journal.pone.0130169	http://dx.doi.org/10.1371/journal.pone.0130169			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090859	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000093
J	Kusters, DHM; Chatrou, ML; Willems, BAG; De Saint-Hubert, M; Bauwens, M; van der Vorst, E; Bena, S; Biessen, EAL; Perretti, M; Schurgers, LJ; Reutelingsperger, CPM				Kusters, Dennis H. M.; Chatrou, Martijn L.; Willems, Brecht A. G.; De Saint-Hubert, Marijke; Bauwens, Matthias; van der Vorst, Emiel; Bena, Stefania; Biessen, Erik A. L.; Perretti, Mauro; Schurgers, Leon J.; Reutelingsperger, Chris P. M.			Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR-/- Mice on Western Type Diet	PLOS ONE			English	Article							SURFACE-EXPRESSED PHOSPHATIDYLSERINE; FORMYL PEPTIDE RECEPTOR; IN-VIVO; NEUTROPHILS; INFLAMMATION; MECHANISMS; CLEAVAGE; A5; PHAGOCYTOSIS; ENDOTHELIUM	Objective To investigate therapeutic effects of annexin A1 (anxA1) on atherogenesis in LDLR-/- mice. Methods Human recombinant annexin A1 (hr-anxA1) was produced by a prokaryotic expression system, purified and analysed on phosphatidylserine (PS) binding and formyl peptide receptor (FPR) activation. Biodistribution of (99m)Technetium-hr-anxA1 was determined in C57Bl/6J mice. 12 Weeks old LDLR-/- mice were fed a Western Type Diet (WTD) during 6 weeks (Group I) or 12 weeks (Group P). Mice received hr-anxA1 (1 mg/kg) or vehicle by intraperitoneal injection 3 times per week for a period of 6 weeks starting at start of WTD (Group I) or 6 weeks after start of WTD (Group P). Total aortic plaque burden and phenotype were analyzed using immunohistochemistry. Results Hr-anxA1 bound PS in Ca2+-dependent manner and activated FPR2/ALX. It inhibited rolling and adherence of neutrophils but not monocytes on activated endothelial cells. Half lives of circulating Tc-99m-hr-anxA1 were < 10 minutes and approximately 6 hours for intravenously (IV) and intraperitoneally (IP) administered hr-anxA1, respectively. Pharmacological treatment with hr-anxA1 had no significant effect on initiation of plaque formation (-33%; P = 0.21)(Group I) but significantly attenuated progression of existing plaques of aortic arch and subclavian artery (plaque size -50%, P = 0.005; necrotic core size -76% P = 0.015, hr-anxA1 vs vehicle) (Group P). Conclusion Hr-anxA1 may offer pharmacological means to treat chronic atherogenesis by reducing FPR-2 dependent neutrophil rolling and adhesion to activated endothelial cells and by reducing total plaque inflammation.	[Kusters, Dennis H. M.; Chatrou, Martijn L.; Willems, Brecht A. G.; Schurgers, Leon J.; Reutelingsperger, Chris P. M.] Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Willems, Brecht A. G.] Maastricht Univ, VitaK BV, NL-6200 MD Maastricht, Netherlands; [De Saint-Hubert, Marijke; Bauwens, Matthias] Maastricht Univ, Med Ctr, Dept Nucl Med, NL-6200 MD Maastricht, Netherlands; [van der Vorst, Emiel; Biessen, Erik A. L.] Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [Bena, Stefania; Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England	Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of London; Queen Mary University London	Reutelingsperger, CPM (corresponding author), Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	c.reutelingsperger@maastrichtuniversity.nl	Schurgers, Leon/AAT-7100-2021	Schurgers, Leon/0000-0001-7867-6957; De Saint-Hubert, Marijke/0000-0003-2374-3280	European Union through the Interreg IV program of Grensregio Vlaanderen-Nederland to Euregional PACT II [VLA-NED 1.20]; Maastricht University	European Union through the Interreg IV program of Grensregio Vlaanderen-Nederland to Euregional PACT II; Maastricht University	Part of this work was financially supported by the European Union through the Interreg IV program of Grensregio Vlaanderen-Nederland to Euregional PACT II (VLA-NED 1.20). The remaining of the funding is provided by Maastricht University directly to Prof. Chris Reutelingsperger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREE HAM, 1992, J BIOL CHEM, V267, P17907; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bena S, 2012, J BIOL CHEM, V287, P24690, DOI 10.1074/jbc.M112.377101; Blume KE, 2012, J IMMUNOL, V188, P135, DOI 10.4049/jimmunol.1004073; Bot I, 2014, J MOL CELL CARDIOL, V74, P44, DOI 10.1016/j.yjmcc.2014.04.021; Burgmaier M, 2014, J CELL MOL MED, V18, P2117, DOI 10.1111/jcmm.12374; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; D'Amico M, 2000, FASEB J, V14, P1867; Dalli J, 2013, J IMMUNOL, V190, P6478, DOI 10.4049/jimmunol.1203000; Davies John Q, 2005, Methods Mol Biol, V290, P91; de Jager SCA, 2013, ARTERIOSCL THROM VAS, V33, pE75, DOI 10.1161/ATVBAHA.112.300857; De Saint-Hubert M, 2013, MOL IMAGING BIOL; De Saint-Hubert M, 2010, BIOORGAN MED CHEM, V18, P1356, DOI 10.1016/j.bmc.2009.12.021; Doring Y, 2015, ARTERIOSCL THROM VAS, V35, P288, DOI 10.1161/ATVBAHA.114.303564; Drechsler M, 2014, CIRC RES; Drechsler M, 2015, CIRC RES, V116, P827, DOI 10.1161/CIRCRESAHA.116.305825; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Hartwig H, 2015, HAMOSTASEOLOGIE, V35, P121, DOI 10.5482/HAMO-14-09-0040; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Kenis H, 2004, J BIOL CHEM, V279, P52623, DOI 10.1074/jbc.M409009200; Kusters DHM, 2012, MOL IMAGING BIOL, V14, P523, DOI 10.1007/s11307-012-0586-7; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Lim LHK, 1998, P NATL ACAD SCI USA, V95, P14535, DOI 10.1073/pnas.95.24.14535; Locatelli I, 2014, HEPATOLOGY; Locatelli I, 2014, HEPATOLOGY, V60, P531, DOI 10.1002/hep.27141; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nakagawa M, 1998, CIRCULATION, V98, P2307, DOI 10.1161/01.CIR.98.21.2307; Pederzoli-Ribeil M, 2010, BLOOD, V116, P4288, DOI 10.1182/blood-2010-02-270520; Perretti M, 2003, TRENDS PHARMACOL SCI, V24, P574, DOI 10.1016/j.tips.2003.09.010; Perretti M, 2001, AM J PATHOL, V158, P1969, DOI 10.1016/S0002-9440(10)64667-6; PERRETTI M, 1993, J IMMUNOL, V151, P4306; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rosengarth A, 2003, J MOL BIOL, V326, P1317, DOI 10.1016/S0022-2836(03)00027-5; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Schutters K, 2013, CELL DEATH DIFFER, V20, P49, DOI 10.1038/cdd.2012.107; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2010, CIRC RES, V106, P58, DOI 10.1161/CIRCRESAHA.109.208488; Tchaikovski SN, 2007, J THROMB HAEMOST, V5, P2079, DOI 10.1111/j.1538-7836.2007.02719.x; Ungethum L, 2011, J BIOL CHEM, V286, P1903, DOI 10.1074/jbc.M110.163527; Vago JP, 2012, J LEUKOCYTE BIOL, V92, P249, DOI 10.1189/jlb.0112008; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; Vangestel C, 2010, NUCL MED BIOL, V37, P965, DOI 10.1016/j.nucmedbio.2010.06.007; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yang YH, 2009, J IMMUNOL, V183, P1435, DOI 10.4049/jimmunol.0804000; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	58	46	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130484	10.1371/journal.pone.0130484	http://dx.doi.org/10.1371/journal.pone.0130484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090792	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000120
J	Apgaua, DMG; Ishida, FY; Tng, DYP; Laidlaw, MJ; Santos, RM; Rumman, R; Eamus, D; Holtum, JAM; Laurance, SGW				Apgaua, Deborah M. G.; Ishida, Francoise Y.; Tng, David Y. P.; Laidlaw, Melinda J.; Santos, Rubens M.; Rumman, Rizwana; Eamus, Derek; Holtum, Joseph A. M.; Laurance, Susan G. W.			Functional Traits and Water Transport Strategies in Lowland Tropical Rainforest Trees	PLOS ONE			English	Article							SAP FLOW; HYDRAULIC ARCHITECTURE; STOMATAL CONDUCTANCE; WOOD DENSITY; DRY FOREST; DROUGHT SENSITIVITY; CANOPY TREES; SAPWOOD AREA; LEAF-AREA; STORAGE	Understanding how tropical rainforest trees may respond to the precipitation extremes predicted in future climate change scenarios is paramount for their conservation and management. Tree species clearly differ in drought susceptibility, suggesting that variable water transport strategies exist. Using a multi-disciplinary approach, we examined the hydraulic variability in trees in a lowland tropical rainforest in north-eastern Australia. We studied eight tree species representing broad plant functional groups (one palm and seven eudicot mature-phase, and early-successional trees). We characterised the species' hydraulic system through maximum rates of volumetric sap flow and velocities using the heat ratio method, and measured rates of tree growth and several stem, vessel, and leaf traits. Sap flow measures exhibited limited variability across species, although early-successional species and palms had high mean sap velocities relative to most mature-phase species. Stem, vessel, and leaf traits were poor predictors of sap flow measures. However, these traits exhibited different associations in multivariate analysis, revealing gradients in some traits across species and alternative hydraulic strategies in others. Trait differences across and within tree functional groups reflect variation in water transport and drought resistance strategies. These varying strategies will help in our understanding of changing species distributions under predicted drought scenarios.	[Apgaua, Deborah M. G.; Santos, Rubens M.] Univ Fed Lavras, Dept Ciencias Florestais, Lavras, MG, Brazil; [Apgaua, Deborah M. G.; Ishida, Francoise Y.; Tng, David Y. P.; Holtum, Joseph A. M.; Laurance, Susan G. W.] James Cook Univ, Coll Marine & Environm Sci, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Laidlaw, Melinda J.] Queensland Herbarium, Dept Sci Informat Technol Innovat & Arts, Brisbane, Qld, Australia; [Rumman, Rizwana; Eamus, Derek] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	Universidade Federal de Lavras; James Cook University; University of Technology Sydney	Tng, DYP (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia.	davetngcom@gmail.com	Apgaua, Deborah Mattos Guimarães/AAW-7756-2021; Laurance, Susan/G-6021-2011; Apgaua, Deborah M G/C-5410-2017; Tng, David/J-3156-2015; Eamus, Derek/F-7375-2017; Santos, Rubens/ABG-1153-2021; Eamus, Derek/AAX-1276-2021	Apgaua, Deborah Mattos Guimarães/0000-0002-6303-6989; Laurance, Susan/0000-0002-2831-2933; Apgaua, Deborah M G/0000-0002-6303-6989; Tng, David/0000-0001-5135-0922; Eamus, Derek/0000-0003-2765-8040; Santos, Rubens/0000-0002-4075-462X; 	Australian Research Council [DP130104092, FT130101319]; Skyrail Rainforest Foundation; Terrestrial Ecosystem Research Network; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Australian Research Council(Australian Research Council); Skyrail Rainforest Foundation; Terrestrial Ecosystem Research Network; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Australian Research Council (http://www.arc.gov.au/ DP130104092), FT130101319 (grants to SGWL), Skyrail Rainforest Foundation (http://www.skyrailfoundation.org/) (grants to DMGA), Terrestrial Ecosystem Research Network (http://www.tern.org.au/) (grants to DE). Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) funded DMGA during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GIMP 2 8; Azim AAA, 2014, TROPICS, V23, P15; Baas P., 2004, EVOLUTION PLANT PHYS, DOI DOI 10.1016/B978-012339552-8/50016-0; Bartlett MK, 2012, ECOL LETT, V15, P393, DOI 10.1111/j.1461-0248.2012.01751.x; Bonal D, 2007, ANN FOREST SCI, V64, P169, DOI 10.1051/forest:2006101; Borchert R, 2005, TREE PHYSIOL, V25, P457, DOI 10.1093/treephys/25.4.457; BORCHERT R, 1994, ECOLOGY, V75, P1437, DOI 10.2307/1937467; Buckley TN, 2006, TREE PHYSIOL, V26, P145, DOI 10.1093/treephys/26.2.145; Bureau of Meteorology, CLIMATE DATA ONLINE; Burgess S.S.O., 2018, SFM1 SAP FLOW METER; Burgess SSO, 2001, TREE PHYSIOL, V21, P589, DOI 10.1093/treephys/21.9.589; Burnham K. P., 2002, MODEL SELECTION AND; CARLQUIST S, 1977, AM J BOT, V64, P887, DOI 10.2307/2442382; Cruiziat P, 2002, ANN FOREST SCI, V59, P723, DOI 10.1051/forest:2002060; De Costa W. A. J. M., 2000, Journal of the National Science Foundation of Sri Lanka, V28, P63; Dickison WC., 2000, INTEGRATIVE PLANT AN; Eamus D, 2001, ADV ECOL RES, V32, P113, DOI 10.1016/S0065-2504(01)32012-3; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Fortunel C, 2014, NEW PHYTOL, V202, P79, DOI 10.1111/nph.12632; Giorgi F, 2014, J GEOPHYS RES-ATMOS, V119, P11695, DOI 10.1002/2014JD022238; Gleason SM, 2012, FUNCT ECOL, V26, P343, DOI 10.1111/j.1365-2435.2012.01962.x; Goldstein G, 1998, PLANT CELL ENVIRON, V21, P397, DOI 10.1046/j.1365-3040.1998.00273.x; Goosem S, 2013, REPAIRING THE RAINFO; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Hacke UG, 2006, TREE PHYSIOL, V26, P689, DOI 10.1093/treephys/26.6.689; Horna V, 2011, ANN FOREST SCI, V68, P1027, DOI 10.1007/s13595-011-0110-2; Jacobsen AL, 2005, PLANT PHYSIOL, V139, P546, DOI 10.1104/pp.104.058404; James SA, 2003, OECOLOGIA, V134, P37, DOI 10.1007/s00442-002-1080-8; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Krober W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109211; Kueffer C, 2007, J ECOL, V95, P273, DOI 10.1111/j.1365-2745.2007.01213.x; Kynaston WT, 1994, TIMBER SPECIES NOTES; MACHADO JL, 1994, TREE PHYSIOL, V14, P219, DOI 10.1093/treephys/14.3.219; McCune B, 1999, MULTIVARIATE ANALYSI; Meinzer FC, 2003, OECOLOGIA, V134, P1, DOI 10.1007/s00442-002-1088-0; Meinzer FC, 2001, TREE PHYSIOL, V21, P19, DOI 10.1093/treephys/21.1.19; Mendez-Alonzo R, 2012, ECOLOGY, V93, P2397, DOI 10.1890/11-1213.1; Miglietta F, 2011, P NATL ACAD SCI USA, V108, pE275, DOI 10.1073/pnas.1105831108; Motzer T, 2005, TREE PHYSIOL, V25, P1283, DOI 10.1093/treephys/25.10.1283; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; O'Brien JJ, 2004, PLANT CELL ENVIRON, V27, P551, DOI 10.1111/j.1365-3040.2003.01160.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pineda-Garcia F, 2013, PLANT CELL ENVIRON, V36, P405, DOI 10.1111/j.1365-3040.2012.02582.x; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Pratt RB, 2007, NEW PHYTOL, V174, P787, DOI 10.1111/j.1469-8137.2007.02061.x; R Development Core Team, 2009, R A LANGUAGE AND ENV; Renninger HJ, 2013, TREE PHYSIOL, V33, P152, DOI 10.1093/treephys/tps123; Sack L, 2013, J EXP BOT, V64, P4053, DOI 10.1093/jxb/ert316; Schuldt B, 2011, BIOGEOSCIENCES, V8, P2179, DOI 10.5194/bg-8-2179-2011; Sherwood S, 2014, SCIENCE, V343, P737, DOI 10.1126/science.1247620; Silvertown Joanthan, 1997, P3; Smith DM, 1996, J EXP BOT, V47, P1833, DOI 10.1093/jxb/47.12.1833; Sterck F, 2011, P NATL ACAD SCI USA, V108, P20627, DOI 10.1073/pnas.1106950108; Tomlinson P.B., 2011, THE ANATOMY OF PALMS; TYREE MT, 1991, NEW PHYTOL, V119, P345, DOI 10.1111/j.1469-8137.1991.tb00035.x; VERTESSY RA, 1995, TREE PHYSIOL, V15, P559, DOI 10.1093/treephys/15.9.559; Werner C, 2012, BIOGEOSCIENCES, V9, P3083, DOI 10.5194/bg-9-3083-2012; Whitehead D, 1998, TREE PHYSIOL, V18, P633; Worbes M, 2013, TREE PHYSIOL, V33, P527, DOI 10.1093/treephys/tpt028; Wullschleger SD, 1998, TREE PHYSIOL, V18, P499; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238; Zheng JM, 2013, ANN BOT-LONDON, V112, P927, DOI 10.1093/aob/mct153; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zwieniecki MA, 2015, PLANT CELL ENVIRON, V38, P1713, DOI 10.1111/pce.12412	68	28	29	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130799	10.1371/journal.pone.0130799	http://dx.doi.org/10.1371/journal.pone.0130799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087009	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000356567500133
J	Durante, IM; Camara, MD; Buscaglia, CA				Durante, Ignacio M.; de los Milagros Camara, Maria; Buscaglia, Carlos A.			A Novel Trypanosoma cruzi Protein Associated to the Flagellar Pocket of Replicative Stages and Involved in Parasite Growth	PLOS ONE			English	Article							SMALL SURFACE-ANTIGEN; III SECRETION; PDZ DOMAINS; MUCIN GENES; LIFE-CYCLE; HEAT-SHOCK; EXPRESSION; ENDOCYTOSIS; CHAPERONE; SEQUENCE	The flagellar pocket constitutes an active and strategic site in the body of trypanosomatids (i.e. parasitic protozoa that cause important human and/or livestock diseases), which participates in several important processes such as cell polarity, morphogenesis and replication. Most importantly, the flagellar pocket is the unique site of surface protein export and nutrient uptake in trypanosomatids, and thus constitutes a key portal for the interaction with the host. In this work, we identified and characterized a novel Trypanosoma cruzi protein, termed TCLP 1, that accumulates at the flagellar pocket area of parasite replicative forms, as revealed by biochemical, immuno-cytochemistry and electron microscopy techniques. Different in silicoanalyses revealed that TCLP 1 is the founding member of a family of chimeric molecules restricted to trypanosomatids bearing, in addition to eukaryotic ubiquitin-like and protein-protein interacting domains, a motif displaying significant structural homology to bacterial multi-cargo chaperones involved in the secretion of virulence factors. Using the fidelity of an homologous expression system we confirmed TCLP 1 sub-cellular distribution and showed that TCLP 1-over-expressing parasites display impaired survival and accelerated progression to late stationary phase under starvation conditions. The reduced endocytic capacity of TCLP 1-over-expressors likely underlies (at least in part) this growth phenotype. TCLP 1 is involved in the uptake of extracellular macromolecules required for nutrition and hence in T. cruzi growth. Due to the bacterial origin, sub-cellular distribution and putative function(s), we propose TCLP 1 and related orthologs in trypanosomatids as appealing therapeutic targets for intervention against these health-threatening parasites.	[Buscaglia, Carlos A.] Univ Nacl San Martin, IIB, Inst Tecnol Chascomus INTECh, Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Buscaglia, CA (corresponding author), Univ Nacl San Martin, IIB, Inst Tecnol Chascomus INTECh, Buenos Aires, DF, Argentina.	cbuscaglia89@gmail.com	Durante, Ignacio/AAT-9702-2020	Buscaglia, Carlos/0000-0001-6466-4138	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina); Fundacion Bunge y Born (Argentina); CONICET; CAB	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)(ANPCyT); Fundacion Bunge y Born (Argentina); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CAB	This investigation received financial support from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina) and Fundacion Bunge y Born (Argentina) to CAB. IMD holds a fellowship from the CONICET and CAB is a career investigator from the same Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Alvarez P, 2001, INFECT IMMUN, V69, P7946, DOI 10.1128/IAI.69.12.7946-7949.2001; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balouz V, 2015, CLIN VACCINE IMMUNOL, V22, P304, DOI 10.1128/CVI.00684-14; BANGS JD, 1993, J CELL SCI, V105, P1101; Barrett MP, 2006, ADV PARASIT, V63, P125, DOI 10.1016/S0065-308X(06)63002-9; Bartholomeu DC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004399; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; BRICKMAN MJ, 1995, J CELL SCI, V108, P3611; Campo V, 2004, MOL BIOCHEM PARASIT, V133, P81, DOI 10.1016/j.molbiopara.2003.09.006; Campo VA, 2006, MICROBES INFECT, V8, P401, DOI 10.1016/j.micinf.2005.07.008; Canepa GE, 2012, J BIOL CHEM, V287, P26365, DOI 10.1074/jbc.M112.354696; Canepa GE, 2012, BIOCHEM J, V444, P211, DOI 10.1042/BJ20120074; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chung WL, 2008, TRAFFIC, V9, P1681, DOI 10.1111/j.1600-0854.2008.00785.x; Cooper CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000751; Creasey EA, 2003, MOL MICROBIOL, V47, P209, DOI 10.1046/j.1365-2958.2003.03290.x; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; Camara MDM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002044; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; dos Santos MG, 2011, MEM I OSWALDO CRUZ, V106, P190, DOI 10.1590/S0074-02762011000200012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Ferreira ER, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00363; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; Figueiredo RCBQ, 2004, PARASITOLOGY, V129, P431, DOI 10.1017/S0031182004005797; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; Geiger A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-20; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Gupta RS, 2006, TRENDS MICROBIOL, V14, P527, DOI 10.1016/j.tim.2006.10.002; Gutierrez B, 2009, PARASITOL INT, V58, P367, DOI 10.1016/j.parint.2009.07.012; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hill KL, 1999, J CELL SCI, V112, P3091; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Leung KF, 2011, EUKARYOT CELL, V10, P916, DOI 10.1128/EC.05012-11; MartinezCalvillo S, 1997, GENE, V199, P71, DOI 10.1016/S0378-1119(97)00348-X; De Pablos LM, 2011, INFECT IMMUN, V79, P3993, DOI 10.1128/IAI.05329-11; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Miranda MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032760; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Niyogi S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004224; Paape D, 2008, MOL CELL PROTEOMICS, V7, P1688, DOI 10.1074/mcp.M700343-MCP200; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Peng D, 2015, MBIO, V6, DOI 10.1128/mBio.02097-14; Piper RC, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016808; Pitcovsky TA, 2002, J INFECT DIS, V186, P397, DOI 10.1086/341463; Puri V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-334; Qiao XG, 2006, EUKARYOT CELL, V5, P1229, DOI 10.1128/EC.00064-06; Ramos CS, 2011, EXP PARASITOL, V127, P228, DOI 10.1016/j.exppara.2010.08.004; Ramos CS, 2004, FEMS MICROBIOL LETT, V238, P213, DOI 10.1016/j.femsle.2004.07.037; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; Sant'Anna C, 2008, HISTOCHEM CELL BIOL, V130, P1187, DOI 10.1007/s00418-008-0486-8; Schuch R, 1999, INFECT IMMUN, V67, P1982; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Silva Danielle C. F., 2013, Frontiers in Genetics, V4, P143, DOI 10.3389/fgene.2013.00143; SOARES MJ, 1991, PARASITOL RES, V77, P461, DOI 10.1007/BF00928410; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Thomas NA, 2005, MOL MICROBIOL, V57, P1762, DOI 10.1111/j.1365-2958.2005.04802.x; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Urban I, 2011, BIOCHEM J, V438, P303, DOI 10.1042/BJ20110683	73	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130099	10.1371/journal.pone.0130099	http://dx.doi.org/10.1371/journal.pone.0130099			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086767	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500078
J	Gupta, AK; Jadhav, SH; Tripathy, NK; Nityanand, S				Gupta, Ashwani Kumar; Jadhav, Sachin H.; Tripathy, Naresh Kumar; Nityanand, Soniya			Fetal Kidney Cells Can Ameliorate Ischemic Acute Renal Failure in Rats through Their Anti-Inflammatory, Anti-Apoptotic and Anti-Oxidative Effects	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; MULTIPOTENT PROGENITORS; REPERFUSION INJURY; CONDITIONED MEDIUM; MOUSE KIDNEY; TRANSPLANTATION; REPAIR; EXPRESSION; CONTRIBUTE	Fetal kidney cells may contain multiple populations of kidney stem cells and thus appear to be a suitable cellular therapy for the treatment of acute renal failure (ARF) but their biological characteristics and therapeutic potential have not been adequately explored. We have culture expanded fetal kidney cells derived from rat fetal kidneys, characterized them and evaluated their therapeutic effect in an ischemia reperfusion (IR) induced rat model of ARF. The fetal kidney cells grew in culture as adherent spindle shaped/polygonal cells and expressed CD29, CD44, CD73, CD90, CD105, CD24 and CD133 markers. Administration of PKH26 labeled fetal kidney cells in ARF rats resulted in a significant decrease in the levels of blood urea nitrogen, creatinine, and neutrophil gelatinase-associated lipocalin and decreased tubular necrosis in the kidney tissues (p<0.05 for all). The injected fetal kidney cells were observed to engraft around injured tubular cells, and there was increased proliferation and decreased apoptosis of tubular cells in the kidneys (p<0.05 for both). In addition, the kidney tissues of ARF rats treated with fetal kidney cells had a higher gene expression of renotropic growth factors (VEGF-A, IGF-1, BMP-7 and bFGF) and anti-inflammatory cytokine (IL10); up regulation of anti-oxidative markers (HO-1 and NQO-1); and a lower Bax/Bcl2 ratio as compared to saline treated rats (p<0.05 for all). Our data shows that culture expanded fetal kidney cells express mesenchymal and renal progenitor markers, and ameliorate ischemic ARF predominantly by their anti-apoptotic, anti-inflammatory and anti-oxidative effects.	[Gupta, Ashwani Kumar; Jadhav, Sachin H.; Tripathy, Naresh Kumar; Nityanand, Soniya] Sanjay Gandhi Post Grad Inst Med Sci, Dept Hematol, SCRF, Lucknow 226014, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences	Nityanand, S (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Hematol, SCRF, Raebareli Rd, Lucknow 226014, Uttar Pradesh, India.	soniya_nityanand@yahoo.co.in	Tripathy, Naresh Kumar/AAQ-1889-2021; Gupta, Ashwani Kumar/AAS-1084-2021	Tripathy, Naresh Kumar/0000-0002-2621-802X; Gupta, Ashwani Kumar/0000-0001-7069-5299; Jadhav, S H/0000-0002-4752-4202	Department of Biotechnology, Government of India [BT/PR6519/MED/14/826/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by an extramural grant sanctioned by Department of Biotechnology, Government of India, to Dr. Soniya Nityanand (BT/PR6519/MED/14/826/2005) (http://dbtindia.nic.in/index.asp).	Aali E, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-76; Aggarwal S, 2013, STEM CELL TRANSL MED, V2, P1011, DOI 10.5966/sctm.2013-0097; Agrawal H, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt532; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Dekel B, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134977; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Garikipati VNS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100982; Gheisari Y, 2011, CELL BIOL INT, V35, P209, DOI 10.1042/CBI20100183; Gui DK, 2013, APOPTOSIS, V18, P409, DOI 10.1007/s10495-013-0801-2; Gupta AK, 2015, WORLD J STEM CELLS, V7, P776, DOI 10.4252/wjsc.v7.i4.776; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hayashi T, 2010, INT J UROL, V17, P989, DOI 10.1111/j.1442-2042.2010.02644.x; Hynes B, 2013, EUR HEART J, V34, P782, DOI 10.1093/eurheartj/ehr435; JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002; Kean TJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/732742; Khan AA, 2010, CELL TRANSPLANT, V19, P409, DOI 10.3727/096368910X498241; Kim SS, 2007, STEM CELLS, V25, P1393, DOI 10.1634/stemcells.2006-0183; Kim SS, 2007, TRANSPLANTATION, V83, P1249, DOI 10.1097/01.tp.0000261712.93299.a6; Kwon O, 2010, J HISTOCHEM CYTOCHEM, V58, P687, DOI 10.1369/jhc.2010.956011; Lazzeri E, 2007, J AM SOC NEPHROL, V18, P3128, DOI 10.1681/ASN.2007020210; Lee PT, 2010, STEM CELLS, V28, P573, DOI 10.1002/stem.310; Leonard EC, 2008, AM J PHYSIOL-RENAL, V295, pF1648, DOI 10.1152/ajprenal.00099.2008; Li L, 2012, AM J PHYSIOL-RENAL, V302, pF9, DOI 10.1152/ajprenal.00377.2011; Li PKT, 2013, KIDNEY INT, V83, P372, DOI 10.1038/ki.2012.427; Lu JF, 2013, CYTOTHERAPY, V15, P649, DOI 10.1016/j.jcyt.2013.01.009; Metsuyanim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006709; Mizuno S, 2005, AM J PATHOL, V166, P1895, DOI 10.1016/S0002-9440(10)62498-4; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Sadek Eman Mostafa, 2013, International Journal of Stem Cells, V6, P55; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Soler Maria Jose, 2012, J Stem Cells, V7, P245, DOI jsc.2013.7.4.245; Srikanth GVN, 2012, INT J REGN MED, V1, P1; Sun JH, 2008, CELL TRANSPLANT, V17, P279, DOI 10.3727/096368908784153878; Sun ZL, 2008, AM J PHYSIOL-RENAL, V294, pF491, DOI 10.1152/ajprenal.00263.2007; Villanueva S, 2006, AM J PHYSIOL-REG I, V291, pR1677, DOI 10.1152/ajpregu.00023.2006; Xing L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt489; Zhang WJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt352	38	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0131057	10.1371/journal.pone.0131057	http://dx.doi.org/10.1371/journal.pone.0131057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086475	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500140
J	Lai, SH; Wong, KS; Liao, SL				Lai, Shen-Hao; Wong, Kin-Sun; Liao, Sui-Ling			Value of Lung Ultrasonography in the Diagnosis and Outcome Prediction of Pediatric Community-Acquired Pneumonia with Necrotizing Change	PLOS ONE			English	Article							CHILDREN; ULTRASOUND; CT; RESECTION	Background Lung ultrasonography has been advocated in diagnosing pediatric community-acquired pneumonia. However, its function in identifying necrotizing pneumonia, a complication, has not been explored. This study investigated the value of lung ultrasonography in diagnosing pediatric necrotizing pneumonia and its role in predicting clinical outcomes. Methods We retrospectively reviewed 236 children with community-acquired pneumonia who were evaluated using lung ultrasonography within 2-3 days after admission. The ultrasonographic features assessed included lung perfusion, the presence of hypoechoic lesions, and the amount of pleural effusion. Chest computed tomography was also performed in 96 patients as clinically indicated. Detailed records of clinical information were obtained. Results Our results showed a high correlation between the degree of impaired perfusion in ultrasonography and the severity of necrosis in computed tomography (r = 0.704). The degree of impaired perfusion can favorably be used to predict massive necrosis in computed tomography (area under the receiver operating characteristic curve, 0.908). The characteristics of impaired perfusion and hypoechoic lesions in ultrasonography were associated with an increased risk of pneumatocele formation (odds ratio (OR), 10.11; 95% CI, 2.95-34.64) and the subsequent requirement for surgical lung resection (OR, 8.28; 95% CI, 1.86-36.93). Furthermore, a longer hospital stay would be expected if moderate-to-massive pleural effusion was observed in addition to impaired perfusion in ultrasonography (OR, 3.08; 95% CI, 1.15-8.29). Conclusion Lung ultrasonography is favorably correlated with chest computed tomography in the diagnosis of necrotizing pneumonia, especially regarding massive necrosis of the lung. Because it is a simple and reliable imaging tool that is valuable in predicting clinical outcomes, we suggest that ultrasonography be applied as a surrogate for computed tomography for the early detection of severe necrotizing pneumonia in children.	[Lai, Shen-Hao; Wong, Kin-Sun] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Liao, Sui-Ling] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Lai, Shen-Hao; Wong, Kin-Sun; Liao, Sui-Ling] Chang Gung Univ, Dept Pediat, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Liao, SL (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan.	suiliao@adm.cgmh.org.tw			Chang Gung Medical Research Program [CMRPG490091, 490092, 490093]	Chang Gung Medical Research Program	This work was supported by grants from Chang Gung Medical Research Program (CMRPG490091, 490092 and 490093). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyaratnam P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/623684; Ayed A, 2005, PEDIATR SURG INT, V21, P604, DOI 10.1007/s00383-005-1485-7; Bender JM, 2008, CLIN INFECT DIS, V46, P1346, DOI 10.1086/586747; Caiulo VA, 2013, PEDIATR PULM, V48, P280, DOI 10.1002/ppul.22585; Cheng CH, 2009, PEDIATR INFECT DIS J, V28, P300, DOI 10.1097/INF.0b013e31818ffe7d; Chiu CY, 2008, TURKISH J PEDIATR, V50, P58; Copetti R, 2008, RADIOL MED, V113, P190, DOI 10.1007/s11547-008-0247-8; Cowles RA, 2002, J PEDIATR SURG, V37, P643, DOI 10.1053/jpsu.2002.31629; Darge K, 2013, JAMA PEDIATR, V167, P187, DOI 10.1001/2013.jamapediatrics.409; Don M, 2013, ACTA PAEDIATR, V102, P6, DOI 10.1111/apa.12002; Donnelly LF, 1997, RADIOLOGY, V205, P817, DOI 10.1148/radiology.205.3.9393541; Hacimustafaoglu M, 2004, ACTA PAEDIATR, V93, P1172, DOI 10.1080/08035250410026699; Hoffer FA, 1999, PEDIATR RADIOL, V29, P87, DOI 10.1007/s002470050547; Hsieh YC, 2004, CLIN INFECT DIS, V38, P830, DOI 10.1086/381974; Hsieh YC, 2011, PEDIATR INFECT DIS J, V30, P740, DOI 10.1097/INF.0b013e31821b10c3; Iuri D, 2009, RADIOL MED, V114, P321, DOI 10.1007/s11547-008-0336-8; Kendrick APT, 2002, PEDIATR RADIOL, V32, P16, DOI 10.1007/s00247-001-0583-5; Kurian J, 2009, AM J ROENTGENOL, V193, P1648, DOI 10.2214/AJR.09.2791; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lemaitre C, 2013, PEDIATR INFECT DIS J, V32, P1146, DOI 10.1097/INF.0b013e31829be1bb; Macedo M, 2010, J BRAS PNEUMOL, V36, P301, DOI 10.1590/S1806-37132010000300006; McCarthy VP, 1999, PEDIATR PULM, V28, P217, DOI 10.1002/(SICI)1099-0496(199909)28:3<217::AID-PPUL9>3.0.CO;2-R; Pande A, 2012, CLIN INFECT DIS, V54, P10, DOI 10.1093/cid/cir749; Peters RT, 2013, PEDIATR PULM, V48, P617, DOI 10.1002/ppul.22649; Pinotti KF, 2006, PEDIATR SURG INT, V22, P775, DOI 10.1007/s00383-006-1754-0; Refaely Y, 1997, ANN THORAC SURG, V64, P970, DOI 10.1016/S0003-4975(97)00837-0; Reimel Beth Ann, 2006, Can Respir J, V13, P369; Reissig A, 2009, ULTRASCHALL MED, V30, P438, DOI 10.1055/s-0028-1109703; Sawicki GS, 2008, EUR RESPIR J, V31, P1285, DOI 10.1183/09031936.00099807; Shah VP, 2013, JAMA PEDIATR, V167, P119, DOI 10.1001/2013.jamapediatrics.107; TAN TQ, 2002, PEDIATRICS, V110, pNIL81; Volpicelli G, 2012, INTENS CARE MED, V38, P577, DOI 10.1007/s00134-012-2513-4; Westphal FL, 2010, J BRAS PNEUMOL, V36, P716, DOI [10.1590/S1806-37132010000600008, 10.1590/S1806-37132010000600020]	33	33	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130082	10.1371/journal.pone.0130082	http://dx.doi.org/10.1371/journal.pone.0130082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086718	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500077
J	Baldeon, RL; Weigelt, K; de Wit, H; Ozcan, B; van Oudenaren, A; Sempertegui, F; Sijbrands, E; Grosse, L; van Zonneveld, AJ; Drexhage, HA; Leenen, PJM				Baldeon, Lucy R.; Weigelt, Karin; de Wit, Harm; Ozcan, Behiye; van Oudenaren, Adri; Sempertegui, Fernando; Sijbrands, Eric; Grosse, Laura; van Zonneveld, Anton-Jan; Drexhage, Hemmo A.; Leenen, Pieter J. M.			Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation	PLOS ONE			English	Article							ADIPOSE-TISSUE DYSFUNCTION; BLOOD MONONUCLEAR-CELLS; METABOLIC SYNDROME; INSULIN-RESISTANCE; RETINOIC ACID; OBESITY; DISEASE; MIR-146A; CANCER; TETRASPANINS	There is increasing evidence that inflammatory macrophages in adipose tissue are involved in insulin resistance of type 2 diabetes (T2D). Due to a relative paucity of data on circulating monocytes in T2D, it is unclear whether the inflammatory changes of adipose tissue macrophages are reflected in these easily accessible cells. Objective To study the expression pattern of microRNAs and mRNAs related to inflammation in T2D monocytes. Design A microRNA finding study on monocytes of T2D patients and controls using array profiling was followed by a quantitative Real Time PCR (qPCR) study on monocytes of an Ecuadorian validation cohort testing the top over/under-expressed microRNAs. In addition, monocytes of the validation cohort were tested for 24 inflammation-related mRNAs and 2 microRNAs previously found deregulated in (auto)-inflammatory monocytes. Results In the finding study, 142 significantly differentially expressed microRNAs were identified, 15 having the strongest power to discriminate T2D patients from controls (sensitivity 66%, specificity 90%). However, differences in expression of these microRNAs between patients and controls were small. On the basis of >1.4 or <0.6-fold change expression 5 microRNAs were selected for further validation. One microRNA (miR-34c-5p) was validated as significantly over-expressed in T2D monocytes. In addition, we found over expression of 3 mRNAs (CD9, DHRS3 and PTPN7) in the validation cohort. These mRNAs are important for cell morphology, adhesion, shape change, and cell differentiation. Classical inflammatory genes (e.g. TNFAIP3) were only over-expressed in monocytes of patients with normal serum lipids. Remarkably, in dyslipidemia, there was a reduction in the expression of inflammatory genes (e.g. ATF3, DUSP2 and PTGS2). Conclusions The expression profile of microRNAs/mRNAs in monocytes of T2D patients indicates an altered adhesion, differentiation, and shape change potential. Monocyte inflammatory activation was only found in patients with normal serum lipids. Abnormal lipid values coincided with a reduced monocyte inflammatory state.	[Baldeon, Lucy R.; Weigelt, Karin; de Wit, Harm; van Oudenaren, Adri; Drexhage, Hemmo A.; Leenen, Pieter J. M.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Ozcan, Behiye; Sijbrands, Eric] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Baldeon, Lucy R.; Sempertegui, Fernando] Cent Univ Ecuador, Dept Immunol, Quito, Ecuador; [Grosse, Laura] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [van Zonneveld, Anton-Jan] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Drexhage, Hemmo A.] Cent Univ Ecuador, Prometeo Program SENESCYT, Quito, Ecuador; [Drexhage, Hemmo A.] Univ Fuerzas Armadas, Quito, Ecuador	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Universidad Central del Ecuador; University of Munster; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidad Central del Ecuador	Baldeon, RL (corresponding author), Erasmus MC, Dept Immunol, Rotterdam, Netherlands.	l.baldeonrojas@erasmusmc.nl	Sijbrands, Eric/A-1065-2009; Baldeon, Lucy/AAE-6323-2022; van Zonneveld, Anton Jan/D-8060-2018; Leenen, Pieter JM/I-5839-2013	Sijbrands, Eric/0000-0001-8857-7389; Baldeon, Lucy/0000-0002-0447-0136; van Zonneveld, Anton Jan/0000-0002-1676-7738; Leenen, Pieter JM/0000-0001-9860-2920; Grosse, Laura/0000-0001-6273-5035	Dutch Diabetes Research Foundation, The Netherlands [2007.00.035]	Dutch Diabetes Research Foundation, The Netherlands	This study was supported by grant 2007.00.035 from the Dutch Diabetes Research Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Averill MM, 2009, CURR DIABETES REP, V9, P18, DOI 10.1007/s11892-009-0005-x; Balasubramanyam M, 2011, MOL CELL BIOCHEM, V351, P197, DOI 10.1007/s11010-011-0727-3; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Belmont P., 2013, ENSANUT ECU 2011 201, VI; Beyan H, 2010, DIABETES, V59, P1751, DOI 10.2337/db09-1433; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Carolan E, 2014, J CLIN ENDOCR METAB, V99, pE474, DOI 10.1210/jc.2013-3529; Corral-Fernandez NE, 2013, EXP CLIN ENDOCR DIAB, V121, P347, DOI 10.1055/s-0033-1341516; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Gacka M, 2010, J DIABETES COMPLICAT, V24, P1, DOI 10.1016/j.jdiacomp.2008.07.001; Grosse L, 2015, BRAIN BEHAV IMMUN, V44, P48, DOI 10.1016/j.bbi.2014.08.004; Guillen P GG, 2014, THESIS U CUENCA CUEN; Hagman Z, 2013, BRIT J CANCER, V109, P1271, DOI 10.1038/bjc.2013.449; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang YQ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-142; Hulsmans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032794; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Jara M, 2011, FRECUENCIA AUTOMEDIC, DOI [10.1016/j.arbres.2015.03.008, DOI 10.1016/J.ARBRES.2015.03.008]; Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092; Jockers JJ, 2006, ALLERGY, V61, P1419, DOI 10.1111/j.1398-9995.2006.01191.x; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Knijff EM, 2006, BIPOLAR DISORD, V8, P740, DOI 10.1111/j.1399-5618.2006.00359.x; Kolseth IBM, 2012, J INNATE IMMUN, V4, P176, DOI 10.1159/000332375; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Meng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068611; Mocharla P, 2013, BLOOD, V121, P226, DOI 10.1182/blood-2012-01-407106; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Padmos RC, 2008, DIABETES, V57, P2768, DOI 10.2337/db08-0496; Pauley KM, 2011, EUR J IMMUNOL, V41, P2029, DOI 10.1002/eji.201040757; Perry J, 2014, GWAS T2DM DIAPEDIA 3; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Pino-Lagos K, 2010, BIOFACTORS, V36, P430, DOI 10.1002/biof.117; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Rebane A, 2013, J ALLERGY CLIN IMMUN, V132, P15, DOI 10.1016/j.jaci.2013.04.011; Riek AE, 2013, J STEROID BIOCHEM, V136, P309, DOI 10.1016/j.jsbmb.2012.12.019; Rocha-Perugini V, 2014, EUR J IMMUNOL, V44, P1967, DOI 10.1002/eji.201344235; Sergienko E, 2012, ACS CHEM BIOL, V7, P366, DOI 10.1021/cb2004274; Shim WS, 2006, DIABETES RES CLIN PR, V73, P284, DOI 10.1016/j.diabres.2006.02.001; Shiny A, 2013, CYTOKINE, V64, P564, DOI 10.1016/j.cyto.2013.08.003; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Simar D, 2012, CELL STRESS CHAPERON, V17, P615, DOI 10.1007/s12192-012-0336-4; Sorisky A, 2013, ADV NUTR, V4, P67, DOI 10.3945/an.112.003020; Swirski FK, 2011, ARTERIOSCL THROM VAS, V31, P1517, DOI 10.1161/ATVBAHA.110.221150; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tome-Carneiro J, 2013, PHARMACOL RES, V72, P69, DOI 10.1016/j.phrs.2013.03.011; Unlu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038899; van der Heul-Nieuwenhuijsen L, 2010, J CLIN ENDOCR METAB, V95, P1962, DOI 10.1210/jc.2009-1455; Wajchenberg BL, 2009, ARQ BRAS ENDOCRINOL, V53, P145, DOI 10.1590/S0004-27302009000200005; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wu ZD, 2013, ONCOL LETT, V6, P1447, DOI 10.3892/ol.2013.1579; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu WD, 2012, INFLAMMATION, V35, P1525, DOI 10.1007/s10753-012-9467-0; Zhao JL, 2013, ELIFE, V2, DOI 10.7554/eLife.00537; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	66	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129421	10.1371/journal.pone.0129421	http://dx.doi.org/10.1371/journal.pone.0129421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083362	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400094
J	Moon, KL; Banks, SC; Fraser, CI				Moon, Katherine L.; Banks, Sam C.; Fraser, Ceridwen I.			Phylogeographic Structure in Penguin Ticks across an Ocean Basin Indicates Allopatric Divergence and Rare Trans-Oceanic Dispersal	PLOS ONE			English	Article							ECTOPARASITE IXODES-URIAE; LONG-DISTANCE DISPERSAL; EUDYPTULA-MINOR; MAXIMUM-LIKELIHOOD; GENETIC-STRUCTURE; LOCAL ADAPTATION; CLIMATE-CHANGE; LYME-DISEASE; PARASITE; BIOGEOGRAPHY	The association of ticks (Acarina) and seabirds provides an intriguing system for assessing the influence of long-distance dispersal on the evolution of parasitic species. Recent research has focused on host-parasite evolutionary relationships and dispersal capacity of ticks parasitising flighted seabirds. Evolutionary research on the ticks of non-flighted seabirds is, in contrast, scarce. We conducted the first phylogeographic investigation of a hard tick species (Ixodes eudyptidis) that parasitises the Little Blue Penguin (Eudyptula minor). Using one nuclear (28S) and two mitochondrial (COI and 16S) markers, we assessed genetic diversity among several populations in Australia and a single population on the South Island of New Zealand. Our results reveal two deeply divergent lineages, possibly representing different species: one comprising all New Zealand samples and some from Australia, and the other representing all other samples from Australian sites. No significant population differentiation was observed among any Australian sites from within each major clade, even those separated by hundreds of kilometres of coastline. In contrast, the New Zealand population was significantly different to all samples from Australia. Our phylogenetic results suggest that the New Zealand and Australian populations are effectively isolated from each other; although rare long-distance dispersal events must occur, these are insufficient to maintain trans-Tasman gene flow. Despite the evidence for limited dispersal of penguin ticks between Australia and New Zealand, we found no evidence to suggest that ticks are unable to disperse shorter distances at sea with their hosts, with no pattern of population differentiation found among Australian sites. Our results suggest that terrestrial seabird parasites may be quite capable of short-distance movements, but only sporadic longer-distance (trans-oceanic) dispersal.	[Moon, Katherine L.; Banks, Sam C.; Fraser, Ceridwen I.] Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT 2601, Australia	Australian National University	Moon, KL (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT 2601, Australia.	katielouisemoon@gmail.com	Banks, Sam/K-4907-2012	Banks, Sam/0000-0003-2415-0057; Fraser, Ceridwen/0000-0002-6918-8959	Fenner School of Environment and Society (Australian National University)	Fenner School of Environment and Society (Australian National University)	Funding was provided by the Fenner School of Environment and Society (Australian National University) via a start-up research fund to CIF. Except via institutional affiliation of the authors, the funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	(AHD) AHD, 2012, BRUSH ISL NAT RES BA; Ancel A, 2013, CR BIOL, V336, P1, DOI 10.1016/j.crvi.2013.02.002; AUSTIN FJ, 1984, NEW ZEAL ENTOMOL, V8, P105, DOI 10.1080/00779962.1984.9722481; Banks Jonathan C., 2002, Notornis, V49, P29; Banks JC, 2008, NEW ZEAL J ZOOL, V35, P265, DOI 10.1080/03014220809510123; Barbosa A, 2011, POLAR BIOL, V34, P1621, DOI 10.1007/s00300-011-1000-7; Benoit JB, 2009, ANTARCT SCI, V21, P151, DOI 10.1017/S0954102008001685; Bergstrom S, 1999, J PARASITOL, V85, P25, DOI 10.2307/3285694; Bethge P, 1997, J ZOOL, V242, P483; Bishop DM, 1998, PARASITES BIRDS NZ 1, P15; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Bool N, 2007, SARDI RES REPORT SER; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Burridge CP, 2015, J HERED, V106, P228, DOI 10.1093/jhered/esv009; Chiaradia Andre F., 1999, Marine Ornithology, V27, P13; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins M, 1999, WILDLIFE RES, V26, P705, DOI 10.1071/WR98003; Coulson SJ, 2009, POLAR RES, V28, P399, DOI 10.1111/j.1751-8369.2009.00117.x; Croteau E, 2010, NATURE ED KNOWLEDGE, V1, P12; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; DANCHIN E, 1992, IBIS, V134, P134, DOI 10.1111/j.1474-919X.1992.tb08390.x; Danielova V, 2008, INT J MED MICROBIOL, V298, P68, DOI 10.1016/j.ijmm.2008.02.005; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Descamps S, ANN BREEDING CYCLE U; Dietrich M, 2011, VECTOR-BORNE ZOONOT, V11, P453, DOI 10.1089/vbz.2010.0009; Eveleigh E. S., 1974, Acarologia, V16, P621; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feria-Arroyo TP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-199; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frenot Y, 2001, INT J PARASITOL, V31, P1040, DOI 10.1016/S0020-7519(01)00232-6; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gern L, 2008, INT J MED MICROBIOL, V298, P55, DOI 10.1016/j.ijmm.2008.01.005; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heath A, 1977, ZOOGEOGRAPHY NZ TICK, V23, P26; Heath A. C. G., 2006, Systematic and Applied Acarology, V11, P131; Hoskins AJ, 2008, MAR ECOL PROG SER, V366, P293, DOI 10.3354/meps07507; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jansen van Rensburg M, 2010, PARASITISM DIS BREED; Johnson KP, 2003, MOL PHYLOGENET EVOL, V26, P231, DOI 10.1016/S1055-7903(02)00342-1; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Jore S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-84; Kempf F, 2009, MOL ECOL, V18, P4450, DOI 10.1111/j.1365-294X.2009.04356.x; Kinsky F, 1976, SUBSPECIFIC REVISION; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lion S, 2015, J EVOLUTION BIOL, V28, P10, DOI 10.1111/jeb.12551; Lynch HJ, 2010, POLAR BIOL, V33, P493, DOI 10.1007/s00300-009-0726-y; McCoy KD, 2012, MAR ECOL PROG SER, V459, P109, DOI 10.3354/meps09749; McCoy KD, 2005, P ROY SOC B-BIOL SCI, V272, P2389, DOI 10.1098/rspb.2005.3230; McCoy KD, 2003, HEREDITY, V91, P422, DOI 10.1038/sj.hdy.6800339; McCoy KD, 2003, EVOLUTION, V57, P288, DOI 10.1111/j.0014-3820.2003.tb00263.x; McCoy KD, 2002, EVOL ECOL RES, V4, P441; McCoy KD, 2001, J EVOLUTION BIOL, V14, P395, DOI 10.1046/j.1420-9101.2001.00290.x; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Murray M, 1990, ECTOPARASITES AUSTR; MURRAY M. D., 1967, AUST J ZOOL, V15, P715, DOI 10.1071/ZO9670715; Nakamine H, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.7001; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nice CC, 2005, MOL ECOL, V14, P1741, DOI 10.1111/j.1365-294X.2005.02527.x; OamaruPenguinColony, 2013, OAMARU PENGUN COLONY; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olsen B, 1993, LYME BORRELIOSIS CYC; Overeem RL, 2008, CONSERV GENET, V9, P893, DOI 10.1007/s10592-007-9414-z; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Peucker AJ, 2009, AUK, V126, P397, DOI 10.1525/auk.2009.08055; Preston TJ, 2010, J EXP MAR BIOL ECOL, V390, P196, DOI 10.1016/j.jembe.2010.04.034; Priddel D, 2008, EMU, V108, P35, DOI 10.1071/MU07038; REILLY PN, 1983, EMU, V83, P94, DOI 10.1071/MU9830094; Roberts F.H.S., 1970, AUSTR TICKS; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stedt J, 2009, PARASITIZING BEHAV I; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Waters JM, 2006, SYST BIOL, V55, P351, DOI 10.1080/10635150600681659; Waters JM, 2008, J BIOGEOGR, V35, P417, DOI 10.1111/j.1365-2699.2007.01724.x; WEAVERS BW, 1992, EMU, V91, P302, DOI 10.1071/MU9910302; WILSON N, 1970, Pacific Insects Monograph, V23, P78	88	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128514	10.1371/journal.pone.0128514	http://dx.doi.org/10.1371/journal.pone.0128514			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083353	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400053
J	Noreen, S; Qasim, M				Noreen, Saima; Qasim, Muhammad			Influence of Hall Current and Viscous Dissipation on Pressure Driven Flow of Pseudoplastic Fluid with Heat Generation: A Mathematical Study	PLOS ONE			English	Article							INDUCED MAGNETIC-FIELD; PERISTALTIC TRANSPORT; NEWTONIAN FLUID	In this paper, we study the influence of heat sink (or source) on the peristaltic motion of pseudoplastic fluid in the presence of Hall current, where channel walls are non-conducting in nature. Flow analysis has been carried out under the approximations of a low Reynolds number and long wavelength. Coupled equations are solved using shooting method for numerical solution for the axial velocity function, temperature and pressure gradient distributions. We analyze the influence of various interesting parameters on flow quantities. The present study can be considered as a mathematical presentation of the dynamics of physiological organs with stones.	[Noreen, Saima; Qasim, Muhammad] COMSATS Inst Informat Technol, Dept Math, Islamabad 44000, Pakistan	COMSATS University Islamabad (CUI)	Noreen, S (corresponding author), COMSATS Inst Informat Technol, Dept Math, Pk Rd, Islamabad 44000, Pakistan.	laurel_lichen@yahoo.com	QASIM, MUHAMMAD/D-5593-2011	QASIM, MUHAMMAD/0000-0001-6516-9809				BOGER DV, 1977, NATURE, V265, P126, DOI 10.1038/265126a0; Eldabe NTM, 2007, PHYSICA A, V383, P253, DOI 10.1016/j.physa.2007.05.027; Gad NS, 2011, APPL MATH COMPUT, V217, P4313, DOI 10.1016/j.amc.2010.08.016; Hayat T, 2007, PHYS LETT A, V363, P397, DOI 10.1016/j.physleta.2006.10.104; Hayat T, 2012, INT J HEAT MASS TRAN, V55, P443, DOI 10.1016/j.ijheatmasstransfer.2011.09.044; Hayat T, 2011, CHEM ENG COMMUN, V198, P609, DOI 10.1080/00986445.2011.532696; Hayat T, 2013, Z NATURFORSCH A, V68, P751, DOI 10.5560/ZNA.2013-0068; Kothandapani M, 2008, INT J NONLIN MECH, V43, P915, DOI 10.1016/j.ijnonlinmec.2008.06.009; Latham T., 1966, THESIS MIT PRESS CAM; Mehmood OU, 2012, APPL MATH MECH-ENGL, V33, P1313, DOI 10.1007/s10483-012-1624-6; Mehmood OU, 2013, WASJ, V21, P36; Mekheimer KS, 2008, PHYS LETT A, V372, P1657, DOI 10.1016/j.physleta.2007.10.028; Mekheimer KS, 2010, NUMER METH PART D E, V26, P747, DOI 10.1002/num.20451; Noreen S, 2013, INDIAN J PHYS, V87, P889, DOI 10.1007/s12648-013-0316-2; Noreen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073248; Nowar K, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/389581; Ogulu A, 2006, INT COMMUN HEAT MASS, V33, P790, DOI 10.1016/j.icheatmasstransfer.2006.02.002; SHAPIRO AH, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; Siddiqui AM, 2008, COMMUN NONLINEAR SCI, V13, P1554, DOI 10.1016/j.cnsns.2006.10.005; SrinivaS S, 2008, INT COMMUN HEAT MASS, V35, P514, DOI 10.1016/j.icheatmasstransfer.2007.08.011; Srinivas S, 2011, MATH COMPUT MODEL, V54, P1213, DOI 10.1016/j.mcm.2011.03.032; Srinivas S, 2009, APPL MATH COMPUT, V213, P197, DOI 10.1016/j.amc.2009.02.054; Tripathi D, 2010, APPL MATH COMPUT, V215, P3645, DOI 10.1016/j.amc.2009.11.002	23	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129588	10.1371/journal.pone.0129588	http://dx.doi.org/10.1371/journal.pone.0129588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083027	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400101
J	Hahn, C; Weiss, SJ; Stojanovski, S; Bachmann, L				Hahn, Christoph; Weiss, Steven J.; Stojanovski, Stojmir; Bachmann, Lutz			Co-Speciation of the Ectoparasite Gyrodactylus teuchis (Monogenea, Platyhelminthes) and Its Salmonid Hosts	PLOS ONE			English	Article							MITOCHONDRIAL CONTROL REGION; BROWN TROUT POPULATIONS; ATLANTIC SALMON; THYMALLI PLATYHELMINTHES; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; TRUTTA; PARASITES; SALARIS; FISH	Co-speciation is a fundamental concept of evolutionary biology and intuitively appealing, yet in practice hard to demonstrate as it is often blurred by other evolutionary processes. We investigate the phylogeographic history of the monogenean ectoparasites Gyrodactylus teuchis and G. truttae on European salmonids of the genus Salmo. Mitochondrial cytochrome oxidase subunit 1 and the nuclear ribosomal internal transcribed spacer 2 were sequenced for 189 Gyrodactylus individuals collected from 50 localities, distributed across most major European river systems, from the Iberian-to the Balkan Peninsula. Despite both anthropogenic and naturally caused admixture of the principal host lineages among major river basins, co-phylogenetic analyses revealed significant global congruence for host and parasite phylogenies, providing firm support for co-speciation of G. teuchis and its salmonid hosts brown trout (S. trutta) and Atlantic salmon (S. salar). The major split within G. teuchis, coinciding with the initial divergence of the hosts was dated to similar to 1.5 My BP, using a Bayesian framework based on an indirect calibration point obtained from the host phylogeny. The presence of G. teuchis in Europe thus predates some of the major Pleistocene glaciations. In contrast, G. truttae exhibited remarkably low intraspecific genetic diversity. Given the direct life cycle and potentially high transmission potential of gyrodactylids, this finding is interpreted as indication for a recent emergence (<60 ky BP) of G. truttae via a host-switch. Our study thus suggests that instances of two fundamentally different mechanisms of speciation (co-speciation vs. host-switching) may have occurred on the same hosts in Europe within a time span of less than 1.5 My in two gyrodactylid ectoparasite species.	[Hahn, Christoph; Bachmann, Lutz] Univ Oslo, Nat Hist Museum, N-0318 Oslo, Norway; [Hahn, Christoph] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Weiss, Steven J.] Karl Franzens Univ Graz, Inst Zool, A-8010 Graz, Austria; [Stojanovski, Stojmir] Inst Hydrobiol, Dept Fish Parasitol, Ohrid 6000, North Macedonia	University of Oslo; University of Hull; University of Graz	Hahn, C (corresponding author), Univ Oslo, Nat Hist Museum, N-0318 Oslo, Norway.	c.hahn@hull.ac.uk	Weiss, Steven J/L-6016-2015	Weiss, Steven J/0000-0002-4734-5984; Hahn, Christoph/0000-0003-4265-4793	Natural History Museum, University of Oslo	Natural History Museum, University of Oslo	The study was financed exclusively by the Natural History Museum, University of Oslo, in the form of a PhD fellowship including material costs to CH.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, TRACER V1 6; Balbuena JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061048; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; Bakke TA, 2002, INT J PARASITOL, V32, P281, DOI 10.1016/S0020-7519(01)00331-9; Bakke TA, 1999, PARASITOLOGY, V119, P467, DOI 10.1017/S0031182099004990; Bernatchez L, 2001, EVOLUTION, V55, P351, DOI 10.1111/j.0014-3820.2001.tb01300.x; Bouza C, 2008, CONSERV GENET, V9, P917, DOI 10.1007/s10592-007-9398-8; Cable J, 2005, SYST PARASITOL, V60, P159, DOI 10.1007/s11230-004-6348-4; Cable J, 2002, INT J PARASITOL, V32, P255, DOI 10.1016/S0020-7519(01)00330-7; COHEN J, 1977, REPRODUCTION; Cortey M, 2004, MOL PHYLOGENET EVOL, V33, P831, DOI 10.1016/j.ympev.2004.08.012; Cortey M, 2002, J FISH BIOL, V60, P1058, DOI 10.1111/j.1095-8649.2002.tb02429.x; Cortey M, 2009, BIOL J LINN SOC, V97, P904, DOI 10.1111/j.1095-8312.2009.01220.x; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Cunningham CO, 2001, SYST PARASITOL, V48, P141, DOI 10.1023/A:1006407428666; Darwin C., 1877, VARIOUS CONTRIVANCES; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Descroix A, 2009, ECOL FRESHW FISH, V18, P282, DOI 10.1111/j.1600-0633.2008.00345.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duftner N, 2003, J FISH BIOL, V62, P427, DOI 10.1046/j.1095-8649.2003.00038.x; Eichler W., 1948, ANN MAG NAT HIST, V1, P588, DOI DOI 10.1080/00222934808653932; Fahrenholz H, 1913, ZOOL ANZ, V41, P371; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Fromm B, 2014, INT J PARASITOL, V44, P787, DOI 10.1016/j.ijpara.2014.05.010; Gilmore SR, 2010, J FISH DIS, V33, P461, DOI 10.1111/j.1365-2761.2010.01154.x; Hahn C, 2011, PARASITOL INT, V60, P480, DOI 10.1016/j.parint.2011.08.016; Hansen H, 2007, TRENDS PARASITOL, V23, P363, DOI 10.1016/j.pt.2007.06.007; Hansen H, 2007, PARASITOL RES, V100, P1389, DOI 10.1007/s00436-006-0423-5; Harris PD, 2004, SYST PARASITOL, V59, P1, DOI 10.1023/B:SYPA.0000038447.52015.e4; Huyse T, 2005, SYST BIOL, V54, P710, DOI 10.1080/10635150500221036; Johnson KP, 2003, SYST BIOL, V52, P37, DOI 10.1080/10635150390132704; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kellogg VL, 1913, AM NAT, V47, P129, DOI 10.1086/279337; Lautraite A, 1999, B FR PECHE PISCIC, P305, DOI 10.1051/kmae:1999001; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Lerceteau-Kohler E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-176; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Martinez JL, 2001, FRESHWATER BIOL, V46, P835, DOI 10.1046/j.1365-2427.2001.00711.x; Matejusova I, 2001, INT J PARASITOL, V31, P738, DOI 10.1016/S0020-7519(01)00176-X; Meinila M, 2004, INT J PARASITOL, V34, P515, DOI 10.1016/j.ijpara.2003.12.002; Nylander JAA., 2004, BIOINFORMATICS; Page RDM, 1996, INT J PARASITOL, V26, P213, DOI 10.1016/0020-7519(95)00115-8; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Poinar G, 2003, INVERTEBR BIOL, V122, P308, DOI 10.1111/j.1744-7410.2003.tb00095.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saura M, 2008, J FISH BIOL, V72, P1223, DOI 10.1111/j.1095-8649.2007.01782.x; Schenekar T, 2014, CONSERVATION GENETIC; Shedko S V, 2013, Genetika, V49, P718; Simkova A, 2004, EVOLUTION, V58, P1001, DOI 10.1111/j.0014-3820.2004.tb00434.x; Snoj A, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-22; Soleng A, 2001, INT J PARASITOL, V31, P793, DOI 10.1016/S0020-7519(01)00188-6; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Susnik S, 2007, MOL PHYLOGENET EVOL, V44, P63, DOI 10.1016/j.ympev.2006.08.021; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vignon M, 2011, SYST PARASITOL, V79, P161, DOI 10.1007/s11230-011-9303-1; Weiss S, 2001, MOL ECOL, V10, P1241, DOI 10.1046/j.1365-294X.2001.01261.x; Willett CS, 2012, J MOL EVOL, V74, P310, DOI 10.1007/s00239-012-9508-1; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yip KY, 2008, BIOINFORMATICS, V24, P290, DOI 10.1093/bioinformatics/btm584; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zietara MS, 2002, EVOLUTION, V56, P2445, DOI 10.1111/j.0014-3820.2002.tb00170.x	64	17	18	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0127340	10.1371/journal.pone.0127340	http://dx.doi.org/10.1371/journal.pone.0127340			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080029	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300004
J	Wang, ZH; Yang, QQ; Li, TH; Cong, PS				Wang, Zhiheng; Yang, Qianqian; Li, Tonghua; Cong, Peisheng			DisoMCS: Accurately Predicting Protein Intrinsically Disordered Regions Using a Multi-Class Conservative Score Approach	PLOS ONE			English	Article							SEQUENCE-BASED PREDICTION; NATIVELY UNFOLDED PROTEINS; UNSTRUCTURED PROTEINS; WEB SERVER; DISEASES; UNFOLDOMICS; SEGMENTS; DATABASE; WHETHER; SINGLE	The precise prediction of protein intrinsically disordered regions, which play a crucial role in biological procedures, is a necessary prerequisite to further the understanding of the principles and mechanisms of protein function. Here, we propose a novel predictor, DisoMCS, which is a more accurate predictor of protein intrinsically disordered regions. The DisoMCS bases on an original multi-class conservative score (MCS) obtained by sequence-order/disorder alignment. Initially, near-disorder regions are defined on fragments located at both the terminus of an ordered region connecting a disordered region. Then the multi-class conservative score is generated by sequence alignment against a known structure database and represented as order, near-disorder and disorder conservative scores. The MCS of each amino acid has three elements: order, near-disorder and disorder profiles. Finally, the MCS is exploited as features to identify disordered regions in sequences. DisoMCS utilizes a non-redundant data set as the training set, MCS and predicted secondary structure as features, and a conditional random field as the classification algorithm. In predicted near-disorder regions a residue is determined as an order or a disorder according to the optimized decision threshold. DisoMCS was evaluated by cross-validation, large-scale prediction, independent tests and CASP (Critical Assessment of Techniques for Protein Structure Prediction) tests. All results confirmed that DisoMCS was very competitive in terms of accuracy of prediction when compared with well-established publicly available disordered region predictors. It also indicated our approach was more accurate when a query has higher homologous with the knowledge database.	[Wang, Zhiheng; Yang, Qianqian; Li, Tonghua; Cong, Peisheng] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China	Tongji University	Li, TH (corresponding author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.	lith@tongji.edu.cn; pshcong@tongji.edu.cn			National Natural Science Foundation of China [21275108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (21275108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082252; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bulashevska A, 2008, J THEOR BIOL, V254, P799, DOI 10.1016/j.jtbi.2008.05.040; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Cong PS, 2013, BIOCHIMIE, V95, P2460, DOI 10.1016/j.biochi.2013.09.007; Deng X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-436; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eickholt J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-88; Eickholt J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-43; Galzitskaya OV, 2006, BIOINFORMATICS, V22, P2948, DOI 10.1093/bioinformatics/btl504; Hirose S, 2007, BIOINFORMATICS, V23, P2046, DOI 10.1093/bioinformatics/btm302; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Lafferty John, 2001, P INT C MACH LEARN, P282; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lobanov MY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000958; McGuffin LJ, 2008, BIOINFORMATICS, V24, P1798, DOI 10.1093/bioinformatics/btn326; Midic U, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S12; Mizianty MJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-245; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Shimizu K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-78; Shimizu K, 2007, BIOINFORMATICS, V23, P2337, DOI 10.1093/bioinformatics/btm330; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sormanni P, 2015, J MOL BIOL, V427, P982, DOI 10.1016/j.jmb.2014.12.007; Su CT, 2007, NUCLEIC ACIDS RES, V35, pW465, DOI 10.1093/nar/gkm353; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2008, CURR ALZHEIMER RES, V5, P260, DOI 10.2174/156720508784533312; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Walsh I, 2011, NUCLEIC ACIDS RES, V39, pW190, DOI 10.1093/nar/gkr411; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang LX, 2008, BIOINFORMATICS, V24, P1401, DOI 10.1093/bioinformatics/btn132; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; WILLIAMS RJP, 1979, BIOL REV, V54, P389, DOI 10.1111/j.1469-185X.1979.tb00843.x; Xue B, 2009, FEBS LETT, V583, P1469, DOI 10.1016/j.febslet.2009.03.070; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022	51	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128334	10.1371/journal.pone.0128334	http://dx.doi.org/10.1371/journal.pone.0128334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090958	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835000017
J	Pinhasi, R; Fernandes, D; Sirak, K; Novak, M; Connell, S; Alpaslan-Roodenberg, S; Gerritsen, F; Moiseyev, V; Gromov, A; Raczky, P; Anders, A; Pietrusewsky, M; Rollefson, G; Jovanovic, M; Trinhhoang, H; Bar-Oz, G; Oxenham, M; Matsumura, H; Hofreiter, M				Pinhasi, Ron; Fernandes, Daniel; Sirak, Kendra; Novak, Mario; Connell, Sarah; Alpaslan-Roodenberg, Songul; Gerritsen, Fokke; Moiseyev, Vyacheslav; Gromov, Andrey; Raczky, Pal; Anders, Alexandra; Pietrusewsky, Michael; Rollefson, Gary; Jovanovic, Marija; Trinhhoang, Hiep; Bar-Oz, Guy; Oxenham, Marc; Matsumura, Hirofumi; Hofreiter, Michael			Optimal Ancient DNA Yields from the Inner Ear Part of the Human Petrous Bone	PLOS ONE			English	Article							GENOME SEQUENCE; EXTRACTION; PATTERNS; SURVIVAL; DAMAGE	The invention and development of next or second generation sequencing methods has resulted in a dramatic transformation of ancient DNA research and allowed shotgun sequencing of entire genomes from fossil specimens. However, although there are exceptions, most fossil specimens contain only low (similar to 1% or less) percentages of endogenous DNA. The only skeletal element for which a systematically higher endogenous DNA content compared to other skeletal elements has been shown is the petrous part of the temporal bone. In this study we investigate whether (a) different parts of the petrous bone of archaeological human specimens give different percentages of endogenous DNA yields, (b) there are significant differences in average DNA read lengths, damage patterns and total DNA concentration, and (c) it is possible to obtain endogenous ancient DNA from petrous bones from hot environments. We carried out intra-petrous comparisons for ten petrous bones from specimens from Holocene archaeological contexts across Eurasia dated between 10,0001,800 calibrated years before present (cal. BP). We obtained shotgun DNA sequences from three distinct areas within the petrous: a spongy part of trabecular bone (part A), the dense part of cortical bone encircling the osseous inner ear, or otic capsule (part B), and the dense part within the otic capsule (part C). Our results confirm that dense bone parts of the petrous bone can provide high endogenous aDNA yields and indicate that endogenous DNA fractions for part C can exceed those obtained for part B by up to 65-fold and those from part A by up to 177-fold, while total endogenous DNA concentrations are up to 126-fold and 109-fold higher for these comparisons. Our results also show that while endogenous yields from part C were lower than 1% for samples from hot (both arid and humid) parts, the DNA damage patterns indicate that at least some of the reads originate from ancient DNA molecules, potentially enabling ancient DNA analyses of samples from hot regions that are otherwise not amenable to ancient DNA analyses.	[Pinhasi, Ron; Fernandes, Daniel; Novak, Mario; Connell, Sarah] Univ Coll Dublin, Sch Archaeol, Dublin 4, Ireland; [Pinhasi, Ron; Fernandes, Daniel; Novak, Mario; Connell, Sarah] Univ Coll Dublin, Earth Inst, Dublin 4, Ireland; [Sirak, Kendra] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Gerritsen, Fokke] Netherlands Inst Turkey, Istanbul, Turkey; [Moiseyev, Vyacheslav; Gromov, Andrey] Russian Acad Sci, Peter Great Museum Anthropol & Ethnog Kunstkamera, St Petersburg, Russia; [Raczky, Pal; Anders, Alexandra] Eotvos Lorand Univ Univ, Fac Humanities, Inst Archaeol Sci, Budapest, Hungary; [Pietrusewsky, Michael] Univ Hawaii Manoa, Dept Anthropol, Honolulu, HI 96822 USA; [Rollefson, Gary] Whitman Coll, Walla Walla, WA 99362 USA; [Jovanovic, Marija] Museum Vojvodina, Novi Sad 21000, Serbia; [Trinhhoang, Hiep] Inst Archaeol, Hanoi, Vietnam; [Bar-Oz, Guy] Univ Haifa, Zinman Inst Archaeol, Har Hakarmel, Israel; [Oxenham, Marc] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Matsumura, Hirofumi] Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Hofreiter, Michael] Univ Potsdam, Fac Math & Nat Sci, Inst Biochem & Biol, D-14476 Potsdam Golm, Germany; [Hofreiter, Michael] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University College Dublin; University College Dublin; Emory University; Netherlands Institute in Turkey; Russian Academy of Sciences; The Kunstkamera; University of Hawaii System; University of Hawaii Manoa; Whitman College; University of Haifa; Australian National University; Sapporo Medical University; University of Potsdam; University of York - UK	Pinhasi, R (corresponding author), Univ Coll Dublin, Sch Archaeol, Dublin 4, Ireland.	ron.pinhasi@ucd.ie	Moiseyev, Vyacheslav/AAD-2659-2019; BarOz, Guy/ABF-6518-2020; Novak, Mario/AAW-6417-2021; Novak, Mario/AAX-1795-2021; Anders, Alexandra/I-6999-2017; Pinhasi, Ron/AAT-1531-2020; Raczky, Pál/AAY-1635-2021; Hofreiter, Michael/A-3996-2017	BarOz, Guy/0000-0002-1009-5619; Pinhasi, Ron/0000-0003-1629-8131; Raczky, Pál/0000-0001-5556-723X; Pietrusewsky, Michael/0000-0002-6886-0950; Hofreiter, Michael/0000-0003-0441-4705; M Fernandes, Daniel/0000-0002-7434-6552; Novak, Mario/0000-0002-4567-8742	Ron Pinhasi's European Research Council [ERC-2010-StG 263441]; ERC Grant (ADNABIOARC) [263441]; ERC grant GeneFlow [310763]	Ron Pinhasi's European Research Council; ERC Grant (ADNABIOARC); ERC grant GeneFlow	This research was supported by Ron Pinhasi's European Research Council Starting grant (ERC-2010-StG 263441); ERC Grant to RP (ADNABIOARC, 263441); MH was supported by ERC grant GeneFlow (310763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CJ, 2011, J ARCHAEOL SCI, V38, P956, DOI 10.1016/j.jas.2010.11.010; Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Barta JL, 2014, FORENSIC SCI INT, V239, P11, DOI 10.1016/j.forsciint.2014.02.029; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Edson SM, 2009, FORENS SCI INT-GEN S, V2, P269, DOI 10.1016/j.fsigss.2009.09.029; Ekdale EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066624; Frisch T, 1998, BONE, V22, P677, DOI 10.1016/S8756-3282(98)00050-7; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gilbert MTP, 2005, AM J PHYS ANTHROPOL, V128, P110, DOI 10.1002/ajpa.20045; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Higgins Denice, 2013, Investig Genet, V4, P18, DOI 10.1186/2041-2223-4-18; KOLLIAS SS, 2004, RADIOLOGY PETROUS BO; Kruttli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086251; Leney MD, 2006, HIST ARCHAEOL, V40, P31, DOI 10.1007/BF03376731; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MacHugh DE., 2000, ANCIENT BIOMOLECULES, V3, P81; Mansour S., 2013, COMPREHENSIVE CLIN A, V1st ed., DOI [10.1007/978-3-642-36967-4, DOI 10.1007/978-3-642-36967-4]; Margaryan A, 2015, 014985 BIORXIV, DOI [10.1101/014985, DOI 10.1101/014985]; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Meyer M., 2010, COLD SPRING HARB PRO, V2010, P5448; Misner LM, 2009, J FORENSIC SCI, V54, P822, DOI 10.1111/j.1556-4029.2009.01043.x; Prinz M, 2007, FORENSIC SCI INT-GEN, V1, P3, DOI 10.1016/j.fsigen.2006.10.003; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; SORENSEN MS, 1992, ACTA OTO-LARYNGOL, V112, P462, DOI 10.3109/00016489209137427; Warinner C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0376; Weyrich LS, 2015, J HUM EVOL, V79, P119, DOI 10.1016/j.jhevol.2014.06.018; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	34	158	162	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129102	10.1371/journal.pone.0129102	http://dx.doi.org/10.1371/journal.pone.0129102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CK9NT	26086078	Green Published, gold			2022-12-26	WOS:000356567500033
J	Scoles, DR; Ho, MHT; Dansithong, W; Pflieger, LT; Petersen, LW; Thai, KK; Pulst, SM				Scoles, Daniel R.; Ho, Mi H. T.; Dansithong, Warunee; Pflieger, Lance T.; Petersen, Lance W.; Thai, Khanh K.; Pulst, Stefan M.			Repeat Associated Non-AUG Translation (RAN Translation) Dependent on Sequence Downstream of the ATXN2 CAG Repeat	PLOS ONE			English	Article							NUCLEOTIDE RESOLUTION; MAMMALIAN-CELLS; FRAGILE-X; RNA; INITIATION; DISEASE; C9ORF72; NEURODEGENERATION; EXPANSION; PROTEINS	Spinocerebellar ataxia type 2 (SCA2) is a progressive autosomal dominant disorder caused by the expansion of a CAG tract in the ATXN2 gene. The SCA2 disease phenotype is characterized by cerebellar atrophy, gait ataxia, and slow saccades. ATXN2 mutation causes gains of toxic and normal functions of the ATXN2 gene product, ataxin-2, and abnormally slow Purkinje cell firing frequency. Previously we investigated features of ATXN2 controlling expression and noted expression differences for ATXN2 constructs with varying CAG lengths, suggestive of repeat associated non-AUG translation (RAN translation). To determine whether RAN translation occurs for ATXN2 we assembled various ATXN2 constructs with ATXN2 tagged by luciferase, HA or FLAG tags, driven by the CMV promoter or the ATXN2 promoter. Luciferase expression from ATXN2-luciferase constructs lacking the ATXN2 start codon was weak vs AUG translation, regardless of promoter type, and did not increase with longer CAG repeat lengths. RAN translation was detected on western blots by the anti-polyglutamine antibody 1C2 for constructs driven by the CMV promoter but not the ATXN2 promoter, and was weaker than AUG translation. Strong RAN translation was also observed when driving the ATXN2 sequence with the CMV promoter with ATXN2 sequence downstream of the CAG repeat truncated to 18 bp in the polyglutamine frame but not in the polyserine or polyalanine frames. Our data demonstrate that ATXN2 RAN translation is weak compared to AUG translation and is dependent on ATXN2 sequences flanking the CAG repeat.	[Scoles, Daniel R.; Ho, Mi H. T.; Dansithong, Warunee; Pflieger, Lance T.; Petersen, Lance W.; Thai, Khanh K.; Pulst, Stefan M.] Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Scoles, DR (corresponding author), Univ Utah, Dept Neurol, 175 North Med Dr East,5th Floor, Salt Lake City, UT 84132 USA.	Daniel.Scoles@hsc.utah.edu		Pflieger, Lance/0000-0003-2237-5674	National Institutes of Neurological Disorders and Stroke [R01NS33123, R56NS33123, R37NS033123]; Noorda foundation; Target ALS Foundation;  [RC4NS073009];  [R21NS081182]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS033123, R21NS081182, R37NS033123, R01NS033123, RC4NS073009] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Noorda foundation; Target ALS Foundation; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants R01NS33123, R56NS33123 and R37NS033123 from the National Institutes of Neurological Disorders and Stroke to SMP, the Noorda foundation to SMP, and grants RC4NS073009 and R21NS081182 to DRS and SMP. SMP received grant support from the Target ALS Foundation and is a consultant for Ataxion Pharmaceuticals. DRS and SMP are consultants for Progenitor Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2010, HUM MOL GENET, V19, P2380, DOI 10.1093/hmg/ddq111; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Belzil VV, 2012, MOL CELL NEUROSCI; Boy J, 2009, HUM MOL GENET, V18, P4282, DOI 10.1093/hmg/ddp381; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Echeverria GV, 2012, BRAIN RES, V1462, P100, DOI 10.1016/j.brainres.2012.02.030; Fernandez M, 2000, NEUROLOGY, V55, P569, DOI 10.1212/WNL.55.4.569; Figueroa KP, 2003, EXP NEUROL, V184, P669, DOI 10.1016/S0014-4886(03)00287-5; GACY AM, 1995, CELL, V81, P533; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Lashley T, 2013, NEURON, V77, P597, DOI 10.1016/j.neuron.2013.02.009; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ragothaman M, 2004, ANN NEUROL, V55, P130, DOI 10.1002/ana.10815; Reddy K, 2013, NEURON, V78, P405, DOI 10.1016/j.neuron.2013.04.034; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renoux AJ, 2012, PROG NEUROBIOL, V97, P173, DOI 10.1016/j.pneurobio.2011.10.006; Scoles DR, 2012, HUM MOL GENET, V21, P5048, DOI 10.1093/hmg/dds349; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Taylor JP, 2013, SCIENCE, V339, P1282, DOI 10.1126/science.1236450; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Toulouse A, 2005, HUM MOL GENET, V14, P2649, DOI 10.1093/hmg/ddi299; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	33	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128769	10.1371/journal.pone.0128769	http://dx.doi.org/10.1371/journal.pone.0128769			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086378	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500022
J	Fisichelli, NA; Schuurman, GW; Monahan, WB; Ziesler, PS				Fisichelli, Nicholas A.; Schuurman, Gregor W.; Monahan, William B.; Ziesler, Pamela S.			Protected Area Tourism in a Changing Climate: Will Visitation at US National Parks Warm Up or Overheat?	PLOS ONE			English	Article								Climate change will affect not only natural and cultural resources within protected areas but also tourism and visitation patterns. The U.S. National Park Service systematically collects data regarding its 270+ million annual recreation visits, and therefore provides an opportunity to examine how human visitation may respond to climate change from the tropics to the polar regions. To assess the relationship between climate and park visitation, we evaluated historical monthly mean air temperature and visitation data (1979-2013) at 340 parks and projected potential future visitation (2041-2060) based on two warming-climate scenarios and two visitation-growth scenarios. For the entire park system a third-order polynomial temperature model explained 69% of the variation in historical visitation trends. Visitation generally increased with increasing average monthly temperature, but decreased strongly with temperatures > 25 degrees C. Linear to polynomial monthly temperature models also explained historical visitation at individual parks (R-2 0.12-0.99, mean = 0.79, median = 0.87). Future visitation at almost all parks (95%) may change based on historical temperature, historical visitation, and future temperature projections. Warming-mediated increases in potential visitation are projected for most months in most parks (67-77% of months; range across future scenarios), resulting in future increases in total annual visits across the park system (8-23%) and expansion of the visitation season at individual parks (13-31 days). Although very warm months at some parks may see decreases in future visitation, this potential change represents a relatively small proportion of visitation across the national park system. A changing climate is likely to have cascading and complex effects on protected area visitation, management, and local economies. Results suggest that protected areas and neighboring communities that develop adaptation strategies for these changes may be able to both capitalize on opportunities and minimize detriment related to changing visitation.	[Fisichelli, Nicholas A.; Schuurman, Gregor W.; Monahan, William B.; Ziesler, Pamela S.] Natl Pk Serv, Nat Resource Sci & Stewardship, Ft Collins, CO 80525 USA	United States Department of the Interior	Fisichelli, NA (corresponding author), Natl Pk Serv, Nat Resource Sci & Stewardship, Ft Collins, CO 80525 USA.	nicholas_fisichelli@nps.gov						Albano C.M., 2013, PARK SCI, V30, P37; Amelung B., 2007, Journal of Travel Research, V45, P285, DOI 10.1177/0047287506295937; [Anonymous], 2014, R LANG ENV STAT COMP; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bigano A, 2006, CLIMATIC CHANGE, V79, P175, DOI 10.1007/s10584-006-9190-7; Buckley LB, 2012, INT J BIOMETEOROL, V56, P1173, DOI 10.1007/s00484-011-0508-4; CARRARA PE, 1981, ARCTIC ALPINE RES, V13, P183, DOI 10.2307/1551194; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Dolanc CR, 2013, GLOBAL ECOL BIOGEOGR, V22, P264, DOI 10.1111/j.1466-8238.2011.00748.x; Endler C, 2010, INT J BIOMETEOROL, V54, P45, DOI 10.1007/s00484-009-0251-2; Giersch JJ, 2015, FRESHW SCI, V34, P53, DOI 10.1086/679490; Gossling S, 2012, ANN TOURISM RES, V39, P36, DOI 10.1016/j.annals.2011.11.002; Hadwen WL, 2011, TOURISM GEOGR, V13, P187, DOI 10.1080/14616688.2011.569568; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; MIECZKOWSKI Z, 1985, CAN GEOGR-GEOGR CAN, V29, P220, DOI 10.1111/j.1541-0064.1985.tb00365.x; Monahan WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101302; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; National Park Service (NPS), 2014, NAT PARK SERV; National Park Service (NPS), NAT PARK SERV VIS US; NPS, 2010, US PRES PROJ STAND; Recreation Advisory Council Study Committee Number Two, 1965, UN METH MEAS REP REC, P56; Richardson RB, 2005, J LEISURE RES, V37, P307, DOI 10.1080/00222216.2005.11950055; Rossello-Nadal J, 2014, TOURISM MANAGE, V42, P334, DOI 10.1016/j.tourman.2013.11.006; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott D, 2010, PROCEDIA ENVIRON SCI, V1, P146, DOI 10.1016/j.proenv.2010.09.011; Scott D, 2007, TOURISM MANAGE, V28, P570, DOI 10.1016/j.tourman.2006.04.020; Scott D, 2012, WIRES CLIM CHANGE, V3, P213, DOI 10.1002/wcc.165; Stegner W., 1999, MARKING SPARROWS FAL; Thomas C. C., 2014, NPSNRSSEQDNRR2014824; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; WTTC: World Travel & Tourism Council, 2014, TRAV TOUR EC IMP 201	32	84	94	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128226	10.1371/journal.pone.0128226	http://dx.doi.org/10.1371/journal.pone.0128226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NS	26083361	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400034
J	Hand, SJ; Lee, DE; Worthy, TH; Archer, M; Worthy, JP; Tennyson, AJD; Salisbury, SW; Scofield, RP; Mildenhall, DC; Kennedy, EM; Lindqvist, JK				Hand, Suzanne J.; Lee, Daphne E.; Worthy, Trevor H.; Archer, Michael; Worthy, Jennifer P.; Tennyson, Alan J. D.; Salisbury, Steven W.; Scofield, R. Paul; Mildenhall, Dallas C.; Kennedy, Elizabeth M.; Lindqvist, Jon K.			Miocene Fossils Reveal Ancient Roots for New Zealand's Endemic Mystacina (Chiroptera) and Its Rainforest Habitat	PLOS ONE			English	Article							SHORT-TAILED BAT; MOLECULAR PHYLOGENY; MANUHERIKIA GROUP; CENTRAL-OTAGO; BODY-MASS; TUBERCULATA; LONG; OLIGOCENE; MICROCHIROPTERA; OLIGOMIOCENE	The New Zealand endemic bat family Mystacinidae comprises just two Recent species referred to a single genus, Mystacina. The family was once more diverse and widespread, with an additional six extinct taxa recorded from Australia and New Zealand. Here, a new mystacinid is described from the early Miocene (19-16 Ma) St Bathans Fauna of Central Otago, South Island, New Zealand. It is the first pre-Pleistocene record of the modern genus and it extends the evolutionary history of Mystacina back at least 16 million years. Extant Mystacina species occupy old-growth rainforest and are semi-terrestrial with an exceptionally broad omnivorous diet. The majority of the plants inhabited, pollinated, dispersed or eaten by modern Mystacina were well-established in southern New Zealand in the early Miocene, based on the fossil record from sites at or near where the bat fossils are found. Similarly, many of the arthropod prey of living Mystacina are recorded as fossils in the same area. Although none of the Miocene plant and arthropod species is extant, most are closely related to modern taxa, demonstrating potentially long-standing ecological associations with Mystacina.	[Hand, Suzanne J.; Archer, Michael] Univ New S Wales, Sch Biol Environm & Earth Sci, Sydney, NSW, Australia; [Lee, Daphne E.; Lindqvist, Jon K.] Univ Otago, Dept Geol, Dunedin, New Zealand; [Worthy, Trevor H.; Worthy, Jennifer P.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Tennyson, Alan J. D.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand; [Salisbury, Steven W.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Scofield, R. Paul] Canterbury Museum, Christchurch, New Zealand; [Mildenhall, Dallas C.; Kennedy, Elizabeth M.] GNS Sci, Lower Hutt, New Zealand	University of New South Wales Sydney; University of Otago; Flinders University South Australia; University of Queensland; GNS Science - New Zealand	Hand, SJ (corresponding author), Univ New S Wales, Sch Biol Environm & Earth Sci, Sydney, NSW, Australia.	s.hand@unsw.edu.au	Worthy, Trevor/B-3781-2012; Salisbury, Steven W./A-7518-2011; Scofield, R. Paul/A-4271-2011	Worthy, Trevor/0000-0001-7047-4680; Salisbury, Steven W./0000-0003-4097-8567; Scofield, R. Paul/0000-0002-7510-6980; Kennedy, Elizabeth/0000-0002-1989-779X; Archer, Michael/0000-0002-0304-4039; Hand, Suzanne/0000-0002-4940-3391	Australian Research Council [DP120100486, DP130100197]; Marsden Grant from the Royal Society of New Zealand	Australian Research Council(Australian Research Council); Marsden Grant from the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	This research has been supported by Australian Research Council grants DP120100486 and DP130100197 and a Marsden Grant from the Royal Society of New Zealand.	ARCHER M, 1978, Proceedings of the Royal Society of Queensland, V89, P23; Arkins AM, 1999, J ZOOL, V247, P183, DOI 10.1111/j.1469-7998.1999.tb00982.x; Birch JL, 2012, MOL PHYLOGENET EVOL, V65, P102, DOI 10.1016/j.ympev.2012.05.031; Carpenter RJ, 2012, AUST SYST BOT, V25, P375, DOI 10.1071/SB12018; Carter Gerald G., 2006, Mammalian Species, P1; Carthew SM, 1997, TRENDS ECOL EVOL, V12, P104, DOI 10.1016/S0169-5347(96)10067-7; Cummings G, 2014, J ZOOL, V293, P281, DOI 10.1111/jzo.12147; Czaplewski NJ, 2012, CAM STUD MORPHOL MOL, P162; Daniel M.J., 1990, P123; DANIEL MJ, 1979, NEW ZEAL J ZOOL, V6, P357, DOI 10.1080/03014223.1979.10428375; DANIEL MJ, 1976, NEW ZEAL J ZOOL, V3, P391, DOI 10.1080/03014223.1976.9517927; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; Davalos LM, 2012, BIOL REV, V87, P991, DOI 10.1111/j.1469-185X.2012.00240.x; Dobson G. E., 1884, Annals of Natural History, V(5), P153; Dwyer P. D., 1962, Zool Pub Victoria Univ Wellington, VNo. 28, P1; DWYER P. D., 1960, TUATARA, V8, P61; Ecroyd CE, 1996, NAT CONSERV SER, V4, P78; Eiting TP, 2009, J MAMM EVOL, V16, P151, DOI 10.1007/s10914-009-9118-x; Fleming TH, 2009, ANN BOT-LONDON, V104, P1017, DOI 10.1093/aob/mcp197; FREEMAN PW, 1988, BIOL J LINN SOC, V33, P249, DOI 10.1111/j.1095-8312.1988.tb00811.x; Gaina C, 1998, J GEOPHYS RES-SOL EA, V103, P12413, DOI 10.1029/98JB00386; Giannini NP, 2012, CAM STUD MORPHOL MOL, P530; Gunnell GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086712; Gunnell GF, 2009, ACTA CHIROPTEROL, V11, P271, DOI 10.3161/150811009X485512; Hand S, 2005, GEOBIOS-LYON, V38, P339, DOI 10.1016/j.geobios.2003.11.005; HAND S J, 1990, Memoirs of the Queensland Museum, V28, P175; Hand S, 2009, ROUTL CRIT THINKERS, P9; Hand SJ, 1998, J PALEONTOL, V72, P538, DOI 10.1017/S0022336000024318; Hand SJ, 2013, J VERTEBR PALEONTOL, V33, P1442, DOI 10.1080/02724634.2013.775950; Jones MEH, 2009, P ROY SOC B-BIOL SCI, V276, P1385, DOI 10.1098/rspb.2008.1785; Jordan GJ, 2011, AUST SYST BOT, V24, P121, DOI 10.1071/SB11004; Kaulfuss U, 2015, LETHAIA, V48, P299, DOI 10.1111/let.12106; Kaulfuss U, 2010, ACTA GEOL SIN-ENGL, V84, P705, DOI 10.1111/j.1755-6724.2010.00275.x; Kennedy M, 1999, MOL PHYLOGENET EVOL, V13, P405, DOI 10.1006/mpev.1999.0660; Lee DE, 2014, NEW ZEAL J GEOL GEOP, V57, P195, DOI 10.1080/00288306.2014.898666; Lee DE, 2012, BOT REV, V78, P235, DOI 10.1007/s12229-012-9102-7; Lee MSY, 2009, BIOL LETTERS, V5, P833, DOI 10.1098/rsbl.2009.0440; Lindqvist JK., 1994, PHANEROZOIC STROMATO, P227; Lloyd BD, 2002, NEW ZEAL J ECOL, V26, P53; Lloyd BD, 2001, J ROY SOC NEW ZEAL, V31, P59, DOI 10.1080/03014223.2001.9517639; Lloyd BD, 2005, HDB NZ MAMMALS, P111; Maciunas E, 2011, AUST SYST BOT, V24, P19, DOI 10.1071/SB10035; Macphail MK, 1980, NEW ZEAL J BOT, V18, P148; Mccartney J, 2007, NEW ZEAL J ZOOL, V34, P227, DOI 10.1080/03014220709510081; Mildenhall D. C., 1989, NZ GEOLOGICAL SURVEY, V59, P1; Mildenhall DC, 2014, REV PALAEOBOT PALYNO, V204, P27, DOI 10.1016/j.revpalbo.2014.02.003; MILDENHALL DC, 1989, J ROY SOC NEW ZEAL, V19, P19; Mildenhall DC, 1980, NZ J GEOLOGY GEOPHYS, V22, P499; Miller Jr G.S., 1907, B US NAT MUS, V57, P1; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; Monteiro LR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-137; O'Donnell CFJ, 1999, SEARCH PEKAPEKA BATS; O'Donnell Colin F.J., 2009, P460; ODONNELL CFJ, 2005, HDB NZ MAMMALS, P98; Pattemore DE, 2012, P ROY SOC B-BIOL SCI, V279, P1597, DOI 10.1098/rspb.2011.2036; POCKNALL DT, 1989, NEW ZEAL J GEOL GEOP, V32, P371, DOI 10.1080/00288306.1989.10425716; Pole M, 1998, J ROY SOC NEW ZEAL, V28, P405, DOI 10.1080/03014223.1998.9517572; Pole M, 2003, J ROY SOC NEW ZEAL, V33, P415, DOI 10.1080/03014223.2003.9517737; Pole M, 2007, AUST J BOT, V55, P118, DOI 10.1071/BT06055; Pole M, 2014, PALAEONTOL ELECTRON, V17; Raine JI, 2011, GNS SCI MISCELLANEOU, V4; Ravel A, 2015, J SYST PALAEONTOL, V13, P691, DOI 10.1080/14772019.2014.941422; Reichgelt T, 2015, J PALEOLIMNOL, V53, P349, DOI 10.1007/s10933-015-9827-5; Riskin DK, 2006, J EXP BIOL, V209, P1725, DOI 10.1242/jeb.02186; Rojas D, 2011, MOL ECOL, V20, P2217, DOI 10.1111/j.1365-294X.2011.05082.x; Rojas-Martinez A, 1999, J BIOGEOGR, V26, P1065, DOI 10.1046/j.1365-2699.1999.00354.x; Samonds KE, 2014, J VERTEBR PALEONTOL, V2014, P220; Schwarzhans W, 2012, ACTA PALAEONTOL POL, V57, P319, DOI 10.4202/app.2010.0127; Sedgeley JA, 2003, NEW ZEAL J ZOOL, V30, P227, DOI 10.1080/03014223.2003.9518341; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; SUSSMAN RW, 1978, SCIENCE, V200, P731, DOI 10.1126/science.200.4343.731; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tennyson AJD, 2010, REC AUST MUS, V62, P105, DOI 10.3853/j.0067-1975.62.2010.1546; Van den Bussche RA, 2000, J MAMMAL, V81, P865, DOI 10.1644/1545-1542(2000)081<0865:FEFIOT>2.3.CO;2; Walton D.W., 1970, pUnpaginated; Wood JR, 2012, CONSERV BIOL, V26, P1091, DOI 10.1111/j.1523-1739.2012.01931.x; Worthy TH, 2007, J SYST PALAEONTOL, V5, P1, DOI 10.1017/S1477201906001957; Worthy TH, 2013, J ROY SOC NEW ZEAL, V43, P211, DOI 10.1080/03036758.2013.825300; Worthy T. H., 2002, LOST WORLD MOA PREHI; Worthy T.H., 2011, GEOSCIENCES SOC NZ A, V130A, P120; Worthy TH, 1996, NEW ZEAL J ZOOL, V23, P99, DOI 10.1080/03014223.1996.9518071; Worthy TH, 2004, NEW ZEAL J ZOOL, V31, P351, DOI 10.1080/03014223.2004.9518388; WORTHY TH, 1994, ALCHERINGA, V18, P229, DOI 10.1080/03115519408619497; Worthy TH, 2006, P NATL ACAD SCI USA, V103, P19419, DOI 10.1073/pnas.0605684103; Worthy Trevor H., 2013, P63; Worthy TH, 2011, J VERTEBR PALEONTOL, V31, P1102, DOI 10.1080/02724634.2011.595857; [No title captured]	88	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128871	10.1371/journal.pone.0128871	http://dx.doi.org/10.1371/journal.pone.0128871			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083758	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400070
J	Ikeda, T; Takahashi, T; Tsujita, M; Kanazawa, M; Toriyabe, M; Koyama, M; Itoh, K; Nakada, T; Nishizawa, M; Shimohata, T				Ikeda, Tetsuhiko; Takahashi, Tetsuya; Tsujita, Mika; Kanazawa, Masato; Toriyabe, Masafumi; Koyama, Misaki; Itoh, Kosuke; Nakada, Tsutomu; Nishizawa, Masatoyo; Shimohata, Takayoshi			Effects of Alda-1, an Aldehyde Dehydrogenase-2 Agonist, on Hypoglycemic Neuronal Death	PLOS ONE			English	Article							BRAIN-INJURY; COGNITIVE IMPAIRMENT; DAMAGE; SUPEROXIDE; ACTIVATION; HEART; RAT	Hypoglycemic encephalopathy (HE) is caused by a lack of glucose availability to neuronal cells, and no neuroprotective drugs have been developed as yet. Studies on the pathogenesis of HE and the development of new neuroprotective drugs have been conducted using animal models such as the hypoglycemic coma model and non-coma hypoglycemia model. However, both models have inherent problems, and establishment of animal models that mimic clinical situations is desirable. In this study, we first developed a short-term hypoglycemic coma model in which rats could be maintained in an isoelectric electroencephalogram (EEG) state for 2 min and subsequent hyperglycemia without requiring anti-seizure drugs and an artificial ventilation. This condition caused the production of 4-hydroxy-2-nonenal (4-HNE), a cytotoxic aldehyde, in neurons of the hippocampus and cerebral cortex, and a marked increase in neuronal death as evaluated by Fluoro-Jade B (FJB) staining. We also investigated whether N-(1,3-benzodioxole-5-ylmethyl)-2,6-dichlorobenzamide (Alda-1), a small-molecule agonist of aldehyde dehydrogenase-2, could attenuate 4-HNE levels and reduce hypoglycemic neuronal death. After confirming that EEG recordings remained isoelectric for 2 min, Alda-1 (8.5 mg/kg) or vehicle (dimethyl sulfoxide; DMSO) was administered intravenously with glucose to maintain a blood glucose level of 250 to 270 mg/dL. Fewer 4-HNE and FJB-positive cells were observed in the cerebral cortex of Alda-1-treated rats than in DMSO-treated rats 24 h after glucose administration (P = 0.002 and P = 0.020). Thus, activation of the ALDH2 pathway could be a molecular target for HE treatment, and Alda-1 is a potentially neuroprotective agent that exerts a beneficial effect on neurons when intravenously administered simultaneously with glucose.	[Ikeda, Tetsuhiko; Takahashi, Tetsuya; Kanazawa, Masato; Toriyabe, Masafumi; Koyama, Misaki; Nishizawa, Masatoyo; Shimohata, Takayoshi] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; [Tsujita, Mika; Itoh, Kosuke; Nakada, Tsutomu] Niigata Univ, Brain Res Inst, Dept Ctr Integrated Human Brain Sci, Niigata, Japan	Niigata University; Niigata University	Shimohata, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan.	t-shimo@bri.niigata-u.ac.jp	Kanazawa, Masato/AAK-1982-2020; Itoh, Kosuke/ABI-2750-2020; Kanazawa, Masato/J-3267-2017	Kanazawa, Masato/0000-0001-6337-8156; Itoh, Kosuke/0000-0003-0289-8048	Grant for Promotion of Niigata University Research Projects	Grant for Promotion of Niigata University Research Projects	This work was supported by a grant from Grant for Promotion of Niigata University Research Projects.	AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; Cathy A., 1996, EXOTIC COMPANION MED; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; de Courten-Myers GM, 2000, J CEREBR BLOOD F MET, V20, P82, DOI 10.1097/00004647-200001000-00012; Eaton P, 1999, AM J PHYSIOL-HEART C, V276, pH935, DOI 10.1152/ajpheart.1999.276.3.H935; FISCHER KF, 1986, NEW ENGL J MED, V315, P1245, DOI 10.1056/NEJM198611133152002; Haces ML, 2010, NEUROSCIENCE, V165, P28, DOI 10.1016/j.neuroscience.2009.10.003; Haces ML, 2008, EXP NEUROL, V211, P85, DOI 10.1016/j.expneurol.2007.12.029; HUGHES RN, 1972, PSYCHOPHARMACOLOGIA, V27, P359, DOI 10.1007/BF00429389; Ikeda T, 2013, DIABETES RES CLIN PR, V101, P159, DOI 10.1016/j.diabres.2013.05.007; Kawai H, 2011, BRAIN RES, V1368, P317, DOI 10.1016/j.brainres.2010.10.046; Keller JN, 1998, J NEUROSCI, V18, P687; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; SELTZER HS, 1989, ENDOCRIN METAB CLIN, V18, P163, DOI 10.1016/S0889-8529(18)30395-5; Shin BS, 2010, J CEREBR BLOOD F MET, V30, P390, DOI 10.1038/jcbfm.2009.229; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2005, DIABETES, V54, P1452, DOI 10.2337/diabetes.54.5.1452; Suh SW, 2003, J NEUROSCI, V23, P10681; Tkacs NC, 2005, J CEREBR BLOOD F MET, V25, P1645, DOI 10.1038/sj.jcbfm.9600152	21	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128844	10.1371/journal.pone.0128844	http://dx.doi.org/10.1371/journal.pone.0128844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083658	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400069
J	Nobutani, K; Shimono, Y; Mizutani, K; Ueda, Y; Suzuki, T; Kitayama, M; Minami, A; Momose, K; Miyawaki, K; Akashi, K; Azuma, T; Takai, Y				Nobutani, Kentaro; Shimono, Yohei; Mizutani, Kiyohito; Ueda, Yuki; Suzuki, Toshihiro; Kitayama, Midori; Minami, Akihiro; Momose, Kenji; Miyawaki, Kohta; Akashi, Koichi; Azuma, Takeshi; Takai, Yoshimi			Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; MOLECULAR CHARACTERIZATION; GROWTH; HEMATOPOIESIS; MECHANISMS; EXPRESSION; MIGRATION; DYNAMICS; SURVIVAL; AMD3100	Our understanding of the mechanism of cancer dormancy is emerging, but the underlying mechanisms are not fully understood. Here we analyzed mouse xenograft tumors derived from human breast cancer tissue and the human breast cancer cell line MDA-MB-231 to identify the molecules associated with cancer dormancy. In immunohistological examination using the proliferation marker Ki-67, the tumors included both proliferating and dormant cancer cells, but the number of dormant cells was remarkably increased when they metastasized to the lung. In the gene expression analysis of the orthotopic cancer cells by a single-cell multiplex real-time quantitative reverse transcription PCR followed by flow cytometric analysis, restrained cellular proliferation was associated with downregulation of the chemokine receptor CXCR4. In the immunohistological and flow cytometric analyses, the expression level of CXCR4 in the metastasized cancer cells was decreased compared with that in the cancer cells in orthotopic tumors, although the expression level of the CXCR4 ligand CXCL12 was not reduced in the lung. In addition, the proliferation of the metastasized cancer cells was further decreased by the CXCR4 antagonist administration. In the ex vivo culture of the metastasized cancer cells, the expression level of CXCR4 was increased, and in the xenotransplantation of ex vivo cultured cancer cells, the expression level of CXCR4 was again decreased in the metastasized cancer cells in the lung. These findings indicate that CXCR4 is downregulated in metastasized breast cancer cells and implicated in their dormancy.	[Nobutani, Kentaro; Mizutani, Kiyohito; Ueda, Yuki; Suzuki, Toshihiro; Kitayama, Midori; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Pathogenet Signaling, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Nobutani, Kentaro; Minami, Akihiro; Momose, Kenji; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan; [Nobutani, Kentaro; Shimono, Yohei; Mizutani, Kiyohito; Suzuki, Toshihiro; Kitayama, Midori; Minami, Akihiro; Momose, Kenji; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Kitayama, Midori] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 657, Japan; [Miyawaki, Kohta; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka, Fukuoka, Japan	Kobe University; Kobe University; Kobe University; Kobe University; Kyushu University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Pathogenet Signaling, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan.	ytakai@med.kobe-u.ac.jp	Mizutani, Kiyohito/L-8474-2019	Shimono, Yohei/0000-0002-6256-4704	Global COE Program; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science from the Japanese Science and Technology Agency [21227005]; Naito Foundation; Sagawa Foundation; Yasuda Medical Foundation; Grants-in-Aid for Scientific Research [15K14381, 26114007] Funding Source: KAKEN	Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science from the Japanese Science and Technology Agency; Naito Foundation(Naito Memorial Foundation); Sagawa Foundation; Yasuda Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Global COE Program "Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation" and "Global Center for Education and Research in Integrative Membrane Biology" (http://www.jsps.go.jp/english/e_globalcoe/), the Targeted Proteins Research Program (http://www.tanpaku.org/e_index.php) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Grants-in-Aid from the Japan Society for the Promotion of Science (S) (21227005 to Y.T.) from the Japanese Science and Technology Agency (https://www.jsps.go.jp/english/e-grants/), grants from the Naito Foundation (https://www.naito-f.or.jp/en/), and the Sagawa Foundation (http://www.sagawa-gan.or.jp/), the Yasuda Medical Foundation (http://www.yasuda-mf.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Arora S, 2013, J BIOL CHEM; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Hassan S, 2011, INT J CANCER, V129, P225, DOI 10.1002/ijc.25665; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Heckmann D, 2013, TRANSL ONCOL, V6, P124, DOI 10.1593/tlo.12268; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Krook MA, 2014, MOL CANCER RES, V12, P953, DOI 10.1158/1541-7786.MCR-13-0668; LARSEN JK, 1991, CYTOMETRY, V12, P429, DOI 10.1002/cyto.990120508; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Mo W, 2013, CELL, V152, P1077, DOI 10.1016/j.cell.2013.01.053; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nobutani K, 2014, GENES CELLS, V19, P141, DOI 10.1111/gtc.12122; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Scotton CJ, 2002, CANCER RES, V62, P5930; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Xu L, 2009, CANCER RES, V69, P7905, DOI 10.1158/0008-5472.CAN-09-2099; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	34	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130032	10.1371/journal.pone.0130032	http://dx.doi.org/10.1371/journal.pone.0130032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083776	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400120
J	Philip, AM; Vijayan, MM				Philip, Anju M.; Vijayan, Mathilakath M.			Stress-Immune-Growth Interactions: Cortisol Modulates Suppressors of Cytokine Signaling and JAK/STAT Pathway in Rainbow Trout Liver	PLOS ONE			English	Article							HORMONE GH RECEPTOR; MESSENGER-RNA; FACTOR-I; GLUCOCORTICOID-RECEPTOR; BINDING-PROTEINS; GENE-EXPRESSION; INNATE IMMUNITY; FISH; INSULIN; ENDOTOXIN	Chronic stress is a major factor in the poor growth and immune performance of salmonids in aquaculture. However, the molecular mechanisms linking stress effects to growth and immune dysfunction is poorly understood. The suppressors of cytokine signaling (SOCS), a family of genes involved in the inhibition of JAK/STAT pathway, negatively regulates growth hormone and cytokine signaling, but their role in fish is unclear. Here we tested the hypothesis that cortisol modulation of SOCS gene expression is a key molecular mechanism leading to growth and immune suppression in response to stress in fish. Exposure of rainbow trout (Oncorhynchus mykiss) liver slices to cortisol, mimicking stress level, upregulated SOCS-1 and SOCS-2 mRNA abundance and this response was abolished by the glucocorticoid receptor antagonist mifepristone. Bioinformatics analysis confirmed the presence of putative glucocorticoid response elements in rainbow trout SOCS-1 and SOCS-2 promoters. Prior cortisol treatment suppressed acute growth hormone (GH)-stimulated IGF-1 mRNA abundance in trout liver and this involved a reduction in STAT5 phosphorylation and lower total JAK2 protein expression. Prior cortisol treatment also suppressed lipopolysaccharide (LPS)-induced IL-6 but not IL-8 transcript levels; the former but not the latter cytokine expression is via JAK/STAT phosphorylation. LPS treatment reduced GH signaling, but this was associated with the downregulation of GH receptors and not due to the upregulation of SOCS transcript levels by this endotoxin. Collectively, our results suggest that upregulation of SOCS-1 and SOCS-2 transcript levels by cortisol, and the associated reduction in JAK/STAT signaling pathway, may be a novel mechanism leading to growth reduction and immune suppression during stress in trout.	[Philip, Anju M.; Vijayan, Mathilakath M.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Vijayan, MM (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	matt.vijayan@ucalgary.ca	boudinot, pierre/L-4246-2016; Vijayan, Mathilakath/AAC-2190-2020		Natural Sciences and Engineering Research Council of Canada Discovery Grant	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant to MMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru N, 2007, PHYSIOL GENOMICS, V31, P483, DOI 10.1152/physiolgenomics.00118.2007; Aluru N, 2009, GEN COMP ENDOCR, V164, P142, DOI 10.1016/j.ygcen.2009.03.020; Ashley PJ, 2007, APPL ANIM BEHAV SCI, V104, P199, DOI 10.1016/j.applanim.2006.09.001; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bayne CJ, 2001, DEV COMP IMMUNOL, V25, P725, DOI 10.1016/S0145-305X(01)00033-7; Bernier NJ, 2004, GEN COMP ENDOCR, V135, P230, DOI 10.1016/j.ygcen.2003.09.016; Boltana S, 2014, FISH SHELLFISH IMMUN, V39, P475, DOI 10.1016/j.fsi.2014.06.003; Castillo J, 2009, FISH SHELLFISH IMMUN, V27, P493, DOI 10.1016/j.fsi.2009.06.021; Castro R, 2011, FISH SHELLFISH IMMUN, V30, P215, DOI 10.1016/j.fsi.2010.10.010; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Chen Y, 2007, AM J PHYSIOL-ENDOC M, V292, pE1856, DOI 10.1152/ajpendo.00581.2006; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Dejkhamron P, 2007, MOL CELL ENDOCRINOL, V274, P35, DOI 10.1016/j.mce.2007.05.013; Eide M, 2014, AQUAT TOXICOL, V153, P110, DOI 10.1016/j.aquatox.2013.10.027; Engelsma MY, 2002, VET IMMUNOL IMMUNOP, V87, P467, DOI 10.1016/S0165-2427(02)00077-6; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Flores-Morales A, 2006, MOL ENDOCRINOL, V20, P241, DOI 10.1210/me.2005-0170; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jiao BW, 2006, J MOL ENDOCRINOL, V36, P23, DOI 10.1677/jme.1.01945; Kajimura S, 2003, J ENDOCRINOL, V178, P91, DOI 10.1677/joe.0.1780091; Kile BT, 2001, CELL MOL LIFE SCI, V58, P1627, DOI 10.1007/PL00000801; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; MacKenzie S, 2003, DEV COMP IMMUNOL, V27, P393, DOI 10.1016/S0145-305X(02)00135-0; MacKenzie SA, 2010, MOL IMMUNOL, V47, P1450, DOI 10.1016/j.molimm.2010.02.009; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Philip AM, 2014, DEV COMP IMMUNOL, V45, P133, DOI 10.1016/j.dci.2014.02.012; Philip AM, 2012, DEV COMP IMMUNOL, V38, P360, DOI 10.1016/j.dci.2012.07.005; Pierce AL, 2012, GEN COMP ENDOCR, V179, P22, DOI 10.1016/j.ygcen.2012.07.010; Pierce AL, 2011, J ENDOCRINOL, V211, P201, DOI 10.1530/JOE-10-0456; Rauw Wendy M., 2012, Frontiers in Genetics, V3, P267, DOI 10.3389/fgene.2012.00267; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Reindl KM, 2011, AM J PHYSIOL-REG I, V301, pR236, DOI 10.1152/ajpregu.00414.2010; Reinecke M, 2005, GEN COMP ENDOCR, V142, P20, DOI 10.1016/j.ygcen.2005.01.016; Reinecke M, 2010, J FISH BIOL, V76, P1233, DOI 10.1111/j.1095-8649.2010.02605.x; RODGERS BD, 1995, DIABETES, V44, P1420, DOI 10.2337/diabetes.44.12.1420; Sathiyaa R, 2003, AM J PHYSIOL-CELL PH, V284, pC1508, DOI 10.1152/ajpcell.00448.2002; Secombes CJ, 2001, DEV COMP IMMUNOL, V25, P713, DOI 10.1016/S0145-305X(01)00032-5; Segner H, 2012, FISH PHYSIOL BIOCHEM, V38, P85, DOI 10.1007/s10695-011-9517-9; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Shepherd BS, 2012, FISH SHELLFISH IMMUN, V33, P468, DOI 10.1016/j.fsi.2012.05.026; Swain P, 2008, FISH SHELLFISH IMMUN, V25, P191, DOI 10.1016/j.fsi.2008.04.009; Tort L, 2011, BASIC CLIN ENDOCRINO, DOI [10.5772/21446, DOI 10.5772/21446]; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; UNTERMAN TG, 1993, ENDOCRINOLOGY, V133, P2531, DOI 10.1210/en.133.6.2531; Vijayan MM, 2010, FISH DISEASES AND DISORDERS, VOL 2: NON-INFECTIOUS DISORDERS, 2ND EDITION, P182, DOI 10.1079/9781845935535.0182; Wang T, 2008, MOL IMMUNOL, V45, P1449, DOI 10.1016/j.molimm.2007.08.016; Wang Tiehui, 2011, J Signal Transduct, V2011, P905813, DOI 10.1155/2011/905813; Wang XD, 2008, MOL ENDOCRINOL, V22, P1427, DOI 10.1210/me.2007-0561	51	48	53	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129299	10.1371/journal.pone.0129299	http://dx.doi.org/10.1371/journal.pone.0129299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083490	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400087
J	Zu, Y; Gong, YP; Wan, LJ; Lv, Y; Cui, SY; Jin, XY; Li, CL; Chen, XM				Zu, Yuan; Gong, Yanping; Wan, Lijuan; Lv, Yang; Cui, Shaoyuan; Jin, Xinye; Li, Chunlin; Chen, Xiangmei			Pericentrin Is Related to Abnormal beta-Cell Insulin Secretion through F-Actin Regulation in Mice	PLOS ONE			English	Article							DISEASE; PROJECTIONS; EXOCYTOSIS; PROTEINS; BURDEN; ROLES	The aim of this study was to investigate the regulating effect of pericentrin (PCNT) on insulin secretion in the development of insulin resistance and to determine the underlying mechanism. PCNT expression was studied in different tissues of C57/B6 mice by reverse transcriptase-PCR and immunofluorescence. PCNT was highly expressed in organs involved in the regulation of metabolism, while cytoplasmic expression was only enriched in islet cells. PCNT expression was significantly lower in the central regions of insulin resistance (IR) mouse islets than in those of control mouse islets. PCNT expression was further studied in mouse MIN6 cells exposed to glucose stimulation, small interfering RNA (siRNA) against PCNT, and an ERK inhibitor (PD98095). The results revealed that PCNT expression in glucose-stimulated MIN6 cells reduced linearly with cytoplasmic insulin levels. MIN6 cells transfected with PCNT siRNA showed significantly decreased intracellular insulin and F-actin expression. The change in F-actin expression in MIN6 cells during PCNT siRNA interference showed a linear relationship with PCNT expression at different time points. The ERK inhibitor affected PCNT expression and F-actin expression linearly. The abnormal insulin secretion observed both in vivo and in vitro was associated with decreased PCNT expression, and F-actin was found to be the target of PCNT regulation.	[Zu, Yuan; Gong, Yanping; Wan, Lijuan; Li, Chunlin] Chinese Peoples Liberat Army, Gen Hosp, Dept Geriatr Endocrinol, Beijing 100853, Peoples R China; [Lv, Yang; Cui, Shaoyuan; Chen, Xiangmei] Chinese Peoples Liberat Army, Gen Hosp, Natl Clin Res Ctr Kidney Dis, Inst Nephrol,Dept Nephrol,State Key Lab Kidney Di, Beijing 100853, Peoples R China; [Jin, Xinye] Chinese Peoples Liberat Army, Gen Hosp, Dept Internal, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Li, CL (corresponding author), Chinese Peoples Liberat Army, Gen Hosp, Dept Geriatr Endocrinol, Beijing 100853, Peoples R China.	lichunlin301@163.com	wan, li/GRY-7634-2022		National Natural Science Foundation of China (NSFC) [81173625, 81373458]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC, No. 81173625, No. 81373458, http://www.nsfc.gov.cn/Portal0/default152.htm).	Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Henquin JC, 2002, DIABETES, V51, pS1, DOI 10.2337/diabetes.51.2007.S1; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Jurczyk A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011812; Ma D, 2004, J CLIN INVEST, V114, P339, DOI 10.1172/jci200419876; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Miyoshi K, 2006, BIOCHEM BIOPH RES CO, V351, P745, DOI 10.1016/j.bbrc.2006.10.101; Miyoshi K, 2006, DEV GENES EVOL, V216, P537, DOI 10.1007/s00427-006-0065-8; Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420; Muhlhans J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026496; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Shi YK, 2014, LANCET, V383, P1947, DOI 10.1016/S0140-6736(14)60886-2; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	20	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130458	10.1371/journal.pone.0130458	http://dx.doi.org/10.1371/journal.pone.0130458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083368	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400144
J	Besser, S; Sicker, M; Marx, G; Winkler, U; Eulenburg, V; Hulsmann, S; Hirrlinger, J				Besser, Stefanie; Sicker, Marit; Marx, Grit; Winkler, Ulrike; Eulenburg, Volker; Huelsmann, Swen; Hirrlinger, Johannes			A Transgenic Mouse Line Expressing the Red Fluorescent Protein tdTomato in GABAergic Neurons	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; MESSENGER-RNAS; 2 FORMS; COMPARATIVE LOCALIZATION; GLYCINERGIC NEURONS; ADULT NEUROGENESIS; CELL-PROLIFERATION; SUBEPENDYMAL LAYER; MICE LACKING	GABAergic inhibitory neurons are a large population of neurons in the central nervous system (CNS) of mammals and crucially contribute to the function of the circuitry of the brain. To identify specific cell types and investigate their functions labelling of cell populations by transgenic expression of fluorescent proteins is a powerful approach. While a number of mouse lines expressing the green fluorescent protein (GFP) in different subpopulations of GABAergic cells are available, GFP expressing mouse lines are not suitable for either crossbreeding to other mouse lines expressing GFP in other cell types or for Ca2+-imaging using the superior green Ca2+-indicator dyes. Therefore, we have generated a novel transgenic mouse line expressing the red fluorescent protein tdTomato in GABAergic neurons using a bacterial artificial chromosome based strategy and inserting the tdTomato open reading frame at the start codon within exon 1 of the GAD2 gene encoding glutamic acid decarboxylase 65 (GAD65). TdTomato expression was observed in all expected brain regions; however, the fluorescence intensity was highest in the olfactory bulb and the striatum. Robust expression was also observed in cortical and hippocampal neurons, Purkinje cells in the cerebellum, amacrine cells in the retina as well as in cells migrating along the rostral migratory stream. In cortex, hippocampus, olfactory bulb and brainstem, 80% to 90% of neurons expressing endogenous GAD65 also expressed the fluorescent protein. Moreover, almost all tdTomato-expressing cells coexpressed GAD65, indicating that indeed only GABAergic neurons are labelled by tdTomato expression. This mouse line with its unique spectral properties for labelling GABAergic neurons will therefore be a valuable new tool for research addressing this fascinating cell type.	[Besser, Stefanie; Sicker, Marit; Marx, Grit; Hirrlinger, Johannes] Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany; [Eulenburg, Volker] Univ Erlangen Nurnberg, Inst Biochem & Mol Med, D-91054 Erlangen, Germany; [Huelsmann, Swen] Univ Hosp Gottingen, Anesthesiol Clin, Lab Expt Neuroanesthesiol, Gottingen, Germany; [Huelsmann, Swen] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany; [Hirrlinger, Johannes] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany	Leipzig University; University of Erlangen Nuremberg; University of Gottingen; Max Planck Society	Hirrlinger, J (corresponding author), Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany.	johannnes.hirrlinger@medizin.uni-leipzig.de	Hülsmann, Swen/F-7169-2010; Hirrlinger, Johannes/F-5984-2010; Eulenburg, Volker/B-7263-2013	Hülsmann, Swen/0000-0001-5042-8724; Eulenburg, Volker/0000-0002-4878-5746	"Deutsche Forschungsgemeinschaft" (DFG) [HI1414/2-1, HU797/7-1]	"Deutsche Forschungsgemeinschaft" (DFG)(German Research Foundation (DFG))	The work was supported by the "Deutsche Forschungsgemeinschaft" (DFG; www.dfg.de), grants to JH (HI1414/2-1) and SH (HU797/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2015, CURR OPIN NEUROBIOL, V31, P81, DOI 10.1016/j.conb.2014.08.016; ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Balasubramanian Revathi, 2014, Curr Ophthalmol Rep, V2, P100; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P69, DOI 10.1007/BF01098647; Botcher NA, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00104; BRECHA NC, 1991, CELL MOL NEUROBIOL, V11, P497, DOI 10.1007/BF00734812; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Caputi A, 2013, CURR OPIN NEUROBIOL, V23, P179, DOI 10.1016/j.conb.2013.01.021; Connaughton VP, 1999, VISUAL NEUROSCI, V16, P483, DOI 10.1017/S0952523899163090; CROOKS J, 1992, J COMP NEUROL, V315, P287, DOI 10.1002/cne.903150305; De Marchis S, 2004, EUR J NEUROSCI, V20, P1307, DOI 10.1111/j.1460-9568.2004.03584.x; DeFelipe J, 2002, PROG BRAIN RES, V136, P215; Deniz S, 2011, J NEUROCHEM, V116, P350, DOI 10.1111/j.1471-4159.2010.07114.x; Dkhissi O, 2001, BRAIN RES, V919, P242, DOI 10.1016/S0006-8993(01)03022-0; Dumoulin A, 2001, J NEUROSCI, V21, P6045, DOI 10.1523/JNEUROSCI.21-16-06045.2001; Dupuy ST, 1996, J NEUROSCI, V16, P6919; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; ESCLAPEZ M, 1993, J COMP NEUROL, V331, P339, DOI 10.1002/cne.903310305; FELDBLUM S, 1993, J NEUROSCI RES, V34, P689, DOI 10.1002/jnr.490340612; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fujita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086679; Fukuda T, 1997, BRAIN RES, V764, P237, DOI 10.1016/S0006-8993(97)00683-5; Gelman D.M., 2012, JASPERS BASIC MECH E; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Ishibashi H, 2013, J PHYSIOL-LONDON, V591, P3821, DOI 10.1113/jphysiol.2012.250647; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kao YH, 2006, VISUAL NEUROSCI, V23, P931, DOI 10.1017/S0952523806230293; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; KATAROVA Z, 1990, EUR J NEUROSCI, V2, P190, DOI 10.1111/j.1460-9568.1990.tb00412.x; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; KOBAYASHI Y, 1987, J NEUROSCI, V7, P2768; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; Liu YQ, 2014, NEUROSCI BULL, V30, P985, DOI 10.1007/s12264-014-1478-4; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Lovett-Barron M, 2014, CURR OPIN NEUROBIOL, V26, P27, DOI 10.1016/j.conb.2013.11.002; Lu T, 2008, NEURON, V57, P524, DOI 10.1016/j.neuron.2007.12.010; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARTIN DL, 1991, J NEUROSCI, V11, P2725; MARTIN DL, 1991, NEUROCHEM RES, V16, P243, DOI 10.1007/BF00966087; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; MCDERMOTT KWG, 1990, DEV BRAIN RES, V57, P269, DOI 10.1016/0165-3806(90)90053-2; Meyer AH, 2002, J NEUROSCI, V22, P7055; Millen KJ, 1995, DEVELOPMENT, V121, P3935; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Namba K, 2011, J COMP NEUROL, V519, P2594, DOI 10.1002/cne.22640; Nolte C, 2001, GLIA, V33, P72; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Plachez C, 2012, J MOL HISTOL, V43, P215, DOI 10.1007/s10735-012-9394-2; PRIVAT A, 1972, J COMP NEUROL, V146, P277, DOI 10.1002/cne.901460302; Rahman J, 2013, EUR J NEUROSCI, V37, P1229, DOI 10.1111/ejn.12136; Roux L, 2015, NEUROPHARMACOLOGY, V88, P10, DOI 10.1016/j.neuropharm.2014.09.011; Sakamoto M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00121; Schnell C, 2015, BRAIN STRUCT FUNCT, V220, P193, DOI 10.1007/s00429-013-0645-0; Stephan Heckers, 2014, SCHIZOPHR RES; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Trudeau LE, 2007, MOL INTERV, V7, P138, DOI 10.1124/mi.7.3.5; VARDI N, 1995, J COMP NEUROL, V351, P374, DOI 10.1002/cne.903510305; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442	69	21	21	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129934	10.1371/journal.pone.0129934	http://dx.doi.org/10.1371/journal.pone.0129934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076353	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900114
J	Fan, XH; Hughes, BG; Ali, MAM; Cho, WJ; Lopez, W; Schulz, R				Fan, Xiaohu; Hughes, Bryan G.; Ali, Mohammad A. M.; Cho, Woo Jung; Lopez, Waleska; Schulz, Richard			Dynamic Alterations to alpha-Actinin Accompanying Sarcomere Disassembly and Reassembly during Cardiomyocyte Mitosis	PLOS ONE			English	Article							BINUCLEATED CARDIAC MYOCYTES; MATRIX METALLOPROTEINASE-2; CELL-CYCLE; IMMUNOELECTRON MICROSCOPY; MAMMALIAN CARDIOMYOCYTES; PHOSPHORYLATION SITES; PROTEIN PHOSPHATASES; HEART REGENERATION; REPERFUSION INJURY; MYOCARDIAL INJURY	Although mammals are thought to lose their capacity to regenerate heart muscle shortly after birth, embryonic and neonatal cardiomyocytes in mammals are hyperplastic. During proliferation these cells need to selectively disassemble their myofibrils for successful cytokinesis. The mechanism of sarcomere disassembly is, however, not understood. To study this, we performed a series of immunofluorescence studies of multiple sarcomeric proteins in proliferating neonatal rat ventricular myocytes and correlated these observations with biochemical changes at different cell cycle stages. During myocyte mitosis, alpha-actinin and titin were disassembled as early as prometaphase. alpha-actinin (representing the sarcomeric Z-disk) disassembly precedes that of titin (M-line), suggesting that titin disassembly occurs secondary to the collapse of the Z-disk. Sarcomere disassembly was concurrent with the dissolution of the nuclear envelope. Inhibitors of several intracellular proteases could not block the disassembly of alpha-actinin or titin. There was a dramatic increase in both cytosolic (soluble) and sarcomeric alpha-actinin during mitosis, and cytosolic alpha-actinin exhibited decreased phosphorylation compared to sarcomeric alpha-actinin. Inhibition of cyclin-dependent kinase 1 (CDK1) induced the quick reassembly of the sarcomere. Sarcomere dis- and re-assembly in cardiomyocyte mitosis is CDK1-dependent and features dynamic differential post-translational modifications of sarcomeric and cytosolic alpha-actinin.	[Fan, Xiaohu; Hughes, Bryan G.; Ali, Mohammad A. M.; Lopez, Waleska; Schulz, Richard] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada; [Fan, Xiaohu; Hughes, Bryan G.; Ali, Mohammad A. M.; Lopez, Waleska; Schulz, Richard] Univ Alberta, Fac Med & Dent, Dept Pharmacol, Edmonton, AB, Canada; [Fan, Xiaohu; Hughes, Bryan G.; Ali, Mohammad A. M.; Lopez, Waleska; Schulz, Richard] Univ Alberta, Fac Med & Dent, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Fan, Xiaohu; Hughes, Bryan G.; Ali, Mohammad A. M.; Lopez, Waleska; Schulz, Richard] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Cho, Woo Jung] Univ Alberta, Fac Med & Dent, Dept Med Microbiol & Immunol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Schulz, R (corresponding author), Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada.	Richard.schulz@ualberta.ca	Hughes, Bryan/L-4964-2017	Hughes, Bryan/0000-0002-2718-3818; Ali, Mohammad/0000-0002-6404-4198	Canadian Institutes of Health Research [MOP-66953]; Alberta Innovates - Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions	This work was supported by the Canadian Institutes of Health Research (MOP-66953). MAM received a trainee award from Alberta Innovates - Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2004, J CELL SCI, V117, P3295, DOI 10.1242/jcs.01159; Ali MAM, 2012, J CELL PHYSIOL, V227, P3397, DOI 10.1002/jcp.24040; Ali MAM, 2012, BIOCHEM BIOPH RES CO, V423, P1, DOI 10.1016/j.bbrc.2012.05.005; Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Atkinson RA, 2000, BIOCHEMISTRY-US, V39, P5255, DOI 10.1021/bi991891u; Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Barta J, 2005, MOL CELL BIOCHEM, V278, P1, DOI 10.1007/s11010-005-1370-7; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; Ellis JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021169; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, J MOL CELL CARDIOL, V41, P601, DOI 10.1016/j.yjmcc.2006.06.012; Fisher D, 2012, J CELL SCI, V125, P4703, DOI 10.1242/jcs.106351; Fukuda N, 2008, J PHYSIOL SCI, V58, P151, DOI 10.2170/physiolsci.RV005408; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Gupta V, 2012, FASEB J, V26, P1892, DOI 10.1096/fj.11-194548; Hernandez-Verdun D, 2011, NUCLEUS-PHILA, V2, P189, DOI 10.4161/nucl.2.3.16246; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kandasamy AD, 2009, CARDIOVASC RES, V83, P698, DOI 10.1093/cvr/cvp175; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1541, DOI 10.1006/jmcc.1997.0381; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1553, DOI 10.1006/jmcc.1997.0403; Linke WA, 2010, CIRCULATION, V122, P2002, DOI 10.1161/CIRCULATIONAHA.110.985317; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; O'Donovan DS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.208; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Rossello A, 2004, BIOORGAN MED CHEM, V12, P2441, DOI 10.1016/j.bmc.2004.01.047; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Schoenwolf GC, 1995, CELL MOL BIOL RES, V41, P233; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Srivastava D, 1997, TRENDS CELL BIOL, V7, P447, DOI 10.1016/S0962-8924(97)01150-1; Sung MM, 2007, J MOL CELL CARDIOL, V43, P429, DOI 10.1016/j.yjmcc.2007.07.055; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Viappiani S, 2009, BIOCHEM PHARMACOL, V77, P826, DOI 10.1016/j.bcp.2008.11.004; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Wang WJ, 2002, CARDIOVASC RES, V53, P165, DOI 10.1016/S0008-6363(01)00445-X; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	53	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129176	10.1371/journal.pone.0129176	http://dx.doi.org/10.1371/journal.pone.0129176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076379	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900051
J	Hayashi, T; Yao, SY; Crain, B; Promessi, VJ; Shyu, L; Sheng, C; Kang, M; Cottam, HB; Carson, DA; Corr, M				Hayashi, Tomoko; Yao, Shiyin; Crain, Brian; Promessi, Victor J.; Shyu, Luke; Sheng, Caroline; Kang, McNancy; Cottam, Howard B.; Carson, Dennis A.; Corr, Maripat			Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes	PLOS ONE			English	Article							INNATE IMMUNITY; T-CELLS; CD127 EXPRESSION; NOD MICE; ACTIVATION; PREVENTION; AUTOIMMUNITY; STIMULATION; VITAMIN-D-3; INHIBITION	Autoimmune diabetes mellitus (DM) results from the destruction of pancreatic islet cells by activated T lymphocytes, which have been primed by activated dendritic cells (DC). Individualized therapy with ex vivo DC manipulation and reinfusion has been proposed as a treatment for DM, but this treatment is limited by cost, and requires specialized facilities. A means of in situ modulation of the DC phenotype in the host would be more accessible. Here we report a novel innate immune modulator, 1Z1, generated by conjugating a TLR7 ligand to six units of polyethylene glycol (PEG), which skews DC phenotype in vivo. 1Z1 was less potent in inducing cytokine production by DC than the parent ligand in vitro and in vivo. In addition, this drug only modestly increased DC surface expression of activation markers such as MHC class II, CD80, and CD86; however, the expression of negative regulatory molecules, such as programmed death ligand 1 (PD-L1), and interleukin-1 receptor-associated kinase M (IRAK-M) were markedly increased. In vivo transfer of 1Z1 treated DC into prediabetic NOD mice delayed pancreatic insulitis. Daily administration of 1Z1 effectively prevented the clinical onset of hyperglycemia and reduced histologic islet inflammation. Daily treatment with 1Z1 increased PD-L1 expression in the CD11c(+) population in peri-pancreatic lymph nodes; however, it did not induce an increase in regulatory T cells. Pharmaceutical modulation of DC maturation and function in situ, thus represents an opportunity to treat autoimmune disease.	[Hayashi, Tomoko; Yao, Shiyin; Crain, Brian; Promessi, Victor J.; Shyu, Luke; Sheng, Caroline; Kang, McNancy; Cottam, Howard B.; Carson, Dennis A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Corr, Maripat] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Corr, M (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mcorr@ucsd.edu			Juvenile Diabetes Research Foundation [5-2011-212]; Telormedix SA (Bioggio, Switzerland); NIAMS [R21 AR062236-02]; Innovative Research Grant from the Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062236] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Telormedix SA (Bioggio, Switzerland); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Innovative Research Grant from the Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was supported in part by research grants from Juvenile Diabetes Research Foundation (5-2011-212, http://jdrf.org)(DAC), Telormedix SA (Bioggio, Switzerland, http://www.telormedix.com) (TH), R21 AR062236-02 from NIAMS (http://www.niams.nih.gov) and an Innovative Research Grant from the Rheumatology Research Foundation (http://www.rheumatology.org) (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2003, ANN NY ACAD SCI, V987, P258, DOI 10.1111/j.1749-6632.2003.tb06057.x; Arora M, 2011, INT IMMUNOPHARMACOL, V11, P827, DOI 10.1016/j.intimp.2011.01.034; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Tabarrozzi AEB, 2013, CLIN EXP IMMUNOL, V171, P135, DOI 10.1111/cei.12019; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Bluestone JA, 2007, NAT REV IMMUNOL, V7, P650, DOI 10.1038/nri2137; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chan M, 2011, BIOCONJUGATE CHEM, V22, P445, DOI 10.1021/bc1004813; Chan M, 2009, BIOCONJUGATE CHEM, V20, P1194, DOI 10.1021/bc900054q; Cole TS, 2012, IMMUNOL LETT, V144, P49, DOI 10.1016/j.imlet.2012.03.006; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Diana J, 2011, DISCOV MED, V11, P513; Farias AS, 2013, CNS NEUROSCI THER, V19, P269, DOI 10.1111/cns.12071; Feili-Hariri M, 2002, EUR J IMMUNOL, V32, P2021, DOI 10.1002/1521-4141(200207)32:7<2021::AID-IMMU2021>3.0.CO;2-J; Feili-Hariri M, 1999, DIABETES, V48, P2300, DOI 10.2337/diabetes.48.12.2300; Filippi CM, 2011, EUR J IMMUNOL, V41, P1399, DOI 10.1002/eji.200939841; Garate D, 2013, ARTHRITIS RHEUM-US, V65, P120, DOI 10.1002/art.37702; Giannoukakis N, 2012, IMMUNOTHERAPY-UK, V4, P1063, DOI [10.2217/IMT.12.76, 10.2217/imt.12.76]; Grieco FA, 2011, SEMIN IMMUNOPATHOL, V33, P57, DOI 10.1007/s00281-010-0206-z; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; Hayashi T, 2008, AM J PHYSIOL-REG I, V295, pR123, DOI 10.1152/ajpregu.00527.2007; Hayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045860; Hayashi T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/262394; Hayashi T, 2009, P NATL ACAD SCI USA, V106, P2764, DOI 10.1073/pnas.0813037106; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Jaen O, 2009, IMMUNOLOGY, V126, P35, DOI 10.1111/j.1365-2567.2008.02875.x; Karumuthil-Melethil S, 2008, J IMMUNOL, V181, P8323, DOI 10.4049/jimmunol.181.12.8323; Kim DH, 2012, DIABETOLOGIA, V55, P3308, DOI 10.1007/s00125-012-2723-x; Kim DH, 2011, J IMMUNOL, V187, P5211, DOI 10.4049/jimmunol.1001388; Kim HS, 2009, CURR MOL MED, V9, P30, DOI 10.2174/156652409787314471; Kurimoto A, 2004, BIOORGAN MED CHEM, V12, P1091, DOI 10.1016/j.bmc.2003.12.008; Lan YY, 2006, J IMMUNOL, V177, P5868, DOI 10.4049/jimmunol.177.9.5868; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Leiter Edward H, 2001, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1509s24; Lewkowicz P, 2006, J IMMUNOL, V177, P7155, DOI 10.4049/jimmunol.177.10.7155; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lo J, 2006, AUTOIMMUN REV, V5, P419, DOI 10.1016/j.autrev.2005.12.001; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Ma LL, 2003, DIABETES, V52, P1976, DOI 10.2337/diabetes.52.8.1976; Mackern-Oberti JP, 2014, INT J MOL SCI, V15, P16381, DOI 10.3390/ijms150916381; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Marin-Gallen S, 2010, CLIN EXP IMMUNOL, V160, P207, DOI 10.1111/j.1365-2249.2009.04082.x; Mbongue J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/857143; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Mukherjee G, 2010, CLIN EXP IMMUNOL, V161, P197, DOI 10.1111/j.1365-2249.2010.04157.x; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Phillips B, 2011, CLIN DEV IMMUNOL, P1, DOI 10.1155/2011/432016; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Salazar L, 2007, EUR CYTOKINE NETW, V18, P78, DOI 10.1684/ecn.2007.0089; Sathish JG, 2013, NAT REV DRUG DISCOV, V12, P306, DOI 10.1038/nrd3974; Shiu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066914; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; TOCHINO Y, 1988, CRIT REV IMMUNOL, V8, P49; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; Zipris D, 2008, CURR OPIN ENDOCRINOL, V15, P326, DOI 10.1097/MED.0b013e3283073a46	59	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129867	10.1371/journal.pone.0129867	http://dx.doi.org/10.1371/journal.pone.0129867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076454	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900106
J	Jabbour, G; Iancu, HD; Paulin, A; Lavoie, JM; Lemoine-Morel, S; Zouhal, H				Jabbour, Georges; Iancu, Horia-Daniel; Paulin, Anne; Lavoie, Jean-Marc; Lemoine-Morel, Sophie; Zouhal, Hassane			Effects of Acute Supramaximal Cycle Exercise on Plasma FFA Concentration in Obese Adolescent Boys	PLOS ONE			English	Article							ACCUMULATED OXYGEN DEFICIT; OXIDATION; METABOLISM; LIPOLYSIS; CHILDREN; INSULIN; SPRINT; GENDER; POWER	Aims The aims of the present study are 1) to evaluate the free fatty acid (FFA) profile and 2) to determine the relative anaerobic and aerobic contributions to total energy consumption during repeated supramaximal cycling bouts (SCE) in adolescent boys with different body weight statuses. Materials and Methods Normal-weight (NW), overweight (OW), and obese (OB) adolescent boys (n = 15 per group) completed a SCE sessions consisted of 6 x 6s maximal sprints with 2 min of passive rest between each repetition. Plasma FFA levels were determined at rest, immediately after a 10 min warm-up, and immediately at the end of SCE. The anaerobic and aerobic contributions (%) were measured via repeated SCE bouts. Insulin resistance was calculated using the homoeostatic model assessment (HOMA-IR) index. Results The FFA concentrations measured immediately after SCE were higher in the OB group than in the OW and NW (p<0.01 and p<0.01, respectively) groups. Moreover, the anaerobic contributions to SCE were significantly lower in obese adolescents (p<0.01) and decreased significantly during the 2nd, 3rd and 4th repetitions. The FFA levels were significantly associated with the HOMA-IR index and aerobic contribution among adolescent boys (r=0.83 and r=0.91, respectively, p<0.01). Conclusion In contrast to the NW and OW groups, there is an increase in lipid mobilization and sift to aerobic energy metabolism during SCE in the OB group.	[Jabbour, Georges; Iancu, Horia-Daniel; Paulin, Anne] Univ Moncton, Fac Hlth Sci & Community Serv, Sch Kinesiol & Leisure, Moncton, NB E1A 3E9, Canada; [Lavoie, Jean-Marc] Univ Montreal, Dept Kinesiol, Montreal, PQ H3C 3J7, Canada; [Lemoine-Morel, Sophie; Zouhal, Hassane] Univ Rennes 2, ENS Cachan, Movement Sport & Hlth Sci Lab, F-35043 Rennes, France	University of Moncton; Universite de Montreal; UDICE-French Research Universities; Universite Paris Saclay; Universite Rennes 2	Jabbour, G (corresponding author), Univ Moncton, Fac Hlth Sci & Community Serv, Sch Kinesiol & Leisure, Moncton, NB E1A 3E9, Canada.	georgesjabbour1980@hotmail.com	ZOUHAL, Hassane/AAE-6877-2021; Jabbour, Georges/P-1393-2019	ZOUHAL, Hassane/0000-0001-6743-6464; Jabbour, Georges/0000-0003-4758-8772	Faculty of Superior Studies and Research; Leadership Institute of the Ecole de kinesiologie et de Loisir of the Universte de Moncton	Faculty of Superior Studies and Research; Leadership Institute of the Ecole de kinesiologie et de Loisir of the Universte de Moncton	This work was funded by the Faculty of Superior Studies and Research and the Leadership Institute of the Ecole de kinesiologie et de Loisir of the Universte de Moncton (to GJ).	BLIMKIE CJR, 1990, EUR J APPL PHYSIOL, V61, P313, DOI 10.1007/BF00357619; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; CAMPBELL PJ, 1992, AM J PHYSIOL, V263, pE1063; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DANNUNZIO G, 2004, QUAD PEDIAT, V3, P44; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Duche P, 2002, MED SCI SPORT EXER, V34, P2072, DOI 10.1249/01.MSS.0000039305.73223.2E; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fox E.L., 1974, INTERVAL TRAINING CO; GASTIN PB, 1995, MED SCI SPORT EXER, V27, P255; Greenhaff PL, 2002, BIOCHEM SOC T, V30, P275, DOI 10.1042/BST0300275; GUSTAFSON AB, 1990, METABOLISM, V39, P410, DOI 10.1016/0026-0495(90)90257-D; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; JENSEN MD, 1987, J CLIN INVEST, V79, P207, DOI 10.1172/JCI112785; Jensen MD, 1997, ANNU REV NUTR, V17, P127, DOI 10.1146/annurev.nutr.17.1.127; Lanzi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088707; Lazzer S, 2007, CLIN ENDOCRINOL, V67, P582, DOI 10.1111/j.1365-2265.2007.02929.x; Marker JC, 1996, AM J PHYSIOL, V260, P705; MARTIN ML, 1991, J CLIN INVEST, V88, P609, DOI 10.1172/JCI115345; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; Nevill ME, 1996, EUR J APPL PHYSIOL, V72, P460, DOI 10.1007/BF00242276; Perez-Martin A, 2001, DIABETES METAB, V27, P466; Ramsbottom R, 1994, J SPORT SCI, V12, P447, DOI 10.1080/02640419408732194; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Romijn JA, 1995, J APPL PHYSIOL, V79, P1939, DOI 10.1152/jappl.1995.79.6.1939; Sartorio A, 2006, J ENDOCRINOL INVEST, V29, P48, DOI 10.1007/BF03349176; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Spiro SG, 1997, BR J DIS CHEST, V71, P145; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; VANBEAUMONT W, 1972, J APPL PHYSIOL, V32, P712, DOI 10.1152/jappl.1972.32.5.712; Vandewalle H.P., 1988, SCI MOV, V4, P38; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002	33	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129654	10.1371/journal.pone.0129654	http://dx.doi.org/10.1371/journal.pone.0129654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076464	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900088
J	Tasev, D; van Wijhe, MH; Weijers, EM; van Hinsbergh, VWM; Koolwijk, P				Tasev, Dimitar; van Wijhe, Michiel H.; Weijers, Ester M.; van Hinsbergh, Victor W. M.; Koolwijk, Pieter			Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; EX-VIVO EXPANSION; FETAL CALF SERUM; PROGENITOR CELLS; IN-VITRO; CORD BLOOD; CIRCULATING PROGENITORS; PLASMINOGEN-ACTIVATOR; ANGIOGENIC PROPERTIES	Introduction Efficient implementation of peripheral blood-derived endothelial-colony cells (PB-ECFCs) as a therapeutical tool requires isolation and generation of a sufficient number of cells in ex vivo conditions devoid of animal-derived products. At present, little is known how the isolation and expansion procedure in xenogeneic-free conditions affects the therapeutical capacity of PB-ECFCs. Results The findings presented in this study indicate that human platelet lysate (PL) as a serum substitute yields twice more colonies per mL blood compared to the conventional isolation with fetal bovine serum (FBS). Isolated ECFCs displayed a higher proliferative ability in PL supplemented medium than cells in FBS medium during 30 days expansion. The cells at 18 cumulative population doubling levels (CPDL) retained their proliferative capacity, showed higher sprouting ability in fibrin matrices upon stimulation with FGF-2 and VEGF-A than the cells at 6 CPDL, and displayed low beta-galactosidase activity. The increased sprouting of PBECFCs at 18 CPDL was accompanied by an intrinsic activation of the uPA/uPAR fibrinolytic system. Induced deficiency of uPA (urokinase-type plasminogen activator) or uPAR (uPA receptor) by siRNA technology completely abolished the angiogenic ability of PB-ECFCs in fibrin matrices. During the serial expansion, the gene induction of the markers associated with inflammatory activation such as VCAM-1 and ICAM-1 did not occur or only to limited extent. While further propagation up to 31 CPDL proceeded at a comparable rate, a marked upregulation of inflammatory markers occurred in all donors accompanied by a further increase of uPA/uPAR gene induction. The observed induction of inflammatory genes at later stages of long-term propagation of PB-ECFCs underpins the necessity to determine the right time-point for harvesting of sufficient number of cells with preserved therapeutical potential. Conclusion The presented isolation method and subsequent cell expansion in platelet lysate supplemented culture medium permits suitable large-scale propagation of PB-ECFC. For optimal use of PB-ECFCs in clinical settings, our data suggest that 15-20 CPDL is the most adequate maturation stage.	[Tasev, Dimitar; van Wijhe, Michiel H.; Weijers, Ester M.; van Hinsbergh, Victor W. M.; Koolwijk, Pieter] Vrije Univ Amsterdam, Med Ctr, ICaR VU, Dept Physiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Koolwijk, P (corresponding author), Vrije Univ Amsterdam, Med Ctr, ICaR VU, Dept Physiol, Amsterdam, Netherlands.	p.koolwijk@vumc.nl		Tasev, Dimitar/0000-0002-2185-9899	Netherlands Initiative for Regenerative Medicine (NIRM) [NIRM WP1.6]	Netherlands Initiative for Regenerative Medicine (NIRM)	The project (NIRM WP1.6) was financially supported by a grant from the Netherlands Initiative for Regenerative Medicine (NIRM).	Allen JB, 2010, STEM CELLS, V28, P318, DOI 10.1002/stem.275; Basire A, 2006, THROMB HAEMOSTASIS, V95, P678, DOI 10.1160/TH05-07-0511; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Carrell RW, 1996, BIOL CHEM H-S, V377, P1; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]; Corselli M, 2008, EXP HEMATOL, V36, P340, DOI 10.1016/j.exphem.2007.10.008; Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376; de Korte D, 2006, TRANSFUSION, V46, P476, DOI 10.1111/j.1537-2995.2006.00746.x; Do Kang S, 2013, ANN BIOMED ENG, V41, P2181, DOI 10.1007/s10439-013-0807-5; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Gluckman E, 2009, BONE MARROW TRANSPL, V44, P621, DOI 10.1038/bmt.2009.280; Hofbauer P, 2014, CYTOTHERAPY, V16, P1238, DOI 10.1016/j.jcyt.2014.04.009; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kilian O, 2004, EUR J MED RES, V9, P337; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; Krilleke D, 2009, BIOCHEM SOC T, V37, P1201, DOI 10.1042/BST0371201; Mackensen A, 2000, CANCER IMMUNOL IMMUN, V49, P152, DOI 10.1007/s002620050614; Mauge L, 2014, CYTOTHERAPY, V16, P213, DOI 10.1016/j.jcyt.2013.09.007; Medina RJ, 2013, STEM CELLS, V31, P1657, DOI 10.1002/stem.1414; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Nimura A, 2008, ARTHRITIS RHEUM, V58, P501, DOI 10.1002/art.23219; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Sahota PS, 2003, WOUND REPAIR REGEN, V11, P275, DOI 10.1046/j.1524-475X.2003.11407.x; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Shumiya T, 2010, CIRC J, V74, P1006, DOI 10.1253/circj.CJ-09-0584; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Smadja DM, 2007, J CELL MOL MED, V11, P1149, DOI 10.1111/j.1582-4934.2007.00090.x; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com; Tuschong L, 2002, HUM GENE THER, V13, P1605, DOI 10.1089/10430340260201699; Van Beem RT, 2009, J THROMB HAEMOST, V7, P217, DOI 10.1111/j.1538-7836.2008.03192.x; VANHINSBERGH VWM, 1987, ARTERIOSCLEROSIS, V7, P389, DOI 10.1161/01.ATV.7.4.389; VANHINSBERGH VWM, 1994, BLOOD, V84, P2984; VANHINSBERGH VWM, 1990, BLOOD, V75, P1991; Wang CH, 2011, AM J PHYSIOL-REG I, V300, pR586, DOI 10.1152/ajpregu.00450.2010; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296	41	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129935	10.1371/journal.pone.0129935	http://dx.doi.org/10.1371/journal.pone.0129935			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076450	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900115
J	Chang, TT; Spurlock, SM; Candelario, TLT; Grenon, SM; Hughes-Fulford, M				Chang, Tammy T.; Spurlock, Sandra M.; Candelario, Tara Lynne T.; Grenon, S. Marlene; Hughes-Fulford, Millie			Spaceflight impairs antigen-specific tolerance induction in vivo and increases inflammatory cytokines	FASEB JOURNAL			English	Article						inflammation; microgravity; T-cell memory; T-cell tolerance; transgenic model	T-CELL-ACTIVATION; MICROBIAL CHARACTERIZATION; SPACE-STATION; MEMORY CELLS; INTERLEUKIN-2; MICROGRAVITY; EXPRESSION; RESPONSES; RECEPTOR; MICE	The health risks of a dysregulated immune response during spaceflight are important to understand as plans emerge for humans to embark on long-term space travel to Mars. In this first-of-its-kind study, we used adoptive transfer of T-cell receptor transgenic OT-II CD4 T cells to track an in vivo antigen-specific immune response that was induced during the course of spaceflight. Experimental mice destined for spaceflight and mice that remained on the ground received transferred OT-II cells and cognate peptide stimulation with ovalbumin (OVA) 323-339 plus the inflammatory adjuvant, monophosphoryl lipid A. Control mice in both flight and ground cohorts received monophosphoryl lipid A alone without additional OVA stimulation. Numbers of OT-II cells in flight mice treated with OVA were significantly increased by 2-fold compared with ground mice treated with OVA, suggesting that tolerance induction was impaired by spaceflight. Production of proinflammatory cytokines were significantly increased in flight compared with ground mice, including a 5-fold increase in IFN-gamma and a 10-fold increase in IL-17. This study is the first to show that immune tolerance may be impaired in spaceflight, leading to excessive inflammatory responses.	[Chang, Tammy T.; Grenon, S. Marlene] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Hughes-Fulford, Millie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Spurlock, Sandra M.; Candelario, Tara Lynne T.; Hughes-Fulford, Millie] Northern Calif Inst Res & Educ, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northern California Institute for Research & Education	Chang, TT (corresponding author), Univ Calif San Francisco, Dept Surg, 521 Parnassus Ave,C341, San Francisco, CA 94143 USA.	tammy.chang@ucsf.edu		Hughes-Fulford, Millie/0000-0002-0756-068X	U.S. National Aeronautics and Space Administration (NASA) [NNH07ZTT001N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL122446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [UH3AG037628] Funding Source: NIH RePORTER	U.S. National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Aeronautics and Space Administration (NASA) Grant NNH07ZTT001N. The authors thank P. M. Dumars for science integration with NASA operations and S. Litherland (Sanford-Burnham Medical Research Institute, Orlando, FL, USA) for providing access their flow cytometer. The authors also thank S. Keating (Blood Systems Research Institute, San Francisco, CA, USA) for excellent technical assistance in processing the multiplex cytokine assays, Q. Tang and A. Abbas for thoughtful scientific feedback, and P. Derish for editorial work.	Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Castro VA, 2004, MICROB ECOL, V47, P119, DOI 10.1007/s00248-003-1030-y; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; COGOLI A, 1993, J LEUKOCYTE BIOL, V53, P569, DOI 10.1002/jlb.53.5.569; COGOLI A, 1984, SCIENCE, V225, P228, DOI 10.1126/science.6729481; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dooms H, 2006, IMMUNOL REV, V211, P23, DOI 10.1111/j.0105-2896.2006.00387.x; Gridley DS, 2006, RADIAT RES, V165, P78, DOI 10.1667/RR3490.1; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hashemi BB, 1999, FASEB J, V13, P2071, DOI 10.1096/fasebj.13.14.2071; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Hughes-Fulford M, 2011, FASEB J, V25, P2858, DOI 10.1096/fj.11-0902ufm; Ioannou YA, 1996, NUCLEIC ACIDS RES, V24, P992; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McKinstry KK, 2007, J EXP MED, V204, P2199, DOI 10.1084/jem.20070041; Mehta SK, 2014, BRAIN BEHAV IMMUN, V41, P210, DOI 10.1016/j.bbi.2014.05.014; Naidu S, 1995, J Gravit Physiol, V2, pP140; Ott CM, 2004, MICROBIAL ECOL, V47, P133, DOI 10.1007/s00248-003-1038-3; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stowe RP, 2008, AVIAT SPACE ENVIR MD, V79, P117, DOI 10.3357/ASEM.2205.2008; TAYLOR GR, 1992, J LEUKOCYTE BIOL, V51, P129, DOI 10.1002/jlb.51.2.129; Walther I, 1998, FEBS LETT, V436, P115, DOI 10.1016/S0014-5793(98)01107-7; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044329	35	20	20	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4122	4132		10.1096/fj.15-275073	http://dx.doi.org/10.1096/fj.15-275073			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26085131	Green Published			2022-12-26	WOS:000361367300004
J	Wang, BL; Wei, H; Prabhu, L; Zhao, W; Martin, M; Hartley, AV; Lu, T				Wang, Benlian; Wei, Han; Prabhu, Lakshmi; Zhao, Wei; Martin, Matthew; Hartley, Antja-Voy; Lu, Tao			Role of Novel Serine 316 Phosphorylation of the p65 Subunit of NF-kappa B in Differential Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; PROTEIN-PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVATION; LYSINE METHYLATION; IKK-EPSILON; RELA/P65; KINASES; CANCER; INFLAMMATION	Nuclear factor kappa B (NF-kappa B) is a central coordinator in immune and inflammatory responses. Constitutive NF-kappa B is often found in some types of cancers, contributing to oncogenesis and tumor progression. Therefore, knowing how NF-kappa B is regulated is important for its therapeutic control. Post-translational modification of the p65 subunit of NF-kappa B is a well known approach for its regulation. Here, we reported that in response to interleukin 1 beta, the p65 subunit of NF-kappa B is phosphorylated on the novel serine 316. Overexpression of S316A (serine 316 -> alanine) mutant exhibited significantly reduced ability to activate NF-kappa B and decreased cell growth as compared with wtp65 (wild type p65). Moreover, conditioned media from cells expressing the S316A-p65 mutant had a considerably lower ability to induce NF-kappa B than that of wtp65. Our data suggested that phosphorylation of p65 on Ser-316 controls the activity and function of NF-kappa B. Importantly, we found that phosphorylation at the novel Ser-316 site and other two known phosphorylation sites, Ser-529 and Ser-536, either individually or cooperatively, regulated distinct groups of NF-kappa B-dependent genes, suggesting the unique role of each individual phosphorylation site on NF-kappa B-dependent gene regulation. Our novel findings provide an important piece of evidence regarding differential regulation of NF-kappa B-dependent genes through phosphorylation of different p65 serine residues, thus shedding light on novel mechanisms for the pathway-specific control of NF-kappa B. This knowledge is key to develop strategies for prevention and treatment of constitutive NF-kappa B-driven inflammatory diseases and cancers.	[Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wei, Han; Prabhu, Lakshmi; Martin, Matthew; Hartley, Antja-Voy; Lu, Tao] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Zhao, Wei; Lu, Tao] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Lu, Tao] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Case Western Reserve University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lu, T (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	lut@iupui.edu	Prabhu, Lakshmi/AAK-8659-2020	Prabhu, Lakshmi/0000-0002-2093-1115				Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Casey SC, 2015, SEMIN CANCER BIOL, V35, pS199, DOI 10.1016/j.semcancer.2015.02.007; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Foster JS, 1996, MOL ENDOCRINOL, V10, P488, DOI 10.1210/me.10.5.488; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hochrainer K, 2013, J BIOL CHEM, V288, P285, DOI 10.1074/jbc.M112.385625; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Lu T, 2004, P NATL ACAD SCI USA, V101, P7112, DOI 10.1073/pnas.0402048101; Lu T, 2013, P NATL ACAD SCI USA, V110, P13510, DOI 10.1073/pnas.1311770110; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Lu T, 2009, P NATL ACAD SCI USA, V106, P16339, DOI 10.1073/pnas.0908560106; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Nasr R, 2006, BLOOD, V107, P4021, DOI 10.1182/blood-2005-09-3572; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Sabatel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038246; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	35	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20336	20347		10.1074/jbc.M115.639849	http://dx.doi.org/10.1074/jbc.M115.639849			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26082493	Green Published, hybrid			2022-12-26	WOS:000359608900032
J	Guttmann, A; Li, XR; Feschet, F; Gaudart, J; Demongeot, J; Boire, JY; Ouchchane, L				Guttmann, Aline; Li, Xinran; Feschet, Fabien; Gaudart, Jean; Demongeot, Jacques; Boire, Jean-Yves; Ouchchane, Lemlih			Cluster Detection Tests in Spatial Epidemiology: A Global Indicator for Performance Assessment	PLOS ONE			English	Article							POWER; DESIGN	In cluster detection of disease, the use of local cluster detection tests (CDTs) is current. These methods aim both at locating likely clusters and testing for their statistical significance. New or improved CDTs are regularly proposed to epidemiologists and must be subjected to performance assessment. Because location accuracy has to be considered, performance assessment goes beyond the raw estimation of type I or II errors. As no consensus exists for performance evaluations, heterogeneous methods are used, and therefore studies are rarely comparable. A global indicator of performance, which assesses both spatial accuracy and usual power, would facilitate the exploration of CDTs behaviour and help between-studies comparisons. The Tanimoto coefficient (TC) is a well-known measure of similarity that can assess location accuracy but only for one detected cluster. In a simulation study, performance is measured for many tests. From the TC, we here propose two statistics, the averaged TC and the cumulated TC, as indicators able to provide a global overview of CDTs performance for both usual power and location accuracy. We evidence the properties of these two indicators and the superiority of the cumulated TC to assess performance. We tested these indicators to conduct a systematic spatial assessment displayed through performance maps.	[Guttmann, Aline; Boire, Jean-Yves; Ouchchane, Lemlih] Clermont Univ Hosp, Dept Biostat, Clermont Ferrand, France; [Guttmann, Aline; Li, Xinran; Boire, Jean-Yves; Ouchchane, Lemlih] Auvergne Univ, ISIT, UMR CNRS UDA 6284, Clermont Ferrand, France; [Feschet, Fabien] Auvergne Univ, IGCNC, EA 7282, Clermont Ferrand, France; [Gaudart, Jean] Aix Marseille Univ, SESSTIM, UMR INSERM 912, Marseille, France; [Demongeot, Jacques] Univ Grenoble 1, Fac Med Grenoble, AGIM, FRE CNRS 3405, La Tronche, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Guttmann, A (corresponding author), Clermont Univ Hosp, Dept Biostat, Clermont Ferrand, France.	aline.guttmann@udamail.fr	Demongeot, Jacques/AAZ-2539-2020; Demongeot, Jacques/GQI-1558-2022; gaudart, jean/D-9071-2013; Guttmann, Aline/G-1879-2014	Demongeot, Jacques/0000-0002-8335-9240; gaudart, jean/0000-0001-9006-5729; Guttmann, Aline/0000-0003-0162-837X				Aamodt Geir, 2006, Int J Health Geogr, V5, P15, DOI 10.1186/1476-072X-5-15; AHRENS JH, 1982, ACM T MATH SOFTWARE, V8, P163, DOI 10.1145/355993.355997; Bellec S, 2005, EUR J EPIDEMIOL, V20, P663, DOI 10.1007/s10654-005-7924-x; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Chatzichristofis SA, 2008, LECT NOTES COMPUT SC, V5008, P312; Chen C, 2013, SPATIALEPI PERFORMS; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Goujon-Bellec S, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-53; Guttmann A, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-47; Huang L, 2008, STAT MED, V27, P5111, DOI 10.1002/sim.3342; Jacquez GM, 2009, SPAT SPATIO-TEMPORAL, V1, P19, DOI 10.1016/j.sste.2009.08.002; Kara LB, 2005, COMPUT GRAPH-UK, V29, P501, DOI 10.1016/j.cag.2005.05.004; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2003, COMPUT STAT DATA AN, V42, P665, DOI 10.1016/S0167-9473(02)00160-3; Li XZ, 2011, MATH BIOSCI, V233, P135, DOI 10.1016/j.mbs.2011.07.004; MARTIN EJ, 1995, J MED CHEM, V38, P1431, DOI 10.1021/jm00009a003; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Ozonoff A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-52; Revolution Analytics, 2013, DISNOW FOR PAR AD SN; Ribeiro SHR, 2012, SPAT SPATIO-TEMPORAL, V3, P107, DOI 10.1016/j.sste.2012.04.004; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Takahashi K, 2006, STAT MED, V25, P841, DOI 10.1002/sim.2419; Tanimoto T.T., 1957, NOV, V17, P1957; Waller LA, 2006, STAT MED, V25, P853, DOI 10.1002/sim.2418; Willett P, 2003, BIOCHEM SOC T, V31, P603, DOI 10.1042/bst0310603; Zhang TL, 2012, STAT MED, V31, P762, DOI 10.1002/sim.4404	27	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130594	10.1371/journal.pone.0130594	http://dx.doi.org/10.1371/journal.pone.0130594			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086911	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500119
J	Karvonen, A; Lucek, K; Marques, DA; Seehausen, O				Karvonen, Anssi; Lucek, Kay; Marques, David A.; Seehausen, Ole			Divergent Macroparasite Infections in Parapatric Swiss Lake-Stream Pairs of Threespine Stickleback (Gasterosteus aculeatus)	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; WHITEFISH COREGONUS-LAVARETUS; ADAPTIVE DIVERGENCE; GENE FLOW; EYE FLUKE; 3-SPINED STICKLEBACKS; SALVELINUS-ALPINUS; SEXUAL SELECTION; ARCTIC CHARR; ECOLOGICAL SPECIATION	Spatial heterogeneity in diversity and intensity of parasitism is a typical feature of most host-parasite interactions, but understanding of the evolutionary implications of such variation is limited. One possible outcome of infection heterogeneities is parasite-mediated divergent selection between host populations, ecotypes or species which may facilitate the process of ecological speciation. However, very few studies have described infections in population-pairs along the speciation continuum from low to moderate or high degree of genetic differentiation that would address the possibility of parasite-mediated divergent selection in the early stages of the speciation process. Here we provide an example of divergent parasitism in freshwater fish ecotypes by examining macroparasite infections in threespine stickleback (Gasterosteus aculeatus) of four Swiss lake systems each harbouring parapatric lake-stream ecotype pairs. We demonstrate significant differences in infections within and between the pairs that are driven particularly by the parasite taxa transmitted to fish from benthic invertebrates. The magnitude of the differences tended to correlate positively with the extent of neutral genetic differentiation between the parapatric lake and stream populations of stickleback, whereas no such correlation was found among allopatric populations from similar or contrasting habitats. This suggests that genetic differentiation is unrelated to the magnitude of parasite infection contrasts when gene flow is constrained by geographical barriers while in the absence of physical barriers, genetic differentiation and the magnitude of differences in infections tend to be positively correlated.	[Karvonen, Anssi] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Lucek, Kay; Marques, David A.; Seehausen, Ole] Eawag, Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, Kastanienbaum, Switzerland; [Lucek, Kay; Marques, David A.; Seehausen, Ole] Univ Bern, Inst Ecol & Evolut, Div Aquat Ecol & Macroevolut, Bern, Switzerland	University of Jyvaskyla; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Bern	Karvonen, A (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland.	anssi.t.karvonen@jyu.fi	Seehausen, Ole/C-8272-2011; Lucek, Kay/AAC-9893-2021; Marques, David/B-3977-2016	Seehausen, Ole/0000-0001-6598-1434; Lucek, Kay/0000-0002-2253-2556; Marques, David/0000-0003-4590-4575; Karvonen, Anssi/0000-0002-2731-3344	University of Jyvaskyla; Academy of Finland [263864]; Eawag action field grant AquaDiverse	University of Jyvaskyla; Academy of Finland(Academy of Finland); Eawag action field grant AquaDiverse	Support was provided by: University of Jyvaskyla [https://www.jyu.fi/]; 263864 Academy of Finland [http://www.aka.fi/en-GB/A/]; Eawag action field grant AquaDiverse [http://www.eawag.ch/index_EN]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Barber I, 2003, PARASITOLOGY, V126, P359, DOI 10.1017/S0031182002002925; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Berner D, 2008, J EVOLUTION BIOL, V21, P1653, DOI 10.1111/j.1420-9101.2008.01583.x; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Blais J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000734; Byers JE, 2008, ECOLOGY, V89, P439, DOI 10.1890/06-1036.1; CROWDEN AE, 1980, ANIM BEHAV, V28, P287, DOI 10.1016/S0003-3472(80)80031-5; de Roij J, 2012, PARASITOLOGY, V139, P1478, DOI 10.1017/S0031182012000789; Deagle BE, 2012, P ROY SOC B-BIOL SCI, V279, P1277, DOI 10.1098/rspb.2011.1552; Eizaguirre C, 2009, MOL ECOL, V18, P3316, DOI 10.1111/j.1365-294X.2009.04243.x; Eizaguirre C, 2012, ECOL LETT, V15, P723, DOI 10.1111/j.1461-0248.2012.01791.x; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Eizaguirre C, 2011, EVOL ECOL, V25, P605, DOI 10.1007/s10682-010-9424-z; Eizaguirre C, 2009, ECOL LETT, V12, P5, DOI 10.1111/j.1461-0248.2008.01247.x; Endler J.A., 1977, Monographs in Population Biology, pi; Faltynkova A, 2008, PARASITOLOGY, V135, P1691, DOI 10.1017/S0031182008005027; Feulner PGD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004966; FRANDSEN F, 1989, J FISH BIOL, V34, P281, DOI 10.1111/j.1095-8649.1989.tb03309.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Georgieva S, 2013, INT J PARASITOL, V43, P57, DOI 10.1016/j.ijpara.2012.10.019; HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626; Hendry AP, 2009, J FISH BIOL, V75, P2000, DOI 10.1111/j.1095-8649.2009.02419.x; Hendry AP, 2004, EVOLUTION, V58, P2319; Hendry AP, 2001, EVOLUTION, V55, P459, DOI 10.1554/0014-3820(2001)055[0459:PMATAD]2.0.CO;2; Hudson AG, 2011, P ROY SOC B-BIOL SCI, V278, P58, DOI 10.1098/rspb.2010.0925; JOKELA J, 1995, OECOLOGIA, V103, P509, DOI 10.1007/BF00328690; Kaeuffer R, 2012, EVOLUTION, V66, P402, DOI 10.1111/j.1558-5646.2011.01440.x; Kalbe M, 2006, PARASITOLOGY, V132, P105, DOI 10.1017/S0031182005008681; Karvonen A, 2006, PARASITOLOGY, V133, P229, DOI 10.1017/S0031182006000242; Karvonen A, 2005, PARASITOLOGY, V131, P817, DOI 10.1017/S0031182005008425; Karvonen A, 2004, PARASITOLOGY, V129, P473, DOI 10.1017/S0031182004006006; Karvonen A, 2004, J PARASITOL, V90, P471, DOI 10.1645/GE-3099; Karvonen A, 2008, AQUACULTURE, V279, P6, DOI 10.1016/j.aquaculture.2008.04.013; Karvonen A, 2013, ECOL EVOL, V3, P1507, DOI 10.1002/ece3.568; Karvonen Anssi, 2012, International Journal of Ecology, P1; Karvonen A, 2013, OIKOS, V122, P122, DOI 10.1111/j.1600-0706.2012.20555.x; Knudsen R, 2003, J FISH BIOL, V62, P847, DOI 10.1046/j.1095-8649.2003.00069.x; Knudsen R, 1997, CAN J ZOOL, V75, P2003, DOI 10.1139/z97-833; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; LAVIN PA, 1986, CAN J FISH AQUAT SCI, V43, P2455, DOI 10.1139/f86-305; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Locke SA, 2010, INT J PARASITOL, V40, P333, DOI 10.1016/j.ijpara.2009.08.012; Lucek K, 2014, J EVOLUTION BIOL, V27, P1878, DOI 10.1111/jeb.12439; Lucek K, 2013, J EVOLUTION BIOL, V26, P2691, DOI 10.1111/jeb.12267; Lucek K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049377; Lucek K, 2010, MOL ECOL, V19, P3995, DOI 10.1111/j.1365-294X.2010.04781.x; Maan ME, 2008, BIOL J LINN SOC, V94, P53, DOI 10.1111/j.1095-8312.2008.00989.x; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; MacColl ADC, 2009, ECOGRAPHY, V32, P153, DOI 10.1111/j.1600-0587.2008.05486.x; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Natsopoulou ME, 2012, J FISH BIOL, V81, P1696, DOI 10.1111/j.1095-8649.2012.03430.x; Nosil P, 2004, EVOLUTION, V58, P102, DOI 10.1111/j.0014-3820.2004.tb01577.x; Nosil P, 2005, EVOLUTION, V59, P705; Olafsdottir GA, 2007, J EVOLUTION BIOL, V20, P1870, DOI 10.1111/j.1420-9101.2007.01375.x; Owen S. F., 1993, Journal of Fish Biology, V42, P803, DOI 10.1111/j.1095-8649.1993.tb00387.x; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Ravinet M, 2013, J EVOLUTION BIOL, V26, P186, DOI 10.1111/jeb.12049; Reimchen TE, 2001, BIOL J LINN SOC, V73, P51, DOI 10.1006/bijl.2001.0523; Reimchen TE, 2001, J EVOLUTION BIOL, V14, P632, DOI 10.1046/j.1420-9101.2001.00305.x; REIMCHEN TE, 1982, CAN J ZOOL, V60, P1091, DOI 10.1139/z82-150; REIMCHEN TE, 1985, CAN J ZOOL, V63, P2944, DOI 10.1139/z85-441; Reimchen TE, 1997, CAN J ZOOL, V75, P2084, DOI 10.1139/z97-843; Rellstab C, 2011, INFECT GENET EVOL, V11, P1276, DOI 10.1016/j.meegid.2011.04.018; SANDLUND OT, 1992, OIKOS, V64, P305, DOI 10.2307/3545056; Scharsack JP, 2007, P ROY SOC B-BIOL SCI, V274, P1523, DOI 10.1098/rspb.2007.0210; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen Ole, 2009, P155; Seppala O, 2005, ANIM BEHAV, V70, P889, DOI 10.1016/j.anbehav.2005.01.020; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Stutz WE, 2014, AM NAT, V183, P810, DOI 10.1086/676005; Taylor EB, 1999, REV FISH BIOL FISHER, V9, P299, DOI 10.1023/A:1008955229420; Thompson CE, 1997, EVOLUTION, V51, P1955, DOI 10.1111/j.1558-5646.1997.tb05117.x; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	80	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130579	10.1371/journal.pone.0130579	http://dx.doi.org/10.1371/journal.pone.0130579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086778	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000356567500117
J	Pourpirali, S; Valacca, C; Merlo, P; Rizza, S; D'Amico, S; Cecconi, F				Pourpirali, Somayeh; Valacca, Cristina; Merlo, Paola; Rizza, Salvatore; D'Amico, Silvia; Cecconi, Francesco			Prolonged Pseudohypoxia Targets Ambra1 mRNA to P-Bodies for Translational Repression	PLOS ONE			English	Article							HYPOXIA; AUTOPHAGY; LOCALIZATION; APOPTOSIS; PATHWAYS; CELLS	Hypoxia has been associated with several pathological conditions ranging from stroke to cancer. This condition results in the activation of autophagy, a cyto-protective response involving the formation of double-membraned structures, the autophagosomes, in the cytoplasm. In this study, we investigated the cellular mechanisms regulating the autophagy gene Ambra1, after exposure to a hypoxia mimetic, cobalt chloride (CoCl2). We observed that, upon CoCl2 administration, activation of the apoptotic machinery was concomitant with down-regulation of the pro-autophagic factor Ambra1, without affecting transcription. Additionally, co-treating the cells with the caspase inhibitor z-VAD-FMK did not restore Ambra1 protein levels, this implying the involvement of other regulatory mechanisms. Partial re-localization of Ambra1 mRNA to non-translating fractions and cytoplasmic P-bodies was further detected. Thus, in this pseudohypoxic context, Ambra1 mRNA translocation to P-bodies and translational suppression correlated with increased cell death.	[Pourpirali, Somayeh; Valacca, Cristina; D'Amico, Silvia; Cecconi, Francesco] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Valacca, Cristina; Merlo, Paola; Cecconi, Francesco] IRCCS Fdn Santa Lucia, Rome, Italy; [Rizza, Salvatore; Cecconi, Francesco] Danish Canc Soc, Res Ctr, Unit Cell Stress & Survival, Copenhagen, Denmark	University of Rome Tor Vergata; IRCCS Santa Lucia; Danish Cancer Society	Cecconi, F (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	cecconi@cancer.dk	Cecconi, Francesco/K-3969-2016; Pourpirali, Somayeh/AAN-3663-2021; Rizza, Salvatore/GWZ-7823-2022; DAmico, Silvia/AAA-6700-2020	Cecconi, Francesco/0000-0002-5614-4359; Rizza, Salvatore/0000-0001-7335-4684; DAmico, Silvia/0000-0002-9805-4589; Pourpirali, Somayeh/0000-0002-1168-3420	AIRC [IG2010, IG2012]; FISM; Telethon Foundation [GGP14202, GGP10225]; Italian Ministry of University and Research (PRIN); Italian Ministry of Health; Danish National Research Foundation; Kraeftens Bekaempelse Videnskabelige Udvalg [R72-A4408]; Lundbeck Foundation [R167-2013-16100]; Novo Nordisk Foundation [7559]; Bjarne Saxhofs Fond; Italian Ministry of University and Research (FIRB Accordi di Programma); Novo Nordisk Fonden [NNF13OC0007559] Funding Source: researchfish; The Danish Cancer Society [R72-A4408] Funding Source: researchfish	AIRC(Fondazione AIRC per la ricerca sul cancro); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Telethon Foundation(Fondazione Telethon); Italian Ministry of University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health(Ministry of Health, Italy); Danish National Research Foundation(Danmarks Grundforskningsfond); Kraeftens Bekaempelse Videnskabelige Udvalg; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Bjarne Saxhofs Fond; Italian Ministry of University and Research (FIRB Accordi di Programma)(Ministry of Education, Universities and Research (MIUR)); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	This work was supported in part by grants from AIRC (IG2010 and IG2012), and in part from FISM (2009), Telethon Foundation (GGP14202 and GGP10225), the Italian Ministry of University and Research (PRIN 2009 and FIRB Accordi di Programma 2011) and the Italian Ministry of Health (Ricerca Corrente and RF 2009). Also, Francesco Cecconi's lab in Copenhagen is part of the newly established Center of Excellence in Autophagy, Recycling and Disease (CARD), funded by the Danish National Research Foundation. This research was also supported in part by grants from Kraeftens Bekaempelse Videnskabelige Udvalg (R72-A4408), The Lundbeck Foundation (R167-2013-16100), The Novo Nordisk Foundation (7559), and the Bjarne Saxhofs Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Battaglia V, 2009, INT J BIOCHEM CELL B, V41, P586, DOI 10.1016/j.biocel.2008.07.012; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Esclatine A, 2009, CURR TOP MICROBIOL, V335, P33, DOI 10.1007/978-3-642-00302-8_2; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Naves T, 2013, BIOCHEM PHARMACOL, V85, P1153, DOI 10.1016/j.bcp.2013.01.022; Pagliarini V, 2012, CELL DEATH DIFFER, V19, P1495, DOI 10.1038/cdd.2012.27; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Strappazzon F, 2011, EMBO J, V30, P1195, DOI 10.1038/emboj.2011.49; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Xu X, 2013, J NEUROSCI, V33, P14791, DOI 10.1523/JNEUROSCI.5864-12.2013	23	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129750	10.1371/journal.pone.0129750	http://dx.doi.org/10.1371/journal.pone.0129750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086269	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567500060
J	Fitzsimmons, KE; Stern, N; Murray-Wallace, CV; Truscott, W; Pop, C				Fitzsimmons, Kathryn E.; Stern, Nicola; Murray-Wallace, Colin V.; Truscott, William; Pop, Cornel			The Mungo Mega-Lake Event, Semi-Arid Australia: Non-Linear Descent into the Last Ice Age, Implications for Human Behaviour	PLOS ONE			English	Article							NEW-SOUTH-WALES; REGENERATIVE-DOSE PROTOCOL; SOUTHEASTERN AUSTRALIA; WILLANDRA LAKES; CLIMATE VARIABILITY; HUMAN OCCUPATION; GLACIAL MAXIMUM; LUMINESCENCE; SINGLE; QUARTZ	The Willandra Lakes complex is one of the few locations in semi-arid Australia to preserve both paleoenvironmental and Paleolithic archeological archives at high resolution. The stratigraphy of transverse lunette dunes on the lakes' downwind margins record a late Quaternary sequence of wetting and drying. Within the Willandra system, the Lake Mungo lunette is best known for its preservation of the world's oldest known ritual burials, and high densities of archeological traces documenting human adaptation to changing environmental conditions over the last 45 ka. Here we identify evidence at Lake Mungo for a previously unrecognised short-lived, very high lake filling phase at 24 ka, just prior to the Last Glacial Maximum. Mega-lake Mungo was up to 5 m deeper than preceding or subsequent lake full events and represented a lake volume increase of almost 250%. Lake Mungo was linked with neighboring Lake Leaghur at two overflow points, creating an island from the northern part of the Mungo lunette. This event was most likely caused by a pulse of high catchment rainfall and runoff, combined with neotectonic activity which may have warped the lake basin. It indicates a non-linear transition to more arid ice age conditions. The mega-lake restricted mobility for people living in the area, yet archeological traces indicate that humans rapidly adapted to the new conditions. People repeatedly visited the island, transporting stone tools across water and exploiting food resources stranded there. They either swam or used watercraft to facilitate access to the island and across the lake. Since there is no evidence for watercraft use in Australia between initial colonization of the continent prior to 45 ka and the mid-Holocene, repeated visits to the island may represent a resurrection of waterfaring technologies following a hiatus of at least 20 ky.	[Fitzsimmons, Kathryn E.; Pop, Cornel] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Stern, Nicola; Truscott, William] La Trobe Univ, Archaeol Program, Bundoora, Vic 3086, Australia; [Murray-Wallace, Colin V.] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia	Max Planck Society; La Trobe University; University of Wollongong	Fitzsimmons, KE (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany.	kathryn_fitzsimmons@eva.mpg.de	Fitzsimmons, Kathryn/U-3565-2018; Murray-Wallace, Colin V/U-5338-2017	Fitzsimmons, Kathryn/0000-0002-9337-0793; Murray-Wallace, Colin/0000-0002-3029-9141; Pop, Cornel/0000-0002-1462-3677	Australian Research Council [DP1092966]; Max Planck Institute for Evolutionary Anthropology; La Trobe University	Australian Research Council(Australian Research Council); Max Planck Institute for Evolutionary Anthropology(Max Planck Society); La Trobe University	This research was funded by an Australian Research Council Discovery Project (DP1092966), and supported in-kind by the Max Planck Institute for Evolutionary Anthropology and La Trobe University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiec G., 1998, ANCIENT TL, V16, P37, DOI DOI 10.1016/S0277-3791(03)00021-0; [Anonymous], 1996, THESIS U MELBOURNE M; [Anonymous], 2006, EARTHQUAKE ENG AUSTR; Balme J, 2013, QUATERN INT, V285, P68, DOI 10.1016/j.quaint.2011.02.029; Barrows TT, 2004, QUATERNARY SCI REV, V23, P697, DOI 10.1016/j.quascirev.2003.10.011; Barrows TT, 2001, QUATERNARY RES, V55, P179, DOI 10.1006/qres.2001.2216; Botter-Jensen L, 1997, RADIAT MEAS, V27, P749, DOI 10.1016/S1350-4487(97)00206-0; Botter-Jensen L, 2000, RADIAT MEAS, V32, P523, DOI 10.1016/S1350-4487(00)00039-1; Bowler J. M., 1978, P R SOC VICTORIA, V90, P5; Bowler J.M., 1998, ARCHAEOL OCEAN, V33, P120, DOI DOI 10.1002/J.1834-4453.1998.TB00414.X; Bowler J.M., 1976, ORIGIN AUSTR, P127; Bowler JM, 2012, TERRA AUSTRALIS, V34, P271; BOWLER JM, 1986, PALAEOGEOGR PALAEOCL, V54, P21, DOI 10.1016/0031-0182(86)90116-1; BOWLER JM, 1976, EARTH-SCI REV, V12, P279, DOI 10.1016/0012-8252(76)90008-8; BOWLER JM, 1970, WORLD ARCHAEOL, V2, P39, DOI 10.1080/00438243.1970.9979463; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; COSTIN AB, 1973, AUST J SOIL RES, V11, P13, DOI 10.1071/SR9730013; Fitzsimmons KE, 2014, J ARCHAEOL SCI, V41, P349, DOI 10.1016/j.jas.2013.08.004; Fitzsimmons KE, 2013, QUATERNARY SCI REV, V74, P78, DOI 10.1016/j.quascirev.2012.09.007; Fitzsimmons KE, 2009, SEDIMENT GEOL, V218, P61, DOI 10.1016/j.sedgeo.2009.04.004; GALBRAITH RF, 1990, NUCL TRACKS RAD MEAS, V17, P197; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; GOULD RA, 1978, AM ANTHROPOL, V80, P815, DOI 10.1525/aa.1978.80.4.02a00030; HESSE PP, 1994, QUATERNARY SCI REV, V13, P257, DOI 10.1016/0277-3791(94)90029-9; Hesse PP, 2004, QUATERN INT, V118, P87, DOI 10.1016/S1040-6182(03)00132-0; Holdaway S, 2012, J ARCHAEOL METHOD TH, V19, P101, DOI 10.1007/s10816-011-9103-6; Jarvis A, 2009, HOLE FILLED SRTM GLO; Kellett J.R., 1989, BMR J AUST GEOL GEOP, V11, P333; Kemp J, 2004, GEOMORPHOLOGY, V60, P171, DOI 10.1016/j.geomorph.2003.07.007; Kemp J, 2010, QUATERNARY SCI REV, V29, P732, DOI 10.1016/j.quascirev.2009.12.001; Kemp J, 2007, J QUATERNARY SCI, V22, P423, DOI 10.1002/jqs.1125; Lawrie K.C., 2012, BROKEN HILL MANAGED; Lomax J, 2011, QUATERNARY SCI REV, V30, P723, DOI 10.1016/j.quascirev.2010.12.015; Long K, 2014, QUATERNARY SCI REV, V88, P82, DOI 10.1016/j.quascirev.2014.01.012; McPherson A., 2012, P AUSTR REGOLITH CLA, P7; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Mountford CP., 1941, T ROYAL SOC S AUSTR, V65, P312; Murray AS, 2003, RADIAT MEAS, V37, P377, DOI 10.1016/S1350-4487(03)00053-2; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Nanson G.C., 2008, PALAEOHYDROLOGY UNDE, P233; O'Connor S, 2000, MOD QUAT RE, V16, P99; OConnell J.F., 2010, GLOBAL ORIGINS DEV S, P57; OConnor Susan, 2003, PACIFIC ARCHAEOLOGY, P17; PAGE K, 1994, J QUATERNARY SCI, V9, P47, DOI 10.1002/jqs.3390090105; Page K, 1996, J QUATERNARY SCI, V11, P311; Page KJ, 2001, QUATERN INT, V83-5, P187, DOI 10.1016/S1040-6182(01)00039-8; Petherick L, 2013, QUATERNARY SCI REV, V74, P58, DOI 10.1016/j.quascirev.2012.12.012; Pethierick L, 2008, J QUATERNARY SCI, V23, P787, DOI 10.1002/jqs.1186; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Quigley MC, 2006, AUST J EARTH SCI, V53, P285, DOI 10.1080/08120090500499271; Radczewski OE, 1939, RECENT MARINE SEDIME; Reeves JM, 2013, QUATERNARY SCI REV, V74, P21, DOI 10.1016/j.quascirev.2013.01.001; Stern N., 2013, ARCHAEOLOGY ENV TECH, P31; Stone T, 2006, THESIS U MELBOURNE M; Tindale N. B., 1972, HUNTERS GATHERERS TO, P217; Twidale C. R., 2007, CRUSTAL STRUCTURES M, P153; Webb S, 2006, J HUM EVOL, V50, P405, DOI 10.1016/j.jhevol.2005.10.002	57	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127008	10.1371/journal.pone.0127008	http://dx.doi.org/10.1371/journal.pone.0127008			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CK9NS	26083665	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400009
J	Golomb, BA; Bui, AK				Golomb, Beatrice Alexandra; Bui, Alexis K.			A Fat to Forget: Trans Fat Consumption and Memory	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; INSULIN-RESISTANCE; ACID-COMPOSITION; HEALTHY-SUBJECTS; SYSTEMIC INFLAMMATION; ELDERLY SUBJECTS; BLOOD-PRESSURE; DIETARY-INTAKE	Purpose We sought to assess the relation of dietary trans fatty acid (dTFA) consumption to word-memory. Methods We analyzed cross-sectional data from the 1999-2005 UCSD Statin Study. Participants were 1018 adult men and non-procreative women age >= 20 without diagnosed diabetes, CVD, or extreme LDL-cholesterol. Primary analyses focused on men, as only men (N = 694) were effectively represented in younger adult ages. "Recurrent words" assessed word memory. dTFA (grams/day) estimates were calculated from the Fred Hutchinson Food Frequency Questionnaire. Regression, stratified at age 45, assessed the relation between memory and dTFA in various adjustment models. Major findings were replicated in the full sample (including women). Potential mediators were examined. Results An age-by-dTFA interaction was significant. dTFA adversely predicted memory in younger adults (only), robust to adjustment model. Each gram/day dTFA was associated with an estimated 0.76 fewer words recalled (full model) (SE = 0.27, 95% CI = 0.22,1.3, P = 0.006). Adjustment for systolic blood pressure, waist circumference and BMI (but not lipid or glycemic variables) attenuated the relationship, consistent with mediation by factors involving, relating to, or concurrently influencing, these factors. Conclusion Greater dTFA was significantly associated with worse word recall in younger adults. Prooxidant and energetic detriments of dTFA and triangulation with other evidence offer prospects for causality.	[Golomb, Beatrice Alexandra; Bui, Alexis K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Golomb, BA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	bgolomb@ucsd.edu			NHLBI, NIH [RO1 HL63055-05]; UCSD General Clinical Research Center (NIH) [MO1 RR00827]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063055] Funding Source: NIH RePORTER	NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UCSD General Clinical Research Center (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Collection of data was funded by the NHLBI, NIH grant# RO1 HL63055-05; and supported by the UCSD General Clinical Research Center (NIH #MO1 RR00827). Analysis was funded by a donation from Dr. Murray Rosenthal. The funding sources did not influence the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. All authors had full access to the data (statistical printouts validating each finding were independently reproduced) and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Albuquerque KT, 2006, NUTRITION, V22, P820, DOI 10.1016/j.nut.2006.04.009; Atzmon G, 2002, J GERONTOL A, V57, pM712; Berr C, 2000, J AM GERIATR SOC, V48, P1285, DOI 10.1111/j.1532-5415.2000.tb02603.x; Berr C, 2000, BIOFACTORS, V13, P205, DOI 10.1002/biof.5520130132; Cassagno N, 2005, BRIT J NUTR, V94, P346, DOI 10.1079/BJN20051512; Conklin SM, 2007, PSYCHIAT RES, V152, P1, DOI 10.1016/j.psychres.2006.10.006; Corcoran MP, 2007, AM J CLIN NUTR, V85, P662; DESCHRIJVER R, 1982, LIPIDS, V17, P27, DOI 10.1007/BF02535118; Desideri G, 2012, HYPERTENSION, V60, P794, DOI 10.1161/HYPERTENSIONAHA.112.193060; Dyerberg J, 2006, ATHEROSCLEROSIS SUPP, V7, P33, DOI 10.1016/j.atherosclerosissup.2006.04.017; Eggermont LHP, 2012, HEART, V98, P1334, DOI 10.1136/heartjnl-2012-301682; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Fehm HL, 2006, PROG BRAIN RES, V153, P129, DOI 10.1016/S0079-6123(06)53007-9; Fontani G, 2005, EUR J CLIN INVEST, V35, P691, DOI 10.1111/j.1365-2362.2005.01570.x; Food and Drug Administration, FDA TARG TRANS FATS; Fukui K, 2002, ANN NY ACAD SCI, V959, P275, DOI 10.1111/j.1749-6632.2002.tb02099.x; Geroldi C, 2005, ARCH NEUROL-CHICAGO, V62, P1067, DOI 10.1001/archneur.62.7.1067; Golomb BA, 2004, CONTROL CLIN TRIALS, V25, P178, DOI 10.1016/j.cct.2003.08.014; Golomb BA, 2011, NATURE PRECEDINGS; Golomb BA, 2014, CIRCULATION UNPUB; Golomb BA, 2012, MORE FREQUENT CHOCOL, V126; Golomb BA, 2008, ARCH INTERN MED, V168, P721, DOI 10.1001/archinte.168.7.721; Golomb BA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000833; Golomb BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032175; Golomb BA, 2012, ARCH INTERN MED, V172, P519, DOI 10.1001/archinternmed.2011.2100; Harnack L, 2003, J AM DIET ASSOC, V103, P1160, DOI 10.1016/S0002-8223(03)00976-3; HILL EG, 1979, J NUTR, V109, P1759, DOI 10.1093/jn/109.10.1759; Hong YM, 2003, FEBS LETT, V543, P170, DOI 10.1016/S0014-5793(03)00444-7; Ibrahim A, 2005, METABOLISM, V54, P240, DOI 10.1016/j.metabol.2004.08.019; Iribarren C, 2004, EUR J CLIN NUTR, V58, P24, DOI 10.1038/sj.ejcn.1601739; Kavanagh K, 2007, OBESITY, V15, P1675, DOI 10.1038/oby.2007.200; Lavenex P, 2011, HIPPOCAMPUS, V21, P142, DOI 10.1002/hipo.20730; Lemaitre RN, 2002, CIRCULATION, V105, P697, DOI 10.1161/hc0602.103583; Lemaitre RN, 2006, CIRCULATION, V114, P209, DOI 10.1161/CIRCULATIONAHA.106.620336; Lim WS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005379.pub2; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; MENSINK RP, 1993, PROG LIPID RES, V32, P111, DOI 10.1016/0163-7827(93)90007-J; Mensink RP, 2005, CURR OPIN LIPIDOL, V16, P27, DOI 10.1097/00041433-200502000-00006; MENSINK RP, 1994, ANN MED, V26, P461, DOI 10.3109/07853899409148369; MENSINK RP, 1989, NEW ENGL J MED, V321, P436, DOI 10.1056/NEJM198908173210705; Messerotti Benvenuti S, 2012, PERFUSION; Mozaffarian D, 2004, AM J CLIN NUTR, V80, P1521, DOI 10.1093/ajcn/80.6.1521; Mozaffarian D, 2004, AM J CLIN NUTR, V79, P606, DOI 10.1093/ajcn/79.4.606; Muldoon MF, 2000, AM J MED, V108, P538, DOI 10.1016/S0002-9343(00)00353-3; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Natarajan S, 2005, BRIT J NUTR, V93, P829, DOI 10.1079/BJN20051442; Nogueira L, 2011, J PHYSIOL-LONDON, V589, P4615, DOI 10.1113/jphysiol.2011.209924; Pu DH, 2013, AUTISM RES, V6, P384, DOI 10.1002/aur.1300; Robinson JG, 2010, WOMENS HEALTH, V6, P119, DOI 10.2217/WHE.09.75; Rose N, 2010, ARCH INTERN MED, V170, P699, DOI 10.1001/archinternmed.2010.78; Sanchez-Villegas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016268; Schakel Sally F., 1997, Journal of Food Composition and Analysis, V10, P102, DOI 10.1006/jfca.1997.0527; Sorond Farzaneh A, 2008, Neuropsychiatr Dis Treat, V4, P433; Spadafranca A, 2010, BRIT J NUTR, V103, P1008, DOI 10.1017/S0007114509992698; Stender S, 2008, FOOD NUTR RES, P52; Sundram K, 1997, J NUTR, V127, pS514, DOI 10.1093/jn/127.3.514S; Sundram K, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-3; Tanaka Yoichiro, 2008, Kobe J Med Sci, V54, pE97; Tomey KM, 2007, J NUTR, V137, P2412, DOI 10.1093/jn/137.11.2412; US Food and Drug Administration, 2003, TRANS FATT AC NUTR L; van Exel E, 2003, NEUROLOGY, V61, P1695, DOI 10.1212/01.WNL.0000098877.07653.7C; Vinson JA, 2006, J AGR FOOD CHEM, V54, P8071, DOI 10.1021/jf062175j; Vohnout B, 2011, NUTRITION, V27, P1209, DOI 10.1016/j.nut.2011.07.008	63	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128129	10.1371/journal.pone.0128129	http://dx.doi.org/10.1371/journal.pone.0128129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083739	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400029
J	Breckel, TPK; Giessing, C; Gieseler, A; Querbach, S; Reuter, M; Thiel, CM				Breckel, Thomas P. K.; Giessing, Carsten; Gieseler, Anja; Querbach, Sarah; Reuter, Martin; Thiel, Christiane M.			Nicotinergic Modulation of Attention-Related Neural Activity Differentiates Polymorphisms of DRD2 and CHRNA4 Receptor Genes	PLOS ONE			English	Article							C957T POLYMORPHISM; VISUOSPATIAL ATTENTION; ACETYLCHOLINE-RECEPTORS; INDIVIDUAL-DIFFERENCES; PERFORMANCE; AVAILABILITY; ADDICTION; NETWORKS; AREAS	Cognitive and neuronal effects of nicotine show high interindividual variability. Recent findings indicate that genetic variations that affect the cholinergic and dopaminergic neurotransmitter system impact performance in cognitive tasks and effects of nicotine. The current pharmacogenetic functional magnetic resonance imaging (fMRI) study aimed to investigate epistasis effects of CHRNA4/DRD2 variations on behavioural and neural correlates of visuospatial attention after nicotine challenge using a data driven partial least squares discriminant analysis (PLS-DA) approach. Fifty young healthy non-smokers were genotyped for CHRNA4 (rs1044396) and DRD2 (rs6277). They received either 7mg transdermal nicotine or a matched placebo in a double blind within subject design prior to performing a cued target detection task with valid and invalid trials. On behavioural level, the strongest benefits of nicotine in invalid trials were observed in participants carrying both, the DRD2 T-and CHRNA4 C+ variant. Neurally, we were able to demonstrate that different DRD2/CHRNA4 groups can be decoded from the pattern of brain activity in invalid trials under nicotine. Neural substrates of interindividual variability were found in a network of attention-related brain regions comprising the pulvinar, the striatum, the middle and superior frontal gyri, the insula, the left precuneus, and the right middle temporal gyrus. Our findings suggest that polymorphisms in the CHRNA4 and DRD2 genes are a relevant source of individual variability in pharmacological studies with nicotine.	[Breckel, Thomas P. K.; Giessing, Carsten; Gieseler, Anja; Querbach, Sarah; Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, European Med Sch, Dept Psychol, Biol Psychol, D-26111 Oldenburg, Germany; [Breckel, Thomas P. K.; Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany; [Reuter, Martin] Univ Bonn, Dept Psychol, Personal & Biol Psychol, Bonn, Germany; [Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany; [Reuter, Martin] Univ Bonn, Ctr Econ Neurosci CENs, Neurogenet Lab, Bonn, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; University of Bonn; Carl von Ossietzky Universitat Oldenburg; University of Bonn	Thiel, CM (corresponding author), Carl von Ossietzky Univ Oldenburg, European Med Sch, Dept Psychol, Biol Psychol, D-26111 Oldenburg, Germany.	chritiane.thiel@uni-oldenburg.de		, Christiane/0000-0003-4788-4301	German Research Foundation DFG [TH766/6-1]	German Research Foundation DFG(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation DFG TH766/6-1.	Abdi Herve, 2013, Methods Mol Biol, V930, P549, DOI 10.1007/978-1-62703-059-5_23; Ahrens S, 2015, PSYCHOPHARMACOLOGY, V232, P2323, DOI 10.1007/s00213-015-3869-2; Behler O, 2015, PSYCHOPHARMACOLOGY, V232, P1269, DOI 10.1007/s00213-014-3761-5; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Caplan JB, 2007, CEREB CORTEX, V17, P1650, DOI 10.1093/cercor/bhl076; Colzato LS, 2010, NEUROSCIENCE, V170, P782, DOI 10.1016/j.neuroscience.2010.07.050; Cook R. D., 1982, RESIDUALS AND INFLUE; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; Di Giorgio A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095997; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Espeseth T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014407; Evans S, 2013, J PSYCHOPHARMACOL, V27, P1007, DOI 10.1177/0269881113499828; Exley R, 2008, BRIT J PHARMACOL, V153, pS283, DOI 10.1038/sj.bjp.0707510; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Giessing C, 2012, NEUROIMAGE, V59, P831, DOI 10.1016/j.neuroimage.2011.07.061; Gosselin R, 2010, CHEMOMETR INTELL LAB, V100, P12, DOI 10.1016/j.chemolab.2009.09.005; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Greenwood PM, 2012, NEUROSCI BIOBEHAV R, V36, P1331, DOI 10.1016/j.neubiorev.2012.02.010; Greenwood PM, 2005, J COGNITIVE NEUROSCI, V17, P1611, DOI 10.1162/089892905774597281; Hahn B, 2007, J NEUROSCI, V27, P3477, DOI 10.1523/JNEUROSCI.5129-06.2007; Hahn B, 2009, CEREB CORTEX, V19, P1990, DOI 10.1093/cercor/bhn226; Hammersley JJ, 2013, PHARMACOL BIOCHEM BE, V105, P199, DOI 10.1016/j.pbb.2013.02.017; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Herman AI, 2014, PHARMACOGENOMICS, V15, P221, DOI 10.2217/pgs.13.246; Herman AI, 2010, ADDICT BIOL, V15, P250, DOI 10.1111/j.1369-1600.2010.00213.x; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; Hirvonen MM, 2009, PROG NEURO-PSYCHOPH, V33, P630, DOI 10.1016/j.pnpbp.2009.02.021; Jacobsen LK, 2006, PSYCHOPHARMACOLOGY, V188, P530, DOI 10.1007/s00213-006-0469-1; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lee MR, 2013, GENES BRAIN BEHAV, V12, P554, DOI 10.1111/gbb.12027; Markett S, 2014, NEUROSCI LETT, V566, P216, DOI 10.1016/j.neulet.2014.02.052; Markett S, 2013, NEUROIMAGE, V64, P167, DOI 10.1016/j.neuroimage.2012.08.059; Markett S, 2011, EMOTION, V11, P450, DOI 10.1037/a0021784; Markett SA, 2010, J COGNITIVE NEUROSCI, V22, P1944, DOI 10.1162/jocn.2009.21354; Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010; Newhouse PA, 2004, CURR OPIN PHARMACOL, V4, P36, DOI 10.1016/j.coph.2003.11.001; NISELL M, 1994, SYNAPSE, V16, P36, DOI 10.1002/syn.890160105; Parasuraman R, 2005, PSYCHOL SCI, V16, P200, DOI 10.1111/j.0956-7976.2005.00804.x; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Qu HN, 2010, PATTERN RECOGN, V43, P3448, DOI 10.1016/j.patcog.2010.05.002; Rodriguez-Jimenez R, 2006, NEUROPSYCHOBIOLOGY, V54, P166, DOI 10.1159/000098652; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Shulman GL, 2009, J NEUROSCI, V29, P4392, DOI 10.1523/JNEUROSCI.5609-08.2009; Smolka MN, 2004, PSYCHOPHARMACOLOGY, V175, P374, DOI 10.1007/s00213-004-1824-8; Strumpf H, 2013, HUM BRAIN MAPP, V34, P1115, DOI 10.1002/hbm.21496; Thiel CM, 2008, NEUROSCIENCE, V152, P381, DOI 10.1016/j.neuroscience.2007.10.061; Thiel CM, 2005, NEUROPSYCHOPHARMACOL, V30, P810, DOI 10.1038/sj.npp.1300633; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VANDERVOET H, 1994, CHEMOMETR INTELL LAB, V25, P313, DOI 10.1016/0169-7439(94)85050-X; Vossel S, 2008, NEUROPSYCHOPHARMACOL, V33, P731, DOI 10.1038/sj.npp.1301469; Vossel S, 2011, J PSYCHOPHARMACOL, V25, P1485, DOI 10.1177/0269881110391830; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Wong DF, 2013, J NUCL MED, V54, P1308, DOI 10.2967/jnumed.112.108001; Xu HY, 2007, SCHIZOPHR RES, V90, P104, DOI 10.1016/j.schres.2006.10.001	56	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0126460	10.1371/journal.pone.0126460	http://dx.doi.org/10.1371/journal.pone.0126460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079805	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300002
J	Chakrabarti, L; Morgan, C; Sandler, AD				Chakrabarti, Lina; Morgan, Clifford; Sandler, Anthony D.			Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; OPSOCLONUS-MYOCLONUS; T-CELLS; FAVORABLE PROGNOSIS; ANTITUMOR IMMUNITY; PHASE-II; CANCER; IMMUNOTHERAPY; CHILDREN; CTLA-4	Tumor vaccines have held much promise, but to date have demonstrated little clinical success. This lack of success is conceivably due to poor tumor antigen presentation combined with immuno-suppressive mechanisms exploited by the tumor itself. Knock down of Inhibitor of differentiation protein 2 (Id2-kd) in mouse neuroblastoma whole tumor cells rendered these cells immunogenic. Id2-kd neuroblastoma (Neuro2a) cells (Id2-kd N2a) failed to grow in most immune competent mice and these mice subsequently developed immunity against further wild-type Neuro2a tumor cell challenge. Id2-kd N2a cells grew aggressively in immune-compromised hosts, thereby establishing the immunogenicity of these cells. Therapeutic vaccination with Id2-kd N2a cells alone suppressed tumor growth even in established neuroblastoma tumors and when used in combination with immune checkpoint blockade eradicated large established tumors. Mechanistically, immune cell depletion studies demonstrated that while CD8+ T cells are critical for antitumor immunity, CD4+ T cells are also required to induce a sustained long-lasting helper effect. An increase in number of CD8+ T-cells and enhanced production of interferon gamma (IFN gamma) was observed in tumor antigen stimulated splenocytes of vaccinated mice. More importantly, a massive influx of cytotoxic CD8+ T-cells infiltrated the shrinking tumor following combined immunotherapy. These findings show that down regulation of Id2 induced tumor cell immunity and in combination with checkpoint blockade produced a novel, potent, T-cell mediated tumor vaccine strategy.	[Sandler, Anthony D.] George Washington Univ, Childrens Natl Med Ctr, Joseph E Robert Jr Ctr Surg Care, Washington, DC 20052 USA; George Washington Univ, Childrens Natl Med Ctr, Sheikh Zayed Inst Pediat Surg Innovat, Washington, DC USA	Children's National Health System; George Washington University; Children's National Health System; George Washington University	Sandler, AD (corresponding author), George Washington Univ, Childrens Natl Med Ctr, Joseph E Robert Jr Ctr Surg Care, Washington, DC 20052 USA.	asandler@childrensnational.org		Morgan, Clifford/0000-0001-9559-6860; Sandler, Anthony/0000-0001-9440-2964	Sheikh Zayed Institute for Pediatric Surgical Innovation; Michael Sandler Cancer research fund	Sheikh Zayed Institute for Pediatric Surgical Innovation; Michael Sandler Cancer research fund	The work is supported by grants from Sheikh Zayed Institute for Pediatric Surgical Innovation and Michael Sandler Cancer research fund to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN AJ, 1976, CANCER, V37, P846, DOI 10.1002/1097-0142(197602)37:2<846::AID-CNCR2820370233>3.0.CO;2-L; Blank CU, 2014, CURR OPIN ONCOL, V26, P204, DOI 10.1097/CCO.0000000000000054; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; Brahmer JR, 2013, CANCER IMMUNOL RES, V1, P85, DOI 10.1158/2326-6066.CIR-13-0078; Carlson LM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23618; CARREL S, 1982, ACTA NEUROPATHOL, V57, P158, DOI 10.1007/BF00685384; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Ceschel S, 2006, PEDIATR BLOOD CANCER, V47, P560, DOI 10.1002/pbc.20726; Chakrabarti L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083521; Chakrabarti Lina, 2012, Front Oncol, V2, P82, DOI 10.3389/fonc.2012.00082; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Chung KY, 2010, J CLIN ONCOL, V28, P3485, DOI 10.1200/JCO.2010.28.3994; Cooper R, 2001, MED PEDIATR ONCOL, V36, P623, DOI 10.1002/mpo.1139; Coughlin CM, 2006, J CLIN ONCOL, V24, P5725, DOI 10.1200/JCO.2005.05.3314; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gray JC, 2006, CLIN SCI, V111, P93, DOI 10.1042/CS20060024; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Gurney JG, 2007, PEDIATRICS, V120, pE1229, DOI 10.1542/peds.2007-0178; Gurney JG, 1997, J PEDIAT HEMATOL ONC, V19, P428, DOI 10.1097/00043426-199709000-00004; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurwitz AA, 2000, CANCER RES, V60, P2444; Hurwitz AA, 1998, P NATL ACAD SCI USA, V95, P10067, DOI 10.1073/pnas.95.17.10067; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Johnson BD, 2003, CELL IMMUNOL, V222, P15, DOI 10.1016/S0008-8749(03)00079-0; KOH PS, 1994, J PEDIATR-US, V125, P712, DOI 10.1016/S0022-3476(94)70062-1; Kyi C, 2014, FEBS LETT, V588, P368, DOI 10.1016/j.febslet.2013.10.015; Lasorella A, 2002, CANCER RES, V62, P301; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Lee S, 2012, CURR ONCOL REP, V14, P468, DOI 10.1007/s11912-012-0257-5; Liu DF, 2012, J CLIN INVEST, V122, P2221, DOI 10.1172/JCI59535; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Met O, 2006, CANCER LETT, V231, P247, DOI 10.1016/j.canlet.2005.02.005; Miska J, 2012, EUR J IMMUNOL, V42, P2584, DOI 10.1002/eji.201242590; Naidoo J, 2014, BR J CANCER; Nishikawa H, 2005, J EXP MED, V201, P681, DOI 10.1084/jem.20041959; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Prigione I, 2004, ANN NY ACAD SCI, V1028, P69, DOI 10.1196/annals.1322.008; Raffaghello L, 2005, CANCER LETT, V228, P155, DOI 10.1016/j.canlet.2004.11.064; Raffaghello L, 2004, NEOPLASIA, V6, P558, DOI 10.1593/neo.04316; Ralph C, 2010, CLIN CANCER RES, V16, P1662, DOI 10.1158/1078-0432.CCR-09-2870; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Russo C, 1997, MED PEDIATR ONCOL, V28, P284, DOI 10.1002/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E; Salgia R, 2003, J CLIN ONCOL, V21, P624, DOI 10.1200/JCO.2003.03.091; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shurin GV, 1998, NAT IMMUN, V16, P263, DOI 10.1159/000069452; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Williams EL, 2013, CLIN CANCER RES, V19, P3545, DOI 10.1158/1078-0432.CCR-12-3226; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	58	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129237	10.1371/journal.pone.0129237	http://dx.doi.org/10.1371/journal.pone.0129237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079374	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300020
J	Jung, S; Kim, MK; Choi, BY				Jung, Sukyoung; Kim, Mi Kyung; Choi, Bo Youl			The Relationship between Zinc Status and Inflammatory Marker Levels in Rural Korean Adults Aged 40 and Older	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; HEALTH; RISK; CONSUMPTION; PREVENTION; CYTOKINES; INTIMA; IRON	Background Serum cytokines and C-reactive protein (CRP) are known as one of the major risk factors in atherosclerosis. The antioxidant and anti-inflammatory properties of zinc have been suggested, but few data are available on the relationship between zinc status and inflammatory markers in epidemiological studies. Objective The present study aims to investigate the cross-sectional relationships of serum cytokines and CRP with dietary zinc intake and serum zinc levels in healthy men and women aged 40 and older in rural areas of South Korea. Materials and Methods A group of 1,055 subjects (404 men, 651 women) was included in dietary zinc analysis while another group of 695 subjects (263 men, 432 women) was included in serum zinc analysis. Serum IL-6, TNF-alpha, and CRP were measured as inflammatory markers. Results There was no significant inverse relationship between dietary zinc intake and inflammatory markers. We found a significant inverse relationship between serum zinc levels and all three inflammatory markers in women (P for trend = 0.0236 for IL-6; P for trend = 0.0017 for TNF-alpha; P for trend = 0.0301 for CRP) and between serum zinc levels and a single inflammatory marker (IL-6) in men (P for trend = 0.0191), although all R2 values by regression were less than 10%. Conclusion In conclusion, serum zinc levels may be inversely related to inflammatory markers (IL-6, TNF-alpha, and CRP), particularly in women.	[Jung, Sukyoung; Kim, Mi Kyung; Choi, Bo Youl] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Jung, Sukyoung; Kim, Mi Kyung; Choi, Bo Youl] Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea	Hanyang University; Hanyang University	Kim, MK (corresponding author), Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea.	kmkkim@hanyang.ac.kr		Jung, Sukyoung/0000-0001-9200-2158	National Research Foundation of Korea [NRF-2012R1A1A2001930]; Research of Korea Centers for Disease Control and Prevention [2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00]	National Research Foundation of Korea(National Research Foundation of Korea); Research of Korea Centers for Disease Control and Prevention	This study was supported by the National Research Foundation of Korea (NRF-2012R1A1A2001930) with additional funding (2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00 and 2009-E71006-00) from the Research of Korea Centers for Disease Control and Prevention. The funders played no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, pS37, DOI 10.1038/sj.ejcn.1602296; de Benoist B, 2007, FOOD NUTR BULL, V28, pS480, DOI 10.1177/15648265070283S306; De Paula R, 2014, BBA CLIN; Fabian E, 2008, ANN NUTR METAB, V52, P57, DOI 10.1159/000115352; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Gibson RS, 2001, BRIT J NUTR, V86, P71, DOI 10.1079/BJN2001370; Harland B F, 1987, World Rev Nutr Diet, V52, P235; Health Canada, 2010, DIETARY REFERENCE IN; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Joung H, 2004, J FOOD COMPOS ANAL, V17, P713, DOI 10.1016/j.jfca.2003.10.002; Jung SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080115; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kogirima M, 2007, EUR J CLIN NUTR, V61, P375, DOI 10.1038/sj.ejcn.1602520; Lee DH, 2005, AM J CLIN NUTR, V81, P787, DOI 10.1093/ajcn/81.4.787; Libby P, 2006, AM J CLIN NUTR, V83, p456S; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Little PJ, 2010, NUTRITION, V26, P1050, DOI 10.1016/j.nut.2010.03.007; Lowe NM, 2012, BRIT J NUTR, V108, P1962, DOI 10.1017/S0007114512004382; Lowe NM, 2009, AM J CLIN NUTR, V89, p2040S, DOI 10.3945/ajcn.2009.27230G; Male D. K., 2012, IMMUNOLOGY; Maret W, 2013, METAL IONS LIFE SCI, V11, P1, DOI 10.1007/978-94-007-5179-8_1; Otto MCCD, 2011, J NUTR, V141, P1508, DOI 10.3945/jn.111.138115; Otto MCD, 2012, J NUTR, V142, P526, DOI 10.3945/jn.111.149781; Pasceri V, 2000, CIRCULATION, V102, P2165; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; REEVES PG, 1995, J NUTR BIOCHEM, V6, P48, DOI 10.1016/0955-2863(94)00008-A; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Roohani N, 2013, J RES MED SCI, V18, P144; Seo JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105990; The Korean Nutrition Society, 2011, REC DIET ALL KOR; The Korean Nutrition Society, 2000, RECOMMENDED DIETARY, V7th; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Tsai DH, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-24; U.S. Department of Agriculture ARS, 2014, NUTR INT FOOD BEV ME; Uh HW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-59; Willett W, 2012, NUTR EPIDEMIOLOGY; Wood RJ, 2000, J NUTR, V130, p1350S, DOI 10.1093/jn/130.5.1350S; Yang YJ, 2010, BRIT J NUTR, V104, P1202, DOI 10.1017/S0007114510001893; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016; Zhao GX, 2007, AM J CLIN NUTR, V85, P385, DOI 10.1093/ajcn/85.2.385	44	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130016	10.1371/journal.pone.0130016	http://dx.doi.org/10.1371/journal.pone.0130016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080030	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300037
J	Takeishi, Y; Iwaya-Omi, R; Ohashi, E; Tsurimoto, T				Takeishi, Yukimasa; Iwaya-Omi, Rie; Ohashi, Eiji; Tsurimoto, Toshiki			Intramolecular Binding of the Rad9 C Terminus in the Checkpoint Clamp Rad9-Hus1-Rad1 Is Closely Linked with Its DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; HOMOLOGOUS RECOMBINATIONAL REPAIR; ATAXIA-TELANGIECTASIA; DAMAGE CHECKPOINT; IONIZING-RADIATION; EXCISION-REPAIR; HUMAN PCNA; ATR-ATRIP; COMPLEX; TOPBP1	The human checkpoint clamp Rad9-Hus1-Rad1 (9-1-1) is loaded onto chromatin by its loader complex, Rad17-RFC, following DNA damage. The 120-amino acid (aa) stretch of the Rad9 C terminus (C-tail) is unstructured and projects from the core ring structure (CRS). Recent studies showed that 9-1-1 and CRS bind DNA independently of Rad17-RFC. The DNA-binding affinity of mutant 9(Delta C)-1-1, which lacked the Rad9 C-tail, was much higher than that of wild-type 9-1-1, suggesting that 9-1-1 has intrinsic DNA binding activity that manifests in the absence of the C-tail. C-tail added in trans interacted with CRS and prevented it from binding to DNA. We narrowed down the amino acid sequence in the C-tail necessary for CRS binding to a 15-aa stretch harboring two conserved consecutive phenylalanine residues. We prepared 9-1-1 mutants containing the variant C-tail deficient for CRS binding, and we demonstrated that the mutant form restored DNA binding as efficiently as 9(Delta C)-1-1. Furthermore, we mapped the sequence necessary for TopBP1 binding within the same 15-aa stretch, demonstrating that TopBP1 and CRS share the same binding region in the C-tail. Indeed, we observed their competitive binding to the C-tail with purified proteins. The importance of interaction between 9-1-1 and TopBP1 for DNA damage signaling suggests that the competitive interactions of TopBP1 and CRS with the C-tail will be crucial for the activation mechanism.	[Takeishi, Yukimasa; Iwaya-Omi, Rie; Ohashi, Eiji; Tsurimoto, Toshiki] Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, Fukuoka 8128581, Japan	Kyushu University	Tsurimoto, T (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	ttsurimoto@kyudai.jp	Ohashi, Eiji/AAO-5794-2021	Ohashi, Eiji/0000-0002-1771-5585; Tsurimoto, Toshiki/0000-0001-7597-2216; Takeishi, Yukimasa/0000-0001-9049-3117	KAKENHI [25131714, 22770172]; Uehara Memorial Foundation [103-2012];  [11J04189]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); 	This work was supported by Grant-in-aid for Scientific Research (KAKENHI) 25131714 (to T. T.) and 22770172 (to E. O.), Uehara Memorial Foundation Grant 103-2012 (to E. O.), and Grant-in-aid for Research Fellows of the Japan Society for the Promotion of Science 11J04189 (to Y. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Brandt PD, 2006, BIOCHEM BIOPH RES CO, V347, P232, DOI 10.1016/j.bbrc.2006.06.064; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Burtelow MA, 2001, J BIOL CHEM, V276, P25903, DOI 10.1074/jbc.M102946200; Canfield C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-110; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Hirai I, 2002, J BIOL CHEM, V277, P25722, DOI 10.1074/jbc.M203079200; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Liu QH, 2000, GENE DEV, V14, P1448; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Mayanagia K, 2009, P NATL ACAD SCI USA, V106, P4647, DOI 10.1073/pnas.0811196106; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Ohashi E, 2014, DNA REPAIR, V21, P1, DOI 10.1016/j.dnarep.2014.05.001; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Park MJ, 2009, DNA REPAIR, V8, P1190, DOI 10.1016/j.dnarep.2009.06.004; PATERSON MC, 1976, NATURE, V260, P444, DOI 10.1038/260444a0; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; St Onge RP, 2003, J BIOL CHEM, V278, P26620, DOI 10.1074/jbc.M303134200; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Ueda S, 2012, GENES CELLS, V17, P807, DOI 10.1111/j.1365-2443.2012.01630.x; Wang X, 2006, ONCOGENE, V25, P1980, DOI 10.1038/sj.onc.1209212; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yang YT, 2012, J BIOCHEM, V151, P317, DOI 10.1093/jb/mvr145; Yilmaz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022986; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	57	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19923	19932		10.1074/jbc.M115.669002	http://dx.doi.org/10.1074/jbc.M115.669002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088138	hybrid, Green Published			2022-12-26	WOS:000359364600047
J	Cook, JD; Soto-Montoya, H; Korpela, MK; Lee, JE				Cook, Jonathan D.; Soto-Montoya, Hazel; Korpela, Markus K.; Lee, Jeffrey E.			Electrostatic Architecture of the Infectious Salmon Anemia Virus (ISAV) Core Fusion Protein Illustrates a Carboxyl-Carboxylate pH Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; INFLUENZA HEMAGGLUTININ; MEMBRANE-FUSION; STRUCTURAL-CHARACTERIZATION; STRUCTURE REFINEMENT; GLYCOPROTEIN GP2; VIRAL FUSION; COILED-COIL; MECHANISM; ENTRY	Segment 5, ORF 1 of the infectious salmon anemia virus (ISAV) genome, encodes for the ISAV F protein, which is responsible for viral-host endosomal membrane fusion during a productive ISAV infection. The entry machinery of ISAV is composed of a complex of the ISAV F and ISAV hemagglutinin esterase (HE) proteins in an unknown stoichiometry prior to receptor engagement by ISAV HE. Following binding of the receptor to ISAV HE, dissociation of the ISAV F protein from HE, and subsequent endocytosis, the ISAV F protein resolves into a fusion-competent oligomeric state. Here, we present a 2.1 angstrom crystal structure of the fusion core of the ISAV F protein determined at low pH. This structure has allowed us to unambiguously demonstrate that the ISAV entry machinery exhibits typical class I viral fusion protein architecture. Furthermore, we have determined stabilizing factors that accommodate the pH-dependent mode of ISAV transmission, and our structure has allowed the identification of a central coil that is conserved across numerous and varied post-fusion viral glycoprotein structures. We then discuss a mechanistic model of ISAV fusion that parallels the paramyxoviral class I fusion strategy wherein attachment and fusion are relegated to separate proteins in a similar fashion to ISAV fusion.	[Cook, Jonathan D.; Soto-Montoya, Hazel; Korpela, Markus K.; Lee, Jeffrey E.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Lee, JE (corresponding author), Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada.	jeff.lee@utoronto.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council of Canada; Canadian Institutes of Health Research (CIHR); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work is based upon data collected by Canadian Light Source (CLS) staff under the instruction of J. D. C. at beamline 08ID-1 at the CLS. The CLS is supported by Natural Sciences and Engineering Research Council of Canada (NSERC), National Research Council of Canada, Canadian Institutes of Health Research (CIHR), the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. In addition, we thank Dr. Azmiri Sultana for extensive discussion and tutelage with regards to the XDS software program and Aiping Dong, Dr. Cheryl Arrowsmith, and Dr. Aled Edwards for access to the Structural Genomics Consortium x-ray diffraction facility. Finally, the authors would like to acknowledge the comments and suggestions made by the reviewers to improve this manuscript.	Aamelfot M, 2015, J FISH DIS, V38, P687, DOI 10.1111/jfd.12284; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aspehaug V, 2005, J VIROL, V79, P12544, DOI 10.1128/JVI.79.19.12544-12553.2005; Aydin H, 2014, J VIROL, V88, P143, DOI 10.1128/JVI.02023-13; Aydin H, 2013, FASEB J, V27, P5059, DOI 10.1096/fj.13-232371; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; BULLOUGH PA, 1994, J MOL BIOL, V236, P1262, DOI 10.1016/0022-2836(94)90027-2; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chen J, 1995, P NATL ACAD SCI USA, V92, P12205, DOI 10.1073/pnas.92.26.12205; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Clouthier SC, 2002, J GEN VIROL, V83, P421, DOI 10.1099/0022-1317-83-2-421; Cook JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003258; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Falk K, 2004, J VIROL, V78, P3063, DOI 10.1128/JVI.78.6.3063-3071.2004; Falk K, 2014, FISH VACCINATION, P313; Fourrier M, 2014, J GEN VIROL, V95, P1015, DOI 10.1099/vir.0.061648-0; Harrison JS, 2013, STRUCTURE, V21, P1085, DOI 10.1016/j.str.2013.05.009; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Igonet S, 2012, CELL, V151, P1634, DOI 10.1016/j.cell.2012.11.041; Igonet S, 2011, P NATL ACAD SCI USA, V108, P19967, DOI 10.1073/pnas.1108910108; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalani MR, 2013, BIOPHYS J, V105, P993, DOI 10.1016/j.bpj.2013.06.047; Koellhoffer JF, 2014, J MOL BIOL, V426, P1452, DOI 10.1016/j.jmb.2013.12.009; Langkilde A, 2008, ACTA CRYSTALLOGR D, V64, P851, DOI 10.1107/S0907444908017083; Lu B, 1996, VIROLOGY, V225, P11, DOI 10.1006/viro.1996.0570; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ni FY, 2014, BIOCHEMISTRY-US, V53, P846, DOI 10.1021/bi401525h; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; Rachakonda PS, 2007, FASEB J, V21, P995, DOI 10.1096/fj.06-7052hyp; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; RUIGROK RWH, 1988, J GEN VIROL, V69, P2785, DOI 10.1099/0022-1317-69-11-2785; SAWYER L, 1982, NATURE, V295, P79, DOI 10.1038/295079a0; Schlecht-Louf G, 2010, P NATL ACAD SCI USA, V107, P3782, DOI 10.1073/pnas.0913122107; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stampfer SD, 2010, J VIROL, V84, P12924, DOI 10.1128/JVI.01750-10; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wohlfahrt G, 2005, PROTEINS, V58, P396, DOI 10.1002/prot.20328; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Zheng AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4877	48	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18495	18504		10.1074/jbc.M115.644781	http://dx.doi.org/10.1074/jbc.M115.644781			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26082488	Green Published, hybrid			2022-12-26	WOS:000358512100022
J	Akram, A; Khan, HAA; Qadir, A; Sabir, AM				Akram, Ayesha; Khan, Hafiz Azhar Ali; Qadir, Abdul; Sabir, Arshad Makhdoom			A Cross-Sectional Survey of Knowledge, Attitude and Practices Related to Cutaneous Leishmaniasis and Sand Flies in Punjab, Pakistan	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; RURAL COMMUNITIES; KALA-AZAR; STATE	Background Recent outbreaks of cutaneous leishmaniasis make the disease a public health concern in Punjab, Pakistan. The knowledge of how the population perceives the disease and its vector is essential in order to design an effective management strategy, but such studies are rare in Pakistan. Methodology/Principal Findings The present study was based on a cross-sectional self-administered survey comprising 250 household samples collected from five localities including Bhawalpur, Multan, Jhang, Faisalabad and Lahore. The results revealed that the respondents had a poor knowledge of the vector and disease. Few of the respondents were aware about the identification of sand flies, their breeding place, biting time, transmission of leishmaniasis and control measures. Skin infection and sandflies as the main disease symptom and vector of the disease, respectively, were known to some of the respondents. Some believed that summer was the main peak incidence of the disease and it could be transmitted from man to man via contact. However, most of the respondents believed that the disease could be cured. Admission to hospitals, cleanliness and use of bed nets were the treatment measures for the disease in suspected patients, whereas some thought that the use of bed nets could be helpful in preventing leishmaniasis infection. Conclusions/Significance Poor knowledge of the disease and its vector in the study population emphasize the need to initiate health education and awareness campaigns to minimize the risks of cutaneous leishmaniasis outbreaks in the future.	[Akram, Ayesha; Qadir, Abdul] Univ Punjab, Coll Earth & Environm Sci, Lahore, Pakistan; [Khan, Hafiz Azhar Ali] Univ Punjab, Inst Agr Sci, Lahore, Pakistan; [Sabir, Arshad Makhdoom] Rice Res Inst, Kala Shah Kaku, Pakistan	University of Punjab; University of Punjab	Khan, HAA (corresponding author), Univ Punjab, Inst Agr Sci, Lahore, Pakistan.	azhar_naturalist@yahoo.com	Khan, Hafiz Azhar Ali/AAI-7476-2021	Khan, Hafiz Azhar Ali/0000-0002-7209-4750	University of the Punjab, Lahore, Pakistan	University of the Punjab, Lahore, Pakistan	The authors give sincere thanks to the University of the Punjab, Lahore, Pakistan, for financial assistance of the publication fee.	Ahluwalia IB, 2003, AM J TROP MED HYG, V69, P624, DOI 10.4269/ajtmh.2003.69.624; [Anonymous], 2013, LEISHMANIASIS PAKIST; Bari A, 2012, J PAK ASS DERMATOL, V22, P191; Frary R. B., 1998, BRIEF GUIDE QUESTION; Khan HMR, 2013, JP J BIOSTAT, V9, P1; Koirala S, 1998, B WORLD HEALTH ORGAN, V76, P485; Kraipeerapun K, 2007, INT EDUC J, V8, P64; Lopez-Perea N, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002799; Matthews GA, 2008, CROP PROT, V27, P834, DOI 10.1016/j.cropro.2007.10.013; Mekbib F, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-19; Okwor I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00128; Polseela R, 2011, SE ASIAN J TROP MED, V42, P1395; Saberi S, 2012, VECTOR-BORNE ZOONOT, V12, P306, DOI 10.1089/vbz.2010.0259; Shakoor Muhammad T, 2012, WHO South East Asia J Public Health, V1, P229, DOI 10.4103/2224-3151.207018; Singh SP, 2006, AM J TROP MED HYG, V75, P505, DOI 10.4269/ajtmh.2006.75.505; Vandebroek I, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-35; VAZQUEZ M L, 1991, Boletin de la Oficina Sanitaria Panamericana, V110, P402; WHO, 2010, CONTR LEISHM; WHO, 2002, LEISHM PAK RAP RESP	19	20	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130929	10.1371/journal.pone.0130929	http://dx.doi.org/10.1371/journal.pone.0130929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090870	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000161
J	de Bie, S; Ferrajolo, C; Straus, SMJM; Verhamme, KMC; Bonhoeffer, J; Wong, ICK; Sturkenboom, MCJM				de Bie, Sandra; Ferrajolo, Carmen; Straus, Sabine M. J. M.; Verhamme, Katia M. C.; Bonhoeffer, Jan; Wong, Ian C. K.; Sturkenboom, Miriam C. J. M.		GRiP Network	Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project	PLOS ONE			English	Article							REPORTING SYSTEM; SIGNAL-DETECTION; CHILDREN; VIGIBASE; WORLDWIDE; FOOD	Individual case safety reports (ICSRs) are a cornerstone in drug safety surveillance. The knowledge on using these data specifically for children is limited. We studied characteristics of pediatric ICSRs reported to the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS). Public available ICSRs reported in children (0-18 years) to FAERS were downloaded from the FDA-website for the period Jan 2004-Dec 2011. Characteristics of these ICSRs, including the reported drugs and events, were described and stratified by age-groups. We included 106,122 pediatric ICSRs (55% boys and 58% from United States) with a median of 1 drug [range 1-3] and 1 event [1-2] per ICSR. Mean age was 9.1 years. 90% was submitted through expedited (15-days) (65%) or periodic reporting (25%) and 10% by non-manufacturers. The proportion and type of pediatric ICSRs reported were relatively stable over time. Most commonly reported drug classes by decreasing frequency were 'nervous system drugs' (58%), 'antineoplastics' (32%) and 'anti-infectives' (25%). Most commonly reported system organ classes were 'general' (13%), 'nervous system' (12%) and 'psychiatric' (11%) disorders. Duration of use could be calculated for 19.7% of the reported drugs, of which 14.5% concerned drugs being used long-term (>6 months). Knowledge on the distribution of the drug classes and events within FAERS is a key first step in developing pediatric specific methods for drug safety surveillance. Because of several differences in terms of drugs and events among age-categories, drug safety signal detection analysis in children needs to be stratified by each age group.	[de Bie, Sandra; Ferrajolo, Carmen; Straus, Sabine M. J. M.; Verhamme, Katia M. C.; Sturkenboom, Miriam C. J. M.] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [de Bie, Sandra] Med Evaluat Board, Utrecht, Netherlands; [Ferrajolo, Carmen] Univ Naples 2, Campania Reg Ctr Pharmacovigilance & Pharmacoepid, Dept Expt Med, Pharmacol Sect, Naples, Italy; [Bonhoeffer, Jan] Brighton Collaborat Fdn, Basel, Switzerland; [Bonhoeffer, Jan] Univ Basel, Univ Childrens Hosp Basel, Basel, Switzerland; [Wong, Ian C. K.] Univ Hong Kong, Ctr Safe Medicat Practice & Res, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Sturkenboom, Miriam C. J. M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Universita della Campania Vanvitelli; University of Basel; University of Hong Kong; Erasmus University Rotterdam; Erasmus MC	Ferrajolo, C (corresponding author), Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands.	c.ferrajolo@erasmusmc.nl	Hirschfeld, Steven/E-2987-2016	Hirschfeld, Steven/0000-0003-0627-7249; Wong, Ian Chi Kei/0000-0001-8242-0014; Bonhoeffer, Jan/0000-0001-9704-8315; Verhamme, Anne/0000-0002-2201-1865; Gazarian, Madlen/0000-0001-9007-0595; Offringa, Martin/0000-0002-4402-5299; GIAQUINTO, CARLO/0000-0001-9365-0413; Sturkenboom, Miriam/0000-0003-1360-2388; Verhamme, Katia/0000-0001-8162-4904	European Union [261060]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no 261060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2010, DRUG SAFETY, V33, P475, DOI 10.2165/11534410-000000000-00000; [Anonymous], 2012, DRUG INFORM ONLINE; [Anonymous], 2012, EUDRAVIGILANCE ACCES; [Anonymous], 2012, UMC ACC POL WHO GLOB; [Anonymous], 2012, PHARMACY CODES; [Anonymous], 2012, DATA; Breslow LH, 2003, HARVARD J LEGIS, V40, P133; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; de Bie S, 2012, DRUG SAFETY, V35, P335, DOI 10.2165/11598120-000000000-00000; Dunne J, 2007, PAEDIATR RESPIR REV, V8, P177, DOI 10.1016/j.prrv.2007.04.004; Ferrajolo C, 2014, EXPERT OPIN DRUG SAF, V13, pS9, DOI 10.1517/14740338.2014.939581; Harnmond IW, 2007, EXPERT OPIN DRUG SAF, V6, P713, DOI 10.1517/14740338.6.6.713; International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use, 2012, POPULATION E; Jacqz-Aigrain E, 2011, EARLY HUM DEV, V87, pS27, DOI 10.1016/j.earlhumdev.2011.01.007; Johann-Liang R, 2009, PHARMACOEPIDEM DR S, V18, P24, DOI 10.1002/pds.1679; Lindquist M, 2008, DRUG INF J, V42, P409, DOI 10.1177/009286150804200501; Moore TJ, 2007, ARCH INTERN MED, V167, P1752, DOI 10.1001/archinte.167.16.1752; Moore TJ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e53; Noren GN, 2007, DATA MIN KNOWL DISC, V14, P305, DOI 10.1007/s10618-006-0052-8; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Reich L, 2007, DRUG SAFETY, V30, P551, DOI 10.2165/00002018-200730060-00009; Sakaeda T, 2013, INT J MED SCI, V10, P796, DOI 10.7150/ijms.6048; Singleton JA, 1999, VACCINE, V17, P2908, DOI 10.1016/S0264-410X(99)00132-2; Star K, 2011, DRUG SAFETY, V34, P415, DOI 10.2165/11587540-000000000-00000; Star K, 2011, PEDIATR DRUGS, V13, P71, DOI 10.2165/11589100-000000000-00000; Sturkenboom MCJM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2245; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Tekgul S, 2012, EUR UROL, V62, P534, DOI 10.1016/j.eururo.2012.05.059; van Hunsel F, 2012, DRUG SAFETY, V35, P45, DOI 10.2165/11594320-000000000-00000; VIII CWG, 2010, PRACT ASP SIGN DET P; WHO Collaborating Centre for Drug Statistics Methodology, GUID ATC CLASS DDD A; WHO. International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use, 2014, EXPERT OPINION DR S1, V13, pS9, DOI [10.1517/14740338, DOI 10.1517/14740338]; Zito JM, 2003, ARCH PEDIAT ADOL MED, V157, P17, DOI 10.1001/archpedi.157.1.17	33	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130399	10.1371/journal.pone.0130399	http://dx.doi.org/10.1371/journal.pone.0130399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090678	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000112
J	Mohammad, H; Reddy, PVN; Monteleone, D; Mayhoub, AS; Cushman, M; Hammac, GK; Seleem, MN				Mohammad, Haroon; Reddy, P. V. Narasimha; Monteleone, Dennis; Mayhoub, Abdelrahman S.; Cushman, Mark; Hammac, G. Kenitra; Seleem, Mohamed N.			Antibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermedius	PLOS ONE			English	Article							CLINICAL-SAMPLES; AUREUS; PREVALENCE; INFECTION; AGENTS; DOGS; ANTIBIOTICS; COMBINATION; VANCOMYCIN; RIFAMPICIN	Staphylococcus pseudintermedius is a commensal organism of companion animals that is a significant source of opportunistic infections in dogs. With the emergence of clinical isolates of S. pseudintermedius (chiefly methicillin-resistant S. pseudintermedius (MRSP)) exhibiting increased resistance to nearly all antibiotic classes, new antimicrobials and therapeutic strategies are urgently needed. Thiazole compounds have been previously shown to possess potent antibacterial activity against multidrug-resistant strains of Staphylococcus aureus of human and animal concern. Given the genetic similarity between S. aureus and S. pseudintermedius, this study explores the potential use of thiazole compounds as novel antibacterial agents against methicillin-sensitive S. pseudintermedius (MSSP) and MRSP. A broth microdilution assay confirmed these compounds exhibit potent bactericidal activity (at sub-microgram/mL concentrations) against both MSSA and MRSP clinical isolates while the MTS assay confirmed three compounds (at 10 mu g/mL) were not toxic to mammalian cells. A time-kill assay revealed two derivatives rapidly kill MRSP within two hours. However, this rapid bactericidal activity was not due to disruption of the bacterial cell membrane indicating an alternative mechanism of action for these compounds against MRSP. A multi-step resistance selection analysis revealed compounds 4 and 5 exhibited a modest (twofold) shift in activity over ten passages. Furthermore, all six compounds (at a subinihibitory concentration) demonstrated the ability to re-sensitize MRSP to oxacillin, indicating these compounds have potential use for extending the therapeutic utility of beta-lactam antibiotics against MRSP. Metabolic stability analysis with dog liver microsomes revealed compound 3 exhibited an improved physicochemical profile compared to the lead compound. In addition to this, all six thiazole compounds possessed a long post-antibiotic effect (at least 8 hours) against MRSP. Collectively the present study demonstrates these synthetic thiazole compounds possess potent antibacterial activity against both MSSP and MRSP and warrant further investigation into their use as novel antimicrobial agents.	[Mohammad, Haroon; Hammac, G. Kenitra; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Reddy, P. V. Narasimha; Monteleone, Dennis; Mayhoub, Abdelrahman S.; Cushman, Mark] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Reddy, P. V. Narasimha; Monteleone, Dennis; Mayhoub, Abdelrahman S.; Cushman, Mark] Purdue Ctr Canc Res, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	mseleem@purdue.edu	Seleem, Mohamed/H-2774-2018; Mayhoub, Abdelrahman/P-7579-2016	Seleem, Mohamed/0000-0003-0939-0458; Mohammad, Haroon/0000-0002-8843-8933; Monteleone, Dennis/0000-0001-9172-663X; Mayhoub, Abdelrahman/0000-0002-3987-3680				Baldoni D, 2013, INT J ANTIMICROB AG, V42, P220, DOI 10.1016/j.ijantimicag.2013.05.019; Baldoni D, 2009, ANTIMICROB AGENTS CH, V53, P1142, DOI 10.1128/AAC.00775-08; Beco L, 2013, VET REC, V172, P156, DOI 10.1136/vr.101070; Ben Zakour NL, 2011, J BACTERIOL, V193, P2363, DOI 10.1128/JB.00137-11; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781, DOI 10.1128/CMR.10.4.781; Chi CY, 2014, J INFECT DIS, V209, P224, DOI 10.1093/infdis/jit445; Clinical and Laboratory Standards Institute, 2012, M7A9 NCCLS; Bastos MDD, 2010, PHARMACEUTICALS, V3, P1139, DOI 10.3390/ph3041139; Eckholm NG, 2013, VET DERMATOL, V24, P154, DOI 10.1111/j.1365-3164.2012.01051.x; Farrell DJ, 2011, ANTIMICROB AGENTS CH, V55, P1177, DOI 10.1128/AAC.01285-10; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Furlani RE, 2013, EUR J MED CHEM, V62, P59, DOI 10.1016/j.ejmech.2012.12.005; Geoghegan JA, 2009, VET MICROBIOL, V138, P345, DOI 10.1016/j.vetmic.2009.03.030; Giguere S, 2012, VET MICROBIOL, V160, P207, DOI 10.1016/j.vetmic.2012.05.031; Haenni M, 2010, J VET DIAGN INVEST, V22, P953, DOI 10.1177/104063871002200617; HAYS SJ, 1994, J PHARM SCI, V83, P1425, DOI 10.1002/jps.2600831013; Hutchinson I, 2003, BIOORG MED CHEM LETT, V13, P471, DOI 10.1016/S0960-894X(02)00930-7; Jacqueline C, 2003, J ANTIMICROB CHEMOTH, V51, P857, DOI 10.1093/jac/dkg160; Jones RD, 2007, JAVMA-J AM VET MED A, V230, P221, DOI 10.2460/javma.230.2.221; Koosha RZ, 2014, J INFECT PUBLIC HEAL, V7, P177, DOI 10.1016/j.jiph.2013.11.003; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Levison ME, 2004, INFECT DIS CLIN N AM, V18, P451, DOI 10.1016/j.idc.2004.04.012; Lloyd DH, 1996, VET DERMATOL, V7, P171, DOI 10.1111/j.1365-3164.1996.tb00242.x; May ER, 2006, VET CLIN N AM-SMALL, V36, P185, DOI 10.1016/j.cvsm.2005.09.014; Mayhoub AS, 2011, BIOORGAN MED CHEM, V19, P3845, DOI 10.1016/j.bmc.2011.04.041; Milani C, 2012, THERIOGENOLOGY, V78, P1321, DOI 10.1016/j.theriogenology.2012.05.033; Mohammad H, 2015, J ANTIBIOT, V68, P259, DOI 10.1038/ja.2014.142; Mohammad H, 2015, EUR J MED CHEM, V94, P306, DOI 10.1016/j.ejmech.2015.03.015; Mohammad H, 2014, J MED CHEM, V57, P1609, DOI 10.1021/jm401905m; Murugaiyan J, 2014, CLIN MICROBIOL INFEC, V20, P1007, DOI 10.1111/1469-0691.12662; O'Neill AJ, 2004, J ANTIMICROB CHEMOTH, V54, P1127, DOI 10.1093/jac/dkh476; Oliva B, 2003, ANTIMICROB AGENTS CH, V47, P458, DOI 10.1128/AAC.47.2.458-466.2003; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; PAGET CJ, 1969, J MED CHEM, V12, P1016, DOI 10.1021/jm00306a011; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Rubin JE, 2011, CAN VET J, V52, P162; Ruscher C, 2009, VET MICROBIOL, V136, P197, DOI 10.1016/j.vetmic.2008.10.023; Singh MP, 2003, ANTIMICROB AGENTS CH, V47, P62, DOI 10.1128/AAC.47.1.62-69.2003; SPIVEY JM, 1992, CLIN PHARMACY, V11, P865; Su ZM, 2012, CHEMMEDCHEM, V7, P2030, DOI 10.1002/cmdc.201200350; Su ZM, 2011, CHEMMEDCHEM, V6, P2243, DOI 10.1002/cmdc.201100316; VANNUFFEL P, 1995, J CLIN MICROBIOL, V33, P2864, DOI 10.1128/JCM.33.11.2864-2867.1995; Versalovic J, 2011, MANUAL CLIN MICROBIO; Weese JS, 2012, JAVMA-J AM VET MED A, V240, P1450, DOI 10.2460/javma.240.12.1450; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039	46	43	43	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130385	10.1371/journal.pone.0130385	http://dx.doi.org/10.1371/journal.pone.0130385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086336	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500100
J	Tuncel, AT; Ruppert, T; Wang, BT; Okun, JG; Kolker, S; Morath, MA; Sauer, SW				Tuncel, Ali Tunc; Ruppert, Thorsten; Wang, Bei-Tzu; Okun, Juergen Guenther; Koelker, Stefan; Morath, Marina Alexandra; Sauer, Sven Wolfgang			Maleic Acid - but Not Structurally Related Methylmalonic Acid - Interrupts Energy Metabolism by Impaired Calcium Homeostasis	PLOS ONE			English	Article							FANCONI SYNDROME; CELL-DEATH; TUBULOINTERSTITIAL NEPHRITIS; DEHYDROGENASE-DEFICIENCY; MITOCHONDRIAL; ACIDURIAS; MALEATE; KIDNEY; NEURODEGENERATION; INJURY	Maleic acid (MA) has been shown to induce Fanconi syndrome via disturbance of renal energy homeostasis, though the underlying pathomechanism is still under debate. Our study aimed to examine the pathomechanism underlying maleic acid-induced nephrotoxicity. Methylmalonic acid (MMA) is structurally similar to MA and accumulates in patients affected with methymalonic aciduria, a defect in the degradation of branched-chain amino acids, odd-chain fatty acids and cholesterol, which is associated with the development of tubulointerstitial nephritis resulting in chronic renal failure. We therefore used MMA application as a control experiment in our study and stressed hPTECs with MA and MMA to further validate the specificity of our findings. MMA did not show any toxic effects on proximal tubule cells, whereas maleic acid induced concentration-dependent and time-dependent cell death shown by increased lactate dehydrogenase release as well as ethidium homodimer and calcein acetoxymethyl ester staining. The toxic effect of MA was blocked by administration of single amino acids, in particular L-alanine and L-glutamate. MA application further resulted in severe impairment of cellular energy homeostasis on the level of glycolysis, respiratory chain, and citric acid cycle resulting in ATP depletion. As underlying mechanism we could identify disturbance of calcium homeostasis. MA toxicity was critically dependent on calcium levels in culture medium and blocked by the extra-and intracellular calcium chelators EGTA and BAPTA-AM respectively. Moreover, MA-induced cell death was associated with activation of calcium-dependent calpain proteases. In summary, our study shows a comprehensive pathomechanistic concept for MA-induced dysfunction and damage of human proximal tubule cells.	[Tuncel, Ali Tunc; Ruppert, Thorsten; Wang, Bei-Tzu; Okun, Juergen Guenther; Koelker, Stefan; Morath, Marina Alexandra; Sauer, Sven Wolfgang] Univ Childrens Hosp, Div Inborn Metab Dis, Dept Gen Pediat, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Tuncel, AT (corresponding author), Univ Childrens Hosp, Div Inborn Metab Dis, Dept Gen Pediat, Heidelberg, Germany.	alitunctuncel@gmail.com		Tuncel, Ali Tunc/0000-0002-7210-2503	German Research Foundation (Deutsche Forschungsgemeinschaft - DFG) [SA19701-2]; postdoc program of the Medical Faculty of Heidelberg, University Heidelberg; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	German Research Foundation (Deutsche Forschungsgemeinschaft - DFG)(German Research Foundation (DFG)); postdoc program of the Medical Faculty of Heidelberg, University Heidelberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This project was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft - DFG) (SA19701-2, to Dr. rer. nat. Sven Sauer and Dr. med. Marina Morath) and the postdoc program of the Medical Faculty of Heidelberg, University Heidelberg. We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGIELSKI S, 1962, ACTA BIOCHIM POL, V9, P357; Bokenkamp A, 2011, NEPHRON PHYSIOL, V118, pP1, DOI 10.1159/000320880; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; BURCKHARDT G, 1984, PFLUG ARCH EUR J PHY, V401, P254, DOI 10.1007/BF00582592; BUSCHMEIER B, 1987, J BIOL CHEM, V262, P9454; EIAMONG S, 1995, KIDNEY INT, V48, P1542, DOI 10.1038/ki.1995.444; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Hagenbuch B, 2010, CLIN PHARMACOL THER, V87, P39, DOI 10.1038/clpt.2009.235; Heerlein K, 2005, AM J RESP CELL MOL, V32, P44, DOI 10.1165/rcmb.2004-0202OC; Horster F, 2009, J INHERIT METAB DIS, V32, P630, DOI 10.1007/s10545-009-1189-6; Horster F, 2007, PEDIATR RES, V62, P225; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Kolker S, 2003, J BIOL CHEM, V278, P47388, DOI 10.1074/jbc.M308861200; KRAMER HJ, 1970, J LAB CLIN MED, V76, P799; Martin-Hernandez E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z; McLeese J, 1996, CELL TISSUE RES, V283, P29; Morath MA, 2008, J INHERIT METAB DIS, V31, P35, DOI 10.1007/s10545-007-0571-5; MUJAIS SK, 1993, J AM SOC NEPHROL, V4, P142; Muruganandan S, 2006, TOXICOL SCI, V94, P118, DOI 10.1093/toxsci/kfl084; Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140; Nissim I, 1996, KIDNEY INT, V49, P684, DOI 10.1038/ki.1996.97; Okun JG, 2002, J BIOL CHEM, V277, P14674, DOI 10.1074/jbc.M200997200; Petrat F, 2012, BRIT J PHARMACOL, V165, P2059, DOI 10.1111/j.1476-5381.2011.01711.x; ROTIG A, 1995, J PEDIATR-US, V126, P597, DOI 10.1016/S0022-3476(95)70359-4; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; SCHARER K, 1972, RES EXP MED, V157, P136, DOI 10.1007/BF01851694; Terentyev D, 2002, CIRC RES, V91, P414, DOI 10.1161/01.RES.0000032490.04207.BD; Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x; Ueda Y, 2004, PEDIATR NEPHROL, V19, P107, DOI 10.1007/s00467-003-1318-7; Waters SL, 1998, TOXICOL PATHOL, V26, P58, DOI 10.1177/019262339802600108; WEINBERG JM, 1990, FASEB J, V4, P3347, DOI 10.1096/fasebj.4.15.2253849; Zager RA, 2008, AM J PHYSIOL-RENAL, V294, pF187, DOI 10.1152/ajprenal.00434.2007; Zwickler T, 2008, J INHERIT METAB DIS, V31, P361, DOI 10.1007/s10545-008-0804-2	35	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128770	10.1371/journal.pone.0128770	http://dx.doi.org/10.1371/journal.pone.0128770			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086473	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500023
J	Zhang, SL; He, ZM; Wang, J; Wang, L; Wu, Y; Wang, J; Lv, TT; Liu, HR				Zhang, Suli; He, Zhongmei; Wang, Jin; Wang, Li; Wu, Ye; Wang, Jie; Lv, Tingting; Liu, Huirong			Mitochondrial Ultrastructural Alterations and Declined M-2 Receptor Density Were Involved in Cardiac Dysfunction in Rats after Long Term Treatment with Autoantibodies against M-2 Muscarinic Receptor	PLOS ONE			English	Article							2ND EXTRACELLULAR LOOP; ACETYLCHOLINE-RECEPTORS; SERUM AUTOANTIBODIES; OXIDATIVE STRESS; BETA(1)-ADRENOCEPTORS; CARDIOMYOPATHY; MYOCARDITIS; ACTIVATION; EPITOPE; CELLS	Background Previous studies showed that autoantibodies (M-2-AA) against the second extracellular loop of M-2 muscarinic receptor (M(2)AChR-el2) from dilated cardiomyopathy (DCM) serum could induce DCM-like morphological changes in mice hearts. However, the effects of M-2-AA on the cardiac function during the process of DCM and the potential mechanisms are not fully known. The present study was designed to dynamically observe the cardiac function, mitochondrial changes, and M-2 receptor binding characteristics in rats long-term stimulated with M-2-AA in vivo. Methods M-2-AA-positive model was established by actively immunizing healthy male Wistar rats with synthetic M(2)AChR-el2 peptide for 18 months. Meanwhile, vehicle group rats were administrated with physiological saline. The change of mitochondrial membrane potential (Delta psi m) was detected by radionuclide imaging. The ultrastructure of mitochondria was observed under electron microscopy. The M-2 receptor binding characteristics were determined by radioactive ligand binding assay. Results After immunization for 12 months, compared with vehicle group, M(2)AChR-el2-immunized rats showed decreased myocardial contractility and cardiac diastolic function evidenced by declined maximal rate of rise of ventricular pressure and increased left ventricular end-diastolic pressure, respectively. Additionally, mitochondrial swelling and vacuolation were observed. At 18 months, M(2)AChR-el2-immunized rats manifested significant decreased cardiac systolic and diastolic function and pathological changes such as enlargement of right ventricular cavity and wall thinning; and the mitochondrial damage was aggravated. Furthermore, the M-2 receptor maximum binding capacity (B-max) of the M(2)AChR-el2-immunized rats significantly decreased, while the M-2 receptor dissociation constant (K-d) was increased. Conclusions Our study suggested that long-term stimulation with M-2-AA leaded to the ventricular dilatation and gradual deterioration of cardiac dysfunction. Mitochondrial damage and the down-regulation of M-2 receptor density and affinity may be involved in the process.	[Zhang, Suli; Wu, Ye; Lv, Tingting; Liu, Huirong] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100069, Peoples R China; [Zhang, Suli] Capital Med Univ, Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing 100069, Peoples R China; [He, Zhongmei; Wang, Jin; Liu, Huirong] Shanxi Med Univ, Sch Basic Med Sci, Dept Physiol, Taiyuan 030001, Shanxi, Peoples R China; [Wang, Li] Shanxi Med Univ, Sch Basic Med Sci, Dept Pathol, Taiyuan 030001, Shanxi, Peoples R China; [Wang, Jie] Shanxi Med Univ, Hosp 1, Dept Neurol, Taiyuan 030001, Shanxi, Peoples R China; [Liu, Huirong] Capital Med Univ, Beijing Key Lab Metab Disorders Related Cardiovas, Beijing 100069, Peoples R China	Capital Medical University; Capital Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Capital Medical University	Liu, HR (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100069, Peoples R China.	liuhr2000@126.com			973 Program Earlier Research Project [2014CB560704]; National Natural Science Foundation Youth Project [81300694]; Specialized Research Fund for Doctoral Program of Higher Education [20131107120021]; Scientific Research Base Construction-Scientific and Technological Innovation Platform-Metabolic Disorders Related Cardiovascular Diseases Research Platform Construction [PXM2014_014226_000038]	973 Program Earlier Research Project(National Basic Research Program of China); National Natural Science Foundation Youth Project; Specialized Research Fund for Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Base Construction-Scientific and Technological Innovation Platform-Metabolic Disorders Related Cardiovascular Diseases Research Platform Construction	This study was supported by grants from the 973 Program Earlier Research Project (2014CB560704) to Huirong Liu (http://program.most.gov.cn); the National Natural Science Foundation Youth Project (81300694) to Suli Zhang (http://www.nsfc.gov.cn/); the 2013 Specialized Research Fund for Doctoral Program of Higher Education (20131107120021) to Suli Zhang (http://www.moe.gov.cn/); and grants from the Scientific Research Base Construction-Scientific and Technological Innovation Platform-Metabolic Disorders Related Cardiovascular Diseases Research Platform Construction (municipal level) (PXM2014_014226_000038; http://www.bjedu.gov.cn/publish/portal27/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba A, 2004, EUR HEART J, V25, P1108, DOI 10.1016/j.ehj.2004.05.012; Bornholz B, 2013, CARDIOVASC RES, V97, P472, DOI 10.1093/cvr/cvs350; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; De Sarno P, 2003, J BIOL CHEM, V278, P11086, DOI 10.1074/jbc.M212157200; Delaney KA, 2002, J BIOL CHEM, V277, P33439, DOI 10.1074/jbc.M205293200; FU LX, 1993, J CLIN INVEST, V91, P1964, DOI 10.1172/JCI116416; FU MLX, 1995, J MOL CELL CARDIOL, V27, P427, DOI 10.1016/S0022-2828(08)80039-9; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Kawai C, 1999, CIRCULATION, V99, P1091, DOI 10.1161/01.CIR.99.8.1091; Kikusato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064412; Liu HR, 1999, AUTOIMMUNITY, V29, P43, DOI 10.3109/08916939908995971; Liu HR, 2002, J AM COLL CARDIOL, V39, P1866, DOI 10.1016/S0735-1097(02)01865-X; Ma Xiurui, 2010, CHINESE JOURNAL OF C, V8, P218; Matsuo S, 2007, J NUCL CARDIOL, V14, P215, DOI 10.1016/j.nuclcard.2006.10.022; Myslivecek J, 2008, ANN NY ACAD SCI, V1148, P367, DOI 10.1196/annals.1410.028; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; PIWNICAWORMS D, 1990, CIRCULATION, V82, P1826, DOI 10.1161/01.CIR.82.5.1826; Cardena MMSG, 2013, MITOCHONDR DNA, V24, P46, DOI 10.3109/19401736.2012.717933; Stavrakis S, 2011, INT J CARDIOL, V148, P331, DOI 10.1016/j.ijcard.2009.11.025; Stope MB, 2003, BIOCHEM PHARMACOL, V66, P2099, DOI 10.1016/S0006-2952(03)00580-X; VANDERMOLEN DT, 1986, LAB INVEST, V54, P353; Wallukat G, 1996, Blood Press Suppl, V3, P31; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081296; Xu J, 2014, INT J CLIN EXP PATHO, V7, P1495; Yan L, 2009, BASIC RES CARDIOL, V104, P581, DOI 10.1007/s00395-009-0020-8; Yan MX, 2006, BIOCHEM BIOPH RES CO, V347, P192, DOI 10.1016/j.bbrc.2006.06.063; Yoshizawa A, 2012, EUR J IMMUNOL, V42, P1152, DOI 10.1002/eji.201142104; Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066779; Zuo L, 2011, INT J CARDIOL, V149, P89, DOI 10.1016/j.ijcard.2009.12.023	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129563	10.1371/journal.pone.0129563	http://dx.doi.org/10.1371/journal.pone.0129563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086781	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500052
J	Zhu, YB; Wang, Q; Pang, GM; Lin, L; Origasa, H; Wang, YY; Di, J; Shi, M; Fan, C; Shi, HM				Zhu, Yanbo; Wang, Qi; Pang, Guoming; Lin, Lin; Origasa, Hideki; Wang, Yangyang; Di, Jie; Shi, Mai; Fan, Chunpok; Shi, Huimei			Association between Body Mass Index and Health-Related Quality of Life: The "Obesity Paradox" in 21,218 Adults of the Chinese General Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEART-FAILURE; CARDIORESPIRATORY FITNESS; RHEUMATOID-ARTHRITIS; METROPOLITAN CHINA; ASIAN POPULATION; MORTALITY; RISK; PREVALENCE; ADIPOSITY	Background There was no consistent recognition of the association between high or low body mass index (BMI) and health related quality of life (HRQL). The aim of this research was to study the association between BMI and HRQL in Chinese adults, and to further explore the stability of that association in the subgroup analysis stratified by status of chronic conditions. Methods A total of 21,218 adults aged 18 and older were classified as underweight, normal weight, overweight, class I obese, and class II obese based on their BMI. HRQL was measured by the SF-36 Health Survey. The independent impact of each BMI category on HRQL was examined through standard least squares regression by comparing the difference of SF-36 scores and the minimum clinically important differences (MCID), which was defined as 3 points. Results Compared to the normal weight, the class I obese was significantly associated with better HRQL scores in the mental component summary (MCS) (75.1 vs. 73.4, P<0.001). The underweight had the lowest score in both the physical components summary (PCS) (75.4 vs. 77.5, P<0.001) and mental components summary (MCS) (71.8 vs. 73.4, P<0.001). For the MCID, the HRQL score was reduced by more than 3 points in the physical functioning for the class II obese (D=-3.43) and the general health for the underweight (D=-3.71). Stratified analyses showed a similar result in the health subjects and chronic conditions, and it was significant in the chronic conditions. Conclusions The class I obese showed the best HRQL, especially in the mental domain. The worst HRQL was found in the underweight. The class II obese reduced HRQL in the physical functioning only. "Obesity paradox" was more obvious in the participants with chronic conditions.	[Zhu, Yanbo; Wang, Yangyang; Di, Jie; Shi, Huimei] Beijing Univ Chinese Med, Sch Management, Beijing, Peoples R China; [Wang, Qi; Fan, Chunpok] Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China; [Pang, Guoming] Kaifeng Hosp Tradit Chinese Med, Dept Internal Med, Kaifeng, Henan, Peoples R China; [Lin, Lin] China Japan Friendship Hosp, Dept Qual Management, Beijing, Peoples R China; [Origasa, Hideki] Toyama Univ, Sch Med, Div Biostat & Clin Epidemiol, Toyama 930, Japan; [Shi, Mai] China Japan Friendship Hosp, Dept Clin Nutr, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; China-Japan Friendship Hospital; University of Toyama; China-Japan Friendship Hospital	Zhu, YB (corresponding author), Beijing Univ Chinese Med, Sch Management, Beijing, Peoples R China.	yanbo0722@sina.com			National Program on Key Basic Research Project of China (973 Program) [2011CB505403, 2005CB523501]; National Natural Science Foundation of China [30873256]	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Program on Key Basic Research Project of China (973 Program) (No. 2011CB505403;2005CB523501) and the National Natural Science Foundation of China (No. 30873256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Cerne A, 2012, ZDRAV VARST, V51, P147; Chang VW, 2010, JAMA-J AM MED ASSOC, V303, P1274, DOI 10.1001/jama.2010.339; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; DANO P, 1979, SCAND J GASTROENTERO, V14, P167, DOI 10.3109/00365527909179863; Dekkers JC, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-69; Dey M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1028; Diehr P, 2012, J OBES, V2012, DOI 10.1155/2012/894894; Doehner W, 2010, EUR HEART J, V31, P146, DOI 10.1093/eurheartj/ehp339; Fan VS, 2002, CHEST, V122, P429, DOI 10.1378/chest.122.2.429; Farrell SW, 2010, MED SCI SPORT EXER, V42, P2006, DOI 10.1249/MSS.0b013e3181df12bf; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Foster JH, 1999, QUAL LIFE RES, V8, P255, DOI 10.1023/A:1008802711478; Gielen S, 2013, INT J CARDIOL, V162, P140, DOI 10.1016/j.ijcard.2012.01.089; Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317; Hopman WM, 2007, QUAL LIFE RES, V16, P1595, DOI 10.1007/s11136-007-9273-6; Huang IC, 2006, INT J OBESITY, V30, P1250, DOI 10.1038/sj.ijo.0803250; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Kalantar-Zadeh K, 2006, CONTRIB NEPHROL, V151, P57, DOI 10.1159/000095319; Kato N, 2011, CIRC J, V75, P1661, DOI 10.1253/circj.CJ-10-1308; Korhonen PE, 2014, QUAL LIFE RES, V23, P67, DOI 10.1007/s11136-013-0433-6; Kortt MA, 2011, CLIN THER, V33, P1466, DOI 10.1016/j.clinthera.2011.08.009; Lainscak M, 2012, J CACHEXIA SARCOPENI, V3, P1, DOI 10.1007/s13539-012-0059-5; Lee S, 2007, PSYCHOL MED, V37, P61, DOI 10.1017/S0033291706008993; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Li ZB, 2004, INT J GERIATR PSYCH, V19, P68, DOI 10.1002/gps.1040; Litwin SE, 2008, J AM COLL CARDIOL, V52, P616, DOI 10.1016/j.jacc.2008.05.017; Lopez-Garcia E, 2003, INT J OBESITY, V27, P701, DOI 10.1038/sj.ijo.0802275; Lubeck DP, 2004, PHARMACOECONOMICS, V22, P27; LYONS RA, 1994, TOB CONTROL, V3, P213, DOI DOI 10.1136/TC.3.3.213; Ma Guan-sheng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P311; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; McAuley PA, 2009, AM J HYPERTENS, V22, P1062, DOI 10.1038/ajh.2009.122; McDonough C, 2013, DIABETES OBES METAB, V15, P342, DOI 10.1111/dom.12033; Mease PJ, 2008, J RHEUMATOL, V35, P20; National Health Service Information Centre, 2012, HLTH SURV ENGL 2010; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Oreopoulos A, 2010, INT J OBESITY, V34, P1434, DOI 10.1038/ijo.2010.73; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Pacchioni A, 2013, INT J CARDIOL, V168, P2912, DOI 10.1016/j.ijcard.2013.03.107; Public Health Agency of Canada and the Canadian Institute for Health Information, 2012, OB CAN JOINT REP PUB; Rodriguez-Artalejo F, 2005, ARCH INTERN MED, V165, P1274, DOI 10.1001/archinte.165.11.1274; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Sach TH, 2007, INT J OBESITY, V31, P189, DOI 10.1038/sj.ijo.0803365; Schenkeveld L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000535; Schreiner PJ, 1996, AM J EPIDEMIOL, V144, P335, DOI 10.1093/oxfordjournals.aje.a008934; Shen YC, 2006, PSYCHOL MED, V36, P257, DOI 10.1017/S0033291705006367; Soltoft F, 2009, QUAL LIFE RES, V18, P1293, DOI 10.1007/s11136-009-9541-8; Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019; Thumboo J, 2003, SOC SCI MED, V56, P1761, DOI 10.1016/S0277-9536(02)00171-5; Tillmann M, 1997, J PUBLIC HEALTH MED, V19, P268, DOI 10.1093/oxfordjournals.pubmed.a024629; Tsai WL, 2004, AM J EPIDEMIOL, V160, P557, DOI 10.1093/aje/kwh251; Ul-Haq Z, 2013, OBESITY, V21, pE322, DOI 10.1002/oby.20107; Ul-Haq Z, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-143; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Vasiljevic N, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-106; Wang R, 2012, EUR J PUBLIC HEALTH, V22, P497, DOI 10.1093/eurpub/ckr080; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 1994, SF 36 PHYS MENTAL HL, DOI [10.1007/s11136-010-9658-9, DOI 10.1007/S11136-010-9658-9]; Wee HL, 2008, VALUE HEALTH, V11, pS105, DOI 10.1111/j.1524-4733.2008.00374.x; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; [谢秀梅 Xie Xiumei], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P104; Zhu Yan-Bo, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P687; [朱燕波 ZHU Yan-bo], 2009, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V18, P254	70	21	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130613	10.1371/journal.pone.0130613	http://dx.doi.org/10.1371/journal.pone.0130613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NT	26087128	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500121
J	Chen, J; Zhu, YL; Wu, YS; Cui, TW; Ishizaka, J; Ju, YT				Chen, Jun; Zhu, Yuanli; Wu, Yongsheng; Cui, Tingwei; Ishizaka, Joji; Ju, Yongtao			A Neural Network Model for K(lambda) Retrieval and Application to Global K-par Monitoring	PLOS ONE			English	Article							DIFFUSE ATTENUATION COEFFICIENT; PHOTOSYNTHETICALLY ACTIVE RADIATION; REMOTE-SENSING METHODS; COASTAL WATERS; OCEAN; PHYTOPLANKTON; PRODUCTS; VALIDATION; ABSORPTION; SEDIMENT	Accurate estimation of diffuse attenuation coefficients in the visible wavelengths K-d(lambda) from remotely sensed data is particularly challenging in global oceanic and coastal waters. The objectives of the present study are to evaluate the applicability of a semi-analytical K-d(lambda) retrieval model (SAKM) and Jamet's neural network model (JNNM), and then develop a new neural network K-d(lambda) retrieval model (NNKM). Based on the comparison of K-d(lambda) predicted by these models with in situ measurements taken from the global oceanic and coastal waters, all of the NNKM, SAKM, and JNNM models work well in K-d(lambda) retrievals, but the NNKM model works more stable and accurate than both SAKM and JNNM models. The near-infrared band-based and shortwave infrared band-based combined model is used to remove the atmospheric effects on MODIS data. The K-d(lambda) data was determined from the atmospheric corrected MODIS data using the NNKM, JNNM, and SAKM models. The results show that the NNKM model produces <30% uncertainty in deriving K-d(lambda) from global oceanic and coastal waters, which is 4.88-17.18% more accurate than SAKM and JNNM models. Furthermore, we employ an empirical approach to calculate K-par from the NNKM model-derived diffuse attenuation coefficient at visible bands (443, 488, 555, and 667 nm). The results show that our model presents a satisfactory performance in deriving K-par from the global oceanic and coastal waters with 20.2% uncertainty. The K-par are quantified from MODIS data atmospheric correction using our model. Comparing with field measurements, our model produces similar to 31.0% uncertainty in deriving K-par from Bohai Sea. Finally, the applicability of our model for general oceanographic studies is briefly illuminated by applying it to climatological monthly mean remote sensing reflectance for time ranging from July, 2002-July 2014 at the global scale. The results indicate that the high K-d(lambda) and K-par values are usually found around the coastal zones in the high latitude regions, while low K-d(lambda) and K-par values are usually found in the open oceans around the low-latitude regions. These results could improve our knowledge about the light field under waters at either the global or basin scales, and be potentially used into general circulation models to estimate the heat flux between atmosphere and ocean.	[Chen, Jun] Qingdao Inst Marine Geol, Key Lab Coastal Wetland Biogeosci, China Geol Survey, Qingdao 266071, Peoples R China; [Zhu, Yuanli] Nagoya Univ, Hydrospher Atmospher Res Ctr, Nagoya, Aichi 4648601, Japan; [Zhu, Yuanli; Ishizaka, Joji] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Wu, Yongsheng] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [Cui, Tingwei] State Ocean Adm, Inst Oceanog 1, Qingdao 266071, Peoples R China; [Ju, Yongtao] Hebei United Univ, Coll Min Engn, Tangshan 063009, Peoples R China	China Geological Survey; Qingdao Institute of Marine Geology (QIMG); Nagoya University; Nagoya University; Bedford Institute of Oceanography; Fisheries & Oceans Canada; State Oceanic Administration; North China University of Science & Technology	Ju, YT (corresponding author), Hebei United Univ, Coll Min Engn, Tangshan 063009, Peoples R China.	juyongtao_cugb@163.com	Ishizaka, Joji/B-3587-2009	Ishizaka, Joji/0000-0003-0398-1572	National Natural Science Foundation of China [41401597]; China State Major Basic Research Project [2013CB429701]; China Geological Survey [GZH201400201, 201300501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China State Major Basic Research Project; China Geological Survey(China Geological Survey)	This study is supported by the National Natural Science Foundation of China (No. 41401597); the China State Major Basic Research Project (2013CB429701); and China Geological Survey (No. GZH201400201; No. 201300501).	AAS E, 1987, APPL OPTICS, V26, P2095, DOI 10.1364/AO.26.002095; Bailey SW, 2006, REMOTE SENS ENVIRON, V102, P12, DOI 10.1016/j.rse.2006.01.015; Binding CE, 2005, REMOTE SENS ENVIRON, V94, P373, DOI 10.1016/j.rse.2004.11.002; Blondeau-Patissier D, 2014, PROG OCEANOGR, V123, P123, DOI 10.1016/j.pocean.2013.12.008; Brewin RJW, 2015, REMOTE SENS ENVIRON, V162, P271, DOI 10.1016/j.rse.2013.09.016; Bukata RP, 1995, OPTICAL PROPERTIES A; Byun DS, 2014, ESTUARINE COASTAL AN, V115, P1; Capacci D, 2005, METEOROL APPL, V12, P291, DOI 10.1017/S1350482705001787; Carder KL, 2004, ADV SPACE RES-SERIES, V33, P1152, DOI 10.1016/S0273-1177(03)00365-X; Chen J, 2015, J GEOPHYS RES-OCEANS, V120, P36, DOI 10.1002/2014JC010461; Chen J, 2014, REMOTE SENS ENVIRON, V149, P213, DOI 10.1016/j.rse.2014.04.013; Chen J, 2014, REMOTE SENS ENVIRON, V148, P168, DOI 10.1016/j.rse.2014.02.019; Chen J, 2014, REMOTE SENS ENVIRON, V140, P78, DOI 10.1016/j.rse.2013.08.031; Chen J, 2013, J GEOPHYS RES-OCEANS, V118, P6006, DOI 10.1002/2013JC009349; Chen J, 2013, ENVIRON MONIT ASSESS, V185, P2243, DOI 10.1007/s10661-012-2705-y; Chen JX, 2003, MATHEMATICAL ANALYSI; D'Sa EJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031192; DELESALLE B, 1993, J PLANKTON RES, V15, P1413, DOI 10.1093/plankt/15.12.1413; FASHAM MJR, 1990, J MAR RES, V48, P591, DOI 10.1357/002224090784984678; FROUIN R, 1995, REMOTE SENS ENVIRON, V51, P98, DOI 10.1016/0034-4257(94)00068-X; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; Gorai T, 2014, J EXP MAR BIOL ECOL, V459, P87, DOI 10.1016/j.jembe.2014.05.013; Gordon HR, 1999, UNDER CONTRACT NUMBE; Hui S, 2014, AGR FOREST METEOROL, V198, P320, DOI 10.1016/j.agrformet.2014.09.002; Ioannou I, 2013, REMOTE SENS ENVIRON, V134, P78, DOI 10.1016/j.rse.2013.02.015; IOCCG, 2006, REPORTS OF THE INTER; Jamet C, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008076; Jerlov N. G., 1976, MARINE OPTICS; Lee ZP, 2013, J GEOPHYS RES-OCEANS, V118, P4241, DOI 10.1002/jgrc.20308; Lee ZP, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002573; Liu XM, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004934; Matsumoto K, 2009, J MARINE SYST, V75, P245, DOI 10.1016/j.jmarsys.2008.10.007; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; Mobley CD, 1994, LIGHT AND WATER RADI; Morel A, 1996, APPL OPTICS, V35, P4850, DOI 10.1364/AO.35.004850; MOREL A, 1977, LIMNOL OCEANOGR, V22, P709, DOI 10.4319/lo.1977.22.4.0709; Morel A, 2007, REMOTE SENS ENVIRON, V111, P69, DOI 10.1016/j.rse.2007.03.012; Mueller JL, 1997, NASA SEAWIFS TECHNIC, V41, P18; Mueller JL, 2000, SEAWIFS POSTLAUNCH C; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; Palmer JR, 2001, DEEP-SEA RES PT I, V48, P1169, DOI 10.1016/S0967-0637(00)00080-7; Rahimi S, 2014, ARCHIVES OF AGRONOMY, V61, P1; Saulquin B, 2013, REMOTE SENS ENVIRON, V128, P224, DOI 10.1016/j.rse.2012.10.002; Schaeffer BA, 2011, REMOTE SENS ENVIRON, V115, P3748, DOI 10.1016/j.rse.2011.09.013; Shang SL, 2011, REMOTE SENS ENVIRON, V115, P180, DOI 10.1016/j.rse.2010.08.016; Shi K, 2014, REMOTE SENS ENVIRON, V140, P365, DOI 10.1016/j.rse.2013.09.013; SIEGEL DA, 1987, DEEP-SEA RES, V34, P547, DOI 10.1016/0198-0149(87)90005-7; TILZER MM, 1994, POLAR BIOL, V14, P127; Valipour M., 2012, Journal of Applied Sciences, V12, P2139; Vantrepotte V, 2011, DEEP-SEA RES PT I, V58, P429, DOI 10.1016/j.dsr.2011.02.003; Werdell PJ, 2005, REMOTE SENS ENVIRON, V98, P122, DOI 10.1016/j.rse.2005.07.001; Zhang RH, 1998, NATURE, V391, P879, DOI 10.1038/36081; Zhang RH, 2011, J ATMOS OCEAN TECH, V28, P944, DOI 10.1175/2011JTECHO797.1; Zhang XT, 2014, REMOTE SENS ENVIRON, V152, P318, DOI 10.1016/j.rse.2014.07.003	54	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127514	10.1371/journal.pone.0127514	http://dx.doi.org/10.1371/journal.pone.0127514			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083341	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400013
J	Freeman, BG; Mason, NA				Freeman, Benjamin G.; Mason, Nicholas A.			The Geographic Distribution of a Tropical Montane Bird Is Limited by a Tree: Acorn Woodpeckers (Melanerpes formicivorus) and Colombian Oaks (Quercus humboldtii) in the Northern Andes	PLOS ONE			English	Article							BIOTIC INTERACTIONS; COMPETITIVE-EXCLUSION; SPECIES DISTRIBUTIONS; SOCIAL-ORGANIZATION; FOOD-HABITS; CLIMATE; RANGE; PERFORMANCE; EVOLUTION; ECOLOGY	Species distributions are limited by a complex array of abiotic and biotic factors. In general, abiotic (climatic) factors are thought to explain species' broad geographic distributions, while biotic factors regulate species' abundance patterns at local scales. We used species distribution models to test the hypothesis that a biotic interaction with a tree, the Colombian oak (Quercus humboldtii), limits the broad-scale distribution of the Acorn Woodpecker (Melanerpes formicivorus) in the Northern Andes of South America. North American populations of Acorn Woodpeckers consume acorns from Quercus oaks and are limited by the presence of Quercus oaks. However, Acorn Woodpeckers in the Northern Andes seldom consume Colombian oak acorns (though may regularly drink sap from oak trees) and have been observed at sites without Colombian oaks, the sole species of Quercus found in South America. We found that climate-only models overpredicted Acorn Woodpecker distribution, suggesting that suitable abiotic conditions (e.g. in northern Ecuador) exist beyond the woodpecker's southern range margin. In contrast, models that incorporate Colombian oak presence outperformed climate-only models and more accurately predicted the location of the Acorn Woodpecker's southern range margin in southern Colombia. These findings support the hypothesis that a biotic interaction with Colombian oaks sets Acorn Woodpecker's broad-scale geographic limit in South America, probably because Acorn Woodpeckers rely on Colombian oaks as a food resource (possibly for the oak's sap rather than for acorns). Although empirical examples of particular plants limiting tropical birds' distributions are scarce, we predict that similar biotic interactions may play an important role in structuring the geographic distributions of many species of tropical montane birds with specialized foraging behavior.	[Freeman, Benjamin G.; Mason, Nicholas A.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; [Freeman, Benjamin G.; Mason, Nicholas A.] Cornell Lab Ornithol, Ithaca, NY USA	Cornell University; Cornell University	Freeman, BG (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	bgf27@cornell.edu						Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Anderson RP, 2002, OIKOS, V98, P3, DOI 10.1034/j.1600-0706.2002.t01-1-980116.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Areta JI, 2009, BIOTROPICA, V41, P66, DOI 10.1111/j.1744-7429.2008.00458.x; Beehler B.M., 1986, HDB WAU ECOLOGY I, V9; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; BROWN JH, 1971, ECOLOGY, V52, P305, DOI 10.2307/1934589; Bullock JM, 2000, ECOGRAPHY, V23, P257, DOI 10.1111/j.1600-0587.2000.tb00281.x; Burney CW, 2009, AM NAT, V174, P358, DOI 10.1086/603613; Cadena CD, 2007, ECOGRAPHY, V30, P491, DOI 10.1111/j.2007.0906-7590.05045.x; Cahill AE, 2014, J BIOGEOGR, V41, P429, DOI 10.1111/jbi.12231; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; de Araujo CB, 2014, J BIOGEOGR, V41, P513, DOI 10.1111/jbi.12234; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; Fernandez JF, 2007, BIOTROPICA, V39, P72, DOI 10.1111/j.1744-7429.2006.00219.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Freeman BG, 2014, P NATL ACAD SCI USA, V111, P4490, DOI 10.1073/pnas.1318190111; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Godsoe W, 2012, ECOGRAPHY, V35, P811, DOI 10.1111/j.1600-0587.2011.07103.x; Gonzalez-Pola C, 2006, INT CTR TROP AGR CIA, P1; Gotelli NJ, 2010, P NATL ACAD SCI USA, V107, P5030, DOI 10.1073/pnas.0914089107; Gutierrez EE, 2014, ECOGRAPHY, V37, P741, DOI 10.1111/ecog.00620; HAIRSTON NG, 1980, ECOLOGY, V61, P817, DOI 10.2307/1936752; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hargreaves AL, 2014, AM NAT, V183, P157, DOI 10.1086/674525; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans R.J., 2011, DISMO SPECIES DISTRI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; KATTAN G, 1988, CONDOR, V90, P100, DOI 10.2307/1368438; Kissling W.D., 2012, Journal of Biogeography, V39, P2163; Koenig WD, 1999, J BIOGEOGR, V26, P159, DOI 10.1046/j.1365-2699.1999.00256.x; Koenig WD, 1987, POPULATION ECOLOGY C, P435; Leathwick JR, 2001, ECOLOGY, V82, P2560, DOI 10.1890/0012-9658(2001)082[2560:CIBTSI]2.0.CO;2; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Martin PR, 2001, ECOLOGY, V82, P189, DOI 10.1890/0012-9658(2001)082[0189:EAFCOS]2.0.CO;2; Mayr E., 2001, BIRDS NO MELANESIA S; MILLER ALDEN H., 1963, UNIV CALIF PUBL ZOOL, V66, P1; Monahan WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042097; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; Ridgely R., 2009, FIELD GUIDE SONGBIRD; Ridgely RS, 2001, THE BIRDS OF ECUADOR; ROBSON C, 2008, FIELD GUIDE BIRDS S; Rusk CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058624; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Smith BT, 2014, NATURE, V515, P406, DOI 10.1038/nature13687; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; STANBACK MT, 1989, CONDOR, V91, P1005, DOI 10.2307/1368094; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Temeles EJ, 2010, PHILOS T R SOC B, V365, P1053, DOI 10.1098/rstb.2009.0284; TERBORGH J, 1975, ECOLOGY, V56, P562, DOI 10.2307/1935491; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zheng BY, 2000, STAT MED, V19, P1771, DOI 10.1002/1097-0258(20000715)19:13<1771::AID-SIM485>3.3.CO;2-G	67	19	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128675	10.1371/journal.pone.0128675	http://dx.doi.org/10.1371/journal.pone.0128675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083262	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400062
J	Homfray, V; Tanton, C; Miller, RF; Beddows, S; Field, N; Sonnenberg, P; Wellings, K; Panwar, K; Johnson, AM; Mercer, CH				Homfray, Virginia; Tanton, Clare; Miller, Robert F.; Beddows, Simon; Field, Nigel; Sonnenberg, Pam; Wellings, Kaye; Panwar, Kavita; Johnson, Anne M.; Mercer, Catherine H.			Male Circumcision and STI Acquisition in Britain: Evidence from a National Probability Sample Survey	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SEXUALLY-TRANSMITTED INFECTIONS; RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLES NATSAL; REAL-TIME PCR; HIV PREVENTION; YOUNG MEN; RISK; ATTITUDES; METAANALYSIS	Background It is well-established that male circumcision reduces acquisition of HIV, herpes simplex virus 2, chancroid, and syphilis. However, the effect on the acquisition of non-ulcerative sexually transmitted infections (STIs) remains unclear. We examined the relationship between circumcision and biological measures of three STIs: human papillomavirus (HPV), Chlamydia trachomatis and Mycoplasma genitalium. Methods A probability sample survey of 15,162 men and women aged 16-74 years (including 4,060 men aged 16-44 years) was carried out in Britain between 2010 and 2012. Participants completed a computer-assisted personal interview, including a computer-assisted selfinterview, which asked about experience of STI diagnoses, and circumcision. Additionally, 1,850 urine samples from sexually-experienced men aged 16-44 years were collected and tested for STIs. Multivariable logistic regression was used to calculate adjusted odds ratios (AOR) to quantify associations between circumcision and i) self-reporting any STI diagnosis and ii) presence of STIs in urine, in men aged 16-44 years, adjusting for key socio-demographic and sexual behavioural factors. Results The prevalence of circumcision in sexually-experienced men aged 16-44 years was 17.4% (95% CI 16.0-19.0). There was no association between circumcision and reporting any previous STI diagnoses, and specifically previous chlamydia or genital warts. However, circumcised men were less likely to have any HPV type (AOR 0.26, 95% confidence interval (CI) 0.13-0.50) including high-risk HPV types (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and/or 68) (AOR 0.14, 95% CI 0.05-0.40) detected in urine. Conclusions Circumcised men had reduced odds of HPV detection in urine. These findings have implications for improving the precision of models of STI transmission in populations with different circumcision prevalence and in designing interventions to reduce STI acquisition.	[Homfray, Virginia; Tanton, Clare; Miller, Robert F.; Field, Nigel; Sonnenberg, Pam; Johnson, Anne M.; Mercer, Catherine H.] UCL, Res Dept Infect & Populat Hlth, London, England; [Beddows, Simon; Panwar, Kavita] Publ Hlth England, Virus Reference Dept, London, England; [Wellings, Kaye] London Sch Hyg & Trop Med, Ctr Sexual & Reprod Hlth Res, London WC1, England	University of London; University College London; Public Health England; University of London; London School of Hygiene & Tropical Medicine	Mercer, CH (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	c.mercer@ucl.ac.uk	Field, Nigel/ABG-3948-2020	Miller, Robert/0000-0003-2067-4291; Tanton, Clare/0000-0002-4612-1858; Field, Nigel/0000-0002-2825-6652; Johnson, Anne/0000-0003-1330-7100; Mercer, Catherine/0000-0002-4220-5034; Beddows, Simon/0000-0002-6879-6215; Sonnenberg, Pam/0000-0002-1067-1583	Medical Research Council [G0701757]; Wellcome Trust [084840]; Economic and Social Research Council; National Institute for Health Research Academic Clinical Lectureship; Department of Health; National Institute for Health Research [CL-2010-18-010, NF-SI-0508-10244] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research Academic Clinical Lectureship; Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Natsal-3 was supported by grants to AMJ from the Medical Research Council (www.mrc.ac.uk; G0701757) and the Wellcome Trust (www.wellcome.ac.uk; 084840), with contributions from the Economic and Social Research Council and Department of Health. NF is supported by a National Institute for Health Research Academic Clinical Lectureship (www.nihr.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bissett SL, 2011, J MED VIROL, V83, P1744, DOI 10.1002/jmv.22167; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Cancer IAfRo, 2009, REV HUM CARC B; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Dave SS, 2003, SEX TRANSM INFECT, V79, P499, DOI 10.1136/sti.79.6.499; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Field N, 2012, J MED ETHICS, V38, P380, DOI 10.1136/medethics-2011-100068; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hardick J, 2006, J CLIN MICROBIOL, V44, P1236, DOI 10.1128/JCM.44.4.1236-1240.2006; Hernandez BY, 2008, J INFECT DIS, V197, P787, DOI 10.1086/528379; International Agency for Research on Cancer, 2012, GLOB 2012 EST CANC I; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Larke N, 2011, J INFECT DIS, V204, P1375, DOI 10.1093/infdis/jir523; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Nielson CM, 2009, J INFECT DIS, V199, P7, DOI 10.1086/595567; Sobngwi-Tambekou J, 2009, SEX TRANSM INFECT, V85, P116, DOI 10.1136/sti.2008.032334; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Weaver BA, 2004, J INFECT DIS, V189, P677, DOI 10.1086/381395; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; WHO/UNAIDS, 2013, MAL CIRC HIV PREV	25	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130396	10.1371/journal.pone.0130396	http://dx.doi.org/10.1371/journal.pone.0130396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083250	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400142
J	Laurence, NC; Labuschagne, LG; Lura, BG; Hillman, KL				Laurence, Nicholas C.; Labuschagne, Lisa G.; Lura, Brent G.; Hillman, Kristin L.			Regular Exercise Enhances Task-Based Industriousness in Laboratory Rats	PLOS ONE			English	Article							PERSONALITY-FACTORS; PHYSICAL-ACTIVITY; PERSISTENCE; SELF; REINFORCEMENT; WORK; PERSEVERANCE; PERFORMANCE; DIMENSIONS; STRATEGIES	Individuals vary greatly in their willingness to select and persist in effortful tasks, even when high-effort will knowingly result in high-reward. Individuals who select and successively complete effortful, goal-directed tasks can be described as industrious. Trying to increase one's industriousness is desirable from a productivity standpoint, yet intrinsically challenging given that effort expenditure is generally aversive. Here we show that in laboratory rats, a basic physical exercise regimen (20 min/day, five days/week) is sufficient to increase industriousness across a battery of subsequent testing tasks. Exercised rats outperformed their non-exercised counterparts in tasks designed to tax effort expenditure, strategic decision-making, problem solving and persistence. These increases in performance led to quicker reward obtainment and greater reward gain over time, and could not be accounted for simply by increased locomotor activity. Our results suggest that a basic exercise regimen can enhance effortful goal-directed behaviour in goal-directed tasks, which highlights a potential productivity benefit of staying physically active.	[Laurence, Nicholas C.; Labuschagne, Lisa G.; Lura, Brent G.; Hillman, Kristin L.] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago	Hillman, KL (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	khillman@psy.otago.ac.nz		Hillman, Kristin/0000-0002-8541-0134	Marsden Fast Start Grant [108864]	Marsden Fast Start Grant(Royal Society of New ZealandMarsden Fund (NZ))	This project was funded by the Marsden Fast Start Grant 108864 (KLH) administered by the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL A, 1976, J COMP PHYSIOL PSYCH, V90, P808, DOI 10.1037/h0077242; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; BIDDLE SJH, 2001, PSYCHOL PHYS ACTIVIT; BOYAGIAN LG, 1981, AM J PSYCHOL, V94, P619, DOI 10.2307/1422423; CHEN JS, 1980, DEV PSYCHOBIOL, V13, P469, DOI 10.1002/dev.420130505; Clark PJ, 2008, NEUROSCIENCE, V155, P1048, DOI 10.1016/j.neuroscience.2008.06.051; Cocker PJ, 2012, NEUROPSYCHOPHARMACOL, V37, P1825, DOI 10.1038/npp.2012.30; Coe DP, 2006, MED SCI SPORT EXER, V38, P1515, DOI 10.1249/01.mss.0000227537.13175.1b; Conn VS, 2010, ANN BEHAV MED, V39, P128, DOI 10.1007/s12160-010-9172-x; Converse PD, 2009, J APPL PSYCHOL, V94, P1318, DOI 10.1037/a0014604; Costa PT, 1996, APPL PSYCHOL-INT REV, V45, P225; COSTA PT, 1986, CLIN PSYCHOL REV, V6, P407, DOI 10.1016/0272-7358(86)90029-2; COSTA PT, 1988, J PERS SOC PSYCHOL, V54, P853, DOI 10.1037/0022-3514.54.5.853; DIGMAN JM, 1989, J PERS, V57, P195, DOI 10.1111/j.1467-6494.1989.tb00480.x; Donnelly JE, 2009, PREV MED, V49, P336, DOI 10.1016/j.ypmed.2009.07.022; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; EISENBERGER R, 1992, PSYCHOL REV, V99, P248, DOI 10.1037/0033-295X.99.2.248; EISENBERGER R, 1980, AM J PSYCHOL, V93, P285, DOI 10.2307/1422233; FEATHER NT, 1962, PSYCHOL BULL, V59, P94, DOI 10.1037/h0042645; Ferster C.B., 1957, SCHEDULES REINFORCEM, DOI 10.1037/10627-000; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; Green T, 2008, MED SCI SPORT EXER, V40, pS488; Highhouse S, 2010, J APPL PSYCHOL, V95, P349, DOI 10.1037/a0018359; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hough L.M., 1992, HUM PERFORM, V5, P139, DOI [10.1080/08959285.1992.9667929, DOI 10.1207/S15327043HUP0501&2_8]; Hull C., 1943, PRINCIPLES BEHAV; JENKINS HM, 1962, J EXP PSYCHOL, V64, P441, DOI 10.1037/h0048700; JENSEN GD, 1963, J EXP PSYCHOL, V65, P451, DOI 10.1037/h0049174; Kearns H, 2008, HIGH EDUC RES DEV, V27, P77, DOI 10.1080/07294360701658781; Krebs RM, 2010, COGNITION, V117, P341, DOI 10.1016/j.cognition.2010.08.018; Lambert KG, 2006, ANN NY ACAD SCI, V1094, P319, DOI 10.1196/annals.1376.042; Leamer EE, 1999, J POLIT ECON, V107, P1127, DOI 10.1086/250092; Lechner M, 2009, J HEALTH ECON, V28, P839, DOI 10.1016/j.jhealeco.2009.05.003; MacCann C, 2009, LEARN INDIVID DIFFER, V19, P451, DOI 10.1016/j.lindif.2009.03.007; MEEUSEN R, 1995, SPORTS MED, V20, P160, DOI 10.2165/00007256-199520030-00004; MITCHELL P, 1977, B PSYCHONOMIC SOC, V10, P121; Nelson MC, 2006, PEDIATRICS, V117, P1281, DOI 10.1542/peds.2005-1692; O'Connell KA, 2008, PSYCHOL ADDICT BEHAV, V22, P486, DOI 10.1037/0893-164X.22.4.486; OKOLO CM, 1992, J LEARN DISABIL, V25, P327, DOI 10.1177/002221949202500507; Ones DS, 2007, PERS PSYCHOL, V60, P995, DOI 10.1111/j.1744-6570.2007.00099.x; Peabody D, 2002, J PERS SOC PSYCHOL, V83, P983, DOI 10.1037//0022-3514.83.4.983; Puig-Ribera Anna, 2008, Promot Educ, V15, P11, DOI 10.1177/1025382308097693; Roberts BW, 2004, J RES PERS, V38, P164, DOI 10.1016/S0092-6566(03)00065-5; Saucier G, 1999, J PERS SOC PSYCHOL, V76, P613, DOI 10.1037/0022-3514.76.4.613; SCHWARZ L, 1992, SPORTS MED, V13, P25, DOI 10.2165/00007256-199213010-00003; Seefeldt V, 2002, SPORTS MED, V32, P143, DOI 10.2165/00007256-200232030-00001; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; SOLOMON RL, 1948, PSYCHOL BULL, V45, P1, DOI 10.1037/h0055527; Szasz PL, 2012, BEHAV RES THER, V50, P333, DOI 10.1016/j.brat.2012.02.010; Tice DM, 2007, J EXP SOC PSYCHOL, V43, P379, DOI 10.1016/j.jesp.2006.05.007; Trudeau F, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-10; Tyler JM, 2008, SELF IDENTITY, V7, P305, DOI 10.1080/15298860701799997; VECCHIO RP, 1980, ACAD MANAGE J, V23, P361, DOI 10.2307/255439; WARR P, 1982, J OCCUP PSYCHOL, V55, P297, DOI 10.1111/j.2044-8325.1982.tb00103.x; Wenrich WW, 1967, PSYCHON SCI, V9, P247; White TL, 2007, EXP CLIN PSYCHOPHARM, V15, P599, DOI 10.1037/1064-1297.15.6.599; Williams LA, 2008, J PERS SOC PSYCHOL, V94, P1007, DOI 10.1037/0022-3514.94.6.1007; WONG PTP, 1976, ANIM LEARN BEHAV, V4, P461, DOI 10.3758/BF03214440; Zentall SR, 2012, PSYCHON B REV, V19, P1073, DOI 10.3758/s13423-012-0294-y	59	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129831	10.1371/journal.pone.0129831	http://dx.doi.org/10.1371/journal.pone.0129831			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083255	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400112
J	Macedo, AB; Moraes, LHR; Mizobuti, DS; Fogaca, AR; Moraes, FDR; Hermes, TD; Pertille, A; Minatel, E				Macedo, Aline Barbosa; Rapucci Moraes, Luis Henrique; Mizobuti, Daniela Sayuri; Fogaca, Aline Reis; Rapucci Moraes, Fernanda dos Santos; Hermes, Tulio de Almeida; Pertille, Adriana; Minatel, Elaine			Low-Level Laser Therapy (LLLT) in Dystrophin-Deficient Muscle Cells: Effects on Regeneration Capacity, Inflammation Response and Oxidative Stress	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; MDX MOUSE MUSCLE; SKELETAL-MUSCLE; TNF-ALPHA; IRRADIATION PROMOTES; CALCIUM-TRANSPORT; RESTING CALCIUM; HELIUM-NEON; FIBERS; PROLIFERATION	The present study evaluated low-level laser therapy (LLLT) effects on some physiological pathways that may lead to muscle damage or regeneration capacity in dystrophin-deficient muscle cells of mdx mice, the experimental model of Duchenne muscular dystrophy (DMD). Primary cultures of mdx skeletal muscle cells were irradiated only one time with laser and analyzed after 24 and 48 hours. The LLLT parameter used was 830 nm wavelengths at 5 J/cm(2) fluence. The following groups were set up: Ctrl (untreated C57BL/10 primary muscle cells), mdx (untreated mdx primary muscle cells), mdx LA 24 (mdx primary muscle cells - LLLT irradiated and analyzed after 24 h), and mdx LA 48 (mdx primary muscle cells - LLLT irradiated and analyzed after 48 h). The mdx LA 24 and mdx LA 48 groups showed significant increase in cell proliferation, higher diameter in muscle cells and decreased MyoD levels compared to the mdx group. The mdx LA 48 group showed significant increase in Myosin Heavy Chain levels compared to the untreated mdx and mdx LA 24 groups. The mdx LA 24 and mdx LA 48 groups showed significant increase in [Ca2+]i. The mdx group showed significant increase in H2O2 production and 4-HNE levels compared to the Ctrl group and LLLT treatment reduced this increase. GSH levels and GPx, GR and SOD activities increased in the mdx group. Laser treatment reduced the GSH levels and GR and SOD activities in dystrophic muscle cells. The mdx group showed significant increase in the TNF-alpha and NF-kappa B levels, which in turn was reduced by the LLLT treatment. Together, these results suggest that the laser treatment improved regenerative capacity and decreased inflammatory response and oxidative stress in dystrophic muscle cells, indicating that LLLT could be a helpful alternative therapy to be associated with other treatment for dystrophinopathies.	[Macedo, Aline Barbosa; Rapucci Moraes, Luis Henrique; Mizobuti, Daniela Sayuri; Fogaca, Aline Reis; Rapucci Moraes, Fernanda dos Santos; Hermes, Tulio de Almeida; Minatel, Elaine] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Estrut & Func, Campinas, SP, Brazil; [Pertille, Adriana] Univ Metodista Piracicaba UNIMEP, Grad Program Sci Human Movement, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Metodista de Piracicaba	Minatel, E (corresponding author), Univ Estadual Campinas, Dept Biol Estrut & Func, Campinas, SP, Brazil.	minatel@unicamp.br	Mizobuti, Daniela Sayuri/GPF-5727-2022; Minatel, Elaine/ABI-1583-2020; Hermes, Túlio/W-1288-2019; Pertille, Adriana/AAE-3285-2021; Hermes, Tulio/AAK-3362-2021; Rapucci Moraes, Luis Henrique/K-3515-2013	Mizobuti, Daniela Sayuri/0000-0002-6114-4863; Hermes, Tulio/0000-0003-2937-3890; Minatel, Elaine/0000-0001-9863-0761; Rapucci Moraes, Luis Henrique/0000-0002-3096-7250; Pertille, Adriana/0000-0002-6979-342X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/50189-1, 11/02474-4]; CAPES fellowship; CNPq fellowship; FAPESP fellowships [10/01087-4, 13/17299-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP fellowships(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grants 07/50189-1, 11/02474-4). ABM was the recipient of CAPES and CNPq fellowships. DSM and TAH were the recipients of CAPES fellowships. LHRM and ARF were the recipients of FAPESP fellowships (grants 10/01087-4, 13/17299-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel Salam E, 2007, Acta Myol, V26, P14; Aimbire F, 2006, PHOTOMED LASER SURG, V24, P33, DOI 10.1089/pho.2006.24.33; Albertini R, 2007, INFLAMM RES, V56, P228, DOI 10.1007/s00011-007-6211-6; Albertini R, 2004, J PHOTOCH PHOTOBIO B, V74, P101, DOI 10.1016/j.jphotobiol.2004.03.002; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Angelini C, 2007, MUSCLE NERVE, V36, P424, DOI 10.1002/mus.20812; Ben-Dov N, 1999, BBA-MOL CELL RES, V1448, P372, DOI 10.1016/S0167-4889(98)00147-5; Breitbart H, 1996, J PHOTOCH PHOTOBIO B, V34, P117, DOI 10.1016/1011-1344(95)07281-0; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Collins RA, 2001, J HISTOCHEM CYTOCHEM, V49, P989, DOI 10.1177/002215540104900807; Culligan K, 2002, J APPL PHYSIOL, V92, P435, DOI 10.1152/japplphysiol.00903.2001; de Almeida P, 2011, PHOTOCHEM PHOTOBIOL, V87, P1159, DOI 10.1111/j.1751-1097.2011.00968.x; Disatnik MH, 1998, J NEUROL SCI, V161, P77, DOI 10.1016/S0022-510X(98)00258-5; Engel AG, 1994, MYOLOGY BASIC CLIN, V2, P1133; Ferraresi Cleber, 2012, Photonics Lasers Med, V1, P267; GAILLY P, 1993, CELL CALCIUM, V14, P473, DOI 10.1016/0143-4160(93)90006-R; Guatimosim S, 2011, METHODS MOL BIOL, V689, P205, DOI 10.1007/978-1-60761-950-5_12; HEAD SI, 1993, J PHYSIOL-LONDON, V469, P11, DOI 10.1113/jphysiol.1993.sp019801; Hemvani N, 2005, PHOTOMED LASER SURG, V23, P571, DOI 10.1089/pho.2005.23.571; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; Hu WP, 2007, J INVEST DERMATOL, V127, P2048, DOI 10.1038/sj.jid.5700826; Huang YY, 2013, J BIOPHOTONICS, V6, P829, DOI 10.1002/jbio.201200157; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Lim W, 2012, PHOTOMED LASER SURG, V30, P451, DOI 10.1089/pho.2011.3199; Liu XG, 2009, PHOTOMED LASER SURG, V27, P863, DOI 10.1089/pho.2008.2443; Lubart R, 2005, PHOTOMED LASER SURG, V23, P3, DOI 10.1089/pho.2005.23.3; LUBART R, 1992, J PHOTOCH PHOTOBIO B, V15, P337, DOI 10.1016/1011-1344(92)85139-L; Luo L, 2013, LASER MED SCI, V28, P725, DOI 10.1007/s10103-012-1133-0; Mauricio AF, 2013, CLIN NUTR, V32, P636, DOI 10.1016/j.clnu.2012.11.013; Mesquita-Ferrari RA, 2011, LASER MED SCI, V26, P335, DOI 10.1007/s10103-010-0850-5; Messina S, 2011, NEUROMUSCULAR DISORD, V21, P579, DOI 10.1016/j.nmd.2011.04.014; Pinto RDM, 2013, CLIN NUTR, V32, P472, DOI 10.1016/j.clnu.2012.06.001; Nakano J, 2009, EXP PHYSIOL, V94, P1005, DOI 10.1113/expphysiol.2009.047738; Oron A, 2014, PHOTOMED LASER SURG, V32, P606, DOI 10.1089/pho.2014.3757; Leal ECP, 2010, EUR J APPL PHYSIOL, V108, P1083, DOI 10.1007/s00421-009-1321-1; Leal ECP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089453; PRESSMAR J, 1994, PFLUG ARCH EUR J PHY, V426, P499, DOI 10.1007/BF00378527; Rando TA, 1998, NEUROMUSCULAR DISORD, V8, P14, DOI 10.1016/S0960-8966(97)00124-7; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Moraes LHR, 2015, REDOX REP, V20, P109, DOI 10.1179/1351000214Y.0000000112; Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371; Shefer G, 2003, BBA-MOL CELL RES, V1593, P131, DOI 10.1016/S0167-4889(02)00350-6; Stergioulas A, 2008, AM J SPORT MED, V36, P881, DOI 10.1177/0363546507312165; Terrill JR, 2013, INT J BIOCHEM CELL B, V45, P2097, DOI 10.1016/j.biocel.2013.07.009; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; WILLIAMS DA, 1990, J PHYSIOL-LONDON, V428, P243, DOI 10.1113/jphysiol.1990.sp018210; WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602; YOSHIKAWA T, 1993, GUT, V34, P732, DOI 10.1136/gut.34.6.732	50	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128567	10.1371/journal.pone.0128567	http://dx.doi.org/10.1371/journal.pone.0128567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083527	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400057
J	Ruf-Zamojski, F; Trivedi, V; Fraser, SE; Trinh, LA				Ruf-Zamojski, Frederique; Trivedi, Vikas; Fraser, Scott E.; Trinh, Le A.			Spatio-Temporal Differences in Dystrophin Dynamics at mRNA and Protein Levels Revealed by a Novel FlipTrap Line	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; EMBRYONIC-DEVELOPMENT; ZEBRAFISH; GENE; SKELETAL; EXPRESSION; MUTANT; DIFFERENTIATION; LOCALIZATION; VISUALIZE	Dystrophin (Dmd) is a structural protein that links the extracellular matrix to actin filaments in muscle fibers and is required for the maintenance of muscles integrity. Mutations in Dmd lead to muscular dystrophies in humans and other vertebrates. Here, we report the characterization of a zebrafish gene trap line that fluorescently labels the endogenous Dmd protein (Dmd-citrine, Gt(dmd-citrine) (ct90a)). We show that the Dmd-citrine line recapitulates endogenous dmd transcript expression and Dmd protein localization. Using this Dmd-citrine line, we follow Dmd localization to the myosepta in real-time using time-lapse microscopy, and find that the accumulation of Dmd protein at the transverse myosepta coincides with the onset of myotome formation, a critical stage in muscle maturation. We observed that Dmd protein localizes specifically to the myosepta prior to dmd mRNA localization. Additionally, we demonstrate that the Dmd-citrine line can be used to assess muscular dystrophy following both genetic and physical disruptions of the muscle.	[Ruf-Zamojski, Frederique; Fraser, Scott E.; Trinh, Le A.] CALTECH, Beckman Inst, Div Biol, Biol Imaging Ctr, Pasadena, CA 91125 USA; [Trivedi, Vikas] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Trinh, LA (corresponding author), Univ So Calif, Mol & Computat Biol, Los Angeles, CA 90089 USA.	letrinh@usc.edu	Fraser, Scott/Y-3406-2019; Trivedi, Vikas/GXG-1552-2022; Zamojski, Frederique M Ruf/N-5718-2015	Fraser, Scott/0000-0002-5377-0223; Zamojski, Frederique M Ruf/0000-0002-2451-8598; Trivedi, Vikas/0000-0003-0953-0553	National Human Genome research Institute (NHGRI) Center of Excellence in Genomic Science grant [P50HG004071]; Muscular Dystrophy Association Development grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER	National Human Genome research Institute (NHGRI) Center of Excellence in Genomic Science grant; Muscular Dystrophy Association Development grant(Muscular Dystrophy Association); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a National Human Genome research Institute (NHGRI) Center of Excellence in Genomic Science grant P50HG004071 (SEF) and by a Muscular Dystrophy Association Development grant (FRZ), http://mda.org/http://www.genome.gov/.	Abmayr S, 2005, MOL MECH MUSCULAR DY; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; Banks GB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000958; Bassett D, 2004, CLIN EXP PHARMACOL P, V31, P537, DOI 10.1111/j.1440-1681.2004.04030.x; Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Berger J, 2011, J CELL MOL MED, V15, P2643, DOI 10.1111/j.1582-4934.2011.01260.x; Berger J, 2010, NEUROMUSCULAR DISORD, V20, P826, DOI 10.1016/j.nmd.2010.08.004; Boehm S, 2008, GENE EXPR PATTERNS, V8, P71, DOI 10.1016/j.modgep.2007.10.004; Bolanos-Jimenez F, 2001, MECH DEVELOP, V102, P239, DOI 10.1016/S0925-4773(01)00310-0; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chambers SP, 2001, BIOCHEM BIOPH RES CO, V286, P478, DOI 10.1006/bbrc.2001.5424; CHEVRON MP, 1994, NEUROMUSCULAR DISORD, V4, P419, DOI 10.1016/0960-8966(94)90081-7; Choi HMT, 2014, ACS NANO, V8, P4284, DOI 10.1021/nn405717p; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; COFFEY AJ, 1992, GENOMICS, V12, P474, DOI 10.1016/0888-7543(92)90437-W; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Emery AEH, 2002, NEUROMUSCULAR DISORD, V12, P343, DOI 10.1016/S0960-8966(01)00303-0; Etard C, 2010, J CELL BIOL, V189, P527, DOI 10.1083/jcb.200912125; Gibbs EM, 2013, FEBS J, V280, P4187, DOI 10.1111/febs.12412; Granato M, 1996, DEVELOPMENT, V123, P399; Guyon JR, 2009, HUM MOL GENET, V18, P202, DOI 10.1093/hmg/ddn337; Guyon JR, 2003, HUM MOL GENET, V12, P601, DOI 10.1093/hmg/ddg071; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jacoby AS, 2009, DEVELOPMENT, V136, P3367, DOI 10.1242/dev.034561; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KUNKEL LM, 1986, COLD SPRING HARB SYM, V51, P349, DOI 10.1101/SQB.1986.051.01.041; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; MCARDLE A, 1995, NEUROMUSCULAR DISORD, V5, P445, DOI 10.1016/0960-8966(95)00001-4; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; MIRANDA AF, 1988, AM J PATHOL, V132, P410; Mitsui T, 1997, J NEUROPATH EXP NEUR, V56, P94, DOI 10.1097/00005072-199701000-00010; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MONACO AP, 1992, GENOMICS, V12, P465, DOI 10.1016/0888-7543(92)90436-V; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; MOSTACCIUOLO ML, 1993, NEUROEPIDEMIOLOGY, V12, P326, DOI 10.1159/000110334; Pagnon-Minot A, 2008, DEV BIOL, V316, P21, DOI 10.1016/j.ydbio.2007.12.033; PEARSON M, 1979, J EMBRYOL EXP MORPH, V51, P27; PRIMMETT DRN, 1988, DEVELOPMENT, V104, P331; Roy MN, 1999, MECH DEVELOP, V85, P27, DOI 10.1016/S0925-4773(99)00039-8; Snow CJ, 2009, GENE EXPR PATTERNS, V9, P37, DOI 10.1016/j.gep.2008.08.003; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; Stickney HL, 2000, DEV DYNAM, V219, P287; Thisse B, 2001, EXPRESSION OF THE ZE; TOME FMS, 1994, NEUROMUSCULAR DISORD, V4, P343, DOI 10.1016/0960-8966(94)90070-1; Trinh LA, 2007, BIOTECHNIQUES, V42, P756, DOI 10.2144/000112476; Trinh LA, 2011, GENE DEV, V25, P2306, DOI 10.1101/gad.174037.111; Webb SE, 2012, CLIN EXP PHARMACOL P, V39, P78, DOI 10.1111/j.1440-1681.2011.05582.x; Wein N, 2014, NAT MED, V20, P992, DOI 10.1038/nm.3628; Westerfield M., 1994, THE ZEBRAFISH BOOK; WINAND NJ, 1994, NEUROMUSCULAR DISORD, V4, P433, DOI 10.1016/0960-8966(94)90082-5; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	59	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128944	10.1371/journal.pone.0128944	http://dx.doi.org/10.1371/journal.pone.0128944			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083378	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000356567400074
J	Zininga, T; Achilonu, I; Hoppe, H; Prinsloo, E; Dirr, HW; Shonhai, A				Zininga, Tawanda; Achilonu, Ikechukwu; Hoppe, Heinrich; Prinsloo, Earl; Dirr, Heini W.; Shonhai, Addmore			Overexpression, Purification and Characterisation of the Plasmodium falciparum Hsp70-z (PfHsp70-z) Protein	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE DNAK; NUCLEOTIDE EXCHANGE; SECONDARY STRUCTURE; HSP110; HEAT-SHOCK-PROTEIN-70; IDENTIFICATION; STABILIZES; MECHANISM; DOMAINS	Six Hsp70-like genes are represented on the genome of Plasmodium falciparum. Of these two occur in the cytosol: P. falciparum Hsp70-z (PfHsp70-z) and PfHsp70-1. PfHsp70-1 is a well characterised canonical Hsp70 that facilitates protein quality control and is crucial for the development of malaria parasites. There is very little known about PfHsp70-z. However, PfHsp70-z is known to be essential and is implicated in suppressing aggregation of asparagine-rich proteins of P. falciparum. In addition, its expression at the clinical stage of malaria correlates with disease prognosis. Based on structural evidence PfHsp70-z belongs to the Hsp110 family of proteins. Since Hsp110 proteins have been described as nucleotide exchange factors (NEFs) of their canonical Hsp70 counterparts, it has been speculated that PfHsp70-z may serve as a NEF of PfHsp70-1. In the current study, P. falciparum cells cultured in vitro were subjected to heat stress, triggering the enhanced expression of PfHsp70-z. Biochemical assays conducted using recombinant PfHsp70-z protein demonstrated that the protein is heat stable and possesses ATPase activity. Furthermore, we observed that PfHsp70-z is capable of self-association. The structural-functional features of PfHsp70-z provide further evidence for its role as a chaperone and possible nucleotide exchange factor of PfHsp70-1.	[Zininga, Tawanda; Shonhai, Addmore] Univ Venda, Sch Math & Nat Sci, Dept Biochem, ZA-0950 Thohoyandou, South Africa; [Achilonu, Ikechukwu; Dirr, Heini W.] Univ Witwatersrand, Sch Mol & Cell Biol, Prot Struct Funct Res Unit, ZA-2050 Johannesburg, South Africa; [Hoppe, Heinrich] Rhodes Univ, Dept Biochem Microbiol & Biotechnol, ZA-6140 Grahamstown, South Africa; [Prinsloo, Earl] Rhodes Univ, Biotechnol Innovat Ctr, ZA-6140 Grahamstown, South Africa	University of Venda; University of Witwatersrand; Rhodes University; Rhodes University	Shonhai, A (corresponding author), Univ Venda, Sch Math & Nat Sci, Dept Biochem, ZA-0950 Thohoyandou, South Africa.	addmore.shonhai@univen.ac.za	Zininga, Tawanda/Q-4131-2019; Prinsloo, Earl/F-9737-2012; Shonhai, Addmore/AAS-4506-2021	Zininga, Tawanda/0000-0001-8689-0152; Prinsloo, Earl/0000-0002-3048-4304; Dirr, Heini/0000-0003-1455-7769; Hoppe, Heinrich/0000-0003-4409-1955	Deutsche Forchungsgemeinshaft (DFG) under the theme, "German-African Cooperation Projects in Infectology" [L1/402/14-1]; Department of Science and Technology/National Research Foundation (NRF) of South Africa [UID, 75464, 78558]; NRF (South Africa) [64788]; Georg Foster research fellowship by the Alexander von Humboldt Foundation, Germany; South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation [64788]	Deutsche Forchungsgemeinshaft (DFG) under the theme, "German-African Cooperation Projects in Infectology"; Department of Science and Technology/National Research Foundation (NRF) of South Africa; NRF (South Africa)(National Research Foundation - South Africa); Georg Foster research fellowship by the Alexander von Humboldt Foundation, Germany; South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation	This project was through a grant (L1/402/14-1) provided to AS by the Deutsche Forchungsgemeinshaft (DFG) under the theme, "German-African Cooperation Projects in Infectology". The authors are grateful to the Department of Science and Technology/National Research Foundation (NRF) of South Africa for providing an equipment grant (grant UID, 75464) to AS and (grant UID, 78558) to EP. HWD was awarded a research grant (64788) by the NRF (South Africa). AS is a recipient of a Georg Foster research fellowship awarded by the Alexander von Humboldt Foundation, Germany. The South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (grant 64788 to HWD) which partially facilitated the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gerald N, 2011, EUKARYOT CELL, V10, P474, DOI 10.1128/EC.00314-10; Gitau GW, 2012, CELL STRESS CHAPERON, V17, P191, DOI 10.1007/s12192-011-0299-x; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Makhnevych T, 2013, FEBS LETT, V587, P1067, DOI 10.1016/j.febslet.2013.02.018; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Marcion G, 2015, CELL STRESS CHAPERON, V20, P61, DOI 10.1007/s12192-014-0526-3; Matambo TS, 2004, PROTEIN EXPRES PURIF, V33, P214, DOI 10.1016/j.pep.2003.09.010; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Misra G, 2009, BIOPHYS CHEM, V142, P55, DOI 10.1016/j.bpc.2009.03.006; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Moriarty L, 2010, BIORAD B, V5821; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Nemoto TK, 2006, J BIOCHEM, V139, P677, DOI 10.1093/jb/mvj071; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; Pallavi R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-236; Patury S, 2009, CURR TOP MED CHEM, V9, P1337, DOI 10.2174/156802609789895674; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Sharma D, 2009, PROTEIN PEPTIDE LETT, V16, P571, DOI 10.2174/092986609788490230; Shonhai A., 2014, HEAT SHOCK PROTEINS, P47, DOI [10.1007/978-94-007-7438-4_3, DOI 10.1007/978-94-007-7438-4_3]; Shonhai A, 2008, PROTEIN PEPTIDE LETT, V15, P1117, DOI 10.2174/092986608786071067; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zininga T, 2014, AM J BIOCH BIOTECHNO, V10, P208	43	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129445	10.1371/journal.pone.0129445	http://dx.doi.org/10.1371/journal.pone.0129445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083397	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400096
J	Lawson, A; Cogger, C; Bary, A; Fortuna, AM				Lawson, Andrew; Cogger, Craig; Bary, Andy; Fortuna, Ann-Marie			Influence of Seeding Ratio, Planting Date, and Termination Date on Rye-Hairy Vetch Cover Crop Mixture Performance under Organic Management	PLOS ONE			English	Article							NITROGEN AVAILABILITY; SOIL QUALITY; KILL DATE; CORN; TILLAGE; GRASS; TIME; RELEASE; GROWTH; CARBON	Cover crop benefits include nitrogen accumulation and retention, weed suppression, organic matter maintenance, and reduced erosion. Organic farmers need region-specific information on winter cover crop performance to effectively integrate cover crops into their crop rotations. Our research objective was to compare cover crop seeding mixtures, planting dates, and termination dates on performance of rye (Secale cereale L.) and hairy vetch (Vicia villosa Roth) monocultures and mixtures in the maritime Pacific Northwest USA. The study included four seed mixtures (100% hairy vetch, 25% rye-75% hairy vetch, 50% rye-50% hairy vetch, and 100% rye by seed weight), two planting dates, and two termination dates, using a split-split plot design with four replications over six years. Measurements included winter ground cover; stand composition; cover crop biomass, N concentration, and N uptake; and June soil NO3--N. Rye planted in mid-September and terminated in late April averaged 5.1 Mg ha(-1) biomass, whereas mixtures averaged 4.1 Mg ha(-1) and hairy vetch 2.3 Mg ha(-1). Delaying planting by 2.5 weeks reduced average winter ground cover by 65%, biomass by 50%, and cover crop N accumulation by 40%. Similar reductions in biomass and N accumulation occurred for late March termination, compared with late April termination. Mixtures had less annual biomass variability than rye. Mixtures accumulated 103 kg ha(-1) N and had mean C:N ratio <17:1 when planted in mid-September and terminated in late April. June soil NO3--N (0 to 30 cm depth) averaged 62 kg ha(-1) for rye, 97 kg ha(-1) for the mixtures, and 119 kg ha(-1) for hairy vetch. Weeds comprised less of the mixtures biomass (20% weeds by weight at termination) compared with the monocultures (29%). Cover crop mixtures provided a balance between biomass accumulation and N concentration, more consistent biomass over the six-year study, and were more effective at reducing winter weeds compared with monocultures.	[Lawson, Andrew; Cogger, Craig; Bary, Andy] Washington State Univ, Puyallup Res & Extens Ctr, Puyallup, WA 98371 USA; [Fortuna, Ann-Marie] N Dakota State Univ, Dept Soil Sci, Fargo, ND 58105 USA	Washington State University; North Dakota State University Fargo	Cogger, C (corresponding author), Washington State Univ, Puyallup Res & Extens Ctr, Puyallup, WA 98371 USA.	cogger@wsu.edu		Fortuna, Ann-Marie/0000-0002-6966-7781	Western Sustainable Agriculture Research and Education [SW03-040]; United States Department of Agriculture Integrated Organic Program [00394397]; Washington State University College of Agriculture Human and Natural Resource Sciences Emerging Research Issues; Washington State University College of Agriculture Human and Natural Resource Sciences Center for Sustaining Agriculture and Natural Resources Organic Cropping Research for the Northwest	Western Sustainable Agriculture Research and Education; United States Department of Agriculture Integrated Organic Program; Washington State University College of Agriculture Human and Natural Resource Sciences Emerging Research Issues; Washington State University College of Agriculture Human and Natural Resource Sciences Center for Sustaining Agriculture and Natural Resources Organic Cropping Research for the Northwest	Funding for this work came from Western Sustainable Agriculture Research and Education SW03-040 (http://www.westernsare.org/) to CC, United States Department of Agriculture Integrated Organic Program GRANT00394397 (http://www.csrees.usda.gov/) to CC and AF, and Washington State University College of Agriculture Human and Natural Resource Sciences Emerging Research Issues 2007 http://cahnrs.wsu.edu/ to CC, AF, and AB. Additional funding for this work came from the Washington State University College of Agriculture Human and Natural Resource Sciences Center for Sustaining Agriculture and Natural Resources Organic Cropping Research for the Northwest 2004 (http://csanr.wsu.edu/) to CC and AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Ayuso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109587; Baributsa DN, 2008, AGRON J, V100, P981, DOI 10.2134/agronj2007.0110; Bich A. D., 2014, Crop Management, V13, pCM, DOI 10.2134/cm-2014-0009-rs; BrandiDohrn FM, 1997, J ENVIRON QUAL, V26, P181, DOI 10.2134/jeq1997.00472425002600010026x; Brennan EB, 2011, AGRON J, V103, P449, DOI 10.2134/agronj2010.0152; Brennan EB, 2012, AGRON J, V104, P684, DOI 10.2134/agronj2011.0330; CLARK AJ, 1995, AGRON J, V87, P579, DOI 10.2134/agronj1995.00021962008700030031x; Clark AJ, 1997, AGRON J, V89, P427, DOI 10.2134/agronj1997.00021962008900030010x; Cline GR, 2002, HORTTECHNOLOGY, V12, P118, DOI 10.21273/HORTTECH.12.1.118; Fortuna A, 2008, COMMUN SOIL SCI PLAN, V39, P1680, DOI 10.1080/00103620802073628; Gavlak RG, 2005, W REGIONAL EXT PUBL, V125; Hayden ZD, 2012, WEED TECHNOL, V26, P818, DOI 10.1614/WT-D-12-00084.1; Hively WD, 2001, AGRON J, V93, P308, DOI 10.2134/agronj2001.932308x; HOLDERBAUM JF, 1990, AGRON J, V82, P117, DOI 10.2134/agronj1990.00021962008200010026x; Horneck DA, 2011, OREGON STATE U EXTEN, V1478; Kruidhof HM, 2008, WEED RES, V48, P492, DOI 10.1111/j.1365-3180.2008.00665.x; Kuo S, 2000, BIOL FERT SOILS, V31, P470, DOI 10.1007/s003740000193; Kuo S, 1997, SOIL SCI SOC AM J, V61, P1392, DOI 10.2136/sssaj1997.03615995006100050016x; Kuo S, 2002, AGRON J, V94, P501; Lawson A, 2013, RENEW AGR FOOD SYST, V28, P59, DOI 10.1017/S1742170512000014; Odhiambo JJO, 2001, AGRON J, V93, P299, DOI 10.2134/agronj2001.932299x; Pritchett K, 2011, SOIL SCI SOC AM J, V75, P605, DOI 10.2136/sssaj2009.0294; Ranells NN, 1997, AGRON J, V89, P659, DOI 10.2134/agronj1997.00021962008900040019x; Ranells NN, 1996, AGRON J, V88, P777, DOI 10.2134/agronj1996.00021962008800050015x; Sainju UM, 2000, CAN J SOIL SCI, V80, P523, DOI 10.4141/S99-107; Sainju UM, 2005, AGRON J, V97, P1279, DOI 10.2134/agronj2004.0213; Sattel R, 1998, OREGON STATE U EXTEN, V8704; Sustainable Agriculture Network, 2007, MAN COV CROPS PROF; Teasdale JR, 2004, AGRON J, V96, P1429, DOI 10.2134/agronj2004.1429; Thorup-Kristensen K, 2010, SOIL USE MANAGE, V26, P27, DOI 10.1111/j.1475-2743.2009.00255.x; Vaughan JD, 1998, AGRON J, V90, P536, DOI 10.2134/agronj1998.00021962009000040016x; Vaughan JD, 2000, COMMUN SOIL SCI PLAN, V31, P1017, DOI 10.1080/00103620009370495; WAGGER MG, 1989, AGRON J, V81, P236, DOI 10.2134/agronj1989.00021962008100020020x; Wayman S, 2015, AGROECOL SU IN PRESS; Wayman S, 2015, RENEW AGR FOOD SYST, V30, P450, DOI 10.1017/S1742170514000246	35	63	64	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129597	10.1371/journal.pone.0129597	http://dx.doi.org/10.1371/journal.pone.0129597			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080008	Green Submitted, Green Published, gold			2022-12-26	WOS:000356542300026
J	Hu, SF; Huang, YH; Lin, CP; Liu, LYD; Hong, SF; Yang, CY; Lo, HF; Tseng, TY; Chen, WY; Lin, SS				Hu, Sin-Fen; Huang, Yu-Hsin; Lin, Chan-Pin; Liu, Li-Yu Daisy; Hong, Syuan-Fei; Yang, Chiao-Yin; Lo, Hsiao-Feng; Tseng, Ting-Yu; Chen, Wei-Yao; Lin, Shih-Shun			Development of a Mild Viral Expression System for Gain-Of-Function Study of Phytoplasma Effector In Planta	PLOS ONE			English	Article							YELLOW-MOSAIC-VIRUS; GENE-EXPRESSION; VECTOR; SUPPRESSION; PROTEIN; MERISTEMS; INFECTION; PATHWAYS	PHYL1 and SAP54 are orthologs of pathogenic effectors of Aster yellow witches'-broom (AYWB) phytoplasma and Peanut witches'-broom (PnWB) phytoplasma, respectively. These effectors cause virescence and phyllody symptoms (hereafter leafy flower) in phytoplasma- infected plants. T-0 lines of transgenic Arabidopsis expressing the PHYL1 or SAP54 genes (PHYL1 or SAP54 plants) show a leafy flower phenotype and result in seedless, suggesting that PHYL1 and SAP54 interfere with reproduction stage that restrict gain-of-function studies in the next generation of transgenic plants. Turnip mosaic virus (TuMV) mild strain (TuGK) has an Arg182Lys mutation in the helper-component proteinase (HC-Pro(R182K)) that blocks suppression of the miRNA pathway and prevents symptom development in TuGK-infected plants. We exploited TuGK as a viral vector for gain-of-function studies of PHYL1 and SAP54 in Arabidopsis plants. TuGK-PHYL1-and TuGK-SAP54-infected Arabidopsis plants produced identical leafy flower phenotypes and similar gene expression profiles as PHYL1 and SAP54 plants. In addition, the leafy flower formation rate was enhanced in TuGK-PHYL1-or TuGK-SAP54-infected Arabidopsis plants that compared with the T-0 lines of PHYL1 plants. These results provide more evidence and novel directions for further studying the mechanism of PHYL1/SAP54-mediated leafy flower development. In addition, the TuGK vector is a good alternative in transgenic plant approaches for rapid gene expression in gain-of-function studies.	[Hu, Sin-Fen; Chen, Wei-Yao; Lin, Shih-Shun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Lin, Shih-Shun] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Lin, Shih-Shun] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Huang, Yu-Hsin; Lin, Chan-Pin; Yang, Chiao-Yin] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Hong, Syuan-Fei; Lo, Hsiao-Feng] Natl Taiwan Univ, Dept Hort & Landscape Architecture, Taipei 10764, Taiwan; [Liu, Li-Yu Daisy] Natl Taiwan Univ, Dept Agron, Taipei 10764, Taiwan; [Tseng, Ting-Yu] Natl Taiwan Univ, Coll Bioresources & Agr, Joint Ctr Instruments & Res, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lin, SS (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan.	linss01@ntu.edu.tw	Lin, Shih-Shun/HCH-9241-2022	Liu, Li-yu/0000-0001-6997-8101; LIN, SHIH-SHUN/0000-0002-7295-5004; LO, HSIAO-FENG/0000-0002-1574-2854; Lin, Chan-Pin/0000-0002-9951-687X	Ministry of Science and Technology, Taiwan [NSC-102-2313-B-002-068-MY3, NSC-102-2313-B-002066-B-MY3, NSC-103-2313-B-002-007]; National Taiwan University [104R7602B2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This study was supported by grants NSC-102-2313-B-002-068-MY3, NSC-102-2313-B-002066-B-MY3, and NSC-103-2313-B-002-007 from the Ministry of Science and Technology, Taiwan; and 104R7602B2 from National Taiwan University.	Aguero J, 2012, MOL PLANT MICROBE IN, V25, P1326, DOI 10.1094/MPMI-02-12-0048-R; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; APPIANO A, 1972, J GEN VIROL, V14, P273, DOI 10.1099/0022-1317-14-3-273; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Carrio-Segui A, 2015, PLANT CELL PHYSIOL, V56, P442, DOI 10.1093/pcp/pcu180; Chiu MingTzu, 2013, Plant Pathology Bulletin, V22, P21; Chung W-C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062770, DOI 10.1371/JOURNAL.PONE.0062770]; Collens JI, 2007, BIOTECHNOL PROGR, V23, P570, DOI 10.1021/bp060342u; Dhillon T, 2009, PLANT CELL REP, V28, P639, DOI 10.1007/s00299-009-0675-5; Gleba Y, 2004, CURR OPIN PLANT BIOL, V7, P182, DOI 10.1016/j.pbi.2004.01.003; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Haikonen T, 2013, J VIROL METHODS, V193, P687, DOI 10.1016/j.jviromet.2013.07.054; Hanley K, 2003, ASSAY DRUG DEV TECHN, V1, P147, DOI 10.1089/154065803762851315; Harpaz-Saad S, 2007, PLANT CELL, V19, P1007, DOI 10.1105/tpc.107.050633; Hsu CH, 2004, J ALLERGY CLIN IMMUN, V113, P1079, DOI 10.1016/j.jaci.2004.02.047; Huang CF, 2010, PLANT PHYSIOL, V153, P1669, DOI 10.1104/pp.110.155028; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; KITAJIMA EW, 1969, J GEN VIROL, V4, P177, DOI 10.1099/0022-1317-4-2-177; Kung YJ, 2014, MOL PLANT MICROBE IN, V27, P944, DOI 10.1094/MPMI-04-14-0116-R; Lacomme Christophe, 2008, Curr Protoc Microbiol, VChapter 16, DOI 10.1002/9780471729259.mc16i01s8; LIN NS, 1984, J GEN VIROL, V65, P2217, DOI 10.1099/0022-1317-65-12-2217; Lin YY, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-22; Liu LYD, 2014, PLANT CELL PHYSIOL, V55, P942, DOI 10.1093/pcp/pcu029; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; MacLean AM, 2011, PLANT PHYSIOL, V157, P831, DOI 10.1104/pp.111.181586; Maejima K, 2014, PLANT J, V78, P541, DOI 10.1111/tpj.12495; Minato N, 2014, ARCH VIROL, V159, P885, DOI 10.1007/s00705-013-1860-y; Mochizuki T, 2015, METHODS MOL BIOL, V1236, P275, DOI 10.1007/978-1-4939-1743-3_20; ROBERTS DA, 1970, VIROLOGY, V42, P217, DOI 10.1016/0042-6822(70)90255-2; Ruiz-Ferrer V, 2007, BIOESSAYS, V29, P319, DOI 10.1002/bies.20556; Shamekova M, 2014, VIROLOGY, V452, P159, DOI 10.1016/j.virol.2013.12.031; Takeshita M, 2012, MOL PLANT MICROBE IN, V25, P18, DOI 10.1094/MPMI-06-11-0170; TOUSSAINT A, 1984, PHYSIOL PLANT PATHOL, V25, P297, DOI 10.1016/0048-4059(84)90037-7; Wu HW, 2010, MOL PLANT MICROBE IN, V23, P17, DOI 10.1094/MPMI-23-1-0017; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhao Y, 2014, PLANT PHYSIOL, V164, P1068, DOI 10.1104/pp.113.227595; Zwart MP, 2014, MOL BIOL EVOL, V31, P121, DOI 10.1093/molbev/mst175	38	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130139	10.1371/journal.pone.0130139	http://dx.doi.org/10.1371/journal.pone.0130139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076458	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900142
J	Reske, M; Stewart, JL; Flagan, TM; Paulus, MP				Reske, Martina; Stewart, Jennifer L.; Flagan, Taru M.; Paulus, Martin P.			Attenuated Neural Processing of Risk in Young Adults at Risk for Stimulant Dependence	PLOS ONE			English	Article							IOWA GAMBLING TASK; ANTERIOR CINGULATE CORTEX; DELAY DISCOUNTING TASK; TAKING DECISION-MAKING; PREFRONTAL CORTEX; COCAINE ADDICTION; COGNITIVE CONTROL; PRESCRIPTION STIMULANTS; COLLEGE-STUDENTS; NONMEDICAL USE	Objective Approximately 10% of young adults report non-medical use of stimulants (cocaine, amphetamine, methylphenidate), which puts them at risk for the development of dependence. This fMRI study investigates whether subjects at early stages of stimulant use show altered decision making processing. Methods 158 occasional stimulants users (OSU) and 50 comparison subjects (CS) performed a "risky gains" decision making task during which they could select safe options (cash in 20 cents) or gamble them for double or nothing in two consecutive gambles (win or lose 40 or 80 cents, "risky decisions"). The primary analysis focused on risky versus safe decisions. Three secondary analyses were conducted: First, a robust regression examined the effect of lifetime exposure to stimulants and marijuana; second, subgroups of OSU with > 1000 (n = 42), or <50 lifetime marijuana uses (n = 32), were compared to CS with <50 lifetime uses (n = 46) to examine potential marijuana effects; third, brain activation associated with behavioral adjustment following monetary losses was probed. Results There were no behavioral differences between groups. OSU showed attenuated activation across risky and safe decisions in prefrontal cortex, insula, and dorsal striatum, exhibited lower anterior cingulate cortex (ACC) and dorsal striatum activation for risky decisions and greater inferior frontal gyrus activation for safe decisions. Those OSU with relatively more stimulant use showed greater dorsal ACC and posterior insula attenuation. In comparison, greater lifetime marijuana use was associated with less neural differentiation between risky and safe decisions. OSU who chose more safe responses after losses exhibited similarities with CS relative to those preferring risky options. Discussion Individuals at risk for the development of stimulant use disorders presented less differentiated neural processing of risky and safe options. Specifically, OSU show attenuated brain response in regions critical for performance monitoring, reward processing and interoceptive awareness. Marijuana had additive effects by diminishing neural risk differentiation.	[Reske, Martina; Stewart, Jennifer L.; Flagan, Taru M.; Paulus, Martin P.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Reske, Martina] Forschungszentrum Julich, INM 6, Computat & Syst Neurosci, D-52425 Julich, Germany; [Reske, Martina] Forschungszentrum Julich, IAS 6, Theoret Neurosci, D-52425 Julich, Germany; [Reske, Martina] JARA BRAIN Inst 1, Julich, Germany; [Stewart, Jennifer L.] CUNY Queens Coll, New York, NY USA; [Flagan, Taru M.] Univ Texas Austin, Austin, TX 78712 USA; [Paulus, Martin P.] VA San Diego Healthcare Syst, Psychiat Serv, La Jolla, CA USA; [Paulus, Martin P.] Laureate Inst Brain Res, Tulsa, OK USA	University of California System; University of California San Diego; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; City University of New York (CUNY) System; University of Texas System; University of Texas Austin; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Laureate Institute for Brain Research, Inc.	Paulus, MP (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	mpaulus@laureateinstitute.org	Reske, Martina/M-6083-2013	Reske, Martina/0000-0001-5754-4795; Stewart, Jennifer/0000-0003-0123-9438	National Institute on Drug Abuse [R01-DA016663, P20-DA027834, R01-DA027797, R01-DA018307]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018307, R01DA027797, R01DA016663] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institute on Drug Abuse (Grants R01-DA016663, P20-DA027834, R01-DA027797, and R01-DA018307 to Martin Paulus). Funding authorities had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report or the decision to submit the manuscript for publication.	Arce E, 2006, PSYCHOPHARMACOLOGY, V189, P105, DOI 10.1007/s00213-006-0519-8; Arias AJ, 2008, ADDICT BEHAV, V33, P1199, DOI 10.1016/j.addbeh.2008.05.003; Asensio S, 2010, ADDICT BIOL, V15, P504, DOI 10.1111/j.1369-1600.2010.00230.x; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barry D, 2008, BRAIN COGNITION, V66, P243, DOI 10.1016/j.bandc.2007.09.001; Bechara A, 2001, Semin Clin Neuropsychiatry, V6, P205, DOI 10.1053/scnp.2001.22927; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Bjork JM, 2008, DRUG ALCOHOL DEPEN, V95, P115, DOI 10.1016/j.drugalcdep.2007.12.014; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Bolla KI, 1999, J NEUROPSYCH CLIN N, V11, P361, DOI 10.1176/jnp.11.3.361; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Camus M, 2009, EUR J NEUROSCI, V30, P1980, DOI 10.1111/j.1460-9568.2009.06991.x; Claus ED, 2012, ALCOHOL CLIN EXP RES, V36, P408, DOI 10.1111/j.1530-0277.2011.01694.x; Connolly CG, 2012, DRUG ALCOHOL DEPEN, V121, P45, DOI 10.1016/j.drugalcdep.2011.08.007; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Dietz P, 2013, PHARMACOTHERAPY, V33, P44, DOI 10.1002/phar.1166; Ersche KD, 2005, PSYCHOPHARMACOLOGY, V180, P612, DOI 10.1007/s00213-005-2205-7; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; Fishbein DH, 2005, COGNITIVE BRAIN RES, V23, P119, DOI 10.1016/j.cogbrainres.2004.12.010; Garavan H, 2008, PHILOS T R SOC B, V363, P3267, DOI 10.1098/rstb.2008.0106; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; Gowin JL, 2014, NEUROPSYCHOPHARMACOL; Gowin JL, 2014, ADDICTION, V109, P237, DOI 10.1111/add.12354; Hall KM, 2005, J AM COLL HEALTH, V53, P167, DOI 10.3200/JACH.53.4.167-174; Harle KM, 2014, J NEUROSCI, V34, P4567, DOI 10.1523/JNEUROSCI.2297-13.2014; Herman-Stahl MA, 2006, J ADOLESCENT HEALTH, V39, P374, DOI 10.1016/j.jadohealth.2006.01.006; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Hyatt CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034917; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lane SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011591; Lawrence NS, 2009, CEREB CORTEX, V19, P1134, DOI 10.1093/cercor/bhn154; Leland DS, 2005, DRUG ALCOHOL DEPEN, V78, P83, DOI 10.1016/j.drugalcdep.2004.10.001; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Meade CS, 2011, PSYCHIAT RES-NEUROIM, V192, P167, DOI 10.1016/j.pscychresns.2010.12.011; Meade CS, 2011, J BEHAV MED, V34, P128, DOI 10.1007/s10865-010-9293-5; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; Monterosso JR, 2007, HUM BRAIN MAPP, V28, P383, DOI 10.1002/hbm.20281; Nestor LJ, 2011, PSYCHIAT RES-NEUROIM, V194, P287, DOI 10.1016/j.pscychresns.2011.04.010; Park SQ, 2011, J NEUROSCI, V31, P9307, DOI 10.1523/JNEUROSCI.4973-10.2011; Pattij T, 2008, EUR J PHARMACOL, V585, P458, DOI 10.1016/j.ejphar.2008.02.099; Paulus MP, 2008, BIOL PSYCHIAT, V63, P1054, DOI 10.1016/j.biopsych.2007.09.007; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P761, DOI 10.1001/archpsyc.62.7.761; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paulus MP, 2003, BIOL PSYCHIAT, V53, P65, DOI 10.1016/S0006-3223(02)01442-7; Paulus MP, 2002, NEUROIMAGE, V15, P836, DOI 10.1006/nimg.2001.1031; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Rao H, 2008, NEUROIMAGE, V42, P902, DOI 10.1016/j.neuroimage.2008.05.046; Reske M, 2011, J PSYCHIATR RES, V45, P361, DOI 10.1016/j.jpsychires.2010.07.005; Reske M, 2010, BIOL PSYCHIAT, V68, P762, DOI 10.1016/j.biopsych.2010.04.021; Rudorf S, 2012, J NEUROSCI, V32, P16683, DOI 10.1523/JNEUROSCI.4235-11.2012; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Slovic P, 2000, PERCEPTION OF RISK; Smith BW, 2009, NEUROIMAGE, V44, P600, DOI 10.1016/j.neuroimage.2008.08.016; Sobell LC, 1996, DRUG ALCOHOL DEPEN, V42, P49, DOI 10.1016/0376-8716(96)01263-X; Stewart JL, 2013, BIOL PSYCHIAT, V73, P235, DOI 10.1016/j.biopsych.2012.08.018; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tapert SF, 2002, J INT NEUROPSYCH SOC, V8, P873, DOI 10.1017/S1355617702870011; Teter CJ, 2003, PHARMACOTHERAPY, V23, P609, DOI 10.1592/phco.23.5.609.34187; van der Plas EAA, 2009, J CLIN EXP NEUROPSYC, V31, P706, DOI 10.1080/13803390802484797; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V90, P2, DOI 10.1016/j.drugalcdep.2007.02.004; Vorhold V, 2008, ANN NY ACAD SCI, V1128, P41, DOI 10.1196/annals.1399.006; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; Ward B. D., 2000, SIMULTANEOUS INTERFE	80	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0127010	10.1371/journal.pone.0127010	http://dx.doi.org/10.1371/journal.pone.0127010			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076493	Green Published, gold			2022-12-26	WOS:000356329900008
J	Xu, KW; Harrison, RE				Xu, Kewei; Harrison, Rene E.			Down-regulation of Stathmin Is Required for the Phenotypic Changes and Classical Activation of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; RECEPTOR-MEDIATED PHAGOCYTOSIS; CATASTROPHE-PROMOTING ACTIVITY; CELL-CYCLE; POSTTRANSLATIONAL MODIFICATIONS; INTERPHASE MICROTUBULES; NERVOUS-SYSTEM; PROTEIN-KINASE; PHORBOL ESTER	Macrophages are important cells of innate immunity with specialized capacity for recognition and elimination of pathogens and presentation of antigens to lymphocytes for adaptive immunity. Macrophages become activated upon exposure to pro-inflammatory cytokines and pathogenic stimuli. Classical activation of macrophages with interferon-gamma (IFN gamma) and lipopolysaccharide (LPS) triggers a wide range of signaling events and morphological changes to induce the immune response. Our previous microtubule (MT) proteomic work revealed that the stathmin association with MTs is considerably reduced in activated macrophages, which contain significantly more stabilized MTs. Here, we show that there is a global decrease in stathmin levels, an MT catastrophe protein, in activated macrophages using both immunoblotting and immunofluorescent microscopy. This is an LPS-specific response that induces proteasome-mediated degradation of stathmin. We explored the functions of stathmin down-regulation in activated macrophages by generating a stable cell line overexpressing stathmin-GFP. We show that stathmin-GFP overexpression impacts MT stability, impairs cell spreading, and reduces activation-associated phenotypes. Furthermore, overexpressing stathmin reduces complement receptor 3-mediated phagocytosis and cellular activation, implicating a pivotal inhibitory role for stathmin in classically activated macrophages.	Univ Toronto Scarborough, Dept Cell & Syst Biol, Toronto, ON M1C 1A4, Canada; [Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada	University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Scarborough	Harrison, RE (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada.	harrison@utsc.utoronto.ca			Canadian Institutes of Health Research [MOP-68992]; Natural Science and Engineering Research Council [RGPIN 298538-09]; Alfred and Florence Aiken and Dorothy Woods Memorial Graduate Scholarship; Canadian Institutes of Health Research New Investigator Award; Ontario Early Researcher Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alfred and Florence Aiken and Dorothy Woods Memorial Graduate Scholarship; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	This work was supported by Canadian Institutes of Health Research Grant MOP-68992 and Natural Science and Engineering Research Council Grant RGPIN 298538-09 (to R. E. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of the Alfred and Florence Aiken and Dorothy Woods Memorial Graduate Scholarship.; Recipient of a Canadian Institutes of Health Research New Investigator Award and an Ontario Early Researcher Award.	Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belmont L, 1996, TRENDS BIOCHEM SCI, V21, P197, DOI 10.1016/S0968-0004(96)80013-2; Beningo KA, 2002, J CELL SCI, V115, P849; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Bergqvist S, 2008, PROTEIN SCI, V17, P2051, DOI 10.1110/ps.037481.108; Bieche I, 1998, BRIT J CANCER, V78, P701, DOI 10.1038/bjc.1998.565; Binker MG, 2007, J IMMUNOL, V179, P3780, DOI 10.4049/jimmunol.179.6.3780; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CANNON GJ, 1992, J CELL SCI, V101, P907; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200; Dai Q, 2005, BIOCHEM BIOPH RES CO, V332, P37, DOI 10.1016/j.bbrc.2005.04.088; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; DOWNEY GP, 1992, J CELL BIOL, V116, P695, DOI 10.1083/jcb.116.3.695; FLORQUIN S, 1994, J EXP MED, V180, P1153, DOI 10.1084/jem.180.3.1153; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Ghazanfari T, 2010, IMMUNOPHARM IMMUNOT, V32, P47, DOI [10.3109/08923970903117357, 10.1080/08923970903117357]; Gomes NE, 2010, BRAZ J MED BIOL RES, V43, P853, DOI 10.1590/S0100-879X2010000900007; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gupta KK, 2013, P NATL ACAD SCI USA, V110, P20449, DOI 10.1073/pnas.1309958110; HAMEROFF SR, 1982, J THEOR BIOL, V98, P549, DOI 10.1016/0022-5193(82)90137-0; Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676; HANASH SM, 1988, J BIOL CHEM, V263, P12813; Harvat BL, 1997, ONCOGENE, V14, P2111, DOI 10.1038/sj.onc.1201055; Holmfeldt P, 2001, MOL BIOL CELL, V12, P73, DOI 10.1091/mbc.12.1.73; Howell B, 1999, J CELL SCI, V112, P3713; Iancu-Rubin C, 2005, TRENDS CELL BIOL, V15, P346, DOI 10.1016/j.tcb.2005.05.008; Iancu-Rubin C, 2011, BLOOD, V117, P4580, DOI 10.1182/blood-2010-09-305540; JOHNSON HM, 1985, P NATL ACAD SCI USA, V82, P5959, DOI 10.1073/pnas.82.17.5959; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; Kalis C, 2003, EUR J IMMUNOL, V33, P798, DOI 10.1002/eji.200323431; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kasas S, 2004, BIOL CELL, V96, P697, DOI 10.1016/j.biolcel.2004.09.002; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469; LANE TE, 1994, INFECT IMMUN, V62, P1478, DOI 10.1128/IAI.62.4.1478-1479.1994; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lin XC, 2012, CANCER SCI, V103, P993, DOI 10.1111/j.1349-7006.2012.02271.x; Liu P, 2013, ONCOL REP, V29, P419, DOI 10.3892/or.2012.2157; Liu XW, 2004, WORLD J GASTROENTERO, V10, P2701, DOI 10.3748/wjg.v10.i18.2701; Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754; Luo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5407; Mackenzie GG, 2006, J NEUROCHEM, V99, P402, DOI 10.1111/j.1471-4159.2006.04005.x; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; Morimura S., 2011, INT J CELL BIOL, V2011; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; O'Dea E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000216; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Pace J, 1988, J LEUKOCYTE BIOL, V520, P514; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Patel PC, 2009, MOL CELL PROTEOMICS, V8, P2500, DOI 10.1074/mcp.M900190-MCP200; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Pixley Fiona J, 2012, Int J Cell Biol, V2012, P501962, DOI 10.1155/2012/501962; Pustylnik S, 2013, J BIOL CHEM, V288, P22096, DOI 10.1074/jbc.M113.481515; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Rubin CI, 2003, EXP HEMATOL, V31, P389, DOI 10.1016/S0301-472X(03)00043-2; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Sherbet G., 2005, CANCER GENOM PROTEOM, V238, P227; Silver KE, 2011, J IMMUNOL, V186, P816, DOI 10.4049/jimmunol.1002161; Spencer W, 1999, ONCOGENE, V18, P495, DOI 10.1038/sj.onc.1202335; SWALLOW CJ, 1992, J LEUKOCYTE BIOL, V52, P395, DOI 10.1002/jlb.52.4.395; SWANSON JA, 1989, J CELL SCI, V94, P135; Takahashi K, 2010, CELL SIGNAL, V22, P510, DOI 10.1016/j.cellsig.2009.11.005; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Tsukamoto H, 2013, J IMMUNOL, V190, P195, DOI 10.4049/jimmunol.1201047; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3; Welliver TP, 2011, J CELL SCI, V124, P4106, DOI 10.1242/jcs.091538; Wenzel RP, 1996, CLIN INFECT DIS, V22, P407, DOI 10.1093/clinids/22.3.407; Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764; Zhang DW, 2010, MOL CANCER THER, V9, P3090, DOI 10.1158/1535-7163.MCT-10-0362	91	11	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19245	19260		10.1074/jbc.M115.639625	http://dx.doi.org/10.1074/jbc.M115.639625			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26082487	Green Published, hybrid			2022-12-26	WOS:000358781100038
J	Yu, J; Pian, YY; Ge, JP; Guo, J; Zheng, YL; Jiang, H; Hao, HJ; Yuan, Y; Jiang, YQ; Yang, MJ				Yu, Jie; Pian, Yaya; Ge, Jingpeng; Guo, Jie; Zheng, Yuling; Jiang, Hua; Hao, Huaijie; Yuan, Yuan; Jiang, Yongqiang; Yang, Maojun			Functional and Structural Characterization of the Antiphagocytic Properties of a Novel Transglutaminase from Streptococcus suis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING ENZYMES; CRYSTAL-STRUCTURE; IDENTIFICATION; VIRULENCE; PROTEINS; SUILYSIN; PURIFICATION; SEROTYPE-2; VECTORS; GENE	Streptococcus suis serotype 2 (Ss2) is an important swine and human zoonotic pathogen. In the present study, we identified a novel secreted immunogenic protein, SsTGase, containing a highly conserved eukaryotic-like transglutaminase (TGase) domain at the N terminus. We found that inactivation of SsTGase significantly reduced the virulence of Ss2 in a pig infection model and impaired its antiphagocytosis in human blood. We further solved the crystal structure of the N-terminal portion of the protein in homodimer form at 2.1 angstrom Structure-based mutagenesis and biochemical studies suggested that disruption of the homodimer directly resulted in the loss of its TGase activity and antiphagocytic ability. Characterization of SsTGase as a novel virulence factor of Ss2 by acting as a TGase would be beneficial for developing new therapeutic agents against Ss2 infections.	[Yu, Jie; Pian, Yaya; Zheng, Yuling; Jiang, Hua; Yuan, Yuan; Jiang, Yongqiang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Yu, Jie; Pian, Yaya; Ge, Jingpeng; Yang, Maojun] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Key Lab Prot Sci,Minist Educ, Beijing 100084, Peoples R China; [Guo, Jie; Hao, Huaijie] Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing 100101, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Tsinghua University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Yuan, Y (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	miniminiyuan@163.com; jiangyq@nic.bmi.ac.cn; maojunyang@tsinghua.edu.cn	Ge, Jingpeng/AGG-3471-2022; Hao, Huaijie/D-3861-2017; Gai, Jingpeng/AAT-9369-2021	Hao, Huaijie/0000-0002-1928-4205; Gai, Jingpeng/0000-0001-6164-1221; Yang, Maojun/0000-0002-6798-3094	Ministry of Science and Technology [2011CB910502, 2012CB911101]; National Natural Science Foundation [31030020, 31170679, 31101824, 81171528, 81441062, 81371766, 81401642]; State Key Laboratory of Pathogen and Biosecurity (Academy of Military Medical Science) [SKLPBS1414]; National Basic Research Program (973) of China [2012CB518804, 2012YQ18011706]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pathogen and Biosecurity (Academy of Military Medical Science); National Basic Research Program (973) of China(National Basic Research Program of China)	This work was supported by Ministry of Science and Technology Grants 2011CB910502 and 2012CB911101 (to M. Y.); National Natural Science Foundation Grants 31030020 and 31170679 (to M. Y.), 31101824 (to H. X.), 81171528, 81441062, and 81371766 (to Y. J.), and 81401642 (to Y. P.)); State Key Laboratory of Pathogen and Biosecurity (Academy of Military Medical Science) Grant SKLPBS1414 (to Y. Y.); and National Basic Research Program (973) of China Grants 2012CB518804 and 2012YQ18011706 (to Y. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beninati S, 2004, AMINO ACIDS, V26, P367, DOI 10.1007/s00726-004-0091-7; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Csosz E, 2008, J MOL BIOL, V383, P390, DOI 10.1016/j.jmb.2008.08.026; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; FOLK JE, 1973, ADV ENZYMOL RAMB, V38, P109; Geng HR, 2008, J PROTEOME RES, V7, P4132, DOI 10.1021/pr800196v; GOOD L, 1992, NUCLEIC ACIDS RES, V20, P4934, DOI 10.1093/nar/20.18.4934; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Han BG, 2010, INT J BIOL MACROMOL, V47, P190, DOI 10.1016/j.ijbiomac.2010.04.023; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200; Kobayashi K., 1998, European Patent Application EP, Patent No. [0851029A1, 0851029]; Kuraishi C, 2001, FOOD REV INT, V17, P221, DOI 10.1081/FRI-100001258; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Martins IM, 2014, APPL MICROBIOL BIOT, V98, P6957, DOI 10.1007/s00253-014-5894-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmieri C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00235; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Pian YY, 2012, INFECT IMMUN, V80, P2402, DOI 10.1128/IAI.06294-11; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Reiss K, 2011, J BIOL CHEM, V286, P42585, DOI 10.1074/jbc.M111.290544; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Serafini-Fracassini D, 2008, ANN BOT-LONDON, V102, P145, DOI 10.1093/aob/mcn075; Shleikin A G, 2011, Zh Evol Biokhim Fiziol, V47, P3; Smith HE, 1999, INFECT IMMUN, V67, P1750; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takeuchi D, 2014, J INFECT DIS, V209, P1509, DOI 10.1093/infdis/jit661; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Yang MT, 2011, J BIOL CHEM, V286, P7301, DOI 10.1074/jbc.M110.203315; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5	48	18	24	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19081	19092		10.1074/jbc.M115.643338	http://dx.doi.org/10.1074/jbc.M115.643338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085092	hybrid, Green Published			2022-12-26	WOS:000358781100025
J	Baroncelli, R; Zapparata, A; Sarrocco, S; Sukno, SA; Lane, CR; Thon, MR; Vannacci, G; Holub, E; Sreenivasaprasad, S				Baroncelli, Riccardo; Zapparata, Antonio; Sarrocco, Sabrina; Sukno, Serenella A.; Lane, Charles R.; Thon, Michael R.; Vannacci, Giovanni; Holub, Eric; Sreenivasaprasad, Surapareddy			Molecular Diversity of Anthracnose Pathogen Populations Associated with UK Strawberry Production Suggests Multiple Introductions of Three Different Colletotrichum Species	PLOS ONE			English	Article							LIFE-STYLES; 1ST REPORT; ACUTATUM; IDENTIFICATION; RESISTANCE; FUNGI; ROT	Fragaria x ananassa (common name: strawberry) is a globally cultivated hybrid species belonging to Rosaceae family. Colletotrichum acutatum sensu lato(s.l.) is considered to be the second most economically important pathogen worldwide affecting strawberries. A collection of 148 Colletotrichum spp. isolates including 67 C. acutatum s.l. isolates associated with the phytosanitary history of UK strawberry production were used to characterize multilocus genetic variation of this pathogen in the UK, relative to additional reference isolates that represent a worldwide sampling of the diversity of the fungus. The evidence indicates that three different species C. nymphaeae, C. godetiae and C. fioriniae are associated with strawberry production in the UK, which correspond to previously designated genetic groups A2, A4 and A3, respectively. Among these species, 12 distinct haplotypes were identified suggesting multiple introductions into the country. A subset of isolates was also used to compare aggressiveness in causing disease on strawberry plants and fruits. Isolates belonging to C. nymphaeae, C. godetiae and C. fioriniae representative of the UK anthracnose pathogen populations showed variation in their aggressiveness. Among the three species, C. nymphaeae and C. fioriniae appeared to be more aggressive compared to C. godetiae. This study highlights the genetic and pathogenic heterogeneity of the C. acutatum s.l. populations introduced into the UK linked to strawberry production.	[Baroncelli, Riccardo; Holub, Eric] Univ Warwick, Warwick Crop Ctr, Sch Life Sci, Wellesbourne, Warwick, England; [Baroncelli, Riccardo; Zapparata, Antonio; Sarrocco, Sabrina; Vannacci, Giovanni] Univ Pisa, Dipartimento Sci Agr Alimentari & Agroambientali, Pisa, Italy; [Sukno, Serenella A.; Thon, Michael R.] Univ Salamanca, Inst Hispano Luso Invest Agr, Dept Microbiol & Genet, E-37008 Salamanca, Spain; [Lane, Charles R.] Food & Environm Res Agcy, York, N Yorkshire, England; [Sreenivasaprasad, Surapareddy] Univ Bedfordshire, Dept Life Sci, Luton, Beds, England	University of Warwick; University of Pisa; University of Salamanca; Food & Environment Research Agency; University of Bedfordshire	Baroncelli, R (corresponding author), Univ Bretagne Occidentale, Lab Univ Biodiversite & Ecol Microbienne, Brest, France.	riccardobaroncelli@gmail.com	Sarrocco, Sabrina/H-6191-2015; Baroncelli, Riccardo/L-2598-2014; Sukno, Serenella/T-5919-2019; Vannacci, Giovanni/ABD-3672-2020; Thon, Michael/M-9463-2014; Sukno, Serenella A/K-1449-2014; Vannacci, Giovanni/H-6078-2015	Sarrocco, Sabrina/0000-0002-7080-8369; Baroncelli, Riccardo/0000-0002-5878-1159; Sukno, Serenella/0000-0003-3248-6490; Vannacci, Giovanni/0000-0001-8218-6029; Thon, Michael/0000-0002-7225-7003; Sukno, Serenella A/0000-0003-3248-6490; Vannacci, Giovanni/0000-0001-8218-6029; SREENIVASAPRASAD, SURAPAREDDY/0000-0001-5391-0380	University of Warwick	University of Warwick	The authors would like to thank University of Warwick for funding this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroncelli R, 2015, PLANT PATHOL, V64, P375, DOI 10.1111/ppa.12268; Baroncelli R., 2014, New Disease Reports, V29, P26, DOI 10.5197/j.2044-0588.2014.029.026; Baroncelli R, 2014, PLANT DIS, V98, P1000, DOI 10.1094/PDIS-11-13-1177-PDN; Baroncelli R, 2014, GENOME ANNOUNCEMENT, V2; Baroncelli R, 2012, THESIS U WARWICK; Beech MG, 1989, ISHS ACTA HORTICULTU, V265, P693; Buddie AG, 1999, MYCOL RES, V103, P385, DOI 10.1017/S0953756298007254; Calleja EJ, 2013, PLANT PATHOL, V62, P266, DOI 10.1111/j.1365-3059.2012.02647.x; Damm U, 2012, STUD MYCOL, P37, DOI 10.3114/sim0010; Denoyes-Rothan B, 2003, PHYTOPATHOLOGY, V93, P219, DOI 10.1094/PHYTO.2003.93.2.219; Denoyes-Rothan B, 1999, PLANT DIS, V83, P549, DOI 10.1094/PDIS.1999.83.6.549; Du MZ, 2005, MYCOLOGIA, V97, P641, DOI 10.3852/mycologia.97.3.641; Freeman S, 1997, PHYTOPATHOLOGY, V87, P516, DOI 10.1094/PHYTO.1997.87.5.516; Freeman S, 2001, PHYTOPATHOLOGY, V91, P986, DOI 10.1094/PHYTO.2001.91.10.986; Garrido C, 2008, EUR J PLANT PATHOL, V120, P409, DOI 10.1007/s10658-007-9224-7; Guerber JC, 2003, MYCOLOGIA, V95, P872, DOI 10.2307/3762016; HOWARD CM, 1992, PLANT DIS, V76, P976, DOI 10.1094/PD-76-0976; Howard CM, 1984, COMPENDIUM STRAWBERR, P85; Jelev ZJ, 2008, J PHYTOPATHOL, V156, P668, DOI 10.1111/j.1439-0434.2008.01438.x; Jones DR, 2007, PLANT PATHOL, V56, P891, DOI 10.1111/j.1365-3059.2007.01619.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; MAAS JL, 1985, PLANT DIS, V69, P164, DOI 10.1094/PD-69-164; Martinez-Culebras PV, 2000, FEMS MICROBIOL LETT, V189, P97, DOI 10.1016/S0378-1097(00)00260-3; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Peres NA, 2005, PLANT DIS, V89, P784, DOI 10.1094/PD-89-0784; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SEPP R, 1994, J CLIN PATHOL, V47, P318, DOI 10.1136/jcp.47.4.318; SIMPSON DW, 1994, EUPHYTICA, V77, P161, DOI 10.1007/BF02551480; SMITH BJ, 1986, PLANT DIS, V70, P1074, DOI 10.1094/PD-70-1074e; Sreenivasaprasad S, 2005, MOL PLANT PATHOL, V6, P361, DOI 10.1111/J.1364-3703.2005.00291.X; Sreenivasaprasad S, 1996, PLANT PATHOL, V45, P650, DOI 10.1046/j.1365-3059.1996.d01-3.x; Sutton, 1992, COLLETOTRICHUM BIOL; Talhinhas P, 2002, PHYTOPATHOLOGY, V92, P986, DOI 10.1094/PHYTO.2002.92.9.986; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urena-Padilla AR, 2002, PHYTOPATHOLOGY, V92, P1245, DOI 10.1094/PHYTO.2002.92.11.1245; Van Hemelrijck W, 2010, PLANT PATHOL, V59, P853, DOI 10.1111/j.1365-3059.2010.02324.x; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; Whitelaw-Weckert MA, 2007, PLANT PATHOL, V56, P448, DOI 10.1111/j.1365-3059.2007.01569.x	39	63	72	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129140	10.1371/journal.pone.0129140	http://dx.doi.org/10.1371/journal.pone.0129140			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086351	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500035
J	Korzeniowska-Kowal, A; Kochman, A; Gamian, E; Lis-Nawara, A; Lipinski, T; Seweryn, E; Ziolkowski, P; Gamian, A				Korzeniowska-Kowal, Agnieszka; Kochman, Agata; Gamian, Elzbieta; Lis-Nawara, Anna; Lipinski, Tomasz; Seweryn, Ewa; Ziolkowski, Piotr; Gamian, Andrzej			Antibodies against Escherichia coli O24 and O56 O-Specific Polysaccharides Recognize Epitopes in Human Glandular Epithelium and Nervous Tissue	PLOS ONE			English	Article							POLYACRYLAMIDE-GELS; LIPOPOLYSACCHARIDES; PROTEINS	Lipopolysaccharide (LPS), the major component of the outer membrane of Gram-negative bacteria, contains the O-polysaccharide, which is important to classify bacteria into different O-serological types within species. The O-polysaccharides of serotypes O24 and O56 of E. coli contain sialic acid in their structures, already established in our previous studies. Here, we report the isolation of specific antibodies with affinity chromatography using immobilized lipopolysaccharides. Next, we evaluated the reactivity of anti-O24 and anti-O56 antibody on human tissues histologically. The study was conducted under the assumption that the sialic acid based molecular identity of bacterial and tissue structures provides not only an understanding of the mimicry-based bacterial pathogenicity. Cross-reacting antibodies could be used to recognize specific human tissues depending on their histogenesis and differentiation, which might be useful for diagnostic purposes. The results indicate that various human tissues are recognized by anti-O24 and anti-O56 antibodies. Interestingly, only a single specific reactivity could be found in the anti-O56 antibody preparation. Several tissues studied were not reactive with either antibody, thus proving that the presence of cross-reactive antigens was tissue specific. In general, O56 antibody performed better than O24 in staining epithelial and nervous tissues. Positive staining was observed for both normal (ganglia) and tumor tissue (ganglioneuroma). Epithelial tissue showed positive staining, but an epitope recognized by O56 antibody should be considered as a marker of glandular epithelium. The reason is that malignant glandular tumor and its metastasis are stained, and also epithelium of renal tubules and glandular structures of the thyroid gland are stained. Stratified epithelium such as that of skin is definitely not stained. Therefore, the most relevant observation is that the epitope recognized by anti-O56 antibodies is a new marker specific for glandular epithelium and nervous tissue. Further studies should be performed to determine the structure of the tissue epitope recognized.	[Korzeniowska-Kowal, Agnieszka; Lipinski, Tomasz; Gamian, Andrzej] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; [Kochman, Agata; Gamian, Elzbieta; Lis-Nawara, Anna; Ziolkowski, Piotr] Wroclaw Med Univ, Dept Pathol, PL-50368 Wroclaw, Poland; [Gamian, Elzbieta; Seweryn, Ewa] Wroclaw Med Univ, Dept Med Biochem, PL-50368 Wroclaw, Poland; [Lipinski, Tomasz; Gamian, Andrzej] Wroclaw Res Ctr EIT, PL-54066 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw Medical University; Wroclaw Medical University	Korzeniowska-Kowal, A (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Weigla 12, PL-53114 Wroclaw, Poland.	akorzen@iitd.pan.wroc.pl	Ziolkowski, Piotr/AAU-2452-2021	Ziolkowski, Piotr/0000-0003-3036-2611; Seweryn, Ewa/0000-0003-4004-8968; Gamian, Andrzej/0000-0002-2206-6591; Korzeniowska-Kowal, Agnieszka/0000-0001-7569-8018	Wroclaw Research Centre EIT+ within the project "The Application of Nanotechnology in Advanced Materials" - NanoMat [POIG.01.01.02-02-002/08]; European Regional Development Fund (Operational Programme Innovative Economy) [1.1.2]; Polish Academy of Sciences [501-15]	Wroclaw Research Centre EIT+ within the project "The Application of Nanotechnology in Advanced Materials" - NanoMat; European Regional Development Fund (Operational Programme Innovative Economy)(European Commission); Polish Academy of Sciences	This work was supported by Wroclaw Research Centre EIT+ within the project "The Application of Nanotechnology in Advanced Materials" - NanoMat (POIG.01.01.02-02-002/08), co-financed by the European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2), and with grant 501-15 from the Polish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brade H, 1999, ENDOTOXIN HLTH DIS, P115; Corfield AP, 1982, SIALIC ACIDS CHEM ME, V10, P5; Ebaid H, 2008, FEMS IMMUNOL MED MIC, V52, P352, DOI 10.1111/j.1574-695X.2008.00380.x; FOMSGAARD A, 1990, J CLIN MICROBIOL, V28, P2627, DOI 10.1128/JCM.28.12.2627-2631.1990; GAMIAN A, 1992, FEMS MICROBIOL IMMUN, V89, P323, DOI 10.1016/0378-1097(92)90272-P; GAMIAN A, 1994, EUR J BIOCHEM, V225, P1211, DOI 10.1111/j.1432-1033.1994.1211b.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; LACKIE PM, 1991, DIFFERENTIATION, V47, P85, DOI 10.1111/j.1432-0436.1991.tb00226.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Minervini MI, 1997, MODERN PATHOL, V10, P686; Ordonez NG, 2013, HUM PATHOL, V44, P1195, DOI 10.1016/j.humpath.2012.11.016; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; SCOTT JE, 1969, HISTOCHEMISTRY, V19, P295; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	16	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129492	10.1371/journal.pone.0129492	http://dx.doi.org/10.1371/journal.pone.0129492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086646	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500050
J	Torell, F; Bennett, K; Cereghini, S; Rannar, S; Lundstedt-Enkel, K; Moritz, T; Haumaitre, C; Trygg, J; Lundstedt, T				Torell, Frida; Bennett, Kate; Cereghini, Silvia; Raennar, Stefan; Lundstedt-Enkel, Katrin; Moritz, Thomas; Haumaitre, Cecile; Trygg, Johan; Lundstedt, Torbjoern			Multi-Organ Contribution to the Metabolic Plasma Profile Using Hierarchical Modelling	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; SMALL-INTESTINE; FATTY-ACIDS; RAT-KIDNEY; IN-VIVO; MUSCLE; MOUSE; STIMULATION; LIVER; GUT	Hierarchical modelling was applied in order to identify the organs that contribute to the levels of metabolites in plasma. Plasma and organ samples from gut, kidney, liver, muscle and pancreas were obtained from mice. The samples were analysed using gas chromatography time-of-flight mass spectrometry (GC TOF-MS) at the Swedish Metabolomics centre, Umea University, Sweden. The multivariate analysis was performed by means of principal component analysis (PCA) and orthogonal projections to latent structures (OPLS). The main goal of this study was to investigate how each organ contributes to the metabolic plasma profile. This was performed using hierarchical modelling. Each organ was found to have a unique metabolic profile. The hierarchical modelling showed that the gut, kidney and liver demonstrated the greatest contribution to the metabolic pattern of plasma. For example, we found that metabolites were absorbed in the gut and transported to the plasma. The kidneys excrete branched chain amino acids (BCAAs) and fatty acids are transported in the plasma to the muscles and liver. Lactic acid was also found to be transported from the pancreas to plasma. The results indicated that hierarchical modelling can be utilized to identify the organ contribution of unknown metabolites to the metabolic profile of plasma.	[Torell, Frida; Trygg, Johan] Umea Univ, Dept Chem, Computat Life Sci Cluster CLiC, Umea, Sweden; [Torell, Frida] Karlsruhe Inst Technol, D-76021 Karlsruhe, Germany; [Bennett, Kate; Raennar, Stefan; Lundstedt-Enkel, Katrin; Moritz, Thomas; Lundstedt, Torbjoern] AcureOmics AB, Umea, Sweden; [Cereghini, Silvia; Haumaitre, Cecile] CNRS, UMR7622, F-75005 Paris, France; [Cereghini, Silvia; Haumaitre, Cecile] Univ Paris 06, Sorbonne Univ, UMR7622, F-75005 Paris, France; [Cereghini, Silvia; Haumaitre, Cecile] INSERM, U1156, Paris, France	Umea University; Helmholtz Association; Karlsruhe Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Trygg, J (corresponding author), Umea Univ, Dept Chem, Computat Life Sci Cluster CLiC, Umea, Sweden.	johan.trygg@chem.umu.se	Haumaitre, Cecile/E-5455-2017	Haumaitre, Cecile/0000-0003-3526-7832; Moritz, Thomas/0000-0002-4258-3190	Swedish Research Council [2011-6044]; Biology of Liver and Pancreatic Development and Disease (BOLD) Marie Curie Initial Training Network (MCITN) within EU's FP7 programme; CNRS; Universite Pierre et Marie Curie; Institut National de la Sante et de la Recherche Medicale, INSERM; Societe Francophone du Diabete and Emergence UPMC	Swedish Research Council(Swedish Research CouncilEuropean Commission); Biology of Liver and Pancreatic Development and Disease (BOLD) Marie Curie Initial Training Network (MCITN) within EU's FP7 programme; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie; Institut National de la Sante et de la Recherche Medicale, INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Societe Francophone du Diabete and Emergence UPMC	This research was supported by the Swedish Research Council, grant no. 2011-6044 (to JT); the Biology of Liver and Pancreatic Development and Disease (BOLD) Marie Curie Initial Training Network (MCITN) within EU's FP7 programme (to TL, JT, KB, FT, SC, CH, TM); the CNRS and Universite Pierre et Marie Curie (to SC, CH); the Institut National de la Sante et de la Recherche Medicale, INSERM (to SC); and the Societe Francophone du Diabete and Emergence UPMC (to CH). These funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AcureOmics AB did not provide support in the form of salaries for authors JT, TM and TL, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adeva-Andany M, 2014, MITOCHONDRION, V17, P76, DOI 10.1016/j.mito.2014.05.007; [Anonymous], 2005, VANNOSTRANDS SCI ENC; Berdanier CD, 2008, HDB NUTR FOOD, P121; Berg J, 2006, BIOCHEMISTRY-US, P851; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; BROWNE JL, 1977, PROC R SOC SER B-BIO, V195, P307, DOI 10.1098/rspb.1977.0011; BROWNE JL, 1978, PROC R SOC SER B-BIO, V200, P117, DOI 10.1098/rspb.1978.0010; Cui X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100963; Eriksson L., 2013, MULTI MEGAVARIATE DA, P355; Eriksson L, 2006, MULTI MEGAVARIATE DA, P381; Eriksson L, 2006, MULTI MEGAVARIATE DA, P39; GRISOLIA S, 1957, BIOCHIM BIOPHYS ACTA, V25, P430, DOI 10.1016/0006-3002(57)90498-5; Guan GM, 2003, ARCH BIOCHEM BIOPHYS, V417, P251, DOI 10.1016/S0003-9861(03)00388-6; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Gunnarsson I, 2003, J CHEMOMETR, V17, P82, DOI 10.1002/cem.777; HANISCH ME, 1972, COMP BIOCHEM PHYSIOL, V42, P601, DOI 10.1016/0300-9629(72)90439-2; Herzberg GR, 1997, CAN J PHYSIOL PHARM, V75, P945, DOI 10.1139/cjpp-75-8-945; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; HIATT HH, 1960, J BIOL CHEM, V235, P1241; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hung RJ, 2004, CANCER EPIDEM BIOMAR, V13, P1013; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kaphalia BS, 1995, FUND APPL TOXICOL, V28, P264, DOI 10.1006/faat.1995.1167; Kriz W, 2004, J CLIN INVEST, V114, P611, DOI 10.1172/JCI200422669; Kumar JS, 2013, AM J PHYSIOL-GASTR L, V305, pG207, DOI 10.1152/ajpgi.00148.2013; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Lindstrom A, 2006, J CHEM INF MODEL, V46, P1154, DOI 10.1021/ci050323k; LOTSPEICH WD, 1947, FED PROC, V6, P156; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Miller S, 2004, AM J PHYSIOL-ENDOC M, V287, pE136, DOI 10.1152/ajpendo.00092.2004; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; MURER H, 1980, INT J BIOCHEM, V12, P223, DOI 10.1016/0020-711X(80)90074-9; Nelson DL, 2008, PRINCIPLES BIOCH, P527; Nelson DL, 2008, PRINCIPLES BIOCH, P371; Nelson DL, 2008, PRINCIPLES BIOCH, P647; Nelson DL, 2008, PRINCIPLES BIOCH, P271; Ren J, 2008, J PHARMACOL EXP THER, V325, P920, DOI 10.1124/jpet.108.137752; Schaffer SW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S2; Shimoda M, 2009, PATHOBIOLOGY, V76, P193, DOI 10.1159/000218335; SILBERNAGL S, 1983, PFLUG ARCH EUR J PHY, V396, P218, DOI 10.1007/BF00587858; Taylor P, 1995, BIOMEDICAL TRANSPORT, P295; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J, 2003, J CHEMOMETR, V17, P53, DOI 10.1002/cem.775; van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185; Van Regenmortel MHV, 2004, EMBO REP, V5, P1016, DOI 10.1038/sj.embor.7400284; WACHSMUTH ED, 1975, HISTOCHEMISTRY, V45, P143, DOI 10.1007/BF00495158; Wardlaw G, 2011, CONT NUTR FUNCTIONAL, P80; Warskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fje; WEBER FL, 1982, AM J PHYSIOL, V242, pG552, DOI 10.1152/ajpgi.1982.242.6.G552; Werch SC, 1941, P SOC EXP BIOL MED, V48, P9, DOI 10.3181/00379727-48-13203; Wold S, 1996, J CHEMOMETR, V10, P463; Wold S., 1984, CHEMOMETRICS, V138, P17; WOLFFRAM S, 1990, J NUTR, V120, P767, DOI 10.1093/jn/120.7.767; WRIGHT SH, 1980, J MEMBRANE BIOL, V57, P73, DOI 10.1007/BF01868987; YOUNG G A, 1991, Amino Acids (Vienna), V1, P183, DOI 10.1007/BF00806915; ZAHAREVITZ DW, 1988, EUR J BIOCHEM, V175, P193, DOI 10.1111/j.1432-1033.1988.tb14183.x	59	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129260	10.1371/journal.pone.0129260	http://dx.doi.org/10.1371/journal.pone.0129260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086868	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500041
J	Yu, N; Yan, WJ; Yin, TL; Wang, YQ; Guo, Y; Zhou, DN; Xu, M; Ding, JL; Yang, J				Yu, Nan; Yan, Wenjie; Yin, Tailang; Wang, Yaqin; Guo, Yue; Zhou, Danni; Xu, Mei; Ding, Jinli; Yang, Jing			HCG-Activated Human Peripheral Blood Mononuclear Cells (PBMC) Promote Trophoblast Cell Invasion	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STIMULATE PROGESTERONE PRODUCTION; EARLY-PREGNANCY; LUTEINIZING-HORMONE; MESSENGER-RNA; MATRIX; IMPLANTATION; EXPRESSION; ENDOMETRIUM; LYMPHOCYTES	Successful embryo implantation and placentation depend on appropriate trophoblast invasion into the maternal endometrial stroma. Human chorionic gonadotropin (hCG) is one of the earliest embryo-derived secreted signals in the peripheral blood mononuclear cells (PBMC) that abundantly expresses hCG receptors. The aims of this study were to estimate the effect of human embryo-secreted hCG on PBMC function and investigate the role and underlying mechanisms of activated PBMC in trophoblast invasion. Blood samples were collected from women undergoing benign gynecological surgery during the mid-secretory phase. PBMC were isolated and stimulated with or without hCG for 0 or 24 h. Interleukin-1 beta (IL-1 beta) and leukemia inhibitory factor (LIF) expressions in PBMC were detected by enzyme-linked immunosorbent assay and real-time polymerase chain reaction (PCR). The JAR cell line served as a model for trophoblast cells and was divided into four groups: control, hCG only, PBMC only, and PBMC with hCG. JAR cell invasive and proliferative abilities were detected by trans-well and CCK8 assays and matrix metalloproteinase (MMP)-2 (MMP-2), MMP-9, vascular endothelial growth factor (VEGF), tissue inhibitor of metalloproteinase (TIMP)-1, and TIMP-2 expressions in JAR cells were detected by western blotting and real-time PCR analysis. We found that hCG can remarkably promote IL-1 beta and LIF promotion in PBMC after 24-h culture. PBMC activated by hCG significantly increased the number of invasive JAR cells in an invasion assay without affecting proliferation, and hCG-activated PBMC significantly increased MMP-2, MMP-9, and VEGF and decreased TIMP-1 and TIMP-2 expressions in JAR cells in a dose-dependent manner. This study demonstrated that hCG stimulates cytokine secretion in human PBMC and could stimulate trophoblast invasion.	Wuhan Univ, Renmin Hosp, Reprod Med Ctr, Wuhan 430072, Peoples R China; [Yu, Nan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Yang, J (corresponding author), Wuhan Univ, Renmin Hosp, Reprod Med Ctr, Wuhan 430072, Peoples R China.	nny86@163.com			Fundamental Research Funds for the Central Universities [2012302020201]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities (No. 2012302020201).	Anumba DOC, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-62; Bischof P, 2000, BEST PRACT RES CL OB, V14, P801, DOI 10.1053/beog.2000.0120; Bischof P, 1995, Early Pregnancy, V1, P263; Bischof P, 2001, ANN NY ACAD SCI, V943, P157, DOI 10.1111/j.1749-6632.2001.tb03799.x; Boyd W., 1998, ARMADILLO; Carbone F, 2010, J REPROD IMMUNOL, V85, P172, DOI 10.1016/j.jri.2010.02.009; Cole LA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-8; Crocker IP, 2001, J SOC GYNECOL INVEST, V8, P341, DOI 10.1016/S1071-5576(01)00134-4; Dimitriadis E, 2010, INT J DEV BIOL, V54, P313, DOI 10.1387/ijdb.082772ed; Doridot Ludivine, 2013, Frontiers in Genetics, V4, DOI 10.3389/fgene.2013.00248; Egawa H, 2002, HUM REPROD, V17, P473, DOI 10.1093/humrep/17.2.473; EMI N, 1991, AM J OBSTET GYNECOL, V165, P1469; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; FISHER SJ, 1985, J CELL BIOCHEM, V27, P31, DOI 10.1002/jcb.240270105; Fu JJ, 2009, PLACENTA, V30, P305, DOI 10.1016/j.placenta.2009.01.005; Fujiwara H, 2009, MOL HUM REPROD, V15, P335, DOI 10.1093/molehr/gap027; Guzelogiu-Kayisli Z, 2009, SEMIN REPROD MED, V27, P62, DOI 10.1055/s-0028-1108011; Hammer A, 2011, J REPROD IMMUNOL, V90, P21, DOI 10.1016/j.jri.2011.05.001; Hashii K, 1998, HUM REPROD, V13, P2738, DOI 10.1093/humrep/13.10.2738; Hotakainen PK, 2000, MOL CELL ENDOCRINOL, V162, P79, DOI 10.1016/S0303-7207(00)00208-2; Ideta A, 2010, MOL REPROD DEV, V77, P954, DOI 10.1002/mrd.21243; Ideta A, 2010, ANIM REPROD SCI, V117, P18, DOI 10.1016/j.anireprosci.2009.04.004; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Licht P, 2003, FERTIL STERIL, V79, P718, DOI 10.1016/S0015-0282(02)04822-7; LIN J, 1995, MOL CELL ENDOCRINOL, V111, pR13, DOI 10.1016/0303-7207(95)03565-O; LOPATA A, 1993, HUM REPROD, V8, P932, DOI 10.1093/oxfordjournals.humrep.a138170; Nakayama T, 2002, HUM REPROD, V17, P207, DOI 10.1093/humrep/17.1.207; Nissi R, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-2; Okitsu O, 2011, J REPROD IMMUNOL, V92, P82, DOI 10.1016/j.jri.2011.07.001; Onogi A, 2011, PLACENTA, V32, P665, DOI 10.1016/j.placenta.2011.06.023; Seval Y, 2004, ACTA HISTOCHEM, V106, P353, DOI 10.1016/j.acthis.2004.07.005; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Trew A J, 2000, Early Pregnancy, V4, P176; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Welter H, 2003, EXP CLIN ENDOCR DIAB, V111, P33, DOI 10.1055/s-2003-37498; Winther H, 2001, PLACENTA, V22, P457, DOI 10.1053/plac.2001.0655; Wulff C, 2002, BIOL REPROD, V66, P802, DOI 10.1095/biolreprod66.3.802; Xu P, 2000, BIOL REPROD, V62, P988, DOI 10.1095/biolreprod62.4.988; Yoshinaga K, 2008, SEMIN CELL DEV BIOL, V19, P161, DOI 10.1016/j.semcdb.2007.10.006; Yoshioka S, 2006, HUM REPROD, V21, P3290, DOI 10.1093/humrep/del312; Yu N, 2014, AM J REPROD IMMUNOL, V71, P24, DOI 10.1111/aji.12150	41	22	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0125589	10.1371/journal.pone.0125589	http://dx.doi.org/10.1371/journal.pone.0125589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087261	gold, Green Submitted, Green Published			2022-12-26	WOS:000356567500006
J	Ananphongmanee, V; Srisala, J; Sritunyalucksana, K; Boonchird, C				Ananphongmanee, Vorawit; Srisala, Jiraporn; Sritunyalucksana, Kallaya; Boonchird, Chuenchit			Yeast Surface Display of Two Proteins Previously Shown to Be Protective Against White Spot Syndrome Virus (WSSV) in Shrimp	PLOS ONE			English	Article							MAJOR ENVELOPE PROTEINS; PENAEUS-MONODON; PROCAMBARUS-CLARKII; CELLS; CONSTRUCTION; EXPRESSION; VACCINE; SYSTEM; IDENTIFICATION; RESISTANCE	Cell surface display using the yeasts Saccharomyces cerevisiae and Pichia pastoris has been extensively developed for application in bioindustrial processes. Due to the rigid structure of their cell walls, a number of proteins have been successfully displayed on their cell surfaces. It was previously reported that the viral binding protein Rab7 from the giant tiger shrimp Penaeus monodon (PmRab7) and its binding partner envelope protein VP28 of white spot syndrome virus (WSSV) could independently protect shrimp against WSSV infection. Thus, we aimed to display these two proteins independently on the cell surfaces of 2 yeast clones with the ultimate goal of using a mixture of the two clones as an orally deliverable, antiviral agent to protect shrimp against WSSV infection. PmRab7 and VP28 were modified by N-terminal tagging to the C-terminal half of S. cerevisiae alpha-agglutinin. DNA fragments, harboring fused-gene expression cassettes under control of an alcohol oxidase I (AOX1) promoter were constructed and used to transform the yeast cells. Immunofluorescence microscopy with antibodies specific to both proteins demonstrated that mutated PmRab7 (mPmRab7) and partial VP28 (pVP28) were localized on the cell surfaces of the respective clones, and fluorescence intensity for each was significantly higher than that of control cells by flow cytometry. Enzyme-linked immunosorbant assay (ELISA) using cells displaying mPmRab7 or pVP28 revealed that the binding of specific antibodies for each was dose-dependent, and could be saturated. In addition, the binding of mPmRab7-expressing cells with free VP28, and vice versa was dose dependent. Binding between the two surface-expressed proteins was confirmed by an assay showing agglutination between cells expressing complementary mPmRab7 and pVP28. In summary, our genetically engineered P. pastoris can display biologically active mPmRab7 and pVP28 and is now ready for evaluation of efficacy in protecting shrimp against WSSV by oral administration.	[Ananphongmanee, Vorawit; Sritunyalucksana, Kallaya; Boonchird, Chuenchit] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Srisala, Jiraporn; Sritunyalucksana, Kallaya] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Shrimp Virus Interact Lab ASVI, Bangkok, Thailand; [Srisala, Jiraporn; Sritunyalucksana, Kallaya] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol, Bangkok 10400, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Boonchird, C (corresponding author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand.	chuenchit.boo@mahidol.ac.th	Ananphongmanee, Vorawit/AAO-3650-2020		Institutional Strengthening Program and Central Instrument Facility Grant; Faculty of Science, Mahidol University; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative	Institutional Strengthening Program and Central Instrument Facility Grant; Faculty of Science, Mahidol University; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative	This work was partially supported by Institutional Strengthening Program and Central Instrument Facility Grant, Faculty of Science, Mahidol University, as well as the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akramiene D, 2007, MEDICINA-LITHUANIA, V43, P597, DOI 10.3390/medicina43080076; BOONYARATPALIN S, 1993, FISH PATHOL, V28, P103, DOI 10.3147/jsfp.28.103; Calero M, 2003, MOL BIOL CELL, V14, P1852, DOI 10.1091/mbc.E02-11-0707; Chang YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010718; CHANTANACHOOKIN C, 1993, DIS AQUAT ORGAN, V17, P145, DOI 10.3354/dao017145; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; Du HH, 2013, FISH SHELLFISH IMMUN, V34, P332, DOI 10.1016/j.fsi.2012.11.007; Du HH, 2006, AQUACULTURE, V260, P39, DOI 10.1016/j.aquaculture.2006.06.032; Harnpicharnchai P, 2010, FEMS MICROBIOL LETT, V302, P8, DOI 10.1111/j.1574-6968.2009.01811.x; Huang R, 2005, J GEN VIROL, V86, P1357, DOI 10.1099/vir.0.80923-0; Invitrogen&TRADE; Life Technologies Corporation, 2000, PICH EXPR KIT MAN ME; Jha RK, 2007, FISH SHELLFISH IMMUN, V22, P295, DOI 10.1016/j.fsi.2006.04.006; Jin Z, 2012, J BIOTECHNOL, V159, P108, DOI 10.1016/j.jbiotec.2012.02.013; Jo JH, 2011, BIOTECHNOL LETT, V33, P1113, DOI 10.1007/s10529-011-0536-5; Kim CS, 2007, FISH SHELLFISH IMMUN, V23, P242, DOI 10.1016/j.fsi.2006.10.012; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kondo A, 2004, APPL MICROBIOL BIOT, V64, P28, DOI 10.1007/s00253-003-1492-3; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Liu QH, 2009, LETT APPL MICROBIOL, V48, P44, DOI 10.1111/j.1472-765X.2008.02482.x; Lo CF, 2012, VIRUS TAXONOMY CLASS, P229; Marks H, 2003, J GEN VIROL, V84, P1517, DOI 10.1099/vir.0.19018-0; Mergler M, 2004, APPL MICROBIOL BIOT, V63, P418, DOI 10.1007/s00253-003-1361-0; Nakamura Y, 2001, APPL MICROBIOL BIOT, V57, P500; Namikoshi A, 2004, AQUACULTURE, V229, P25, DOI 10.1016/S0044-8486(03)00363-6; Pierini R, 2009, SEMIN CELL DEV BIOL, V20, P828, DOI 10.1016/j.semcdb.2009.03.015; Rios-Hernandez M, 1994, Arch Med Res, V25, P179; Russell D., 2001, ENDOCYTOSIS PATHOG E, P247; Sakuragi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/416931; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Shibata Y, 1997, J IMMUNOL, V159, P2462; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Sritunyalucksana K, 2012, FISH SHELLFISH IMMUN, V33, P1269, DOI 10.1016/j.fsi.2012.09.017; Stubbs AC, 2001, NAT MED, V7, P625, DOI 10.1038/87974; Su GD, 2010, BIOTECHNOL LETT, V32, P1131, DOI 10.1007/s10529-010-0270-4; Su GD, 2010, APPL MICROBIOL BIOT, V86, P1493, DOI 10.1007/s00253-009-2382-0; Sun PN, 2010, BIOTECHNOL PROGR, V26, P968, DOI 10.1002/btpr.413; Tamaru Y, 2006, BIOTECHNOL PROGR, V22, P949, DOI 10.1021/bp060130x; Tanaka T, 2012, APPL MICROBIOL BIOT, V95, P577, DOI 10.1007/s00253-012-4175-0; Tang XH, 2007, ACTA CRYSTALLOGR F, V63, P624, DOI 10.1107/S1744309107029351; Tang YQ, 2008, APPL MICROBIOL BIOT, V79, P1019, DOI 10.1007/s00253-008-1509-z; Thammasorn T, 2013, ANTIVIR RES, V100, P202, DOI 10.1016/j.antiviral.2013.08.005; Toda S, 1997, IMMUNOLOGY, V92, P111, DOI 10.1046/j.1365-2567.1997.00307.x; Tsai JM, 2006, J VIROL, V80, P3021, DOI 10.1128/JVI.80.6.3021-3029.2006; Tsai MF, 2000, VIROLOGY, V277, P92, DOI 10.1006/viro.2000.0596; Vallejo JA, 2013, APPL MICROBIOL BIOT, V97, P2305, DOI 10.1007/s00253-013-4735-y; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; van Hulten MCW, 2000, VIROLOGY, V266, P227, DOI 10.1006/viro.1999.0088; Verma AK, 2013, J MOL MODEL, V19, P1285, DOI 10.1007/s00894-012-1672-0; Wang QJ, 2007, BIOTECHNOL LETT, V29, P1561, DOI 10.1007/s10529-007-9430-6; Wasilenko JL, 2010, BIOTECHNOL PROGR, V26, P542, DOI 10.1002/btpr.343; WILLIAMS DL, 1992, CARBOHYD RES, V235, P247, DOI 10.1016/0008-6215(92)80093-G; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; WONGTEERASUPAYA C, 1995, DIS AQUAT ORGAN, V21, P69, DOI 10.3354/dao021069; Zhou Q, 2009, J VIROL, V83, P4709, DOI 10.1128/JVI.02360-08; Zhu KL, 2006, VACCINE, V24, P6046, DOI 10.1016/j.vaccine.2006.05.043	58	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128764	10.1371/journal.pone.0128764	http://dx.doi.org/10.1371/journal.pone.0128764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083446	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400066
J	Chen, YH; Chiang, MH; Liu, JS; Chang, YK; Kuo, KL; Hung, SC; Tai, HL; Hsu, CC; Tarng, DC				Chen, Yu-Hsin; Chiang, Ming-Han; Liu, Jia-Sin; Chang, Yu-Kang; Kuo, Ko-Lin; Hung, Szu-Chun; Tai, Hsin-Ling; Hsu, Chih-Cheng; Tarng, Der-Cherng			Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study	PLOS ONE			English	Article							PIOGLITAZONE CLINICAL-TRIAL; MACROVASCULAR EVENTS; RENAL-FUNCTION; TYPE-2; ROSIGLITAZONE; ASSOCIATION; DECLINE	Thiazolidinediones (TZDs) reduce urinary albumin excretion and proteinuria in diabetic nephropathy. The effect of TZDs on hard renal outcome in diabetic patients with chronic kidney disease (CKD) is unknown. We investigate the association of TZDs and risk of long-term dialysis or death in diabetic patients with advanced CKD. The nationwide population-based cohort study was conducted using Taiwan's National Health Insurance Research Database. From January 2000 to June 2009, 12350 diabetic patients with advanced CKD (serum creatinine levels greater than 6 mg/dL but not yet receiving renal replacement therapy) were selected for the study. We used multivariable Cox regression models and a propensity score-based matching technique to estimate hazard ratios (HRs) for development of long-term dialysis and the composite outcome of long-term dialysis or death for TZD users (n=1224) as compared to nonusers (n=11126). During a median follow-up of 6 months, 8270 (67.0%) patients required long-term dialysis and 2593 (21.0%) patients died before starting long-term dialysis. Using propensity score matched analysis, we found TZD users were associated with a lower risk for long-term dialysis (HR, 0.80; 95% confidence interval [CI], 0.74-0.86) and the composite outcome of long-term dialysis or death (HR, 0.85; 95% CI, 0.80-0.91). The results were consistent across most patient subgroups. Use of TZDs among diabetic patients with advanced CKD was associated with lower risk for progression to end-stage renal disease necessitating long-term dialysis or death. Further randomized controlled studies are required to validate this association.	[Chen, Yu-Hsin] Taipei City Hosp, Dept Internal Med, Div Nephrol, Yang Ming Branch, Taipei, Taiwan; [Chen, Yu-Hsin] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chiang, Ming-Han; Liu, Jia-Sin; Chang, Yu-Kang; Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Kuo, Ko-Lin; Hung, Szu-Chun] Taipei Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Div Nephrol, Taipei, Taiwan; [Tai, Hsin-Ling] Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan; [Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; China Medical University Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hsu, CC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan.	cch@nhri.org.tw; dctarng@vghtpe.gov.tw		Kuo, Ko-Lin/0000-0002-7477-0388	National Science Council [NSC 102-2314-B-010-004-MY3, NSC 102-2314-B-303-003]; Taipei Veterans General Hospital [V102C129, V103C-024]; Foundation for Poison Control; Ministry of Education Aim for the Top University Plan in Taiwan; National Health Research Institutes [NHRI PH-104-SP08-018]; Ministry of Health and Welfare [04D9-PHBHP01]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Foundation for Poison Control; Ministry of Education Aim for the Top University Plan in Taiwan; National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part to Dr. DC Tarng by grants from the National Science Council (NSC 102-2314-B-010-004-MY3; NSC 102-2314-B-303-003), Taipei Veterans General Hospital (V102C129; V103C-024), Foundation for Poison Control, and Ministry of Education Aim for the Top University Plan in Taiwan; and to Dr. CC Hsu by grants from the National Health Research Institutes (NHRI PH-104-SP08-018), and Ministry of Health and Welfare (04D9-PHBHP01). The funders had no involvement in the study design, data collection, data analysis, manuscript preparation, and/or publication decisions.	Bolignano D, 2012, NUTR METAB CARDIOVAS, V22, P167, DOI 10.1016/j.numecd.2011.11.005; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Erdmann E, 2007, J AM COLL CARDIOL, V49, P1772, DOI 10.1016/j.jacc.2006.12.048; Feldman L, 2010, J NEPHROL, V23, P350; Guan YF, 2001, AM J PHYSIOL-RENAL, V281, pF1036, DOI 10.1152/ajprenal.0025.2001; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Iezzoni LI, 1997, RISK ADJUSTMENT MEAS; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kim Mee Kyoung, 2009, Korean Journal of Internal Medicine, V24, P227, DOI 10.3904/kjim.2009.24.3.227; Sarafidis PA, 2006, KIDNEY INT, V70, P1223, DOI 10.1038/sj.ki.5001620; Sarafidis PA, 2010, AM J KIDNEY DIS, V55, P835, DOI 10.1053/j.ajkd.2009.11.013; Schneider CA, 2008, J AM SOC NEPHROL, V19, P182, DOI 10.1681/ASN.2007060678; United States Renal Data System, 2014 INT COMP; United States Renal Data System, 2013 ANN DAT REP; Whelton A., 1999, AM J MED, V106, p13S, DOI [10.1016/s0002-9343(99)00113-8, DOI 10.1016/S0002-9343(99)00113-8]; Wilcox R, 2007, STROKE, V38, P865, DOI 10.1161/01.STR.0000257974.06317.49; Zheng F, 2002, AM J PHYSIOL-RENAL, V282, pF639, DOI 10.1152/ajprenal.00189.2001; Zoccali C, 2009, CLIN J AM SOC NEPHRO, V4, pS18, DOI 10.2215/CJN.05210709	20	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129922	10.1371/journal.pone.0129922	http://dx.doi.org/10.1371/journal.pone.0129922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083376	gold, Green Submitted, Green Published			2022-12-26	WOS:000356567400114
J	Gao, XY; Liang, H; Hou, F; Zhang, ZP; Nuo, MT; Guo, XD; Liu, DJ				Gao, Xiaoyu; Liang, Hao; Hou, Fang; Zhang, Zhipeng; Nuo, Mingtu; Guo, Xudong; Liu, Dongjun			Thymosin Beta-4 Induces Mouse Hair Growth	PLOS ONE			English	Article							PROMOTES; ACTIVATION; CELLS; VEGF; MIGRATION; PROLIFERATION; METASTASIS; EXPRESSION; PEPTIDE; PROTEIN	Thymosin beta-4 (T beta 4) is known to induce hair growth and hair follicle (HF) development; however, its mechanism of action is unknown. We generated mice that overexpressed T beta 4 in the epidermis, as well as T beta 4 global knockout mice, to study the role of T beta 4 in HF development and explore the mechanism of T beta 4 on hair growth. To study T beta 4 function, we depilated control and experimental mice and made tissue sections stained with hematoxylin and eosin (H&E). To explore the effect of T beta 4 on hair growth and HF development, the mRNA and protein levels of T beta 4 and VEGF were detected by real-time PCR and western blotting in control and experimental mice. Protein expression levels and the phosphorylation of P38, ERK and AKT were also examined by western blotting. The results of depilation indicated that hair re-growth was faster in T beta 4-overexpressing mice, but slower in knockout mice. Histological examination revealed that T beta 4-overexpressing mice had a higher number of hair shafts and HFs clustered together to form groups, while the HFs of control mice and knockout mice were separate. Hair shafts in knockout mice were significantly reduced in number compared with control mice. Increased T beta 4 expression at the mRNA and protein levels was confirmed in T beta 4-overexpressing mice, which also had increased VEGF expression. On the other hand, knockout mice had reduced levels of VEGF expression. Mechanistically, T beta 4-overexpressing mice showed increased protein expression levels and phosphorylation of P38, ERK and AKT, whereas knockout mice had decreased levels of both expression and phosphorylation of these proteins. T beta 4 appears to regulate P38/ERK/AKT signaling via its effect on VEGF expression, with a resultant effect on the speed of hair growth, the pattern of HFs and the number of hair shafts.	[Gao, Xiaoyu; Liang, Hao; Hou, Fang; Zhang, Zhipeng; Nuo, Mingtu; Guo, Xudong; Liu, Dongjun] Inner Mongolia Univ, Natl Res Ctr Anim Transgen Biotechnol, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia University	Guo, XD (corresponding author), Inner Mongolia Univ, Natl Res Ctr Anim Transgen Biotechnol, Hohhot, Inner Mongolia, Peoples R China.	xudguo@163.com; nmliudongjun@sina.com		ming tu, nuo/0000-0002-4752-9038; gao, xiaoyu/0000-0001-5003-5058	National Natural Science Foundation of China [31160228]; National High Technology Research and Development Program of China (863 Program) [2013AA102506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Program of National Natural Science Foundation of China (Grant No. 31160228) and The National High Technology Research and Development Program of China (863 Program)(Grant No. 2013AA102506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2013, CIRC RES, V112, pE25, DOI 10.1161/CIRCRESAHA.111.300197; Banerjee I, 2012, CIRC RES, V110, P456, DOI 10.1161/CIRCRESAHA.111.258616; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Cha HJ, 2010, INT J DEV BIOL, V54, P135, DOI 10.1387/ijdb.082735hc; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gensure RC, 2014, EXP DERMATOL, V23, P865, DOI 10.1111/exd.12504; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Kang F, 1999, J BIOL CHEM, V274, P36963, DOI 10.1074/jbc.274.52.36963; Kang YJ, 2011, VET PARASITOL, V181, P222, DOI 10.1016/j.vetpar.2011.03.058; Kwon OS, 2007, J KOREAN MED SCI, V22, P283, DOI 10.3346/jkms.2007.22.2.283; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Leung K, 2004, CY5 5 CHITOSAN ANTIV; Li W, 2012, EXP CELL RES, V318, P1633, DOI 10.1016/j.yexcr.2012.05.003; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; Moon EY, 2007, ONCOL RES, V16, P507, DOI 10.3727/096504007783438349; Ock MS, 2013, INT J MOL SCI, V14, P23492, DOI 10.3390/ijms141223492; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Park GH, 2015, J MED FOOD, V18, P354, DOI 10.1089/jmf.2013.3031; PAUS R, 1994, J INVEST DERMATOL, V103, P143, DOI 10.1111/1523-1747.ep12392542; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Philp D, 2004, MECH AGEING DEV, V125, P113, DOI 10.1016/j.mad.2003.11.005; Philp D, 2007, ANN NY ACAD SCI, V1112, P95, DOI 10.1196/annals.1415.009; SAFER D, 1991, J BIOL CHEM, V266, P4029; Shuxia Y, 1999, CHINESE J DERMATOL, V32, P252; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sun W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068840; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Viac J, 1997, ARCH DERMATOL RES, V289, P158, DOI 10.1007/s004030050172; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Wu XJ, 2014, J DERMATOL SCI, V73, P152, DOI 10.1016/j.jdermsci.2013.10.002; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317	35	13	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130040	10.1371/journal.pone.0130040	http://dx.doi.org/10.1371/journal.pone.0130040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083021	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400121
J	Gois, F; Ruiz, LRG; Scillato-Yane, GJ; Soibelzon, E				Gois, Flavio; Gonzalez Ruiz, Laureano Raul; Juan Scillato-Yane, Gustavo; Soibelzon, Esteban			A Peculiar New Pampatheriidae (Mammalia: Xenarthra: Cingulata) from the Pleistocene of Argentina and Comments on Pampatheriidae Diversity	PLOS ONE			English	Article							MIDDLE PLEISTOCENE; ITABORAI BASIN; GLYPTODONTIDAE; EVOLUTION; AMEGHINO; MIOCENE; REDESCRIPTION; PALEOCENE	Pampatheriidae are a group of cingulates native to South American that are known from the middle Miocene to the lower Holocene. Two genera have been recognized between the lower Pleistocene and the lower Holocene: Pampatherium Gervais and Ameghino (Ensenadan, Bonaerian and Lujanian, lower Pleistocene-lower Holocene) and Holmesina Simpson (Blancan, Irvingtonian, upper Pliocene-lower Holocene). They have been mainly differentiated by their osteoderm morphology and cranio-dental characters. These taxa had a wide latitudinal distribution, extending from the southern part of South America (Peninsula Valdes, Argentina) to North America (Florida, USA). In this contribution, we describe a new genus and species of Pampatheriidae for the lower and middle Pleistocene of Buenos Aires Province and for the upper Pleistocene of Santa Fe Province (Argentina). The new taxon is represented by disarticulated osteoderms, one skull element, two thoracic vertebrae and a right femur and patella. It has extremely complex osteoderm ornamentations and particular morphological characters of the cranial element and femur that are not found in any other species of the family. This new taxon, recorded in the lower-middle Pleistocene (Ensenadan Stage/Age) and in the upper Pleistocene-early Holocene (Lujanian Stage/Age), is incorporated to the Pleistocene mammal assemblage of South America. Finally, the Pampatheriidae diversity is greater during the Lujanian Stage/Age than the Ensenadan Stage/Age.	[Gois, Flavio] Consejo Nacl Invest Cient & Tecn, CICYTTP, Lab Paleontol Vertebrados, RA-3105 Diamante, Entre Rios, Argentina; [Gonzalez Ruiz, Laureano Raul] Univ Nacl Patagonia San Juan Bosco Sede Esquel UN, Lab Invest Evoluc & Biodiversid, RA-9200 Esquel, Chubut, Argentina; [Juan Scillato-Yane, Gustavo; Soibelzon, Esteban] Museo La Plata, Div Paleontol Vertebrados, RA-1900 La Plata, Buenos Aires, Argentina; [Gois, Flavio; Gonzalez Ruiz, Laureano Raul; Juan Scillato-Yane, Gustavo; Soibelzon, Esteban] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gois, F (corresponding author), Consejo Nacl Invest Cient & Tecn, CICYTTP, Lab Paleontol Vertebrados, RA-3105 Diamante, Entre Rios, Argentina.	flaviogois@gmail.com						ABRANTES EAL, 2006, PALEONTOLOGIA VERTEB, P261; Ameghino F., 1889, ACTAS ACAD NACL CIEN, V6; Bergqvist LP, 2004, GEODIVERSITAS, V26, P323; Bordas A. F., 1939, Physis Buenos Aires, V14, P447; BURMEISTER H, 1866, Z GESAMMTEN NATURWIS, V28, P138, DOI DOI 10.1107/S0108767309007235; Carlini A.A., 1993, J VERTEBR PALEONTOL, V3, p28A; Carlini AA, 1999, QUATERNARY SOUTH AM, V12, P149; CARLINI AA, 2002, 1 C LAT PAL VERT RES, P23; Carlini AA, 2004, INSUGEO MISCELANEAS, V12, P5; Carlini Alfredo A., 2010, P106; Cartelle C., 1984, REV BRAS ZOOL, V2, P229; Castellanos A., 1937, Publ Univ nac Santa Fe, Vno. 8, P1; Castellanos A, 1927, PUBLICACION CTR ESTU, P1; Castro MC, 2013, J VERTEBR PALEONTOL, V33, P434, DOI 10.1080/02724634.2013.729961; CIFELLI R, 1983, American Museum Novitates, P1; Cione A.L., 2005, GEOLOG A RECURSOS MI, P183; Cione AL, 1999, QUATERNARY SOUTH AM, V12, P23; Cione Alberto L., 2001, Bollettino della Societa Paleontologica Italiana, V40, P167; Couto Paula., 1979, TRATADO PALEOMASTOZO; Croft DA, 2007, J VERTEBR PALEONTOL, V27, P781, DOI 10.1671/0272-4634(2007)27[781:ANBGAO]2.0.CO;2; De Esteban-Trivigno S., 2010, AMEGHINIANA, V48, P189, DOI DOI 10.5710/AMGH.V48I2(313); De Esteban-Trivigno S, 2011, AMEGHINIANA, V48, P381; De Iuliis G, 2002, SM C PALEOB, P49; Edmund A.G., 1985, PEARCE SELLARDS SERI, V40, P1; Edmund A.G., 1997, VERTEBRATE PALEONTOL, P227; Edmund AG, 1987, PEARCE SELLARDS SERI, V45, P1; Edmund G., 1985, P83; Zurita AE, 2009, GEOBIOS-LYON, V42, P663, DOI 10.1016/j.geobios.2009.03.003; Engelmann G.F., 1985, P51; Fernicola JC, 2012, J MAMM EVOL, V19, P171, DOI 10.1007/s10914-012-9186-1; Fernicola JC, 2008, AMEGHINIANA, V45, P553; Gaudin Timothy J., 2006, P153; Gaudin Timothy J., 1999, Fieldiana Geology, V41, P1; Gois F, 2012, ARGENTINA AMEGHINIAN, V49, pR30, DOI [10.1186/gb-2012-13-4-r30, DOI 10.1186/GB-2012-13-4-R30]; Gois F, 2013, THESIS U NACL LA PLA; Gois F, 2013, 8 C LAT PAL 13 C MEX, P51; Gois F, 2013, ALCHERINGA, V37, P177, DOI 10.1080/03115518.2013.733510; Gois F, 2012, REV BRAS PALEONTOLOG, V15, P211, DOI 10.4072/rbp.2012.2.09; Gonzalez Ruiz LR, 2013, REV BRAS PALEONTOLOG, V16, P319; Hoffstetter R., 1958, TRAITE PALEONTOL, V6(2), P535; Hoffstetter R., 1956, ANN PALEONTOL, V42, P535; JAMES GT, 1957, J PALEONTOL, V31, P796; Lahille F, 1895, ANALES MUSEO LA PLAT, Vll; Lydekker R., 1887, CATALOGUE FOSSIL MAM, P345; McKenna MC, 1997, CLASSIFICATION MAMMA; Noriega Jorge I., 2004, Instituto Superior de Correlacion Geologica (INSUGEO) Miscelanea, V12, P71; Oliveira EV, 1998, ASOC PAL ARGENT PUBL, P35; Patterson B., 1989, CINGULATES FIELDIANA, V18, P1; Perea D, 2005, AMEGHINIANA, V42, P175; PRADO J L, 1987, Ameghiniana, V24, P217; Prado JL, 2001, ACTA PALAEONTOL POL, V46, P261; Quinteros RB, 2004, AMEGHINIANA, V41, P641; Rinderknecht A, 2000, AMEGHINIANA, V37, P369; Robertson J.S., 1976, Bulletin Fla St Mus biol Sci, V20, P111; Salas-Gismondi R, 2011, AMEGHINIANA, V48, pR127; Scillato-Yane G.J., 1978, ACT 2 C ARG PAL BIOE, V3, P7; Scillato-Yane GJ, 2005, J S AM EARTH SCI, V20, P131, DOI 10.1016/j.jsames.2005.06.012; Scillato-Yane GJ, 1982, THESSI U NACL LA PLA; ScillatoYane G.J., 1986, 4 C ARG PAL BIOESTR, V2, P151; SCILLATOYANE GJ, 1976, AN ACAD BRAS CIENC, V48, P527; Simpson G.G., 1930, AM MUS NOVIT, V422, P1; SIMPSON GEORGE GAYLORD, 1948, BULL AMER MUS NAT HIST, V91, P1; Soibelzon E, 2006, AMEGHINIANA, V43, P377; Soibelzon E, 2010, REV MEX CIENC GEOL, V27, P449; Soibelzon Esteban, 2009, Current Research in the Pleistocene, V26, P175; Soibelzon Esteban, 2008, Rev. Asoc. Geol. Argent., V63, P421; Tauber AA, 2000, REPUBLICA ARGENTINA, V64, P336; Tejedor MF, 2009, AM MUS NOVIT, P1, DOI 10.1206/577.1; Tonni EP, 1999, PALAEOGEOGR PALAEOCL, V147, P257, DOI 10.1016/S0031-0182(98)00140-0; Verzi DH, 2004, PALAEOGEOGR PALAEOCL, V212, P315, DOI 10.1016/j.palaeo.2004.06.010; Vizcaino SF, 2009, PALEOBIOLOGY, V35, P343, DOI 10.1666/0094-8373-35.3.343; Wible JR, 2004, ANN CARNEGIE MUS, V73, P260; Woodburne MO, 2014, J MAMM EVOL, V21, P1, DOI 10.1007/s10914-012-9222-1; Zamorano M, 2013, ALCHERINGA, V37, P442, DOI 10.1080/03115518.2013.770224; Zurita AE, 2013, J VERTEBR PALEONTOL, V33, P696, DOI 10.1080/02724634.2013.726677	75	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128296	10.1371/journal.pone.0128296	http://dx.doi.org/10.1371/journal.pone.0128296			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083486	Green Published, gold			2022-12-26	WOS:000356567400037
J	Marton, L; Nagy, GN; Ozohanics, O; Labas, A; Kramos, B; Olah, J; Vekey, K; Vertessy, BG				Marton, Livia; Nagy, Gergely N.; Ozohanics, Oliver; Labas, Aniko; Kramos, Balazs; Olah, Julianna; Vekey, Karoly; Vertessy, Beata G.			Molecular Mechanism for the Thermo-Sensitive Phenotype of CHO-MT58 Cell Line Harbouring a Mutant CTP:Phosphocholine Cytidylyltransferase	PLOS ONE			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; HAMSTER OVARY CELLS; PROTEIN STRUCTURES; PHOSPHATIDYLCHOLINE SYNTHESIS; MEMBRANE-BINDING; FORCE-FIELD; ALPHA; APOPTOSIS; DOMAINS; SIMULATIONS	Control and elimination of malaria still represents a major public health challenge. Emerging parasite resistance to current therapies urges development of antimalarials with novel mechanism of action. Phospholipid biosynthesis of the Plasmodium parasite has been validated as promising candidate antimalarial target. The most prevalent de novo pathway for synthesis of phosphatidylcholine is the Kennedy pathway. Its regulatory and often also rate limiting step is catalyzed by CTP:phosphocholine cytidylyltransferase (CCT). The CHO-MT58 cell line expresses a mutant variant of CCT, and displays a thermo-sensitive phenotype. At non-permissive temperature (40 degrees C), the endogenous CCT activity decreases dramatically, blocking membrane synthesis and ultimately leading to apoptosis. In the present study we investigated the impact of the analogous mutation in a catalytic domain construct of Plasmodium falciparum CCT in order to explore the underlying molecular mechanism that explains this phenotype. We used temperature dependent enzyme activity measurements and modeling to investigate the functionality of the mutant enzyme. Furthermore, MS measurements were performed to determine the oligomerization state of the protein, and MD simulations to assess the inter-subunit interactions in the dimer. Our results demonstrate that the R681H mutation does not directly influence enzyme catalytic activity. Instead, it provokes increased heat-sensitivity by destabilizing the CCT dimer. This can possibly explain the significance of the PfCCT pseudoheterodimer organization in ensuring proper enzymatic function. This also provide an explanation for the observed thermo-sensitive phenotype of CHO-MT58 cell line.	[Marton, Livia; Nagy, Gergely N.; Vertessy, Beata G.] HAS, Natl Ctr Sci Res, Inst Enzymol, Budapest, Hungary; [Marton, Livia] Univ Szeged, Doctoral Sch Multidisciplinary Med Sci, Szeged, Hungary; [Nagy, Gergely N.; Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Budapest, Hungary; [Ozohanics, Oliver; Vekey, Karoly] HAS, Natl Ctr Sci Res, Inst Organ Chem, Budapest, Hungary; [Labas, Aniko; Kramos, Balazs; Olah, Julianna] Budapest Univ Technol & Econ, Dept Inorgan & Analyt Chem, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Szeged University; Budapest University of Technology & Economics; Hungarian Academy of Sciences; Budapest University of Technology & Economics	Marton, L (corresponding author), HAS, Natl Ctr Sci Res, Inst Enzymol, Budapest, Hungary.	marton.livia@ttk.mta.hu; vertessy@mail.bme.hu	Nagy, Gergely/O-1143-2017; Ozohanics, Oliver/AAH-4449-2019; Vertessy, Beata G/H-6202-2012; Olah, Julianna/E-5941-2011	Nagy, Gergely/0000-0003-1761-5610; Ozohanics, Oliver/0000-0002-2705-9921; Olah, Julianna/0000-0003-4608-3115; Vertessy, Beata G./0000-0002-1288-2982	Hungarian Scientific Research Fund [OTKA NK 84008, OTKA K109486]; Intramural Grant Support [ICGEB CRP/HUN14-01]; European Commission FP7 Biostruct X-project [283570]; Hungarian Academy of Sciences [TTKIF-28/2012]; Pro Progressio Foundation; European Union; State of Hungary; European Social Fund in the framework of 'National Excellence Program' [TAMOP 4.2.4.A/2-11-1-2012-0001]; Bolyai Janos Research Fellowship; Richter Gedeon Talentum Foundation	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Intramural Grant Support; European Commission FP7 Biostruct X-project; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Pro Progressio Foundation; European Union(European Commission); State of Hungary; European Social Fund in the framework of 'National Excellence Program'; Bolyai Janos Research Fellowship(Hungarian Academy of Sciences); Richter Gedeon Talentum Foundation	Hungarian Scientific Research Fund (OTKA NK 84008, OTKA K109486), the Intramural Grant Support, ICGEB CRP/HUN14-01, European Commission FP7 Biostruct X-project (Contract No 283570), and Hungarian Academy of Sciences TTKIF-28/2012 for BGV. GNN was supported by the Pro Progressio Foundation. This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 'National Excellence Program' for LM. JO acknowledges the financial support of a Bolyai Janos Research Fellowship. AL acknowledges the financial support of Richter Gedeon Talentum Foundation.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Aravind L, 2002, PROTEINS, V48, P1, DOI 10.1002/prot.10064; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Beluzic R, 2006, BIOCHEM J, V400, P245, DOI 10.1042/BJ20060749; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; CORNELL R, 1989, J BIOL CHEM, V264, P9077; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Dechamps S, 2010, MOL BIOCHEM PARASIT, V173, P69, DOI 10.1016/j.molbiopara.2010.05.006; Ding ZW, 2012, J BIOL CHEM, V287, P38980, DOI 10.1074/jbc.M112.402081; ESKO JD, 1980, P NATL ACAD SCI-BIOL, V77, P5192, DOI 10.1073/pnas.77.9.5192; ESKO JD, 1981, J BIOL CHEM, V256, P7388; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Larvor MP, 2003, BIOCHEM J, V375, P653, DOI 10.1042/BJ20031011; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lee J, 2014, J BIOL CHEM, V289, P1742, DOI 10.1074/jbc.M113.526970; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Marijani R, 2011, PHARM ANAL ACTA; Morton CC, 2013, J LIPID RES, V54, P3373, DOI 10.1194/jlr.M041434; Nagy GN, 2014, ANGEW CHEM INT EDIT, V53, P13471, DOI 10.1002/anie.201408246; Nagy GN, 2013, FEBS J, V280, P3132, DOI 10.1111/febs.12282; Niebergall LJ, 2012, BBA-MOL CELL BIOL L, V1821, P324, DOI 10.1016/j.bbalip.2011.10.018; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Park YS, 1997, J BIOL CHEM, V272, P15161, DOI 10.1074/jbc.272.24.15161; Pavlovic Z, 2014, GENE, V543, P58, DOI 10.1016/j.gene.2014.04.005; Payne F, 2014, P NATL ACAD SCI USA, V111, P8901, DOI 10.1073/pnas.1408523111; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sarri E, 2011, J BIOL CHEM, V286, P28632, DOI 10.1074/jbc.M111.267534; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; Takacs E, 2004, FEBS LETT, V566, P48, DOI 10.1016/j.febslet.2004.04.039; Tamura A, 1997, J MOL BIOL, V273, P1048, DOI 10.1006/jmbi.1997.1368; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Tian SQ, 2014, BIOCHEM BIOPH RES CO, V449, P26, DOI 10.1016/j.bbrc.2014.04.131; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; TSUKAGOSHI Y, 1987, EUR J BIOCHEM, V169, P477, DOI 10.1111/j.1432-1033.1987.tb13635.x; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Veitch DP, 1998, EUR J BIOCHEM, V255, P227, DOI 10.1046/j.1432-1327.1998.2550227.x; Vial HJ, 2004, P NATL ACAD SCI USA, V101, P15458, DOI 10.1073/pnas.0404037101; Visser BJ, 2014, EXPERT OPIN PHARMACO, V15, P2219, DOI 10.1517/14656566.2014.944499; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WANG YL, 1993, J BIOL CHEM, V268, P5899; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; Weber U, 2003, DEV CELL, V5, P559, DOI 10.1016/S1534-5807(03)00273-9; Wein S, 2012, BRIT J PHARMACOL, V166, P2263, DOI 10.1111/j.1476-5381.2012.01966.x; World Health Organization, 2014, MALARIA, DOI [10.1007/s00108-013-3390-9, DOI 10.1007/S00108-013-3390-9]; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Yeo HJ, 1997, BIOCHEM J, V324, P903, DOI 10.1042/bj3240903; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200	65	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129632	10.1371/journal.pone.0129632	http://dx.doi.org/10.1371/journal.pone.0129632			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083347	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000356567400103
J	Woolf, EC; Curley, KL; Liu, QW; Turner, GH; Charlton, JA; Preul, MC; Scheck, AC				Woolf, Eric C.; Curley, Kara L.; Liu, Qingwei; Turner, Gregory H.; Charlton, Julie A.; Preul, Mark C.; Scheck, Adrienne C.			The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model	PLOS ONE			English	Article							ANTIANGIOGENIC THERAPY; ENDOTHELIAL-CELLS; GLIOBLASTOMA; SURVIVAL; CANCER; GROWTH; PROMOTES; EDEMA; ANGIOPOIETIN-1; HYPERGLYCEMIA	Background The successful treatment of malignant gliomas remains a challenge despite the current standard of care, which consists of surgery, radiation and temozolomide. Advances in the survival of brain cancer patients require the design of new therapeutic approaches that take advantage of common phenotypes such as the altered metabolism found in cancer cells. It has therefore been postulated that the high-fat, low-carbohydrate, adequate protein ketogenic diet (KD) may be useful in the treatment of brain tumors. We have demonstrated that the KD enhances survival and potentiates standard therapy in a mouse model of malignant glioma, yet the mechanisms are not fully understood. Methods To explore the effects of the KD on various aspects of tumor growth and progression, we used the immunocompetent, syngeneic GL261-Luc2 mouse model of malignant glioma. Results Tumors from animals maintained on KD showed reduced expression of the hypoxia marker carbonic anhydrase 9, hypoxia inducible factor 1-alpha, and decreased activation of nuclear factor kappa B. Additionally, tumors from animals maintained on KD had reduced tumor microvasculature and decreased expression of vascular endothelial growth factor receptor 2, matrix metalloproteinase-2 and vimentin. Peritumoral edema was significantly reduced in animals fed the KD and protein analyses showed altered expression of zona occludens-1 and aquaporin-4. Conclusions The KD directly or indirectly alters the expression of several proteins involved in malignant progression and may be a useful tool for the treatment of gliomas.	[Woolf, Eric C.; Curley, Kara L.; Charlton, Julie A.; Scheck, Adrienne C.] St Josephs Hosp, Barrow Neurol Inst Dba, Barrow Brain Tumor Res Ctr, Neurooncol Res, Phoenix, AZ 85013 USA; [Woolf, Eric C.; Scheck, Adrienne C.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Liu, Qingwei; Turner, Gregory H.] St Josephs Hosp, Barrow Neurol Inst Dba, BNI ASU Ctr Preclin Imaging, Phoenix, AZ 85013 USA; [Preul, Mark C.; Scheck, Adrienne C.] St Josephs Hosp, Barrow Neurol Inst Dba, Neurosurg Res, Phoenix, AZ 85013 USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Downtown Phoenix; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Scheck, AC (corresponding author), St Josephs Hosp, Barrow Neurol Inst Dba, Barrow Brain Tumor Res Ctr, Neurooncol Res, Phoenix, AZ 85013 USA.	Adrienne.scheck@dignityhealth.org	Scheck, Adrienne/AAH-5040-2020	Scheck, Adrienne/0000-0003-3497-1895; Curley, Kara/0000-0001-5959-5932	Students Supporting Brain Tumor Research; Nutricia Advanced Medical Nutrition through Nutricia North America; Remi Savioz GLUT1 Foundation; KetoCal	Students Supporting Brain Tumor Research; Nutricia Advanced Medical Nutrition through Nutricia North America(Danone Nutricia); Remi Savioz GLUT1 Foundation; KetoCal	This work was supported by an unrestricted grant from Students Supporting Brain Tumor Research (www.ssbtr.org). The authors also received a grant-in-kind from Nutricia Advanced Medical Nutrition through Nutricia North America (http://nutrition.nutricia.com/), who provided KetoCal and the Remi Savioz GLUT1 Foundation (http://www.rsg1foundation.com/) who provided the blood analysis equipment. The funders had no role in data collection and analysis, decision to publish or preparation of the manuscript, or the study design. No additional external funding was received for this study.	Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Abdelwahab MG, 2011, JOVE-J VIS EXP, DOI 10.3791/3403; Azzi S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00211; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Carbonell WS, 2013, CANCER RES, V73, P3145, DOI 10.1158/0008-5472.CAN-13-0011; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Crocker M, 2011, NEURO-ONCOLOGY, V13, P99, DOI 10.1093/neuonc/noq170; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; Dai W, 2013, CLIN CANCER RES, V19, P5788, DOI 10.1158/1078-0432.CCR-13-1217; de Groot J., 2013, AM SOC CLIN ONCOL ED, V2013, P71, DOI DOI 10.1200/EDB00K_; Derr RL, 2009, J CLIN ONCOL, V27, P1082, DOI 10.1200/JCO.2008.19.1098; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Ishihara H, 2008, J NEUROPATH EXP NEUR, V67, P435, DOI 10.1097/NEN.0b013e31816fd622; Jahangiri A, 2014, CANCER RES, V74, P3, DOI 10.1158/0008-5472.CAN-13-1742; Jain R, 2011, ACAD RADIOL, V18, P955, DOI 10.1016/j.acra.2011.04.003; Jain RK, 2008, NAT REV CANCER, V8, P309, DOI 10.1038/nrc2346; Jiang YS, 2013, J NEURO-ONCOL, V114, P25, DOI 10.1007/s11060-013-1154-y; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kossoff Eric H, 2013, Biomed J, V36, P2, DOI 10.4103/2319-4170.107152; Li XR, 2012, TRENDS MOL MED, V18, P119, DOI 10.1016/j.molmed.2011.11.006; Liu D, 2010, ONCOTARGET, V1, P700; Lucio-Eterovic AK, 2009, CLIN CANCER RES, V15, P4589, DOI 10.1158/1078-0432.CCR-09-0575; Ma J, 2014, J CELL PHYSIOL, V229, P916, DOI 10.1002/jcp.24523; Machein MR, 2004, AM J PATHOL, V165, P1557, DOI 10.1016/S0002-9440(10)63413-X; Mayer A, 2014, STRAHLENTHER ONKOL, V190, P933, DOI 10.1007/s00066-014-0696-z; McGirt MJ, 2008, NEUROSURGERY, V63, P286, DOI 10.1227/01.NEU.0000315282.61035.48; Mulrooney TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018085; Myung JK, 2014, INT J CLIN EXP PATHO, V7, P1977; Navis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058262; Nogueira L, 2011, ONCOTARGET, V2, P646, DOI 10.18632/oncotarget.322; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Proescholdt MA, 2012, NEURO-ONCOLOGY, V14, P1357, DOI 10.1093/neuonc/nos216; Raghu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012458; Raghua H, 2012, MOL ONCOL, V6, P33, DOI 10.1016/j.molonc.2011.11.008; Reardon DA, 2012, J NEURO-ONCOL, V107, P213, DOI 10.1007/s11060-011-0740-0; Ribatti D, 2014, BBA-GEN SUBJECTS, V1840, P1550, DOI 10.1016/j.bbagen.2013.09.025; Rous P, 1914, J EXP MED, V20, P433, DOI 10.1084/jem.20.5.433; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Seyfried TN, 2014, CARCINOGENESIS, V35, P515, DOI 10.1093/carcin/bgt480; Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Urits I, 2012, J ONCOL, V2012, DOI 10.1155/2012/264039; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Woolf EC, 2015, J LIPID RES, V56, P5, DOI 10.1194/jlr.R046797; Woolf Eric C, 2012, CNS Oncol, V1, P7, DOI 10.2217/cns.12.9; Yang LJ, 2012, ONCOL REP, V28, P1633, DOI 10.3892/or.2012.1973; Yang LQ, 2012, EXP CELL RES, V318, P2417, DOI 10.1016/j.yexcr.2012.07.017; Zadeh G, 2005, NEOPLASIA, V7, P1081, DOI 10.1593/neo.05424; Zadeh G, 2004, J NEUROPATH EXP NEUR, V63, P978, DOI 10.1093/jnen/63.9.978; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5	57	68	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130357	10.1371/journal.pone.0130357	http://dx.doi.org/10.1371/journal.pone.0130357			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083629	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400139
J	Chowdhury, N; Sapru, S				Chowdhury, Nilotpal; Sapru, Shantanu			Association of Protein Translation and Extracellular Matrix Gene Sets with Breast Cancer Metastasis: Findings Uncovered on Analysis of Multiple Publicly Available Datasets Using Individual Patient Data Approach	PLOS ONE			English	Article							PROGNOSTIC SIGNATURE; MOLECULAR-MECHANISMS; EXPRESSION PROFILES; IMMUNE-RESPONSE; MICROARRAY DATA; SUBTYPES; IDENTIFICATION; CLASSIFICATION; RESOURCE; ONTOLOGY	Introduction Microarray analysis has revolutionized the role of genomic prognostication in breast cancer. However, most studies are single series studies, and suffer from methodological problems. We sought to use a meta-analytic approach in combining multiple publicly available datasets, while correcting for batch effects, to reach a more robust oncogenomic analysis. Aim The aim of the present study was to find gene sets associated with distant metastasis free survival (DMFS) in systemically untreated, node-negative breast cancer patients, from publicly available genomic microarray datasets. Methods Four microarray series (having 742 patients) were selected after a systematic search and combined. Cox regression for each gene was done for the combined dataset (univariate, as well as multivariate - adjusted for expression of Cell cycle related genes) and for the 4 major molecular subtypes. The centre and microarray batch effects were adjusted by including them as random effects variables. The Cox regression coefficients for each analysis were then ranked and subjected to a Gene Set Enrichment Analysis (GSEA). Results Gene sets representing protein translation were independently negatively associated with metastasis in the Luminal A and Luminal B subtypes, but positively associated with metastasis in Basal tumors. Proteinaceous extracellular matrix (ECM) gene set expression was positively associated with metastasis, after adjustment for expression of cell cycle related genes on the combined dataset. Finally, the positive association of the proliferation-related genes with metastases was confirmed. Conclusion To the best of our knowledge, the results depicting mixed prognostic significance of protein translation in breast cancer subtypes are being reported for the first time. We attribute this to our study combining multiple series and performing a more robust meta-analytic Cox regression modeling on the combined dataset, thus discovering 'hidden' associations. This methodology seems to yield new and interesting results and may be used as a tool to guide new research.	[Chowdhury, Nilotpal] All India Inst Med Sci, Dept Pathol & Lab Med, Rishikesh, Uttarakhand, India; [Sapru, Shantanu] All India Inst Med Sci, Dept Radiotherapy, Rishikesh, Uttarakhand, India	All India Institute of Medical Sciences (AIIMS) Rishikesh; All India Institute of Medical Sciences (AIIMS) Rishikesh	Sapru, S (corresponding author), Dr Ram Manohar Lohia Inst Med Sci, Dept Radiat Oncol, Lucknow, Uttar Pradesh, India.	nilotpal.chowdhury@gmail.com	Chowdhury, Nilotpal/GRJ-3148-2022	Chowdhury, Nilotpal/0000-0002-3178-2039				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Ejeh F, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.14; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Carlson M., HGU133A DB AFFYMETRI; Chanrion M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-39; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; Cheng WY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005974; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Darlington RB, 2000, PSYCHOL METHODS, V5, P496, DOI 10.1037/1082-989X.5.4.496; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gordon AY, 2008, STAT PROBABIL LETT, V78, P1878, DOI 10.1016/j.spl.2008.01.055; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Griffith OL, 2013, GENOME MED, V5, DOI 10.1186/gm496; GSEA Team MSigDB Scientific Advisory Board, 2014, GSEA USER GUIDE; GSEA Team MSigDB Scientific Advisory Board, 2013, GSEA MSIGDB MSIGDB C; Hahne F, 2008, PROCESSING AFFYMETRI, P25; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Haibe-Kains B, 2013, GENOM DATA, V1, P7, DOI 10.1016/j.gdata.2013.09.001; Haibe-Kains B, 2013, GENEFU RELEVANT FUNC; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kupfer P, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-23; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Liu JC, 2012, P NATL ACAD SCI USA, V109, P5832, DOI 10.1073/pnas.1201105109; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mulligan JM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt335; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Pusztai L, 2006, ONCOLOGIST, V11, P868, DOI 10.1634/theoncologist.11-8-868; R Core Team, 2014, R A LANGUAGE AND ENV; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Sabatier R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-86; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Therneau T, 2012, COXME MIXED EFFECTS; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Woltmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098229; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753	64	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129610	10.1371/journal.pone.0129610	http://dx.doi.org/10.1371/journal.pone.0129610			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080057	Green Submitted, Green Published, gold			2022-12-26	WOS:000356542300027
J	Sha, XJ; Meng, S; Li, XY; Xi, H; Maddaloni, M; Pascual, DW; Shan, HM; Jiang, XH; Wang, H; Yang, XF				Sha, Xiaojin; Meng, Shu; Li, Xinyuan; Xi, Hang; Maddaloni, Massimo; Pascual, David W.; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-feng			Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; INDUCED ARTHRITIS; IL-35; EXPRESSION; ATHEROSCLEROSIS; CYTOKINE; RECEPTOR; FAMILY; AUTOIMMUNE; PROTECTION	Vascular response is an essential pathological mechanism underlying various inflammatory diseases. This study determines whether IL-35, a novel responsive anti-inflammatory cytokine, inhibits vascular response in acute inflammation. Using a mouse model of LPS-induced acute inflammation and plasma samples from sepsis patients, we found that IL-35 was induced in the plasma of mice after LPS injection as well as in the plasma of sepsis patients. In addition, IL-35 decreased LPS-induced proinflammatory cytokines and chemokines in the plasma of mice. Furthermore, IL-35inhibited leukocyte adhesion to the endothelium in the vessels of lung and cremaster muscle and decreased the numbers of inflammatory cells in bronchoalveolar lavage fluid. Mechanistically, IL-35 inhibited the LPS-induced up-regulation of endothelial cell (EC) adhesion molecule VCAM-1 through IL-35 receptors gp130 and IL-12R beta 2 via inhibition of the MAPK-activator protein-1 (AP-1) signaling pathway. We also found that IL-27, which shares the EBI3 subunit with IL-35, promoted LPS-induced VCAM-1 in human aortic ECs and that EBI3-deficient mice had similar vascular response to LPS when compared with that of WT mice. These results demonstrated for the first time that inflammation-induced IL-35 inhibits LPS-induced EC activation by suppressing MAPK-AP1-mediated VCAM-1 expression and attenuates LPS-induced secretion of proinflammatory cytokines/chemokines. Our results provide insight into the control of vascular inflammation by IL-35 and suggest that IL-35 is an attractive novel therapeutic reagent for sepsis and cardiovascular	[Sha, Xiaojin; Meng, Shu; Li, Xinyuan; Xi, Hang; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-feng] Temple Univ, Sch Med, Ctr Metab Dis Res, Dept Pharmacol, Philadelphia, PA 19140 USA; [Sha, Xiaojin; Meng, Shu; Li, Xinyuan; Xi, Hang; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-feng] Temple Univ, Sch Med, Cardiovasc Res Ctr, Dept Pharmacol, Philadelphia, PA 19140 USA; [Sha, Xiaojin; Meng, Shu; Li, Xinyuan; Xi, Hang; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-feng] Temple Univ, Sch Med, Thrombosis Res Ctr, Dept Pharmacol, Philadelphia, PA 19140 USA; [Maddaloni, Massimo; Pascual, David W.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32608 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; University of Florida	Yang, XF (corresponding author), Temple Univ, Sch Med, Ctr Metab Dis Res, 3500 North Broad St,MERB 1059, Philadelphia, PA 19140 USA.	xfyang@temple.edu	Li, Xinyuan/B-1139-2015; Regan, Clinton/E-6250-2012; Li, Xinyuan/Z-6299-2019; Pascual, David/AAC-2248-2022	Li, Xinyuan/0000-0002-6746-8367; Li, Xinyuan/0000-0002-6746-8367; 	National Institutes of Health [5R01HL108910-05, 5R01HL116917-03, 5R01HL077288-11, 5R01HL110764-05, 5R01HL117654-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116917, R01HL110764, R01HL108910, R01HL117654, R01HL077288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by National Institutes of Health Grants 5R01HL108910-05; 5R01HL116917-03; 5R01HL077288-11; 5R01HL110764-05; and 5R01HL117654-03 (to X.F.Y and H.W). The authors declare that they have no conflicts of interest with the contents of this article.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Choi JJ, 2015, CLIN REV ALLERG IMMU, V49, P327, DOI 10.1007/s12016-015-8468-9; CHOWIENCZYK PJ, 1992, LANCET, V340, P1430, DOI 10.1016/0140-6736(92)92621-L; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dixon KO, 2015, EUR J IMMUNOL, V45, P1736, DOI 10.1002/eji.201445217; Guzzo C, 2012, J IMMUNOL, V188, P864, DOI 10.4049/jimmunol.1101912; He SL, 2010, ARTERIOSCL THROM VAS, V30, P2621, DOI 10.1161/ATVBAHA.110.210492; Henke PK, 2000, J IMMUNOL, V164, P2131, DOI 10.4049/jimmunol.164.4.2131; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jersmann HPA, 2001, INFECT IMMUN, V69, P1273, DOI 10.1128/IAI.69.3.1273-1279.2001; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kochetkova I, 2010, J IMMUNOL, V184, P7144, DOI 10.4049/jimmunol.0902739; Koltsova EK, 2012, CIRC RES, V111, P1274, DOI 10.1161/CIRCRESAHA.112.277525; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Mannam P, 2013, J IMMUNOL, V190, P1264, DOI 10.4049/jimmunol.1202012; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Tsoyi K, 2009, ATHEROSCLEROSIS, V207, P412, DOI 10.1016/j.atherosclerosis.2009.05.012; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang RX, 2012, J BIOL CHEM, V287, P36012, DOI 10.1074/jbc.M112.390625; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Wood KA, 2004, PHARMACOECONOMICS, V22, P895, DOI 10.2165/00019053-200422140-00001; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Yang WY, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0001-0; Yang Xiao-Feng, 2008, Drug Discov Today Ther Strateg, V5, P125, DOI 10.1016/j.ddstr.2008.11.003	38	74	84	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19307	19318		10.1074/jbc.M115.663286	http://dx.doi.org/10.1074/jbc.M115.663286			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085094	Green Published, hybrid			2022-12-26	WOS:000358781100042
J	Chen, JQ; Long, FX				Chen, Jianquan; Long, Fanxin			mTORC1 Signaling Promotes Osteoblast Differentiation from Preosteoblasts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; SKELETAL GROWTH; STROMAL CELLS; RAPAMYCIN; INHIBITION; MICE; PROGENITORS; SUPPRESSION; ACTIVATION	Preosteoblasts are precursor cells that are committed to the osteoblast lineage. Differentiation of these cells to mature osteoblasts is regulated by the extracellular factors and environmental cues. Recent studies have implicated mTOR signaling in the regulation of osteoblast differentiation. However, mTOR exists in two distinct protein complexes (mTORC1 and mTORC2), and the specific role of mTORC1 in regulating the progression of preosteoblasts to mature osteoblastis still unclear. In this study, we first deleted Raptor, a unique and essential component of mTORC1, in primary calvarial cells. Deletion of Raptor resulted in loss of mTORC1 but an increase in mTORC2 signaling without overtly affecting autophagy. Under the osteogenic culture condition, Raptor-deficient cells exhibited a decrease in matrix synthesis and mineralization. qPCR analyses revealed that deletion of Raptor reduced the expression of late-stage markers for osteoblast differentiation (Bglap, Ibsp, and Col1a), while slightly increasing early osteoblast markers (Runx2, Sp7, and Alpl). Consistent with the findings in vitro, genetic ablation of Raptor in osterix-expressing cells led to osteopenia in mice. Together, our findings have identified a specific role for mTORC1 in the transition from preosteoblasts to mature osteoblasts.	[Chen, Jianquan] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Jiangsu, Peoples R China; [Chen, Jianquan] Soochow Univ, Inst Orthoped, Suzhou, Jiangsu, Peoples R China; [Long, Fanxin] Washington Univ, Dept Orthoped Surg, St Louis, MO USA; [Long, Fanxin] Washington Univ, Dept Med, St Louis, MO USA; [Long, Fanxin] Washington Univ, Dept Dev Biol, St Louis, MO USA	Soochow University - China; Soochow University - China; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Chen, JQ (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Jiangsu, Peoples R China.	jqchen2004@gmail.com			National Institutes of Health [R01 AR055923, P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055923, P30AR057235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work is funded by National Institutes of Health grants R01 AR055923 (FL) and P30 AR057235 (Washington University Musculoskeletal Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellows CG, 2001, J BONE MINER RES, V16, P1983, DOI 10.1359/jbmr.2001.16.11.1983; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen C, 2015, J EXP MED, V212, P73, DOI 10.1084/jem.20140643; Chen JQ, 2015, J BONE MINER RES, V30, P369, DOI 10.1002/jbmr.2348; Chen JQ, 2014, DEVELOPMENT, V141, P2848, DOI 10.1242/dev.108811; Chen JQ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004145; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Isomoto S, 2007, J ORTHOP SCI, V12, P83, DOI 10.1007/s00776-006-1079-9; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Liu F, 2013, J BONE MINER RES, V28, P2414, DOI 10.1002/jbmr.1971; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Martin SK, 2015, STEM CELLS, V33, P1359, DOI 10.1002/stem.1931; Martin SK, 2010, J BONE MINER RES, V25, P2126, DOI 10.1002/jbmr.114; Ogawa T, 1998, BIOCHEM BIOPH RES CO, V249, P226, DOI 10.1006/bbrc.1998.9118; Onal M, 2013, J BIOL CHEM, V288, P17432, DOI 10.1074/jbc.M112.444190; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sen B, 2014, J BONE MINER RES, V29, P78, DOI 10.1002/jbmr.2031; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shoba LNN, 2003, J CELL BIOCHEM, V88, P1247, DOI 10.1002/jcb.10474; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793	27	21	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130627	10.1371/journal.pone.0130627	http://dx.doi.org/10.1371/journal.pone.0130627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090674	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000140
J	He, B; Ge, H; Yang, F; Sun, YJ; Li, Z; Jiang, M; Fan, YT; Pu, J; Shen, XD				He, Ben; Ge, Heng; Yang, Fan; Sun, Yujun; Li, Zheng; Jiang, Meng; Fan, Yiting; Pu, Jun; Shen, Xuedong			A Novel Method in the Stratification of Post-Myocardial-Infarction Patients Based on Pathophysiology	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CARDIAC MAGNETIC-RESONANCE; MITRAL REGURGITATION; HEART-FAILURE; PROGNOSTIC-SIGNIFICANCE; CLINICAL-IMPLICATIONS; SIZE; EDEMA; ECHOCARDIOGRAPHY; ASSOCIATION	Objectives We proposed that the severity of ST-segment elevation myocardial infarction (STEMI) could be classified based on pathophysiological changes. Methods First-STEMI patients were classified within hospitalization. Grade 0: no detectable myocardial necrosis; Grade 1: myocardial necrosis without functional and morphological abnormalities; Grade 2: myocardial necrosis with reduced LVEF; Grade 3: reduced LVEF on the basis of cardiac remodeling; Grade 4: mitral regurgitation additional to the Grade-3 criteria. Results Of 180 patients, 1.7, 43.9, 26.1, 23.9 and 4.4% patients were classified as Grade 0 to 4, respectively. The classification is an independent predicator of 90-day MACEs (any death, resuscitated cardiac arrest, acute heart failure and stroke): the rate was 0, 5.1, 8.5, 48.8 and 75% from Grade 0 to 4 (p < 0.001), respectively. The Grade-2 patients were more likely to have recovered left ventricular ejection fraction than the Grade-3/4 patients did after 90 days (48.9% vs. 19.1%, p < 0.001). Avoiding complicated quantification, the classification served as a good reflection of infarction size as measured by cardiac magnetic resonance imaging (0 +/- 0, 15.68 +/- 8.48, 23.68 +/- 9.32, 36.12 +/- 11.35 and 40.66 +/- 14.33% of the left ventricular mass by Grade 0 to 4, P<0.001), and with a comparable prognostic value (AUC 0.819 vs. 0.813 for infarction size, p = 0.876 by C-statistics) for MACEs. Conclusions The new classification represents an easy and objective method to scale the cardiac detriments for STEMI patients.	[He, Ben; Ge, Heng; Yang, Fan; Sun, Yujun; Li, Zheng; Jiang, Meng; Fan, Yiting; Pu, Jun; Shen, Xuedong] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	He, B (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China.	heben@medmail.com.cn; dr.geheng@foxmail.com			Program of Shanghai Hospital Development Center [SHDC 12013119]; International Cooperation Program of Shanghai Committee of Science and Technology [12410708300]; Shanghai Leading Talents Program [LJ 10007]; Program of Joint Research for Major Diseases from Shanghai committee of hygiene and family plan [2014ZYJB0501]; Program for New Century Excellent Talents in University from Ministry of Education of China [NCET-12-0352]; National Natural Science Foundation of China [81400261, 81270282]; Shanghai Leading Medical Talents Program	Program of Shanghai Hospital Development Center; International Cooperation Program of Shanghai Committee of Science and Technology; Shanghai Leading Talents Program; Program of Joint Research for Major Diseases from Shanghai committee of hygiene and family plan; Program for New Century Excellent Talents in University from Ministry of Education of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Medical Talents Program	This work has been supported by the Program of Shanghai Hospital Development Center (SHDC 12013119, for BH); International Cooperation Program of Shanghai Committee of Science and Technology (12410708300, for BH); Shanghai Leading Medical Talents Program and Shanghai Leading Talents Program (LJ 10007, for BH); Program of Joint Research for Major Diseases from Shanghai committee of hygiene and family plan (2014ZYJB0501 for BH); Program for New Century Excellent Talents in University from Ministry of Education of China (NCET-12-0352 for BH) and National Natural Science Foundation of China (81400261, 81270282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NM, 2008, CRIT CARE NURSE, V28, P20; Amigoni M, 2007, EUR HEART J, V28, P326, DOI 10.1093/eurheartj/ehl464; Anand IS, 2002, J CARD FAIL, V8, pS452, DOI 10.1054/jcaf.2002.129286; Brener SJ, 2013, JACC-CARDIOVASC INTE, V6, P718, DOI 10.1016/j.jcin.2013.03.013; Bruder O, 2008, HERZ, V33, P136, DOI 10.1007/s00059-008-3102-8; Buck T, 2006, HERZ, V31, P30, DOI 10.1007/s00059-006-2774-1; Carrabba N, 2008, J CARD FAIL, V14, P48, DOI 10.1016/j.cardfail.2007.08.005; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Dongaonkar RM, 2010, CARDIOVASC RES, V87, P331, DOI 10.1093/cvr/cvq145; Eitel I, 2009, AM HEART J, V158, P806, DOI 10.1016/j.ahj.2009.08.025; Feinberg MS, 2000, AM J CARDIOL, V86, P903, DOI 10.1016/S0002-9149(00)01119-X; Ferreira R, 2010, REV PORT CARDIOL, V29, P1037; Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7; Gheorghiade M, 2007, AM J MED, V120, P109, DOI 10.1016/j.amjmed.2005.08.010; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Lamas GA, 1997, CIRCULATION, V96, P827; Lepper W, 2002, J AM SOC ECHOCARDIOG, V15, P849, DOI 10.1067/mje.2002.121277; Lonborg J, 2013, EUR HEART J-CARD IMG, V14, P387, DOI 10.1093/ehjci/jes271; Manka R, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-47; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; Mill JG, 2011, BRAZ J MED BIOL RES, V44, P890, DOI 10.1590/S0100-879X2011000900010; Minicucci MF, 2011, CLIN CARDIOL, V34, P410, DOI 10.1002/clc.20922; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; POGATSA G, 1976, BASIC RES CARDIOL, V71, P263, DOI 10.1007/BF01906451; Pu J, 2011, ATHEROSCLEROSIS, V215, P203, DOI 10.1016/j.atherosclerosis.2010.11.019; Pu J, 2010, AGING CLIN EXP RES, V22, P295, DOI [10.1007/BF03337726, 10.3275/6711]; Raman SV, 2010, J AM COLL CARDIOL, V55, P2480, DOI 10.1016/j.jacc.2010.01.047; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Verheugt FWA, 2006, EUR HEART J, V27, P901, DOI 10.1093/eurheartj/ehi829; Wu E, 2008, HEART, V94, P730, DOI 10.1136/hrt.2007.122622	34	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130158	10.1371/journal.pone.0130158	http://dx.doi.org/10.1371/journal.pone.0130158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090807	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000092
J	Wang, L; Huang, JB; Luo, Y; Yao, Y; Zhao, ZC				Wang, Lei; Huang, Jianbin; Luo, Yong; Yao, Yao; Zhao, Zongci			Changes in Extremely Hot Summers over the Global Land Area under Various Warming Targets	PLOS ONE			English	Article							HEAT WAVES; CLIMATE EXTREMES; INCREASE; AMPLIFICATION; PROJECTIONS; FREQUENT; MODEL	Summer temperature extremes over the global land area were investigated by comparing 26 models of the fifth phase of the Coupled Model Intercomparison Project (CMIP5) with observations from the Goddard Institute for Space Studies (GISS) and the Climate Research Unit (CRU). Monthly data of the observations and models were averaged for each season, and statistics were calculated for individual models before averaging them to obtain ensemble means. The summers with temperature anomalies (relative to 1951-1980) exceeding 3 sigma (sigma is based on the local internal variability) are defined as "extremely hot". The models well reproduced the statistical characteristics evolution, and partly captured the spatial distributions of historical summer temperature extremes. If the global mean temperature increases 2 degrees C relative to the pre-industrial level, "extremely hot" summers are projected to occur over nearly 40% of the land area (multi-model ensemble mean projection). Summers that exceed 5 sigma warming are projected to occur over approximately 10% of the global land area, which were rarely observed during the reference period. Scenarios reaching warming levels of 3 degrees C to 5 degrees C were also analyzed. After exceeding the 5 degrees C warming target, "extremely hot" summers are projected to occur throughout the entire global land area, and summers that exceed 5s warming would become common over 70% of the land area. In addition, the areas affected by "extremely hot" summers are expected to rapidly expand by more than 25%/degrees C as the global mean temperature increases by up to 3 degrees C before slowing to less than 16%/degrees C as the temperature continues to increase by more than 3 degrees C. The area that experiences summers with warming of 5s or more above the warming target of 2 degrees C is likely to maintain rapid expansion of greater than 17%/degrees C. To reduce the impacts and damage from severely hot summers, the global mean temperature increase should remain low.	[Huang, Jianbin] Tsinghua Univ, Ctr Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing 100084, Peoples R China; Tsinghua Univ, JCGCS, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Huang, JB (corresponding author), Tsinghua Univ, Ctr Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing 100084, Peoples R China.	jbh@mail.tsinghua.edu.cn	Huang, Jianbin/AAP-5941-2020; LUO, Yong/AAP-3596-2021		China Meteorological Administration Special Public Welfare Research Fund [GYHY201306019]; Tsinghua University Initiative Scientific Research Program [20131089356]; National Natural Science Foundation of China [41175066]	China Meteorological Administration Special Public Welfare Research Fund; Tsinghua University Initiative Scientific Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the China Meteorological Administration Special Public Welfare Research Fund (GYHY201306019, http://guoqing.china.com.cn/2012-03/23/content_24968247.htm-received by JH), the Tsinghua University Initiative Scientific Research Program (Grant No. 20131089356, http://kyxxxt.cic.tsinghua.edu.cn/received by JH), and the National Natural Science Foundation of China (Grant No. 41175066, http://www.nsfc.gov.cn/-received by YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Ballester J, 2010, CLIMATIC CHANGE, V98, P277, DOI 10.1007/s10584-009-9758-0; Barnston AG, 2011, WEATHER FORECAST, V26, P545, DOI 10.1175/WAF-D-10-05009.1; Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224; Benestad RE, 2003, CLIMATE RES, V25, P3, DOI 10.3354/cr025003; Beniston M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018857; Cassou C, 2005, J CLIMATE, V18, P2805, DOI 10.1175/JCLI3506.1; Clark RT, 2006, J CLIMATE, V19, P4418, DOI 10.1175/JCLI3877.1; Coumou D, 2015, SCIENCE, V348, P324, DOI 10.1126/science.1261768; Coumou D, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034018; Coumou D, 2013, CLIMATIC CHANGE, V118, P771, DOI 10.1007/s10584-012-0668-1; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Diffenbaugh NS, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/044007; Dole R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046582; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fischer EM, 2007, J CLIMATE, V20, P5081, DOI 10.1175/JCLI4288.1; Garcia-Herrera R, 2010, CRIT REV ENV SCI TEC, V40, P267, DOI 10.1080/10643380802238137; Gershunov A, 2009, J CLIMATE, V22, P6181, DOI 10.1175/2009JCLI2465.1; Good P, 2006, CLIM RES, V31, P19, DOI 10.3354/cr031019; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hao ZC, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034014; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Huntingford C, 2013, NATURE, V500, P327, DOI 10.1038/nature12310; Ji F, 2014, NAT CLIM CHANGE, V4, P462, DOI [10.1038/nclimate2223, 10.1038/NCLIMATE2223]; Lau NC, 2012, J CLIMATE, V25, P4761, DOI 10.1175/JCLI-D-11-00575.1; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Orlowsky B, 2012, CLIMATIC CHANGE, V110, P669, DOI 10.1007/s10584-011-0122-9; Peterson TC, 2013, B AM METEOROL SOC, V94, P821, DOI 10.1175/BAMS-D-12-00066.1; Petoukhov V, 2013, P NATL ACAD SCI USA, V110, P5336, DOI 10.1073/pnas.1222000110; Pezza AB, 2012, CLIM DYNAM, V38, P209, DOI 10.1007/s00382-011-1016-2; Rhines A, 2013, P NATL ACAD SCI USA, V110, pE546, DOI 10.1073/pnas.1218748110; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schneider SH, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P779; Seneviratne SI, 2014, NAT CLIM CHANGE, V4, P161, DOI 10.1038/nclimate2145; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sun Y, 2014, NAT CLIM CHANGE, V4, P1082, DOI 10.1038/NCLIMATE2410; Trenberth KE, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018020; White MA, 2006, P NATL ACAD SCI USA, V103, P11217, DOI 10.1073/pnas.0603230103; Yao Y, 2013, J CLIMATE, V26, P7692, DOI 10.1175/JCLI-D-12-00560.1	41	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130660	10.1371/journal.pone.0130660	http://dx.doi.org/10.1371/journal.pone.0130660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090931	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000142
J	Lye, MS; Visuvanathan, S; Chong, PP; Yap, YY; Lim, CC; Ban, EZ				Lye, Munn-Sann; Visuvanathan, Shaneeta; Chong, Pei-Pei; Yap, Yoke-Yeow; Lim, Chin-Chye; Ban, Eng-Zhuan			Homozygous Wildtype of XPD K751Q Polymorphism Is Associated with Increased Risk of Nasopharyngeal Carcinoma in Malaysian Population	PLOS ONE			English	Article							DNA-REPAIR GENE; NUCLEOTIDE EXCISION-REPAIR; SALTED FISH; LUNG-CANCER; TFIIH; TRANSCRIPTION; CONSUMPTION; CHINESE; DAMAGE; XRCC1	The xeroderma pigmentosum group D (XPD) gene encodes a DNA helicase, an important component in transcription factor IIH (TFIIH) complex. XPD helicase plays a pivotal role in unwinding DNA at the damaged region during nucleotide excision repair (NER) mechanism. Dysfunctional XPD helicase protein from polymorphic diversity may contribute to increased risk of developing cancers. This study aims to determine the association between XPD K751Q polymorphism (rs13181) and risk of nasopharyngeal carcinoma (NPC) in the Malaysian population. In this hospital-based matched case-control study, 356 controls were matched by age, gender and ethnicity to 356 cases. RFLP-PCR was used to genotype the XPD K751Q polymorphism. A significant association was observed between XPD K751Q polymorphism and the risk of NPC using conditional logistic regression. Subjects with homozygous Lys/Lys (wildtype) genotype have 1.58 times higher odds of developing NPC compared to subjects with recessive combination of heterozygous Lys/Gln and homozygous Gln/Gln genotypes (OR = 1.58, 95% CI = 1.05-2.38 p = 0.028) adjusted for cigarette smoking, alcohol and salted fish consumption. Our data suggests that Lys/Lys (wildtype) of XPD K751Q contributes to increased risk of NPC in the Malaysian population.	[Lye, Munn-Sann; Visuvanathan, Shaneeta; Ban, Eng-Zhuan] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang 43400, Selangor, Malaysia; [Chong, Pei-Pei] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang 43400, Selangor, Malaysia; [Yap, Yoke-Yeow] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Surg, Serdang, Selangor, Malaysia; [Lim, Chin-Chye] Minist Hlth Malaysia, Natl Canc Inst, Putrajaya, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Kementerian Kesihatan Malaysia	Lye, MS (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang 43400, Selangor, Malaysia.	lyems9@yahoo.com	Chong, Pei Pei/AAP-4227-2021; Chong, Pei pei/G-1367-2018	Chong, Pei Pei/0000-0002-8229-3593; Chong, Pei pei/0000-0002-8229-3593	Ministry of Science, Technology and Innovation [5450414]	Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was funded by the Ministry of Science, Technology and Innovation, grant name: ScienceFund, grant number: 5450414, URL: http://www.mosti.gov.my/en/funds-grants/science-fund/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrahman W, 2013, P NATL ACAD SCI USA, V110, pE633, DOI 10.1073/pnas.1213981110; Araujo SJ, 2000, GENE DEV, V14, P349; Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Banerjee M, 2007, CARCINOGENESIS, V28, P672, DOI 10.1093/carcin/bgl181; Banescu C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/213790; BARTSCH H, 1984, CARCINOGENESIS, V5, P1381, DOI 10.1093/carcin/5.11.1381; Benhamou S, 2005, AM J EPIDEMIOL, V161, P1, DOI 10.1093/aje/kwi018; Cheng YJ, 1999, CANCER CAUSE CONTROL, V10, P201, DOI 10.1023/A:1008893109257; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Court M, 2008, COURT LAB CALCULATOR; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Du HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096301; Du Y, 2016, CLIN RESPIR J, V10, P311, DOI 10.1111/crj.12218; Duell EJ, 2000, CARCINOGENESIS, V21, P965, DOI 10.1093/carcin/21.5.965; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Guo JG, 2011, MOL CELL BIOL, V31, P639, DOI 10.1128/MCB.00919-10; Guo XC, 2009, INT J CANCER, V124, P2942, DOI 10.1002/ijc.24293; HARTGE P, 1987, J NATL CANCER I, V78, P1119; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035220; Huang CG, 2012, MOL BIOL REP, V39, P709, DOI 10.1007/s11033-011-0789-z; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kuper J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001954; Laine JP, 2006, METHOD ENZYMOL, V408, P246, DOI 10.1016/S0076-6879(06)08015-3; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Majumder M, 2007, INT J CANCER, V120, P2148, DOI 10.1002/ijc.22547; Mi YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044756; Mirecka A, 2014, GENE, V546, P156, DOI 10.1016/j.gene.2014.06.026; Moghtit FZ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0942-3; Ng CC, 2009, J HUM GENET, V54, P392, DOI 10.1038/jhg.2009.49; NING JP, 1990, J NATL CANCER I, V82, P291, DOI 10.1093/jnci/82.4.291; NLM, DAT SINGL NUCL POL D; Ozcan A, 2011, AFR J BIOTECHNOL, V10, P8860; Parkin DM, 1997, CANC INCIDENCE 5 CON, V7, P334; Pesch B, 2012, INT J CANCER, V131, P1210, DOI 10.1002/ijc.27339; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Proudfoot NJ, 2001, EMBO REP, V2, P891, DOI 10.1093/embo-reports/kve207; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sturgis EM, 2000, CARCINOGENESIS, V21, P2219, DOI 10.1093/carcin/21.12.2219; Sun LM, 2005, AM J EPIDEMIOL, V162, P1174, DOI 10.1093/aje/kwi345; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; Tardiff RG, 1994, METHODS ACCESS DNA D; Tulalamba Warut, 2012, Int J Cell Biol, V2012, P594681, DOI 10.1155/2012/594681; Wang T, 2014, GENET TEST MOL BIOMA, V18, P703, DOI 10.1089/gtmb.2014.0028; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Xue HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043431; Yang B, 2013, ASIAN PAC J CANCER P, V14, P5839, DOI 10.7314/APJCP.2013.14.10.5839; Yang ZH, 2007, DNA CELL BIOL, V26, P491, DOI 10.1089/dna.2006.0537; Yin ZH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-153; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; YU MC, 1986, CANCER RES, V46, P956; Zainal AO, 2011, NATL CANC REPORT 201; Zhou C, 2013, BIOMED REP, V1, P679, DOI 10.3892/br.2013.123; Zou Xiaonong, 1992, Chinese Medical Sciences Journal, V7, P201	62	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130530	10.1371/journal.pone.0130530	http://dx.doi.org/10.1371/journal.pone.0130530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086338	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500113
J	Otmakhov, N; Regmi, S; Lisman, JE				Otmakhov, Nikolai; Regmi, Shaurav; Lisman, John E.			Fast Decay of CaMKII FRET Sensor Signal in Spines after LTP Induction Is Not Due to Its Dephosphorylation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-II; SYNAPTIC STRENGTH; CALMODULIN; AUTOPHOSPHORYLATION; ALPHA; PHOSPHORYLATION; MECHANISMS; INFORMATION; HIPPOCAMPUS	Because CaMKII is the critical Ca2+ sensor that triggers long-term potentiation (LTP), understanding its activation and deactivation is important. A major advance has been the development of a FRET indicator of the conformational state of CaMKII called Camui. Experiments using Camui have demonstrated that the open (active) conformation increases during LTP induction and then decays in tens of seconds, with the major fast component decaying with a time-constant of similar to 6 sec (tau1). Because this decay is faster if autophosphorylation of T286 is prevented (the autophosphorylation prolongs activity by making the enzyme active even after Ca2+ falls), it seemed likely that the fast decay is due to the T286 dephosphorylation. To test this interpretation, we studied the effect of phosphatase inhibitors on the single-spine Camui signal evoked by two-photon glutamate uncaging. We applied inhibitors of PP1 and PP2A, two phosphatases that are present at synapses and that have been shown to dephosphorylate CaMKII in vitro. The inhibitors increased the basal Camui activation state, indicating their effectiveness in cells. However, in no case did we find that tau1 was prolonged, contrary to what would be expected if the decay was phosphatase-dependent. This could either mean that decay was due to some unknown phosphatase or that the decay was not due to dephosphorylation. To distinguish between these possibilities, we expressed pseudo-phosphorylated Camui (T286D) (plus additional mutations [T/A] that prevented inhibitory 305/306 phosphorylation). This form had an elevated basal activation state, but was further activated during glutamate uncaging; importantly the activation state decayed with tau1 nearly the same as that of WT Camui. Therefore, the data strongly indicate that tau1 is not due to T286 dephosphorylation. We conclude that, although Camui is an excellent tool for observing CaMKII signaling, further experimentation is needed to determine how CaMKII is turned off by its dephosphorylation.	[Otmakhov, Nikolai; Regmi, Shaurav; Lisman, John E.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Lisman, JE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	lisman@brandeis.edu			NIH CRCNS [R01MH102841]; Angelman Syndrome Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS103168] Funding Source: NIH RePORTER	NIH CRCNS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angelman Syndrome Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The following sources of funding supported this study: NIH CRCNS grant # R01MH102841; Angelman Syndrome Foundation Grant http://www.angelman.org/.	Asrican B, 2005, MEASURING CORRELATIO; Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bliss TVP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0129; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Erickson JR, 2011, CIRC RES, V109, P729, DOI 10.1161/CIRCRESAHA.111.247148; Fujii H, 2013, CELL REP, V3, P978, DOI 10.1016/j.celrep.2013.03.033; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Ishida A, 2008, BRIT J PHARMACOL, V154, P729, DOI 10.1038/bjp.2008.127; Ishida A, 1998, J BIOL CHEM, V273, P1904, DOI 10.1074/jbc.273.4.1904; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kato K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-37; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Nicoll RA, 2013, NEUROPHARMACOLOGY, V74, P18, DOI 10.1016/j.neuropharm.2013.02.010; Otmakhov N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120881; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Ruzsnavszky O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061507; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Sessoms-Sikes S, 2005, MOL CELL NEUROSCI, V29, P139, DOI 10.1016/j.mcn.2005.01.006; Shonesy BC, 2014, PROG MOL BIOL TRANSL, V122, P61, DOI 10.1016/B978-0-12-420170-5.00003-9; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	38	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130457	10.1371/journal.pone.0130457	http://dx.doi.org/10.1371/journal.pone.0130457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086939	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500107
J	Braga, J; Loubes, JM; Descouens, D; Dumoncel, J; Thackeray, JF; Kahn, JL; de Beer, F; Riberon, A; Hoffman, K; Balaresque, P; Gilissen, E				Braga, J.; Loubes, J-M.; Descouens, D.; Dumoncel, J.; Thackeray, J. F.; Kahn, J-L.; de Beer, F.; Riberon, A.; Hoffman, K.; Balaresque, P.; Gilissen, E.			Disproportionate Cochlear Length in Genus Homo Shows a High Phylogenetic Signal during Apes' Hearing Evolution	PLOS ONE			English	Article							BODY-SIZE; AUDITORY-CORTEX; LIFE-HISTORY; INNER-EAR; FOSSIL; PRIMATES; HOMININ; ORGANIZATION; SENSITIVITY; DIMORPHISM	Changes in lifestyles and body weight affected mammal life-history evolution but little is known about how they shaped species' sensory systems. Since auditory sensitivity impacts communication tasks and environmental acoustic awareness, it may have represented a deciding factor during mammal evolution, including apes. Here, we statistically measure the influence of phylogeny and allometry on the variation of five cochlear morphological features associated with hearing capacities across 22 living and 5 fossil catarrhine species. We find high phylogenetic signals for absolute and relative cochlear length only. Comparisons between fossil cochleae and reconstructed ape ancestral morphotypes show that Australopithecus absolute and relative cochlear lengths are explicable by phylogeny and concordant with the hypothetized ((Pan,Homo),Gorilla) and (Pan,Homo) most recent common ancestors. Conversely, deviations of the Paranthropus oval window area from these most recent common ancestors are not explicable by phylogeny and body weight alone, but suggest instead rapid evolutionary changes (directional selection) of its hearing organ. Premodern (Homo erectus) and modern human cochleae set apart from living non-human catarrhines and australopiths. They show cochlear relative lengths and oval window areas larger than expected for their body mass, two features corresponding to increased low-frequency sensitivity more recent than 2 million years ago. The uniqueness of the "hypertrophied" cochlea in the genus Homo (as opposed to the australopiths) and the significantly high phylogenetic signal of this organ among apes indicate its usefulness to identify homologies and monophyletic groups in the hominid fossil record.	[Braga, J.; Descouens, D.; Dumoncel, J.; Balaresque, P.] Univ Toulouse 3, AMIS UMR CNRS 5288, Hominid Evolutionary Biol, F-31062 Toulouse, France; [Braga, J.; Thackeray, J. F.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Loubes, J-M.] Univ Toulouse 3, UMR CNRS 5219, Inst Math Toulouse, Stat & Probabil Team, F-31062 Toulouse, France; [Kahn, J-L.] Fac Med Strasbourg, Inst Anat Normale & Pathol, Strasbourg, France; [de Beer, F.; Hoffman, K.] South African Nucl Energy Corp, Pelindaba, North West Prov, South Africa; [Riberon, A.] Univ Toulouse 3, UMR 5174, CNRS, Lab Evolut & Diversite Biol, F-31062 Toulouse, France; [Gilissen, E.] Royal Museum Cent Africa, Tervuren, Belgium; [Gilissen, E.] Univ Libre Bruxelles, Lab Histol & Neuropathol, Brussels, Belgium	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Witwatersrand; Universite de Toulouse; Universite Toulouse 1 Capitole; Universite Toulouse III - Paul Sabatier; Universite de Toulouse - Jean Jaures; Institut National des Sciences Appliquees de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; The South African Nuclear Energy Corporation SOC Limited (Necsa); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Royal Museum for Central Africa; Universite Libre de Bruxelles	Braga, J (corresponding author), Univ Toulouse 3, AMIS UMR CNRS 5288, Hominid Evolutionary Biol, F-31062 Toulouse, France.	jose.braga@univ-tlse3.fr	De Beer, Frederik/AAA-1724-2020; Loubes, Jean-Michel/B-7663-2019; Braga, Jose/A-4025-2010	De Beer, Frederik/0000-0001-9810-6038; Loubes, Jean-Michel/0000-0002-1252-2960; Braga, Jose/0000-0002-8483-076X; Thackeray, Francis/0000-0001-6884-382X; Dumoncel, Jean/0000-0003-0789-7458; BALARESQUE, Patricia/0000-0003-3516-5537	Projet exploratoire pluridisciplinaire inter-instituts (PEP II) "AUDEVO" of the Centre National de la Recherche Scientifique; French Ministry of Foreign Affairs; French Embassy in South Africa through the Cultural and Cooperation Services	Projet exploratoire pluridisciplinaire inter-instituts (PEP II) "AUDEVO" of the Centre National de la Recherche Scientifique; French Ministry of Foreign Affairs; French Embassy in South Africa through the Cultural and Cooperation Services	This work was supported by the Projet exploratoire pluridisciplinaire inter-instituts (PEP II) "AUDEVO" of the Centre National de la Recherche Scientifique, the French Ministry of Foreign Affairs, the French Embassy in South Africa through the Cultural and Cooperation Services.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Braga J, 2013, J HUM EVOL, V65, P447, DOI 10.1016/j.jhevol.2013.07.013; Brown JH, 2006, P NATL ACAD SCI USA, V103, P17595, DOI 10.1073/pnas.0608522103; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Coleman MN, 2012, ANAT REC, V295, P615, DOI 10.1002/ar.22422; Coleman MN, 2010, ANAT REC, V293, P1711, DOI 10.1002/ar.21199; Coleman MN, 2010, J MORPHOL, V271, P511, DOI 10.1002/jmor.10814; Coleman MN, 2009, INT J PRIMATOL, V30, P55, DOI 10.1007/s10764-008-9330-1; Collard Mark, 2007, P1575, DOI 10.1007/978-3-540-33761-4_51; Da Costa S, 2011, J NEUROSCI, V31, P14067, DOI 10.1523/JNEUROSCI.2000-11.2011; Dangles O, 2009, Q REV BIOL, V84, P51, DOI 10.1086/596463; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; Diogo R, 2011, J ANAT, V219, P273, DOI 10.1111/j.1469-7580.2011.01403.x; Durrleman S, 2012, J HUM EVOL, V62, P74, DOI 10.1016/j.jhevol.2011.10.004; Echteler Stephen M., 1994, Springer Handbook of Auditory Research, V4, P134; Ekdale EG, 2015, J ANAT, V226, P22, DOI 10.1111/joa.12253; FRANCIS HW, 1993, HEARING RES, V64, P217, DOI 10.1016/0378-5955(93)90009-P; Garamszegi L. Z., 2014, MODERN PHYLOGENETIC; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Geisler JH, 2014, NATURE, V508, P383, DOI 10.1038/nature13086; Gordon AD, 2006, INT J PRIMATOL, V27, P27, DOI 10.1007/s10764-005-9003-2; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; HEFFNER RS, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P691; Herculano-Houzel S, 2011, BRAIN BEHAV EVOLUT, V77, P33, DOI 10.1159/000322729; Holliday TW, 2012, CURR ANTHROPOL, V53, pS330, DOI 10.1086/667360; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Humphries C, 2010, NEUROIMAGE, V50, P1202, DOI 10.1016/j.neuroimage.2010.01.046; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Ives AR, 2007, SYST BIOL, V56, P252, DOI 10.1080/10635150701313830; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; JUNGERS WL, 1987, J HUM EVOL, V16, P445, DOI 10.1016/0047-2484(87)90072-8; Kamilar JM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0341; Kim SH, 2006, PLOS GENET, V2, P1527, DOI 10.1371/journal.pgen.0020163; Lockwood CA, 2007, SCIENCE, V318, P1443, DOI 10.1126/science.1149211; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Manoussaki D, 2008, P NATL ACAD SCI USA, V105, P6162, DOI 10.1073/pnas.0710037105; Martins EP, 1999, SYST BIOL, V48, P642, DOI 10.1080/106351599260210; McConkey EH, 2005, SCIENCE, V309, P1499, DOI 10.1126/science.1113863; McFadden D, 2009, HEARING RES, V252, P37, DOI 10.1016/j.heares.2009.01.002; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; NUMMELA S, 1995, HEARING RES, V85, P18, DOI 10.1016/0378-5955(95)00030-8; Nunn C. L., 2011, COMP APPROACH EVOLUT; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Parker J, 2013, NATURE, V502, P228, DOI 10.1038/nature12511; Plavcan JM, 2012, CURR ANTHROPOL, V53, pS409, DOI 10.1086/667605; Rampont M., 1994, THESIS U STRASBOURG; Revell LJ, 2012, EVOLUTION, V66, P2697, DOI 10.1111/j.1558-5646.2012.01645.x; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Rook L, 2004, J HUM EVOL, V46, P349, DOI 10.1016/j.jhevol.2004.01.001; Ruggero MA, 2002, P NATL ACAD SCI USA, V99, P13206, DOI 10.1073/pnas.202492699; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schoenemann PT, 2006, ANNU REV ANTHROPOL, V35, P379, DOI 10.1146/annurev.anthro.35.081705.123210; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Stearns S.C., 1992, pi; Steiper ME, 2008, EVOL ANTHROPOL, V17, P179, DOI 10.1002/evan.20177; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Vater M, 2011, HEARING RES, V273, P89, DOI 10.1016/j.heares.2010.05.018; vonBekesy G., 1960, EXPT HEARING; VRBA ES, 1979, BIOL J LINN SOC, V11, P207, DOI 10.1111/j.1095-8312.1979.tb00035.x; WEST CD, 1985, J ACOUST SOC AM, V77, P1091, DOI 10.1121/1.392227; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709	71	34	34	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127780	10.1371/journal.pone.0127780	http://dx.doi.org/10.1371/journal.pone.0127780			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083484	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400018
J	Dahlin, A; Litonjua, A; Lima, JJ; Tamari, M; Kubo, M; Irvin, CG; Peters, SP; Tantisira, KG				Dahlin, Amber; Litonjua, Augusto; Lima, John J.; Tamari, Mayumi; Kubo, Michiaki; Irvin, Charles G.; Peters, Stephen P.; Tantisira, Kelan G.			Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma	PLOS ONE			English	Article							LEUKOTRIENE RECEPTOR ANTAGONISTS; PERSISTENT ASTHMA; INHALED CORTICOSTEROIDS; CHILDHOOD ASTHMA; KOREAN CHILDREN; TRIAL; POLYMORPHISMS; PATHWAY; RESPONSIVENESS; HETEROGENEITY	Background Genome-wide association study (GWAS) is a powerful tool to identify novel pharmacogenetic single nucleotide polymorphisms (SNPs). Leukotriene receptor antagonists (LTRAs) are a major class of asthma medications, and genetic factors contribute to variable responses to these drugs. We used GWAS to identify novel SNPs associated with the response to the LTRA, montelukast, in asthmatics. Methods Using genome-wide genotype and phenotypic data available from American Lung Association - Asthma Clinical Research Center (ALA-ACRC) cohorts, we evaluated 8-week change in FEV1 related to montelukast administration in a discovery population of 133 asthmatics. The top 200 SNPs from the discovery GWAS were then tested in 184 additional samples from two independent cohorts. Results Twenty-eight SNP associations from the discovery GWAS were replicated. Of these, rs6475448 achieved genome-wide significance (combined P = 1.97 x 10(-09)), and subjects from all four studies who were homozygous for rs6475448 showed increased Delta FEV1 from baseline in response to montelukast. Conclusions Through GWAS, we identified a novel pharmacogenomic locus related to improved montelukast response in asthmatics.	[Dahlin, Amber; Litonjua, Augusto; Tantisira, Kelan G.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Dahlin, Amber; Litonjua, Augusto; Tantisira, Kelan G.] Harvard Univ, Sch Med, Boston, MA USA; [Litonjua, Augusto; Tantisira, Kelan G.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Lima, John J.] Nemours Childrens Clin, Jacksonville, FL USA; [Tamari, Mayumi; Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Irvin, Charles G.] Univ Vermont, Burlington, VT USA; [Peters, Stephen P.] Wake Forest Sch Med, Winston Salem, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; RIKEN; University of Vermont; Wake Forest University	Dahlin, A (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	amber.dahlin@channing.harvard.edu	Kubo, Michiaki/N-7947-2015; Tamari, Mayumi/N-5378-2015		National Institutes of Health [R01 HL092197, U01 HL65899, T32 HL007427, R01 NR013391]; NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance; BioBank Japan project (Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government); American Lung Association (ALA); NHLBI [HL071394, HL074755]; Nemours Children's' Clinic; GlaxoSmithKline; National Heart Lung and Blood Institute (NHLBI), single nucleotide polymorphism health association resource (SHARe) Asthma Resource Project (SHARP); NHLBI (U.S. Federal Government) [N02-HL-6-4278]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007427, R01HL074755, R01HL092197, R01HL064278, R01HL071394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance; BioBank Japan project (Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government); American Lung Association (ALA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Nemours Children's' Clinic; GlaxoSmithKline(GlaxoSmithKline); National Heart Lung and Blood Institute (NHLBI), single nucleotide polymorphism health association resource (SHARe) Asthma Resource Project (SHARP); NHLBI (U.S. Federal Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study is supported by the National Institutes of Health grants R01 HL092197, U01 HL65899, T32 HL007427 (support for A.D.) and R01 NR013391, the NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance and funding from the BioBank Japan project (supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government). Funding for LOCCS and LODO is provided from American Lung Association (ALA) and the ALA's Asthma Clinical Research Centers investigators and research teams for use of LOCCS and LODO data, with additional funding from HL071394 and HL074755 from the NHLBI, and Nemours Children's' Clinic. GlaxoSmithKline supported the conduct of the LOCCS Trial by an unrestricted grant to the ALA. The CARE study is supported by funding through National Heart Lung and Blood Institute (NHLBI), as part of the single nucleotide polymorphism health association resource (SHARe) Asthma Resource Project (SHARP); genotyping of SHARP was supported by the NHLBI (U.S. Federal Government contract number N02-HL-6-4278). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drazen J, 1998, AM J RESP CRIT CARE, V157, pS233, DOI 10.1164/ajrccm.157.6.mar-5; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Dupuis F, 1997, J LIPID MEDIAT CELL, V16, P117, DOI 10.1016/S0929-7855(97)00007-2; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; HAMMARSTROM S, 1983, ANNU REV BIOCHEM, V52, P355, DOI 10.1146/annurev.bi.52.070183.002035; HAMMARSTROM S, 1983, MONOGR ALLERGY, V18, P265; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Holloway JW, 2008, ALLERGY, V63, P1046, DOI 10.1111/j.1398-9995.2008.01667.x; Irvin CG, 2007, AM J RESP CRIT CARE, V175, P235, DOI 10.1164/rccm.200603-416OC; Israel E, 1996, JAMA-J AM MED ASSOC, V275, P931, DOI 10.1001/jama.275.12.931; Kang MJ, 2008, PHARMACOGENET GENOM, V18, P551, DOI 10.1097/FPC.0b013e3282fe94c5; Kang MJ, 2011, J HUM GENET, V56, P284, DOI 10.1038/jhg.2011.3; Kim SH, 2006, YONSEI MED J, V47, P15, DOI 10.3349/ymj.2006.47.1.15; Klotsman M, 2007, PHARMACOGENET GENOM, V17, P189, DOI 10.1097/FPC.0b013e3280120043; Knorr B, 1998, JAMA-J AM MED ASSOC, V279, P1181, DOI 10.1001/jama.279.15.1181; Lima JJ, 2006, AM J RESP CRIT CARE, V173, P379, DOI 10.1164/rccm.200509-1412OC; Lima JJ, 2007, MOL DIAGN THER, V11, P97, DOI 10.1007/BF03256228; Lima JJ, 2009, CURR OPIN PULM MED, V15, P57, DOI 10.1097/MCP.0b013e32831da8be; Liptak T., 1958, MAGYAR TUD AKAD MAT, V3, P171; Moritani C, 1998, CHEST, V113, P452, DOI 10.1378/chest.113.2.452; Mougey EB, 2013, PHARMACOGENOMICS J, V13, P242, DOI 10.1038/tpj.2012.5; Mougey EB, 2009, PHARMACOGENET GENOM, V19, P129, DOI 10.1097/FPC.0b013e32831bd98c; Nelson H, 2007, ANN ALLERG ASTHMA IM, V99, P178, DOI 10.1016/S1081-1206(10)60642-4; Palikhe NS, 2009, YONSEI MED J, V50, P744, DOI 10.3349/ymj.2009.50.6.744; Park HW, 2014, J ALLERGY CLIN IMMUN; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SALMON JA, 1987, BRIT MED BULL, V43, P285, DOI 10.1093/oxfordjournals.bmb.a072183; SHEPPARD KA, 1992, BIOCHIM BIOPHYS ACTA, V1133, P223, DOI 10.1016/0167-4889(92)90073-K; Shrestha N, 2012, J ALLERGY, V2012, DOI [10.1155/2012/794890, DOI 10.1155/2012/794890]; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Tantisira KG, 2012, AM J RESP CRIT CARE, V185, P1286, DOI 10.1164/rccm.201111-2061OC; Tantisira KG, 2009, PHARMACOGENET GENOM, V19, P244, DOI 10.1097/FPC.0b013e328326e0b1; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; Tcheurekdjian H, 2010, J ALLERGY CLIN IMMUN, V126, P853, DOI 10.1016/j.jaci.2010.06.048; Via M, 2010, CLIN EXP ALLERGY, V40, P582, DOI 10.1111/j.1365-2222.2009.03438.x	41	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129385	10.1371/journal.pone.0129385	http://dx.doi.org/10.1371/journal.pone.0129385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083242	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400092
J	Ma, ZH; Huang, BL; Xu, SS; Chen, Y; Li, SB; Lin, SZ				Ma, Zhihui; Huang, Binlong; Xu, Shanshan; Chen, Yu; Li, Shubin; Lin, Sizu			Isolation of High-Quality Total RNA from Chinese Fir (Cunninghamia lanceolata (Lamb.) Hook)	PLOS ONE			English	Article							POLYSACCHARIDE-RICH; PLANT-TISSUES; EXTRACTION; PROTOCOL	RNA isolation with RNA in a high quantity is a basic analytical method in plant genetics, molecular biology and related physiological investigations. To understand the genetic and molecular biology of Chinese fir, sufficient high-quality total RNA must be obtained for cDNA library construction and other downstream molecular applications. However, extracting RNA from Chinese fir is difficult and often requires the modification of existing protocols. Chinese fir tissues containing large amounts of polysaccharides and polyphenol compounds and are one of the most difficult plant tissues for RNA isolation. Therefore, we developed a simple method for extracting high-quality RNA from Chinese fir tissues. RNA isolations were performed within two hours, RNA quality was measured for yield and purity. Total RNA obtained from this procedure was successfully used for cDNA library construction, RT-PCR and transcriptome sequencing. It was proven that extracted RNA was intact and suitable for downstream molecular applications, including RT-PCR and qPCR, and other downstream molecular applications. Thus, this protocol represents a simple, efficient, and low-cost method.	[Ma, Zhihui] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Ma, Zhihui; Huang, Binlong; Xu, Shanshan; Chen, Yu; Li, Shubin; Lin, Sizu] State Forestry Adm, Engn Res Ctr Chinese Fir, Fuzhou, Peoples R China; [Huang, Binlong; Xu, Shanshan; Chen, Yu; Li, Shubin; Lin, Sizu] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Lin, SZ (corresponding author), State Forestry Adm, Engn Res Ctr Chinese Fir, Fuzhou, Peoples R China.	szlin53@126.com			Chinese fir plantation in colleges and universities cultivate innovation team building [6213c0111]	Chinese fir plantation in colleges and universities cultivate innovation team building	Funding for this work was provided by central financial support from the local special: Chinese fir plantation in colleges and universities cultivate innovation team building (6213c0111).	Birtic S, 2006, PHYTOCHEM ANALYSIS, V17, P144, DOI 10.1002/pca.903; CHAN KL, 2007, NATURE PROTOCOL, V184; Christou A, 2014, GENE, V537, P169, DOI 10.1016/j.gene.2013.11.066; Fort F, 2008, J SCI FOOD AGR, V88, P179, DOI 10.1002/jsfa.3066; Gao Zhi-hui, 2000, Forest Research, V13, P659; Guan K, 1994, J ZHEJIANG FORESTRY, V11, P105; Huang HH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-648; Isolation Peng S., 2011, ISOLATION EXPRESSION; [蒋向辉 Jiang Xianghui], 2009, [江苏农业科学, Jiangsu Agricultural Sciences], P81; Kiefer E, 2000, PLANT MOL BIOL REP, V18, P33, DOI 10.1007/BF02825291; Kumar GRK, 2011, ANAL BIOCHEM, V413, P63, DOI 10.1016/j.ab.2011.01.046; [李霞 Li Xia], 2010, [分子植物育种, Molecular Plant Breeding], V8, P410; Ni D., 2013, CLONING EXPRESSION A; Peng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095687; Peng ShaSha, 2012, Journal of Zhejiang A&F University, V29, P1; Qiu ZB, 2013, NEW PHYTOL, V199, P708, DOI 10.1111/nph.12301; Rubio-Pina JA, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue5-fulltext-10; Shu CW, 2014, ELECTRON J BIOTECHN, V17, DOI 10.1016/j.ejbt.2013.12.009; Sivakumar S, 2007, PREP BIOCHEM BIOTECH, V37, P323, DOI 10.1080/10826060701593217; Smart M, 2010, S AFR J BOT, V76, P375, DOI 10.1016/j.sajb.2010.01.002; Wan LC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-146; Wang LM, 2010, BIOMATERIALS, V31, P1612, DOI 10.1016/j.biomaterials.2009.11.024; Wang ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071562; Xu LiLi, 2013, Scientia Silvae Sinicae, V49, P64; Yang LiWei, 2005, Journal of Nanjing Forestry University (Natural Sciences Edition), V29, P85; Yockteng R, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300070; [俞新妥 YU Xintuo], 2006, [福建林学院学报, Journal of Fujian College of Forestry], V26, P177	27	10	11	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130234	10.1371/journal.pone.0130234	http://dx.doi.org/10.1371/journal.pone.0130234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083257	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400132
J	Nishibayashi, R; Inoue, R; Harada, Y; Watanabe, T; Makioka, Y; Ushida, K				Nishibayashi, Ryoichiro; Inoue, Ryo; Harada, Yuri; Watanabe, Takumi; Makioka, Yuko; Ushida, Kazunari			RNA of Enterococcus faecalis Strain EC-12 Is a Major Component Inducing Interleukin-12 Production from Human Monocytic Cells	PLOS ONE			English	Article							BORRELIA-BURGDORFERI RNA; LACTOBACILLUS-CASEI; ATOPIC-DERMATITIS; STRANDED-RNA; RECEPTOR 7; RECOGNITION; MICE; TLR7; BIFIDOBACTERIA; SPLENOCYTES	Interleukin-12 (IL-12) is an important cytokine for the immunomodulatory effects of lactic acid bacteria (LAB). Using murine immune cells, we previously reported that the RNA of Enterococcus faecalis EC-12, a LAB strain exerting probiotic-like beneficial effects, is the major IL-12-inducing immunogenic component. However, it was recently revealed that bacterial RNA can be a ligand for Toll-like receptor (TLR) 13, which is only expressed in mice. Because TLR13 is not expressed in humans, the immuno-stimulatory and -modulatory effects of LAB RNA in human cells should be augmented excluding TLR13 contribution. In experiment 1 of this study, the role of LAB RNA in IL-12 induction in human immune cells was studied using three LAB strains, E.faecalis EC-12, Lactobacillus gasseri JCM5344, and Bifidobacterium breve JCM1192. RNase A treatment of heat-killed LAB significantly decreased the IL-12 production of human peripheral blood mononuclear cells on stimulation, while RNase III treatment revealed virtually no effects. Further, IL-12 production against heat-killed E. faecalis EC-12 was abolished by depleting monocytes. These results demonstrated that single stranded RNA (ssRNA) of LAB is a strong inducer of IL-12 production from human monocytes. In experiment 2, major receptor for ssRNA of E. faecalis EC-12 was identified using THP-1 cells, a human monocytic cell line. The type of RNA molecules of E. faecalis EC-12 responsible for IL-12 induction was also identified. IL-12 production induced by the total RNA of E. faecalis EC-12 was significantly reduced by the treatment of siRNA for TLR8 but not for TLR7. Furthermore, both 23S and 16S rRNA, but not mRNA, of E. faecalis EC-12 markedly induced IL-12 production from THP-1 cells. These results suggested that the recognition of ssRNA of E. faecalis EC-12 was mediated by TLR8 and that rRNA was the RNA molecule that exhibited IL-12-inducing ability in human cells.	[Nishibayashi, Ryoichiro; Inoue, Ryo; Harada, Yuri; Ushida, Kazunari] Kyoto Prefectural Univ, Lab Anim Sci, Kyoto, Kyoto, Japan; [Watanabe, Takumi; Makioka, Yuko] Combi Corp, Dept Funct Foods, Saitama, Saitama, Japan	Kyoto Prefectural University	Inoue, R (corresponding author), Kyoto Prefectural Univ, Lab Anim Sci, Kyoto, Kyoto, Japan.	r-inoue@kpu.ac.jp			Kyoto Prefectural University; Combi Corporation (Saitama, Japan)	Kyoto Prefectural University; Combi Corporation (Saitama, Japan)	This work was supported by institutional grant from Kyoto Prefectural University and by a grant from Combi Corporation (Saitama, Japan). Combi Corporation provided support in the form of salaries for authors TW and YM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Asahara T, 2004, INFECT IMMUN, V72, P2240, DOI 10.1128/IAI.72.4.2240-2247.2004; Cervantes JL, 2013, J LEUKOCYTE BIOL, V94, P1231, DOI 10.1189/jlb.0413206; Chuang L, 2007, J AGR FOOD CHEM, V55, P11080, DOI 10.1021/jf071786o; Cross ML, 2001, INT IMMUNOPHARMACOL, V1, P891, DOI 10.1016/S1567-5769(01)00025-X; Eberle F, 2009, EUR J IMMUNOL, V39, P2537, DOI 10.1002/eji.200838978; FAO/WHO, 2002, REPORT OF A JOINT FA; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hovden AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031217; Inoue R, 2007, BRIT J DERMATOL, V156, P499, DOI 10.1111/j.1365-2133.2006.07695.x; Inoue R, 2011, FEMS IMMUNOL MED MIC, V61, P94, DOI 10.1111/j.1574-695X.2010.00752.x; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; KATO I, 1994, INT J IMMUNOPHARMACO, V16, P29, DOI 10.1016/0192-0561(94)90116-3; Kawase M, 2012, FEMS IMMUNOL MED MIC, V64, P280, DOI 10.1111/j.1574-695X.2011.00903.x; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Li XD, 2012, ELIFE, V1, DOI 10.7554/eLife.00102; Love AC, 2014, INFECT IMMUN, V82, P2405, DOI 10.1128/IAI.01617-14; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Murosaki S, 2000, CANCER IMMUNOL IMMUN, V49, P157, DOI 10.1007/s002620050615; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Pandey S., 2015, COLD SPRING HARB PER, V5; REID G, 1990, CLIN MICROBIOL REV, V3, P335, DOI 10.1128/CMR.3.4.335-344.1990; Sawada J, 2007, CLIN EXP ALLERGY, V37, P296, DOI 10.1111/j.1365-2222.2006.02645.x; Shida K, 2002, CLIN EXP ALLERGY, V32, P563, DOI 10.1046/j.0954-7894.2002.01354.x; Struhl K, 2001, Curr Protoc Mol Biol, VChapter 3, DOI 10.1002/0471142727.mb0313s08; Takagi A, 2001, CARCINOGENESIS, V22, P599, DOI 10.1093/carcin/22.4.599; Tobita K, 2009, J AGR FOOD CHEM, V57, P5586, DOI 10.1021/jf900703q; Trinchieri G, 1996, J LEUKOCYTE BIOL, V59, P505, DOI 10.1002/jlb.59.4.505; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x	35	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129806	10.1371/journal.pone.0129806	http://dx.doi.org/10.1371/journal.pone.0129806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083838	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400110
J	Schmieg, N; Thomas, C; Yabe, A; Lynch, DS; Iglesias, T; Chakravarty, P; Schiavo, G				Schmieg, Nathalie; Thomas, Claire; Yabe, Arisa; Lynch, David S.; Iglesias, Teresa; Chakravarty, Probir; Schiavo, Giampietro			Novel Kidins220/ARMS Splice Isoforms: Potential Specific Regulators of Neuronal and Cardiovascular Development	PLOS ONE			English	Article							MEMBRANE-SPANNING PROTEIN; NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; SIGNALING PATHWAYS; MESSENGER-RNA; BDNF; NEUROTROPHIN; EXPRESSION; VEGF; GENE	Kidins220/ARMS is a transmembrane protein playing a crucial role in neuronal and cardiovascular development. Kidins220/ARMS is a downstream target of neurotrophin receptors and interacts with several signalling and trafficking factors. Through computational modelling, we found two potential sites for alternative splicing of Kidins220/ARMS. The first is located between exon 24 and exon 29, while the second site replaces exon 32 by a short alternative terminal exon 33. Here we describe the conserved occurrence of several Kidins220/ARMS splice isoforms at RNA and protein levels. Kidins220/ARMS splice isoforms display spatio-temporal regulation during development with distinct patterns in different neuronal populations. Neurotrophin receptor stimulation in cortical and hippocampal neurons and neuroendocrine cells induces specific Kidins220/ARMS splice isoforms and alters the appearance kinetics of the full-length transcript. Remarkably, alternative terminal exon splicing generates Kidins220/ARMS variants with distinct cellular localisation: Kidins220/ARMS containing exon 32 is targeted to the plasma membrane and neurite tips, whereas Kidins220/ARMS without exon 33 mainly clusters the full-length protein in a perinuclear intracellular compartment in PC12 cells and primary neurons, leading to a change in neurotrophin receptor expression. Overall, this study demonstrates the existence of novel Kidins220/ARMS splice isoforms with unique properties, revealing additional complexity in the functional regulation of neurotrophin receptors, and potentially other signalling pathways involved in neuronal and cardiovascular development.	[Schmieg, Nathalie; Lynch, David S.; Schiavo, Giampietro] UCL, UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, Mol Neuropathobiol Lab, London WC1N 3BG, England; [Schmieg, Nathalie; Thomas, Claire; Yabe, Arisa; Chakravarty, Probir] Francis Crick Inst, London WC2A 3LY, England; [Lynch, David S.] UCL, Leonard Wolfson Ctr Expt Neurol, London W1G 9LD, England; [Iglesias, Teresa] Inst Invest Biomed Alberto Sols CSIC UAM, Madrid 28029, Spain; [Iglesias, Teresa] CIBERNED ISCIII, Madrid 28031, Spain	University of London; University College London; Francis Crick Institute; University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBERNED	Schiavo, G (corresponding author), UCL, UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, Mol Neuropathobiol Lab, London WC1N 3BG, England.	giampietro.schiavo@ucl.ac.uk	Vacas, Teresa Iglesias/ABF-8663-2020	Vacas, Teresa Iglesias/0000-0002-4326-9005; chakravarty, probir/0000-0003-1146-8824	Cancer Research UK [LF4605]; Sobell Department of Motor Neuroscience & Movement Disorders [6E8A]; Leonard Wolfson Centre for Experimental Neurology, University College London [6HCA]; The Francis Crick Institute [10002] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Sobell Department of Motor Neuroscience & Movement Disorders; Leonard Wolfson Centre for Experimental Neurology, University College London; The Francis Crick Institute	This work was supported by Cancer Research UK (LF4605), NS, CT, AY and GS; Sobell Department of Motor Neuroscience & Movement Disorders (6E8A) GS; and Leonard Wolfson Centre for Experimental Neurology, University College London (6HCA) DSL.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Baj G, 2013, HIPPOCAMPUS, V23, P413, DOI 10.1002/hipo.22100; Baj G, 2011, P NATL ACAD SCI USA, V108, P16813, DOI 10.1073/pnas.1014168108; Bercsenyi K, 2014, SCIENCE, V346, P1118, DOI 10.1126/science.1258138; Bracale A, 2007, MOL BIOL CELL, V18, P142, DOI 10.1091/mbc.E06-05-0453; Cesca F, 2012, CELL DEATH DIFFER, V19, P194, DOI 10.1038/cdd.2011.141; Cesca F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.108; Chang MS, 2004, J NEUROSCI RES, V78, P186, DOI 10.1002/jnr.20262; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Garzon D, 2002, J NEUROCHEM, V82, P1058, DOI 10.1046/j.1471-4159.2002.01030.x; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Grumolato L, 2003, EUR J NEUROSCI, V17, P71, DOI 10.1046/j.1460-9568.2003.02426.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Kotlyanskaya L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003824; Lara-Pezzi E, 2013, J CARDIOVASC TRANSL, V6, P945, DOI 10.1007/s12265-013-9482-z; Lazo OM, 2013, J NEUROSCI, V33, P6112, DOI 10.1523/JNEUROSCI.4630-12.2013; Lee CJ, 2003, BIOL PSYCHIAT, V54, P771, DOI 10.1016/S0006-3223(03)00375-5; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Luberg K, 2010, J NEUROCHEM, V113, P952, DOI 10.1111/j.1471-4159.2010.06662.x; Neubrand VE, 2012, J CELL SCI, V125, P1845, DOI 10.1242/jcs.102764; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schmieg N, 2014, SEMIN CELL DEV BIOL, V27, P32, DOI 10.1016/j.semcdb.2013.10.004; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Terenzio M, 2014, EMBO J, V33, P1582, DOI 10.15252/embj.201387579; Wong J, 2012, NEUROSCIENCE, V210, P363, DOI 10.1016/j.neuroscience.2012.02.037; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yu T, 2014, J NEUROSCI, V34, P6098, DOI 10.1523/JNEUROSCI.4271-13.2014	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129944	10.1371/journal.pone.0129944	http://dx.doi.org/10.1371/journal.pone.0129944			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083449	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400116
J	Li, H; Shen, LY; Yan, WP; Dong, B; Kang, XZ; Dai, L; Yang, YB; Fu, H; Yang, HL; Zhou, HT; Huang, C; Liang, Z; Xiong, HC; Chen, KN				Li, Hui; Shen, Lu-Yan; Yan, Wan-Pu; Dong, Bin; Kang, Xiao-Zheng; Dai, Liang; Yang, Yong-Bo; Fu, Hao; Yang, He-Li; Zhou, Hai-Tao; Huang, Chuan; Liang, Zhen; Xiong, Hong-Chao; Chen, Ke-Neng			Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo	PLOS ONE			English	Article							HOMEOBOX GENE-EXPRESSION; MESSENGER-RNA; GROWTH-FACTOR; PROGRESSION; OVEREXPRESSION	Background We observed abnormal HOXB7 expression in esophageal squamous cell carcinoma (ESCC) previously. This study was to evaluate the prognostic significance of HOXB7 and reveal the potential mechanism. Methods Immunohistochemistry was used to confirm the abnormal expression of HOXB7 in ESCC. The prognostic significance of HOXB7 expression was analyzed in two independent cohorts. RNAi was used to establish two stable HOXB7-knockdown cell strains. CCK8 assay, cell growth curve assay, colony formation assay, flow cycle analysis and tumorigenicity assay in nude mice were employed to investigate the effect of HOXB7 on proliferation in vitro and in vivo. Results Immunohistochemistry confirmed the abnormal expression of HOXB7 in ESCC compared with paracancerous mucosa (18/23 vs. 9/23, p=0.039). HOXB7 expression was positively correlated with the T stage, lymph node metastasis and TNM stage. The median survival of patients with high HOXB7 expression was significantly shorter than that with low expression (45 months vs. 137 months, p = 0.007 for cohort 1; 19 months vs. 34 months, p = 0.001 for cohort 2). Multivariate survival analysis showed that HOXB7 expression was another independent prognostic factor (HR [95% CI] = 0.573 [0.341-0.963], p = 0.036 for cohort 1; HR [95% CI] = 0.543 [0.350-0.844], p = 0.024 for cohort 2). Experiments in vitro and in vivo showed that after knockdown of HOXB7, the proliferation rate dropped, growth rate descended, colony-formation ability reduced, G1-phase arrest occurred and the tumorigenicity reduced remarkably. Conclusions HOXB7 could promote cancer cell proliferation and might be an independent prognostic factor for patients with ESCC.	[Li, Hui; Shen, Lu-Yan; Yan, Wan-Pu; Kang, Xiao-Zheng; Dai, Liang; Yang, Yong-Bo; Fu, Hao; Yang, He-Li; Zhou, Hai-Tao; Huang, Chuan; Liang, Zhen; Xiong, Hong-Chao; Chen, Ke-Neng] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Surg 1, Beijing 100871, Peoples R China; [Dong, Bin] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University	Chen, KN (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Surg 1, Beijing 100871, Peoples R China.	chenkeneng@bjmu.edu.cn	Kang, Xiaozheng/J-1996-2019; Kang, Xiaozheng/CAF-6485-2022; LI, Hui/AHA-9715-2022	Kang, Xiaozheng/0000-0003-0334-1487; 				Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Agnelli L, 2011, AM J HEMATOL, V86, pE64, DOI 10.1002/ajh.22164; Kovochich AN, 2013, CANCER-AM CANCER SOC, V119, P529, DOI 10.1002/cncr.27725; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Care A, 1998, ONCOGENE, V16, P3285, DOI 10.1038/sj.onc.1201875; Care A, 1996, MOL CELL BIOL, V16, P4842; Care A, 1999, ONCOGENE, V18, P1993, DOI 10.1038/sj.onc.1202498; Care A, 2001, CANCER RES, V61, P6532; Chen HX, 2008, CANCER RES, V68, P3637, DOI 10.1158/0008-5472.CAN-07-2926; Chen KN, 2005, CLIN CANCER RES, V11, P1044; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Chile T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-451; Destro MFDS, 2010, INT J ONCOL, V36, P141, DOI 10.3892/ijo_00000485; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Liao WT, 2011, CLIN CANCER RES, V17, P3569, DOI 10.1158/1078-0432.CCR-10-2533; Liu S, 2015, CANCER RES, V75, P709, DOI 10.1158/0008-5472.CAN-14-3100; Long QY, 2014, ASIAN PAC J CANCER P, V15, P1563, DOI 10.7314/APJCP.2014.15.4.1563; Ma YL, 2010, J CELL MOL MED, V14, P2697, DOI 10.1111/j.1582-4934.2010.01191.x; Naora H, 2001, P NATL ACAD SCI USA, V98, P4060, DOI 10.1073/pnas.071594398; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; Storti P, 2011, LEUKEMIA, V25, P527, DOI 10.1038/leu.2010.270; Takahashi O, 2007, ONCOL REP, V17, P753; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Xie X, 2013, BIOMARKERS, V18, P297, DOI 10.3109/1354750X.2013.773380; Yahagi Naohisa, 2004, Congenital Anomalies, V44, P18, DOI 10.1111/j.1741-4520.2003.00004.x; Yuan WW, 2014, MOL CARCINOGEN, V53, P49, DOI 10.1002/mc.21947; Zhang R, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-61	30	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130551	10.1371/journal.pone.0130551	http://dx.doi.org/10.1371/journal.pone.0130551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076456	gold, Green Submitted, Green Published			2022-12-26	WOS:000356329900178
J	Tong, ZW; Li, M; Wang, W; Mo, PL; Yu, L; Liu, K; Ren, WJ; Li, WG; Zhang, H; Xu, JM; Yu, CD				Tong, Zhangwei; Li, Ming; Wang, Wei; Mo, Pingli; Yu, Li; Liu, Kun; Ren, Wenjing; Li, Wengang; Zhang, Hao; Xu, Jianming; Yu, Chundong			Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-B-VIRUS; BETA-CATENIN; TRANSCRIPTIONAL COACTIVATOR; ANDROGEN RECEPTOR; CELL-GROWTH; C-MYC; EXPRESSION; PROTEINS; SRC-1; AIB1	Steroid receptor coactivator 1 (SRC-1) is a transcriptional coactivator not only for steroid receptors, such as androgen receptor and estrogen receptor, but also for other transcription factors. SRC-1 has been shown to play an important role in the progression of breast cancer and prostate cancer. However, its role in liver cancer progression remains unknown. In this study, we report that SRC-1 was overexpressed in 25 (62.5%) of 40 human hepatocellular carcinoma (HCC) specimens. Down-regulation of SRC-1 decreased HCC cell proliferation and impaired tumor maintenance in HCC xenografts. Knockdown of SRC-1 reduced protein levels of the proliferation marker proliferating cell nuclear antigen (PCNA) and the oncogene c-Myc. Knockout of SRC-1 in mice reduced diethylnitrosamine/CCl4-induced tumor formation in the liver and the expression of c-Myc and PCNA in liver tumors. SRC-1 promoted c-Myc expression, at least in part, by directly interacting with beta-catenin to enhance Wnt/beta-catenin signaling. Consistent with these results, the expression of SRC-1 was positively correlated with PCNA expression in human HCC specimens, and the expression levels of c-Myc in SRC-1-positive HCC specimens were higher than in SRC-1-negative HCC specimens. In addition, SRC-1 and SRC-3 were co-overexpressed in 47.5% of HCC specimens, and they cooperated to promote HCC cell proliferation. Simultaneous down-regulation of SRC-1 and SRC-3 dramatically inhibited HCC cell proliferation. Our results demonstrate that SRC-1 promotes HCC progression by enhancing Wnt/beta-catenin signaling and suggest that SRC-1 is a potential therapeutic molecular target for HCC.	[Tong, Zhangwei; Li, Ming; Wang, Wei; Mo, Pingli; Yu, Li; Liu, Kun; Ren, Wenjing; Yu, Chundong] Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China; [Tong, Zhangwei; Yu, Chundong] Xiamen Univ, Engn Res Ctr Mol Diagnost, Minist Educ, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China; [Li, Ming; Li, Wengang] Xiamen Univ, Chenggong Hosp, Dept Hepatobiliary Pancreas & Vessel Surg, Xiamen 361003, Fujian, Peoples R China; [Liu, Kun] Xiamen Univ, Chenggong Hosp, Dept Pathol, Xiamen, Peoples R China; [Zhang, Hao] Shantou Univ, Coll Med, Canc Res Ctr, Shantou 515041, Guangdong, Peoples R China; [Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Xiamen University; Xiamen University; Xiamen University; Xiamen University; Shantou University; Baylor College of Medicine	Yu, CD (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China.	cdyu@xmu.edu.cn	Regan, Clinton/E-6250-2012; Tong, Zhangwei/V-2475-2019		National Basic Research Program of China (973 Program) [2015CB553800]; Natural Science Foundation of China [81372176, 31301128]; Fundamental Research Funds for the Central Universities [2012121038]; Xiamen Science and Technology Plan [3502Z20124049]; National Institutes of Health [R01 CA112403]; NATIONAL CANCER INSTITUTE [R01CA193455, R01CA112403] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Xiamen Science and Technology Plan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Basic Research Program of China (973 Program) Grant 2015CB553800 (to C. Y.); Natural Science Foundation of China Grants 81372176 (to C. Y.) and 31301128 (to P. M.); Fundamental Research Funds for the Central Universities Grant 2012121038 (to C. Y.); and Xiamen Science and Technology Plan Grant 3502Z20124049 (to W. L.). This work was also supported in part by National Institutes of Health Grant R01 CA112403 (to J. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams BD, 2009, MOL ENDOCRINOL, V23, P1215, DOI 10.1210/me.2009-0062; Agoulnik IU, 2005, CANCER RES, V65, P7959, DOI 10.1158/0008-5472.CAN-04-3541; Al-Azawi D, 2008, ONCOGENE, V27, P3021, DOI 10.1038/sj.onc.1210964; Du QA, 2006, CANCER RES, V66, P7024, DOI 10.1158/0008-5472.CAN-05-4110; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fleming FJ, 2004, J CLIN ENDOCR METAB, V89, P375, DOI 10.1210/jc.2003-031048; Fonte C, 2005, P NATL ACAD SCI USA, V102, P14260, DOI 10.1073/pnas.0506930102; Gregory CW, 2001, CANCER RES, V61, P4315; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hudelist G, 2003, BREAST CANCER RES TR, V78, P193, DOI 10.1023/A:1022930710850; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong JW, 2006, MOL ENDOCRINOL, V20, P1138, DOI 10.1210/me.2005-0407; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; Lin CP, 2010, WORLD J HEPATOL, V2, P16, DOI 10.4254/wjh.v2.i1.16; Liu YH, 2012, HEPATOLOGY, V56, P1015, DOI 10.1002/hep.25751; McBryan J, 2012, CANCER RES, V72, P548, DOI 10.1158/0008-5472.CAN-11-2073; Minguez B, 2011, J HEPATOL, V55, P1325, DOI 10.1016/j.jhep.2011.02.034; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; O'Donnell KA, 2012, P NATL ACAD SCI USA, V109, pE1377, DOI 10.1073/pnas.1115433109; ONATE SA, 1995, SCIENCE, V270, P1354; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Qin L, 2011, CANCER RES, V71, P1742, DOI 10.1158/0008-5472.CAN-10-3453; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Song LN, 2005, J BIOL CHEM, V280, P37853, DOI 10.1074/jbc.M503850200; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Tai H, 2000, BIOCHEM BIOPH RES CO, V267, P311, DOI 10.1006/bbrc.1999.1954; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Uriarte I, 2015, INT J CANCER, V136, P2469, DOI 10.1002/ijc.29287; Walsh CA, 2012, INT J BIOL SCI, V8, P470, DOI 10.7150/ijbs.4125; Wang Y, 2014, CANCER RES, V74, P1506, DOI 10.1158/0008-5472.CAN-13-2939; Wang Y, 2011, MOL ENDOCRINOL, V25, P2041, DOI 10.1210/me.2011-1222; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu Y, 2010, ONCOGENE, V29, P3386, DOI 10.1038/onc.2010.90	35	21	23	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18596	18608		10.1074/jbc.M115.640490	http://dx.doi.org/10.1074/jbc.M115.640490			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26082485	Green Published, hybrid			2022-12-26	WOS:000358512100030
J	Li, YK; Carrillo, JA; Ding, Y; He, YH; Zhao, CP; Zan, LS; Song, JZ				Li, Yaokun; Carrillo, Jose A.; Ding, Yi; He, YangHua; Zhao, Chunping; Zan, Linsen; Song, Jiuzhou			Ruminal Transcriptomic Analysis of Grass-Fed and Grain-Fed Angus Beef Cattle	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; RUMEN FERMENTATION; VITAMIN-E; PASTURE; CARCASS; MEAT; SUPPLEMENTATION; IDENTIFICATION; PREDICTION; EPITHELIUM	Beef represents a major diet component and one of the major sources of protein in human. The beef industry in the United States is currently undergoing changes and is facing increased demands especially for natural grass-fed beef. The grass-fed beef obtained their nutrients directly from pastures, which contained limited assimilable energy but abundant amount of fiber. On the contrary, the grain-fed steers received a grain-based regime that served as an efficient source of high-digestible energy. Lately, ruminant animals have been accused to be a substantial contributor for the green house effect. Therefore, the concerns from environmentalism, animal welfare and public health have driven consumers to choose grass-fed beef. Rumen is one of the key workshops to digest forage constituting a critical step to supply enough nutrients for animals' growth and production. We hypothesize that rumen may function differently in grass-and grain-fed regimes. The objective of this study was to find the differentially expressed genes in the ruminal wall of grass-fed and grain-fed steers, and then explore the potential biopathways. In this study, the RNA Sequencing (RNA-Seq) method was used to measure the gene expression level in the ruminal wall. The total number of reads per sample ranged from 24,697,373 to 36,714,704. The analysis detected 342 differentially expressed genes between ruminal wall samples of animals raised under different regimens. The Fisher's exact test performed in the Ingenuity Pathway Analysis (IPA) software found 16 significant molecular networks. Additionally, 13 significantly enriched pathways were identified, most of which were related to cell development and biosynthesis. Our analysis demonstrated that most of the pathways enriched with the differentially expressed genes were related to cell development and biosynthesis. Our results provided valuable insights into the molecular mechanisms resulting in the phenotype difference between grass-fed and grain-fed cattle.	[Li, Yaokun; Zhao, Chunping; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Carrillo, Jose A.; Ding, Yi; He, YangHua; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	Northwest A&F University - China; University System of Maryland; University of Maryland College Park	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	zanlinsen@163.com; songj88@umd.edu	Song, Jiuzhou/AAD-6440-2020; Ding, Yi/U-3314-2019		China Scholarship Council (CSC); Jorgensen Endowment Funds	China Scholarship Council (CSC)(China Scholarship Council); Jorgensen Endowment Funds	The work was supported by China Scholarship Council (CSC) and Jorgensen Endowment Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz HO, 2007, J CANCER RES CLIN, V133, P107, DOI 10.1007/s00432-006-0149-x; [Anonymous], 2010, FASTQC QUAL CONTR TO; Beck M, 2013, BIOMED TECH BERL; Bondzio A, 2011, AM J PHYSIOL-GASTR L, V301, pG260, DOI 10.1152/ajpgi.00304.2010; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Castrillo C, 2013, ANIM FEED SCI TECH, V180, P34, DOI 10.1016/j.anifeedsci.2013.01.004; Daley CA, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-10; De la Fuente J, 2009, MEAT SCI, V82, P331, DOI 10.1016/j.meatsci.2009.02.002; De Smet S, 2004, ANIM RES, V53, P81, DOI 10.1051/animres:2004003; Descalzo AM, 2007, MEAT SCI, V75, P299, DOI 10.1016/j.meatsci.2006.07.015; Descalzo AM, 2005, MEAT SCI, V70, P35, DOI 10.1016/j.meatsci.2004.11.018; Elmore JS, 2004, MEAT SCI, V68, P27, DOI 10.1016/j.meatsci.2004.01.010; Garcia PT, 2008, MEAT SCI, V79, P500, DOI 10.1016/j.meatsci.2007.10.019; Higgs JD, 2000, TRENDS FOOD SCI TECH, V11, P85, DOI 10.1016/S0924-2244(00)00055-8; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jia PL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S12; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Li RW, 2012, FUNCT INTEGR GENOMIC, V12, P35, DOI 10.1007/s10142-011-0259-7; Maughan C, 2012, MEAT SCI, V90, P116, DOI 10.1016/j.meatsci.2011.06.006; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Merrick BA, 2012, CHEM RES TOXICOL, V25, P1132, DOI 10.1021/tx3000945; Mitra A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-557; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Naeem A, 2014, FUNCT INTEGR GENOMIC, V14, P261, DOI 10.1007/s10142-013-0351-2; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Pinloche E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067824; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; Priolo A, 2002, MEAT SCI, V62, P179, DOI 10.1016/S0309-1740(01)00244-3; PRIYANTO R, 1993, ANIM PROD, V57, P65, DOI 10.1017/S0003356100006619; PUTTAGUNTA S, 1994, J BIOL CHEM, V269, P1949; QUIGLEY JD, 1985, J DAIRY SCI, V68, P694, DOI 10.3168/jds.S0022-0302(85)80875-4; Realini CE, 2004, MEAT SCI, V68, P35, DOI 10.1016/j.meatsci.2004.02.002; Realini CE, 2004, MEAT SCI, V66, P567, DOI 10.1016/S0309-1740(03)00160-8; SCOTT LW, 1994, ARCH INTERN MED, V154, P1261, DOI 10.1001/archinte.154.11.1261; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Wanapat M, 2013, ASIAN AUSTRAL J ANIM, V26, P1127, DOI 10.5713/ajas.2013.13013; Wanapat M, 2013, BUFFALO BULL, V32, P258; Yang A, 2002, MEAT SCI, V60, P35, DOI 10.1016/S0309-1740(01)00102-4; Yang CJ, 2013, BUFFALO BULL, V32, P951; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	41	17	18	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0116437	10.1371/journal.pone.0116437	http://dx.doi.org/10.1371/journal.pone.0116437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090810	gold, Green Published			2022-12-26	WOS:000356835000001
J	Loren, V; Cabre, E; Ojanguren, I; Domenech, E; Pedrosa, E; Garcia-Jaraquemada, A; Manosa, M; Manye, J				Loren, Violeta; Cabre, Eduard; Ojanguren, Isabel; Domenech, Eugeni; Pedrosa, Elisabet; Garcia-Jaraquemada, Arce; Manosa, Miriam; Manye, Josep			Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MITOGEN-ACTIVATED PROTEIN; GLUCOCORTICOID-RECEPTOR; DOWN-REGULATION; CROHNS-DISEASE; EXPRESSION; KINASE; CELLS; MODEL; INHIBITION	Glucocorticosteroids are the first line therapy for moderate-severe flare-ups of ulcerative colitis. Despite that, up to 60% of patients do not respond adequately to steroid treatment. Previously, we reported that low IL-10 mRNA levels in intestine are associated with a poor response to glucocorticoids in active Crohn's disease. Here, we test whether IL-10 can favour the response to glucocorticoids by improving the TNF alpha-induced intestinal barrier damage (assessed by transepithelial electrical resistance) in Caco-2 monolayers, and their possible implications on glucocorticoid responsiveness in active ulcerative colitis. We show that the association of IL-10 and glucocorticoids improves the integrity of TNF alpha-treated Caco-2 cells and that p38 MAPK plays a key role. In vitro, IL-10 facilitates the nuclear translocation of p38 MAPK-phosphorylated thereby modulating glucocorticoids-receptor-alpha, IL-10- receptor-a and desmoglein-2 expression. In glucocorticoids-refractory patients, p38 MAPK phosphorylation and membrane desmoglein-2 expression are reduced in colonic epithelial cells. These results suggest that p38 MAPK-mediated synergism between IL-10 and glucocorticoids improves desmosome straightness contributing to the recovery of intestinal epithelium and reducing luminal antigens contact with lamina propria in ulcerative colitis. This study highlights the link between the intestinal epithelium in glucocorticoids-response in ulcerative colitis.	[Loren, Violeta; Pedrosa, Elisabet; Garcia-Jaraquemada, Arce; Manye, Josep] Res Inst Hlth Sci Germans Trias & Pujol, Inflammatory Bowel Dis Unit, Barcelona, Spain; [Loren, Violeta; Cabre, Eduard; Domenech, Eugeni; Pedrosa, Elisabet; Manosa, Miriam; Manye, Josep] CIBER, Madrid, Spain; [Cabre, Eduard; Domenech, Eugeni; Manosa, Miriam] Germans Trias & Pujol Univ Hosp, Dept Gastroenterol, Inflammatory Bowel Dis & GI Unit, Barcelona, Spain; [Ojanguren, Isabel] Germans Trias & Pujol Univ Hosp, Dept Pathol, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red	Cabre, E (corresponding author), CIBER, Madrid, Spain.	ecabre.germanstrias@gencat.cat			Spanish Gastroenterological Association (AEG); Spanish Education Ministry [BFU 2006-15063-C03-2]; CIBER [G0034]	Spanish Gastroenterological Association (AEG); Spanish Education Ministry(Spanish Government); CIBER	This work was funded by the following: a 2012 Spanish Gastroenterological Association (AEG; http://www.aegastro.es/) grant to J. Manye, a 2006 Spanish Education Ministry grant (BFU 2006-15063-C03-2; http://www.mecd.gob.es) to J. Manye, and CIBER G0034 (http://www.ciberisciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artursson P, 2012, ADV DRUG DELIVER REV, V64, P280, DOI 10.1016/j.addr.2012.09.005; Boivin MA, 2007, AM J PHYSIOL-GASTR L, V292, pG590, DOI 10.1152/ajpgi.00252.2006; Chaturvedi LS, 2011, AM J PHYSIOL-CELL PH, V301, pC1224, DOI 10.1152/ajpcell.00518.2010; Dai C, 2012, INT J MOL MED, V29, P202, DOI 10.3892/ijmm.2011.839; Docena G, 2010, CLIN EXP IMMUNOL, V162, P108, DOI 10.1111/j.1365-2249.2010.04203.x; Domenech E, 2008, INFLAMM BOWEL DIS, V14, P1373, DOI 10.1002/ibd.20498; Farrell RJ, 2000, GASTROENTEROLOGY, V118, P279, DOI 10.1016/S0016-5085(00)70210-1; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Fujishima S, 2009, CLIN IMMUNOL, V133, P208, DOI 10.1016/j.clim.2009.07.006; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Homer CR, 2012, J BIOL CHEM, V287, P25565, DOI 10.1074/jbc.M111.326835; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Honda M, 2000, GASTROENTEROLOGY, V118, P859, DOI 10.1016/S0016-5085(00)70172-7; Ina K, 1999, J IMMUNOL, V163, P1081; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lee HE, 2009, J BIOL CHEM, V284, P12524, DOI 10.1074/jbc.M808204200; Madsen KL, 1999, INFLAMM BOWEL DIS, V5, P262, DOI 10.1097/00054725-199911000-00004; Malamut G, 2006, DIGEST DIS SCI, V51, P1443, DOI 10.1007/s10620-006-9116-2; Mao XM, 2011, J BIOL CHEM, V286, P1283, DOI 10.1074/jbc.M110.172874; Nishimura T, 2008, WORLD J GASTROENTERO, V14, P5851, DOI 10.3748/wjg.14.5851; Otsuka M, 2010, GASTROENTEROLOGY, V138, P1255, DOI 10.1053/j.gastro.2010.01.005; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Raddatz D, 2004, ALIMENT PHARM THERAP, V19, P47, DOI 10.1046/j.1365-2036.2003.01802.x; Reichardt SD, 2012, ENDOCRINOLOGY, V153, P1783, DOI 10.1210/en.2011-1747; Sambruy Y, 2001, CELL BIOL TOXICOL, V17, P301, DOI 10.1023/A:1012533316609; Santaolalla R, 2009, GASTROENTEROLOGY S1, V136; Santaolalla R, 2011, INFLAMM BOWEL DIS, V17, P1490, DOI 10.1002/ibd.21507; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Sun XY, 2008, AM J PHYSIOL-GASTR L, V294, pG139, DOI 10.1152/ajpgi.00386.2007; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; ten Hove T, 2002, GUT, V50, P507, DOI 10.1136/gut.50.4.507; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; Tremblay E, 2006, J CELL BIOCHEM, V99, P1175, DOI 10.1002/jcb.21015; Ueno N, 2011, INFLAMM BOWEL DIS, V17, P2235, DOI 10.1002/ibd.21597; van Breemen Richard B, 2005, Expert Opin Drug Metab Toxicol, V1, P175, DOI 10.1517/17425255.1.2.175; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Wakeman D, 2012, AM J PHYSIOL-GASTR L, V302, pG997, DOI 10.1152/ajpgi.00485.2011; Zen M, 2011, AUTOIMMUN REV, V10, P305, DOI 10.1016/j.autrev.2010.11.009	41	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130921	10.1371/journal.pone.0130921	http://dx.doi.org/10.1371/journal.pone.0130921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090671	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000159
J	Chen, JM; Zhang, X; Xu, Y; Li, XW; Ren, S; Zhou, YN; Duan, YY; Zern, M; Zhang, H; Chen, GF; Liu, CH; Mu, YP; Liu, P				Chen, Jiamei; Zhang, Xiao; Xu, Ying; Li, Xuewei; Ren, Shuang; Zhou, Yaning; Duan, Yuyou; Zern, Mark; Zhang, Hua; Chen, Gaofeng; Liu, Chenghai; Mu, Yongping; Liu, Ping			Hepatic Progenitor Cells Contribute to the Progression of 2-Acetylaminofluorene/Carbon Tetrachloride-Induced Cirrhosis via the Non-Canonical Wnt Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LIVER STEM-CELLS; STELLATE-CELLS; OVAL CELLS; SIGNALING PATHWAY; DUCTULAR REACTION; OXIDATIVE-STRESS; KUPFFER CELLS; RAT-LIVER; IN-VIVO	Hepatic progenitor cells (HPCs) appear to play an important role in chronic liver injury. In this study, cirrhosis was induced in F-344 rats (n = 32) via subcutaneous injection of 50% carbon tetrachloride (CCl4) twice a week for 8 weeks. Then, 30% CCl4 was administered in conjunction with intragastric 2-acetylaminofluorine (2-AAF) for 4 weeks to induce activation of HPCs. WB-F344 cells were used to provide direct evidence for differentiation of HPCs to myofibroblasts. The results showed that after administration of 2-AAF, the hydroxyproline content and the expressions of alpha-SMA, Col I, Col IV, TGF-beta 1, CD68, TNF-alpha, CK19 and OV6 were significantly increased. OV6 and alpha-SMA were largely co-expressed in fibrous septum and the expressions of Wnt5b, frizzled2, frizzled3 and frizzled6 were markedly increased, while beta-catenin expression was not statistically different among the different groups. Consistent with the above results, WB-F344 cells, treated with TGF-beta 1 in vitro, differentiated into myofibroblasts and alpha-SMA, Col I, Col IV, Wnt5b and frizzled2 expressions were significantly increased, while beta-catenin expression was decreased. After blocking the non-canonical Wnt pathway via WIF-1, the Wnt5b level was down regulated, and a-SMA and F-actin expressions were significantly decreased in the WIF-1-treated cells. In conclusion, these results indicate that HPCs appear to differentiate into myofibroblasts and exhibit a profibrotic effect in progressive cirrhosis via activation of the non-canonical Wnt pathway. Blocking the non-canonical Wnt pathway can inhibit the differentiation of HPCs into myofibroblasts, suggesting that blocking this pathway and changing the fate of differentiated HPCs may be a potential treatment for cirrhosis.	[Chen, Jiamei; Zhang, Xiao; Xu, Ying; Li, Xuewei; Ren, Shuang; Zhou, Yaning; Zhang, Hua; Chen, Gaofeng; Liu, Chenghai; Mu, Yongping; Liu, Ping] Shanghai Univ Tradit Chinese Med, Inst Liver Dis, Shuguang Hosp, Shanghai, Peoples R China; [Duan, Yuyou; Zern, Mark] Univ Calif Davis, Med Ctr, Inst Regenerat Cures, Dept Internal Med, Sacramento, CA 95817 USA	Shanghai University of Traditional Chinese Medicine; University of California System; University of California Davis	Mu, YP (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Liver Dis, Shuguang Hosp, Shanghai, Peoples R China.	ypmu8888@126.com; liuliver@vip.sina.com	Duan, Yuyou/L-2301-2015	Duan, Yuyou/0000-0002-1402-7402	National Natural Science Foundation of China [81173223, 81273728]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (2011, NO. 81173223) and (2012, NO. 81273728). Dr. Yongping Mu received the funding.	Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Behari J, 2010, EXPERT REV GASTROENT, V4, P745, DOI [10.1586/egh.10.74, 10.1586/EGH.10.74]; Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gastro.2007.06.016; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; Crosby HA, 1998, HEPATOLOGY, V28, P980, DOI 10.1002/hep.510280412; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Di Bonzo LV, 2008, GUT, V57, P223, DOI 10.1136/gut.2006.111617; Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; GHOSHAL AK, 1983, LAB INVEST, V48, P224; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; Kristensen DB, 2000, HEPATOLOGY, V32, P268; Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076; Michalopoulos GK, 2011, INT J BIOCHEM CELL B, V43, P173, DOI 10.1016/j.biocel.2009.09.014; Micsenyi A, 2004, GASTROENTEROLOGY, V126, P1134, DOI 10.1053/j.gastro.2003.12.047; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nagy P, 1998, HEPATOLOGY, V28, P423, DOI 10.1002/hep.510280220; Nagy P, 1996, HEPATOLOGY, V23, P71, DOI 10.1053/jhep.1996.v23.pm0008550051; Nakatani K, 2002, VIRCHOWS ARCH, V441, P466, DOI 10.1007/s00428-002-0631-z; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nieto N, 2006, HEPATOLOGY, V44, P1487, DOI 10.1002/hep.21427; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Otogawa K, 2007, AM J PATHOL, V170, P967, DOI 10.2353/ajpath.2007.060441; Petersen BE, 1998, HEPATOLOGY, V27, P1030, DOI 10.1002/hep.510270419; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Roderfeld M, 2010, HEPATOLOGY, V51, P267, DOI 10.1002/hep.23274; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Sell S, 1997, STEM CELLS, V15, P378, DOI 10.1002/stem.150378; Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V291, pG575, DOI 10.1152/ajpgi.00102.2006; Tanaka M, 2011, J BIOCHEM, V149, P231, DOI 10.1093/jb/mvr001; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang P, 2009, LIVER INT, V29, P575, DOI 10.1111/j.1478-3231.2009.01992.x; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047	43	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130310	10.1371/journal.pone.0130310	http://dx.doi.org/10.1371/journal.pone.0130310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087010	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500094
J	Junginger, J; Hansmann, F; Herder, V; Lehmbecker, A; Peters, M; Beyerbach, M; Wohlsein, P; Baumgartner, W				Junginger, Johannes; Hansmann, Florian; Herder, Vanessa; Lehmbecker, Annika; Peters, Martin; Beyerbach, Martin; Wohlsein, Peter; Baumgaertner, Wolfgang			Pathology in Captive Wild Felids at German Zoological Gardens	PLOS ONE			English	Article							TIGER PANTHERA-TIGRIS; CHEETAHS ACINONYX-JUBATUS; IMMUNODEFICIENCY VIRUS-INFECTION; LEOPARD NEOFELIS-NEBULOSA; CANINE-DISTEMPER VIRUS; CENTRAL-NERVOUS-SYSTEM; CHRONIC-RENAL-FAILURE; LEUKEMIA-VIRUS; LENTIVIRUS INFECTION; CLOUDED LEOPARD	This retrospective study provides an overview on spontaneous diseases occurring in 38 captive wild felids submitted for necropsy by German zoological gardens between 2004 and 2013. Species included 18 tigers, 8 leopards, 7 lions, 3 cheetahs and 2 cougars with an age ranging from 0.5 to 22 years. Renal lesions, predominantly tubular alterations (intra-tubular concrements, tubular degeneration, necrosis, intra-tubular cellular debris, proteinaceous casts, dilated tubuli) followed by interstitial (lympho-plasmacytic inflammation, fibrosis, metastatic- suppurative inflammation, eosinophilic inflammation) and glomerular lesions (glomerulonephritis, glomerulosclerosis, amyloidosis) were detected in 33 out of 38 animals (87%). Tumors were found in 19 of 38 felids (50%) with 12 animals showing more than one neoplasm. The tumor prevalence increased with age. Neoplasms originated from endocrine (11), genital (8), lympho-hematopoietic (5) and alimentary organs (4) as well as the mesothelium (3). Most common neoplasms comprised uterine/ovarian leiomyomas (5/2), thyroid adenomas/adenocarcinoma (5/1), pleural mesotheliomas (3), hemangiosarcomas (2) and glossal papillomas (2). Inflammatory changes were frequently encountered in the intestine and the lung. Two young animals displayed metastatic mineralization suggestive of a vitamin D-or calcium intoxication. One tiger exhibited degenerative white matter changes consistent with an entity termed large felid leukoencephalomyelopathy. Various hyperplastic, degenerative and inflammatory changes with minor clinical significance were found in several organs. Summarized, renal lesions followed by neoplastic changes as well as inflammatory changes in lung and gastrointestinal tract represent the most frequent findings in captive wild felids living in German zoological gardens.	[Junginger, Johannes; Hansmann, Florian; Herder, Vanessa; Lehmbecker, Annika; Wohlsein, Peter; Baumgaertner, Wolfgang] Univ Vet Med, Dept Pathol, Hannover, Lower Saxony, Germany; [Hansmann, Florian; Herder, Vanessa; Lehmbecker, Annika; Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Lower Saxony, Germany; [Peters, Martin] Chem & Veterinaeruntersuchungsamt Westphalia, Arnsberg, North Rhine Wes, Germany; [Beyerbach, Martin] Univ Vet Med, Dept Biometry Epidemiol & Informat Proc, Hannover, Lower Saxony, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Baumgartner, W (corresponding author), Univ Vet Med, Dept Pathol, Hannover, Lower Saxony, Germany.	wolfgang.baumgaertner@tiho-hannover.de	Herder, Vanessa/AAG-6647-2020	Junginger, Johannes/0000-0002-4965-4553; Herder, Vanessa/0000-0003-4814-1382; Hansmann, Florian/0000-0001-6064-7728				ABRAMO F, 1995, AIDS RES HUM RETROV, V11, P1247, DOI 10.1089/aid.1995.11.1247; Adams H, 2009, J S AFR VET ASSOC, V80, P151; Adams H, 2010, J ZOO WILDLIFE MED, V41, P608, DOI 10.1638/2009-0137.1; Agudelo CF, 2005, VET QUART, V27, P174; Akin EY, 2013, J ZOO WILDLIFE MED, V44, P761, DOI 10.1638/2012-0215R.1; [Anonymous], 2014, R LANG ENV STAT COMP; Barber PJ, 1998, J SMALL ANIM PRACT, V39, P108, DOI 10.1111/j.1748-5827.1998.tb03613.x; BARR MC, 1989, J ZOO WILDLIFE MED, V20, P265; BAXBY D, 1982, J HYG-CAMBRIDGE, V89, P365, DOI 10.1017/S0022172400070935; Beatty J, 2014, VET J, V201, P174, DOI 10.1016/j.tvjl.2014.05.026; Binns S H, 2000, J Feline Med Surg, V2, P123, DOI 10.1053/jfms.2000.0084; Bollo E, 2011, RES VET SCI, V91, P116, DOI 10.1016/j.rvsc.2010.08.005; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Bracarense APFRL, 2013, J COMP PATHOL, V149, P402, DOI 10.1016/j.jcpa.2013.06.002; Brower AI, 2014, VET PATHOL, V51, P1013, DOI 10.1177/0300985813506917; Brown MA, 2008, EMERG INFECT DIS, V14, P252, DOI 10.3201/eid1402.070981; Calsyn JDR, 2010, J AM ANIM HOSP ASSOC, V46, P36, DOI 10.5326/0460036; Camus AC, 2004, J VET DIAGN INVEST, V16, P567, DOI 10.1177/104063870401600612; CARDY RH, 1978, VET PATHOL, V15, P556, DOI 10.1177/030098587801500414; Carvallo FR, 2010, J VET DIAGN INVEST, V22, P136, DOI 10.1177/104063871002200130; Choi JH, 2002, J WILDLIFE DIS, V38, P199, DOI 10.7589/0090-3558-38.1.199; CITINO SB, 1986, J ZOO WILDLIFE MED, V17, P5, DOI 10.2307/20094780; Cunningham AA, 1998, VET REC, V143, P22, DOI 10.1136/vr.143.1.22; Cunningham MW, 2008, J WILDLIFE DIS, V44, P537, DOI 10.7589/0090-3558-44.3.537; DOSTER AR, 1989, J COMP PATHOL, V100, P475, DOI 10.1016/0021-9975(89)90016-9; Edmondson EF, 2015, VET PATHOL, V52, P338, DOI 10.1177/0300985814533805; EFFRON M, 1977, JNCI-J NATL CANCER I, V59, P185, DOI 10.1093/jnci/59.1.185; Elliott J, 1998, J SMALL ANIM PRACT, V39, P78, DOI 10.1111/j.1748-5827.1998.tb03598.x; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Erdman SE, 1997, AM J PATHOL, V151, P273; FENWICK BW, 1983, J AM VET MED ASSOC, V183, P1315; Fox JG, 1997, VET PATHOL, V34, P225, DOI 10.1177/030098589703400308; GELBERG HB, 1985, VET PATHOL, V22, P572, DOI 10.1177/030098588502200610; Gerhauser I, 2009, EUR J WILDLIFE RES, V55, P433, DOI 10.1007/s10344-009-0260-9; Gupta A, 2013, VET ARHIV, V83, P115; HANNA PE, 1990, CAN J VET RES, V54, P487; Harrenstien LA, 1996, J ZOO WILDLIFE MED, V27, P468; Harrison TM, 2010, VET PATHOL, V47, P952, DOI 10.1177/0300985810375054; Harrison TM, 2007, J ZOO WILDLIFE MED, V38, P333, DOI 10.1638/1042-7260(2007)038[0333:TOMLIA]2.0.CO;2; Hartmann K, 2011, VET IMMUNOL IMMUNOP, V143, P190, DOI 10.1016/j.vetimm.2011.06.003; Helmick KE, 2006, J ZOO WILDLIFE MED, V37, P542, DOI 10.1638/04-042.1; Henschel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083500; HOCHWALD GM, 1984, J NEUROL SCI, V63, P381, DOI 10.1016/0022-510X(84)90161-8; Hora AS, 2013, J CLIN MICROBIOL, V51, P676, DOI 10.1128/JCM.02462-12; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jakob W, 1997, J COMP PATHOL, V116, P21, DOI 10.1016/S0021-9975(97)80040-0; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kelly P, 2013, TOP COMPANION ANIM M, V28, P163, DOI 10.1053/j.tcam.2013.09.004; Kohler K, 2011, TIERARZTLICHE PRAXIS, V39, pA2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LANE VM, 1985, AM J VET RES, V46, P1550; LEAV I, 1976, AM J PATHOL, V83, P61; LIU SK, 1984, J AM VET MED ASSOC, V185, P52; LOMBARD LS, 1959, CANCER RES, V19, P127; LOMBARD LS, 1968, PATHOL VET, V5, P127, DOI 10.1177/030098586800500204; LULICH JP, 1992, COMP CONT EDUC PRACT, V14, P127; MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339; Magden E, 2011, VET IMMUNOL IMMUNOP, V143, P227, DOI 10.1016/j.vetimm.2011.06.016; Maher ER, 1997, VET CLIN N AM-SMALL, V27, P359, DOI 10.1016/S0195-5616(97)50037-4; Marker L, 2003, J WILDLIFE DIS, V39, P690, DOI 10.7589/0090-3558-39.3.690; McAloose D, 2009, NAT REV CANCER, V9, P517, DOI 10.1038/nrc2665; McCain S, 2009, J ZOO WILDLIFE MED, V40, P147, DOI 10.1638/2008-0008.1; MCLAUGHLIN BG, 1988, CAN J VET RES, V52, P476; Mellanby RJ, 2005, J SMALL ANIM PRACT, V46, P334, DOI 10.1111/j.1748-5827.2005.tb00329.x; Miller MA, 2003, J VET DIAGN INVEST, V15, P515, DOI 10.1177/104063870301500602; Motta L, 2012, VET J, V192, P153, DOI 10.1016/j.tvjl.2011.10.008; Mulisch M, 2010, ROMEIS MIKROSKOPISCH; Munson L, 2002, VET PATHOL, V39, P419, DOI 10.1354/vp.39-4-419; Munson L, 1999, J ZOO WILDLIFE MED, V30, P342; Munson Linda, 2007, Breast Dis, V28, P7; Newkirk KM, 2011, VET PATHOL, V48, P698, DOI 10.1177/0300985810382089; O'Brien SJ, 2012, VIRUSES-BASEL, V4, P236, DOI 10.3390/v4020236; Owston MA, 2008, J ZOO WILDLIFE MED, V39, P608, DOI 10.1638/2008-068.1; PAL M, 1991, MYCOSES, V34, P313, DOI 10.1111/j.1439-0507.1991.tb00666.x; PEDEN WM, 1985, J WILDLIFE DIS, V21, P301, DOI 10.7589/0090-3558-21.3.301; Peterson M, 2012, J FELINE MED SURG, V14, P804, DOI 10.1177/1098612X12464462; POLI A, 1995, J WILDLIFE DIS, V31, P70, DOI 10.7589/0090-3558-31.1.70; Poncelet L, 2008, VET PATHOL, V45, P140, DOI 10.1354/vp.45-2-140; PORT CD, 1981, J COMP PATHOL, V91, P115, DOI 10.1016/0021-9975(81)90051-7; Reynolds BS, 2013, J FELINE MED SURG, V15, P3, DOI 10.1177/1098612X13495234; Roelke ME, 2006, J WILDLIFE DIS, V42, P234, DOI 10.7589/0090-3558-42.2.234; Roelke ME, 2009, VIROLOGY, V390, P1, DOI 10.1016/j.virol.2009.04.011; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Roertgen KE, 1996, NEUROBIOL AGING, V17, P243, DOI 10.1016/0197-4580(95)02069-1; Rosen RF, 2008, J COMP NEUROL, V509, P259, DOI 10.1002/cne.21744; SCHONING P, 1980, J FORENSIC SCI, V25, P53; Schrenzel MD, 2010, HELICOBACTER, V15, P126, DOI 10.1111/j.1523-5378.2009.00744.x; Schultheiss PC, 2004, J VET DIAGN INVEST, V16, P522, DOI 10.1177/104063870401600606; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Serizawa S, 2012, VET PATHOL, V49, P304, DOI 10.1177/0300985811410719; Shin NS, 1998, J ZOO WILDLIFE MED, V29, P81; Simpson K. W., 2013, CANINE FELINE GASTRO, P606; Stephenson N, 2013, J WILDLIFE DIS, V49, P408, DOI 10.7589/2012-08-210; Terio KA, 2012, VET PATHOL, V49, P824, DOI 10.1177/0300985811412620; Thalwitzer S, 2010, CLIN VACCINE IMMUNOL, V17, P232, DOI 10.1128/CVI.00345-09; Troxel MT, 2003, J VET INTERN MED, V17, P850, DOI 10.1892/0891-6640(2003)017&lt;0850:FINRRO&gt;2.3.CO;2; Vail DM, 1998, J VET INTERN MED, V12, P349, DOI 10.1111/j.1939-1676.1998.tb02134.x; van der Burg SH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-108; Wada Y, 1996, J COMP PATHOL, V115, P305, DOI 10.1016/S0021-9975(96)80087-9; Wiedner EB, 2008, J ZOO WILDLIFE MED, V39, P121, DOI 10.1638/2007-0080.1; Wohlsein P, 2013, VET PATHOL, V50, P122, DOI 10.1177/0300985812450719; Woo PCY, 2012, P NATL ACAD SCI USA, V109, P5435, DOI 10.1073/pnas.1119972109; YAMAMOTO JK, 1989, J AM VET MED ASSOC, V194, P213; YANO BL, 1981, VET PATHOL, V18, P310, DOI 10.1177/030098588101800303; YANO BL, 1981, VET PATHOL, V18, P621, DOI 10.1177/030098588101800507	105	49	50	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130573	10.1371/journal.pone.0130573	http://dx.doi.org/10.1371/journal.pone.0130573			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086731	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000356567500116
J	Losina, E; Dervan, EE; Paltiel, AD; Dong, Y; Wright, RJ; Spindler, KP; Mandl, LA; Jones, MH; Marx, RG; Safran-Norton, CE; Katz, JN				Losina, Elena; Dervan, Elizabeth E.; Paltiel, A. David; Dong, Yan; Wright, R. John; Spindler, Kurt P.; Mandl, Lisa A.; Jones, Morgan H.; Marx, Robert G.; Safran-Norton, Clare E.; Katz, Jeffrey N.			Defining the Value of Future Research to Identify the Preferred Treatment of Meniscal Tear in the Presence of Knee Osteoarthritis	PLOS ONE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; COST-EFFECTIVENESS ANALYSIS; SURGEON PROCEDURE VOLUME; QUALITY-OF-LIFE; ARTHROSCOPIC SURGERY; RHEUMATOID-ARTHRITIS; COMPLICATIONS; MENISCECTOMY; REPLACEMENT; HEALTH	Background Arthroscopic partial meniscectomy (APM) is extensively used to relieve pain in patients with symptomatic meniscal tear (MT) and knee osteoarthritis (OA). Recent studies have failed to show the superiority of APM compared to other treatments. We aim to examine whether existing evidence is sufficient to reject use of APM as a cost-effective treatment for MT+OA. Methods We built a patient-level microsimulation using Monte Carlo methods and evaluated three strategies: Physical therapy ('PT') alone; PT followed by APM if subjects continued to experience pain ('Delayed APM'); and 'Immediate APM'. Our subject population was US adults with symptomatic MT and knee OA over a 10 year time horizon. We assessed treatment outcomes using societal costs, quality-adjusted life years (QALYs), and calculated incremental cost-effectiveness ratios (ICERs), incorporating productivity costs as a sensitivity analysis. We also conducted a value-of-information analysis using probabilistic sensitivity analyses. Results Calculated ICERs were estimated to be $12,900/QALY for Delayed APM as compared to PT and $103,200/QALY for Immediate APM as compared to Delayed APM. In sensitivity analyses, inclusion of time costs made Delayed APM cost-saving as compared to PT. Improving efficacy of Delayed APM led to higher incremental costs and lower incremental effectiveness of Immediate APM in comparison to Delayed APM. Probabilistic sensitivity analyses indicated that PT had 3.0% probability of being cost-effective at a willingness-to-pay (WTP) threshold of $50,000/QALY. Delayed APM was cost effective 57.7% of the time at WTP = $50,000/QALY and 50.2% at WTP = $100,000/QALY. The probability of Immediate APM being cost-effective did not exceed 50% unless WTP exceeded $103,000/QALY. Conclusions We conclude that current cost-effectiveness evidence does not support unqualified rejection of either Immediate or Delayed APM for the treatment of MT+OA. The amount to which society would be willing to pay for additional information on treatment outcomes greatly exceeds the cost of conducting another randomized controlled trial on APM.	[Losina, Elena; Dervan, Elizabeth E.; Dong, Yan; Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Orthopaed Surg, Orthopaed & Arthrit Ctr Outcomes Res, Boston, MA 02115 USA; [Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Clin Sci Sect, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Losina, Elena; Katz, Jeffrey N.] Harvard Univ, Sch Med, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Paltiel, A. David] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Paltiel, A. David] Yale Univ, Sch Management, New Haven, CT USA; [Wright, R. John] Brigham & Womens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Spindler, Kurt P.; Jones, Morgan H.] Cleveland Clin, Dept Orthopaed Surg, Garfield Hts, OH USA; [Mandl, Lisa A.; Marx, Robert G.] Weill Cornell Med Coll, New York, NY USA; [Mandl, Lisa A.; Marx, Robert G.] Hosp Special Surg, New York, NY 10021 USA; [Safran-Norton, Clare E.] Brigham & Womens Hosp, Dept Rehabil Serv, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Losina, E (corresponding author), Brigham & Womens Hosp, Dept Orthopaed Surg, Orthopaed & Arthrit Ctr Outcomes Res, 75 Francis St, Boston, MA 02115 USA.	elosina@partners.org	Jones, Morgan H/ABG-3503-2021	Jones, Morgan H/0000-0002-5466-0624; Losina, ELENA/0000-0002-3424-0892; Paltiel, A. David/0000-0002-4861-3290	National Institute of Arthritis and Musculoskeletal and Skin Diseases (United States of America) [R01AR055557, R01AR064320, K24AR057827]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064320, R01AR055557, K24AR057827] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (United States of America); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (United States of America, http://www.niams.nih.gov/) grants R01AR055557 (PI: JNK), R01AR064320 (PI: EL), and K24AR057827 (PI: EL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, RED BOOK ONL; [Anonymous], 2011, NAT INP SAMPL; [Anonymous], 2012, MED FEE SCHED; [Anonymous], 2013, MAY 2013 NAT OCC EMP; [Anonymous], 2012, MED HOSP OUTP PROS P; [Anonymous], 2011, MED HOSP INP PROSP P; [Anonymous], 2014, NAT VIT STAT REP CTR; BRANDT KD, 1991, ARTHRITIS RHEUM, V34, P1381; Briggs A, 2006, DECISION MODELLING H; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Buntin MB., 2005, COMP MEDICARE SPENDI; Cullen Karen A, 2009, Natl Health Stat Report, P1; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Farshad M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-317; Gauffin H, 2014, OSTEOARTHR CARTILAGE, V22, P1808, DOI 10.1016/j.joca.2014.07.017; Goldstein JL, 2000, AM J GASTROENTEROL, V95, P1681; Gottlob C A, 2000, Am J Orthop (Belle Mead NJ), V29, P472; Gottlob CA, 1999, CLIN ORTHOP RELAT R, P272, DOI 10.1097/00003086-199910000-00034; Hame SL, 2012, AM J SPORT MED, V40, P1402, DOI 10.1177/0363546512443043; Herrlin S, 2007, KNEE SURG SPORT TR A, V15, P393, DOI 10.1007/s00167-006-0243-2; Herrlin SV, 2013, KNEE SURG SPORT TR A, V21, P358, DOI 10.1007/s00167-012-1960-3; Holt HL, 2011, OSTEOARTHR CARTILAGE, V19, P44, DOI 10.1016/j.joca.2010.10.009; HURST NP, 1994, BRIT J RHEUMATOL, V33, P655; Jordan JM, 2007, J RHEUMATOL, V34, P172; Katz JN, 2007, ARTHRITIS RHEUM, V56, P568, DOI 10.1002/art.22333; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; Katz JN, 2004, J BONE JOINT SURG AM, V86A, P1909, DOI 10.2106/00004623-200409000-00008; Khan M, 2014, CAN MED ASSOC J, V186, P1057, DOI 10.1503/cmaj.140433; Losina E, 2013, ARTHRIT CARE RES, V65, P703, DOI 10.1002/acr.21898; Lubowitz JH, 2011, ARTHROSCOPY, V27, P1317, DOI 10.1016/j.arthro.2011.06.001; Mather RC, 2014, AM J SPORT MED, V42, P1583, DOI 10.1177/0363546514530866; NAHIN RL, 2009, COSTS COMPLEMENTARY; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Toossi M, 2012, MON LABOR REV, V135, P43; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; Weinstein AM, 2013, J BONE JOINT SURG AM, V95A, P385, DOI 10.2106/JBJS.L.00206; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wolfe F, 1997, BRIT J RHEUMATOL, V36, P786; Yim JH, 2013, AM J SPORT MED, V41, P1565, DOI 10.1177/0363546513488518	45	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130256	10.1371/journal.pone.0130256	http://dx.doi.org/10.1371/journal.pone.0130256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086246	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500086
J	Savonenko, AV; Melnikova, T; Wang, YC; Ravert, H; Gao, YJ; Koppel, J; Lee, D; Pletnikova, O; Cho, E; Sayyida, N; Hiatt, A; Troncoso, J; Davies, P; Dannals, RF; Pomper, MG; Horti, AG				Savonenko, Alena V.; Melnikova, Tatiana; Wang, Yuchuan; Ravert, Hayden; Gao, Yongjun; Koppel, Jeremy; Lee, Deidre; Pletnikova, Olga; Cho, Eugenia; Sayyida, Nuzhat; Hiatt, Andrew; Troncoso, Juan; Davies, Peter; Dannals, Robert F.; Pomper, Martin G.; Horti, Andrew G.			Cannabinoid CB2 Receptors in a Mouse Model of A beta Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; ACID AMIDE HYDROLASE; IN-VITRO; TRANSGENIC MICE; DIAGNOSTIC GUIDELINES; COGNITIVE DEFICITS; NATIONAL INSTITUTE; APOLIPOPROTEIN-E; DISEASE; BRAIN	In Alzheimer's disease (AD), one of the early responses to A beta amyloidosis is recruitment of microglia to areas of new plaque. Microglial receptors such as cannabinoid receptor 2 (CB2) might be a suitable target for development of PET radiotracers that could serve as imaging biomarkers of A beta-induced neuroinflammation. Mouse models of amyloidosis (J20APPswe/ind and APPswe/PS1 Delta E9) were used to investigate the cellular distribution of CB2 receptors. Specificity of CB2 antibody (H60) was confirmed using J20APPswe/ind mice lacking CB2 receptors. APPswe/PS1 Delta E9 mice were used in small animal PET with a CB2-targeting radiotracer, [C-11]A836339. These studies revealed increased binding of [C-11]A836339 in amyloid-bearing mice. Specificity of the PET signal was confirmed in a blockade study with a specific CB2 antagonist, AM630. Confocal microscopy revealed that CB2-receptor immunoreactivity was associated with astroglial (GFAP) and, predominantly, microglial (CD68) markers. CB2 receptors were observed, in particular, in microglial processes forming engulfment synapses with A beta plaques. In contrast to glial cells, neuron (NeuN)-derived CB2 signal was equal between amyloid-bearing and control mice. The pattern of neuronal CB2 staining in amyloid-bearing mice was similar to that in human cases of AD. The data collected in this study indicate that A beta amyloidosis without concomitant tau pathology is sufficient to activate CB2 receptors that are suitable as an imaging biomarker of neuroinflammation. The main source of enhanced CB2 PET binding in amyloid-bearing mice is increased CB2 immunoreactivity in activated microglia. The presence of CB2 immunoreactivity in neurons does not likely contribute to the enhanced CB2 PET signal in amyloid-bearing mice due to a lack of significant neuronal loss in this model. However, significant loss of neurons as seen at late stages of AD might decrease the CB2 PET signal due to loss of neuronally-derived CB2. Thus this study in mouse models of AD indicates that a CB2-specific radiotracer can be used as a biomarker of neuroinflammation in the early preclinical stages of AD, when no significant neuronal loss has yet developed.	[Savonenko, Alena V.; Melnikova, Tatiana; Lee, Deidre; Pletnikova, Olga; Cho, Eugenia; Sayyida, Nuzhat; Troncoso, Juan] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Savonenko, Alena V.; Troncoso, Juan] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Wang, Yuchuan; Ravert, Hayden; Gao, Yongjun; Dannals, Robert F.; Pomper, Martin G.; Horti, Andrew G.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Koppel, Jeremy; Davies, Peter] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Litwin Zucker Res Ctr, Manhasset, NY USA; [Hiatt, Andrew] MAPP Biopharmaceut Inc, San Diego, CA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Northwell Health	Savonenko, AV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	asavone1@jhmi.edu; ahorti1@jhmi.edu	Savonenko, Alena/AAT-2274-2021	Wang, Yuchuan/0000-0001-5111-6562	Alzheimer's Drug Discovery Foundation [20120602]; National Institute of Neurological Disease and Stroke [5R01NS047225-08]; National Institutes on Aging (ADRC) [P50AG005146, AG0 25641]; NIH [S10 RR024550, S10 OD016374]; MAPP Biopharmaceutical Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R44AG025641, P50AG005146, R43AG025641] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016374] Funding Source: NIH RePORTER	Alzheimer's Drug Discovery Foundation; National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes on Aging (ADRC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MAPP Biopharmaceutical Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Alzheimer's Drug Discovery Foundation (AH, grant 20120602), National Institute of Neurological Disease and Stroke (AS; 5R01NS047225-08) and the National Institutes on Aging (ADRC: AS; grant number P50AG005146; AH; AG0 25641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Johns Hopkins School of Medicine Microscope Core Facility (www.hopkinsmedicine.org/micfac/) provided access to confocal microscopes acquired by an NIH shared instrumentation grants NIH Award# S10 RR024550, S10 OD016374. Coauthor Andrew Hiatt is employed by MAPP Biopharmaceutical Inc. MAPP Biopharmaceutical Inc. provided support in the form of salary for author AH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ahmad R, 2013, MOL IMAGING BIOL, V15, P384, DOI 10.1007/s11307-013-0626-y; Ashton JC, 2007, CURR OPIN INVEST DR, V8, P373; Aso E, 2013, J ALZHEIMERS DIS, V35, P847, DOI 10.3233/JAD-130137; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; Benito C, 2003, J NEUROSCI, V23, P11136; Berdyshev EV, 2000, CHEM PHYS LIPIDS, V108, P169, DOI 10.1016/S0009-3084(00)00195-X; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Budson AE, 2012, NEUROLOGIST, V18, P356, DOI 10.1097/NRL.0b013e31826a998d; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cecyre B, 2014, N-S ARCH PHARMACOL, V387, P175, DOI 10.1007/s00210-013-0930-8; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; Dowie MJ, 2014, J CHEM NEUROANAT, V59-60, P62, DOI 10.1016/j.jchemneu.2014.06.004; Durand D, 2014, NEUROPHARMACOLOGY, V79, P180, DOI 10.1016/j.neuropharm.2013.11.015; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Esposito G, 2007, J PHARMACOL EXP THER, V322, P1144, DOI 10.1124/jpet.107.121566; Evens N, 2012, NUCL MED BIOL, V39, P389, DOI 10.1016/j.nucmedbio.2011.09.005; Evens N, 2011, BIOORGAN MED CHEM, V19, P4499, DOI 10.1016/j.bmc.2011.06.033; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; GRAEBER MB, 1990, J NEUROIMMUNOL, V27, P121, DOI 10.1016/0165-5728(90)90061-Q; Hortala L, 2014, BIOORG MED CHEM LETT, V24, P283, DOI 10.1016/j.bmcl.2013.11.023; Horti A. G., 2014, PET SPECT NEUROBIOLO, P249; Horti AG, 2010, BIOORGAN MED CHEM, V18, P5202, DOI 10.1016/j.bmc.2010.05.058; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Koppel J, 2013, MOL MED, V19, P357, DOI 10.2119/molmed.2013.00140; Latta CH, 2015, NEUROSCIENCE, V302, P103, DOI 10.1016/j.neuroscience.2014.09.061; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Liu Y, 2008, J NEUROSCI, V28, P13805, DOI 10.1523/JNEUROSCI.4218-08.2008; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; LYNN AB, 1994, J PHARMACOL EXP THER, V268, P1612; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Marchalant Y, 2014, J HISTOCHEM CYTOCHEM, V62, P395, DOI 10.1369/0022155414530995; Martin-Moreno AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-8; Tolon RM, 2009, BRAIN RES, V1283, P148, DOI 10.1016/j.brainres.2009.05.098; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Melnikova T, 2006, NEUROSCIENCE, V141, P1149, DOI 10.1016/j.neuroscience.2006.05.001; Melnikova T, 2013, J NEUROSCI, V33, P3765, DOI 10.1523/JNEUROSCI.4251-12.2013; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Mirrione MM, 2007, NEUROIMAGE, V38, P34, DOI 10.1016/j.neuroimage.2007.06.032; Morgan D, 2005, J NEUROPATH EXP NEUR, V64, P743, DOI 10.1097/01.jnen.0000178444.33972.e0; Morris GH, 2004, NEUROPATHOLOGY DEMEN; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MUFSON EJ, 1994, NEUROBIOL AGING, V15, P621, DOI 10.1016/0197-4580(94)00064-6; Mukhopadhyay S, 2006, J NEUROIMMUNOL, V181, P82, DOI 10.1016/j.jneuroim.2006.08.002; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nunez E, 2008, NEUROSCIENCE, V151, P104, DOI 10.1016/j.neuroscience.2007.10.029; Onaivi ES, 2008, ANN NY ACAD SCI, V1139, P434, DOI 10.1196/annals.1432.036; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; Perez SE, 2010, J NEUROSCI RES, V88, P1026, DOI 10.1002/jnr.22266; Postnov A, 2013, J NUCL MED, V54, P2101, DOI 10.2967/jnumed.113.120857; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; REBECK GW, 1993, NEURON, V11, P575; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Ruiz-Valdepenas L, 2010, EXP NEUROL, V224, P66, DOI 10.1016/j.expneurol.2010.03.024; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmole AC, 2015, NEUROBIOL AGING, V36, P710, DOI 10.1016/j.neurobiolaging.2014.09.019; Sepulveda-Falla D, 2014, J CLIN INVEST, V124, P1552, DOI 10.1172/JCI66407; Sepulveda-Falla D, 2012, J ALZHEIMERS DIS, V32, P1, DOI 10.3233/JAD-2012-120907; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sugiura T, 2000, CHEM PHYS LIPIDS, V108, P89, DOI 10.1016/S0009-3084(00)00189-4; TOMITA M, 1994, HEPATOLOGY, V20, P317, DOI 10.1002/hep.1840200208; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vandeputte C, 2011, J NUCL MED, V52, P1102, DOI 10.2967/jnumed.110.084426; Wang YC, 2006, J NUCL MED, V47, P1891; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Yao BB, 2009, J PHARMACOL EXP THER, V328, P141, DOI 10.1124/jpet.108.145011; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE5007, DOI 10.1073/pnas.1413210111	81	69	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129618	10.1371/journal.pone.0129618	http://dx.doi.org/10.1371/journal.pone.0129618			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086915	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500054
J	Tryjanowski, P; Sparks, TH; Biadun, W; Brauze, T; Hetmanski, T; Martyka, R; Skorka, P; Indykiewicz, P; Myczko, L; Kunysz, P; Kawa, P; Czyz, S; Czechowski, P; Polakowski, M; Zduniak, P; Jerzak, L; Janiszewski, T; Golawski, A; Dudus, L; Nowakowski, JJ; Wuczynski, A; Wysocki, D				Tryjanowski, Piotr; Sparks, Tim H.; Biadun, Waldemar; Brauze, Tomasz; Hetmanski, Tomasz; Martyka, Rafal; Skorka, Piotr; Indykiewicz, Piotr; Myczko, Lukasz; Kunysz, Przemyslaw; Kawa, Piotr; Czyz, Stanislaw; Czechowski, Pawel; Polakowski, Michal; Zduniak, Piotr; Jerzak, Leszek; Janiszewski, Tomasz; Golawski, Artur; Dudus, Leszek; Nowakowski, Jacek J.; Wuczynski, Andrzej; Wysocki, Dariusz			Winter Bird Assemblages in Rural and Urban Environments: A National Survey	PLOS ONE			English	Article							CENTRAL POLAND; URBANIZATION; POPULATION; DIVERSITY; AREAS; COMMUNITIES; LANDSCAPES; FEATURES; DENSITY; ECOLOGY	Urban development has a marked effect on the ecological and behavioural traits of many living organisms, including birds. In this paper, we analysed differences in the numbers of wintering birds between rural and urban areas in Poland. We also analysed species richness and abundance in relation to longitude, latitude, human population size, and landscape structure. All these parameters were analysed using modern statistical techniques incorporating species detectability. We counted birds in 156 squares (0.25 km(2) each) in December 2012 and again in January 2013 in locations in and around 26 urban areas across Poland (in each urban area we surveyed 3 squares and 3 squares in nearby rural areas). The influence of twelve potential environmental variables on species abundance and richness was assessed with Generalized Linear Mixed Models, Principal Components and Detrended Correspondence Analyses. Totals of 72 bird species and 89,710 individual birds were recorded in this study. On average (+/- SE) 13.3 +/- 0.3 species and 288 +/- 14 individuals were recorded in each square in each survey. A formal comparison of rural and urban areas revealed that 27 species had a significant preference; 17 to rural areas and 10 to urban areas. Moreover, overall abundance in urban areas was more than double that of rural areas. There was almost a complete separation of rural and urban bird communities. Significantly more birds and more bird species were recorded in January compared to December. We conclude that differences between rural and urban areas in terms of winter conditions and the availability of resources are reflected in different bird communities in the two environments.	[Tryjanowski, Piotr; Sparks, Tim H.; Martyka, Rafal; Myczko, Lukasz; Kawa, Piotr] Poznan Univ Life Sci, Inst Zool, PL-60625 Poznan, Poland; [Biadun, Waldemar] John Paul II Catholic Univ Lublin, Dept Zool & Invertebrate Ecol, PL-20718 Lublin, Poland; [Brauze, Tomasz] Nicholas Copernicus Univ, Dept Vertebrate Zool, Fac Biol & Environm Protect, PL-87100 Torun, Poland; [Hetmanski, Tomasz] Pomeranian Univ, Dept Zool, PL-76200 Slupsk, Poland; [Skorka, Piotr] Polish Acad Sci, Inst Nat Conservat, PL-31120 Krakow, Poland; [Indykiewicz, Piotr] Univ Technol & Life Sci, Dept Zool & Landscaping, PL-85225 Bydgoszcz, Poland; [Kunysz, Przemyslaw] Przemysl Ornithol Soc, PL-37700 Przemysl, Poland; [Czyz, Stanislaw] Upper Silesian Ornithol Soc, PL-41902 Bytom, Poland; [Czechowski, Pawel] State Higher Vocat Sch Sulechow, Inst Tourism & Recreat, PL-66100 Sulechow, Poland; [Polakowski, Michal] Bialystok Tech Univ, Dept Environm Protect & Management, PL-15351 Bialystok, Poland; [Zduniak, Piotr] Adam Mickiewicz Univ, Fac Biol, Dept Avian Biol & Ecol, PL-61614 Poznan, Poland; [Jerzak, Leszek] Univ Zielona Gora, Fac Biol Sci, PL-65516 Zielona Gora, Poland; [Janiszewski, Tomasz] Univ Lodz, Dept Teacher Training & Biodivers Studies, PL-90237 Lod, Poland; [Golawski, Artur] Univ Nat Sci & Humanities Siedlce, Dept Zool, PL-08110 Siedlce, Poland; [Dudus, Leszek; Wuczynski, Andrzej] Polish Acad Sci, Lower Silesian Field Stn, Inst Nat Conservat, PL-50449 Wroclaw, Poland; [Nowakowski, Jacek J.] Univ Warmia & Mazury, Dept Ecol & Environm Protect, PL-10727 Olsztyn, Poland; [Wysocki, Dariusz] Univ Szczecin, Dept Vertebrate Anat & Zool, PL-71412 Szczecin, Poland	Poznan University of Life Sciences; Catholic University of Lublin; Nicolaus Copernicus University; Pomeranian Medical University; Polish Academy of Sciences; Bydgoszcz University of Science & Technology; Bialystok University of Technology; Adam Mickiewicz University; University of Zielona Gora; University of Lodz; Polish Academy of Sciences; University of Warmia & Mazury; University of Szczecin	Tryjanowski, P (corresponding author), Poznan Univ Life Sci, Inst Zool, Wojska Polskiego 71C, PL-60625 Poznan, Poland.	piotr.tryjanowski@gmail.com	Skórka, Piotr/B-7218-2009; Wuczyński, Andrzej/G-4372-2014; Polakowski, Michał/AAZ-3956-2020; Nowakowski, Jacek/J-2917-2013; Martyka, Rafał/E-7019-2010; Wuczyński, Andrzej/AAB-1792-2020	Skórka, Piotr/0000-0002-3221-296X; Wuczyński, Andrzej/0000-0001-9577-3855; Nowakowski, Jacek/0000-0001-9475-2868; Martyka, Rafał/0000-0002-0676-6432; Wuczyński, Andrzej/0000-0001-9577-3855; Myczko, Lukasz/0000-0002-9305-2306; Zduniak, Piotr/0000-0003-1804-125X; Indykiewicz, Piotr/0000-0003-1254-2424; Tryjanowski, Piotr/0000-0002-8358-0797; Skorka, Piotr/0000-0002-7486-2928; Polakowski, Michal/0000-0002-0150-7431; Golawski, Artur/0000-0001-9806-2119; Janiszewski, Tomasz/0000-0002-4636-5844; Hetmanski, Tomasz/0000-0002-1187-1333	Polish National Science Centre [DEC-2012/04/S/NZ8/00213]	Polish National Science Centre	R. Martyka was financially supported by a postdoctoral grant from the Polish National Science Centre (DEC-2012/04/S/NZ8/00213). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2005, INT REGIONAL SCI REV, V28, P168, DOI 10.1177/0160017605275160; Anderies JM, 2007, J THEOR BIOL, V247, P36, DOI 10.1016/j.jtbi.2007.01.030; [Anonymous], 1988, ADV ECOL RES; Barbraud C, 2009, J AVIAN BIOL, V40, P584, DOI 10.1111/j.1600-048X.2009.04653.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezzel E., 1985, Ornis Fennica, V62, P90; Brauze T, 2006, ACTA ORNITHOL, V41, P93, DOI 10.3161/068.041.0205; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cannon A, 1999, BIRD CONSERV INT, V9, P287, DOI 10.1017/S095927090000349X; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2009, SPADE SOFTWARE; Chao A., 2005, ENCY STAT SCI, V12, P7907, DOI DOI 10.1890/13-0133.1; Ciach M, 2012, POL J ECOL, V60, P193; Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035; Clergeau P, 2001, J APPL ECOL, V38, P1122, DOI 10.1046/j.1365-2664.2001.00666.x; Clergeau P, 2006, TRENDS ECOL EVOL, V21, P660, DOI 10.1016/j.tree.2006.09.006; Domonkos P, 1998, INT J CLIMATOL, V18, P1405, DOI 10.1002/(SICI)1097-0088(19981115)18:13<1405::AID-JOC323>3.0.CO;2-D; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Fuller RA, 2012, STUD AVIAN BIOL, V45, P249; Fuller RA, 2009, DIVERS DISTRIB, V15, P328, DOI 10.1111/j.1472-4642.2008.00537.x; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gaston K. J, 2010, URBAN ECOLOGY; Gilbert O.L., 1989, ECOLOGY URBAN HABITA; Golawski A, 2011, ITAL J ZOOL, V78, P364, DOI 10.1080/11250003.2010.535858; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hill MO, 1979, DECORANA A FORTRAN P; Hines JE., 2006, PRESENCESOFTWARE EST; IBM corporation, 2012, SPSS 21 WIND; Jokimaki J, 1998, LANDSCAPE URBAN PLAN, V39, P253, DOI 10.1016/S0169-2046(97)00089-3; Jokimaki J, 1996, J BIOGEOGR, V23, P379, DOI 10.1046/j.1365-2699.1996.00033.x; Jokimaki J, 2012, ANN ZOOL FENN, V49, P240, DOI 10.5735/086.049.0404; Jokimaki J, 2012, ORNIS FENNICA, V89, P20; Kendall WL, 2013, ECOLOGY, V94, P610, DOI 10.1890/12-1720.1; Leps J, 2003, MULTIVARIATE ANAL EC; Marzluff JM, 1998, AVIAN CONSERVATION: RESEARCH AND MANAGEMENT, P283; Matthysen E., 1990, Current Ornithology, V7, P209; Mazgajski TD, 2008, POL J ECOL, V56, P521; Miller D., 2005, URBAN ENV PLANNING P; Moller AP, 2012, OECOLOGIA, V170, P867, DOI 10.1007/s00442-012-2355-3; Myczko L, 2013, ECOL RES, V28, P503, DOI 10.1007/s11284-013-1039-8; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; PULLIAINEN ERKKI, 1963, ORNIS FENN, V40, P45; REBELE F, 1994, GLOBAL ECOL BIOGEOGR, V4, P173, DOI 10.2307/2997649; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Skorka P, 2006, J ORNITHOL, V147, P371, DOI 10.1007/s10336-005-0022-8; Stephan B., 1999, AMSEL TURDUS MERULA; Suhonen J, 2009, ECOSCIENCE, V16, P502, DOI 10.2980/16-4-3280; Tryjanowski P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063482; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x	50	33	41	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130299	10.1371/journal.pone.0130299	http://dx.doi.org/10.1371/journal.pone.0130299			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086819	gold, Green Submitted, Green Published			2022-12-26	WOS:000356567500092
J	Wara, A; Hunsucker, S; Bove, K; Backus, R				Wara, Allison; Hunsucker, Sara; Bove, Krystal; Backus, Robert			Short-Term Estrogen Replacement Effects on Insulin Sensitivity and Glucose Tolerance in At-Risk Cats for Feline Diabetes Mellitus	PLOS ONE			English	Article							FOOD-INTAKE; WEIGHT-GAIN; BODY-WEIGHT; OBESE CATS; PHYSICAL-ACTIVITY; EUGLYCEMIC CLAMP; OVERWEIGHT CATS; ESTRADIOL; FEMALE; HORMONES	Male domestic cats that are neutered and overweight are at an increased risk for developing a type-2-like diabetes mellitus. Beneficial effects of 17 beta-estradiol (E2) on glucose homeostasis may be lost with neutering and thereby account for increased diabetes risk. To evaluate this, adult male neutered overweight cats (n=6) were given daily E2 (1.0 mu g/kg) or vehicle (Vh; ethanol, 1.0 mu L/kg) in a single crossover trial of 14-day periods with a 7-day washout. The E2 and Vh were voluntarily ingested on food. The E2 dosage was determined in a pre-trial to significantly and transiently reduce food intake with no measurable change in plasma E2 concentration. During treatments, physical activity was assessed with collar-mounted accelerometers on days 9-11, and tests of intravenous insulin tolerance and intravenous glucose tolerance were conducted on days 13 and 14, respectively. Over the 14 days, E2 compared to Vh treatment reduced (p=0.03) food intake (-22%) but not enough to significantly reduce body weight; activity counts were not significantly changed. With E2 compared to Vh treatment, the late-phase plasma insulin response of the glucose tolerance test was less (p=0.03) by 31%, while glucose tolerance and insulin sensitivity indexes were not significantly changed. The results indicate that oral E2 at a dosage that moderately affects food intake may reduce insulin requirement for achieving glucose homeostasis in neutered male cats. Further investigation is needed to identify the mechanism underlying the E2 effect.	[Wara, Allison; Hunsucker, Sara; Bove, Krystal; Backus, Robert] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Wara, A (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA.	waraa@missouri.edu			Nestle Purina Endowed Program in Small Animal Nutrition, University of Missouri, Columbia, Missouri, USA; Morris Animal Foundation, Denver, Colorado, USA	Nestle Purina Endowed Program in Small Animal Nutrition, University of Missouri, Columbia, Missouri, USA; Morris Animal Foundation, Denver, Colorado, USA	This study was supported by the Nestle Purina Endowed Program in Small Animal Nutrition, University of Missouri, Columbia, Missouri, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Krystal Bove was granted for this research a veterinary student training scholarship by the Morris Animal Foundation, Denver, Colorado, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINMOKUN A, 1992, DIABETIC MED, V9, P432, DOI 10.1111/j.1464-5491.1992.tb01813.x; AMOIKON EK, 1995, J ANIM SCI, V73, P1123; Appleton D J, 2001, J Feline Med Surg, V3, P211, DOI 10.1053/jfms.2001.0138; Appleton DJ, 2005, J FELINE MED SURG, V7, P183, DOI 10.1016/j.jfms.2004.12.002; Asarian L, 2006, PHILOS T R SOC B, V361, P1251, DOI 10.1098/rstb.2006.1860; Backus RC, 2010, J ANIM PHYSIOL AN N, V94, pE318, DOI 10.1111/j.1439-0396.2010.01014.x; Backus R, 2011, BRIT J NUTR, V106, pS15, DOI 10.1017/S0007114511001796; Balkau B, 2008, DIABETES, V57, P2613, DOI 10.2337/db07-1605; Biourge V, 1997, J VET INTERN MED, V11, P86, DOI 10.1111/j.1939-1676.1997.tb00078.x; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Bunting LD, 2000, J DAIRY SCI, V83, P2491, DOI 10.3168/jds.S0022-0302(00)75141-1; Cave NJ, 2007, NEW ZEAL VET J, V55, P113, DOI 10.1080/00480169.2007.36752; Cave NJ, 2007, J ANIM PHYSIOL AN N, V91, P400, DOI 10.1111/j.1439-0396.2006.00667.x; Espeland MA, 1998, DIABETES CARE, V21, P1589, DOI 10.2337/diacare.21.10.1589; Ferreira JA, 2012, EUR J APPL PHYSIOL, V112, P3007, DOI 10.1007/s00421-011-2271-y; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; HASEGAWA S, 1992, J VET MED SCI, V54, P583, DOI 10.1292/jvms.54.583; Hoenig M, 2007, AM J PHYSIOL-REG I, V292, pR227, DOI 10.1152/ajpregu.00313.2006; Hoenig M, 2006, DOMEST ANIM ENDOCRIN, V31, P373, DOI 10.1016/j.domaniend.2005.12.004; Hoenig M, 2002, MOL CELL ENDOCRINOL, V197, P221, DOI 10.1016/S0303-7207(02)00264-2; Hoenig Margarethe, 2012, J Diabetes Sci Technol, V6, P525; Kanchuk ML, 2003, J NUTR, V133, P1866, DOI 10.1093/jn/133.6.1866; Kim JH, 2014, MOL METAB, V3, P177, DOI 10.1016/j.molmet.2013.12.009; KUMAGAI S, 1993, ACTA PHYSIOL SCAND, V149, P91, DOI 10.1111/j.1748-1716.1993.tb09596.x; Laflamme D, 1997, FELINE PRACT, V25, P13; Lascelles BDX, 2008, VET ANAESTH ANALG, V35, P173, DOI 10.1111/j.1467-2995.2007.00367.x; LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172; Lightfoot JT, 2008, INT J BIOL SCI, V4, P126; Litwak SA, 2014, ENDOCRINOLOGY, V155, P4447, DOI 10.1210/en.2014-1342; LOKIND KB, 1991, INT J PHARM, V76, P177, DOI 10.1016/0378-5173(91)90356-S; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; Lund E. M., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P88; MICHAEL RP, 1964, J PHYSIOL-LONDON, V171, P254, DOI 10.1113/jphysiol.1964.sp007376; NELSON RW, 1990, AM J VET RES, V51, P1357; Pechereau D, 2001, REV MED VET-TOULOUSE, V152, P479; Petrus DJ, 1998, RES VET SCI, V65, P179, DOI 10.1016/S0034-5288(98)90174-6; Rand J, 1999, J Feline Med Surg, V1, P143, DOI 10.1016/S1098-612X(99)90203-6; REES HD, 1984, DEV BRAIN RES, V13, P73, DOI 10.1016/0165-3806(84)90078-6; Saglam K, 2002, ENDOCRINE, V18, P211, DOI 10.1385/ENDO:18:3:211; SCARLETT JM, 1994, INT J OBESITY, V18, pS22; SHILLE VM, 1990, THERIOGENOLOGY, V34, P779, DOI 10.1016/0093-691X(90)90032-O; Slingerland LI, 2009, VET J, V179, P247, DOI 10.1016/j.tvjl.2007.08.035; Spears J.W., 1998, RECENT ADV CANINE FE, P103; Xie HS, 1996, J PHARMACOL TOXICOL, V35, P77, DOI 10.1016/1056-8719(96)00003-2	44	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130696	10.1371/journal.pone.0130696	http://dx.doi.org/10.1371/journal.pone.0130696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086714	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500129
J	Cabral, JS; Petter, G; Mendieta-Leiva, G; Wagner, K; Zotz, G; Kreft, H				Cabral, Juliano Sarmento; Petter, Gunnar; Mendieta-Leiva, Glenda; Wagner, Katrin; Zotz, Gerhard; Kreft, Holger			Branchfall as a Demographic Filter for Epiphyte Communities: Lessons from Forest Floor-Based Sampling	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; VASCULAR EPIPHYTES; ATLANTIC FOREST; VERTICAL STRATIFICATION; SPATIAL-DISTRIBUTION; POPULATION-DYNAMICS; MONTANE FOREST; INNER-CROWN; LOWLAND; DIVERSITY	Local variation in the abundance and richness of vascular epiphytes is often attributed to environmental characteristics such as substrate and microclimate. Less is known, however, about the impacts of tree and branch turnover on epiphyte communities. To address this issue, we surveyed branches and epiphytes found on the forest floor in 96 transects in two forests (Atlantic rainforest in Brazil and Caribbean rainforest in Panama). In the Brazilian forest, we additionally distinguished between edge and core study sites. We quantified branch abundance, epiphyte abundance, richness and proportion of adults to investigate the trends of these variables over branch diameter. Branches < 2 cm in diameter comprised > 90% of all branches on the forest floor. Abundance and richness of fallen epiphytes per transect were highest in the Brazilian core transects and lowest in the Panamanian transects. The majority of epiphytes on the floor (c. 65%) were found attached to branches. At all three study sites, branch abundance and branch diameter were negatively correlated, whereas epiphyte abundance and richness per branch, as well as the proportion of adults were positively correlated with branch diameter. The relationship between branch diameter and absolute epiphyte abundance or richness differed between study sites, which might be explained by differences in forest structure and dynamics. In the Panamanian forest, epiphytes had been previously inventoried, allowing an evaluation of our surveying method by comparing canopy and forest floor samplings. Individuals found on the forest floor corresponded to 13% of all individuals on branches < 10 cm in diameter (including crowns), with abundance, richness and composition trends on forest floor reflecting canopy trends. We argue that forest floor surveys provide useful floristic and, most notably, demographic information particularly on epiphytes occurring on the thinnest branches, which are least accessible. Here, branchfall acts as an important demographic filter structuring epiphyte communities.	[Cabral, Juliano Sarmento; Petter, Gunnar; Kreft, Holger] Univ Gottingen, Fac Forest Sci & Forest Ecol, Biodivers Macroecol & Conservat Biogeog Grp, D-37073 Gottingen, Germany; [Mendieta-Leiva, Glenda; Wagner, Katrin; Zotz, Gerhard] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Funct Ecol Plants, D-26111 Oldenburg, Germany; [Zotz, Gerhard] Smithsonian Trop Res Inst, Panama City, Panama	University of Gottingen; Carl von Ossietzky Universitat Oldenburg; Smithsonian Institution; Smithsonian Tropical Research Institute	Cabral, JS (corresponding author), Univ Gottingen, Fac Forest Sci & Forest Ecol, Biodivers Macroecol & Conservat Biogeog Grp, D-37073 Gottingen, Germany.	jsarmen@uni-goettingen.de	Mendieta, Glenda/H-4626-2019; Zotz, Gerhard/Q-5365-2018; Sarmento Cabral, Juliano/K-3973-2012; Kreft, Holger/AAY-7573-2020; Kreft, Holger/A-4736-2008	Mendieta, Glenda/0000-0002-0156-4153; Zotz, Gerhard/0000-0002-6823-2268; Sarmento Cabral, Juliano/0000-0002-0116-220X; Kreft, Holger/0000-0003-4471-8236; Kreft, Holger/0000-0003-4471-8236; Petter, Gunnar/0000-0002-3691-5267	German Research Foundation (DFG) [SA-21331]; DFG Initiative of Excellence Free Floater Program at the University of Gottingen; DFG [Zo 94/5-1]; Smithsonian Tropical Research Institute	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG Initiative of Excellence Free Floater Program at the University of Gottingen; DFG(German Research Foundation (DFG)); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute)	J.S.C. acknowledges financial support by a German Research Foundation (DFG) grant (SA-21331). G.P. and H.K. were funded by the DFG Initiative of Excellence Free Floater Program at the University of Gottingen. G.Z., K.W. and G.M.L.'s work in Panama was supported by the DFG (Zo 94/5-1) and the Smithsonian Tropical Research Institute.	Addicott F, 1991, PHYSL TREES, P273; Benzing D.H., 1990, VASCULAR EPIPHYTES G; Cardelus CL, 2007, BIOTROPICA, V39, P171, DOI 10.1111/j.1744-7429.2006.00253.x; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; Cardelus CL, 2005, BIOTROPICA, V37, P238, DOI 10.1111/j.1744-7429.2005.00032.x; CHASE M W, 1987, Selbyana, V10, P24; CHASE MW, 1986, AM J BOT, V73, P756; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Einzmann HJR, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu073; Fichtler E, 2003, BIOTROPICA, V35, P306, DOI 10.1111/j.1744-7429.2003.tb00585.x; Freiberg M, 1996, BIOTROPICA, V28, P345, DOI 10.2307/2389198; Freiberg M, 2000, J TROP ECOL, V16, P673, DOI 10.1017/S0266467400001644; Halle F., 1978, TROPICAL TREES FORES, Vfirst; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Hietz P, 2002, J TROP ECOL, V18, P177, DOI 10.1017/S0266467402002122; Hietz P, 1997, J ECOL, V85, P767, DOI 10.2307/2960600; Kromer T, 2007, PLANT ECOL, V189, P261, DOI 10.1007/s11258-006-9182-8; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lieberman M., 1985, J TROP ECOL, V1, P97, DOI DOI 10.1017/S026646740000016X; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; MATELSON TJ, 1993, ECOLOGY, V74, P265, DOI 10.2307/1939523; Metcalf CJE, 2009, ECOLOGY, V90, P2766, DOI 10.1890/08-1645.1; Millington W., 1973, SHEDDING PLANT PARTS, P149, DOI DOI 10.1016/B978-0-12-424250-0.50010-5; Moffett MW, 2000, BIOTROPICA, V32, P569, DOI 10.1646/0006-3606(2000)032[0569:WSUACL]2.0.CO;2; Chaparro DM, 2011, CONSERV BIOL, V25, P797, DOI 10.1111/j.1523-1739.2011.01691.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NADKARNI NM, 1992, BIOTROPICA, V24, P24, DOI 10.2307/2388470; Nieder J, 2000, BIOTROPICA, V32, P385, DOI 10.1111/j.1744-7429.2000.tb00485.x; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Oliveira AT, 1997, PLANT ECOL, V131, P45, DOI 10.1023/A:1009744207641; Oliveira MA, 2004, ORYX, V38, P389, DOI 10.1017/S0030605304000754; PRANCE GT, 1982, ANN MO BOT GARD, V69, P594, DOI 10.2307/2399085; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; Rust S, 2004, BASIC APPL ECOL, V5, P283, DOI 10.1016/j.baae.2004.03.003; Shaw JD, 1997, SELBYANA, V18, P195; Siqueira Filho JA, 2005, DIVERSIDADE BIOL CTR, P123, DOI [10.1590/1519-6984.10513, DOI 10.1590/1519-6984.10513]; Siqueira Filho JA, 2006, FRAGMENTOS MATA ATLA, P101; Tabarelli M, 1999, BIOL CONSERV, V91, P119, DOI 10.1016/S0006-3207(99)00085-3; Toledo-Aceves T, 2014, FOREST ECOL MANAG, V329, P129, DOI 10.1016/j.foreco.2014.06.022; VanderMeer PJ, 1996, J ECOL, V84, P19, DOI 10.2307/2261696; Wagner K, 2013, J TROP ECOL, V29, P277, DOI 10.1017/S0266467413000291; Werner FA, 2009, J VEG SCI, V20, P59, DOI 10.1111/j.1654-1103.2009.05286.x; Wolf JHD, 2009, J TROP ECOL, V25, P107, DOI 10.1017/S0266467408005786; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Woods CL, 2015, J ECOL, V103, P421, DOI 10.1111/1365-2745.12357; Wright S.J., 2003, STUDYING FOREST CANO, P196; Zotz G, 2007, J VEG SCI, V18, P123, DOI 10.1111/j.1654-1103.2007.tb02522.x; Zotz G, 2005, ECOGRAPHY, V28, P806, DOI 10.1111/j.2005.0906-7590.04292.x; Zotz G, 2008, PLANT ECOL, V195, P131, DOI 10.1007/s11258-007-9310-0; Zotz G, 2011, ECOTROPICA, V17, P103; Zuur Alain F., 2009, P1	52	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128019	10.1371/journal.pone.0128019	http://dx.doi.org/10.1371/journal.pone.0128019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083417	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400025
J	Mannion, CA; Vinturache, AE; McDonald, SW; Tough, SC				Mannion, Cynthia A.; Vinturache, Angela E.; McDonald, Sheila W.; Tough, Suzanne C.			The Influence of Back Pain and Urinary Incontinence on Daily Tasks of Mothers at 12 Months Postpartum	PLOS ONE			English	Article							PELVIC GIRDLE PAIN; QUALITY-OF-LIFE; OBSTETRIC RISK-FACTORS; 1ST 18 MONTHS; CESAREAN-SECTION; VAGINAL DELIVERY; PHYSICAL HEALTH; STRESS-INCONTINENCE; PREGNANCY; PREVALENCE	Objective The present study examined back pain (BP) and/or urinary incontinence (UI) impact on the ability to perform daily tasks at 12 months after childbirth in healthy reproductive women who sought maternity care in community based family practice clinics. Methods This study is a secondary analysis from the All Our Babies Study, a prospective, community-based pregnancy cohort in Calgary, Alberta. Maternal self-reported information on demographics, lifestyle, experiences with pregnancy and childbirth, occurrence of BP, UI and consequent impairment of daily tasks were collected by questionnaires administered before 25 weeks, at 34-36 weeks gestation and at 4 and 12 months postpartum. The occurrence and severity of BP and UI at one year after childbirth was assessed using descriptive and bivariate analyses. Logistic regression models examined the association between demographic and obstetrical variables and the severity of functional impairment due to UI and BP. Results From 1574 women with singleton pregnancies included in the study, 1212 (77%) experienced BP, 773 (49%) UI, and 620 (40%) both BP and UI. From the 821 women reporting impairment of daily tasks due to BP, 199 (24 %) were moderately and 90 (11%) severely affected with the remainder, 532 (64%) being mildly affected. From 267 women with functional impairment due to UI, 52 (19%) reported moderately to severe impairment in their ability to perform daily tasks. Obesity and parity were risk factors for impairment of daily functioning due to BP, whereas obesity and vaginal delivery increased the risk of moderate to severe impairment due to UI. Conclusions BP and UI are common occurrences 1 year after childbirth. Maternal performance of daily tasks and women's health and quality of life are more often impaired due to BP than UI. Our study brings new evidence of the risk factors that predict severity and impact of these conditions on women functioning at 12 months postpartum.	[Mannion, Cynthia A.] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Vinturache, Angela E.; McDonald, Sheila W.; Tough, Suzanne C.] Univ Calgary, Fac Med, Dept Paediat, Calgary, AB, Canada; [Tough, Suzanne C.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Vinturache, AE (corresponding author), Univ Calgary, Fac Med, Dept Paediat, Calgary, AB, Canada.	aevintur@ucalgary.ca		Vinturache, Angela/0000-0002-2432-2616	Alberta Innovates Health Solutions (AIHS) Interdisciplinary Team Grant [200700595]; Three Cheers for the Early Years, Alberta Health Services; Alberta Children's Hospital Foundation	Alberta Innovates Health Solutions (AIHS) Interdisciplinary Team Grant; Three Cheers for the Early Years, Alberta Health Services; Alberta Children's Hospital Foundation	An Alberta Innovates Health Solutions (AIHS) Interdisciplinary Team Grant (Preterm Birth and Healthy Outcomes #200700595) and Three Cheers for the Early Years, Alberta Health Services, provided funding for the development of the cohort. Additional funding was provided from the Alberta Children's Hospital Foundation.	Altman D, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.083; Arrue M, 2011, INT J GYNECOL OBSTET, V115, P256, DOI 10.1016/j.ijgo.2011.07.024; BRODIE D J, 1990, Journal of Orthopaedic and Sports Physical Therapy, V11, P519; Brown S, 2000, BRIT J OBSTET GYNAEC, V107, P1194, DOI 10.1111/j.1471-0528.2000.tb11607.x; Brown SJ, 2011, BJOG-INT J OBSTET GY, V118, P991, DOI 10.1111/j.1471-0528.2011.02928.x; Burgio KL, 2003, OBSTET GYNECOL, V102, P1291, DOI 10.1016/j.obstetgynecol.2003.09.013; C Perinatal Health Agency of Canada, 2012, PERINATAL HEALTH IND; Cheng CY, 2008, WOMEN HEALTH ISS, V18, P267, DOI 10.1016/j.whi.2008.02.004; Connolly TJ, 2007, INT UROGYNECOL J, V18, P1033, DOI 10.1007/s00192-006-0286-4; Diez-Itza I, 2010, INT UROGYNECOL J, V21, P439, DOI 10.1007/s00192-009-1055-y; Dolan LM, 2004, INT UROGYNECOL J, V15, P160, DOI 10.1007/s00192-004-1128-x; Ekstrom A, 2008, INT UROGYNECOL J, V19, P459, DOI 10.1007/s00192-007-0461-2; Eliasson K, 2008, MANUAL THER, V13, P206, DOI 10.1016/j.math.2006.12.006; Gartland D, 2012, BJOG-INT J OBSTET GY, V119, P1361, DOI 10.1111/j.1471-0528.2012.03437.x; Pavon AG, 2014, ATEN PRIM, V46, P100, DOI 10.1016/j.aprim.2013.07.004; Gutke A, 2011, EUR SPINE J, V20, P440, DOI 10.1007/s00586-010-1487-6; Gyhagen M, 2013, BJOG-INT J OBSTET GY, V120, P1548, DOI 10.1111/1471-0528.12367; Haddow G, 2005, INT J EVID-BASED HEA, V3, P103, DOI 10.1111/j.1479-6988.2005.00023.x; Hijaz A, 2012, INT UROGYNECOL J, V23, P395, DOI 10.1007/s00192-011-1562-5; Kovacs FM, 2012, SPINE, V37, P1516, DOI 10.1097/BRS.0b013e31824dcb74; MacLennan AH, 2000, BRIT J OBSTET GYNAEC, V107, P1460, DOI 10.1111/j.1471-0528.2000.tb11669.x; Mason L, 2010, J CLIN NURS, V19, P2777, DOI 10.1111/j.1365-2702.2010.03297.x; McDonald SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S2; Monz B, 2007, EUR UROL, V51, P1073, DOI 10.1016/j.eururo.2006.09.022; Morkved S, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P394, DOI 10.1007/s001920050067; Noren L, 2002, EUR SPINE J, V11, P267, DOI 10.1007/s00586-001-0357-7; Nygaard I, 2006, SEMIN PERINATOL, V30, P267, DOI 10.1053/j.semperi.2006.07.007; Olsson C, 2004, ACTA OBSTET GYN SCAN, V83, P351, DOI 10.1080/j.0001-6349.2004.00384.x; Ostgaard HC, 1996, SPINE, V21, P2777, DOI 10.1097/00007632-199612010-00013; Robinson Dudley, 2003, J Br Menopause Soc, V9, P75, DOI 10.1258/136218003100322233; Rortveit G, 2001, OBSTET GYNECOL, V98, P1004, DOI 10.1016/S0029-7844(01)01566-6; Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788; Sangsawang B, 2013, INT UROGYNECOL J, V24, P901, DOI 10.1007/s00192-013-2061-7; Saurel-Cubizolles MJ, 2000, BRIT J OBSTET GYNAEC, V107, P1202, DOI 10.1111/j.1471-0528.2000.tb11608.x; Schytt E, 2004, ACTA OBSTET GYN SCAN, V83, P928, DOI 10.1111/j.0001-6349.2004.00431.x; Smith MD, 2008, INT UROGYNECOL J, V19, P205, DOI 10.1007/s00192-007-0421-x; Smith MD, 2014, CLIN J PAIN, V30, P162, DOI 10.1097/AJP.0b013e31828b10fe; Steen Mary, 2013, Nurs Stand, V28, P49, DOI 10.7748/ns2013.09.28.1.49.e7510; Sultan AH, 1996, BRIT J OBSTET GYNAEC, V103, P731, DOI 10.1111/j.1471-0528.1996.tb09864.x; Thompson JF, 2002, BIRTH-ISS PERINAT C, V29, P83, DOI 10.1046/j.1523-536X.2002.00167.x; Thornton MJ, 2006, AUST NZ J OBSTET GYN, V46, P468, DOI 10.1111/j.1479-828X.2006.00644.x; To WWK, 2003, ACTA OBSTET GYN SCAN, V82, P1086, DOI 10.1046/j.1600-0412.2003.00235.x; Torrisi G, 2012, EUR J OBSTET GYN R B, V160, P110, DOI 10.1016/j.ejogrb.2011.10.010; Vermani E, 2010, PAIN PRACT, V10, P60, DOI 10.1111/j.1533-2500.2009.00327.x; Wang SM, 2004, OBSTET GYNECOL, V104, P65, DOI 10.1097/01.AOG.0000129403.54061.0e; Wax JR, 2004, OBSTET GYNECOL SURV, V59, P601, DOI 10.1097/01.OGX.0000133942.76239.57; Wesnes SL, 2009, BJOG-INT J OBSTET GY, V116, P700, DOI 10.1111/j.1471-0528.2008.02107.x; Wohlrab KJ, 2008, CLIN PERINATOL, V35, P583, DOI 10.1016/j.clp.2008.06.001; Woolhouse H, 2012, BIRTH-ISS PERINAT C, V39, P221, DOI 10.1111/j.1523-536X.2012.00551.x; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Wu WH, 2004, EUR SPINE J, V13, P575, DOI 10.1007/s00586-003-0615-y	51	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129615	10.1371/journal.pone.0129615	http://dx.doi.org/10.1371/journal.pone.0129615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083252	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400102
J	Ramachandran, H; Herfurth, K; Grosschedl, R; Schafer, T; Walz, G				Ramachandran, Haribaskar; Herfurth, Konstantin; Grosschedl, Rudolf; Schaefer, Tobias; Walz, Gerd			SUMOylation Blocks the Ubiquitin-Mediated Degradation of the Nephronophthisis Gene Product Glis2/NPHP7	PLOS ONE			English	Article							PRIMARY CILIUM; GLIS2; TRANSACTIVATION; TRANSCRIPTION; MECHANISMS; MUTATIONS; APOPTOSIS; ROLES	Glis2/NPHP7 is a transcriptional regulator mutated in type 7 nephronophthisis, an autosomal recessive ciliopathy associated with cystic and fibrotic kidney disease as well as characteristic extrarenal manifestations. While most ciliopathy-associated molecules are found in the cilium, Glis2/NPHP7 presumably localizes to the nucleus. However, the detection of endogenous Glis2/NPHP7 has remained unsuccessful, potentially due to its ubiquitylation-dependent rapid degradation. We report now that Glis2/NPHP7 is also SUMOylated, preferentially by PIAS4, which conjugates Glis2/NPHP7 to SUMO3. SUMOylation interferes with ubiquitylation and degradation of Glis2/NPHP7, suggesting that Glis2/NPHP7 protein levels are regulated by competing ubiquitylation/SUMOylation. SUMOylation also alters the transcriptional activity of Glis2/NPHP7. While Glis2/NPHP7 activates the mouse insulin-2-promotor (mIns2), SUMOylated Glis2/NPHP7 lacks this property, and seems to act as a repressor. Taken together, our data reveal that Glis2/NPHP7 is extensively modified by post-translational modifications, suggesting that a tight control of this transcriptional regulator is required for normal development and tissue homeostasis.	[Ramachandran, Haribaskar; Herfurth, Konstantin; Schaefer, Tobias; Walz, Gerd] Univ Freiburg, Med Ctr, Div Renal, Dept Med, D-79106 Freiburg, Germany; [Grosschedl, Rudolf] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Walz, Gerd] BIOSS Ctr Biol Signaling Studies, D-79108 Freiburg, Germany	University of Freiburg; Max Planck Society	Walz, G (corresponding author), Univ Freiburg, Med Ctr, Div Renal, Dept Med, D-79106 Freiburg, Germany.	gerd.walz@uniklinik-freiburg.de			DFG [SFB 746]; European Community [241955]	DFG(German Research Foundation (DFG)); European Community(European Commission)	DFG SFB 746 (R.G., T.S. and G.W.) European Community's Seventh Framework Program (grant agreement number 241955, SSCILIA) (G.W.). The funders had no role in any of the above.	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dimitri P, 2011, EUR J ENDOCRINOL, V164, P437, DOI 10.1530/EJE-10-0893; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goetz SC, 2009, METHOD CELL BIOL, V94, P199, DOI 10.1016/S0091-679X(08)94010-3; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kee H Lynn, 2013, Cilia, V2, P11, DOI 10.1186/2046-2530-2-11; Kim SC, 2005, NUCLEIC ACIDS RES, V33, P6805, DOI 10.1093/nar/gki985; Kim YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072549; Li YJ, 2012, J CELL BIOL, V199, P589, DOI 10.1083/jcb.201203150; Lichti-Kaiser K, 2012, VITAM HORM, V88, P141, DOI 10.1016/B978-0-12-394622-5.00007-9; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Ramachandran H, 2014, J BIOL CHEM, V289, P8390, DOI 10.1074/jbc.M113.534024; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Vasanth S, 2011, J BIOL CHEM, V286, P4749, DOI 10.1074/jbc.M110.165951; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Wolf MTF, 2011, PEDIATR NEPHROL, V26, P181, DOI 10.1007/s00467-010-1585-z; ZeRuth GT, 2011, J BIOL CHEM, V286, P22077, DOI 10.1074/jbc.M111.224964; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200; Zhang F, 2001, GENE, V280, P49, DOI 10.1016/S0378-1119(01)00764-8	27	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130275	10.1371/journal.pone.0130275	http://dx.doi.org/10.1371/journal.pone.0130275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083374	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400134
J	van der Hiele, K; van Gorp, D; Ruimschotel, R; Kamminga, N; Visser, L; Middelkoop, H				van der Hiele, Karin; van Gorp, Dennis; Ruimschotel, Rob; Kamminga, Noelle; Visser, Leo; Middelkoop, Huub			Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE DYSFUNCTION; EMPLOYMENT STATUS; IMPACT; IMPAIRMENT; FATIGUE; PERFORMANCE; DEPRESSION	The majority of patients with Multiple Sclerosis (MS) are unable to retain employment within 10 years from disease onset. Executive abilities, such as planning, working memory, attention, problem solving, inhibition and mental flexibility may have a direct impact on the ability to maintain a job. This study investigated differences in subjective and objective executive abilities between relapsing-remitting MS patients with and without a paid job. We included 55 relapsing-remitting MS patients from a community-based sample (47 females; mean age: 47 years; 36% employed). Patients underwent neurological, cognitive and psychological assessments at their homes, including an extensive executive test battery. We found that unemployed patients had a longer disease duration (t(53)=2.76, p=0.008) and reported more organising and planning problems (chi(2)(1)=6.3, p=0.012), higher distractibility (Kendall's tau-b= -0.24, p=0.03) and more cognitive fatigue (U=205.0, p=0.028, r=-0.30) than employed patients. Unemployed patients completed slightly less categories on the Wisconsin Card Sorting Test (U=243.5, p=0.042, r=-0.28). Possible influential factors such as age, educational level, physical functioning, depression and anxiety did not differ between groups. In conclusion, while relapsing-remitting MS patients without a paid job reported more executive problems and cognitive fatigue than patients with a paid job, little differences were found in objective executive abilities. Further research is needed to examine possible causal relations.	[van der Hiele, Karin; van Gorp, Dennis] Natl MS Fdn, Maassluis, Netherlands; [van der Hiele, Karin; van Gorp, Dennis; Middelkoop, Huub] Leiden Univ, Dept Psychol, Sect Hlth Med & Neuropsychol, Leiden, Netherlands; [Ruimschotel, Rob] Med Psychiat Ctr PsyToBe, Rotterdam, Netherlands; [Kamminga, Noelle; Middelkoop, Huub] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [van der Hiele, Karin; van Gorp, Dennis; Visser, Leo] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [van Gorp, Dennis; Visser, Leo] Univ Humanist Studies, Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Elisabeth-TweeSteden Ziekenhuis (ETZ)	van der Hiele, K (corresponding author), Natl MS Fdn, Maassluis, Netherlands.	hiele@fsw.leidenuniv.nl		van der Hiele, Karin/0000-0002-1567-0627	National MS Foundation The Netherlands	National MS Foundation The Netherlands	This research was financially supported by the National MS Foundation The Netherlands. The first author, Karin van der Hiele, was employed by the National MS Foundation and had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The second author, Dennis van Gorp, is currently affiliated with the National MS Foundation. Volunteers working for the National MS Foundation helped with data collection by sending out questionnaires.	Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Bol Y, 2010, CLIN REHABIL, V24, P854, DOI 10.1177/0269215510367540; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cutajar R, 2000, J NEUROVIROL, V6, pS186; Drew M, 2008, ARCH CLIN NEUROPSYCH, V23, P1, DOI 10.1016/j.acn.2007.09.005; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton R.K., 1993, WISCONSIN CARD SORTI; Honarmand K, 2011, J NEUROL, V258, P244, DOI 10.1007/s00415-010-5736-8; Jougleux-Vie C, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/692468; Julian L, 2007, MULT SCLER J, V13, P81, DOI 10.1177/1352458506070255; Julian LJ, 2008, J NEUROL, V255, P1354, DOI 10.1007/s00415-008-0910-y; Krabbendam L, 1997, BADS BEHAVIOURAL ASS; Krause I, 2013, MULT SCLER J, V19, P1792, DOI 10.1177/1352458513485655; Krokavcova M, 2012, INT J REHABIL RES, V35, P40, DOI 10.1097/MRR.0b013e32834e6520; Lunde HMB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103317; Meyers J. E., 1995, REY COMPLEX FIGURE T; Morrow SA, 2010, CLIN NEUROPSYCHOL, V24, P1131, DOI 10.1080/13854046.2010.511272; Morse CL, 2013, ARCH PHYS MED REHAB, V94, P2509, DOI 10.1016/j.apmr.2013.06.033; Parmenter BA, 2007, J CLIN EXP NEUROPSYC, V29, P215, DOI 10.1080/13803390600672163; PEYSER JM, 1990, ARCH NEUROL-CHICAGO, V47, P94, DOI 10.1001/archneur.1990.00530010120030; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Reitan R, 1956, TRAIL MAKING TEST MA; Rijken M, 2013, BMC PUBLIC HEALTH, V13; Roessler Richard T, 2003, Work, V21, P17; Schmand B., 1992, NEDERLANDSE LEESTEST; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; Strober L, 2014, MULT SCLER J, V20, P112, DOI 10.1177/1352458513488235; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; van der Hiele K, 2012, EUR J NEUROL, V19, P562, DOI 10.1111/j.1468-1331.2011.03538.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129228	10.1371/journal.pone.0129228	http://dx.doi.org/10.1371/journal.pone.0129228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NS	26083386	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400085
J	Wilson, PS; Vopel, K				Wilson, Peter S.; Vopel, Kay			Assessing the Sulfide Footprint of Mussel Farms with Sediment Profile Imagery: A New Zealand Trial	PLOS ONE			English	Article							SULFATE REDUCTION; ESTUARINE SEDIMENTS; ORGANIC ENRICHMENT; AQUACULTURE; IMPACTS; CULTURE; BIODEPOSITION; COMMUNITIES; DEPOSITION; DISPERSAL	Growing numbers and increased stocking of marine mussel farms make reliable techniques for environmental effect assessment a priority. Previously, we showed how the color intensity of soft sediment could be used to estimate its acid volatile sulfide (AVS) content, a product of the anaerobic microbial degradation of organic matter deposits. We then proposed to include assessments of the AVS farm footprint in marine farm monitoring, in particular, to investigate temporal changes in the extent of the seafloor area of elevated sediment AVS content. Such assessment requires accurate detection of the AVS footprint boundary. Here, we demonstrate how to detect this boundary with analyses of sediment color intensity. We analyzed 182 sediment profile images taken along three transects leading from approximately 50 m inside to 200 m outside a long-line mussel farm in New Zealand and found that the mean sediment color intensity inside the farm boundary was almost one third lower than that of the sediment distant from the farm. Segmented regression analysis of the combined color intensity data revealed a breakpoint in the trend of increasing grey values with increasing distance from the farm at 56 +/- 13 m (+/- 95% confidence interval of the breakpoint) outside the mussel farm. Statistical analyses indicated that the extent of the color intensity footprint was a function of water column depth, as was shown visually using mapping methods; organic particles disperse further in a deeper seawater column. We conclude that for soft coastal sediments, our sampling and data analysis techniques may provide a rapid and reliable supplement to existing benthic surveys that assess environmental effects of mussel farms.	[Wilson, Peter S.; Vopel, Kay] Auckland Univ Technol, Sch Appl Sci, Inst Appl Ecol New Zealand, Auckland, New Zealand	Auckland University of Technology	Wilson, PS (corresponding author), Auckland Univ Technol, Sch Appl Sci, Inst Appl Ecol New Zealand, Auckland, New Zealand.	peter.wilson@aut.ac.nz	Vopel, Kay/AAZ-5474-2020	Wilson, Peter/0000-0002-4710-4769	Faculty of Health and Environmental Sciences of Auckland University of Technology	Faculty of Health and Environmental Sciences of Auckland University of Technology	The Faculty of Health and Environmental Sciences of Auckland University of Technology funded the research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; BERNER RA, 1978, EARTH PLANET SC LETT, V37, P492, DOI 10.1016/0012-821X(78)90065-1; Bruchert V, 1998, GEOCHIM COSMOCHIM AC, V62, P1567, DOI 10.1016/S0016-7037(98)00089-1; Bull DC, 2001, ENVIRON SCI TECHNOL, V35, P1658, DOI 10.1021/es0015646; Callier MD, 2008, AQUACULTURE, V278, P77, DOI 10.1016/j.aquaculture.2008.03.026; Callier MD, 2009, MAR POLLUT BULL, V58, P1544, DOI 10.1016/j.marpolbul.2009.05.010; Carroll ML, 2003, AQUACULTURE, V226, P165, DOI 10.1016/S0044-8486(03)00475-7; Castine SA, 2009, AQUACULTURE, V297, P91, DOI 10.1016/j.aquaculture.2009.09.013; Chamberlain J, 2001, ICES J MAR SCI, V58, P411, DOI 10.1006/jmsc.2000.1037; Cornwell JC, 1995, ACS SYM SER, V612, P224; Cranford PJ, 2009, AQUACULTURE, V292, P189, DOI 10.1016/j.aquaculture.2009.04.039; Crawford CM, 2003, AQUACULTURE, V224, P117, DOI 10.1016/S0044-8486(03)00210-2; DAHLBACK B, 1981, MAR BIOL, V63, P269, DOI 10.1007/BF00395996; DIAZ RJ, 1993, WATER AIR SOIL POLL, V66, P251; Diaz RJ, 1988, UNDERSTANDING ESTUAR, V129, P222; Duarte P, 2008, AQUACULTURE, V274, P300, DOI 10.1016/j.aquaculture.2007.11.025; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Giles H, 2004, MAR ECOL PROG SER, V282, P205, DOI 10.3354/meps282205; Giles H, 2009, AQUACULTURE, V291, P168, DOI 10.1016/j.aquaculture.2009.03.010; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; GRANT J, 1995, ESTUARIES, V18, P124, DOI 10.2307/1352288; Grant J, 2008, J MARINE SYST, V73, P155, DOI 10.1016/j.jmarsys.2007.10.007; Hartstein ND, 2005, IEEE J OCEANIC ENG, V30, P85, DOI 10.1109/JOE.2004.841388; Hartstein ND, 2004, MAR ENVIRON RES, V57, P339, DOI 10.1016/j.marenvres.2003.11.003; Hartstein ND, 2005, AQUACULT ENG, V33, P192, DOI 10.1016/j.aquaeng.2005.01.002; HAY CH, 1990, BRIT PHYCOL J, V25, P301, DOI 10.1080/00071619000650331; Karakassis I, 2002, MAR ECOL PROG SER, V227, P125, DOI 10.3354/meps227125; KASPAR HF, 1985, MAR BIOL, V85, P127, DOI 10.1007/BF00397431; Mackay KA, 2012, MISCELLANEOUS SERIES, V91; MATTSSON J, 1983, SARSIA, V68, P97, DOI 10.1080/00364827.1983.10420561; McKindsey CW, 2011, CAN J ZOOL, V89, P622, DOI [10.1139/Z11-037, 10.1139/z11-037]; Mirto S, 2000, MAR POLLUT BULL, V40, P244, DOI 10.1016/S0025-326X(99)00209-X; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Nilsson HC, 1997, J MARINE SYST, V11, P249, DOI 10.1016/S0924-7963(96)00111-X; O'Reilly R, 2006, J MARINE SYST, V62, P189, DOI 10.1016/j.jmarsys.2006.01.008; OCONNOR BDS, 1989, MAR POLLUT BULL, V20, P384, DOI 10.1016/0025-326X(89)90316-0; OENEMA O, 1990, BIOGEOCHEMISTRY, V9, P53, DOI 10.1007/BF00002717; Plew DR, 2005, IEEE J OCEANIC ENG, V30, P95, DOI 10.1109/JOE.2004.841387; R Core Team, 2021, R LANGUAGE ENV STAT; RHOADS DC, 1986, HYDROBIOLOGIA, V142, P291, DOI 10.1007/BF00026766; RHOADS DC, 1982, MAR ECOL PROG SER, V8, P115, DOI 10.3354/meps008115; Robert P, 2013, MAR POLLUT BULL, V66, P92, DOI 10.1016/j.marpolbul.2012.11.003; Sorokin YI, 2012, ESTUAR COAST SHELF S, V98, P42, DOI 10.1016/j.ecss.2011.11.020; THODEANDERSEN S, 1989, LIMNOL OCEANOGR, V34, P793, DOI 10.4319/lo.1989.34.5.0793; Wildish DJ, 2003, J EXP MAR BIOL ECOL, V285, P403, DOI 10.1016/S0022-0981(02)00540-3; Wilson PS, 2012, LIMNOL OCEANOGR-METH, V10, P1070, DOI 10.4319/lom.2012.10.1070; Wong KLC, 2011, NEW ZEAL J MAR FRESH, V45, P187, DOI 10.1080/00288330.2010.550628	47	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129894	10.1371/journal.pone.0129894	http://dx.doi.org/10.1371/journal.pone.0129894			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083351	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400113
J	Taubert, M; Wenzel, U; Draganski, B; Kiebel, SJ; Ragert, P; Krug, J; Villringer, A				Taubert, Marco; Wenzel, Uwe; Draganski, Bogdan; Kiebel, Stefan J.; Ragert, Patrick; Krug, Juergen; Villringer, Arno			Investigating Neuroanatomical Features in Top Athletes at the Single Subject Level	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MOTOR SKILL; INDIVIDUAL-DIFFERENCES; BRAIN; PLASTICITY; NETWORK; NEUROPLASTICITY; ARCHITECTURE; PERFORMANCE; MECHANISMS	In sport events like Olympic Games or World Championships competitive athletes keep pushing the boundaries of human performance. Compared to team sports, high achievements in many athletic disciplines depend solely on the individual's performance. Contrasting previous research looking for expertise-related differences in brain anatomy at the group level, we aim to demonstrate changes in individual top athlete's brain, which would be averaged out in a group analysis. We compared structural magnetic resonance images (MRI) of three professional track-and-field athletes to age-, gender- and education-matched control subjects. To determine brain features specific to these top athletes, we tested for significant deviations in structural grey matter density between each of the three top athletes and a carefully matched control sample. While total brain volumes were comparable between athletes and controls, we show regional grey matter differences in striatum and thalamus. The demonstrated brain anatomy patterns remained stable and were detected after 2 years with Olympic Games in between. We also found differences in the fusiform gyrus in two top long jumpers. We interpret our findings in reward-related areas as correlates of top athletes' persistency to reach top-level skill performance over years.	[Taubert, Marco; Draganski, Bogdan; Kiebel, Stefan J.; Ragert, Patrick; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Wenzel, Uwe; Ragert, Patrick; Krug, Juergen] Univ Leipzig, Inst Gen Kinesiol & Athlet Training, D-04109 Leipzig, Germany; [Draganski, Bogdan] Univ Lausanne, CHUV, Dept Clin Neurosci, LREN, Lausanne, Switzerland; [Kiebel, Stefan J.] Tech Univ, Neuroimaging Ctr, Dept Psychol, Dresden, Germany	Max Planck Society; Leipzig University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Technische Universitat Dresden	Taubert, M (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	taubert@cbs.mpg.de	Ragert, Patrick/AAI-7290-2020; Draganski, Bogdan/C-3096-2016; Kiebel, Stefan J/B-1551-2009	Draganski, Bogdan/0000-0002-5159-5919; Kiebel, Stefan J/0000-0002-5052-1117; Villringer, Arno/0000-0003-2604-2404	European Union; European Regional Development Fund (ERDF); Free State of Saxony within the framework of the Excellence Initiative	European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within the framework of the Excellence Initiative	This work was supported by the European Union, European Regional Development Fund (ERDF) and Free State of Saxony within the framework of the Excellence Initiative to LIFE-Leipzig Research Centre for Civilization Diseases at the University of Leipzig (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Berman Y, 2010, PHYSIOLOGY, V25, P250, DOI 10.1152/physiol.00008.2010; BOBBERT MF, 1986, EUR J APPL PHYSIOL O, V54, P566, DOI 10.1007/BF00943342; Bradshaw EJ, 2000, J APPL BIOMECH, V16, P331, DOI 10.1123/jab.16.4.331; Bradshaw EJ, 2006, SPORT BIOMECH, V5, P1, DOI 10.1080/14763141.2006.9628221; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Castro-Alamancos MA, 2009, NEUROSCIENTIST, V15, P625, DOI 10.1177/1073858409333074; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Gartner H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00636; Gaser C, 2003, J NEUROSCI, V23, P9240; Gerber P, 2014, NEUROIMAGE, V95, P320, DOI 10.1016/j.neuroimage.2014.04.023; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Haith AM, 2013, ADV EXP MED BIOL, V782, P1, DOI 10.1007/978-1-4614-5465-6_1; HAY L, 1986, PERCEPT MOTOR SKILL, V62, P51, DOI 10.2466/pms.1986.62.1.51; HENSON R, 2006, COMP SINGLE PATIENT; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kilavik BE, 2009, J NEUROSCI, V29, P12653, DOI 10.1523/JNEUROSCI.1554-09.2009; LEE DN, 1982, J EXP PSYCHOL HUMAN, V8, P448; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Muhlau M, 2009, AM J NEURORADIOL, V30, P539, DOI 10.3174/ajnr.A1390; Muhlau M, 2012, PLOS ONE, V7; Noppeney U, 2007, BRAIN, V130, P1138, DOI 10.1093/brain/awl344; Park IS, 2011, HUM MOVEMENT SCI, V30, P56, DOI 10.1016/j.humov.2010.09.001; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Pavlov I.P., 1927, CONDITIONED REFLEXES; Picard N, 2013, NAT NEUROSCI, V16, P1340, DOI 10.1038/nn.3477; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Roberts RE, 2013, CEREB CORTEX, V23, P2282, DOI 10.1093/cercor/bhs219; Salmond CH, 2003, PHILOS T R SOC B, V358, P405, DOI 10.1098/rstb.2002.1210; Scarpazza C, 2013, NEUROIMAGE, V70, P175, DOI 10.1016/j.neuroimage.2012.12.045; Schlaffke L, 2014, NEUROSCIENCE, V259, P35, DOI 10.1016/j.neuroscience.2013.11.046; Schultz J, 2008, CEREB CORTEX, V18, P1302, DOI 10.1093/cercor/bhm162; Schultz W, 2003, SCIENCE, V300, P1662, DOI 10.1126/science.1085353; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; Shmuelof L, 2011, NEURON, V72, P469, DOI 10.1016/j.neuron.2011.10.017; Smesny S, 2010, NEUROIMAGE, V52, P1314, DOI 10.1016/j.neuroimage.2010.05.009; Stanley J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00503; Tennant KA, 2012, NEUROBIOL LEARN MEM, V98, P291, DOI 10.1016/j.nlm.2012.09.004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Walsh V, 2014, CURR BIOL, V24, pR859, DOI 10.1016/j.cub.2014.08.003; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Wei GX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028309; Wenzel U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096871; WINNER E, 1993, J AESTHET EDUC, V27, P31, DOI 10.2307/3333498; Wong AL, 2014, NEUROSCIENTIST; Xu T., 2009, NATURE; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672	59	9	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129508	10.1371/journal.pone.0129508	http://dx.doi.org/10.1371/journal.pone.0129508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9EB	26079870	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300025
J	Brenig, B; Schutz, E; Hardt, M; Scheuermann, P; Freick, M				Brenig, Bertram; Schuetz, Ekkehard; Hardt, Michael; Scheuermann, Petra; Freick, Markus			A 20 bp Duplication in Exon 2 of the Aristaless-Like Homeobox 4 Gene (ALX4) Is the Candidate Causative Mutation for Tibial Hemimelia Syndrome in Galloway Cattle	PLOS ONE			English	Article							COMPLEX VERTEBRAL MALFORMATION; GOLLOP-WOLFGANG COMPLEX; SWISS-MODEL WORKSPACE; LIMB DEVELOPMENT; FRONTONASAL DYSPLASIA; OSSIFICATION DEFECTS; HOMEODOMAIN; AGENESIS; CALF; DNA	Aristaless-like homeobox 4 (ALX4) gene is an important transcription regulator in skull and limb development. In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis. Here we show that a complex skeletal malformation of the hind limb in Galloway cattle together with other developmental anomalies is a recessive autosomal disorder most likely caused by a duplication of 20 bp in exon 2 of the bovine ALX4 gene. A second duplication of 34 bp in exon 4 of the same gene has no known effect, although both duplications result in a frameshift and premature stop codon leading to a truncated protein. Genotyping of 1,688 Black/Red/Belted/Riggit Galloway (GA) and 289 White Galloway (WGA) cattle showed that the duplication in exon 2 has allele frequencies of 1% in GA and 6% in WGA and the duplication in exon 4 has frequencies of 23% in GA and 38% in WGA. Both duplications were not detected in 876 randomly selected German Holstein Friesian and 86 cattle of 21 other breeds. Hence, we have identified a candidate causative mutation for tibial hemimelia syndrome in Galloway cattle and selection against this mutation can be used to eliminate the mutant allele from the breed.	[Brenig, Bertram; Schuetz, Ekkehard] Univ Gottingen, Inst Vet Med, D-37077 Gottingen, Germany; [Hardt, Michael; Scheuermann, Petra] Landesuntersuchungsanstalt Gesundheits & Vet Sach, D-04158 Leipzig, Germany; [Freick, Markus] Vet Practice Zettlitz, D-09306 Zettlitz, Germany	University of Gottingen	Brenig, B (corresponding author), Univ Gottingen, Inst Vet Med, D-37077 Gottingen, Germany.	bbrenig@gwdg.de	Freick, Markus/H-6545-2019	Brenig, Bertram/0000-0002-7635-9656	Erxleben Research AMP; Innovation Council [ERIC-BR1959-2013-01]; Veterinary Practice Zettlitz	Erxleben Research AMP; Innovation Council; Veterinary Practice Zettlitz	This work was supported by a grant of the Erxleben Research & Innovation Council to BB (ERIC-BR1959-2013-01). Veterinary Practice Zettlitz provided support in the form of a salary for author MF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "author contributions" section.	Agerholm JS, 2006, J VET DIAGN INVEST, V18, P418, DOI 10.1177/104063870601800421; Agerholm JS, 2001, J VET DIAGN INVEST, V13, P283, DOI 10.1177/104063870101300401; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beever J, 2012, INVENTORSSCREENING G; Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Bennett Robin L, 2008, J Genet Couns, V17, P424, DOI 10.1007/s10897-008-9169-9; Bertola DR, 2013, AM J MED GENET A, V161A, P600, DOI 10.1002/ajmg.a.35762; Boras-Granic K, 2006, INT J DEV BIOL, V50, P601, DOI 10.1387/ijdb.062153kb; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brouwer A, 2003, MECH DEVELOP, V120, P241, DOI 10.1016/S0925-4773(02)00416-1; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; Chen B, 2013, GENET MOL RES, V12, P2771, DOI 10.4238/2013.August.2.2; Colloton J., 2014, BOVINE REPROD, P226; Dee CT, 2013, HUM MOL GENET, V22, P239, DOI 10.1093/hmg/dds423; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Drogemuller C, 2006, VET J, V171, P120, DOI 10.1016/j.tvjl.2004.09.009; Erickson RP, 2005, AM J MED GENET A, V134A, P315, DOI 10.1002/ajmg.a.30636; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; Evans JA, 1999, AM J MED GENET, V85, P13, DOI 10.1002/(SICI)1096-8628(19990702)85:1<13::AID-AJMG5>3.0.CO;2-N; Ferrarini A, 2014, AM J MED GENET A, V164, P346, DOI 10.1002/ajmg.a.36140; GUFFY MM, 1977, J AM VET RADIOL SOC, V18, P109; Hall CR, 2001, CLIN GENET, V60, P356, DOI 10.1034/j.1399-0004.2001.600506.x; Hudson R, 1998, DEV DYNAM, V213, P159, DOI 10.1002/(SICI)1097-0177(199810)213:2<159::AID-AJA1>3.0.CO;2-F; JONES D, 1978, J BONE JOINT SURG BR, V60, P31, DOI 10.1302/0301-620X.60B1.627576; Kariminejad A, 2014, AM J MED GENET A, V164, P1322, DOI 10.1002/ajmg.a.36008; Kayserili H, 2012, AM J MED GENET A, V158A, P236, DOI 10.1002/ajmg.a.34390; Kayserili H, 2009, HUM MOL GENET, V18, P4357, DOI 10.1093/hmg/ddp391; Kuijper S, 2005, DEV BIOL, V285, P533, DOI 10.1016/j.ydbio.2005.06.017; Lapointe JM, 2000, VET PATHOL, V37, P508, DOI 10.1354/vp.37-5-508; Leipold HW, 1998, J VET DIAGN INVEST, V10, P247, DOI 10.1177/104063879801000304; Lynch VJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-86; Matsumaru D, 2014, EUR J HUM GENET, V22, P350, DOI 10.1038/ejhg.2013.160; Mavrogiannis LA, 2001, NAT GENET, V27, P17, DOI 10.1038/83703; Mendilcioglu I, 2009, PRENATAL DIAG, V29, P182, DOI 10.1002/pd.2204; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; OJO SA, 1974, J AM VET MED ASSOC, V165, P548; Panman L, 2005, INT J DEV BIOL, V49, P443, DOI 10.1387/ijdb.051984lp; POLLOCK DL, 1979, VET REC, V104, P258, DOI 10.1136/vr.104.12.258; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; Rozen S, 2000, Methods Mol Biol, V132, P365; SALAKO MA, 1982, VET REC, V110, P430, DOI 10.1136/vr.110.18.430; Schutz E, 1999, BIOTECHNIQUES, V27, P1218, DOI 10.2144/99276bc04; SHANG ZG, 1994, P NATL ACAD SCI USA, V91, P8373, DOI 10.1073/pnas.91.18.8373; Stevens CA, 1999, AM J MED GENET, V85, P409, DOI 10.1002/(SICI)1096-8628(19990806)85:4<409::AID-AJMG19>3.0.CO;2-6; Szczerbal I, 2006, VET PATHOL, V43, P789, DOI 10.1354/vp.43-5-789; Takahashi M, 1998, DEVELOPMENT, V125, P4417; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Tung CS, 1999, J BIOMOL STRUCT DYN, V17, P347, DOI 10.1080/07391102.1999.10508366; von Ahsen N, 1999, CLIN CHEM, V45, P2094; Whitlock BK, 2008, THERIOGENOLOGY, V70, P535, DOI 10.1016/j.theriogenology.2008.04.016; Wohlke A, 2006, CYTOGENET GENOME RES, V115, P123, DOI 10.1159/000095231; Wuyts W, 2000, J MED GENET, V37, P916, DOI 10.1136/jmg.37.12.916; Xu Xianzhong, 2014, Journal of Structural and Functional Genomics, V15, P201, DOI 10.1007/s10969-014-9184-z; YOUNG G B, 1951, Br Vet J, V107, P23	58	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129208	10.1371/journal.pone.0129208	http://dx.doi.org/10.1371/journal.pone.0129208			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076463	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900052
J	Ctori, I; Huntjens, B				Ctori, Irene; Huntjens, Byki			Repeatability of Foveal Measurements Using Spectralis Optical Coherence Tomography Segmentation Software	PLOS ONE			English	Article							RETINAL THICKNESS MEASUREMENTS; MACULAR THICKNESS; TIME-DOMAIN; MULTIPLE-SCLEROSIS; LAYER THICKNESS; REPRODUCIBILITY; OCT; HEALTHY; PIGMENT; MORPHOLOGY	Purpose To investigate repeatability and reproducibility of thickness of eight individual retinal layers at axial and lateral foveal locations, as well as foveal width, measured from Spectralis spectral domain optical coherence tomography (SD-OCT) scans using newly available retinal layer segmentation software. Methods High-resolution SD-OCT scans were acquired for 40 eyes of 40 young healthy volunteers. Two scans were obtained in a single visit for each participant. Using new Spectralis segmentation software, two investigators independently obtained thickness of each of eight individual retinal layers at 0 degrees, 2 degrees and 5 degrees eccentricities nasal and temporal to foveal centre, as well as foveal width measurements. Bland-Altman Coefficient of Repeatability (CoR) was calculated for inter-investigator and inter-scan agreement of all retinal measurements. Spearman's. indicated correlation of manually located central retinal thickness (RT0) with automated minimum foveal thickness (MFT) measurements. In addition, we investigated nasal-temporal symmetry of individual retinal layer thickness within the foveal pit. Results Inter-scan CoR values ranged from 3.1 mu m for axial retinal nerve fibre layer thickness to 15.0 mu m for the ganglion cell layer at 5 degrees eccentricity. Mean foveal width was 2550 mu m +/- 322 mu m with a CoR of 13 mu m for inter-investigator and 40 mu m for inter-scan agreement. Correlation of RT0 and MFT was very good (rho = 0.97, P < 0.0005). There were no significant differences in thickness of any individual retinal layers at 2 degrees nasal compared to temporal to fovea (P > 0.05); however this symmetry could not be found at 5 degrees eccentricity. Conclusions We demonstrate excellent repeatability and reproducibility of each of eight individual retinal layer thickness measurements within the fovea as well as foveal width using Spectralis SDOCT segmentation software in a young, healthy cohort. Thickness of all individual retinal layers were symmetrical at 2 degrees, but not at 5 degrees eccentricity away from the fovea.	[Ctori, Irene; Huntjens, Byki] City Univ London, Henry Wellcome Labs Vis Sci, Appl Vis Res Ctr, London EC1V 0HB, England	City University London	Huntjens, B (corresponding author), City Univ London, Henry Wellcome Labs Vis Sci, Appl Vis Res Ctr, Northampton Sq, London EC1V 0HB, England.	Byki.Huntjens.1@city.ac.uk		Huntjens, Byki/0000-0002-4864-0723; ctori, irene/0000-0003-1523-4996				Anger EM, 2004, EXP EYE RES, V78, P1117, DOI 10.1016/j.exer.2004.01.011; [Anonymous], 2013, SPECTR HRA OCT US MA; Balasubramanian M, 2009, OPT EXPRESS, V17, P4019, DOI 10.1364/OE.17.004019; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bressler SB, 2014, JAMA OPHTHALMOL, V132, P1113, DOI 10.1001/jamaophthalmol.2014.1698; Carpineto P, 2010, EYE, V24, P251, DOI 10.1038/eye.2009.76; Chakravarthy U, 2013, EYE, V27, P1429, DOI 10.1038/eye.2013.233; Chiu SJ, 2012, INVEST OPHTH VIS SCI, V53, P53, DOI 10.1167/iovs.11-7640; Comyn O, 2012, INVEST OPHTH VIS SCI, V53, P7754, DOI 10.1167/iovs.12-10895; Ctori I, 2015, GRAEF ARCH CLIN EXP, V253, P733, DOI 10.1007/s00417-014-2915-9; Dubis AM, 2009, BRIT J OPHTHALMOL, V93, P1223, DOI 10.1136/bjo.2008.150110; El-Ashry M, 2008, CURR EYE RES, V33, P693, DOI 10.1080/02713680802323140; Eriksson U, 2009, ACTA OPHTHALMOL, V87, P725, DOI 10.1111/j.1755-3768.2008.01345.x; Fiore T, 2015, OPHTHALMOLOGICA, V233, P186, DOI 10.1159/000380832; Folgar FA, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016014; Gilmore ED, 2004, BRIT J OPHTHALMOL, V88, P62, DOI 10.1136/bjo.88.1.62; Hammer DX, 2008, INVEST OPHTH VIS SCI, V49, P2061, DOI 10.1167/iovs.07-1228; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Krebs I, 2011, INVEST OPHTH VIS SCI, V52, P6925, DOI 10.1167/iovs.10-6612; Langenegger SJ, 2011, INVEST OPHTH VIS SCI, V52, P3338, DOI 10.1167/iovs.10-6611; Lee S, 2013, INVEST OPHTH VIS SCI, V54, P2864, DOI 10.1167/iovs.12-11521; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4893, DOI 10.1167/iovs.07-1326; Matsumoto H, 2009, AM J OPHTHALMOL, V148, P105, DOI 10.1016/j.ajo.2009.01.018; McAlinden C, 2011, OPHTHAL PHYSL OPT, V31, P330, DOI 10.1111/j.1475-1313.2011.00851.x; Menke MN, 2009, AM J OPHTHALMOL, V147, P467, DOI 10.1016/j.ajo.2008.09.005; Mohammad S, 2011, OPHTHALMOLOGY, V118, P1645, DOI 10.1016/j.ophtha.2011.01.037; Mojana F, 2008, AM J OPHTHALMOL, V146, P218, DOI 10.1016/j.ajo.2008.04.027; Moreno-Montanes J, 2010, INVEST OPHTH VIS SCI, V51, P335, DOI 10.1167/iovs.08-2988; Nassif N, 2004, OPT LETT, V29, P480, DOI 10.1364/OL.29.000480; Nolan JM, 2008, INVEST OPHTH VIS SCI, V49, P2134, DOI 10.1167/iovs.07-0933; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Patel PJ, 2008, INVEST OPHTH VIS SCI, V49, P1084, DOI 10.1167/iovs.07-1203; Patel PJ, 2011, ACTA OPHTHALMOL, V89, P229, DOI 10.1111/j.1755-3768.2009.01659.x; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Paunescu LA, 2004, INVEST OPHTH VIS SCI, V45, P1716, DOI 10.1167/iovs.03-0514; Pesudovs K, 2004, OPTOMETRY VISION SCI, V81, P554, DOI 10.1097/00006324-200407000-00018; Pierro L, 2010, AM J OPHTHALMOL, V150, P199, DOI 10.1016/j.ajo.2010.03.015; Pinilla I, 2013, RETINA-J RET VIT DIS, V33, P1448, DOI 10.1097/IAE.0b013e3182807683; Polito A, 2005, ARCH OPHTHALMOL-CHIC, V123, P1330, DOI 10.1001/archopht.123.10.1330; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; Regatieri Caio V, 2011, Ophthalmic Surg Lasers Imaging, V42 Suppl, pS56, DOI 10.3928/15428877-20110627-05; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Seigo MA, 2012, J NEUROL, V259, P2119, DOI 10.1007/s00415-012-6466-x; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; Tan CSH, 2012, INVEST OPHTH VIS SCI, V53, P5515, DOI 10.1167/iovs.12-9868; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Tick S, 2011, INVEST OPHTH VIS SCI, V52, P5105, DOI 10.1167/iovs.10-7005; Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004; Van Der Veen RLP, 2009, EUR J OPHTHALMOL, V19, P836, DOI 10.1177/112067210901900524; Varma R, 1996, OPHTHALMOLOGY, V103, P2114, DOI 10.1016/S0161-6420(96)30381-3; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Westrup VMZ, 2014, INVEST OPHTH VIS SCI, V55, P1169, DOI 10.1167/iovs.13-12903; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; ZEFFREN BS, 1990, INVEST OPHTH VIS SCI, V31, P2099	56	79	79	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129005	10.1371/journal.pone.0129005	http://dx.doi.org/10.1371/journal.pone.0129005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076457	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000356329900043
J	Martins, TAF; Diniz, LD; Mazzeti, AL; do Nascimento, AFS; Caldas, S; Caldas, IS; de Andrade, IM; Ribeiro, I; Bahia, MT				Fontes Martins, Tassiane Assiria; Diniz, Livia de Figueiredo; Mazzeti, Ana Lia; da Silva do Nascimento, Alvaro Fernando; Caldas, Sergio; Caldas, Ivo Santana; de Andrade, Isabel Mayer; Ribeiro, Isabela; Bahia, Maria Terezinha			Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease	PLOS ONE			English	Article							EXPERIMENTAL CHEMOTHERAPY; ERGOSTEROL BIOSYNTHESIS; PARASITE PERSISTENCE; BENZNIDAZOLE; ITRACONAZOLE; INFECTION; TISSUE; PHASE; HOST	The nitroheterocyclic drugs nifurtimox and benznidazole are first-line drugs available to treat Chagas disease; however, they have limitations, including long treatment courses and toxicity. Strategies to overcome these limitations include the identification of new drugs with specific target profiles, re-dosing regimens for the current drugs, drug repositioning and combination therapy. In this work, we evaluated combination therapy as an approach for optimization of the current therapeutic regimen for Chagas disease. The curative action of benznidazole/itraconazole combinations was explored in an established infection of the mice model with the T. cruzi Y strain. The activities of the benznidazole/itraconazole combinations were compared with the results from those receiving the same dosage of each individual drug. The administration of benznidazole/itraconazole in combination eliminated parasites from the blood more efficiently than each drug alone. Here, there was a significant reduction of the number of treatment days (number of doses) necessary to induce parasitemia suppression with the benznidazole/itraconazole combination, as compared to each compound administered alone. These results clearly indicate the enhanced effects of these drugs in combination, particularly at the dose of 75 mg/kg, as the effects observed with the drug combinations were four times more effective than those of each drug used alone. Moreover, benznidazole/itraconazole treatment was shown to prevent or decrease the typical lesions associated with chronic experimental Chagas disease, as illustrated by similar levels of inflammatory cells and fibrosis in the cardiac muscle tissue of healthy and treated mice. These results emphasize the importance of exploring the potential of combination treatments with currently available compounds to specifically treat Chagas disease.	[Fontes Martins, Tassiane Assiria; Diniz, Livia de Figueiredo; Mazzeti, Ana Lia; da Silva do Nascimento, Alvaro Fernando; Caldas, Sergio; Caldas, Ivo Santana; de Andrade, Isabel Mayer; Bahia, Maria Terezinha] Univ Fed Ouro Preto, Escola Med, Lab Doencas Parasitarias, Ouro Preto, MG, Brazil; [Fontes Martins, Tassiane Assiria; Diniz, Livia de Figueiredo; Mazzeti, Ana Lia; da Silva do Nascimento, Alvaro Fernando; Caldas, Sergio; Caldas, Ivo Santana; de Andrade, Isabel Mayer; Bahia, Maria Terezinha] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil; [Caldas, Sergio] Fundacao Ezequiel Dias, Belo Horizonte, MG, Brazil; [Diniz, Livia de Figueiredo; Caldas, Ivo Santana] Univ Fed Alfenas, Inst Ciencias Biomed, Dept Patol & Parasitol, Alfenas, MG, Brazil; [Ribeiro, Isabela] DNDi, CH-1202 Geneva, Switzerland	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Alfenas	Bahia, MT (corresponding author), Univ Fed Ouro Preto, Escola Med, Lab Doencas Parasitarias, Campus Univ, Ouro Preto, MG, Brazil.	mtbahia@nupeb.ufop.br	Mazzeti, Ana Lia/AAB-9944-2019; Diniz, Lívia F/I-7704-2018; Caldas, Ivo S/G-9531-2012; Diniz, Lívia F/Y-9853-2019; Caldas, Sérgio/P-3572-2015	Mazzeti, Ana Lia/0000-0003-1642-306X; Caldas, Ivo S/0000-0002-4937-2425; Caldas, Sérgio/0000-0003-1489-794X; Diniz, Livia/0000-0001-9398-6478	Drugs for Neglected Diseases initiative (DNDi; Geneva, Switzerland); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CAPES; Department for International Development (DFID), UK; Medecins Sans Frontieres/Doctors without Borders (MSF), International; Spanish Agency for International Development Cooperation (AECID), Spain; Swiss Agency for Development and Cooperation (SDC), Switzerland	Drugs for Neglected Diseases initiative (DNDi; Geneva, Switzerland); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Department for International Development (DFID), UK; Medecins Sans Frontieres/Doctors without Borders (MSF), International; Spanish Agency for International Development Cooperation (AECID), Spain; Swiss Agency for Development and Cooperation (SDC), Switzerland	This work received financial support from the Drugs for Neglected Diseases initiative (DNDi; Geneva, Switzerland); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and research fellowships from CNPq (MTB) and CAPES (LFD). DNDi would like to thank the following donors for their support: Department for International Development (DFID), UK; Medecins Sans Frontieres/Doctors without Borders (MSF), International; Spanish Agency for International Development Cooperation (AECID), Spain; Swiss Agency for Development and Cooperation (SDC), Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ANT DRUG COMB THER R; Apt W, 1998, AM J TROP MED HYG, V59, P133, DOI 10.4269/ajtmh.1998.59.133; Araujo MSS, 2000, J ANTIMICROB CHEMOTH, V45, P819, DOI 10.1093/jac/45.6.819; AVILA H, 1990, MOL BIOCHEM PARASIT, V42, P175, DOI 10.1016/0166-6851(90)90160-N; Bahia MT, 2014, EXPERT OPIN INV DRUG, V23, P1225, DOI 10.1517/13543784.2014.922952; Benvenuti LA, 2008, ANN TROP MED PARASIT, V102, P481, DOI 10.1179/136485908X311740; Bustamante JM, 2002, INT J PARASITOL, V32, P889, DOI 10.1016/S0020-7519(02)00023-1; Caldas IS, 2008, PARASITOL RES, V103, P413, DOI 10.1007/s00436-008-0992-6; Caldas S, 2008, EXP PARASITOL, V118, P315, DOI 10.1016/j.exppara.2007.08.016; Caldas S, 2012, ACTA TROP, V123, P170, DOI 10.1016/j.actatropica.2012.05.002; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; da Silva RM, 2012, ANTIMICROB AGENTS CH, V56, P3344, DOI 10.1128/AAC.05785-11; Diniz LD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002367; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; FILARDI LS, 1987, T ROY SOC TROP MED H, V81, P755, DOI 10.1016/0035-9203(87)90020-4; Garcia S, 2005, ANTIMICROB AGENTS CH, V49, P1521, DOI 10.1128/AAC.49.4.1521-1528.2005; Gomes ML, 1998, EXP PARASITOL, V88, P28, DOI 10.1006/expr.1998.4191; Guedes P. M. M., 2006, Anti-Infective Agents in Medicinal Chemistry, V5, P175, DOI 10.2174/187152106776359020; Lienhardt C, 2012, J INFECT DIS, V205, pS241, DOI 10.1093/infdis/jis034; Lo Presti MS, 2004, INT J ANTIMICROB AG, V23, P634, DOI 10.1016/j.ijantimicag.2003.10.006; MALDONADO RA, 1993, ANTIMICROB AGENTS CH, V37, P1353, DOI 10.1128/AAC.37.6.1353; Molina I, 2014, NEW ENGL J MED, V371, P966, DOI 10.1056/NEJMc1407914; MOREIRA AAB, 1992, REV I MED TROP, V34, P177, DOI 10.1590/S0036-46651992000200015; NYE FJ, 1979, J ANTIMICROB CHEMOTH, V5, P244, DOI 10.1093/jac/5.3.244; Soeiro MNC, 2009, EXPERT OPIN THER TAR, V13, P105, DOI [10.1517/14728220802623881, 10.1517/14728220802623881 ]; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Toledo MJD, 2003, ANTIMICROB AGENTS CH, V47, P223, DOI 10.1128/AAC.47.1.223-230.2003; Torrico F, 2013, ANN M AM SOC TROP ME; Urbina J A, 1988, Ann N Y Acad Sci, V544, P357, DOI 10.1111/j.1749-6632.1988.tb40421.x; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Van Cauteren H, 1987, RECENT TRENDS DISCOV, P101; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WHO. World Health Organization, 2010, CHAG DIS	34	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128707	10.1371/journal.pone.0128707	http://dx.doi.org/10.1371/journal.pone.0128707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076455	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900025
J	Lee, JW; Park, JW; Khang, D				Lee, Jin Woo; Park, Jin-Woo; Khang, Dongwoo			Analysis of Osteoblast Differentiation on Polymer Thin Films Embedded with Carbon Nanotubes	PLOS ONE			English	Article							SUBMICRON-SURFACE-FEATURES; BONE-FORMATION; CELL-ADHESION; STEM-CELLS; IN-VIVO; TITANIUM; PROLIFERATION; OSTEOPONTIN; ROUGHNESS; SCALE	Osteoblast differentiation can be modulated by variations in order of nanoscale topography. Biopolymers embedded with carbon nanotubes can cause various orders of roughness at the nanoscale and can be used to investigate the dynamics of extracellular matrix interaction with cells. In this study, clear relationship between the response of osteoblasts to integrin receptor activation, their phenotype, and transcription of certain genes on polymer composites embedded with carbon nanotubes was demonstrated. We generated an ultrathin nanocomposite film embedded with carbon nanotubes and observed improved adhesion of pre-osteoblasts, with a subsequent increase in their proliferation. The expression of genes encoding integrin subunits alpha(5), alpha(v), beta(1), and beta(3) was significantly upregulated at the early of time-point when cells initially attached to the carbon nanotube/polymer composite. The advantage of ultrathin nanocomposite film for pre-osteoblasts was demonstrated by staining for the cytoskeletal protein vinculin and cell nuclei. The expression of essential transcription factors for osteoblastogenesis, such as Runx2 and Sp7 transcription factor 7 (known as osterix), was upregulated after 7 days. Consequently, the expression of genes that determine osteoblast phenotype, such as alkaline phosphatase, type I collagen, and osteocalcin, was accelerated on carbon nanotube embedded polymer matrix after 14 days. In conclusion, the ultrathin nanocomposite film generated various orders of nanoscale topography that triggered processes related to osteoblast bone formation.	[Lee, Jin Woo; Khang, Dongwoo] Gachon Univ, Sch Med, Dept Mol Med, Inchon, South Korea; [Park, Jin-Woo] Kyungpook Natl Univ, Sch Dent, Dept Periodontol, Daegu, South Korea	Gachon University; Kyungpook National University	Park, JW (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Periodontol, Daegu, South Korea.	jinwoo@knu.ac.kr; dkhang@gachon.ac.kr		Park, Jin-Woo/0000-0002-6632-023X; Khang, Dongwoo/0000-0003-2353-8017	National Research Foundation [NRF 2012R1A1A2041157, MSIP 2008-0062282]; Korea Health Industry Development Institute (KHIDI) by South Korea [HI14C3228]	National Research Foundation; Korea Health Industry Development Institute (KHIDI) by South Korea(Korea Health Industry Development Institute (KHIDI))	This research was supported by grants from National Research Foundation (NRF 2012R1A1A2041157 and MSIP 2008-0062282) and the Korea Health Industry Development Institute (KHIDI, HI14C3228) by South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniket Reid R, 2014, J BIOMED MAT RES A; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Baik KY, 2011, SMALL, V7, P741, DOI 10.1002/smll.201001930; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067; Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7; Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502; Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Harmey D, 2006, J BONE MINER RES, V21, P1377, DOI 10.1359/JBMR.060619; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Joy A, 2011, LANGMUIR, V27, P1891, DOI 10.1021/la103722m; Kato RB, 2014, J CELL PHYSIOL, V229, P1690, DOI 10.1002/jcp.24614; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009; Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005; Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005; Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009; Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054; Marie PJ, 2013, NAT REV ENDOCRINOL, V9, P288, DOI 10.1038/nrendo.2013.4; Nayak TR, 2010, ACS NANO, V4, P7717, DOI 10.1021/nn102738c; Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105; Pan LL, 2012, COLLOID SURFACE B, V93, P226, DOI 10.1016/j.colsurfb.2012.01.011; Park JW, 2008, J BIOMED MATER RES A, V86A, P117, DOI 10.1002/jbm.a.31618; Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P398, DOI 10.1111/j.1600-0501.2009.01863.x; Sahithi K, 2010, INT J BIOL MACROMOL, V46, P281, DOI 10.1016/j.ijbiomac.2010.01.006; Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sotobori T, 2006, EXP CELL RES, V312, P3927, DOI 10.1016/j.yexcr.2006.08.024; Stary V, 2014, J BIOMED MATER RES A, V102, P1868, DOI 10.1002/jbm.a.34833; Wade-Gueye NM, 2012, BONE, V50, P1064, DOI 10.1016/j.bone.2012.02.014; Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016; Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005; Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013; Yang JL, 2014, ACS NANO, V8, P9941, DOI 10.1021/nn504767g; Zamir E, 2001, J CELL SCI, V114, P3577; Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111	42	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129856	10.1371/journal.pone.0129856	http://dx.doi.org/10.1371/journal.pone.0129856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076355	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900105
J	Liu, SY; Manly, JJ; Capistrant, BD; Glymour, MM				Liu, Sze Yan; Manly, Jennifer J.; Capistrant, Benjamin D.; Glymour, M. Maria			Historical Differences in School Term Length and Measured Blood Pressure: Contributions to Persistent Racial Disparities among US-Born Adults	PLOS ONE			English	Article							RISK-FACTORS; EDUCATION; HEALTH; HYPERTENSION; PATHWAYS; QUALITY	Introduction Legally mandated segregation policies dictated significant differences in the educational experiences of black and white Americans through the first half of the 20th century, with markedly lower quality in schools attended by black children. We determined whether school term length, a common marker of school quality, was associated with blood pressure and hypertension among a cohort of older Americans who attended school during the de jure segregation era. Methods National Health and Nutrition Examination Survey I and II data were linked to state level historical information on school term length. We used race and gender-stratified linear regression models adjusted for age, state and year of birth to estimate effects of term length on systolic and diastolic blood pressure (SBP and DBP) and hypertension for US-born adults. We also tested whether correcting years of schooling for term length differences attenuated estimated racial disparities. Results Among black women, 10% longer school term was associated with lower SBP, DBP and hypertension prevalence (2.1 mmHg, 1.0 mmHg, and 5.0 percentage points respectively). Associations for whites and for black men were not statistically significant. Adjustment for education incorporating corrections for differences in school term length slightly attenuated estimated racial disparities. Conclusions Longer school term length predicted better BP outcomes among black women, but not black men or whites.	[Liu, Sze Yan] Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Manly, Jennifer J.] Columbia Univ, Gertrude H Sergievsky Ctr, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Manly, Jennifer J.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Capistrant, Benjamin D.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Glymour, M. Maria] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Liu, SY (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA.	szeliu@hsph.harvard.edu	Capistrant, Benjamin/AAM-1169-2020; Liu, Sze/ABB-4170-2021	Capistrant, Benjamin/0000-0001-5841-6592; Liu, Sze Yan/0000-0002-7148-356X; Glymour, M. Maria/0000-0001-9644-3081	American Heart Association [10SDG2640243]	American Heart Association(American Heart Association)	The authors gratefully acknowledge financial support from the American Heart Association grant 10SDG2640243.	Ailshire JA, 2011, SOC FORCES, V90, P397, DOI 10.1093/sf/sor001; Balamurugan A, 2013, CIRC-CARDIOVASC QUAL, V6, P668, DOI 10.1161/CIRCOUTCOMES.113.000265; Bellei C, 2006, DOES LENGTHENING SCH; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; CARD D, 1992, J POLIT ECON, V100, P1, DOI 10.1086/261805; Carlsson AC, 2008, AM J HYPERTENS, V21, P771, DOI 10.1038/ajh.2008.167; CDC, 2011, LEAD CAUS DEATH; Chandola T, 2006, J R STAT SOC A STAT, V169, P337, DOI 10.1111/j.1467-985X.2006.00411.x; Cohen AK, 2013, AM J PUBLIC HEALTH, pe1; Collins WJ, 2003, IND LABOR RELAT REV, V56, P244, DOI 10.2307/3590937; Conti G, 2010, AM ECON REV, V100, P234, DOI 10.1257/aer.100.2.234; Crenshaw K., 1989, UNIV CHICAGO LEG FOR, V1989, P139; Crowe M, 2012, J GERONTOLOGY A; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Cutler DM, 2006, ED HLTH EVALUATING T; DYER AR, 1976, CIRCULATION, V54, P987, DOI 10.1161/01.CIR.54.6.987; ECS, 2011, NUMB INSTR DAYS HOUR; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Fletcher J, 2012, REV ECON HOUSEHOLD, P1; Fletcher JM, 2011, ECON EDUC REV, V30, P826, DOI 10.1016/j.econedurev.2011.04.005; FREEMAN RB, 1973, BROOKINGS PAP ECO AC, P67; Frisvold D, 2010, J HLTH EC, V30, P1232; Frisvold D, 2013, DEMOGRAPHY IN PRESS; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Ganguli MC, 1999, AM J HYPERTENS, V12, P69, DOI 10.1016/S0895-7061(98)00218-0; Glymour MM, 2008, NEUROPSYCHOL REV, V18, P194, DOI 10.1007/s11065-008-9066-x; Haines DJ, 2007, J AM COLL HEALTH, V55, P219, DOI 10.3200/JACH.55.4.219-225; Heckman JJ, 2005, INVITED COMMENTS; Hoffmeister H, 1996, PREV MED, V25, P135, DOI 10.1006/pmed.1996.0039; Jones AM, 2011, J HUM CAPITAL, V5, P342, DOI 10.1086/662441; Kaplan G, 2008, MAKING AM HLTH SOCIA, P145; Knight EL, 2001, HYPERTENSION, V38, P809, DOI 10.1161/hy0901.091681; Kotchen TA, 1997, CIRCULATION, V96, P1071, DOI 10.1161/01.CIR.96.4.1071; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lahelma E, 2004, J EPIDEMIOL COMMUN H, V58, P327, DOI 10.1136/jech.2003.011148; Liu SY, 2011, ANN EPIDEMIOL, V21, P128, DOI 10.1016/j.annepidem.2010.11.004; Non AL, 2012, AM J PUBLIC HEALTH, V102, P1559, DOI 10.2105/AJPH.2011.300448; PLEIS JR, 2010, SUMMARY HLTH STAT US; Ross CE, 2006, SOC SCI MED, V63, P1400, DOI 10.1016/j.socscimed.2006.03.013; Ross CE, 2011, SOC SCI MED, V72, P591, DOI 10.1016/j.socscimed.2010.11.028; Ross CE, 2010, SOCIOL QUART, V51, P1, DOI 10.1111/j.1533-8525.2009.01164.x; Sansani S, 2011, ECON EDUC REV, V30, P1320, DOI 10.1016/j.econedurev.2011.06.003; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Walsemann KM, 2013, AM BEHAV SCI, V57, P1082, DOI 10.1177/0002764213487346; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th; World Health Organization, 2021, TOP 10 CAUS DEATH; Yeung Edwina H, 2014, Curr Epidemiol Rep, V1, P9; Yoon S, 2012, HYPERTENSION ADULTS	50	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129673	10.1371/journal.pone.0129673	http://dx.doi.org/10.1371/journal.pone.0129673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076495	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900089
J	Campos, SS; Diez, GR; Oresti, GM; Salvador, GA				Sanchez Campos, Sofia; Rodriguez Diez, Guadalupe; Martin Oresti, Gerardo; Alejandra Salvador, Gabriela			Dopaminergic Neurons Respond to Iron-Induced Oxidative Stress by Modulating Lipid Acylation and Deacylation Cycles	PLOS ONE			English	Article							SYNAPTIC ENDINGS; PARKINSONS; BRAIN; ALZHEIMERS; DEATH; PHOSPHOLIPASE-A(2); ACTIVATION; MEDIATORS; PATHWAY; ADULT	Metal-imbalance has been reported as a contributor factor for the degeneration of dopaminergic neurons in Parkinson Disease (PD). Specifically, iron (Fe)-overload and copper (Cu) mis-compartmentalization have been reported to be involved in the injury of dopaminergic neurons in this pathology. The aim of this work was to characterize the mechanisms of membrane repair by studying lipid acylation and deacylation reactions and their role in oxidative injury in N27 dopaminergic neurons exposed to Fe-overload and Cu-supplementation. N27 dopaminergic neurons incubated with Fe (1mM) for 24 hs displayed increased levels of reactive oxygen species (ROS), lipid peroxidation and elevated plasma membrane permeability. Cu-supplemented neurons (10, 50 mu M) showed no evidence of oxidative stress markers. A different lipid acylation profile was observed in N27 neurons pre-labeled with [H-3] arachidonic acid (AA) or [H-3] oleic acid (OA). In Fe-exposed neurons, AA uptake was increased in triacylglycerols (TAG) whereas its incorporation into the phospholipid (PL) fraction was diminished. TAG content was 40% higher in Fe-exposed neurons than in controls. This increase was accompanied by the appearance of Nile red positive lipid bodies. Contrariwise, OA incorporation increased in the PL fractions and showed no changes in TAG. Lipid acylation profile in Cu-supplemented neurons showed AA accumulation into phosphatidylserine and no changes in TAG. The inhibition of deacylation/acylation reactions prompted an increase in oxidative stress markers and mitochondrial dysfunction in Fe-overloaded neurons. These findings provide evidence about the participation of lipid acylation mechanisms against Fe-induced oxidative injury and postulate that dopaminergic neurons cleverly preserve AA in TAG in response to oxidative stress.	[Alejandra Salvador, Gabriela] Univ Nacl Sur UNS, Inst Invest Bioquim Bahia Blanca INIBIBB, Bahia Blanca, Buenos Aires, Argentina; Consejo Nacl Invest Cient & Tecn CONICET, Bahia Blanca, Buenos Aires, Argentina	National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Salvador, GA (corresponding author), Univ Nacl Sur UNS, Inst Invest Bioquim Bahia Blanca INIBIBB, Bahia Blanca, Buenos Aires, Argentina.	salvador@criba.edu.ar	Salvador, Gabriela/GOJ-7718-2022		Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2010-0936, PICT-2013-0987]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP1122009010068]; Universidad Nacional del Sur [PGI24B179]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional del Sur	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica www.agencia.mincyt.gob.ar/ (PICT-2010-0936, PICT-2013-0987) to GAS, Consejo Nacional de Investigaciones Cientificas y Tecnicas www.conicet.gov.ar (PIP1122009010068) to GAS and the Universidad Nacional del Sur www.uns.edu.ar (PGI24B179) to GAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2003, ANTIOXID REDOX SIGN, V5, P647, DOI 10.1089/152308603770310329; Balboa MA, 2006, BBA-MOL CELL BIOL L, V1761, P385, DOI 10.1016/j.bbalip.2006.03.014; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Davies KM, 2014, NEUROBIOL AGING, V35, P858, DOI 10.1016/j.neurobiolaging.2013.09.034; Devos D, 2013, CLIN THER, V35, P1640, DOI 10.1016/j.clinthera.2013.08.011; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Double Kay L, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS52, DOI 10.1016/S1353-8020(11)70018-9; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Else PL, 2015, BBA-BIOMEMBRANES, V1848, P417, DOI 10.1016/j.bbamem.2014.10.039; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Farooqui AA, 2009, NEUROSCIENTIST, V15, P392, DOI 10.1177/1073858409337035; Fonteh AN, 2013, J LIPID RES, V54, P2884, DOI 10.1194/jlr.M037622; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Gal S, 2006, J NEURAL TRANSM-SUPP, P447; Glynn P, 2013, BBA-MOL CELL BIOL L, V1831, P633, DOI 10.1016/j.bbalip.2012.07.023; Gui YX, 2013, PARKINSONISM RELAT D, V19, P21, DOI 10.1016/j.parkreldis.2012.07.016; He Q, 2013, INT J BIOCHEM CELL B, V45, P2749, DOI 10.1016/j.biocel.2013.09.011; Howitt J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087119; Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Khaselev N, 1999, FREE RADICAL BIO MED, V26, P275, DOI 10.1016/S0891-5849(98)00211-1; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015946; Uranga RM, 2013, J BIOL CHEM, V288, P19773, DOI 10.1074/jbc.M113.457622; Uranga RM, 2009, TOXICOL SCI, V111, P331, DOI 10.1093/toxsci/kfp152; Mateos MV, 2012, BBA-MOL CELL RES, V1823, P2136, DOI 10.1016/j.bbamcr.2012.09.005; Mateos MV, 2008, NEUROCHEM INT, V53, P199, DOI 10.1016/j.neuint.2008.07.005; Mounsey Ross B, 2012, Int J Cell Biol, V2012, P983245, DOI 10.1155/2012/983245; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Raha AA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-55; Diez GR, 2013, EXP EYE RES, V113, P172, DOI 10.1016/j.exer.2013.05.019; Diez GR, 2012, NEUROCHEM INT, V61, P749, DOI 10.1016/j.neuint.2012.06.012; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Stayte S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00113; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Ulmann L, 2001, PROSTAG LEUKOTR ESS, V64, P189, DOI 10.1054/plef.2001.0260; Uranga RM, 2007, J NEUROSCI RES, V85, P2924, DOI 10.1002/jnr.21406; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Wilson-Ashworth HA, 2004, J MEMBRANE BIOL, V200, P25, DOI 10.1007/s00232-004-0691-x; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010	46	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130726	10.1371/journal.pone.0130726	http://dx.doi.org/10.1371/journal.pone.0130726			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076361	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900186
J	Sattler, SA; Wang, X; Lewis, KM; Dehan, PJ; Park, CM; Xin, YF; Liu, HL; Xian, M; Xun, LY; Kang, C				Sattler, Steven A.; Wang, Xia; Lewis, Kevin M.; DeHan, Preston J.; Park, Chung-Min; Xin, Yufeng; Liu, Honglei; Xian, Ming; Xun, Luying; Kang, ChulHee			Characterizations of Two Bacterial Persulfide Dioxygenases of the Metallo-beta-lactamase Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE METABOLISM; ETHYLMALONIC ENCEPHALOPATHY; CRYSTAL-STRUCTURE; SULFANE SULFUR; ETHE1; PROTEIN; MUTATIONS; H2S; ORGANIZATION; SUBSTRATE	Persulfide dioxygenases (PDOs), also known as sulfur dioxygenases (SDOs), oxidize glutathione persulfide (GSSH) to sulfite and GSH. PDOs belong to the metallo-beta-lactamase superfamily and play critical roles in animals, plants, and microorganisms, including sulfide detoxification. The structures of two PDOs from human and Arabidopsis thaliana have been reported; however, little is known about the substrate binding and catalytic mechanism. The crystal structures of two bacterial PDOs from Pseudomonas putida and Myxococcus xanthus were determined at 1.5- and 2.5-angstrom resolution, respectively. The structures of both PDOs were homodimers, and their metal centers and beta-lactamase folds were superimposable with those of related enzymes, especially the glyoxalases II. The PDOs share similar Fe(II) coordination and a secondary coordination sphere-based hydrogen bond network that is absent in glyoxalases II, in which the corresponding residues are involved instead in coordinating a second metal ion. The crystal structure of the complex between the Pseudomonas PDO and GSH also reveals the similarity of substrate binding between it and glyoxalases II. Further analysis implicates an identical mode of substrate binding by known PDOs. Thus, the data not only reveal the differences in metal binding and coordination between the dioxygenases and the hydrolytic enzymes in the metallo-beta-lactamase superfamily, but also provide detailed information on substrate binding by PDOs.	[Sattler, Steven A.; Wang, Xia; DeHan, Preston J.; Xun, Luying; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Wang, Xia; Xin, Yufeng; Liu, Honglei; Xun, Luying] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Lewis, Kevin M.; Park, Chung-Min; Xian, Ming; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Shandong University; Washington State University	Xun, LY (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	luying_xun@vetmed.wsu.edu; chkang@wsu.edu	xin, yufeng/GZB-1798-2022	Lewis, Kevin/0000-0003-3403-9520; Kang, ChulHee/0000-0002-0693-7860	National Science Foundation [MCB 1021148, DBI 0959778]; M. J. Murdock Charitable Trust; China Scholarship Council [201208370133]	National Science Foundation(National Science Foundation (NSF)); M. J. Murdock Charitable Trust; China Scholarship Council(China Scholarship Council)	This work was supported in part by National Science Foundation Grants MCB 1021148 and DBI 0959778 and the M. J. Murdock Charitable Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by China Scholarship Council Grant 201208370133 during a visit to Washington State University.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arisawa M, 2006, J ORGANOMET CHEM, V691, P1159, DOI 10.1016/j.jorganchem.2005.11.049; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bugg TDH, 2001, CURR OPIN CHEM BIOL, V5, P550, DOI 10.1016/S1367-5931(00)00236-2; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; Choi LS, 2012, ANGEW CHEM INT EDIT, V51, P7972, DOI 10.1002/anie.201202365; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hayes RP, 2013, MOL MICROBIOL, V88, P523, DOI 10.1111/mmi.12204; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Holdorf MM, 2012, PLANT PHYSIOL, V160, P226, DOI 10.1104/pp.112.201855; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Liu HL, 2014, APPL ENVIRON MICROB, V80, P1799, DOI 10.1128/AEM.03281-13; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; Mineri R, 2008, J MED GENET, V45, P473, DOI 10.1136/jmg.2008.058271; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettinati I, 2015, HUM MOL GENET, V24, P2458, DOI 10.1093/hmg/ddv007; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Stockdreher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040785; Tiranti V, 2006, J MED GENET, V43, P340, DOI 10.1136/jmg.2005.036210; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135	32	20	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18914	18923		10.1074/jbc.M115.652537	http://dx.doi.org/10.1074/jbc.M115.652537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26082492	Green Published, hybrid			2022-12-26	WOS:000358781100004
J	Schorr, S; Klein, MC; Gamayun, I; Melnyk, A; Jung, M; Schauble, N; Wang, Q; Hemmis, B; Bochen, F; Greiner, M; Lampel, P; Urban, SK; Hassdenteufel, S; Dudek, J; Chen, XZ; Wagner, R; Cavalie, A; Zimmermann, R				Schorr, Stefan; Klein, Marie-Christine; Gamayun, Igor; Melnyk, Armin; Jung, Martin; Schaeuble, Nico; Wang, Qian; Hemmis, Birgit; Bochen, Florian; Greiner, Markus; Lampel, Pavel; Urban, Sabine Katharina; Hassdenteufel, Sarah; Dudek, Johanna; Chen, Xing-Zhen; Wagner, Richard; Cavalie, Adolfo; Zimmermann, Richard			Co-chaperone Specificity in Gating of the Polypeptide Conducting Channel in the Membrane of the Human Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CALCIUM LEAK; CA2+ LEAK; INTRACELLULAR CA2+; SECRETORY PROTEINS; DIABETES-MELLITUS; SEC61 TRANSLOCON; DNAJ HOMOLOG; BIP; STRESS	In mammalian cells, signal peptide-dependent protein transport into the endoplasmic reticulum (ER) is mediated by a dynamic polypeptide-conducting channel, the heterotrimeric Sec61 complex. Previous work has characterized the Sec61 complex as a potential ER Ca2+ leak channel in HeLa cells and identified ER lumenal molecular chaper one immunoglobulin heavy-chain-binding protein (BiP) as limiting Ca2+ leakage via the open Sec61 channel by facilitating channel closing. This BiP activity involves binding of BiP to the ER lumenal loop 7 of Sec61 alpha in the vicinity of tyrosine 344. Of note, the Y344H mutation destroys the BiP binding site and causes pancreatic alpha-cell apoptosis and diabetes in mice. Here, we systematically depleted HeLa cells of the BiP co-chaperones by siRNA-mediated gene silencing and used live cell Ca2+ imaging to monitor the effects on ER Ca2+ leakage. Depletion of either one of the ER lumenal BiP co-chaperones, ERj3 and ERj6, but not the ER membrane-resident co-chaperones (such as Sec63 protein, which assists BiP in Sec61 channel opening) led to increased Ca2+ leakage via Sec6 complex, thereby phenocopying the effect of BiP depletion. Thus, BiP facilitates Sec61 channel closure (i.e. limits ER Ca2+ leakage) via the Sec61 channel with the help of ERj3 and ERj6. Interestingly, deletion of ERj6 causes pancreatic beta-cell failure and diabetes in mice and humans. We suggest that co-chaperone-controlled gating of the Sec61 channel by BiP is particularly important for cells, which are highly active in protein secretion, and that breakdown of this regulatory mechanism can cause apoptosis and disease.	[Schorr, Stefan; Klein, Marie-Christine; Melnyk, Armin; Jung, Martin; Schaeuble, Nico; Bochen, Florian; Greiner, Markus; Lampel, Pavel; Urban, Sabine Katharina; Hassdenteufel, Sarah; Dudek, Johanna; Zimmermann, Richard] Univ Saarland, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Gamayun, Igor; Cavalie, Adolfo] Univ Saarland, Dept Expt & Clin Pharmacol & Toxicol, D-66421 Homburg, Germany; [Wang, Qian; Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Hemmis, Birgit; Wagner, Richard] Univ Osnabruck, Div Biophys, FB Biol Chem, D-49076 Osnabruck, Germany	Saarland University; Saarland University; University of Alberta; University Osnabruck	Zimmermann, R (corresponding author), Univ Saarland, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany.	richard.zimmermann@uks.eu	Jung, Martin/D-2207-2012; Jung, Martin/AAM-4547-2021; Hassdenteufel, Sarah/AAE-8915-2022	Jung, Martin/0000-0002-1482-7020; Jung, Martin/0000-0002-1482-7020; Hassdenteufel, Sarah/0000-0001-7243-6602; Bochen, Florian/0000-0002-1210-980X	Deutsche Forschungsgemeinschaft [FOR 967, IRTG 1830, SFB 894]; HOMFOR	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HOMFOR	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR 967, IRTG 1830, and SFB 894 and by a HOMFOR grant (to M. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Aneiros E, 2005, J IMMUNOL, V174, P119, DOI 10.4049/jimmunol.174.1.119; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043; Bies C, 1999, BIOL CHEM, V380, P1175, DOI 10.1515/BC.1999.149; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BRIGHTMAN SE, 1995, GENE, V153, P249, DOI 10.1016/0378-1119(94)00741-A; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Dudek J, 2002, EMBO J, V21, P2958, DOI 10.1093/emboj/cdf315; Dudek J, 2015, J MOL BIOL, V427, P1159, DOI 10.1016/j.jmb.2014.06.011; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Erdmann F, 2011, EMBO J, V30, P17, DOI 10.1038/emboj.2010.284; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Flourakis M, 2006, FASEB J, V20, P1215, DOI 10.1096/fj.05-5254fje; Fritz JM, 2014, MOL BIOL CELL, V25, P431, DOI 10.1091/mbc.E13-06-0319; Giunti R, 2007, ARCH BIOCHEM BIOPHYS, V462, P115, DOI 10.1016/j.abb.2007.03.039; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Greiner M, 2011, INT J CANCER, V128, P2284, DOI 10.1002/ijc.25580; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Hu QL, 2005, J BIOCHEM MOL BIOL, V38, P709; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Lang S, 2011, JOVE-J VIS EXP, DOI 10.3791/2730; Lang S, 2011, CHANNELS, V5, P228, DOI 10.4161/chan.5.3.15314; Linxweiler M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-574; Linxweiler M, 2012, AM J PATHOL, V180, P473, DOI 10.1016/j.ajpath.2011.10.039; Lloyd DJ, 2010, DIABETES, V59, P460, DOI 10.2337/db08-1362; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Melnyk Armin, 2015, Subcell Biochem, V78, P179, DOI 10.1007/978-3-319-11731-7_9; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; Ong HL, 2007, PFLUG ARCH EUR J PHY, V453, P797, DOI 10.1007/s00424-006-0163-5; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Roos A, 2014, ACTA NEUROPATHOL, V127, P761, DOI 10.1007/s00401-013-1224-4; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Suyama K, 2011, NEUROSCI LETT, V504, P271, DOI 10.1016/j.neulet.2011.09.045; Synofzik M, 2014, AM J HUM GENET, V95, P689, DOI 10.1016/j.ajhg.2014.10.013; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Weitzmann A, 2007, FEBS J, V274, P5175, DOI 10.1111/j.1742-4658.2007.06039.x; Williams JM, 2013, MOL BIOL CELL, V24, P785, DOI 10.1091/mbc.E12-07-0522; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1; Yang J, 2012, J BIOL CHEM, V287, P6551, DOI 10.1074/jbc.M111.305854; Zahedi RP, 2009, PROTEOMICS, V9, P3463, DOI 10.1002/pmic.200800722; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	72	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18621	18635		10.1074/jbc.M115.636639	http://dx.doi.org/10.1074/jbc.M115.636639			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26085089	Green Published, hybrid			2022-12-26	WOS:000358512100032
J	Choi, HJ; Gwon, YD; Jang, Y; Cho, Y; Heo, YK; Lee, HJ; Kim, KC; Choi, J; Lee, JB; Kim, YB				Choi, Hyo Jung; Gwon, Yong-Dae; Jang, Yuyeon; Cho, Yeondong; Heo, Yoon-Ki; Lee, Hee-Jung; Kim, Kang Chang; Choi, Jiwon; Lee, Joong Bok; Kim, Young Bong			Effect of AcHERV-GmCSF as an Influenza Virus Vaccine Adjuvant	PLOS ONE			English	Article							GM-CSF; IMMUNE-RESPONSE; DNA VACCINE; BACULOVIRUS; EXPRESSION; CELLS; MICE; PATHOGENESIS; NEUTROPHILS; CHICKENS	Introduction The first identification of swine-originated influenza A/CA/04/2009 (pH1N1) as the cause of an outbreak of human influenza accelerated efforts to develop vaccines to prevent and control influenza viruses. The current norm in many countries is to prepare influenza vaccines using cell-based or egg-based killed vaccines, but it is difficult to elicit a sufficient immune response using this approach. To improve immune responses, researchers have examined the use of cytokines as vaccine adjuvants, and extensively investigated their functions as chemoattractants of immune cells and boosters of vaccine-mediated protection. Here, we evaluated the effect of Granulocyte-macrophage Colony-Stimulating Factor (GmCSF) as an influenza vaccine adjuvant in BALB/c mice. Method and Results Female BALB/c mice were immunized with killed vaccine together with a murine GmCSF gene delivered by human endogenous retrovirus (HERV) envelope coated baculovirus (1x10(7) FFU AcHERV-GmCSF, i.m.) and were compared with mice immunized with the killed vaccine alone. On day 14, immunized mice were challenged with 10 median lethal dose of mouse adapted pH1N1 virus. The vaccination together with GmCSF treatment exerted a strong adjuvant effect on humoral and cellular immune responses. In addition, the vaccinated mice together with GmCSF were fully protected against infection by the lethal influenza pH1N1 virus. Conclusion Thus, these results indicate that AcHERV-GmCSF is an effective molecular adjuvant that augments immune responses against influenza virus.	[Choi, Hyo Jung; Gwon, Yong-Dae; Jang, Yuyeon; Cho, Yeondong; Heo, Yoon-Ki; Lee, Hee-Jung; Kim, Kang Chang; Choi, Jiwon; Kim, Young Bong] Konkuk Univ, Dept Bioind Technol, Seoul, South Korea; [Lee, Joong Bok] Konkuk Univ, Coll Vet Med, Seoul, South Korea	Konkuk University; Konkuk University	Kim, YB (corresponding author), Konkuk Univ, Dept Bioind Technol, Seoul, South Korea.	kimera@konkuk.ac.kr		Gwon, Yong-Dae/0000-0002-0703-4188	National Agenda Project grant from Korea Research Council of Fundamental Science and Technology [NTM1311423]; Korea Research Institute for Bioscience and Biotechnology (KRIBB) Initiative program [KGM3121423]; Korean Health Technology 3 RD Project [A092010]; iPET(Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries) from Ministry of Agriculture, Food and Rural Affairs [112157-03-2-SB020]	National Agenda Project grant from Korea Research Council of Fundamental Science and Technology; Korea Research Institute for Bioscience and Biotechnology (KRIBB) Initiative program; Korean Health Technology 3 RD Project; iPET(Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries) from Ministry of Agriculture, Food and Rural Affairs	This work was supported by the National Agenda Project grant from Korea Research Council of Fundamental Science and Technology (NTM1311423) and the Korea Research Institute for Bioscience and Biotechnology (KRIBB) Initiative program (KGM3121423), by grants from the Korean Health Technology 3 R&D Project (No. A092010) and iPET(Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries) from Ministry of Agriculture, Food and Rural Affairs (112157-03-2-SB020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; CDC, 2011, CDC FRAM PREV INF DI; Zoth SC, 2012, VET IMMUNOL IMMUNOP, V145, P241, DOI 10.1016/j.vetimm.2011.11.008; Cho H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095961; Choi JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080762, DOI 10.1371/J0URNAL.P0NE.0080762]; Dormitzer PR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006368; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Hartoonian C, 2009, CYTOKINE, V46, P43, DOI 10.1016/j.cyto.2008.12.007; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Institute of Laboratory Animal Resources (U.S.). Committee on Revision of the Guide for Laboratory Animals Facilities and Care. Institute of Laboratory Animal Resources (U.S.). Committee on the Guide for Laboratory Animal Facilities and Care. Animal Care Panel (U.S.). Animal Facilities Standards Committee, GUID LAB AN FAC CAR; Khajah M, 2011, J LEUKOCYTE BIOL, V89, P945, DOI 10.1189/jlb.0809546; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Kusakabe K, 2000, J IMMUNOL, V164, P3102, DOI 10.4049/jimmunol.164.6.3102; Lee HJ, 2012, ASIAN J ENDOSC SURG, V5, P5, DOI 10.1111/j.1758-5910.2011.00111.x; Li YT, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-41; Liu FX, 2012, RES VET SCI, V93, P553, DOI 10.1016/j.rvsc.2011.10.018; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; McDermott AJ, 2014, GUT MICROBES, V5, P476, DOI 10.4161/gmic.29964; McPherson CE, 2008, BIOLOGICALS, V36, P350, DOI 10.1016/j.biologicals.2008.08.001; MORRISSEY PJ, 1991, CELL IMMUNOL, V136, P462, DOI 10.1016/0008-8749(91)90367-K; Musthaq SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026428; Parmiani G, 2007, ANN ONCOL, V18, P226, DOI 10.1093/annonc/mdl158; Pu OY, 2002, J MED VIROL, V66, P320, DOI 10.1002/jmv.2148; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Sadasivan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124047; Scheerlinck JPY, 2001, VACCINE, V19, P4053, DOI 10.1016/S0264-410X(01)00133-5; Smith GE, 2013, VACCINE, V31, P4305, DOI 10.1016/j.vaccine.2013.07.043; TAO W, 1993, J LEUKOCYTE BIOL, V53, P679, DOI 10.1002/jlb.53.6.679; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Wu QF, 2009, MOL IMMUNOL, V46, P2210, DOI 10.1016/j.molimm.2009.04.017	36	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129761	10.1371/journal.pone.0129761	http://dx.doi.org/10.1371/journal.pone.0129761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090848	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000057
J	Michelotto, MD; Barioni, W; de Resende, MDV; de Godoy, IJ; Leonardecz, E; Favero, AP				Michelotto, Marcos Doniseti; Barioni, Waldomiro, Jr.; Vilela de Resende, Marcos Deon; de Godoy, Ignacio Jose; Leonardecz, Eduardo; Favero, Alessandra Pereira			Identification of Fungus Resistant Wild Accessions and Interspecific Hybrids of the Genus Arachis	PLOS ONE			English	Article							LATE LEAF-SPOT; CULTIVATED PEANUT; ARACHIDICOLA; RELATIVES; HYPOGAEA; RUST	Peanut, Arachis hypogaea L., is a protein-rich species consumed worldwide. A key improvement to peanut culture involves the development of cultivars that resist fungal diseases such as rust, leaf spot and scab. Over three years, we evaluated fungal resistance under field conditions of 43 wild accessions and three interspecific hybrids of the genus Arachis, as well as six A. hypogaea genotypes. In the first year, we evaluated resistance to early and late leaf spot, rust and scab. In the second and third years, we evaluated the 18 wild species with the best resistance scores and control cultivar IAC Caiapo for resistance to leaf spot and rust. All wild accessions displayed greater resistance than A. hypogaea but differed in their degree of resistance, even within the same species. We found accessions with as good as or better resistance than A. cardenasii, including: A. stenosperma (V15076 and Sv 3712), A. kuhlmannii (V 6413), A. kempff-mercadoi (V 13250), A. hoehnei (KG 30006), and A. helodes (V 6325). Amphidiploids and hybrids of A. hypogaea behaved similarly to wild species. An additional four accessions deserve further evaluation: A. magna (V 13751 and KG 30097) and A. gregoryi (V 14767 and V 14957). Although they did not display as strong resistance as the accessions cited above, they belong to the B genome type that is crucial to resistance gene introgression and pyramidization in A. hypogaea.	[Michelotto, Marcos Doniseti] Agencia Paulista Tecnol Agron, Polo Ctr Norte, Pindorama, SP, Brazil; [Barioni, Waldomiro, Jr.; Favero, Alessandra Pereira] Embrapa Southeast Livestock, Sao Carlos, SP, Brazil; [Vilela de Resende, Marcos Deon] Embrapa Forestry, Colombo, Parana, Brazil; [de Godoy, Ignacio Jose] Agron Inst Campinas, Campinas, SP, Brazil; [Leonardecz, Eduardo] Univ Brasilia, Comp Sci Lab, Planaltina, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Instituto Agronomico de Campinas (IAC); Universidade de Brasilia	Favero, AP (corresponding author), Embrapa Southeast Livestock, Sao Carlos, SP, Brazil.	alessandra.favero@embrapa.br	Leonardecz, Eduardo/E-9164-2012; Barioni Jr, Waldomiro/AFK-0489-2022; Fávero, Alessandra P/I-3557-2012; Michelotto, Marcos Doniseti/AAY-6542-2020	Barioni Jr, Waldomiro/0000-0001-5970-6591; Michelotto, Marcos Doniseti/0000-0002-2381-2090; Leonardecz, Eduardo/0000-0002-4654-5159; Favero, Alessandra/0000-0001-9461-1539	CNPq; Embrapa	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	APF received funds of Embrapa for this work, and IJG received funds of CNPq for this work. The funders provided support in the form of salaries for authors [APF, WBJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2002, SOFTW 9 3 2002 2010; Favero AP, 2006, CROP SCI, V46, P1546, DOI 10.2135/cropsci2005.09-0331; Favero AP, 2009, SCI AGR, V66, P110, DOI 10.1590/S0103-90162009000100015; FOSTER DJ, 1981, OLEAGINEUX, V36, P139; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; Krapovickas A., 1994, Bonplandia, V8, P1; Pande S, 2001, PLANT DIS, V85, P851, DOI 10.1094/PDIS.2001.85.8.851; Resende MDV, 2002, SELEGEN REML BLUP; Robledo G, 2010, THEOR APPL GENET, V121, P1033, DOI 10.1007/s00122-010-1369-7; Seijo G, 2007, AM J BOT, V94, P1963, DOI 10.3732/ajb.94.12.1963; Seijo JG, 2004, AM J BOT, V91, P1294, DOI 10.3732/ajb.91.9.1294; STALKER HT, 1987, ADV AGRON, V41, P1, DOI 10.1016/S0065-2113(08)60801-9; STALKER HT, 1984, EUPHYTICA, V33, P529, DOI 10.1007/BF00021154; StatSoft Inc, STATISTICA DAT AN SO; SUBRAHMANYAM P, 1985, OLEAGINEUX, V40, P553; Valls JF, 2005, BONPLANDIA, V14, P35, DOI [10.30972/bon.141-21387, DOI 10.2307/41941266]; Varman P. V., 2000, Journal of Ecobiology, V12, P223; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	18	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128811	10.1371/journal.pone.0128811	http://dx.doi.org/10.1371/journal.pone.0128811			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090811	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000029
J	Rydberg, H; Marrone, G; Stromdahl, S; von Schreeb, J				Rydberg, Henny; Marrone, Gaetano; Stromdahl, Susanne; von Schreeb, Johan			A Promising Tool to Assess Long Term Public Health Effects of Natural Disasters: Combining Routine Health Survey Data and Geographic Information Systems to Assess Stunting after the 2001 Earthquake in Peru	PLOS ONE			English	Article								Background Research on long-term health effects of earthquakes is scarce, especially in low- and middle-income countries, which are disproportionately affected by disasters. To date, progress in this area has been hampered by the lack of tools to accurately measure these effects. Here, we explored whether long-term public health effects of earthquakes can be assessed using a combination of readily available data sources on public health and geographic distribution of seismic activity. Methods We used childhood stunting as a proxy for public health effects. Data on stunting were attained from Demographic and Health Surveys. Earthquake data were obtained from U.S. Geological Survey's ShakeMaps, geographic information system-based maps that divide earthquake affected areas into different shaking intensity zones. We combined these two data sources to categorize the surveyed children into different earthquake exposure groups, based on how much their area of residence was affected by the earthquake. We assessed the feasibility of the approach using a real earthquake case - an 8.4 magnitude earthquake that hit southern Peru in 2001. Results and conclusions Our results indicate that the combination of health survey data and disaster data may offer a readily accessible and accurate method for determining the long-term public health consequences of a natural disaster. Our work allowed us to make pre- and post-earthquake comparisons of stunting, an important indicator of the well-being of a society, as well as comparisons between populations with different levels of exposure to the earthquake. Furthermore, the detailed GIS based data provided a precise and objective definition of earthquake exposure. Our approach should be considered in future public health and disaster research exploring the long-term effects of earthquakes and potentially other natural disasters.	[Rydberg, Henny; Marrone, Gaetano; Stromdahl, Susanne; von Schreeb, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Karolinska Institutet	Rydberg, H (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	hennyrydberg@gmail.com		Marrone, Gaetano/0000-0002-2991-1663; Stromdahl, Susanne/0000-0002-6706-0177	Swedish National Board of Health and Welfare	Swedish National Board of Health and Welfare	Supported by a grant from the Swedish National Board of Health and Welfare. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T.I., 2008, ATLAS SHAKEMAPS SELE; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Carter MR, 2007, WORLD DEV, V35, P835, DOI 10.1016/j.worlddev.2006.09.010; Central Intelligence Agency, 2013, WORLD FACTB PER; Centre for Research on the Epidemiology of Disasters (CRED), EM DAT OFDA CRED INT; Dong C, 2014, PLOS ONE, V19, P1260; Doocy Shannon, 2013, PLoS Curr, V5, DOI 10.1371/currents.dis.2664354a5571512063ed29d25ffbce74; Fisker PS, 2012, 012012 I ADV DEV STU; Guha-Sapir D, 2011, NAT HAZARDS, V58, P845, DOI 10.1007/s11069-011-9775-y; Hammer J, 2001, TERREMOTO 23 JUNIO 2, P1; Kahn ME, 2005, REV EC STAT, V87; Kawasaki A, 2013, DISASTERS, V37, P201, DOI 10.1111/j.1467-7717.2012.01302.x; Measure DHS, WHAT WE DO GPS DAT C; MEASURE DHS, STATCOMPILER; Naghii MR, 2005, REV PANAM SALUD PUBL, V18, P216, DOI 10.1590/S1020-49892005000800013; National Institute of Statistics and Informatics (INEI), 2002, PRINC RES ENC NAC HO; National Institute of Statistics and Informatics (INEI) Measure/DHS+ Macro International Inc, 2001, PER DHS 2000 FIN REP; National Institute of Statistics and Informatics (INEI) United Nations Children's Fund (UNICEF), 2010, EST NIN IND PER; National Institute of Statistics and Informatics (INEI) United States Agency for International Develop-ment (USAID) ICF Macro, 2009, PER DHS 2007 08 FIN; National Institute of Statistics and Informatics (INEI) United States Agency for International Development (USAID) Macro International Inc., 2007, PER DHS 2004 06 FIN; Polonsky J, 2013, ASIA PAC J CLIN NUTR; Roy N, 2011, DISASTER MED PUBLIC, V5, P112, DOI 10.1001/dmp.2011.35; Sun J, 2013, ASIA PAC J CLIN NUTR, V22, P100, DOI 10.6133/apjcn.2013.22.1.19; The World Bank Group, COUNTR PER; Ukoumunne OC, 2001, STAT MED, V20, P417, DOI 10.1002/1097-0258(20010215)20:3<417::AID-SIM802>3.0.CO;2-G; United Nations World Health Organization International Federation of Red Cross and Red Crescent Societies, TRIAMS WORKSH BANGK; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Wald DJ, 2006, SHAKEMAP MANUAL TECH; WATERLOW JC, 1994, EUR J CLIN NUTR, V48, pS1; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Zolala F., 2011, Eastern Mediterranean Health Journal, V17, P976	31	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130889	10.1371/journal.pone.0130889	http://dx.doi.org/10.1371/journal.pone.0130889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26090999	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000155
J	Uro, M; Beauchet, O; Cherif, M; Graffe, A; Milea, D; Annweiler, C				Uro, Mathieu; Beauchet, Olivier; Cherif, Mehdi; Graffe, Alix; Milea, Dan; Annweiler, Cedric			Age-Related Vitamin D Deficiency Is Associated with Reduced Macular Ganglion Cell Complex: A Cross-Sectional High-Definition Optical Coherence Tomography Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HYPOVITAMINOSIS D; DEGENERATION; IMPAIRMENT; THICKNESS; D-3	Background Vitamin D deficiency is associated with smaller volume of optic chiasm in older adults, indicating a possible loss of the visual axons and their cellular bodies. Our objective was to determine whether vitamin D deficiency in older adults is associated with reduced thickness of the ganglion cell complex(GCC) and of the retinal nerve fibre layer(RNFL), as measured with high-definition optical coherence tomography(HD-OCT). Methods Eighty-five French older community-dwellers without open-angle glaucoma and patent age-related macular degeneration(mean, 71.1 +/- 4.7years; 45.9% female) from the GAIT study were separated into 2 groups according to serum 25OHD level(i.e., deficient <= 25nmol/L or sufficient>25nmol/L). Measurements of GCC and RNFL thickness were performed using HD-OCT. Age, gender, body mass index, number of comorbidities, dementia, functional autonomy, intracranial volume, visual acuity, serum calcium concentration and season of testing were considered as potential confounders. Results Mean serum 25OHD concentration was 58.4 +/- 26.8nmol/L. Mean logMAR visual acuity was 0.03 +/- 0.06. Mean visual field mean deviation was -1.25 +/- 2.29dB. Patients with vitamin D deficiency(n=11) had a reduced mean GCC thickness compared to those without vitamin D deficiency(72.1 +/- 7.4 mu m versus 77.5 +/- 7.5 mu m, P=0.028). There was no difference of the mean RNFL thickness in these two groups(P=0.133). After adjustment for potential confounders, vitamin D deficiency was associated with reduced GCC thickness(beta=-5.12, P=0.048) but not RNFL thickness(beta=-9.98, P=0.061). Specifically, vitamin D deficiency correlated with the superior medial GCC area(P=0.017) and superior temporal GCC area(P=0.010). Conclusions Vitamin D deficiency in older patients is associated with reduced mean GCC thickness, which can represent an early stage of optic nerve damage, prior to RNFL loss.	[Uro, Mathieu; Cherif, Mehdi; Graffe, Alix; Milea, Dan] Angers Univ Hosp, Dept Ophthalmol, Angers, France; [Beauchet, Olivier; Annweiler, Cedric] Univ Angers, UNAM, Angers Univ Hosp,UPRES EA 4638, Dept Neurosci,Div Geriatr Med,Univ Memory Clin An, Angers, France; [Milea, Dan] Singapore Natl Eye Ctr, Singapore, Singapore; [Milea, Dan] Singapore Eye Res Inst, Singapore, Singapore; [Milea, Dan] Duke NUS, Neurosci & Behav Dis, Singapore, Singapore; [Annweiler, Cedric] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med Biophys, Robarts Res Inst, London, ON, Canada	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore; Western University (University of Western Ontario)	Annweiler, C (corresponding author), Univ Angers, UNAM, Angers Univ Hosp,UPRES EA 4638, Dept Neurosci,Div Geriatr Med,Univ Memory Clin An, Angers, France.	CeAnnweiler@chu-angers.fr	Milea, Dan/AAT-8661-2021; Beauchet, Olivier/AAP-8108-2020	Annweiler, Cedric/0000-0002-7199-8109	French Ministry of Health (Projet Hospitalier de Recherche Clinique national) [2009-A00533-54]	French Ministry of Health (Projet Hospitalier de Recherche Clinique national)	The study was financially supported by the French Ministry of Health (Projet Hospitalier de Recherche Clinique national no 2009-A00533-54). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Annweiler C, 2015, J INTERN MED, V277, P45, DOI 10.1111/joim.12279; Annweiler C, 2012, EUR J NEUROL, V19, P1023, DOI 10.1111/j.1468-1331.2012.03675.x; Annweiler C, 2009, EUR J NEUROL, V16, P1083, DOI 10.1111/j.1468-1331.2009.02755.x; Annweiler C, 2013, J AM GERIATR SOC, V61, P1026, DOI 10.1111/jgs.12249; Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Annweiler C, 2012, OPHTHALMOLOGY, V119, P1090, DOI 10.1016/j.ophtha.2012.02.005; Annweiler C, 2011, GERIATR PSYCHOL NEUR, V9, P259, DOI 10.1684/pnv.2011.0288; Annweiler C, 2010, NEUROPSYCHOBIOLOGY, V62, P139, DOI 10.1159/000318570; Barboni P, 2014, AM J OPHTHALMOL, V158, P628, DOI 10.1016/j.ajo.2014.05.034; Bayhan HA, 2015, CLIN EXP OPHTHALMOL, V43, P145, DOI 10.1111/ceo.12386; Beauchet O, 2012, AGING CLIN EXP RES, V24, P188, DOI 10.3275/7838; Beauchet O, 2011, J AM GERIATR SOC, V59, P568, DOI 10.1111/j.1532-5415.2010.03299.x; Brown J, 2003, NEUROSCI LETT, V343, P139, DOI 10.1016/S0304-3940(03)00303-3; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Graffe A, 2014, INVEST OPHTH VIS SCI, V55, P5298, DOI 10.1167/iovs.14-13918; Graffe A, 2012, J AM GERIATR SOC, V60, P1367, DOI 10.1111/j.1532-5415.2012.04015.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Ibi M, 2001, NEUROPHARMACOLOGY, V40, P761, DOI 10.1016/S0028-3908(01)00009-0; Jindal V., 2014, MOL NEUROBIOL; Kalueff AV, 2007, CURR OPIN CLIN NUTR, V10, P12, DOI 10.1097/MCO.0b013e328010ca18; Kardon RH, 2011, J NEURO-OPHTHALMOL, V31, P353, DOI 10.1097/WNO.0b013e318238b9cb; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Kirby E, 2010, J ALZHEIMERS DIS, V21, P15, DOI 10.3233/JAD-2010-080785; Kutuzova GD, 2012, ARCH BIOCHEM BIOPHYS, V518, P53, DOI 10.1016/j.abb.2011.10.022; Larrosa JM, 2014, INVEST OPHTH VIS SCI, V55, P3043, DOI 10.1167/iovs.13-13629; Lee V, 2012, NEUROBIOL AGING, V33, P2382, DOI 10.1016/j.neurobiolaging.2011.12.002; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; Morrison Margaux A., 2011, Human Genomics, V5, P538; Parekh N, 2007, ARCH OPHTHALMOL-CHIC, V125, P661, DOI 10.1001/archopht.125.5.661; Peres K, 2006, NEUROLOGY, V67, P461, DOI 10.1212/01.wnl.0000228228.70065.f1; Rochon J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-81; Ronnback C, 2013, OPHTHALMOLOGY, V120, P2672, DOI 10.1016/j.ophtha.2013.08.008; Saidha S, 2013, JAMA NEUROL, V70, P34, DOI 10.1001/jamaneurol.2013.573; Seddon JM, 2011, OPHTHALMOLOGY, V118, P1386, DOI 10.1016/j.ophtha.2010.12.020; Sung MS, 2014, J GLAUCOMA, V23, P341, DOI 10.1097/IJG.0b013e318279c932; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Vannier-Nitenberg C, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-55; Wostyn P, 2009, BRIT J OPHTHALMOL, V93, P1557, DOI 10.1136/bjo.2008.148064; Yoo TK, 2014, PUBLIC HEALTH NUTR, V17, P833, DOI 10.1017/S1368980013003492	43	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130879	10.1371/journal.pone.0130879	http://dx.doi.org/10.1371/journal.pone.0130879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090872	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000154
J	Liu, YP; Karg, M; Herrera-Carrillo, E; Berkhout, B				Liu, Ying Poi; Karg, Margarete; Herrera-Carrillo, Elena; Berkhout, Ben			Towards Antiviral shRNAs Based on the AgoshRNA Design	PLOS ONE			English	Article							RNA INTERFERENCE; REGULATORY RNAS; IN-VIVO; DICER; HIV-1; MIRNA; GENE; VECTOR; PATHWAY; TRANSDUCTION	RNA interference (RNAi) can be induced by intracellular expression of a short hairpin RNA (shRNA). Processing of the shRNA requires the RNaseIII-like Dicer enzyme to remove the loop and to release the biologically active small interfering RNA (siRNA). Dicer is also involved in microRNA (miRNA) processing to liberate the mature miRNA duplex, but recent studies indicate that miR-451 is not processed by Dicer. Instead, this miRNA is processed by the Argonaute 2 (Ago2) protein, which also executes the subsequent cleavage of a complementary mRNA target. Interestingly, shRNAs that structurally resemble miR-451 can also be processed by Ago2 instead of Dicer. The key determinant of these "AgoshRNA" molecules is a relatively short basepaired stem, which avoids Dicer recognition and consequently allows alternative processing by Ago2. AgoshRNA processing yields a single active RNA strand, whereas standard shRNAs produce a duplex with guide and passenger strands and the latter may cause adverse off-target effects. In this study, we converted previously tested active anti-HIV-1 shRNA molecules into AgoshRNA. We tested several designs that could potentially improve AgoshRNA activity, including extension of the complementarity between the guide strand and the mRNA target and reduction of the thermodynamic stability of the hairpins. We demonstrate that active AgoshRNAs can be generated. However, the RNAi activity is reduced compared to the matching shRNAs. Despite reduced RNAi activity, comparison of an active AgoshRNA and the matching shRNA in a sensitive cell toxicity assay revealed that the AgoshRNA is much less toxic.	[Liu, Ying Poi; Karg, Margarete; Herrera-Carrillo, Elena; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Berkhout, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	b.berkhout@amc.uva.nl		, Ying Poi/0000-0002-4152-9168; Liu, Ying Poi/0000-0002-9932-718X; Herrera Carrillo, Elena/0000-0001-9986-8552	NWO-CW (the Netherlands Organisation for Scientific Research in Chemical Sciences) (TOP grant); ZonMW (the Netherlands Organisation for Health Research and Development) (Translational Gene Therapy program)	NWO-CW (the Netherlands Organisation for Scientific Research in Chemical Sciences) (TOP grant); ZonMW (the Netherlands Organisation for Health Research and Development) (Translational Gene Therapy program)	This research was supported by the NWO-CW (the Netherlands Organisation for Scientific Research in Chemical Sciences) (TOP grant) and ZonMW (the Netherlands Organisation for Health Research and Development) (Translational Gene Therapy program).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Berkhout B, 2014, FUTURE MICROBIOL, V9, P561, DOI 10.2217/fmb.14.5; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Centlivre M, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.48; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Dallas A, 2012, NUCLEIC ACIDS RES, V40, P9255, DOI 10.1093/nar/gks662; Denise H, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.73; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Eekels JJM, 2012, GENE THER, V19, P1058, DOI 10.1038/gt.2011.191; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; Ge Q, 2010, RNA, V16, P106, DOI 10.1261/rna.1894510; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Herrera-Carrillo E, 2014, RNA, V20, P1410, DOI 10.1261/rna.043950.113; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Knoepfel Stefanie A, 2012, World J Virol, V1, P79, DOI 10.5501/wjv.v1.i3.79; Konstantinova P, 2006, NUCLEIC ACIDS RES, V34, P2206, DOI 10.1093/nar/gkl226; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; Li MJ, 2005, METHOD ENZYMOL, V392, P218, DOI 10.1016/S0076-6879(04)92013-7; Liu YP, 2013, NUCLEIC ACIDS RES, V41, P3723, DOI 10.1093/nar/gkt036; Low JT, 2012, MOL THER, V20, P820, DOI 10.1038/mt.2011.299; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Petri S, 2011, RNA, V17, P737, DOI 10.1261/rna.2348111; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seppen J, 2002, J HEPATOL, V36, P459, DOI 10.1016/S0168-8278(01)00308-7; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/nmeth.3029, 10.1038/NMETH.3029]; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07; Westerhout EM, 2007, NUCLEIC ACIDS RES, V35, P4322, DOI 10.1093/nar/gkm437; Westerhout EM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-57; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128618	10.1371/journal.pone.0128618	http://dx.doi.org/10.1371/journal.pone.0128618			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087209	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500018
J	Sim, VXY; Dafforn, KA; Simpson, SL; Kelaher, BP; Johnston, EL				Sim, Vivian X. Y.; Dafforn, Katherine A.; Simpson, Stuart L.; Kelaher, Brendan P.; Johnston, Emma L.			Sediment Contaminants and Infauna Associated with Recreational Boating Structures in a Multi-Use Marine Park	PLOS ONE			English	Article							URBAN STRUCTURES; BENTHIC INFAUNA; WATER-QUALITY; ESTUARINE; POLLUTION; COPPER; COMMUNITIES; ASSEMBLAGES; MANAGEMENT; PATTERNS	Multi-use marine parks achieve conservation through spatial management of activities. Zoning of marine parks in New South Wales, Australia, includes high conservation areas and special purpose zones (SPZ) where maritime activities are concentrated. Although such measures geographically constrain anthropogenic impacts, we have limited understanding of potential ecological effects. We assessed sediment communities and contaminants adjacent to boating infrastructure (boat ramps, jetties and a marina) in a SPZ from the Clyde Estuary in Batemans Marine Park. Metal concentrations and fines content were elevated at boating structures compared to reference sites. Species richness was higher at sites with boating structures, where capitellid polychaetes and nematodes dominated the communities. Changes associated with boating structures were localised and did not extend beyond breakwalls or to reference sites outside the SPZ. The study highlights the benefits of appropriate zoning in a multi-use marine park and the potential to minimise stress on pristine areas through the application of spatial management.	[Sim, Vivian X. Y.; Dafforn, Katherine A.; Johnston, Emma L.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Sim, Vivian X. Y.; Dafforn, Katherine A.; Johnston, Emma L.] Sydney Inst Marine Sci, Mosman, Australia; [Simpson, Stuart L.] CSIRO Land & Water, Ctr Environm Contaminants Res, Sydney, NSW, Australia; [Kelaher, Brendan P.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, Australia; [Kelaher, Brendan P.] So Cross Univ, Ctr Coastal Biogeochem Res, Sch Environm Sci & Engn, Coffs Harbour, Australia	University of New South Wales Sydney; Sydney Institute of Marine Science; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Southern Cross University; Southern Cross University	Sim, VXY (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	simxinyee@gmail.com	Simpson, Stuart L/A-6044-2011; Johnston, Emma/AAC-2878-2022; Kelaher, Brendan/P-3647-2017; Dafforn, Katherine/J-9647-2013	Simpson, Stuart L/0000-0003-1759-0564; Johnston, Emma/0000-0002-2117-366X; Kelaher, Brendan/0000-0002-7505-4412; Dafforn, Katherine/0000-0001-8848-377X	Australian Research Council, Linkage Grant [LP0990640]	Australian Research Council, Linkage Grant(Australian Research Council)	This work was supported by the Australian Research Council, Linkage Grant LP0990640 to EJ and BK (http://www.arc.gov.au/pdf/LP09_Rnd2/LP09_Rd2_allstates_orgs.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Romero JG, 2014, J ENVIRON MANAGE, V146, P164, DOI 10.1016/j.jenvman.2014.07.007; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [ARMCANZ ANZECC], 2000, AUSTR NZ GUID FRESHW; Barros F, 2001, ESTUAR COAST SHELF S, V52, P191, DOI 10.1006/ecss.2000.0734; Batley Graeme, 2008, Australasian Journal of Ecotoxicology, V14, P11; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; BILYARD GR, 1987, MAR POLLUT BULL, V18, P581, DOI 10.1016/0025-326X(87)90277-3; Blockley DJ, 2007, MAR ENVIRON RES, V63, P409, DOI 10.1016/j.marenvres.2006.10.007; Bulleri F, 2005, ENVIRON CONSERV, V32, P101, DOI 10.1017/S0376892905002183; Burton GA, 2010, ENVIRON TOXICOL CHEM, V29, P2625, DOI 10.1002/etc.332; BUTMAN CA, 1987, OCEANOGR MAR BIOL, V25, P113; Chapman PM, 1998, CAN J FISH AQUAT SCI, V55, P2221, DOI 10.1139/cjfas-55-10-2221; CHAPMAN PM, 1990, SCI TOTAL ENVIRON, V97-8, P815, DOI 10.1016/0048-9697(90)90277-2; Chariton AA, 2010, MAR FRESHWATER RES, V61, P1109, DOI 10.1071/MF09263; Clark GF, 2015, ENVIRON POLLUT, V196, P12, DOI 10.1016/j.envpol.2014.09.017; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Dafforn KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077018; Dafforn KA, 2012, ENVIRON POLLUT, V163, P207, DOI 10.1016/j.envpol.2011.12.029; Di Franco A, 2011, MAR POLLUT BULL, V62, P926, DOI 10.1016/j.marpolbul.2011.02.053; Downes B.J., 2002, MONITORING ECOLOGICA; Engle VD, 2009, ENVIRON MONIT ASSESS, V150, P193, DOI 10.1007/s10661-008-0677-8; Floerl O, 2003, AUSTRAL ECOL, V28, P116, DOI 10.1046/j.1442-9993.2003.01254.x; Glasby TM, 1999, AMBIO, V28, P595; Guerra-Garcia J, 2004, HELGOLAND MAR RES, V58, P183, DOI 10.1007/s10152-004-0184-4; HOPKINSON CS, 1995, ESTUARIES, V18, P598, DOI 10.2307/1352380; Johnston EL, 2011, MAR POLLUT BULL, V62, P2137, DOI 10.1016/j.marpolbul.2011.07.009; Kelaher BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085825; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; KOKOVIDES K, 1992, ENVIRON TECHNOL, V13, P239, DOI 10.1080/09593339209385149; Lindegarth M, 2001, MAR ENVIRON RES, V51, P289, DOI 10.1016/S0141-1136(00)00030-1; Long ER, 2001, ENVIRON TOXICOL CHEM, V20, P46, DOI 10.1002/etc.5620200105; McAllister TL, 1996, ENVIRON MANAGE, V20, P385, DOI 10.1007/BF01203846; MCGEE BL, 1995, ECOTOXICOLOGY, V4, P39, DOI 10.1007/BF00350649; McKinley AC, 2011, ENVIRON POLLUT, V159, P1499, DOI 10.1016/j.envpol.2011.03.008; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Rivero NK, 2013, BIOFOULING, V29, P803, DOI 10.1080/08927014.2013.805751; Schiff K, 2007, MAR POLLUT BULL, V54, P322, DOI 10.1016/j.marpolbul.2006.10.013; Simpson S.L., 2013, 0807 CSIRO, DOI [10.1016/j.proeng.2012.04.061, DOI 10.1016/J.PROENG.2012.04.061]; Simpson SL, 2013, CHEMOSPHERE, V93, P2499, DOI 10.1016/j.chemosphere.2013.08.100; Simpson SL, 2011, ENVIRON TOXICOL CHEM, V30, P2326, DOI 10.1002/etc.633; Sun MY, 2012, MAR POLLUT BULL, V64, P1029, DOI 10.1016/j.marpolbul.2012.01.035; Takahashi CK, 2012, MAR POLLUT BULL, V64, P133, DOI 10.1016/j.marpolbul.2011.10.010; TSUTSUMI H, 1990, MAR ECOL PROG SER, V63, P157, DOI 10.3354/meps063157; Turner A, 2010, MAR POLLUT BULL, V60, P159, DOI 10.1016/j.marpolbul.2009.12.004; USEPA, 2007, METH 3051A MICR ASS; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Warnken J, 2004, MAR POLLUT BULL, V49, P833, DOI 10.1016/j.marpolbul.2004.06.012; WBM, 2004, BAT BAY CLYD RIV EST; WEIS P, 1993, ESTUAR COAST SHELF S, V36, P71, DOI 10.1006/ecss.1993.1006; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001	50	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130537	10.1371/journal.pone.0130537	http://dx.doi.org/10.1371/journal.pone.0130537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086427	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500114
J	Szpakowicz, A; Kiliszek, M; Pepinski, W; Waszkiewicz, E; Franaszczyk, M; Skawronska, M; Ploski, R; Niemcunowicz-Janica, A; Burzynska, B; Tulacz, D; Maciejak, A; Kaminski, MJ; Opolski, G; Musial, WJ; Kaminski, KA				Szpakowicz, Anna; Kiliszek, Marek; Pepinski, Witold; Waszkiewicz, Ewa; Franaszczyk, Maria; Skawronska, Malgorzata; Ploski, Rafal; Niemcunowicz-Janica, Anna; Burzynska, Beata; Tulacz, Dorota; Maciejak, Agata; Kaminski, Marcin Jakub; Opolski, Grzegorz; Musial, Wlodzimierz Jerzy; Kaminski, Karol Adam			The rs12526453 Polymorphism in an Intron of the PHACTR1 Gene and Its Association with 5-Year Mortality of Patients with Myocardial Infarction	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CALCIFICATION	Objective The rs12526453 (C/G) is a single nucleotide polymorphism in an intron of the PHACTR1 gene (phosphatase and actin regulator 1). The C allele is associated with increased risk of coronary artery disease in an unknown mechanism. We investigated its association with long-term overall mortality in patients with ST-elevation myocardial infarction (STEMI) treated invasively. Methods Two independent groups of patients with STEMI were analyzed: a derivation group (n=638) and a validation one (n=348). Genotyping was performed with the TaqMan method. The analyzed end-point was total long term mortality. Additionally, transcriptomic analysis was performed in mononuclear blood leukocytes from rs12526453 CC monozygotes or G allele carriers. Results In the study group (mean age 62.3 +/- 11.9 years; 24.9% of females, n=159), percentages of CC, CG, and GG genotypes were 45.3%(n=289), 44.7%(n=285), and 10% (n=64), respectively. In the 5-year follow-up 105 patients died (16.46%). CC homozygotes had significantly lower mortality compared to other genotypes: 13.1% (n=38) vs. 18.3% in G-allele carriers (n=67), (p=0.017, Cox's F test). In the validation group 47 patients died within 3 years (13.5%). We confirmed lower mortality of CC homozygotes: 10.1 %(n=18) vs. 16.95% in G-allele carriers (n=29), (p=0.031, Cox's F test). Transcriptomic analysis revealed a markedly higher expression of NLRP-2 in CC homozygotes. Conclusions The rs12526453 CC homozygotes (previously associated with increased risk of myocardial infarction) showed, in 2 independent samples, better long-term survival. The finding of such high effect size, after appropriate validation, could potentially be translated into clinical practice.	[Szpakowicz, Anna; Waszkiewicz, Ewa; Kaminski, Marcin Jakub; Musial, Wlodzimierz Jerzy; Kaminski, Karol Adam] Med Univ Bialystok, Dept Cardiol, Bialystok, Poland; [Kiliszek, Marek; Opolski, Grzegorz] Med Univ Warsaw, Chair & Dept Cardiol 1, Warsaw, Poland; [Kiliszek, Marek] Mil Inst Med, Dept Cardiol & Internal Dis, Warsaw, Poland; [Pepinski, Witold; Skawronska, Malgorzata; Niemcunowicz-Janica, Anna] Med Univ Bialystok, Dept Forens Med, Bialystok, Poland; [Franaszczyk, Maria] Cardinal Stefan Wyszynski Inst Cardiol, Mol Biol Lab, Warsaw, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Burzynska, Beata; Tulacz, Dorota; Maciejak, Agata] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Medical University of Bialystok; Medical University of Warsaw; Military Institute of Aviation Medicine; Medical University of Bialystok; Medical University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Kaminski, KA (corresponding author), Med Univ Bialystok, Dept Cardiol, Bialystok, Poland.	fizklin@wp.pl	Maciejak-Jastrzębska, Agata/ABG-5609-2020; Szpakowicz, Anna/T-4059-2018; Tarasiuk, Ewa/Y-1757-2018; Pepiński, Witold/U-9250-2018; Burzynska, Beata/A-4691-2013; Maciejak, Agata/O-7427-2018; Skawrońska, Małgorzata/U-9251-2018; Niemcunowicz-Janica, Anna/ABH-1454-2021; Kaminski, Karol A./J-4515-2014	Maciejak-Jastrzębska, Agata/0000-0002-7654-8414; Szpakowicz, Anna/0000-0002-4665-5227; Tarasiuk, Ewa/0000-0002-0614-1352; Pepiński, Witold/0000-0003-1244-2247; Maciejak, Agata/0000-0002-7654-8414; Skawrońska, Małgorzata/0000-0002-1237-4240; Niemcunowicz-Janica, Anna/0000-0003-2807-8312; Kaminski, Karol A./0000-0002-9465-2581; Opolski, Grzegorz/0000-0003-4744-2554; Kaminski, Marcin/0000-0002-5641-4910; Ploski, Rafal/0000-0001-6286-5526; Burzynska, Beata/0000-0003-1595-0036	National Science Center (Poland) [N N 402 529139]; Polish Cardiac Society; National Centre for Research and Development (NCBiR) [N R13 0001 06]; Medical University of Bialystok	National Science Center (Poland); Polish Cardiac Society; National Centre for Research and Development (NCBiR); Medical University of Bialystok	This work was supported by grant N N 402 529139 from the National Science Center (Poland), (analysis on derivation group), grant of Polish Cardiac Society 2010 (analysis on population group) and by grant N R13 0001 06 from The National Centre for Research and Development (NCBiR), (analysis on validation group and transcriptomic analysis). Statutory Grants from Medical University of Bialystok cover publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; BEAGLEHOLE R, 1987, INT J EPIDEMIOL, V16, P373, DOI 10.1093/ije/16.3.373; Bevan S, 2012, STROKE, V43, P3161, DOI 10.1161/STROKEAHA.112.665760; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Gong Y, 2011, CIRC-CARDIOVASC GENE, V4, P169, DOI 10.1161/CIRCGENETICS.110.959296; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Hager J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038663; Horne BD, 2008, CIRC-CARDIOVASC GENE, V1, P85, DOI 10.1161/CIRCGENETICS.108.793158; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kiliszek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050054; Kozieradzka A, 2011, INT J CARDIOL, V148, P70, DOI 10.1016/j.ijcard.2009.10.026; Kozieradzka A, 2009, AM J CARDIOL, V103, P435, DOI 10.1016/j.amjcard.2008.11.025; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Lupfer C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00285; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Patel RS, 2011, CIRC-CARDIOVASC GENE, V4, pE11, DOI 10.1161/CIRCGENETICS.111.960641; Pechlivanis S, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-23; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030344; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Thygesen K, 2007, EUR HEART J, V28, P2525; van Setten J, 2013, ATHEROSCLEROSIS, V228, P400, DOI 10.1016/j.atherosclerosis.2013.02.039	27	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129820	10.1371/journal.pone.0129820	http://dx.doi.org/10.1371/journal.pone.0129820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086777	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500065
J	Bernardi, M; Klein, H; Petti, FM; Ezcurra, MD				Bernardi, Massimo; Klein, Hendrik; Petti, Fabio Massimo; Ezcurra, Martin D.			The Origin and Early Radiation of Archosauriforms: Integrating the Skeletal and Footprint Record	PLOS ONE			English	Article							HOLY-CROSS MOUNTAINS; BASAL ARCHOSAURIFORM; TETRAPOD FOOTPRINTS; FOSSILIFEROUS SITE; SOUTHERN ALPS; DINOSAURS; REPTILIA; TRACK; ARCHOSAUROMORPHA; EVOLUTION	We present a holistic approach to the study of early archosauriform evolution by integrating body and track records. The ichnological record supports a Late Permian-Early Triassic radiation of archosauriforms not well documented by skeletal material, and new footprints from the Upper Permian of the southern Alps (Italy) provide evidence for a diversity not yet sampled by body fossils. The integrative study of body fossil and footprint data supports the hypothesis that archosauriforms had already undergone substantial taxonomic diversification by the Late Permian and that by the Early Triassic archosauromorphs attained a broad geographical distribution over most parts of Pangea. Analysis of body size, as deduced from track size, suggests that archosauriform average body size did not change significantly from the Late Permian to the Early Triassic. A survey of facies yielding both skeletal and track record indicate an ecological preference for inland fluvial (lacustrine) environments for early archosauromorphs. Finally, although more data is needed, Late Permian chirotheriid imprints suggest a shift from sprawling to erect posture in archosauriforms before the end-Permian mass extinction event. We highlight the importance of approaching palaeobiological questions by using all available sources of data, specifically through integrating the body and track fossil record.	[Bernardi, Massimo; Petti, Fabio Massimo] MuSe Museo Sci, Trento, Italy; [Bernardi, Massimo] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Klein, Hendrik] Saurierwelt Palaontol Museum, Neumarkt, Germany; [Ezcurra, Martin D.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England	University of Bristol; University of Birmingham	Bernardi, M (corresponding author), MuSe Museo Sci, Trento, Italy.	massimo.bernardi@muse.it	Petti, Fabio Massimo/W-4284-2017		Promotion of Educational Policies, University and Research Department of the Autonomous Province of Bolzano-South Tyrol (Progetti nel campo della ricerca scientifica) [22]; DFG Emmy Noether Programme [BU 2587/3-1]	Promotion of Educational Policies, University and Research Department of the Autonomous Province of Bolzano-South Tyrol (Progetti nel campo della ricerca scientifica); DFG Emmy Noether Programme(German Research Foundation (DFG))	MB and FMP were supported by the Promotion of Educational Policies, University and Research Department of the Autonomous Province of Bolzano-South Tyrol (Progetti nel campo della ricerca scientifica 2009, Ifd. Nr. n.ord. 22). MDE was supported by a grant of the DFG Emmy Noether Programme to Richard J. Butler (BU 2587/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1935, VORZEITLICHE LEBENSS, P644; Alroy J., 2013, ONLINE PALEOGEOGRAPH; [Anonymous], 2006, SPECIAL PUBLICATION; [Anonymous], 1923, FORTSCHRITTE GEOLOGI; [Anonymous], 2000, PALEONTOLOGIA RIO GR; Avanzini M, 2002, PALAEOGEOGR PALAEOCL, V185, P391, DOI 10.1016/S0031-0182(02)00441-8; Avanzini M., 2004, STUD TRENT SCI NAT A, V79, P1; Avanzini M, 2010, DOLOMITES, P20; Avanzini M, 2011, EARTH AND ENVIRONMENTAL SCIENCES, P591; Baird D., 1980, P219; Bartholomai A, 1979, ALCHERINGA, V3, P225, DOI 10.1080/03115517908527795; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton MJ, 2014, CURR BIOL, V24, pR87, DOI 10.1016/j.cub.2013.11.063; BENTON MJ, 1990, PHILOS T ROY SOC B, V328, P213, DOI 10.1098/rstb.1990.0114; Benton MJ, 1999, PHILOS T ROY SOC B, V354, P1423, DOI 10.1098/rstb.1999.0489; Bernardi M, PALAEOGEO PALA UNPUB; Bernardi M, SERIES TOPICS GEOBIO; BEURLEN KARL, 1950, NEUES JAHRB F MINERAL USW MONATS ABT B, V1950, P308; Borsuk-Bialynicka M, 2003, ACTA PALAEONTOL POL, V48, P649; Borsuk-Bialynicka Magdalena, 2009, PALAEONTOLOGIA POLONICA, P283; Borsuk-Bialynicka Magdalena, 2009, PALAEONTOLOGIA POLONICA, P235; Bowden AJ, 2010, GEOL SOC SPEC PUBL, V343, P209, DOI 10.1144/SP343.12; Broom R., 1903, ANN S AFR MUS, V4, P161; Brusatte SL, 2010, EARTH ENV SCI T R SO, V101, P367, DOI 10.1017/S1755691011020056; Brusatte SL, 2011, P ROY SOC B-BIOL SCI, V278, P1107, DOI 10.1098/rspb.2010.1746; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Butler RJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-128; Butler RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025693; Camp CL, 1978, ALCHERINGA, V2, P143, DOI 10.1080/03115517808619085; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; CARROLL R L, 1976, Annals of the South African Museum, V72, P37; Ceoloni P, 1988, MEM SOC GEOL ITAL, V34, P45; Charig A.J., 1972, P121; Cheng Z.W., 1980, MESOZOIC STRATIGRAPH, P114; Colbert EH, 1987, AM MUS NOVIT, V2882, P1; CONTI M A, 1975, Memorie Geopaleontologiche dell'Universita di Ferrara, V3, P139; Conti M.A, 1977, Palaeontographia Italica, V70, P1; Conti M.A., 1986, FIELD C PERM PERM TR, P91; CONTI MA, 2000, DINOSAURI ITALIA ORM, P297; Cosgriff J.W., 1983, Antarctic Journal of the United States, V18, P52; Cruickshank A.R.I., 1972, P89; Demathieu G, 1982, HALLESCHES JB GEOWIS, V7, P97; Demathieu Georges, 2004, Ichnos, V11, P79, DOI 10.1080/10420940490444898; Desojo JB, 2013, GEOL SOC SPEC PUBL, V379, P203, DOI 10.1144/SP379.17; Dias-da-Silva S, 1998, ACTA GEOLOGICA LEOPO, V21, P101; Dias-da-Silva S, 2011, REV BRAS PALEONTOLOG, V14, P157, DOI 10.4072/rbp.2011.2.04; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; Evans S.E., 1993, Proceedings of the Yorkshire Geological Society, V49, P229; Evans SE, 2005, ACTA PALAEONTOL POL, V50, P725; EVANS SE, 1987, ZOOL J LINN SOC-LOND, V90, P275, DOI 10.1111/j.1096-3642.1987.tb01356.x; Ezcurra MD, 2015, PALAEONTOLOGY, V58, P141, DOI 10.1111/pala.12130; Ezcurra MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089165; Ezcurra MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086864; Ezcurra MD, 2013, GEOL SOC SPEC PUBL, V379, P9, DOI 10.1144/SP379.11; Ezcurra MD, 2010, J VERTEBR PALEONTOL, V30, P1433, DOI 10.1080/02724634.2010.501446; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2014, P NATL ACAD SCI USA, V111, P18279, DOI 10.1073/pnas.1416252111; Farlow JO, 2014, ANAT REC, V297, P1022, DOI 10.1002/ar.22863; Farlow JO, 2000, PALAIOS, V15, P235, DOI 10.2307/3515645; Fichter J., 2013, Comunicacoes Geologicas, V100, P81; Fichter Juergen, 2004, Ichnos, V11, P183, DOI 10.1080/10420940490444997; Fichter Juergen, 1997, Philippia, V8, P35; Fichter Juergen, 2011, Geologisches Jahrbuch Hessen, V137, P5; FUGLEWICZ R, 1990, Acta Palaeontologica Polonica, V35, P109; Gand Georges, 2007, Palaeovertebrata (Montpellier), V35, P1; Gand G, 2010, HIST BIOL, V22, P40, DOI 10.1080/08912961003644096; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gottmann-Quesada A, 2009, PALAEONTOGR ABT A, V287, P123; Gower DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111154; Gower David J., 2000, P140; Gower DJ, 1996, ZOOL J LINN SOC-LOND, V116, P347, DOI 10.1006/zjls.1996.0024; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Gregory J.T., 1945, U TEXAS PUBLICATION, V4401, P273; Gumbel F, 2009, MITTEILUNGEN BIOSPHA, V14, P7; Hancox P. J., 2000, ZENTRALBLATT GEOLOGI, V1998, P1285; Haubold H., 1971, P1; Haubold H., 1984, SAURIERFAHRTEN; Haubold H., 1999, ZBL GEOL PALAONTOL, V1, P783; Haubold H., 1971, PALAONTOLOGISCHE A A, V4, P395; Haubold H., 1967, HALLESCHES JB MITTEL, V8, P12; Haubold Hartmut, 2002, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V24, P1; Haubold Hartmut, 2000, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V22, P59; Haubold Hartmut, 2006, Veroeffentlichungen Naturhistorisches Museum Schloss Bertholdsburg Schleusingen, V21, P3; Haumbold H., 1986, P189; Heckert AB, 2010, J VERTEBR PALEONTOL, V30, P619, DOI 10.1080/02724631003763524; Huene F.von., 1940, NEUES JB MINERALOG B, V84, P1; Huxley T. H., 1865, MEMOIR GEOLOGICAL SU, V3, P1; Irmis RB, 2013, GEOL SOC SPEC PUBL, V379, P275, DOI 10.1144/SP379.24; Irmis RB, 2010, EARTH ENV SCI T R SO, V101, P397, DOI 10.1017/S1755691011020068; Trotteyn MJ, 2013, GEOL SOC SPEC PUBL, V379, P59, DOI 10.1144/SP379.23; Karl Caroline, 1998, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V20, P33; Kaup J.J., 1835, NEUES JB MINERALOGIE, P327; Kear BP, 2009, ALCHERINGA, V33, P331, DOI 10.1080/03115510903270944; Klein H., 2010, NEW MEXICO MUSEUM NA, V50, P1; Klein H, 2013, ICHNOS, V20, P24, DOI 10.1080/10420940.2012.757699; Klein H, 2010, GEOL SOC SPEC PUBL, V334, P419, DOI 10.1144/SP334.14; Klein H, 2010, ICHNOS, V17, P215, DOI 10.1080/10420940.2010.510030; Klein Hendrik, 2004, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V26, P1; Krainer Karl, 2012, Jahrbuch der Geologischen Bundesanstalt, V152, P205; Krassilov V, 2009, PALAEOGEOGR PALAEOCL, V284, P326, DOI 10.1016/j.palaeo.2009.10.012; Krebs B. E., 1965, Schweizerische Palaeontologische Abhandlungen, V81, P1; Kubo T, 2013, PALAIOS, V28, P259, DOI 10.2110/palo.2012.p12-099r; Kubo T, 2009, PALAEONTOLOGY, V52, P1029, DOI 10.1111/j.1475-4983.2009.00897.x; Kuhn O., 1964, Jahresheft des Vereins fuer Vaterlaendische Naturkunde in Wuerttemberg, V18-119, P293; Kustatscher E, 2012, REV PALAEOBOT PALYNO, V182, P1, DOI 10.1016/j.revpalbo.2012.06.001; Langer MC, 2013, GEOL SOC SPEC PUBL, V379, P157, DOI 10.1144/SP379.9; Leonardi G., 1987, GLOSSARY MANUAL TETR; LEONARDI P, 1974, ATTI ACCAD NAZ LIN, V57, P221; Leonardi P., 1951, RIC SCI, V21, P783; Leonardi P., 1948, MEM IST GEOL MIN U P, V16, P3; Lockley M, 1991, U WYOMING NAT PARK S, V15, P16; LOCKLEY M, 1995, DINOSAUR TRACKS OTHE; Lockley M.G., 2000, DINOSAUR TRACKS OTHE; Lockley Martin G., 1994, Gaia, V10, P233; Lucas SG, 2011, ICHNOS, V18, P197, DOI 10.1080/10420940.2011.632456; Mannion PD, 2010, PALEOBIOLOGY, V36, P253, DOI 10.1666/08085.1; Melchor RN, 2006, PALAEONTOLOGY, V49, P355, DOI 10.1111/j.1475-4983.2006.00538.x; Meyer H.von., 1830, ISIS OKEN, V1830, P517; Mietto P., 1987, Memorie di Scienze Geologiche, V39, P37; Milan J, 2006, PALAEOGEOGR PALAEOCL, V231, P253, DOI 10.1016/j.palaeo.2004.12.022; Modesto SP, 2008, J VERTEBR PALEONTOL, V28, P914, DOI 10.1671/0272-4634(2008)28[914:EOASLA]2.0.CO;2; Modesto SP, 2004, ZOOL J LINN SOC-LOND, V140; Modesto SR, 2004, ZOOL J LINN SOC-LOND, V140, P335, DOI 10.1111/j.1096-3642.2003.00102.x; Munk Wolfgang, 1993, Palaeontologische Zeitschrift, V67, P169; Nesbitt S.J., 2005, MESA SOUTHWEST MUS B, V11, P18; Nesbitt SJ, 2003, P ROY SOC B-BIOL SCI, V270, pS234, DOI 10.1098/rsbl.2003.0066; Nesbitt SJ, 2013, GEOL SOC LONDON SPEC; Nesbitt SJ, 2010, EARTH ENV SCI T R SO, V101, P271, DOI 10.1017/S1755691011020044; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Niedzwiedzki G., 2012, NEW MEXICO MUSEUM NA, V56, P1; Niedzwiedzki G, 2007, ACTA GEOL POL, V57, P325; Niedzwiedzki G, 2013, GEOL SOC SPEC PUBL, V379, P319, DOI 10.1144/SP379.12; Nosotti Stefania, 2007, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V35, P1; Ochev V.G., 1986, Ezhegodnik Vsesoyuznogo Paleontologicheskogo Obshchestva, V29, P171; Olsen P.E., 1986, P61; Olsen P. E., 1995, GEOLOGICAL SOC AM AB, V27, P72; Olsen PE, 1998, J VERTEBR PALEONTOL, V18, P586, DOI 10.1080/02724634.1998.10011086; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Padian Kevin, 2003, Ichnos, V10, P115, DOI 10.1080/10420940390255501; Padian K, 2012, EARTH ENV SCI T R SO, V103, P423, DOI 10.1017/S1755691013000431; Padian K, 2010, PALAEONTOLOGY, V53, P175, DOI 10.1111/j.1475-4983.2009.00924.x; Parrington F. R., 1935, Annals & Magazine of Natural History, V16, P197; PEABODY FRANK E., 1948, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V27, P295; Peng Jianghua, 1991, Vertebrata Palasiatica, V29, P95; Pineiro G, C URUGUAYO IN PRESS; Pittau P., 2005, BLETTERBACH CANYON L, P9; Ptaszynski T, 2000, ACTA PALAEONTOL POL, V45, P151; Romer A.S., 1972, Breviora, VNo. 385, P1; Sarjeant W.S., 1990, P299, DOI 10.1017/CBO9780511608377.025; SATSANGI PP, 1964, CURR SCI INDIA, V33, P651; Sennikov AG, 2006, PALEONTOL J+, V40, pS475, DOI 10.1134/S0031030106100078; Sennikov AG, 2011, PALEONTOL J+, V45, P90, DOI 10.1134/S0031030111010151; Sennikov A.G., 1997, PALEONTOL J, V31, P94; Sennikov AG, 2005, PALEONTOL J+, V39, P199; SENNIKOV AG, 1988, PALEONTOL ZH, P78; SENNIKOV AG, 1992, DOKL AKAD NAUK+, V326, P896; Sereno P.C., 1990, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V180, P21; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Sereno PC, 2005, SYST BIOL, V54, P595, DOI 10.1080/106351591007453; Smith ND, 2011, J VERTEBR PALEONTOL, V31, P784, DOI 10.1080/02724634.2011.586662; Smith RMH, 1996, PALAEONTOLOGY, V39, P289; Sookias RB, 2014, PEERJ, V2, DOI 10.7717/peerj.658; Sookias RB, 2013, GEOL SOC SPEC PUBL, V379, P35, DOI 10.1144/SP379.6; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Da-Rosa AAS, 2009, REV BRAS PALEONTOLOG, V12, P67, DOI 10.4072/rbp.2009.1.06; Sues HD, 2013, GEOL SOC SPEC PUBL, V379, P49, DOI 10.1144/SP379.13; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Tatarinov LP, 1960, PALEONTOL ZH, V4, P74; Thomson Tracy J., 2014, Bulletin of the New Mexico Museum of Natural History and Science, P129; THULBORN R A, 1979, Memoirs of the Queensland Museum, V19, P331; Thulborn R.A., 1986, Journal of Vertebrate Paleontology, V6, P123; Thulborn T., 1990, DINOSAUR TRACKS; Thulborn T, 2006, ALCHERINGA, V30, P273, DOI 10.1080/03115510608619318; Tresise G, 2012, ICHNOS, V19, P228, DOI 10.1080/10420940.2012.717131; Turner AH, 2013, GEOL SOC SPEC PUBL, V379, P573, DOI 10.1144/SP379.15; Uhl D, 2012, RIV ITAL PALEONTOL S, V118, P223, DOI 10.13130/2039-4942/6002; Valentini M, 2009, NEUES JAHRB GEOL P-A, V251, P71, DOI 10.1127/0077-7749/2009/0251-0071; Voigt S, 2012, J VERTEBR PALEONTOL, V27, P553; von Meyer H, 1832, PALAEOLOGICA GESCH E, P1; VONHUENE F, 1960, PALAEONTOGR ABT A, V114, P105; Watson DMS, 1912, RECORDS ALBANY MUSEU, V2, P298; WELLES S. P., 1947, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V27, P241; Welman J, 1998, J VERTEBR PALEONTOL, V18, P340, DOI 10.1080/02724634.1998.10011062; Wild R., 1973, ABHANDLUNGEN SCHWEIZ, V95, P1; Wilson JA, 2005, PALEOBIOLOGY, V31, P400, DOI 10.1666/0094-8373(2005)031[0400:IIABFR]2.0.CO;2; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Wopfner H, 1999, SCHLERN, V73, P23; Wright JL, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P252; Young C., 1958, Vertebrata Palasiatica, V2, P259; Young C. C., 1936, Bulletin of the Geological Society of China, V15, P291; Young C. C., 1963, Vertebrata Palasiatica, V7, P215; Young C- C., 1978, MEM I VERT PALENTO B, V13, P26	192	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128449	10.1371/journal.pone.0128449	http://dx.doi.org/10.1371/journal.pone.0128449			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083612	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400049
J	Jungke, P; Hammer, J; Hans, S; Brand, M				Jungke, Peggy; Hammer, Juliane; Hans, Stefan; Brand, Michael			Isolation of Novel CreER(T2)-Driver Lines in Zebrafish Using an Unbiased Gene Trap Approach	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; INSERTIONAL MUTAGENESIS; EMBRYONIC-DEVELOPMENT; TRANSGENIC ZEBRAFISH; ENHANCER TRAP; IN-VIVO; EXPRESSION; TRANSPOSON; CRE; TOL2	Gene manipulation using the Cre/loxP-recombinase system has been successfully employed in zebrafish to study gene functions and lineage relationships. Recently, gene trapping approaches have been applied to produce large collections of transgenic fish expressing conditional alleles in various tissues. However, the limited number of available cell-and tissue-specific Cre/CreER(T2)-driver lines still constrains widespread application in this model organism. To enlarge the pool of existing CreER(T2)-driver lines, we performed a genome-wide gene trap screen using a Tol2-based mCherry-T2a-CreER(T2) (mCT2aC) gene trap vector. This cassette consists of a splice acceptor and a mCherry-tagged variant of CreER(T2) which enables simultaneous labeling of the trapping event, as well as CreER(T2) expression from the endogenous promoter. Using this strategy, we generated 27 novel functional CreER(T2)-driver lines expressing in a cell-and tissue-specific manner during development and adulthood. This study summarizes the analysis of the generated CreER(T2)-driver lines with respect to functionality, expression, integration, as well as associated phenotypes. Our results significantly enlarge the existing pool of CreER(T2)-driver lines in zebrafish and combined with Cre-dependent effector lines, the new CreER(T2)-driver lines will be important tools to manipulate the zebrafish genome.	[Hans, Stefan] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Hans, S (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Fetscherstr 105, D-01307 Dresden, Germany.	stefan.hans@biotec.tu-dresden.de; michael.brand@biotec.tu-dresden.de	Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512; Jungke, Peggy/0000-0001-6376-6212	Deutsche Forschungsgemeinschaft [BR 1746/3-1, SFB 655]; European Union [F-002339-535-000-2301201]; German Federal and State Governments	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); German Federal and State Governments	This project is supported by the Deutsche Forschungsgemeinschaft (BR 1746/3-1 and SFB 655, project A3) and the European Union (ZF Health F-002339-535-000-2301201). In addition, Michael Brand is supported by funding of the Excellence Initiative by the German Federal and State Governments (Institutional Strategy, measure "support the best"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe G, 2004, METHODS IN CELL BIOL, V104, P23; Amsterdam A, 2005, DEV DYNAM, V234, P255, DOI 10.1002/dvdy.20541; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Auer T.O., 2014, METHODS; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bailey JM, 2009, ZEBRAFISH, V6, P329, DOI 10.1089/zeb.2009.0626; Balciunas D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-62; Bischof Johannes, 2008, V420, P175, DOI 10.1007/978-1-59745-583-1_10; Boniface EJ, 2009, GENESIS, V47, P484, DOI 10.1002/dvg.20526; Brand M, 2002, KEEPING AND RAISING; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Cambier S, 2010, ENVIRON SCI TECHNOL, V44, P469, DOI 10.1021/es901980t; Chandras C, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas029; Chen Y, 2002, J BIOL CHEM, V277, P30495, DOI 10.1074/jbc.M202076200; Clark BS, 2011, DEV DYNAM, V240, P2452, DOI 10.1002/dvdy.22758; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Clark KJ, 2004, GENESIS, V39, P225, DOI 10.1002/gene.20049; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Doyon Y, 2008, NATURE METHODS, V8, P74; Driever W, 1996, DEVELOPMENT, V123, P37; Ekker M, 1997, MOL BIOL EVOL, V14, P1008, DOI 10.1093/oxfordjournals.molbev.a025707; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Foucher I, 2006, DEVELOPMENT, V133, P1891, DOI 10.1242/dev.02352; Friedel RH, 2010, METHOD ENZYMOL, V477, P243, DOI 10.1016/S0076-6879(10)77013-0; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Guner-Ataman B, 2013, DEVELOPMENT, V140, P1353, DOI 10.1242/dev.088351; Haffter P, 1996, DEVELOPMENT, V123, P1; Hammond KL, 2006, DEVELOPMENT, V133, P1347, DOI 10.1242/dev.02306; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Herbomel P, 2004, METH MOLEC MED, V105, P199; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Hirano N, 2011, APPL MICROBIOL BIOT, V92, P227, DOI 10.1007/s00253-011-3519-5; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jackson HE, 2013, MECH DEVELOP, V130, P447, DOI 10.1016/j.mod.2013.06.001; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Jungke P, 2013, THE ZEBRAFISH CREZOO; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Keller PJ, 2013, IN VIVO IMAGING OF Z; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Knowlton MN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-7; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Lane BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049357; Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; Liu XJ, 2008, DEV DYNAM, V237, P2955, DOI 10.1002/dvdy.21701; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mongera A, 2013, CURR BIOL, V23, pR338, DOI 10.1016/j.cub.2013.02.056; Morsli H, 1999, DEVELOPMENT, V126, P2335; Mosimann C, 2011, METHOD CELL BIOL, V104, P175, DOI 10.1016/B978-0-12-374814-0.00010-0; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Murakami A, 2001, NUCLEIC ACIDS RES, V29, P3347, DOI 10.1093/nar/29.16.3347; Nagy Andras, 2009, V530, P365, DOI 10.1007/978-1-59745-471-1_19; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ni TT, 2012, PROCEEDINGS OF THE N; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Reifers F, 1998, DEVELOPMENT, V125, P2381; SADOWSKI PD, 1995, PROG NUCLEIC ACID RE, V51, P53, DOI 10.1016/S0079-6603(08)60876-4; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Siegal ML, 2000, METH MOL B, V136, P487; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; Smedley D, 2011, METHODS, V53, P411, DOI 10.1016/j.ymeth.2010.12.027; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Thummel R, 2005, DEV DYNAM, V233, P1366, DOI 10.1002/dvdy.20475; Tian T, 2009, J GENET GENOMICS, V36, P581, DOI 10.1016/S1673-8527(08)60150-2; Trinh LA, 2013, DEV GROWTH DIFFER, V55, P434, DOI 10.1111/dgd.12055; Trinh le A, 2012, GENES DEVELOPMENT, V25, P2306; Turan S, 2011, FASEB J, V25, P4088, DOI 10.1096/fj.11-186940; Ul-Hussain M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-92; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Wang XK, 2000, BIOTECHNIQUES, V29, P814, DOI 10.2144/00294st09; Weber M, 2011, CURR OPIN GENET DEV, V21, P566, DOI 10.1016/j.gde.2011.09.009; Weber T, 2013, METHODS; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Wong ET, 2002, GENE THER, V9, P337, DOI 10.1038/sj.gt.3301667; Zigman M, 2014, DEVELOPMENT, V141, P639, DOI 10.1242/dev.098731; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	93	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129072	10.1371/journal.pone.0129072	http://dx.doi.org/10.1371/journal.pone.0129072			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083735	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400079
J	Persson, M; Elfstrom, KM; Olsson, SE; Dillner, J; Andersson, S				Persson, Maria; Elfstrom, K. Miriam; Olsson, Sven-Erik; Dillner, Joakim; Andersson, Sonia			Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL-CANCER; WOMEN; TRENDS; PREVALENCE; MANAGEMENT; NEOPLASIA; DISEASE; TRIAGE; TESTS	Objective Diagnoses of atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesions (LSIL) are common, but the corresponding risk of disease varies by human papillomavirus (HPV) status, complicating management strategies. Our aim was to estimate the longer-term risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) among women with ASCUS/LSIL by age, HPV status, and genotype(s). Methods A total of 314 women with ASCUS/LSIL were followed for a median of 3.8 years. Baseline HPV status was determined by reflex testing and women with histologically confirmed CIN2 + were identified through linkage to the Swedish National Quality Register for Cervical Cancer Prevention. Cumulative incidence and hazard ratios were estimated to explore differences between index data and associations with CIN2+. Results In total, 89 women (28.3%) developed CIN2+. High-risk (HR) HPV-positive women developed significantly more CIN2+ than HR-HPV-negative women (cumulative incidence 3.5 years after the index test: 42.2%, 95% CI: 32.5-53.5 for HPV16/18; 36.2%, 95% CI: 28.3-45.4 for other HR-HPV types; and 2.0%, 95% CI: 0.5-7.8 for HR-HPV-negative women; p<0.0001). Conclusion HPV status was of greatest importance in determining the risk of CIN2+. The risk was low among HPV-negative women during the first years of follow-up, suggesting these women could be followed less intensively. HPV16/18-positive women may need intensified followup as they showed the highest risk of CIN2+.	[Persson, Maria; Andersson, Sonia] Karolinska Univ Hosp Solna, Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Elfstrom, K. Miriam; Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Olsson, Sven-Erik] Danderyds Hosp AB, Karolinska Inst, Div Obstet & Gynecol, Dept Clin Sci, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet	Andersson, S (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Elevhemmet H2 00, Stockholm, Sweden.	sonia.andersson@karolinska.se			Swedish Cancer Foundation [070623, CAN 2007/1044, 11 0544, CAN 2011/471]; Karolinska Institutet Cancer Strategic Grants [5888/05-722]; Swedish Research Council [521-2008-2899]; Stockholm County Council [20130097]	Swedish Cancer Foundation; Karolinska Institutet Cancer Strategic Grants; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council)	This research was supported by the Swedish Cancer Foundation (070623, CAN 2007/1044, 11 0544, CAN 2011/471), URL: www.cancerfonden.se, SA; Karolinska Institutet Cancer Strategic Grants (5888/05-722), URL: www.ki.se, SA; Swedish Research Council (521-2008-2899), URL: www.vr.se, SA; Stockholm County Council (20130097) URL: www.skl.se, SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e804; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Brismar-Wendel S, 2009, BRIT J CANCER, V101, P511, DOI 10.1038/sj.bjc.6605165; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Carreon JD, 2007, INT J GYNECOL PATHOL, V26, P441, DOI 10.1097/pgp.0b013e31805152ab; Castle PE, 2008, OBSTET GYNECOL, V111, P847, DOI 10.1097/AOG.0b013e318168460b; Castle PE, 2012, J CLIN ONCOL, V30, P3044, DOI 10.1200/JCO.2011.38.8389; Castle PE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.049; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Dahlstrom LA, 2010, INT J CANCER, V127, P1923, DOI 10.1002/ijc.25408; Dillner J, 2013, PREVENTION OF CERVIC; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Dillner L, 2011, INT J CANCER, V129, P151, DOI 10.1002/ijc.25649; Elfstrom KM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g130; Froberg M, 2013, CURR PHARM DESIGN, V19, P1406; Hemminki K, 2002, EUR J OBSTET GYN R B, V101, P64, DOI 10.1016/S0301-2115(01)00508-5; IARC, 2012, IARC MONOGRAPHS ON T; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS28, DOI 10.1097/LGT.0b013e318285423c; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS36, DOI 10.1097/LGT.0b013e3182854253; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS43, DOI 10.1097/LGT.0b013e3182854269; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Kocken M, 2012, BRIT J CANCER, V106, P817, DOI 10.1038/bjc.2012.5; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Lindemann MLM, 2012, J MOL DIAGN, V14, P65, DOI 10.1016/j.jmoldx.2011.09.005; Mesher D, 2010, BRIT J CANCER, V102, P1405, DOI 10.1038/sj.bjc.6605619; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Nygard M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003460; Schiffman M, 2011, CANCER EPIDEM BIOMAR, V20, P1398, DOI 10.1158/1055-9965.EPI-11-0206; Scott DR, 2002, CANCER CYTOPATHOL, V96, P14, DOI 10.1002/cncr.10317; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	37	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127444	10.1371/journal.pone.0127444	http://dx.doi.org/10.1371/journal.pone.0127444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083247	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400012
J	Sato, H; Hattori, T				Sato, Hirotoshi; Hattori, Tsutomu			New Species of Boletellus Section Boletellus (Boletaceae, Boletales) from Japan, B. aurocontextus sp nov and B. areolatus sp nov.	PLOS ONE			English	Article							ECTOMYCORRHIZAL GENUS STROBILOMYCES; SELECTION; MODEL	We describe and illustrate two new species of Boletellus section Boletellus, B. aurocontextus sp. nov. and B. areolatus sp. nov., which are generally assumed to be B. emodensis. In this study, we reconstructed separate molecular phylogenetic trees of section Boletellus using the nucleotide sequences of the internal transcribed spacer (ITS) region of nuclear ribosomal DNA, the largest subunit (RPB1) and the second-largest subunit (RPB2) of nuclear RNA polymerase II gene and mitochondrial cytochrome oxidase subunit 3 (cox3) gene. We also examined the morphologies of B. emodensis sensu lato (s.l.) and other related species for comparison. The molecular phylogenetic tree inferred from the sequences of nuclear DNA (ITS, and combined dataset of RPB1 and RPB2) indicated that three genetically and phylogenetically well-separated lineages were present within B. emodensis s.l. These three lineages were also distinguished on the basis of the molecular phylogenetic tree constructed using the sequences of mitochondrial DNA (cox3), suggesting distinct cytonuclear disequilibria (i.e., evidence of reproductive isolation) among these lineages. Therefore, these three lineages can be treated as independent species: B. aurocontextus, B. areolatus, and B. emodensis. Boletellus aurocontextus and B. areolatus are also distinct from B. emodensis by the macro-and microscopic morphologies. Boletellus aurocontextus is characterized by a pileus with bright yellow to lemon yellow context, which can be observed through a gap in the scales, and basidiospores with relatively large length (mean spore length, 21.4 mu m; quotient of spore length and width, 2.51). In contrast, B. areolatus is characterized by a pileus with floccose to appressed thin scaly patches, a stipe with pallid or pale cream color at the upper half, and basidiospores with relatively small length (mean spore length, 16.5 mu m; quotient of spore length and width, 1.80).	[Sato, Hirotoshi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Hattori, Tsutomu] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Kyoto University; Forestry & Forest Products Research Institute - Japan	Sato, H (corresponding author), Kyoto Univ, Ctr Ecol Res, 509-3,2 Chome, Otsu, Shiga 5202113, Japan.	h-sato@sys.bot.kyoto-u.ac.jp			 [26840128]; Grants-in-Aid for Scientific Research [26840128] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research (to H. S.; 26840128).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ARNOLD J, 1993, ANNU REV ECOL SYST, V24, P521, DOI 10.1146/annurev.es.24.110193.002513; Avise J, 2004, MOL MARKERS NATURAL; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Corner E. J. H., 1972, Boletus in Malaysia.; Dentinger BTM, 2010, MOL PHYLOGENET EVOL, V57, P1276, DOI 10.1016/j.ympev.2010.10.004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gamble JS, 1878, LIST TREES SHRUBS LA; Halling RE., 2005, COMMON MUSHROOMS TAL; Imazeki R, 1952, NAGAOA, V2, P30; Jobb G., 2011, TREEFINDER VERSION O; Kirk PM, 2008, AINSWORTH BISBYS DIC; Murrill W.A., 1909, MYCOLOGIA, V1, P4, DOI DOI 10.2307/3753167; Nagasawa E., 1997, REP TOTTORI MYCOL I, V35, P39; Nagasawa E, 1987, STROBILOMYCETACEAE; Nuhn ME, 2013, FUNGAL BIOL-UK, V117, P479, DOI 10.1016/j.funbio.2013.04.008; PEGLER DN, 1981, T BRIT MYCOL SOC, V76, P103, DOI 10.1016/S0007-1536(81)80013-7; Sato H, 2008, MOL PHYLOGENET EVOL, V48, P326, DOI 10.1016/j.ympev.2008.01.033; Sato H, 2007, AM J BOT, V94, P1630, DOI 10.3732/ajb.94.10.1630; Sato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049777; Sato H, 2012, MOL ECOL, V21, P5599, DOI 10.1111/mec.12053; Singer R., 1942, ANN MYCOLOGICI, V40, P1; Singer R., 1970, STROBILOMYCETACEAE B, V5; Singer R, 1975, AGARICALES MODERN TA; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Watling R, 2001, AUST SYST BOT, V14, P407, DOI 10.1071/SB99031; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu G, 2014, FUNGAL DIVERS, V69, P93, DOI 10.1007/s13225-014-0283-8; Zeng NK, 2011, MYCOTAXON, V115, P413, DOI 10.5248/115.413	34	9	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128184	10.1371/journal.pone.0128184	http://dx.doi.org/10.1371/journal.pone.0128184			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083243	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400032
J	Swat, MH; Thomas, GL; Shirinifard, A; Clendenon, SG; Glazier, JA				Swat, Maciej H.; Thomas, Gilberto L.; Shirinifard, Abbas; Clendenon, Sherry G.; Glazier, James A.			Emergent Stratification in Solid Tumors Selects for Reduced Cohesion of Tumor Cells: A Multi-Cell, Virtual-Tissue Model of Tumor Evolution Using CompuCell3D	PLOS ONE			English	Article							E-CADHERIN; MIGRATION; INVASION; ADHESION; NECROSIS	Tumor cells and structure both evolve due to heritable variation of cell behaviors and selection over periods of weeks to years (somatic evolution). Micro-environmental factors exert selection pressures on tumor-cell behaviors, which influence both the rate and direction of evolution of specific behaviors, especially the development of tumor-cell aggression and resistance to chemotherapies. In this paper, we present, step-by-step, the development of a multi-cell, virtual-tissue model of tumor somatic evolution, simulated using the open-source CompuCell3D modeling environment. Our model includes essential cell behaviors, microenvironmental components and their interactions. Our model provides a platform for exploring selection pressures leading to the evolution of tumor-cell aggression, showing that emergent stratification into regions with different cell survival rates drives the evolution of less cohesive cells with lower levels of cadherins and higher levels of integrins. Such reduced cohesivity is a key hallmark in the progression of many types of solid tumors.	[Swat, Maciej H.; Clendenon, Sherry G.; Glazier, James A.] Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA; [Swat, Maciej H.; Clendenon, Sherry G.; Glazier, James A.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Thomas, Gilberto L.] Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil; [Shirinifard, Abbas] St Jude Childrens Res Hosp, Dept Informat Sci, Div Clin Informat, Memphis, TN 38105 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universidade Federal do Rio Grande do Sul; St Jude Children's Research Hospital	Swat, MH (corresponding author), Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA.	mswat@indiana.edu	Clendenon, Sherry/AAG-6655-2019; Clendenon, Sherry G/F-7651-2010; Thomas, Gilberto L/H-8944-2012; Thomas, Gilberto L/AAW-4072-2020	Clendenon, Sherry/0000-0002-3353-0919; Clendenon, Sherry G/0000-0002-3353-0919; Thomas, Gilberto L/0000-0003-0317-6186; Glazier, James Alexander/0000-0003-3634-190X	NIH NIGMS [R01 GM077138, R01 GM076692]; Environmental Protection Agency; Office of Vice President for Research; College of Arts and Sciences; Pervasive Technologies Laboratories; Biocomplexity Institute at Indiana University; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [PRONEX-10/0008-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Environmental Protection Agency(United States Environmental Protection Agency); Office of Vice President for Research; College of Arts and Sciences; Pervasive Technologies Laboratories; Biocomplexity Institute at Indiana University; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the NIH NIGMS grants R01 GM077138 and R01 GM076692, the Environmental Protection Agency, and the Office of Vice President for Research, the College of Arts and Sciences, the Pervasive Technologies Laboratories and the Biocomplexity Institute at Indiana University and Brazilian agencies Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) under the grant PRONEX-10/0008-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andasari V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033726; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Basanta D, 2008, EUR PHYS J B, V63, P393, DOI 10.1140/epjb/e2008-00249-y; Berruti Alfredo, 2011, Hormones & Cancer, V2, P378, DOI 10.1007/s12672-011-0087-1; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Enderling H, 2009, BRIT J CANCER, V100, P1917, DOI 10.1038/sj.bjc.6605071; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Glazier JA, 2007, SINGLE CELL BASED MO, P79, DOI [10.1007/978-3-7643-8123-3_4, DOI 10.1007/978-3-7643-8123-3_4]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hester SD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002155; HLATKY L, 1988, J CELL PHYSIOL, V134, P167, DOI 10.1002/jcp.1041340202; Jing SW, 2013, DIS ESOPHAGUS, V26, P75, DOI 10.1111/j.1442-2050.2011.01321.x; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Merks RMH, 2006, NONLINEARITY, V19, pC1, DOI 10.1088/0951-7715/19/1/000; Merks RMH, 2006, DEV BIOL, V289, P44, DOI 10.1016/j.ydbio.2005.10.003; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Popawski NJ, 2009, B MATH BIOL, V71, P1189, DOI 10.1007/s11538-009-9399-5; Poplawski NJ, 2007, PHYSICA A, V373, P521, DOI 10.1016/j.physa.2006.05.028; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Ramis-Conde I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016008; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; Shirinifard A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002440; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	28	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127972	10.1371/journal.pone.0127972	http://dx.doi.org/10.1371/journal.pone.0127972			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083246	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400022
J	Ueno, T; Takeuchi, H; Kawasaki, K; Kubo, T				Ueno, Takayuki; Takeuchi, Hideaki; Kawasaki, Kiyoshi; Kubo, Takeo			Changes in the Gene Expression Profiles of the Hypopharyngeal Gland of Worker Honeybees in Association with Worker Behavior and Hormonal Factors	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; INSECT JUVENILE-HORMONE; DEPENDENT ROLE CHANGE; DIVISION-OF-LABOR; APIS-MELLIFERA L; BHLH-PAS FAMILY; METHOPRENE-TOLERANT; ALPHA-GLUCOSIDASE; 2 ISOFORMS; E74 GENE	The hypopharyngeal glands (HPGs) of worker honeybees undergo physiological changes along with the age-dependent role change from nursing to foraging: nurse bee HPGs secrete mainly major royal jelly proteins, whereas forager HPGs secrete mainly a-glucosidase III, which converts the sucrose in the nectar into glucose and fructose. We previously identified two other genes, Apis mellifera buffy(Ambuffy) and Apis mellifera matrix metalloproteinase 1(AmMMP1), with enriched expression in nurse bee and forager HPGs, respectively. In the present study, to clarify the molecular mechanisms that coordinate HPG physiology with worker behavior, we first analyzed whether Ambuffy, AmMMP1, mrjp2(a gene encoding one of major royal jelly protein isoforms), and Hbg3 (a gene encoding a-glucosidase III) expression, is associated with worker behavior in 'single-cohort colonies' where workers of almost the same age perform different tasks. Expression of these genes correlated with the worker's role, while controlling for age, indicating their regulation associated with the worker's behavior. Associated gene expression suggested the possible involvement of some hormonal factors in its regulation. We therefore examined the relationship between ecdysone- and juvenile hormone (JH)-signaling, and the expression profiles of these 'indicator' genes (nurse bee HPG-selective genes: mrjp2 and Ambuffy, and forager HPG-selective genes: Hbg3and AmMMP1). Expression of both ecdysone-regulated genes (ecdysone receptor, mushroom body large type Kenyon cell specific protein-1, and E74) and JH-regulated genes (Methoprene tolerant and Kruppel homolog 1) was higher in the forager HPGs than in the nurse bee HPGs, suggesting the possible roles of ecdysone-and JH-regulated genes in worker HPGs. Furthermore, 20-hydroxyecdysone-treatment repressed both nurse bee-and forager-selective gene expression, whereas methoprene-treatment enhanced the expression of forager-selective genes and repressed nurse bee-selective genes in the HPGs. Our findings suggest that both ecdysone-and JH-signaling cooperatively regulate the physiological state of the HPGs in association with the worker's behavior.	[Ueno, Takayuki; Takeuchi, Hideaki; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ueno, Takayuki; Kawasaki, Kiyoshi] Doshisha Womens Coll, Fac Pharmaceut Sci, Kyotanabe, Kyoto 6100395, Japan	University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	stkubo@biol.s.u-tokyo.ac.jp	Takeuchi, Hideaki/W-6739-2018; KUBO, TAKEO/G-4951-2014	Takeuchi, Hideaki/0000-0001-6610-3895; Kubo, Takeo/0000-0002-5914-5269	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [26291068] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B) and a Grant-in Aid for Scientific Research on Innovative Areas 'Systems Molecular Ethology' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. T.U. was the recipient of a Grant-in-Aid from the Japan Society for the Promotion of Science for Young Scientists.	Amdam GV, 2010, EVOL DEV, V12, P428, DOI 10.1111/j.1525-142X.2010.00429.x; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; BAEHRECKE EH, 1995, DEV BIOL, V171, P85, DOI 10.1006/dbio.1995.1262; Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bozic J, 2000, PFLUG ARCH EUR J PHY, V439, pR163, DOI 10.1007/s004240000131; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Danforth BN, 1998, MOL BIOL EVOL, V15, P225, DOI 10.1093/oxfordjournals.molbev.a025920; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hartfelder K, 2002, INSECT BIOCHEM MOLEC, V32, P211, DOI 10.1016/S0965-1748(01)00100-X; Hartfelder K., 2012, INSECT ENDOCRINOLOGY, P464, DOI [10.1016/B978-0-12-384749-2.10011-1, DOI 10.1016/B978-0-12-384749-2.10011-1]; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P929, DOI 10.1016/S0022-1910(98)00058-4; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; LeBoeuf' AC, 2013, CURR OPIN NEUROBIOL, V23, P3, DOI 10.1016/j.conb.2012.08.008; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lehman HK, 2006, J EXP BIOL, V209, P2774, DOI 10.1242/jeb.02296; Li JK, 2008, APIDOLOGIE, V39, P199, DOI 10.1051/apido:2007059; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; Mello TRP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00445; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Miura T, 1999, P NATL ACAD SCI USA, V96, P13874, DOI 10.1073/pnas.96.24.13874; Mutti NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022195; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nilsen KA, 2011, J EXP BIOL, V214, P1488, DOI 10.1242/jeb.050393; Ohashi K, 1996, BIOCHEM BIOPH RES CO, V221, P380, DOI 10.1006/bbrc.1996.0604; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Ohashi K, 2000, ZOOL SCI, V17, P1089, DOI 10.2108/zsj.17.1089; Ohashi K, 1997, EUR J BIOCHEM, V249, P797, DOI 10.1111/j.1432-1033.1997.t01-1-00797.x; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Paul RK, 2005, INSECT MOL BIOL, V14, P9, DOI 10.1111/j.1365-2583.2004.00524.x; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pinto LZ, 2002, J INSECT PHYSIOL, V48, P783, DOI 10.1016/S0022-1910(02)00103-8; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; ROBINSON GE, 1985, J INSECT PHYSIOL, V31, P277, DOI 10.1016/0022-1910(85)90003-4; RUTZ W, 1976, J INSECT PHYSIOL, V22, P1485, DOI 10.1016/0022-1910(76)90214-6; Sakagami S, 1953, I JPN J ZOOL, V11, P117; SASAGAWA H, 1989, APPL ENTOMOL ZOOL, V24, P66, DOI 10.1303/aez.24.66; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; Sekimoto T, 2007, INSECT MOL BIOL, V16, P581, DOI 10.1111/j.1365-2583.2007.00751.x; Sigg D, 1997, J NEUROSCI, V17, P7148; Soares MPM, 2007, INSECT BIOCHEM MOLEC, V37, P1272, DOI 10.1016/j.ibmb.2007.07.014; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; Sun GQ, 2002, MOL CELL ENDOCRINOL, V190, P147, DOI 10.1016/S0303-7207(01)00726-2; Takeuchi H, 2001, INSECT MOL BIOL, V10, P487, DOI 10.1046/j.0962-1075.2001.00288.x; Takeuchi H, 2007, ZOOL SCI, V24, P596, DOI 10.2108/zsj.24.596; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Ueno T, 2009, ZOOL SCI, V26, P557, DOI 10.2108/zsj.26.557; Velarde RA, 2009, J INSECT PHYSIOL, V55, P59, DOI 10.1016/j.jinsphys.2008.10.006; Wang Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002779; Wang Y, 2012, J EXP BIOL, V215, P124, DOI 10.1242/jeb.060889; Wang Y, 2010, J INSECT PHYSIOL, V56, P1816, DOI 10.1016/j.jinsphys.2010.07.013; Wang YY, 2009, ELECTRON J QUAL THEO, P1; WHEELER DE, 1983, J INSECT PHYSIOL, V29, P847, DOI 10.1016/0022-1910(83)90151-8; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Wilson E.O., 1971, INSECT SOC; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Winston ML, 1987, THE BIOLOGY OF THE H; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016; Yamazaki Y, 2011, INSECT BIOCHEM MOLEC, V41, P283, DOI 10.1016/j.ibmb.2011.01.005; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007	67	20	20	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130206	10.1371/journal.pone.0130206	http://dx.doi.org/10.1371/journal.pone.0130206			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083737	gold, Green Submitted, Green Published			2022-12-26	WOS:000356567400130
J	Vogt, F; Tayler-Smith, K; Bernasconi, A; Makondo, E; Taziwa, F; Moyo, B; Havazvidi, L; Satyanarayana, S; Manzi, M; Khogali, M; Reid, A				Vogt, Florian; Tayler-Smith, Katie; Bernasconi, Andrea; Makondo, Eliphas; Taziwa, Fabian; Moyo, Buhlebenkosi; Havazvidi, Liberty; Satyanarayana, Srinath; Manzi, Marcel; Khogali, Mohammed; Reid, Anthony			Access to CD4 Testing for Rural HIV Patients: Findings from a Cohort Study in Zimbabwe	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; DEVELOPING-COUNTRIES; VIRAL LOAD; SCALE-UP; CARE; INITIATION; RESIDENCE; HIV/AIDS; BLOOD	Background CD4 cell count measurement remains an important diagnostic tool for HIV care in developing countries. Insufficient laboratory capacity in rural Sub-Saharan Africa is frequently mentioned but data on the impact at an individual patient level are lacking. Urban-rural discrepancies in CD4 testing have not been quantified to date. Such evidence is crucial for public health planning and to justify new yet more expensive diagnostic procedures that could circumvent access constraints in rural areas. Objective To compare CD4 testing among rural and urban HIV patients during the first year of treatment. Methods Records from 2,145 HIV positive adult patients from a Medecins sans Frontieres (Doctors without Borders) HIV project in Beitbridge, Zimbabwe, during 2011 and 2012 were used for a retrospective cohort analysis. Covariate-adjusted risk ratios were calculated to estimate the effects of area of residence on CD4 testing at treatment initiation, six and 12 months among rural and urban patients. Findings While the proportion of HIV patients returning for medical consultations at six and 12 months decreased at a similar rate in both patient groups, CD4 testing during consultations dropped to 21% and 8% for urban, and 2% and 1% for rural patients at six and 12 months, respectively. Risk ratios for missing CD4 testing were 0.8 (95% CI 0.7-0.9), 9.2 (95% CI 5.5-15.3), and 7.6 (95% 3.7-17.1) comparing rural versus urban patients at treatment initiation, six and 12 months, respectively. Conclusions CD4 testing was low overall, and particularly poor in rural patients. Difficulties with specimen transportation were probably a major factor underlying this difference and requires new diagnostic approaches. Our findings point to severe health system constraints in providing CD4 testing overall that need to be addressed if effective monitoring of HIV patients is to be achieved, whether by alternative CD4 diagnostics or newly-recommended routine viral load testing.	[Vogt, Florian; Bernasconi, Andrea] Operat Ctr Barcelona, Med Sans Frontieres Doctors Borders, Barcelona, Spain; [Tayler-Smith, Katie; Manzi, Marcel; Khogali, Mohammed; Reid, Anthony] Operat Res Unit Luxembourg, Med Sans Frontieres Doctors Borders, Luxembourg, Luxembourg; [Bernasconi, Andrea] Epictr, Dept Field Epidemiol & Training, Paris, France; [Makondo, Eliphas] Beitbridge Dist Hosp, Dept Lab, Minist Hlth & Child Welf, Beitbridge, Zimbabwe; [Taziwa, Fabian] Zimbabwe Miss, Med Sans Frontieres Doctors Borders, Harare, Zimbabwe; [Moyo, Buhlebenkosi; Havazvidi, Liberty] Beitbridge Project, Med Sans Frontieres Doctors Borders, Beitbridge, Zimbabwe; [Satyanarayana, Srinath] Ctr Operat Res, South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India		Vogt, F (corresponding author), Operat Ctr Barcelona, Med Sans Frontieres Doctors Borders, Barcelona, Spain.	florianvogt@hotmail.com		Satyanarayana, Srinath/0000-0002-5420-2551; Vogt, Florian/0000-0003-2686-3149	Medecins sans Frontieres/Doctors without Borders (MSF); International Union Against Tuberculosis and Lung Disease (The Union); UK Department for International Development (DFID); WHO	Medecins sans Frontieres/Doctors without Borders (MSF); International Union Against Tuberculosis and Lung Disease (The Union); UK Department for International Development (DFID); WHO(World Health Organization)	This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The programme is funded by Medecins sans Frontieres/Doctors without Borders (MSF), the International Union Against Tuberculosis and Lung Disease (The Union), the UK Department for International Development (DFID) and WHO. The specific SORT IT programme which resulted in this publication was jointly developed and implemented by: the Operational Research Unit (LUXOR), Medecins sans Frontieres/Doctors without Borders, Brussels Operational Center, Luxembourg; the Centre for Operational Research, the International Union Against Tuberculosis and Lung Disease (The Union), Paris, France; The Union South-East Asia Regional Office, New Delhi, India; and the Centre for International Health, University of Bergen, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemnji G, 2011, INDIAN J MED RES, V134, P779, DOI 10.4103/0971-5916.92625; [Anonymous], 2013, FUCHIA VERS 1 7 1 CO; [Anonymous], 2011, STATA VERS 11 2 COMP; Bui N, 2009, USE CD4 STABILIZATIO; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; Desai D, 2011, LAB CHIP, V11, P194, DOI 10.1039/c0lc00340a; Fajardo E, 2014, HIGH FREQUENCY INVAL; Fredlund VG, 2007, J INFECT DIS, V196, pS469, DOI 10.1086/521115; Galiwango RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088928; [ICF International Zimbabwe National Statistics Agency (ZIMSTAT)], 2012, ZIMB DEM HLTH SURV 2; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Justman JE, 2009, JAIDS-J ACQ IMM DEF, V52, pS30, DOI 10.1097/QAI.0b013e3181bbc9f5; Marinucci F, 2011, CYTOM PART A, V79A, P368, DOI 10.1002/cyto.a.21064; Ministry of Health and Child Care Zimbabwe, 2013, GUID ANT THER PREV T; Ministry of Health and Child Welfare of Zimbabwe, 2010, GUID ANT THER ZIMB; Muchedzi A, 2012, 19 INT AIDS C; Mwaba P, 2003, LANCET, V362, P2067, DOI 10.1016/S0140-6736(03)15103-3; Ohl M, 2013, AIDS BEHAV, V17, P250, DOI 10.1007/s10461-011-0107-8; Peter T, 2008, CYTOM PART B-CLIN CY, V74B, pS123, DOI 10.1002/cyto.b.20416; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Schacht CD, 2012, 19 INT AIDS C; Setty MKHG, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/497046; Shott JP, 2008, CLIN VACCINE IMMUNOL, V15, P1623, DOI 10.1128/CVI.00176-08; Sieleunou I, 2009, TROP MED INT HEALTH, V14, P36, DOI 10.1111/j.1365-3156.2008.02183.x; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Stevens WS, 2010, J INFECT DIS, V201, pS16, DOI 10.1086/650392; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; Weis KE, 2010, J RURAL HEALTH, V26, P105, DOI 10.1111/j.1748-0361.2010.00271.x; Wilson LE, 2011, AIDS CARE, V23, P971, DOI 10.1080/09540121.2010.543878; Wools-Kaloustian Kara, 2006, Curr HIV/AIDS Rep, V3, P182, DOI 10.1007/s11904-006-0014-1; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Yao J, 2014, HEALTH PLACE, V28, P133, DOI 10.1016/j.healthplace.2014.04.007; Zimbabwe National Statistics Agency, 2012, ZIMB NAT POP CENS 20	41	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129166	10.1371/journal.pone.0129166	http://dx.doi.org/10.1371/journal.pone.0129166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NS	26083342	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400083
J	Wijarnpreecha, K; Siri-Angkul, N; Shinlapawittayatorn, K; Charoenkwan, P; Silvilairat, S; Siwasomboon, C; Visarutratna, P; Srichairatanakool, S; Tantiworawit, A; Phrommintikul, A; Chattipakorn, SC; Chattipakorn, N				Wijarnpreecha, Karn; Siri-Angkul, Natthaphat; Shinlapawittayatorn, Krekwit; Charoenkwan, Pimlak; Silvilairat, Suchaya; Siwasomboon, Chate; Visarutratna, Pannee; Srichairatanakool, Somdet; Tantiworawit, Adisak; Phrommintikul, Arintaya; Chattipakorn, Siriporn C.; Chattipakorn, Nipon			Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients	PLOS ONE			English	Article							TRANSFERRIN-BOUND IRON; LABILE PLASMA IRON; OXIDATIVE STRESS; OVERLOAD CARDIOMYOPATHY; MAGNETIC-RESONANCE; CHELATION-THERAPY; SERUM FERRITIN; RISK; PATHOPHYSIOLOGY; METABOLISM	Background Iron-overload cardiomyopathy is a major cause of death in thalassemia patients due to the lack of an early detection strategy. Although cardiac magnetic resonance (CMR) T2* is used for early detection of cardiac iron accumulation, its availability is limited. Heart rate variability (HRV) has been used to evaluate cardiac autonomic function and found to be depressed in thalassemia. However, its direct correlation with cardiac iron accumulation has never been investigated. We investigated whether HRV can be used as an alternative indicator for early identification of cardiac iron deposition in thalassemia patients. Methods Ninety-nine non-transfusion dependent thalassemia patients (23.00 (17.00, 32.75) years, 35 male) were enrolled. The correlation between HRV recorded using 24-hour Holter monitoring and non-transferrin bound iron (NTBI), hemoglobin (Hb), serum ferritin, LV ejection fraction (LVEF), and CMR-T2* were determined. Results The median NTBI value was 3.15 (1.11, 6.59) mu M. Both time and frequency domains of HRV showed a significant correlation with the NTBI level, supporting HRV as a marker of iron overload. Moreover, the LF/HF ratio showed a significant correlation with CMR-T2* with the receiver operating characteristic (ROC) curve of 0.684 +/- 0.063, suggesting that it could represent the cardiac iron deposit in thalassemia patients. HRV was also significantly correlated with serum ferritin and Hb. Conclusions This novel finding regarding the correlation between HRV and CMR-T2* indicates that HRV could be a potential marker in identifying early cardiac iron deposition prior to the development of LV dysfunction, and may be used as an alternative to CMR-T2* for screening cardiac iron status in thalassemia patients.	[Wijarnpreecha, Karn; Siri-Angkul, Natthaphat; Shinlapawittayatorn, Krekwit; Chattipakorn, Siriporn C.; Chattipakorn, Nipon] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand; [Wijarnpreecha, Karn; Siri-Angkul, Natthaphat; Shinlapawittayatorn, Krekwit; Chattipakorn, Nipon] Chiang Mai Univ, Fac Med, Dept Physiol, Cardiac Electrophysiol Unit, Chiang Mai 50000, Thailand; [Wijarnpreecha, Karn; Siri-Angkul, Natthaphat; Shinlapawittayatorn, Krekwit; Charoenkwan, Pimlak; Silvilairat, Suchaya; Chattipakorn, Siriporn C.; Chattipakorn, Nipon] Chiang Mai Univ, Ctr Excellence Cardiac Elect, Chiang Mai 50000, Thailand; [Charoenkwan, Pimlak; Silvilairat, Suchaya] Chiang Mai Univ, Fac Med, Dept Pediat, Chiang Mai 50000, Thailand; [Siwasomboon, Chate; Visarutratna, Pannee] Chiang Mai Univ, Fac Med, Dept Radiol, Chiang Mai 50000, Thailand; [Srichairatanakool, Somdet] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50000, Thailand; [Tantiworawit, Adisak; Phrommintikul, Arintaya] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50000, Thailand; [Chattipakorn, Siriporn C.] Chiang Mai Univ, Fac Med, Dept Oral Biol & Diagnost Sci, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Chattipakorn, N (corresponding author), Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand.	nchattip@gmail.com	Phrommintikul, Arintaya/X-1881-2019; Charoenkwan, Pimlak/AAP-5905-2021; Charoenkwan, Pimlak/AGL-9582-2022; Shinlapawittayatorn, Krekwit/AAW-2698-2021; Chattipakorn, Nipon/AAJ-4049-2021	Phrommintikul, Arintaya/0000-0003-3986-1951; Charoenkwan, Pimlak/0000-0002-9123-9177; Siri-Angkul, Natthaphat/0000-0002-2776-3759; Chattipakorn, Nipon/0000-0003-3026-718X; Srichairatanakool, Somdet/0000-0002-5706-8781; tantiworawit, adisak/0000-0002-2381-9292; Wijarnpreecha, Karn/0000-0002-6232-6343; Shinlapawittayatorn, Krekwit/0000-0003-1114-0087	National Science and Technology Development Agency; Faculty of Medicine Endowment Fund; Thailand Research Fund [BRG5780016, RSA5780040]; Chiang Mai University Center of Excellence Award	National Science and Technology Development Agency; Faculty of Medicine Endowment Fund; Thailand Research Fund(Thailand Research Fund (TRF)); Chiang Mai University Center of Excellence Award	A Research Chair Grant from the National Science and Technology Development Agency (NC), Faculty of Medicine Endowment Fund (PC and NC), Thailand Research Fund BRG5780016 (SCC) and RSA5780040 (AP) and the Chiang Mai University Center of Excellence Award (NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aessopos A, 2005, CHEST, V127, P1523, DOI 10.1378/chest.127.5.1523; Alp A, 2014, CARDIOL YOUNG, V24, P263, DOI 10.1017/S1047951113000036; ALREFAIE FN, 1992, BRIT J HAEMATOL, V82, P431, DOI 10.1111/j.1365-2141.1992.tb06441.x; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Apaijai N, 2013, BRIT J PHARMACOL, V169, P1048, DOI 10.1111/bph.12176; Apaijai N, 2012, ENDOCRINOLOGY, V153, P3878, DOI 10.1210/en.2012-1262; Bartfay W J, 2000, Biol Res Nurs, V2, P49, DOI 10.1177/109980040000200106; Berdoukas V, 2005, HAEMATOLOGICA, V90, P685; Blackmore S, 2008, CLIN CHEM LAB MED, V46, P1450, DOI 10.1515/CCLM.2008.304; Borgna-Pignatti C, 2014, BRIT J HAEMATOL, V164, P579, DOI 10.1111/bjh.12643; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; Cabantchik ZI, 2005, BEST PRACT RES CL HA, V18, P277, DOI 10.1016/j.beha.2004.10.003; Camm AJ, 1996, EUR HEART J, V17, P354; Campos C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/218749; Cappellini Maria Domenica, 2000, Transfusion Science, V23, P245; Cavallaro L, 1993, Minerva Cardioangiol, V41, P297; Chansiw N, 2014, ASIAN PAC J TROP MED, V7, pS155, DOI 10.1016/S1995-7645(14)60223-6; Chuang HC, 2013, TOXICOL APPL PHARM, V266, P298, DOI 10.1016/j.taap.2012.11.006; Davis BA, 2000, BLOOD, V95, P1229, DOI 10.1182/blood.V95.4.1229.004k32_1229_1236; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; FIORELLI G, 1990, HAEMATOLOGICA, V75, P89; FITCHETT DH, 1980, CARDIOVASC RES, V14, P719, DOI 10.1093/cvr/14.12.719; Fronzoni F, 2004, HAEMATOLOGICA, V89, P233; Gao XS, 2009, J BIOL CHEM, V284, P4767, DOI 10.1074/jbc.M806235200; Gujja P, 2010, J AM COLL CARDIOL, V56, P1001, DOI 10.1016/j.jacc.2010.03.083; Gurses D, 2005, ACTA CARDIOL, V60, P477, DOI 10.2143/AC.60.5.2004967; Harris PRE, 2014, NEUROPSYCH DIS TREAT, V10, P1335, DOI 10.2147/NDT.S57523; Hershko C, 1998, ANN NY ACAD SCI, V850, P191, DOI 10.1111/j.1749-6632.1998.tb10475.x; Horwitz LD, 1999, VASC MED, V4, P93, DOI 10.1191/135886399676588477; Incharoen T, 2007, INT J CARDIOL, V121, P203, DOI 10.1016/j.ijcard.2006.08.076; KALTWASSER JP, 1980, DEUT MED WOCHENSCHR, V105, P319, DOI 10.1055/s-2008-1070657; Kardelen F, 2008, PEDIATR CARDIOL, V29, P935, DOI 10.1007/s00246-008-9240-1; Koonrungsesomboon N, 2013, WORLD J CARDIOL, V5, P270, DOI 10.4330/wjc.v5.i8.270; Kremastinos DT, 2010, CIRC-HEART FAIL, V3, P451, DOI 10.1161/CIRCHEARTFAILURE.109.913863; Kumfu S, 2012, EUR J HAEMATOL, V88, P535, DOI 10.1111/j.1600-0609.2012.01779.x; La Rovere MT, 2001, CIRCULATION, V103, P2072; Lee MS, 2014, INT J CARDIOL, V176, P166, DOI 10.1016/j.ijcard.2014.07.012; Lekawanvijit S, 2009, CAN J CARDIOL, V25, P213, DOI 10.1016/S0828-282X(09)70064-9; Maakaron Joseph E, 2013, J Med Liban, V61, P175; Maas Roderick P P W M, 2013, Ned Tijdschr Geneeskd, V157, pA6258; Malfitano C, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0131-x; Malliani Alberto, 2005, Eur J Intern Med, V16, P12, DOI 10.1016/j.ejim.2004.06.016; Murphy CJ, 2010, J CARD FAIL, V16, P888, DOI 10.1016/j.cardfail.2010.05.009; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; OLIVIERI NF, 1995, NEW ENGL J MED, V332, P918, DOI 10.1056/NEJM199504063321404; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Pavithran P, 2008, CLIN EXP HYPERTENS, V30, P486, DOI 10.1080/10641960802251875; Piga A, 2009, AM J HEMATOL, V84, P29, DOI 10.1002/ajh.21317; Piperno A, 1998, HAEMATOLOGICA, V83, P447; PIPPARD MJ, 1979, LANCET, V2, P819; Porter JB, 2014, HEMATOL ONCOL CLIN N, V28, P683, DOI 10.1016/j.hoc.2014.04.003; Rutjanaprom W, 2009, EUR J HAEMATOL, V83, P483, DOI 10.1111/j.1600-0609.2009.01314.x; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Shabanian R, 2010, PEDIATR CARDIOL, V31, P680, DOI 10.1007/s00246-010-9693-x; Shander A, 2009, VOX SANG, V97, P185, DOI 10.1111/j.1423-0410.2009.01207.x; SINGH S, 1990, ANAL BIOCHEM, V186, P320, DOI 10.1016/0003-2697(90)90088-Q; Supakul L, 2014, EUR J NUTR, V53, P919, DOI 10.1007/s00394-013-0595-6; Taher A., 2013, GUIDELINES MANAGEMEN; Taher A, 2008, HAEMATOL-HEMATOL J, V93, P1584, DOI 10.3324/haematol.13098; Taher A, 2009, BRIT J HAEMATOL, V146, P569, DOI 10.1111/j.1365-2141.2009.07810.x; Tanner MA, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-12; Thiyagarajan R, 2013, AM J HYPERTENS, V26, P850, DOI 10.1093/ajh/hpt025; Weatherall DJ, 2012, BLOOD REV, V26, pS3, DOI 10.1016/S0268-960X(12)70003-6; Wijarnpreecha K, 2015, HEMOGLOBIN, V39, P9, DOI 10.3109/03630269.2014.987869; Wood JC, 2005, ANN NY ACAD SCI, V1054, P386, DOI 10.1196/annals.1345.047; Yetimakman AF, 2014, PEDIATR HEMAT ONCOL, V31, P597, DOI 10.3109/08880018.2014.891681	70	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130837	10.1371/journal.pone.0130837	http://dx.doi.org/10.1371/journal.pone.0130837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083259	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400162
J	Malik, FA; Meissner, A; Semenkov, I; Molinski, S; Pasyk, S; Ahmadi, S; Bui, HH; Bear, CE; Lidington, D; Bolz, SS				Malik, Firhan A.; Meissner, Anja; Semenkov, Illya; Molinski, Steven; Pasyk, Stan; Ahmadi, Saumel; Bui, Hai H.; Bear, Christine E.; Lidington, Darcy; Bolz, Steffen-Sebastian			Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SMALL-MOLECULE MODULATOR; HEART-FAILURE; R-DOMAIN; DELTA-F508-CFTR TRAFFICKING; MYOGENIC RESPONSIVENESS; ENDOTHELIAL-CELLS; CHLORIDE CHANNEL; MOUSE MODEL; PHOSPHORYLATION	The cystic fibrosis transmembrane conductance regulator (CFTR) attenuates sphingosine-1-phosphate (S1P) signaling in resistance arteries and has emerged as a prominent regulator of myogenic vasoconstriction. This investigation demonstrates that S1P inhibits CFTR activity via adenosine monophosphate-activated kinase (AMPK), establishing a potential feedback link. In Baby Hamster Kidney (BHK) cells expressing wild-type human CFTR, S1P (1 mu mol/L) attenuates forskolin-stimulated, CFTR-dependent iodide efflux. S1P's inhibitory effect is rapid (within 30 seconds), transient and correlates with CFTR serine residue 737 (S737) phosphorylation. Both S1P receptor antagonism (4 mu mol/L VPC 23019) and AMPK inhibition (80 mu mol/L Compound C or AMPK siRNA) attenuate S1P-stimluated (i) AMPK phosphorylation, (ii) CFTR S737 phosphorylation and (iii) CFTR activity inhibition. In BHK cells expressing the Delta F508 CFTR mutant (CFTR Delta F508), the most common mutation causing cystic fibrosis, both S1P receptor antagonism and AMPK inhibition enhance CFTR activity, without instigating discernable correction. In summary, we demonstrate that S1P/AMPK signaling transiently attenuates CFTR activity. Since our previous work positions CFTR as a negative S1P signaling regulator, this signaling link may positively reinforce S1P signals. This discovery has clinical ramifications for the treatment of disease states associated with enhanced S1P signaling and/or deficient CFTR activity (e.g. cystic fibrosis, heart failure). S1P receptor/AMPK inhibition could synergistically enhance the efficacy of therapeutic strategies aiming to correct aberrant CFTR trafficking.	[Malik, Firhan A.; Meissner, Anja; Semenkov, Illya; Ahmadi, Saumel; Bear, Christine E.; Lidington, Darcy; Bolz, Steffen-Sebastian] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Meissner, Anja] Inst Invest Biomed August Pi I Sunyer IDIBAPS, Dept Brain Ischemia & Neurodegenerat, Barcelona 08036, Spain; [Molinski, Steven; Pasyk, Stan; Bear, Christine E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Molinski, Steven; Pasyk, Stan; Ahmadi, Saumel; Bear, Christine E.] Hosp Sick Children, Programme Mol Struct & Funct, Res Inst, Toronto, ON MG5 1X8, Canada; [Bui, Hai H.] Lilly Res Labs, Indianapolis, IN 46285 USA; [Lidington, Darcy; Bolz, Steffen-Sebastian] Univ Toronto, Toronto Ctr Microvasc Med, Toronto, ON M5B 1T8, Canada; [Lidington, Darcy; Bolz, Steffen-Sebastian] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1T8, Canada; [Bolz, Steffen-Sebastian] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON M5S 3E2, Canada	University of Toronto; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Eli Lilly; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Bolz, SS (corresponding author), Univ Toronto, Dept Physiol, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	sts.bolz@utoronto.ca	Meissner, Anja/M-7666-2014; Ahmadi, Saumel/O-3570-2018; Molinski, Steven V/J-9509-2015	Meissner, Anja/0000-0002-0793-7213; Ahmadi, Saumel/0000-0002-5800-6945; Lidington, Darcy/0000-0001-7582-7924; Molinski, Steven/0000-0001-9215-8232	Heart and Stroke Foundation of Ontario [G13-0002610]; University of Toronto Research Funding; Heart and Stroke Foundation of Ontario Career Investigator Award [CI-7432]; HSFO [NIA-6581]; Natural Sciences and Engineering Research Council of Canada; Eli Lilly and Company	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); University of Toronto Research Funding; Heart and Stroke Foundation of Ontario Career Investigator Award(Heart & Stroke Foundation of Ontario); HSFO; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Eli Lilly and Company(Eli Lilly)	Operating Funding: Heart and Stroke Foundation of Ontario Grant in Aid G13-0002610 (Operating Grant to Steffen-Sebastian Bolz). University of Toronto Research Funding (Operations Funding provided to Steffen-Sebastian Bolz). Stipend Support: Heart and Stroke Foundation of Ontario Career Investigator Award CI-7432 (Stipend Support to Steffen-Sebastian Bolz). This work is also supported by HSFO New Investigator (SSB, NIA-6581) and the Natural Sciences and Engineering Research Council of Canada PGS-D Doctoral Scholarship (Stipend Support to Firhan A Malik). The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the publication. Eli Lilly and Company provided support in the form of salaries for authors [HBH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Bigaud M, 2014, BBA-MOL CELL BIOL L, V1841, P745, DOI 10.1016/j.bbalip.2013.11.001; Bolz SS, 2003, CIRCULATION, V108, P342, DOI 10.1161/01.CIR.0000080324.12530.0D; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; DALEMANS W, 1992, EXP CELL RES, V201, P235, DOI 10.1016/0014-4827(92)90368-I; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hoefer J, 2010, CIRC RES, V107, P923, DOI 10.1161/CIRCRESAHA.110.226464; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Lidington D, 2013, CARDIOVASC RES, V97, P404, DOI 10.1093/cvr/cvs345; Lidington D, 2009, ARTERIOSCL THROM VAS, V29, P1916, DOI 10.1161/ATVBAHA.109.194803; Lim M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035177; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Luz S, 2014, J BIOL CHEM, V289, P15080, DOI 10.1074/jbc.M114.563742; Meissner A, 2012, CIRCULATION, V125, P2739, DOI 10.1161/CIRCULATIONAHA.111.047316; Pasyk S, 2015, PROTEOMICS, V15, P447, DOI 10.1002/pmic.201400218; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Schmidt A, 2008, BRIT J PHARMACOL, V153, P1311, DOI 10.1038/sj.bjp.0707663; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Yang JL, 2012, CIRCULATION, V126, P196, DOI 10.1161/CIRCULATIONAHA.111.039644; Yatomi Y, 1997, J BIOCHEM, V121, P969; Yu W, 2011, J BIOL CHEM, V286, P24714, DOI 10.1074/jbc.M111.239699	40	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130313	10.1371/journal.pone.0130313	http://dx.doi.org/10.1371/journal.pone.0130313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079370	Green Submitted, gold, Green Published			2022-12-26	WOS:000356542300042
J	Cabana-Munoz, ME; Parmigiani-Izquierdo, JM; Bravo-Gonzalez, LA; Kyung, HM; Merino, JJ				Eugenia Cabana-Munoz, Maria; Maria Parmigiani-Izquierdo, Jose; Alberto Bravo-Gonzalez, Luis; Kyung, Hee-Moon; Joaquin Merino, Jose			Increased Zn/Glutathione Levels and Higher Superoxide Dismutase-1 Activity as Biomarkers of Oxidative Stress in Women with Long-Term Dental Amalgam Fillings: Correlation between Mercury/Aluminium Levels (in Hair) and Antioxidant Systems in Plasma	PLOS ONE			English	Article							MERCURY EXPOSURE; CORTICAL-NEURONS; GENE-EXPRESSION; IN-VITRO; METHYLMERCURY; GLUTATHIONE; BLOOD; METALLOTHIONEIN; POLYMORPHISMS; CONTAMINATION	Background The induction of oxidative stress by Hg can affect antioxidant enzymes. However, epidemiological studies have failed to establish clear association between dental fillings presence and health problems. Objectives To determine whether heavy metals (in hair), antioxidant enzymes (SOD-1) and glutathione levels could be affected by the chronic presence of heavy metals in women who had dental amalgam fillings. Materials and Methods 55 hair samples (42 females with amalgam fillings and 13 female control subjects) were obtained. All subjects (mean age 44 years) who had dental amalgam filling for more than 10 years (average 15 years). Certain metals were quantified by ICP-MS (Mass Spectrophotometry) in hair (mu g/g: Al, Hg, Ba, Ag, Sb, As, Be, Bi, Cd, Pb, Pt, Tl, Th, U, Ni, Sn, Ti) and SOD-1 and Glutathione (reduced form) levels in plasma. Data were compared with controls without amalgams, and analyzed to identify any significant relation between metals and the total number of amalgam fillings, comparing those with four or less (n = 27) with those with more than four (n = 15). As no significant differences were detected, the two groups were pooled (Amlgam; n = 42). Findings Hg, Ag, Al and Ba were higher in the amalgam group but without significant differences for most of the heavy metals analyzed. Increased SOD-1 activity and glutathione levels (reduced form) were observed in the amalgam group. Aluminum (Al) correlated with glutathione levels while Hg levels correlated with SOD-1. The observed Al/glutathione and Hg/SOD-1 correlation could be adaptive responses against the chronic presence of mercury. Conclusions Hg, Ag, Al and Ba levels increased in women who had dental amalgam fillings for long periods. Al correlated with glutathione, and Hg with SOD-1. SOD-1 may be a possible biomarker for assessing chronic Hg toxicity.	[Eugenia Cabana-Munoz, Maria; Maria Parmigiani-Izquierdo, Jose] Ctr CIROM, Murcia, Spain; [Eugenia Cabana-Munoz, Maria; Alberto Bravo-Gonzalez, Luis] Univ Murcia, Fac Med, Unidad Docente Ortodoncia, Murcia, Spain; [Kyung, Hee-Moon] Kyungpook Nacl Univ, Sch Dent, Dept Orthodont, Daegu, South Korea; [Joaquin Merino, Jose] Univ Complutense Madrid, IUIN, Inst Invest Neuroquim, Madrid, Spain	University of Murcia; Complutense University of Madrid	Merino, JJ (corresponding author), Univ Complutense Madrid, IUIN, Inst Invest Neuroquim, Madrid, Spain.	mecjj@clinicacirom.com; josem2005@yahoo.es	BRAVO-GONZÁLEZ, LUIS-ALBERTO/S-5963-2016	BRAVO-GONZÁLEZ, LUIS-ALBERTO/0000-0002-5141-4145	Maria Eugenia Cabana (CIROM Clinic (Murcia, Spain)	Maria Eugenia Cabana (CIROM Clinic (Murcia, Spain)	This study has been supported by own findings from Maria Eugenia Cabana (CIROM Clinic (Murcia, Spain; personnal money). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarve TD, 2013, GENET MOL RES, V12, P5134, DOI 10.4238/2013.October.29.7; Ariza ME, 1998, ENVIRON MOL MUTAGEN, V31, P352, DOI 10.1002/(SICI)1098-2280(1998)31:4<352::AID-EM8>3.0.CO;2-K; Babi D, 2000, SCI TOTAL ENVIRON, V259, P55, DOI 10.1016/S0048-9697(00)00549-0; BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9; Bellinger DC, 2006, JAMA-J AM MED ASSOC, V15, P1775; DIERICKX PJ, 1985, PHARMACOL RES COMMUN, V17, P489, DOI 10.1016/0031-6989(85)90084-0; Dziegielewska-Gesiak S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/987303; Farina M, 2011, TOXICOL APPL PHARM, V256, P405, DOI 10.1016/j.taap.2011.05.001; Geier DA, 2011, BIOMETALS, V24, P215, DOI 10.1007/s10534-010-9387-0; Gibson LA, 2014, ECOTOXICOLOGY, V23, P1004, DOI 10.1007/s10646-014-1243-5; Grotto D, 2010, SCI TOTAL ENVIRON, V408, P806, DOI 10.1016/j.scitotenv.2009.10.053; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Homme KG, 2014, BIOMETALS, V27, P19, DOI 10.1007/s10534-013-9700-9; Hussain S, 1999, J ENVIRON SCI HEAL B, V34, P645, DOI 10.1080/03601239909373219; Jenko K, 2012, ENVIRON TOXICOL CHEM, V31, P2588, DOI 10.1002/etc.1985; Merino JJ, 2014, INT J MOL SCI, V15, P2475, DOI 10.3390/ijms15022475; Jones L, 2007, HUM EXP TOXICOL, V26, P367, DOI 10.1177/0960327107076824; Khwaja Mahmood A., 2014, Reviews on Environmental Health, V29, P29, DOI 10.1515/reveh-2014-0010; Kim M, 2013, ENVIRON MONIT ASSESS, V185, P2221, DOI 10.1007/s10661-012-2703-0; Lopez E, 2006, FREE RADICAL BIO MED, V40, P940, DOI 10.1016/j.freeradbiomed.2005.10.062; Makhija SK, 2011, J AM DENT ASSOC, V142, P622, DOI 10.14219/jada.archive.2011.0244; Marques RC, 2014, ENVIRON POLLUT, V187, P130, DOI 10.1016/j.envpol.2014.01.004; Barcelos GRM, 2013, SCI TOTAL ENVIRON, V463, P319, DOI 10.1016/j.scitotenv.2013.06.029; Mortazavi SMJ, 2014, INT J OCCUP ENV MED, V5, P101; Mutter J, 2004, INT J HYG ENVIR HEAL, V207, P391, DOI 10.1078/1438-4639-00305; Mutter J, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-2; Naganuma A, 1998, LIFE SCI, V62, pPL157, DOI 10.1016/S0024-3205(98)00037-X; Nedd S, 2014, J MOL BIOL, V426, P4112, DOI 10.1016/j.jmb.2014.07.016; Okati N, 2012, BIOL TRACE ELEM RES, V149, P155, DOI 10.1007/s12011-012-9424-7; Park Jung-Duck, 2012, J Prev Med Public Health, V45, P344, DOI 10.3961/jpmph.2012.45.6.344; Pigatto PD, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/356235; Puchyr RF, 1998, BIOL TRACE ELEM RES, V62, P167, DOI 10.1007/BF02783969; Richardson GM, 2011, SCI TOTAL ENVIRON, V409, P4257, DOI 10.1016/j.scitotenv.2011.06.035; Saghiri MA, 2014, J TRACE ELEM MED BIO, V28, P200, DOI 10.1016/j.jtemb.2014.01.008; Shraim A, 2011, CHEMOSPHERE, V84, P1133, DOI 10.1016/j.chemosphere.2011.04.034; Soussa E, 2013, ARCH ORAL BIOL, V58, P981, DOI 10.1016/j.archoralbio.2013.03.012; Tiwari V, 2013, NEUROCHEM INT, V62, P861, DOI 10.1016/j.neuint.2013.02.012; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Woods JS, 2013, NEUROTOXICOL TERATOL, V39, P36, DOI 10.1016/j.ntt.2013.06.004	39	7	7	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0126339	10.1371/journal.pone.0126339	http://dx.doi.org/10.1371/journal.pone.0126339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076368	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900006
J	Durham, TB; Toth, JL; Klimkowski, VJ; Cao, JXC; Siesky, AM; Alexander-Chacko, J; Wu, GY; Dixon, JT; Mcgee, JE; Wang, Y; Guo, SY; Cavitt, RN; Schindler, J; Thibodeaux, SJ; Calvert, NA; Coghlan, MJ; Sindelar, DK; Christe, M; Kiselyov, VV; Michael, MD; Sloop, KW				Durham, Timothy B.; Toth, James L.; Klimkowski, Valentine J.; Cao, Julia X. C.; Siesky, Angela M.; Alexander-Chacko, Jesline; Wu, Ginger Y.; Dixon, Jeffrey T.; Mcgee, James E.; Wang, Yong; Guo, Sherry Y.; Cavitt, Rachel Nicole; Schindler, John; Thibodeaux, Stefan J.; Calvert, Nathan A.; Coghlan, Michael J.; Sindelar, Dana K.; Christe, Michael; Kiselyov, Vladislav V.; Michael, M. Dodson; Sloop, Kyle W.			Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE; IDE; PEPTIDE; SOMATOSTATIN; DEGRADATION; METABOLISM; SECRETION; RECOGNITION; PATHWAYS; PROTEIN	Insulin-degrading enzyme (IDE, insulysin) is the best characterized catabolic enzyme implicated in proteolysis of insulin. Recently, a peptide inhibitor of IDE has been shown to affect levels of insulin, amylin, and glucagon in vivo. However, IDE-/- mice display variable phenotypes relating to fasting plasma insulin levels, glucose tolerance, and insulin sensitivity depending on the cohort and age of animals. Here, we interrogated the importance of IDE-mediated catabolism on insulin clearance in vivo. Using a structure-based design, we linked two newly identified ligands binding at unique IDE exosites together to construct a potent series of novel inhibitors. These compounds do not interact with the catalytic zinc of the protease. Because one of these inhibitors (NTE-1) was determined to have pharmacokinetic properties sufficient to sustain plasma levels >50 times its IDE IC50 value, studies in rodents were conducted. In oral glucose tolerance tests with diet-induced obese mice, NTE-1 treatment improved the glucose excursion. Yet in insulin tolerance tests and euglycemic clamp experiments, NTE-1 did not enhance insulin action or increase plasma insulin levels. Importantly, IDE inhibition with NTE-1 did result in elevated plasma amylin levels, suggesting the in vivo role of IDE action on amylin may be more significant than an effect on insulin. Furthermore, using the inhibitors described in this report, we demonstrate that in HEK cells IDE has little impact on insulin clearance. In total, evidence from our studies supports a minimal role for IDE in insulin metabolism in vivo and suggests IDE may be more important in helping regulate amylin clearance.	[Durham, Timothy B.; Toth, James L.; Klimkowski, Valentine J.; Dixon, Jeffrey T.; Mcgee, James E.; Wang, Yong; Guo, Sherry Y.; Cavitt, Rachel Nicole; Schindler, John; Coghlan, Michael J.] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA; [Cao, Julia X. C.; Siesky, Angela M.; Alexander-Chacko, Jesline; Wu, Ginger Y.; Sindelar, Dana K.; Christe, Michael; Kiselyov, Vladislav V.; Michael, M. Dodson; Sloop, Kyle W.] Eli Lilly & Co, Lilly Res Labs, Endocrine Discovery, Indianapolis, IN 46285 USA; [Thibodeaux, Stefan J.] Eli Lilly & Co, Lilly Res Labs, Translat Sci & Technol, Indianapolis, IN 46285 USA; [Calvert, Nathan A.] Eli Lilly & Co, Lilly Res Labs, Drug Disposit, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly	Durham, TB (corresponding author), Lilly Res Labs, Discovery Chem Res & Technol, Drop Code 1920, Indianapolis, IN 46285 USA.	durham_timothy_barrett@lilly.com		Michael, Mervyn/0000-0002-0224-1065				Abdul-Hay SO, 2013, J MED CHEM, V56, P2246, DOI 10.1021/jm301280p; Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; ALBERTI KGM, 1973, LANCET, V2, P1299; Amata O, 2009, J AM CHEM SOC, V131, P14804, DOI 10.1021/ja9037142; AUTHIER F, 1995, P NATL ACAD SCI USA, V92, P3859, DOI 10.1073/pnas.92.9.3859; Beck B., 2004, ASSAY GUIDANCE MANUA; Bennett RG, 1997, DIABETES, V46, P197, DOI 10.2337/diabetes.46.2.197; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; Cakir B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031787; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; Duckworth WC, 1997, BBA-MOL CELL RES, V1358, P163, DOI 10.1016/S0167-4889(97)00066-9; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; EFENDIC S, 1974, FEBS LETT, V42, P169, DOI 10.1016/0014-5793(74)80778-7; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fawcett J, 2010, BIOCHEM BIOPH RES CO, V402, P762, DOI 10.1016/j.bbrc.2010.10.104; GERICH JE, 1974, DIABETES, V23, P876, DOI 10.2337/diab.23.11.876; Godfrey A. G., 2011, 42 CENTR REG M AM CH; Grasso G, 2009, J MASS SPECTROM, V44, P735, DOI 10.1002/jms.1550; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; KOERKER DJ, 1974, SCIENCE, V184, P482, DOI 10.1126/science.184.4135.482; KUO WL, 1991, MOL ENDOCRINOL, V5, P1467, DOI 10.1210/mend-5-10-1467; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Liu ZH, 2012, J ALZHEIMERS DIS, V29, P329, DOI 10.3233/JAD-2011-111472; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; MCCLAIN DA, 1988, DIABETES, V37, P806, DOI 10.2337/diabetes.37.6.806; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; Morita M, 2000, CELL STRUCT FUNCT, V25, P309, DOI 10.1247/csf.25.309; MULLER D, 1991, EUR J BIOCHEM, V202, P285, DOI 10.1111/j.1432-1033.1991.tb16374.x; Noinaj N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020864; OZAKI S, 1983, ENDOCRINOLOGY, V112, P381, DOI 10.1210/endo-112-1-381; Pak S. C., 1998, P 15 ESACT M TOURS F, P59; Ralat LA, 2011, J MOL BIOL, V406, P454, DOI 10.1016/j.jmb.2010.12.026; Ralat LA, 2011, J BIOL CHEM, V286, P4670, DOI 10.1074/jbc.M110.173252; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2005, J BIOL CHEM, V280, P17701, DOI 10.1074/jbc.M501896200; Song ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046790; Song ES, 2006, BIOCHEMISTRY-US, V45, P15085, DOI 10.1021/bi061298u; Song ES, 2011, J BIOL CHEM, V286, P13852, DOI 10.1074/jbc.M110.191668; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Steneberg P, 2013, DIABETES, V62, P2004, DOI 10.2337/db12-1045; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; YONEZAWA K, 1988, BIOCHEM BIOPH RES CO, V150, P605, DOI 10.1016/0006-291X(88)90436-6; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	49	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20044	20059		10.1074/jbc.M115.638205	http://dx.doi.org/10.1074/jbc.M115.638205			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26085101	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000359608900004
J	Sasse, SK; Zuo, Z; Kadiyala, V; Zhang, LY; Pufall, MA; Jain, MK; Phang, TL; Stormo, GD; Gerber, AN				Sasse, Sarah K.; Zuo, Zheng; Kadiyala, Vineela; Zhang, Liyang; Pufall, Miles A.; Jain, Mukesh K.; Phang, Tzu L.; Stormo, Gary D.; Gerber, Anthony N.			Response Element Composition Governs Correlations between Binding Site Affinity and Transcription in Glucocorticoid Receptor Feed-forward Loops	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; DNA-BINDING; REGULATORY NETWORK; NUCLEAR RECEPTORS; CELL-TYPE; CHIP-SEQ; IN-VIVO; SEQUENCE; UNIT; SPECIFICITY	Combinatorial gene regulation through feed-forward loops (FFLs) can bestow specificity and temporal control to client gene expression; however, characteristics of binding sites that mediate these effects are not established. We previously showed that the glucocorticoid receptor (GR) and KLF15 form coherent FFLs that cooperatively induce targets such as the amino acid-metabolizing enzymes AASS and PRODH and incoherent FFLs exemplified by repression of MT2A by KLF15. Here, we demonstrate that GR and KLF15 physically interact and identify low affinity GR binding sites within glucocorticoid response elements (GREs) for PRODH and AASS that contribute to combinatorial regulation with KLF15. We used deep sequencing and electrophoretic mobility shift assays to derive in vitro GR binding affinities across sequence space. We applied these data to show that AASS GRE activity correlated (r(2) = 0.73) with predicted GR binding affinities across a 50-fold affinity range in transfection assays; however, the slope of the linear relationship more than doubled when KLF15 was expressed. Whereas activity of the MT2A GRE was even more strongly (r(2) = 0.89) correlated with GR binding site affinity, the slope of the linear relationship was sharply reduced by KLF15, consistent with incoherent FFL logic. Thus, GRE architecture and co-regulator expression together determine the functional parameters that relate GR binding site affinity to hormone-induced transcriptional responses. Utilization of specific affinity response functions and GR binding sites by FFLs may contribute to the diversity of gene expression patterns within GR-regulated transcriptomes.	[Sasse, Sarah K.; Kadiyala, Vineela; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Zuo, Zheng; Stormo, Gary D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [Zuo, Zheng; Stormo, Gary D.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Zhang, Liyang; Pufall, Miles A.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Harrington Heart & Vasc Inst, Dept Med, Cleveland, OH 44106 USA; [Phang, Tzu L.; Gerber, Anthony N.] Univ Colorado, Dept Med, Denver, CO 80045 USA	National Jewish Health; Washington University (WUSTL); Washington University (WUSTL); University of Iowa; Case Western Reserve University; Case Western Reserve University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gerber, AN (corresponding author), Natl Jewish Hlth, Dept Med, Rm K621,1400 Jackson St, Denver, CO 80206 USA.	gerbera@njhealth.org		Pufall, Miles/0000-0002-7022-6916	National Institutes of Health from the NCI [P30-CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109557] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007762] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ChIP-sequencing was performed at the University of Colorado Cancer Center, which is supported by National Institutes of Health Grant P30-CA046934 from the NCI. We thank David Granas for technical assistance. We thank Keith Yamamoto for the generous gift of the GR antibody and for critical review of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bain DL, 2012, J MOL BIOL, V422, P18, DOI 10.1016/j.jmb.2012.06.005; Chen SY, 2000, J BIOL CHEM, V275, P30106, DOI 10.1074/jbc.M005418200; Chinenov Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-656; Chinenov Y, 2013, MOL CELL ENDOCRINOL, V380, P55, DOI 10.1016/j.mce.2013.04.006; Chodankar R, 2014, P NATL ACAD SCI USA, V111, P4007, DOI 10.1073/pnas.1400522111; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; KLEMM DJ, 1990, MOL CELL BIOL, V10, P480, DOI 10.1128/MCB.10.2.480; LABAER J, 1994, J MOL BIOL, V239, P664, DOI 10.1006/jmbi.1994.1405; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liang K, 2012, BIOINFORMATICS, V28, P121, DOI 10.1093/bioinformatics/btr605; Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Miranda TB, 2013, MOL CELL ENDOCRINOL, V380, P16, DOI 10.1016/j.mce.2013.03.002; MITCHELL J, 1994, MOL ENDOCRINOL, V8, P585, DOI 10.1210/me.8.5.585; Noack C, 2012, EMBO MOL MED, V4, P992, DOI 10.1002/emmm.201101043; Pearce D, 1998, J BIOL CHEM, V273, P30081, DOI 10.1074/jbc.273.46.30081; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Quax RA, 2013, NAT REV ENDOCRINOL, V9, P670, DOI 10.1038/nrendo.2013.183; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sasse SK, 2015, PHARMACOL THERAPEUT, V145, P85, DOI 10.1016/j.pharmthera.2014.08.004; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Scott DK, 1998, MOL ENDOCRINOL, V12, P482, DOI 10.1210/me.12.4.482; Smith CL, 2000, MOL ENDOCRINOL, V14, P956, DOI 10.1210/me.14.7.956; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Stafford JM, 2001, J BIOL CHEM, V276, P39885, DOI 10.1074/jbc.M105370200; Starick SR, 2015, GENOME RES, V25, P825, DOI 10.1101/gr.185157.114; Stormo GD, 2015, BRIEF FUNCT GENOMICS, V14, P30, DOI 10.1093/bfgp/elu043; Stormo Gary D, 2013, Quant Biol, V1, P115; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Tang BH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00875; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Waterman WR, 2006, MOL IMMUNOL, V43, P773, DOI 10.1016/j.molimm.2005.07.003; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Werner T, 2000, Methods Mol Biol, V132, P337; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zuo Z, 2014, GENETICS, V198, P1329, DOI 10.1534/genetics.114.170100	58	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19756	19769		10.1074/jbc.M115.668558	http://dx.doi.org/10.1074/jbc.M115.668558			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088140	Green Published, hybrid			2022-12-26	WOS:000359364600033
J	Zhao, M; Li, XJ; Tang, ZM; Yang, F; Wang, SL; Cai, W; Zhang, K; Xia, NS; Zheng, ZZ				Zhao, Min; Li, Xiao-Jing; Tang, Zi-Min; Yang, Fan; Wang, Si-Ling; Cai, Wei; Zhang, Ke; Xia, Ning-Shao; Zheng, Zi-Zheng			A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMITTED NON-A; NON-B-HEPATITIS; MONOCLONAL-ANTIBODIES; ORF3 PROTEIN; CRYSTAL-STRUCTURE; PARTICLES; IDENTIFICATION; EPITOPES; RELEASE; EXPRESSION	The hepatitis E virus (HEV) ORF2 encodes a single structural capsid protein. The E2s domain (amino acids 459-606) of the capsid protein has been identified as the major immune target. All identified neutralizing epitopes are located on this domain; however, a comprehensive characterization of antigenic sites on the domain is lacking due to its high degree of conformation dependence. Here, we used the statistical software SPSS to analyze cELISA (competitive ELISA) data to classify monoclonal antibodies (mAbs), which recognized conformational epitopes on E2s domain. Using this novel analysis method, we identified various conformational mAbs that recognized the E2s domain. These mAbs were distributed into 6 independent groups, suggesting the presence of at least 6 epitopes. Twelve representative mAbs covering the six groups were selected as a tool box to further map functional antigenic sites on the E2s domain. By combining functional and location information of the 12 representative mAbs, this study provided a complete picture of potential neutralizing epitope regions and immune-dominant determinants on E2s domain. One epitope region is located on top of the E2s domain close to the monomerinterface; the other is located on the monomer side of the E2s dimer around the groove zone. Besides, two non-neutralizing epitopes were also identified on E2s domain that did not stimulate neutralizing antibodies. Our results help further the understanding of protective mechanisms induced by the HEV vaccine. Furthermore, the tool box with 12 representative mAbs will be useful for studying the HEV infection process.	[Zhao, Min; Li, Xiao-Jing; Cai, Wei; Xia, Ning-Shao] Xiamen Univ, State Key Lab Mol Vaccinol & Mol Diagnost, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Tang, Zi-Min; Yang, Fan; Wang, Si-Ling; Zhang, Ke; Xia, Ning-Shao; Zheng, Zi-Zheng] Xiamen Univ, Sch Publ Hlth, Xiamen 361005, Fujian, Peoples R China	Xiamen University; Xiamen University	Xia, NS (corresponding author), Xiamen Univ, State Key Lab Mol Vaccinol & Mol Diagnost, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	nsxia@xmu.edu.cn; zhengzizheng@xmu.edu.cn		Wang, Siling/0000-0001-5485-0818; Xia, Ningshao/0000-0003-0179-5266	Chinese National High-tech R&D Program (863 program) [2011AA02A101]; Xiamen Science and Technology Platform Project Grant [3502Z20131001]; Xiamen Science and Technology Plan Project Grant [3502Z201410045]	Chinese National High-tech R&D Program (863 program); Xiamen Science and Technology Platform Project Grant; Xiamen Science and Technology Plan Project Grant	This work was supported in part by Chinese National High-tech R&D Program (863 program) Grant 2011AA02A101, Xiamen Science and Technology Platform Project Grant 3502Z20131001, and Xiamen Science and Technology Plan Project Grant 3502Z201410045. The authors declare that they have no conflicts of interest with the contents of this article.	BRYAN JP, 1994, J INFECT DIS, V170, P517, DOI 10.1093/infdis/170.3.517; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Dong JH, 2011, P NATL ACAD SCI USA, V108, P12681, DOI 10.1073/pnas.1104834108; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; He JK, 2007, J BIOMED SCI, V14, P555, DOI 10.1007/s11373-007-9172-4; He SZ, 2008, J GEN VIROL, V89, P245, DOI 10.1099/vir.0.83308-0; Im SWK, 2001, VACCINE, V19, P3726, DOI 10.1016/S0264-410X(01)00100-1; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li SW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000537; Li SW, 2005, J BIOL CHEM, V280, P3400, DOI 10.1074/jbc.M410361200; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Li TC, 2005, J VIROL, V79, P12999, DOI 10.1128/JVI.79.20.12999-13006.2005; Meng JH, 2001, VIROLOGY, V288, P203, DOI 10.1006/viro.2001.1093; Mushahwar IK, 1996, EUR J GASTROEN HEPAT, V8, P312, DOI 10.1097/00042737-199604000-00004; Nagashima S, 2011, J GEN VIROL, V92, P2838, DOI 10.1099/vir.0.035378-0; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; PURDY MA, 1992, ARCH VIROL, V123, P335, DOI 10.1007/BF01317268; Reyes G R, 1993, Arch Virol Suppl, V7, P15; Reyes G R, 1993, Prog Liver Dis, V11, P203; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; REYES GR, 1991, GASTROENTEROL JPN, V26, P142; RH P., 2005, VIRAL HEPATITIS, V3rd, P635; Schofield DJ, 2000, J VIROL, V74, P5548, DOI 10.1128/JVI.74.12.5548-5555.2000; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Takahashi M, 2008, ARCH VIROL, V153, P1703, DOI 10.1007/s00705-008-0179-6; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Wei MX, 2014, VACCINE, V32, P2859, DOI 10.1016/j.vaccine.2014.02.025; World Health Organization South-East Asia Region, 2012, VIR HEP WHO S E AS R; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009; Xing L, 1999, VIROLOGY, V265, P35, DOI 10.1006/viro.1999.0005; Xing L, 2010, J BIOL CHEM, V285, P33175, DOI 10.1074/jbc.M110.106336; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhang J, 2005, VACCINE, V23, P2881, DOI 10.1016/j.vaccine.2004.11.065; Zhang J, 2012, REV MED VIROL, V22, P339, DOI 10.1002/rmv.1719; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	41	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19910	19922		10.1074/jbc.M115.649764	http://dx.doi.org/10.1074/jbc.M115.649764			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26085097	Green Published, hybrid			2022-12-26	WOS:000359364600046
J	Hawkins, LK; Mylroie, JE; Oliveira, DA; Smith, JS; Ozkan, S; Windham, GL; Williams, WP; Warburton, ML				Hawkins, Leigh K.; Mylroie, J. Erik; Oliveira, Dafne A.; Smith, J. Spencer; Ozkan, Seval; Windham, Gary L.; Williams, W. Paul; Warburton, Marilyn L.			Characterization of the Maize Chitinase Genes and Their Effect on Aspergillus flavus and Aflatoxin Accumulation Resistance	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DIFFERENTIAL EXPRESSION; CONTRIBUTING RESISTANCE; CHITINOLYTIC ENZYMES; PLANT CHITINASES; IDENTIFICATION; INFECTION; PROTEIN; FAMILY; POPULATION	Maize (Zea mays L.) is a crop of global importance, but prone to contamination by aflatoxins produced by fungi in the genus Aspergillus. The development of resistant germplasm and the identification of genes contributing to resistance would aid in the reduction of the problem with a minimal need for intervention by farmers. Chitinolytic enzymes respond to attack by potential pathogens and have been demonstrated to increase insect and fungal resistance in plants. Here, all chitinase genes in the maize genome were characterized via sequence diversity and expression patterns. Recent evolution within this gene family was noted. Markers from within each gene were developed and used to map the phenotypic effect on resistance of each gene in up to four QTL mapping populations and one association panel. Seven chitinase genes were identified that had alleles associated with increased resistance to aflatoxin accumulation and A. flavus infection in field grown maize. The chitinase in bin 1.05 identified a new and highly significant QTL, while chitinase genes in bins 2.04 and 5.03 fell directly beneath the peaks of previously published QTL. The expression patterns of these genes corroborate possible grain resistance mechanisms. Markers from within the gene sequences or very closely linked to them are presented to aid in the use of marker assisted selection to improve this trait.	[Hawkins, Leigh K.; Mylroie, J. Erik; Smith, J. Spencer; Windham, Gary L.; Williams, W. Paul; Warburton, Marilyn L.] USDA ARS, Corn Host Plant Resistance Res Unit, Mississippi State, MS 39762 USA; [Oliveira, Dafne A.; Ozkan, Seval] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Starkville, MS 39762 USA	Mississippi State University; United States Department of Agriculture (USDA); Mississippi State University	Hawkins, LK (corresponding author), USDA ARS, Corn Host Plant Resistance Res Unit, Mississippi State, MS 39762 USA.	Leigh.Hawkins@ars.usda.gov	Warburton, Marilyn/J-2250-2017	Warburton, Marilyn/0000-0002-9542-9912	USDA; USDA/USAID Feed the Future initiative project [58-0210-3-0012]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	USDA(United States Department of Agriculture (USDA)); USDA/USAID Feed the Future initiative project(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the USDA (http://www.ars.usda.gov/main/site_main.htm? modecode=64-06-15-05) and the joint USDA/USAID Feed the Future initiative project number 58-0210-3-0012 (www.usaid.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bekesiova B, 2008, MOL BIOL REP, V35, P579, DOI 10.1007/s11033-007-9127-x; Betran FJ, 2004, AGRON J, V96, P565, DOI 10.2134/agronj2004.0565; Boller T., 1987, PLANT MICROBE INTERA, V3, P385; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bravo JM, 2003, PLANT MOL BIOL, V52, P745, DOI 10.1023/A:1025016416951; Brooks TD, 2005, CROP SCI, V45, P171; Brown R L, 2006, Mycotoxin Res, V22, P22, DOI 10.1007/BF02954553; Castells M, 2008, INT J FOOD MICROBIOL, V123, P81, DOI 10.1016/j.ijfoodmicro.2007.12.001; Cletus J, 2013, BIOTECHNOL LETT, V35, P1719, DOI 10.1007/s10529-013-1269-4; Cleveland TE, 2003, PEST MANAG SCI, V59, P629, DOI 10.1002/ps.724; CORDERO MJ, 1994, MOL PLANT MICROBE IN, V7, P23, DOI 10.1094/MPMI-7-0023; Doerge RW, 1996, GENETICS, V142, P285; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Finn RD, 2013, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, DOI 10.1093/NAR/GKH121]; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Food and Agriculture Organization of the United Nations, 2004, 81 FAO UN; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Lawrence Carolyn J, 2008, Int J Plant Genomics, V2008, P496957, DOI 10.1155/2008/496957; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mideros SX, 2014, CROP SCI, V54, P127, DOI 10.2135/cropsci2013.04.0249; Monaco MK, 2014, PLANT GEN, DOI [10.3835/plantgenome2012.9.0025, DOI 10.3835/PLANTGENOME2012.9.0025]; Moore KG, 2004, PHYTOPATHOLOGY, V94, P82, DOI 10.1094/PHYTO.2004.94.1.82; Naumann TA, 2009, PHYSIOL MOL PLANT P, V74; Naumann TA, 2011, J BIOL CHEM, V286, P35358, DOI 10.1074/jbc.M111.279646; Naumann TA, 2010, PHYTOPATHOLOGY, V100, P645, DOI 10.1094/PHYTO-100-7-0645; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Peethambaran B, 2010, TOXIN REV, V29, P27, DOI 10.3109/15569540903402874; Pontius J., 2003, NCBI HDB, P1; Pritchard JK, 2000, GENETICS, V155, P945; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; SAS Institute Inc, 2009, BAS SAS 9 2 PROC GUI; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schnable J, QTELLER SIMPLE TOOL; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; SHAIKH SA, 1993, WORLD J MICROB BIOT, V9, P468, DOI 10.1007/BF00328035; Shoresh M, 2008, MOL GENET GENOMICS, V280, P173, DOI 10.1007/s00438-008-0354-1; Shoresh M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-136; Tiffin P, 2004, GENETICS, V167, P1331, DOI 10.1534/genetics.104.026856; United Stated Food and Drug Administration, 2008, MYC DOM IMP FOODS CP; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang Y, 2013, NUCLEIC ACIDS RES, V41, pD1159, DOI 10.1093/nar/gks1109; Warburton ML, 2013, CROP SCI, V53, P2374, DOI 10.2135/cropsci2012.10.0616; Warburton ML, 2011, TOXINS, V3, P754, DOI 10.3390/toxins3070754; Warburton ML, 2011, MOL BREEDING, V27, P491, DOI 10.1007/s11032-010-9446-9; Warburton ML, 2009, CROP SCI, V49, P1403, DOI 10.2135/cropsci2008.12.0696; Wessler S, 2009, MAIZE TRANSPOSABLE E; Willcox MC, 2013, MOL BREEDING, V32, P15, DOI 10.1007/s11032-012-9821-9; Windham GL, 1998, PLANT DIS, V82, P281, DOI 10.1094/PDIS.1998.82.3.281; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; WU SC, 1994, PLANT PHYSIOL, V105, P1097, DOI 10.1104/pp.105.4.1097; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZUMMO N, 1990, PLANT DIS, V74, P627, DOI 10.1094/PD-74-0627	60	35	38	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0126185	10.1371/journal.pone.0126185	http://dx.doi.org/10.1371/journal.pone.0126185			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090679	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000007
J	Lai, YH; Zhu, XS; Chen, YH; Li, YJ				Lai, Yinghui; Zhu, Xiaoshuang; Chen, Yinghe; Li, Yanjun			Effects of Mathematics Anxiety and Mathematical Metacognition on Word Problem Solving in Children with and without Mathematical Learning Difficulties	PLOS ONE			English	Article							MIDDLE SCHOOL STUDENTS; MATH SELF-CONCEPT; WORKING-MEMORY; STRATEGY-USE; DISABILITIES; ACHIEVEMENT; PERFORMANCE; EFFICACY; DEFICITS; REPRESENTATIONS	Mathematics is one of the most objective, logical, and practical academic disciplines. Yet, in addition to cognitive skills, mathematical problem solving also involves affective factors. In the current study, we first investigated effects of mathematics anxiety (MA) and mathematical metacognition on word problem solving (WPS). We tested 224 children (116 boys, M = 10.15 years old, SD = 0.56) with the Mathematics Anxiety Scale for Children, the Chinese Revised-edition Questionnaire of Pupil's Metacognitive Ability in Mathematics, and WPS tasks. The results indicated that mathematical metacognition mediated the effect of MA on WPS after controlling for IQ. Second, we divided the children into four mathematics achievement groups including high achieving (HA), typical achieving (TA), low achieving (LA), and mathematical learning difficulty (MLD). Because mathematical metacognition and MA predicted mathematics achievement, we compared group differences in metacognition and MA with IQ partialled out. The results showed that children with MLD scored lower in self-image and higher in learning mathematics anxiety (LMA) than the TA and HA children, but not in mathematical evaluation anxiety (MEA). MLD children's LMA was also higher than that of their LA counterparts. These results provide insight into factors that may mediate poor WPS performance which emerges under pressure in mathematics. These results also suggest that the anxiety during learning mathematics should be taken into account in mathematical learning difficulty interventions.	[Lai, Yinghui; Zhu, Xiaoshuang; Chen, Yinghe; Li, Yanjun] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China	Beijing Normal University	Chen, YH (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China.	chenyinghe@bnu.edu.cn	zhu, xiaoshuang/GYV-0942-2022		National Natural Science Foundation of China [31271106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work described in this paper was supported by grants from National Natural Science Foundation of China (31271106) (http://www.nsfc.gov.cn/nsfc/cen/2014sqsl/index.html).	Aarnos E, 2012, PROCD SOC BEHV, V46, P1495, DOI 10.1016/j.sbspro.2012.05.328; Ackerman PL, 2005, PSYCHOL BULL, V131, P30, DOI 10.1037/0033-2909.131.1.30; Ahmad A, 2010, PROCD SOC BEHV, V8, P356, DOI 10.1016/j.sbspro.2010.12.050; Ahmed W, 2010, J YOUTH ADOLESCENCE, V39, P36, DOI 10.1007/s10964-008-9367-7; Alikamar MA, 2013, EUROPEAN J CHILD DEV, V1, P125; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1997, MATH COGNITION, DOI [DOI 10.1080/135467997387443, 10.1080/135467997387443]; Ashcraft MH, 2009, J PSYCHOEDUC ASSESS, V27, P197, DOI 10.1177/0734282908330580; Ashcraft MH, 2002, CURR DIR PSYCHOL SCI, V11, P181, DOI 10.1111/1467-8721.00196; Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; Bandalos DL, 1995, J EDUC PSYCHOL, V87, P611, DOI 10.1037/0022-0663.87.4.611; BRYAN JH, 1983, LEARN DISABILITY Q, V6, P217, DOI 10.2307/1510800; Bryant DP, 2000, J LEARN DISABIL-US, V33, P168, DOI 10.1177/002221940003300205; CHIU LH, 1990, MEAS EVAL COUNS DEV, V23, P121; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Desoete A, 2004, J LEARN DISABIL-US, V37, P50, DOI 10.1177/00222194040370010601; Desoete A, 2001, J LEARN DISABIL-US, V34, P435, DOI 10.1177/002221940103400505; Desoete A, 2012, BRIT J EDUC PSYCHOL, V82, P64, DOI 10.1348/2044-8279.002002; EVERSON HT, 1994, ANXIETY STRESS COPIN, V7, P85, DOI 10.1080/10615809408248395; Flavell J.H., 1976, NATURE INTELLIGENCE, P231, DOI DOI 10.1038/HDY.1976.85; Fuchs LS, 2004, J LEARN DISABIL-US, V37, P293, DOI 10.1177/00222194040370040201; Furinghetti F, 2009, EDUC STUD MATH, V70, P71, DOI 10.1007/s10649-008-9134-4; Garrett Adia J, 2006, Learn Disabil Res Pract, V21, P77, DOI 10.1111/j.1540-5826.2006.00208.x; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; Geary DC, 2012, J EDUC PSYCHOL, V104, P206, DOI 10.1037/a0025398; Geary DC, 2011, J DEV BEHAV PEDIATR, V32, P250, DOI 10.1097/DBP.0b013e318209edef; Geary DC, 2011, J LEARN DISABIL; Geary DC, 2003, HDB LEARNING DISABIL, P199; Gold AB, 2013, CHILD NEUROPSYCHOL, V19, P420, DOI 10.1080/09297049.2012.690371; Gonzalez JEJ, 2002, LEARN DISABILITY Q, V25, P113, DOI 10.2307/1511278; GROLNICK WS, 1990, J LEARN DISABIL-US, V23, P177, DOI 10.1177/002221949002300308; Guven B, 2013, LEARN INDIVID DIFFER, V23, P131, DOI 10.1016/j.lindif.2012.10.003; Hannula MS., 2014, ENCY MATH ED, P23; Hao JJ., 2011, CHINESE J SPECIAL ED, V128, P52; Hoard MK, 2008, DEV NEUROPSYCHOL, V33, P251, DOI 10.1080/87565640801982338; Hoffman B, 2008, CONTEMP EDUC PSYCHOL, V33, P875, DOI 10.1016/j.cedpsych.2007.07.002; Hoffman B, 2010, LEARN INDIVID DIFFER, V20, P276, DOI 10.1016/j.lindif.2010.02.001; Jacobse AE, 2012, METACOGN LEARN, V7, P133, DOI 10.1007/s11409-012-9088-x; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jain S, 2009, CONTEMP EDUC PSYCHOL, V34, P240, DOI 10.1016/j.cedpsych.2009.05.004; Jansen BRJ, 2013, LEARN INDIVID DIFFER, V24, P190, DOI 10.1016/j.lindif.2012.12.014; Johnson ES, 2010, LEARN DISABILITY Q, V33, P3, DOI 10.1177/073194871003300101; Karimi A., 2009, INT J ED SCI, V1, P33; Kesici S, 2011, LEARN INDIVID DIFFER, V21, P472, DOI 10.1016/j.lindif.2011.02.006; Kulm G, 1980, RES MATH ED, P380; Lai YH, 2014, STUDIES PSYCHOL BEHA, V12, P36; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Lee J, 2009, LEARN INDIVID DIFFER, V19, P355, DOI 10.1016/j.lindif.2008.10.009; Legg A.M., 2009, N AM J PSYCHOL, V11, P471; Liu J, 2002, CHINESE MATH CURRICU; Long A., 2013, J ED STUD, V9, P121; Lu H.D., 2008, J NE NORMAL U PHILOS, V6, P24; Ma X, 2004, J ADOLESCENCE, V27, P165, DOI 10.1016/j.adolescence.2003.11.003; Mayer R.E., 2006, HDB ED PSYCHOL, V2, P287; Mazzocco MMM, 2008, DEVELOPMENTAL SCI, V11, P681, DOI 10.1111/j.1467-7687.2008.00717.x; Mazzocco MMM, 2013, J EXP CHILD PSYCHOL, V115, P371, DOI 10.1016/j.jecp.2013.01.005; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; MONTAGUE M, 1993, LEARN DISABILITY Q, V16, P19, DOI 10.2307/1511157; Montague M, 1997, REM SPEC EDUC, V18, P46, DOI 10.1177/074193259701800108; Montague M, 2008, LEARN DISABILITY Q, V31, P37, DOI 10.2307/30035524; Murphy MM, 2007, J LEARN DISABIL-US, V40, P458, DOI 10.1177/00222194070400050901; Nelson JM, 2011, J LEARN DISABIL-US, V44, P3, DOI 10.1177/0022219409359939; Ostad SA, 2007, J LEARN DISABIL-US, V40, P2, DOI 10.1177/00222194070400010101; Panaoura A., 2003, INT GROUP PSYCHOL MA, V3, P437; Panaoura A, 2007, COGNITIVE DEV, V22, P149, DOI 10.1016/j.cogdev.2006.08.004; Pennequin V, 2010, J ADULT DEV, V17, P168, DOI 10.1007/s10804-010-9098-3; PLAKE BS, 1982, EDUC PSYCHOL MEAS, V42, P551, DOI 10.1177/001316448204200218; REYES LH, 1984, ELEM SCHOOL J, V84, P558, DOI 10.1086/461384; RICHARDSON FC, 1972, J COUNS PSYCHOL, V19, P551, DOI 10.1037/h0033456; Rosenzweig C, 2011, J LEARN DISABIL-US, V44, P508, DOI 10.1177/0022219410378445; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Sajadi M, 2013, MATH ED TRENDS RES, V3, P1, DOI DOI 10.5899/2013/METR-00007; Stone CA, 2002, J LEARN DISABIL-US, V35, P370, DOI 10.1177/00222194020350040801; Swanson H.L., 2013, HDB LEARNING DISABIL, V2nd ed.; SWANSON HL, 1990, J EDUC PSYCHOL, V82, P306, DOI 10.1037/0022-0663.82.2.306; Teong SK, 2003, J COMPUT ASSIST LEAR, V19, P46, DOI 10.1046/j.0266-4909.2003.00005.x; van de Vijver FJR, 2010, LEARN INDIVID DIFFER, V20, P574, DOI 10.1016/j.lindif.2010.08.005; van der Stel M, 2008, LEARN INDIVID DIFFER, V18, P128, DOI 10.1016/j.lindif.2007.08.003; Veenman MVJ, 2005, LEARN INDIVID DIFFER, V15, P159, DOI 10.1016/j.lindif.2004.12.001; von Aster MG, 2007, DEV MED CHILD NEUROL, V49, P868, DOI 10.1111/j.1469-8749.2007.00868.x; Wu SS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00162; Zan R., 2006, EDUC STUD MATH, V63, P113, DOI DOI 10.1007/S10649-006-9028-2; Zhang H., 1989, ACTA PSYCHOL SINICA, V21, P113; [张厚粲 Zhang Houcan], 2009, [心理科学, Psychological Science], V32, P1177; Zheng XH, 2011, J EXP CHILD PSYCHOL, V110, P481, DOI 10.1016/j.jecp.2011.06.001	85	26	26	6	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130570	10.1371/journal.pone.0130570	http://dx.doi.org/10.1371/journal.pone.0130570			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26090806	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000127
J	Furo, ID; Kretschmer, R; O'Brien, PC; Ferguson-Smith, MA; de Oliveira, EHC				Furo, Ivanete de Oliveira; Kretschmer, Rafael; O'Brien, Patricia C.; Ferguson-Smith, Malcolm A.; Correa de Oliveira, Edivaldo Herculano			Chromosomal Diversity and Karyotype Evolution in South American Macaws (Psittaciformes, Psittacidae)	PLOS ONE			English	Article							PARROTS PSITTACIFORMES; PHYLOGENETIC-RELATIONSHIPS; AVIAN GENOME; AVES; BIRDS; MITOCHONDRIAL; SEQUENCES; REVEALS	Most species of macaws, which represent the largest species of Neotropical Psittacidae, characterized by their long tails and exuberant colours, are endangered, mainly because of hunting, illegal trade and habitat destruction. Long tailed species seem to represent a monophyletic group within Psittacidae, supported by cytogenetic data. Hence, these species show karyotypes with predominance of biarmed macrochromosomes, in contrast to short tailed species, with a predominance of acro/telocentric macrochromosomes. Because of their similar karyotypes, it has been proposed that inversions and translocations may be the main types of rearrangements occurring during the evolution of this group. However, only one species of macaw, Ara macao, that has had its genome sequenced was analyzed by means of molecular cytogenetics. Hence, in order to verify the rearrangements, we analyzed the karyotype of two species of macaws, Ara chloropterus and Anodorhynchus hyacinthinus, using cross-species chromosome painting with two different sets of probes from chicken and white hawk. Both intra-and interchromosomal rearrangements were observed. Chicken probes revealed the occurrence of fusions, fissions and inversions in both species, while the probes from white hawk determined the correct breakpoints or chromosome segments involved in the rearrangements. Some of these rearrangements were common for both species of macaws (fission of GGA1 and fusions of GGA1p/GGA4q, GGA6/GGA7 and GGA8/GGA9), while the fissions of GGA 2 and 4p were found only in A. chloropterus. These results confirm that despite apparent chromosomal similarity, macaws have very diverse karyotypes, which differ from each other not only by inversions and translocations as postulated before, but also by fissions and fusions.	[Furo, Ivanete de Oliveira] Fed Univ Para, Inst Ciencias Biol, Programa Posgrad Genet & Biol Mol, Belem, PA, Brazil; [Furo, Ivanete de Oliveira; Correa de Oliveira, Edivaldo Herculano] SAMAM, Inst Evandro Chagas, Lab Cultura Tecidos & Citogenet, Ananindeua, PA, Brazil; [Kretschmer, Rafael] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [O'Brien, Patricia C.; Ferguson-Smith, Malcolm A.] Univ Cambridge, Cambridge Resource Ctr Comparat Gen, Dept Vet Med, Cambridge, England; [Correa de Oliveira, Edivaldo Herculano] Fed Univ Para, Fac Ciencias Nat, Inst Ciencias Exatas & Nat, Belem, PA, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Universidade Federal do Rio Grande do Sul; University of Cambridge; Universidade Federal do Para	de Oliveira, EHC (corresponding author), SAMAM, Inst Evandro Chagas, Lab Cultura Tecidos & Citogenet, Ananindeua, PA, Brazil.	ehco@ufpa.br	Kretschmer, Rafael/B-7206-2017; Furo, Ivanete/P-1180-2018; de Oliveira, Edivaldo H. C./C-3368-2013; Kretschmer, Rafael/M-7293-2019	Kretschmer, Rafael/0000-0002-6856-2152; de Oliveira, Edivaldo H. C./0000-0001-6315-3352; Kretschmer, Rafael/0000-0002-6856-2152	CAPES; CNPq; Instituto Evandro Chagas; Wellcome Trust	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Evandro Chagas; Wellcome Trust(Wellcome TrustEuropean Commission)	We are also grateful to CAPES, CNPq and Instituto Evandro Chagas for financial and logistic support, and to the Wellcome Trust for a grant to MAFS in support of the Cambridge Resource Centre for Comparative Genomics.	CHRISTIDIS L, 1991, HEREDITAS, V114, P47, DOI 10.1111/j.1601-5223.1991.tb00552.x; Oliveira EHC, 2010, CHROMOSOME RES, V18, P349, DOI 10.1007/s10577-010-9117-z; del Hoyo J, 1997, HDB BIRDS WORLD, P246; DELUCCA EJ, 1991, REV BRAS GENET, V14, P73; DUARTE JMB, 1990, REV BRAS GENET, V13, P137; Duarte JMB, 1995, BRAZ J GENET, V18, P623; Forshaw J, 1989, PARROTS WORLD; Francisco MR, 2001, HEREDITAS, V134, P225, DOI 10.1111/j.1601-5223.2001.00225.x; Frankl-Vilches C, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0578-9; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; Guttenbach M, 2003, CYTOGENET GENOME RES, V103, P173, DOI 10.1159/000076309; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Kretschmer R, 2015, BIOL J LINN SOC, V115, P391, DOI 10.1111/bij.12504; Kretschmer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103338; Lunardi VD, 2003, GENET MOL BIOL, V26, P283, DOI 10.1590/S1415-47572003000300011; Nanda I, 2007, CYTOGENET GENOME RES, V117, P43, DOI 10.1159/000103164; Santos LP, 2006, REV BRASILEIRA ORNIT, V14, P35; SASAKI M, 1968, EXPERIENTIA, V24, P1292, DOI 10.1007/BF02146680; Seabury CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062415; Sick H, 2001, ORNITOLOGIA BRASILEI; Skinner BM, 2012, HEREDITY, V108, P37, DOI 10.1038/hdy.2011.99; Tavares ES, 2006, SYST BIOL, V55, P454, DOI 10.1080/10635150600697390; Tavares ES, 2004, AUK, V121, P230, DOI 10.1642/0004-8038(2004)121[0230:PRASNP]2.0.CO;2; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	25	15	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130157	10.1371/journal.pone.0130157	http://dx.doi.org/10.1371/journal.pone.0130157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087053	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500082
J	Jeong, JH; Moon, SJ; Jhun, JY; Yang, EJ; Cho, ML; Min, JK				Jeong, Jeong-Hee; Moon, Su-Jin; Jhun, Joo-Yeon; Yang, Eun-Ji; Cho, Mi-La; Min, Jun-Ki			Eupatilin Exerts Antinociceptive and Chondroprotective Properties in a Rat Model of Osteoarthritis by Downregulating Oxidative Damage and Catabolic Activity in Chondrocytes	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NF-KAPPA-B; GENE-EXPRESSION; ARTICULAR-CARTILAGE; MATRIX-METALLOPROTEINASE; NITRIC-OXIDE; PAIN; DEGRADATION; ASSOCIATION; INHIBITION	Increases in oxidative stress are thought to be associated with the development of osteoarthritis (OA). Eupatilin, one of the major compounds present in artemisia species, was shown to have both anti-oxidative and anti-inflammatory properties. Here, we investigated the in vivo effects of eupatilin on pain severity and cartilage degradation in an experimental rat model of OA, along with the mechanisms of action underlying these effects. Experimental OA was induced via an intra-articular injection of monosodium iodoacetate (MIA), with oral administration of eupatilin initiated on the day of MIA injection. Pain was assessed by measuring the paw withdrawal latency and threshold. Cartilage destruction was analyzed macroscopically and histomorphologically. The effects of eupatilin on mRNA expression were investigated in interleukin-1 beta (IL-1 beta)-stimulated human OA chondrocytes. Eupatilin treatment exhibited clear antinociceptive effects, along with an attenuation of cartilage degradation in OA rats. Additionally, the number of osteoclasts present in the subchondral bone region was significantly decreased following eupatilin treatment. Eupatilin reduced the expression of interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), nitrotyrosine and inducible nitric oxide synthase (iNOS) in cartilage. mRNA levels of matrix metalloproteinase-3 (MMP-3), MMP13, and a disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS5) were reduced in IL-1 beta-stimulated human OA chondrocytes, while tissue inhibitor of metalloproteinases-1 (TIMP-1) was induced. Phosphorylated protein levels of the c-jun N-terminal kinase (JNK) was reduced by eupatilin. Taken together, these results suggest that eupatilin suppresses oxidative damage and reciprocally enhances extracellular matrix production in articular chondrocytes, making eupatilin a promising therapeutic option for the treatment of OA.	[Jeong, Jeong-Hee; Jhun, Joo-Yeon; Yang, Eun-Ji; Cho, Mi-La] Catholic Univ Korea, Rheumatism Res Ctr, Catholic Res Inst Med Sci, Seoul, South Korea; [Moon, Su-Jin; Min, Jun-Ki] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Min, JK (corresponding author), Catholic Univ Korea, Rheumatism Res Ctr, Catholic Res Inst Med Sci, Seoul, South Korea.	min6403@catholic.ac.kr			National Research Foundation (NRF) - Korean government (MEST) [2012M3A9C6049783]	National Research Foundation (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (No. 2012M3A9C6049783).	Abramson SB, 2006, NAT CLIN PRACT RHEUM, V2, P304, DOI 10.1038/ncprheum0193; Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; Ahn BO, 2001, INT J COLORECTAL DIS, V16, P174, DOI 10.1007/s003840000282; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; BLANCO FJ, 1995, AM J PATHOL, V146, P75; BULSTRA SK, 1989, CLIN ORTHOP RELAT R, P294; Chadjichristos C, 2003, J BIOL CHEM, V278, P39762, DOI 10.1074/jbc.M303541200; Chang MC, 2005, OSTEOARTHR CARTILAGE, V13, P1004, DOI 10.1016/j.joca.2005.06.011; Cheong JH, 2011, J GASTRIC CANCER, V11, P16, DOI 10.5230/jgc.2011.11.1.16; Choi EJ, 2008, PHARM RES, V25, P1355, DOI 10.1007/s11095-008-9531-5; Cifuentes DJ, 2010, OSTEOARTHR CARTILAGE, V18, P1088, DOI 10.1016/j.joca.2010.04.004; Davies CM, 2008, OSTEOARTHR CARTILAGE, V16, P624, DOI 10.1016/j.joca.2007.09.012; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Hahm KB, 1998, PANCREAS, V17, P153, DOI 10.1097/00006676-199808000-00007; Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002; Henry D, 1996, BRIT MED J, V312, P1563, DOI 10.1136/bmj.312.7046.1563; Hill CL, 2001, J RHEUMATOL, V28, P1330; Jeon JI, 2015, SCAND J IMMUNOL, V81, P166, DOI 10.1111/sji.12263; Ji HY, 2010, MOLECULES, V15, P6466, DOI 10.3390/molecules15096466; Jiang LP, 2013, J ORTHOP RES, V31, P364, DOI 10.1002/jor.22250; Alcaraz MJ, 2010, BIOCHEM PHARMACOL, V80, P13, DOI 10.1016/j.bcp.2010.02.017; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kobayashi K, 2003, J VET MED SCI, V65, P1195, DOI 10.1292/jvms.65.1195; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Lanas A, 2006, ANN MED, V38, P415, DOI 10.1080/07853890600925843; Lim JC, 2012, KOREAN J PHYSIOL PHA, V16, P313, DOI 10.4196/kjpp.2012.16.5.313; Lubberts E, 2000, ARTHRITIS RHEUM-US, V43, P1300, DOI 10.1002/1529-0131(200006)43:6<1300::AID-ANR12>3.0.CO;2-D; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Pelletier JP, 1999, J RHEUMATOL, V26, P2002; Ruiz-Romero C, 2009, MOL CELL PROTEOMICS, V8, P172, DOI 10.1074/mcp.M800292-MCP200; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; Scott JL, 2010, ANN RHEUM DIS, V69, P1502, DOI 10.1136/ard.2009.119966; Shakibaei M, 2005, ANN ANAT, V187, P487, DOI 10.1016/j.aanat.2005.06.007; Tiku ML, 2000, J BIOL CHEM, V275, P20069, DOI 10.1074/jbc.M907604199; Tsutsumi R, 2008, RHEUMATOL INT, V28, P727, DOI 10.1007/s00296-007-0511-6; Wluka A, 2004, ANN RHEUM DIS, V63, P264, DOI 10.1136/ard/2003.007666; Wolfe F, 2000, ARTHRITIS RHEUM-US, V43, P378, DOI 10.1002/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2; Wu GJ, 2007, J CELL BIOCHEM, V101, P1520, DOI 10.1002/jcb.21268	45	44	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130882	10.1371/journal.pone.0130882	http://dx.doi.org/10.1371/journal.pone.0130882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083352	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400163
J	Maruthur, NM; Li, M; Halushka, MK; Astor, BC; Pankow, JS; Boerwinkle, E; Coresh, J; Selvin, E; Kao, WHL				Maruthur, Nisa M.; Li, Man; Halushka, Marc K.; Astor, Brad C.; Pankow, James S.; Boerwinkle, Eric; Coresh, Josef; Selvin, Elizabeth; Kao, Wen Hong Linda			Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GLY82SER POLYMORPHISM; RAGE GENE; DISEASE; ASSOCIATION; SRAGE; MORTALITY; BIOLOGY; GENDER	Plasma soluble Receptor for Advanced Glycation End-products (sRAGE) is a strong marker of vascular outcomes although evidence on the direction of association is mixed. Compared to whites, blacks have lower levels of sRAGE. We hypothesized that genetic determinants of sRAGE would help clarify the causal role of sRAGE and the black-white difference in sRAGE levels. We conducted a genome-wide analysis of sRAGE in whites and blacks from the Atherosclerosis Risk in Communities Study. Median plasma sRAGE levels were lower in blacks than whites (728 vs. 1067 pg/ml; P<0.0001). The T (vs. C) allele of rs2070600, a missense variant in AGER, the gene encoding RAGE, was associated with approximately 50% lower sRAGE levels in both whites (N = 1,737; P = 7.26x10(-16); minor allele frequency (MAF) = 0.04) and blacks (N = 581; P = 0.02; MAF = 0.01). In blacks, the T (vs. C) allele of rs2071288, intronic to AGER, was associated with 43% lower sRAGE levels (P = 2.22x10(-8); MAF = 0.10) and was nearly absent in whites. These AGER SNPs explained 21.5% and 26% of the variation in sRAGE in blacks and whites, respectively, but did not explain the black-white difference in sRAGE. These SNPs were not significantly associated with incident death, coronary heart disease, diabetes, heart failure, or chronic kidney disease in whites (N = 8,130-9,017) or blacks (N = 2,293-2,871) (median follow up similar to 20 years). We identified strong genetic determinants of sRAGE that did not explain the large black-white difference in sRAGE levels or clearly influence risk of clinical outcomes, suggesting that sRAGE may not be a causal factor in development of these outcomes.	[Maruthur, Nisa M.; Coresh, Josef; Selvin, Elizabeth; Kao, Wen Hong Linda] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Maruthur, Nisa M.; Coresh, Josef; Selvin, Elizabeth; Kao, Wen Hong Linda] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Maruthur, Nisa M.; Li, Man; Coresh, Josef; Selvin, Elizabeth; Kao, Wen Hong Linda] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Halushka, Marc K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Astor, Brad C.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Astor, Brad C.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI USA; [Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Boerwinkle, Eric] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Maruthur, NM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA.	maruthur@jhmi.edu	Li, Man/AAX-3400-2020	Li, Man/0000-0002-3839-0281; Pankow, James/0000-0001-7076-483X; Halushka, Marc/0000-0002-7112-7389	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research; National Institute of Diabetes and Digestive and Kidney Disease of National Institutes of Health [R01-DK076770]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL087641, R01HL086694, T32HL007024] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076770] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease of National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694 (JC ES); National Human Genome Research Institute contract U01HG004402 (WHLK); and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. Additional support provided by the National Institute of Diabetes and Digestive and Kidney Disease of the National Institutes of Health grant R01-DK076770 (ES).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bower JK, 2014, CLIN BIOCHEM, V47, P132, DOI 10.1016/j.clinbiochem.2013.11.005; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Center ARiCC, 1987, OPERATIONS MANUAL NO; Cheng DT, 2013, AM J RESP CRIT CARE, V188, P948, DOI 10.1164/rccm.201302-0247OC; Colhoun HM, 2011, DIABETES, V60, P2379, DOI 10.2337/db11-0291; Cunningham TJ, 2012, SOC SCI MED, V75, P922, DOI 10.1016/j.socscimed.2012.04.027; Daborg J, 2010, J NEURAL TRANSM, V117, P861, DOI 10.1007/s00702-010-0437-0; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Forbes JM, 2011, DIABETOLOGIA, V54, P1032, DOI 10.1007/s00125-011-2058-z; Gaens KHJ, 2009, J CLIN ENDOCR METAB, V94, P5174, DOI 10.1210/jc.2009-1067; Gross S, 2007, TRANSPLANTATION, V84, P659, DOI 10.1097/01.tp.0000280556.16275.2a; Gruenewald TL, 2009, SOC SCI MED, V69, P451, DOI 10.1016/j.socscimed.2009.05.018; Herd P, 2012, J GERONTOL B-PSYCHOL, V67, P503, DOI 10.1093/geronb/gbs048; Hudson BI, 2011, ATHEROSCLEROSIS, V216, P192, DOI 10.1016/j.atherosclerosis.2011.01.024; Jang Y, 2007, METABOLISM, V56, P199, DOI 10.1016/j.metabol.2006.09.013; Kalea AZ, 2011, FRONT BIOSCI-LANDMRK, V16, P2756, DOI 10.2741/3884; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Katakami N, 2009, ATHEROSCLEROSIS, V204, P288, DOI 10.1016/j.atherosclerosis.2008.08.026; Kim JK, 2012, ATHEROSCLEROSIS, V220, P208, DOI 10.1016/j.atherosclerosis.2011.07.115; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lindsey JB, 2009, DIABETES CARE, V32, P1218, DOI 10.2337/dc09-0053; Majka DS, 2009, AM J PREV MED, V36, P56, DOI 10.1016/j.amepre.2008.09.031; Nin JWM, 2010, DIABETES, V59, P2027, DOI 10.2337/db09-1509; Paul K, 2008, J NATL MED ASSOC, V100, P540, DOI 10.1016/S0027-9684(15)31300-6; Peng F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070834; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; ROSNER B., 2006, FUNDAMENTALS OF BIOS; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Selvin E, 2013, DIABETES, V62, P2116, DOI 10.2337/db12-1528; Semba RD, 2009, AGING CLIN EXP RES, V21, P182; Suchankova P, 2012, J PSYCHIATR NEUROSCI, V37, P122, DOI 10.1503/jpn.110024; Therneau T.M, 2000, GPM MODELING SURVIVA; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P427, DOI 10.1097/EDE.0000000000000081; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050790; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yang L, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/264579; Yu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076966; Zee RYL, 2006, STROKE, V37, P1686, DOI 10.1161/01.STR.0000226994.93914.6c	42	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128452	10.1371/journal.pone.0128452	http://dx.doi.org/10.1371/journal.pone.0128452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083729	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400050
J	Olori, JC				Olori, Jennifer C.			Skeletal Morphogenesis of Microbrachis and Hyloplesion (Tetrapoda: Lepospondyli), and Implications for the Developmental Patterns of Extinct, Early Tetrapods	PLOS ONE			English	Article							VERTEBRAL DEVELOPMENT; PHYLOGENETIC ANALYSIS; CRANIAL MORPHOLOGY; EVOLUTION; METAMORPHOSIS; ONTOGENY; APATEON; LIMB; HETEROCHRONY; OSSIFICATION	The ontogeny of extant amphibians often is used as a model for that of extinct early tetrapods, despite evidence for a spectrum of developmental modes in temnospondyls and a paucity of ontogenetic data for lepospondyls. I describe the skeletal morphogenesis of the extinct lepospondyls Microbrachis pelikani and Hyloplesion longicostatum using the largest samples examined for either taxon. Nearly all known specimens were re-examined, allowing for substantial anatomical revisions that affect the scoring of characters commonly used in phylogenetic analyses of early tetrapods. The palate of H. longicostatum is re-interpreted and suggested to be more similar to that of M. pelikani, especially in the nature of the contact between the pterygoids. Both taxa possess lateral lines, and M. pelikani additionally exhibits branchial plates. However, early and rapid ossification of the postcranial skeleton, including a well-developed pubis and ossified epipodials, suggests that neither taxon metamorphosed nor were they neotenic in the sense of branchiosaurids and salamanders. Morphogenetic patterns in the foot suggest that digit 5 was developmentally delayed and the final digit to ossify in M. pelikani and H. longicostatum. Overall patterns of postcranial ossification may indicate postaxial dominance in limb and digit formation, but also more developmental variation in early tetrapods than has been appreciated. The phylogenetic position and developmental patterns of M. pelikani and H. longicostatum are congruent with the hypothesis that early tetrapods lacked metamorphosis ancestrally and that stem-amniotes exhibited derived features of development, such as rapid and complete ossification of the skeleton, potentially prior to the evolution of the amniotic egg.	[Olori, Jennifer C.] Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX USA	University of Texas System; University of Texas Austin	Olori, JC (corresponding author), SUNY Coll Oswego, Dept Biol Sci, Oswego, NY 13126 USA.	Jennifer.olori@oswego.edu		Olori, Jennifer/0000-0003-0479-6264	Jackson School of Geosciences; Banks Fellowship (The University of Texas at Austin); Society of Vertebrate Paleontology; Paleontological Society	Jackson School of Geosciences; Banks Fellowship (The University of Texas at Austin); Society of Vertebrate Paleontology; Paleontological Society	Financial support was provided to JCO by The Jackson School of Geosciences and the Banks Fellowship (The University of Texas at Austin; http://www.utexas.edu) as well as the Society of Vertebrate Paleontology (Estes Memorial Grant; http://vertpaleo.org/Awards) and the Paleontological Society (Lane Student Award; http://www.paleosoc.org/grantin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Alberch P., 1989, Progress in Zoology, V35, P163; Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Anderson Jason S., 2007, P182; Anderson JS, 2003, CAN J EARTH SCI, V40, P1071, DOI 10.1139/E03-023; Anderson JS, 2002, J PALEONTOL, V76, P1029, DOI 10.1666/0022-3360(2002)076<1029:ROTAGP>2.0.CO;2; Anderson JS, 2001, SYST BIOL, V50, P170; Augusta J, 1939, ZVLASTNI OTISK CASOP, V32, P1; BAIRD D, 1965, AM ZOOL, V5, P287; BERMAN DS, 1973, J PALEONTOL, V47, P932; Boisvert CA, 2009, J EXP ZOOL PART B, V312B, P1, DOI 10.1002/jez.b.21238; BOLT JR, 1983, J PALEONTOL, V57, P911; Brinkman D., 1988, Journal of Vertebrate Paleontology, V8, P172; BROUGH MC, 1967, PHILOS T ROY SOC B, V252, P131, DOI 10.1098/rstb.1967.0005; Carroll R. L., 1970, Forma Functio, V1970, P165; Carroll R.L., 1978, Memoirs of the American Philosophical Society, V126, P1; Carroll R.L., 1989, Historical Biology, V3, P1; CARROLL RL, 1995, J VERTEBR PALEONTOL, V15, P37, DOI 10.1080/02724634.1995.10011206; CARROLL RL, 2004, RECENT ADV ORIGIN EA, P321; Duellman W. E., 1986, BIOL AMPHIBIANS; Fritsch A, 1876, SITZUNGS BERICHTE KO, V1875, P70; Frobisch NB, 2007, EVOL DEV, V9, P69; Frobisch NB, 2009, FOSS REC, V12, P83, DOI 10.1002/mmng.200800012; Frobisch NB, 2008, BIOL REV, V83, P571, DOI 10.1111/j.1469-185X.2008.00055.x; GODFREY SJ, 1989, PHILOS T ROY SOC B, V323, P75, DOI 10.1098/rstb.1989.0002; Goloboff P, 2008, CLADISTICS, V24, P91; Gould S. J., 1977, ONTOGENY PHYLOGENY; Huttenlocker AK, 2013, J VERTEBR PALEONTOL, V33, P540, DOI 10.1080/02724634.2013.728998; Klembara Jozef, 1995, Palaeontologische Zeitschrift, V69, P265; Klembara J, 2006, ANN CARNEGIE MUS, V75, P37, DOI 10.2992/0097-4463(2006)75[37:COCAAP]2.0.CO;2; Klembara J, 2009, SPEC PAP PALAEONTOL, P61, DOI 10.1111/j.1475-4983.2009.00864.x; Kluge A.G., 1988, P57; Kollmann J., 1885, VERHANDLUNGEN NATURF, V7, P387; Liu J, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3582[1:AJSOAR]2.0.CO;2; Maddin HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050743; Milner A.C., 1980, TERRESTRIAL ENV ORIG, V15, P439; Milner AR, 2008, LETHAIA, V41, P257, DOI 10.1111/j.1502-3931.2007.00049.x; Milner Angela C., 1996, Special Papers in Palaeontology, V52, P129; Olori JC, 2013, J VERTEBR PALEONTOL, V33, P1300, DOI 10.1080/02724634.2013.775141; Olori JC, 2013, PALEOBIOLOGY, V39, P400, DOI 10.1666/12031; Olson E. C., 1951, FIELDIANA GEOLOGY, V11, P57; Pawley K., 2006, THESIS; Reilly SM, 1997, BIOL J LINN SOC, V60, P119; REILLY SM, 1987, J MORPHOL, V191, P205, DOI 10.1002/jmor.1051910210; Reiss J, 1996, J HERPETOL, V30, P27, DOI 10.2307/1564703; Rinehart LF, 2001, J VERTEBR PALEONTOL, V21, P803, DOI 10.1671/0272-4634(2001)021[0803:ASAOAG]2.0.CO;2; Romer A. S., 1969, Breviora, VNo. 314, P1; Rose Christopher S., 1993, P289; Ruta M, 2003, P ROY SOC B-BIOL SCI, V270, P2507, DOI 10.1098/rspb.2003.2524; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; Sanchez S, 2008, BIOL LETTERS, V4, P411, DOI 10.1098/rsbl.2008.0159; Sanchez S, 2010, EVOL DEV, V12, P315, DOI 10.1111/j.1525-142X.2010.00417.x; Schoch RR, 2006, EVOLUTION, V60, P1467, DOI 10.1111/j.0014-3820.2006.tb01225.x; Schoch RR, 2010, PALEOBIOLOGY, V36, P318, DOI 10.1666/09011.1; Schoch RR, 2009, ANNU REV EARTH PL SC, V37, P135, DOI 10.1146/annurev.earth.031208.100113; Schoch RR, 2002, LETHAIA, V35, P309, DOI 10.1080/002411602320790634; Schoch RR, 2001, NEUES JAHRB GEOL P-A, V220, P335; Shubin Neil H., 2003, Amphibian Biology, V5, P1782; Sigurdsen T, 2011, ZOOL J LINN SOC-LOND, V162, P457, DOI 10.1111/j.1096-3642.2010.00683.x; Skocek V, 1968, VESTNIK USTREDNIHO U, V43, P113; Steen MC, 1938, P ZOOL SOC LOND B-SY, V108, P205, DOI 10.1111/j.1096-3642.1938.tb00027.x; Steyer JS, 2000, ZOOL J LINN SOC-LOND, V130, P449, DOI 10.1006/zjls.1999.0220; Swofford DL, 2009, PAUP VERS 4 0A109 BE; SWOFFORD DL, 2002, PAUP VERSION 4 0B10; ULTSCH GR, 1988, J HERPETOL, V22, P347, DOI 10.2307/1564161; Vaglia JL, 1997, J MORPHOL, V233, P15, DOI 10.1002/(SICI)1097-4687(199707)233:1<15::AID-JMOR2>3.0.CO;2-N; Vallin G, 2004, J VERTEBR PALEONTOL, V24, P56, DOI 10.1671/5.1; Witzmann F, 2007, ZOOL J LINN SOC-LOND, V150, P815, DOI 10.1111/j.1096-3642.2007.00309.x; Witzmann F, 2004, NEUES JAHRB GEOL P-A, V232, P375; Witzmann F, 2006, PALAEONTOLOGY, V49, P1211, DOI 10.1111/j.1475-4983.2006.00593.x; Zanon T, 1985, THESIS	71	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128333	10.1371/journal.pone.0128333	http://dx.doi.org/10.1371/journal.pone.0128333			69	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083733	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400039
J	Panwar, D; Rawal, L; Sehgal, N; Ali, S				Panwar, Deepak; Rawal, Leena; Sehgal, Neeta; Ali, Sher			Cross Talk between KGF and KITLG Proteins Implicated with Ovarian Folliculogenesis in Buffalo Bubalus bubalis	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; GRANULOSA CELL-INTERACTIONS; C-KIT; HORMONAL-REGULATION; LIGAND; EXPRESSION; PROMOTES; DIFFERENTIATION; IDENTIFICATION; RECRUITMENT	Molecular interactions between mesenchymal-derived Keratinocyte growth factor (KGF) and Kit ligand (KITLG) are essential for follicular development. These factors are expressed by theca and granulosa cells. We determined full length coding sequence of buffalo KGF and KITLG proteins having 194 and 274 amino acids, respectively. The recombinant KGF and KITLG proteins were solubilized in 10 mM Tris, pH 7.5 and 50 mM Tris, pH 7.4 and purified using Ni-NTA column and GST affinity chromatography, respectively. The purity and molecular weight of His-KGF (similar to 23 kDa) and GST-KITLG (similar to 57 kDa) proteins were confirmed by SDS-PAGE and western blotting. The co-immunoprecipitation assay accompanied with computational analysis demonstrated the interaction between KGF and KITLG proteins. We deduced 3D structures of the candidate proteins and assessed their binding based on protein docking. In the process, KGF specific residues, Lys123, Glu135, Lys140, Lys155 and Trp156 and KITLG specific ones, Ser226, Phe233, Gly234, Ala235, Phe236, Trp238 and Lys239 involved in the formation of KGF-KITLG complex were detected. The hydrophobic interactions surrounding KGF-KITLG complex affirmed their binding affinity and stability to the interacting interface. Additionally, in-silico site directed mutagenesis enabled the assessment of changes that occurred in the binding energies of mutated KGF-KITLG protein complex. Our results demonstrate that in the presence of KITLG, KGF mimics its native binding mode suggesting all the KGF residues are specific to their binding complex. This study provides an insight on the critical amino acid residues participating in buffalo ovarian folliculogenesis.	[Panwar, Deepak; Rawal, Leena; Ali, Sher] Natl Inst Immunol, Mol Genet Lab, New Delhi 110067, India; [Sehgal, Neeta] Univ Delhi, Dept Zool, Delhi 110007, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Delhi	Ali, S (corresponding author), Natl Inst Immunol, Mol Genet Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	alisher@nii.ac.in			Department of Biotechnology (DBT); DBT, New Delhi [BT/PR11805/MED/12/424/2009, BT/PR14102/AAQ/01/438/2010]; Department of Science and Technology (DST), New Delhi [SR/SO/AS-115/2012]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); DBT, New Delhi(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), New Delhi(Department of Science & Technology (India))	This work was supported by a core grant from the Department of Biotechnology (DBT) (http://www.dbtindia.nic.in/) to the National Institute of Immunology, New Delhi and research grants nos. BT/PR11805/MED/12/424/2009, BT/PR14102/AAQ/01/438/2010 from DBT, New Delhi and no. SR/SO/AS-115/2012 from the Department of Science and Technology (DST) (http://www.dst.gov.in/), New Delhi to SA. SA acknowledges award of the J.C. Bose National Fellowship by DST, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; AVRAHAM H, 1992, BLOOD, V79, P365; Biro JC, 2003, BIOCHEM BIOPH RES CO, V306, P408, DOI 10.1016/S0006-291X(03)00974-4; Cho JH, 2008, MOL REPROD DEV, V75, P1736, DOI 10.1002/mrd.20912; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; De Giorgi V, 2007, DERMATOL CLIN, V25, P477, DOI 10.1016/j.det.2007.06.017; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Driancourt MA, 2000, REV REPROD, V5, P143, DOI 10.1530/revreprod/5.3.143; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Faustino LR, 2013, SMALL RUMINANT RES, V114, P112, DOI 10.1016/j.smallrumres.2013.05.002; Faustino LR, 2010, ANIM REPROD SCI, V122, P90, DOI 10.1016/j.anireprosci.2010.08.001; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; HORIE K, 1991, BIOL REPROD, V45, P547, DOI 10.1095/biolreprod45.4.547; Hsueh AJW, 2000, MOL CELL ENDOCRINOL, V163, P95, DOI 10.1016/S0303-7207(99)00245-2; Hutt KJ, 2006, MOL HUM REPROD, V12, P61, DOI 10.1093/molehr/gal010; Ismail RS, 1996, MOL REPROD DEV, V43, P458, DOI 10.1002/(SICI)1098-2795(199604)43:4&lt;458::AID-MRD8&gt;3.0.CO;2-O; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kezele P, 2005, BIOL REPROD, V73, P967, DOI 10.1095/biolreprod.105.043117; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Ledoux Dominique, 1992, Progress in Growth Factor Research, V4, P107, DOI 10.1016/0955-2235(92)90026-E; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McGee EA, 1999, FERTIL STERIL, V71, P732, DOI 10.1016/S0015-0282(98)00547-0; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Midgley ARJ, 1974, ADV FERTILITY REGULA, P1; PACKER AI, 1994, DEV BIOL, V161, P194, DOI 10.1006/dbio.1994.1020; Panwar D, 2014, J BIOMOL STRUCT DYN, P1; Parrott JA, 2000, MOL REPROD DEV, V55, P55, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;55::AID-MRD8&gt;3.0.CO;2-L; Parrott JA, 1998, ENDOCRINOLOGY, V139, P228, DOI 10.1210/en.139.1.228; Parrott JA, 1997, ENDOCRINOLOGY, V138, P3819, DOI 10.1210/en.138.9.3819; Parrott JA, 1998, ENDOCRINOLOGY, V139, P2240, DOI 10.1210/en.139.5.2240; PARROTT JA, 1994, ENDOCRINOLOGY, V135, P569, DOI 10.1210/en.135.2.569; Pawlowski M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103099; Peters H., 1979, OVARIAN FOLLICULAR D, P1; Rawal L, 2015, DNA CELL BIOL, V34, P1, DOI [10.1089/dna.2014.2701, DOI 10.1089/DNA.2014.2701]; Rawal L, 2012, GENE, V492, P290, DOI 10.1016/j.gene.2011.10.004; RUBIN JS, 1995, CELL BIOL INT, V19, P399, DOI 10.1006/cbir.1995.1085; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sharma M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-638; Sher I, 2003, FEBS LETT, V552, P150, DOI 10.1016/S0014-5793(03)00909-8; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; SKINNER MK, 1990, REPROD FERT DEVELOP, V2, P237, DOI 10.1071/RD9900237; Skinner MK, 1994, MOL BIOL FEMALE REPR, P67; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Udoff LC, 1999, ENDOCRINOLOGIST, V9, P99, DOI 10.1097/00019616-199903000-00006; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	54	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127993	10.1371/journal.pone.0127993	http://dx.doi.org/10.1371/journal.pone.0127993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083339	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400023
J	Thio, CLP; Yusof, R; Ashrafzadeh, A; Bahari, S; Abdul-Rahman, PS; Karsani, SA				Thio, Christina Li-Ping; Yusof, Rohana; Ashrafzadeh, Ali; Bahari, Syareena; Abdul-Rahman, Puteri Shafinaz; Karsani, Saiful Anuar			Differential Analysis of the Secretome of WRL68 Cells Infected with the Chikungunya Virus	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; INDIAN-OCEAN; PROTEINS; ADHESION; GENOME; APOPTOSIS	The Chikungunya virus (CHIKV) is an arthropod borne virus. In the last 50 years, it has been the cause of numerous outbreaks in tropical and temperate regions, worldwide. There is limited understanding regarding the underlying molecular mechanisms involved in CHIKV replication and how the virus interacts with its host. In the present study, comparative proteomics was used to identify secreted host proteins that changed in abundance in response to early CHIKV infection. Two-dimensional gel electrophoresis was used to analyse and compare the secretome profiles of WRL-68 cells infected with CHIKV against mock control WRL-68 cells. The analysis identified 25 regulated proteins in CHIKV infected cells. STRING network analysis was then used to predict biological processes that may be affected by these proteins. The processes predicted to be affected include signal transduction, cellular component and extracellular matrix (ECM) organization, regulation of cytokine stimulus and immune response. These results provide an initial view of CHIKV may affect the secretome of infected cells during early infection. The results presented here will compliment earlier results from the study of late host response. However, functional characterization will be necessary to further enhance our understanding of the roles played by these proteins in the early stages of CHIKV infection in humans.	[Thio, Christina Li-Ping; Bahari, Syareena; Karsani, Saiful Anuar] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Yusof, Rohana; Abdul-Rahman, Puteri Shafinaz] Univ Malaya, Dept Mol Med, Fac Med, Kuala Lumpur 50603, Malaysia; [Abdul-Rahman, Puteri Shafinaz; Karsani, Saiful Anuar] Univ Malaya, Fac Med, Med Biotechnol Lab, UMCPR, Kuala Lumpur 50603, Malaysia; [Thio, Christina Li-Ping; Yusof, Rohana; Karsani, Saiful Anuar] Univ Malaya, DDDRG, Kuala Lumpur 50603, Malaysia; [Ashrafzadeh, Ali] Univ Malaya, Med Biotechnol Lab, Fac Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Karsani, SA (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.	saiful72@um.edu.my	SA, karsani/B-9667-2010; YUSOF, ROHANA/B-9589-2010; Rahman, Puteri Shafinaz Akmar Binti Abdul/B-9511-2010	SA, karsani/0000-0003-1617-9554; YUSOF, ROHANA/0000-0002-6591-3236; Rahman, Puteri Shafinaz Akmar Binti Abdul/0000-0002-1818-4552	University of Malaya Postgraduate Researh Fund [PV088/2012A]; Ministry of Science, Technology and Innovation Malaysia [02-01-03-SF0807]	University of Malaya Postgraduate Researh Fund; Ministry of Science, Technology and Innovation Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported by the University of Malaya Postgraduate Researh Fund (Grant no.: PV088/2012A) and Science Fund from the Ministry of Science, Technology and Innovation Malaysia (Grant no.: 02-01-03-SF0807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Chang KC, 2002, MOL PHARMACOL, V61, P1184, DOI 10.1124/mol.61.5.1184; Dahlan HM, 2012, J NUTR BIOCHEM, V23, P741, DOI 10.1016/j.jnutbio.2011.03.018; Dahlberg JE, 1998, CURR OPIN CELL BIOL, V10, P400, DOI 10.1016/S0955-0674(98)80017-3; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Frykman S, 2001, BIOTECHNOL BIOENG, V76, P259, DOI 10.1002/bit.10003; Fu J, 2010, NATURE ED, V3, P32; GREGORY CD, 1988, J EXP MED, V167, P1811, DOI 10.1084/jem.167.6.1811; Haves-Zburof D, 2011, J CELL MOL MED, V15, P2421, DOI 10.1111/j.1582-4934.2010.01229.x; JENO P, 1995, ANAL BIOCHEM, V224, P75, DOI 10.1006/abio.1995.1010; Kagedal K, 2001, FASEB J, V15, P1592, DOI 10.1096/fj.00-0708fje; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Labonte P, 2009, HEPATOLOGY, V50, P17, DOI 10.1002/hep.22911; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; Niles AL, 2007, ANAL BIOCHEM, V366, P197, DOI 10.1016/j.ab.2007.04.007; Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0; Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517; Pattanakitsakul S, 2007, J PROTEOME RES, V6, P4592, DOI 10.1021/pr070366b; Peri P, 2007, J GEN VIROL, V88, P2101, DOI 10.1099/vir.0.82990-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031; Rintahaka J, 2011, J IMMUNOL, V186, P3085, DOI 10.4049/jimmunol.1002051; Ruiz MC, 2000, CELL CALCIUM, V28, P137, DOI 10.1054/ceca.2000.0142; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sokol JP, 2004, MOL CANCER RES, V2, P183; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sun M, 2011, J CELL SCI, V124, P4096, DOI 10.1242/jcs.091363; Tan EC, 2012, PLANT CELL TISS ORG, V111, P219, DOI 10.1007/s11240-012-0188-8; Thio CLP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061444; Thor F, 2009, TRAFFIC, V10, P1819, DOI 10.1111/j.1600-0854.2009.00989.x; Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129033	10.1371/journal.pone.0129033	http://dx.doi.org/10.1371/journal.pone.0129033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083627	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400078
J	Lu, CF; Liu, YC; Yang, YR; Wu, YT; Wang, RY				Lu, Chia-Feng; Liu, Yan-Ci; Yang, Yea-Ru; Wu, Yu-Te; Wang, Ray-Yau			Maintaining Gait Performance by Cortical Activation during Dual-Task Interference: A Functional Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							COGNITIVE-MOTOR INTERFERENCE; GAITRITE(R) WALKWAY SYSTEM; STRIDE-TIME VARIABILITY; AGE-RELATED DIFFERENCES; CEREBRAL OXYGENATION; EXECUTIVE FUNCTION; BRAIN ACTIVATION; PARKINSONS-DISEASE; MOTION ARTIFACTS; ELDERLY FALLERS	In daily life, mobility requires walking while performing a cognitive or upper-extremity motor task. Although previous studies have evaluated the effects of dual tasks on gait performance, few studies have evaluated cortical activation and its association with gait disturbance during dual tasks. In this study, we simultaneously assessed gait performance and cerebral oxygenation in the bilateral prefrontal cortices (PFC), premotor cortices (PMC), and supplemental motor areas (SMA), using functional near-infrared spectroscopy, in 17 young adults performing dual tasks. Each participant was evaluated while performing normal-pace walking (NW), walking while performing a cognitive task (WCT), and walking while performing a motor task (WMT). Our results indicated that the left PFC exhibited the strongest and most sustained activation during WCT, and that NW and WMT were associated with minor increases in oxygenation levels during their initial phases. We observed increased activation in channels in the SMA and PMC during WCT and WMT. Gait data indicated that WCT and WMT both caused reductions in walking speed, but these reductions resulted from differing alterations in gait properties. WCT was associated with significant changes in cadence, stride time, and stride length, whereas WMT was associated with reductions in stride length only. During dual-task activities, increased activation of the PMC and SMA correlated with declines in gait performance, indicating a control mechanism for maintaining gait performance during dual tasks. Thus, the regulatory effects of cortical activation on gait behavior enable a second task to be performed while walking.	[Lu, Chia-Feng] Taipei Med Univ, Coll Med, Translat Imaging Res Ctr, Taipei, Taiwan; [Lu, Chia-Feng] Taipei Med Univ, Sch Med, Dept Radiol, Taipei, Taiwan; [Lu, Chia-Feng; Liu, Yan-Ci; Yang, Yea-Ru; Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Yang, Yea-Ru] Taipei City Hosp, Taipei, Taiwan; [Wu, Yu-Te] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Wu, Yu-Te] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Wu, Yu-Te] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan	Taipei Medical University; Taipei Medical University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wu, YT (corresponding author), Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan.	ytwu@ym.edu.tw; rywang@ym.edu.tw			National Science Council [NSC102-2221-E-010-013-MY3, NSC102-2314-B-010-059, MOST103-2314-B-01-002-MY3]; Taipei City Hospital [102TPECH10]; National Science Council support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 101-2911-I-008-001]; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei City Hospital; National Science Council support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	The study was funded in part by the National Science Council (NSC102-2221-E-010-013-MY3, NSC102-2314-B-010-059, and MOST103-2314-B-01-002-MY3), the Taipei City Hospital (102TPECH10), the National Science Council support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 101-2911-I-008-001) and Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; Atsumori H, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3462996; Beauchet Olivier, 2005, J Neuroeng Rehabil, V2, P26, DOI 10.1186/1743-0003-2-26; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beurskens R, 2014, INT J PSYCHOPHYSIOL, V92, P122, DOI 10.1016/j.ijpsycho.2014.03.005; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Bock O, 2011, GAIT POSTURE, V33, P190, DOI 10.1016/j.gaitpost.2010.10.095; Bond JM, 2000, ARCH PHYS MED REHAB, V81, P110, DOI 10.1016/S0003-9993(00)90230-2; Brigadoi S, 2014, NEUROIMAGE, V85, P181, DOI 10.1016/j.neuroimage.2013.04.082; Camicioli R, 1997, JOURNAL OF GERIATRIC, V11, P181; Camicioli R, 2006, J NEUROL SCI, V248, P205, DOI 10.1016/j.jns.2006.05.013; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; Chetverikov D, 2002, 2002 PROCEEDINGS 16T; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Cockburn J, 2003, CLIN REHABIL, V17, P167, DOI 10.1191/0269215503cr597oa; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Collette F, 2005, HUM BRAIN MAPP, V25, P409, DOI 10.1002/hbm.20118; Cooper RJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00147; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Coppin AK, 2006, AGE AGEING, V35, P619, DOI 10.1093/ageing/afl107; deTalhouet H, 1996, PHYSIOL MEAS, V17, P81, DOI 10.1088/0967-3334/17/2/003; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Franceschini MA, 2006, BIOMEDO, V11; Gagnon Roy E, 2002, J Clin Monit Comput, V17, P385, DOI 10.1023/A:1026274124837; Galletly R, 2005, AUST J PHYSIOTHER, V51, P175, DOI 10.1016/S0004-9514(05)70024-6; Grassi B, 1999, J APPL PHYSIOL, V87, P348, DOI 10.1152/jappl.1999.87.1.348; Grubhofer G, 1999, ACTA ANAESTH SCAND, V43, P470, DOI 10.1034/j.1399-6576.1999.430417.x; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harada T, 2009, EXP BRAIN RES, V193, P445, DOI 10.1007/s00221-008-1643-y; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Hodges PW, 2001, EXP BRAIN RES, V141, P261, DOI 10.1007/s002210100873; Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; Holtzer R, 2011, J GERONTOL A-BIOL, V66, P879, DOI 10.1093/gerona/glr068; HOSHI Y, 1993, BRAIN RES, V603, P215, DOI 10.1016/0006-8993(93)91240-S; Houglum PA, 2011, BRUNNSTROMS CLINICAL; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Immisch I, 2001, NEUROIMAGE, V14, P674, DOI 10.1006/nimg.2001.0856; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Kocsis L, 2006, PHYS MED BIOL, V51, pN91, DOI 10.1088/0031-9155/51/5/N02; Kurz MJ, 2012, NEUROIMAGE, V59, P1602, DOI 10.1016/j.neuroimage.2011.08.084; Lajoie Y, 1996, EXP AGING RES, V22, P185, DOI 10.1080/03610739608254006; Lassnigg A, 1999, J CARDIOTHOR VASC AN, V13, P544, DOI 10.1016/S1053-0770(99)90005-8; Lee KM, 2000, ANN NEUROL, V48, P657, DOI 10.1002/1531-8249(200010)48:4<657::AID-ANA13>3.3.CO;2-B; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; Li KZH, 2001, PSYCHOL SCI, V12, P230, DOI 10.1111/1467-9280.00341; Liao LD, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-38; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Lovden M, 2008, J GERONTOL B-PSYCHOL, V63, pP121; Meester D, 2014, FRONTIERS IN HUMAN N, P8; Mehagnoul-Schipper DJ, 2002, HUM BRAIN MAPP, V16, P14, DOI 10.1002/hbm.10026; Menz HB, 2004, GAIT POSTURE, V20, P20, DOI 10.1016/S0966-6362(03)00068-7; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Mihara M, 2007, NEUROIMAGE, V37, P1338, DOI 10.1016/j.neuroimage.2007.06.014; Mirelman A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-85; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Miyai I, 2003, STROKE, V34, P2866, DOI 10.1161/01.STR.0000100166.81077.8A; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Nagdyman N, 2008, PEDIATR ANESTH, V18, P160, DOI 10.1111/j.1460-9592.2007.02365.x; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Patel P, 2014, NEUROSCIENCE, V260, P140, DOI 10.1016/j.neuroscience.2013.12.016; Pettersson AF, 2007, J GERIATR PSYCH NEUR, V20, P58, DOI 10.1177/0891988706293528; Pfurtscheller G, 2010, INT J PSYCHOPHYSIOL, V76, P186, DOI 10.1016/j.ijpsycho.2010.03.013; Piper SK, 2014, NEUROIMAGE, V85, P64, DOI 10.1016/j.neuroimage.2013.06.062; Rochester L, 2005, ARCH PHYS MED REHAB, V86, P999, DOI 10.1016/j.apmr.2004.10.040; Ruthruff E, 2001, PSYCHON B REV, V8, P73, DOI 10.3758/BF03196141; Schmidt RA, 1988, MOTOR CONTROL AND LE; Schmitz CH, 2005, APPL OPTICS, V44, P2140, DOI 10.1364/AO.44.002140; Schneider P, 2011, ROFO-FORTSCHR RONTG, V183, P956, DOI 10.1055/s-0031-1281726; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Seitz RJ, 1998, ARCH NEUROL-CHICAGO, V55, P1081, DOI 10.1001/archneur.55.8.1081; Serrien DJ, 2002, NEUROSCI LETT, V328, P89, DOI 10.1016/S0304-3940(02)00499-8; Sparrow WA, 2002, HUM MOVEMENT SCI, V21, P961, DOI 10.1016/S0167-9457(02)00154-9; Sparrow WA, 2006, MOTOR CONTROL, V10, P201, DOI 10.1123/mcj.10.3.201; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Tian F, 2014, BIOMEDICAL OPTICS; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Toulotte C, 2006, DISABIL REHABIL, V28, P125, DOI 10.1080/09638280500163653; VIALLET F, 1992, EXP BRAIN RES, V88, P674; Wilcox T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852551; Wolf M, 2002, NEUROIMAGE, V16, P704, DOI 10.1006/nimg.2002.1128; Wu T, 2010, BRAIN; Wylie GR, 2009, NEUROIMAGE, V47, P473, DOI 10.1016/j.neuroimage.2009.04.056; Yennu AS, 2012, BIOMEDICAL OPTICS; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697; Zhang YH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852552	96	42	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129390	10.1371/journal.pone.0129390	http://dx.doi.org/10.1371/journal.pone.0129390			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9EB	26079605	Green Submitted, gold, Green Published			2022-12-26	WOS:000356542300022
J	Wang, ZP; Niu, WB; Wang, YJ; Teng, Z; Wen, J; Xia, GL; Wang, C				Wang, Zhengpin; Niu, Wanbao; Wang, Yijing; Teng, Zhen; Wen, Jia; Xia, Guoliang; Wang, Chao			Follistatin288 Regulates Germ Cell Cyst Breakdown and Primordial Follicle Assembly in the Mouse Ovary	PLOS ONE			English	Article							OOCYTE NEST BREAKDOWN; INTRACELLULAR DOMAIN; GRANULOSA-CELL; IN-VITRO; ACTIVIN; NOTCH; PROTEINS; SURVIVAL; DEFECTS; BINDING	In mammals, the primordial follicle pool represents the entire reproductive potential of a female. The transforming growth factor-beta (TGF-beta) family member activin (ACT) contributes to folliculogenesis, although the exact mechanism is not known. The role of FST288, the strongest ACT-neutralizing isoform of follistatin (FST), during cyst breakdown and primordial follicle formation in the fetal mice ovary was assessed using an in vitro culture system. FST was continuously expressed in the oocytes as well as the cuboidal granulosa cells of growing follicles in perinatal mouse ovaries. Treatment with FST288 delayed germ cell nest breakdown, particularly near the periphery of the ovary, and dramatically decreased the percentage of primordial follicles. In addition, there was a dramatic decrease in proliferation of granulosa cells and somatic cell expression of Notch signaling was impaired. In conclusion, FST288 impacts germ cell nest breakdown and primordial follicle assembly by inhibiting somatic cell proliferation.	[Wang, Zhengpin; Niu, Wanbao; Wang, Yijing; Teng, Zhen; Wen, Jia; Xia, Guoliang; Wang, Chao] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	China Agricultural University	Wang, C (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	wangcam@cau.edu.cn	Teng, Zhen/I-4601-2019; Wang, Zhengpin/AAM-3021-2020	Teng, Zhen/0000-0002-3827-2197; Wang, Zhengpin/0000-0001-5388-1516	National Basic Research Program of China (973) [2013CB945500, 2012CB944701]	National Basic Research Program of China (973)(National Basic Research Program of China)	This work was supported by the National Basic Research Program Grant 2013CB945500, 2012CB944701 of China (973).	Abe T, 2005, MECH DEVELOP, V122, P671, DOI 10.1016/j.mod.2004.12.006; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Chen Y, 2007, ENDOCRINOLOGY, V148, P3580, DOI 10.1210/en.2007-0088; Drummond AE, 2005, CELL TISSUE RES, V322, P107, DOI 10.1007/s00441-005-1153-1; Gao XW, 2010, J BIOL CHEM, V285, P36857, DOI 10.1074/jbc.M110.144477; Gosden RG, 1998, REPROD FERT DEVELOP, V10, P73, DOI 10.1071/R98043; Guo Meng, 2012, Front Biosci (Elite Ed), V4, P2631; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Jefferson W, 2006, BIOL REPROD, V74, P161, DOI 10.1095/biolreprod.105.045724; Jorgez CJ, 2004, MOL ENDOCRINOL, V18, P953, DOI 10.1210/me.2003-0301; Kaivo-Oja N, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-21; Kimura F, 2011, ENDOCRINOLOGY, V152, P697, DOI 10.1210/en.2010-0950; Kimura F, 2010, ENDOCRINOLOGY, V151, P1310, DOI 10.1210/en.2009-1176; KOGAWA K, 1991, ENDOCRINOL JAPON, V38, P383; LING N, 1985, P NATL ACAD SCI USA, V82, P7217, DOI 10.1073/pnas.82.21.7217; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; Myers M, 2009, DEV BIOL, V334, P458, DOI 10.1016/j.ydbio.2009.08.001; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Rodrigues P, 2009, REPRODUCTION, V137, P709, DOI 10.1530/REP-08-0203; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Trombly DJ, 2009, ENDOCRINOLOGY, V150, P1014, DOI 10.1210/en.2008-0213; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; VALE W, 1988, RECENT PROG HORM RES, V44, P1; Vanorny DA, 2014, MOL ENDOCRINOL, V28, P499, DOI 10.1210/me.2013-1288; Wang HB, 2001, CHINESE SCI BULL, V46, P672, DOI 10.1007/BF03182833; Wang ZP, 2014, J BIOL CHEM, V289, P8299, DOI 10.1074/jbc.M113.532952; WEISS J, 1993, ENDOCRINOLOGY, V132, P2307, DOI 10.1210/en.132.6.2307; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Xu JX, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-13; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	39	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129643	10.1371/journal.pone.0129643	http://dx.doi.org/10.1371/journal.pone.0129643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076381	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900087
J	Faridounnia, M; Wienk, H; Kovacic, L; Folkers, GE; Jaspers, NGJ; Kaptein, R; Hoeijmakers, JHJ; Boelens, R				Faridounnia, Maryam; Wienk, Hans; Kovacic, Lidija; Folkers, Gert E.; Jaspers, Nicolaas G. J.; Kaptein, Robert; Hoeijmakers, Jan H. J.; Boelens, Rolf			The Cerebro-oculo-facio-skeletal Syndrome Point Mutation F231L in the ERCC1 DNA Repair Protein Causes Dissociation of the ERCC1-XPF Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM; LATE-ONSET; ENDONUCLEASE ERCC1-XPF; MOLECULAR-MECHANISM; INTERACTION DOMAINS; HYDROGEN-EXCHANGE; MAMMALIAN-CELLS; CHEMICAL-SHIFTS; FANCONI-ANEMIA	The ERCC1-XPF heterodimer, a structure-specific DNA endonuclease, is best known for its function in the nucleotide excision repair (NER) pathway. The ERCC1 point mutation F231L, located at the hydrophobic interaction interface of ERCC1 (excision repair cross-complementation group 1) and XPF (xeroderma pigmentosum complementation group F), leads to severe NER pathway deficiencies. Here, we analyze biophysical properties and report the NMR structure of the complex of the C-terminal tandem helix-hairpin- helix domains of ERCC1-XPF that contains this mutation. The structures of wild type and the F231L mutant are very similar. The F231L mutation results in only a small disturbance of the ERCC1-XPF interface, where, in contrast to Phe(231), Leu(231) lacks interactions stabilizing the ERCC1-XPF complex. One of the two anchor points is severely distorted, and this results in a more dynamic complex, causing reduced stability and an increased dissociation rate of the mutant complex as compared with wild type. These data provide a biophysical explanation for the severe NER deficiencies caused by this mutation.	[Faridounnia, Maryam; Wienk, Hans; Folkers, Gert E.; Kaptein, Robert; Boelens, Rolf] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Kovacic, Lidija] Jozef Stefan Inst, Dept Mol & Biomed Sci, SI-1000 Ljubljana, Slovenia; [Jaspers, Nicolaas G. J.; Hoeijmakers, Jan H. J.] Erasmus MC, Dept Genet, NL-3000 CA Rotterdam, Netherlands	Utrecht University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Erasmus University Rotterdam; Erasmus MC	Boelens, R (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	r.boelens@uu.nl	Folkers, Gert E/C-2863-2009; Hoeijmakers, Jan/AAX-6972-2021; Faridounnia, Maryam/X-7736-2018; Wienk, Hans/P-8929-2015; Boelens, Rolf/B-4702-2009	Folkers, Gert E/0000-0003-1070-0505; Faridounnia, Maryam/0000-0002-6260-7639; Wienk, Hans/0000-0001-9577-0064; Boelens, Rolf/0000-0002-6939-8913	Netherlands Foundation of Chemical Research (NWO-CW); European Union [261863]; Royal Academy of Arts and Sciences of the Netherlands; European Research Council [GA233424]; Slovenian Ministry of Higher Education, Science, and Technology [Z1-4071]; Infrastructural Centre for Analysis of Molecular Interactions, Department of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	Netherlands Foundation of Chemical Research (NWO-CW); European Union(European Commission); Royal Academy of Arts and Sciences of the Netherlands; European Research Council(European Research Council (ERC)European Commission); Slovenian Ministry of Higher Education, Science, and Technology; Infrastructural Centre for Analysis of Molecular Interactions, Department of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Netherlands Foundation of Chemical Research (NWO-CW) and the European Union (Project BioNMR, No. 261863); the Royal Academy of Arts and Sciences of the Netherlands (academic professorship to J. H. J. H.); the European Research Council (Project DamAge No. GA233424; to J. H. J. H.); and the Slovenian Ministry of Higher Education, Science, and Technology (Z1-4071; to L. K.) and their support of the Infrastructural Centre for Analysis of Molecular Interactions, Department of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Al-Minawi AZ, 2008, NUCLEIC ACIDS RES, V36, P1, DOI 10.1093/nar/gkm888; Al-Minawi AZ, 2009, NUCLEIC ACIDS RES, V37, P6400, DOI 10.1093/nar/gkp705; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P533, DOI 10.1016/B978-012164491-8/50009-9; Chelli R, 2002, J AM CHEM SOC, V124, P6133, DOI 10.1021/ja0121639; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Das D, 2008, PROTEINS, V70, P1551, DOI 10.1002/prot.21635; Das D, 2012, STRUCTURE, V20, P667, DOI 10.1016/j.str.2012.02.009; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; de Laat WL, 1998, NUCLEIC ACIDS RES, V26, P4146, DOI 10.1093/nar/26.18.4146; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; FARABAUGH PJ, 1978, NATURE, V274, P765, DOI 10.1038/274765a0; Finkelstein A. V., 2002, METHODS MOL BIOPHYSI, p[57, 117]; Friedberg E.C., 1995, DNA REPAIR MUTAGENES, P135; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Goddard TD, 2006, SPARKY 3 VERSION 3 1; Gregg SQ, 2011, DNA REPAIR, V10, P781, DOI 10.1016/j.dnarep.2011.04.026; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Imoto K, 2007, J INVEST DERMATOL, V127, pS92; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; KONDO S, 1989, PHOTODERMATOLOGY, V6, P89; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; Politou AS, 1995, BIOPHYS J, V69, P2601, DOI 10.1016/S0006-3495(95)80131-1; PURICH DL, 1980, METHOD ENZYMOL, V64, P3; Sargent RG, 2000, NUCLEIC ACIDS RES, V28, P3771, DOI 10.1093/nar/28.19.3771; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Serdyuk I. N., 2007, METHODS MOL BIOPHYSI, P21; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sijbers AM, 1998, J INVEST DERMATOL, V110, P832, DOI 10.1046/j.1523-1747.1998.00171.x; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014; Tripsianes K, 2007, NUCLEIC ACIDS RES, V35, P5789, DOI 10.1093/nar/gkm503; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; VANDUIN M, 1988, NUCLEIC ACIDS RES, V16, P5305, DOI 10.1093/nar/16.12.5305; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wu YL, 2008, MECH AGEING DEV, V129, P602, DOI 10.1016/j.mad.2008.08.004; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	66	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20541	20555		10.1074/jbc.M114.635169	http://dx.doi.org/10.1074/jbc.M114.635169			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26085086	Green Published, hybrid			2022-12-26	WOS:000359608900050
J	Askenasy, I; Pennington, JM; Tao, YQ; Marshall, AG; Young, NL; Shang, WF; Stroupe, ME				Askenasy, Isabel; Pennington, Joseph M.; Tao, Yeqing; Marshall, Alan G.; Young, Nicolas L.; Shang, Weifeng; Stroupe, M. Elizabeth			The N-terminal Domain of Escherichia coli Assimilatory NADPH-Sulfite Reductase Hemoprotein Is an Oligomerization Domain That Mediates Holoenzyme Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CYCLOTRON RESONANCE; FLAVIN ADENINE-DINUCLEOTIDE; MOLTEN GLOBULE STATE; IRON-SULFUR; SALMONELLA-TYPHIMURIUM; FLAVOPROTEIN COMPONENT; MASS-SPECTROMETRY; CATALYTIC PARAMETERS; PROSTHETIC GROUPS; BINDING DOMAIN	Assimilatory NADPH-sulfite reductase (SiR) from Escherichia coli is a structurally complex oxidoreductase that catalyzes the six-electron reduction of sulfite to sulfide. Two subunits, one a flavin-binding flavoprotein (SiRFP, the alpha subunit) and the other an iron-containing hemoprotein (SiRHP, the beta subunit), assemble to make a holoenzyme of about 800 kDa. How the two subunits assemble is not known. The iron-rich cofactors in SiRHP are unique because they are a covalent arrangement of a Fe4S4 cluster attached through a cysteine ligand to an iron-containing porphyrinoid called siroheme. The link between cofactor biogenesis and SiR stability is also ill-defined. By use of hydrogen/deuterium exchange and biochemical analysis, we show that the alpha(8)beta(4) SiR holoenzyme assembles through the N terminus of SiRHP and the NADPH binding domain of SiRFP. By use of small angle x-ray scattering, we explore the structure of the SiRHP N-terminal oligomerization domain. We also report a novel form of the hemoprotein that occurs in the absence of its cofactors. Apo-SiRHP forms a homotetramer, also dependent on its N terminus, that is unable to assemble with SiRFP. From these results, we propose that homotetramerization of apo-SiRHP serves as a quality control mechanism to prevent formation of inactive holoenzyme in the case of limiting cellular siroheme.	[Askenasy, Isabel; Pennington, Joseph M.; Stroupe, M. Elizabeth] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Askenasy, Isabel; Pennington, Joseph M.; Stroupe, M. Elizabeth] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Tao, Yeqing; Marshall, Alan G.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Marshall, Alan G.; Young, Nicolas L.] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Shang, Weifeng] IIT, Ctr Synchrotron Radiat Res & Instrumentat, Chicago, IL 60616 USA; [Shang, Weifeng] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Illinois Institute of Technology; Illinois Institute of Technology	Stroupe, ME (corresponding author), Florida State Univ, Dept Biol Sci, 91 Chieftain Way, Tallahassee, FL 32306 USA.	mestroupe@bio.fsu.edu	Young, Nicolas/AAI-5242-2020	Young, Nicolas/0000-0002-3323-2815; Stroupe, M. Elizabeth/0000-0002-4393-1951	DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER; Direct For Biological Sciences [1149763] Funding Source: National Science Foundation	DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. CD and DLS were performed in Florida State University Physical Biochemistry Facility, managed by Dr. Claudius Mundoma. HDX experiments were performed at the National High Magnetic Field Laboratory in Tallahassee, FL. We kindly thank Drs. Christopher Stroupe, Scott Stagg, and Kathryn Jones for helpful conversations.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Andersson D, 2001, BIOCHEMISTRY-US, V40, P2653, DOI 10.1021/bi000957e; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; BEU SC, 1992, ANAL CHEM, V64, P177, DOI 10.1021/ac00026a016; Blasco F, 1998, MOL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2958.1998.00795.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Coves J, 1997, BIOCHEMISTRY-US, V36, P5921, DOI 10.1021/bi9623744; Crane BR, 1997, BIOCHEMISTRY-US, V36, P12101, DOI 10.1021/bi971065q; Crane BR, 1997, BIOCHEMISTRY-US, V36, P12120, DOI 10.1021/bi971066i; Crane BR, 1996, CURR OPIN STRUC BIOL, V6, P744, DOI 10.1016/S0959-440X(96)80003-0; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; FAEDER EJ, 1974, J BIOL CHEM, V249, P1599; Fischetti R, 2004, J SYNCHROTRON RADIAT, V11, P399, DOI 10.1107/S0909049504016760; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; Gruez A, 1998, ACTA CRYSTALLOGR D, V54, P135, DOI 10.1107/S090744499701069X; Hermann B, 2015, NATURE, V520, P706, DOI 10.1038/nature14109; Kaiser NK, 2011, ANAL CHEM, V83, P6907, DOI 10.1021/ac201546d; KRUEGER RJ, 1982, BIOCHEMISTRY-US, V21, P2892, DOI 10.1021/bi00541a014; Leal SS, 2007, PROTEINS, V68, P606, DOI 10.1002/prot.21448; LEDFORD EB, 1984, ANAL CHEM, V56, P2744, DOI 10.1021/ac00278a027; Lofgren M, 2013, NAT CHEM BIOL, V9, P535, DOI [10.1038/NCHEMBIO.1298, 10.1038/nchembio.1298]; Marshall AG, 1996, RAPID COMMUN MASS SP, V10, P1819, DOI 10.1002/(SICI)1097-0231(199611)10:14<1819::AID-RCM686>3.0.CO;2-Z; MURPHY MJ, 1973, J BIOL CHEM, V248, P2801; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; OSTROWSKI J, 1989, J BACTERIOL, V171, P130, DOI 10.1128/jb.171.1.130-140.1989; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15726; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15796; PEAKMAN T, 1990, EUR J BIOCHEM, V191, P325, DOI 10.1111/j.1432-1033.1990.tb19126.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PILON M, 1992, J BIOL CHEM, V267, P19907; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rollings J. E., 1992, LASER LIGHT SCATTERI, P275; ROSE WC, 1950, J BIOL CHEM, V182, P541; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Sambrook J., 1989, MOL CLONING LAB MANU; Schaub TM, 2008, ANAL CHEM, V80, P3985, DOI 10.1021/ac800386h; Schwartz JC, 2002, J AM SOC MASS SPECTR, V13, P659, DOI 10.1016/S1044-0305(02)00384-7; Senko MW, 1997, J AM SOC MASS SPECTR, V8, P970, DOI 10.1016/S1044-0305(97)00126-8; Shi SDH, 2000, INT J MASS SPECTROM, V195, P591, DOI 10.1016/S1387-3806(99)00226-2; Shibuya T, 2006, RNA, V12, P360, DOI 10.1261/rna.2190706; Sibille N, 2005, BIOCHEMISTRY-US, V44, P9086, DOI 10.1021/bi050437p; SIEGEL LM, 1982, J BIOL CHEM, V257, P6343; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SIEGEL LM, 1974, J BIOL CHEM, V249, P1587; SIEGEL LM, 1973, J BIOL CHEM, V248, P251; SIEGEL LM, 1974, J BIOL CHEM, V249, P1572; Silberg JJ, 2004, J BIOL CHEM, V279, P53924, DOI 10.1074/jbc.M410117200; Smith KW, 2012, BIOCHEMISTRY-US, V51, P9857, DOI 10.1021/bi300947a; STEUBER J, 1994, ARCH MICROBIOL, V162, P255, DOI 10.1007/s002030050134; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Swamy U, 2005, BIOCHEMISTRY-US, V44, P16054, DOI 10.1021/bi050981y; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wilcox BE, 2002, J AM SOC MASS SPECTR, V13, P1304, DOI 10.1016/S1044-0305(02)00622-0; Wu HC, 1998, MOL MICROBIOL, V27, P493, DOI 10.1046/j.1365-2958.1998.00699.x; WU JY, 1991, J BACTERIOL, V173, P325, DOI 10.1128/jb.173.1.325-333.1991; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; Yu XK, 2008, STRUCTURE, V16, P104, DOI 10.1016/j.str.2007.10.024; Zeghouf M, 2000, J BIOL CHEM, V275, P37651, DOI 10.1074/jbc.M005619200; Zeghouf M, 1998, BIOCHEMISTRY-US, V37, P6114, DOI 10.1021/bi9728699; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200; Zhang ZQ, 1997, PROTEIN SCI, V6, P2203	69	8	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19319	19333		10.1074/jbc.M115.662379	http://dx.doi.org/10.1074/jbc.M115.662379			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26088143	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000358781100043
J	Motozono, C; Pearson, JA; De Leenheer, E; Rizkallah, PJ; Beck, K; Trimby, A; Sewell, AK; Wong, FS; Cole, DK				Motozono, Chihiro; Pearson, James A.; De Leenheer, Evy; Rizkallah, Pierre J.; Beck, Konrad; Trimby, Andrew; Sewell, Andrew K.; Wong, F. Susan; Cole, David K.			Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; KILL BETA-CELLS; CD8 CORECEPTOR; NOD MICE; MOLECULAR MIMICRY; STRUCTURAL BASIS; SELF-PEPTIDE; TCR-BINDING; MHC; RECOGNITION	The non-obese diabetic mouse model of type 1 diabetes continues to be an important tool for delineating the role of T-cell mediated destruction of pancreatic beta-cells. However, little is known about the molecular mechanisms that enable this disease pathway. We show that insulin reactivity by a CD8(+) T-cell clone, known to induce type 1 diabetes, is characterized by weak T-cell antigen receptor binding to a relatively unstable peptide-MHC. The structure of the native 9- and 10-mer insulin epitopes demonstrated that peptide residues 7 and 8 form a prominent solvent-exposed bulge that could potentially be the main focus of T-cell receptor binding. The C terminus of the peptide governed peptide-MHC stability. Unexpectedly, we further demonstrate a novel mode of flexible peptide presentation in which the MHC peptide-binding groove is able to "open the back door" to accommodate extra C-terminal peptide residues.	[Motozono, Chihiro; Rizkallah, Pierre J.; Trimby, Andrew; Sewell, Andrew K.; Cole, David K.] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Pearson, James A.; De Leenheer, Evy; Wong, F. Susan] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF14 4XN, S Glam, Wales; [Motozono, Chihiro] Kinki Univ, Sch Med, Dept Immunol, Osaka 5898511, Japan; [Beck, Konrad] Cardiff Univ, Sch Dent, Cardiff CF14 4XY, S Glam, Wales	Cardiff University; Cardiff University; Kindai University (Kinki University); Cardiff University	Wong, FS (corresponding author), Cardiff Univ, Sch Med, Inst Mol & Expt Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	wongfs@cf.ac.uk	Sewell, Andrew/GPT-4220-2022; Rizkallah, Pierre J/A-5367-2012; Beck, Konrad/AAX-1351-2020	Sewell, Andrew/0000-0003-3194-3135; Rizkallah, Pierre J/0000-0002-9290-0369; Beck, Konrad/0000-0001-5098-9484; Pearson, James/0000-0002-2867-2269; Cole, David/0000-0003-0028-9396; Wong, F. Susan/0000-0002-2812-8845	Wellcome Trust ISSF grant; United Kingdom Biotechnology and Biological Sciences Research Council [BB/H001085/1]; Medical Research Council [G0901155]; Diabetes UK PhD studentship; Research Councils United Kingdom fellowship; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Wellcome Trust [100327/Z/12/Z] Funding Source: researchfish; BBSRC [BB/H001085/1] Funding Source: UKRI; MRC [G0901155] Funding Source: UKRI	Wellcome Trust ISSF grant(Wellcome Trust); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK PhD studentship(Diabetes UK); Research Councils United Kingdom fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust ISSF grant (to F. S. W., D. K. C., and A. K. S.), United Kingdom Biotechnology and Biological Sciences Research Council Grant BB/H001085/1 (to A. K. S.), and Medical Research Council Grant G0901155 (to F. S. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Diabetes UK PhD studentship.; Supported by a Research Councils United Kingdom fellowship.	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Alleva DG, 2002, DIABETES, V51, P2126, DOI 10.2337/diabetes.51.7.2126; Alleva DG, 2001, J CLIN INVEST, V107, P173, DOI 10.1172/JCI8525; Babad J, 2010, IMMUNOLOGY, V131, P459, DOI 10.1111/j.1365-2567.2010.03362.x; Bettini M, 2011, CURR OPIN IMMUNOL, V23, P754, DOI 10.1016/j.coi.2011.10.002; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Bulek AM, 2012, J IMMUNOL METHODS, V382, P203, DOI 10.1016/j.jim.2012.06.007; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2014, J BIOL CHEM, V289, P628, DOI 10.1074/jbc.M113.522110; Cole DK, 2012, IMMUNOLOGY, V137, P139, DOI 10.1111/j.1365-2567.2012.03625.x; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; de Marquesini LGP, 2008, EUR J IMMUNOL, V38, P240, DOI 10.1002/eji.2007377621; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Ekeruche-Makinde J, 2013, BLOOD, V121, P1112, DOI 10.1182/blood-2012-06-437202; Ekeruche-Makinde J, 2012, J BIOL CHEM, V287, P37269, DOI 10.1074/jbc.M112.386409; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Jayasimhan A, 2014, CLIN SCI, V126, P1, DOI 10.1042/CS20120627; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Madura F, 2013, J BIOL CHEM, V288, P18766, DOI 10.1074/jbc.M113.464560; Martinez CR, 2012, CHEM SCI, V3, P2191, DOI 10.1039/c2sc20045g; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melenhorst JJ, 2008, J IMMUNOL METHODS, V338, P31, DOI 10.1016/j.jim.2008.07.008; Miles KM, 2011, MOL IMMUNOL, V48, P728, DOI 10.1016/j.molimm.2010.11.004; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Sandalova T, 2005, J BIOL CHEM, V280, P27069, DOI 10.1074/jbc.M500927200; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Uchtenhagen H, 2013, EUR J IMMUNOL, V43, P3051, DOI 10.1002/eji.201343456; van Stipdonk MJB, 2009, CANCER RES, V69, P7784, DOI 10.1158/0008-5472.CAN-09-1724; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Vizler C, 1999, IMMUNOL REV, V169, P81; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wong FS, 2009, DIABETES, V58, P1156, DOI 10.2337/db08-0800; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Wong FS, 2002, P NATL ACAD SCI USA, V99, P5551, DOI 10.1073/pnas.072037299; Wong FS, 1998, J EXP MED, V187, P1985; Wooldridge L, 2005, J BIOL CHEM, V280, P27491, DOI 10.1074/jbc.M500555200; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21	68	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18924	18933		10.1074/jbc.M114.622522	http://dx.doi.org/10.1074/jbc.M114.622522			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085090	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000358781100005
J	Myers, CL; Ireland, RG; Garrett, TA; Brown, ED				Myers, Cullen L.; Ireland, Ronald G.; Garrett, Teresa A.; Brown, Eric D.			Characterization of Wall Teichoic Acid Degradation by the Bacteriophage phi 29 Appendage Protein GP12 Using Synthetic Substrate Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO RECONSTITUTION; CELL-WALL; STAPHYLOCOCCUS-AUREUS; PHOSPHODIESTERASE ACTIVITIES; GLYCEROL PHOSPHATE; POLYMERASE TAGF; MECHANISM; GLYCEROPHOSPHODIESTERASE; PROCESSIVITY; CATALYZES	The genetics and enzymology of the biosynthesis of wall teichoic acid have been the extensively studied, however, comparatively little is known regarding the enzymatic degradation of this biological polymer. The GP12 protein from the Bacillus subtilis bacteriophage phi 29 has been implicated as a wall teichoic acid hydrolase. We have studied the wall teichoic acid hydrolase activity of pure, recombinant GP12 using chemically defined wall teichoic acid analogs. The GP12 protein had potent wall teichoic acid hydrolytic activity in vitro and demonstrated similar to 13-fold kinetic preference for glycosylated poly(glycerol phosphate) teichoic acid compared with non-glycosylated. Product distribution patterns suggested that the degradation of glycosylated polymers proceeded from the hydroxyl terminus of the polymer, whereas hydrolysis occurred at random sites in the non-glycosylated polymer. In addition, we present evidence that the GP12 protein possesses both phosphodiesterase and phosphomonoesterase activities.	[Myers, Cullen L.; Ireland, Ronald G.; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Garrett, Teresa A.] Vassar Coll, Dept Chem, Poughkeepsie, NY 12604 USA	McMaster University; Vassar College	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada.	ebrown@mcmaster.ca		Ireland, Ronald G/0000-0002-4464-5412; Myers, Cullen/0000-0002-5789-2260	Canada Research Chair award; Canadian Institutes for Health Research [MOP-15496]	Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canada Research Chair award (to E.D.B.) and Canadian Institutes for Health Research Grant MOP-15496. The authors declare that they have no conflicts of interest with the contents of this article.	Allison SE, 2011, J BIOL CHEM, V286, P23708, DOI 10.1074/jbc.M111.241265; Badurina DS, 2003, BBA-PROTEINS PROTEOM, V1646, P196, DOI 10.1016/S1570-9639(03)00019-0; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; Bhavsar AP, 2005, J BIOL CHEM, V280, P36691, DOI 10.1074/jbc.M507154200; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; Botella E, 2011, MICROBIOL-SGM, V157, P2470, DOI 10.1099/mic.0.049205-0; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Bulat E, 2011, J BIOL CHEM, V286, P33819, DOI 10.1074/jbc.M111.269779; Cox RS, 2007, J AM CHEM SOC, V129, P9550, DOI 10.1021/ja072647q; Farha MA, 2013, ACS CHEM BIOL, V8, P226, DOI 10.1021/cb300413m; Ghodge SV, 2013, J AM CHEM SOC, V135, P16360, DOI 10.1021/ja409376k; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; GLASER L, 1977, J BACTERIOL, V130, P610, DOI 10.1128/JB.130.2.610-619.1977; GRANT WD, 1979, J BACTERIOL, V137, P35, DOI 10.1128/JB.137.1.35-43.1979; Hadler KS, 2008, J AM CHEM SOC, V130, P14129, DOI 10.1021/ja803346w; Hadler KS, 2010, J INORG BIOCHEM, V104, P211, DOI 10.1016/j.jinorgbio.2009.10.012; Hadler KS, 2009, J AM CHEM SOC, V131, P11900, DOI 10.1021/ja903534f; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P7721, DOI 10.1093/nar/gkm868; Keppetipola N, 2006, J BIOL CHEM, V281, P19251, DOI 10.1074/jbc.M602549200; KUSSER W, 1983, J BACTERIOL, V155, P302, DOI 10.1128/JB.155.1.302-310.1983; KUSSER W, 1984, FEBS LETT, V166, P301, DOI 10.1016/0014-5793(84)80100-3; KUSSER W, 1982, FEBS LETT, V149, P67, DOI 10.1016/0014-5793(82)81073-9; LANG WK, 1982, J BACTERIOL, V151, P367, DOI 10.1128/JB.151.1.367-375.1982; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; MAUCK J, 1971, J BIOL CHEM, V246, P1820; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Pereira MP, 2008, CHEMBIOCHEM, V9, P1385, DOI 10.1002/cbic.200800026; Pereira MP, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P337; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Schenk G, 2005, P NATL ACAD SCI USA, V102, P273, DOI 10.1073/pnas.0407239102; Schenk G, 2012, ACCOUNTS CHEM RES, V45, P1593, DOI 10.1021/ar300067g; Schertzer JW, 2008, J BACTERIOL, V190, P6940, DOI 10.1128/JB.00851-08; Schertzer JW, 2003, J BIOL CHEM, V278, P18002, DOI 10.1074/jbc.M300706200; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Schulz EC, 2011, CURR OPIN STRUC BIOL, V21, P232, DOI 10.1016/j.sbi.2011.01.009; Sewell EWC, 2014, J ANTIBIOT, V67, P43, DOI 10.1038/ja.2013.100; Sewell EWC, 2009, J BIOL CHEM, V284, P21132, DOI 10.1074/jbc.M109.010215; Sobhanifar S, 2015, P NATL ACAD SCI USA, V112, pE576, DOI 10.1073/pnas.1418084112; Soldo B, 1999, MOL MICROBIOL, V31, P795, DOI 10.1046/j.1365-2958.1999.01218.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wang H, 2013, CHEM BIOL, V20, P272, DOI 10.1016/j.chembiol.2012.11.013; Wiersma-Koch H, 2013, BIOCHEMISTRY-US, V52, P9167, DOI 10.1021/bi4010045; Winstel V, 2014, INT J MED MICROBIOL, V304, P215, DOI 10.1016/j.ijmm.2013.10.009; WISE EM, 1972, P NATL ACAD SCI USA, V69, P233, DOI 10.1073/pnas.69.1.233; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; Xiang Y, 2006, EMBO J, V25, P5229, DOI 10.1038/sj.emboj.7601386; Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009	54	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19133	19145		10.1074/jbc.M115.662866	http://dx.doi.org/10.1074/jbc.M115.662866			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085106	Green Published, hybrid			2022-12-26	WOS:000358781100029
J	Ben Haij, N; Planes, R; Leghmari, K; Serrero, M; Delobel, P; Izopet, J; BenMohamed, L; Bahraoui, E				Ben Haij, Nawal; Planes, Remi; Leghmari, Kaoutar; Serrero, Manutea; Delobel, Pierre; Izopet, Jacques; BenMohamed, Lbachir; Bahraoui, Elmostafa			HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-kappa B Pathway	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PERIPHERAL-BLOOD MONOCYTES; TNF-ALPHA; IL-10 PRODUCTION; IMMUNE ACTIVATION; ANTIINFLAMMATORY CYTOKINES; DISEASE PROGRESSION; KAPOSI-SARCOMA; GROWTH-FACTOR; SERUM-LEVELS	We recently reported that the human immunodeficiency virus type-1 (HIV-1) Tat protein induced the expression of programmed death ligand-1 (PD-L1) on dendritic cells (DCs) through a TLR4 pathway. However, the underlying mechanisms by which HIV-1 Tat protein induces the abnormal hyper-activation of the immune system seen in HIV-1 infected patients remain to be fully elucidated. In the present study, we report that HIV-1 Tat protein induced the production of significant amounts of the pro-inflammatory IL-6 and IL-8 cytokines by DCs and monocytes from both healthy and HIV-1 infected patients. Such production was abrogated in the presence of anti-TLR4 blocking antibodies or soluble recombinant TLR4-MD2 as a decoy receptor, suggesting TLR4 was recruited by Tat protein. Tat-induced murine IL-6 and CXCL1/KC a functional homologue of human IL-8 was abolished in peritoneal macrophages derived from TLR4 KO but not from Wt mice, confirming the involvement of the TLR4 pathway. Furthermore, the recruitment of TLR4-MD2-CD14 complex by Tat protein was demonstrated by the activation of TLR4 downstream pathways including NF-kappa B and SOCS-1 and by down-modulation of cell surface TLR4 by endocytosis in dynamin and lipid-raft-dependent manners. Collectively, these findings demonstrate, for the first time, that HIV-1 Tat interacts with TLR4-MD2-CD14 complex and activates the NF-kappa B pathway, leading to overproduction of IL-6 and IL-8 pro-inflammatory cytokines by myeloid cells from both healthy and HIV-1 infected patients. This study reveals a novel mechanism by which HIV-1, via its early expressed Tat protein, hijacks the TLR4 pathway, hence establishing abnormal hyper-activation of the immune system.	[Ben Haij, Nawal; Planes, Remi; Leghmari, Kaoutar; Serrero, Manutea; Delobel, Pierre; Izopet, Jacques; Bahraoui, Elmostafa] CNRS, INSERM, U1043, U5282, Toulouse, France; [Ben Haij, Nawal; Planes, Remi; Leghmari, Kaoutar; Serrero, Manutea; Delobel, Pierre; Izopet, Jacques; Bahraoui, Elmostafa] Univ Toulouse, Toulouse, France; [Ben Haij, Nawal; Planes, Remi; Leghmari, Kaoutar; Serrero, Manutea; Delobel, Pierre; Izopet, Jacques; Bahraoui, Elmostafa] Toulouse Univ Hosp, Dept Infect Dis, Toulouse, France; [BenMohamed, Lbachir] Univ Calif Irvine, Sch Med, Gavin Herbert Eye Inst, Lab Cellular & Mol Immunol, Irvine, CA 92697 USA; [BenMohamed, Lbachir] Inst Immunol, Irvine, CA 92697 USA; [BenMohamed, Lbachir] Univ Calif Irvine, Sch Med, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; CHU de Toulouse; University of California System; University of California Irvine; University of California System; University of California Irvine	Bahraoui, E (corresponding author), CNRS, INSERM, U1043, U5282, Toulouse, France.	bahraoui@cict.fr	Delobel, Pierre/K-3166-2014; Delobel, Pierre/Q-6028-2019	Delobel, Pierre/0000-0002-2874-3581; Delobel, Pierre/0000-0002-2874-3581; IZOPET, JACQUES/0000-0002-8462-3234; Serrero, Manutea Christophe/0000-0001-8221-2725	ANRS (Agence nationale de reccherche sur le SIDA); US public health NIH [EY14900 LB, EY 019896 LB]; NATIONAL EYE INSTITUTE [R01EY019896, R01EY014900] Funding Source: NIH RePORTER	ANRS (Agence nationale de reccherche sur le SIDA); US public health NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by ANRS (Agence nationale de reccherche sur le SIDA): 2013 EB - SIDACTION (Ensemble contre le SIDA): 2011 EB - US public health NIH: EY14900 LB - US public health NIH: EY 019896 LB.	Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10; Akhtar LN, 2010, J IMMUNOL, V185, P2393, DOI 10.4049/jimmunol.0903563; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; AMEGLIO F, 1994, CLIN EXP IMMUNOL, V95, P455, DOI 10.1111/j.1365-2249.1994.tb07018.x; Aoki Y, 2004, BLOOD, V104, P810, DOI 10.1182/blood-2003-07-2533; Aoki Yoshiyasu, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P81, DOI 10.2174/1568006033337294; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; Barreto-de-Souza V, 2008, MICROBES INFECT, V10, P642, DOI 10.1016/j.micinf.2008.02.014; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Ben Haij N, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-123; Benlahrech A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017525; Bennasser Y, 2002, VIROLOGY, V303, P174, DOI 10.1006/viro.2002.1676; Bennasser Y, 2002, FASEB J, V16, P546, DOI 10.1096/fj.01-0775com; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Blasdall SA, 1999, J ACQ IMMUN DEF SYND, V20, P97, DOI 10.1097/00042560-199901010-00016; Breckpot K, 2010, J VIROL, V84, P5627, DOI 10.1128/JVI.00014-10; Breen EC, 2002, PHARMACOL THERAPEUT, V95, P295, DOI 10.1016/S0163-7258(02)00263-2; BREEN EC, 1990, J IMMUNOL, V144, P480; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brigino E, 1997, P NATL ACAD SCI USA, V94, P3178, DOI 10.1073/pnas.94.7.3178; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; Clerici Mario, 1994, Acta Microbiologica et Immunologica Hungarica, V41, P5; Cohen SS, 1999, P NATL ACAD SCI USA, V96, P10842, DOI 10.1073/pnas.96.19.10842; Contreras X, 2005, VIROLOGY, V332, P316, DOI 10.1016/j.virol.2004.11.032; Contreras X, 2004, MICROBES INFECT, V6, P1182, DOI 10.1016/j.micinf.2004.06.008; Contreras Xavier, 2003, Journal de la Societe de Biologie, V197, P267; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; FAUCI AS, 1984, CLIN RES, V32, P491; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Gandhi N, 2009, AIDS RES HUM RETROV, V25, P691, DOI 10.1089/aid.2008.0299; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Goldstein G, 1996, NAT MED, V2, P960, DOI 10.1038/nm0996-960; Grela F, 2011, J IMMUNOL, V186, P284, DOI 10.4049/jimmunol.1001348; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Guo H, 2014, J BIOL CHEM; Gupta S, 2008, J IMMUNOL, V180, P79, DOI 10.4049/jimmunol.180.1.79; Gupta S, 2007, INDIAN J BIOCHEM BIO, V44, P269; GUTHEIL WG, 1994, P NATL ACAD SCI USA, V91, P6594, DOI 10.1073/pnas.91.14.6594; Hofman FM, 1999, J NEUROIMMUNOL, V94, P28, DOI 10.1016/S0165-5728(98)00198-2; Hoshino S, 2010, J LEUKOCYTE BIOL, V87, P1133, DOI 10.1189/jlb.0809547; Ipp H, 2013, CLIN CHIM ACTA, V416, P96, DOI 10.1016/j.cca.2012.11.025; Johri MK, 2011, EXPERT OPIN BIOL TH, V11, P269, DOI 10.1517/14712598.2011.546339; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Keating SM, 2012, CYTOKINE GROWTH F R, V23, P193, DOI 10.1016/j.cytogfr.2012.05.006; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; KOLSON DL, 1994, J GEN VIROL, V75, P1927, DOI 10.1099/0022-1317-75-8-1927; Kutsch O, 2000, J VIROL, V74, P9214, DOI 10.1128/JVI.74.19.9214-9221.2000; Leghmari K, 2008, CELL IMMUNOL, V254, P46, DOI 10.1016/j.cellimm.2008.06.011; Leghmari K, 2008, CELL IMMUNOL, V253, P45, DOI 10.1016/j.cellimm.2008.04.015; Leghmari K, 2008, EUR J CELL BIOL, V87, P947, DOI 10.1016/j.ejcb.2008.06.005; LEVINE AM, 1992, MED CLIN N AM, V76, P253, DOI 10.1016/S0025-7125(16)30379-0; Li CJ, 1997, P NATL ACAD SCI USA, V94, P8116, DOI 10.1073/pnas.94.15.8116; Li JCB, 2010, AIDS, V24, P1609, DOI 10.1097/QAD.0b013e32833ac6a0; Mahajan SD, 2010, BIOCHEM BIOPH RES CO, V396, P348, DOI 10.1016/j.bbrc.2010.04.095; Martinson JA, 2010, ANTIMICROB AGENTS CH, V54, P871, DOI 10.1128/AAC.01246-09; MASOOD R, 1994, BIOCHEM BIOPH RES CO, V202, P374, DOI 10.1006/bbrc.1994.1938; MATSUMOTO T, 1993, CLIN EXP IMMUNOL, V93, P149; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Mayne M, 1998, NEUROIMMUNOMODULAT, V5, P184, DOI 10.1159/000026336; Miller RC, 2011, EUR J IMMUNOL, V41, P1058, DOI 10.1002/eji.201041198; Muthumani K, 2005, INT IMMUNOL, V17, P103, DOI 10.1093/intimm/dxh190; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Noonan D, 2000, Adv Pharmacol, V48, P229; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ott M, 1998, J IMMUNOL, V160, P2872; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Planes R, 2014, J VIROL, V88, P6672, DOI 10.1128/JVI.00825-14; Planes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074551; Poggi A, 2006, CLIN DEV IMMUNOL, V13, P369, DOI 10.1080/17402520600645712; POLI G, 1992, PATHOBIOLOGY, V60, P246, DOI 10.1159/000163729; PURI RK, 1992, CANCER RES, V52, P3787; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; SABATIER JM, 1991, J VIROL, V65, P961, DOI 10.1128/JVI.65.2.961-967.1991; Sacchi A, 2007, JAIDS-J ACQ IMM DEF, V46, P519, DOI 10.1097/QAI.0b013e31815b1278; Samikkannu T, 2010, J NEUROVIROL, V16, P255, DOI 10.3109/13550284.2010.497809; Sarkar Roni, 2013, PLoS One, V8, pe59073, DOI 10.1371/journal.pone.0059073; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Spudich S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007120; Tangsinmankong N, 2000, CYTOKINE, V12, P1506, DOI 10.1006/cyto.2000.0741; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Uleri E, 2014, AIDS, V28, P2659, DOI 10.1097/QAD.0000000000000477; Urbinati C, 2005, ARTERIOSCL THROM VAS, V25, P2315, DOI 10.1161/01.ATV.0000186182.14908.7b; Urbinati C, 2009, BLOOD, V114, P3335, DOI 10.1182/blood-2009-01-198945; VIVES E, 1994, J VIROL, V68, P3343, DOI 10.1128/JVI.68.5.3343-3353.1994; Wang XC, 2008, EUR J IMMUNOL, V38, P3226, DOI 10.1002/eji.200838285; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WESTENDORP MO, 1994, J VIROL, V68, P4177, DOI 10.1128/JVI.68.7.4177-4185.1994; Williams MA, 2002, J HEMATOTH STEM CELL, V11, P829, DOI 10.1089/152581602760404630; Wong JK, 2010, J BIOL CHEM, V285, P18319, DOI 10.1074/jbc.M110.120840; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yang YB, 2010, J MED VIROL, V82, P735, DOI 10.1002/jmv.21720; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; ZAULI G, 1992, BLOOD, V80, P3036; Zocchi MR, 1998, J IMMUNOL, V161, P2938; Zocchi MR, 1997, AIDS, V11, P1227, DOI 10.1097/00002030-199710000-00005	112	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129425	10.1371/journal.pone.0129425	http://dx.doi.org/10.1371/journal.pone.0129425			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090662	Green Published, gold			2022-12-26	WOS:000356835000042
J	Grey, JA; Rothenberg, RB; Sullivan, PS; Rosenberg, ES				Grey, Jeremy Alexander; Rothenberg, Richard B.; Sullivan, Patrick Sean; Rosenberg, Eli Samuel			Disassortative Age-Mixing Does Not Explain Differences in HIV Prevalence between Young White and Black MSM: Findings from Four Studies	PLOS ONE			English	Article							OLDER PARTNER SELECTION; SEXUAL RISK BEHAVIOR; UNITED-STATES; MEN; INFECTION; DISPARITIES; NETWORKS; SPREAD; RACE; GAY	Objective Age disassortativity is one hypothesis for HIV disparities between Black and White MSM. We examined differences in age mixing by race and the effect of partner age difference on the association between race and HIV status. Design We used data from four studies of MSM. Participants reported information about recent sexual partners, including age, race, and sexual behavior. Two studies were online with a US sample and two focused on MSM in Atlanta. Methods We computed concordance correlation coefficients (CCCs) by race across strata of partner type, participant HIV status, condom use, and number of partners. We used Wilcoxon rank-sum tests to compare Black and White MSM on partner age differences across five age groups. Finally, we used logistic regression models using race, age, and partner age difference to determine the odds ratio of HIV-positive serostatus. Results Of 48 CCC comparisons, Black MSM were more age-disassortative than White MSM in only two. Furthermore, of 20 comparisons of median partner age, Black and White MSM differed in two age groups. One indicated larger age gaps among the Black MSM (18-19). Prevalent HIV infection was associated with race and age. Including partner age difference in the model resulted in a 2% change in the relative odds of infection among Black MSM. Conclusions Partner age disassortativity and partner age differences do not differ by race. Partner age difference offers little predictive value in understanding prevalent HIV infection among Black and White MSM, including diagnosis of HIV-positive status among self-reported HIV-negative individuals.	[Grey, Jeremy Alexander; Sullivan, Patrick Sean; Rosenberg, Eli Samuel] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Rothenberg, Richard B.] Georgia State Univ, Inst Publ Hlth, Atlanta, GA 30303 USA	Emory University; Rollins School Public Health; University System of Georgia; Georgia State University	Grey, JA (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.	jeremy.grey@emory.edu		Sullivan, Patrick Sean/0000-0002-7728-0587	National Institute on Minority Health and Health Disparities [RC1MD004370]; National Institute of Mental Health [R01MH085600]; Eunice Kennedy Shriver National Institute for Child Health and Human Development [R01HD067111]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067111, R21HD074502] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC1MD004370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085600] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute on Minority Health and Health Disparities (RC1MD004370); National Institute of Mental Health (R01MH085600); Eunice Kennedy Shriver National Institute for Child Health and Human Development (R01HD067111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral SO, 2000, SEX TRANSM INFECT, V76, P415, DOI 10.1136/sti.76.6.415; Balaji AB, 2013, AIDS, V27, P269, DOI 10.1097/QAD.0b013e32835ad489; Berry M, 2007, AIDS, V21, P2349, DOI 10.1097/QAD.0b013e3282f12f41; Bingham TA, 2003, AIDS EDUC PREV, V15, P39, DOI 10.1521/aeap.15.1.5.39.23613; Blower SMSS, 1997, AIDS BEHAV, V1, P273; Centers for Disease Control and Prevention, 2015, HIV SURV REP, P25; Dierkhising R., 2011, MCCC SAS MACRO; Finlayson TJ, 2011, HIV RISK PREVENTION; Garofalo R, 2010, J URBAN HEALTH, V87, P318, DOI 10.1007/s11524-009-9430-z; Hurt CB, 2010, JAIDS-J ACQ IMM DEF, V54, P185, DOI 10.1097/QAI.0b013e3181c99114; Jin FY, 2013, AIDS BEHAV, V17, P2426, DOI 10.1007/s10461-012-0350-7; Joseph HA, 2011, SEX TRANSM INFECT, V87, P442, DOI 10.1136/sextrans-2011-050010; Kelley CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053284; Khosropour CM, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1717; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; MORRIS M, 1995, AIDS EDUC PREV, V7, P24; Morris M, 2004, NETWORK EPIDEMIOLOGY; Mustanski B, 2013, J ADOLESCENT HEALTH, V52, P666, DOI 10.1016/j.jadohealth.2013.03.019; Newcomb ME, 2013, JAIDS-J ACQ IMM DEF, V62, P329, DOI 10.1097/QAI.0b013e31827e5f8c; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; Prejean J, 2013, J COMMUN HEALTH, V38, P414, DOI 10.1007/s10900-012-9633-1; Prestage G, 2013, SEX TRANSM INFECT, V89, P653, DOI 10.1136/sextrans-2012-050947; Rosenberg ES, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3211; Rosenberg ES, 2012, NAT STD PREV C; Service SK, 1996, J ACQ IMMUN DEF SYND, V11, P311, DOI 10.1097/00042560-199603010-00016; SERVICE SK, 1995, P ROY SOC B-BIOL SCI, V260, P237, DOI 10.1098/rspb.1995.0086; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; Sullivan PS, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1797; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878; Xia Q, 2006, AIDS, V20, P2081, DOI 10.1097/01.aids.0000247566.57762.b2; Zhu YD, 2013, BIOMETRICS, V69, P214, DOI 10.1111/j.1541-0420.2012.01807.x	39	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129877	10.1371/journal.pone.0129877	http://dx.doi.org/10.1371/journal.pone.0129877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26090814	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000071
J	Laconcha, U; Iriondo, M; Arrizabalaga, H; Manzano, C; Markaide, P; Montes, I; Zarraonaindia, I; Velado, I; Bilbao, E; Goni, N; Santiago, J; Domingo, A; Karakulak, S; Oray, I; Estonba, A				Laconcha, Urtzi; Iriondo, Mikel; Arrizabalaga, Haritz; Manzano, Carmen; Markaide, Pablo; Montes, Iratxe; Zarraonaindia, Iratxe; Velado, Igor; Bilbao, Eider; Goni, Nicolas; Santiago, Josu; Domingo, Andres; Karakulak, Saadet; Oray, Isik; Estonba, Andone			New Nuclear SNP Markers Unravel the Genetic Structure and Effective Population Size of Albacore Tuna (Thunnus alalunga)	PLOS ONE			English	Article							ATLANTIC BLUEFIN TUNA; MARINE FISH; NORTHEAST ATLANTIC; MITOCHONDRIAL-DNA; GROWTH; SEA; DIFFERENTIATION; UNCERTAINTY; STABILITY; MIGRATION	In the present study we have investigated the population genetic structure of albacore (Thunnus alalunga, Bonnaterre 1788) and assessed the loss of genetic diversity, likely due to overfishing, of albacore population in the North Atlantic Ocean. For this purpose, 1,331 individuals from 26 worldwide locations were analyzed by genotyping 75 novel nuclear SNPs. Our results indicated the existence of four genetically homogeneous populations delimited within the Mediterranean Sea, the Atlantic Ocean, the Indian Ocean and the Pacific Ocean. Current definition of stocks allows the sustainable management of albacore since no stock includes more than one genetic entity. In addition, short-and long-term effective population sizes were estimated for the North Atlantic Ocean albacore population, and results showed no historical decline for this population. Therefore, the genetic diversity and, consequently, the adaptive potential of this population have not been significantly affected by overfishing.	[Laconcha, Urtzi; Arrizabalaga, Haritz; Goni, Nicolas] AZTI, Div Marine Res, Pasaia, Gipuzkoa, Spain; [Laconcha, Urtzi; Iriondo, Mikel; Manzano, Carmen; Markaide, Pablo; Montes, Iratxe; Zarraonaindia, Iratxe; Velado, Igor; Estonba, Andone] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, UPV EHU, Leioa, Bizkaia, Spain; [Bilbao, Eider] Univ Basque Country, Cell Biol & Environm Toxicol Res Grp, Res Ctr Expt Marine Biol & Biotechnol PIE, UPV EHU, Leioa, Bizkaia, Spain; [Bilbao, Eider] Univ Basque Country, Dept Zool & Anim Cell Biol, UPV EHU, Leioa, Bizkaia, Spain; [Santiago, Josu] AZTI, Div Marine Res, Sukarrieta, Bizkaia, Spain; [Domingo, Andres] Direcc Nacl Recursos Acuaticos DINARA, Lab Pelag Resources, Montevideo, Uruguay; [Karakulak, Saadet; Oray, Isik] Istanbul Univ, Fac Fisheries, Istanbul, Turkey	AZTI; University of Basque Country; University of Basque Country; University of Basque Country; AZTI; Istanbul University	Arrizabalaga, H (corresponding author), AZTI, Div Marine Res, Pasaia, Gipuzkoa, Spain.	harri@azti.es; andone.estonba@ehu.es	Zarraonaindia, Iratxe/ABF-4618-2020; Arrizabalaga, Haritz/B-8238-2009; , Eiderb/Y-6831-2018; Montes Asperilla, Iratxe/J-3127-2016; Karakulak, F. Saadet/B-7602-2018; Iriondo, Mikel/AAA-7997-2019	Zarraonaindia, Iratxe/0000-0002-0615-0187; Arrizabalaga, Haritz/0000-0002-3861-6316; , Eiderb/0000-0001-7155-2724; Montes Asperilla, Iratxe/0000-0002-6341-8768; Karakulak, F. Saadet/0000-0002-6053-5256; Iriondo, Mikel/0000-0001-7835-0041; Manzano, Carmen/0000-0002-8261-0608; Estonba, Andone/0000-0003-2851-5201	ATM Hegaluze - Basque Government [351BI20090047]; TUNASNIP - Basque Government [SPE10UN92]; Fundacion Centros Tecnologicos Inaki Goenaga	ATM Hegaluze - Basque Government; TUNASNIP - Basque Government(Basque Government); Fundacion Centros Tecnologicos Inaki Goenaga	This research was supported by the projects ATM2010 Hegaluze (351BI20090047) and TUNASNIP (SPE10UN92) funded by the Basque Government. Urtzi Laconcha's work was supported by a PhD grant by the Fundacion Centros Tecnologicos Inaki Goenaga. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaina A, 2013, ANIM GENET, V44, P678, DOI 10.1111/age.12051; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Arrizabalaga H, 2004, MAR ECOL PROG SER, V282, P245, DOI 10.3354/meps282245; Arrizabalaga H, 2014, TOPICAL STUDIES OC 2; Arrizabalaga H, 2007, FISH B-NOAA, V105, P140; Arrizabalaga Haritz, 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P1479; Bard FX, 1981, THESIS U PARIS 6; BEARDSLE.GL, 1969, T AM FISH SOC, V98, P589, DOI 10.1577/1548-8659(1969)98[589:PMOATA]2.0.CO;2; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P., 2002, MIGRATE DOCUMENTATIO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bravington M.V., 2014, 2007034 FRDC CSIRO; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Childers J, 2011, FISH OCEANOGR, V20, P157, DOI 10.1111/j.1365-2419.2011.00575.x; CHOW S, 1995, MAR BIOL, V123, P39, DOI 10.1007/BF00350321; Davies CA, 2011, MAR BIOL, V158, P2727, DOI 10.1007/s00227-011-1772-x; Dicenta A., 1975, Boletin Inst esp Oceanogr, VNo. 204,1975, P25; Duclerc J, 1973, REV TRAV I PECHES, V37, P2; Falush D, 2003, GENETICS, V164, P1567; FAO, 2014, FISH AQ SOFTW FISHST; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; FELSENSTEIN J, 1971, GENETICS, V68, P581; Flowers JM, 2002, EVOLUTION, V56, P1445, DOI 10.1111/j.0014-3820.2002.tb01456.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Fromentin JM, 2014, MAR POLICY, V47, P8, DOI 10.1016/j.marpol.2014.01.018; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Garcia A, 2006, SCI MAR, V70, P67, DOI 10.3989/scimar.2006.70s267; Gemmell NJ, 2004, P ROY SOC B-BIOL SCI, V271, pS430, DOI 10.1098/rsbl.2004.0234; Gomez-Uchida D, 2006, J HERED, V97, P603, DOI 10.1093/jhered/esl042; Goni N, 2011, MAR BIOL, V158, P1057, DOI 10.1007/s00227-011-1630-x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GRAVES JE, 1989, CAN J FISH AQUAT SCI, V46, P870, DOI 10.1139/f89-110; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Helyar SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042089; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hutchinson WF, 2003, P ROY SOC B-BIOL SCI, V270, P2125, DOI 10.1098/rspb.2003.2493; ICCAT, 2014, ICCAT COLL IN PRESS; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064744; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; JORDE PE, 1995, GENETICS, V139, P1077; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Kettle AJ, 2011, CLIM PAST, V7, P181, DOI 10.5194/cp-7-181-2011; Koto T., 1969, B FAR SEAS FISH RES, V1, P115; Lalami Y, 1973, Pelagos, V4, P54; Langella O, 2002, POPULATIONS 1 2 32; Lewis AD, 1990, S PACIFIC ALBACORE S, P13; Macdonald JI, 2013, FISH RES, V148, P56, DOI 10.1016/j.fishres.2013.08.004; Marano G., 1999, Biologia Marina Mediterranea, V6, P192; Megalofonou P, 2000, J FISH BIOL, V57, P700, DOI 10.1006/jfbi.2000.1345; Miller JA, 2010, MAR ECOL PROG SER, V408, P227, DOI 10.3354/meps08613; Montes I, 2012, MAR ECOL PROG SER, V471, P183, DOI 10.3354/meps09991; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Nakadate M, 2005, J FISH BIOL, V66, P1545, DOI 10.1111/j.0022-1112.2005.00705.x; Nakamura H, 1969, TUNA DISTRIBUTION MI; Nomura S, 2014, FISHERIES SCI, V80, P1193, DOI 10.1007/s12562-014-0789-8; Nunney L, 1999, EVOLUTION, V53, P1, DOI [10.2307/2640915, 10.1111/j.1558-5646.1999.tb05328.x]; NUNNEY L, 1993, TRENDS ECOL EVOL, V8, P234, DOI 10.1016/0169-5347(93)90197-W; O'Leary SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066126; Ortiz de Zarate V., 1998, COLLECT VOL SCI PAP, V1, P251; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Pawson MG, 1996, FISH RES, V25, P203, DOI 10.1016/0165-7836(95)00441-6; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; Pujolar JM, 2003, MAR BIOL, V143, P613, DOI 10.1007/s00227-003-1080-1; Qiu F, 2013, MOL PHYLOGENET EVOL, V66, P463, DOI 10.1016/j.ympev.2012.05.002; Qiu F, 2011, COPEIA, P264, DOI 10.1643/CI-10-112; REYNOLDS J, 1983, GENETICS, V105, P767; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; RICKER WE, 1981, CAN J FISH AQUAT SCI, V38, P1636, DOI 10.1139/f81-213; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1996, GENETICS, V142, P1357; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; Santiago J, 2005, ICES J MAR SCI, V62, P740, DOI 10.1016/j.icesjms.2005.01.015; Santiago J., 1993, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V40, P316; Shiohama T, 1985, TWS852291109 IPTP, P1952; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sund P.N., 1981, Oceanography and Marine Biology an Annual Review, V19, P443; Suzuki A., 1962, REP NANKAI REG FISH, V16, P67; Takagi M, 2001, FISH B-NOAA, V99, P697; Therkildsen NO, 2010, CAN J FISH AQUAT SCI, V67, P1585, DOI 10.1139/F10-084; Turner TF, 2002, GENETICS, V162, P1329; UEYANAGI S, 1969, Bulletin Far Seas Fisheries Research Laboratory (Shimizu), V2, P177; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; Vucetich JA, 1997, EVOLUTION, V51, P2017, DOI 10.1111/j.1558-5646.1997.tb05123.x; Waldman JR, 1999, FISH RES, V43, P237, DOI 10.1016/S0165-7836(99)00075-2; Waples RS, 2007, GENETICS, V175, P219, DOI 10.1534/genetics.106.065300; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WAPLES RS, 1989, GENETICS, V121, P379; Ward RD, 2000, HYDROBIOLOGIA, V420, P191, DOI 10.1023/A:1003928327503; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 1997, GENETICS, V146, P427	103	36	36	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128247	10.1371/journal.pone.0128247	http://dx.doi.org/10.1371/journal.pone.0128247			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090851	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000016
J	Hochberg, I; Tran, QT; Barkan, AL; Saltiel, AR; Chandler, WF; Bridges, D				Hochberg, Irit; Tran, Quynh T.; Barkan, Ariel L.; Saltiel, Alan R.; Chandler, William F.; Bridges, Dave			Gene Expression Signature in Adipose Tissue of Acromegaly Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GROWTH-HORMONE; SKELETAL-MUSCLE; LIPOPROTEIN-LIPASE; CERAMIDE; INHIBITION; MECHANISM; IDENTIFICATION; LIPOLYSIS; LOCI	To study the effect of chronic excess growth hormone on adipose tissue, we performed RNA sequencing in adipose tissue biopsies from patients with acromegaly (n = 7) or non-functioning pituitary adenomas (n = 11). The patients underwent clinical and metabolic profiling including assessment of HOMA-IR. Explants of adipose tissue were assayed ex vivo for lipolysis and ceramide levels. Patients with acromegaly had higher glucose, higher insulin levels and higher HOMA-IR score. We observed several previously reported transcriptional changes (IGF1, IGFBP3, CISH, SOCS2) that are known to be induced by GH/IGF-1 in liver but are also induced in adipose tissue. We also identified several novel transcriptional changes, some of which may be important for GH/IGF responses (PTPN3 and PTPN4) and the effects of acromegaly on growth and proliferation. Several differentially expressed transcripts may be important in GH/IGF-1-induced metabolic changes. Specifically, induction of LPL, ABHD5, and NRIP1 can contribute to enhanced lipolysis and may explain the elevated adipose tissue lipolysis in acromegalic patients. Higher expression of TCF7L2 and the fatty acid desaturases FADS1, FADS2 and SCD could contribute to insulin resistance. Ceramides were not different between the two groups. In summary, we have identified the acromegaly gene expression signature in human adipose tissue. The significance of altered expression of specific transcripts will enhance our understanding of the metabolic and proliferative changes associated with acromegaly.	[Hochberg, Irit] Inst Endocrinol Diabet & Metab, Haifa, Israel; [Hochberg, Irit; Saltiel, Alan R.; Bridges, Dave] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Tran, Quynh T.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Barkan, Ariel L.; Saltiel, Alan R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Barkan, Ariel L.; Chandler, William F.] Univ Tennessee, Dept Neurosurg, Hlth Sci Ctr, Memphis, TN USA; [Bridges, Dave] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Memphis, TN USA; [Bridges, Dave] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA	University of Michigan System; University of Michigan; University of Tennessee System; University of Tennessee Health Science Center; University of Michigan System; University of Michigan; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Hochberg, I (corresponding author), Inst Endocrinol Diabet & Metab, Rambam Hlth Care Campus, Haifa, Israel.	i_hochberg@rambam.health.gov.il; dbridge9@uthsc.edu		Saltiel, Alan/0000-0002-9726-9828; Hochberg, Irit/0000-0002-4232-5191; Bridges, Dave/0000-0002-5334-972X	Motor City Golf Classic (MCGC) [G010640]; NIH [U24 DK097153]; Le Bonheur Grant [650 700]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153, P30DK020572] Funding Source: NIH RePORTER	Motor City Golf Classic (MCGC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Le Bonheur Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Motor City Golf Classic (MCGC) Grant # G010640. This work utilized Metabolomics Core Services supported by grant U24 DK097153 of the NIH Common Fund to the University of Michigan. This work was also supported by a Le Bonheur Grant # 650 700 to DB.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayuk J, 2006, POSTGRAD MED J, V82, P24, DOI 10.1136/pgmj.2005.036087; BARCELLINICOUGET S, 1994, BIOCHEM BIOPH RES CO, V199, P136, DOI 10.1006/bbrc.1994.1205; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; BOLINDER J, 1986, J CLIN INVEST, V77, P1201, DOI 10.1172/JCI112422; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Clasen BFF, 2013, J LIPID RES, V54, P1988, DOI 10.1194/jlr.P034520; Colao A, 2000, J CLIN ENDOCR METAB, V85, P193, DOI 10.1210/jc.85.1.193; del Rincon JP, 2007, DIABETES, V56, P1638, DOI 10.2337/db06-0299; EZZAT S, 1994, MEDICINE, V73, P233, DOI 10.1097/00005792-199409000-00001; Fleenor D, 2006, HORM RES, V66, P101, DOI 10.1159/000093667; Fox J., 2019, R COMPANION APPL REG, V.; Frajese Giovanni V, 2004, Horm Res, V61, P246, DOI 10.1159/000077135; Gravholt CH, 1999, AM J PHYSIOL-ENDOC M, V277, pE848, DOI 10.1152/ajpendo.1999.277.5.E848; Haluzik M, 2003, DIABETES, V52, P2483, DOI 10.2337/diabetes.52.10.2483; HEINRICH UE, 1978, J CLIN ENDOCR METAB, V46, P672, DOI 10.1210/jcem-46-4-672; Hindle AK, 2009, SURG ENDOSC, V23, P700, DOI 10.1007/s00464-008-0001-2; Ho PC, 2011, CELL SIGNAL, V23, P1396, DOI 10.1016/j.cellsig.2011.03.023; Holdaway I M, 1999, Pituitary, V2, P29, DOI 10.1023/A:1009965803750; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Huo JS, 2006, J BIOL CHEM, V281, P4132, DOI 10.1074/jbc.M508492200; Ip W, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-28; Jorgensen JOL, 2006, AM J PHYSIOL-ENDOC M, V291, pE899, DOI 10.1152/ajpendo.00024.2006; KALINYAK JE, 1987, J BIOL CHEM, V262, P10441; Kasumov T, 2010, ANAL BIOCHEM, V401, P154, DOI 10.1016/j.ab.2010.02.023; Khalfallah Y, 2001, J ENDOCRINOL, V171, P285, DOI 10.1677/joe.0.1710285; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mayneris-Perxachs J, 2014, CLIN NUTR, V33, P90, DOI 10.1016/j.clnu.2013.03.001; Moller L, 2009, J CLIN ENDOCR METAB, V94, P4524, DOI 10.1210/jc.2009-0381; Moore JS, 1999, J CLIN ENDOCR METAB, V84, P4172, DOI 10.1210/jc.84.11.4172; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Napolitano A, 1998, J STEROID BIOCHEM, V64, P251, DOI 10.1016/S0960-0760(97)00200-8; Nielsen S, 2001, DIABETES, V50, P2301, DOI 10.2337/diabetes.50.10.2301; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Oberbauer AM, 2011, LIPIDS, V46, P495, DOI 10.1007/s11745-011-3548-y; Pasquali C, 2003, MOL ENDOCRINOL, V17, P2228, DOI 10.1210/me.2003-0011; Paulsen SK, 2006, J CLIN ENDOCR METAB, V91, P1093, DOI 10.1210/jc.2005-1694; Pilecka I, 2007, J BIOL CHEM, V282, P35405, DOI 10.1074/jbc.M705814200; PRADINESFIGUERES A, 1990, BIOCHEM BIOPH RES CO, V166, P1118, DOI 10.1016/0006-291X(90)90982-S; PRADINESFIGUERES A, 1990, J LIPID RES, V31, P1283; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richelsen B, 2000, METABOLISM, V49, P906, DOI 10.1053/meta.2000.6738; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SIMSOLO RB, 1995, J CLIN ENDOCR METAB, V80, P3233, DOI 10.1210/jc.80.11.3233; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanimoto K, 2008, EUR J ENDOCRINOL, V159, P375, DOI 10.1530/EJE-08-0243; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Waters MJ, 2012, ENDOCR DEV, V23, P86, DOI 10.1159/000341761; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	60	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129359	10.1371/journal.pone.0129359	http://dx.doi.org/10.1371/journal.pone.0129359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087292	Green Published, gold			2022-12-26	WOS:000356567500045
J	Litovkin, K; Van Eynde, A; Joniau, S; Lerut, E; Laenen, A; Gevaert, T; Gevaert, O; Spahn, M; Kneitz, B; Gramme, P; Helleputte, T; Isebaert, S; Haustermans, K; Bollen, M				Litovkin, Kirill; Van Eynde, Aleyde; Joniau, Steven; Lerut, Evelyne; Laenen, Annouschka; Gevaert, Thomas; Gevaert, Olivier; Spahn, Martin; Kneitz, Burkhard; Gramme, Pierre; Helleputte, Thibault; Isebaert, Sofie; Haustermans, Karin; Bollen, Mathieu			DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; PROMOTER METHYLATION; RECEPTOR-BETA; GENE; GSTP1; BIOMARKERS; DIAGNOSIS; REVEALS; METASTASIS; RECURRENCE	Background Prostate cancer (PCa) is a very heterogeneous disease with respect to clinical outcome. This study explored differential DNA methylation in a priori selected genes to diagnose PCa and predict clinical failure (CF) in high-risk patients. Methods A quantitative multiplex, methylation-specific PCR assay was developed to assess promoter methylation of the APC, CCND2, GSTP1, PTGS2 and RARB genes in formalin-fixed, paraffin-embedded tissue samples from 42 patients with benign prostatic hyperplasia and radical prostatectomy specimens of patients with high-risk PCa, encompassing training and validation cohorts of 147 and 71 patients, respectively. Log-rank tests, univariate and multivariate Cox models were used to investigate the prognostic value of the DNA methylation. Results Hypermethylation of APC, CCND2, GSTP1, PTGS2 and RARB was highly cancer-specific. However, only GSTP1 methylation was significantly associated with CF in both independent high-risk PCa cohorts. Importantly, trichotomization into low, moderate and high GSTP1 methylation level subgroups was highly predictive for CF. Patients with either a low or high GSTP1 methylation level, as compared to the moderate methylation groups, were at a higher risk for CF in both the training (Hazard ratio [HR], 3.65; 95% CI, 1.65 to 8.07) and validation sets (HR, 4.27; 95% CI, 1.03 to 17.72) as well as in the combined cohort ( HR, 2.74; 95% CI, 1.42 to 5.27) in multivariate analysis. Conclusions Classification of primary high-risk tumors into three subtypes based on DNA methylation can be combined with clinico-pathological parameters for a more informative risk-stratification of these PCa patients.	[Litovkin, Kirill; Van Eynde, Aleyde; Bollen, Mathieu] Univ Leuven, KU Leuven Dept Cellular & Mol Med, Lab Biosignaling & Therapeut, Leuven, Belgium; [Joniau, Steven; Gevaert, Thomas] Univ Hosp Leuven, Urol, Leuven, Belgium; [Joniau, Steven; Gevaert, Thomas] Univ Leuven, KU Leuven Dept Dev & Regenerat, Leuven, Belgium; [Lerut, Evelyne] Univ Hosp Leuven, Pathol, Leuven, Belgium; [Lerut, Evelyne] Univ Leuven, KU Leuven Dept Imaging & Pathol, Leuven, Belgium; [Laenen, Annouschka] Univ Leuven, KU Leuven Biostat & Stat Bioinformat Ctr, Leuven, Belgium; [Gevaert, Olivier] Stanford Univ, Stanford Ctr Canc Syst Biol, Sch Med, Stanford, CA 94305 USA; [Gevaert, Olivier] Univ Leuven, KU Leuven Dept Oncol, Lab Canc Data Fus, Leuven, Belgium; [Spahn, Martin] Univ Hosp Bern, Inselspital, Dept Urol, CH-3010 Bern, Switzerland; [Spahn, Martin; Kneitz, Burkhard] Univ Hosp, Dept Urol & Paediat Urol, Wurzburg, Germany; [Gramme, Pierre; Helleputte, Thibault] DNAlyt SA, B-1348 Louvain, Belgium; [Isebaert, Sofie; Haustermans, Karin] Univ Hosp Leuven, Radiat Oncol, Leuven, Belgium; [Isebaert, Sofie; Haustermans, Karin] Univ Leuven, KU Leuven Dept Oncol, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; Stanford University; KU Leuven; University of Bern; University Hospital of Bern; University of Wurzburg; KU Leuven; University Hospital Leuven; KU Leuven	Van Eynde, A (corresponding author), Univ Leuven, KU Leuven Dept Cellular & Mol Med, Lab Biosignaling & Therapeut, Leuven, Belgium.	Aleyde.VanEynde@med.kuleuven.be	Gevaert, Olivier/H-3413-2019; Joniau, Steven/K-7655-2013; Haustermans, Karin/AAB-5912-2021; Spahn, Martin/A-9128-2015	Gevaert, Olivier/0000-0002-9965-5466; Joniau, Steven/0000-0003-3195-9890; Haustermans, Karin/0000-0003-0364-682X; Spahn, Martin/0000-0002-5770-9489	Foundation Fournier-Majoie (FFM); Industrial Research Fund of KU Leuven [IOF-HB 07/04, IOF-HB/12/011]; Belgian National Cancer Plan [Action 29_023]; DNAlytics SA	Foundation Fournier-Majoie (FFM); Industrial Research Fund of KU Leuven; Belgian National Cancer Plan; DNAlytics SA	This work was supported by the Foundation Fournier-Majoie (FFM), the Industrial Research Fund of KU Leuven (IOF-HB 07/04 and IOF-HB/12/011), and the Belgian National Cancer Plan (Action 29_023). DNAlytics SA provided support in the form of salaries for authors [PG and TH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alumkal JJ, 2008, UROLOGY, V72, P1234, DOI 10.1016/j.urology.2007.12.060; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Bastian PJ, 2005, CLIN CANCER RES, V11, P4037, DOI 10.1158/1078-0432.CCR-04-2446; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Bohle Andreas, 2010, Int. braz j urol., V36, P774, DOI 10.1590/S1677-55382010000600027; Brocks D, 2014, CELL REP, V8, P798, DOI 10.1016/j.celrep.2014.06.053; Chao C, 2013, CANCER CAUSE CONTROL, V24, P1615, DOI 10.1007/s10552-013-0249-2; Cooperberg MR, 2008, WORLD J UROL, V26, P211, DOI 10.1007/s00345-008-0250-7; Devaney J, 2011, CANCER EPIDEM BIOMAR, V20, P148, DOI 10.1158/1055-9965.EPI-10-0719; Ellinger J, 2008, UROLOGY, V71, P161, DOI 10.1016/j.urology.2007.09.056; Feng JH, 2015, INT J CLIN EXP MED, V8, P203; Florl AL, 2004, BRIT J CANCER, V91, P985, DOI 10.1038/sj.bjc.6602030; Fossa SD, 2014, UROLOGY, V83, P146, DOI 10.1016/j.urology.2013.08.081; Friedlander TW, 2012, CANCER RES, V72, P616, DOI 10.1158/0008-5472.CAN-11-2079; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Haldrup C, 2013, J CLIN ONCOL, V31, P3250, DOI 10.1200/JCO.2012.47.1847; Harrell FE, 2001, REGRESSION MODELING; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Jeronimo C, 2002, CANCER EPIDEM BIOMAR, V11, P445; Jeronimo C, 2014, CANCER LETT, V342, P264, DOI 10.1016/j.canlet.2011.12.026; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Joniau S, 2015, EUR UROL, V67, P157, DOI 10.1016/j.eururo.2014.01.020; Joniau S, 2013, CURR OPIN UROL, V23, P342, DOI 10.1097/MOU.0b013e3283620f60; Kalogirou C, 2013, INT J MOL SCI, V14, P21414, DOI 10.3390/ijms141121414; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Kim SJ, 2011, CANCER LETT, V302, P47, DOI 10.1016/j.canlet.2010.12.010; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kron K, 2012, CLIN CANCER RES, V18, P2896, DOI 10.1158/1078-0432.CCR-11-2901; Litovkin K, 2014, J CANCER RES CLIN, V140, P1849, DOI 10.1007/s00432-014-1738-8; Mahapatra S, 2012, CLIN CANCER RES, V18, P2882, DOI 10.1158/1078-0432.CCR-11-2090; Mahon KL, 2014, BRIT J CANCER, V111, P1802, DOI 10.1038/bjc.2014.463; Maldonado L, 2014, J UROLOGY, V192, P1542, DOI 10.1016/j.juro.2014.04.082; Mikeska T, 2010, EPIGENOMICS-UK, V2, P561, DOI 10.2217/EPI.10.32; Mishra DK, 2010, MOL CANCER THER, V9, P33, DOI 10.1158/1535-7163.MCT-09-0486; Nakayama M, 2004, J CELL BIOCHEM, V91, P540, DOI 10.1002/jcb.10740; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Patron JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035345; Perry AS, 2010, NAT REV UROL, V7, P668, DOI 10.1038/nrurol.2010.185; Phe V, 2010, BJU INT, V105, P1364, DOI 10.1111/j.1464-410X.2009.09167.x; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qureshi A, 2010, J PAK MED ASSOC, V60, P350; Re A, 2011, MOL ENDOCRINOL, V25, P2003, DOI 10.1210/me.2011-1024; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Rosenbaum E, 2005, CLIN CANCER RES, V11, P8321, DOI 10.1158/1078-0432.CCR-05-1183; Salagierski M, 2012, J UROLOGY, V187, P795, DOI 10.1016/j.juro.2011.10.133; Schnekenburger M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00170; Schulz W, 2005, J BIOMED BIOTECHNOL, P227, DOI 10.1155/JBB.2005.227; Schwartzman J, 2011, EPIGENETICS-US, V6, P1248, DOI 10.4161/epi.6.10.17727; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Strand SH, 2014, INT J MOL SCI, V15, P16544, DOI 10.3390/ijms150916544; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tu JJ, 2007, MODERN PATHOL, V20, P921, DOI 10.1038/modpathol.3800903; Van Neste L, 2012, PROSTATE, V72, P1248, DOI 10.1002/pros.22459; Vasiljevic N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-655; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972; Yegnasubramanian S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-313; Zhang JM, 2004, ONCOGENE, V23, P2241, DOI 10.1038/sj.onc.1207328	61	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130651	10.1371/journal.pone.0130651	http://dx.doi.org/10.1371/journal.pone.0130651			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086362	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500126
J	Osswald, A; Westermann, C; Sun, ZK; Riedel, CU				Osswald, Annika; Westermann, Christina; Sun, Zhongke; Riedel, Christian U.			A Phytase-Based Reporter System for Identification of Functional Secretion Signals in Bifidobacteria	PLOS ONE			English	Article							LONGUM SUBSP INFANTIS; CANCER GENE-THERAPY; DELIVERY-SYSTEM; SELECTIVE LOCALIZATION; PROTEIN SECRETION; GENOME SEQUENCE; EXPRESSION; ENDOSTATIN; BIFIDUM; GROWTH	Health-promoting effects have been attributed to a number of Bifidobacterium sp. strains. These effects as well as the ability to colonise the host depend on secreted proteins. Moreover, rational design of protein secretion systems bears the potential for the generation of novel probiotic bifidobacteria with improved health-promoting or therapeutic properties. To date, there is only very limited data on secretion signals of bifidobacteria available. Using in silico analysis, we demonstrate that all bifidobacteria encode the major components of Sec-dependent secretion machineries but only B. longum strains harbour Tat protein translocation systems. A reporter plasmid for secretion signals in bifidobacteria was established by fusing the coding sequence of the signal peptide of a sialidase of Bifidobacterium bifidum S17 to the phytase gene appA of E. coli. The recombinant strain showed increased phytase activity in spent culture supernatants and reduced phytase levels in crude extracts compared to the control indicating efficient phytase secretion. The reporter plasmid was used to screen seven predicted signal peptides in B. bifidum S17 and B. longum E18. The tested signal peptides differed substantially in their efficacy to mediate protein secretion in different host strains. An efficient signal peptide was used for expression and secretion of a therapeutically relevant protein in B. bifidum S17. Expression of a secreted cytosine deaminase led to a 100-fold reduced sensitivity of B. bifidum S17 to 5-fluorocytosine compared to the non-secreted cytosine deaminase suggesting efficient conversion of 5-fluorocytosine to the cytotoxic cancer drug 5-fluorouracil by cytosine deaminase occurred outside the bacterial cell. Selection of appropriate signal peptides for defined protein secretion might improve therapeutic efficacy as well as probiotic properties of bifidobacteria.	[Osswald, Annika; Westermann, Christina; Sun, Zhongke; Riedel, Christian U.] Univ Ulm, Inst Microbiol & Biotechnol, D-89068 Ulm, Germany; [Sun, Zhongke] Zhoukou Normal Univ, Coll Life Sci & Agr, Zhoukou City 466001, Peoples R China	Ulm University; Zhoukou Normal University	Sun, ZK (corresponding author), Univ Ulm, Inst Microbiol & Biotechnol, D-89068 Ulm, Germany.	sunzh@daad-alumni.de; christian.riedel@uni-ulm.de	Sun, Zhongke/R-2274-2019; Sun, Zhongke/AAF-5743-2020	Sun, Zhongke/0000-0002-9784-9769; Riedel, Christian U./0000-0001-7134-7085	German Academic Exchange Service/Federal Ministry of Education and Research [D/09/04778]; German Academic Exchange Service; Landesgraduiertenforderung Baden-Wurttemberg; International Graduate School of Molecular Medicine Ulm - Excellence Initiative of German Federal and State Government [GSC 270]	German Academic Exchange Service/Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)Deutscher Akademischer Austausch Dienst (DAAD)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Landesgraduiertenforderung Baden-Wurttemberg; International Graduate School of Molecular Medicine Ulm - Excellence Initiative of German Federal and State Government	This study was partially funded by the German Academic Exchange Service/Federal Ministry of Education and Research (grant D/09/04778) to CUR. ZS received a PhD fellowship of the German Academic Exchange Service. AO and CW were supported by PhD fellowships of the "Landesgraduiertenforderung Baden-Wurttemberg". AO received further funding by the International Graduate School of Molecular Medicine Ulm funded by the Excellence Initiative of German Federal and State Government (grant GSC 270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISAKA K, 1991, AGR BIOL CHEM TOKYO, V55, P997, DOI 10.1080/00021369.1991.10870705; AISAKA K, 1987, FEMS MICROBIOL LETT, V44, P289; Alvarez-Martin P, 2012, APPL ENVIRON MICROB, V78, P7032, DOI 10.1128/AEM.01776-12; Tamayo-Ramos JA, 2012, APPL ENVIRON MICROB, V78, P5013, DOI 10.1128/AEM.00782-12; Baban Chwanrow K, 2010, Bioeng Bugs, V1, P385, DOI 10.4161/bbug.1.6.13146; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bottacini F, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S4; Bottacini F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-170; Cronin M, 2012, CANCER GENE THER, V19, P731, DOI 10.1038/cgt.2012.59; Cronin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030940; Cronin M, 2010, MOL THER, V18, P1397, DOI 10.1038/mt.2010.59; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Escogido MLR, 2007, BIOTECHNOL LETT, V29, P1249, DOI 10.1007/s10529-007-9376-8; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Gleinser M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-80; Gonzalez-Rodriguez I, 2013, FEMS MICROBIOL LETT, V340, P1, DOI 10.1111/1574-6968.12056; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; Grimm V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/960826; Grimm V, 2014, APPL ENVIRON MICROB, V80, P2842, DOI 10.1128/AEM.04261-13; Haros M, 2007, INT J FOOD MICROBIOL, V117, P76, DOI 10.1016/j.ijfoodmicro.2007.02.021; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hu B, 2009, CANCER GENE THER, V16, P655, DOI 10.1038/cgt.2009.7; Ivanov D, 2006, J BIOL CHEM, V281, P17246, DOI 10.1074/jbc.M601678200; Kerovuo J, 2000, LETT APPL MICROBIOL, V30, P325, DOI 10.1046/j.1472-765X.2000.00660.x; Khokhlova EV, 2010, ARCH MICROBIOL, V192, P769, DOI 10.1007/s00203-010-0606-4; Kim TW, 2005, J ANIM SCI, V83, P1062; KIMURA NT, 1980, CANCER RES, V40, P2061; Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341; LAMBRECHTS C, 1992, BIOTECHNOL LETT, V14, P61, DOI 10.1007/BF01030915; Lehouritis P, 2013, J CONTROL RELEASE, V170, P120, DOI 10.1016/j.jconrel.2013.05.005; Lei XG, 2013, ANNU REV ANIM BIOSCI, V1, P283, DOI 10.1146/annurev-animal-031412-103717; Li X, 2003, CANCER GENE THER, V10, P105, DOI 10.1038/sj.cgt.7700530; LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10; Long RT, 2010, INT J OBESITY, V34, P712, DOI 10.1038/ijo.2009.277; Loquasto JR, 2013, APPL ENV MICROBIOL; MacConaill LE, 2003, APPL ENVIRON MICROB, V69, P6994, DOI 10.1128/AEM.69.12.6994-7001.2003; Marcobal A, 2012, CLIN MICROBIOL INFEC, V18, P12, DOI 10.1111/j.1469-0691.2012.03863.x; Motherway MO, 2008, APPL ENVIRON MICROB, V74, P6271, DOI 10.1128/AEM.01169-08; Nakamura T, 2002, BIOSCI BIOTECH BIOCH, V66, P2362, DOI 10.1271/bbb.66.2362; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Palacios MC, 2008, FOOD MICROBIOL, V25, P169, DOI 10.1016/j.fm.2007.06.001; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela DA, 2012, APPL ENVIRON MICROB, V78, P795, DOI 10.1128/AEM.06762-11; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Shkoporov AN, 2008, BIOTECHNOL LETT, V30, P1983, DOI 10.1007/s10529-008-9772-8; Sun ZK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088328, 10.1371/journal.pone.0088260]; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Turroni F, 2010, APPL ENVIRON MICROB, V76, P3206, DOI 10.1128/AEM.02938-09; Ventura M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000785; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Wang L, 2014, INT J MOL SCI, V15, P12842, DOI 10.3390/ijms150712842; White BA, 2014, ANNU REV MICROBIOL, V68, P279, DOI 10.1146/annurev-micro-092412-155618; Xu YF, 2007, CANCER GENE THER, V14, P151, DOI 10.1038/sj.cgt.7701003; Yamamoto S, 2010, VACCINE, V28, P6684, DOI 10.1016/j.vaccine.2010.08.007; Yao J, 2011, MOL PHARMACEUT, V8, P488, DOI 10.1021/mp100331r; Yazawa K, 2000, CANCER GENE THER, V7, P269, DOI 10.1038/sj.cgt.7700122; Yi C, 2005, ACTA PHARMACOL SIN, V26, P629, DOI 10.1111/j.1745-7254.2005.00094.x; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093; Yu ZJ, 2012, INT IMMUNOPHARMACOL, V12, P125, DOI 10.1016/j.intimp.2011.10.022; Zhu H, 2011, CANCER GENE THER, V18, P884, DOI 10.1038/cgt.2011.57; Zhu LP, 2009, CANCER SCI, V100, P1986, DOI 10.1111/j.1349-7006.2009.01275.x; Zhurina D, 2013, GENOME ANNOUNC, V1; Zhurina D, 2011, J BACTERIOL, V193, P301, DOI 10.1128/JB.01180-10	69	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128802	10.1371/journal.pone.0128802	http://dx.doi.org/10.1371/journal.pone.0128802			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086721	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500025
J	Scandolera, A; Rabenoelina, F; Chaintreuil, C; Rusciani, A; Maurice, P; Blaise, S; Romier-Crouzet, B; El Btaouri, H; Martiny, L; Debelle, L; Duca, L				Scandolera, Amandine; Rabenoelina, Fanja; Chaintreuil, Carine; Rusciani, Anthony; Maurice, Pascal; Blaise, Sebastien; Romier-Crouzet, Beatrice; El Btaouri, Hassan; Martiny, Laurent; Debelle, Laurent; Duca, Laurent			Uncoupling of Elastin Complex Receptor during In Vitro Aging Is Related to Modifications in Its Intrinsic Sialidase Activity and the Subsequent Lactosylceramide Production	PLOS ONE			English	Article							HUMAN SKIN FIBROBLASTS; LAMININ-BINDING-PROTEIN; SMOOTH-MUSCLE CELLS; BETA-GALACTOSIDASE; MATRIX METALLOPROTEINASE-1; SIGNALING PATHWAYS; UP-REGULATION; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; PEPTIDE VGVAPG	Degradation of elastin leads to the production of elastin-derived peptides (EDP), which exhibit several biological effects, such as cell proliferation or protease secretion. Binding of EDP on the elastin receptor complex (ERC) triggers lactosylceramide (LacCer) production and ERK1/2 activation following ERC Neu-1 subunit activation. The ability for ERC to transduce signals is lost during aging, but the mechanism involved is still unknown. In this study, we characterized an in vitro model of aging by subculturing human dermal fibroblasts. This model was used to understand the loss of EDP biological activities during aging. Our results show that ERC uncoupling does not rely on Neu-1 or PPCA mRNA or protein level changes. Furthermore, we observe that the membrane targeting of these subunits is not affected with aging. However, we evidence that Neu-1 activity and LacCer production are altered. Basal Neu-1 catalytic activity is strongly increased in aged cells. Consequently, EDP fail to promote Neu-1 catalytic activity and LacCer production in these cells. In conclusion, we propose, for the first time, an explanation for ERC uncoupling based on the age-related alterations of Neu-1 activity and LacCer production that may explain the loss of EDP-mediated effects occurring during aging.	[Scandolera, Amandine; Rabenoelina, Fanja; Chaintreuil, Carine; Rusciani, Anthony; Maurice, Pascal; Blaise, Sebastien; Romier-Crouzet, Beatrice; El Btaouri, Hassan; Martiny, Laurent; Debelle, Laurent; Duca, Laurent] Univ Reims, Fac Sci, SFR CAP Sante, Lab Signalisat & Recepteurs Matriciels SiRMa,UMR, Reims, France	Universite de Reims Champagne-Ardenne	Duca, L (corresponding author), Univ Reims, Fac Sci, SFR CAP Sante, Lab Signalisat & Recepteurs Matriciels SiRMa,UMR, Reims, France.	laurent.duca@univ-reims.fr	MARTINY, Laurent/ABI-5531-2020; BLAISE, Sebastien/AAS-1022-2020; Maurice, Pascal/AAM-9126-2021	BLAISE, Sebastien/0000-0003-3012-1500; SCANDOLERA, Amandine/0000-0001-6403-1664; DUCA, Laurent/0000-0002-6035-4906; MAURICE, Pascal/0000-0003-2167-4808	CNRS (Centre National de la Recherche Scientifique); Ministere de l'Enseignement Superieur et de la Recherche	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche	This work was supported by grants from the CNRS (Centre National de la Recherche Scientifique) and the Ministere de l'Enseignement Superieur et de la Recherche. Amandine Scandolera is a fellow of the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2002, CURR OPIN STRUC BIOL, V12, P587, DOI 10.1016/S0959-440X(02)00376-7; Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; Baranek T, 2007, J IMMUNOL, V179, P6184, DOI 10.4049/jimmunol.179.9.6184; Blaise S, 2013, DIABETES, V62, P3807, DOI 10.2337/db13-0508; Blanchevoye C, 2013, J BIOL CHEM, V288, P1317, DOI 10.1074/jbc.M112.419929; Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200; Chen HP, 2013, METHODS MOL BIOL, V1048, P1, DOI 10.1007/978-1-62703-556-9_1; Chuaire-Noack L, 2010, INVEST CLIN, V51, P351; Coquerel B, 2009, GLIA, V57, P1716, DOI 10.1002/glia.20884; Dasgupta J, 2010, J CELL PHYSIOL, V225, P52, DOI 10.1002/jcp.22193; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Devy J, 2010, BRIT J CANCER, V103, P1562, DOI 10.1038/sj.bjc.6605926; Duca L, 2005, MOL PHARMACOL, V67, P1315, DOI 10.1124/mol.104.002725; Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007; Duca L, 2002, FEBS LETT, V524, P193, DOI 10.1016/S0014-5793(02)03057-0; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Dupont A, 2013, THORAX, V68, P421, DOI 10.1136/thoraxjnl-2012-201833; Fahem A, 2008, INT J BIOCHEM CELL B, V40, P1581, DOI 10.1016/j.biocel.2007.11.022; Faury G, 1997, MECH AGEING DEV, V95, P31, DOI 10.1016/S0047-6374(96)01842-8; Faury G, 1998, P NATL ACAD SCI USA, V95, P2967, DOI 10.1073/pnas.95.6.2967; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; FULOP T, 1986, BIOCHEM BIOPH RES CO, V141, P92, DOI 10.1016/S0006-291X(86)80339-4; Fulop T, 2011, PATHOL BIOL; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gayral S, 2014, CARDIOVASC RES, V102, P118, DOI 10.1093/cvr/cvt336; GHUYSENITARD AF, 1992, CR ACAD SCI III-VIE, V315, P473; Gillery P, 1996, BIOCHEM BIOPH RES CO, V228, P94, DOI 10.1006/bbrc.1996.1621; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280; Hornebeck W, 2005, ANTICANCER RES, V25, P2617; Huet E, 2002, CLIN EXP METASTAS, V19, P107, DOI 10.1023/A:1014547324918; Hyun JW, 2002, ANTICANCER RES, V22, P943; Kamoun A, 1995, CELL ADHES COMMUN, V3, P273, DOI 10.3109/15419069509081013; LEE KA, 1994, DEV BIOL, V163, P241, DOI 10.1006/dbio.1994.1140; MECHAM RP, 1991, J CELL BIOL, V113, P187, DOI 10.1083/jcb.113.1.187; Mecham RP, 2011, THE EXTRACELLULAR MA; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200; Moroy G, 2005, BIOPOLYMERS, V78, P206, DOI 10.1002/bip.20276; Moroy G, 2009, PROTEINS, V76, P461, DOI 10.1002/prot.22361; Ntayi C, 2004, J INVEST DERMATOL, V122, P256, DOI 10.1046/j.0022-202X.2004.22228.x; Petersen E, 2002, EUR J VASC ENDOVASC, V24, P440, DOI 10.1053/ejvs.2002.1750; Pocza P, 2008, INT J CANCER, V122, P1972, DOI 10.1002/ijc.23296; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; Robert L, 1996, ATHEROSCLEROSIS, V123, P169, DOI 10.1016/0021-9150(96)05804-2; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Robinet A, 2007, FASEB J, V21, P1968, DOI 10.1096/fj.06-6477com; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; ROTH GS, 1995, EXP GERONTOL, V30, P361, DOI 10.1016/0531-5565(94)00029-3; Rubin H, 1997, MECH AGEING DEV, V98, P1, DOI 10.1016/S0047-6374(97)00067-5; Rusciani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014010; SAITO M, 1995, J NEUROSCI RES, V40, P401, DOI 10.1002/jnr.490400315; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; Siemianowicz K, 2010, EXP THER MED, V1, P1057, DOI 10.3892/etm.2010.157; Tajima S, 1997, ARCH DERMATOL RES, V289, P489, DOI 10.1007/s004030050227; Tatano Y, 2006, J MED INVESTIG, V53, P103, DOI 10.2152/jmi.53.103; Toupance S, 2012, CLIN EXP METASTAS, V29, P511, DOI 10.1007/s10585-012-9467-3; Varga Z, 1997, EXP GERONTOL, V32, P653, DOI 10.1016/S0531-5565(97)00042-9; VARGA Z, 1990, MECH AGEING DEV, V52, P61, DOI 10.1016/0047-6374(90)90144-5; VARGA Z, 1988, CLIN BIOCHEM, V21, P127, DOI 10.1016/S0009-9120(88)80101-2; Vigneron A, 2010, AGING-US, V2, P471, DOI 10.18632/aging.100189; WACHI H, 1995, FEBS LETT, V368, P215, DOI 10.1016/0014-5793(95)00641-L	64	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129994	10.1371/journal.pone.0129994	http://dx.doi.org/10.1371/journal.pone.0129994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086247	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500073
J	Yehia, BR; Stephens-Shields, AJ; Fleishman, JA; Berry, SA; Agwu, AL; Metlay, JP; Moore, RD; Mathews, WC; Nijhawan, A; Rutstein, R; Gaur, AH; Gebo, KA				Yehia, Baligh R.; Stephens-Shields, Alisa J.; Fleishman, John A.; Berry, Stephen A.; Agwu, Allison L.; Metlay, Joshua P.; Moore, Richard D.; Mathews, W. Christopher; Nijhawan, Ank; Rutstein, Richard; Gaur, Aditya H.; Gebo, Kelly A.		HIV Res Network	The HIV Care Continuum: Changes over Time in Retention in Care and Viral Suppressionqs	PLOS ONE			English	Article							SELF-MANAGEMENT; CHRONIC DISEASE; UNITED-STATES; ADHERENCE; OUTCOMES; CASCADE; TRENDS	Background The HIV care continuum (diagnosis, linkage to care, retention in care, receipt of antiretroviral therapy (ART), viral suppression) has been used to identify opportunities for improving the delivery of HIV care. Continuum steps are typically calculated in a conditional manner, with the number of persons completing the prior step serving as the base population for the next step. This approach may underestimate the prevalence of viral suppression by excluding patients who are suppressed but do not meet standard definitions of retention in care. Understanding how retention in care and viral suppression interact and change over time may improve our ability to intervene on these steps in the continuum. Methods We followed 17,140 patients at 11 U.S. HIV clinics between 2010-2012. For each calendar year, patients were classified into one of five categories: (1) retained/suppressed, (2) retained/not-suppressed, (3) not-retained/suppressed, (4) not-retained/not-suppressed, and (5) lost to follow-up (for calendar years 2011 and 2012 only). Retained individuals were those completing >= 2 HIV medical visits separated by >= 90 days in the year. Persons not retained completed >= 1 HIV medical visit during the year, but did not meet the retention definition. Persons lost to follow-up had no HIV medical visits in the year. HIV viral suppression was defined as HIV-1 RNA <= 200 copies/mL at the last measure in the year. Multinomial logistic regression was used to determine the probability of patients' transitioning between retention/suppression categories from 2010 to 2011 and 2010 to 2012, adjusting for age, sex, race/ethnicity, HIV risk factor, insurance status, CD4 count, and use of ART. Results Overall, 65.8% of patients were retained/suppressed, 17.4% retained/not-suppressed, 10.0% not-retained/suppressed, and 6.8% not-retained/not-suppressed in 2010. 59.5% of patients maintained the same status in 2011 (kappa=0.458) and 53.3% maintained the same status in 2012 (kappa=0.437). Conclusions Not counting patients not-retained/suppressed as virally suppressed, as is commonly done in the HIV care continuum, underestimated the proportion suppressed by 13%. Applying the care continuum in a longitudinal manner will enhance its utility.	[Yehia, Baligh R.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yehia, Baligh R.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Yehia, Baligh R.; Stephens-Shields, Alisa J.] Univ Penn, Perelman Sch Med, Ctr Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Fleishman, John A.] Agcy Healthcare Res & Qual, Ctr Financing Access & Cost Trends, Rockville, MD USA; [Berry, Stephen A.; Agwu, Allison L.; Moore, Richard D.; Gebo, Kelly A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Metlay, Joshua P.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Mathews, W. Christopher] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Nijhawan, Ank] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Rutstein, Richard] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Gaur, Aditya H.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Agency for Healthcare Research & Quality; Johns Hopkins University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; St Jude Children's Research Hospital	Yehia, BR (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	byehia@upenn.edu	Gebo, Kelly/AHA-7533-2022; Gaur, Aditya H/N-8057-2018	Gebo, Kelly/0000-0003-4010-398X; Gaur, Aditya H/0000-0002-6639-5231; Korthuis, Philip/0000-0001-5556-3597	Agency for Healthcare Research and Quality [HHSA290201100007C]; National Institutes of Health [K23-MH097647, K23-AI084854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, K23AI084854, P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097647] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Agency for Healthcare Research and Quality [HHSA290201100007C] and the National Institutes of Health [K23-MH097647 to BRY; K23-AI084854 to SAB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2012, ANN INTERN MED, V157, P325, DOI 10.7326/0003-4819-157-5-201209040-00005; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2010, NAT HIV AIDS STRAT U; Arribas JR, 2013, CURR OPIN HIV AIDS, V8, P341, DOI 10.1097/COH.0b013e328361fabd; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Berry SA, 2012, JAIDS-J ACQ IMM DEF, V59, P368, DOI 10.1097/QAI.0b013e318246b862; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Cohen CJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003028; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Department for Health and Human Services, GUIDELINES USE ANTIR; Eberhart MG, 2013, JAIDS-J ACQ IMM DEF, V64, pS42, DOI 10.1097/QAI.0b013e3182a90112; Fleishman JA, 2012, JAIDS-J ACQ IMM DEF, V60, P249, DOI 10.1097/QAI.0b013e318258c696; Gray KM, 2013, AM J PUBLIC HEALTH, V103, P141, DOI 10.2105/AJPH.2012.300859; Holtzman CW, 2015, AIDS CARE, V27, P817, DOI 10.1080/09540121.2015.1009362; Horberg M, 20 INT AIDS C 2014 M; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; Viera AJ, 2005, FAM MED, V37, P360; Wiewel EW, 2015, JAIDS-J ACQ IMM DEF, V68, P217, DOI 10.1097/QAI.0000000000000424; Yehia Baligh, 2011, Am J Public Health, V101, pe4, DOI 10.2105/AJPH.2011.300259; Yehia BR, 2014, AIDS BEHAV, V18, P1511, DOI 10.1007/s10461-013-0625-7; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa; Yehia BR, 2010, JAIDS-J ACQ IMM DEF, V53, P397, DOI 10.1097/QAI.0b013e3181bcdc16; Yehia BR, 2008, AIDS PATIENT CARE ST, V22, P1007, DOI 10.1089/apc.2008.0093	30	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129376	10.1371/journal.pone.0129376	http://dx.doi.org/10.1371/journal.pone.0129376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NT	26086089	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500046
J	Zhao, CP; Carrillo, JA; Tian, F; Zan, LS; Updike, SM; Zhao, K; Zhan, F; Song, JZ				Zhao, Chunping; Carrillo, Jose A.; Tian, Fei; Zan, Linsen; Updike, Scott M.; Zhao, Keji; Zhan, Fei; Song, Jiuzhou			Genome-Wide H3K4me3 Analysis in Angus Cattle with Divergent Tenderness	PLOS ONE			English	Article							SKELETAL-MUSCLE; MEAT QUALITY; HISTONE DEACETYLASES; REGULATORY FACTORS; GENE-EXPRESSION; BEEF TENDERNESS; METHYLATION; METHYLTRANSFERASE; DIFFERENTIATION; POSTMORTEM	Tenderness is one of the most important properties of meat quality, which is influenced by genetic and environmental factors. As an intensively studied epigenetic marker, histone methylation, occurring on arginine and lysine residues, has pivotal regulatory functions on gene expression. To examine whether histone methylation involves in beef tenderness variation, we analyzed the transcriptome and H3K4me3 enrichment profiles of muscle strips obtained from the longissimus dorsi (LD) of Angus steers previously classify to the tender or tough group. We first plotted a global bovine H3K4me3 map on chromosomes and called peak-enriched regions and genes. We found that majorities of H3K4me3 on genes were occupying the first intron and intergenic regions and its maps displayed similar patterns in tender and tough groups, with high H3K4me3 enrichment surrounding the transcription start site (TSS). We also explored the relationship of H3K4me3 and gene expression. The results showed that H3K4me3 enrichment is highly positively correlated with gene expression across the whole genome. Cluster analysis results confirmed the relationship of H3K4me3 enrichment and gene expression. By using a pathway-based approach in genes with H3K4me3 enrichment in promoter regions from the tender cluster, we revealed that those genes involved in the development of different tissues-connective tissue, skeletal and muscular system and functional tissues-; while in tough group those genes engaged in cell death, lipid metabolism and small molecule biochemistry. The results from this study provide a deep insight into understanding of the mechanisms of epigenetic regulations in meat quality and beef tenderness.	[Zhao, Chunping; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhao, Chunping; Carrillo, Jose A.; Tian, Fei; Updike, Scott M.; Zhan, Fei; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Northwest A&F University - China; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Song, JZ (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	songj88@umd.edu	Song, Jiuzhou/AAD-6440-2020		Maryland Agricultural Experiment Station (MAES); Jorgensen Endowment Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER	Maryland Agricultural Experiment Station (MAES); Jorgensen Endowment Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by Maryland Agricultural Experiment Station (MAES) and Jorgensen Endowment Funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Baar K, 2010, ACTA PHYSIOL, V199, P477, DOI 10.1111/j.1748-1716.2010.02121.x; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Eom GH, J BIOL CHEM; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; He YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039094; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Klont RE, 1998, MEAT SCI, V49, pS219; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041849; Maltin C, 2003, P NUTR SOC, V62, P337, DOI 10.1079/PNS2003248; McGee SL, 2010, CLIN EXP PHARMACOL P, V37, P392, DOI 10.1111/j.1440-1681.2009.05311.x; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Pandorf CE, 2009, AM J PHYSIOL-CELL PH, V297, pC6, DOI 10.1152/ajpcell.00075.2009; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Robinson DL, 2001, AUST J EXP AGR, V41, P997, DOI 10.1071/EA00039; Sawdy JC, 2004, MEAT SCI, V67, P421, DOI 10.1016/j.meatsci.2003.11.014; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thompson JM, 2006, MEAT SCI, V74, P59, DOI 10.1016/j.meatsci.2006.04.022; Verrier L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001390; Warner RD, 2010, MEAT SCI, V86, P171, DOI 10.1016/j.meatsci.2010.04.042; Yang Q, 2013, CELL PROLIFERAT, V46, P654, DOI 10.1111/cpr.12076; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zapata I, 2009, J AGR FOOD CHEM, V57, P4956, DOI 10.1021/jf900041j; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zhao CP, 2012, MOL BIOL REP, V39, P4185, DOI 10.1007/s11033-011-1203-6	36	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0115358	10.1371/journal.pone.0115358	http://dx.doi.org/10.1371/journal.pone.0115358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086782	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500001
J	Lee, JA; Yerbury, JJ; Farrawell, N; Shearer, RF; Constantinescu, P; Hatters, DM; Schroder, WA; Suhrbier, A; Wilson, MR; Saunders, DN; Ranson, M				Lee, Jodi A.; Yerbury, Justin J.; Farrawell, Natalie; Shearer, Robert F.; Constantinescu, Patrick; Hatters, Danny M.; Schroder, Wayne A.; Suhrbier, Andreas; Wilson, Mark R.; Saunders, Darren N.; Ranson, Marie			SerpinB2 (PAI-2) Modulates Proteostasis via Binding Misfolded Proteins and Promotion of Cytoprotective Inclusion Formation	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; HEAT-SHOCK PROTEINS; UBIQUITIN-PROTEASOME SYSTEM; ALZHEIMERS-DISEASE; FIBRIL FORMATION; POLYGLUTAMINE AGGREGATION; MOLECULAR CHAPERONES; MUTANT HUNTINGTIN; PEPTIDE TOXICITY; CELLS	SerpinB2 (PAI-2), a member of the clade B family of serine protease inhibitors, is one of the most upregulated proteins following cellular stress. Originally described as an inhibitor of urokinase plasminogen activator, its predominant cytoplasmic localisation suggests an intracellular function. SerpinB2 has been reported to display cytoprotective properties in neurons and to interact with intracellular proteins including components of the ubiquitin-proteasome system (UPS). In the current study we explored the potential role of SerpinB2 as a modulator of proteotoxic stress. Initially, we transiently transfected wild-type SerpinB2 and SerpinB2-/- murine embryonic fibroblasts (MEFs) with Huntingtin exon1-polyglutamine (fused C-terminally to mCherry). Inclusion body formation as result of Huntingtin aggregation was evident in the SerpinB2 expressing cells but significantly impaired in the SerpinB2-/- cells, the latter concomitant with loss in cell viability. Importantly, recovery of the wild-type phenotype and cell viability was rescued by retroviral transduction of SerpinB2 expression. SerpinB2 modestly attenuated Huntingtin and amyloid beta fibril formation in vitro and was able to bind preferentially to misfolded proteins. Given the modest chaperonelike activity of SerpinB2 we tested the ability of SerpinB2 to modulate UPS and autophagy activity using a GFP reporter system and autophagy reporter, respectively. Activity of the UPS was reduced and autophagy was dysregulated in SerpinB2-/- compared to wild-type MEFs. Moreover, we observed a non-covalent interaction between ubiquitin and SerpinB2 in cells using GFP-pulldown assays and bimolecular fluorescence complementation. We conclude that SerpinB2 plays an important role in proteostasis as its loss leads to a proteotoxic phenotype associated with an inability to compartmentalize aggregating proteins and a reduced capacity of the UPS.	[Lee, Jodi A.; Yerbury, Justin J.; Farrawell, Natalie; Constantinescu, Patrick; Wilson, Mark R.; Ranson, Marie] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Lee, Jodi A.; Yerbury, Justin J.; Farrawell, Natalie; Constantinescu, Patrick; Wilson, Mark R.; Ranson, Marie] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Shearer, Robert F.; Saunders, Darren N.] Garvan Inst Med Res, Kinghorn Canc Ctr & Canc Res Program, Sydney, NSW, Australia; [Shearer, Robert F.; Saunders, Darren N.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Hatters, Danny M.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Hatters, Danny M.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Schroder, Wayne A.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia	University of Wollongong; University of Wollongong; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute	Saunders, DN (corresponding author), Garvan Inst Med Res, Kinghorn Canc Ctr & Canc Res Program, Sydney, NSW, Australia.	d.saunders@garvan.org.au; mranson@uow.edu.au	Ranson, Marie/A-6324-2008; Ranson, Marie/AAC-4468-2019; Wilson, Mark R/B-3254-2018; Ranson, Marie/GRO-5792-2022; Yerbury, Justin/AAC-7054-2022	Ranson, Marie/0000-0002-5570-9645; Ranson, Marie/0000-0002-5570-9645; Wilson, Mark R/0000-0002-9551-7445; Ranson, Marie/0000-0002-5570-9645; Yerbury, Justin/0000-0003-2528-7039; Hatters, Danny/0000-0002-9965-2847; Saunders, Darren/0000-0003-0924-0513; Suhrbier, Andreas/0000-0001-8986-9025; Farrawell, Natalie/0000-0001-8060-4629; Matic (nee Lee), Jodi/0000-0002-2124-9345				ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; AKIYAMA H, 1993, NEUROSCI LETT, V164, P233, DOI 10.1016/0304-3940(93)90899-V; Aksenov MY, 1996, NEUROSCI LETT, V217, P117, DOI 10.1016/0304-3940(96)13082-2; Aksenova MV, 1996, NEUROSCI LETT, V211, P45, DOI 10.1016/0304-3940(96)12717-8; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Broyl A, 2010, LANCET ONCOL, V11, P1057, DOI 10.1016/S1470-2045(10)70206-0; Brummer T, 2008, EMBO J, V27, P2305, DOI 10.1038/emboj.2008.159; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chuang SY, 2013, P NATL ACAD SCI USA, V110, P16079, DOI 10.1073/pnas.1306556110; Cochran BJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-43; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; ERIKSSON S, 1995, P NATL ACAD SCI USA, V92, P2313, DOI 10.1073/pnas.92.6.2313; Fan J, 2004, ACTA BIOCH BIOPH SIN, V36, P42, DOI 10.1093/abbs/36.1.42; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Francois A, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-151; GOLLIN PA, 1992, NEUROREPORT, V3, P201, DOI 10.1097/00001756-199202000-00020; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Hatters DA, 2008, IUBMB LIFE, V60, P724, DOI 10.1002/iub.111; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Kinghorn KJ, 2006, J BIOL CHEM, V281, P29268, DOI 10.1074/jbc.M600690200; Korcsmaros T, 2007, J BIOSCIENCES, V32, P441, DOI 10.1007/s12038-007-0043-y; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; Lee JA, 2011, SEMIN THROMB HEMOST, V37, P395, DOI 10.1055/s-0031-1276589; Major L, 2011, EXP CELL RES, V317, P338, DOI 10.1016/j.yexcr.2010.10.016; Medcalf RL, 2011, METHOD ENZYMOL, V499, P105, DOI 10.1016/B978-0-12-386471-0.00006-7; Nardai G, 2006, TRENDS IMMUNOL, V27, P74, DOI 10.1016/j.it.2005.11.009; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Olah J, 2011, J BIOL CHEM, V286, P34088, DOI 10.1074/jbc.M111.243907; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Polling S, 2014, J BIOL CHEM, V289, P6669, DOI 10.1074/jbc.M113.520189; Ramdzan YM, 2010, CHEM BIOL, V17, P371, DOI 10.1016/j.chembiol.2010.03.011; Roscic A, 2011, J NEUROCHEM, V119, P398, DOI 10.1111/j.1471-4159.2011.07435.x; ROZEMULLER JM, 1991, ACTA NEUROPATHOL, V82, P200, DOI 10.1007/BF00294446; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder WA, 2014, CANCER MED-US, V3, P500, DOI 10.1002/cam4.229; Schroder WA, 2011, CRIT REV IMMUNOL, V31, P15, DOI 10.1615/CritRevImmunol.v31.i1.20; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Weisberg SJ, 2012, P NATL ACAD SCI USA, V109, P15811, DOI 10.1073/pnas.1205829109; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2013, CELL STRESS CHAPERON, V18, P251, DOI 10.1007/s12192-012-0371-1; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	58	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130136	10.1371/journal.pone.0130136	http://dx.doi.org/10.1371/journal.pone.0130136			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083412	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400126
J	Paul, M; Hemshekhar, M; Thushara, RM; Sundaram, MS; NaveenKumar, SK; Naveen, S; Devaraja, S; Somyajit, K; West, R; Basappa; Nayaka, SC; Zakai, UI; Nagaraju, G; Rangappa, KS; Kemparaju, K; Girish, KS				Paul, Manoj; Hemshekhar, Mahadevappa; Thushara, Ram M.; Sundaram, Mahalingam S.; NaveenKumar, Somanathapura K.; Naveen, Shivanna; Devaraja, Sannaningaiah; Somyajit, Kumar; West, Robert; Basappa; Nayaka, Siddaiah C.; Zakai, Uzma I.; Nagaraju, Ganesh; Rangappa, Kanchugarakoppal S.; Kemparaju, Kempaiah; Girish, Kesturu S.			Methotrexate Promotes Platelet Apoptosis via JNK-Mediated Mitochondrial Damage: Alleviation by N-Acetylcysteine and N-Acetylcysteine Amide	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; OXIDATIVE STRESS; CANCER; ISCHEMIA/REPERFUSION; DYSFUNCTION; MEMBRANE; SURVIVAL	Thrombocytopenia in methotrexate (MTX)-treated cancer and rheumatoid arthritis (RA) patients connotes the interference of MTX with platelets. Hence, it seemed appealing to appraise the effect of MTX on platelets. Thereby, the mechanism of action of MTX on platelets was dissected. MTX (10 mu M) induced activation of pro-apoptotic proteins Bid, Bax and Bad through JNK phosphorylation leading Delta psi m dissipation, cytochrome c release and caspase activation, culminating in apoptosis. The use of specific inhibitor for JNK abrogates the MTX-induced activation of pro-apoptotic proteins and downstream events confirming JNK phosphorylation by MTX as a key event. We also demonstrate that platelet mitochondria as prime sources of ROS which plays a central role in MTX-induced apoptosis. Further, MTX induces oxidative stress by altering the levels of ROS and glutathione cycle. In parallel, the clinically approved thiol antioxidant N-acetylcysteine (NAC) and its derivative N-acetylcysteine amide (NACA) proficiently alleviate MTX-induced platelet apoptosis and oxidative damage. These findings underpin the dearth of research on interference of therapeutic drugs with platelets, despite their importance in human health and disease. Therefore, the use of antioxidants as supplementary therapy seems to be a safe bet in pathologies associated with altered platelet functions.	[Paul, Manoj; Hemshekhar, Mahadevappa; Thushara, Ram M.; Sundaram, Mahalingam S.; NaveenKumar, Somanathapura K.; Kemparaju, Kempaiah; Girish, Kesturu S.] Univ Mysore, Dept Studies Biochem, Mysore 570006, Karnataka, India; [Hemshekhar, Mahadevappa] Univ Manitoba, Dept Internal Med, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB R3E 3P4, Canada; [Naveen, Shivanna] Def Food Res Lab, Appl Nutr Discipline, Mysore 570011, Karnataka, India; [Devaraja, Sannaningaiah; Girish, Kesturu S.] Tumkur Univ, Dept Studies & Res Biochem, Tumkur 572103, India; [Somyajit, Kumar; Nagaraju, Ganesh] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [West, Robert; Zakai, Uzma I.] Univ Wisconsin, Organosilicon Res Ctr, Madison, WI 53706 USA; [Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560056, Karnataka, India; [Nayaka, Siddaiah C.] Univ Mysore, Dept Appl Bot & Biotechnol, Mysore 570006, Karnataka, India; [Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India	University of Mysore; University of Manitoba; Defence Research & Development Organisation (DRDO); Defence Food Research Laboratory (DFRL); Tumkur University; Indian Institute of Science (IISC) - Bangalore; University of Wisconsin System; University of Wisconsin Madison; Bangalore University; University of Mysore; University of Mysore	Kemparaju, K (corresponding author), Univ Mysore, Dept Studies Biochem, Mysore 570006, Karnataka, India.	kemparajuom@gmail.com; ksgbaboo@gmail.com	KS, Girish/GWZ-7128-2022; S., Naveen/E-8678-2013	S., Naveen/0000-0001-6316-7973; /0000-0001-6121-0771; KS, Girish/0000-0002-7284-3707; Basappa, Basappa/0000-0002-8844-468X; Somyajit, Kumar/0000-0003-2496-7155	UGC-BSR	UGC-BSR	Manoj Paul and Mahalingam S. Sundaram thank UGC-BSR for the research fellowship. Authors thank Pavan MS, Sharath BN, IISc Bangalore and Mr. Jagadish S, UOM Mysore for their kind help during the study and also thank Vashishta from the IISc FACS facility, Bangalore. Authors also thank Central instrumentation facility, Institute of excellence (IOE), University of Mysore, Mysore.	Abdel-Raheem IT, 2014, N-S ARCH PHARMACOL, V387, P341, DOI 10.1007/s00210-013-0949-x; Abolmaali SS, 2013, CANCER CHEMOTH PHARM, V71, P1115, DOI 10.1007/s00280-012-2062-0; Ali N, 2014, MOL CELL BIOCHEM, V385, P215, DOI 10.1007/s11010-013-1830-4; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; CONDREA E, 1983, THROMB HAEMOSTASIS, V49, P151; Conway R, 2014, ARTHRITIS RHEUMATOL, V66, P2642, DOI [10.1002/art.38732, 10.1002/art.38322]; Dasari P, 2012, BMJ CASE REP; de Broucker T, 2013, J NEUROL SCI, V335, P201, DOI 10.1016/j.jns.2013.09.032; Demiryilmaz I, 2012, MED SCI MONITOR, V18, pBR475, DOI 10.12659/MSM.883591; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Dubsky P, 2008, CLIN CANCER RES, V14, P2082, DOI 10.1158/1078-0432.CCR-07-2068; Feketeova L, 2012, RHEUMATOL INT, V32, P3517, DOI 10.1007/s00296-011-2177-3; Ferlini C, 2007, NAT PROTOC, V2, P3111, DOI 10.1038/nprot.2007.397; Genestier L, 1998, J CLIN INVEST, V102, P322, DOI 10.1172/JCI2676; Girish KS, 2013, BIOCHEM BIOPH RES CO, V438, P198, DOI 10.1016/j.bbrc.2013.07.053; Glantz MJ, 1998, J CLIN ONCOL, V16, P1561, DOI 10.1200/JCO.1998.16.4.1561; Gyulkhandanyan AV, 2012, J THROMB THROMBOLYS, V33, P397, DOI 10.1007/s11239-012-0688-8; Hashkes PJ, 2014, J PEDIATR-US, V164, P231, DOI 10.1016/j.jpeds.2013.10.029; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Jaffe N, 2014, ADV EXP MED BIOL, V804, P1, DOI 10.1007/978-3-319-04843-7_1; Kamada H, 2007, J CEREBR BLOOD F MET, V27, P521, DOI 10.1038/sj.jcbfm.9600367; Kilic S, 2013, ARCH DERMATOL RES, V305, P495, DOI 10.1007/s00403-013-1366-1; Kolli VK, 2014, HUM EXP TOXICOL, V33, P1051, DOI 10.1177/0960327113515503; Korytowski W, 2011, J BIOL CHEM, V286, P26334, DOI 10.1074/jbc.M110.188516; Kubota M, 2013, LEUKEMIA LYMPHOMA, V5, P1591; Kusunoki-Nakamoto F, 2013, INTERNAL MED, V52, P623, DOI 10.2169/internalmedicine.52.8785; Leytin V, 2012, BLOOD REV, V26, P51, DOI 10.1016/j.blre.2011.10.002; Lipets E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087692; Lopez JJ, 2007, J THROMB HAEMOST, V5, P1283, DOI 10.1111/j.1538-7836.2007.02505.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mukherjee S, 2013, J NUTR BIOCHEM, V24, P2040, DOI 10.1016/j.jnutbio.2013.07.005; Nikiphorou E, 2014, CLIN RHEUMATOL, V33, P609, DOI 10.1007/s10067-014-2546-x; Pagadigorria CLS, 2006, COMP BIOCHEM PHYS C, V143, P340, DOI 10.1016/j.cbpc.2006.03.007; Pamuk ON, 2013, RHEUMATOL INT, V33, P2631, DOI 10.1007/s00296-013-2792-2; Park JS, 2014, CLIN RHEUMATOL, V33, P1415, DOI 10.1007/s10067-014-2719-7; Petrosillo G, 2009, FREE RADICAL BIO MED, V47, P969, DOI 10.1016/j.freeradbiomed.2009.06.032; Rosado JA, 2006, J CELL PHYSIOL, V209, P142, DOI 10.1002/jcp.20715; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sener A, 2012, FOLIA BIOL-PRAGUE, V58, P193; Srinivasan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077129; Sunitha K, 2013, FREE RADICAL RES, V47, P357, DOI 10.3109/10715762.2013.781595; Thushara RM, 2014, ARCH TOXICOL, V88, P185, DOI 10.1007/s00204-013-1185-3; Thushara RM, 2013, BIOCHIMIE, V95, P2060, DOI 10.1016/j.biochi.2013.07.032; Thushara RM, 2013, CURR MED CHEM, V20, P1018; Thushara RM, 2013, MOL CELL BIOCHEM, V373, P73, DOI 10.1007/s11010-012-1476-7; Vora A, 2014, LANCET ONCOL, V15, P809, DOI 10.1016/S1470-2045(14)70243-8; Wang ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075044	52	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127558	10.1371/journal.pone.0127558	http://dx.doi.org/10.1371/journal.pone.0127558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083398	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000356567400016
J	Yoon, S; Mitra, S; Wyse, C; Alnabulsi, A; Zou, J; Weerdenburg, EM; van der Sar, AM; Wang, DF; Secombes, CJ; Bird, S				Yoon, Sohye; Mitra, Suman; Wyse, Cathy; Alnabulsi, Ayham; Zou, Jun; Weerdenburg, Eveline M.; van der Sar, Astrid M.; Wang, Difei; Secombes, Christopher J.; Bird, Steve			First Demonstration of Antigen Induced Cytokine Expression by CD4-1(+) Lymphocytes in a Poikilotherm: Studies in Zebrafish (Danio rerio)	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; CARASSIUS-AURATUS-LANGSDORFII; GINBUNA CRUCIAN CARP; TROUT ONCORHYNCHUS-MYKISS; T-CELL DEVELOPMENT; TELEOST FISH; MOLECULAR-CLONING; RAINBOW-TROUT; SEQUENCE ALIGNMENT; ADAPTIVE IMMUNITY	Adaptive immunity in homeotherms depends greatly on CD4+ Th cells which release cytokines in response to specific antigen stimulation. Whilst bony fish and poikilothermic tetrapods possess cells that express TcR and CD4-related genes ( that exist in two forms in teleost fish; termed CD4-1 and CD4-2), to date there is no unequivocal demonstration that cells equivalent to Th exist. Thus, in this study we determined whether CD4-1+ lymphocytes can express cytokines typical of Th cells following antigen specific stimulation, using the zebrafish ( Danio rerio). Initially, we analyzed the CD4 locus in zebrafish and found three CD4 homologues, a CD4-1 molecule and two CD4-2 molecules. The zfCD4-1 and zfCD4-2 transcripts were detected in immune organs and were most highly expressed in lymphocytes. A polyclonal antibody to zfCD4-1 was developed and used with an antibody to ZAP70 and revealed double positive cells by immunohistochemistry, and in the Mycobacterium marinum disease model CD4-1+ cells were apparent surrounding the granulomas typical of the infection. Next a prime-boost experiment, using human gamma globulin as antigen, was performed and revealed for the first time in fish that zfCD4-1+ lymphocytes increase the expression of cytokines and master transcription factors relevant to Th1/Th2-type responses as a consequence of boosting with specific antigen.	[Yoon, Sohye; Mitra, Suman; Wyse, Cathy; Zou, Jun; Secombes, Christopher J.; Bird, Steve] Univ Aberdeen, Sch Biol Sci, Scottish Fish Immunol Res Ctr, Aberdeen, Scotland; [Alnabulsi, Ayham] Univ Aberdeen, Vertebrate Antibodies Ltd, Aberdeen, Scotland; [Weerdenburg, Eveline M.; van der Sar, Astrid M.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, NL-1081 BT Amsterdam, Netherlands; [Wang, Difei] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA	University of Aberdeen; University of Aberdeen; Vrije Universiteit Amsterdam; Georgetown University	Secombes, CJ (corresponding author), Univ Aberdeen, Sch Biol Sci, Scottish Fish Immunol Res Ctr, Aberdeen, Scotland.	c.secombes@abdn.ac.uk	Bird, Steve/K-4822-2014; van der Sar, Astrid M/A-3698-2008; Wang, Difei/E-7066-2010	Bird, Steve/0000-0003-2937-8579; van der Sar, Astrid M/0000-0001-5790-5036; 	Scottish Overseas Research Scholarship Awards Scheme (SORSAS)	Scottish Overseas Research Scholarship Awards Scheme (SORSAS)	Both first authors were supported by the Scottish Overseas Research Scholarship Awards Scheme (SORSAS) to undertake a PhD program at the University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aubin JE, 1979, J HISTOCHEM CYTOCHEM; Bandin I, 1997, FISH SHELLFISH IMMUN, V7, P487, DOI 10.1006/fsim.1997.0102; Biswas P, 2003, BLOOD, V101, P4452, DOI 10.1182/blood-2002-10-3056; Buonocore F, 2008, MOL IMMUNOL, V45, P3168, DOI 10.1016/j.molimm.2008.02.024; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Castro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060175; Castro R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003098; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Dijkstra JM, 2006, MOL IMMUNOL, V43, P410, DOI 10.1016/j.molimm.2005.03.005; Edholm ES, 2007, DEV COMP IMMUNOL, V31, P172, DOI 10.1016/j.dci.2006.05.012; FILION LG, 1990, J IMMUNOL METHODS, V135, P59, DOI 10.1016/0022-1759(90)90256-U; Fischer U, 2013, FISH SHELLFISH IMMUN, V35, P197, DOI 10.1016/j.fsi.2013.04.018; Forlenza M, 2009, THESIS U WAGENINGEN; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q; Gunimaladevi I, 2006, FISH SHELLFISH IMMUN, V21, P393, DOI 10.1016/j.fsi.2006.01.004; Hong S, 2013, J IMMUNOL, V191, P5959, DOI 10.4049/jimmunol.1301584; Jiang SP, 2013, IMMUNOL REV, V252, P5, DOI 10.1111/imr.12041; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Kato G, 2013, DEV COMP IMMUNOL, V39, P293, DOI 10.1016/j.dci.2012.09.004; Kono T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066364; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Laing KJ, 2006, J IMMUNOL, V177, P3939, DOI 10.4049/jimmunol.177.6.3939; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; LEAHY DJ, 1995, FASEB J, V9, P17, DOI 10.1096/fasebj.9.1.7821755; Mitra S, 2011, THESIS U ABERDEEN; Mitra S, 2010, FEBS J, V277, P128, DOI 10.1111/j.1742-4658.2009.07460.x; Moller AM, 2014, DEV COMP IMMUNOL, V46, P518, DOI 10.1016/j.dci.2014.03.020; Moore LJ, 2009, FISH SHELLFISH IMMUN, V26, P10, DOI 10.1016/j.fsi.2008.09.019; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Nonaka S, 2008, FISHERIES SCI, V74, P341, DOI 10.1111/j.1444-2906.2008.01530.x; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Ohtani M, 2008, IMMUNOGENETICS, V60, P383, DOI 10.1007/s00251-008-0299-x; Overgard AC, 2010, FISH SHELLFISH IMMUN, V29, P987, DOI 10.1016/j.fsi.2010.08.011; Patel S, 2009, FISH SHELLFISH IMMUN, V26, P377, DOI 10.1016/j.fsi.2008.11.013; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Petrie-Hanson L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-8; Picchietti S, 2011, FISH SHELLFISH IMMUN, V30, P609, DOI 10.1016/j.fsi.2010.12.006; Pionnier N, 2014, FISH SHELLFISH IMMUN, V39, P285, DOI 10.1016/j.fsi.2014.05.008; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALMON P, 1993, P NATL ACAD SCI USA, V90, P7739, DOI 10.1073/pnas.90.16.7739; SECOMBES CJ, 1984, J FISH BIOL, V24, P193, DOI 10.1111/j.1095-8649.1984.tb04790.x; SECOMBES CJ, 1982, J EXP ZOOL, V220, P277, DOI 10.1002/jez.1402200303; SECOMBES CJ, 1982, IMMUNOLOGY, V47, P101; Somamoto T, 2014, DEV COMP IMMUNOL, V44, P111, DOI 10.1016/j.dci.2013.12.008; Somamoto T, 2013, DEV COMP IMMUNOL, V39, P370, DOI 10.1016/j.dci.2012.11.001; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Suetake H, 2004, IMMUNOGENETICS, V56, P368, DOI 10.1007/s00251-004-0694-x; Sun XF, 2007, FISH SHELLFISH IMMUN, V23, P1242, DOI 10.1016/j.fsi.2007.06.004; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; TATNER MF, 1987, J FISH BIOL, V31, P177, DOI 10.1111/j.1095-8649.1987.tb05224.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toda H, 2009, DEV COMP IMMUNOL, V33, P646, DOI 10.1016/j.dci.2008.11.008; Toda H, 2011, DEV COMP IMMUNOL, V35, P650, DOI 10.1016/j.dci.2011.01.013; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Weerdenburg EM, 2012, CELL MICROBIOL, V14, P728, DOI 10.1111/j.1462-5822.2012.01755.x; Wen Y, 2011, CELL MOL LIFE SCI, V68, P2615, DOI 10.1007/s00018-010-0574-5; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Xu W, 2013, J NEUROIMMUNOL, V261, P87, DOI 10.1016/j.jneuroim.2013.04.021; Yamaguchi T, 2013, FISH SHELLFISH IMMUN, V34, P433, DOI 10.1016/j.fsi.2012.11.005; Yamasaki M, 2014, FISH SHELLFISH IMMUN, V36, P299, DOI 10.1016/j.fsi.2013.11.016; Yin YY, 2012, P NATL ACAD SCI USA, V109, P5405, DOI 10.1073/pnas.1118801109; Zhu LY, 2014, J IMMUNOL, V192, P2699, DOI 10.4049/jimmunol.1301312	72	57	62	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0126378	10.1371/journal.pone.0126378	http://dx.doi.org/10.1371/journal.pone.0126378			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083432	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400006
J	Bal, HK; Grewal, PS				Bal, Harit K.; Grewal, Parwinder S.			Lateral Dispersal and Foraging Behavior of Entomopathogenic Nematodes in the Absence and Presence of Mobile and Non-Mobile Hosts	PLOS ONE			English	Article							INSECT-PARASITIC NEMATODES; STEINERNEMA-CARPOCAPSAE; NEOAPLECTANA-CARPOCAPSAE; HETERORHABDITIS-MEGIDIS; FINDING ABILITY; PLANT-ROOTS; STRATEGIES; CUES; ORIENTATION; INFECTIVITY	Entomopathogenic nematodes have been classified into cruisers (active searchers) and ambushers (sit and wait foragers). However, little is known about their dispersal and foraging behavior at population level in soil. We studied lateral dispersal of the ambush foraging Steinernema carpocapsae (ALL strain) and cruise foraging Heterorhabditis bacteriophora (GPS11 strain) from infected host cadavers in microcosms (0.05 m(2)) containing Wooster silt-loam soil (Oxyaquic fragiudalf) and vegetation in the presence or absence of non-mobile and mobile hosts. Results showed that the presence of a non-mobile host (Galleria mellonella larva in a wire mesh cage) enhanced H. bacteriophora dispersal for up to 24 hr compared with no-host treatment, but had no impact on S. carpocapsae dispersal. In contrast, presence of a mobile host (G. mellonella larvae) increased dispersal of S. carpocapsae compared with no host treatment, but had no effect on H. bacteriophora dispersal. Also H. bacteriophora was better at infecting non-mobile than mobile hosts released into the microcosms and S. carpocapsae was better at infecting mobile than non-mobile hosts, thus affirming the established cruiser-ambusher theory. However, results also revealed that a large proportion of infective juveniles (IJs) of both species stayed near (<= 3.8 cm) the source cadaver (88-96% S. carpocapsae; 67-79% H. bacteriophora), and the proportion of IJs reaching the farthest distance (11.4 cm) was significantly higher for S. carpocapsae (1.4%) than H. bacteriophora (0.4%) in the presence of mobile hosts. S. carpocapsae also had higher average population displacement than H. bacteriophora in the presence of both the non-mobile (5.07 vs. 3.6 cm/day) and mobile (8.06 vs. 5.3 cm/day) hosts. We conclude that the two species differ in their dispersal and foraging behavior at the population level and this behavior is affected by both the presence and absence of hosts and by their mobility.	[Bal, Harit K.; Grewal, Parwinder S.] Ohio State Univ, Dept Entomol, OARDC, Wooster, OH USA	University System of Ohio; Ohio State University	Grewal, PS (corresponding author), Univ Tennessee, Dept Entomol Plant Pathol & Nematol, Knoxville, TN 37996 USA.	pgrewal@utk.edu			SEEDS: The OARDC Research Enhancement Competitive Grants Program The Ohio State University	SEEDS: The OARDC Research Enhancement Competitive Grants Program The Ohio State University	This work was supported by SEEDS: The OARDC Research Enhancement Competitive Grants Program The Ohio State University. (http://www.oardc.ohio-state.edu/seeds/t08_pageview/Home.htm) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATORREROSAS R, 1990, J INVERTEBR PATHOL, V55, P179, DOI 10.1016/0022-2011(90)90053-9; Ali JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038146; Ali JG, 2011, J ECOL, V99, P26, DOI 10.1111/j.1365-2745.2010.01758.x; Ali JG, 2010, J CHEM ECOL, V36, P361, DOI 10.1007/s10886-010-9773-7; Allendorf F., 2007, CONSERVATION GENETIC; Bal HK, 2014, J PARASITOL, V100, P422, DOI 10.1645/12-165.1; Bal HK, 2014, EVOL ECOL, V28, P923, DOI 10.1007/s10682-014-9706-y; BEDDING RA, 1975, NEMATOLOGICA, V21, P109, DOI 10.1163/187529275X00419; BIRD AF, 1986, INT J PARASITOL, V16, P511, DOI 10.1016/0020-7519(86)90086-X; Boff MIC, 2002, BIOCONTROL, V47, P67, DOI 10.1023/A:1014435627268; Boff MIC, 2001, ENTOMOL EXP APPL, V98, P329, DOI 10.1023/A:1018907812376; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Campbell JF, 1999, PARASITOLOGY, V118, P499, DOI 10.1017/S0031182099003984; Campbell JF, 1999, NATURE, V397, P485, DOI 10.1038/17254; Campbell JF, 1997, FUND APPL NEMATOL, V20, P393; Campbell JF, 2002, NEMATOLOGY, V4, P471, DOI 10.1163/156854102760290455; CAMPBELL JF, 1993, BEHAVIOUR, V126, P155, DOI 10.1163/156853993X00092; Cutler GC, 2003, NEMATOLOGY, V5, P601, DOI 10.1163/156854103322683319; Dillman AR, 2012, P NATL ACAD SCI USA, V109, pE2324, DOI 10.1073/pnas.1211436109; El-Borai FE, 2011, J INVERTEBR PATHOL, V106, P347, DOI 10.1016/j.jip.2010.12.001; GAUGLER R, 1989, J NEMATOL, V21, P247; GAUGLER R, 1980, ENVIRON ENTOMOL, V9, P649, DOI 10.1093/ee/9.5.649; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Glazer I, 1997, PARASITOLOGY, V114, P597; GREWAL PS, 1993, EXPERIENTIA, V49, P605, DOI 10.1007/BF01955173; GREWAL PS, 1994, PARASITOLOGY, V108, P207, DOI 10.1017/S003118200006830X; Grewal PS, 1997, J CHEM ECOL, V23, P503, DOI 10.1023/B:JOEC.0000006374.95624.7e; Griffin CT, 1996, FUND APPL NEMATOL, V19, P95; Hallem EA, 2011, CURR BIOL, V21, P377, DOI 10.1016/j.cub.2011.01.048; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; HASSELL MP, 1978, ANNU REV ECOL SYST, V9, P75, DOI 10.1146/annurev.es.09.110178.000451; Hominick W. M., 1990, Entomopathogenic nematodes in biological control., P327; Hui E, 2000, J INVERTEBR PATHOL, V75, P152, DOI 10.1006/jipa.1999.4910; Ishibashi N., 1990, P139; Kaplan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038735; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; Kruitbos LM, 2010, NEMATOLOGY, V12, P309, DOI 10.1163/138855409X12506855979794; Lewis EE, 2006, BIOL CONTROL, V38, P66, DOI 10.1016/j.biocontrol.2005.11.007; LEWIS EE, 1992, PARASITOLOGY, V105, P309, DOI 10.1017/S0031182000074230; LEWIS EE, 1995, PARASITOLOGY, V110, P207, DOI 10.1017/S0031182000063976; LEWIS EE, 1994, J INVERTEBR PATHOL, V64, P238, DOI 10.1016/S0022-2011(94)90325-5; LEWIS EE, 1993, CAN J ZOOL, V71, P765, DOI 10.1139/z93-101; Lewis EE, 2002, J NEMATOL, V34, P328; Mankin RW, 2002, J ECON ENTOMOL, V95, P981, DOI 10.1603/0022-0493-95.5.981; McCartney DA, 1997, SOIL BIOL BIOCHEM, V29, P397, DOI 10.1016/S0038-0717(96)00171-X; Neves JM, 1998, NEMATOLOGICA, V44, P95, DOI 10.1163/005225998X00109; O'Halloran DM, 2003, PARASITOLOGY, V127, P375, DOI 10.1017/S0031182003003688; OBRIEN WJ, 1989, OECOLOGIA, V80, P100, DOI 10.1007/BF00789938; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Rasmann S, 2012, J CHEM ECOL, V38, P615, DOI 10.1007/s10886-012-0118-6; SAS Institute Inc, 2012, WHATS NEW IN SAS 9 3; SCHMIDT J, 1979, ENVIRON ENTOMOL, V8, P55, DOI 10.1093/ee/8.1.55; SELVAN S, 1993, J PARASITOL, V79, P167, DOI 10.2307/3283503; Shapiro-Ilan DI, 2014, INT J PARASITOL, V44, P49, DOI 10.1016/j.ijpara.2013.10.002; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; Taylor L.R., 1986, P265; TAYLOR LR, 1977, NATURE, V265, P415, DOI 10.1038/265415a0; Torr P, 2004, INT J PARASITOL, V34, P997, DOI 10.1016/j.ijpara.2004.05.003; Travis JMJ, 2001, ECOL RES, V16, P157, DOI 10.1046/j.1440-1703.2001.00381.x; Turlings TCJ, 2012, PLANT SOIL, V358, P47, DOI 10.1007/s11104-012-1295-3; van Tol RWHM, 2001, ECOL LETT, V4, P292, DOI 10.1046/j.1461-0248.2001.00227.x; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Wilson MJ, 2012, NEMATOLOGY, V14, P389, DOI 10.1163/156854111X617428; Yoder CA, 2004, J PARASITOL, V90, P1229, DOI 10.1645/GE-3315	66	25	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129887	10.1371/journal.pone.0129887	http://dx.doi.org/10.1371/journal.pone.0129887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079715	Green Published, Green Submitted, gold			2022-12-26	WOS:000356542300034
J	King, JR; Nordman, JC; Bridges, SP; Lin, MK; Kabbani, N				King, Justin R.; Nordman, Jacob C.; Bridges, Samuel P.; Lin, Ming-Kuan; Kabbani, Nadine			Identification and Characterization of a G Protein-binding Cluster in alpha 7 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL SUBUNITS; CELLS; GROWTH; EXPRESSION; NEURONS; BRAIN; MODULATION; ACTIVATION; RELEASE; MICE	alpha 7 nicotinic acetylcholine receptors (nAChRs) play an important role in synaptic transmission and inflammation. In response to ligands, this receptor channel opens to conduct cations into the cell but desensitizes rapidly. In recent studies we show that alpha 7 nAChRs bind signaling proteins such as heterotrimeric GTP-binding proteins (G proteins). Here, we demonstrate that direct coupling of alpha 7 nAChRs to G proteins enables a downstream calcium signaling response that can persist beyond the expected time course of channel activation. This process depends on a G protein-binding cluster (GPBC) in the M3-M4 loop of the receptor. A mutation of the GPBC in the alpha 7 nAChR (alpha 7(345-348A)) abolishes interaction with G alpha(q) as well as G beta gamma while having no effect on receptor synthesis, cell-surface trafficking, or alpha-bungarotoxin binding. Expression of alpha 7(345-348A), however, did significantly attenuate the alpha 7 nAChR-induced G alpha(q) calcium signaling response as evidenced by a decrease in PLC-beta activation and IP3R-mediated calcium store release in the presence of the alpha 7 selective agonist choline. Taken together, the data provides new evidence for the existence of a GPBC in nAChRs serving to promote intracellular signaling.	George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA; George Mason Univ, Dept Comp Sci, Fairfax, VA 22030 USA; INOVA Neurosci Program, Annandale, VA 22003 USA	George Mason University; George Mason University	Kabbani, N (corresponding author), 4400 Univ Dr, Fairfax, VA 22030 USA.	nkabbani@gmu.edu		Nordman, Jacob/0000-0003-2513-7831; Bridges, Samuel/0000-0002-8560-9004	Wings for Life Spinal Cord Research	Wings for Life Spinal Cord Research	This work was supported by a grant from Wings for Life Spinal Cord Research (to N. K.). We declare that they have no conflicts of interest with the contents of this article.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Bourinet E, 1996, J NEUROSCI, V16, P4983; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Castillo M, 2006, J MOL NEUROSCI, V30, P153, DOI 10.1385/JMN:30:1:153; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Dau A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-47; FENG DF, 1985, J MOL EVOL, V21, P112, DOI 10.1007/BF02100085; Fischer H, 2005, J NEUROSCI, V25, P3571, DOI 10.1523/JNEUROSCI.4971-04.2005; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gomez-Varela D, 2013, J NEUROSCI, V 33, P17062, DOI 10.1523/JNEUROSCI.1482-13.2013; Guerra-Alvarez M, 2015, J NEUROCHEM, V133, P309, DOI 10.1111/jnc.13049; Halff AW, 2014, J NEUROSCI, V34, P2051, DOI 10.1523/JNEUROSCI.2795-13.2014; He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191; Jacovina AT, 2001, J BIOL CHEM, V276, P49350, DOI 10.1074/jbc.M106289200; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Kabbani N, 2013, BIOESSAYS, V35, P1025, DOI 10.1002/bies.201300082; Khiroug SS, 2002, J PHYSIOL-LONDON, V540, P425, DOI 10.1113/jphysiol.2001.013847; Kumar A, 2010, J NEUROPHYSIOL, V104, P607, DOI 10.1152/jn.00278.2010; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Liu QS, 1999, J NEUROSCI, V19, P10280; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; Luoma JI, 2008, MOL CELL ENDOCRINOL, V290, P8, DOI 10.1016/j.mce.2008.04.005; Mahajan R, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004075; McClure-Begley Tristan D., 2013, Genomics Proteomics & Bioinformatics, V11, P207, DOI 10.1016/j.gpb.2013.05.005; Murray TA, 2009, ACTA PHARMACOL SIN, V30, P828, DOI 10.1038/aps.2009.78; Nordman JC, 2014, FASEB J, V28, P2995, DOI 10.1096/fj.14-251439; Nordman JC, 2014, J NEUROCHEM, V129, P649, DOI 10.1111/jnc.12641; Nordman JC, 2014, MOL PHARMACOL, V85, P50, DOI 10.1124/mol.113.088484; Nordman JC, 2012, J CELL SCI, V125, P5502, DOI 10.1242/jcs.110379; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Papke RL, 2014, J PHARMACOL EXP THER, V350, P665, DOI 10.1124/jpet.114.215236; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; Paulo JA, 2009, J PROTEOME RES, V8, P1849, DOI 10.1021/pr800731z; Qi XL, 2007, NEUROCHEM INT, V51, P377, DOI 10.1016/j.neuint.2007.04.002; Quarta D, 2007, NEUROPSYCHOPHARMACOL, V32, P35, DOI 10.1038/sj.npp.1301103; RATHOUZ MM, 1994, J NEUROSCI, V14, P6935; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Saragoza PA, 2003, MOL BRAIN RES, V117, P15, DOI 10.1016/S0169-328X(03)00261-4; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Tso PH, 2009, NEUROCHEM RES, V34, P1101, DOI 10.1007/s11064-008-9880-9; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Zhong CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082719	48	63	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20060	20070		10.1074/jbc.M115.647040	http://dx.doi.org/10.1074/jbc.M115.647040			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26088141	Green Published, hybrid			2022-12-26	WOS:000359608900005
J	Murphy, M; Xiong, YB; Pattabiraman, G; Qiu, F; Medvedev, AE				Murphy, Michael; Xiong, Yanbao; Pattabiraman, Goutham; Qiu, Fu; Medvedev, Andrei E.			Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS63-LINKED POLYUBIQUITINATION; TYROSINE PHOSPHORYLATION; PHAGOSOME MATURATION; CYTOKINE PRODUCTION; ADAPTIVE IMMUNITY; CELL RESPONSES; KINASE PATHWAY; ACTIVATION; IL-1; LIPOPOLYSACCHARIDE	Endotoxin tolerance reprograms Toll-like receptor (TLR) 4-mediated macrophage responses by attenuating induction of proinflammatory cytokines while retaining expression of anti-inflammatory and antimicrobial mediators. We previously demonstrated deficient TLR4-induced activation of IL-1 receptor-associated kinase (IRAK) 4, IRAK1, and TANK-binding kinase (TBK) 1 as critical hallmarks of endotoxin tolerance, but mechanisms remain unclear. In this study, we examined the role of the E3 ubiquitin ligase Pellino-1 in endotoxin tolerance and TLR signaling. LPS stimulation increased Pellino-1 mRNA and protein expression in macrophages from mice injected with saline and in medium-pretreated human monocytes, THP-1, and MonoMac-6 cells, whereas endotoxin tolerization abrogated LPS inducibility of Pellino-1. Overexpression of Pellino-1 in 293/TLR2 and 293/TLR4/MD2 cells enhanced TLR2- and TLR4-induced nuclear factor kappa B (NF-kappa B) and expression of IL-8 mRNA, whereas Pellino-1 knockdown reduced these responses. Pellino-1 ablation in THP-1 cells impaired induction of myeloid differentiation primary response protein (MyD88), and Toll-IL-1R domain-containing adapter inducing IFN-beta (TRIF)-dependent cytokine genes in response to TLR4 and TLR2 agonists and heat-killed Escherichia coli and Staphylococcus aureus, whereas only weakly affecting phagocytosis of heat-killed bacteria. Co-expressed Pellino-1 potentiated NF-kappa B activation driven by transfected MyD88, TRIF, IRAK1, TBK1, TGF-beta-activated kinase (TAK) 1, and TNFR-associated factor 6, whereas not affecting p65-induced responses. Mechanistically, Pellino-1 increased LPS-driven K63-linked polyubiquitination of IRAK1, TBK1, TAK1, and phosphorylation of TBK1 and IFN regulatory factor 3. These results reveal a novel mechanism by which endotoxin tolerance re-programs TLR4 signaling via suppression of Pellino-1, a positive regulator of MyD88- and TRIF-dependent signaling that promotes K63-linked polyubiquitination of IRAK1, TBK1, and TAK1.	[Murphy, Michael; Pattabiraman, Goutham; Medvedev, Andrei E.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA; [Xiong, Yanbao; Qiu, Fu] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University of Connecticut; University System of Maryland; University of Maryland Baltimore	Medvedev, AE (corresponding author), 263 Farmington Ave,L Bldg,Rm L3019, Farmington, CT 06030 USA.	medvedev@uchc.edu		Pattabiraman, Goutham/0000-0002-5196-8279	National Institutes of Health from the NIAID [RO1 AI059524]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059524] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI059524 from the NIAID (to A. E. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adib-Conquy M, 2000, AM J RESP CRIT CARE, V162, P1877, DOI 10.1164/ajrccm.162.5.2003058; Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Bennett JA, 2012, J VIROL, V86, P6595, DOI 10.1128/JVI.06755-11; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Butler MP, 2005, J BIOL CHEM, V280, P27759, DOI 10.1074/jbc.M500756200; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Enesa K, 2012, J BIOL CHEM, V287, P34825, DOI 10.1074/jbc.M112.367557; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Haghayeghi A, 2010, MECH DEVELOP, V127, P301, DOI 10.1016/j.mod.2010.01.004; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jacinto R, 2002, J IMMUNOL, V168, P6136, DOI 10.4049/jimmunol.168.12.6136; Jensen LE, 2003, FEBS LETT, V545, P199, DOI 10.1016/S0014-5793(03)00533-7; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim TW, 2012, J BIOL CHEM, V287, P25686, DOI 10.1074/jbc.M112.352625; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Lee YS, 2015, EMBO MOL MED, V7, P577, DOI 10.15252/emmm.201404653; Lee YS, 2010, BIOCHEM BIOPH RES CO, V393, P836, DOI 10.1016/j.bbrc.2010.02.094; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Lin CC, 2008, STRUCTURE, V16, P1806, DOI 10.1016/j.str.2008.09.011; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Moynagh PN, 2014, NAT REV IMMUNOL, V14, P122, DOI 10.1038/nri3599; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Pan HJ, 2010, J IMMUNOL, V184, P5502, DOI 10.4049/jimmunol.0901601; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Peck OM, 2006, SHOCK, V26, P31, DOI 10.1097/01.shk.0000223128.79759.3d; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Quevedo-Diaz MA, 2010, J LEUKOCYTE BIOL, V88, P675, DOI 10.1189/jlb.1009674; Redlich S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-71; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wysocka M, 2001, J IMMUNOL, V166, P7504, DOI 10.4049/jimmunol.166.12.7504; Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111; Xiong YB, 2013, J LEUKOCYTE BIOL, V94, P291, DOI 10.1189/jlb.0812401; Xiong YB, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375493; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Xiong YB, 2011, J BIOL CHEM, V286, P7905, DOI 10.1074/jbc.M110.182873; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yu KY, 2002, J IMMUNOL, V169, P4075, DOI 10.4049/jimmunol.169.8.4075; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	65	27	33	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19218	19232		10.1074/jbc.M115.640128	http://dx.doi.org/10.1074/jbc.M115.640128			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26082489	Green Published, hybrid			2022-12-26	WOS:000358781100036
J	Brennand, A; Rico, E; Rigden, DJ; Van Der Smissen, P; Courtoy, PJ; Michels, PAM				Brennand, Ana; Rico, Eva; Rigden, Daniel J.; Van Der Smissen, Patrick; Courtoy, Pierre J.; Michels, Paul A. M.			ATG24 Represses Autophagy and Differentiation and Is Essential for Homeostasy of the Flagellar Pocket in Trypanosoma brucei	PLOS ONE			English	Article							BLOOD-STREAM-FORM; RECEPTOR-MEDIATED ENDOCYTOSIS; SELECTIVE DEGRADATION; LOCALIZATION; COMPLEX; BINDING; GROWTH; GLYCOLYSIS; BIOGENESIS; PEXOPHAGY	We have previously identified homologs for nearly half of the approximately 30 known yeast Atg's in the genome database of the human sleeping sickness parasite Trypanosoma brucei. So far, only a few of these homologs have their role in autophagy experimentally confirmed. Among the candidates was the ortholog of Atg24 that is involved in pexophagy in yeast. In T. brucei, the peroxisome-like organelles named glycosomes harbor core metabolic processes, especially glycolysis. In the autotrophic yeast, autophagy is essential for adaptation to different nutritional environments by participating in the renewal of the peroxisome population. We hypothesized that autophagic turnover of the parasite's glycosomes plays a role in differentiation during its life cycle, which demands adaptation to different host environments and associated dramatic changes in nutritional conditions. We therefore characterized T. brucei ATG24, the T. brucei ortholog of yeast Atg24 and mammalian SNX4, and found it to have a regulatory role in autophagy and differentiation as well as endocytic trafficking. ATG24 partially localized on endocytic membranes where it was recruited via PI3-kinase III/VPS34. ATG24 silencing severely impaired receptor-mediated endocytosis of transferrin, but not adsorptive uptake of a lectin, and caused a major enlargement of the flagellar pocket. ATG24 silencing approximately doubled the number of autophagosomes, suggesting a role in repressing autophagy, and strongly accelerated differentiation, in accordance with a role of autophagy in parasite differentiation. Overexpression of the two isoforms of T. brucei ATG8 fused to GFP slowed down differentiation, possibly by a dominant-negative effect. This was overcome by ATG24 depletion, further supporting its regulatory role.	[Brennand, Ana; Rico, Eva; Michels, Paul A. M.] Catholic Univ Louvain, Duve Inst, Trop Dis Res Unit, B-1200 Brussels, Belgium; [Brennand, Ana; Rico, Eva; Michels, Paul A. M.] Catholic Univ Louvain, Biochem Lab, B-1200 Brussels, Belgium; [Rico, Eva] Univ Alcala, Dept Bioquim & Biol Mol, Madrid, Spain; [Rigden, Daniel J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Van Der Smissen, Patrick; Courtoy, Pierre J.] Catholic Univ Louvain, Duve Inst, Cell Biol Unit, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universidad de Alcala; University of Liverpool; Universite Catholique Louvain	Michels, PAM (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Struct & Mol Biol, Kings Bldg, Edinburgh, Midlothian, Scotland.	paul.michels@ed.ac.uk	Michels, Paul A/A-5637-2009	Michels, Paul A/0000-0003-3726-6104; Rigden, Daniel/0000-0002-7565-8937	'Fonds de la Recherche Scientifique' (F.R.S-FNRS); Belgian Interuniversity Attraction Poles-Federal Office for Scientific, Technical and Cultural Affairs; 'Region Bruxelloise'; 'Region Wallonne'; 'Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA); Patrimoine de Faculte Medicine, Universite catholique de Louvain; Lotterie Nationale; EU's COST Action [BM0802]; Federation of European Biochemical Societies (FEBS); 'Universidad de Alcala' (Spain); F.R.S	'Fonds de la Recherche Scientifique' (F.R.S-FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian Interuniversity Attraction Poles-Federal Office for Scientific, Technical and Cultural Affairs; 'Region Bruxelloise'(Innoviris); 'Region Wallonne'; 'Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA)(Fonds de la Recherche Scientifique - FNRS); Patrimoine de Faculte Medicine, Universite catholique de Louvain; Lotterie Nationale; EU's COST Action; Federation of European Biochemical Societies (FEBS); 'Universidad de Alcala' (Spain); F.R.S(Fonds de la Recherche Scientifique - FNRS)	This research received financial support (to PAMM and PJC) from the 'Fonds de la Recherche Scientifique' (F.R.S-FNRS) and the Belgian Interuniversity Attraction Poles-Federal Office for Scientific, Technical and Cultural Affairs. The imaging facility at 'de Duve Institute' is supported by the F.R.S, 'Lotterie Nationale', 'Region Bruxelloise' and 'Region Wallonne'. AB was supported by PhD scholarships from the 'Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA) and the 'Patrimoine de Faculte Medicine, Universite catholique de Louvain'. ER received support from the EU's COST Action BM0802 and the Federation of European Biochemical Societies (FEBS), for two missions, each of three months, from the 'Universidad de Alcala' (Spain) to the 'de Duve Institute' (Belgium), to participate in the research project on autophagy in trypanosomes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Ano Y, 2005, MOL BIOL CELL, V16, P446, DOI 10.1091/mbc.E04-09-0842; Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; Bellu AR, 2003, MICROSC RES TECHNIQ, V61, P161, DOI 10.1002/jemt.10325; Bellu AR, 2002, J BIOL CHEM, V277, P42875, DOI 10.1074/jbc.M205437200; Bellu AR, 2001, J BIOL CHEM, V276, P44570, DOI 10.1074/jbc.M107599200; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; COPPENS I, 1988, P NATL ACAD SCI USA, V85, P6753, DOI 10.1073/pnas.85.18.6753; COPPENS I, 1987, J PROTOZOOL, V34, P465, DOI 10.1111/j.1550-7408.1987.tb03216.x; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; Galland N, 2010, EUR J CELL BIOL, V89, P621, DOI 10.1016/j.ejcb.2010.04.001; Gualdron-Lopez M, 2013, DRUG DISCOV INFEC DI, P121; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Haanstra JR, 2012, INT J PARASITOL, V42, P667, DOI 10.1016/j.ijpara.2012.04.009; Haanstra JR, 2008, P NATL ACAD SCI USA, V105, P17718, DOI 10.1073/pnas.0806664105; Hall BS, 2006, J BIOL CHEM, V281, P27600, DOI 10.1074/jbc.M602183200; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Herman M, 2008, AUTOPHAGY, V4, P294, DOI 10.4161/auto.5443; Herman M, 2006, AUTOPHAGY, V2, P107, DOI 10.4161/auto.2.2.2369; Koumandou VL, 2011, J CELL SCI, V124, P1496, DOI 10.1242/jcs.081596; LANGRETH SG, 1975, J PROTOZOOL, V22, P40, DOI 10.1111/j.1550-7408.1975.tb00943.x; Leprince C, 2003, J CELL SCI, V116, P1937, DOI 10.1242/jcs.00403; Li FJ, 2012, CELL MICROBIOL, V14, P1242, DOI 10.1111/j.1462-5822.2012.01795.x; Liu JY, 2000, J BIOL CHEM, V275, P12032, DOI 10.1074/jbc.275.16.12032; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Nei M., 2000, MOL EVOLUTION PHYLOG; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; Proto WR, 2014, MICROB CELL, V1, P9, DOI 10.15698/mic2014.01.120; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmidt RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093875; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Till Andreas, 2012, Int J Cell Biol, V2012, P512721, DOI 10.1155/2012/512721; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; van Grinsven KWA, 2009, EUKARYOT CELL, V8, P1307, DOI 10.1128/EC.00091-09; Vassella E, 1996, MOL BIOCHEM PARASIT, V82, P91, DOI 10.1016/0166-6851(96)02727-2; VENKATESAN S, 1977, INT J PARASITOL, V7, P139, DOI 10.1016/0020-7519(77)90082-0; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Yernaux C, 2006, MOL MEMBR BIOL, V23, P157, DOI 10.1080/09687860500460124; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	55	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130365	10.1371/journal.pone.0130365	http://dx.doi.org/10.1371/journal.pone.0130365			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090847	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000107
J	Saito, K; Hisasue, S; Ide, H; Aoki, H; Muto, S; Yamaguchi, R; Tsujimura, A; Horie, S				Saito, Keisuke; Hisasue, Shin-ichi; Ide, Hisamitsu; Aoki, Hiroaki; Muto, Satoru; Yamaguchi, Raizo; Tsujimura, Akira; Horie, Shigeo			The Impact of Increased Bladder Blood Flow on Storage Symptoms after Holmium Laser Enucleation of the Prostate	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; MEN	In order to investigate how holmium laser enucleation of the prostate (HoLEP) improves urinary storage symptoms, we assessed blood flow in the urinary bladder mucosa of patients with benign prostatic hyperplasia (BPH) before and after laser surgery. Seventy-four consecutive patients with BPH (median age 69 years, range; 53-88) underwent HoLEP at our institution and are included in this study. We prospectively assessed the International Prostate Symptom Score (IPSS), IPSS-QOL Score, the Overactive Bladder Symptom Score (OABSS), uroflowmetry, and blood flow in the urinary bladder, before and after surgery. Blood flow in the bladder mucosa was measured using the OMEGA FLOW (OMEGA-WAVE, Tokyo, Japan) laser Doppler flowmeter. The median volume of the enucleated adenomas was 45.0 g (range: 25.0 to 83.2). The median IPSS improved significantly from 20 (range: 6-35) to 3 (0-22) (p<0.001; Wilcoxon signed-rank test), as did the storage symptoms score, which decreased from 13 (2-20) to 3 (1-8) (p<0.001). Median bladder blood flow increased at the trigone from 9.57 +/- 0.83 ml/sec to 17.60 +/- 1.08 ml/sec. Multiple regression analysis for the improved storage symptom score eliminated all explanatory variables except increased bladder perfusion. The data suggest that HoLEP improves blood flow in the bladder mucosa, which independently leads to the improvement of storage symptoms.	[Hisasue, Shin-ichi; Aoki, Hiroaki; Tsujimura, Akira; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Bunkyo Ku, Tokyo 1130033, Japan; [Saito, Keisuke; Ide, Hisamitsu; Muto, Satoru; Yamaguchi, Raizo] Teikyo Univ, Sch Med, Dept Urol, Itabashi Ku, Tokyo 1738605, Japan	Juntendo University; Teikyo University	Horie, S (corresponding author), Juntendo Univ, Grad Sch Med, Dept Urol, Bunkyo Ku, Hongo 2-1-1, Tokyo 1130033, Japan.	shorie@juntendo.ac.jp						ABRAMS PH, 1979, J UROLOGY, V121, P640, DOI 10.1016/S0022-5347(17)56918-9; Azadzoi KM, 1999, J UROLOGY, V162, P1768, DOI 10.1016/S0022-5347(05)68236-5; Buttyan R, 1997, EUR UROL, V32, P32; Chapple CR, 2008, EUR UROL, V54, P563, DOI 10.1016/j.eururo.2008.03.109; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Kuntz RM, 2002, J UROLOGY, V168, P1465, DOI 10.1016/S0022-5347(05)64475-8; Matlaga BR, 2007, CURR OPIN UROL, V17, P27, DOI 10.1097/MOU.0b013e3280111447; Matsumoto S, 2003, UROLOGY, V62, P1129, DOI 10.1016/S0090-4295(03)00686-1; Mitterberger M, 2007, BJU INT, V99, P830, DOI 10.1111/j.1464-410X.2006.06735.x; Mostwin JL, 2002, UROLOGY, V60, P22, DOI 10.1016/S0090-4295(02)01788-0; Pinggera GM, 2008, BJU INT, V102, P470, DOI 10.1111/j.1464-410X.2008.07587.x; Sriplakich Supon, 2007, Journal of the Medical Association of Thailand, V90, P2326	12	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129111	10.1371/journal.pone.0129111	http://dx.doi.org/10.1371/journal.pone.0129111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090819	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000036
J	Bayzid, MS; Mirarab, S; Boussau, B; Warnow, T				Bayzid, Md Shamsuzzoha; Mirarab, Siavash; Boussau, Bastien; Warnow, Tandy			Weighted Statistical Binning: Enabling Statistically Consistent Genome-Scale Phylogenetic Analyses	PLOS ONE			English	Article							INFERRING SPECIES TREES; GENE TREES; SEQUENCE ALIGNMENTS; MAXIMUM-LIKELIHOOD; BAYESIAN-INFERENCE; PHYLOGENOMICS	Because biological processes can result in different loci having different evolutionary histories, species tree estimation requires multiple loci from across multiple genomes. While many processes can result in discord between gene trees and species trees, incomplete lineage sorting (ILS), modeled by the multi-species coalescent, is considered to be a dominant cause for gene tree heterogeneity. Coalescent-based methods have been developed to estimate species trees, many of which operate by combining estimated gene trees, and so are called "summary methods". Because summary methods are generally fast (and much faster than more complicated coalescent-based methods that co-estimate gene trees and species trees), they have become very popular techniques for estimating species trees from multiple loci. However, recent studies have established that summary methods can have reduced accuracy in the presence of gene tree estimation error, and also that many biological datasets have substantial gene tree estimation error, so that summary methods may not be highly accurate in biologically realistic conditions. Mirarab et al. (Science 2014) presented the "statistical binning" technique to improve gene tree estimation in multi-locus analyses, and showed that it improved the accuracy of MP-EST, one of the most popular coalescent-based summary methods. Statistical binning, which uses a simple heuristic to evaluate "combinability" and then uses the larger sets of genes to re-calculate gene trees, has good empirical performance, but using statistical binning within a phylogenomic pipeline does not have the desirable property of being statistically consistent. We show that weighting the re-calculated gene trees by the bin sizes makes statistical binning statistically consistent under the multispecies coalescent, and maintains the good empirical performance. Thus, "weighted statistical binning" enables highly accurate genome-scale species tree estimation, and is also statistically consistent under the multi-species coalescent model. New data used in this study are available at DOI: http://dx.doi.org/10.6084/m9. figshare. 1411146, and the software is available at https://github.com/smirarab/binning.	[Bayzid, Md Shamsuzzoha; Mirarab, Siavash] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Boussau, Bastien] Univ Lyons, Lab Biometrie & Biol Evolut, Lyon, France; [Warnow, Tandy] Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA	University of Texas System; University of Texas Austin; VetAgro Sup; University of Illinois System; University of Illinois Urbana-Champaign	Warnow, T (corresponding author), Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA.	warnow@illinois.edu		Mirarab, Siavash/0000-0001-5410-1518; Boussau, Bastien/0000-0003-0776-4460	National Science Foundation (NSF) [1461364, 0733029, 1062335]; Howard Hughes Medical Institutes (HHMI) graduate international student fellowship; Direct For Biological Sciences [1461364] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Howard Hughes Medical Institutes (HHMI) graduate international student fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (NSF) grant numbers 1461364, 0733029, and 1062335 to TW; and also by Howard Hughes Medical Institutes (HHMI) graduate international student fellowship to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayzid MS, 2013, BIOINFORMATICS, V29, P2277, DOI 10.1093/bioinformatics/btt394; BRELAZ D, 1979, COMMUN ACM, V22, P251, DOI 10.1145/359094.359101; Dasarathy G, 2014, ARXIV14047055; Dasarathy G, 2014, IEEE INT SYMP INFO, P2037, DOI 10.1109/ISIT.2014.6875191; DeGiorgio M, 2014, SYST BIOL, V63, P66, DOI 10.1093/sysbio/syt059; DeGiorgio M, 2010, MOL BIOL EVOL, V27, P552, DOI 10.1093/molbev/msp250; Degnan JH, 2009, SYST BIOL, V58, P35, DOI 10.1093/sysbio/syp008; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Dutheil J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-255; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; Fuglede B, 2004, 2004 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, PROCEEDINGS, P31; Gatesy J, 2014, MOL PHYLOGENET EVOL, V80, P231, DOI 10.1016/j.ympev.2014.08.013; GUSFIELD D, 1991, NETWORKS, V21, P19, DOI 10.1002/net.3230210104; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Karp R. M., 1972, P COMPL COMP COMP, P85; Kimball RT, 2013, MOL PHYLOGENET EVOL, V69, P1021, DOI 10.1016/j.ympev.2013.05.029; Kubatko L., 2014, BIOINFORMATICS; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lanier HC, 2012, SYST BIOL, V61, P691, DOI 10.1093/sysbio/syr128; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu L, 2011, SYST BIOL, V60, P661, DOI 10.1093/sysbio/syr027; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallo D, 2015, SIMPHY COMPREH UNPUB; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; Mirarab S, 2014, BIOINFORMATICS, V30, pI541, DOI 10.1093/bioinformatics/btu462; Mirarab S, 2015, P ISMB 2015 IN PRESS; Mirarab S, 2016, SYST BIOL, V65, P366, DOI 10.1093/sysbio/syu063; Mirarab S, 2014, SCIENCE, V346, P1337, DOI 10.1126/science.1250463; Mirarab S, 2014, LECT N BIOINFORMAT, V8394, P177, DOI 10.1007/978-3-319-05269-4_15; Patel S., 2013, J PHYLOGENETICS EVOL, V1, P2, DOI DOI 10.4172/2329-9002.1000110; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; Roch S, 2015, SYST BIOL, V64, P663, DOI 10.1093/sysbio/syv016; Roch S, 2015, THEOR POPUL BIOL, V100, P56, DOI 10.1016/j.tpb.2014.12.005; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rosenberg NA, 2013, MOL BIOL EVOL, V30, P2709, DOI 10.1093/molbev/mst160; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Wang N, 2012, MOL BIOL EVOL, V29, P737, DOI 10.1093/molbev/msr230; WARNOW TJ, 1994, J ALGORITHM, V16, P388, DOI 10.1006/jagm.1994.1018; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Wu YF, 2012, EVOLUTION, V66, P763, DOI 10.1111/j.1558-5646.2011.01476.x	55	70	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129183	10.1371/journal.pone.0129183	http://dx.doi.org/10.1371/journal.pone.0129183			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086579	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500037
J	Cajnko, MM; Marusic, M; Kisovec, M; Rojko, N; Bencina, M; Caserman, S; Anderluh, G				Cajnko, Misa Mojca; Marusic, Maja; Kisovec, Matic; Rojko, Nejc; Bencina, Mojca; Caserman, Simon; Anderluh, Gregor			Listeriolysin O Affects the Permeability of Caco-2 Monolayer in a Pore-Dependent and Ca2+-Independent Manner	PLOS ONE			English	Article							TO-CELL SPREAD; PLASMA-MEMBRANE; SEA-ANEMONE; EQUINATOXIN-II; L-MONOCYTOGENES; BARRIER FUNCTION; SURFACE PROTEIN; TIGHT JUNCTIONS; STICHOLYSIN-I; E-CADHERIN	Listeria monocytogenes is a food and soil-borne pathogen that secretes a pore-forming toxin listeriolysin O (LLO) as its major virulence factor. We tested the effects of LLO on an intestinal epithelial cell line Caco-2 and compared them to an unrelated pore-forming toxin equinatoxin II (EqtII). Results showed that apical application of both toxins causes a significant drop in transepithelial electrical resistance (TEER), with higher LLO concentrations or prolonged exposure time needed to achieve the same magnitude of response than with EqtII. The drop in TEER was due to pore formation and coincided with rearrangement of claudin-1 within tight junctions and associated actin cytoskeleton; however, no significant increase in permeability to fluorescein or 3 kDa FITC-dextran was observed. Influx of calcium after pore formation affected the magnitude of the drop in TEER. Both toxins exhibit similar effects on epithelium morphology and physiology. Importantly, LLO action upon the membrane is much slower and results in compromised epithelium on a longer time scale at lower concentrations than EqtII. This could favor listerial invasion in hosts resistant to Ecadherin related infection.	[Cajnko, Misa Mojca; Marusic, Maja; Kisovec, Matic; Rojko, Nejc; Caserman, Simon; Anderluh, Gregor] Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Ljubljana 1000, Slovenia; [Bencina, Mojca] Natl Inst Chem, Biotechnol Lab, Ljubljana 1000, Slovenia; [Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; National Institute of Chemistry - Slovenia; University of Ljubljana	Anderluh, G (corresponding author), Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Hajdrihova 19, Ljubljana 1000, Slovenia.	gregor.anderluh@ki.si	Anderluh, Gregor/C-6905-2014; Kisovec, Matic/R-3626-2019	Anderluh, Gregor/0000-0002-9916-8465; Kisovec, Matic/0000-0003-4131-2177	Slovenian Research Agency [J1-4305]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The study was supported by the Slovenian Research Agency (http://www.arrs.gov.si/sl/index. asp), grant number J1-4305, to GA.	Amasheh S, 2005, CELL TISSUE RES, V321, P89, DOI 10.1007/s00441-005-1101-0; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bakrac B, 2010, ADV EXP MED BIOL, V677, P106; Bavdek A, 2007, BIOCHEMISTRY-US, V46, P4425, DOI 10.1021/bi602497g; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Bishop BL, 2010, BIOCHEM BIOPH RES CO, V394, P254, DOI 10.1016/j.bbrc.2010.02.091; Bourdeau RW, 2009, J BIOL CHEM, V284, P14645, DOI 10.1074/jbc.M807631200; Bucker R, 2011, J INFECT DIS, V204, P1283, DOI 10.1093/infdis/jir504; Carrero JA, 2004, J IMMUNOL, V172, P4866, DOI 10.4049/jimmunol.172.8.4866; Cassidy SKB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002628; COLLARESBUZATO CB, 1994, BBA-MOL CELL RES, V1222, P147, DOI 10.1016/0167-4889(94)90163-5; Corrotte M, 2012, TRAFFIC, V13, P483, DOI 10.1111/j.1600-0854.2011.01323.x; Dalton CB, 1997, NEW ENGL J MED, V336, P100, DOI 10.1056/NEJM199701093360204; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Dramsi S, 2003, INFECT IMMUN, V71, P3614, DOI 10.1128/IAI.71.6.3614-3618.2003; FERRUZZA S, 1995, J NUTR, V125, P2577; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012; Garcia-Saez AJ, 2011, J BIOL CHEM, V286, P37768, DOI 10.1074/jbc.M111.281592; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; Gekara NO, 2008, INFECT IMMUN, V76, P857, DOI 10.1128/IAI.00622-07; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Giepmans BNG, 2009, BBA-BIOMEMBRANES, V1788, P820, DOI 10.1016/j.bbamem.2008.07.015; Gitter AH, 2001, GASTROENTEROLOGY, V121, P1320, DOI 10.1053/gast.2001.29694; Gonzalez MR, 2011, CELL MICROBIOL, V13, P1026, DOI 10.1111/j.1462-5822.2011.01600.x; Grundling A, 2003, J BACTERIOL, V185, P6295, DOI 10.1128/JB.185.21.6295-6307.2003; HALLEUX C, 1994, J CELL PHYSIOL, V158, P17, DOI 10.1002/jcp.1041580104; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; Hamon MA, 2011, INFECT IMMUN, V79, P2839, DOI 10.1128/IAI.01243-10; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Hupp S, 2013, J MOL BIOL, V425, P636, DOI 10.1016/j.jmb.2012.11.034; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104; Inai T, 1999, EUR J CELL BIOL, V78, P849, DOI 10.1016/S0171-9335(99)80086-7; Ireton K, 2007, CELL MICROBIOL, V9, P1365, DOI 10.1111/j.1462-5822.2007.00933.x; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Kayal S, 2002, MOL MICROBIOL, V44, P1407, DOI 10.1046/j.1365-2958.2002.02973.x; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Koster S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4690; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; MARQUIS H, 1995, INFECT IMMUN, V63, P4531, DOI 10.1128/IAI.63.11.4531-4534.1995; Marusic M, 2013, NEW BIOTECHNOL, V30, P507, DOI 10.1016/j.nbt.2013.05.008; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; MOUNIER J, 1990, INFECT IMMUN, V58, P1048, DOI 10.1128/IAI.58.4.1048-1058.1990; Narai A, 1997, TOXICOL IN VITRO, V11, P347, DOI 10.1016/S0887-2333(97)00026-X; Nikitas G, 2011, J EXP MED, V208, P2263, DOI 10.1084/jem.20110560; Nishibori T, 1996, INFECT IMMUN, V64, P3188, DOI 10.1128/IAI.64.8.3188-3195.1996; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Pillich H, 2012, CELL MICROBIOL, V14, P949, DOI 10.1111/j.1462-5822.2012.01769.x; Podobnik M, 2014, J BIOL CHEM, V289, P16588, DOI 10.1074/jbc.M114.560086; Press B, 2008, CURR DRUG METAB, V9, P893, DOI 10.2174/138920008786485119; Ratner AJ, 2006, J BIOL CHEM, V281, P12994, DOI 10.1074/jbc.M511431200; Ribet D, 2010, NATURE, V464, P1192, DOI 10.1038/nature08963; Richter JF, 2009, AM J PHYSIOL-GASTR L, V296, pG1350, DOI 10.1152/ajpgi.00040.2009; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Seveau S, 2007, MICROBES INFECT, V9, P1167, DOI 10.1016/j.micinf.2007.05.004; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; SILICIANO JD, 1988, J CELL BIOL, V107, P2389, DOI 10.1083/jcb.107.6.2389; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Tsuchiya K, 2005, INFECT IMMUN, V73, P3869, DOI 10.1128/IAI.73.7.3869-3877.2005; Vadia S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002356; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Zysk G, 2001, INFECT IMMUN, V69, P845, DOI 10.1128/IAI.69.2.845-852.2001	86	16	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130471	10.1371/journal.pone.0130471	http://dx.doi.org/10.1371/journal.pone.0130471			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087154	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500109
J	Chen, SF; Wu, F; Shen, LC; Chen, J; Ramchurn, SD				Chen, Shaofei; Wu, Feng; Shen, Lincheng; Chen, Jing; Ramchurn, Sarvapali D.			Multi-Agent Patrolling under Uncertainty and Threats	PLOS ONE			English	Article							COORDINATION; EFFICIENT; TEAMS	We investigate a multi-agent patrolling problem where information is distributed alongside threats in environments with uncertainties. Specifically, the information and threat at each location are independently modelled as multi-state Markov chains, whose states are not observed until the location is visited by an agent. While agents will obtain information at a location, they may also suffer damage from the threat at that location. Therefore, the goal of the agents is to gather as much information as possible while mitigating the damage incurred. To address this challenge, we formulate the single-agent patrolling problem as a Partially Observable Markov Decision Process (POMDP) and propose a computationally efficient algorithm to solve this model. Building upon this, to compute patrols for multiple agents, the single-agent algorithm is extended for each agent with the aim of maximising its marginal contribution to the team. We empirically evaluate our algorithm on problems of multi-agent patrolling and show that it outperforms a baseline algorithm up to 44% for 10 agents and by 21% for 15 agents in large domains.	[Chen, Shaofei; Shen, Lincheng; Chen, Jing] Natl Univ Def Technol, Coll Mech & Automat, Changsha 410073, Hunan, Peoples R China; [Chen, Shaofei; Ramchurn, Sarvapali D.] Univ Southampton, Sch Elect & Comp Sci, Southampton SO17 1BJ, Hants, England; [Wu, Feng] Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei 230026, Anhui, Peoples R China	National University of Defense Technology - China; University of Southampton; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Chen, SF (corresponding author), Natl Univ Def Technol, Coll Mech & Automat, Changsha 410073, Hunan, Peoples R China.	chensf005@163.com	Wu, Feng/Q-9657-2017	Wu, Feng/0000-0003-3989-0509	China Scholarship Council; Hunan Provincial Innovation Foundation [CX2013B013]; National University of Defense Technology for Outstanding Graduate Innovation Fund [B130302]; National Natural Science Foundation of China [61403411]	China Scholarship Council(China Scholarship Council); Hunan Provincial Innovation Foundation; National University of Defense Technology for Outstanding Graduate Innovation Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	SC is supported in part by China Scholarship Council for sponsoring his visiting study in University of Southampton, Hunan Provincial Innovation Foundation for Postgraduate (No. CX2013B013), and National University of Defense Technology for Outstanding Graduate Innovation Fund (No. B130302). SC, LS, and JC acknowledge support by National Natural Science Foundation of China (No. 61403411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1811; An B, 2012, AAAI; An B., 2013, P 12 INT C AUTONOMOU, P223; Balakirsky S, 2007, J FIELD ROBOT, V24, P943, DOI 10.1002/rob.20212; Basilico Nicola, 2011, AAAI; Castanon DA, 2005, IEEE DECIS CONTR P, P4939; Delle Fave FM, 2012, IEEE INT CONF ROBOT, P469, DOI 10.1109/ICRA.2012.6225053; Farinelli A., 2008, P AAMAS, P639; Jennings NR, 2000, ARTIF INTELL, V117, P277, DOI 10.1016/S0004-3702(99)00107-1; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Kaminka GA, 2002, J ARTIF INTELL RES, V17, P83, DOI 10.1613/jair.970; Keilson J., 1977, STOCHASTIC PROCESSES, V5, P231, DOI [10.1016/0304-4149(77)90033-3, DOI 10.1016/0304-4149(77)90033-3]; Kurniawati H., 2008, ROBOTICS SCI SYSTEMS; Le Ny J, 2008, P AMER CONTR CONF, P4220, DOI 10.1109/ACC.2008.4587156; Maza I, 2011, J INTELL ROBOT SYST, V61, P563, DOI 10.1007/s10846-010-9497-5; NEMHAUSER GL, 1978, MATH PROGRAM, V14, P265, DOI 10.1007/BF01588971; Ouyang Y, 2014, IEEE T INFORM THEORY, V60, P681, DOI 10.1109/TIT.2013.2288636; Pollanen R, 2009, APPL RADIAT ISOTOPES, V67, P340, DOI 10.1016/j.apradiso.2008.10.008; Qian YD, 2014, AAMAS'14: PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS, P733; Sandholm WH, 2010, THEOR ECON, V5, P1, DOI 10.3982/TE554; Schut M, 2002, LECT NOTES ARTIF INT, V2403, P243; Silver D., 2010, ADV NEURAL INFORM PR, P2164; Singh A, 2009, J ARTIF INTELL RES, V34, P707, DOI 10.1613/jair.2674; Stranders R, 2013, ARTIF INTELL, V195, P63, DOI 10.1016/j.artint.2012.10.006; Vorobeychik Y., 2014, ICAPS; Watts AC, 2012, REMOTE SENS-BASEL, V4, P1671, DOI 10.3390/rs4061671; Whittle P., 1988, J APPL PROB A, V25A, P287, DOI DOI 10.2307/3214163; Yost KA, 2000, TECHNICAL REPORT; Zhao Q, 2007, IEEE J SEL AREA COMM, V25, P589, DOI 10.1109/JSAC.2007.070409; Zois DS, 2013, IEEE T SIGNAL PROCES, V61, P1581, DOI 10.1109/TSP.2012.2236320	31	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130154	10.1371/journal.pone.0130154	http://dx.doi.org/10.1371/journal.pone.0130154			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086946	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000356567500081
J	D'Osualdo, A; Anania, VG; Yu, KB; Lill, JR; Kaufman, RJ; Matsuzawa, SI; Reed, JC				D'Osualdo, Andrea; Anania, Veronica G.; Yu, Kebing; Lill, Jennie R.; Kaufman, Randal J.; Matsuzawa, Shu-Ichi; Reed, John C.			Transcription Factor ATF4 Induces NLRP1 Inflammasome Expression during Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; THIOREDOXIN-INTERACTING PROTEIN; ER-STRESS; CELL-DEATH; METABOLIC DISEASE; ACTIVATION; IRE1-ALPHA; APOPTOSIS; TARGET; BETA	Perturbation of endoplasmic reticulum (ER) homeostasis triggers the ER stress response (also known as Unfolded Protein Response), a hallmark of many pathological disorders. However the connection between ER stress and inflammation remains largely unexplored. Recent data suggest that ER stress controls the activity of inflammasomes, key signaling platforms that mediate innate immune responses. Here we report that expression of NLRP1, a core inflammasome component, is specifically up-regulated during severe ER stress conditions in human cell lines. Both IRE1 alpha and PERK, but not the ATF6 pathway, modulate NLRP1 gene expression. Furthermore, using mutagenesis, chromatin immuno-precipitation and CRISPR-Cas9-mediated genome editing technology, we demonstrate that ATF4 transcription factor directly binds to NLRP1 promoter during ER stress. Although involved in different types of inflammatory responses, XBP-1 splicing was not required for NLRP1 induction. This study provides further evidence that links ER stress with innate	[D'Osualdo, Andrea; Matsuzawa, Shu-Ichi; Reed, John C.] Sanford Burnham Med Res Inst, Cell Death & Survival Networks Program, La Jolla, CA 92037 USA; [Anania, Veronica G.; Yu, Kebing; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA USA; [Kaufman, Randal J.] Sanford Burnham Med Res Inst, Degenerat Dis Res Program, La Jolla, CA USA; [Reed, John C.] Pharma Res & Early Dev pRED, Basel, Switzerland	Sanford Burnham Prebys Medical Discovery Institute; Roche Holding; Genentech; Sanford Burnham Prebys Medical Discovery Institute	Matsuzawa, SI (corresponding author), Sanford Burnham Med Res Inst, Cell Death & Survival Networks Program, La Jolla, CA 92037 USA.	smatsuzawa@sanfordburnham.org; John_C.Reed@roche.com			National Institutes of Health (NIH) [AI-091967]; NIH [R37DK042394, RO1DK088227, RO1HL052173]; Genentech Inc.; Roche Group, AG; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, R01DK088227, R37DK042394] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech Inc.(Roche HoldingGenentech); Roche Group, AG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grant AI-091967 to SM, and NIH grants R37DK042394, RO1DK088227, and RO1HL052173 to RJK. Genentech Inc., and Roche Group, AG, provided support in the form of salaries for authors VGA, KY, JRL and JCR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Bian ZM, 2011, INVEST OPHTH VIS SCI, V52, P8646, DOI 10.1167/iovs.11-7570; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Dieude P, 2011, ANN RHEUM DIS, V70, P668, DOI 10.1136/ard.2010.131243; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Guey B, 2014, P NATL ACAD SCI USA, V111, P17254, DOI 10.1073/pnas.1415756111; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaufman RJ, 2014, BBA-MOL CELL RES, V1843, P2233, DOI 10.1016/j.bbamcr.2014.03.022; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Medinas DB, 2013, CELL METAB, V18, P771, DOI 10.1016/j.cmet.2013.11.009; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Pontillo A, 2013, INFECT GENET EVOL, V19, P274, DOI 10.1016/j.meegid.2013.06.006; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roy CR, 2006, NAT REV IMMUNOL, V6, P136, DOI 10.1038/nri1775; Sanz C, 2004, BIOCHEM J, V384, P281, DOI 10.1042/BJ20040867; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	50	39	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130635	10.1371/journal.pone.0130635	http://dx.doi.org/10.1371/journal.pone.0130635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086088	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500124
J	Josephs, TM; Hibbs, ME; Ong, L; Morison, IM; Ledgerwood, EC				Josephs, Tracy M.; Hibbs, Moira E.; Ong, Lily; Morison, Ian M.; Ledgerwood, Elizabeth C.			Interspecies Variation in the Functional Consequences of Mutation of Cytochrome c	PLOS ONE			English	Article							CONFORMATIONAL-CHANGE; CASPASE ACTIVATION; APOPTOSIS; MEGAKARYOCYTES; PLATELETS; THROMBOCYTOPENIA; APAF-1; DEATH; PATHWAY; RELEASE	The naturally occurring human cytochrome c variant (G41S) is associated with a mild autosomal dominant thrombocytopenia (Thrombocytopenia Cargeeg) caused by dysregulation of platelet production. The molecular basis of the platelet production defect is unknown. Despite high conservation of cytochrome c between human and mouse (91.4% identity), introducing the G41S mutation into mouse cytochrome c in a knockin mouse (Cycs(G41S/G41S)) did not recapitulate the low platelet phenotype of Thrombocytopenia Cargeeg. While investigating the cause of this disparity we found a lack of conservation of the functional impact of cytochrome c mutations on caspase activation across species. Mutation of cytochrome c at residue 41 has distinct effects on the ability of cytochrome c to activate caspases depending on the species of both the cytochrome c and its binding partner Apaf-1. In contrast to our previous results showing the G41S mutation increases the ability of human cytochrome c to activate caspases, here we find this activity is decreased in mouse G41S cytochrome c. Additionally unlike wildtype human cytochrome c, G41S cytochrome c is unable to activate caspases in Xenopus embryo extracts. Taken together these results demonstrate a previously unreported species-specific component to the interaction of cytochrome c with Apaf-1. This suggests that the electrostatic interaction between cytochrome c and Apaf-1 is not the sole determinant of binding, with additional factors controlling binding specificity and affinity. These results have important implications for studies of the effects of cytochrome c mutations on the intrinsic apoptosis pathway.	[Josephs, Tracy M.; Hibbs, Moira E.; Ong, Lily; Ledgerwood, Elizabeth C.] Univ Otago, Dept Biochem, Otago Sch Med Sci, Dunedin, New Zealand; [Morison, Ian M.] Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand	University of Otago; University of Otago	Ledgerwood, EC (corresponding author), Univ Otago, Dept Biochem, Otago Sch Med Sci, Dunedin, New Zealand.	liz.ledgerwood@otago.ac.nz	Ledgerwood, Elizabeth/M-3939-2018; Morison, Ian M/A-1236-2008	Ledgerwood, Elizabeth/0000-0002-4956-6043; Morison, Ian M/0000-0003-3616-0025	Royal Society of New Zealand Marsden Fund [UOO0801]; Lottery Health (New Zealand); Maurice and Phyllis Paykel Trust (New Zealand); Elman Poole Travelling Scholarship (University of Otago, New Zealand)	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Lottery Health (New Zealand); Maurice and Phyllis Paykel Trust (New Zealand); Elman Poole Travelling Scholarship (University of Otago, New Zealand)	This work was funded by: Royal Society of New Zealand Marsden Fund, UOO0801 to ECL and IMM (http://www.royalsociety.org.nz/programmes/funds/marsden); Lottery Health (New Zealand) to ECL (http://www.communitymatters.govt.nz/Funding-and-grants-Lottery-grants-Lottery-Health-Research); Maurice and Phyllis Paykel Trust (New Zealand) to ECL and IMM (http://www.paykeltrust.co.nz/); Elman Poole Travelling Scholarship (University of Otago, New Zealand) to TMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER MJ, 1993, ARCH BIOCHEM BIOPHYS, V301, P294, DOI 10.1006/abbi.1993.1146; Borde EC, 2011, SEMIN THROMB HEMOST, V37, P664, DOI 10.1055/s-0031-1291376; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chertkova RV, 2008, MOL CELL BIOCHEM, V314, P85, DOI 10.1007/s11010-008-9768-7; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; De Rocco D, 2014, BBA-MOL BASIS DIS, V1842, P269, DOI 10.1016/j.bbadis.2013.12.002; Deming Paula, 2006, V322, P379; Deming PB, 2004, MOL CELL BIOL, V24, P10289, DOI 10.1128/MCB.24.23.10289-10299.2004; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Hilton DJ, 2009, BLOOD, V113, P5599, DOI 10.1182/blood-2008-12-195255; Hutcheson J, 2005, J EXP MED, V201, P1949, DOI 10.1084/jem.20041484; Jemmerson R, 1999, BIOCHEMISTRY-US, V38, P3599, DOI 10.1021/bi9809268; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Josefsson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4455; Josefsson EC, 2011, J EXP MED, V208, P2017, DOI 10.1084/jem.20110750; Josephs TM, 2014, BIOCHEM J, V458, P259, DOI 10.1042/BJ20131386; Josephs TM, 2013, J BIOL INORG CHEM, V18, P289, DOI 10.1007/s00775-012-0973-1; Kile BT, 2014, BRIT J HAEMATOL, V165, P217, DOI 10.1111/bjh.12757; Kluck RM, 2000, J BIOL CHEM, V275, P16127, DOI 10.1074/jbc.275.21.16127; Ledgerwood EC, 2009, CLIN CANCER RES, V15, P420, DOI 10.1158/1078-0432.CCR-08-1172; Liptak MD, 2011, J AM CHEM SOC, V133, P1153, DOI 10.1021/ja106328k; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; Purring-Koch C, 2000, P NATL ACAD SCI USA, V97, P11928, DOI 10.1073/pnas.220416197; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Schmitt A, 2001, EXP HEMATOL, V29, P1295, DOI 10.1016/S0301-472X(01)00733-0; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; VANGELDER BF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593, DOI 10.1016/0006-3002(62)90073-2; White MJ, 2012, BLOOD, V119, P4283, DOI 10.1182/blood-2011-11-394858; Yuan SJ, 2013, BIOCHEMISTRY-US, V52, P2319, DOI 10.1021/bi301721g; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	31	4	4	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130292	10.1371/journal.pone.0130292	http://dx.doi.org/10.1371/journal.pone.0130292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086723	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500090
J	Thabet, S; Namouchi, A; Mardassi, H				Thabet, Sara; Namouchi, Amine; Mardassi, Helmi			Evolutionary Trends of the Transposase-Encoding Open Reading Frames A and B (orfA and orfB) of the Mycobacterial IS6110 Insertion Sequence	PLOS ONE			English	Article							IS6110-MEDIATED DELETION POLYMORPHISM; TUBERCULOSIS COMPLEX; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; PREFERENTIAL LOCUS; POSITIVE SELECTION; ADAPTIVE EVOLUTION; GENOMIC ANALYSIS; ELEMENT IS6110; COPY NUMBER	Background The IS6110 insertion sequence, a member of the IS3 family of insertion sequences, was found to be specific to the Mycobacterium tuberculosis complex (MTBC). Although IS6110 has been extensively characterized as a transposable genetic marker, the evolutionary history of its own transposase-encoding sequence has not, to the best of our knowledge, been investigated. Methodology/Principal Findings Here we explored the evolution of the IS6110 sequence by analysing the genetic variability and the selective forces acting on its transposase-encoding open reading frames (ORFs) A and B (orfA and orfB). For this purpose, we used a strain collection consisting of smooth tubercle bacilli (STB), an early branching lineage of the MTBC, and present-day M. tuberculosis strains representing the full breadth of genetic diversity in Tunisia. In each ORF, we found a major haplotype that dominated over a flat distribution of rare descendent haplotypes, consisting mainly of single-and double-nucleotide variant singletons. The predominant haplotypes consisted of both ancestral and present-day strains, suggesting that IS6110 acquisition predated the emergence of the MTBC. There was no evidence of recombination and both ORFs were subjected to strict purifying selection, as demonstrated by their dN/dS ratios (0.29 and 0.51, respectively), as well as their significantly negative Tajima's D statistics. Strikingly, the purifying selection acting on orfA proved much more stringent, suggesting its critical role in regulating the transpositional process. Maximum likelihood analyses further excluded any possibility of positive selection acting on single amino acid residues. Conclusions/Significance Taken together our data fit with an evolutionary scenario according to which the observed variability pattern of the IS6110 transposase-encoding ORFs is generated mainly through random point mutations that accrued on a functionally optimal IS6110 copy, whose acquisition predated the emergence of the MTBC complex. Background selection acting against deleterious mutations led to an excess of low-frequency variants.	[Thabet, Sara; Namouchi, Amine; Mardassi, Helmi] Inst Pasteur Tunis, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Unit Typing & Genet Mycobacteria, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis	Mardassi, H (corresponding author), Inst Pasteur Tunis, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Unit Typing & Genet Mycobacteria, Tunis, Tunisia.	helmi.merdassi@pasteur.rns.tn			Tunisian Ministry of Higher Education and Scientific Research	Tunisian Ministry of Higher Education and Scientific Research	HM received funding from the Tunisian Ministry of Higher Education and Scientific Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-422; Alonso H, 2011, TUBERCULOSIS, V91, P117, DOI 10.1016/j.tube.2010.12.007; Aryan E, 2013, J INFECTION, V66, P487, DOI 10.1016/j.jinf.2013.02.005; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Beggs ML, 2000, J CLIN MICROBIOL, V38, P2923, DOI 10.1128/JCM.38.8.2923-2928.2000; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Brosch R, 1999, INFECT IMMUN, V67, P5768, DOI 10.1128/IAI.67.11.5768-5774.1999; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; CANETTI G, 1970, LILLE MED, V15, P280; Cerveau N, 2011, GENOME BIOL EVOL, V3, P1175, DOI 10.1093/gbe/evr096; CHARLIER D, 1982, NUCLEIC ACIDS RES, V10, P5935, DOI 10.1093/nar/10.19.5935; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coros A, 2008, J BACTERIOL, V190, P3408, DOI 10.1128/JB.00009-08; Dalovisio JR, 1996, CLIN INFECT DIS, V23, P1099, DOI 10.1093/clinids/23.5.1099; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Dominique SA, 2004, RES MICROBIOL, V155, P319, DOI 10.1016/j.resmic.2003.12.008; Fabre M, 2004, J CLIN MICROBIOL, V42, P3248, DOI 10.1128/JCM.42.7.3248-3255.2004; Fang ZG, 1997, J CLIN MICROBIOL, V35, P479, DOI 10.1128/JCM.35.2.479-481.1997; FAYET O, 1990, MOL MICROBIOL, V4, P1771, DOI 10.1111/j.1365-2958.1990.tb00555.x; Filee J, 2007, MICROBIOL MOL BIOL R, V71, P121, DOI 10.1128/MMBR.00031-06; Gordon SV, 1999, MICROBIOL-SGM, V145, P881, DOI 10.1099/13500872-145-4-881; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; HERMANS PWM, 1991, INFECT IMMUN, V59, P2695, DOI 10.1128/IAI.59.8.2695-2705.1991; HERMANS PWM, 1990, J CLIN MICROBIOL, V28, P2051, DOI 10.1128/JCM.28.9.2051-2058.1990; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KHAN E, 1991, NUCLEIC ACIDS RES, V19, P851, DOI 10.1093/nar/19.4.851; Kim EY, 2010, J CLIN MICROBIOL, V48, P1422, DOI 10.1128/JCM.02210-09; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lysnyansky I, 2009, FEMS MICROBIOL LETT, V294, P172, DOI 10.1111/j.1574-6968.2009.01562.x; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Maurya AK, 2012, INDIAN J MED MICROBI, V30, P182, DOI 10.4103/0255-0857.96688; Maurya AK, 2011, BIOSCI TRENDS, V5, P159, DOI 10.5582/bst.2011.v5.4.159; MCADAM RA, 1990, MOL MICROBIOL, V4, P1607, DOI 10.1111/j.1365-2958.1990.tb02073.x; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; McHugh TD, 1998, J CLIN MICROBIOL, V36, P1410, DOI 10.1128/JCM.36.5.1410-1413.1998; Mes THM, 2006, J BACTERIOL, V188, P7176, DOI 10.1128/JB.01021-06; Namouchi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064718; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ooka T, 2009, GENOME RES, V19, P1809, DOI 10.1101/gr.089615.108; Parkhill J, 2003, COLD SPRING HARB SYM, V68, P151, DOI 10.1101/sqb.2003.68.151; Petersen L, 2007, GENOME RES, V17, P1336, DOI 10.1101/gr.6254707; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; PRERE MF, 1990, J BACTERIOL, V172, P4090, DOI 10.1128/jb.172.7.4090-4099.1990; Preston A, 2004, NAT REV MICROBIOL, V2, P379, DOI 10.1038/nrmicro886; Reyes A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-249; Safi H, 2004, MOL MICROBIOL, V52, P999, DOI 10.1111/j.1365-2958.2004.04037.x; Sampson SL, 2004, J CLIN MICROBIOL, V42, P895, DOI 10.1128/JCM.42.2.895-898.2004; Sampson SL, 2003, J BACTERIOL, V185, P2856, DOI 10.1128/JB.185.9.2856-2866.2003; SEKINE Y, 1994, J MOL BIOL, V235, P1406, DOI 10.1006/jmbi.1994.1097; Sekine Y, 1997, GENES CELLS, V2, P547, DOI 10.1046/j.1365-2443.1997.1440342.x; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Siguier P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067; Soto CY, 2004, J CLIN MICROBIOL, V42, P212, DOI 10.1128/JCM.42.1.212-219.2004; Stoebel DM, 2010, MOL BIOL EVOL, V27, P2105, DOI 10.1093/molbev/msq101; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Tanaka MM, 2004, MOL BIOL EVOL, V21, P2195, DOI 10.1093/molbev/msh234; THIERRY D, 1993, FEMS IMMUNOL MED MIC, V6, P287, DOI 10.1111/j.1574-695X.1993.tb00341.x; THIERRY D, 1990, NUCLEIC ACIDS RES, V18, P188, DOI 10.1093/nar/18.1.188; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Vera-Cabrera L, 2001, J CLIN MICROBIOL, V39, P3499, DOI 10.1128/JCM.39.10.3499-3504.2001; Wagner A, 2006, MOL BIOL EVOL, V23, P723, DOI 10.1093/molbev/msj085; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yesilkaya H, 2005, J BACTERIOL, V187, P6726, DOI 10.1128/JB.187.19.6726-6732.2005	77	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130161	10.1371/journal.pone.0130161	http://dx.doi.org/10.1371/journal.pone.0130161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087177	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500083
J	Boyd, HA; Basit, S; Harpsoe, MC; Wohlfahrt, J; Jess, T				Boyd, Heather A.; Basit, Saima; Harpsoe, Maria C.; Wohlfahrt, Jan; Jess, Tine			Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes	PLOS ONE			English	Article							BIRTH OUTCOMES; CONGENITAL-ABNORMALITIES; ULCERATIVE-COLITIS; CROHNS-DISEASE; CHILDREN BORN; COHORT; WOMEN	Background and Objectives Existing data on pregnancy complications in inflammatory bowel disease (IBD) are inconsistent. To address these inconsistencies, we investigated potential associations between IBD, IBD-related medication use during pregnancy, and pregnancy loss, pre-eclampsia, preterm delivery, Apgar score, and congenital abnormalities. Methods We conducted a cohort study in >85,000 Danish National Birth Cohort women who were pregnant in the period 1996-2002 and had information on IBD, IBD-related medication use (systemic or local corticosteroids, 5-aminosalicylates), pregnancy outcomes and potential confounders. We evaluated associations between IBD and adverse pregnancy/birth outcomes using Cox regression and log-linear binomial regression. Results IBD was strongly and significantly associated with severe pre-eclampsia, preterm premature rupture of membranes and medically indicated preterm delivery in women using systemic corticosteroids during pregnancy (hazard ratios [HRs] >7). IBD was also associated with premature preterm rupture of membranes in women using local corticosteroid medications (HR 3.30, 95% confidence interval [CI] 1.33-8.20) and with medically indicated preterm delivery (HR 1.91, 95% CI 0.99-3.68) in non-medicated women. Furthermore, IBD was associated with low 5-minute Apgar score in term infants (risk ratio [RR] 2.19, 95% CI 1.03-4.66). Finally, Crohn's disease (but not ulcerative colitis) was associated with major congenital abnormalities in the offspring (RR 1.85, 95% CI 1.06-3.21). No child with a congenital abnormality born to a woman with IBD was exposed to systemic corticosteroids in utero. Conclusion Women with IBD are at increased risk of severe pre-eclampsia, medically indicated preterm delivery, preterm premature rupture of membranes, and delivering infants with low Apgar score and major congenital malformations. These associations are only partly explained by severe disease as reflected by systemic corticosteroid use.	[Boyd, Heather A.; Basit, Saima; Harpsoe, Maria C.; Wohlfahrt, Jan; Jess, Tine] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Boyd, HA (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	hoy@ssi.dk		Boyd, Heather/0000-0001-6849-9985	Aase og Ejnar Danielsens Fond [10-000390]	Aase og Ejnar Danielsens Fond	Aase og Ejnar Danielsens Fond provided financial support for this study (grant 10-000390 to TJ) (www.danielsensfond.dk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajslev TA, 2012, INFLAMM BOWEL DIS, V18, P709, DOI 10.1002/ibd.21780; Andersen NN, 2014, JAMA-J AM MED ASSOC, V311, P2406, DOI 10.1001/jama.2014.5613; Andersen TF, 1999, DAN MED BULL, V46, P263; Bortoli A, 2011, ALIMENT PHARM THER, V34, P724, DOI 10.1111/j.1365-2036.2011.04794.x; Bush M C, 2004, J Matern Fetal Neonatal Med, V15, P237, DOI 10.1080/14767050410001668662; Cornish J, 2007, GUT, V56, P830, DOI 10.1136/gut.2006.108324; Dominitz JA, 2002, AM J GASTROENTEROL, V97, P641; Hegyi T, 1998, PEDIATRICS, V101, P77, DOI 10.1542/peds.101.1.77; Knudsen LB, 1998, DAN MED BULL, V45, P320; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Nasef NA, 2012, TRANSL RES, V160, P65, DOI 10.1016/j.trsl.2011.12.002; Norgard B, 2003, AM J GASTROENTEROL, V98, P2006, DOI 10.1016/S0002-9270(03)00427-1; Norgard B, 2007, AM J GASTROENTEROL, V102, P1947, DOI 10.1111/j.1572-0241.2007.01355.x; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Raatikainen K, 2011, ALIMENT PHARM THER, V33, P333, DOI 10.1111/j.1365-2036.2010.04538.x; Stephansson O, 2011, INFLAMM BOWEL DIS, V17, P795, DOI 10.1002/ibd.21369; Stephansson O, 2010, CLIN GASTROENTEROL H, V8, P509, DOI 10.1016/j.cgh.2010.02.014; van der Woude CJ, 2010, J CROHNS COLITIS, V4, P493, DOI 10.1016/j.crohns.2010.07.004; Vermeire S, 2012, J CROHNS COLITIS, V6, P811, DOI 10.1016/j.crohns.2012.04.009	19	54	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129567	10.1371/journal.pone.0129567	http://dx.doi.org/10.1371/journal.pone.0129567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083614	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400099
J	Caldwell, AC; Silva, LCF; da Silva, CC; Ouverney, CC				Caldwell, Adam Collins; Fideles Silva, Livia Carneiro; da Silva, Cynthia Canedo; Ouverney, Cleber Costa			Prokaryotic Diversity in the Rhizosphere of Organic, Intensive, and Transitional Coffee Farms in Brazil	PLOS ONE			English	Article							ACETOBACTER-DIAZOTROPHICUS; CHRONIC-BRONCHITIS; ARABICA L.; PLANT; BIODIVERSITY; AGRICULTURE; COMMUNITIES; SEQUENCES; STRATEGY; BACTERIA	Despite a continuous rise in consumption of coffee over the past 60 years and recent studies showing positive benefits linked to human health, intensive coffee farming practices have been associated with environmental damage, risks to human health, and reductions in biodiversity. In contrast, organic farming has become an increasingly popular alternative, with both environmental and health benefits. This study aimed to characterize and determine the differences in the prokaryotic soil microbiology of three Brazilian coffee farms: one practicing intensive farming, one practicing organic farming, and one undergoing a transition from intensive to organic practices. Soil samples were collected from 20 coffee plant rhizospheres (soil directly influenced by the plant root exudates) and 10 control sites (soil 5 m away from the coffee plantation) at each of the three farms for a total of 90 samples. Profiling of 16S rRNA gene V4 regions revealed high levels of prokaryotic diversity in all three farms, with thousands of species level operational taxonomic units identified in each farm. Additionally, a statistically significant difference was found between each farm's coffee rhizosphere microbiome, as well as between coffee rhizosphere soils and control soils. Two groups of prokaryotes associated with the nitrogen cycle, the archaeal genus Candidatus Nitrososphaera and the bacterial order Rhizobiales were found to be abundant and statistically different in composition between the three farms and in inverse relationship to each other. Many of the nitrogen-fixing genera known to enhance plant growth were found in low numbers (e.g. Rhizobium, Agrobacter, Acetobacter, Rhodospirillum, Azospirillum), but the families in which they belong had some of the highest relative abundance in the dataset, suggesting many new groups may exist in these samples that can be further studied as potential plant growth-promoting bacteria to improve coffee production while diminishing negative environmental impacts.	[Caldwell, Adam Collins; Ouverney, Cleber Costa] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Fideles Silva, Livia Carneiro; da Silva, Cynthia Canedo] Univ Fed Vicosa, Dept Microbiol, BR-36570 Vicosa, MG, Brazil	California State University System; San Jose State University; Universidade Federal de Vicosa	Ouverney, CC (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	cleber.ouverney@sjsu.edu		Ouverney, Cleber/0000-0002-4135-7562	National Institutes of Health [GM082291]; National Science Foundation [0923573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM082291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for ACC and CCO provided by National Institutes of Health (www.nih.gov) Grant #GM082291 and National Science Foundation (www.nsf.gov) Grant #0923573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou El Azm Abdel Raouf, 2014, J Gastrointest Cancer, V45, P276, DOI 10.1007/s12029-013-9573-8; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Barros S, 2013, BRAZIL COFFEE SEMIAN; Bashan Y, 1998, BIOTECHNOL ADV, V16, P729, DOI 10.1016/S0734-9750(98)00003-2; Bhattacharya S, 2002, BIOL AGRIC HORTIC, V20, P125, DOI 10.1080/01448765.2002.9754956; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412; Caldwell AC, 2014, 16S RRNA SEQUENCE DA; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carvalho DD, 2011, PLANT FOOD HUM NUTR, V66, P114, DOI 10.1007/s11130-011-0221-9; Carvalho FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-37; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Lima Filho O. F. de, 2003, Braz. J. Biol., V63, P481, DOI 10.1590/S1519-69842003000300014; de-Bashan LE, 2012, APPL SOIL ECOL, V61, P171, DOI 10.1016/j.apsoil.2011.09.003; Dini-Andreote F, 2010, PLANT SOIL, V336, P337, DOI 10.1007/s11104-010-0486-z; Diriba Muleta, 2013, Journal of the Saudi Society of Agricultural Sciences, V12, P73, DOI 10.1016/j.jssas.2012.07.002; Silva Maria do Céu, 2006, Braz. J. Plant Physiol., V18, P119, DOI 10.1590/S1677-04202006000100010; dos Santos JS, 2010, J BRAZIL CHEM SOC, V21, P1468, DOI 10.1590/S0103-50532010000800009; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009; Hoppin JA, 2007, AM J IND MED, V50, P969, DOI 10.1002/ajim.20523; Hu HW, 2013, SOIL BIOL BIOCHEM, V64, P18, DOI 10.1016/j.soilbio.2013.04.003; Hungria M, 2000, FIELD CROP RES, V65, P151, DOI 10.1016/S0378-4290(99)00084-2; International Coffee Organization (ICO), 2014, EXP COUNTR TOT PROD; JimenezSalgado T, 1997, APPL ENVIRON MICROB, V63, P3676, DOI 10.1128/AEM.63.9.3676-3683.1997; Konstantinidis KT, 2015, SYST APPL MICROBIOL, V38, P223, DOI 10.1016/j.syapm.2015.01.001; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; Lyngbaek AE, 2001, AGROFOREST SYST, V53, P205, DOI 10.1023/A:1013332722014; Mann RM, 2009, ENVIRON POLLUT, V157, P2903, DOI 10.1016/j.envpol.2009.05.015; Mondelaers K, 2009, BRIT FOOD J, V111, P1098, DOI 10.1108/00070700910992925; Muthukumarasamy R, 2002, PLANT SOIL, V243, P91, DOI 10.1023/A:1019963928947; Nogueira AM, 2005, CIENC AGROTEC, V29, P27, DOI 10.1590/S1413-70542005000100003; Noponen MRA, 2012, AGR ECOSYST ENVIRON, V151, P6, DOI 10.1016/j.agee.2012.01.019; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Op den Camp RHM, 2012, MOL PLANT MICROBE IN, V25, P954, DOI 10.1094/MPMI-11-11-0304; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quirino BF, 2009, MICROBIOL RES, V164, P59, DOI 10.1016/j.micres.2006.12.001; Rampelotto PH, 2013, MICROB ECOL, V66, P593, DOI 10.1007/s00248-013-0235-y; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rodrigues W. N., 2014, American Journal of Plant Sciences, V5, P3702, DOI 10.4236/ajps.2014.525386; Rodriguez H, 2006, PLANT SOIL, V287, P15, DOI 10.1007/s11104-006-9056-9; Second Genome Inc, 2013, GREENGENES DAT; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Siqueira JO, 1998, MYCORRHIZA, V7, P293, DOI 10.1007/s005720050195; Smrke S, 2015, FOOD CHEM, V174, P637, DOI 10.1016/j.foodchem.2014.11.060; Tual S, 2013, ANN EPIDEMIOL, V23, P539, DOI 10.1016/j.annepidem.2013.06.005; UNCTAD, 2012, MARK UN C TRAD DEV; Valkila J, 2009, ECOL ECON, V68, P3018, DOI 10.1016/j.ecolecon.2009.07.002; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; Vandermeer J, 2014, BIOSCIENCE, V64, P210, DOI 10.1093/biosci/bit034; Velmourougane K., 2006, Indian Coffee, V70, P10; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wedhastri S., 2012, Journal of Agricultural Science and Technology A, V2, P660; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Zhalnina K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00104	60	23	25	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0106355	10.1371/journal.pone.0106355	http://dx.doi.org/10.1371/journal.pone.0106355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083033	Green Published, gold			2022-12-26	WOS:000356567400001
J	Cristia, A; Seidl, A				Cristia, Alejandrina; Seidl, Amanda			Parental Reports on Touch Screen Use in Early Childhood	PLOS ONE			English	Article							TELEVISION; CHILDREN	Touch screens are increasingly prevalent, and anecdotal evidence suggests that young children are very drawn towards them. Yet there is little data regarding how young children use them. A brief online questionnaire queried over 450 French parents of infants between the ages of 5 and 40 months on their young child's use of touch-screen technology. Parents estimated frequency of use, and further completed several checklists. Results suggest that, among respondent families, the use of touch screens is widespread in early childhood, meaning that most children have some exposure to touch screens. Among child users, certain activities are more frequently reported to be liked than others, findings that we discuss in light of current concern for children's employment of time and the cognitive effects of passive media exposure. Additionally, these parental reports point to clear developmental trends for certain types of interactive gestures. These results contribute to the investigation of touch screen use on early development and suggest a number of considerations that should help improve the design of applications geared towards toddlers, particularly for scientific purposes.	[Cristia, Alejandrina] PSL Res Univ, Ecole Normale Super, Dept Etud Cognit, Lab Sci Cognit & Psycholinguist,ENS,EHESS,CNRS, Paris, France; [Seidl, Amanda] Purdue Univ, Speech Language & Hearing Sci, W Lafayette, IN 47907 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cristia, A (corresponding author), PSL Res Univ, Ecole Normale Super, Dept Etud Cognit, Lab Sci Cognit & Psycholinguist,ENS,EHESS,CNRS, Paris, France.	alecristia@gmail.com	Cristia, Alejandrina/H-2768-2019	Cristia, Alejandrina/0000-0003-2979-4556	AC Agence Nationale de la Recherche [ANR-10-LABX-0087 IEC, ANR-10-IDEX-0001-02 PSL]	AC Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by AC Agence Nationale de la Recherche ANR-10-LABX-0087 IEC and AC Agence Nationale de la Recherche ANR-10-IDEX-0001-02 PSL*. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academie des sciences, 2013, LENFANT ET LESECRANS; [Anonymous], 2011, ZER 8 CHILDR MED US; Barr R, 2013, CHILD DEV PERSPECT, V7, P205, DOI 10.1111/cdep.12041; BHATT RS, 1992, J EXP ANAL BEHAV, V57, P219, DOI 10.1901/jeab.1992.57-219; Brandone AC, 2008, PERSPECTIVES SCH BAS, V9, P57, DOI [10.1044/sbi9.2.57, DOI 10.1044/SBI9.2.57]; Brown A, 2011, PEDIATRICS, V128, P1040, DOI 10.1542/peds.2011-1753; Chiasson S, 2005, INTERFACES, V7, P28; Christakis DA, 2013, PEDIATRICS, V131, P431, DOI 10.1542/peds.2012-1493; Common Sense Media, 2013, ZER 8 CHILDR MED US; Fagot J, 2014, AM J PRIMATOL, V76, P56, DOI 10.1002/ajp.22193; Fox J., CAR COMPANION APPL R; Frank MC, USING TABLE IN PRESS; Hendrickson K, 2014, DEV SCI; Lillard AS, 2011, PEDIATRICS, V128, P644, DOI 10.1542/peds.2010-1919; National Association for the Education of Young Children Fred Rogers Center for Early Learning and Children's Media, 2012, TECHNOLOGY INTERACTI; Pempek, 2013, ZERO 3, V33, P33; R Core Team, 2021, R LANGUAGE ENV STAT; Richards JE, 2001, CHILD DEV, V72, P963, DOI 10.1111/1467-8624.00328; Roseberry S, 2014, CHILD DEV, V85, P956, DOI 10.1111/cdev.12166; Vandewater EA, 2006, PEDIATRICS, V117, pE181, DOI 10.1542/peds.2005-0812; Zack E, 2013, SCAND J PSYCHOL, V54, P20, DOI 10.1111/sjop.12001; Zack E, 2009, BRIT J DEV PSYCHOL, V27, P13, DOI 10.1348/026151008X334700	22	90	91	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128338	10.1371/journal.pone.0128338	http://dx.doi.org/10.1371/journal.pone.0128338			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NS	26083848	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400040
J	De Moura, FF; Moursi, M; Lubowa, A; Ha, B; Boy, E; Oguntona, B; Sanusi, RA; Maziya-Dixon, B				De Moura, Fabiana F.; Moursi, Mourad; Lubowa, Abdelrahman; Ha, Barbara; Boy, Erick; Oguntona, Babatunde; Sanusi, Rasaki A.; Maziya-Dixon, Busie			Cassava Intake and Vitamin A Status among Women and Preschool Children in Akwa-Ibom, Nigeria	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; BETA-CAROTENE; PLASMA; DEFICIENCY; RETENTION; FERRITIN; IMPACT; FOODS; SERUM	Background As part of the HarvestPlus provitamin A-biofortified cassava program in Nigeria we conducted a survey to determine the cassava intake and prevalence of vitamin A deficiency among children 6-59 months and women of childbearing age in the state of Akwa Ibom. Methods A cluster-randomized cross-sectional survey was conducted in 2011 in Akwa Ibom, Nigeria. The usual food and nutrient intakes were estimated using a multi-pass 24-hour recall with repeated recall on a subsample. Blood samples of children and women were collected to analyze for serum retinol, serum ferritin, and acute phase proteins as indicators of infection. Vitamin A deficiency was defined as serum retinol <0.70 mu mol/L adjusted for infection. Results A total of 587 households of a mother-child dyad participated in the dietary intake assessment. Cassava was very widely consumed in Akwa Ibom, mainly as gari or foofoo. Daily cassava consumption frequency was 92% and 95% among children and women, respectively. Mean (+/- SD) cassava intake (expressed as raw fresh weight) was 348 +/- 317 grams/day among children and 940 +/- 777 grams/day among women. Intakes of most micronutrients appeared to be adequate with the exception of calcium. Median vitamin A intake was very high both for children (1038 mu g RAE/day) and women (2441 mu g RAE/day). Red palm oil and dark green leafy vegetables were the main sources of vitamin A in the diet, with red palm oil alone contributing almost 60% of vitamin A intake in women and children. Prevalence of vitamin A deficiency ranged from moderate (16.9 %) among children to virtually non-existent (3.4 %) among women. Conclusion Consumption of cassava and vitamin A intake was high among women and children in Akwa Ibom with a prevalence of vitamin A deficiency ranging from moderate in children to non-existent among women. The provitamin A biofortified cassava and other vitamin A interventions should focus dissemination in states where red palm oil is not widely consumed.	[De Moura, Fabiana F.; Moursi, Mourad; Ha, Barbara; Boy, Erick] HarvestPlus Int Food Policy Res Inst, Washington, DC 20006 USA; [Lubowa, Abdelrahman] HarvestPlus Consultant, Kampala, Uganda; [Oguntona, Babatunde] Fed Univ Agr, Abeokuta, Nigeria; [Sanusi, Rasaki A.] Univ Ibadan, Coll Med, Dept Human Nutr, Ibadan, Nigeria; [Maziya-Dixon, Busie] Int Inst Trop Agr, Ibadan, Nigeria	CGIAR; International Food Policy Research Institute (IFPRI); University of Agriculture, Abeokuta; University of Ibadan; CGIAR; International Institute of Tropical Agriculture (IITA)	De Moura, FF (corresponding author), HarvestPlus Int Food Policy Res Inst, 2033 K St NW, Washington, DC 20006 USA.	f.moura@cgiar.org	Boy, Erick/HDO-0821-2022	Moursi, Mourad/0000-0002-5071-8534; De Moura, Fabiana F./0000-0001-8176-5352	Bill and Melinda Gates Foundation [7208, 2011X212LUB]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The funds for the study were made available through a grant from the Bill and Melinda Gates Foundation to HarvestPlus through agreements HP#7208 and 2011X212LUB. FFM, MM, and EB are HarvestPlus employees who were involved in the study design and preparation of manuscript.	[Anonymous], 2014, FAOSTAT; Baingana RK, 2008, PUBLIC HEALTH NUTR, V11, P513, DOI [10.1017/S1368980007000821, DOI 10.1017/S1368980007000821]; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; CATIGNANI GL, 1983, CLIN CHEM, V29, P708; Chavez AL, 2007, J SCI FOOD AGR, V87, P388, DOI 10.1002/jsfa.2704; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Das BS, 1997, BRIT J NUTR, V78, P751, DOI 10.1079/BJN19970192; Engle-Stone R, 2011, J NUTR, V141, P2233, DOI 10.3945/jn.111.145805; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; ETEJERE EO, 1985, ECON BOT, V39, P157, DOI 10.1007/BF02907839; Etukudo I, 1990, COMMON PLANTS AKWA I; FAO, 2010, COMP SEL FOODS W AFR; Flaherty K., 2014, ZIMBABWE AGR R D IND; Gamble MV, 2001, AM J CLIN NUTR, V73, P594; Gegios A, 2010, PLANT FOOD HUM NUTR, V65, P64, DOI 10.1007/s11130-010-0157-5; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson RS, 2008, INTERACTIVE 24 HOUR; Hotz C., 2012, HARVESTPLUS TECHNICA, V9; Hotz C, 2007, FOOD NUTR BULL, V28, pS271, DOI 10.1177/15648265070282S206; Institute of Medicine, 2006, ESSENTIAL GUIDE NUTR, DOI [10.17226/11537, DOI 10.17226/11537, DOI 10.17226/11537.HTTPS://WWW.NAL.USDA.GOV/SITES/DEFAULT/FILES/FNIC_UPLOADS/DRIESSENTIALGUIDENUTREQ.PDF]; La Frano MR, 2013, BRIT J NUTR, V110, P310, DOI 10.1017/S0007114512005004; Maziya-Dixon B., 2004, NIGERIA FOOD CONSUMP; Maziya-Dixon B, 2009, INT J FOOD SCI TECH, V44, P2350, DOI 10.1111/j.1365-2621.2007.01638.x; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Philips TA, 1982, AGR GUIDE NOTEBOOK S, P5; Prynne, 2011, FOOD COMPOSITION TAB; Saltzman A, 2013, GLOB FOOD SECUR-AGR, V2, P9, DOI 10.1016/j.gfs.2012.12.003; Talsma EF, 2014, YELLOW CASSAVA EFFIC; Talsma EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073433; Thakkar SK, 2009, J AGR FOOD CHEM, V57, P1344, DOI 10.1021/jf803053d; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Tooze JA, 2006, J AM DIET ASSOC, V106, P1575, DOI 10.1016/j.jada.2006.07.003; TRUJILLOQUIJANO JA, 1990, FETT WISS TECHNOL, V92, P222, DOI 10.1002/lipi.19900920603; U. S. Department of Agriculture Agricultural Research Service, 2010, USDA NAT NUTR DAT ST; *WHO, 1996, IND ASS VIT A DEF TH; WHO, 2011, WHO GLOBAL DATABASE; WHO, 2007, REP WHO EXP COMM TEC, V854; WHO/CDC, 2007, INF PREV CONTR ASS F; World Health Organization, 2000, WHO TECHN REP SER, V894	41	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129436	10.1371/journal.pone.0129436	http://dx.doi.org/10.1371/journal.pone.0129436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083382	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400095
J	Jarrett, OD; Brady, KE; Modur, SP; Plants, J; Landay, AL; Ghassemi, M; Golub, ET; Spear, GT; Novak, RM				Jarrett, Olamide D.; Brady, Kirsten E.; Modur, Sharada P.; Plants, Jill; Landay, Alan L.; Ghassemi, Mahmood; Golub, Elizabeth T.; Spear, Greg T.; Novak, Richard M.			T. vaginalis Infection Is Associated with Increased IL-8 and TNFr1 Levels but with the Absence of CD38 and HLADR Activation in the Cervix of ESN	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; SEXUALLY-TRANSMITTED-DISEASES; FACTOR RECEPTOR P55; HEPATITIS-C VIRUS; TRICHOMONAS-VAGINALIS; HIV-INFECTION; FACTOR-ALPHA; HIGH-RISK; WOMEN	Introduction Trichomonas vaginalis infection is associated with an increased risk of HIV infection in exposed-seronegative women (ESN) despite their unique immune quiescent profile. It is important to understand possible mechanisms, such as recruitment of activated T cells, by which T. vaginalis could facilitate HIV infection in this population. Methods We conducted a cross-sectional study exploring the relationships between T. vaginalis infection, inflammatory markers and T cell activation in the cervix of ESN. During scheduled study visits, participants completed a behavioral questionnaire and physical exam, including sexually transmitted infection (STI) screening and collection of endocervical sponge and cytobrush specimens. T cell and monocyte phenotypes were measured in cervical cytobrush specimens using multi-parameter flow cytometry. Cervical sponge specimens were used to measure cytokines (IL-6, IL-8, IL-10, IP-10, RANTES) using Luminex immunoassays and the immune activation marker soluble TNF receptor 1 using ELISA. Results Specimens of 65 women were tested. Twenty-one of these women were infected with T. vaginalis. T. vaginalis infection was associated with significantly increased concentrations of IL-8 (1275pg/ml vs. 566pg/ml, p =.02) and sTNFr1 (430 pg/ml vs. 264 pg/ml, p =.005). However, T. vaginalis infection was not associated with increased percent expression of CCR5+ T cells nor increased CD38 and HLADR activation compared to uninfected women. It was also not associated with increased expression of CCR5+ monocytes. Conclusions Among ESN T. vaginalis infection is associated with increased levels of genital pro-inflammatory/immune activation markers IL-8 and TNFr1, but was not associated with an increased percentage of activated endocervical T cells along the CD38 and HLADR pathways. Thus, while T.vaginalis infection may result in some reversal of the immune quiescent profile of ESN, enhanced recruitment of activated CD38 and HLADR expressing CD4+ cells into the endocervix may not be part of the mechanism by which Trichomonas infection alters HIV susceptibility in this unique subset of women.	[Jarrett, Olamide D.; Ghassemi, Mahmood; Novak, Richard M.] Univ Illinois, Sch Med, Dept Med, Infect Dis Sect, Chicago, IL 60612 USA; [Brady, Kirsten E.; Plants, Jill; Landay, Alan L.; Spear, Greg T.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Modur, Sharada P.; Golub, Elizabeth T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jarrett, OD (corresponding author), Univ Illinois, Sch Med, Dept Med, Infect Dis Sect, Chicago, IL 60612 USA.	ojarrett@uic.edu		Lindley, Jill/0000-0001-8218-359X	National Institutes of Health [P01AI082971-02S1, P30AI082151-02S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI082151, P01AI082971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following National Institutes of Health grants: P01AI082971-02S1 and P30AI082151-02S1. Funding was received by OJ, which supported work performed by OJ, KB, JP, AL, SM, and RN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento CAM, 2009, AIDS, V23, P9, DOI 10.1097/QAD.0b013e328317461e; Campbell L, 2008, J CLIN MICROBIOL, V46, P3467, DOI 10.1128/JCM.00671-08; Chiao C, 2001, AIDS RES HUM RETROV, V17, P1125, DOI 10.1089/088922201316912736; Cohen CR, 1999, AIDS, V13, P327, DOI 10.1097/00002030-199902250-00004; Croghan CW, 2003, METHODS DEALING VALU; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Edfjall C, 1996, AIDS RES HUM RETROV, V12, P199, DOI 10.1089/aid.1996.12.199; Guenthner PC, 2005, INFECT IMMUN, V73, P4155, DOI 10.1128/IAI.73.7.4155-4160.2005; Han IH, 2012, PARASITE IMMUNOL, V34, P8, DOI 10.1111/j.1365-3024.2011.01338.x; Han IH, 2009, KOREAN J PARASITOL, V47, P205, DOI 10.3347/kjp.2009.47.3.205; Henning TR, 2014, J INFECT DIS, V210, P1239, DOI 10.1093/infdis/jiu240; Koblin BA, 2013, JAIDS-J ACQ IMM DEF, V63, P239, DOI 10.1097/QAI.0b013e31828ded1a; Kovacs A, 2008, J INFECT DIS, V197, P1402, DOI 10.1086/587696; Kovacs A, 2010, J INFECT DIS, V201, P823, DOI 10.1086/650997; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Lajoie J, 2014, J INFECT DIS, V210, P319, DOI 10.1093/infdis/jiu023; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Mavedzenge SN, 2010, SEX TRANSM DIS, V37, P460, DOI 10.1097/OLQ.0b013e3181cfcc4b; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; McKinnon LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085675; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Narimatsu R, 2005, AIDS RES HUM RETROV, V21, P228, DOI 10.1089/aid.2005.21.228; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Saba E, 2010, MUCOSAL IMMUNOL, V3, P280, DOI 10.1038/mi.2010.2; Scheller C, 2002, J BIOL CHEM, V277, P15459, DOI 10.1074/jbc.M200763200; Schmid G., 2011, PREVALENCE INCIDENCE; Spear GT, 2008, AIDS RES HUM RETROV, V24, P973, DOI 10.1089/aid.2008.0004; Spear GT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019560; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496	31	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130146	10.1371/journal.pone.0130146	http://dx.doi.org/10.1371/journal.pone.0130146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083468	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400127
J	Majewska, R; Santoro, M; Bolanos, F; Chaves, G; De Stefano, M				Majewska, Roksana; Santoro, Mario; Bolanos, Federico; Chaves, Gerardo; De Stefano, Mario			Diatoms and Other Epibionts Associated with Olive Ridley (Lepidochelys olivacea) Sea Turtles from the Pacific Coast of Costa Rica	PLOS ONE			English	Article							REEF FISHES; COMMUNITIES; ATLANTIC; ADHESION	Although the sea turtles have long been familiar and even iconic to marine biologists, many aspects of their ecology remain unaddressed. The present study is the first of the epizoic diatom community covering the olive ridley turtle's (Lepidochelys olivacea) carapace and the first describing diatoms living on sea turtles in general, with the primary objective of providing detailed information on turtle epibiotic associations. Samples of turtle carapace including the associated diatom biofilm and epizoic macro-fauna were collected from Ostional beach (9 degrees 59' 23.7" N 85 degrees 41' 52.6" W), Costa Rica, during the arribada event in October 2013. A complex diatom community was present in every sample. In total, 11 macrofaunal and 21 diatom taxa were recorded. Amongst diatoms, the most numerous were erect (Achnanthes spp., Tripterion spp.) and motile (Haslea sp., Navicula spp., Nitzschia spp., Proschkinia sp.) forms, followed by adnate Amphora spp., while the most common macrofaunal species was Stomatolepas elegans (Cirripedia). Diatom densities ranged from 8179 +/- 750 to 27685 +/- 4885 cells mm(-2). Epizoic microalgae were either partly immersed or entirely encapsulated within an exopolymeric coat. The relatively low diatom species number, stable species composition and low inter-sample dissimilarities (14.4% on average) may indicate a mutualistic relationship between the epibiont and the basibiont. Dispersal of sea turtle diatoms is probably highly restricted and similar studies will help to understand both diatom diversity, evolution and biogeography, and sea turtle ecology and foraging strategies.	[Majewska, Roksana; De Stefano, Mario] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Santoro, Mario] Univ Roma La Sapienza, Sect Parasitol, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Santoro, Mario] Ist Zooprofilatt Sperimentale Mezzogiorno, Portici, Italy; [Bolanos, Federico; Chaves, Gerardo] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica	Universita della Campania Vanvitelli; Sapienza University Rome; IZS del Mezzogiorno; Universidad Costa Rica	Majewska, R (corresponding author), Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy.	roksana.majewska@unina2.it	Majewska, Roksana/P-1280-2015; Santoro, Mario/K-3251-2019	Majewska, Roksana/0000-0003-2681-4304; Chaves, Gerardo/0000-0002-4301-6569	University of Costa Rica	University of Costa Rica	University of Costa Rica organized samplings while the II University of Naples provided reagents and analytical tools (including scanning electron microscopy facilities). The authors received no other funding for this work.	Baez Jose C., 2002, Marine Turtle Newsletter, V98, P1; Bolten Alan B., 1999, P110; CAINE EA, 1986, J EXP MAR BIOL ECOL, V95, P15, DOI 10.1016/0022-0981(86)90084-5; DAVIS J S, 1972, Biologist (Charleston), V54, P52; Denys Luc, 2010, Polish Botanical Journal, V55, P175; Di Camillo C, 2005, J MAR BIOL ASSOC UK, V85, P1373, DOI 10.1017/S0025315405012555; Fee EJ, 1973, AM MIDL NAT, V81, P318; Frick MG, 2004, SOUTHEAST NAT, V3, P613, DOI 10.1656/1528-7092(2004)003[0613:NRAOOE]2.0.CO;2; Frick MG, 2013, CRC MAR BIOL SER, P399; Frick Michael G., 1998, Herpetological Review, V29, P211; Fukami K, 1989, JAP SOC MARINE BIOTE, P415; Gillan DC, 2000, J SEA RES, V43, P83, DOI 10.1016/S1385-1101(99)00041-6; Gorley C.K., 2006, GETTING STARTED PRIM; Grossman A, 2006, CHELONIAN CONSERV BI, V5, P284, DOI 10.2744/1071-8443(2006)5[284:CSBHTA]2.0.CO;2; Hart T.J., 1935, DISCOVERY REP, V10, P249; HOAGLAND KD, 1993, J PHYCOL, V29, P537, DOI 10.1111/j.0022-3646.1993.00537.x; Holmes Robert W., 1993, Bulletin of the National Science Museum Series B (Botany), V19, P1; HOLMES RW, 1985, BRIT PHYCOL J, V20, P43, DOI 10.1080/00071618500650061; HOSTETTER HP, 1970, AM J BOT, V57, P512, DOI 10.2307/2441048; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; Lutz P.L., 1997, BIOL SEA TURTLES; Majewska R, 2013, POLAR BIOL, V36, P73, DOI 10.1007/s00300-012-1240-1; MCCLATCHIE S, 1990, MAR BIOL, V104, P227, DOI 10.1007/BF01313262; Nemoto T., 1956, SCI REP-UK, V11, P99; Patil JS, 2000, MAR BIOL, V136, P699, DOI 10.1007/s002270050730; Romagnoli T, 2007, MAR BIOL, V151, P537, DOI 10.1007/s00227-006-0487-x; Santoro M, 2007, VET REC, V161, P482, DOI 10.1136/vr.161.14.482; Sazima C, 2010, NEOTROP ICHTHYOL, V8, P187, DOI 10.1590/S1679-62252010005000003; Schwartz FJ, 1978, FLORIDA MARINE RES P, V33, P16; Sekar R, 2004, HYDROBIOLOGIA, V512, P109, DOI 10.1023/B:HYDR.0000020315.40349.38; Stoermer EF, 2010, DIATOMS APPL ENV EAR, P267; TOSTESON TR, 1975, CAN J MICROBIOL, V21, P1025, DOI 10.1139/m75-152; Totti C, 2011, CELL ORIG LIFE EXTRE, V16, P327; Wahl M, 1999, MAR ECOL PROG SER, V187, P59, DOI 10.3354/meps187059; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x	35	34	39	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130351	10.1371/journal.pone.0130351	http://dx.doi.org/10.1371/journal.pone.0130351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083535	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400138
J	Ueti, MW; Olafson, PU; Freeman, JM; Johnson, WC; Scoles, GA				Ueti, Massaro W.; Olafson, Pia U.; Freeman, Jeanne M.; Johnson, Wendell C.; Scoles, Glen A.			A Virulent Babesia bovis Strain Failed to Infect White-Tailed Deer (Odocoileus virginianus)	PLOS ONE			English	Article							TICK-BORNE PATHOGENS; ACARI IXODIDAE; THEILERIA-PARVA; CATTLE TICKS; IDENTIFICATION; SUPERINFECTION; TRANSMISSION; INFESTATIONS; MICROPLUS; SEQUENCE	Wildlife are an important component in the vector-host-pathogen triangle of livestock diseases, as they maintain biological vectors that transmit pathogens and can serve as reservoirs for such infectious pathogens. Babesia bovis is a tick-borne pathogen, vectored by cattle fever ticks, Rhipicephalus spp., that can cause up to 90% mortality in naive adult cattle. While cattle are the primary host for cattle fever ticks, wild and exotic ungulates, including white-tailed deer (WTD), are known to be viable alternative hosts. The presence of cattle fever tick populations resistant to acaricides raises concerns regarding the possibility of these alternative hosts introducing tick-borne babesial parasites into areas free of infection. Understanding the B. bovis reservoir competence of these alternative hosts is critical to mitigating the risk of introduction. In this study, we tested the hypothesis that WTD are susceptible to infection with a B. bovis strain lethal to cattle. Two groups of deer were inoculated intravenously with either B. bovis blood stabilate or a larval extract supernatant containing sporozoites from infected R. microplus larvae. The collective data demonstrated that WTD are neither a transient host nor reservoir of B. bovis. This conclusion is supported by the failure of B. bovis to establish an infection in deer regardless of inoculum. Although specific antibody was detected for a short period in the WTD, the PCR results were consistently negative at multiple time points throughout the experiment and blood from WTD that had been exposed to parasite, transferred into naive recipient susceptible calves, failed to establish infection. In contrast, naive steers inoculated intravenously with either B. bovis blood stabilate or the larval extract supernatant containing sporozoites rapidly succumbed to disease. These findings provide evidence that WTD are not an epidemiological component in the maintenance of B. bovis infectivity to livestock.	[Ueti, Massaro W.; Johnson, Wendell C.; Scoles, Glen A.] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Olafson, Pia U.; Freeman, Jeanne M.] USDA ARS, Knipling Bushland US Livestock Insects Res Lab, Kerrville, TX USA	United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA)	Ueti, MW (corresponding author), Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA.	massaro@vetmed.wsu.edu		Ueti, Massaro/0000-0002-2680-6091	USDA-ARS CRIS project [5348-32000-034-00D, 6205-32000-034D-00D]	USDA-ARS CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by USDA-ARS CRIS project number 5348-32000-034-00D and 6205-32000-034D-00D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awinda PO, 2013, CLIN VACCINE IMMUNOL, V20, P1752, DOI 10.1128/CVI.00479-13; Berggoetz M, 2014, TICKS TICK-BORNE DIS, V5, P176, DOI 10.1016/j.ttbdis.2013.10.003; Berggoetz M, 2014, TICKS TICK-BORNE DIS, V5, P166, DOI 10.1016/j.ttbdis.2013.10.007; Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Busch JD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-188; Cantu A, 2007, J WILDLIFE DIS, V43, P504, DOI 10.7589/0090-3558-43.3.504; Cantu A, 2009, J PARASITOL, V95, P536, DOI 10.1645/GE-1648.1; Caron A, 2013, EPIDEMIOL INFECT, V141, P1522, DOI 10.1017/S0950268813000204; COOKSEY LM, 1989, J MED ENTOMOL, V26, P155, DOI 10.1093/jmedent/26.3.155; DAVEY RB, 1990, J PARASITOL, V76, P356, DOI 10.2307/3282666; De Moraes CM, 2014, P NATL ACAD SCI USA, V111, P11079, DOI 10.1073/pnas.1405617111; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Githaka N, 2014, VET PARASITOL, V202, P180, DOI 10.1016/j.vetpar.2014.02.056; Goff WL, 1998, ANN NY ACAD SCI, V849, P161, DOI 10.1111/j.1749-6632.1998.tb11046.x; Holman PJ, 2011, VET PARASITOL, V177, P298, DOI 10.1016/j.vetpar.2010.11.052; HOLMAN PJ, 1993, J PARASITOL, V79, P233, DOI 10.2307/3283513; Howell JM, 2007, J CLIN MICROBIOL, V45, P3155, DOI 10.1128/JCM.00766-07; Howell JM, 2007, J CLIN MICROBIOL, V45, P426, DOI 10.1128/JCM.01757-06; Kramsky JA, 2003, J VET DIAGN INVEST, V15, P253, DOI 10.1177/104063870301500306; KUTTLER K L, 1972, Journal of Wildlife Diseases, V8, P63; Lohmeyer KH, 2011, J MED ENTOMOL, V48, P770, DOI 10.1603/ME10209; Lopez M, 2008, ANN NY ACAD SCI, V1149, P131, DOI 10.1196/annals.1428.072; Odongo DO, 2009, J MED ENTOMOL, V46, P888, DOI 10.1603/033.046.0422; Oosthuizen MC, 2008, J CLIN MICROBIOL, V46, P2247, DOI 10.1128/JCM.00167-08; Phillips PL, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.88; Pound JM, 2010, J ECON ENTOMOL, V103, P211, DOI 10.1603/EC09359; Ramos CM, 2010, VET PARASITOL, V172, P214, DOI 10.1016/j.vetpar.2010.05.004; Sondgeroth KS, 2014, INFECT IMMUN, V82, P4426, DOI 10.1128/IAI.02126-14; Suarez CE, 2011, VET PARASITOL, V180, P109, DOI 10.1016/j.vetpar.2011.05.032; Ueti MW, 2012, INFECT IMMUN, V80, P2354, DOI 10.1128/IAI.00341-12; Walker JG, 2014, VET PARASITOL, V199, P206, DOI 10.1016/j.vetpar.2013.11.008; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337	33	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0131018	10.1371/journal.pone.0131018	http://dx.doi.org/10.1371/journal.pone.0131018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083429	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400166
J	Mahe, I; Sterpu, R; Bertoletti, L; Lopez-Jimenez, L; Joan, MM; Trujillo-Santos, J; Ballaz, A; Blasco, LMH; Marchena, PJ; Monreal, M				Mahe, Isabelle; Sterpu, Raluca; Bertoletti, Laurent; Lopez-Jimenez, Luciano; Joan, Meritxell Mellado; Trujillo-Santos, Javier; Ballaz, Aitor; Hernandez Blasco, Luis Manuel; Javier Marchena, Pablo; Monreal, Manuel		RIETE Investigators	Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?	PLOS ONE			English	Article							LOW-MOLECULAR-WEIGHT; FATAL PULMONARY-EMBOLISM; RIETE REGISTRY; SECONDARY PREVENTION; MEDICAL PATIENTS; VEIN THROMBOSIS; CANCER; HEPARIN; GUIDELINES; RISK	Current guidelines of antithrombotic therapy suggest early initiation of vitamin K antagonists (VKA) in non-cancer patients with venous thromboembolism (VTE), and long-term therapy with low-molecular weight heparin (LMWH) for those with cancer. We used data from RIETE (international registry of patients with VTE) to report the use of long-term anticoagulant therapy over time and to identify predictors of anticoagulant choice (regarding international guidelines) in patients with-and without cancer. Among 35,280 patients without cancer, 82% received long-term VKA (but 17% started after the first week). Among 4,378 patients with cancer, 66% received long term LMWH as monotherapy. In patients without cancer, recent bleeding (odds ratio [OR] 2.70, 95% CI 2.26-3.23), age > 70 years (OR 1.15, 95% CI 1.06-1.24), immobility (OR 2.06, 95% CI 1.93-2.19), renal insufficiency (OR 2.42, 95% CI 2.15-2.71) and anemia (OR 1.75, 95% CI 1.65-1.87) predicted poor adherence to guidelines. In those with cancer, anemia (OR 1.83, 95% CI 1.64-2.06), immobility (OR 1.51, 95% CI 1.30-1.76) and metastases (OR 3.22, 95% CI 2.87-3.61) predicted long-term LMWH therapy. In conclusion, we report practices of VTE therapy in real life and found that a significant proportion of patients did not receive the recommended treatment. The perceived increased risk for bleeding has an impact on anticoagulant treatment decision.	[Mahe, Isabelle] Univ Paris Diderot, Univ Paris 07, Sorbonne Paris Cite,EA REMES 7334, Dept Internal Med,Hop Louis Mourier,Colombes APHP, Paris, France; [Sterpu, Raluca] Univ Paris 07, Hop Louis Mourier, Colombes APHP, Dept Internal Med, Paris, France; [Bertoletti, Laurent] CHU St Etienne, Hop Nord, Dept Vasc & Therapeut Med, St Etienne, France; [Lopez-Jimenez, Luciano] Hosp Prov Reina Sofia, Dept Internal Med, Cordoba, Spain; [Joan, Meritxell Mellado] Hosp Mar, Dept Angiol & Vasc Surg, Barcelona, Spain; [Trujillo-Santos, Javier] Complejo Hosp Univ Cartagena, Dept Internal Med, Murcia, Spain; [Ballaz, Aitor] Hosp Galdakao, Dept Pneumonol, Vizcaya, Spain; [Hernandez Blasco, Luis Manuel] Hosp Gen Univ Alicante, Dept Pneumonol, Alicante, Spain; [Javier Marchena, Pablo] Parc Sanitari St Joan de Deu Hosp Gen, Dept Internal Med, Barcelona, Spain; [Monreal, Manuel] Hosp Badalona Germans Trias & Pujol, Dept Internal Med, Badalona, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Galdakao Hospital; General University Hospital of Alicante; Hospital Germans Trias i Pujol	Mahe, I (corresponding author), Univ Paris Diderot, Univ Paris 07, Sorbonne Paris Cite,EA REMES 7334, Dept Internal Med,Hop Louis Mourier,Colombes APHP, Paris, France.	isabelle.mahe@lmr.aphp.fr	Mahé, Isabelle/ABA-3641-2020; Bertoletti, Laurent/X-1319-2019; Madridano, Olga/F-1745-2019; Tufano, Antonella/AHD-0570-2022; Pasca, Samantha/AAM-5310-2020; LOPEZ-SAEZ, JUAN-BOSCO/J-5449-2014	Mahé, Isabelle/0000-0003-1760-7880; Bertoletti, Laurent/0000-0001-8214-3010; Madridano, Olga/0000-0002-8872-8260; Tufano, Antonella/0000-0003-2398-6135; Pasca, Samantha/0000-0002-0954-013X; Jaras Hernandez, Maria Jesus/0000-0001-8477-0413; LOPEZ-SAEZ, JUAN-BOSCO/0000-0002-4897-5283; Sanchez Munoz-Torrero, Juan Francisco/0000-0003-0055-8875; Barillari, Giovanni/0000-0002-0706-8839; Porras Ledantes, Jose Antonio/0000-0001-6418-1822; Alatri, Adriano/0000-0001-7116-1846	Sanofi Spain; Bayer Pharma AG	Sanofi Spain(Sanofi-Aventis); Bayer Pharma AG	This Registry is supported by unrestricted educational grants from Sanofi Spain and Bayer Pharma AG. The funding source had no role in the design, protocol development, or conduct of the study; data collection, management, or analysis; interpretation, preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Bergmann JF, 2010, THROMB HAEMOSTASIS, V103, P736, DOI 10.1160/TH09-09-0667; Caprini JA, 2005, J VASC SURG, V42, P726, DOI 10.1016/j.jvs.2005.05.053; Cohen AT, 2014, ADV THER, V31, P473, DOI 10.1007/s12325-014-0119-7; Delate T, 2012, ONCOLOGIST, V17, P419, DOI 10.1634/theoncologist.2011-0323; Hull RD, 2006, AM J MED, V119, P1062, DOI 10.1016/j.amjmed.2006.02.022; Kahn SR, 2012, THROMB HAEMOSTASIS, V108, P493, DOI 10.1160/TH12-03-0169; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729; Monreal M, 2004, J THROMB HAEMOST, V2, P1892, DOI 10.1111/j.1538-7836.2004.01012.x; Monreal M, 2006, J THROMB HAEMOST, V4, P1950, DOI 10.1111/j.1538-7836.2006.02082.x; Palareti G, 2009, THROMB HAEMOSTASIS, V102, P268, DOI 10.1160/TH08-11-0730; Rahme E, 2013, THROMB RES, V131, P210, DOI 10.1016/j.thromres.2012.12.004; Ruiz-Gimenez N, 2008, THROMB HAEMOSTASIS, V100, P26, DOI 10.1160/TH08-03-0193; Munoz-Torrero JFS, 2011, J VASC SURG, V54, p26S, DOI 10.1016/j.jvs.2011.05.114; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993; Trujillo-Santos J, 2013, AM J MED, V126, P425, DOI 10.1016/j.amjmed.2012.09.021	19	34	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128741	10.1371/journal.pone.0128741	http://dx.doi.org/10.1371/journal.pone.0128741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076483	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900026
J	Knockenhauer, KE; Schwartz, TU				Knockenhauer, Kevin E.; Schwartz, Thomas U.			Structural Characterization of Bardet-Biedl Syndrome 9 Protein (BBS9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; CILIARY MEMBRANE; COMPARATIVE GENOMICS; PRIMARY CILIUM; BBSOME; CONSERVATION; SEQUENCE; SUBUNIT; COPII; GENE	The Bardet-Biedl syndrome protein complex (BBSome) is an octameric complex that transports membrane proteins into the primary cilium signaling organelle in eukaryotes and is implicated in human disease. Here we have analyzed the 99-kDa human BBS9 protein, one of the eight BBSome components. The protein is composed of four structured domains, including a beta-stranded N-terminal domain. The 1.8 angstrom crystal structure of the 46-kDa N-terminal domain reveals a seven-bladed beta-propeller. A structure-based homology search suggests that it functions in protein-protein interactions. We show that the Bardet-Biedl syndrome-causing G141R mutation in BBS9 likely results in misfolding of the beta-propeller. Although the C-terminal half of BBS9 dimerizes in solution, the N-terminal domain only does so in the crystal lattice. This C-terminal dimerization interface might be important for the assembly of the BBSome.	[Knockenhauer, Kevin E.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512	NIGMS, National Institutes of Health [GM103403]; Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, T32GM007287] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Saxton for performing the HEK 293T transient transfection and subsequent Western blot, N. Leksa for experimental advice, S. Bilokapic for help with crystal fishing, and E. Spooner for performing the LC-MS/MS. The x-ray crystallography work was conducted at the Advanced Photon Source (APS) NE-CAT beamlines, which are supported by award GM103403 from the NIGMS, National Institutes of Health. Use of the APS is supported by the Department of Energy, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. The Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (NSF-007031) is gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Heenan EJ, 2009, BIOCHEMISTRY-US, V48, P6390, DOI 10.1021/bi900621w; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Mans BJ, 2004, CELL CYCLE, V3, P1612; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mourao A, 2014, NAT STRUCT MOL BIOL, V21, P1035, DOI 10.1038/nsmb.2920; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nishimura DY, 2005, AM J HUM GENET, V77, P1021, DOI 10.1086/498323; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Veleri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034389; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Wilkins MR, 1999, METH MOL B, V112, P531; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1	44	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19569	19583		10.1074/jbc.M115.649202	http://dx.doi.org/10.1074/jbc.M115.649202			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26085087	Green Published, hybrid			2022-12-26	WOS:000359364600020
J	Butkinaree, C; Canuel, M; Essalmani, R; Poirier, S; Benjannet, S; Asselin, MC; Roubtsova, A; Hamelin, J; Marcinkiewicz, J; Chamberland, A; Guillemot, J; Mayer, G; Sisodia, SS; Jacob, Y; Prat, A; Seidah, NG				Butkinaree, Chutikarn; Canuel, Maryssa; Essalmani, Rachid; Poirier, Steve; Benjannet, Suzanne; Asselin, Marie-Claude; Roubtsova, Anna; Hamelin, Josee; Marcinkiewicz, Jadwiga; Chamberland, Ann; Guillemot, Johann; Mayer, Gaetan; Sisodia, Sangram S.; Jacob, Yves; Prat, Annik; Seidah, Nabil G.			Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; CHONDROITIN SULFATE GLYCOSAMINOGLYCAN; LDL RECEPTOR; SECRETED PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; COMPLEMENTATION ASSAY; LIVER-REGENERATION; ADAPTER PROTEIN; HEPG2 CELLS; MOUSE-LIVER	Amyloid precursor-like protein 2 (APLP2) and sortilin were reported to individually bind the proprotein convertase subtilisin/kexin type 9 (PCSK9) and regulate its activity on the low-density lipoprotein receptor (LDLR). The data presented herein demonstrate that mRNA knockdowns of APLP2, sortilin, or both in the human hepatocyte cell lines HepG2 and Huh7 do not affect the ability of extracellular PCSK9 to enhance the degradation of the LDLR. Furthermore, mice deficient in APLP2 or sortilin do not exhibit significant changes in liver LDLR or plasma total cholesterol levels. Moreover, cellular overexpression of one or both proteins does not alter PCSK9 secretion, or its activity on the LDLR. We conclude that PCSK9 enhances the degradation of the LDLR independently of either APLP2 or sortilin both ex vivo and in mice. Interestingly, when co-expressed with PCSK9, both APLP2 and sortilin were targeted for lysosomal degradation. Using chemiluminescence proximity and co-immunoprecipitation assays, as well as biosynthetic analysis, we discovered that sortilin binds and stabilizes APLP2, and hence could regulate its intracellular functions on other targets.	[Butkinaree, Chutikarn; Canuel, Maryssa; Essalmani, Rachid; Benjannet, Suzanne; Asselin, Marie-Claude; Roubtsova, Anna; Hamelin, Josee; Marcinkiewicz, Jadwiga; Chamberland, Ann; Guillemot, Johann; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Poirier, Steve; Mayer, Gaetan] Montreal Heart Inst, Mol Cell Biol Lab, Montreal, PQ H18 1C8, Canada; [Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Jacob, Yves] Inst Pasteur, Unite Genet Mol Virus ARN, Dept Virol, F-75015 Paris, France; [Jacob, Yves] CNRS, URA3015, F-75015 Paris, France; [Jacob, Yves] Univ Paris Diderot, Sorbonne Paris Cite, Unite Genet Mol Virus ARN, F-75015 Paris, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; University of Chicago; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Seidah, NG (corresponding author), 110 Pine Ave, West Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013; Prat, Annik/S-6757-2018; Guillemot, Johann/O-1066-2013	Seidah, Nabil/0000-0001-6503-9342; Prat, Annik/0000-0002-8007-5277; Guillemot, Johann/0000-0002-5902-9188; Jacob, Yves/0000-0001-9125-2374	Canadian Institutes of Health Research [MOP-102741, CTP-82946]; Canada Chair Grant [216684]; Leducq Foundation [13CVD03]; University of Pennsylvania Orphan Disease Center; Canadian Heart and Stroke Research Fellowship Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Chair Grant; Leducq Foundation(Leducq Foundation); University of Pennsylvania Orphan Disease Center; Canadian Heart and Stroke Research Fellowship Award	This work was supported in part by Canadian Institutes of Health Research Grants MOP-102741 and CTP-82946, Canada Chair Grant 216684, and Leducq Foundation Grant 13CVD03. The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a research fellowship from the University of Pennsylvania Orphan Disease Center.; Supported by a Canadian Heart and Stroke Research Fellowship Award.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Cousins SL, 2015, J NEUROCHEM, V133, P879, DOI 10.1111/jnc.13063; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Devay RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125127; DeVay RM, 2013, J BIOL CHEM, V288, P10805, DOI 10.1074/jbc.M113.453373; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fasano T, 2009, ATHEROSCLEROSIS, V203, P166, DOI 10.1016/j.atherosclerosis.2008.10.027; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Holla OL, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-9; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Leren TP, 2014, ATHEROSCLEROSIS, V237, P76, DOI 10.1016/j.atherosclerosis.2014.08.038; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; MBIKAY M, 1989, INT J PEPT PROT RES, V33, P39; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Neveu G, 2012, METHODS, V58, P349, DOI 10.1016/j.ymeth.2012.07.029; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2013, CURR PHARM DESIGN, V19, P3161; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stein EA, 2014, ANNU REV MED, V65, P417, DOI 10.1146/annurev-med-022613-090402; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; THINAKARAN G, 1995, J BIOL CHEM, V270, P16522, DOI 10.1074/jbc.270.28.16522; Tuli A, 2008, J IMMUNOL, V181, P1978, DOI 10.4049/jimmunol.181.3.1978; Tuli A, 2009, J BIOL CHEM, V284, P34296, DOI 10.1074/jbc.M109.039727; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang Y, 2012, J LIPID RES, V53, P1932, DOI 10.1194/jlr.M028563; Yang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063049; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zeng JB, 2009, EXP CELL RES, V315, P3112, DOI 10.1016/j.yexcr.2009.08.016; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	61	35	35	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18609	18620		10.1074/jbc.M115.647180	http://dx.doi.org/10.1074/jbc.M115.647180			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26085104	Green Published, hybrid			2022-12-26	WOS:000358512100031
J	Herbert, JA; Mitchell, AM; Mitchell, TJ				Herbert, Jenny A.; Mitchell, Andrea M.; Mitchell, Timothy J.			A Serine-Threonine Kinase (StkP) Regulates Expression of the Pneumococcal Pilus and Modulates Bacterial Adherence to Human Epithelial and Endothelial Cells In Vitro	PLOS ONE			English	Article							SERINE/THREONINE PROTEIN-KINASE; PENICILLIN-BINDING PROTEIN; RLRA PATHOGENICITY ISLET; STREPTOCOCCUS-PNEUMONIAE; GENE-EXPRESSION; 2-COMPONENT SYSTEM; RESPONSE REGULATOR; DNA-BINDING; VIRULENCE; IDENTIFICATION	The pneumococcal serine threonine protein kinase (StkP) acts as a global regulator in the pneumococcus. Bacterial mutants deficient in StkP are less virulent in animal models of infection. The gene for this regulator is located adjacent to the gene for its cognate phosphatase in the pneumococcal genome. The phosphatase dephosphorylates proteins phosphorylated by StkP and has been shown to regulate a number of key pneumococcal virulence factors and to modulate adherence to eukaryotic cells. The role of StkP in adherence of pneumococci to human cells has not previously been reported. In this study we show StkP represses the pneumococcal pilus, a virulence factor known to be important for bacterial adhesion. In a serotype 4 strain regulation of the pilus by StkP modulates adherence to human brain microvascular endothelial cells (HBMEC) and human lung epithelial cells. This suggests that the pneumococcal pilus may play a role in adherence during infections such as meningitis and pneumonia. We show that regulation of the pilus occurs at the population level as StkP alters the number of pili-positive cells within a single culture. As far as we are aware this is the first gene identified outside of the pilus islet that regulates the biphasic expression of the pilus. These findings suggest StkPs role in cell division may be linked to regulation of expression of a cell surface adhesin.	[Herbert, Jenny A.; Mitchell, Andrea M.; Mitchell, Timothy J.] Univ Birmingham, Sch Immun & Infect, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Birmingham	Mitchell, TJ (corresponding author), Univ Birmingham, Sch Immun & Infect, Inst Microbiol & Infect, Birmingham, W Midlands, England.	t.j.mitchell@bham.ac.uk		Mitchell, Andrea/0000-0002-2530-4460; Mitchell, Timothy/0000-0002-8309-5556; Herbert, Jenny/0000-0003-4179-775X	BBSRC	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a scholarship from the BBSRC to JAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABERGE IS, 1995, MICROB PATHOGENESIS, V18, P141, DOI 10.1016/S0882-4010(95)90125-6; Agarwal S, 2012, INFECT IMMUN, V80, P1361, DOI 10.1128/IAI.06311-11; Agarwal S, 2011, J BIOL CHEM, V286, P41368, DOI 10.1074/jbc.M111.286690; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Basset A, 2013, J BIOL CHEM, V288, P2665, DOI 10.1074/jbc.M112.398875; Basset A, 2011, INFECT IMMUN, V79, P2974, DOI 10.1128/IAI.05117-11; Beilharz K, 2012, P NATL ACAD SCI USA, V109, pE905, DOI 10.1073/pnas.1119172109; Blue CE, 2003, INFECT IMMUN, V71, P4405, DOI 10.1128/IAI.71.8.4405-4413.2003; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; Coffey TJ, 1999, MICROBIOL-SGM, V145, P2023, DOI 10.1099/13500872-145-8-2023; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; De Angelis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021269; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; El Mortaji L, 2012, BIOCHEMISTRY-US, V51, P342, DOI 10.1021/bi201591n; FRERE JM, 1985, CRC CR REV MICROBIOL, V11, P299; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Giefing C, 2010, MICROBIOL-SGM, V156, P1697, DOI 10.1099/mic.0.036335-0; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Guiral S, 2006, MICROBIOL-SGM, V152, P343, DOI 10.1099/mic.0.28433-0; Haas W, 2004, J BACTERIOL, V186, P8463, DOI 10.1128/JB.186.24.8463-8471.2004; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hava DL, 2003, J BACTERIOL, V185, P413, DOI 10.1128/JB.185.2.413-421.2003; Hemsley C, 2003, J BACTERIOL, V185, P6640, DOI 10.1128/JB.185.22.6640-6647.2003; Hendriksen WT, 2007, J BACTERIOL, V189, P1382, DOI 10.1128/JB.01144-06; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maestro B, 2011, FEBS LETT, V585, P357, DOI 10.1016/j.febslet.2010.12.016; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mann B, 2006, INFECT IMMUN, V74, P821, DOI 10.1128/IAI.74.2.821-829.2006; Maurer P, 2012, MICROB DRUG RESIST, V18, P314, DOI 10.1089/mdr.2012.0022; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Moschioni M, 2012, VACCINE, V30, P1349, DOI 10.1016/j.vaccine.2011.12.080; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Novakova L, 2005, FEBS J, V272, P1243, DOI 10.1111/j.1742-4658.2005.04560.x; Novakova L, 2010, J BACTERIOL, V192, P3629, DOI 10.1128/JB.01564-09; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Orrskog S, 2013, MBIO, V4, DOI 10.1128/mBio.00535-12; Osaki M, 2009, J BACTERIOL, V191, P4943, DOI 10.1128/JB.00196-09; Pallova P, 2007, BIOCHEM BIOPH RES CO, V355, P526, DOI 10.1016/j.bbrc.2007.01.184; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Regev-Yochay G, 2010, VACCINE, V28, P4842, DOI 10.1016/j.vaccine.2010.04.042; Regev-Yochay G, 2009, CLIN INFECT DIS, V48, P760, DOI 10.1086/597040; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Saskova L, 2007, J BACTERIOL, V189, P4168, DOI 10.1128/JB.01616-06; Schmid P, 2011, VACCINE, V29, P3982, DOI 10.1016/j.vaccine.2011.03.081; Sebert ME, 2002, INFECT IMMUN, V70, P4059, DOI 10.1128/IAI.70.8.4059-4067.2002; Song XM, 2009, MICROB PATHOGENESIS, V46, P28, DOI 10.1016/j.micpath.2008.10.006; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; SPRATT BG, 1977, EUR J BIOCHEM, V72, P341, DOI 10.1111/j.1432-1033.1977.tb11258.x; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	64	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0127212	10.1371/journal.pone.0127212	http://dx.doi.org/10.1371/journal.pone.0127212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090876	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000009
J	Luijcks, R; Vossen, CJ; Hermens, HJ; van Os, J; Lousberg, R				Luijcks, Rosan; Vossen, Catherine J.; Hermens, Hermie J.; van Os, Jim; Lousberg, Richel			The Influence of Perceived Stress on Cortical Reactivity: A Proof-Of-Principle Study	PLOS ONE			English	Article							FRONTAL EEG ASYMMETRY; EMOTION; ALPHA; MEMORY; SCALE; PERFORMANCE; DISORDER; ADULTS; BAND; PAIN	The aim of this study was to investigate how perceived stress may affect electroencephalographical (EEG) activity in a stress paradigm in a sample of 76 healthy participants. EEG activity was analyzed using multilevel modeling, allowing estimation of nested effects (EEG time segments within subjects). The stress paradigm consisted of a 3-minute pre-stimulus stress period and a 2-minute post-stimulus phase. At t=3 minutes, a single electrical stimulus was delivered. Participants were unaware of the precise moment of stimulus delivery and its intensity level. In the EEG time course of alpha activity, a stronger increase was observed during the post-stimulus period as compared to the pre-stimulus period. An opposite time course effect was apparent for gamma activity. Both effects were in line with a priori expectations and support the validity of this experimental EEG-stress paradigm. Secondly, we investigated whether interaction effects of stress and coping, as measured with the Perceived Stress Scale-10 questionnaire (PSS-10), could be demonstrated. A higher perceived stress score was accompanied by a greater increase in delta- and theta-activity during the post-stimulus phase, compared to low scores. In contrast, low coping capacity was associated with a stronger decrease in slow beta, fast beta and gamma activity during the post-stimulus phase. The results of the present article may be interpreted as proof-of-principle that EEG stress-related activity depends on the level of subjectively reported perceived stress. The inclusion of psychosocial variables measuring coping styles as well as stress-related personality aspects permits further examination of the interconnection between mind and body and may inform on the process of transformation from acute to chronic stress.	[Luijcks, Rosan; Vossen, Catherine J.; van Os, Jim; Lousberg, Richel] Maastricht Univ, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Netherlands; [Vossen, Catherine J.] Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Med, NL-6200 MD Maastricht, Netherlands; [Hermens, Hermie J.] Roessingh Res & Dev, Enschede, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England	Maastricht University; Maastricht University; University of London; King's College London	Luijcks, R (corresponding author), Maastricht Univ, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Netherlands.	rosanluijcks@gmail.com	Vossen, Catherine/S-7436-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; Vossen, Catherine/0000-0003-3523-1696				Bellinghausen Lisa, 2009, Sante Publique, V21, P365; BROMM B, 1984, METHOD FIND EXP CLIN, V6, P405; Chang PF, 2002, BRAIN RES BULL, V57, P667, DOI 10.1016/S0361-9230(01)00763-8; CHEN ACN, 1989, PAIN, V37, P129, DOI 10.1016/0304-3959(89)90125-5; Cipresso Pietro, 2012, Stud Health Technol Inform, V173, P102; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Cole C, 2012, BRAIN COGNITION, V78, P156, DOI 10.1016/j.bandc.2011.10.013; de Carvalho MR, 2013, J AFFECT DISORDERS, V151, P259, DOI 10.1016/j.jad.2013.06.002; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Ezzati A, 2014, INT J GERIATR PSYCH, V29, P645, DOI 10.1002/gps.4049; Feuerstein M., 1986, HLTH PSYCHOL PSYCHOB; Goodman RN, 2013, INT J PSYCHOPHYSIOL, V87, P115, DOI 10.1016/j.ijpsycho.2012.09.008; GROENEWEGEN HJ, 1990, PROG BRAIN RES, V85, P95; Ishitani N, 2005, PSYCHIAT CLIN NEUROS, V59, P644, DOI 10.1111/j.1440-1819.2005.01431.x; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lazarus R.S., 1984, EMOTION ADAPTATION; Lewis RS, 2007, BIOL PSYCHOL, V75, P239, DOI 10.1016/j.biopsycho.2007.03.004; Luijcks R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095215; Master SL, 2009, BRAIN BEHAV IMMUN, V23, P27, DOI 10.1016/j.bbi.2008.04.007; Miskovic V, 2010, BIOL PSYCHOL, V83, P125, DOI 10.1016/j.biopsycho.2009.11.010; Mitchell AM, 2008, RES NURS HEALTH, V31, P576, DOI 10.1002/nur.20284; Nitschke JB, 2000, ANXIETY STRESS CORTI; Nordin M, 2013, SCAND J PSYCHOL, V54, P502, DOI 10.1111/sjop.12071; Oathes DJ, 2008, BIOL PSYCHOL, V79, P165, DOI 10.1016/j.biopsycho.2008.04.005; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pizzagalli DA, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P56, DOI 10.1017/CBO9780511546396.003; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Vanneste S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088253; Vossen H, 2011, INT J METH PSYCH RES, V20, pE56, DOI 10.1002/mpr.348; Yu XL, 2009, AUTON NEUROSCI-BASIC, V146, P81, DOI 10.1016/j.autneu.2008.12.005	32	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129220	10.1371/journal.pone.0129220	http://dx.doi.org/10.1371/journal.pone.0129220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26090882	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000037
J	Matsuda, T; Takahashi, H; Mieda, Y; Shimizu, S; Kawamoto, T; Matsuura, Y; Takai, T; Suzuki, E; Kanno, A; Koyanagi-Kimura, M; Asahara, S; Bartolome, A; Yokoi, N; Inoue, H; Ogawa, W; Seino, S; Kido, Y				Matsuda, Tomokazu; Takahashi, Hiroaki; Mieda, Yusuke; Shimizu, Shinobu; Kawamoto, Takeshi; Matsuura, Yuki; Takai, Tomoko; Suzuki, Emi; Kanno, Ayumi; Koyanagi-Kimura, Maki; Asahara, Shun-ichiro; Bartolome, Alberto; Yokoi, Norihide; Inoue, Hiroshi; Ogawa, Wataru; Seino, Susumu; Kido, Yoshiaki			Regulation of Pancreatic beta Cell Mass by Cross-Interaction between CCAAT Enhancer Binding Protein beta Induced by Endoplasmic Reticulum Stress and AMP-Activated Protein Kinase Activity	PLOS ONE			English	Article							C/EBP-BETA; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE; MICE; APOPTOSIS; PHOSPHORYLATION; INHIBITION; EXPRESSION; SECRETION	During the development of type 2 diabetes, endoplasmic reticulum (ER) stress leads to not only insulin resistance but also to pancreatic beta cell failure. Conversely, cell function under various stressed conditions can be restored by reducing ER stress by activating AMP-activated protein kinase (AMPK). However, the details of this mechanism are still obscure. Therefore, the current study aims to elucidate the role of AMPK activity during ER stress-associated pancreatic beta cell failure. MIN6 cells were loaded with 5-amino-1-beta-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) and metformin to assess the relationship between AMPK activity and CCAAT enhancer binding protein beta (C/EBP beta) expression levels. The effect of C/EBP beta phosphorylation on expression levels was also investigated. Vildagliptin and metformin were administered to pancreatic beta cell-specific C/EBP beta transgenic mice to investigate the relationship between C/EBP beta expression levels and AMPK activity in the pancreatic islets. When pancreatic beta cells are exposed to ER stress, the accumulation of the transcription factor C/EBP beta lowers the AMP/ATP ratio, thereby decreasing AMPK activity. In an opposite manner, incubation of MIN6 cells with AICAR or metformin activated AMPK, which suppressed C/EBP beta expression. In addition, administration of the dipeptidyl peptidase-4 inhibitor vildagliptin and metformin to pancreatic beta cell-specific C/EBP beta transgenic mice decreased C/EBP beta expression levels and enhanced pancreatic beta cell mass in proportion to the recovery of AMPK activity. Enhanced C/EBP beta expression and decreased AMPK activity act synergistically to induce ER stress-associated pancreatic beta cell failure.	[Matsuda, Tomokazu; Takai, Tomoko; Suzuki, Emi; Kanno, Ayumi; Koyanagi-Kimura, Maki; Asahara, Shun-ichiro; Ogawa, Wataru; Seino, Susumu; Kido, Yoshiaki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo 657, Japan; [Takahashi, Hiroaki; Mieda, Yusuke; Shimizu, Shinobu; Kawamoto, Takeshi; Matsuura, Yuki; Kido, Yoshiaki] Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Div Med Chem, Kobe, Hyogo 657, Japan; [Bartolome, Alberto] Columbia Univ, Naomi Berrie Diabet Ctr, Dept Med, New York, NY USA; [Yokoi, Norihide; Seino, Susumu] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Mol & Metab Med, Kobe, Hyogo 657, Japan; [Inoue, Hiroshi] Kanazawa Univ, Brain Liver Interface Med Res Ctr, Dept Physiol & Metab, Kanazawa, Ishikawa, Japan	Kobe University; Kobe University; Columbia University; Kobe University; Kanazawa University	Kido, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo 657, Japan.	kido@med.kobe-u.ac.jp	OGAWA, Wataru/AAQ-9586-2020; Bartolome, Alberto/AAV-1735-2020; Asahara, Shun-ichiro/I-6645-2019	Bartolome, Alberto/0000-0002-3382-0553; Asahara, Shun-ichiro/0000-0001-6661-9402; Inoue, Hiroshi/0000-0002-7724-6637	Japanese Ministry of Education, Culture, Sports, Science and Technology; Novartis	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novartis(Novartis)	This study was funded by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology to YK and S. Seino (www.mext.to.go.jp); a Grant-in-Aid for Young Scientists from the Japanese Ministry of Education, Culture, Sports, Science and Technology to TM (www.mext.to.go.jp); and a Novartis research grant to YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Beall C, 2010, BIOCHEM J, V429, P323, DOI 10.1042/BJ20100231; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Choudhury M, 2011, MOL CELL ENDOCRINOL, V331, P102, DOI 10.1016/j.mce.2010.08.014; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hashimoto N, 2005, J CLIN INVEST, V115, P138, DOI 10.1172/JCI200522232; Hwang SL, 2013, BRIT J PHARMACOL, V169, P69, DOI 10.1111/bph.12124; Ishikawa T, 2013, MOL BIOL CELL, V24, P1387, DOI 10.1091/mbc.E12-11-0830; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031394; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Mizukami H, 2014, DIABETES CARE, V37, P1966, DOI 10.2337/dc13-2018; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; NybIorn HK, 2008, J MOL ENDOCRINOL, V41, P187, DOI 10.1677/JME-08-0006; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Salmenpera P, 2003, AM J PHYSIOL-CELL PH, V284, pC1133, DOI 10.1152/ajpcell.00293.2002; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Salvado L, 2014, DIABETOLOGIA, V57, P2126, DOI 10.1007/s00125-014-3331-8; Samson SL, 2013, J HEPATOL, V58, P634, DOI 10.1016/j.jhep.2012.10.032; Shimizu S, 2012, J MOL ENDOCRINOL, V49, P125, DOI 10.1530/JME-12-0039; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhang YY, 2012, BIOCHEM BIOPH RES CO, V419, P550, DOI 10.1016/j.bbrc.2012.02.058; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	39	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130757	10.1371/journal.pone.0130757	http://dx.doi.org/10.1371/journal.pone.0130757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091000	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000150
J	Houk, P; Camacho, R; Johnson, S; McLean, M; Maxin, S; Anson, J; Joseph, E; Nedlic, O; Luckymis, M; Adams, K; Hess, D; Kabua, E; Yalon, A; Buthung, E; Graham, C; Leberer, T; Taylor, B; van Woesik, R				Houk, Peter; Camacho, Rodney; Johnson, Steven; McLean, Matthew; Maxin, Selino; Anson, Jorg; Joseph, Eugene; Nedlic, Osamu; Luckymis, Marston; Adams, Katrina; Hess, Don; Kabua, Emma; Yalon, Anthony; Buthung, Eva; Graham, Curtis; Leberer, Trina; Taylor, Brett; van Woesik, Robert			The Micronesia Challenge: Assessing the Relative Contribution of Stressors on Coral Reefs to Facilitate Science-to-Management Feedback	PLOS ONE			English	Article							ACANTHASTER-PLANCI OUTBREAKS; ZONE CHLOROPHYLL FRONT; CLIMATE-CHANGE; COMMUNITIES; STABILITY; OCEAN; INTENSITY; DIVERSITY; PATTERNS; TRENDS	Fishing and pollution are chronic stressors that can prolong recovery of coral reefs and contribute to ecosystem decline. While this premise is generally accepted, management interventions are complicated because the contributions from individual stressors are difficult to distinguish. The present study examined the extent to which fishing pressure and pollution predicted progress towards the Micronesia Challenge, an international conservation strategy initiated by the political leaders of 6 nations to conserve at least 30% of marine resources by 2020. The analyses were rooted in a defined measure of coral-reef-ecosystem condition, comprised of biological metrics that described functional processes on coral reefs. We report that only 42% of the major reef habitats exceeded the ecosystem-condition threshold established by the Micronesia Challenge. Fishing pressure acting alone on outer reefs, or in combination with pollution in some lagoons, best predicted both the decline and variance in ecosystem condition. High variances among ecosystem-condition scores reflected the large gaps between the best and worst reefs, and suggested that the current scores were unlikely to remain stable through time because of low redundancy. Accounting for the presence of marine protected area (MPA) networks in statistical models did little to improve the models' predictive capabilities, suggesting limited efficacy of MPAs when grouped together across the region. Yet, localized benefits of MPAs existed and are expected to increase over time. Sensitivity analyses suggested that (i) grazing by large herbivores, (ii) high functional diversity of herbivores, and (iii) high predator biomass were most sensitive to fishing pressure, and were required for high ecosystem-condition scores. Linking comprehensive fisheries management policies with these sensitive metrics, and targeting the management of pollution, will strengthen the Micronesia Challenge and preserve ecosystem services that coral reefs provide to societies in the face of climate change.	[Houk, Peter; Camacho, Rodney; McLean, Matthew] Univ Guam, Marine Lab, UOG Stn, Mangilao, GU 96923 USA; [Maxin, Selino; Anson, Jorg; Joseph, Eugene] Conservat Soc Pohnpei, Kolonia, Pohnpei State, Micronesia; [Nedlic, Osamu; Luckymis, Marston] Kosrae Conservat & Safety Org, Lelu, Kosrae State, Micronesia; [Adams, Katrina] Kosrae Village Resort, Malem, Kosrae State, Micronesia; [Hess, Don] Coll Marshall Isl, Majuro, Marshall Island; [Kabua, Emma] Marshall Islands Marine Resources Author, Majuro, Marshall Island; [Yalon, Anthony; Buthung, Eva] Yap Community Act Program, Colonia, Yap State, Micronesia; [Graham, Curtis] Chuuk Marine Resources Dept, Weno, Yap State, Micronesia; [Taylor, Brett] James Cook Univ, Townsville, Qld 4811, Australia; [van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	University of Guam; James Cook University; Florida Institute of Technology	Houk, P (corresponding author), Univ Guam, Marine Lab, UOG Stn, Mangilao, GU 96923 USA.	houkp@uguam.uog.edu	Johnson, Steven Mana'oakamai/ABC-7915-2021; Taylor, Brett/AAC-6787-2019	Johnson, Steven Mana'oakamai/0000-0001-6998-9759; Taylor, Brett/0000-0002-4746-7228; McLean, Matthew/0000-0001-6518-6043	National Oceanic and Atmospheric Administration (NOAA) coral conservation program [NA11NOS482001]; David and Lucile Packard Foundation; Margaret A. Cargill Foundation; Kosrae Village Resort	National Oceanic and Atmospheric Administration (NOAA) coral conservation program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Margaret A. Cargill Foundation; Kosrae Village Resort	This study was funded by coral-reef monitoring and management grants administered to the Micronesian jurisdictions by the the National Oceanic and Atmospheric Administration (NOAA) coral conservation program (NA11NOS482001), the David and Lucile Packard Foundation monitoring for decision support grant, and the Margaret A. Cargill Foundation small grants program administered by the Micronesia Conservation Trust. Kosrae Village Resort provided support in the form of a salary for author KA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; Bak RPM, 1999, AM ZOOL, V39, P56; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bascompte J, 2005, ECOLOGY, V86, P2868, DOI 10.1890/05-0101; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bograd SJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020637; Brose U, 2008, P ROY SOC B-BIOL SCI, V275, P2507, DOI 10.1098/rspb.2008.0718; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Edwards HJ, 2011, GLOBAL CHANGE BIOL, V17, P2033, DOI 10.1111/j.1365-2486.2010.02366.x; Ekebom J, 2003, ESTUAR COAST SHELF S, V57, P887, DOI 10.1016/S0272-7714(02)00419-5; FOSTER KB, 1993, OCEAN COAST MANAGE, V20, P1, DOI 10.1016/0964-5691(93)90010-V; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houk P, 2012, CORAL REEFS, V31, P13, DOI 10.1007/s00338-011-0826-3; Houk P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105731; Houk P, 2013, MAR ECOL PROG SER, V488, P23, DOI 10.3354/meps10410; Houk P, 2013, BIOSCIENCE, V63, P297, DOI 10.1525/bio.2013.63.4.10; Houk P, 2010, J OCEANOGR, V66, P435, DOI 10.1007/s10872-010-0038-4; Houk P, 2010, MAR ECOL-EVOL PERSP, V31, P318, DOI 10.1111/j.1439-0485.2009.00301.x; Houk P, 2007, J OCEANOGR, V63, P149, DOI 10.1007/s10872-007-0013-x; Johannes R.E., 1981, WORDS LAGOON FISHING; JOHANNES RE, 1978, ANNU REV ECOL SYST, V9, P349, DOI 10.1146/annurev.es.09.110178.002025; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; Meehl GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023680; Montambault J, CONSERV BIO IN PRESS; Otypkova Z, 2006, J VEG SCI, V17, P465, DOI 10.1111/j.1654-1103.2006.tb02467.x; Remengesau T, 2006, DECLARATION COMMITME; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Taylor BM, 2014, CORAL REEFS, V33, P869, DOI 10.1007/s00338-014-1187-5; Thibaut LM, 2012, ECOLOGY, V93, P891, DOI 10.1890/11-1753.1; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; United Nations Development Programme, 2013, EQ IN CAS STUD SER; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Veron J.E.N., 2000, CORALS WORLD, V1-3; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Wenger AS, 2015, ECOLOGY FISHES CORAL	55	39	39	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130823	10.1371/journal.pone.0130823	http://dx.doi.org/10.1371/journal.pone.0130823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087252	Green Published, gold, Green Accepted			2022-12-26	WOS:000356567500135
J	Qu, BG; Su, JL; Wang, ZD; Wang, YF; Han, XH; Wang, H; Liu, YX; Jia, YG; Pan, JD; Ren, GY				Qu, Baoge; Su, Jiliang; Wang, Zhongdong; Wang, Yafei; Han, Xinghai; Wang, Hui; Liu, Yuanxun; Jia, Yiguo; Pan, Jindun; Ren, Guangying			Effect of H-pylori Infection on Cytokine Profiles and Oxidative Balance in Subjects with Chronic Alcohol Ingestion	PLOS ONE			English	Article							CYTOTOXIN-ASSOCIATED GENE; GASTRIC-MUCOSA; SERUM-LEVELS; TNF-ALPHA; POLYMORPHISMS; ASSOCIATION; CONSUMPTION; STOMACH; STRESS; CELLS	Different amounts of ingested alcohol can have distinct effects on the human body. However, there is limited research on chronic alcohol consumption with Helicobacter pylori infection. We sought to investigate the relationship between the cytokine profile, oxidative balance and H. pylori infection in subjects with chronic alcohol consumption. A total of 142 subjects were divided into three groups: 59 subjects with chronic alcohol ingestion and H. pylori infection (group A); 53 subjects with chronic alcohol ingestion without H. pylori infection (group B); and 30 control subjects (group C). The serum levels of CagA, interleukin (IL)-10, E-selectin, TNF-alpha, malondialdehyde (MDA) and superoxide dismutase (SOD) activity were measured by enzyme-linked immunosorbent assay (ELISA). We found that the ages and serum H. pylori CagA levels among the three groups, as well as both the mean drinking age and the mean daily alcohol consumption between groups A and B, were matched and comparable. Comparing the BMIs among the three groups, the BMI differences were found to be statistically significant (F=3.921, P<0.05). Compared with group C, the BMIs in groups A and B were significantly higher (P<0.001 and P<0.01, respectively); however, the BMI differences between group A and group B were not statistically significant (P>0.05). Additionally, no differences in the serum CagA levels were found in comparisons among the groups (all P>0.05). The serum IL-10 and E-selectin levels in group A were significantly lower than those in group B (serum IL-10: P<0.05; E-selectin: P<0.05). The serum IL-10 in group A was significantly higher than that in group C (P<0.01); the serum E-selectin levels in group A did not significantly differ compared with those in group C (P>0.05). Furthermore, the serum IL-10 and E-selectin levels in group B were significantly higher than those in group C (serum IL-10: P<0.001; E-selectin: P<0.05); however, the serum TNF-alpha levels did not differ among groups (all P>0.05). Although the serum levels of MDA and SOD in groups A and B were slightly lower than those in group C, there were no significant differences among groups (all P>0.05). In conclusion, we believe that H. pylori infection might cause a significant inhibition of certain cytokine profiles in subjects with chronic alcohol ingestion. Moreover, chronically ingested alcohol may exert an adjusted inflammatory effect, but there was no association between H. pylori infection, chronic alcohol consumption and oxidative balance.	[Qu, Baoge; Su, Jiliang; Wang, Zhongdong; Wang, Yafei; Han, Xinghai; Wang, Hui; Liu, Yuanxun; Jia, Yiguo; Pan, Jindun; Ren, Guangying] Taishan Hosp, Dept Gastroenterol, Tai An 271000, Shandong, Peoples R China; [Wang, Hui; Liu, Yuanxun; Jia, Yiguo] Taishan Med Coll, Tai An 271000, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences	Qu, BG (corresponding author), Taishan Hosp, Dept Gastroenterol, Tai An 271000, Shandong, Peoples R China.	qubaoge@sina.com			Technology Bureau of Taian City [20123039]; Health Department of Shandong Province [2013BJYB26]	Technology Bureau of Taian City; Health Department of Shandong Province	This research was supported by a grant from the Technology Bureau of Taian City (Number 20123039) and the Health Department of Shandong Province (Number 2013BJYB26).	Abdollahi H, 2011, IRAN J ALLERGY ASTHM, V10, P267, DOI 010.04/ijaai.267271; Aksoy H, 2009, J CLIN LAB ANAL, V23, P219, DOI 10.1002/jcla.20330; Amedei A, 2006, J CLIN INVEST, V116, P1092, DOI 10.1172/JCI27177; Arikawa AY, 2015, NUTR RES, V35, P7, DOI 10.1016/j.nutres.2014.10.005; Arslan D, 2007, SAUDI MED J, V28, P1222; Asquith M, 2014, ALCOHOL CLIN EXP RES, V38, P980, DOI 10.1111/acer.12325; Bartuzi Z, 2000, Med Sci Monit, V6, P1128; Boonyanugomol W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077358; Calvino-Fernandez M, 2010, REV ESP ENFERM DIG, V102, P41, DOI 10.4321/s1130-01082010000100006; Chen WX, 2001, J GASTROEN HEPATOL, V16, P377, DOI 10.1046/j.1440-1746.2001.02459.x; Christine GA, 2003, FEMS IMMUNOL MED MIC, V36, P127, DOI 10.1016/S0928-8244(03)00021-X; Chrostek L, 2002, DIGESTION, V66, P14, DOI 10.1159/000064416; Con SA, 2009, WORLD J GASTROENTERO, V15, P211, DOI 10.3748/wjg.15.211; Giamarellos-Bourboulis EJ, 2003, PROSTAG LEUKOTR ESS, V68, P257, DOI 10.1016/S0952-3278(03)00003-6; Gil JH, 2014, J PEDIATR GASTR NUTR, V58, P245, DOI 10.1097/MPG.0000000000000194; Heberlein A, 2014, ALCOHOL, V48, P671, DOI 10.1016/j.alcohol.2014.08.003; Huang ZG, 2009, WORLD J GASTROENTERO, V15, P599, DOI 10.3748/wjg.15.599; Hussein NR, 2010, J INFECT DIS, V202, P261, DOI 10.1086/653587; Innocenti M, 2002, INFECT IMMUN, V70, P4581, DOI 10.1128/IAI.70.8.4581-4590.2002; Jalalzadeh Mojgan, 2012, J Nephropathol, V1, P170, DOI 10.5812/nephropathol.8115; Kaebisch R, 2014, J IMMUNOL, V192, P316, DOI 10.4049/jimmunol.1302476; Kalaz Esra Betul, 2012, Pathophysiology, V19, P49, DOI 10.1016/j.pathophys.2012.01.003; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kantor ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067833; Kim DJ, 2003, ALCOHOL, V31, P167, DOI 10.1016/j.alcohol.2003.09.003; Klupinska Grazyna, 2003, Medycyna Pracy, V54, P549; Liu YD, 2013, EUR REV MED PHARMACO, V17, P403; Mandrekar P, 2006, ALCOHOL CLIN EXP RES, V30, P135, DOI 10.1111/j.1530-0277.2006.00012.x; Mashimo M, 2006, HELICOBACTER, V11, P266, DOI 10.1111/j.1523-5378.2006.00410.x; Matsumoto M, 2001, ALCOHOL CLIN EXP RES, V25, p29S; Rasmi Y, 2012, HELICOBACTER, V17, P116, DOI 10.1111/j.1523-5378.2011.00923.x; Reshetnikov O V, 2010, Eksp Klin Gastroenterol, P52; Rezaeifar A, 2013, SCAND J INFECT DIS, V45, P584, DOI 10.3109/00365548.2013.794301; Sacanella E, 2003, ADDICT BIOL, V8, P371, DOI 10.1080/13556210310001656376; Saijo Y, 2007, WORLD J GASTROENTERO, V13, P4445; Samy N, 2009, DIS MARKERS, V26, P163, DOI [10.3233/DMA-2009-0627, 10.1155/2009/465203]; Smoot DT, 2000, CARCINOGENESIS, V21, P2091, DOI 10.1093/carcin/21.11.2091; Soundaravally R, 2013, J PEDIATR GASTR NUTR, V56, P519, DOI 10.1097/MPG.0b013e3182845a29; Svensson H, 2009, INFECT IMMUN, V77, P3109, DOI 10.1128/IAI.01460-08; Tamura M, 2014, J CLIN BIOCHEM NUTR, V55, P26, DOI 10.3164/jcbn.14-12; Tiwari Santosh K., 2010, Inflammopharmacology, V18, P59, DOI 10.1007/s10787-010-0031-y; Wang F, 2014, CANCER LETT, V345, P196, DOI 10.1016/j.canlet.2013.08.016	42	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129352	10.1371/journal.pone.0129352	http://dx.doi.org/10.1371/journal.pone.0129352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087062	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500043
J	Reiche, S; Dwai, Y; Bussmann, BM; Horn, S; Sieg, M; Jassoy, C				Reiche, Sven; Dwai, Yamen; Bussmann, Bianca M.; Horn, Susanne; Sieg, Michael; Jassoy, Christian			High Inter-Individual Diversity of Point Mutations, Insertions, and Deletions in Human Influenza Virus Nucleoprotein-Specific Memory B Cells	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODIES; SOMATIC HYPERMUTATION; INFECTED INDIVIDUALS; RATIONAL DESIGN; HIV-1; IMMUNOGLOBULIN; BROAD; POTENT; GENERATION	The diversity of virus-specific antibodies and of B cells among different individuals is unknown. Using single-cell cloning of antibody genes, we generated recombinant human monoclonal antibodies from influenza nucleoprotein-specific memory B cells in four adult humans with and without preceding influenza vaccination. We examined the diversity of the antibody repertoires and found that NP-specific B cells used numerous immunoglobulin genes. The heavy chains (HCs) originated from 26 and the kappa light chains (LCs) from 19 different germ line genes. Matching HC and LC chains gave rise to 43 genetically distinct antibodies that bound influenza NP. The median lengths of the CDR3 of the HC, kappa and lambda LC were 14, 9 and 11 amino acids, respectively. We identified changes at 13.6% of the amino acid positions in the V gene of the antibody heavy chain, at 8.4% in the kappa and at 10.6 % in the lambda V gene. We identified somatic insertions or deletions in 8.1% of the variable genes. We also found several small groups of clonal relatives that were highly diversified. Our findings demonstrate broadly diverse memory B cell repertoires for the influenza nucleoprotein. We found extensive variation within individuals with a high number of point mutations, insertions, and deletions, and extensive clonal diversification. Thus, structurally conserved proteins can elicit broadly diverse and highly mutated B-cell responses.	[Reiche, Sven; Dwai, Yamen; Bussmann, Bianca M.; Horn, Susanne; Sieg, Michael; Jassoy, Christian] Univ Leipzig, Fac Med, Inst Virol, D-04109 Leipzig, Germany; [Dwai, Yamen; Sieg, Michael] Tishreen Univ, Fac Nat Sci, Dept Biol, Latakia, Syria	Leipzig University	Jassoy, C (corresponding author), Univ Leipzig, Fac Med, Inst Virol, D-04109 Leipzig, Germany.	Christian.jassoy@medizin.uni-leipzig.de			Young Scientist Group grant from the European Social Funds; Ministry of Science and Culture, State of Saxony, Germany [080937611, 100140490]; Ministry of Higher Education, Arab Republic of Syria; Open Access Publishing program of the German Research Foundation (DFG); Universitat Leipzig	Young Scientist Group grant from the European Social Funds; Ministry of Science and Culture, State of Saxony, Germany; Ministry of Higher Education, Arab Republic of Syria; Open Access Publishing program of the German Research Foundation (DFG); Universitat Leipzig	The study was supported by a Young Scientist Group grant from the European Social Funds and the Ministry of Science and Culture, State of Saxony, Germany (Project No. 080937611 and 100140490) to CJ and a grant from the Ministry of Higher Education, Arab Republic of Syria, to YD. The authors acknowledge support from the Open Access Publishing program of the German Research Foundation (DFG) and the Universitat Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; [Anonymous], 2011, IMGT GEN FREQ DOC; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Bridges SL, 1998, MOL MED, V4, P525, DOI 10.1007/BF03401757; Briney BS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00042; Bussmann BM, 2010, VIROLOGY, V397, P7, DOI 10.1016/j.virol.2009.11.003; de Wildt RMT, 1999, J MOL BIOL, V294, P701, DOI 10.1006/jmbi.1999.3289; Di Niro R, 2010, J IMMUNOL, V185, P5377, DOI 10.4049/jimmunol.1001587; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Kepler TB, 2014, CELL HOST MICROBE, V16, P304, DOI 10.1016/j.chom.2014.08.006; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Kunz K, 2011, JAIDS-J ACQ IMM DEF, V57, pE56, DOI 10.1097/QAI.0b013e31821dd9d1; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moody MF, 2011, STRUCTURAL BIOLOGY USING ELECTRONS AND X-RAYS: AN INTRODUCTION FOR BIOLOGISTS, P1; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Ohlin M, 1998, MOL IMMUNOL, V35, P233, DOI 10.1016/S0161-5890(98)00030-3; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Parker CE, 1996, SEMIN VIROL, V7, P61, DOI 10.1006/smvy.1996.0008; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Reiche S, 2014, J CLIN VIROL, V59, P218, DOI 10.1016/j.jcv.2014.01.023; Reiche S, 2010, IMMUNOBIOLOGY, V215, P223, DOI 10.1016/j.imbio.2009.02.004; Sauerbrei A, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.5.20687; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	43	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128684	10.1371/journal.pone.0128684	http://dx.doi.org/10.1371/journal.pone.0128684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086076	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500020
J	Ruiz, S; Or, D; Schymanski, SJ				Ruiz, Siul; Or, Dani; Schymanski, Stanislaus J.			Soil Penetration by Earthworms and Plant Roots-Mechanical Energetics of Bioturbation of Compacted Soils	PLOS ONE			English	Article							SINGULAR PLASTIC FIELDS; STEADY PENETRATION; DYNAMICS; GROWTH; STRENGTH; CARBON; PRESSURES; EXPANSION; NITROGEN; BEHAVIOR	We quantify mechanical processes common to soil penetration by earthworms and growing plant roots, including the energetic requirements for soil plastic displacement. The basic mechanical model considers cavity expansion into a plastic wet soil involving wedging by root tips or earthworms via cone-like penetration followed by cavity expansion due to pressurized earthworm hydroskeleton or root radial growth. The mechanical stresses and resulting soil strains determine the mechanical energy required for bioturbation under different soil hydro-mechanical conditions for a realistic range of root/earthworm geometries. Modeling results suggest that higher soil water content and reduced clay content reduce the strain energy required for soil penetration. The critical earthworm or root pressure increases with increased diameter of root or earthworm, however, results are insensitive to the cone apex (shape of the tip). The invested mechanical energy per unit length increase with increasing earthworm and plant root diameters, whereas mechanical energy per unit of displaced soil volume decreases with larger diameters. The study provides a quantitative framework for estimating energy requirements for soil penetration work done by earthworms and plant roots, and delineates intrinsic and external mechanical limits for bioturbation processes. Estimated energy requirements for earthworm biopore networks are linked to consumption of soil organic matter and suggest that earthworm populations are likely to consume a significant fraction of ecosystem net primary production to sustain their subterranean activities.	[Ruiz, Siul; Or, Dani; Schymanski, Stanislaus J.] ETHZ, Dept Environm Syst Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ruiz, S (corresponding author), ETHZ, Dept Environm Syst Sci, Zurich, Switzerland.	siul.ruiz@usys.ethz.ch	Or, Dani/D-8768-2012; Schymanski, Stanislaus J/A-5303-2012; Schymanski, Stan/AAV-3862-2021	Or, Dani/0000-0002-3236-2933; Schymanski, Stanislaus J/0000-0002-0950-2942; Schymanski, Stan/0000-0002-0950-2942	Swiss National Science Foundation [406840_143061]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation grant number 406840_143061 (http://www.nrp68.ch/E/projects/farming/Pages/default.aspx).	ABDALLA AM, 1969, J AGR ENG RES, V14, P236, DOI 10.1016/0021-8634(69)90126-7; Alban DH, 1994, APPL SOIL ECOL, V1, P243, DOI 10.1016/0929-1393(94)90015-9; ATWELL BJ, 1993, ENVIRON EXP BOT, V33, P27, DOI 10.1016/0098-8472(93)90053-I; Beer C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029006; BENGOUGH AG, 1990, J SOIL SCI, V41, P341, DOI 10.1111/j.1365-2389.1990.tb00070.x; BISHOP RF, 1945, P PHYS SOC LOND, V57, P147, DOI 10.1088/0959-5309/57/3/301; Bottinelli N, 2014, SOIL TILLAGE RES; Bowles JE., 1988, FDN ANAL DESIGN; Brown GG, 2000, EUR J SOIL BIOL, V36, P177, DOI 10.1016/S1164-5563(00)01062-1; Capowiez Y, 2001, BIOL FERT SOILS, V33, P310, DOI 10.1007/s003740000327; Capowiez Y, 2009, SOIL BIOL BIOCHEM, V41, P711, DOI 10.1016/j.soilbio.2009.01.006; CARTER JP, 1986, GEOTECHNIQUE, V36, P349, DOI 10.1680/geot.1986.36.3.349; Chan KY, 2001, SOIL TILL RES, V57, P179, DOI 10.1016/S0167-1987(00)00173-2; Cokca E., 2004, GEOTECH GEOL ENG, V22, P285, DOI DOI 10.1023/B:GEGE.0000018349.40866.3e; COMSOL I, 2012, COMS REF MAN; COOPER GRANT S., 1963, SOIL SCI SOC AMER PROC, V27, P659; Cozzarelli F.A., 1997, ELASTIC INELASTIC ST; Crumsey JM, 2013, ECOLOGY, V94, P2827, DOI 10.1890/12-1555.1; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; DANIEL O, 1992, SOIL BIOL BIOCHEM, V24, P1425, DOI 10.1016/0038-0717(92)90128-K; DEXTER AR, 1986, PLANT SOIL, V95, P149, DOI 10.1007/BF02378860; DEXTER AR, 1987, PLANT SOIL, V98, P303, DOI 10.1007/BF02378351; Dorgan KM, 2007, J EXP BIOL, V210, P4198, DOI 10.1242/jeb.010371; Dorgan KM, 2011, J EXP BIOL, V214, P2202, DOI 10.1242/jeb.054700; Dumais J, 2012, ANNU REV FLUID MECH, V44, P453, DOI 10.1146/annurev-fluid-120710-101200; DURBAN D, 1992, J APPL MECH-T ASME, V59, P706, DOI 10.1115/1.2894032; EHLERS W, 1975, SOIL SCI, V119, P242, DOI 10.1097/00010694-197503000-00010; Elder DM, 1985, STRESS STRAIN STRENG; FRAGOSO C, 1992, SOIL BIOL BIOCHEM, V24, P1397, DOI 10.1016/0038-0717(92)90124-G; FREDLUND DG, 1978, CAN GEOTECH J, V15, P313, DOI 10.1139/t78-029; Gabet EJ, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001526; GERARD CJ, 1982, AGRON J, V74, P875, DOI 10.2134/agronj1982.00021962007400050025x; Ghezzehei TA, 2000, WATER RESOUR RES, V36, P367, DOI 10.1029/1999WR900316; Ghezzehei TA, 2001, SOIL SCI SOC AM J, V65, P624, DOI 10.2136/sssaj2001.653624x; Gray J, 1938, J EXP BIOL, V15, P518; GREACEN EL, 1972, NATURE-NEW BIOL, V235, P24, DOI 10.1038/newbio235024a0; GREACEN EL, 1980, AUST J SOIL RES, V18, P163, DOI 10.1071/SR9800163; HARISON JA, 1994, J GEOTECH ENG-ASCE, V120, P872; HETTIARATCHI DRP, 1990, PHILOS T R SOC B, V329, P343, DOI 10.1098/rstb.1990.0175; KEMPER WD, 1984, SOIL SCI SOC AM J, V48, P1001, DOI 10.2136/sssaj1984.03615995004800050009x; Keudel M, 1999, BIOL FERT SOILS, V29, P262, DOI 10.1007/s003740050551; Kroener E, 2014, WATER RESOUR RES, V50, P6479, DOI 10.1002/2013WR014756; KURUP PU, 1994, J GEOTECH ENG-ASCE, V120, P81, DOI 10.1061/(ASCE)0733-9410(1994)120:1(81); Lambers H., 2008, PLANT WATER RELATION; Lavelle P, 2007, THEOR ECOL SER, P77; MATERECHERA SA, 1992, PLANT SOIL, V144, P297, DOI 10.1007/BF00012888; MCKENZIE BM, 1988, BIOL FERT SOILS, V5, P328; MISRA RK, 1986, PLANT SOIL, V95, P315, DOI 10.1007/BF02374612; Murphy EAK, 2011, J EXP BIOL, V214, P1017, DOI 10.1242/jeb.051227; NADELHOFFER KJ, 1985, ECOLOGY, V66, P1377, DOI 10.2307/1939190; NEWELL GE, 1950, J EXP BIOL, V27, P110; Or D, 1999, WATER RESOUR RES, V35, P371, DOI 10.1029/1998WR900008; PRITCHARD J, 1994, NEW PHYTOL, V127, P3, DOI 10.1111/j.1469-8137.1994.tb04255.x; Quillin KJ, 2000, J EXP BIOL, V203, P2757; SCHOLEFIELD D, 1985, PLANT SOIL, V85, P153, DOI 10.1007/BF02139621; Speratti AB, 2008, APPL SOIL ECOL, V38, P27, DOI 10.1016/j.apsoil.2007.08.009; VandenBygaart AJ, 2000, SOIL SCI SOC AM J, V64, P982, DOI 10.2136/sssaj2000.643982x; Walker J, 2006, ACTA GEOTECH, V1, P43, DOI 10.1007/s11440-006-0005-9; Wang JJ, 2007, ENG GEOL, V94, P65, DOI 10.1016/j.enggeo.2007.06.005; WIERSUM L. K., 1957, Plant and Soil, V9, P75, DOI 10.1007/BF01343483; Yoshida S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006055; YU HS, 1993, J APPL MECH-T ASME, V60, P1061, DOI 10.1115/1.2900981	62	51	51	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128914	10.1371/journal.pone.0128914	http://dx.doi.org/10.1371/journal.pone.0128914			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087130	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000356567500030
J	Wang, XL; Guo, RC; Zhao, WJ				Wang, Xiaolu; Guo, Ruichen; Zhao, Wenjing			Distribution of Fos-Like Immunoreactivity, Catecholaminergic and Serotoninergic Neurons Activated by the Laryngeal Chemoreflex in the Medulla Oblongata of Rats	PLOS ONE			English	Article							INFANT-DEATH-SYNDROME; RESPIRATORY NEURONS; BRAIN-STEM; TYROSINE-HYDROXYLASE; NUCLEUS AMBIGUUS; C-FOS; VENTROLATERAL MEDULLA; CHEMICAL-STIMULATION; DECEREBRATE PIGLETS; PHRENIC MOTONEURONS	The laryngeal chemoreflex (LCR) induces apnea, glottis closure, bradycardia and hypertension in young and maturing mammals. We examined the distribution of medullary nuclei that are activated by the LCR and used immunofluorescent detection of Fos protein as a cellular marker for neuronal activation to establish that the medullary catecholaminergic and serotoninergic neurons participate in the modulation of the LCR. The LCR was elicited by the infusion of KCl-HCl solution into the laryngeal lumen of adult rats in the experimental group, whereas the control group received the same surgery but no infusion. In comparison, the number of regions of Fos-like immunoreactivity (FLI) that were activated by the LCR significantly increased in the nucleus of the solitary tract (NTS), the vestibular nuclear complex (VNC), the loose formation of the nucleus ambiguus (AmbL), the rostral ventral respiratory group (RVRG), the ventrolateral reticular complex (VLR), the pre-Botzinger complex (PrBot), the Botzinger complex (Bot), the spinal trigeminal nucleus (SP5), and the raphe obscurus nucleus (ROb) bilaterally from the medulla oblongata. Furthermore, 12.71% of neurons with FLI in the dorsolateral part of the nucleus of the solitary tract (SolDL) showed tyrosine hydroxylase-immunoreactivity (TH-ir, catecholaminergic), and 70.87% of neurons with FLI in the ROb were serotoninergic. Our data demonstrated the distribution of medullary nuclei that were activated by the LCR, and further demonstrated that catecholaminergic neurons of the SolDL and serotoninergic neurons of the ROb were activated by the LCR, indicating the potential central pathway of the LCR.	[Wang, Xiaolu; Guo, Ruichen; Zhao, Wenjing] Shandong Univ, Qilu Hosp, Inst Clin Pharmacol, Jinan 250100, Peoples R China; [Wang, Xiaolu; Zhao, Wenjing] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China	Shandong University; Shandong University	Guo, RC (corresponding author), Shandong Univ, Qilu Hosp, Inst Clin Pharmacol, Jinan 250100, Peoples R China.	grc7636@126.com; 15953110550@163.com			National Natural Science Foundation of China [81202575]; China Postdoctoral Science Foundation Grant [2013M541929]; Basic Scientific Research Expenses Foundation Project of Shandong University [2014QLKY25]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Grant(China Postdoctoral Science Foundation); Basic Scientific Research Expenses Foundation Project of Shandong University	This work was supported by the National Natural Science Foundation of China (81202575, http://www.nsfc.gov.cn/), the China Postdoctoral Science Foundation Grant (2013M541929, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx) and the Basic Scientific Research Expenses Foundation Project of Shandong University (2014QLKY25, http://www.rd.sdu.edu.cn/newsDetail?sno = news1415342008065). All grants were received by WJZ, and WJZ took charge of the study design, data processing, paper drafting and editing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SM, 2001, AM J MED, V111, P90, DOI 10.1016/S0002-9343(01)00862-2; Ambalavanar R, 2004, J NEUROPHYSIOL, V92, P2920, DOI 10.1152/jn.00064.2004; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; ARITA H, 1995, NEUROSCI LETT, V197, P113, DOI 10.1016/0304-3940(95)11907-E; Baekey DM, 2001, J PHYSIOL-LONDON, V534, P565, DOI 10.1111/j.1469-7793.2001.t01-1-00565.x; Berkowitz RG, 2005, LARYNGOSCOPE, V115, P105, DOI 10.1097/01.mlg.0000150695.15883.a4; BIEGER D, 1987, J COMP NEUROL, V262, P546, DOI 10.1002/cne.902620408; BOGGS DF, 1982, J APPL PHYSIOL, V53, P455, DOI 10.1152/jappl.1982.53.2.455; CECCATELLI S, 1989, P NATL ACAD SCI USA, V86, P9569, DOI 10.1073/pnas.86.23.9569; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Dahlstroem A., 1964, ACTA PHYSL SCAND S, V232, P231; Dragomir A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-17; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; EZURE K, 1990, PROG NEUROBIOL, V35, P429, DOI 10.1016/0301-0082(90)90030-K; Gestreau C, 1997, J NEUROSCI, V17, P9340; Goding GS, 1998, LARYNGOSCOPE, V108, P863, DOI 10.1097/00005537-199806000-00015; HANAMORI T, 1986, BRAIN RES BULL, V16, P271, DOI 10.1016/0361-9230(86)90042-0; HARDING R, 1978, J PHYSIOL-LONDON, V277, P409, DOI 10.1113/jphysiol.1978.sp012281; Hayakawa T, 2000, ANAT EMBRYOL, V202, P411, DOI 10.1007/s004290000120; Heman Ackah YD, 2009, LARYNGOSCOPE, V119, P370, DOI [10.1002/lary.20007, DOI 10.1002/LARY.20007]; HOLSTEGE G, 1989, EXP BRAIN RES, V75, P265; Holstein GR, 2014, J COMP NEUROL, V522, P2053, DOI 10.1002/cne.23517; HOLTMAN JR, 1987, BRAIN RES, V417, P12, DOI 10.1016/0006-8993(87)90174-0; JIANG C, 1992, BRAIN RES, V584, P197, DOI 10.1016/0006-8993(92)90895-G; Jurgens U, 2007, BRAIN RES, V1148, P90, DOI 10.1016/j.brainres.2007.02.020; KALIA M, 1985, J COMP NEUROL, V233, P308, DOI 10.1002/cne.902330303; Kinney HC, 2005, PEDIATR DEVEL PATHOL, V8, P258, DOI 10.1007/s10024-005-3176-8; Klintschar M, 2008, J PEDIATR-US, V153, P190, DOI 10.1016/j.jpeds.2008.02.032; Kubin L, 1998, NEWS PHYSIOL SCI, V13, P91; Leiter JC, 2007, RESP PHYSIOL NEUROBI, V159, P127, DOI 10.1016/j.resp.2007.05.014; LOBERA B, 1981, NEUROSCI LETT, V23, P125, DOI 10.1016/0304-3940(81)90028-8; LUCIER GE, 1986, BRAIN RES BULL, V16, P713, DOI 10.1016/0361-9230(86)90143-7; MEGIRIAN D, 1968, ARCH ITAL BIOL, V106, P333; MELLER SM, 1984, OTOLARYNG CLIN N AM, V17, P3; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NOMURA S, 1983, ANAT EMBRYOL, V166, P1, DOI 10.1007/BF00317941; Ono K, 2006, NEUROSCIENCE, V140, P1079, DOI 10.1016/j.neuroscience.2006.02.063; PANNETON WM, 1991, J COMP NEUROL, V308, P51, DOI 10.1002/cne.903080106; Pascual Font A, 2011, J ANAT, V219, P217, DOI [10.1111/j.1469-7580.2011.01390.x, DOI 10.1111/J.1469-7580.2011.01390.X]; Pascual Font A, 2006, ACTA OTORRINOLARINGO, V57, P253; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Peden EM, 1999, BRAIN RES BULL, V48, P629, DOI 10.1016/S0361-9230(99)00050-7; PILOWSKY PM, 1990, J COMP NEUROL, V301, P604, DOI 10.1002/cne.903010409; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Sang Q, 2001, AM J PHYSIOL-GASTR L, V280, pG191, DOI 10.1152/ajpgi.2001.280.2.G191; Shiba K, 2007, J NEUROSCI, V27, P5156, DOI 10.1523/JNEUROSCI.0001-07.2007; Siniaia MS, 1996, BRAIN RES, V736, P160, DOI 10.1016/0006-8993(96)00674-9; Studer J, 2014, J FORENSIC SCI, V59, P1650, DOI 10.1111/1556-4029.12526; SUN QJ, 1994, J COMP NEUROL, V340, P1, DOI 10.1002/cne.903400102; SWEAZEY RD, 1986, J COMP NEUROL, V245, P471, DOI 10.1002/cne.902450404; TAKAGI S, 1995, BRAIN RES BULL, V38, P261, DOI 10.1016/0361-9230(95)00098-Y; TANAKA Y, 1995, J LARYNGOL OTOL, V109, P39, DOI 10.1017/S0022215100129196; Thach BT, 2008, J APPL PHYSIOL, V104, P1828, DOI 10.1152/japplphysiol.01288.2007; Thach BT, 2001, AM J MED, V111, P69, DOI 10.1016/S0002-9343(01)00860-9; Van Daele DJ, 2009, NEUROSCIENCE, V162, P501, DOI 10.1016/j.neuroscience.2009.05.005; van der Velde L, 2003, J APPL PHYSIOL, V94, P1883, DOI 10.1152/japplphysiol.01103.2002; Verner TA, 2004, AM J PHYSIOL-REG I, V287, pR411, DOI 10.1152/ajpregu.00019.2004; Verner TA, 2008, BRAIN RES, V1208, P128, DOI 10.1016/j.brainres.2008.02.028; Xia L, 2007, J APPL PHYSIOL, V102, P54, DOI 10.1152/japplphysiol.00720.2006; Xia L, 2010, RESP PHYSIOL NEUROBI, V171, P17, DOI 10.1016/j.resp.2010.01.011; Xia LX, 2008, J APPL PHYSIOL, V104, P269, DOI 10.1152/japplphysiol.00721.2007; Xia LX, 2008, RESP PHYSIOL NEUROBI, V164, P358, DOI 10.1016/j.resp.2008.08.002; Yates BJ, 2014, COMPR PHYSIOL, V4, P851, DOI 10.1002/cphy.c130041; Zhao WJ, 2015, J COMP NEUROL, V523, P381, DOI 10.1002/cne.23677; Zhao WJ, 2011, RESP PHYSIOL NEUROBI, V178, P337, DOI 10.1016/j.resp.2011.06.002; Zoccal DB, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00238	66	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130822	10.1371/journal.pone.0130822	http://dx.doi.org/10.1371/journal.pone.0130822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087133	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500134
J	Russell, AL; Pinzari, CA; Vonhof, MJ; Olival, KJ; Bonaccorso, FJ				Russell, Amy L.; Pinzari, Corinna A.; Vonhof, Maarten J.; Olival, Kevin J.; Bonaccorso, Frank J.			Two Tickets to Paradise: Multiple Dispersal Events in the Founding of Hoary Bat Populations in Hawai'i	PLOS ONE			English	Article							DNA-SEQUENCE DATA; LASIURUS-CINEREUS; MOLECULAR PHYLOGENY; MITOCHONDRIAL; DIVERSIFICATION; LASIONYCTERIS; BIOGEOGRAPHY; CHIROPTERA; BIOTA	The Hawaiian islands are an extremely isolated oceanic archipelago, and their fauna has long served as models of dispersal in island biogeography. While molecular data have recently been applied to investigate the timing and origin of dispersal events for several animal groups including birds, insects, and snails, these questions have been largely unaddressed in Hawai'i's only native terrestrial mammal, the Hawaiian hoary bat, Lasiurus cinereus semotus. Here, we use molecular data to test the hypotheses that (1) Hawaiian L. c. semotus originated via dispersal from North American populations of L. c. cinereus rather than from South American L. c. villosissimus, and (2) modern Hawaiian populations were founded from a single dispersal event. Contrary to the latter hypothesis, our mitochondrial data support a biogeographic history of multiple, relatively recent dispersals of hoary bats from North America to the Hawaiian islands. Coalescent demographic analyses of multilocus data suggest that modern populations of Hawaiian hoary bats were founded no more than 10 kya. Our finding of multiple evolutionarily significant units in Hawai'i highlights information that should be useful for re-evaluation of the conservation status of hoary bats in Hawai'i.	[Russell, Amy L.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Pinzari, Corinna A.] Univ Hawaii Hilo, Hawaii Cooperat Studies Unit, Hawaii Natl Pk, HI USA; [Vonhof, Maarten J.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Vonhof, Maarten J.] Western Michigan Univ, Environm & Sustainabil Studies Program, Kalamazoo, MI 49008 USA; [Olival, Kevin J.] EcoHlth Alliance, New York, NY USA; [Bonaccorso, Frank J.] US Geol Survey, Hawaii Natl Pk, HI USA	Grand Valley State University; University of Hawaii System; University Hawaii Hilo; Western Michigan University; Western Michigan University; EcoHealth Alliance; United States Department of the Interior; United States Geological Survey	Russell, AL (corresponding author), Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA.	russelam@gvsu.edu	Russell, Amy L/B-2222-2010	Olival, Kevin/0000-0003-3211-1875	Pacific Island Ecosystems Research Center, U.S. Geological Survey [G12AC20117]	Pacific Island Ecosystems Research Center, U.S. Geological Survey	This research was supported financially by the Pacific Island Ecosystems Research Center, U.S. Geological Survey (#G12AC20117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R.J., 1988, Occasional Papers Museum of Texas Tech University, P1; Bonaccorso Frank J., 2013, P187; Burney DA, 2001, ECOL MONOGR, V71, P615, DOI 10.1890/0012-9615(2001)071[0615:FEFADB]2.0.CO;2; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cowie RH, 2008, PHILOS T R SOC B, V363, P3363, DOI 10.1098/rstb.2008.0061; Crandall KA, 1999, ANIM CONSERV, V2, P317, DOI 10.1111/j.1469-1795.1999.tb00078.x; Croucher PJP, 2012, EVOLUTION, V66, P2815, DOI 10.1111/j.1558-5646.2012.01653.x; Cryan PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047586; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Findley J. S., 1964, Journal of Mammalogy, V45, P461, DOI 10.2307/1377421; FINDLEY JS, 1972, J MAMMAL, V53, P429, DOI 10.2307/1379035; Fleischer RC, 2001, STUD AVIAN BIOL-SER, P51; Haines WP, 2014, NATURE COMMUNICATION, V5, pe3502; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hay man R. W., 1959, Journal of Mammalogy, V40, P245, DOI 10.2307/1376445; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HILL JE, 1990, J ZOOL, V222, P694, DOI 10.1111/j.1469-7998.1990.tb06026.x; Holland BS, 2009, AM MALACOL BULL, V27, P59, DOI 10.4003/006.027.0205; Holland BS, 2004, MOL PHYLOGENET EVOL, V32, P588, DOI 10.1016/j.ympev.2004.01.003; Jacobs DS, 1996, FUNCT ECOL, V10, P622, DOI 10.2307/2390172; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; MORALES JC, 1995, J MAMMAL, V76, P730, DOI 10.2307/1382744; Nadin-Davis SA, 2012, OPEN J ZOOLOGY S1M5, V5, P27, DOI DOI 10.2174/1874336601205010027; Olival KJ, 2008, POPULATION GENETIC S; Posada D, 2011, COLLAPSE DESCRIBING; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price JP, 2002, P ROY SOC B-BIOL SCI, V269, P2429, DOI 10.1098/rspb.2002.2175; Reimer JP, 2010, AM MIDL NAT, V164, P230, DOI 10.1674/0003-0031-164.2.230; Shapiro LH, 2006, MOL PHYLOGENET EVOL, V41, P53, DOI 10.1016/j.ympev.2006.04.006; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shump K.A. Jr, 1982, Mammalian Species, P1; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TEMPLETON AR, 1992, GENETICS, V132, P619; Tomich PQ, 1986, MAMMALS IN HAWAII; U.S. Fish and Wildlife Service, 1970, FED REGISTER, P16047; U.S. Fish and Wildlife Service, 2011, OP HAW HOA BAT LAS C, P13; U.S. Fish and Wildlife Service, 1998, REC PLAN UPL SPEC SA, P1; Venta PJ, 1996, BIOCHEM GENET, V34, P321, DOI 10.1007/BF02399951; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Ziegler AC, 2002, HAWAIIAN NATURAL HIS; Zimpfer J, 2010, HAW CONS C HON	55	5	5	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127912	10.1371/journal.pone.0127912	http://dx.doi.org/10.1371/journal.pone.0127912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083029	Green Published, gold			2022-12-26	WOS:000356567400021
J	Svobodova, Z; Habustova, OS; Hutchison, WD; Hussein, HM; Sehnal, F				Svobodova, Zdenka; Habustova, Oxana Skokova; Hutchison, William D.; Hussein, Hany M.; Sehnal, Frantisek			Risk Assessment of Genetically Engineered Maize Resistant to Diabrotica spp.: Influence on Above-Ground Arthropods in the Czech Republic	PLOS ONE			English	Article							CHRYSOMELIDAE)-PROTECTED BT CORN; COLEOMEGILLA-MACULATA COLEOPTERA; CRY3BB1 PROTEIN; ROOTWORM (COLEOPTERA; NONTARGET ORGANISMS; FIELD-EVALUATION; IMPACT; COCCINELLIDAE; ABUNDANCE; POLLEN	Transgenic maize MON88017, expressing the Cry3Bb1 toxin from Bacillus thuringiensis (Bt maize), confers resistance to corn rootworms (Diabrotica spp.) and provides tolerance to the herbicide glyphosate. However, prior to commercialization, substantial assessment of potential effects on non-target organisms within agroecosystems is required. The MON88017 event was therefore evaluated under field conditions in Southern Bohemia in 2009-2011, to detect possible impacts on the above-ground arthropod species. The study compared MON88017, its near-isogenic non-Bt hybrid DK315 (treated or not treated with the soil insecticide Dursban 10G) and two non-Bt reference hybrids (KIPOUS and PR38N86). Each hybrid was grown on five 0.5 ha plots distributed in a 14-ha field with a Latin square design. Semiquantitative ELISA was used to verify Cry3Bb1 toxin levels in the Bt maize. The species spectrum of non-target invertebrates changed during seasons and was affected by weather conditions. The thrips Frankliniella occidentalis was the most abundant species in all three successive years. The next most common species were aphids Rhopalosiphum padi and Metopolophium dirhodum. Frequently observed predators included Orius spp. and several species within the Coccinellidae. Throughout the three-year study, analysis of variance indicated some significant differences (P<0.05). Multivariate analysis showed that the abundance and diversity of plant dwelling insects was similar in maize with the same genetic background, for both Bt (MON88017) and non-Bt (DK315) untreated or insecticide treated. KIPOUS and PR38N86 showed some differences in species abundance relative to the Bt maize and its near-isogenic hybrid. However, the effect of management regime on arthropod community was insignificant and accounted only for a negligible portion of the variability.	[Svobodova, Zdenka; Sehnal, Frantisek] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Svobodova, Zdenka; Habustova, Oxana Skokova; Hussein, Hany M.; Sehnal, Frantisek] CAS, Inst Entomol, Ctr Biol, Ceske Budejovice, Czech Republic; [Hutchison, William D.] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Minnesota System; University of Minnesota Twin Cities	Svobodova, Z (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	svobodova@entu.cas.cz	Svobodová, Zdeňka/L-2361-2015; Habustova, Oxana Skokova/H-1412-2014	Svobodová, Zdeňka/0000-0002-5732-9806; Skokova Habustova, Oxana/0000-0002-7628-317X; Hutchison, William D./0000-0001-9605-2996; Hussein, Hany/0000-0002-4618-0874	National Agency for Agricultural Research [QH91093]; University of South Bohemia [GAJU 038/2014/P]	National Agency for Agricultural Research; University of South Bohemia	Funding: Funding was provided by National Agency for Agricultural Research (http://www.nazv.cz/cz/), grant QH91093. The field rent and the land management were contracted to the Agricultural Company Dubne a.s. and paid from the QH91093 grant. The maize seeds were provided free by the Monsanto CR s.r.o. Research was promoted with institutional support RVO: 60077344 from Institute of Entomology, Biology Centre of the Czech Academy of Sciences (http://www.entu.cas.cz/en/). The PhD student Z. Svobodova was partially supported by grant GAJU 038/2014/P from the University of South Bohemia (http://www.jcu.cz/research/gaju). None of the funders had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2006, J ECON ENTOMOL, V99, P1085, DOI 10.1603/0022-0493-99.4.1085; Al-Deeb MA, 2003, ENVIRON ENTOMOL, V32, P1164, DOI 10.1603/0046-225X-32.5.1164; Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; [Anonymous], EU REG AUTH GMOS; Bhatti MA, 2005, ENVIRON ENTOMOL, V34, P1325, DOI 10.1603/0046-225X(2005)034[1325:FEOTIO]2.0.CO;2; Bhatti MA, 2005, ENVIRON ENTOMOL, V34, P1336, DOI 10.1603/0046-225X(2005)034[1336:FEOTIO]2.0.CO;2; Brookes Graham, 2012, GM Crops Food, V3, P265, DOI 10.4161/gmcr.20097; Bugg R.L., 2008, FLOWER FLIES SYRPHID; Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284; Clark TL, 2012, J APPL ENTOMOL, V136, P721, DOI 10.1111/j.1439-0418.2012.01709.x; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; de la Poza M, 2005, CROP PROT, V24, P677, DOI 10.1016/j.cropro.2004.12.003; Duan JJ, 2008, ENVIRON ENTOMOL, V37, P838, DOI 10.1603/0046-225X(2008)37[838:ATRTNO]2.0.CO;2; Duan JJ, 2006, ENVIRON ENTOMOL, V35, P135, DOI 10.1603/0046-225X-35.1.135; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Edwards C. R., 2012, DIABROTICA VIRGIFERA; Franz TM, 2013, THESIS U MINNESOTA; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Habustova O, 2014, J APPL ENTOMOL, V138, P164, DOI 10.1111/jen.12004; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jasinski JR, 2003, ENVIRON ENTOMOL, V32, P407, DOI 10.1603/0046-225X-32.2.407; Koubova D, 2006, BAZLIVEC KUKURICNY N; Kroutil P., 2011, RES D V VIRGIFERA MO; Kuhlmann Ulrich, 1998, Biocontrol News and Information, V19, p59N; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Leps J, 2003, MULTIVARIATE ANAL EC; Li Y, 2008, 2008 PROCEEDINGS OF INFORMATION TECHNOLOGY AND ENVIRONMENTAL SYSTEM SCIENCES: ITESS 2008, VOL 4, P1; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; Lumbierres B, 2012, BIOL CONTROL, V63, P150, DOI 10.1016/j.biocontrol.2012.07.009; Lumbierres B, 2011, BIOCONTROL, V56, P133, DOI 10.1007/s10526-010-9317-7; Lundgren JG, 2005, ENVIRON ENTOMOL, V34, P1621, DOI 10.1603/0046-225X-34.6.1621; Lundgren JG, 2002, ENVIRON ENTOMOL, V31, P1213, DOI 10.1603/0046-225X-31.6.1213; Marchetti E, 2012, B INSECTOL, V65, P133; Marris C, 2001, EMBO REP, V2, P545, DOI 10.1093/embo-reports/kve142; Marshall A., 2014, Nature Biotechnology, V32, P308, DOI 10.1038/nbt.2875; McManus BL, 2005, J ECON ENTOMOL, V98, P1992, DOI 10.1603/0022-0493-98.6.1992; Meissle M, 2005, AGR ECOSYST ENVIRON, V107, P359, DOI 10.1016/j.agee.2004.12.007; Meissle M, 2012, EFSA SUPP PUBL, VEN-334; Meissle M, 2011, PEST MANAG SCI, V67, P1049, DOI 10.1002/ps.2221; Meissle M, 2009, PLANT BIOTECHNOL J, V7, P645, DOI 10.1111/j.1467-7652.2009.00431.x; Meissle M, 2009, ENTOMOL EXP APPL, V131, P308, DOI 10.1111/j.1570-7458.2009.00859.x; Naranjo S. E., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094011; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1211, DOI 10.1603/0046-225X(2005)034[1211:LAOTEO]2.0.CO;2; Nguyen HT, 2009, J AGR FOOD CHEM, V57, P9990, DOI 10.1021/jf901115m; Obrycki JJ, 1998, ANNU REV ENTOMOL, V43, P295, DOI 10.1146/annurev.ento.43.1.295; Prihoda KR, 2008, CHEMOSPHERE, V73, P1102, DOI 10.1016/j.chemosphere.2008.07.025; Rauschen S, 2009, TRANSGENIC RES, V18, P203, DOI 10.1007/s11248-008-9207-2; Romeis J, 2011, J APPL ENTOMOL, V135, P1, DOI 10.1111/j.1439-0418.2010.01546.x; Romeis J, 2013, TRENDS BIOTECHNOL, V31, P222, DOI 10.1016/j.tibtech.2013.01.020; Sanvido O, 2009, J APPL ENTOMOL, V133, P236, DOI 10.1111/j.1439-0418.2008.01367.x; Schuler TH, 2003, TRANSGENIC RES, V12, P351, DOI 10.1023/A:1023342027192; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Shirai Y, 2006, APPL ENTOMOL ZOOL, V41, P607, DOI 10.1303/aez.2006.607; Steinbrecher I., 2004, THESIS U GOTTINGEN; Svobodova Z, 2013, J APPL ENTOMOL, V137, P56, DOI 10.1111/j.1439-0418.2012.01727.x; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118	58	8	8	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130656	10.1371/journal.pone.0130656	http://dx.doi.org/10.1371/journal.pone.0130656			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083254	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400152
J	Vandenhende, MA; Roussillon, C; Henard, S; Morlat, P; Oksenhendler, E; Aumaitre, H; Georget, A; May, T; Rosenthal, E; Salmon, D; Cacoub, P; Costagliola, D; Chene, G; Bonnet, F				Vandenhende, Marie-Anne; Roussillon, Caroline; Henard, Sandrine; Morlat, Philippe; Oksenhendler, Eric; Aumaitre, Hugues; Georget, Aurore; May, Thierry; Rosenthal, Eric; Salmon, Dominique; Cacoub, Patrice; Costagliola, Dominique; Chene, Genevieve; Bonnet, Fabrice		ANRS EN20 Mortalite 2010 Study Grp	Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; LUNG-CANCER; UNITED-STATES; DEFINING MALIGNANCIES; IMMUNODEFICIENCY; COHORT; MORTALITY; AIDS; SMOKING; ERA	Objectives The current study aimed at describing the distribution and characteristics of malignancy related deaths in human immunodeficiency virus (HIV) infected patients in 2010 and at comparing them to those obtained in 2000 and 2005. Methods Data were obtained from three national surveys conducted in France in 2010, 2005 and 2000. The underlying cause of death was documented using a standardized questionnaire fulfilled in French hospital wards involved in the management of HIV infection. Results Among the 728 deaths reported in 2010, 262 were cancer-related (36%). After a significant increase from 28% in 2000 to 33% in 2005 and 36% in 2010, cancers represent the leading cause of mortality in HIV infected patients. The proportion of deaths attributed to non-AIDS/non-hepatitis-related cancers significantly increased from 2000 to 2010 (11% of the deaths in 2000, 17% in 2005 and 22% in 2010, p<0.001), while those attributed to AIDS-defining cancers decreased during the same period (16% in 2000, 13% in 2005 and 9% in 2010, p = 0.024). Particularly, the proportion of respiratory cancers significantly increased from 5% in 2000 to 6% in 2005 and 11% in 2010 (p = 0.004). Lung cancer was the most common cancer-related cause of death in 2010 (instead of non-Hodgkin lymphoma so far) and represented the leading cause of death in people living with HIV overall. Conclusions Cancer prevention (especially smoking cessation), screening strategies and therapeutic management need to be optimized in HIV-infected patients in order to reduce mortality, particularly in the field of respiratory cancers.	[Vandenhende, Marie-Anne; Roussillon, Caroline; Morlat, Philippe; Georget, Aurore; Chene, Genevieve; Bonnet, Fabrice] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Vandenhende, Marie-Anne; Roussillon, Caroline; Morlat, Philippe; Georget, Aurore; Chene, Genevieve; Bonnet, Fabrice] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Vandenhende, Marie-Anne; Morlat, Philippe; Bonnet, Fabrice] CHU Bordeaux, Serv Med Interne & Malad Infect, Bordeaux, France; [Henard, Sandrine; May, Thierry] Hop Brabois, Serv Malad Infect, Vandoeuvre Les Nancy, France; [Oksenhendler, Eric] Hop St Louis, AP HP, Serv Immunopathol Clin, Paris, France; [Aumaitre, Hugues] Ctr Hosp, Serv Malad Infect, Perpignan, France; [Rosenthal, Eric] Hop Archet, Serv Med Interne, Nice, France; [Rosenthal, Eric] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Salmon, Dominique] Hop Cochin, AP HP, Unite Pathol Infect, Pole Med, F-75674 Paris, France; [Salmon, Dominique] Univ Paris 05, Paris, France; [Cacoub, Patrice] Hop La Pitie Salpetriere, AP HP, Serv Med Interne, Paris, France; [Cacoub, Patrice] Univ Paris 06, Paris, France; [Costagliola, Dominique] INSERM, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [Costagliola, Dominique] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Vandenhende, MA (corresponding author), INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.	vdh.mav@gmail.com	chene, genevieve/H-8665-2014; Bonnet, Fabrice/T-3254-2019; Costagliola, Dominique/H-5849-2011; Vandenhende, Marie-Anne/T-6625-2019	chene, genevieve/0000-0002-8368-6460; Costagliola, Dominique/0000-0003-0765-0869; Cacoub, Patrice/0000-0002-6727-4992	Agence Nationale de Recherche sur le Sida et les hepatites virales (ANRS)/French National Agency for Research on AIDS and Viral Hepatitis	Agence Nationale de Recherche sur le Sida et les hepatites virales (ANRS)/French National Agency for Research on AIDS and Viral Hepatitis	This study was supported by the Agence Nationale de Recherche sur le Sida et les hepatites virales (ANRS)/French National Agency for Research on AIDS and Viral Hepatitis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach CJ, 2011, AIDS, V25, P691, DOI 10.1097/QAD.0b013e3283437f77; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Bonnet F, 2009, CLIN INFECT DIS, V48, P633, DOI 10.1086/596766; Brock MV, 2006, JAIDS-J ACQ IMM DEF, V43, P47, DOI 10.1097/01.qai.0000232260.95288.93; Bruyand M, 2009, CLIN INFECT DIS, V49, P1109, DOI 10.1086/605594; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Chiao EY, 2010, JAMA-J AM MED ASSOC, V304, P334, DOI 10.1001/jama.2010.752; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Deeken JF, 2012, CLIN INFECT DIS, V55, P1228, DOI 10.1093/cid/cis613; Detterbeck FC, 2013, CHEST, V143, pE78, DOI 10.1378/chest.12-2350; Encrenaz G, 2010, CURR HIV RES, V8, P212, DOI 10.2174/157016210791111089; Engels EA, 2006, J CLIN ONCOL, V24, P1383, DOI 10.1200/JCO.2005.03.4413; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Hentrich M, 2012, J CLIN ONCOL, V30, P4117, DOI 10.1200/JCO.2012.41.8137; Hoen B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19034; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Montoto S, 2012, J CLIN ONCOL, V30, P4111, DOI 10.1200/JCO.2011.41.4193; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Polesel J, 2008, AIDS, V22, P301, DOI 10.1097/QAD.0b013e3282f2705d; Reekie J, 2010, CANCER-AM CANCER SOC, V116, P5306, DOI 10.1002/cncr.25311; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shiels MS, 2010, ANN INTERN MED, V153, P452, DOI 10.7326/0003-4819-153-7-201010050-00008; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Winston TA, 2013, CHEST, V143, P305, DOI 10.1378/chest.12-1699; Worm SW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-471	38	67	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129550	10.1371/journal.pone.0129550	http://dx.doi.org/10.1371/journal.pone.0129550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083524	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400098
J	Wang, HH; Zhang, L; Cao, JX; Wu, MM; Ma, XM; Liu, Z; Liu, RZ; Zhao, FP; Wei, CH; Du, LX				Wang, Huihua; Zhang, Li; Cao, Jiaxve; Wu, Mingming; Ma, Xiaomeng; Liu, Zhen; Liu, Ruizao; Zhao, Fuping; Wei, Caihong; Du, Lixin			Genome-Wide Specific Selection in Three Domestic Sheep Breeds	PLOS ONE			English	Article							CANDIDATE GENES; FTO GENE; PRODUCTION TRAITS; SKELETAL-MUSCLE; MEAT QUALITY; FAT-MASS; ASSOCIATION; MUTATIONS; PROTEIN; GROWTH	Background Commercial sheep raised for mutton grow faster than traditional Chinese sheep breeds. Here, we aimed to evaluate genetic selection among three different types of sheep breed: two well-known commercial mutton breeds and one indigenous Chinese breed. Results We first combined locus-specific branch lengths and d(i) statistical methods to detect candidate regions targeted by selection in the three different populations. The results showed that the genetic distances reached at least medium divergence for each pairwise combination. We found these two methods were highly correlated, and identified many growth-related candidate genes undergoing artificial selection. For production traits, APOBR and FTO are associated with body mass index. For meat traits, ALDOA, STK32B and FAM190A are related to marbling. For reproduction traits, CCNB2 and SLC8A3 affect oocyte development. We also found two well-known genes, GHR (which affects meat production and quality) and EDAR (associated with hair thickness) were associated with German mutton merino sheep. Furthermore, four genes (POL, RPL7, MSL1 and SHISA9) were associated with preweaning gain in our previous genome-wide association study. Conclusions Our results indicated that combine locus-specific branch lengths and d(i) statistical approaches can reduce the searching ranges for specific selection. And we got many credible candidate genes which not only confirm the results of previous reports, but also provide a suite of novel candidate genes in defined breeds to guide hybridization breeding.	[Wang, Huihua; Zhang, Li; Cao, Jiaxve; Wu, Mingming; Ma, Xiaomeng; Liu, Zhen; Liu, Ruizao; Zhao, Fuping; Wei, Caihong; Du, Lixin] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Wei, CH (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	weicaihong@caas.cn; lxdu@263.net	wu, mingming/GXN-1864-2022		National Key Technology R&D Program of China [2011BAD28B05-2]; Chinese Academy of Agricultural Sciences [2014ywf-yb-7]	National Key Technology R&D Program of China(National Key Technology R&D Program); Chinese Academy of Agricultural Sciences	This research was supported by the National Key Technology R&D Program of China (2011BAD28B05-2) (http://www.most.gov.cn/eng/index.htm). LZ received funding from the Chinese Academy of Agricultural Sciences (2014ywf-yb-7) (http://en.gscaas.net.cn/). The funder had collected and analyzed data, and decided to publish.	Adams HA, 2011, FUNCT INTEGR GENOMIC, V11, P139, DOI 10.1007/s10142-010-0189-9; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Akhabir L, 2010, ALLERGY ASTHMA CL S3, V6, pP1; Al-Mamun H, 2014, 10TH WORLD CONGRESS; Artemenko Y, 2005, J CELL PHYSIOL, V204, P646, DOI 10.1002/jcp.20314; Ayele FT, 2012, IMMUNOGENETICS, V64, P351, DOI 10.1007/s00251-011-0596-7; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Borras E, 2013, CLIN GENET, V84, P441, DOI 10.1111/cge.12151; Cao TY, 2007, J INVEST DERMATOL, V127, P1375, DOI 10.1038/sj.jid.5700706; Cecchinato A, 2014, ANIMAL, V8, P1062, DOI 10.1017/S1751731114001098; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Crisa A, 2010, J DAIRY SCI, V93, P3834, DOI 10.3168/jds.2009-3014; Doran AG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-837; Eppig JJ, 2005, BIOL REPROD, V73, P351, DOI 10.1095/biolreprod.105.041798; Fahim AT, 2012, ADV EXP MED BIOL, V723, P313, DOI 10.1007/978-1-4614-0631-0_41; Fan B, 2009, ANIM BIOTECHNOL, V20, P58, DOI 10.1080/10495390902800792; Felicio AM, 2013, GENET MOL RES, V12, P472, DOI 10.4238/2013.February.8.12; Fontanesi L, 2009, ANIM GENET, V40, P90, DOI 10.1111/j.1365-2052.2008.01777.x; Fontanesi L, 2008, MEAT SCI, V80, P780, DOI 10.1016/j.meatsci.2008.03.022; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Galic S, 2014, BIOCHEM J, V461, P177, DOI 10.1042/BJ20140143; Geetha-Loganathan P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-32; Grunberg W, 2010, NEUROMUSCULAR DISORD, V20, P467, DOI 10.1016/j.nmd.2010.04.010; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Heaton MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002467; Hering DM, 2014, ANIM REPROD SCI, V146, P89, DOI 10.1016/j.anireprosci.2014.01.012; Holmstrom TE, 2008, EXP CELL RES, V314, P3581, DOI 10.1016/j.yexcr.2008.09.007; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Janowski D, 2012, THERIOGENOLOGY, V78, P656, DOI 10.1016/j.theriogenology.2012.03.012; Kijas JW, 2014, GENOME, V57, P433, DOI 10.1139/gen-2014-0049; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kirikoshi H, 2001, BIOCHEM BIOPH RES CO, V283, P798, DOI 10.1006/bbrc.2001.4855; Komisarek J, 2011, ANIM SCI PAP REP, V29, P29; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Lee JH, 2012, ASIAN AUSTRAL J ANIM, V25, P17, DOI 10.5713/ajas.2011.11337; Lehnert SA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-95; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Li H., 2010, PROC 9 WCGALP, P26; Li LM, 2012, IMMUNOGENETICS, V64, P817, DOI 10.1007/s00251-012-0641-1; Li MH, 2014, HEREDITY, V112, P122, DOI 10.1038/hdy.2013.83; Li W-F, 2014, AFRICAN JOURNAL OF B, V11, P1855; Li Y, 2011, ASIAN AUSTRAL J ANIM, V24, P457; Lindholm-Perry AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080882; Liu F-H, 2014, BIOMED RESEARCH INTE, V2014; Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004; Ma JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004710; Meira C, 2013, PROC ASSOC ADVMT ANI; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Mourot M, 2006, MOL REPROD DEV, V73, P1367, DOI 10.1002/mrd.20585; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Pan DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060440; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pardridge William M, 2005, NeuroRx, V2, P1, DOI 10.1602/neurorx.2.1.1; Pausch H, 2012, ANIM GENET, V43, P689, DOI 10.1111/j.1365-2052.2012.02340.x; Pierce A, 2008, MOL ENDOCRINOL, V22, P2481, DOI 10.1210/me.2008-0169; Raschetti M, 2013, LIVEST SCI, V155, P165, DOI 10.1016/j.livsci.2013.05.008; Rothschild M, 2014, 10TH WORLD CONGRESS; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sadkowski T, 2009, J PHYSIOL PHARMACOL, V60, P15; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sayre BL, 2012, ANIM GENET, V43, P190, DOI 10.1111/j.1365-2052.2011.02231.x; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Setoguchi K, 2011, ANIM GENET, V42, P650, DOI 10.1111/j.1365-2052.2011.02196.x; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; Shakhsi-Niaei M, 2013, ARCH TIERZUCHT, V56, P1, DOI 10.7482/0003-9438-56-001; Shriver Mark D, 2004, Hum Genomics, V1, P274; Smith TPL, 2001, ANIM GENET, V32, P344, DOI 10.1046/j.1365-2052.2001.00797.x; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spencer T., 2000, J BIOL CHEM, V275, P32106; Stephan W, 2010, PHILOS T R SOC B, V365, P1245, DOI 10.1098/rstb.2009.0278; Strillacci MG, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0106-7; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Tetens J, 2013, ANIM GENET, V44, P467, DOI 10.1111/age.12031; Thompson-Crispi KA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-559; Verma A, 2014, THERIOGENOLOGY, V82, P750, DOI 10.1016/j.theriogenology.2014.06.012; Wang X., IDENTIFICATION AND C; Wang YF, 2005, CAN J ANIM SCI, V85, P475, DOI 10.4141/A04-064; WANG ZQ, 2014, PLOS GENET, V10, DOI DOI 10.1371/JOURNAL.PONE.0107101; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS, 1990, GENETIC DATA ANALYSI; White SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047829; Wilson GRS, 2012, MOL VIS, V18, P1384; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wright S., 1984, EVOLUTION AND THE GE, V4; Xu LY, 2015, MOL BIOL EVOL, V32, P711, DOI 10.1093/molbev/msu333; Yu Seong Lan, 2009, Journal of Animal Science and Technology, V51, P443; Zhang C, 2014, PROCEEDINGS 10TH WOR; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052384, 10.1371/journal.pone.0066569]; Zhang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065942; Zhong W, 2010, REPRODUCTION, V140, P921, DOI 10.1530/REP-10-0268	96	36	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128688	10.1371/journal.pone.0128688	http://dx.doi.org/10.1371/journal.pone.0128688			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083354	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400063
J	Zhang, S; Hu, SE; Hu, JP; Wu, PL; Chao, HH; Li, CSR				Zhang, Sheng; Hu, Sien; Hu, Jianping; Wu, Po-Lun; Chao, Herta H.; Li, Chiang-Shan R.			Barratt Impulsivity and Neural Regulation of Physiological Arousal	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; SKIN-CONDUCTANCE RESPONSES; STOP SIGNAL TASK; GENDER-DIFFERENCES; REWARD SENSITIVITY; SENSATION SEEKING; BRAIN ACTIVITY; INDIVIDUAL-DIFFERENCES; PSYCHOSOCIAL STRESS; GRANGER CAUSALITY	Background Theories of personality have posited an increased arousal response to external stimulation in impulsive individuals. However, there is a dearth of studies addressing the neural basis of this association. Methods We recorded skin conductance in 26 individuals who were assessed with Barratt Impulsivity Scale (BIS-11) and performed a stop signal task during functional magnetic resonance imaging. Imaging data were processed and modeled with Statistical Parametric Mapping. We used linear regressions to examine correlations between impulsivity and skin conductance response (SCR) to salient events, identify the neural substrates of arousal regulation, and examine the relationship between the regulatory mechanism and impulsivity. Results Across subjects, higher impulsivity is associated with greater SCR to stop trials. Activity of the ventromedial prefrontal cortex (vmPFC) negatively correlated to and Granger caused skin conductance time course. Furthermore, higher impulsivity is associated with a lesser strength of Granger causality of vmPFC activity on skin conductance, consistent with diminished control of physiological arousal to external stimulation. When men (n = 14) and women (n = 12) were examined separately, however, there was evidence suggesting association between impulsivity and vmPFC regulation of arousal only in women. Conclusions Together, these findings confirmed the link between Barratt impulsivity and heightened arousal to salient stimuli in both genders and suggested the neural bases of altered regulation of arousal in impulsive women. More research is needed to explore the neural processes of arousal regulation in impulsive individuals and in clinical conditions that implicate poor impulse control.	[Zhang, Sheng; Hu, Sien; Hu, Jianping; Wu, Po-Lun; Li, Chiang-Shan R.] Yale Univ, Dept Psychiat, New Haven, CT 06519 USA; [Hu, Jianping] S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Wu, Po-Lun] China Med Univ, Dept Psychiat, Taichung, Taiwan; [Chao, Herta H.] Yale Univ, Dept Med, New Haven, CT 06519 USA; [Chao, Herta H.] VA Connecticut Healthcare Syst, Dept Med, West Haven, CT 06516 USA; [Chao, Herta H.] Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA; [Li, Chiang-Shan R.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; South China Normal University; China Medical University Taiwan; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University	Zhang, S (corresponding author), Yale Univ, Dept Psychiat, New Haven, CT 06519 USA.	sheng.zhang@yale.edu; chiang-shan.li@yale.edu	Li, Chiang-Shan Ray/J-2813-2016	Li, Chiang-Shan Ray/0000-0002-9393-1212	NIH [R01DA023248, R21AA018004, R01AA021449, K02DA026990, R03CA138121]; NATIONAL CANCER INSTITUTE [R03CA138121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018004, R01AA021449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026990, R01DA023248] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01DA023248, R21AA018004, R01AA021449, K02DA026990, R03CA138121. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Acton GS, 2003, SUBST USE MISUSE, V38, P67, DOI 10.1081/JA-120016566; [Anonymous], 1985, PERSONALITY INDIVIDU, DOI 13877; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Barratt ES, 1983, BIOL BASES IMPULSIVE; Barratt ES., 1985, MOTIVATION EMOTION P, P137, DOI DOI 10.1371/JOURNAL.PONE.0129139; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Berridge CW, 2013, NEUROSCI BIOBEHAV R, V37, P1976, DOI 10.1016/j.neubiorev.2012.11.005; Booth C, 2009, ADDICT BEHAV, V34, P730, DOI 10.1016/j.addbeh.2009.04.010; Boutrel B, 2008, PHYSIOL BEHAV, V93, P947, DOI 10.1016/j.physbeh.2007.11.022; CARRILLODELAPENA MT, 1993, PERS INDIV DIFFER, V15, P25, DOI 10.1016/0191-8869(93)90038-5; Castella J, 2004, ACCIDENT ANAL PREV, V36, P947, DOI 10.1016/j.aap.2003.10.003; Castellanos-Ryan N, 2014, AM J PSYCHIAT, V171, P1310, DOI 10.1176/appi.ajp.2014.13111499; Chao HHA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-75; Constantinou E, 2011, ACCIDENT ANAL PREV, V43, P1323, DOI 10.1016/j.aap.2011.02.002; Coskunpinar A, 2013, DRUG ALCOHOL DEPEN, V133, P1, DOI 10.1016/j.drugalcdep.2013.05.008; Coventry KR, 2001, ADDICTION, V96, P871, DOI 10.1046/j.1360-0443.2001.9668718.x; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; Cservenka A, 2013, NEUROIMAGE, V66, P184, DOI 10.1016/j.neuroimage.2012.11.003; Damasio A.R., 2005, DESCARTES ERROR EMOT; Davis C, 2008, APPETITE, V50, P43, DOI 10.1016/j.appet.2007.05.007; De Pascalis V, 2007, INT J PSYCHOPHYSIOL, V63, P16, DOI 10.1016/j.ijpsycho.2006.06.004; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Derefinko KJ, 2014, ARCH SEX BEHAV, V43, P1149, DOI 10.1007/s10508-014-0327-x; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; DeVito EE, 2013, NEUROPSYCHOPHARMACOL, V38, P1854, DOI 10.1038/npp.2013.92; Diekhof EK, 2012, BRAIN RES, V1473, P63, DOI 10.1016/j.brainres.2012.07.010; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Eysenck H.J., 1967, BIOL BASIS PERSONALI; EYSENCK SBG, 1977, BRIT J SOC CLIN PSYC, V16, P57, DOI 10.1111/j.2044-8260.1977.tb01003.x; Fan J, 2012, J NEUROSCI, V32, P11176, DOI 10.1523/JNEUROSCI.1172-12.2012; Farr OM, 2012, NEUROIMAGE, V63, P1070, DOI 10.1016/j.neuroimage.2012.07.049; Figner B., 2010, HDB PROCESS TRACING, P163; FIRESTONE P, 1975, J ABNORM CHILD PSYCH, V3, P201; First M.B., 2016, STRUCTURED CLIN INTE; Fischer H, 2004, COGN AFFECT BEHAV NE, V4, P326, DOI 10.3758/CABN.4.3.326; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRITH CD, 1983, BIOL PSYCHOL, V17, P27, DOI 10.1016/0301-0511(83)90064-9; Gentle J. E., 2004, HDB COMPUTATIONAL ST; Giakoumaki SG, 2013, BIOL PSYCHOL, V94, P582, DOI 10.1016/j.biopsycho.2013.09.005; Goldstein JM, 2010, J NEUROSCI, V30, P431, DOI 10.1523/JNEUROSCI.3021-09.2010; Gomez P, 2010, PSYCHOPHYSIOLOGY, V47, P540, DOI 10.1111/j.1469-8986.2009.00953.x; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hahn T, 2009, NEUROIMAGE, V46, P1148, DOI 10.1016/j.neuroimage.2009.03.038; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Harrison L, 2003, NEUROIMAGE, V19, P1477, DOI 10.1016/S1053-8119(03)00160-5; Houston RJ, 2001, INT J PSYCHOPHYSIOL, V40, P1, DOI 10.1016/S0167-8760(00)00120-3; HUMPHREYS MS, 1984, PSYCHOL REV, V91, P153, DOI 10.1037/0033-295X.91.2.153; Ide JS, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00025; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Kerr KL, 2015, SOC COGN AFFECT NEUR, V10, P36, DOI 10.1093/scan/nsu023; Kirkpatrick MG, 2013, J PSYCHOPHARMACOL, V27, P256, DOI 10.1177/0269881112472564; Leue A, 2008, BRIT J PSYCHOL, V99, P361, DOI 10.1348/000712607X228519; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Li CSR, 2007, PERS INDIV DIFFER, V43, P475, DOI 10.1016/j.paid.2006.12.016; Li CSR, 2009, BRAIN IMAGING BEHAV, V3, P262, DOI 10.1007/s11682-009-9068-1; Li CSR, 2009, CEREB CORTEX, V19, P839, DOI 10.1093/cercor/bhn132; Li YD, 2014, BEHAV BRAIN RES, V274, P400, DOI 10.1016/j.bbr.2014.08.041; Lijffijt M, 2004, J Atten Disord, V8, P25, DOI 10.1177/108705470400800104; Litschauer B, 1998, PSYCHOSOM MED, V60, P219, DOI 10.1097/00006842-199803000-00019; Lombardo MV, 2012, BIOL PSYCHIAT, V72, P839, DOI 10.1016/j.biopsych.2012.05.027; Lyvers M, 2012, ADDICT BEHAV, V37, P940, DOI 10.1016/j.addbeh.2012.03.028; Mathias CW, 2003, PERS INDIV DIFFER, V35, P355, DOI 10.1016/S0191-8869(02)00195-2; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Moodie C, 2005, ADDICTION, V100, P51, DOI 10.1111/j.1360-0443.2005.00942.x; Muller VI, 2015, BRAIN STRUCT FUNCT, V220, P2401, DOI 10.1007/s00429-014-0797-6; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Nili U, 2010, NEURON, V66, P949, DOI 10.1016/j.neuron.2010.06.009; Paquet C, 2010, AM J CLIN NUTR, V91, P771, DOI 10.3945/ajcn.2009.28648; Patterson JC, 2002, NEUROIMAGE, V17, P1797, DOI 10.1006/nimg.2002.1306; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2014, NEUROPHARMACOLOGY, V76, P342, DOI 10.1016/j.neuropharm.2013.07.002; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Perkins KA, 2008, PSYCHOPHARMACOLOGY, V200, P529, DOI 10.1007/s00213-008-1231-7; Perry RI, 2013, DRUG ALCOHOL DEPEN, V133, P222, DOI 10.1016/j.drugalcdep.2013.04.032; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rollins BY, 2014, APPETITE, V72, P21, DOI 10.1016/j.appet.2013.09.018; Romero-Martinez A, 2013, INT J PSYCHOPHYSIOL, V90, P329, DOI 10.1016/j.ijpsycho.2013.10.003; Roussos P, 2009, NEUROPSYCHOLOGIA, V47, P1654, DOI 10.1016/j.neuropsychologia.2009.02.005; Sarlo M, 2013, INT J PSYCHOL, V48, P263, DOI 10.1080/00207594.2012.656127; Sato JR, 2009, HUM BRAIN MAPP, V30, P452, DOI 10.1002/hbm.20513; Scarpa A, 2010, BIOL PSYCHOL, V84, P488, DOI 10.1016/j.biopsycho.2009.11.006; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott-Parker B, 2013, ACCIDENT ANAL PREV, V50, P465, DOI 10.1016/j.aap.2012.05.027; Scott-Parker B, 2012, BRIT J PSYCHOL, V103, P248, DOI 10.1111/j.2044-8295.2011.02069.x; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Simons JS, 2008, PSYCHOL ADDICT BEHAV, V22, P444, DOI 10.1037/0893-164X.22.3.444; Stankovic A, 2014, INT J PSYCHOPHYSIOL, V93, P22, DOI 10.1016/j.ijpsycho.2013.11.001; Stilla R, 2007, J NEUROSCI, V27, P11091, DOI 10.1523/JNEUROSCI.1808-07.2007; Suarez EC, 2004, PSYCHOPHYSIOLOGY, V41, P450, DOI 10.1111/j.1469-8986.00161.x; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Urosevic S, 2012, DEV PSYCHOL, V48, P1488, DOI 10.1037/a0027502; van den Bos W, 2014, J NEUROSCI, V34, P10298, DOI 10.1523/JNEUROSCI.4105-13.2014; Wang TS, 2013, J PHYSIOL SCI, V63, P87, DOI 10.1007/s12576-012-0238-3; Weiland BJ, 2014, PSYCHIAT RES-NEUROIM, V223, P244, DOI 10.1016/j.pscychresns.2014.05.015; Wen XT, 2012, J NEUROSCI, V32, P1284, DOI 10.1523/JNEUROSCI.2817-11.2012; White TL, 2007, EXP CLIN PSYCHOPHARM, V15, P599, DOI 10.1037/1064-1297.15.6.599; Whiteside SP, 2003, EXP CLIN PSYCHOPHARM, V11, P210, DOI 10.1037/1064-1297.11.3.210; Wilbertz T, 2014, NEUROIMAGE, V103, P241, DOI 10.1016/j.neuroimage.2014.09.021; Winhusen T, 2013, DRUG ALCOHOL DEPEN, V129, P158, DOI 10.1016/j.drugalcdep.2012.09.014; Zhang S, 2014, SOC COGN AFFECT NEUR, V9, P900, DOI 10.1093/scan/nst064; Zhang S, 2012, NEUROIMAGE, V62, P1489, DOI 10.1016/j.neuroimage.2012.05.036; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197; Zuckerman M., 1991, PSYCHOBIOLOGY PERSON	113	19	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129139	10.1371/journal.pone.0129139	http://dx.doi.org/10.1371/journal.pone.0129139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9EB	26079873	Green Submitted, gold, Green Published			2022-12-26	WOS:000356542300014
J	Kassem, A; Henning, P; Lundberg, P; Souza, PPC; Lindholm, C; Lerner, UH				Kassem, Ali; Henning, Petra; Lundberg, Pernilla; Souza, Pedro P. C.; Lindholm, Catharina; Lerner, Ulf H.			Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-kappa B Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; OSTEOCLAST PROGENITOR; PATTERN-RECOGNITION; PERIODONTAL-DISEASE; IMMUNE-SYSTEM; IN-VIVO; TLR2; LIPOPOLYSACCHARIDE; EXPRESSION	Periodontitis has been associated with rheumatoid arthritis. In experimental arthritis, concomitant periodontitis caused by oral infection with Porphyromonas gingivalis enhances articular bone loss. The aim of this study was to investigate how lipopolysaccharide (LPS) from P. gingivalis stimulates bone resorption. The effects by LPS P. gingivalis and four other TLR2 ligands on bone resorption, osteoclast formation, and gene expression in wild type and Tlr2-deficient mice were assessed in ex vivo cultures of mouse parietal bones and in an in vivo model in which TLR2 agonists were injected subcutaneously over the skull bones. LPS P. gingivalis stimulated mineral release and matrix degradation in the parietal bone organ cultures by increasing differentiation and formation of mature osteoclasts, a response dependent on increased RANKL (receptor activator of NF-kappa B ligand). LPS P. gingivalis stimulated RANKL in parietal osteoblasts dependent on the presence of TLR2 and through a MyD88 and NF-kappa B-mediated mechanism. Similarly, the TLR2 agonists HKLM, FSL1, Pam2, and Pam3 stimulated RANKL in osteoblasts and parietal bone resorption. LPS P. gingivalis and Pam2 robustly enhanced osteoclast formation in periosteal/endosteal cell cultures by increasing RANKL. LPS P. gingivalis and Pam2 also up-regulated RANKL and osteoclastic genes in vivo, resulting in an increased number of periosteal osteoclasts and immense bone loss in wild type mice but not in Tlr2-deficient mice. These data demonstrate that LPS P. gingivalis stimulates periosteal osteoclast formation and bone resorption by stimulating RANKL in osteoblasts via TLR2. This effect might be important for periodontal bone loss and for the enhanced bone loss seen in rheumatoid arthritis patients with concomitant periodontal disease.	[Kassem, Ali; Lundberg, Pernilla; Souza, Pedro P. C.; Lerner, Ulf H.] Umea Univ, Dept Periodontol, S-90187 Umea, Sweden; [Henning, Petra; Lindholm, Catharina; Lerner, Ulf H.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res,Dept Internal Med & Clin N, S-41345 Gothenburg, Sweden; [Souza, Pedro P. C.] Univ Estadual Paulista, UNESP, Araraquara Sch Dent, Dept Physiol & Pathol, BR-14801903 Araraquara, Brazil; [Lindholm, Catharina] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, S-40350 Gothenburg, Sweden	Umea University; University of Gothenburg; Universidade Estadual Paulista; University of Gothenburg	Lerner, UH (corresponding author), Umea Univ, Dept Periodontol, S-90187 Umea, Sweden.	ulf.lerner@umu.se	Souza, Pedro Paulo Chaves/G-3801-2011; Souza, Pedro/GZH-1275-2022	Souza, Pedro Paulo Chaves/0000-0001-7266-6061; Lerner, Ulf/0000-0002-3579-1960; Henning, Petra/0000-0002-9330-6265; Kassem, Ali/0000-0002-1820-8518	Swedish Research Council; Swedish National Graduate School in Odontological Science; Swedish Dental Association; Swedish Rheumatism Association; Royal 80-Year Fund of King Gustav V; COMBINE; ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg; Lundberg Foundation; County Council of Vasterbotten	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Graduate School in Odontological Science; Swedish Dental Association; Swedish Rheumatism Association; Royal 80-Year Fund of King Gustav V; COMBINE; ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg; Lundberg Foundation(European Commission); County Council of Vasterbotten	This work was supported by the Swedish Research Council, Swedish National Graduate School in Odontological Science, Swedish Dental Association, Swedish Rheumatism Association, Royal 80-Year Fund of King Gustav V, COMBINE, an ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg, the Lundberg Foundation, and County Council of Vasterbotten. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Al-Katma MK, 2007, JCR-J CLIN RHEUMATOL, V13, P134, DOI 10.1097/RHU.0b013e3180690616; Bar-Shavit Z, 2008, AUTOIMMUNITY, V41, P195, DOI 10.1080/08916930701694469; Bartold PM, 2010, J CLIN PERIODONTOL, V37, P405, DOI 10.1111/j.1600-051X.2010.01552.x; Bartold PM, 2010, PERIODONTOL 2000, V53, P55, DOI 10.1111/j.1600-0757.2010.00347.x; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Cantley MD, 2011, J CLIN PERIODONTOL, V38, P532, DOI 10.1111/j.1600-051X.2011.01714.x; Conaway HH, 2011, J BIOL CHEM, V286, P31425, DOI 10.1074/jbc.M111.247734; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; de Aquino SG, 2014, J IMMUNOL, V192, P4103, DOI 10.4049/jimmunol.1301970; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Granholm S, 2013, BONE, V52, P83, DOI 10.1016/j.bone.2012.09.019; Hitchon CA, 2010, J RHEUMATOL, V37, P1105, DOI 10.3899/jrheum.091323; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Itoh K, 2003, J IMMUNOL, V170, P3688, DOI 10.4049/jimmunol.170.7.3688; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim J, 2013, J BONE MINER RES, V28, P2381, DOI 10.1002/jbmr.1973; Koh JM, 2009, BONE, V45, P650, DOI 10.1016/j.bone.2009.06.007; LERNER UH, 1987, J BONE MINER RES, V2, P375; Lin J, 2014, INFECT IMMUN, V82, P4127, DOI 10.1128/IAI.02084-14; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; LJUNGGREN O, 1991, J BONE MINER RES, V6, P543; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Martinez-Martinez RE, 2009, J CLIN PERIODONTOL, V36, P1004, DOI 10.1111/j.1600-051X.2009.01496.x; Mercado F, 2000, J CLIN PERIODONTOL, V27, P267, DOI 10.1034/j.1600-051x.2000.027004267.x; Mikuls TR, 2012, ARTHRITIS RHEUM-US, V64, P655, DOI 10.1002/art.33408; Moen K, 2006, CLIN EXP RHEUMATOL, V24, P656; Nakamura H, 2008, ORAL MICROBIOL IMMUN, V23, P190, DOI 10.1111/j.1399-302X.2007.00410.x; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ortiz P, 2009, J PERIODONTOL, V80, P535, DOI 10.1902/jop.2009.080447; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palmqvist P, 2006, J BIOL CHEM, V281, P2414, DOI 10.1074/jbc.M510160200; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI [10.1902/jop.2008.070501, 10.1902/jop.2008.070501 ]; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schwab AM, 2005, ENDOCRINOLOGY, V146, P4349, DOI 10.1210/en.2005-0601; Shi B, 2012, ANN RHEUM DIS, V71, P1411, DOI 10.1136/annrheumdis-2011-200899; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Walsh NC, 2010, IMMUNOL REV, V233, P301, DOI 10.1111/j.0105-2896.2009.00857.x; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang J, 2009, J LEUKOCYTE BIOL, V86, P823, DOI 10.1189/jlb.0309206; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085	54	73	76	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20147	20158		10.1074/jbc.M115.655787	http://dx.doi.org/10.1074/jbc.M115.655787			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26085099	hybrid, Green Published			2022-12-26	WOS:000359608900017
J	AlSalmi, W; Mahalingam, M; Ananthaswamy, N; Hamlin, C; Flores, D; Gao, GF; Rao, VB				AlSalmi, Wadad; Mahalingam, Marthandan; Ananthaswamy, Neeti; Hamlin, Christopher; Flores, Dalia; Gao, Guofen; Rao, Venigalla B.			A New Approach to Produce HIV-1 Envelope Trimers BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; BROADLY NEUTRALIZING ANTIBODIES; CD4 BINDING-SITE; GLYCOPROTEIN TRIMERS; DEPENDENT EPITOPE; IN-VITRO; ELECTRON-MICROSCOPY; ENV TRIMERS; T4 MOLECULE	The trimeric envelope spike of HIV-1 mediates virus entry into human cells. The exposed part of the trimer, gp140, consists of two noncovalently associated subunits, gp120 and gp41 ectodomain. A recombinant vaccine that mimics the native trimer might elicit entry-blocking antibodies and prevent virus infection. However, preparation of authentic HIV-1 trimers has been challenging. Recently, an affinity column containing the broadly neutralizing antibody 2G12 has been used to capture recombinant gp140 and prepare trimers from clade A BG505 that naturally produces stable trimers. However, this antibody-based approach may not be as effective for the diverse HIV-1 strains with different epitope signatures. Here, we report a new and simple approach to produce HIV-1 envelope trimers. The C terminus of gp140 was attached to Strep-tag II with a long linker separating the tag from the massive trimer base and glycan shield. This allowed capture of nearly homogeneous gp140 directly from the culture medium. Cleaved, uncleaved, and fully or partially glycosylated trimers from different clade viruses were produced. Extensive biochemical characterizations showed that cleavage of gp140 was not essential for trimerization, but it triggered a conformational change that channels trimers into correct glycosylation pathways, generating compact three-blade propeller-shaped trimers. Uncleaved trimers entered aberrant pathways, resulting in hyperglycosylation, nonspecific cross-linking, and conformational heterogeneity. Even the cleaved trimers showed microheterogeneity in gp41 glycosylation. These studies established a broadly applicable HIV-1 trimer production system as well as generating new insights into their assembly and maturation that collectively bear on the HIV-1 vaccine design.	[AlSalmi, Wadad; Mahalingam, Marthandan; Ananthaswamy, Neeti; Hamlin, Christopher; Flores, Dalia; Gao, Guofen; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Catholic University of America	Rao, VB (corresponding author), Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA.	rao@cua.edu		Rao, Venigalla/0000-0002-0777-6587	National Institutes of Health, NIAID [AI102725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102725] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI102725 (to V. B. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Benjelloun F, 2012, J VIROL, V86, P13152, DOI 10.1128/JVI.01110-12; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Cavacini LA, 2002, AIDS, V16, P2409, DOI 10.1097/00002030-200212060-00005; CAVACINI LA, 1993, J ACQ IMMUN DEF SYND, V6, P1093; Cavacini LA, 1998, AIDS RES HUM RETROV, V14, P1271, DOI 10.1089/aid.1998.14.1271; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; Dey AK, 2007, VIROLOGY, V360, P199, DOI 10.1016/j.virol.2006.09.046; Esparza J, 2013, VACCINE, V31, P3502, DOI 10.1016/j.vaccine.2013.05.018; Etemad-Moghadam B, 1999, J VIROL, V73, P8873, DOI 10.1128/JVI.73.10.8873-8879.1999; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gao GF, 2013, J BIOL CHEM, V288, P234, DOI 10.1074/jbc.M112.424432; Georgiev IS, 2015, J VIROL, V89, P5318, DOI 10.1128/JVI.03451-14; Guenaga J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004570; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2001, CURR OPIN IMMUNOL, V13, P489, DOI 10.1016/S0952-7915(00)00246-6; MCDOUGAL JS, 1986, J IMMUNOL, V137, P2937; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14; Nkolola JP, 2014, VACCINE, V32, P2109, DOI 10.1016/j.vaccine.2014.02.001; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; POSNER MR, 1993, J ACQ IMMUN DEF SYND, V6, P7; POSNER MR, 1991, J IMMUNOL, V146, P4325; POSNER MR, 1987, HYBRIDOMA, V6, P611, DOI 10.1089/hyb.1987.6.611; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sathaliyawala T, 2006, J VIROL, V80, P7688, DOI 10.1128/JVI.00235-06; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tao P, 2013, P NATL ACAD SCI USA, V110, P5846, DOI 10.1073/pnas.1300867110; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; Tran K, 2014, P NATL ACAD SCI USA, V111, pE738, DOI 10.1073/pnas.1319512111; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Yu L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00250; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	80	17	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19780	19795		10.1074/jbc.M115.656611	http://dx.doi.org/10.1074/jbc.M115.656611			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088135	hybrid, Green Published			2022-12-26	WOS:000359364600035
J	Bashashati, H; Ward, RK; Birch, GE; Bashashati, A				Bashashati, Hossein; Ward, Rabab K.; Birch, Gary E.; Bashashati, Ali			Comparing Different Classifiers in Sensory Motor Brain Computer Interfaces	PLOS ONE			English	Article							STATISTICAL COMPARISONS; EEG; IMAGERY; DESIGN	A problem that impedes the progress in Brain-Computer Interface (BCI) research is the difficulty in reproducing the results of different papers. Comparing different algorithms at present is very difficult. Some improvements have been made by the use of standard datasets to evaluate different algorithms. However, the lack of a comparison framework still exists. In this paper, we construct a new general comparison framework to compare different algorithms on several standard datasets. All these datasets correspond to sensory motor BCIs, and are obtained from 21 subjects during their operation of synchronous BCIs and 8 subjects using self-paced BCIs. Other researchers can use our framework to compare their own algorithms on their own datasets. We have compared the performance of different popular classification algorithms over these 29 subjects and performed statistical tests to validate our results. Our findings suggest that, for a given subject, the choice of the classifier for a BCI system depends on the feature extraction method used in that BCI system. This is in contrary to most of publications in the field that have used Linear Discriminant Analysis (LDA) as the classifier of choice for BCI systems.	[Bashashati, Hossein; Ward, Rabab K.; Birch, Gary E.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada; [Bashashati, Ali] British Columbia Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 4E6, Canada; [Birch, Gary E.] Neil Squire Soc, Burnaby, BC, Canada	University of British Columbia; British Columbia Cancer Agency	Bashashati, H (corresponding author), Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada.	hosseinbs@ece.ubc.ca						AlZoubi O, 2008, P 7 AUSTR DAT MIN C, V87, P123; Aydemir O, 2011, COMPARING COMMON MAC; Bashashati A, 2007, COMPUTATIONAL INTELL, V2007; Bashashati A, 2007, J NEURAL ENG, V4, pR32, DOI 10.1088/1741-2560/4/2/R03; Bastien F, 2012, DEEP LEARN UNS PERV; Bergstra J, 2010, THEANO CPU GPU MATH; Bishop C. M, 2006, PATTERN RECOGNITION; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Boostani R, 2007, MED BIOL ENG COMPUT, V45, P403, DOI 10.1007/s11517-007-0169-y; Borisoff JF, 2004, IEEE T BIO-MED ENG, V51, P985, DOI 10.1109/TBME.2004.827078; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brodu N., 2011, 2011 IEEE S COMP INT, P1, DOI [DOI 10.1109/CCMB.2011.5952133, 10.1109/CCMB.2011.5952105]; Brodu N, 2012, NEUROCOMPUTING, V79, P87, DOI 10.1016/j.neucom.2011.10.010; Brunner C, 2008, BCI COMPETITION GRAZ; Criminisi A, 2011, DECISION FORESTS CLA; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dietterich TG, 2000, MACH LEARN, V40, P139, DOI 10.1023/A:1007607513941; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Garcia S, 2008, J MACH LEARN RES, V9, P2677; Herman P, 2008, IEEE T NEUR SYS REH, V16, P317, DOI 10.1109/TNSRE.2008.926694; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Hwang HJ, 2013, INT J HUM-COMPUT INT, V29, P814, DOI 10.1080/10447318.2013.780869; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Lee F, 2005, COMPARITIVE ANAL MUL; Leeb R., 2008, BCI COMPETITION 2008; Lei X, 2009, IEEE T NEUR SYS REH, V17, P521, DOI 10.1109/TNSRE.2009.2027705; Li PY, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-77; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Mason S., 2006, EVALUATING PERFORMAN; Mason SG, 2000, IEEE T BIO-MED ENG, V47, P1297, DOI 10.1109/10.871402; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Renard Y, 2010, PRESENCE-TELEOP VIRT, V19, P35, DOI 10.1162/pres.19.1.35; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Segal M.R., 2004, INT C BIOINF, DOI DOI 10.2307/2404188; Selim AE, 2008, CAIRO INT BIOM ENG, P331; van Erp JBF, 2012, COMPUTER, V45, P26, DOI 10.1109/MC.2012.107; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu Peng, 2011, PLoS One, V6, pe14634, DOI 10.1371/journal.pone.0014634; Zhang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074433	51	42	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129435	10.1371/journal.pone.0129435	http://dx.doi.org/10.1371/journal.pone.0129435			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090799	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000043
J	Lee, HW; Chang, DY; Moon, HJ; Chang, HY; Shin, EC; Lee, JS; Kim, KA; Kim, HJ				Lee, Hyun Woong; Chang, Dong-Yeop; Moon, Hong Ju; Chang, Hye Young; Shin, Eui-Cheol; Lee, June Sung; Kim, Kyung-Ah; Kim, Hyung Joon			Clinical Factors and Viral Load Influencing Severity of Acute Hepatitis A	PLOS ONE			English	Article							VIRUS-INFECTION; FULMINANT-HEPATITIS; EPIDEMIC; OUTBREAK; RNA; MANIFESTATIONS; CONSUMPTION; STRAINS; OYSTERS; ADULTS	Background and Aims Clinical manifestations of hepatitis A virus (HAV) infection vary from mild to fulminant hepatic failure (FHF) in adults. We investigated the relationship between laboratory findings, including viral load, and clinical outcomes in patients with acute hepatitis A (AHA) and evaluated predictive factors for severe acute hepatitis (s-AH). Methods We analyzed the clinical manifestations of AHA in 770 patients. Patients with a prothrombin time (PT) of less than 40% of normal were classified as s-AH and included 4 patients with FHF, 11 patients with acute renal failure, and 3 patients with prolonged jaundice (n = 128). Other patients were defined as mild acute hepatitis (m-AH) (n = 642). Serum samples were obtained from 48 patients with acute hepatitis A. Among them, 20 with s-AH, and 28 with m-AH, were tested for HAV RNA titer. Results In a multivariate analysis, age (HR = 1.042, P = 0.041), peak creatinine (HR = 4.014, P = 0.001), bilirubin (HR = 1.153, P = 0.003), alanine aminotransferase (ALT) (HR = 1.001, P<0.001), initial lactate dehydrogenase (LDH) (HR = 1.000, P = 0.045) and total cholesterol (HR = 0.978, P<0.001) were independent factors for s-AH. Serum HAV RNA was detected in 20/20 (100%) patients with s-AH and 22/28 (78.6%) patients with m-AH. In a multivariate analysis of the 48 patients who were tested for HAV RNA, peak ALT (HR = 1.001, P = 0.004) and HAV RNA titer (HR = 2.076, P = 0.012) were independent factors for s-AH. Conclusions Clinical factors including age, peak creatinine, bilirubin, ALT, initial LDH and total cholesterol were independent factors for s-AH in a multivariate analysis. In particular, HAV load strongly correlated with the severity of hepatitis A.	[Lee, Hyun Woong; Moon, Hong Ju; Chang, Hye Young; Kim, Hyung Joon] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Chang, Dong-Yeop; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Daejeon 305701, South Korea; [Lee, June Sung; Kim, Kyung-Ah] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med, Goyang, South Korea	Chung Ang University; Chung Ang University Hospital; Korea Advanced Institute of Science & Technology (KAIST); Inje University	Kim, HJ (corresponding author), Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea.	mdjoon@cau.ac.kr	LEE, HYUN WOONG/ABC-6119-2021; Shin, Eui-Cheol/C-1690-2011	Shin, Eui-Cheol/0000-0002-6308-9503; Lee, Hyun Woong/0000-0002-6958-3035	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2011-0014804]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2011-0014804).	Bower WA, 2000, J INFECT DIS, V182, P12, DOI 10.1086/315701; Conaty S, 2000, EPIDEMIOL INFECT, V124, P121, DOI 10.1017/S0950268899003386; Cuthbert JA, 2001, CLIN MICROBIOL REV, V14, P38, DOI 10.1128/CMR.14.1.38-58.2001; DESENCLOS JCA, 1991, AM J PUBLIC HEALTH, V81, P1268, DOI 10.2105/AJPH.81.10.1268; Fujiwara K, 1997, HEPATOLOGY, V26, P1634, DOI 10.1002/hep.510260636; Fujiwara K, 2002, GUT, V51, P82, DOI 10.1136/gut.51.1.82; Fujiwara K, 2001, J HEPATOL, V35, P112, DOI 10.1016/S0168-8278(01)00074-5; Fujiwara K, 2011, J MED VIROL, V83, P201, DOI 10.1002/jmv.21958; HADLER SC, 1980, NEW ENGL J MED, V302, P1222, DOI 10.1056/NEJM198005293022203; HALLIDAY ML, 1991, J INFECT DIS, V164, P852, DOI 10.1093/infdis/164.5.852; Hussain Z, 2008, DIGEST DIS SCI, V53, P506, DOI 10.1007/s10620-007-9870-9; Jeong SH, 2010, INTERVIROLOGY, V53, P15, DOI 10.1159/000252779; Jung YJ, 2010, J VIRAL HEPATITIS, V17, P611, DOI 10.1111/j.1365-2893.2009.01216.x; KEEFFE EB, 1995, AM J GASTROENTEROL, V90, P201; Kim Jwa Min, 2008, Korean J Hepatol, V14, P474, DOI 10.3350/kjhep.2008.14.4.474; Kim YJ, 2010, INTERVIROLOGY, V53, P10, DOI 10.1159/000252778; Lanford RE, 2011, P NATL ACAD SCI USA, V108, P11223, DOI 10.1073/pnas.1101939108; LEDNAR WM, 1985, AM J EPIDEMIOL, V122, P226, DOI 10.1093/oxfordjournals.aje.a114093; LEMON SM, 1994, INFECT AGENT DIS, V3, P38; Ngui SL, 2008, J MED VIROL, V80, P1181, DOI 10.1002/jmv.21207; Rezende G, 2003, HEPATOLOGY, V38, P613, DOI 10.1053/jhep.2003.50366; Roy K, 2004, J VIRAL HEPATITIS, V11, P277, DOI 10.1111/j.1365-2893.2004.00503.x; Sainokami S, 2005, J GASTROEN HEPATOL, V20, P1165, DOI 10.1111/j.1440-1746.2005.03908.x; Smith PF, 1997, EPIDEMIOL INFECT, V118, P243, DOI 10.1017/S0950268897007462; Takikawa Y, 2006, DIGEST DIS SCI, V51, P359, DOI 10.1007/s10620-006-3138-7; Vento S, 1998, NEW ENGL J MED, V338, P286, DOI 10.1056/NEJM199801293380503; Willner IR, 1998, ANN INTERN MED, V128, P111, DOI 10.7326/0003-4819-128-2-199801150-00006	27	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130728	10.1371/journal.pone.0130728	http://dx.doi.org/10.1371/journal.pone.0130728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090677	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000147
J	Seidel, S; Dal-Bianco, P; Pablik, E; Muller, N; Schadenhofer, C; Lamm, C; Klosch, G; Moser, D; Klug, S; Pusswald, G; Auff, E; Lehrner, J				Seidel, Stefan; Dal-Bianco, Peter; Pablik, Eleonore; Mueller, Nina; Schadenhofer, Claudia; Lamm, Claus; Kloesch, Gerhard; Moser, Doris; Klug, Stefanie; Pusswald, Gisela; Auff, Eduard; Lehrner, Johann			Depressive Symptoms are the Main Predictor for Subjective Sleep Quality in Patients with Mild Cognitive Impairment-A Controlled Study	PLOS ONE			English	Article							DAYTIME SLEEPINESS; OLDER-ADULTS; LATE-LIFE; DISTURBANCES; PREVALENCE; DEMENTIA; DECLINE	Objective Controlled data on predictors of subjective sleep quality in patients with memory complaints are sparse. To improve the amount of comprehensive data on this topic, we assessed factors associated with subjective sleep quality in patients from our memory clinic and healthy individuals. Methods Between February 2012 and August 2014 patients with mild cognitive impairment (MCI) and subjective cognitive decline (SCD) from our memory clinic and healthy controls were recruited. Apart from a detailed neuropsychological assessment, the subjective sleep quality, daytime sleepiness and depressive symptoms were assessed using the Pittsburgh Sleep Quality Index (PSQI), the Epworth Sleepiness Scale (ESS) and the Beck Depression Inventory (BDI-II). Results One hundred fifty eight consecutive patients (132 (84%) MCI patients and 26 (16%) SCD patients) and 75 healthy controls were included in the study. Pairwise comparison of PSQI scores showed that non-amnestic MCI (naMCI) patients (5.4 +/- 3.5) had significantly higher PSQI scores than controls (4.3 +/- 2.8, p = .003) Pairwise comparison of PSQI subscores showed that naMCI patients (1.1 +/- 0.4) had significantly more "sleep disturbances" than controls (0.9 +/- 0.5, p = .003). Amnestic MCI (aMCI) (0.8 +/- 1.2, p = .006) and naMCI patients (0.7 +/- 1.2, p = .002) used "sleep medication" significantly more often than controls (0.1 +/- 0.6) Both, aMCI (11.5 +/- 8.6, p<.001) and naMCI (11.5 +/- 8.6, p<.001) patients showed significantly higher BDI-II scores than healthy controls (6.1 +/- 5.3). Linear regression analysis showed that the subjective sleep quality was predicted by depressive symptoms in aMCI (p<.0001) and naMCI (p<.0001) patients as well as controls (p<.0001). This means, that more depressive symptoms worsened subjective sleep quality. In aMCI patients we also found a significant interaction between depressive symptoms and global cognitive function (p = .002) Discussion Depressive symptoms were the main predictor of subjective sleep quality in MCI patients and controls, but not in SCD patients. Better global cognitive function ameliorated the negative effect of depressive symptoms on the subjective sleep quality in aMCI patients.	[Seidel, Stefan; Dal-Bianco, Peter; Kloesch, Gerhard; Moser, Doris; Klug, Stefanie; Pusswald, Gisela; Auff, Eduard; Lehrner, Johann] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Pablik, Eleonore] Med Univ Vienna, Dept Med Stat, Vienna, Austria; [Mueller, Nina; Schadenhofer, Claudia; Lamm, Claus] Univ Vienna, Fac Psychol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna	Lehrner, J (corresponding author), Med Univ Vienna, Dept Neurol, Vienna, Austria.	Johann.Lehrner@meduniwien.ac.at	Lamm, Claus/B-3357-2014; Kloesch, Gerhard/AGK-5017-2022	Kloesch, Gerhard/0000-0001-9280-7319; Pusswald, gisela/0000-0002-9247-0880; Lamm, Claus/0000-0002-5422-0653; Lehrner, Johann/0000-0001-8270-9272				Adam AM, 2014, INT J GERIATR PSYCH, V29, P970, DOI 10.1002/gps.4087; Ausen B, 2009, DEMENT GERIATR COGN, V28, P528, DOI 10.1159/000255104; Beaulieu-Bonneau S, 2009, INT PSYCHOGERIATR, V21, P654, DOI 10.1017/S1041610209009120; Bixler E, 2009, SLEEP MED, V10, pS3, DOI 10.1016/j.sleep.2009.07.005; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carmeli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072759; Minett TSC, 2008, INT J GERIATR PSYCH, V23, P49, DOI 10.1002/gps.1836; Clarnette RM, 2001, INT J GERIATR PSYCH, V16, P168, DOI 10.1002/1099-1166(200102)16:2<168::AID-GPS291>3.0.CO;2-D; Dilling H., 1991, KLINISCH DIAGNOSTISC; Dlugaj M, 2014, J ALZHEIMERS DIS, V41, P479, DOI 10.3233/JAD-132132; Ferman TJ, 2013, NEUROLOGY, V81, P2032, DOI 10.1212/01.wnl.0000436942.55281.47; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Ganguli M, 2006, ARCH GEN PSYCHIAT, V63, P153, DOI 10.1001/archpsyc.63.2.153; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Hayes TL, 2014, ALZ DIS ASSOC DIS, V28, P145, DOI 10.1097/WAD.0000000000000010; Hita-Yanez E, 2013, SLEEP, V36, P1327, DOI 10.5665/sleep.2956; Ivnik R., 1992, CLIN NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/13854049208401877; Jessen F, 2014, EUR ARCH PSY CLIN N, V264, pS3, DOI 10.1007/s00406-014-0539-z; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Ju YES, 2013, JAMA NEUROL, V70, P587, DOI 10.1001/jamaneurol.2013.2334; Keage HAD, 2012, SLEEP MED, V13, P886, DOI 10.1016/j.sleep.2012.02.003; Kogler B, 2013, SUBJECTIVE MEMORY CO; Lehrner J, 2014, INT PSYCHOGERIATR, V26, P463, DOI 10.1017/S1041610213002263; McKinnon A, 2014, J GERIATR PSYCH NEUR, V27, P204, DOI 10.1177/0891988714527516; Naismith SL, 2011, J AFFECT DISORDERS, V132, P139, DOI 10.1016/j.jad.2011.02.027; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Potvin O, 2012, SLEEP, V35, P491, DOI 10.5665/sleep.1732; Pusswald G, 2013, ALZHEIMERS DEMENT, V9, P366, DOI 10.1016/j.jalz.2011.12.009; Reisberg B, 1989, Prog Clin Biol Res, V317, P23; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Roure N, 2008, SLEEP MED, V9, P727, DOI 10.1016/j.sleep.2008.02.006; Sass H., 2003, DIAGNOSTISCHES STAT; Sexton CE, 2013, AM J GERIAT PSYCHIAT, V21, P184, DOI 10.1016/j.jagp.2012.10.019; Shao YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112222; Smagula SF, 2015, AM J GERIAT PSYCHIAT, V23, P495, DOI 10.1016/j.jagp.2014.06.007; Stasinopoulos D.M., 2007, J STAT SOFTW, V23, P1, DOI [10.18637/jss.v023.i07, DOI 10.18637/JSS.V023.I07]; Terpening Z, 2015, J ALZHEIMERS DIS, V46, P157, DOI 10.3233/JAD-141860; Tranah GJ, 2011, ANN NEUROL, V70, P722, DOI 10.1002/ana.22468; van der Helm E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027421; vanSomeren EJW, 1996, BIOL PSYCHIAT, V40, P259, DOI 10.1016/0006-3223(95)00370-3; Wang YP, 2013, CLINICS, V68, P1274, DOI 10.6061/clinics/2013(09)15; Ward AM, 2013, SLEEP, V36, P1609, DOI 10.5665/sleep.3108; Zheng C, 2015, NEUROSCIENCE, V292, P170, DOI 10.1016/j.neuroscience.2015.01.071	45	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128139	10.1371/journal.pone.0128139	http://dx.doi.org/10.1371/journal.pone.0128139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26090659	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000014
J	Barrantes-Freer, A; Renovanz, M; Eich, M; Braukmann, A; Sprang, B; Spirin, P; Pardo, LA; Giese, A; Kim, EL				Barrantes-Freer, Alonso; Renovanz, Mirjam; Eich, Marcus; Braukmann, Alina; Sprang, Bettina; Spirin, Pavel; Pardo, Luis A.; Giese, Alf; Kim, Ella L.			CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells	PLOS ONE			English	Article							MEMBRANE MICRODOMAINS; INITIATING CELLS; GENE-EXPRESSION; CANCER; GLIOBLASTOMA; MARKER; IDENTIFICATION; GLYCOSYLATION; ANTIGEN; LIMITATIONS	A transmembrane protein CD133 has been implicated as a marker of stem-like glioma cells and predictor for therapeutic response in malignant brain tumours. CD133 expression is commonly evaluated by using antibodies specific for the AC133 epitope located in one of the extracellular domains of membrane-bound CD133. There is conflicting evidence regarding the significance of the AC133 epitope as a marker for identifying stem-like glioma cells and predicting the degree of malignancy in glioma cells. The reasons for discrepant results between different studies addressing the role of CD133/AC133 in gliomas are unclear. A possible source for controversies about CD133/AC133 is the widespread assumption that expression patterns of the AC133 epitope reflect linearly those of the CD133 protein. Consequently, the readouts from AC133 assessments are often interpreted in terms of the CD133 protein. The purpose of this study is to determine whether and to what extent do the readouts obtained with anti-AC133 antibody correspond to the level of CD133 protein expressed in stem-like glioma cells. Our study reveals for the first time that CD133 expressed on the surface of glioma cells is poorly immunoreactive for AC133. Furthermore, we provide evidence that the level of CD133 occupancy on the surface of glioma cells fluctuates during the cell cycle. Our results offer a new explanation for numerous inconsistencies regarding the biological and clinical significance of CD133/AC133 in human gliomas and call for caution in interpreting the lack or presence of AC133 epitope in glioma cells.	[Barrantes-Freer, Alonso; Pardo, Luis A.] Max Planck Inst Expt Med, Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Barrantes-Freer, Alonso] Univ Med Ctr, Inst Neuropathol, Gottingen, Germany; [Renovanz, Mirjam; Eich, Marcus; Sprang, Bettina; Giese, Alf; Kim, Ella L.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Neurosurg, Translat Neurooncol Res Grp, D-55122 Mainz, Germany; [Eich, Marcus] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Toxicol, D-55122 Mainz, Germany; [Spirin, Pavel] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Kim, Ella L.] Univ Med Ctr, Dept Neurosurg, Translat Neurooncol Res Grp, Gottingen, Germany	Max Planck Society; University of Gottingen; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Gottingen	Kim, EL (corresponding author), Max Planck Inst Expt Med, Mol Biol Neuronal Signals, Hermann Rein Str 3, D-37075 Gottingen, Germany.	ella.kim@unimedizin-mainz.de	Renovanz, Mirjam/ABA-3535-2020; Pardo, Luis/C-5066-2013	Pardo, Luis/0000-0003-1375-4349; Spirin, Pavel/0000-0002-0610-5079				Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barrantes-Freer A, 2013, J NEUROPATH EXP NEUR, V72, P307, DOI 10.1097/NEN.0b013e31828afdbd; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; BJURSELL G, 1973, J BIOL CHEM, V248, P3904; Bonifacino J. S., 1998, CURRENT PROTOCOLS CE; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Brescia P, 2012, J ONCOL, V2012, DOI 10.1155/2012/376894; Campos B, 2011, INT J CANCER, V128, P501, DOI 10.1002/ijc.25687; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Cheng JX, 2009, CANCER TREAT REV, V35, P403, DOI 10.1016/j.ctrv.2009.03.002; Clement V, 2009, INT J CANCER, V125, P244, DOI 10.1002/ijc.24352; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; Ding BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062150; Fargeas CA, 2003, STEM CELLS, V21, P506, DOI 10.1634/stemcells.21-4-506; Fargeas CA, 2011, WORLD J GASTROENTERO, V17, P4149, DOI 10.3748/wjg.v17.i36.4149; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hakomori S, 1996, CANCER RES, V56, P5309; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; JETT M, 1977, J BIOL CHEM, V252, P2134; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kase M, 2013, RADIOL ONCOL, V47, P405, DOI 10.2478/raon-2013-0055; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kim KJ, 2011, NEUROPATHOLOGY, V31, P494, DOI 10.1111/j.1440-1789.2010.01194.x; Knights MJ, 2012, BRAIN PATHOL, V22, P592, DOI 10.1111/j.1750-3639.2012.00573.x; Lathia JD, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.80; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lehnus KS, 2013, INT J ONCOL, V42, P1011, DOI 10.3892/ijo.2013.1787; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mak AB, 2011, J BIOL CHEM, V286, P41046, DOI 10.1074/jbc.M111.261545; Melguizo C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-250; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Olausson KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106694; Pelts M, 2011, BIOTECHNIQUES, V50, P389, DOI 10.2144/000113684; Phuphanich S, 2013, CANCER IMMUNOL IMMUN, V62, P125, DOI 10.1007/s00262-012-1319-0; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Tabu K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-39; Tamura K, 2013, J NEUROSURG, V119, P1145, DOI 10.3171/2013.7.JNS122417; Tchoghandjian A, 2010, BRAIN PATHOL, V20, P211, DOI 10.1111/j.1750-3639.2009.00269.x; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; WESTPHAL M, 1994, ACTA NEUROCHIR, V126, P17, DOI 10.1007/BF01476489; Yan XW, 2011, P NATL ACAD SCI USA, V108, P1591, DOI 10.1073/pnas.1018696108; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932	58	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130519	10.1371/journal.pone.0130519	http://dx.doi.org/10.1371/journal.pone.0130519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086074	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500111
J	Dijkstra, AA; Ingrassia, A; de Menezes, RX; van Kesteren, RE; Rozemuller, AJM; Heutink, P; Van de Berg, WDJ				Dijkstra, Anke A.; Ingrassia, Angela; de Menezes, Renee X.; van Kesteren, Ronald E.; Rozemuller, Annemieke J. M.; Heutink, Peter; van de Berg, Wilma D. J.			Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease	PLOS ONE			English	Article							INCIDENTAL LEWY BODY; GENE-EXPRESSION; ALPHA-SYNUCLEIN; TRANSCRIPTIONAL ANALYSIS; NEURONAL LOSS; PATHOLOGY; INVOLVEMENT; MECHANISMS; RAPAMYCIN; PROTEIN	Subjects with incidental Lewy body disease (iLBD) may represent the premotor stage of Parkinson's disease (PD). To elucidate molecular mechanisms underlying neuronal dysfunction and alpha-synuclein pathology in the premotor phase of PD, we investigated the transcriptome of the substantia nigra (SN) of well-characterized iLBD, PD donors and age-matched controls with Braak alpha-synuclein stage ranging from 0-6. In Braak alpha-synuclein stages 1 and 2, we observed deregulation of pathways linked to axonal degeneration, immune response and endocytosis, including axonal guidance signaling, mTOR signaling, EIF2 signaling and clathrin-mediated endocytosis in the SN. In Braak stages 3 and 4, we observed deregulation of pathways involved in protein translation and cell survival, including mTOR and EIF2 signaling. In Braak stages 5 and 6, we observed deregulation of dopa-minergic signaling, axonal guidance signaling and thrombin signaling. Throughout the progression of PD pathology, we observed a deregulation of mTOR, EIF2 and regulation of eIF4 and p70S6K signaling in the SN. Our results indicate that molecular mechanisms related to axonal dysfunction, endocytosis and immune response are an early event in PD pathology, whereas mTOR and EIF2 signaling are impaired throughout disease progression. These pathways may hold the key to altering the disease progression in PD.	[Dijkstra, Anke A.; Ingrassia, Angela; van de Berg, Wilma D. J.] Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Sect Quantitat Morphol, Amsterdam, Netherlands; [de Menezes, Renee X.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van Kesteren, Ronald E.] Vrije Univ Amsterdam, Med Ctr, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Rozemuller, Annemieke J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Heutink, Peter] Vrije Univ Amsterdam, Med Ctr, Dept Med Genom, Amsterdam, Netherlands; [Heutink, Peter] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Dijkstra, AA (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94158 USA.	adijkstra@memory.ucsf.edu	Rozemuller, Annemieke/C-2084-2008; van de Berg, Wilma/AAE-7778-2021; van Kesteren, Ronald E/E-2505-2014; Rozemuller, Annemieke/ABA-7093-2021	van de Berg, Wilma/0000-0002-6175-5357; van Kesteren, Ronald/0000-0002-9592-3777; Heutink, Peter/0000-0001-5218-1737	Prinses Beatrix Spierfonds [WAR07-06]; Stichting Parkinson Fonds [ZO 02-ANW0702]	Prinses Beatrix Spierfonds; Stichting Parkinson Fonds	Prinses Beatrix Spierfonds https://www.prinsesbeatrixspierfonds.nl/ project number: WAR07-06 Funding received by WvB. Project number Stichting Parkinson Fonds (www.parkinsonfonds.nl): ZO 02-ANW0702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Alafuzoff I, 2009, ACTA NEUROPATHOL, V117, P635, DOI 10.1007/s00401-009-0523-2; Alafuzoff I, 2009, ACTA NEUROPATHOL, V117, P309, DOI 10.1007/s00401-009-0485-4; Arduino DM, 2013, AUTOPHAGY, V9, P112, DOI 10.4161/auto.22443; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bossers K, 2009, BRAIN PATHOL, V19, P91, DOI 10.1111/j.1750-3639.2008.00171.x; Botta-Orfila T, 2012, BRAIN RES, V1466, P152, DOI 10.1016/j.brainres.2012.05.036; Botta-Orfila T, 2012, NEUROBIOL DIS, V45, P462, DOI 10.1016/j.nbd.2011.08.033; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Chartier-Harlin MC, 2011, AM J HUM GENET, V89, P398, DOI 10.1016/j.ajhg.2011.08.009; Chu YP, 2012, BRAIN, V135, P2058, DOI 10.1093/brain/aws133; DelleDonne A, 2008, ARCH NEUROL-CHICAGO, V65, P1074, DOI 10.1001/archneur.65.8.1074; Dickson DW, 2010, MOVEMENT DISORD, V25, pS78, DOI 10.1002/mds.22637; Dijkstra AA, 2014, MOVEMENT DISORD, V29, P1244, DOI 10.1002/mds.25952; Duke DC, 2007, NEUROGENETICS, V8, P83, DOI 10.1007/s10048-006-0077-6; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Frigerio R, 2011, NEUROBIOL AGING, V32, P857, DOI 10.1016/j.neurobiolaging.2009.05.019; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Halliday GM, 2008, EXP NEUROL, V209, P12, DOI 10.1016/j.expneurol.2007.07.006; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Jellinger KA, 2009, BBA-MOL BASIS DIS, V1792, P730, DOI 10.1016/j.bbadis.2008.07.006; Kingsbury AE, 2010, MOVEMENT DISORD, V25, P2508, DOI 10.1002/mds.23305; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liesveld JL, 2013, LEUKEMIA RES, V37, P1622, DOI 10.1016/j.leukres.2013.09.002; Liu KY, 2013, NEUROCHEM RES, V38, P201, DOI 10.1007/s11064-012-0909-8; Milber JM, 2012, NEUROLOGY       1114; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Mutez E, 2014, NEUROBIOL DIS, V63, P165, DOI 10.1016/j.nbd.2013.11.007; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pienaar IS, 2012, MOL NEUROBIOL, V45, P126, DOI 10.1007/s12035-011-8226-9; Rochet JC, 2012, PROG MOL BIOL TRANSL, V107, P125, DOI 10.1016/B978-0-12-385883-2.00011-4; Rodriguez AE, 2014, AM J CARDIOL, V113, P815, DOI 10.1016/j.amjcard.2013.11.033; Saha AR, 2004, J CELL SCI, V117, P1017, DOI 10.1242/jcs.00967; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sundal Christina, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS7, DOI 10.1016/S1353-8020(11)70005-0; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Vogt IR, 2006, EXP NEUROL, V199, P465, DOI 10.1016/j.expneurol.2006.01.008; Wolters EC, 2006, J NEURAL TRANSM-SUPP, P309; Yang ML, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-9; Zaccai J, 2008, NEUROLOGY, V70, P1042, DOI 10.1212/01.wnl.0000306697.48738.b6; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195	58	71	72	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128651	10.1371/journal.pone.0128651	http://dx.doi.org/10.1371/journal.pone.0128651			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087293	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500019
J	Madyarova, EV; Adelshin, RV; Dimova, MD; Axenov-Gribanov, DV; Lubyaga, YA; Timofeyev, MA				Madyarova, Ekaterina V.; Adelshin, Renat V.; Dimova, Mariya D.; Axenov-Gribanov, Denis V.; Lubyaga, Yulia A.; Timofeyev, Maxim A.			Microsporidian Parasites Found in the Hemolymph of Four Baikalian Endemic Amphipods	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; PHYLOGENY; DIVERSITY; EVOLUTION; SEX	At present, approximately 187 genera and over 1300 species of Microsporidia have been described, among which almost half infect aquatic species and approximately 50 genera potentially infect aquatic arthropods. Lake Baikal is the deepest and one of the oldest lakes in the world, and it has a rich endemic fauna with a predominance of arthropods. Among the arthropods living in this lake, amphipods (Crustacea) are the most dominant group and are represented by more than 350 endemic species. Baikalian amphipods inhabit almost all depths and all types of substrates. The age and geographical isolation of this group creates excellent opportunities for studying the diversity, evolution and genetics of host-parasite relationships. However, despite more than 150 years of study, data investigating the microsporidia of Lake Baikal remain incomplete. In this study, we used molecular genetic analyses to detect microsporidia in the hemolymph of several endemic species of amphipods from Lake Baikal. We provide the first evidence that microsporidian species belonging to three genera (Microsporidium, Dictyocoela and Nosema) are present in the hemolymph of Baikalian endemic amphipods. In the hemolymph of Eulimnogammarus verrucosus, we detected SSU rDNA of microsporidia belonging to the genus Nozema. In the hemolymph of Pallasea cancellous, we found the DNA of Microsporidium sp. similar to that in other Baikalian endemic amphipods; Dictyocoela sp. was found in the hemolymph of Eulimnogammarus marituji and Acanthogammarus lappaceus longispinus.	[Madyarova, Ekaterina V.; Adelshin, Renat V.; Dimova, Mariya D.; Axenov-Gribanov, Denis V.; Lubyaga, Yulia A.; Timofeyev, Maxim A.] Irkutsk State Univ, Inst Biol, Irkutsk 664003, Russia; [Adelshin, Renat V.] Irkutsk Anti Plague Res Inst Siberia & Far East, Irkutsk, Russia	Irkutsk State University	Timofeyev, MA (corresponding author), Irkutsk State Univ, Inst Biol, Irkutsk 664003, Russia.	m.a.timofeyev@gmail.com	Axenov-Gribanov, Denis/J-5204-2019; Timofeyev, Maxim/F-2071-2010; Adelshin, Renat/AAK-2470-2020; Madyarova, Ekaterina V/O-6593-2017; Axenov-Gribanov, Denis V./F-7360-2017; Lubyaga, Yuliya A./H-1034-2017	Axenov-Gribanov, Denis/0000-0003-2020-6084; Timofeyev, Maxim/0000-0002-5250-6818; Adelshin, Renat/0000-0003-3690-3992; Madyarova, Ekaterina V/0000-0002-3273-6739; Axenov-Gribanov, Denis V./0000-0003-2020-6084; Lubyaga, Yulia/0000-0002-2494-8723	Ministry of education and science of RF as a part of "Goszadanie" [6.382.2014/K, 1354(2014)]; Russian Science Foundation [14-14-00400]; Russian Foundation for Basic Research [14-04-00501, 14-34-50051, 15-04-06685]; CRDF [FSCX-15-61168-0]; program of strategic development at Irkutsk State University; ISU; DAAD	Ministry of education and science of RF as a part of "Goszadanie"; Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); CRDF; program of strategic development at Irkutsk State University; ISU; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This research was supported by Ministry of education and science of RF as a part of "Goszadanie" (No 6.382.2014/K, 1354(2014)), grant of Russian Science Foundation (No 14-14-00400), grant of Russian Foundation for Basic Research (No 14-04-00501, 14-34-50051, 15-04-06685), CRDF (FSCX-15-61168-0), program of strategic development at Irkutsk State University and grants of ISU for young researchers and DAAD. The support is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MD, 1995, J EUKARYOT MICROBIOL, V42, P564, DOI 10.1111/j.1550-7408.1995.tb05906.x; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Dunn AM, 2001, MICROBES INFECT, V3, P381, DOI 10.1016/S1286-4579(01)01394-6; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Issi I.V., 2002, Parazitologiya (St. Petersburg), V36, P478; Issi IV, 2005, PLANT PROTECTION NEW, V3, P16; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kozhova O. M., 1998, LAKE BAIKAL EVOLUTIO; Krebes L, 2010, INFECT GENET EVOL, V10, P1027, DOI 10.1016/j.meegid.2010.06.011; Kuzmenkova ZV, 2008, B IRKUTSK STATE U BE, V1, P56; LIPA J J, 1967, Acta Protozoologica, V5, P93; MacNeil C, 2003, P ROY SOC B-BIOL SCI, V270, P1309, DOI 10.1098/rspb.2003.2358; McClymont HE, 2005, INT J PARASITOL, V35, P1071, DOI 10.1016/j.ijpara.2005.05.008; Meyer T, 2009, DIS WILD CULTURED SH, P94; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Smith JE, 2009, PARASITOLOGY, V136, P1901, DOI 10.1017/S0031182009991818; Smith JE, 2008, 41 ANN M SOC INV PAT, P71; Stentiford GD, 2013, TRENDS PARASITOL, V29, P567, DOI 10.1016/j.pt.2013.08.005; Takhteev VV, 2012, BAICALOGY; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terry RS, 2004, P ROY SOC B-BIOL SCI, V271, P1783, DOI 10.1098/rspb.2004.2793; Timoshkin OA, 2001, INDEX ANIMAL SPECIES, V1; Tokarev Yu. S., 2010, Evraziatskii Entomologicheskii Zhurnal, V9, P571; Vilcinskas A, 2013, SCIENCE, V340, P862, DOI 10.1126/science.1234032; Vorontsova Ya. L., 2004, Parazitologiya (St. Petersburg), V38, P239; Wang LL, 2006, J EUKARYOT MICROBIOL, V53, P310, DOI 10.1111/j.1550-7408.2006.00106.x; WEISS LM, 1994, FOLIA PARASIT, V41, P81; Wilkinson TJ, 2011, INT J PARASITOL, V41, P959, DOI 10.1016/j.ijpara.2011.04.002	30	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130311	10.1371/journal.pone.0130311	http://dx.doi.org/10.1371/journal.pone.0130311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087136	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500095
J	Paes, EF; de Assis, AM; Teixeira, CSC; Aoki, FH; Teixeira, JC				Paes, Eliana Ferreira; de Assis, Angela Maria; Campos Teixeira, Cirbia S.; Aoki, Francisco Hideo; Teixeira, Julio Cesar			Development of a Multiplex PCR Test with Automated Genotyping Targeting E7 for Detection of Six High-Risk Human Papillomaviruses	PLOS ONE			English	Article							CERVICAL-CANCER; DNA; WOMEN; HPV	Cervical cancer is caused by high-risk human papillomaviruses (HPV) and viral detection tests aid in the diagnosis of precursor lesions. In the present study, a molecular test for detection of high-risk HPV DNA, called E7-HPV, was standardized and assessed in samples from women with pre-cancerous lesions. The development of the E7-HPV test for detection and genotyping of six high-risk HPV (types 16, 18, 31, 33, 45 and 52), consisted of evaluating primer quality and adjusting the multiplex PCR conditions. Primer design was based on the E7 region of each HPV, and the fluorochrome 6-FAM was added to PCR primers. Viral detection was performed by capillary electrophoresis in automated sequencer in samples obtained from 60 women (55 with ASC-H/HSIL cytology) from August to September 2013. A non-inferiority analysis was conducted with the cobas HPV test as a reference and following international guidelines for the development of new tests. The two tests had a high concordance rate in HPV16 detection (kappa=0.972), with only one discordant case (cervical intraepithelial neoplasia grade 3, negaive with cobas and positive for HPV16 by E7-HPV) and complete agreement in HPV18 detection. When comparing detection of all high-risk HPV, three cases were positive with cobas but negative with E7-HPV, and another three cases were negative with cobas but positive with E7-HPV (HPV16, 31 and 52). When we evaluate the cases initially suspected by cytology, the two tests had the same sensitivity in detection CIN2 or worse. In conclusion, the E7-HPV test has satisfactory initial results, and its development can be continued.	[Paes, Eliana Ferreira; Campos Teixeira, Cirbia S.; Teixeira, Julio Cesar] Univ Estadual Campinas, Fac Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil; [de Assis, Angela Maria; Aoki, Francisco Hideo] Univ Estadual Campinas, Lab Res AIDS, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Teixeira, JC (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.	juliotex@fcm.unicamp.br	Teixeira, Julio Cesar/H-3151-2013	Teixeira, Julio Cesar/0000-0002-0979-376X				[Anonymous], 2014, FDA APPROVES 1 HUMAN; Chung MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032259; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Resende LSDA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-214; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Gupta V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-19; Hesselink AT, 2014, J CLIN MICROBIOL, V52, P890, DOI 10.1128/JCM.03195-13; Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Molijn A, 2005, J CLIN VIROL, V32, pS43, DOI 10.1016/j.jcv.2004.12.004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Roteli-Martins CM, 2011, INT J GYNECOL PATHOL, V30, P173, DOI 10.1097/PGP.0b013e3181f38dfe; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P946; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	16	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130226	10.1371/journal.pone.0130226	http://dx.doi.org/10.1371/journal.pone.0130226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087285	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500084
J	Shen, Z; Munker, S; Luo, FG; Ma, H; Yu, CH; Li, YM				Shen, Zhe; Munker, Stefan; Luo, Fugang; Ma, Han; Yu, Chaohui; Li, Youming			Effect of Non-Alcoholic Fatty Liver Disease on Estimated Glomerular Filtration Rate Could Be Dependent on Age	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR-I; METABOLIC SYNDROME; RENAL-FUNCTION; OBESITY; RISK; STEATOHEPATITIS; DETERMINANTS; PREVALENCE; MECHANISMS	There is a gap between the association of non-alcoholic fatty liver disease (NAFLD) and renal function in an apparently healthy population. This study aims to assess whether NAFLD is associated with estimated glomerular filtration rate (eGFR) levels and to understand early changes of eGFR in NAFLD. A cross-sectional study was performed among apparently healthy persons who underwent general health screening including laboratory assessments and hepatic ultrasonography from January 2013 to December 2013 at the First Affiliated Hospital of Zhejiang University, College of Medicine, China. This study included 1,193 subjects with a mean age of 48 years. Prevalence of NAFLD was 31.3%. Mean eGFR was significantly lower in NAFLD than in controls (107 +/- 19 mL/min/1.73 m(2) vs. 113 +/- 23 mL/min/1.73 m(2), P<0.001). Correlation analysis between eGFR and NAFLD related risk factors revealed an inverse correlation between eGFR levels and some NAFLD risk factors (all P<0.01). All subjects were classified into five phases according to age. Average eGFR levels of NAFLD were lower than controls in three phases for subjects with <= 50 years of age (all P<0.05), while there were no significant differences on average eGFR levels between NAFLD and controls in two phases for subjects with >50 years of age (Both P>0.05). The eGFR level is significantly associated with NAFLD and its risk factors in an apparently healthy population. Effects of NAFLD on eGFR could be dependent on age.	[Shen, Zhe; Ma, Han; Yu, Chaohui; Li, Youming] Zhejiang Univ, Dept Gastroenterol, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Munker, Stefan] Heidelberg Univ, Med Clin Fac Med Mannheim 2, Mol Hepatol Alcohol Associated Dis, D-68167 Mannheim, Germany; [Luo, Fugang] Zhejiang Univ, Coll Med, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Ruprecht Karls University Heidelberg; Zhejiang University	Li, YM (corresponding author), Zhejiang Univ, Dept Gastroenterol, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.	zjulym@126.com		Ma, Han/0000-0001-9985-3035	National Natural Science Foundation of China [81300303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (No.81300303), http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carbone F, 2013, THROMB HAEMOSTASIS, V110, P940, DOI 10.1160/TH13-06-0499; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chou YC, 2014, J NEPHROL; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Hou X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106778, DOI 10.1371/journal.pone.0106778]; Hribal ML, 2013, J CLIN ENDOCR METAB, V98, pE304, DOI 10.1210/jc.2012-3290; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; Kalaitzidis RG, 2011, INT UROL NEPHROL, V43, P771, DOI 10.1007/s11255-011-9974-1; Kamenicky P, 2014, ENDOCR REV, V35, P234, DOI 10.1210/er.2013-1071; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lonardo A, 1997, ITAL J GASTROENTEROL, V29, P351; Machado MV, 2012, LIVER INT, V32, P241, DOI 10.1111/j.1478-3231.2011.02623.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Meziri M, 2005, ULTRASONICS, V43, P305, DOI 10.1016/j.ultras.2004.09.002; Musso G, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001680; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Prasad G V Ramesh, 2014, World J Nephrol, V3, P210, DOI 10.5527/wjn.v3.i4.210; Sarafidis PA, 2006, AM J NEPHROL, V26, P232, DOI 10.1159/000093632; Shen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080042; Shima T, 2014, HEPATOL RES; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Targher G, 2008, DIABETOLOGIA, V51, P1947, DOI 10.1007/s00125-008-1135-4; Targher G, 2010, NUTR METAB CARDIOVAS, V20, P583, DOI 10.1016/j.numecd.2009.05.012; Targher G, 2010, CLIN J AM SOC NEPHRO, V5, P2166, DOI 10.2215/CJN.05050610; Targher G, 2011, J HEPATOL, V54, P1020, DOI 10.1016/j.jhep.2010.11.007; Wang Q, 2015, J HYPERTENS, V33, P136, DOI 10.1097/HJH.0000000000000360; Weiner DE, 2008, AM J KIDNEY DIS, V51, P212, DOI 10.1053/j.ajkd.2007.10.035; Yasui K, 2011, METABOLISM, V60, P735, DOI 10.1016/j.metabol.2010.07.022; Yokoyama H, 2009, CLIN J AM SOC NEPHRO, V4, P1432, DOI 10.2215/CJN.06511208	32	4	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130614	10.1371/journal.pone.0130614	http://dx.doi.org/10.1371/journal.pone.0130614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087253	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500122
J	Westlund, JK; D'Mello, SK; Olney, AM				Westlund, Jacqueline Kory; D'Mello, Sidney K.; Olney, Andrew M.			Motion Tracker: Camera-Based Monitoring of Bodily Movements Using Motion Silhouettes	PLOS ONE			English	Article							BODY MOVEMENT; POSE RECOGNITION; POSTURAL CONTROL; AFFECTIVE STATES; SYNCHRONY; PERFORMANCE; INTEGRATION; EMOTIONS; FACE	Researchers in the cognitive and affective sciences investigate how thoughts and feelings are reflected in the bodily response systems including peripheral physiology, facial features, and body movements. One specific question along this line of research is how cognition and affect are manifested in the dynamics of general body movements. Progress in this area can be accelerated by inexpensive, non-intrusive, portable, scalable, and easy to calibrate movement tracking systems. Towards this end, this paper presents and validates Motion Tracker, a simple yet effective software program that uses established computer vision techniques to estimate the amount a person moves from a video of the person engaged in a task (available for download from http://jakory.com/motion-tracker/). The system works with any commercially available camera and with existing videos, thereby affording inexpensive, non-intrusive, and potentially portable and scalable estimation of body movement. Strong between-subject correlations were obtained between Motion Tracker's estimates of movement and body movements recorded from the seat (r =.720) and back (r = .695 for participants with higher back movement) of a chair affixed with pressure-sensors while completing a 32-minute computerized task (Study 1). Within-subject cross-correlations were also strong for both the seat (r = .606) and back (r = .507). In Study 2, between-subject correlations between Motion Tracker's movement estimates and movements recorded from an accelerometer worn on the wrist were also strong (rs = .801, .679, and .681) while people performed three brief actions (e.g., waving). Finally, in Study 3 the within-subject cross-correlation was high (r = .855) when Motion Tracker's estimates were correlated with the movement of a person's head as tracked with a Kinect while the person was seated at a desk (Study 3). Best-practice recommendations, limitations, and planned extensions of the system are discussed.	[Westlund, Jacqueline Kory] MIT, Media Lab, Cambridge, MA 02139 USA; [D'Mello, Sidney K.] Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA; [D'Mello, Sidney K.] Univ Notre Dame, Dept Comp Sci, Notre Dame, IN 46556 USA; [Olney, Andrew M.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA	Massachusetts Institute of Technology (MIT); University of Notre Dame; University of Notre Dame; University of Memphis	Westlund, JK (corresponding author), MIT, Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jakory@media.mit.edu		Gui, Yang/0000-0001-8856-4617				Aggarwal JK, 1999, COMPUT VIS IMAGE UND, V73, P428, DOI 10.1006/cviu.1998.0744; Ahad MAR, 2012, MACH VISION APPL, V23, P255, DOI 10.1007/s00138-010-0298-4; [Anonymous], 1997, TEKSC BOD PRESS MEAS; Arroyo I, 2009, FRONT ARTIF INTEL AP, V200, P17, DOI 10.3233/978-1-60750-028-5-17; Bachmann ER, 2003, 2003 IEEE INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN ROBOTICS AND AUTOMATION, VOLS I-III, PROCEEDINGS, P822; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984; BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243; bin Mohd Sidik M. K., 2011, DIG MED DIG CONT MAN, V2, P97; Biswas K.K., 2011, P 5 INT C AUT ROB AP, P100, DOI [10.1109/ICARA.2011.6144864, DOI 10.1109/ICARA.2011.6144864]; Bloemen H., 1997, EQUINE VET J S, V23, P16; Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338; Bradski G, 2000, DR DOBBS J, V25, P120; Bradski GR, 2002, MACH VISION APPL, V13, P174, DOI 10.1007/s001380100064; Brian MacWhinney, 2000, CHILDES PROJECT TOOL; Burba N., 2012, IEEE VIRTUAL REALITY, P1, DOI DOI 10.1109/VR.2012.6180952; Cade WL, 2011, LECT NOTES COMPUT SC, V6975, P305, DOI 10.1007/978-3-642-24571-8_34; Camurri A, 2003, LECT NOTES ARTIF INT, V2915, P460; Castellano G, 2007, LECT NOTES COMPUT SC, V4738, P71; Chen C, 2015, P IEEE INT C IM PROC; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; D'Mello S, 2012, LEARN INSTR, V22, P145, DOI 10.1016/j.learninstruc.2011.10.001; D'Mello S, 2012, COGNITION EMOTION, V26, P362, DOI 10.1080/02699931.2011.575767; D'Mello S, 2011, COGNITION EMOTION, V25, P1299, DOI 10.1080/02699931.2011.613668; Dael N, 2012, EMOTION, V12, P1085, DOI 10.1037/a0025737; Dael N, 2012, J NONVERBAL BEHAV, V36, P97, DOI 10.1007/s10919-012-0130-0; Davis JW, 1997, PROC CVPR IEEE, P928, DOI 10.1109/CVPR.1997.609439; DAVIS M, 1983, AM J DANCE THER, V6, P49, DOI 10.1007/BF02579519; Davis M, 1987, MOVEMENT STUDIES, V2, P29; De la Torre F, 2011, LECT NOTES COMPUT SC, V6974, P57, DOI 10.1007/978-3-642-24600-5_9; Dunne LE, 2008, IEEE T BIOMED CIRC S, V2, P97, DOI 10.1109/TBCAS.2008.927246; Enzweiler M, 2009, IEEE T PATTERN ANAL, V31, P2179, DOI 10.1109/TPAMI.2008.260; Fern'ndez-Baena A., 2012, 2012 4th International Conference on Intelligent Networking and Collaborative Systems (INCoS 2012), P656, DOI 10.1109/iNCoS.2012.66; Fontaine J, 2007, PSYCHOL SCI, V18, P12; FRIESEN WV, 1979, J NONVERBAL BEHAV, V4, P97, DOI 10.1007/BF01006354; Graesser A.C., 2001, INT J ARTIF INTELL E, V12, P257; Grammer K, 1998, J NONVERBAL BEHAV, V22, P3, DOI 10.1023/A:1022986608835; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; Guerra-Filho G, 2012, IMAGE VISION COMPUT, V30, P251, DOI 10.1016/j.imavis.2011.12.002; Ha S., 2011, P 2011 ACM SIGGRAPHE, P129; Harada T, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P3795, DOI 10.1109/ROBOT.2002.1014308; Harms H, 2008, P ICST 3 INT C BOD A, P22; Holden JG, CONT NONLINEAR METHO; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Junker H, 2003, SEVENTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P244, DOI 10.1109/ISWC.2003.1241420; Kamiya K, 2008, INT C PATT RECOG, P2841; Kristensen HH, 2006, APPL ANIM BEHAV SCI, V101, P125, DOI 10.1016/j.applanim.2006.01.007; Lukowicz P., 2005, P 7 INT S WEAR COMP, P267; MacWhinney B, 2007, CREATING AND DIGITIZING LANGUAGE CORPORA VOLUME 1: SYNCHRONIC DATABASES, P163; Mahbub U, 2012, 2012 INTERNATIONAL CONFERENCE ON INFORMATICS, ELECTRONICS & VISION (ICIEV), P919, DOI 10.1109/ICIEV.2012.6317501; Mattmann C, 2007, ELEVENTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P29; McKeown G, 2012, IEEE T AFFECT COMPUT, V3, P5, DOI 10.1109/T-AFFC.2011.20; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mondloch CJ, 2012, J EXP CHILD PSYCHOL, V111, P180, DOI 10.1016/j.jecp.2011.08.003; Morimoto C, 1998, P WORKSH PERC US INT, P117; Morison AM, 2009, SAGE PUBLICATIONS, V17, P1136; Nagaoka C, 2008, IEICE T INF SYST, VE91D, P1634, DOI 10.1093/ietisy/e91-d.6.1634; O'Sullivan K, 2010, P IR ERG SOC ANN C, P45; Olney AM, 2010, LECT NOTES COMPUT SC, V6095, P456; Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2; Pellecchia G, 2007, J MOTOR BEHAV, V37, P239; Pereira MG, 2010, COGN AFFECT BEHAV NE, V10, P94, DOI 10.3758/CABN.10.1.94; Poppe R, 2010, IMAGE VISION COMPUT, V28, P976, DOI 10.1016/j.imavis.2009.11.014; Ramenzoni VC, 2007, GAIT POSTURE, V25, P368, DOI 10.1016/j.gaitpost.2006.04.014; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Redfern MS, 2001, GAIT POSTURE, V14, P211, DOI 10.1016/S0966-6362(01)00144-8; Riley MA, 2012, EXP BRAIN RES, V217, P43, DOI 10.1007/s00221-011-2970-y; Roetenberg Daniel, 2009, 1 XSENS MOT TECHN BV, V1, P1; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Sanghvi J, 2011, ACMIEEE INT CONF HUM, P305, DOI 10.1145/1957656.1957781; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Shapiro L.G., 2002, COMPUTER VISION; Shotton J, 2013, COMMUN ACM, V56, P116, DOI 10.1145/2398356.2398381; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Slivovsky LA, 2000, ECE TECHNICAL REPORT; Stein, 2000, DIGIT SIGNAL PROCESS; Swan L, 2007, GAIT POSTURE, V26, P470, DOI 10.1016/j.gaitpost.2006.11.201; Tognetti A, 2007, T I MEAS CONTROL, V29, P215, DOI 10.1177/0142331207069487; Tooby John, 2008, HDB EMOTIONS, V3, P114, DOI DOI 10.2307/2076468; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; Varlet M, 2011, J EXP PSYCHOL HUMAN, V37, P473, DOI 10.1037/a0020552; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Watanabe K, 2005, IEEE T BIO-MED ENG, V52, P2100, DOI 10.1109/TBME.2005.857637; Weinland D, 2011, COMPUT VIS IMAGE UND, V115, P224, DOI 10.1016/j.cviu.2010.10.002; Xie F, 2011, IET IMAGE PROCESS, V5, P420, DOI 10.1049/iet-ipr.2009.0303; Yang CM, 2008, IEEE ENG MED BIO, P1304, DOI 10.1109/IEMBS.2008.4649403; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772	88	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130293	10.1371/journal.pone.0130293	http://dx.doi.org/10.1371/journal.pone.0130293			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NT	26086771	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500091
J	Blake, LI; Tveit, A; Ovreas, L; Head, IM; Gray, ND				Blake, Lynsay I.; Tveit, Alexander; Ovreas, Lise; Head, Ian M.; Gray, Neil D.			Response of Methanogens in Arctic Sediments to Temperature and Methanogenic Substrate Availability	PLOS ONE			English	Article							MINEROTROPHIC FEN; SP NOV.; METHYLOTROPHIC METHANOGEN; ARCHAEAL COMMUNITY; PEAT SOILS; LAKE; DIVERSITY; CARBON; BACTERIAL; SENSITIVITY	Although cold environments are major contributors to global biogeochemical cycles, comparatively little is known about their microbial community function, structure, and limits of activity. In this study a microcosm based approach was used to investigate the effects of temperature, and methanogenic substrate amendment, (acetate, methanol and H-2/CO2) on methanogen activity and methanogen community structure in high Arctic wetlands (Solvatnet and Stuphallet, Svalbard). Methane production was not detected in Stuphallet sediment microcosms (over a 150 day period) and occurred within Solvatnet sediments microcosms (within 24 hours) at temperatures from 5 to 40 degrees C, the maximum temperature being at far higher than in situ maximum temperatures (which range from air temperatures of -1.4 to 14.1 degrees C during summer months). Distinct responses were observed in the Solvatnet methanogen community under different short term incubation conditions. Specifically, different communities were selected at higher and lower temperatures. At lower temperatures (5 degrees C) addition of exogenous substrates (acetate, methanol or H-2/CO2) had no stimulatory effect on the rate of methanogenesis or on methanogen community structure. The community in these incubations was dominated by members of the Methanoregulaceae/WCHA2-08 family-level group, which were most similar to the psychrotolerant hydrogenotrophic methanogen Methanosphaerula palustris strain E1-9c. In contrast, at higher temperatures, substrate amendment enhanced methane production in H-2/CO2 amended microcosms, and played a clear role in structuring methanogen communities. Specifically, at 30 degrees C members of the Methanoregulaceae/WCHA2-08 predominated following incubation with H-2/CO2, and Methanosarcinaceaeand Methanosaetaceae were enriched in response to acetate addition. These results may indicate that in transiently cold environments, methanogen communities can rapidly respond to moderate short term increases in temperature, but not necessarily to the seasonal release of previously frozen organic carbon from thawing permafrost soils. However, as temperatures increase such inputs of carbon will likely have a greater influence on methane production and methanogen community structure. Understanding the action and limitations of anaerobic microorganisms within cold environments may provide information which can be used in defining region-specific differences in the microbial processes; which ultimately control methane flux to the atmosphere.	[Blake, Lynsay I.; Head, Ian M.; Gray, Neil D.] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tveit, Alexander] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Ovreas, Lise] Univ Bergen, Dept Biol, Bergen, Norway; [Ovreas, Lise] Univ Bergen, Ctr Geobiol, Bergen, Norway	Newcastle University - UK; UiT The Arctic University of Tromso; University of Bergen; University of Bergen	Gray, ND (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	n.d.gray@newcastle.ac.uk	Øvreås, Lise/H-8651-2016	Head, Ian/0000-0002-5373-162X; gray, neil/0000-0002-2395-4320; Blake, Lynsay/0000-0001-8986-3280; Tveit, Alexander Tosdal/0000-0002-4163-3416	Engineering and Physical Sciences Research Council studentship; NERC [NE/E01657X/1] Funding Source: UKRI; Natural Environment Research Council [NE/E01657X/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by an Engineering and Physical Sciences Research Council studentship awarded to Newcastle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; Baringer MO, 2010, B AM METEOROL SOC, V91, pS1, DOI 10.1175/BAMS-91-7-StateoftheClimate; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Basiliko N, 2003, GEOMICROBIOL J, V20, P563, DOI 10.1080/713851165; Blake LI, 2010, THESIS; Boardman CP, 2013, J GEOPHYS RES-BIOGEO, V118, P462, DOI 10.1002/jgrg.20017; Bowen EJ, 2014, WATER SCI TECHNOL, V69, P1004, DOI 10.2166/wst.2013.821; Cadillo-Quiroz H, 2008, APPL ENVIRON MICROB, V74, P2059, DOI 10.1128/AEM.02222-07; Cadillo-Quiroz H, 2009, INT J SYST EVOL MICR, V59, P928, DOI 10.1099/ijs.0.006890-0; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; Cavicchioli R, 2006, NAT REV MICROBIOL, V4, P331, DOI 10.1038/nrmicro1390; CHIN KJ, 1995, FEMS MICROBIOL ECOL, V18, P85, DOI 10.1016/0168-6496(95)00042-9; Christensen TR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018680; DUNFIELD P, 1993, SOIL BIOL BIOCHEM, V25, P321, DOI 10.1016/0038-0717(93)90130-4; Enright AM, 2009, SYST APPL MICROBIOL, V32, P65, DOI 10.1016/j.syapm.2008.10.003; Franzmann PD, 1996, BIODIVERS CONSERV, V5, P1295, DOI 10.1007/BF00051980; Franzmann PD, 1997, INT J SYST BACTERIOL, V47, P1068, DOI 10.1099/00207713-47-4-1068; Galand PE, 2005, APPL ENVIRON MICROB, V71, P2195, DOI 10.1128/AEM.71.4.2195-2198.2005; Ganzert L, 2007, FEMS MICROBIOL ECOL, V59, P476, DOI 10.1111/j.1574-6941.2006.00205.x; Graef C, 2011, ENV MICROBIOL REP, V3, P466, DOI 10.1111/j.1758-2229.2010.00237.x; Gray ND, 2002, ENVIRON MICROBIOL, V4, P158, DOI 10.1046/j.1462-2920.2002.00280.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hobbie SR, 2000, GLOBAL CHANGE BIOL, V6, P169; Hoj L, 2005, FEMS MICROBIOL ECOL, V53, P89, DOI 10.1016/j.femsec.2005.01.004; Hoj L, 2008, ISME J, V2, P37, DOI 10.1038/ismej.2007.84; Hoj L, 2006, ENVIRON MICROBIOL, V8, P984, DOI 10.1111/j.1462-2920.2006.00982.x; IPCC, CLIMATE CHANGE 2007; Jiang XP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043866; Karhu K, 2014, NATURE, V513, P81, DOI 10.1038/nature13604; Kim SY, 2012, APPL SOIL ECOL, V57, P23, DOI 10.1016/j.apsoil.2012.02.015; Kotsyurbenko OR, 2005, FEMS MICROBIOL ECOL, V53, P3, DOI 10.1016/j.femsec.2004.12.009; LIU Y, 1990, INT J SYST BACTERIOL, V40, P111, DOI 10.1099/00207713-40-2-111; Livingstone DM, 1998, J PALEOLIMNOL, V19, P181, DOI 10.1023/A:1007904817619; Lupascu M, 2012, ARCT ANTARCT ALP RES, V44, P469, DOI 10.1657/1938-4246-44.4.469; McHugh S, 2006, BIORESOURCE TECHNOL, V97, P1669, DOI 10.1016/j.biortech.2005.07.020; Metje M, 2007, ENVIRON MICROBIOL, V9, P954, DOI 10.1111/j.1462-2920.2006.01217.x; Mochimaru H, 2009, INT J SYST EVOL MICR, V59, P714, DOI 10.1099/ijs.0.001677-0; Mondav R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4212; Moritz RE, 2002, SCIENCE, V297, P1497, DOI 10.1126/science.1076522; Nedwell DB, 1999, FEMS MICROBIOL ECOL, V30, P101; Nozhevnikova AN, 2007, FEMS MICROBIOL ECOL, V62, P336, DOI 10.1111/j.1574-6941.2007.00389.x; Nozhevnikova AN, 1997, WATER SCI TECHNOL, V36, P57, DOI 10.1016/S0273-1223(97)00507-6; Nozhevnikova AN, 2003, APPL ENVIRON MICROB, V69, P1832, DOI 10.1128/AEM.69.3.1832-1835.2003; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; PATEL GB, 1976, CAN J MICROBIOL, V22, P1404, DOI 10.1139/m76-208; PATEL GB, 1990, INT J SYST BACTERIOL, V40, P79, DOI 10.1099/00207713-40-1-79; Rath AK, 2002, GEOMICROBIOL J, V19, P581, DOI 10.1080/01490450290098595; Sawicka JE, 2010, ISME J, V4, P585, DOI 10.1038/ismej.2009.140; Schulz S, 1997, FEMS MICROBIOL ECOL, V22, P207, DOI 10.1016/S0168-6496(96)00091-8; Simankova MV, 2001, SYST APPL MICROBIOL, V24, P362, DOI 10.1078/0723-2020-00058; Simankova MV, 2003, SYST APPL MICROBIOL, V26, P312, DOI 10.1078/072320203322346173; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Treat C, GLOBAL CHANGE BIOL I; Tveit A, 2013, ISME J, V7, P299, DOI 10.1038/ismej.2012.99; UPDEGRAFF K, 1995, ECOL APPL, V5, P151, DOI 10.2307/1942060; van Verseveld HW., 2004, MOL MICROBIAL ECOLOG, V2nd edn, P1373; Wagner D, 2003, PERMAFROST PERIGLAC, V14, P173, DOI 10.1002/ppp.443; Walter KM, 2007, PHILOS T R SOC A, V365, P1657, DOI 10.1098/rsta.2007.2036; WESTERMANN P, 1993, CHEMOSPHERE, V26, P321, DOI 10.1016/0045-6535(93)90428-8; WESTERMANN P, 1987, APPL ENVIRON MICROB, V53, P2554, DOI 10.1128/AEM.53.10.2554-2559.1987; WIEBE WJ, 1993, MICROBIAL ECOL, V25, P151, DOI 10.1007/BF00177192; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Wuebbles DJ, 2002, EARTH-SCI REV, V57, P177, DOI 10.1016/S0012-8252(01)00062-9; Yashiro Y, 2011, INT J SYST EVOL MICR, V61, P53, DOI 10.1099/ijs.0.014811-0; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164; ZEIKUS JG, 1976, APPL ENVIRON MICROB, V31, P99, DOI 10.1128/AEM.31.1.99-107.1976	68	45	46	6	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129733	10.1371/journal.pone.0129733	http://dx.doi.org/10.1371/journal.pone.0129733			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083466	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000356567400106
J	Muindi, F; Colas, D; Ikeme, J; Ruby, NF; Heller, HC				Muindi, Fanuel; Colas, Damien; Ikeme, Jesse; Ruby, Norman F.; Heller, H. Craig			Loss of Melanopsin Photoreception and Antagonism of the Histamine H3 Receptor by Ciproxifan Inhibit Light-Induced Sleep in Mice	PLOS ONE			English	Article							CIRCADIAN VISUAL-SYSTEM; RETINAL GANGLION-CELLS; H-3 RECEPTOR; NEURON SYSTEM; BRAIN; ENTRAINMENT; MECHANISMS; RESPONSES; RELEASE; DARK	Light has direct effects on sleep and wakefulness causing arousal in diurnal animals and sleep in nocturnal animals. In the present study, we assessed the modulation of light-induced sleep by melanopsin and the histaminergic system by exposing mice to millisecond light flashes and continuous light respectively. First, we show that the induction of sleep by millisecond light flashes is dose dependent as a function of light flash number. We found that exposure to 60 flashes of light occurring once every 60 seconds for 1-h (120-ms of total light over an hour) induced a similar amount of sleep as a continuous bright light pulse. Secondly, the induction of sleep by millisecond light flashes was attenuated in the absence of melanopsin when animals were presented with flashes occurring every 60 seconds over a 3-h period beginning at ZT13. Lastly, the acute administration of a histamine H3 autoreceptor antagonist, ciproxifan, blocked the induction of sleep by a 1-h continuous light pulse during the dark period. Ciproxifan caused a decrease in NREMS delta power and an increase in theta activity during both sleep and wake periods respectively. The data suggest that some form of temporal integration occurs in response to millisecond light flashes, and that this process requires melanopsin photoreception. Furthermore, the pharmacological data suggest that the increase of histaminergic neurotransmission is sufficient to attenuate the light-induced sleep response during the dark period.	[Muindi, Fanuel; Colas, Damien; Ikeme, Jesse; Ruby, Norman F.; Heller, H. Craig] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Muindi, Fanuel] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Stanford University; Massachusetts Institute of Technology (MIT)	Muindi, F (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	fmuindi@mit.edu		Heller, H Craig/0000-0003-4479-5880; Colas, Damien/0000-0002-7008-3257; /0000-0002-1998-1449	Down Syndrome Research and Treatment Foundation (DSRTF); Research Down Syndrome Organization (RDS); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095837] Funding Source: NIH RePORTER	Down Syndrome Research and Treatment Foundation (DSRTF); Research Down Syndrome Organization (RDS); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Down Syndrome Research and Treatment Foundation (DSRTF) and the Research Down Syndrome Organization (RDS).	ALFOLDI P, 1991, BEHAV BRAIN RES, V43, P125, DOI 10.1016/S0166-4328(05)80062-2; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; ARRANG JM, 1985, NEUROSCIENCE, V15, P553, DOI 10.1016/0306-4522(85)90233-7; ARRANG JM, 1987, NEUROSCIENCE, V23, P149, DOI 10.1016/0306-4522(87)90279-X; BORBELY AA, 1975, BRAIN RES, V95, P89, DOI 10.1016/0006-8993(75)90209-7; Colas D, 2008, NEUROBIOL DIS, V30, P1, DOI 10.1016/j.nbd.2007.07.014; Esbenshade TA, 2008, BRIT J PHARMACOL, V154, P1166, DOI 10.1038/bjp.2008.147; Gondard E, 2013, NEUROPSY CHOPHARMACO; Griebel G, 2012, BEHAV BRAIN RES, V232, P416, DOI 10.1016/j.bbr.2012.04.033; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hubbard J, 2013, SLEEP MED REV; ITOH Y, 1991, J NEUROCHEM, V56, P769, DOI 10.1111/j.1471-4159.1991.tb01990.x; Kathmann M, 1998, N-S ARCH PHARMACOL, V358, P623, DOI 10.1007/PL00005303; Lin JS, 2000, SLEEP MED REV, V4, P471, DOI 10.1053/smrv.2000.0116; LIN JS, 1990, BRAIN RES, V523, P325, DOI 10.1016/0006-8993(90)91508-E; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; MONTI JM, 1991, EUR J PHARMACOL, V205, P283, DOI 10.1016/0014-2999(91)90911-9; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Morin LP, 2011, NEUROSCIENCE, V199, P213, DOI 10.1016/j.neuroscience.2011.09.057; Morin LP, 2009, J BIOL RHYTHM, V24, P497, DOI 10.1177/0748730409349059; Morin LP, 2010, J BIOL RHYTHM, V25, P197, DOI 10.1177/0748730410369890; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Muindi F, 2013, EUR J NEUROSCI; Muindi F, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00135; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; PANULA P, 1985, J HISTOCHEM CYTOCHEM, V33, P933, DOI 10.1177/33.9.3894504; Parmentier R, 2007, BIOCHEM PHARMACOL, V73, P1157, DOI 10.1016/j.bcp.2007.01.002; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; RUSAK B, 1979, FED PROC, V38, P2589; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; Studholme KM, 2013, AM J PHYSIOL-REG I, V304, pR459, DOI 10.1152/ajpregu.00460.2012; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Van den Pol AN, 1998, AM J PHYSIOL-REG I, V275, pR654, DOI 10.1152/ajpregu.1998.275.2.R654; van Oosterhout F, 2012, CURR BIOL, V22, P1397, DOI 10.1016/j.cub.2012.05.032; Vidal L, 2007, J NEUROSCI, V27, P3375, DOI 10.1523/JNEUROSCI.5496-06.2007; WATANABE T, 1983, NEUROSCI LETT, V39, P249, DOI 10.1016/0304-3940(83)90308-7; WATANABE T, 1984, BRAIN RES, V295, P13, DOI 10.1016/0006-8993(84)90811-4	44	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128175	10.1371/journal.pone.0128175	http://dx.doi.org/10.1371/journal.pone.0128175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083020	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400031
J	Schoenenberger, AW; Pfaff, D; Dasen, B; Frismantiene, A; Erne, P; Resink, TJ; Philippova, M				Schoenenberger, Andreas W.; Pfaff, Dennis; Dasen, Boris; Frismantiene, Agne; Erne, Paul; Resink, Therese J.; Philippova, Maria			Gender-Specific Associations between Circulating T-Cadherin and High Molecular Weight-Adiponectin in Patients with Stable Coronary Artery Disease	PLOS ONE			English	Article							PLASMA ADIPONECTIN; ENDOTHELIAL-CELLS; STIMULATES ANGIOGENESIS; HORMONE REPLACEMENT; METABOLIC SYNDROME; IN-VITRO; PROTEIN; EXPRESSION; MICROPARTICLES; CDH13	Close relationships exist between presence of adiponectin (APN) within vascular tissue and expression of T-cadherin (T-cad) on vascular cells. APN and T-cad are also present in the circulation but here their relationships are unknown. This study investigates associations between circulating levels of high molecular weight APN (HMW-APN) and T-cad in a population comprising 66 women and 181 men with angiographically proven stable coronary artery disease (CAD). Plasma HMW-APN and T-cad were measured by ELISA and analysed for associations with baseline clinical characteristics and with each other. In multivariable analysis BMI and HDL were independently associated with HMW-APN in both genders, while diabetes and extent of coronary stenosis were independently associated with T-cad in males only. Regression analysis showed no significant association between HMW-APN and T-cad in the overall study population. However, there was a negative association between HMW-APN and T-cad (P=0.037) in a subgroup of young men (age <60 years, had no diabetes and no or 1-vessel CAD) which persisted after multivariable analysis with adjustment for all potentially influential variables (P=0.021). In the corresponding subgroup of women there was a positive association between HMW-APN and T-cad (P=0.013) which disappeared after adjustment for HDL. After exclusion of the young men, a positive association (P=0.008) between HMW-APN and T-cad was found for the remaining participants of the overall population which disappeared after adjustment for HDL and BMI. The existence of opposing correlations between circulating HMW-APN and T-cad in male and female patient populations underscores the necessity to consider gender as a confounding variable when evaluating biomarker potentials of APN and T-cad.	[Schoenenberger, Andreas W.] Univ Hosp Bern, Dept Gen Internal Med, Div Geriatr, CH-3010 Bern, Switzerland; [Schoenenberger, Andreas W.; Pfaff, Dennis; Dasen, Boris; Frismantiene, Agne; Erne, Paul; Resink, Therese J.; Philippova, Maria] Univ Bern, Bern, Switzerland; [Pfaff, Dennis; Dasen, Boris; Frismantiene, Agne; Erne, Paul; Resink, Therese J.; Philippova, Maria] Univ Basel Hosp, Dept Biomed, Lab Signal Transduct, CH-4031 Basel, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Basel	Resink, TJ (corresponding author), Univ Basel Hosp, Dept Biomed, Lab Signal Transduct, CH-4031 Basel, Switzerland.	Therese-J.Resink@unibas.ch	Stefanadis, Christodoulos/ABH-2232-2020; Filippova, Maria/GXH-7313-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; Frismantiene, Agne/0000-0002-2018-2986; Filippova, Maria/0000-0003-3124-3155	Swiss National Science Foundation [310030_132469]; Stiftung fur Herz- und Kreislaufkrankheiten	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung fur Herz- und Kreislaufkrankheiten	This work was supported by the Swiss National Science Foundation, grant no. 310030_132469 (to TJR) and Stiftung fur Herz- und Kreislaufkrankheiten (to TJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2005, CLIN ENDOCRINOL, V62, P114, DOI 10.1111/j.1365-2265.2004.02182.x; Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; Asada K, 2007, INT J MOL MED, V20, P725; Aso Y, 2006, DIABETES, V55, P1954, DOI 10.2337/db05-1525; Barton M, 2013, CURR OPIN LIPIDOL, V24, P214, DOI 10.1097/MOL.0b013e3283613a94; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Bromhead C, 2006, GENE, V374, P58, DOI 10.1016/j.gene.2006.01.013; Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Doyle DD, 1998, J BIOL CHEM, V273, P6937, DOI 10.1074/jbc.273.12.6937; Ebner A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0390-9; El-Menyar A, 2009, J CARDIOVASC MED, V10, P310, DOI 10.2459/JCM.0b013e3283252b50; Fisman EZ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-103; Fuerst M, 2012, J ENDOCRINOL, V215, P107, DOI 10.1530/JOE-12-0021; Gao H, 2013, DIABETES, V62, P4277, DOI 10.2337/db13-0129; Hartwig S, 2014, ARCH PHYSIOL BIOCHEM, V120, P208, DOI 10.3109/13813455.2014.970197; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Ivanov D, 2001, HISTOCHEM CELL BIOL, V115, P231; Joshi MB, 2005, FASEB J, V19, P1737, DOI 10.1096/fj.05-3834fje; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Komura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071271; Kudrjashova E, 2002, HISTOCHEM CELL BIOL, V118, P281, DOI 10.1007/s00418-002-0463-6; Kunnari A, 2008, METABOLISM, V57, P1509, DOI 10.1016/j.metabol.2008.06.004; Kyriakakis E, 2010, CELL SIGNAL, V22, P1308, DOI 10.1016/j.cellsig.2010.04.008; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Liu BH, 2008, J ANIM SCI, V86, P3377, DOI 10.2527/jas.2008-0971; Matsuda K, 2014, ENDOCRINOLOGY; Medina RA, 2003, BIOL RES, V36, P325, DOI 10.4067/S0716-97602003000300005; Nishizawa H, 2002, DIABETES, V51, P2734, DOI 10.2337/diabetes.51.9.2734; Okamoto Y, 2000, HORM METAB RES, V32, P47, DOI 10.1055/s-2007-978586; Otake H, 2008, AM J CARDIOL, V101, P1, DOI 10.1016/j.amjcard.2007.07.041; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Parker-Duffen JL, 2014, BEST PRACT RES CL EN, V28, P81, DOI 10.1016/j.beem.2013.09.001; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; Pfaff D, 2014, EUR HEART J ACUTE CA; Philippova M, 2003, HISTOCHEM CELL BIOL, V120, P353, DOI 10.1007/s00418-003-0584-6; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Philippova M, 2011, EUR HEART J, V32, P760, DOI 10.1093/eurheartj/ehq206; Philippova M, 2009, CELL SIGNAL, V21, P1035, DOI 10.1016/j.cellsig.2009.01.035; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Seino Y, 2007, METABOLISM, V56, P1493, DOI 10.1016/j.metabol.2007.06.015; Sieminska L, 2005, METABOLISM, V54, P1610, DOI 10.1016/j.metabol.2005.06.008; Tamakoshi K, 2007, CLIN ENDOCRINOL, V66, P65, DOI 10.1111/j.1365-2265.2006.02687.x; Uetani E, 2014, DIABETES CARE, V37, P396, DOI 10.2337/dc13-1658; Wang Min, 2012, Shengli Xuebao, V64, P296; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0131140	10.1371/journal.pone.0131140	http://dx.doi.org/10.1371/journal.pone.0131140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083608	Green Published, gold			2022-12-26	WOS:000356567400168
J	Hasan, MM; Zhou, Y; Lu, XT; Li, JY; Song, JN; Zhang, ZD				Hasan, Md. Mehedi; Zhou, Yuan; Lu, Xiaotian; Li, Jinyan; Song, Jiangning; Zhang, Ziding			Computational Identification of Protein Pupylation Sites by Using Profile-Based Composition of k-Spaced Amino Acid Pairs	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; PROTEASOMAL DEGRADATION; PUP; PREDICTION; SIGNAL; METHYLATION; CASCLEAVE; CASPASE; PATHWAY	Prokaryotic proteins are regulated by pupylation, a type of post-translational modification that contributes to cellular function in bacterial organisms. In pupylation process, the prokaryotic ubiquitin-like protein (Pup) tagging is functionally analogous to ubiquitination in order to tag target proteins for proteasomal degradation. To date, several experimental methods have been developed to identify pupylated proteins and their pupylation sites, but these experimental methods are generally laborious and costly. Therefore, computational methods that can accurately predict potential pupylation sites based on protein sequence information are highly desirable. In this paper, a novel predictor termed as pbPUP has been developed for accurate prediction of pupylation sites. In particular, a sophisticated sequence encoding scheme [i.e. the profile-based composition of k-spaced amino acid pairs (pbCKSAAP)] is used to represent the sequence patterns and evolutionary information of the sequence fragments surrounding pupylation sites. Then, a Support Vector Machine (SVM) classifier is trained using the pbCKSAAP encoding scheme. The final pbPUP predictor achieves an AUC value of 0.849 in 10-fold cross-validation tests and outperforms other existing predictors on a comprehensive independent test dataset. The proposed method is anticipated to be a helpful computational resource for the prediction of pupylation sites. The web server and curated datasets in this study are freely available at http://protein.cau.edu.cn/pbPUP/.	[Hasan, Md. Mehedi; Zhou, Yuan; Lu, Xiaotian; Zhang, Ziding] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Li, Jinyan] Univ Technol Sydney, Adv Analyt Inst & Ctr Hlth Technol, Sydney, NSW 2007, Australia; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin 300308, Peoples R China; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Song, Jiangning] Monash Univ, Fac Med, Monash Bioinformat Platform, Melbourne, Vic 3800, Australia; [Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia	China Agricultural University; University of Technology Sydney; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Monash University; Monash University	Zhang, ZD (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	zidingzhang@cau.edu.cn	, zidingzhang/E-9320-2011; Song, Jiangning/F-9787-2010; Hasan, Mehedi/HHC-4236-2022	, zidingzhang/0000-0002-9296-571X; Song, Jiangning/0000-0001-8031-9086; HASAN, MD. MEHEDI/0000-0003-4952-0739; Li, Jinyan/0000-0003-1833-7413	China Scholarship Council (CSC); ARC Discovery Project [DP130102124]; Hundred Talents Program of the Chinese Academy of Sciences (CAS)	China Scholarship Council (CSC)(China Scholarship Council); ARC Discovery Project(Australian Research Council); Hundred Talents Program of the Chinese Academy of Sciences (CAS)	MMH was financially supported by the China Scholarship Council (CSC). JL was supported by an ARC Discovery Project (DP130102124). JS is a recipient of the Hundred Talents Program of the Chinese Academy of Sciences (CAS).	Barandun J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-95; Burns KE, 2010, SUBCELL BIOCHEM, V54, P149, DOI 10.1007/978-1-4419-6676-6_12; Burns KE, 2010, CELL MICROBIOL, V12, P424, DOI 10.1111/j.1462-5822.2010.01447.x; CENTOR RM, 1991, MED DECIS MAKING, V11, P102, DOI 10.1177/0272989X9101100205; Cerda-Maira FA, 2011, EMBO REP, V12, P863, DOI 10.1038/embor.2011.109; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2009, J COMPUT CHEM, V30, P163, DOI 10.1002/jcc.21053; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074002; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Chen Z, 2015, BRIEF BIOINFORM, V16, P640, DOI 10.1093/bib/bbu031; Chen Z, 2013, BBA-PROTEINS PROTEOM, V1834, P1461, DOI 10.1016/j.bbapap.2013.04.006; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Darwin KH, 2009, NAT REV MICROBIOL, V7, P485, DOI 10.1038/nrmicro2148; DeMartino GN, 2009, TRENDS BIOCHEM SCI, V34, P155, DOI 10.1016/j.tibs.2008.12.005; Dong XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056632; Elharar Y, 2014, EMBO J, V33, P1802, DOI 10.15252/embj.201387076; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Goldberg AL, 2005, NEURON, V45, P339, DOI 10.1016/j.neuron.2005.01.019; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Kraut DA, 2010, EMBO J, V29, P1163, DOI 10.1038/emboj.2010.40; Kuberl A, 2014, PROTEOMICS, V14, P1531, DOI 10.1002/pmic.201300531; Li Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05765; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; Lin C-J, 2003, NIPS 2003 FEATURE SE, P1; Liu ZX, 2011, MOL BIOSYST, V7, P2737, DOI 10.1039/c1mb05217a; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Poulsen C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.39; Provost F, 2000, AAAI 2000 WORKSH IMB; Salgame P, 2008, CELL HOST MICROBE, V4, P415, DOI 10.1016/j.chom.2008.10.009; Shi SP, 2012, MOL BIOSYST, V8, P1520, DOI 10.1039/c2mb05502c; Si JN, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-73; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Striebel F, 2014, BBA-MOL CELL RES, V1843, P103, DOI 10.1016/j.bbamcr.2013.03.022; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Tung CW, 2013, J THEOR BIOL, V336, P11, DOI 10.1016/j.jtbi.2013.07.009; Tung CW, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-40; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wang MJ, 2014, BIOINFORMATICS, V30, P71, DOI 10.1093/bioinformatics/btt603; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Watrous J, 2010, MOL BIOSYST, V6, P376, DOI 10.1039/b916104j; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Yan RX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-416; Yun HY, 2012, BIOSCI BIOTECH BIOCH, V76, P1959, DOI 10.1271/bbb.120458; Zhang WY, 2013, PROTEIN PEPTIDE LETT, V20, P911, DOI 10.2174/0929866511320080008; ZHAO XA, 2012, PLOS GENET, V8, DOI DOI 10.1371/JOURNAL.PONE.0046302; Zhao XW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/109549; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083167	56	56	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129635	10.1371/journal.pone.0129635	http://dx.doi.org/10.1371/journal.pone.0129635			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080082	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300028
J	Xie, SL; Chen, TZ; Huang, XL; Chen, C; Jin, R; Huang, ZM; Zhou, MT				Xie, Sai-Li; Chen, Tan-Zhou; Huang, Xie-Lin; Chen, Chao; Jin, Rong; Huang, Zhi-Ming; Zhou, Meng-Tao			Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE GENE; APOLIPOPROTEIN A5 GENE; PLASMA TRIGLYCERIDE LEVELS; CORONARY-ARTERY-DISEASE; HYPERLIPIDEMIC PANCREATITIS; CHINESE POPULATION; PREGNANCY; RISK; POLYMORPHISMS; MUTATIONS	Severe hypertriglyceridemia is a well-known cause of pancreatitis. Usually, there is a moderate increase in plasma triglyceride level during pregnancy. Additionally, certain pre-existing genetic traits may render a pregnant woman susceptible to development of severe hypertriglyceridemia and pancreatitis, especially in the third trimester. To elucidate the underlying mechanism of gestational hypertriglyceridemic pancreatitis, we undertook DNA mutation analysis of the lipoprotein lipase (LPL), apolipoprotein C2 (APOC2), apolipoprotein A5 (APOA5), lipase maturation factor 1 (LMF1), and glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) genes in five unrelated pregnant Chinese women with severe hypertriglyceridemia and pancreatitis. DNA sequencing showed that three out of five patients had the same homozygous variation, p.G185C, in APOA5 gene. One patient had a compound heterozygous mutation, p.A98T and p.L279V, in LPL gene. Another patient had a compound heterozygous mutation, p.A98T & p.C14F in LPL and GPIHBP1 gene, respectively. No mutations were seen in APOC2 or LMF1 genes. All patients were diagnosed with partial LPL deficiency in non-pregnant state. As revealed in our study, genetic variants appear to play an important role in the development of severe gestational hypertriglyceridemia, and, p.G185C mutation in APOA5 gene appears to be the most common variant implicated in the Chinese population. Antenatal screening for mutations in susceptible women, combined with subsequent interventions may be invaluable in the prevention of potentially life threatening gestational hypertriglyceridemia-induced pancreatitis.	[Xie, Sai-Li; Chen, Tan-Zhou; Chen, Chao; Jin, Rong; Huang, Zhi-Ming; Zhou, Meng-Tao] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China; [Huang, Xie-Lin] Wenzhou Med Univ, Ren Ji Study, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Huang, ZM (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China.	hzmwenzhou@163.com; zmt0417@hotmail.com		Jin, Rong/0000-0003-3342-8970				Alvarez JJ, 1996, J LIPID RES, V37, P299; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Crisan LS, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.003; DECHALAIN TMB, 1988, SURG GYNECOL OBSTET, V167, P469; Demirdogen BC, 2012, MOL BIOL REP, V39, P10459, DOI 10.1007/s11033-012-1926-z; Eskandar O, 2007, J OBSTET GYNAECOL RE, V33, P186, DOI 10.1111/j.1447-0756.2007.00506.x; Fisher RM, 1997, ATHEROSCLEROSIS, V135, P145, DOI 10.1016/S0021-9150(97)00199-8; FOJO SS, 1992, J INTERN MED, V231, P669, DOI 10.1111/j.1365-2796.1992.tb01256.x; Fruchart-Najib J, 2004, BIOCHEM BIOPH RES CO, V319, P397, DOI 10.1016/j.bbrc.2004.05.003; Henderson H, 1998, CLIN CHIM ACTA, V269, P1, DOI 10.1016/S0009-8981(97)00144-7; Hishida A, 2012, ENDOCR J, V59, P589, DOI 10.1507/endocrj.EJ11-0310; Hodoglugil U, 2006, J LIPID RES, V47, P144, DOI 10.1194/jlr.M500343-JLR200; HSIA SH, 1995, AM J MED SCI, V309, P213, DOI 10.1097/00000441-199504000-00005; Hsu LA, 2006, ATHEROSCLEROSIS, V185, P143, DOI 10.1016/j.atherosclerosis.2005.05.031; Hubacek JA, 2004, PHYSIOL RES, V53, P225; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; Lee MJ, 2013, CLIN CHIM ACTA, V416, P31, DOI 10.1016/j.cca.2012.10.054; MA YH, 1994, J LIPID RES, V35, P1066; MA YH, 1993, J CLIN INVEST, V91, P1953, DOI 10.1172/JCI116414; Matsunaga A, 2007, CIRC J, V71, P746, DOI 10.1253/circj.71.746; McGladdery SH, 2001, J LIPID RES, V42, P1905; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; MISRA KB, 1994, J BIOL CHEM, V269, P23838; Murugasu CG, 1998, J ROY SOC MED, V91, P205, DOI 10.1177/014107689809100410; Nasstrom B, 2001, J LAB CLIN MED, V138, P206, DOI 10.1067/mlc.2001.117666; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; Pennacchio LA, 2003, ARTERIOSCL THROM VAS, V23, P529, DOI 10.1161/01.ATV.0000054194.78240.45; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Peterfy M, 2007, NAT GENET, V39, P1483, DOI 10.1038/ng.2007.24; Pullinger CR, 2008, J LIPID RES, V49, P1846, DOI 10.1194/jlr.P800011-JLR200; Shenhav S, 2002, ACTA OBSTET GYN SCAN, V81, P788, DOI 10.1034/j.1600-0412.2002.810819.x; Sivakumaran P, 2009, J CLIN APHERESIS, V24, P42, DOI 10.1002/jca.20192; Suga S, 1998, J INTERN MED, V243, P317, DOI 10.1046/j.1365-2796.1998.00306.x; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; SWOBODA K, 1993, GASTROENTEROLOGY, V104, P1527, DOI 10.1016/0016-5085(93)90366-K; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; Tang YB, 2006, ATHEROSCLEROSIS, V185, P433, DOI 10.1016/j.atherosclerosis.2005.06.026; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Yadav D, 2003, J CLIN GASTROENTEROL, V36, P54, DOI 10.1097/00004836-200301000-00016; Yamamoto H, 2013, J ATHEROSCLER THROMB, V20, P777; Yin RX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017954; Zhai GH, 2006, CLIN CHEM LAB MED, V44, P1313, DOI 10.1515/CCLM.2006.255	45	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129488	10.1371/journal.pone.0129488	http://dx.doi.org/10.1371/journal.pone.0129488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079787	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300024
J	Alam, MJ; Kumar, S; Singh, V; Singh, RKB				Alam, Md. Jahoor; Kumar, Sanjay; Singh, Vikram; Singh, R. K. Brojen			Bifurcation in Cell Cycle Dynamics Regulated by p53	PLOS ONE			English	Article							DNA-REPLICATION; DEPENDENT KINASES; IN-VITRO; MDM2; P21; DEGRADATION; INHIBITOR; UBIQUITINATION; PROTEIN; ARREST	We study the regulating mechanism of p53 on the properties of cell cycle dynamics in the light of the proposed model of interacting p53 and cell cycle networks via p53. Irradiation (IR) introduce to p53 compel p53 dynamics to suffer different phases, namely oscillating and oscillation death (stabilized) phases. The IR induced p53 dynamics undergo collapse of oscillation with collapse time Delta t which depends on IR strength. The stress p53 via IR drive cell cycle molecular species MPF and cyclin dynamics to different states, namely, oscillation death, oscillations of periods, chaotic and sustain oscillation in their bifurcation diagram. We predict that there could be a critical Delta t(c) induced by p53 via IRc, where, if Delta t <Delta t(c) the cell cycle may come back to normal state, otherwise it will go to cell cycle arrest (apoptosis).	[Alam, Md. Jahoor; Singh, R. K. Brojen] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Alam, Md. Jahoor] Univ Hail, Coll Appl Med Sci, Hail 2440, Saudi Arabia; [Kumar, Sanjay] Jamia Millia Islamia, Dept Comp Sci, New Delhi 110025, India; [Singh, Vikram] Cent Univ Himachal Pradesh, Sch Life Sci, Dharamshala 176215, India	Jawaharlal Nehru University, New Delhi; University Ha'il; Jamia Millia Islamia; Central University of Himachal Pradesh	Singh, RKB (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	brojen@jnu.ac.in	Alam, MD JAHOOR/AAR-8528-2021; Alam, Jahoor/F-5071-2012	Alam, MD JAHOOR/0000-0003-0144-6517; Singh, Dr. Vikram/0000-0002-7644-4084	Department of Science and Technology (DST), New Delhi, India [SB/S2/HEP-034/2012]	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India))	This work is financially supported by Department of Science and Technology (DST), New Delhi, India under sanction no. SB/S2/HEP-034/2012.	Aguda BD, 1999, P NATL ACAD SCI USA, V96, P11352, DOI 10.1073/pnas.96.20.11352; Alam MJ, 2013, MOL BIOSYST, V9, P508, DOI 10.1039/c3mb25277a; APRELIKOVA O, 1995, J BIOL CHEM, V270, P18195, DOI 10.1074/jbc.270.31.18195; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104; BUENDIA B, 1991, COLD SPRING HARB SYM, V56, P523; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen JY, 2013, MOL CELL, V52, P87, DOI 10.1016/j.molcel.2013.09.009; Chen X, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-73; Chonga KH, 2015, MATH BIOSCI, V259, P2742; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ferrell JE, 2009, FEBS LETT, V583, P3999, DOI 10.1016/j.febslet.2009.10.068; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gerard C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00413; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; HARPER JW, 1993, CELL, V75, P805; HINDS PW, 1994, CURR OPIN GENET DEV, V4, P135, DOI 10.1016/0959-437X(94)90102-3; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Iwamoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101333; Iwamoto K, 2011, BIOSYSTEMS, V103, P384, DOI 10.1016/j.biosystems.2010.11.011; Jensen MH, 2012, FEBS LETT, V586, P1664, DOI 10.1016/j.febslet.2012.04.044; Khan S, 2004, ONCOGENE, V23, P6040, DOI 10.1038/sj.onc.1207824; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; LAM EWF, 1994, CURR OPIN CELL BIOL, V6, P859; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Ling H, 2013, BIOSYSTEMS, V114, P191, DOI 10.1016/j.biosystems.2013.08.004; Maki CG, 1996, CANCER RES, V56, P2649; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; MINSHULL J, 1989, J CELL SCI, P77; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; Moll UM, 2003, MOL CANCER RES, V1, P1001; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Press W. H., 1992, NUMERICAL RECIPE FOR; Proctor CJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-75; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Romond PC, 1999, ANN NY ACAD SCI, V879, P180, DOI 10.1111/j.1749-6632.1999.tb10419.x; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Soria G, 2008, J CELL SCI, V121, P3271, DOI 10.1242/jcs.027730; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Sun TZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-190; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	59	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129620	10.1371/journal.pone.0129620	http://dx.doi.org/10.1371/journal.pone.0129620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090895	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000051
J	Amirav, I; Halamish, A; Gorenberg, M; Omar, H; Newhouse, MT				Amirav, Israel; Halamish, Asaf; Gorenberg, Miguel; Omar, Hamza; Newhouse, Michael T.			More Realistic Face Model Surface Improves Relevance of Pediatric In-Vitro Aerosol Studies	PLOS ONE			English	Article							VALVED HOLDING CHAMBERS; DELIVERY; CHILDREN; MASKS; FORCE; SEAL	Background Various hard face models are commonly used to evaluate the efficiency of aerosol face masks. Softer more realistic "face" surface materials, like skin, deform upon mask application and should provide more relevant in-vitro tests. Studies that simultaneously take into consideration many of the factors characteristic of the in vivo face are lacking. These include airways, various application forces, comparison of various devices, comparison with a hard-surface model and use of a more representative model face based on large numbers of actual faces. Aim To compare mask to "face" seal and aerosol delivery of two pediatric masks using a soft vs. a hard, appropriately representative, pediatric face model under various applied forces. Methods Two identical face models and upper airways replicas were constructed, the only difference being the suppleness and compressibility of the surface layer of the "face." Integrity of the seal and aerosol delivery of two different masks [AeroChamber (AC) and SootherMask (SM)] were compared using a breath simulator, filter collection and realistic applied forces. Results The soft "face" significantly increased the delivery efficiency and the sealing characteristics of both masks. Aerosol delivery with the soft "face" was significantly greater for the SM compared to the AC (p<0.01). No statistically significant difference between the two masks was observed with the hard "face." Conclusions The material and pliability of the model "face" surface has a significant influence on both the seal and delivery efficiency of face masks. This finding should be taken into account during in-vitro aerosol studies.	[Amirav, Israel] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Amirav, Israel; Halamish, Asaf] Ziv Med Ctr, Safed, Israel; [Gorenberg, Miguel; Omar, Hamza] Ziv Med Ctr, Dept Nucl Med, Safed, Israel; [Newhouse, Michael T.] McMaster Univ, St Josephs Hosp, Firestone Inst Resp Hlth, Hamilton, ON, Canada	University of Alberta; Ziv Medical Center; Ziv Medical Center; McGill University; McMaster University	Amirav, I (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	amirav@ualberta.ca	Amirav, Israel/I-9286-2019	Amirav, Israel/0000-0002-6917-5285				Amirav I, 2001, PEDIATRICS, V108, P389, DOI 10.1542/peds.108.2.389; Amirav I, 2015, RESP CARE; Amirav I, 2014, J AEROSOL MED PULM D, V27, P272, DOI 10.1089/jamp.2013.1069; Carrigy NB, 2014, J AEROSOL MED PULM D, V27, P290, DOI 10.1089/jamp.2013.1087; European Medicines Agency (EMA), 2009, CPMPEWP415100REV1 EM; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Hwang TJ, 2014, PEDIATRICS; Janssens HM, 1999, EUR RESPIR J, V13, P787, DOI 10.1034/j.1399-3003.1999.13d15.x; Javaheri E, 2013, J AEROSOL SCI, V55, P137, DOI 10.1016/j.jaerosci.2012.07.013; Louca E, 2006, J AEROSOL MED, V19, P160, DOI 10.1089/jam.2006.19.160; Minh T, 2014, J AEROSOL MED PULM D, V27, DOI [10.1089/jamp.2014.1129, DOI 10.1089/JAMP.2014.1129]; Mitchell J, 2012, J AEROSOL MED PULM D, V25, P217, DOI 10.1089/jamp.2011.0933; Mitchell JP, 2010, RESP DRUG DELIVERY 2, P777; Shah SA, 2006, RESP CARE, V51, P140; Stick S., 1996, INFANT RESP FUNCTION, P134; Xu Z, 2014, J AEROSOL MED PULM D, V27, pS44, DOI 10.1089/jamp.2013.1074	16	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128538	10.1371/journal.pone.0128538	http://dx.doi.org/10.1371/journal.pone.0128538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090661	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000021
J	Balaoing, LR; Post, AD; Lin, AY; Tseng, H; Moake, JL; Grande-Allen, KJ				Balaoing, Liezl Rae; Post, Allison Davis; Lin, Adam Yuh; Tseng, Hubert; Moake, Joel L.; Grande-Allen, K. Jane			Laminin Peptide-Immobilized Hydrogels Modulate Valve Endothelial Cell Hemostatic Regulation	PLOS ONE			English	Article							ENGINEERED HEART-VALVES; PROGENITOR CELLS; SHEAR-STRESS; G-DOMAIN; EX-VIVO; BIOMATERIALS; ADHESION; IDENTIFICATION; CALCIFICATION; SYNDECAN-1	Valve endothelial cells (VEC) have unique phenotypic responses relative to other types of vascular endothelial cells and have highly sensitive hemostatic functions affected by changes in valve tissues. Furthermore, effects of environmental factors on VEC hemostatic function has not been characterized. This work used a poly(ethylene glycol) diacrylate (PEGDA) hydrogel platform to evaluate the effects of substrate stiffness and cell adhesive ligands on VEC phenotype and expression of hemostatic genes. Hydrogels of molecular weights (MWs) 3.4, 8, and 20 kDa were polymerized into platforms of different rigidities and thiol-modified cell adhesive peptides were covalently bound to acrylate groups on the hydrogel surfaces. The peptide RKRLQVQLSIRT (RKR) is a syndecan-1 binding ligand derived from laminin, a trimeric protein and a basement membrane matrix component. Conversely, RGDS is an integrin binding peptide found in many extracellular matrix (ECM) proteins including fibronectin, fibrinogen, and von Willebrand factor (VWF). VECs adhered to and formed a stable monolayer on all RKR-coated hydrogel-MW combinations. RGDS-coated platforms supported VEC adhesion and growth on RGDS-3.4 kDa and RGDS-8 kDa hydrogels. VECs cultured on the softer RKR-8 kDa and RKR-20 kDa hydrogel platforms had significantly higher gene expression for all anti-thrombotic (ADAMTS-13, tissue factor pathway inhibitor, and tissue plasminogen activator) and thrombotic (VWF, tissue factor, and P-selectin) proteins than VECs cultured on RGDS-coated hydrogels and tissue culture polystyrene controls. Stimulated VECs promoted greater platelet adhesion than non-stimulated VECs on their respective culture condition; yet stimulated VECs on RGDS-3.4 kDa gels were not as responsive to stimulation relative to the RKR-gel groups. Thus, the syndecan binding, laminin-derived peptide promoted stable VEC adhesion on the softer hydrogels and maintained VEC phenotype and natural hemostatic function. In conclusion, utilization of non-integrin adhesive peptide sequences derived from basement membrane ECM may recapitulate balanced VEC function and may benefit endothelialization of valve implants.	[Balaoing, Liezl Rae; Post, Allison Davis; Lin, Adam Yuh; Tseng, Hubert; Moake, Joel L.; Grande-Allen, K. Jane] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University	Grande-Allen, KJ (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	grande@rice.edu	; Grande-Allen, Kathryn Jane/P-4042-2014	Lin, Adam/0000-0001-9359-882X; Grande-Allen, Kathryn Jane/0000-0003-1533-3767	American Heart Association; NIH [HL110063]; Mary R. Gibson Foundation; Mabel and Everett Hinkson Memorial Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL110063] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary R. Gibson Foundation; Mabel and Everett Hinkson Memorial Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by a predoctoral fellowship from the American Heart Association (to L.R.B.), NIH HL110063, the Mary R. Gibson Foundation, and the Mabel and Everett Hinkson Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JB, 2010, STEM CELLS, V28, P318, DOI 10.1002/stem.275; Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; Balaoing LR, 2014, ARTERIOSCL THROM VAS, V34, P72, DOI 10.1161/ATVBAHA.113.301936; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Butcher JT, 2007, PHILOS T R SOC B, V362, P1445, DOI 10.1098/rstb.2007.2127; Butcher JT, 2006, TISSUE ENG, V12, P905, DOI 10.1089/ten.2006.12.905; Butcher JT, 2006, ARTERIOSCL THROM VAS, V26, P69, DOI 10.1161/01.ATV.0000196624.70507.0d; Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a; Chalajour F, 2004, EXP CELL RES, V298, P455, DOI 10.1016/j.yexcr.2004.04.034; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Cheung WY, 2008, J HEART VALVE DIS, V17, P674; Denis CV, 1999, CELL MOL LIFE SCI, V56, P977, DOI 10.1007/s000180050487; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Durst CA, 2011, ACTA BIOMATER, V7, P2467, DOI 10.1016/j.actbio.2011.02.018; Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299; Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fang NT, 2007, CHINESE MED J-PEKING, V120, P696, DOI 10.1097/00029330-200704020-00016; Frendl CM, 2014, BIOMATERIALS, V35, P7714, DOI 10.1016/j.biomaterials.2014.05.075; Gwanmesia P, 2010, TISSUE ENG PART A, V49, P1, DOI 10.1089\ten.TEA.2010.0304; Hakuno D, 2009, J MOL MED, V87, P17, DOI 10.1007/s00109-008-0400-9; Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Latif N, 2005, J HEART VALVE DIS, V14, P218; Leask RL, 2003, MICROSC RES TECHNIQ, V60, P129, DOI 10.1002/jemt.10251; Lichtenberg A, 2006, BIOMATERIALS, V27, P4221, DOI 10.1016/j.biomaterials.2006.03.047; McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Mohler ER, 2004, AM J CARDIOL, V94, P1396, DOI 10.1016/j.amjcard.2004.08.013; Moon JJ, 2008, CURR TOP MED CHEM, V8, P300; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; Pearson JD, 1999, BEST PRACT RES CL HA, V12, P329, DOI 10.1053/beha.1999.0028; Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019; Rydholm AE, 2008, J BIOMED MATER RES A, V86A, P23, DOI 10.1002/jbm.a.31526; Sales VL, 2010, TISSUE ENG PT A, V16, P257, DOI 10.1089/ten.TEA.2009.0424; Sewell-Loftin MK, 2011, J CARDIOVASC TRANSL, V4, P658, DOI 10.1007/s12265-011-9300-4; Sha JM, 2010, J HEART VALVE DIS, V19, P506; Thalla PK, 2014, BIOMACROMOLECULES, V15, P2512, DOI 10.1021/bm5003762; Tseng H, 2014, TISSUE ENG PT A, V20, P2634, DOI [10.1089/ten.tea.2013.0397, 10.1089/ten.TEA.2013.0397]; Turner N, 2012, SEMIN THROMB HEMOST, V38, P38, DOI 10.1055/s-0031-1300950; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; Weymann A, 2013, CIRC J, V77, P207, DOI 10.1253/circj.CJ-12-0540; Xu XX, 2010, CYTOTECHNOLOGY, V62, P17, DOI 10.1007/s10616-010-9256-2; Yang JH, 2008, BIOCHEM BIOPH RES CO, V374, P512, DOI 10.1016/j.bbrc.2008.07.057; Young EWK, 2007, LAB CHIP, V7, P1759, DOI 10.1039/b712486d	52	19	19	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130749	10.1371/journal.pone.0130749	http://dx.doi.org/10.1371/journal.pone.0130749			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090873	Green Published, gold			2022-12-26	WOS:000356835000149
J	Giannini, TC; Tambosi, LR; Acosta, AL; Jaffe, R; Saraiva, AM; Imperatriz-Fonseca, VL; Metzger, JP				Giannini, Tereza C.; Tambosi, Leandro R.; Acosta, Andre L.; Jaffe, Rodolfo; Saraiva, Antonio M.; Imperatriz-Fonseca, Vera L.; Metzger, Jean Paul			Safeguarding Ecosystem Services: A Methodological Framework to Buffer the Joint Effect of Habitat Configuration and Climate Change	PLOS ONE			English	Article							NEOTROPICAL STINGLESS BEE; AFRICANIZED HONEY-BEE; LANDSCAPE CONNECTIVITY; LAND-USE; ENVIRONMENTAL NICHE; RANGE SHIFTS; BIODIVERSITY; CONSERVATION; POLLINATION; RESTORATION	Ecosystem services provided by mobile agents are increasingly threatened by the loss and modification of natural habitats and by climate change, risking the maintenance of biodiversity, ecosystem functions, and human welfare. Research oriented towards a better understanding of the joint effects of land use and climate change over the provision of specific ecosystem services is therefore essential to safeguard such services. Here we propose a methodological framework, which integrates species distribution forecasts and graph theory to identify key conservation areas, which if protected or restored could improve habitat connectivity and safeguard ecosystem services. We applied the proposed framework to the provision of pollination services by a tropical stingless bee (Melipona quadrifasciata), a key pollinator of native flora from the Brazilian Atlantic Forest and important agricultural crops. Based on the current distribution of this bee and that of the plant species used to feed and nest, we projected the joint distribution of bees and plants in the future, considering a moderate climate change scenario (following IPPC). We then used this information, the bee's flight range, and the current mapping of Atlantic Forest remnants to infer habitat suitability and quantify local and regional habitat connectivity for 2030, 2050 and 2080. Our results revealed north to south and coastal to inland shifts in the pollinator distribution during the next 70 years. Current and future connectivity maps unraveled the most important corridors, which if protected or restored, could facilitate the dispersal and establishment of bees during distribution shifts. Our results also suggest that coffee plantations from eastern Sao Paulo and southern Minas Gerais States could suffer a pollinator deficit in the future, whereas pollination services seem to be secured in southern Brazil. Landowners and governmental agencies could use this information to implement new land use schemes. Overall, our proposed methodological framework could help design novel conservational and agricultural practices that can be crucial to conserve ecosystem services by buffering the joint effect of habitat configuration and climate change.	[Giannini, Tereza C.; Tambosi, Leandro R.; Acosta, Andre L.; Jaffe, Rodolfo; Imperatriz-Fonseca, Vera L.; Metzger, Jean Paul] Univ Sao Paulo, Inst Biosci, Dept Ecol, R do Matao 321, BR-05508090 Sao Paulo, SP, Brazil; [Giannini, Tereza C.; Saraiva, Antonio M.] Univ Sao Paulo, Sch Engn, Computat & Digital Syst, BR-05508010 Sao Paulo, SP, Brazil; [Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.] Vale Inst Technol Sustainable Dev, BR-66055090 Belem, Para, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Tecnologico Vale Desenvolvimento Sustentavel	Giannini, TC (corresponding author), Univ Sao Paulo, Inst Biosci, Dept Ecol, R do Matao 321, BR-05508090 Sao Paulo, SP, Brazil.	giannini@usp.br	Saraiva, Antonio/ABC-5330-2021; Tambosi, Leandro R/B-2359-2013; Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021; Jaffé, Rodolfo/K-3230-2013; Tambosi, Leandro Reverberi/ABH-7869-2020; Giannini, Tereza Cristina/AAA-2958-2019; Imperatriz-Fonseca, Vera Lucia/H-5582-2012; Saraiva, Antonio M/B-6350-2011; Acosta, Andre Luis/H-2036-2012; Giannini, Tereza C/F-2676-2012; Metzger, Jean Paul/C-2514-2012	Saraiva, Antonio/0000-0003-2283-1123; Tambosi, Leandro R/0000-0001-5486-7310; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Jaffé, Rodolfo/0000-0002-2101-5282; Tambosi, Leandro Reverberi/0000-0001-5486-7310; Giannini, Tereza Cristina/0000-0001-9830-1204; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Saraiva, Antonio M/0000-0003-2283-1123; Acosta, Andre Luis/0000-0002-4244-9637; Metzger, Jean Paul/0000-0002-0087-5240	National Counsel of Technological and Scientific Development (CNPq) [472702/2013-0, 404156/2013-4, 141266/2010-4]; Sao Paulo Research Foundation (FAPESP) [2012/13200-5, 2011/12779-7]; CAPES [068/2013]; Biodiversity and Computation (NAP-Biocomp, University of Sao Paulo)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Biodiversity and Computation (NAP-Biocomp, University of Sao Paulo)	The authors are grateful to National Counsel of Technological and Scientific Development (CNPq) (472702/2013-0, 404156/2013-4, 141266/2010-4), Sao Paulo Research Foundation (FAPESP) (2012/13200-5, 2011/12779-7), CAPES (068/2013), and Biodiversity and Computation (NAP-Biocomp, University of Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Gutierrez Jesus, 2013, PLoS One, V8, pe63708, DOI 10.1371/journal.pone.0063708; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Allendorf F. W., 2012, CONSERV GENET; Antonini Y., 2006, Braz. J. Biol., V66, P463, DOI 10.1590/S1519-69842006000300012; Antonini Y, 2003, J INSECT CONSERV, V7, P167, DOI 10.1023/A:1027378306119; Araújo E. D., 2004, Braz. J. Biol., V64, P563, DOI 10.1590/S1519-69842004000400003; Bartomeus I, 2011, P NATL ACAD SCI USA, V108, P20645, DOI 10.1073/pnas.1115559108; Batalha H, 2010, APIDOLOGIE, V41, P534, DOI 10.1051/apido/2010001; Blignaut J, 2014, ECOL ENG, V65, P54, DOI 10.1016/j.ecoleng.2013.09.003; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Bukovinszky T, 2010, BASIC APPL ECOL, V11, P396, DOI 10.1016/j.baae.2010.04.005; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Colombo AF, 2010, BRAZ J BIOL, V70, P697, DOI 10.1590/S1519-69842010000400002; Cortopassi-Laurino M, 2003, MEM 3 SEM MES AB AG, P99; Costanza R, 2007, ECOL ECON, V61, P478, DOI 10.1016/j.ecolecon.2006.03.021; De Marco P, 2004, BIODIVERS CONSERV, V13, P1245, DOI 10.1023/B:BIOC.0000019402.51193.e8; de Souza TV, 2011, NAT CONSERVACAO, V9, P214, DOI 10.4322/natcon.2011.028; Egoh B, 2007, ECOL ECON, V63, P714, DOI 10.1016/j.ecolecon.2007.04.007; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Englund G, 2007, J ANIM ECOL, V76, P30, DOI 10.1111/j.1365-2656.2006.01174.x; Ferraz SFB, 2014, LANDSCAPE ECOL, V29, P187, DOI 10.1007/s10980-014-9988-z; Ferro VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107792; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2014, FRONT ECOL ENVIRON, V12, P439, DOI 10.1890/130330; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Giannini TC, 2015, APIDOLOGIE, V46, P209, DOI 10.1007/s13592-014-0316-z; Giannini TC, 2012, ECOL MODEL, V244, P127, DOI 10.1016/j.ecolmodel.2012.06.035; Giannini TC, 2013, AGR ECOSYST ENVIRON, V171, P39, DOI 10.1016/j.agee.2013.03.003; Giannini TC, 2013, ECOGRAPHY, V36, P649, DOI 10.1111/j.1600-0587.2012.07191.x; Gillson L, 2013, TRENDS ECOL EVOL, V28, P135, DOI 10.1016/j.tree.2012.10.008; Gonzalez-Varo JP, 2013, TRENDS ECOL EVOL, V28, P524, DOI 10.1016/j.tree.2013.05.008; Gosling SN, 2013, ENVIRON SCI POLICY, V27, pS15, DOI 10.1016/j.envsci.2012.03.011; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Guedes, 2013, MAPEAMENTOS CONSERVA; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Haas CA, 1998, AUK, V115, P929, DOI 10.2307/4089511; Hamback PA, 2007, P NATL ACAD SCI USA, V104, P8368, DOI 10.1073/pnas.0611462104; Hamback PA, 2010, ECOGRAPHY, V33, P1149, DOI 10.1111/j.1600-0587.2009.06125.x; Harris JA, 2006, RESTOR ECOL, V14, P170, DOI 10.1111/j.1526-100X.2006.00136.x; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodgson JA, 2011, J APPL ECOL, V48, P148, DOI 10.1111/j.1365-2664.2010.01919.x; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Horwitz P, 2011, BIOSCIENCE, V61, P678, DOI 10.1525/bio.2011.61.9.6; Hulme PE, 2005, J APPL ECOL, V42, P784, DOI 10.1111/j.1365-2664.2005.01082.x; Innes C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02689; IPCC, 2007, 4 ASS REP CLIM CHANG; Jaffe R, PLOSONE IN PRESS; Joly CA, 2014, NEW PHYTOL, V204, P459, DOI 10.1111/nph.12989; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2009, FOREST ECOL MANAG, V258, P1838, DOI 10.1016/j.foreco.2009.05.005; Klein AM, 2003, J APPL ECOL, V40, P837, DOI 10.1046/j.1365-2664.2003.00847.x; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kuhlmann M, 2012, DIVERS DISTRIB, V18, P885, DOI 10.1111/j.1472-4642.2011.00877.x; Larigauderie A, 2010, CURR OPIN SUST, V2, P1, DOI 10.1016/j.cosust.2010.04.001; Lemes P, 2014, BIODIVERS CONSERV, V23, P357, DOI 10.1007/s10531-013-0605-2; Lemes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054323; Lira PK, 2012, FOREST ECOL MANAG, V278, P80, DOI 10.1016/j.foreco.2012.05.008; Loiselle BA, 2010, J BIOGEOGR, V37, P1288, DOI 10.1111/j.1365-2699.2010.02285.x; Loyola RD, 2013, BIODIVERS CONSERV, V22, P483, DOI 10.1007/s10531-012-0424-x; Luque S, 2012, LANDSCAPE ECOL, V27, P153, DOI 10.1007/s10980-011-9700-5; Lurz PWW, 1997, ANIM BEHAV, V54, P427, DOI 10.1006/anbe.1996.0486; Maia-Silva C., 2012, GUIA PLANTAS VISITAD; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Metzger JP, 2009, BIOL CONSERV, V142, P1138, DOI 10.1016/j.biocon.2008.10.012; Moritz RFA, 2005, ECOSCIENCE, V12, P289, DOI 10.2980/i1195-6860-12-3-289.1; Nelson EJ, 2013, FRONT ECOL ENVIRON, V11, P483, DOI 10.1890/120312; NOGUEIRA-NETO PAULO, 1959, BRAGANTIA, V18, P441; Owen EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080061; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinto HS, 2008, AQUECIMENTO GLOBAL N; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ramalho Mauro, 2004, Acta Bot. Bras., V18, P37, DOI 10.1590/S0102-33062004000100005; Ramirez J, 2008, HIGH RESOLUTION STAT; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Roberts Stuart P.M., 2011, BioRisk, V6, P1; Rodrigues RR, 2009, BIOL CONSERV, V142, P1242, DOI 10.1016/j.biocon.2008.12.008; Rook GA, 2013, P NATL ACAD SCI USA, V110, P18360, DOI 10.1073/pnas.1313731110; Santos ASB, 2009, GEN MOL RES, V8, P751; Saulnier-Talbot E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086561; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Serra BDV, 2010, NEOTROP ENTOMOL, V39, P53; Silva CI, 2010, CATALOGO POLINICO PA; Slaa EJ, 2006, APIDOLOGIE, V37, P293, DOI 10.1051/apido:2006022; SOS Mata Atlantica and Instituto Nacional de Pesquisas Espaciais, 2008, ATL REM FLOR MAT ATL; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Tambosi LR, 2014, RESTOR ECOL, V22, P169, DOI 10.1111/rec.12049; Tambosi LR, 2013, NAT CONSERVACAO, V11, P152, DOI 10.4322/natcon.2013.024; Tamis WLM, 2005, CLIMATIC CHANGE, V72, P37, DOI 10.1007/s10584-005-5287-7; Teixeira AMG, 2009, FOREST ECOL MANAG, V257, P1219, DOI 10.1016/j.foreco.2008.10.011; Thomson JR, 2009, ECOL APPL, V19, P817, DOI 10.1890/08-0915.1; Torne-Noguera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097255; Traill LW, 2010, J ANIM ECOL, V79, P937, DOI 10.1111/j.1365-2656.2010.01695.x; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Van Meerbeek K, 2014, BIODIVERS CONSERV, V23, P2259, DOI 10.1007/s10531-014-0720-8; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vos CC, 2008, J APPL ECOL, V45, P1722, DOI 10.1111/j.1365-2664.2008.01569.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wasserman TN, 2012, LANDSCAPE ECOL, V27, P211, DOI 10.1007/s10980-011-9653-8; White TA, 2001, GLOBAL CHANGE BIOL, V7, P1, DOI 10.1046/j.1365-2486.2001.00381.x; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Williams PH, 2007, BIOL CONSERV, V138, P493, DOI 10.1016/j.biocon.2007.06.001; Wilms W, 1996, STUD NEOTROP FAUNA E, V31, P137, DOI 10.1076/snfe.31.3.137.13336; Wilms W, 1997, APIDOLOGIE, V28, P339, DOI 10.1051/apido:19970602; Wilson KA, 2011, J APPL ECOL, V48, P715, DOI 10.1111/j.1365-2664.2011.01975.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	118	22	23	2	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129225	10.1371/journal.pone.0129225	http://dx.doi.org/10.1371/journal.pone.0129225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091014	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835000038
J	Ruppender, N; Larson, S; Lakely, B; Kollath, L; Brown, L; Coleman, I; Coleman, R; Nguyen, H; Nelson, PS; Corey, E; Snyder, LA; Vessella, RL; Morrissey, C; Lam, HM				Ruppender, Nazanin; Larson, Sandy; Lakely, Bryce; Kollath, Lori; Brown, Lisha; Coleman, Ilsa; Coleman, Roger; Nguyen, Holly; Nelson, Peter S.; Corey, Eva; Snyder, Linda A.; Vessella, Robert L.; Morrissey, Colm; Lam, Hung-Ming			Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; UROKINASE RECEPTOR; INDUCED APOPTOSIS; CARCINOMA-CELLS; TUMOR-CELLS; KINASE; BETA-1-INTEGRIN; MIGRATION; CULTURES; REVEALS	Dissemination of prostate cancer (PCa) cells to the bone marrow is an early event in the disease process. In some patients, disseminated tumor cells (DTC) proliferate to form active metastases after a prolonged period of undetectable disease known as tumor dormancy. Identifying mechanisms of PCa dormancy and reactivation remain a challenge partly due to the lack of in vitro models. Here, we characterized in vitro PCa dormancy-reactivation by inducing cells from three patient-derived xenograft (PDX) lines to proliferate through tumor cell contact with each other and with bone marrow stroma. Proliferating PCa cells demonstrated tumor cell-cell contact and integrin clustering by immunofluorescence. Global gene expression analyses on proliferating cells cultured on bone marrow stroma revealed a downregulation of TGFB2 in all of the three proliferating PCa PDX lines when compared to their non-proliferating counterparts. Furthermore, constitutive activation of myosin light chain kinase (MLCK), a downstream effector of integrin-beta1 and TGF-beta2, in non-proliferating cells promoted cell proliferation. This cell proliferation was associated with an upregulation of CDK6 and a downregulation of E2F4. Taken together, our data provide the first clinically relevant in vitro model to support cellular adhesion and downregulation of TGFB2 as a potential mechanism by which PCa cells may escape from dormancy. Targeting the TGF-beta2-associated mechanism could provide novel opportunities to prevent lethal PCa metastasis.	[Ruppender, Nazanin; Larson, Sandy; Lakely, Bryce; Kollath, Lori; Brown, Lisha; Nguyen, Holly; Corey, Eva; Vessella, Robert L.; Morrissey, Colm; Lam, Hung-Ming] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Coleman, Ilsa; Coleman, Roger; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Snyder, Linda A.] Janssen Res & Dev LLC, Spring House, PA USA; [Vessella, Robert L.] Dept Vet Affairs Med Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Lam, HM (corresponding author), Univ Washington, Dept Urol, Seattle, WA 98195 USA.	minglam@u.washington.edu			Janssen Research and Development LLC; National Institutes of Health [PO1 CA85859]; NATIONAL CANCER INSTITUTE [P01CA085859, P50CA097186] Funding Source: NIH RePORTER	Janssen Research and Development LLC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Janssen Research and Development LLC (http://www.janssenrnd.com), and PO1 CA85859 from the National Institutes of Health (http://grants.nih.gov/grants/funding/ac_search_results.htm?text_curr=p01).	Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Allgayer H, 2008, APMIS, V116, P602, DOI 10.1111/j.1600-0463.2008.00997.x; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Chery L, 2014, ONCOTARGET, V5, P9939, DOI 10.18632/oncotarget.2480; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Crosby ME, 2007, ONCOGENE, V26, P1897, DOI 10.1038/sj.onc.1209998; Gao JF, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0072-1; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Howe GA, 2012, CELL ADHES MIGR, V6, P71, DOI 10.4161/cam.20077; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ihnatovych I, 2007, ENDOCRINOLOGY, V148, P3176, DOI 10.1210/en.2006-1673; Josson S, 2010, J ONCOL, V2010, DOI 10.1155/2010/232831; Keely PJ, 2011, J MAMMARY GLAND BIOL, V16, P205, DOI 10.1007/s10911-011-9226-0; Kim JK, 2013, NEOPLASIA, V15, P1064, DOI 10.1593/neo.13402; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lam Hung-Ming, 2014, Drug Discov Today Technol, V11, P41, DOI 10.1016/j.ddtec.2014.02.002; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Morazzani M, 2004, INT J CANCER, V110, P788, DOI 10.1002/ijc.20198; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Nguyen HM, 2011, METHODS MOL BIOL, V776, P295, DOI 10.1007/978-1-61779-243-4_17; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; PETERS G, 1994, J CELL SCI, P89; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Ruppender NS, 2013, CANCER METAST REV, V32, P501, DOI 10.1007/s10555-013-9422-z; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; SCHLAEPFER DD, 1994, NATURE, V372, P786; Sinpitaksakul SN, 2008, BIOCHEM BIOPH RES CO, V371, P713, DOI 10.1016/j.bbrc.2008.04.128; Song K, 2010, MOL ENDOCRINOL, V24, P2019, DOI 10.1210/me.2010-0165; Sosa MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7170; Street CA, 2011, ANTICANCER RES, V31, P3645; Taichman RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061873; THALMANN GN, 1994, CANCER RES, V54, P2577; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Welty CJ, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-6; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Windus LCE, 2012, EXP CELL RES, V318, P2507, DOI 10.1016/j.yexcr.2012.07.013; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Yang J, 2008, ONCOGENE, V27, P5326, DOI 10.1038/onc.2008.165; Young SR, 2013, PROSTATE, V73, P1251, DOI 10.1002/pros.22610; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	53	39	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130565	10.1371/journal.pone.0130565	http://dx.doi.org/10.1371/journal.pone.0130565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090669	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835000126
J	Bird, NL; Olson, MR; Hurt, AC; Oshansky, CM; Oh, DY; Reading, PC; Chua, BY; Sun, YL; Tang, L; Handel, A; Jackson, DC; Turner, SJ; Thomas, PG; Kedzierska, K				Bird, Nicola L.; Olson, Matthew R.; Hurt, Aeron C.; Oshansky, Christine M.; Oh, Ding Yuan; Reading, Patrick C.; Chua, Brendon Y.; Sun, Yilun; Tang, Li; Handel, Andreas; Jackson, David C.; Turner, Stephen J.; Thomas, Paul G.; Kedzierska, Katherine			Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses	PLOS ONE			English	Article							A VIRUS; IMMUNE-RESPONSES; INFECTION; H5N1; TRANSMISSION; PERSISTENCE; EXPRESSION; PROFILES; REACT	CD8(+) T cells directed against conserved viral regions elicit broad immunity against distinct influenza viruses, promote rapid virus elimination and enhanced host recovery. The influenza neuraminidase inhibitor, oseltamivir, is prescribed for therapy and prophylaxis, although it remains unclear how the drug impacts disease severity and establishment of effector and memory CD8(+) T cell immunity. We dissected the effects of oseltamivir on viral replication, inflammation, acute CD8(+) T cell responses and the establishment of immunological CD8+ T cell memory. In mice, ferrets and humans, the effect of osteltamivir on viral titre was relatively modest. However, prophylactic oseltamivir treatment in mice markedly reduced morbidity, innate responses, inflammation and, ultimately, the magnitude of effector CD8+ T cell responses. Importantly, functional memory CD8(+) T cells established during the drug-reduced effector phase were capable of mounting robust recall responses. Moreover, influenza-specific memory CD4(+) T cells could be also recalled after the secondary challenge, while the antibody levels were unaffected. This provides evidence that long-term memory T cells can be generated during an oseltamivir-interrupted infection. The anti-inflammatory effect of oseltamivir was verified in H1N1-infected patients. Thus, in the case of an unpredicted influenza pandemic, while prophylactic oseltamivir treatment can reduce disease severity, the capacity to generate memory CD8(+) T cells specific for the newly emerged virus is uncompromised. This could prove especially important for any new influenza pandemic which often occurs in separate waves.	[Bird, Nicola L.; Olson, Matthew R.; Reading, Patrick C.; Chua, Brendon Y.; Jackson, David C.; Turner, Stephen J.; Kedzierska, Katherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Hurt, Aeron C.; Oh, Ding Yuan; Reading, Patrick C.] WHO, Collaborating Ctr Reference & Res Influenza, Peter Doherty Inst Infect & Immun, VIDRL, Parkville, Vic 3010, Australia; [Hurt, Aeron C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3052, Australia; [Oshansky, Christine M.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Sun, Yilun; Tang, Li] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Handel, Andreas] Univ Georgia, Dept idemiol & Biostat, Athens, GA 30602 USA; [Oh, Ding Yuan] Federat Univ, Sch Appl Sci & Biomed Sci, Gippsland, Vic 3842, Australia	University of Melbourne; Victorian Infectious Diseases Reference Laboratory; World Health Organization; University of Melbourne; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University System of Georgia; University of Georgia; Federation University Australia	Kedzierska, K (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	kkedz@unimelb.edu.au	Turner, Stephen/GXM-4654-2022; Chua, Brendon Y/A-9755-2012; Thomas, Paul G./H-1063-2018; Tang, Li/N-8123-2018	Chua, Brendon Y/0000-0001-5654-1293; Thomas, Paul G./0000-0001-7955-0256; Handel, Andreas/0000-0002-4622-1146; Jackson, David/0000-0001-7255-270X; Sun, Yilun/0000-0003-1905-9216; Turner, Stephen/0000-0002-1002-0000; Kedzierska, Katherine/0000-0001-6141-335X; Hurt, Aeron/0000-0003-1826-4314; Oh, Ding Yuan/0000-0003-0695-8490; Reading, Patrick/0000-0002-8860-5308; Olson, Matthew/0000-0003-2351-6002	Australian National Health and Medical Research Council (NHMRC) Project Grant [GNT1008854]; NHMRC Program Grant [GNT567122]; CASS Foundation Project Grant; US government funds through the National Institute of Allergy and Infectious Diseases, the National Institutes of Health [HHSN266200700005C, HHSN272201400006C]; Australian Government Department of Health	Australian National Health and Medical Research Council (NHMRC) Project Grant(National Health and Medical Research Council (NHMRC) of AustraliaWellcome Trust); NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); CASS Foundation Project Grant; US government funds through the National Institute of Allergy and Infectious Diseases, the National Institutes of Health; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was supported by Australian National Health and Medical Research Council (NHMRC) Project Grant to KK (GNT1008854), NHMRC Program Grant to SJT (GNT567122), a CASS Foundation Project Grant (to KK), and US government funds through the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, under contract numbers HHSN266200700005C and HHSN272201400006C (Centers of Excellence for Influenza Research and Surveillance) to PT and ALSAC to PT. KK is a NHMRC Career Development Fellow Level 2 and SJT is an ARC Future Fellow Level 3. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health.	Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Croom HA, 2011, EUR J IMMUNOL, V41, P682, DOI 10.1002/eji.201040625; Doherty PC, 1996, IMMUNOL REV, V150, P23, DOI 10.1111/j.1600-065X.1996.tb00694.x; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hurt Aeron C, 2006, Expert Rev Anti Infect Ther, V4, P795, DOI 10.1586/14787210.4.5.795; Ilyushina NA, 2008, ANTIMICROB AGENTS CH, V52, P3889, DOI 10.1128/AAC.01579-07; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kedzierska K, 2008, J IMMUNOL, V180, P7938, DOI 10.4049/jimmunol.180.12.7938; Kedzierska K, 2007, P NATL ACAD SCI USA, V104, P9782, DOI 10.1073/pnas.0703699104; Kedzierska K, 2006, P NATL ACAD SCI USA, V103, P9184, DOI 10.1073/pnas.0603289103; Kedzierska K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00357; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Li Q, 2014, NEW ENGL J MED, V70, P520; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Oh DY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118780; Oh DY, 2014, J ANTIMICROB CHEMOTH, V69, P2458, DOI 10.1093/jac/dku146; Olson MR, 2014, J IMMUNOL, V193, P5420, DOI 10.4049/jimmunol.1303359; Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC; Quinones-Parra S, 2014, P NATL ACAD SCI USA, V111, P1049, DOI 10.1073/pnas.1322229111; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; van de Sandt CE, 2014, J VIROL, V88, P1684, DOI 10.1128/JVI.02843-13; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111	37	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129768	10.1371/journal.pone.0129768	http://dx.doi.org/10.1371/journal.pone.0129768			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086392	Green Published, gold			2022-12-26	WOS:000356567500061
J	Mesnier, A; Champion, S; Louis, L; Sauzet, C; May, P; Portugal, H; Benbrahim, K; Abraldes, J; Alessi, MC; Amiot-Carlin, MJ; Peiretti, F; Piccerelle, P; Nalbone, G; Villard, PH				Mesnier, Aurelia; Champion, Serge; Louis, Laurence; Sauzet, Christophe; May, Phealay; Portugal, Henri; Benbrahim, Karim; Abraldes, Joelle; Alessi, Marie-Christine; Amiot-Carlin, Marie-Josephe; Peiretti, Franck; Piccerelle, Philippe; Nalbone, Gilles; Villard, Pierre-Henri			The Transcriptional Effects of PCB118 and PCB153 on the Liver, Adipose Tissue, Muscle and Colon of Mice: Highlighting of Glut4 and Lipin1 as Main Target Genes for PCB Induced Metabolic Disorders	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS; INSULIN-RESISTANCE; EXPRESSION; EXPOSURE; OBESITY; DIFFERENTIATION; GAMMA	Epidemiological studies have associated environmental exposure to polychlorinated biphenyls (PCBs) with an increased risk of type 2 diabetes; however, little is known about the underlying mechanisms involved in the metabolic side-effects of PCB. Our study evaluated the transcriptional effects of a subchronic exposure (gavage at Day 0 and Day 15 with 10 or 100 mu mol/Kg bw) to PCB118 (dioxin-like PCB), PCB153 (non-dioxin-like PCB), or an equimolar mixture of PCB118 and PCB153 on various tissues (liver, visceral adipose tissue, muscle, and colon) in mice. Our results showed that a short-term exposure to PCB118 and/ or PCB153 enhanced circulating triglyceride levels but did not affect glycemia. Among the studied tissues, we did not observe any modification of the expression of inflammation-related genes, such as cytokines or chemokines. The main transcriptional effects were observed in visceral adipose and liver tissues. We found a downregulation of lipin1 and glut4 expression in these two target organs. In adipose tissue, we also showed a downregulation of Agpat2, Slc25a1, and Fasn. All of these genes are involved in lipid metabolism and insulin resistance. In muscles, we observed an induction of CnR1 and Foxo3 expression, which may be partly involved in PCB metabolic effects. In summary, our results suggest that lipin1 and glut4, notably in adipose tissue, are the main targeted genes in PCB-induced metabolic disorders, however, further studies are required to fully elucidate the mechanisms involved.	[Mesnier, Aurelia; Champion, Serge; Sauzet, Christophe; May, Phealay; Benbrahim, Karim; Abraldes, Joelle; Piccerelle, Philippe; Villard, Pierre-Henri] Avignon Univ, Aix Marseille Univ, IMBE Inst Mediterraneen Biodiversite & Ecol Marin, Fac Pharm,UMR CNRS 7263,IRD 237, F-13385 Marseille 2, France; [Sauzet, Christophe] Fac Med, UMR Genet Med & Genom Fonct S 910, F-13385 Marseille 05, France; [Portugal, Henri; Alessi, Marie-Christine; Amiot-Carlin, Marie-Josephe; Peiretti, Franck; Nalbone, Gilles] Aix Marseille Univ, Fac Med, Nutr Obesite & Risque Thrombot NORT, UMR INSERM 1062,INRA 1260, F-13385 Marseille 05, France	Avignon Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Villard, PH (corresponding author), Avignon Univ, Aix Marseille Univ, IMBE Inst Mediterraneen Biodiversite & Ecol Marin, Fac Pharm,UMR CNRS 7263,IRD 237, Campus Timone,27 Blvd Jean Moulin, F-13385 Marseille 2, France.	pierre.villard@univ-amu.fr	Peiretti, Franck/GLV-3378-2022; AMIOT, MARIE JOSEPHE/N-8894-2019; ALESSI, Marie-christine/AAK-3582-2020; Amiot, Marie Josephe/M-1203-2017; peiretti, franck/L-2718-2017	Peiretti, Franck/0000-0001-7198-0534; AMIOT, MARIE JOSEPHE/0000-0003-4563-4587; ALESSI, Marie-christine/0000-0003-3927-5792; Amiot, Marie Josephe/0000-0003-4563-4587; peiretti, franck/0000-0001-7198-0534; Sauzet, Christophe/0000-0002-6173-3051	PNRPE (Plan National de Recherche sur les Perturbateurs Endocriniens) from the "Ministere de l'ecologie, du developpement durable et de l'energie"	PNRPE (Plan National de Recherche sur les Perturbateurs Endocriniens) from the "Ministere de l'ecologie, du developpement durable et de l'energie"	This work was supported by the PNRPE (Plan National de Recherche sur les Perturbateurs Endocriniens) from the "Ministere de l'ecologie, du developpement durable et de l'energie."	Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Berndt J, 2007, DIABETOLOGIA, V50, P1472, DOI 10.1007/s00125-007-0689-x; Bluher M, 2004, J BIOL CHEM, V279, P31902, DOI 10.1074/jbc.M404570200; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Cabou Cendrine, 2011, Rev Diabet Stud, V8, P418, DOI 10.1900/RDS.2011.8.418; Cheng WY, 2012, ENVIRON HEALTH PERSP, V120, P267, DOI 10.1289/ehp.1104055; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Crinnion WJ, 2011, ALTERN MED REV, V16, P5; Damiano F, 2012, INT J BIOCHEM CELL B, V44, P659, DOI 10.1016/j.biocel.2012.01.003; Despres Jean-Pierre, 2007, Crit Pathw Cardiol, V6, P46, DOI 10.1097/HPC.0b013e318057d4b4; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Everett CJ, 2011, J ENVIRON MONITOR, V13, P241, DOI 10.1039/c0em00400f; Fletcher N, 2005, TOXICOL APPL PHARM, V207, P1, DOI 10.1016/j.taap.2004.12.003; GONZALEZ FJ, 1994, DRUG METAB REV, V26, P165, DOI 10.3109/03602539409029789; Gray SL, 2013, J TOXICOL ENV HEAL A, V76, P701, DOI 10.1080/15287394.2013.796503; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Hanlon PR, 2003, TOXICOL APPL PHARM, V189, P11, DOI 10.1016/S0041-008X(03)00083-8; Im SS, 2007, IUBMB LIFE, V59, P134, DOI 10.1080/15216540701313788; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Karnieli E, 2008, AM J PHYSIOL-ENDOC M, V295, pE38, DOI 10.1152/ajpendo.90306.2008; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Liu PCC, 2006, J BIOCHEM MOL TOXIC, V20, P79, DOI 10.1002/jbt.20120; Nyberg E, 2014, AMBIO, V43, P45, DOI 10.1007/s13280-014-0561-4; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Remillard RBJ, 2002, ENVIRON HEALTH PERSP, V110, P853, DOI 10.1289/ehp.02110853; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Sanchez A. M., 2013, CELL MOL LIFE SCI; Sanders JM, 2005, TOXICOL SCI, V88, P127, DOI 10.1093/toxsci/kfi288; Scerif M, 2013, J ENDOCRINOL, V219, P79, DOI 10.1530/JOE-13-0192; Subauste AR, 2012, DIABETES, V61, P2922, DOI 10.2337/db12-0004; Sueyoshi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021229; Suviolahti E, 2006, HUM MOL GENET, V15, P377, DOI 10.1093/hmg/ddi448; Tew KD, 2012, ANTIOXID REDOX SIGN, V17, P1728, DOI 10.1089/ars.2012.4640; Turpeinen Miia, 2012, Drug Metabolism and Drug Interactions, V27, P185, DOI 10.1515/dmdi-2012-0027; van Harmelen V, 2007, J LIPID RES, V48, P201, DOI 10.1194/jlr.M600272-JLR200; Wada T, 2011, MOL ENDOCRINOL, V25, P1612, DOI 10.1210/me.2011-1089; Zani C, 2013, J ENVIRON SCI HEAL C, V31, P99, DOI 10.1080/10590501.2013.782174	40	15	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128847	10.1371/journal.pone.0128847	http://dx.doi.org/10.1371/journal.pone.0128847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086818	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500027
J	Shin, JH; Park, JK; Lee, DH; Quan, FS; Song, CS; Kim, YC				Shin, Ju-Hyung; Park, Jae-Keun; Lee, Dong-Hun; Quan, Fu-Shi; Song, Chang-Seon; Kim, Yeu-Chun			Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; INTRADERMAL VACCINATION; IMMUNE-RESPONSES; CROSS-PROTECTION; DELIVERY-SYSTEMS; NASAL DELIVERY; VACCINES; MUCOSAL; IMMUNIZATION; INFECTION	Influenza is one of the critical infectious diseases globally and vaccination has been considered as the best way to prevent. In this study, immunogenicity and protection efficacy between intranasal (IN) and microneedle (MN) vaccination was compared using inactivated swine-origin influenza A/H1N1 virus vaccine. Mice were vaccinated by MN or IN administration with 1 mu g of inactivated H1N1 virus vaccine. Antigen-specific antibody responses and hemagglutination-inhibition (HI) titers were measured in all immunized sera after immunization. Five weeks after an immunization, a lethal challenge was performed to evaluate the protective efficacy. Furthermore, mice were vaccinated by IN administration with higher dosages (> 1 mu g), analyzed in the same manner, and compared with 1 mu g-vaccine-coated MN. Significantly higher antigen-specific antibody responses and HI titer were measured in sera in MN group than those in IN group. While 100% protection, slight weight loss, and reduced viral replication were observed in MN group, 0% survival rate were observed in IN group. As vaccine dose for IN vaccination increased, MN-immunized sera showed much higher antigen-specific antibody responses and HI titer than other IN groups. In addition, protective immunity of 1 mu g-MN group was similar to those of 20- and 40 mu g-IN groups. We conclude that MN vaccination showed more potential immune response and protection than IN vaccination at the same vaccine dosage.	[Shin, Ju-Hyung; Kim, Yeu-Chun] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Taejon 305701, South Korea; [Park, Jae-Keun; Lee, Dong-Hun; Song, Chang-Seon] Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul 143701, South Korea; [Quan, Fu-Shi] Kyung Hee Univ, Dept Med Zool, Sch Med, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Konkuk University; Kyung Hee University	Song, CS (corresponding author), Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul 143701, South Korea.	songcs@konkuk.ac.kr; dohnanyi@kaist.ac.kr	Quan, Fu-Shi/V-1826-2019; Lee, Dong-hun/H-5082-2019; Kim, Yeu Chun/B-3389-2012	Lee, Dong-Hun/0000-0002-0820-7378	Animal Disease Management Technology Development Program [313013-3]; Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Korean Health Technology RD Project [HI13C0826]; Ministry of Health & Welfare, Republic of Korea; Ministry of Science, ICT, and Future Planning, Republic of Korea [NRF-2014M3A9E4064580]	Animal Disease Management Technology Development Program; Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Korean Health Technology RD Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Science, ICT, and Future Planning, Republic of Korea	This research was supported by Animal Disease Management Technology Development Program (Grant number: 313013-3), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, grant of the Korean Health Technology R&D Project (Project number: HI13C0826), Ministry of Health & Welfare, Republic of Korea, and grant of Ministry of Science, ICT, and Future Planning (Grant number: NRF-2014M3A9E4064580), Republic of Korea.	Amorij JP, 2012, J CONTROL RELEASE, V161, P363, DOI 10.1016/j.jconrel.2011.12.039; Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; Balmelli C, 1998, J VIROL, V72, P8220, DOI 10.1128/JVI.72.10.8220-8229.1998; Baz M, 2012, CLIN VACCINE IMMUNOL, V19, P209, DOI 10.1128/CVI.05441-11; Budimir N, 2013, INFLUENZA OTHER RESP, V7, P1202, DOI 10.1111/irv.12142; Buonagurio DA, 2006, VACCINE, V24, P2151, DOI 10.1016/j.vaccine.2005.11.007; Carter NJ, 2011, DRUGS, V71, P1591, DOI 10.2165/11206860-000000000-00000; Chen X, 2013, J PHARM PHARMACOL, V65, P807, DOI 10.1111/jphp.12043; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; Eyles JE, 1999, INT J PHARM, V189, P75, DOI 10.1016/S0378-5173(99)00239-2; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Girard MP, 2005, VACCINE, V23, P5708, DOI 10.1016/j.vaccine.2005.07.046; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Kim Y-C, 2013, J CONTROLLED RELEASE; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Kim YC, 2012, CURR TOP MICROBIOL, V351, P77, DOI 10.1007/82_2011_123; Kim YC, 2010, J CONTROL RELEASE, V142, P187, DOI 10.1016/j.jconrel.2009.10.013; Kim YC, 2010, J INFECT DIS, V201, P190, DOI 10.1086/649228; LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4; Li YY, 2014, 2014 IEEE DALLAS CIRCUITS AND SYSTEMS CONFERENCE (IEEE DCAS 2014); Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Madsen F, 1998, J CONTROL RELEASE, V50, P167, DOI 10.1016/S0168-3659(97)00138-7; Matsuo K, 2013, VACCINE; McGhee J.R.C., 1999, MUCOSAL IMMUNOL, Vsecond, P741; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Oh YK, 2003, VACCINE, V21, P1980, DOI 10.1016/S0264-410X(02)00779-X; Ohmit SE, 2013, CLIN INFECT DIS; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Quan FS, 2010, J CONTROL RELEASE, V147, P326, DOI 10.1016/j.jconrel.2010.07.125; Quan FS, 2010, J VIROL, V84, P7760, DOI 10.1128/JVI.01849-09; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; Richert LE, 2012, VACCINE, V30, P3653, DOI 10.1016/j.vaccine.2012.03.035; Roy S, 2009, DES MONOMERS POLYM, V12, P483, DOI 10.1163/138577209X12478283327236; Song JM, 2012, MOL THER, V20, P1472, DOI 10.1038/mt.2012.69; Song JY, 2013, CLIN EXP VACCINE RES, V2, P115, DOI 10.7774/cevr.2013.2.2.115; Subbarao K, 2013, TRENDS MICROBIOL; Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Ugwoke MI, 2000, INT J PHARM, V205, P43, DOI 10.1016/S0378-5173(00)00484-1; Wareing MD, 2001, VACCINE, V19, P3320, DOI 10.1016/S0264-410X(01)00045-7; Weldon WC, 2011, CLIN VACCINE IMMUNOL, V18, P647, DOI 10.1128/CVI.00435-10; Xu XF, 2014, EUR J PHARM BIOPHARM, V88, P998, DOI 10.1016/j.ejpb.2014.08.015; Yang PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030252; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6	57	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130684	10.1371/journal.pone.0130684	http://dx.doi.org/10.1371/journal.pone.0130684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086590	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500128
J	Smith, RJ; Paterson, JS; Sibley, CA; Hutson, JL; Mitchell, JG				Smith, Renee J.; Paterson, James S.; Sibley, Cally A.; Hutson, John L.; Mitchell, James G.			Putative Effect of Aquifer Recharge on the Abundance and Taxonomic Composition of Endemic Microbial Communities	PLOS ONE			English	Article							FLOW-CYTOMETRY; RECOVERY ASR; PARTICLE ABUNDANCES; CARBONATE AQUIFER; RECLAIMED WATER; GROUNDWATER; BACTERIAL; STORAGE; DIVERSITY; VIRUSES	Drought events and the overexploitation of freshwater resources have led to the increased need to manage groundwater reserves. Aquifer storage and recovery (ASR), whereby artificial water is injected into aquifers for storage, is one of the proposed methods by which freshwater supplies can be increased. Microbial clogging following injection, however, is a major issue. Here, during laboratory simulations of ASR, we used flow cytometry and barcoded pyrosequencing to investigate changes in microbial abundance and community dynamics. Bacterial abundance ranged from 5.0 x 10(4) to 1.4 x 10(7) cells ml(-1) before the addition of synthetic wastewater. Following wastewater addition, a 25-fold decrease in abundance was observed, coinciding with a 12-fold increase in viral abundance. Taxa shifted from an overrepresentation of Sphingomonadales, Sphingobacteriales, Rhodospirillales, Caulobacterales, Legionellales, Bacillales, Fusobacteriales and Verrucomicrobiales prior to the addition of synthetic wastewater to Burkholderiales, Actinomycetales, Pseudomonadales, Xanthomonadales, Rhodobacterales, Thizobiales and Thiotrichales following the addition of synthetic wastewater. Furthermore, a significant difference in overall taxonomic composition between the groundwater samples before and after the addition of synthetic wastewater was observed, with water samples exhibiting more similarity to sediment samples after wastewater was added. Collectively, these results suggest that ASR may alter the taxonomic composition of endemic microbial communities and that complete profiles of groundwater properties, including microbial community abundance and composition need to be taken into consideration when selecting aquifers for ASR practices.	[Smith, Renee J.; Paterson, James S.; Sibley, Cally A.; Mitchell, James G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Hutson, John L.] Flinders Univ S Australia, Sch Environm, Adelaide, SA 5001, Australia	Flinders University South Australia; Flinders University South Australia	Smith, RJ (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	renee.smith@flinders.edu.au		Mitchell, Jim/0000-0002-8445-0935; Paterson, James/0000-0002-1193-5739	Australian Research Council, ARC Linkage Grant	Australian Research Council, ARC Linkage Grant(Australian Research Council)	This work was supported by the Australian Research Council, ARC Linkage Grant to JGM.	Amalfitano S, 2014, WATER RES, V65, P384, DOI 10.1016/j.watres.2014.08.004; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Antoniou EA, 2012, APPL GEOCHEM, V27, P2435, DOI 10.1016/j.apgeochem.2012.09.006; Baker MA, 2000, ECOLOGY, V81, P3133, DOI 10.1890/0012-9658(2000)081[3133:OCSAMI]2.0.CO;2; Banning N, 2003, MICROBIOL-SGM, V149, P47, DOI 10.1099/mic.0.25938-0; Baveye P, 2012, CRITICAL REV ENV SCI, V28, P123; Bergey DH., 2001, BERGEYS MANUAL SYSTE; Bestland E, 2009, HYDROL EARTH SYST SC, V13, P1201, DOI 10.5194/hess-13-1201-2009; Bond NR, 2008, HYDROBIOLOGIA, V600, P3, DOI 10.1007/s10750-008-9326-z; Bouwer H, 2002, HYDROGEOL J, V10, P121, DOI 10.1007/s10040-001-0182-4; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Cho JC, 2000, APPL ENVIRON MICROB, V66, P956, DOI 10.1128/AEM.66.3.956-965.2000; Clarke A, 2006, PRIMER V6 USER MANUL; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Danielopol DL, 2000, TRENDS ECOL EVOL, V15, P223, DOI 10.1016/S0169-5347(00)01868-1; Dillon P, 2006, DESALINATION, V188, P123, DOI 10.1016/j.desal.2005.04.109; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fetter CW, 2001, APPL HYDROGEOL; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Foster SSD, 2003, PHILOS T R SOC B, V358, P1957, DOI 10.1098/rstb.2003.1380; Foulquier A, 2011, ECOSYSTEMS, V14, P1339, DOI 10.1007/s10021-011-9484-0; FREDRICKSON JK, 1995, APPL ENVIRON MICROB, V61, P1917, DOI 10.1128/AEM.61.5.1917-1922.1995; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Giordano M, 2009, ANNU REV ENV RESOUR, V34, P153, DOI 10.1146/annurev.environ.030308.100251; Gray CJ, 2013, ISME J, V7, P325, DOI 10.1038/ismej.2012.105; Griebler C, 2009, FRESHWATER BIOL, V54, P649, DOI 10.1111/j.1365-2427.2008.02013.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hoffmann KH, 2007, FEMS MICROBIOL LETT, V273, P224, DOI 10.1111/j.1574-6968.2007.00790.x; Jacquet S, 2005, FRESHWATER BIOL, V50, P627, DOI 10.1111/j.1365-2427.2005.01349.x; Jeffries TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025173; Khan S, 2008, AGR WATER MANAGE, V95, P477, DOI 10.1016/j.agwat.2007.12.002; Kim JW, 2010, WATER RES, V44, P1193, DOI 10.1016/j.watres.2009.05.049; Li D, 2012, APPL ENVIRON MICROB, V78, P6819, DOI 10.1128/AEM.01223-12; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Mermillod-Blondin F, 2013, ECOL INDIC, V25, P230, DOI 10.1016/j.ecolind.2012.09.026; Mitchell JG, 2004, HDB SCALING METHODS, P257; Mpelasoka F, 2008, INT J CLIMATOL, V28, P1283, DOI 10.1002/joc.1649; Page D, 2011, J ENVIRON MANAGE, V92, P2410, DOI 10.1016/j.jenvman.2011.04.005; Pai TY, 2001, APPL MATH MODEL, V25, P1025, DOI 10.1016/S0307-904X(01)00028-2; Pavelic P, 2011, WATER RES, V45, P3153, DOI 10.1016/j.watres.2011.03.027; Pavelic P, 2007, J HYDROL, V334, P1, DOI 10.1016/j.jhydrol.2006.08.009; Pavelic P, 2006, HYDROGEOL J, V14, P1544, DOI 10.1007/s10040-006-0078-4; Rinck-Pfeiffer S, 2000, WATER RES, V34, P2110, DOI 10.1016/S0043-1354(99)00356-5; Roudnew B, 2014, GROUNDWATER, V52, P118, DOI 10.1111/gwat.12044; Roudnew B, 2013, AQUAT MICROB ECOL, V68, P259, DOI 10.3354/ame01615; Roudnew B, 2012, GROUND WATER MONIT R, V32, P72, DOI 10.1111/j.1745-6592.2011.01393.x; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Seymour JR, 2004, AQUAT MICROB ECOL, V35, P1, DOI 10.3354/ame035001; Smith RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081910; Smith RJ, 2012, ENVIRON MICROBIOL, V14, P240, DOI 10.1111/j.1462-2920.2011.02614.x; VanderzalM JL, 2006, APPL GEOCHEM, V21, P1204, DOI 10.1016/j.apgeochem.2006.02.022; VANDEVIVERE P, 1992, APPL ENVIRON MICROB, V58, P1690, DOI 10.1128/AEM.58.5.1690-1698.1992; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; WILCOX RM, 1994, MAR ECOL PROG SER, V114, P35, DOI 10.3354/meps114035; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	66	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129004	10.1371/journal.pone.0129004	http://dx.doi.org/10.1371/journal.pone.0129004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083532	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400077
J	Tayama, J; Nakaya, N; Hamaguchi, T; Saigo, T; Takeoka, A; Sone, T; Fukudo, S; Shirabe, S				Tayama, Jun; Nakaya, Naoki; Hamaguchi, Toyohiro; Saigo, Tatsuo; Takeoka, Atsushi; Sone, Toshimasa; Fukudo, Shin; Shirabe, Susumu			Maladjustment to Academic Life and Employment Anxiety in University Students with Irritable Bowel Syndrome	PLOS ONE			English	Article							QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL DISORDERS; HEALTH-CARE; WORK PRODUCTIVITY; CLINICAL-PRACTICE; MEDICAL-STUDENTS; PANIC DISORDER; QUESTIONNAIRE; POPULATION; SYMPTOMS	The present study tested our hypothesis that university students with irritable bowel syndrome (IBS) may experience less satisfactory academic lives than those of students without IBS. We also verified the hypothesis that university students with IBS might have higher employment anxiety than students without IBS might. We conducted a cross-sectional study of 1,686 university students. Presence or absence of IBS was assessed via the Rome III Questionnaire. Two original items were used to evaluate academic life. The prevalence rates of IBS with diarrhea, IBS with constipation, mixed IBS, and unsubtyped IBS in the study population were 5%, 2%, 10%, and 3%, respectively. Regarding academic life, the proportions of participants who experienced maladjustment and employment anxiety were 29% and 50%, respectively. After adjusting for age, sex, and faculty, the odds ratios for maladjustment and employment anxiety were significantly higher in students who screened positively, relative to those who screened negatively, for IBS (OR, 1.62; 95% CI, 1.24-2.21; OR, 2.16; 95% CI, 1.68-2.81, respectively). In conclusion, maladjustment and anxiety over future employment were higher in university students with IBS relative to those without.	[Tayama, Jun] Nagasaki Univ, Grad Sch Educ, Nagasaki 852, Japan; [Tayama, Jun; Saigo, Tatsuo; Shirabe, Susumu] Nagasaki Univ, Ctr Hlth & Community Med, Nagasaki 852, Japan; [Nakaya, Naoki] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Hamaguchi, Toyohiro] Saitama Prefectural Univ, Sch Hlth & Social Serv, Dept Occupat Therapy, Saitama, Japan; [Takeoka, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Unit Prevent Med, Nagasaki 852, Japan; [Sone, Toshimasa] Tohoku Fukushi Univ, Fac Hlth Sci, Dept Rehabil, Sendai, Miyagi, Japan; [Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan	Nagasaki University; Nagasaki University; Tohoku University; Nagasaki University; Tohoku University	Tayama, J (corresponding author), Nagasaki Univ, Grad Sch Educ, Nagasaki 852, Japan.	jtayama@nagasaki-u.ac.jp	Hamaguchi, Toyohiro/J-4911-2019; Hamaguchi, Toyohiro/AAG-7808-2020; Fukudo, Shin/J-4813-2014	Tayama, Jun/0000-0002-4689-6880; Hamaguchi, Toyohiro/0000-0001-5645-0439	Japan Society for the Promotion of Science (JSPS) [24590890]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from the Japan Society for the Promotion of Science (JSPS) for the Grant-in-Aid for Scientific Research (C) (No. 24590890) (https://kaken.nii.ac.jp/d/p/24590890.ja.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Creed F, 2001, ANN INTERN MED, V134, P860, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00010; DROSSMAN DA, 1982, GASTROENTEROLOGY, V83, P529; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Faresjo A, 2007, AM J GASTROENTEROL, V102, P371, DOI 10.1111/j.1572-0241.2006.01012.x; Farnam Alireza, 2008, Neuropsychiatr Dis Treat, V4, P959; Fossey M D, 1990, Psychiatr Med, V8, P175; Fukudo S, 2015, DIGESTION, V91, P99, DOI 10.1159/000369078; Fukudo S, 2015, J GASTROENTEROL, V50, P11, DOI 10.1007/s00535-014-1017-0; Gwee KA, 2005, NEUROGASTROENT MOTIL, V17, P317, DOI 10.1111/j.1365-2982.2005.00627.x; Gwee KA, 2009, J GASTROEN HEPATOL, V24, P1601, DOI 10.1111/j.1440-1746.2009.05984.x; Ibrahim NKR, 2013, LIBYAN J MED, V8, DOI 10.3402/ljm.v8i0.21287; Jamali A, 2013, MED EDUC, V47, P1001, DOI 10.1111/medu.12247; Jamali R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-12; Jerndal P, 2010, NEUROGASTROENT MOTIL, V22, P646, DOI 10.1111/j.1365-2982.2010.01493.x; Kanazawa M, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-6; Kubo M, 2011, NEUROGASTROENT MOTIL, V23, P249, DOI 10.1111/j.1365-2982.2010.01640.x; Ladep NG, 2006, WORLD J GASTROENTERO, V12, P7844, DOI 10.3748/wjg.v12.i48.7844; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; LYDIARD RB, 1994, AM J PSYCHIAT, V151, P64; Lydiayd RB, 2001, J CLIN PSYCHIAT, V62, P38; MAYER EA, 1990, GASTROENTEROLOGY, V99, P1688, DOI 10.1016/0016-5085(90)90475-G; Miwa Hiroto, 2008, Patient Prefer Adherence, V2, P143; Osterberg E, 2000, SCAND J GASTROENTERO, V35, P264; PALMER RL, 1974, POSTGRAD MED J, V50, P416, DOI 10.1136/pgmj.50.585.416; Pare P, 2006, CLIN THER, V28, P1726, DOI 10.1016/j.clinthera.2006.10.010; Reilly MC, 2004, ALIMENT PHARM THER, V20, P459, DOI 10.1111/j.1365-2036.2004.02091.x; RITCHIE J, 1973, GUT, V14, P125, DOI 10.1136/gut.14.2.125; Sagami Y, 2004, GUT, V53, P958, DOI 10.1136/gut.2003.018911; Sagawa T, 2013, J GASTROEN HEPATOL, V28, P285, DOI 10.1111/j.1440-1746.2012.07257.x; Saigo T, 2014, BIOPSYCHOSOC MED, V8, DOI 10.1186/1751-0759-8-10; Shinozaki M, 2006, J GASTROENTEROL, V41, P491, DOI 10.1007/s00535-006-1799-9; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Sugaya N, 2013, PSYCHIAT CLIN NEUROS, V67, P397, DOI 10.1111/pcn.12069; Sugaya N, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-9; TALLEY NJ, 1995, GASTROENTEROLOGY, V109, P1736, DOI 10.1016/0016-5085(95)90738-6; Tayama J, 2012, BIOPSYCHOSOC MED, V6, DOI 10.1186/1751-0759-6-20; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; Whitehead WE, 1985, GASTROINTESTINAL DIS, P155	39	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129345	10.1371/journal.pone.0129345	http://dx.doi.org/10.1371/journal.pone.0129345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083662	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400089
J	Carpenter, D; Boutin, C; Allison, JE; Parsons, JL; Ellis, DM				Carpenter, David; Boutin, Celine; Allison, Jane E.; Parsons, Jessica L.; Ellis, Deanna M.			Uptake and Effects of Six Rare Earth Elements (REEs) on Selected Native and Crop Species Growing in Contaminated Soils	PLOS ONE			English	Article							LANTHANIDE ELEMENTS; GROWTH; PLANTS; ACCUMULATION; CHLORIDE; CERIUM; CHINA; GERMINATION; METABOLISM; PATTERN	Rare earth elements (REEs) have become increasingly important metals used in modern technology. Processes including mining, oil refining, discarding of obsolete equipment containing REEs, and the use of REE-containing phosphate fertilizers may increase the likelihood of environmental contamination. However, there is a scarcity of information on the toxicity and accumulation of these metals to terrestrial primary producers in contaminated soils. The objective of this work was to assess the phytotoxicity and uptake from contaminated soil of six REEs (chloride forms of praseodymium, neodymium, samarium, terbium, dysprosium, and erbium) on three native plants (Asclepias syriaca L., Desmodium canadense (L.) DC., Panicum virgatum L.) and two crop species (Raphanus sativus L., Solanum lycopersicum L.) in separate dose-response experiments under growth chamber conditions. Limited effects of REEs were found on seed germination and speed of germination. Effects on aboveground and belowground biomass were more pronounced, especially for the three native species, which were always more sensitive than the crop species tested. Inhibition concentrations (IC25 and IC50) causing 25 or 50% reductions in plant biomass respectively, were measured. For the native species, the majority of aboveground biomass IC25s (11 out of 18) fell within 100 to 300 mg REE/kg dry soil. In comparison to the native species, IC25s for the crops were always greater than 400 mg REE/kg, with the majority of results (seven out of 12) falling above 700 mg REE/kg. IC50s were often not detected for the crops. Root biomass of native species was also affected at lower doses than in crops. REE uptake by plants was higher in the belowground parts than in the above-ground plant tissues. Results also revealed that chloride may have contributed to the sensitivity of the native species, Desmodium canadense, one of the most sensitive species studied. Nevertheless, these results demonstrated that phytotoxicity may be a concern in contaminated areas.	[Carpenter, David; Boutin, Celine; Allison, Jane E.; Parsons, Jessica L.; Ellis, Deanna M.] Environm Canada, Sci & Technol Branch, Ottawa, ON K1A 0H3, Canada; [Allison, Jane E.] Univ Ottawa, Ottawa Carleton Inst Biol, Dept Biol, Ottawa, ON K1N 6N5, Canada; [Parsons, Jessica L.] Carleton Univ, Ottawa Carleton Inst Biol, Dept Biol, Ottawa, ON K1S 5B6, Canada	Environment & Climate Change Canada; University of Ottawa; Carleton University; University of Ottawa	Boutin, C (corresponding author), Environm Canada, Sci & Technol Branch, Ottawa, ON K1A 0H3, Canada.	Celine.Boutin@ec.gc.ca			Science and Risk Assessment Directorate of Environment Canada; National Science and Engineering Research Council	Science and Risk Assessment Directorate of Environment Canada; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was provided by the Science and Risk Assessment Directorate of Environment Canada to CB and DC: they provided most of the funding for material and technical assistance. This funder had a role in the study design, data collection and analysis, but had no role in the decision to publish, or preparation of the manuscript. National Science and Engineering Research Council provided funding (to CB) for students. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Better Crops with Plant Food, V83, P4; Avalon Rare Metals Inc, 2015, NECH RAR EARTH EL PR; Babula P, 2008, ENVIRON CHEM LETT, V6, P189, DOI 10.1007/s10311-008-0159-9; BANULS J, 1992, PHYSIOL PLANTARUM, V86, P115, DOI 10.1111/j.1399-3054.1992.tb01319.x; Bar Y, 1997, J PLANT NUTR, V20, P715, DOI 10.1080/01904169709365288; Bibak A, 1999, COMMUN SOIL SCI PLAN, V30, P2409, DOI 10.1080/00103629909370382; Boutin C, 2012, LANTHANUM CHLORIDE L; Brioschi L, 2013, PLANT SOIL, V366, P143, DOI 10.1007/s11104-012-1407-0; Cao XD, 2001, CHEMOSPHERE, V44, P655, DOI 10.1016/S0045-6535(00)00492-6; Carpenter D, 2014, HEAVY RARE EARTH ELE; Carpenter D, 2013, SAMARIUM CHLORIDE HE; COWGILL U M, 1973, Science of the Total Environment, V2, P259, DOI 10.1016/0048-9697(73)90020-X; d'Aquino L, 2009, CHEMOSPHERE, V75, P900, DOI 10.1016/j.chemosphere.2009.01.026; de Boer MA, 2013, CHEMSUSCHEM, V6, P2045, DOI 10.1002/cssc.201200794; Diatloff E, 2008, ANN BOT-LONDON, V101, P971, DOI 10.1093/aob/mcn021; Du XY, 2011, J IND ECOL, V15, P836, DOI 10.1111/j.1530-9290.2011.00362.x; Environment Canada, 2007, BIOLOGICAL TEST METH; Fashui H, 2005, BIOL TRACE ELEM RES, V104, P185, DOI 10.1385/BTER:104:2:185; Franca E. J. de, 2011, International Journal of Environment and Health, V5, P32, DOI 10.1504/IJENVH.2011.039854; Fu FF, 2001, PLANT SOIL, V235, P53, DOI 10.1023/A:1011837326556; Fu FF, 1998, BIOL TRACE ELEM RES, V64, P13, DOI 10.1007/BF02783321; Gonzalez V, 2014, ENVIRON INT, V71, P148, DOI 10.1016/j.envint.2014.06.019; Greenwood N.N., 1997, CHEM ELEMENTS; Hayes-Labruto L, 2013, ENERG POLICY, V63, P55, DOI 10.1016/j.enpol.2013.07.121; He YW, 2000, PLANT SCI, V159, P117, DOI 10.1016/S0168-9452(00)00338-1; Hong FS, 2003, BIOL TRACE ELEM RES, V94, P273, DOI 10.1385/BTER:94:3:273; Hu X, 2002, CHEMOSPHERE, V48, P621, DOI 10.1016/S0045-6535(02)00109-1; Hu ZY, 2006, COMMUN SOIL SCI PLAN, V37, P1381, DOI 10.1080/00103620600628680; Hu ZY, 2004, J PLANT NUTR, V27, P183, DOI 10.1081/PLN-120027555; Hurst C., 2010, CHINAS RARE EARTH EL, V43; ICHIHASHI H, 1992, ENVIRON POLLUT, V76, P157, DOI 10.1016/0269-7491(92)90103-H; Kataoka T, 2002, PLANT CELL ENVIRON, V25, P453, DOI 10.1046/j.0016-8025.2001.00821.x; Li JX, 2010, J RARE EARTH, V28, P957, DOI 10.1016/S1002-0721(09)60233-7; Liang T, 2014, ENVIRON MONIT ASSESS, V186, P1499, DOI 10.1007/s10661-013-3469-8; Liu M, 2005, PLANTA, V220, P658, DOI 10.1007/s00425-004-1379-2; Liu XQ, 2009, BIOL TRACE ELEM RES, V130, P141, DOI 10.1007/s12011-009-8321-1; Long KR, 2012, NONRENEWABLE RESOURC, P131, DOI DOI 10.1007/978-90-481-8679-2_7; MACKENZIE RC, 1951, J COLL SCI IMP U TOK, V6, P219; MARKERT B, 1987, PHYTOCHEMISTRY, V26, P3167, DOI 10.1016/S0031-9422(00)82463-2; MARKERT B, 1991, SCI TOTAL ENVIRON, V103, P27, DOI 10.1016/0048-9697(91)90350-N; Masau M, 2000, CAN MINERAL, V38, P899, DOI 10.2113/gscanmin.38.4.899; Norberg-King T. J., 1993, 0393 US EPA ENV RES; OLDHAM MJ, 1995, FLORISTIC QUALITY AS; Pang X, 2002, ENVIRON SCI POLLUT R, V9, P143, DOI [10.1007/BF02987462, 10.1007/BF02987718]; Patnaik P., 2003, HDB INORGANIC CHEM; PICKARD BG, 1970, PLANTA, V91, P314, DOI 10.1007/BF00387504; Redling K., 2006, THESIS LUDWIG MAXIMI; Shi P, 2006, BIOL TRACE ELEM RES, V109, P181, DOI 10.1385/BTER:109:2:181; Slooff W, 1993, 710401025 NAT I PUBL; Sneller FEC, 2000, 601501 RIVM NAT I PU; Stone R, 2009, SCIENCE, V325, P1336, DOI 10.1126/science.325_1336; Thomas PJ, 2014, CHEMOSPHERE, V96, P57, DOI 10.1016/j.chemosphere.2013.07.020; Turra C., 2011, J ENV CHEM ECOTOXICO, V3, P86, DOI DOI 10.1590/1806; Tyler G, 2005, BIOL TRACE ELEM RES, V106, P177, DOI 10.1385/BTER:106:2:177; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; Tyler G, 2001, PLANT SOIL, V230, P307, DOI 10.1023/A:1010314400976; U.S. Department of Energy, 2010, CRITICAL MAT STRATEG; U. S. Environmental Protection Agency (USEPA), 1996, 1638 USEPA; VOLOKH AA, 1990, SCI TOTAL ENVIRON, V95, P141, DOI 10.1016/0048-9697(90)90059-4; von Tucher S, 2005, J PLANT NUTR SOIL SC, V168, P574, DOI 10.1002/jpln.200520506; Wahid PA, 2003, J PLANT NUTR, V26, P1427, DOI 10.1081/PLN-120021052; Wang LH, 2009, CHEMOSPHERE, V77, P1019, DOI 10.1016/j.chemosphere.2009.07.065; Wyttenbach A, 1998, PLANT SOIL, V199, P267, DOI 10.1023/A:1004331826160; Xie ZB, 2002, J PLANT NUTR, V25, P2315, DOI 10.1081/PLN-120014078; Yang Q, 2015, ECOTOX ENVIRON SAFE, V111, P48, DOI 10.1016/j.ecoenv.2014.10.002; Yoshida S, 1998, ENVIRON INT, V24, P275, DOI 10.1016/S0160-4120(98)00006-3; Yufeng Z, 2001, B ENVIRON CONTAM TOX, V67, P399; Zeng FL, 1999, BIOL TRACE ELEM RES, V67, P277, DOI 10.1007/BF02784427; Zeng Q, 2006, ECOTOX ENVIRON SAFE, V64, P226, DOI 10.1016/j.ecoenv.2005.03.016; Zhang CH, 2013, ACTA PHARM SIN B, V3, P20, DOI 10.1016/j.apsb.2012.12.005; Zhang SZ, 2001, ENVIRON POLLUT, V112, P395, DOI 10.1016/S0269-7491(00)00143-3; Zhang ZY, 2002, J RADIOANAL NUCL CH, V252, P461, DOI 10.1023/A:1015834232718	72	80	83	4	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129936	10.1371/journal.pone.0129936	http://dx.doi.org/10.1371/journal.pone.0129936			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076480	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900116
J	Choi, EPH; Chin, WY; Lam, CLK; Wan, EYF; Chan, AKC; Chan, KHY				Choi, Edmond P. H.; Chin, Weng-Yee; Lam, Cindy L. K.; Wan, Eric Y. F.; Chan, Anca K. C.; Chan, Karina H. Y.			Evaluation of the Effectiveness of Nurse-Led Continence Care Treatments for Chinese Primary Care Patients with Lower Urinary Tract Symptoms	PLOS ONE			English	Article							SELF-MANAGEMENT; INCONTINENCE; ENABLEMENT; DEPRIVATION; HYPERPLASIA; POPULATION	Background The aim of this study was to evaluate whether community-based nurse-led continence care interventions are effective in improving outcomes for adult Chinese primary care patients with lower urinary tract symptoms (LUTS). Research Design and Subjects A case-controlled intervention study was conducted. An intervention group of 360 primary care patients enrolled into a nurse-led continence care programme were recruited by consecutive sampling. A control group of 360 primary care patients with LUTS identified by screening were recruited from the waiting rooms of primary care clinics by consecutive sampling. Both groups were monitored at baseline and at 12 months. Measures Outcome measures included symptom severity, health-related quality of life (HRQOL), self-efficacy, global health and self-reported health service utilization at 12-months. The effect of the continence care programme on symptom severity and HRQOL was assessed by the difference- in-difference estimation, using independent t-test and multiple liner regression. Chi-square test was used to compare the self-efficacy, global health and self-reported health service utilization between the two groups at 12-months. Results After adjusting for baseline severity and socio-demographics, the intervention group had significant improvements in LUTS severity (P<0.05) and HRQOL (P<0.05). Improvements in the amount of urine leakage were not significantly different between the two groups. A higher proportion of subjects in the intervention group reported increased self-efficacy (43.48% vs. 66.83%), improved global health condition (17.74% vs. 41.5%), having doctor consultation (18.5% vs. 8.06), having medication due to LUTS (26.50% vs. 11.29%) and having non-drug therapy due to LUTS (59.5% vs. 9.68%). Conclusions Community-based nurse-led continence care can effectively alleviate symptoms, improve health-related quality of life, and enhance self-efficacy and the global health condition of Chinese male and female primary care patients with LUTS.	[Choi, Edmond P. H.; Chin, Weng-Yee; Lam, Cindy L. K.; Wan, Eric Y. F.; Chan, Anca K. C.; Chan, Karina H. Y.] Univ Hong Kong, Ap Lei Chau Clin, Dept Family Med & Primary Care, Ap Lei Chau, Hong Kong, Peoples R China	University of Hong Kong	Choi, EPH (corresponding author), Univ Hong Kong, Ap Lei Chau Clin, Dept Family Med & Primary Care, Ap Lei Chau, Hong Kong, Peoples R China.	h0714919@connect.hku.hk	Choi, Edmond/HDN-8462-2022; Choi, Edmond/H-4187-2019	Choi, Edmond/0000-0001-9062-3540	University of Hong Kong [201209176016]; Health and Health Services Research Fund; Food and Health Bureau; HKSAR Commissioned Research on Enhancing Primary Care Study [EPC-HKU-2]	University of Hong Kong(University of Hong Kong); Health and Health Services Research Fund; Food and Health Bureau; HKSAR Commissioned Research on Enhancing Primary Care Study	WYC, EPHC, and CLKL received support from The Small Project Funding, Committee on Research and Conference Grants of the University of Hong Kong (reference no: 201209176016). University internal grant: no link provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CLKL and WYC received support from The Health and Health Services Research Fund, Food and Health Bureau, HKSAR Commissioned Research on Enhancing Primary Care Study (reference no: EPC-HKU-2). Link: http://hub.hku.hk/cris/project/hkugrant105312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Baessler K, 2010, PELVIC FLOOR REEDUCA; Chen Y, 2012, UROLOGY, V79, P1385, DOI 10.1016/j.urology.2011.11.091; Choi EPH, 2015, J ADV NURS, V71, P1857, DOI 10.1111/jan.12662; Choi EPH, 2014, PATIENT, V7, P403, DOI 10.1007/s40271-014-0062-3; Choi EPH, 2014, QUAL LIFE RES, V23, P2723, DOI 10.1007/s11136-014-0725-5; Choi EPH, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-1; Clarke LH, 2013, HEALTH-LONDON, V17, P211, DOI 10.1177/1363459312451181; Du Moulin MFMT, 2005, INT J NURS STUD, V42, P479, DOI 10.1016/j.ijnurstu.2004.08.002; Emberton M, 2006, EUR UROL SUPPL, V5, P704, DOI 10.1016/j.eursup.2006.06.008; Espuna-Pons M, 2007, NEUROUROL URODYNAM, V26, P836, DOI 10.1002/nau.20379; Fitzpatrick JM, 2006, BJU INT, V97, P3, DOI 10.1111/j.1464-410X.2006.06097.x; Fung CH, 2007, J AM GERIATR SOC, V55, pS443, DOI 10.1111/j.1532-5415.2007.01354.x; Haughney John, 2007, Prim Care Respir J, V16, P89; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Lam CLK, 2010, FAM PRACT, V27, P395, DOI 10.1093/fampra/cmq021; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Linmans JJ, 2012, J CLIN EPIDEMIOL, V65, P785, DOI 10.1016/j.jclinepi.2012.01.010; Mercer SW, 2008, PATIENT EDUC COUNS, V73, P240, DOI 10.1016/j.pec.2008.07.022; Mercer SW, 2007, BRIT J GEN PRACT, V57, P960, DOI 10.3399/096016407782604910; Milne Jill L, 2004, J Wound Ostomy Continence Nurs, V31, P367; National Clinical Guideline Centre, 2010, MAN LOW UR TRACT SYM; Pang M. W., 2005, Hong Kong Medical Journal, V11, P158; Sexton CC, 2009, BJU INT, V103, P12, DOI 10.1111/j.1464-410X.2009.08369.x; Singer J., 2012, HDB HLTH PSYCHOL; Siu AMH, 2007, PATIENT EDUC COUNS, V65, P42, DOI 10.1016/j.pec.2006.04.013; T Brown C, 2007, BRIT MED J, V334, P25, DOI 10.1136/bmj.39010.551319.AE; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; Thomas LH, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000349, DOI 10.1002/14651858.CD000349]; Wagg A, 2009, AGE AGEING, V38, P730, DOI 10.1093/ageing/afp177	31	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129875	10.1371/journal.pone.0129875	http://dx.doi.org/10.1371/journal.pone.0129875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076486	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900107
J	Opel, A; Nobles, M; Montaigne, D; Finlay, M; Anderson, N; Breckenridge, R; Tinker, A				Opel, Aaisha; Nobles, Muriel; Montaigne, David; Finlay, Malcolm; Anderson, Naomi; Breckenridge, Ross; Tinker, Andrew			Absence of the Regulator of G-protein Signaling, RGS4, Predisposes to Atrial Fibrillation and Is Associated with Abnormal Calcium Handling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; HEART-FAILURE; IN-VITRO; MYOCYTES; EXPRESSION; KINETICS; GENERATION; ARRHYTHMIA; CONNEXIN43; RECEPTOR	The description of potential molecular substrates for predisposition to atrial fibrillation (AF) is incomplete, and it is unknown what role regulators of G/protein signaling might play. We address whether the attenuation of RGS4 function may promote AF and the mechanism through which this occurs. For this purpose, we studied a mouse with global genetic deletion of RGS4 (RGS4(-/-)) and the normal littermate controls (RGS4(-/-)). In vivo electrophysiology using atrial burst pacing revealed that mice with global RGS4 deletion developed AF more frequently than control littermates. Isolated atrial cells from RGS4(-/-) mice show an increase in Ca2+ spark frequency under basal conditions and after the addition of endothelin-1 and abnormal spontaneous Ca2+ release events after field stimulation. Isolated left atria studied on a multielectrode array revealed modest changes in path length for re-entry but abnormal electrical events after a pacing train in RGS4(-/-) mice. RGS4 deletion results in a predisposition to atrial fibrillation from enhanced activity in the G alpha(q/11)-IP3 pathway, resulting in abnormal Ca2+ release and corresponding electrical events.	[Opel, Aaisha; Breckenridge, Ross; Tinker, Andrew] UCL, Rayne Inst, Dept Med, British Heart Fdn Labs, London WC1E 6JJ, England; [Opel, Aaisha; Nobles, Muriel; Montaigne, David; Finlay, Malcolm; Anderson, Naomi; Tinker, Andrew] Barts & London Queen Marys Sch Med & Dent, William Harvey Heart Ctr, London EC1M 6BQ, England	University of London; King's College London; University College London; University of London; Queen Mary University London	Tinker, A (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Heart Ctr, Charter House Sq, London EC1M 6BQ, England.	a.tinker@qmul.ac.uk	Montaigne, David/R-6066-2018; Finlay, Malcolm/Q-2363-2015	Montaigne, David/0000-0002-2346-863X; Finlay, Malcolm/0000-0001-6403-9340	British Heart Foundation [FS/09/042/27860]; Wellcome Trust [081475/Z/06/Z]; National Institute for Health Research Barts Cardiovascular Biomedical Research Unit; Fondation Coeur et Arteres; Institut Servier	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Barts Cardiovascular Biomedical Research Unit; Fondation Coeur et Arteres; Institut Servier	This work was supported by British Heart Foundation Grant FS/09/042/27860, Wellcome Trust Grant 081475/Z/06/Z, and funds from the National Institute for Health Research Barts Cardiovascular Biomedical Research Unit, the Fondation Coeur et Arteres, and Institut Servier. The authors declare that they have no conflicts of interest with the contents of this article.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Beaumont J, 1998, BIOPHYS J, V75, P1, DOI 10.1016/S0006-3495(98)77490-9; Benians A, 2005, J BIOL CHEM, V280, P13383, DOI 10.1074/jbc.M410163200; Benians A, 2003, P NATL ACAD SCI USA, V100, P6239, DOI 10.1073/pnas.1037595100; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bussek A, 2012, J PHARMACOL TOX MET, V66, P145, DOI 10.1016/j.vascn.2011.12.002; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; de Groot JR, 2004, CARDIOVASC RES, V62, P323, DOI 10.1016/j.cardiores.2004.01.033; Doupnik CA, 2001, BBA-GENE STRUCT EXPR, V1522, P97, DOI 10.1016/S0167-4781(01)00342-6; Guasch E, 2013, J AM COLL CARDIOL, V62, P68, DOI 10.1016/j.jacc.2013.01.091; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Janvier NC, 1997, J PHYSIOL-LONDON, V504, P301, DOI 10.1111/j.1469-7793.1997.301be.x; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; Kockskamper J, 2002, J PHYSIOL-LONDON, V545, P65, DOI 10.1113/jphysiol.2002.025502; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; Mittmann C, 2002, CARDIOVASC RES, V55, P778, DOI 10.1016/S0008-6363(02)00459-5; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Opel A., 2011, EUROPACE, V13, P17; Owen VJ, 2001, EUR HEART J, V22, P1015, DOI 10.1053/euhj.2000.2578; Pandit SV, 2013, CIRC RES, V112, P849, DOI 10.1161/CIRCRESAHA.111.300158; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sheehan KA, 2003, J PHYSIOL-LONDON, V546, P119, DOI 10.1113/jphysiol.2002.026963; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; Thomas SA, 1998, CIRCULATION, V97, P686, DOI 10.1161/01.CIR.97.7.686; Tinker A, 2006, SEMIN CELL DEV BIOL, V17, P377, DOI 10.1016/j.semcdb.2006.03.007; Tuomi JM, 2010, AM J PHYSIOL-HEART C, V298, pH554, DOI 10.1152/ajpheart.00779.2009; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Wieland T, 2007, CURR OPIN PHARMACOL, V7, P201, DOI 10.1016/j.coph.2006.11.007; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zuberi Z, 2010, CIRC-ARRHYTHMIA ELEC, V3, P391, DOI 10.1161/CIRCEP.109.894329	39	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19233	19244		10.1074/jbc.M115.666719	http://dx.doi.org/10.1074/jbc.M115.666719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26088132	hybrid, Green Published			2022-12-26	WOS:000358781100037
J	Plotkin, LI; Gortazar, AR; Davis, HM; Condon, KW; Gabilondo, H; Maycas, M; Allen, MR; Bellido, T				Plotkin, Lilian I.; Gortazar, Arancha R.; Davis, Hannah M.; Condon, Keith W.; Gabilondo, Hugo; Maycas, Marta; Allen, Matthew R.; Bellido, Teresita			Inhibition of Osteocyte Apoptosis Prevents the Increase in Osteocytic Receptor Activator of Nuclear Factor kappa B Ligand (RANKL) but Does Not Stop Bone Resorption or the Loss of Bone Induced by Unloading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANICAL STIMULATION; OSTEOCLAST FORMATION; M-CSF; BISPHOSPHONATES; CONNEXIN-43; EXPRESSION; OSTEOBLAST; OPG; GLUCOCORTICOIDS; REQUIREMENT	Apoptosis of osteocytes and osteoblasts precedes bone resorption and bone loss with reduced mechanical stimulation, and receptor activator of NF-kappa B ligand (RANKL) expression is increased with unloading in mice. Because osteocytes are major RANKL producers, we hypothesized that apoptotic osteocytes signal to neighboring osteocytes to increase RANKL expression, which, in turn, increases osteoclastogenesis and bone resorption. The traditional bisphosphonate (BP) alendronate (Aln) or IG9402, a BP analog that does not inhibit resorption, prevented the increase in osteocyte apoptosis and osteocytic RANKL expression. The BPs also inhibited osteoblast apoptosis but did not prevent the increase in osteoblastic RANKL. Unloaded mice exhibited high serum levels of the bone resorption marker C-telopeptide fragments of type I collagen (CTX), elevated osteoclastogenesis, and increased osteoclasts in bone. Aln, but not IG9402, prevented all of these effects. In addition, Aln prevented the reduction in spinal and femoral bone mineral density, spinal bone volume/tissue volume, trabecular thickness, mechanical strength, and material strength induced by unloading. Although IG9402 did not prevent the loss of bone mass, it partially prevented the loss of strength, suggesting a contribution of osteocyte viability to strength independent of bone mass. These results demonstrate that osteocyte apoptosis leads to increased osteocytic RANKL. However, blockade of these events is not sufficient to restrain osteoclast formation, inhibit resorption, or stop bone loss induced by skeletal unloading.	[Plotkin, Lilian I.; Gortazar, Arancha R.; Davis, Hannah M.; Condon, Keith W.; Gabilondo, Hugo; Maycas, Marta; Allen, Matthew R.; Bellido, Teresita] Indiana Univ Sch Med, Dept Anat & Cell Biol, Div Endocrinol, Indianapolis, IN 46202 USA; [Bellido, Teresita] Indiana Univ Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA; [Plotkin, Lilian I.; Bellido, Teresita] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Plotkin, LI (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS 5035, Indianapolis, IN 46202 USA.	lplotkin@iupui.edu; tbellido@iupui.edu	Plotkin, Lilian/H-7188-2019; Gortazar, Arancha/G-5385-2017; Gabilondo, Hugo/B-7138-2016; Regan, Clinton/E-6250-2012; Maycas, Marta/L-8145-2014	Plotkin, Lilian/0000-0002-9537-4544; Gortazar, Arancha/0000-0001-5072-3141; Maycas, Marta/0000-0002-9178-743X	National Institutes of Health [R01DK076007]; ARRA [S10-RR023710, R01AR053643]; Veterans Affairs Merit Award [I01BX002104]; IUSM Biomedical Research grant; Conchita Rabago Foundation; European Molecular Biology Organization; Universidad Autonoma de Madrid; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053643, R01AR067210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076007] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA; Veterans Affairs Merit Award(US Department of Veterans Affairs); IUSM Biomedical Research grant; Conchita Rabago Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Universidad Autonoma de Madrid; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK076007 and ARRA supplement S10-RR023710 (to T.B.) and R01AR053643 (to L.I.P.). This work was also supported by Veterans Affairs Merit Award I01BX002104 (to T. B.) and an IUSM Biomedical Research grant (to L. I. P.) and by scholarships from the Conchita Rabago Foundation (to A. R. G. and M. M.), the European Molecular Biology Organization (to M. M.), and Universidad Autonoma de Madrid (to H. G). The authors declare that they have no conflicts of interest with the contents of this article.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Bakker A, 2004, BIOCHEM BIOPH RES CO, V320, P1163, DOI 10.1016/j.bbrc.2004.06.056; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bellido T, 2014, CALCIFIED TISSUE INT, V94, P25, DOI 10.1007/s00223-013-9774-y; Bellido T, 2010, J CELL BIOCHEM, V111, P1, DOI 10.1002/jcb.22660; Bivi N, 2013, J ORTHOP RES, V31, P1075, DOI 10.1002/jor.22341; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Bivi N, 2011, J CELL BIOCHEM, V112, P2920, DOI 10.1002/jcb.23208; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Cheung MS, 2009, J BONE MINER RES, V24, P669, DOI [10.1359/jbmr.081225, 10.1359/JBMR.081225]; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Eslami B, 2011, CALCIFIED TISSUE INT, V88, P272, DOI 10.1007/s00223-011-9473-5; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Martini G, 2007, BONE, V40, P457, DOI 10.1016/j.bone.2006.08.003; Martini G, 2006, HAEMATOLOGICA, V91, P1720; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Ohe JY, 2012, CLIN ORAL INVEST, V16, P1153, DOI 10.1007/s00784-011-0614-z; Plotkin LI, 2011, BONE, V49, P122, DOI 10.1016/j.bone.2010.08.011; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI [10.1359/jbmr.080617, 10.1359/JBMR.080617]; Plotkin LI, 2006, BONE, V39, P443, DOI 10.1016/j.bone.2006.02.060; Plotkin LI, 2014, CURR OSTEOPOROS REP, V12, P121, DOI 10.1007/s11914-014-0194-3; Riffenburgh RH, 2006, STATISTICS IN MEDICINE, 2ND EDITION, P1; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rogers MJ, 2011, BONE, V49, P34, DOI 10.1016/j.bone.2010.11.008; Sanders JM, 2004, J MED CHEM, V47, P375, DOI 10.1021/jm0303709; Szymczak J, 2013, HORM METAB RES, V45, P759, DOI 10.1055/s-0033-1349842; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tsubaki M, 2012, MOL CELL ENDOCRINOL, V361, P219, DOI 10.1016/j.mce.2012.05.002; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Turner CH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pt3; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	41	63	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18934	18942		10.1074/jbc.M115.642090	http://dx.doi.org/10.1074/jbc.M115.642090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085098	Green Published, hybrid			2022-12-26	WOS:000358781100006
J	Yuan, LL; Tian, YH; Zhang, FF; Ma, HJ; Chen, XG; Dai, F; Wang, K				Yuan, Lili; Tian, Yanghua; Zhang, Fangfang; Ma, Huijuan; Chen, Xingui; Dai, Fang; Wang, Kai			Decision-Making in Patients with Hyperthyroidism: A Neuropsychological Study	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; THYROID-HORMONE; COGNITIVE FUNCTION; BRAIN; EMOTION; METABOLISM; DEFICITS; DISORDERS; DOPAMINE; ANXIETY	Introduction Cognitive and behavioral impairments are common in patients with abnormal thyroid function; these impairments cause a reduction in their quality of life. The current study investigates the decision making performance in patients with hyperthyroidism to explore the possible mechanism of their cognitive and behavioral impairments. Methods Thirty-eight patients with hyperthyroidism and forty healthy control subjects were recruited to perform the Iowa Gambling Task (IGT), which assessed decision making under ambiguous conditions. Results Patients with hyperthyroidism had a higher score on the Zung Self-Rating Anxiety Scale (ZSAS), and exhibited poorer executive function and IGT performance than did healthy control subjects. The patients preferred to choose decks with a high immediate reward, despite a higher future punishment, and were not capable of effectively using feedback information from previous choices. No clinical characteristics were associated with the total net score of the IGT in the current study. Conclusions Patients with hyperthyroidism had decision-making impairment under ambiguous conditions. The deficits may result from frontal cortex and limbic system metabolic disorders and dopamine dysfunction.	[Yuan, Lili; Tian, Yanghua; Zhang, Fangfang; Ma, Huijuan; Chen, Xingui; Wang, Kai] Anhui Med Univ, Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China; [Dai, Fang] Anhui Med Univ, Hosp 1, Dept Endocrinol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Dai, F (corresponding author), Anhui Med Univ, Hosp 1, Dept Endocrinol, Hefei, Anhui, Peoples R China.	dfang1999@163.com; wangkai1964@126.com	Zhang, Fang/HHN-2153-2022	Tian, Yanghua/0000-0001-5038-0599	National Natural Science Foundation of China [81100806, 81300944, 91232717]; National Basic Research Program of China [2011CB707805, 2012CB720704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Grants no. 81100806, no. 81300944, no. 91232717), National Basic Research Program of China (Grant no. 2011CB707805, no. 2012CB720704). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AD, 2014, NEUROBIOL LEARN MEM, V108, P65, DOI 10.1016/j.nlm.2013.11.007; Bauer M, 2008, J NEUROENDOCRINOL, V20, P1101, DOI 10.1111/j.1365-2826.2008.01774.x; Baumgartner A, 1997, NEUROSCI LETT, V227, P25, DOI 10.1016/S0304-3940(97)00290-5; Bayard S, 2013, SLEEP, V36, P1501, DOI 10.5665/sleep.3044; Bayard S, 2011, SLEEP, V34, P99, DOI 10.1093/sleep/34.1.99; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Beis D, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0057; Bhatara VS, 1998, PSYCHONEUROENDOCRINO, V23, P605; Borella E, 2013, CHILD NEUROPSYCHOL, V19, P495, DOI 10.1080/09297049.2012.696603; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Chamberlain SR, 2013, J PSYCHOPHARMACOL, V27, P694, DOI 10.1177/0269881113480988; Claustre J, 1996, NEUROCHEM INT, V28, P277, DOI 10.1016/0197-0186(95)00088-7; Demet MM, 2002, ARCH MED RES, V33, P552, DOI 10.1016/S0188-4409(02)00410-1; Elberling TV, 2003, NEUROLOGY, V60, P142, DOI 10.1212/01.WNL.0000038911.07643.BF; Euteneuer F, 2009, NEUROPSYCHOLOGIA, V47, P2882, DOI 10.1016/j.neuropsychologia.2009.06.014; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Fukui T, 2001, J NEUROL SCI, V184, P81, DOI 10.1016/S0022-510X(00)00487-1; Gerra G, 2000, NEUROPSYCHOBIOLOGY, V42, P82, DOI 10.1159/000026677; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Hassan WA, 2013, INT J DEV NEUROSCI, V31, P311, DOI 10.1016/j.ijdevneu.2013.03.003; Hia B, 2012, J MED SCI, V44, P57; Hogervorst E, 2008, PSYCHONEUROENDOCRINO, V33, P1013, DOI 10.1016/j.psyneuen.2008.05.008; Hommer DW, 2003, ANN NY ACAD SCI, V985, P476; Jablkowska K, 2008, PSYCHIATR POL, V42, P249; Jollant F, 2010, NEUROIMAGE, V51, P1275, DOI 10.1016/j.neuroimage.2010.03.027; Kilic BG, 2007, PSYCHIAT CLIN NEUROS, V61, P142, DOI 10.1111/j.1440-1819.2007.01629.x; Lass P, 2008, MINERVA ENDOCRINOL, V33, P75; Lehto JE, 2003, APPL NEUROPSYCHOL, V10, P234, DOI 10.1207/s15324826an1004_5; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; LIDZ T, 1950, PSYCHOSOM MED, V12, P184, DOI 10.1097/00006842-195005000-00007; Linnet Jakob, 2013, Front Psychol, V4, P709, DOI 10.3389/fpsyg.2013.00709; MACCRIMMON DJ, 1979, PSYCHOSOM MED, V41, P331, DOI 10.1097/00006842-197906000-00007; Mano T, 1998, THYROID, V8, P353, DOI 10.1089/thy.1998.8.353; Miao Q, 2011, AM J NEURORADIOL, V32, P1034, DOI 10.3174/ajnr.A2449; Muller-Oehring EM, 2013, NEUROPSYCHOPHARMACOL, V38, P1844, DOI 10.1038/npp.2013.102; RASTOGI RB, 1976, J PHARMACOL EXP THER, V198, P609; Reid JR, 2005, AM FAM PHYSICIAN, V72, P623; Samuels MH, 2008, CURR OPIN ENDOCRINOL, V15, P429, DOI 10.1097/MED.0b013e32830eb84c; Schreckenberger MF, 2006, J CLIN ENDOCR METAB, V91, P4786, DOI 10.1210/jc.2006-0573; Stern RA, 1996, J NEUROPSYCH CLIN N, V8, P181; Turnbull OH, 2005, BRAIN COGNITION, V57, P244, DOI 10.1016/j.bandc.2004.08.053; Villanueva I, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/218145; Vogel A, 2007, PSYCHONEUROENDOCRINO, V32, P36, DOI 10.1016/j.psyneuen.2006.09.012; Zhang W, 2014, EUR J RADIOL, V83, P1907, DOI 10.1016/j.ejrad.2014.07.003; Zhang W, 2014, EUR J RADIOL, V83, pE43, DOI 10.1016/j.ejrad.2013.09.019	48	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129773	10.1371/journal.pone.0129773	http://dx.doi.org/10.1371/journal.pone.0129773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26090955	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000058
J	Chen, H; Shan, SJC; Mester, T; Wei, YH; Douglas, RS				Chen, Hong; Shan, Shannon J. C.; Mester, Tuende; Wei, Yi-Hsuan; Douglas, Raymond S.			TSH-Mediated TNF alpha Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist	PLOS ONE			English	Article							THYROID-ASSOCIATED OPHTHALMOPATHY; PERIPHERAL-BLOOD FIBROCYTES; POSTBURN HYPERTROPHIC SCAR; CIRCULATING FIBROCYTES; GRAVES OPHTHALMOPATHY; ORBITAL FIBROBLASTS; PULMONARY-FIBROSIS; I RECEPTOR; DISEASE; CELLS	Purpose Fibrocytes (FC) are bone marrow-derived progenitor cells that are more abundant and infiltrate the thyroid and orbit in Graves orbitopathy (GO). FCs express high levels of thyrotropin receptor (TSHR) and insulin-like growth factor-1 receptor (IGF-1R). These receptors are physically and functionally associated, but their role in GO pathogenesis is not fully delineated. Treatment of FCs with thyroid stimulating hormone (TSH) or M22 (activating antibody to TSHR) induces the production of numerous cytokines, including tumor necrosis factor a (TNF alpha). Teprotumumab (TMB) is a human monoclonal IGF-1R blocking antibody currently in clinical trial for GO and inhibits TSHR-mediated actions in FCs. Aim To characterize the molecular mechanisms underlying TSH-induced TNF alpha production by FCs, and the role of IGF-1R blockade by TMB. Design FCs from healthy and GD patients were treated with combinations of TSH, M22, MG132 and AKTi (inhibitors of NF-kappa B and Akt, respectively), and TMB. TNF alpha protein production was measured by Luminex and flow cytometry. Messenger RNA expression was quantified by real time PCR. Results Treatment with TSH/M22 induced TNF alpha protein and mRNA production by FCs, both of which were reduced when FCs were pretreated with MG132 and AKTi (p < 0.0001). TMB decreased TSH-induced TNF alpha protein production in circulating FCs from mean fluorescent index (MFI) value of 2.92 to 1.91, and mRNA expression in cultured FCs from 141- to 52-fold expression (p < 0.0001). TMB also decreased M22-induced TNF alpha protein production from MFI of 1.67 to 1.12, and mRNA expression from 6- to 3-fold expression (p < 0.0001). Conclusion TSH/M22 stimulates FC production of TNFa mRNA and protein. This process involves the transcription factor NF-kappa B and its regulator Akt. Blocking IGF-1R attenuates TSH/M22-induced TNF alpha production. This further delineates the interaction of TSHR and IGF1-R signaling pathways. By modulating the proinflammatory properties of FCs such as TNF alpha production, TMB may be a promising therapeutic agent for GO.	[Chen, Hong; Shan, Shannon J. C.; Mester, Tuende; Wei, Yi-Hsuan; Douglas, Raymond S.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Chen, Hong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Ophthalmol, Wuhan 430074, Hubei, Peoples R China; [Douglas, Raymond S.] Ann Arbor Vet Adm Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Huazhong University of Science & Technology	Douglas, RS (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	raydougl@med.umich.edu		WEI, YI-HSUAN/0000-0002-2087-9855; Douglas, Raymond S./0000-0002-3435-8161	Eye Core Grant [EY008976, EY011708, DK063121, EY016339, EY021197, EY007003]; Research to Prevent Blindness Career Development Award; Research to Prevent Blindness Lew Wasserman Merit Award; Bell Charitable Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY008976, R01EY021197, R01EY011708, K23EY016339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063121] Funding Source: NIH RePORTER	Eye Core Grant; Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Research to Prevent Blindness Lew Wasserman Merit Award(Research to Prevent Blindness (RPB)); Bell Charitable Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by EY008976, EY011708, DK063121, EY016339, EY021197, EY007003 Eye Core Grant, an unrestricted grant from Research to Prevent Blindness, a Research to Prevent Blindness Career Development Award, Research to Prevent Blindness Lew Wasserman Merit Award, and the Bell Charitable Foundation.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Ayabe R, 2014, OPHTHAL PLAST RECONS, V30, P415, DOI 10.1097/IOP.0000000000000211; Bianchetti L, 2012, J CELL MOL MED, V16, P483, DOI 10.1111/j.1582-4934.2011.01344.x; BRENNAN FM, 1989, LANCET, V2, P244; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chen H, 2014, COLLOID SURFACE B, V124, P1, DOI 10.1016/j.colsurfb.2014.10.030; Chesney J, 2000, Curr Rheumatol Rep, V2, P501, DOI 10.1007/s11926-000-0027-5; Chesney J, 1997, P NATL ACAD SCI USA, V94, P6307, DOI 10.1073/pnas.94.12.6307; Clement S, 2001, ENDOCRINOLOGY, V142, P5131, DOI 10.1210/en.142.12.5131; Douglas RS, 2010, J CLIN ENDOCR METAB, V95, P430, DOI 10.1210/jc.2009-1614; Durrani OM, 2005, ORBIT, V24, P117, DOI 10.1080/01676830590912562; Galligan CL, 2012, ARTHRITIS RHEUM-US, V64, P3583, DOI 10.1002/art.34589; Gianoukakis AG, 2008, THYROID, V18, P953, DOI 10.1089/thy.2007.0405; Gillespie EF, 2012, INVEST OPHTH VIS SCI, V53, P7746, DOI 10.1167/iovs.12-9861; Gillespie EF, 2012, J CLIN ENDOCR METAB, V97, pE740, DOI 10.1210/jc.2011-2514; GOLDFELD AE, 1990, P NATL ACAD SCI USA, V87, P9769, DOI 10.1073/pnas.87.24.9769; Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; HEUFELDER AE, 1993, EUR J CLIN INVEST, V23, P10, DOI 10.1111/j.1365-2362.1993.tb00712.x; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Kumar S, 2012, J CLIN ENDOCR METAB, V97, P1681, DOI 10.1210/jc.2011-2890; Li B, 2014, J CLIN ENDOCR METAB, V99, P3363, DOI 10.1210/jc.2014-1257; MACNAUL KL, 1990, J IMMUNOL, V145, P4154; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Paridaens D, 2005, EYE, V19, P1286, DOI 10.1038/sj.eye.6701768; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; PRUMMEL MF, 1989, NEW ENGL J MED, V321, P1353, DOI 10.1056/NEJM198911163212002; Raychaudhuri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075100; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Shan Shannon J C, 2014, J Neuroophthalmol, V34, P177, DOI 10.1097/WNO.0000000000000132; Smith RS, 1997, AM J PATHOL, V151, P317; Smith TJ, 2008, THYROID, V18, P983, DOI 10.1089/thy.2007.0404; Smith TJ, 2011, J CLIN ENDOCR METAB, V96, P3827, DOI 10.1210/jc.2011-1249; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; TRAMONTANO D, 1986, ENDOCRINOLOGY, V119, P940, DOI 10.1210/endo-119-2-940; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Varcoe RL, 2006, J THROMB HAEMOST, V4, P1125, DOI 10.1111/j.1538-7836.2006.01924.x; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Wang JF, 2007, J INTERF CYTOK RES, V27, P921, DOI 10.1089/jir.2007.0008; Wang Y, 2014, INVEST OPHTH VIS SCI, V55, P1735, DOI 10.1167/iovs.14-14002; Yang LJ, 2005, WOUND REPAIR REGEN, V13, P398, DOI 10.1111/j.1067-1927.2005.130407.x; Zulli A, 2005, HISTOCHEM CELL BIOL, V124, P517, DOI 10.1007/s00418-005-0072-2	48	17	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130322	10.1371/journal.pone.0130322	http://dx.doi.org/10.1371/journal.pone.0130322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087256	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500096
J	Korsen, M; Alonso, SB; Peix, L; Broker, BM; Dressel, A				Korsen, Melanie; Alonso, Sara Bragado; Peix, Lizzy; Broeker, Barbara M.; Dressel, Alexander			Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; IN-VITRO; 2-CHLORODEOXYADENOSINE; TOXICITY; TABLETS	Background and Objectives Cladribine is a cytotoxic drug which ameliorates the clinical course of relapsing-remitting multiple sclerosis. In addition to cytotoxicity, the mode of action may include immunomodulatory mechanisms. This in vitro study was designed to investigate cladribine's effects on cell function after the removal of cladribine to distinguish cytotoxic versus immunomodulatory effects. Methods Cells were incubated in the absence or presence of cladribine (1x10(-8) M to 1x10(-5) M) for 72 h. Cladribine was removed from the cell culture and surviving peripheral blood mononuclear cells were cultured up to 58 days to determine the immunomodulatory effects of cladribine on cell function (e.g., proliferation and cytokine release). Results In the long-term, brief cladribine exposure did not impair the proliferation of surviving peripheral blood mononuclear cells. However, it induced an anti-inflammatory shift in the cytokine milieu with significantly enhanced release of IL-4 (Days 9 and 44, p<0.01; Day 58, p<0.05) and IL-5 (Day 9, p<0.01), resulting in an increased IL-4/INF-gamma ratio (Days 9 and 44, p<0.01; Day 58, p<0.05). Additionally, a trend towards an increased IL-10 production was observed. No changes were found in the production of IFN-gamma, TNF-alpha, IL-6, IL-8, IL-17A, IL-23 or NGF-beta. Conclusions In vitro cladribine exposure induces a sustained anti-inflammatory shift in the cytokine profile of surviving peripheral blood mononuclear cells. This immunomodulatory action might contribute to cladribine's beneficial effects in the treatment of multiple sclerosis.	[Korsen, Melanie; Dressel, Alexander] Univ Med Greifswald, Sect Neuroimmunol, Dept Neurol, Greifswald, Germany; [Alonso, Sara Bragado] DFG Res Ctr & Cluster Excellence Dresden, Ctr Regenerat Therapies, Dresden, Germany; [Peix, Lizzy] UCL, Dept Inflammat & Tissue Repair, Ctr Resp Res, London, England; [Broeker, Barbara M.] Univ Med Greifswald, Dept Immunol, Greifswald, Germany	Greifswald Medical School; Technische Universitat Dresden; University of London; University College London; Greifswald Medical School	Dressel, A (corresponding author), Univ Med Greifswald, Sect Neuroimmunol, Dept Neurol, Greifswald, Germany.	adressel@uni-greifswald.de	Bröker, Barbara M/O-4850-2015; Dressel, Alexander/F-9142-2015	Bröker, Barbara M/0000-0002-5020-8542; Dressel, Alexander/0000-0002-9055-4327	Merck Serono GmbH; German National Academic Foundation; DOMAGK program; Spanish Erasmus program	Merck Serono GmbH; German National Academic Foundation; DOMAGK program; Spanish Erasmus program	This work was in part supported by an unrestricted research grant from Merck Serono GmbH to AD. The funders have read the manuscript before submission but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MK was supported by a scholarship from the German National Academic Foundation and from the DOMAGK program. Sara Bragado Alonso received a scholarship from the Spanish Erasmus program.	Bartosik-Psujek H, 2004, ACTA NEUROL SCAND, V109, P390, DOI 10.1111/j.1600-0404.2004.00259.x; Bruck W, 2013, JAMA NEUROL, V70, P1315, DOI 10.1001/jamaneurol.2013.3510; CARRERA CJ, 1990, J CLIN INVEST, V86, P1480, DOI 10.1172/JCI114865; CARSON DA, 1983, BLOOD, V62, P737; Comabella M, 1998, J CLIN INVEST, V102, P671, DOI 10.1172/JCI3125; Comabella M, 2012, CLIN IMMUNOL, V142, P2, DOI 10.1016/j.clim.2011.03.004; Comi G, 2013, J NEUROL, V260, P1136, DOI 10.1007/s00415-012-6775-0; Comi G, 2013, EXPERT OPIN PHARMACO, V14, P123, DOI 10.1517/14656566.2013.754012; Cook S, 2011, MULT SCLER J, V17, P578, DOI 10.1177/1352458510391344; Filippini G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008933.pub2; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Gold R., 2012, DGN KKNMS LEITLINIE; Goodman GR, 2003, BEST PRACT RES CL HA, V16, P101, DOI 10.1016/S1521-6926(02)00089-0; Kantarci OH, 2014, CLIN PHARMACOL THER, V95, P32, DOI 10.1038/clpt.2013.196; Kopadze T, 2009, EUR J NEUROL, V16, P409, DOI 10.1111/j.1468-1331.2008.02433.x; Kraus SH, 2013, INT IMMUNOPHARMACOL; Laugel B, 2011, J NEUROIMMUNOL, V240, P52, DOI 10.1016/j.jneuroim.2011.09.010; LILIEMARK J, 1992, J CLIN ONCOL, V10, P1514, DOI 10.1200/JCO.1992.10.10.1514; Mitosek-Szewczyk K, 2010, ACTA NEUROL SCAND, V122, P409, DOI 10.1111/j.1600-0404.2010.01330.x; Munafo A, 2005, 21 C EUR COMM TREATM; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; SETO S, 1985, J CLIN INVEST, V75, P377, DOI 10.1172/JCI111710; Singh V, 2013, CLIN EXP IMMUNOL, V173, P288, DOI 10.1111/cei.12109; Smith DR, 1997, ANN NEUROL, V42, P313, DOI 10.1002/ana.410420307; Vogelgesang A, 2010, ACTA NEUROL SCAND, V122, P237, DOI 10.1111/j.1600-0404.2009.01295.x	25	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129182	10.1371/journal.pone.0129182	http://dx.doi.org/10.1371/journal.pone.0129182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086440	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500036
J	Traitanon, O; Mathew, JM; La Monica, G; Xu, LT; Mas, V; Gallon, L				Traitanon, Opas; Mathew, James M.; La Monica, Giovanna; Xu, Luting; Mas, Valeria; Gallon, Lorenzo			Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells	PLOS ONE			English	Article							ANTIBODY-MEDIATED REJECTION; ACUTE HUMORAL REJECTION; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; ALLOGRAFT-REJECTION; SALVAGE TREATMENT; RITUXIMAB; BORTEZOMIB; RAPAMYCIN; IMMUNITY	The direct effect of immunosuppressive drugs calcineurin inhibitor (Tacrolimus, TAC) and mTOR inhibitor (Sirolimus, SRL) on B cell activation, differentiation and proliferation is not well documented. Purified human B cells from healthy volunteers were stimulated through the B Cell Receptor with Anti-IgM + anti-CD40 + IL21 in the absence / presence of TAC or SRL. A variety of parameters of B cell activity including activation, differentiation, cytokine productions and proliferation were monitored by flow cytometry. SRL at clinically relevant concentrations (6 ng/ml) profoundly inhibited CD19(+) B cell proliferation compared to controls whereas TAC at similar concentrations had a minimal effect. CD27(+) memory B cells were affected more by SRL than naive CD27(-) B cells. SRL effectively blocked B cell differentiation into plasma cells (CD19(+)CD138(+) and Blimp1(+)/Pax5(low) cells) even at low dose (2 ng/ml), and totally eliminated them at 6 ng/ml. SRL decreased absolute B cell counts, but the residual responding cells acquired an activated phenotype (CD25(+)/CD69(+)) and increased the expression of HLA-DR. SRL-treated stimulated B cells on a per cell basis were able to enhance the proliferation of allogeneic CD4(+)CD25(-) T cells and induce a shift toward the Th1 phenotype. Thus, SRL and TAC have different effects on B lymphocytes. These data may provide insights into the clinical use of these two agents in recipients of solid organ transplants.	[Traitanon, Opas; La Monica, Giovanna; Xu, Luting; Gallon, Lorenzo] Northwestern Univ, Dept Med Nephrol, Chicago, IL 60611 USA; [Traitanon, Opas; Mathew, James M.; La Monica, Giovanna; Xu, Luting; Gallon, Lorenzo] Northwestern Univ, Comprehens Transplant Ctr, Chicago, IL 60611 USA; [Traitanon, Opas] Thammasart Univ Hosp, Dept Med Nephrol, Pathum Thani, Thailand; [Mathew, James M.] Northwestern Univ, Dept Surg, Chicago, IL USA; [Mathew, James M.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Mas, Valeria] Univ Virginia, Dept Surg, Charlottesville, VA USA	Northwestern University; Northwestern University; Thammasat University; Northwestern University; Northwestern University; University of Virginia	Gallon, L (corresponding author), Northwestern Univ, Dept Med Nephrol, Chicago, IL 60611 USA.	L-gallon@northwestern.edu			department of Medicine-Nephrology, Northwestern University, Chicago, IL USA	department of Medicine-Nephrology, Northwestern University, Chicago, IL USA	This research work was funded by the department of Medicine-Nephrology, Northwestern University, Chicago, IL USA.	AAGAARDTILLERY KM, 1994, CELL IMMUNOL, V156, P493, DOI 10.1006/cimm.1994.1193; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Belliere J, 2013, TRANSPL INT, V26, pE12, DOI 10.1111/tri.12015; Billing H, 2012, TRANSPL INT, V25, P1165, DOI 10.1111/j.1432-2277.2012.01544.x; BONNEFOY JY, 1995, CURR OPIN IMMUNOL, V7, P355, DOI 10.1016/0952-7915(95)80110-3; Clatworthy MR, 2011, AM J TRANSPLANT, V11, P1359, DOI 10.1111/j.1600-6143.2011.03554.x; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; Fehr T, 2012, TRANSPL INT, V25, P623, DOI 10.1111/j.1432-2277.2012.01453.x; Gallon L, 2015, TH17 TREGS IN PRESS, V99; Heidt S, 2010, CLIN EXP IMMUNOL, V159, P199, DOI 10.1111/j.1365-2249.2009.04051.x; Heidt S, 2009, TRANSPLANTATION, V87, P307; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; JOVER JA, 1989, CLIN IMMUNOL IMMUNOP, V53, P99, DOI 10.1016/0090-1229(89)90105-0; Kamar N, 2013, CLIN TRANSPLANT, V27, P455, DOI 10.1111/ctr.12127; Kamburova EG, 2013, AM J TRANSPLANT, V13, P1503, DOI 10.1111/ajt.12220; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kaposztas Z, 2009, CLIN TRANSPLANT, V23, P63, DOI 10.1111/j.1399-0012.2008.00902.x; KAY JE, 1991, IMMUNOLOGY, V72, P544; KIM HS, 1994, CLIN EXP IMMUNOL, V96, P508; KISHIMOTO T, 1984, IMMUNOL REV, V78, P97, DOI 10.1111/j.1600-065X.1984.tb00478.x; Klein U, 1997, BLOOD, V89, P1288, DOI 10.1182/blood.V89.4.1288; Kocak B, 2013, TRANSPL P, V45, P1022, DOI 10.1016/j.transproceed.2013.02.062; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; LAVABREBERTRAND T, 1994, LEUKEMIA, V8, P402; Lefaucheur C, 2009, AM J TRANSPLANT, V9, P1099, DOI 10.1111/j.1600-6143.2009.02591.x; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Levitsky J, 2011, TRANSPLANTATION, V91, P199, DOI 10.1097/TP.0b013e318200e97; Liefeldt L, 2012, AM J TRANSPLANT, V12, P1192, DOI 10.1111/j.1600-6143.2011.03961.x; Limon JJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00228; Locke JE, 2009, AM J TRANSPLANT, V9, P231, DOI 10.1111/j.1600-6143.2008.02451.x; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Lund Frances E., 2005, V8, P25; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; MORIKAWA K, 1992, TRANSPLANTATION, V54, P1025, DOI 10.1097/00007890-199212000-00016; Nigos JG, 2012, EXP CLIN TRANSPLANT, V10, P609, DOI 10.6002/ect.2012.0131; Paterno F, 2012, AM J TRANSPLANT, V12, P2526, DOI 10.1111/j.1600-6143.2012.04126.x; Ravichandran AK, 2013, CLIN TRANSPLANT, V27, P961, DOI 10.1111/ctr.12277; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Salvadori Maurizio, 2013, World J Transplant, V3, P7, DOI 10.5500/wjt.v3.i2.7; Sanz I, 2007, FRONT BIOSCI-LANDMRK, V12, P2546, DOI 10.2741/2254; Sautenet B, 2013, AM J TRANSPLANT, V13, P112; SUZUKI N, 1990, CLIN EXP IMMUNOL, V79, P240; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Tzvetanov I, 2012, TRANSPL P, V44, P2971, DOI 10.1016/j.transproceed.2012.02.037; Waiser J, 2012, NEPHROL DIAL TRANSPL, V27, P1246, DOI 10.1093/ndt/gfr465; WASIK M, 1990, IMMUNOPHARMACOLOGY, V20, P57, DOI 10.1016/0162-3109(90)90007-2; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005; Zhang SL, 2013, J IMMUNOL, V191, P1692, DOI 10.4049/jimmunol.1201767	50	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129658	10.1371/journal.pone.0129658	http://dx.doi.org/10.1371/journal.pone.0129658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087255	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500057
J	Isachenko, V; Todorov, P; Isachenko, E; Rahimi, G; Tchorbanov, A; Mihaylova, N; Manoylov, I; Mallmann, P; Merzenich, M				Isachenko, Vladimir; Todorov, Plamen; Isachenko, Evgenia; Rahimi, Gohar; Tchorbanov, Andrey; Mihaylova, Nikolina; Manoylov, Iliyan; Mallmann, Peter; Merzenich, Markus			Long-Time Cooling before Cryopreservation Decreased Translocation of Phosphatidylserine (Ptd-L-Ser) in Human Ovarian Tissue	PLOS ONE			English	Article							APOPTOTIC CELLS; HUMAN SPERMATOZOA; VITRIFICATION; FERTILITY; EXTERNALIZATION; TRANSPLANTATION; DEATH; AUTOTRANSPLANTATION; RECOMMENDATIONS; ENGULFMENT	Objectives To translocation (externalization) of phosphatidylserine lead at least the five negative effects observed during cells cryopreservation: hypoxia, increasing of intracellular Ca2+, osmotic disruption of cellular membranes, generation of reactive oxygen species (ROS) and lipid peroxidation. The aim of this study was to test the intensiveness of the phosphatidylserine translocation immediately after thawing and after 45 d xenografting of human ovarian tissue, which was either frozen just after operative removal from patient or cooled before cryopreservation to 5 degrees C for 24 h and then frozen. Materials and Methods Ovarian fragments from twelve patients were divided into small pieces in form of cortex with medulla, and randomly divided into the following four groups. Pieces of Group 1 (n=30) were frozen immediately after operation, thawed and just after thawing their quality was analyzed. Group 2 pieces (n=30) after operation were cooled to 5 degrees C for 24 h, then frozen after 24 h pre-cooling to 5 degrees C, thawed and just after thawing their quality was analyzed. Group 3 pieces (n=30) were frozen immediately after operation without pre-cooling, thawed, transplanted to SCID mice and then, after 45 d of culture their quality was analyzed. Group 4 pieces (n=30) were frozen after 24 h pre-cooling to 5 degrees C, thawed, transplanted to SCID mice and then, after 45 d their quality was analyzed. The effectiveness of the pre-freezing cooling of tissuewas evaluated by the development of follicles (histology) and by intensiveness of translocation of phosphatidylserine (FACS with FITC-Annexin V and Propidium Iodide). Results For groups 1, 2, 3 and 4 the mean densities of follicles per 1 mm(3) was 19.0, 20.2, 12.9, and 12.2, respectively (P1-2, (3-4) >0.1). For these groups, 99%, 98%, 88% and 90% preantral follicles, respectively were morphologically normal (P1-2, (3-4) >0.1). The FACS analysis showed significantly decreased intensiveness of translocation of phosphatidylserine after pre-cooling of frozen tissue (46.3% and 33.6% in Groups 2 and 4, respectively), in contrast with tissue frozen without pre-cooling (77.1% and 60.2 % in Groups 1 and 3, respectively, P-1, (3-2), (4) <0.05). Conclusions Long time (24 h) cooling of ovarian tissue to 5 degrees C before cryopreservation decreased translocation of phosphatidylserine that evidences about increases the viability of the cells in the tissue after thawing.	[Isachenko, Vladimir; Isachenko, Evgenia; Rahimi, Gohar; Mallmann, Peter] Univ Cologne, Dept Obstet & Genecol, Res Grp Reprod Med, D-50931 Cologne, Germany; [Isachenko, Vladimir; Isachenko, Evgenia; Rahimi, Gohar; Mallmann, Peter] Univ Cologne, Dept Obstet & Genecol, CAM Xenotransplantat Grp, IVF Lab, D-50931 Cologne, Germany; [Todorov, Plamen] Bulgarian Acad Sci, Inst Biol & Immunol Reprod, BU-1113 Sofia, Bulgaria; [Tchorbanov, Andrey; Mihaylova, Nikolina; Manoylov, Iliyan] Bulgarian Acad Sci, Inst Microbiol, BU-1113 Sofia, Bulgaria; [Merzenich, Markus] Praxisklin Schoenhauserstr, Cologne, Germany	University of Cologne; University of Cologne; Bulgarian Academy of Sciences; Bulgarian Academy of Sciences; Medical University Sofia	Isachenko, V (corresponding author), Univ Cologne, Dept Obstet & Genecol, Res Grp Reprod Med, D-50931 Cologne, Germany.	v.isachenko@yahoo.com	Mihaylova, Nikolina/HHM-8871-2022; Todorov, Plamen/C-3882-2012; Mihaylova, Nikolina M/K-3386-2013	Todorov, Plamen/0000-0003-3731-6116; 				[Anonymous], 2010, CANC GERM 2005 2006; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chiarugi A, 2002, SCIENCE, V297, P200, DOI 10.1126/science.1074592; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Dittrich R, 2010, Minerva Ginecol, V62, P63; Duru NK, 2001, J ANDROL, V22, P646; Fiedler J, 2006, J NEUROENDOCRINOL, V18, P367, DOI 10.1111/j.1365-2826.2006.01427.x; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gilmore JA, 2000, HUM REPROD, V15, P335, DOI 10.1093/humrep/15.2.335; Green DR, 2000, METHOD ENZYMOL, V322, P15; Haughland R, 2002, HDB FLUORESCENT PROB; Isachenko E, 2009, FERTIL STERIL, V91, P1556, DOI 10.1016/j.fertnstert.2008.09.068; Isachenko V, 2011, GEBURTSH FRAUENHEILK, V71, P862, DOI 10.1055/s-0031-1280271; Isachenko V, 2009, REPRODUCTION, V138, P319, DOI 10.1530/REP-09-0039; Isachenko V, 2007, CRYOBIOLOGY, V55, P261, DOI 10.1016/j.cryobiol.2007.08.008; Isachenko V, 2013, CELL TRANSPLANT, V22, P2053, DOI 10.3727/096368912X658827; Isachenko V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032549; Isachenko V, 2009, CRYOLETTERS, V30, P449; ISACHENKO VV, 1993, CRYOBIOLOGY, V30, P432, DOI 10.1006/cryo.1993.1043; Johnson L, 2014, TRANSFUSION, V54, P1917, DOI 10.1111/trf.12578; Kenis H, 2010, J NUCL MED, V51, P259, DOI 10.2967/jnumed.109.068429; Kim SS, 2012, J ASSIST REPROD GEN, V29, P465, DOI 10.1007/s10815-012-9786-y; Kim SS, 2009, FERTIL STERIL, V91, P2349, DOI 10.1016/j.fertnstert.2008.04.019; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Martin G, 2004, BIOL REPROD, V71, P28, DOI 10.1095/biolreprod.103.024281; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Mellen MA, 2009, AUTOPHAGY, V5, P964, DOI 10.4161/auto.5.7.9292; Nicotera P, 1999, CELL DEATH DIFFER, V6, P931, DOI 10.1038/sj.cdd.4400583; Ferrusola CO, 2009, REPRODUCTION, V138, P55, DOI [10.1530/REP-08-0484, 10.1530/RFP-08-0484]; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Radwanski K, 2015, J CLIN APHERESIS, V30, P154, DOI 10.1002/jca.21354; Rahimi G, 2004, REPROD BIOMED ONLINE, V9, P187, DOI 10.1016/S1472-6483(10)62128-1; Rahimi G, 2009, CRYOLETTERS, V30, P300; Rahimi G, 2010, EUR J OBSTET GYN R B, V149, P63, DOI 10.1016/j.ejogrb.2009.11.015; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Schuffner A, 2001, HUM REPROD, V16, P2148, DOI 10.1093/humrep/16.10.2148; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Silber SJ, 2012, MOL HUM REPROD, V18, P59, DOI 10.1093/molehr/gar082; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Soleimani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019475; Span LFR, 2002, CYTOMETRY, V47, P24, DOI 10.1002/cyto.10028; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; von Wolff M, 2009, EUR J CANCER, V45, P1547, DOI 10.1016/j.ejca.2009.01.029; Wood TC, 1997, MOL REPROD DEV, V46, P190, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;190::AID-MRD9&gt;3.0.CO;2-L; Yin H, 2003, HUM REPROD, V18, P1165, DOI 10.1093/humrep/deg236	53	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129108	10.1371/journal.pone.0129108	http://dx.doi.org/10.1371/journal.pone.0129108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083026	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400081
J	Nishihara, K; Ohki, N; Kamata, H; Ryo, E; Horiuchi, S				Nishihara, Kyoko; Ohki, Noboru; Kamata, Hideo; Ryo, Eiji; Horiuchi, Shigeko			Automated Software Analysis of Fetal Movement Recorded during a Pregnant Woman's Sleep at Home	PLOS ONE			English	Article								Fetal movement is an important biological index of fetal well-being. Since 2008, we have been developing an original capacitive acceleration sensor and device that a pregnant woman can easily use to record fetal movement by herself at home during sleep. In this study, we report a newly developed automated software system for analyzing recorded fetal movement. This study will introduce the system and compare its results to those of a manual analysis of the same fetal movement signals (Experiment I). We will also demonstrate an appropriate way to use the system (Experiment II). In Experiment I, fetal movement data reported previously for six pregnant women at 28-38 gestational weeks were used. We evaluated the agreement of the manual and automated analyses for the same 10-sec epochs using prevalence-adjusted bias-adjusted kappa (PABAK) including quantitative indicators for prevalence and bias. The mean PABAK value was 0.83, which can be considered almost perfect. In Experiment II, twelve pregnant women at 24-36 gestational weeks recorded fetal movement at night once every four weeks. Overall, mean fetal movement counts per hour during maternal sleep significantly decreased along with gestational weeks, though individual differences in fetal development were noted. This newly developed automated analysis system can provide important data throughout late pregnancy.	[Nishihara, Kyoko] Inst Sci Labour, Fatigue & Working Life Res Grp, Kawasaki, Kanagawa, Japan; [Ohki, Noboru] NoruPro Light Syst, Tokyo, Japan; [Kamata, Hideo; Ryo, Eiji] Teikyo Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 173, Japan; [Horiuchi, Shigeko] St Lukes Int Univ, Dept Maternal Infant Nursing Midwifery, Tokyo, Japan; [Nishihara, Kyoko] Tokyo Metropolitan Inst Med Sci, Integrated Brain Funct Project, Tokyo 113, Japan	Teikyo University; St. Luke's International Hospital; Tokyo Metropolitan Institute of Medical Science	Nishihara, K (corresponding author), Inst Sci Labour, Fatigue & Working Life Res Grp, Kawasaki, Kanagawa, Japan.	nishihara-kk@igakuken.or.jp	horiuchi, shigeko/AAH-2458-2020	horiuchi, shigeko/0000-0001-7412-3941	Japan Society for the Promotion of Science (JSPS) [B 20390566, C 23591737]; Suzuken Memorial Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Suzuken Memorial Foundation	The software was created with the help of a Grant-in-Aid for Scientific Research (B 20390566) provided by the Japan Society for the Promotion of Science (JSPS). Experiment II was supported in part by (C 23591737) of the same JSPS, and in part by the Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESINGER RE, 1989, OBSTET GYNECOL, V74, P277; Blyton DM, 2013, SLEEP, V36, P15, DOI 10.5665/sleep.2292; BONNET M, 1993, SLEEP, V16, P748; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; DiPietro JA, 2010, CHILD DEV, V81, P115, DOI 10.1111/j.1467-8624.2009.01384.x; Froen JF, 2004, J PERINAT MED, V32, P13, DOI 10.1515/JPM.2004.003; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Koyanagi T., 1993, J REPROD INFANT PSYC, V11, P129, DOI [10.1080/02646839308403207, DOI 10.1080/02646839308403207]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maeda K, 1999, CLIN PERINATOL, V26, P829, DOI 10.1016/S0095-5108(18)30022-8; Manconi M, 2004, NEUROLOGY, V63, P1065, DOI 10.1212/01.WNL.0000138427.83574.A6; MANNING FA, 1980, AM J OBSTET GYNECOL, V136, P787, DOI 10.1016/0002-9378(80)90457-3; Morokuma S, 2013, BRAIN DEV-JPN, V35, P61, DOI 10.1016/j.braindev.2012.01.007; Nishihara K, 2008, EARLY HUM DEV, V84, P595, DOI 10.1016/j.earlhumdev.2008.03.001; PEARSON JF, 1976, BRIT MED J, V1, P1305, DOI 10.1136/bmj.1.6021.1305; Ryo E, 2014, J MATERN-FETAL NEO M, V27, P1604, DOI 10.3109/14767058.2013.863868; Ryo E, 2012, J MATERN-FETAL NEO M, V25, P2629, DOI 10.3109/14767058.2012.704449; Ryo E, 2012, MED ENG PHYS, V34, P566, DOI 10.1016/j.medengphy.2011.09.001; SADOVSKY E, 1973, OBSTET GYNECOL, V41, P845; Stacey T, 2011, BMJ-BRIT MED J, V14, P342; WILLIAMS RL, 1964, ELECTROEN CLIN NEURO, V17, P376, DOI 10.1016/0013-4694(64)90160-9; Winer BJ, 1971, STATISTICAL PRINCIPL, P261	22	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130503	10.1371/journal.pone.0130503	http://dx.doi.org/10.1371/journal.pone.0130503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083422	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400146
J	Sebastiani, G; Alshaalan, R; Wong, P; Rubino, M; Salman, A; Metrakos, P; Deschenes, M; Ghali, P				Sebastiani, Giada; Alshaalan, Rasha; Wong, Philip; Rubino, Maria; Salman, Ayat; Metrakos, Peter; Deschenes, Marc; Ghali, Peter			Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; TRANSIENT ELASTOGRAPHY; VITAMIN-E; OUTCOMES; CIRRHOSIS; PREDICT; RISK; TRANSPLANTATION; METAANALYSIS; ASSOCIATION	Background & Aims Non-invasive diagnostic methods for liver fibrosis predict clinical outcomes in viral hepatitis and nonalcoholic fatty liver disease (NAFLD). We specifically evaluated prognostic value of non-invasive fibrosis methods in nonalcoholic steatohepatitis (NASH) against hepatic venous pressure gradient (HVPG) and liver histology. Methods This was a retrospective cohort study of 148 consecutive patients who met the following criteria: transjugular liver biopsy with HVPG measurement; biopsy-proven NASH; absence of decompensation; AST-to-Platelets Ratio Index (APRI), fibrosis-4 (FIB-4), NAFLD fibrosis score, ultrasound, hepatic steatosis index and Xenon-133 scan available within 6 months from biopsy; a minimum follow-up of 1 year. Outcomes were defined by death, liver transplantation, cirrhosis complications. Kaplan-Meier and Cox regression analyses were employed to estimate incidence and predictors of outcomes, respectively. Prognostic value was expressed as area under the curve (AUC). Results During a median follow-up of 5 years (interquartile range 3-8), 16.2% developed outcomes, including 7.4% who died or underwent liver transplantation. After adjustment for age, sex, diabetes, the following fibrosis tools predicted outcomes: HVPG > 10mmHg (HR=9.60; 95% confidence interval [CI] 3.07-30.12), histologic fibrosis F3-F4 (HR=3.14; 1.41-6.95), APRI > 1.5 (HR=5.02; 1.6-15.7), FIB-4 >3.25 (HR=6.33; 1.98-20.2), NAFLD fibrosis score >0.676 (HR=11.9; 3.79-37.4). Prognostic value was as follows: histologic fibrosis stage, AUC=0.85 (95% CI 0.76-0.93); HVPG, AUC=0.81 (0.70-0.91); APRI, AUC=0.89 (0.82-0.96); FIB-4, AUC=0.89 (0.83-0.95); NAFLD fibrosis score, AUC=0.79 (0.69-0.91). Neither histologic steatosis nor non-invasive steatosis methods predicted outcomes (AUC<0.50). Conclusions Non-invasive methods for liver fibrosis predict outcomes of patients with NASH. They could be used for serial monitoring, risk stratification and targeted interventions.	[Sebastiani, Giada; Alshaalan, Rasha; Wong, Philip; Rubino, Maria; Deschenes, Marc; Ghali, Peter] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada; [Salman, Ayat; Metrakos, Peter] McGill Univ, Sect Hepatobiliary & Transplant Surg, Ctr Hlth, Montreal, PQ, Canada	McGill University; McGill University	Sebastiani, G (corresponding author), McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada.	giada.sebastiani@mcgill.ca	metrakos, peter/D-3726-2013; Alshaalan, Rasha/GQH-7074-2022	Sebastiani, Giada/0000-0003-2655-8283	Fonds de la Recherche en Sante du Quebec (FRSQ)	Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	The authors received no specific funding for this work. GS holds a Chercheur-Boursier career award from the Fonds de la Recherche en Sante du Quebec (FRSQ).	Adams LA, 2010, AM J GASTROENTEROL, V105, P1567, DOI 10.1038/ajg.2010.18; Al-Busafi SA, 2012, CAN J GASTROENTEROL, V26, P155, DOI 10.1155/2012/796313; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Child C, 1964, SURG PORTAL HYPERTEN, P50; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Dunn MA, 2013, LIVER INT, V33, P1575, DOI 10.1111/liv.12285; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478; Goossens N, 2014, REV RECENT CLIN TRIA; Heimbach J, 2014, LIVER TRANSPLANT, V20, pS32, DOI 10.1002/lt.23980; Kim BK, 2014, HEPATOLOGY, V60, P1911, DOI 10.1002/hep.27389; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kwok R, 2014, ALIMENT PHARM THER, V39, P254, DOI 10.1111/apt.12569; Lakoff JM, 2015, CAN J SURG, V58, P15, DOI 10.1503/cjs.002914; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Lee SS, 2010, J HEPATOL, V52, P579, DOI 10.1016/j.jhep.2010.01.008; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schwenger KJP, 2014, WORLD J GASTROENTERO, V20, P1712, DOI 10.3748/wjg.v20.i7.1712; Sebastiani G, 2014, CAN J GASTROENTEROL, V28, P23, DOI 10.1155/2014/675409; Sebastiani G, 2010, J HEPATOL, V53, P630, DOI 10.1016/j.jhep.2010.04.019; Sebastiani G, 2009, WORLD J GASTROENTERO, V15, P2190, DOI 10.3748/wjg.15.2190; Shin SH, 2014, LIVER INT; Stepanova M, 2012, CLIN GASTROENTEROL H, V10, P646, DOI 10.1016/j.cgh.2011.12.039; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wong RJ, 2014, GASTROENTEROLOGY; World Health Organization, 2000, WHO TECHN REP SER, V894	43	45	48	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128774	10.1371/journal.pone.0128774	http://dx.doi.org/10.1371/journal.pone.0128774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083565	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400068
J	Yi, GS; Wang, J; Tsang, KM; Wei, XL; Deng, B				Yi, Guo-Sheng; Wang, Jiang; Tsang, Kai-Ming; Wei, Xi-Le; Deng, Bin			Biophysical Insights into How Spike Threshold Depends on the Rate of Membrane Potential Depolarization in Type I and Type II Neurons	PLOS ONE			English	Article							VENTRAL COCHLEAR NUCLEUS; AXON INITIAL SEGMENT; NEOCORTICAL PYRAMIDAL NEURONS; INACTIVATING K+ CURRENT; COINCIDENCE DETECTION; POTASSIUM CURRENTS; CORTICAL-NEURONS; AUDITORY NEURONS; FEATURE SELECTIVITY; CORTEX NEURONS	Dynamic spike threshold plays a critical role in neuronal input-output relations. In many neurons, the threshold potential depends on the rate of membrane potential depolarization (dV/dt) preceding a spike. There are two basic classes of neural excitability, i.e., Type I and Type II, according to input-output properties. Although the dynamical and biophysical basis of their spike initiation has been established, the spike threshold dynamic for each cell type has not been well described. Here, we use a biophysical model to investigate how spike threshold depends on dV/dt in two types of neuron. It is observed that Type II spike threshold is more depolarized and more sensitive to dV/dt than Type I. With phase plane analysis, we show that each threshold dynamic arises from the different separatrix and K+ current kinetics. By analyzing subthreshold properties of membrane currents, we find the activation of hyperpolarizing current prior to spike initiation is a major factor that regulates the threshold dynamics. The outward K+ current in Type I neuron does not activate at the perithresholds, which makes its spike threshold insensitive to dV/dt. The Type II K+ current activates prior to spike initiation and there is a large net hyperpolarizing current at the perithresholds, which results in a depolarized threshold as well as a pronounced threshold dynamic. These predictions are further attested in several other functionally equivalent cases of neural excitability. Our study provides a fundamental description about how intrinsic biophysical properties contribute to the threshold dynamics in Type I and Type II neurons, which could decipher their significant functions in neural coding.	[Yi, Guo-Sheng; Wang, Jiang; Wei, Xi-Le; Deng, Bin] Tianjin Univ, Sch Elect Engn & Automat, Tianjin 300072, Peoples R China; [Tsang, Kai-Ming] Hong Kong Polytech Univ, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China	Tianjin University; Hong Kong Polytechnic University	Wei, XL (corresponding author), Tianjin Univ, Sch Elect Engn & Automat, Tianjin 300072, Peoples R China.	xilewei@tju.edu.cn		TSANG, Kai Ming/0000-0002-1516-3174	National Natural Science Foundation of China [61172009, 61372010]; Tianjin Municipal Natural Science Foundation [12JCZDJC21100, 13JCZDJC27900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin)	This work is supported by the National Natural Science Foundation of China under Grants 61172009 and 61372010, and Tianjin Municipal Natural Science Foundation under Grants 12JCZDJC21100 and 13JCZDJC27900. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bekkers JM, 2001, J NEUROSCI, V21, P6553, DOI 10.1523/JNEUROSCI.21-17-06553.2001; Bender KJ, 2012, ANNU REV NEUROSCI, V35, P249, DOI 10.1146/annurev-neuro-062111-150339; Brette R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003338; Brew HM, 1995, J NEUROSCI, V15, P8011; Cardin JA, 2010, J NEUROSCI, V30, P3652, DOI 10.1523/JNEUROSCI.5279-09.2010; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Dayan P., 2005, THEORETICAL NEUROSCI; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Dodson PD, 2002, J NEUROSCI, V22, P6953; Drion G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041806; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Escabi MA, 2005, J NEUROSCI, V25, P9524, DOI 10.1523/JNEUROSCI.1804-05.2005; Ferragamo MJ, 2002, J NEUROPHYSIOL, V87, P2262, DOI 10.1152/jn.00587.2001; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; FITZHUGH R, 1960, J GEN PHYSIOL, V43, P867, DOI 10.1085/jgp.43.5.867; Fontaine B, 2014, J NEUROPHYSIOL, V112, P430, DOI 10.1152/jn.00132.2014; Fontaine B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003560; Fontaine B, 2013, J NEUROPHYSIOL, V110, P1672, DOI 10.1152/jn.00051.2013; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Guan D, 2007, J NEUROPHYSIOL, V97, P1931, DOI 10.1152/jn.00933.2006; Harvey AL, 2004, CURR MED CHEM, V11, P3065, DOI 10.2174/0929867043363820; Henze DA, 2001, NEUROSCIENCE, V105, P121, DOI 10.1016/S0306-4522(01)00167-1; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Izhikevich E M, 2005, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Mato G, 2008, NEURAL COMPUT, V20, P2418, DOI 10.1162/neco.2008.10-07-632; Meng XY, 2012, DISCRETE CONT DYN-A, V32, P2729, DOI 10.3934/dcds.2012.32.2729; Munoz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030154; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Platkiewicz J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001129; Platkiewicz J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000850; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Prescott SA, 2008, J NEUROPHYSIOL, V100, P3030, DOI 10.1152/jn.90634.2008; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3083, DOI 10.1152/jn.00126.2002; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3070, DOI 10.1152/jn.00125.2002; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; SCHLUE WR, 1974, J NEUROPHYSIOL, V37, P303, DOI 10.1152/jn.1974.37.2.303; Shen WX, 2004, J NEUROPHYSIOL, V91, P1337, DOI 10.1152/jn.00414.2003; SHISHKOV.MA, 1973, DOKL AKAD NAUK SSSR+, V209, P576; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; St-Hilaire M, 2004, J COMPUT NEUROSCI, V16, P299, DOI 10.1023/B:JCNS.0000025690.02886.93; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Svirskis G, 2004, J NEUROPHYSIOL, V91, P2465, DOI 10.1152/jn.00717.2003; Svirskis G, 2002, J NEUROSCI, V22, P11019; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; Wester JC, 2013, J COMPUT NEUROSCI, V35, P1, DOI 10.1007/s10827-012-0436-2; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Yi GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097481; Yi GS, 2014, J COMPUT NEUROSCI, V36, P383, DOI 10.1007/s10827-013-0479-z; Yi GS, 2015, BIOL CYBERN, V109, P287, DOI 10.1007/s00422-014-0642-2; Yi GS, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500075; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	63	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130250	10.1371/journal.pone.0130250	http://dx.doi.org/10.1371/journal.pone.0130250			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083350	gold, Green Submitted, Green Published			2022-12-26	WOS:000356567400133
J	Yoshimi, S; Ochi, H; Murakami, E; Uchida, T; Kan, H; Akamatsu, S; Hayes, CN; Abe, H; Miki, D; Hiraga, N; Imamura, M; Aikata, H; Chayama, K				Yoshimi, Satoshi; Ochi, Hidenori; Murakami, Eisuke; Uchida, Takuro; Kan, Hiromi; Akamatsu, Sakura; Hayes, C. Nelson; Abe, Hiromi; Miki, Daiki; Hiraga, Nobuhiko; Imamura, Michio; Aikata, Hiroshi; Chayama, Kazuaki			Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DACLATASVIR PLUS ASUNAPREVIR; VIROLOGICAL RESPONSE; GENETIC-VARIATION; POLYMORPHISMS; MUTATIONS; INTERFERON; PREVALENCE; POLYMERASE; INHIBITORS	Daclatasvir and asunaprevir dual oral therapy is expected to achieve high sustained virological response (SVR) rates in patients with HCV genotype 1b infection. However, presence of the NS5A-Y93H substitution at baseline has been shown to be an independent predictor of treatment failure for this regimen. By using the Invader assay, we developed a system to rapidly and accurately detect the presence of mutant strains and evaluate the proportion of patients harboring a pre-treatment Y93H mutation. This assay system, consisting of nested PCR followed by Invader reaction with well-designed primers and probes, attained a high overall assay success rate of 98.9% among a total of 702 Japanese HCV genotype 1b patients. Even in serum samples with low HCV titers, more than half of the samples could be successfully assayed. Our assay system showed a better lower detection limit of Y93H proportion than using direct sequencing, and Y93H frequencies obtained by this method correlated well with those of deep-sequencing analysis (r = 0.85, P < 0.001). The proportion of the patients with the mutant strain estimated by this assay was 23.6% (164/694). Interestingly, patients with the Y93H mutant strain showed significantly lower ALT levels (p=8.8 x 10(-4)), higher serum HCV RNA levels (p=4.3 x 10(-7)), and lower HCC risk (p=6.9 x 10(-3)) than those with the wild type strain. Because the method is both sensitive and rapid, the NS5A-Y93H mutant strain detection system established in this study may provide important pretreatment information valuable not only for treatment decisions but also for prediction of disease progression in HCV genotype 1b patients.	[Yoshimi, Satoshi; Ochi, Hidenori; Murakami, Eisuke; Uchida, Takuro; Kan, Hiromi; Akamatsu, Sakura; Hayes, C. Nelson; Abe, Hiromi; Miki, Daiki; Hiraga, Nobuhiko; Imamura, Michio; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Dept Gastroenterol & Metab, Inst Biomed & Hlth Sci, Appl Life Sci, Hiroshima, Japan; [Ochi, Hidenori; Hayes, C. Nelson; Abe, Hiromi; Miki, Daiki; Chayama, Kazuaki] RIKEN, Lab Digest Dis, Ctr Genom Med, Hiroshima, Japan; [Yoshimi, Satoshi; Ochi, Hidenori; Murakami, Eisuke; Uchida, Takuro; Kan, Hiromi; Akamatsu, Sakura; Hayes, C. Nelson; Abe, Hiromi; Miki, Daiki; Hiraga, Nobuhiko; Imamura, Michio; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan	Hiroshima University; RIKEN; Hiroshima University	Chayama, K (corresponding author), Hiroshima Univ, Dept Gastroenterol & Metab, Inst Biomed & Hlth Sci, Appl Life Sci, Hiroshima, Japan.	chayama@hiroshima-u.ac.jp	Uchida, Takuro/G-5011-2019; Miki, Daiki/L-5069-2018; Hayes, C. Nelson N/G-4596-2019; Chayama, Kazuaki/B-2493-2016; Abe-Chayama, Hiromi/M-8256-2019; Murakami, Eisuke/G-4557-2019	Miki, Daiki/0000-0002-6505-9826; Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology, Government of Japan	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Government of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by Grants-in-Aid for scientific research and development from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/) and Ministry of Education, Culture, Sports, Science, and Technology (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm), Government of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akamatsu S, 2015, J HEPATOL; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Akuta N, 2014, J MED VIROL, V86, P1314, DOI 10.1002/jmv.23966; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Chevaliez S, 2007, WORLD J GASTROENTERO, V13, P2461, DOI 10.3748/wjg.v13.i17.2461; Cortes KC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/626083; El-Shamy A, 2007, MICROBIOL IMMUNOL, V51, P471, DOI 10.1111/j.1348-0421.2007.tb03922.x; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hiraga N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/hep.24460; Hirotsu Y, 2015, HEPATOL INT; Hosono N, 2008, HUM MUTAT, V29, P182, DOI 10.1002/humu.20609; Itakura J., 2015, HEPATOL RES; Kamiyama M, 2007, HUM GENET, V122, P397, DOI 10.1007/s00439-007-0414-3; Karino Y, 2013, J HEPATOL, V58, P646, DOI 10.1016/j.jhep.2012.11.012; Kosaka K, 2014, J VIRAL HEPAT; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Miura M, 2014, HEPATOL RES, V44, pE360, DOI 10.1111/hepr.12316; Nagaoki Y, 2012, HEPATOL RES, V42, P368, DOI 10.1111/j.1872-034X.2011.00929.x; Nakahara H, 2010, FORENSIC SCI INT-GEN, V4, P130, DOI 10.1016/j.fsigen.2009.07.005; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Pallier C, 2006, J VIROL, V80, P643, DOI 10.1128/JVI.80.2.643-653.2006; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Paolucci S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-355; Peres-da-Silva A, 2015, J ANTIMICROB CHEMOTH, V70, P726, DOI 10.1093/jac/dku462; Plaza Z, 2012, ANTIVIR THER, V17, P921, DOI 10.3851/IMP2091; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Sarrazin C, 2000, HEPATOLOGY, V31, P1360, DOI 10.1053/jhep.2000.7987; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shin-I T, 2008, HEPATOL RES, V38, P234, DOI 10.1111/j.1872-034X.2007.00262.x; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Suzuki F, 2012, J CLIN VIROL, V54, P352, DOI 10.1016/j.jcv.2012.04.024; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Tadokoro K, 2011, J VIROL METHODS, V171, P67, DOI 10.1016/j.jviromet.2010.10.001; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Uchida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112647; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655	40	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130022	10.1371/journal.pone.0130022	http://dx.doi.org/10.1371/journal.pone.0130022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083687	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400119
J	Darienko, T; Gustavs, L; Eggert, A; Wolf, W; Proschold, T				Darienko, Tatyana; Gustavs, Lydia; Eggert, Anja; Wolf, Wiebke; Proeschold, Thomas			Evaluating the Species Boundaries of Green Microalgae (Coccomyxa, Trebouxiophyceae, Chlorophyta) Using Integrative Taxonomy and DNA Barcoding with Further Implications for the Species Identification in Environmental Samples	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MORPHOLOGICAL CHARACTERIZATION; SECONDARY STRUCTURE; ALGAE; SYSTEMATICS; PREDICTION; DIVERSITY; CHLORELLA; DISCOVERY; SEQUENCES	Integrative taxonomy is an approach for defining species and genera by taking phylogenetic, morphological, physiological, and ecological data into account. This approach is appropriate for microalgae, where morphological convergence and high levels of morphological plasticity complicate the application of the traditional classification. Although DNA barcode markers are well-established for animals, fungi, and higher plants, there is an ongoing discussion about suitable markers for microalgae and protists because these organisms are genetically more diverse compared to the former groups. To solve these problems, we assess the usage of a polyphasic approach combining phenotypic and genetic parameters for species and generic characterization. The application of barcode markers for database queries further allows conclusions about the 'coverage' of culture-based approaches in biodiversity studies and integrates additional aspects into modern taxonomic concepts. Although the culture-dependent approach revealed three new lineages, which are described as new species in this paper, the culture-independent analyses discovered additional putative new species. We evaluated three barcode markers (V4, V9 and ITS-2 regions, nuclear ribosomal operon) and studied the morphological and physiological plasticity of Coccomyxa, which became a model organism because its whole genome sequence has been published. In addition, several biotechnological patents have been registered for Coccomyxa. Coccomyxa representatives are distributed worldwide, are free-living or in symbioses, and colonize terrestrial and aquatic habitats. We investigated more than 40 strains and reviewed the biodiversity and biogeographical distribution of Coccomyxa species using DNA barcoding. The genus Coccomyxa formed a monophyletic group within the Trebouxiophyceae separated into seven independent phylogenetic lineages representing species. Summarizing, the combination of different characteristics in an integrative approach helps to evaluate environmental data and clearly identifies microalgae at generic and species levels.	[Darienko, Tatyana] Natl Acad Sci Ukraine, MG Kholodny Inst Bot, UA-01601 Kiev, Ukraine; [Gustavs, Lydia; Wolf, Wiebke; Proeschold, Thomas] Univ Rostock, Inst Biol Sci Appl Ecol & Phycol, D-18059 Rostock, Germany; [Eggert, Anja] Leibniz Inst Balt Sea Res Warnemunde Phys Oceano, D-18119 Rostock, Germany; [Proeschold, Thomas] Univ Vienna, Dept Limnol & Biooceanog, A-1090 Vienna, Austria	National Academy of Sciences Ukraine; M.G. Kholodny Institute of Botany, NAS of Ukraine; University of Rostock; University of Vienna	Proschold, T (corresponding author), Univ Rostock, Inst Biol Sci Appl Ecol & Phycol, Albert Einstein Str 3, D-18059 Rostock, Germany.	Thomas.Proeschold@univie.ac.at		Proeschold, Thomas/0000-0002-7858-0434; Gustavs, Lydia/0000-0003-3621-8864; Darienko, Tatyana/0000-0002-1957-0076	Deutsche Forschungsgemeinschaft [DFG GU 1278/1-1 : LG]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, grant number DFG GU 1278/1-1 : LG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton E, 1909, ANN BOT-LONDON, V23, P573, DOI 10.1093/oxfordjournals.aob.a089239; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; [Anonymous], 2013, SYST BIOL, V62, P707, DOI [10.1093/sysbio/syt033, DOI 10.1093/SYSBIO/SYT033]; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; BRAUNE W, 1964, ARCH MIKROBIOL, V49, P176, DOI 10.1007/BF00422141; Byun Y, 2009, BIOINFORMATICS, V25, P1435, DOI 10.1093/bioinformatics/btp252; Caisova L, 2013, PROTIST, V164, P482, DOI 10.1016/j.protis.2013.04.005; Caisova L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-262; Chodat R, 1913, MATERIAUX FLORE CRYP, V4, P1; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2000, PROTIST, V151, P1, DOI 10.1078/1434-4610-00002; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Darienko T, 2010, EUR J PHYCOL, V45, P79, DOI 10.1080/09670260903362820; Demchenko E, 2012, EUR J PHYCOL, V47, P264, DOI 10.1080/09670262.2012.678388; Dentinger BTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025081; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ettl H, 2014, SYLLABUS BODEN LUFT; Falagan C, 2014, FEMS MICROBIOL ECOL, V87, P231, DOI 10.1111/1574-6941.12218; Fontaneto D, 2015, MAR BIODIV IN PRESS; Fott B, 1976, ALGOLOGICAL STUDIES, V17, P382; Garbayo I, 2012, J PHYCOL, V48, P607, DOI 10.1111/j.1529-8817.2012.01160.x; Gartner G, 1993, MITT ABT BOT LANDESM, V21, P33; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Gustavs L, 2009, AQUAT MICROB ECOL, V55, P95, DOI 10.3354/ame01291; Hall JD, 2010, CRYPTOGAMIE ALGOL, V31, P529; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Higgs PG, 2003, J MOL EVOL, V57, P435, DOI 10.1007/s00239-003-2494-6; Hudelot C, 2003, MOL PHYLOGENET EVOL, V28, P241, DOI 10.1016/S1055-7903(03)00061-7; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaag O, 1934, BER SCHWEIZ BOT GES, V34, P79; Jaag O, 1933, BEITR KRYPTOGAM SCHW, V8, P1; Jow H, 2002, MOL BIOL EVOL, V19, P1591, DOI 10.1093/oxfordjournals.molbev.a004221; Kiss L, 2012, P NATL ACAD SCI USA, V109, pE1811, DOI 10.1073/pnas.1207143109; Kitzing C, 2014, MICROB ECOL, V67, P327, DOI 10.1007/s00248-013-0317-x; Komarek J., 1983, PHYTOPLANKTON SUSSWA; KRIENITZ L, 1994, BIOLOGIA, V49, P463; Krienitz L, 2012, HYDROBIOLOGIA, V698, P295, DOI 10.1007/s10750-012-1079-z; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Lohtander K, 2003, LICHENOLOGIST, V35, P325, DOI 10.1016/S0024-2829(03)00051-3; Luo W, 2006, PROTIST, V157, P315, DOI 10.1016/j.protis.2006.05.006; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McNeill J, 2012, REGNUM VEG, V154, P1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; PEVELING E, 1976, NEW PHYTOL, V77, P713, DOI 10.1111/j.1469-8137.1976.tb04665.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Proschold T, 2011, ENVIRON MICROBIOL, V13, P350, DOI 10.1111/j.1462-2920.2010.02333.x; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Proschold Thomas, 2007, Systematics Association Special Volume Series, V75, P123; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rivasseau C, 2013, ENERG ENVIRON SCI, V6, P1230, DOI 10.1039/c2ee23129h; Rodriguez F, 2008, DIS AQUAT ORGAN, V81, P231, DOI 10.3354/dao01956; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlosser UG, 1997, BOT ACTA, V110, P424, DOI 10.1111/j.1438-8677.1997.tb00659.x; Schmidle W, 1901, BERICHTE DTSCH BOT G, V19, P10; Schoch CL, 2012, P NATL ACAD SCI USA, V109, pE1812, DOI 10.1073/pnas.1207508109; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Siebert S, 2005, BIOINFORMATICS, V21, P3352, DOI 10.1093/bioinformatics/bti550; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEVENSON R N, 1974, British Phycological Journal, V9, P319; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Syasina IG, 2012, J INVERTEBR PATHOL, V111, P175, DOI 10.1016/j.jip.2012.08.001; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Telford MJ, 2005, MOL BIOL EVOL, V22, P1129, DOI 10.1093/molbev/msi099; Tillier E, 1998, J MOL EVOL, V39, P409; Tremouillaux-Guiller J, 2007, PLANTA, V226, P553, DOI 10.1007/s00425-007-0526-y; Vazquez N, 2010, J INVERTEBR PATHOL, V105, P254, DOI 10.1016/j.jip.2010.07.005; Verma V, 2009, J PHYCOL, V45, P847, DOI 10.1111/j.1529-8817.2009.00718.x; Vinatzer G, 1975, THESIS U INNSBRUCK A; VISCHER WILHELM, 1932, ARCH PROTISTENK, V76, P257; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6; Zoller S, 2003, MOL PHYLOGENET EVOL, V29, P629, DOI 10.1016/S1055-7903(03)00215-X; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	83	98	104	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0127838	10.1371/journal.pone.0127838	http://dx.doi.org/10.1371/journal.pone.0127838			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080086	Green Submitted, gold, Green Published			2022-12-26	WOS:000356542300006
J	Bollmann, F; Jackel, S; Schmidtke, L; Schrick, K; Reinhardt, C; Jurk, K; Wu, ZX; Xia, N; Li, HG; Erkel, G; Walter, U; Kleinert, H; Pautz, A				Bollmann, Franziska; Jaeckel, Sven; Schmidtke, Lisa; Schrick, Katharina; Reinhardt, Christoph; Jurk, Kerstin; Wu, Zhixiong; Xia, Ning; Li, Huige; Erkel, Gerhard; Walter, Ulrich; Kleinert, Hartmut; Pautz, Andrea			Anti-Inflammatory and Anti-Thrombotic Effects of the Fungal Metabolite Galiellalactone in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; ALPHA BLOCKADE; TNF-ALPHA; ATHEROSCLEROSIS; INFLAMMATION; RECRUITMENT; MECHANISMS; GENERATION; INHIBITOR	Patients suffering from chronic inflammatory diseases have an increased mortality risk resulting from cardiovascular disorders due to enhanced atherosclerotic and thrombotic events. Until now, it is not completely understood in which way an abnormal expression of pro-inflammatory mediators contributes to this elevated cardiovascular risk, but there is a need for new drugs that on the one hand suppress the expression of pro-inflammatory mediators and on the other hand inhibit arterial platelet adhesion. Thus, we analyzed the anti-inflammatory and anti-thrombotic capacity of the fungal metabolite Galiellalactone in atherosclerosis-prone apolipoprotein E-deficient mice. Treatment of the mice with Galiellalactone lowered the inflammatory expression profile and improved blood clotting times, as well as platelet adhesion to the injured common carotid artery. The results indicate that administration of Galiellalactone is able to reduce the extent of inflammation and arterial platelet adhesion in this mouse model.	[Bollmann, Franziska; Schmidtke, Lisa; Schrick, Katharina; Wu, Zhixiong; Xia, Ning; Li, Huige; Kleinert, Hartmut; Pautz, Andrea] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, Mainz, Germany; [Bollmann, Franziska; Jaeckel, Sven; Reinhardt, Christoph; Jurk, Kerstin; Walter, Ulrich] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis CTH, D-55122 Mainz, Germany; [Erkel, Gerhard] Tech Univ Kaiserslautern, Dept Mol Biotechnol & Syst Biol, Kaiserslautern, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Kaiserslautern	Kleinert, H (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, Mainz, Germany.	kleinert@uni-mainz.de	Jurk, Kerstin/AAT-7768-2020; Li, Huige/M-2662-2013; Kleinert, Hartmut/M-2988-2018; Walter, ulrich/W-2478-2017; Xia, Ning/P-3535-2015; Xia, Ning/AFT-8078-2022	Li, Huige/0000-0003-3458-7391; Kleinert, Hartmut/0000-0003-2202-3548; Walter, ulrich/0000-0001-6784-2307; Xia, Ning/0000-0002-5553-1752; Xia, Ning/0000-0002-5553-1752	Federal Ministry of Education and Research BMBF [01EO1003]; Innovation Foundation of the State of Rhineland-Palatinate [961-386261/917K, 961-386261/1105AP]; DFG [LI 1759/1-1, RE 3450/3-1, PA 1933/2-3]	Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); Innovation Foundation of the State of Rhineland-Palatinate; DFG(German Research Foundation (DFG))	Funding provided by Federal Ministry of Education and Research BMBF 01EO1003 http://www.bmbf.de/ (UW); Innovation Foundation of the State of Rhineland-Palatinate 961-386261/917K http://stiftung-innovation.rlp.de/ (HK); Innovation Foundation of the State of Rhineland-Palatinate 961-386261/1105AP http://stiftung-innovation.rlp.de/ (AP); DFG LI 1759/1-1 http://www.dfg.de/ (HK); DFG RE 3450/3-1 http://www.dfg.de/ (CR); DFG PA 1933/2-3 http://www.dfg.de/ (AP).	Al-Aly Z, 2011, TRANSL RES, V157, P10, DOI 10.1016/j.trsl.2010.09.005; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Bollmann F, 2014, NUCLEIC ACIDS RES, V42, P12555, DOI 10.1093/nar/gku1033; Bosello S, 2008, CLIN RHEUMATOL, V27, P833, DOI 10.1007/s10067-007-0803-y; Castro C, 2005, FRONT BIOSCI-LANDMRK, V10, P1932, DOI 10.2741/1669; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Don-Doncow N, 2014, J BIOL CHEM, V289, P15969, DOI 10.1074/jbc.M114.564252; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Goodson N, 2005, ANN RHEUM DIS, V64, P1595, DOI 10.1136/ard.2004.034777; Greenberg JD, 2011, ANN RHEUM DIS, V70, P576, DOI 10.1136/ard.2010.129916; Grignani G, 2000, HAEMATOLOGICA, V85, P967; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hausding M, 2011, INT IMMUNOL, V23, P1, DOI 10.1093/intimm/dxq451; Kalz J, 2014, J THROMB THROMBOLYS, V37, P45, DOI 10.1007/s11239-013-1026-5; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Magro F, 2014, WORLD J GASTROENTERO, V20, P4857, DOI 10.3748/wjg.v20.i17.4857; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; McNeill E, 2010, CLIN SCI, V118, P641, DOI 10.1042/CS20090488; Noh JR, 2011, ANN NUTR METAB, V59, P145, DOI 10.1159/000334264; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Perez M, 2014, CHEM-BIOL INTERACT, V214, P69, DOI 10.1016/j.cbi.2014.02.012; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Roman MJ, 2006, ANN INTERN MED, V144, P249, DOI 10.7326/0003-4819-144-4-200602210-00006; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schmidt N, 2012, J PHARMACOL EXP THER, V343, P106, DOI 10.1124/jpet.112.192047; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Weidler M, 2000, FEBS LETT, V484, P1, DOI 10.1016/S0014-5793(00)02115-3	36	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130401	10.1371/journal.pone.0130401	http://dx.doi.org/10.1371/journal.pone.0130401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076475	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900170
J	Diaz, A; Perez, A; Sreevatsan, S; Davies, P; Culhane, M; Torremorell, M				Diaz, Andres; Perez, Andres; Sreevatsan, Srinand; Davies, Peter; Culhane, Marie; Torremorell, Montserrat			Association between Influenza A Virus Infection and Pigs Subpopulations in Endemically Infected Breeding Herds	PLOS ONE			English	Article							PANDEMIC H1N1 2009; UNITED-STATES; SWINE; DYNAMICS; SURVEILLANCE; TRANSMISSION; EVOLUTION; H3N2	Influenza A viruses (IAVs) are distributed worldwide in birds, pigs and humans, and cause important endemic disease affecting hosts in all countries. Although pigs play a key role in the ecology of IAVs, the epidemiology of IAVs within swine herds is poorly understood. In this longitudinal study we describe the prevalence of IAVs infection in three subpopulations of pigs in 5 breeding herds in the Midwestern USA. Each herd was sampled monthly for a year and, at each visit, 30 individual nasal swabs were collected from the three subpopulations, namely, a) replacement females, resident on-farm for less than 4 weeks (new gilts), b) replacement females, resident on-farmfor more than 4 weeks (gilts), and c) neonatal pigs less than 21 days of age (piglets). Real time reverse transcriptase polymerase chain reaction (RRT-PCR) was used to detect IAVs, and the association between IAVs infection and pig subpopulation was measured using a mixed logistic regression model. Nasal swabs (n = 4,190) were collected from 141 groups of pigs. At least, one IAV-positive nasal swab was found in 19.9%(n = 28) of the sampled groups, and 7.7% (n = 324) of all nasal swabs tested positive. After adjusting by annual quarter and sampling event, the odds of testing IAV positive were 7.9 (95% CI 1.4, 43.9) and 4.4 (95% CI 1.1, 17.1) times higher in groups of new gilts and piglets compared to groups of gilts, respectively. Results indicate that new gilts and piglets had higher odds of testing IAV positive than gilts in swine breeding herds and that season influences IAV infection in pigs. Based on these findings, we recommend that IAV control strategies be aimed at preventing infection before gilts are introduced into the farm, and in pigs prior to weaning.	[Diaz, Andres; Perez, Andres; Sreevatsan, Srinand; Davies, Peter; Culhane, Marie; Torremorell, Montserrat] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	torr0033@umn.edu	Culhane, Marie/H-3143-2019; Sreevatsan, Srinand/V-6808-2019; Perez, Andres/HGD-8377-2022	Sreevatsan, Srinand/0000-0002-5162-2403; Culhane, Marie/0000-0002-3547-7576	NIH, National Institute of Allergy and Infectious Diseases; Department of Health and Human Services [HHSN266200700007C]; COLCIENCIAS: Departamento Administrativo de Ciencia, Tecnologia e Innovacion	NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Health and Human Services; COLCIENCIAS: Departamento Administrativo de Ciencia, Tecnologia e Innovacion(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was supported in whole or in part with federal funds from the NIH, National Institute of Allergy and Infectious Diseases and Department of Health and Human Services under the contract No. HHSN266200700007C and COLCIENCIAS: Departamento Administrativo de Ciencia, Tecnologia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson M, 2012, TRANSBOUNDA IN PRESS; Allerson MW, 2014, TRANSBOUND EMERG DIS, V61, P490, DOI 10.1111/tbed.12053; Anderson TK, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12193; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; CHAMBERS TM, 1991, ARCH VIROL, V116, P261, DOI 10.1007/BF01319247; Chen RB, 2010, J MOL EVOL, V70, P98, DOI 10.1007/s00239-009-9312-8; Corzo CA, 2013, EMERG INFECT DIS, V19, P954, DOI 10.3201/eid1906.121637; Corzo CA, 2012, J SWINE HEALTH PROD, V20, P283; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI 10.3201/eid1709.110338; HINSHAW VS, 1978, VIROLOGY, V84, P51, DOI 10.1016/0042-6822(78)90217-9; Knauer MT, 2013, J SWINE HEALTH PROD, V21, P248; Kyriakis CS, 2013, VET MICROBIOL, V162, P543, DOI 10.1016/j.vetmic.2012.11.014; Lesnoff M, 2012, AOD ANAL DISPERSED D; Maldonado J, 2006, VET J, V172, P377, DOI 10.1016/j.tvjl.2005.04.014; MEGURO H, 1979, J CLIN MICROBIOL, V9, P175; Meiners C, 2014, TIERARZTL PRAX AUSG, V42, DOI 10.15653/tpg-131130; Nelson MI, 2014, J VIROL, V88, P10110, DOI 10.1128/JVI.01080-14; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077; Nelson MI, NAT COMMUN, P6696; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Olsen CW, 2000, ARCH VIROL, V145, P1399, DOI 10.1007/s007050070098; Poljak Z, 2014, INFLUENZA OTHER RESP, V8, P482, DOI 10.1111/irv.12248; Ramakrishnan MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007105; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Revelle W., 2014, PSYCH PROCEDURES PER; Sarkar D, 2008, USE R, P1; Schultz-Cherry S, 2013, CURR TOP MICROBIOL, V370, P21, DOI 10.1007/82_2011_197; Simon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115815; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Spackman Erica, 2008, V436, P19, DOI 10.1007/978-1-59745-279-3_4; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Torremorell M, 2012, TRANSBOUND EMERG DIS, V59, P68, DOI 10.1111/j.1865-1682.2011.01300.x; Van Reeth K, 2008, INFLUENZA OTHER RESP, V2, P99, DOI 10.1111/j.1750-2659.2008.00043.x; Vincent AL, ADV VIRUS RES, V72, P127; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	38	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129213	10.1371/journal.pone.0129213	http://dx.doi.org/10.1371/journal.pone.0129213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076494	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900053
J	Lewis, B; Grant, WS; Brenner, RE; Hamazaki, T				Lewis, Bert; Grant, W. Stewart; Brenner, Richard E.; Hamazaki, Toshihide			Changes in Size and Age of Chinook Salmon Oncorhynchus tshawytscha Returning to Alaska	PLOS ONE			English	Article							PRINCE-WILLIAM-SOUND; WILD PINK SALMON; CHUM SALMON; INDUCED EVOLUTION; REACTION NORMS; MATURITY; HATCHERY; GROWTH; TRENDS; FISHERY	The average sizes of Pacific salmon have declined in some areas in the Northeast Pacific over the past few decades, but the extent and geographic distribution of these declines in Alaska is uncertain. Here, we used regression analyses to quantify decadal trends in length and age at maturity in ten datasets from commercial harvests, weirs, and spawner abundance surveys of Chinook salmon Oncorhynchus tshawytscha throughout Alaska. We found that on average these fish have become smaller over the past 30 years (similar to 6 generations), because of a decline in the predominant age at maturity and because of a decrease in age-specific length. The proportion of older and larger 4-ocean age fish in the population declined significantly (P < 0.05) in all stocks examined by return year or brood year. Our analyses also indicated that the age-specific lengths of 4-ocean fish (9 of 10 stocks) and of 3-ocean fish (5 of 10 stocks) have declined significantly (P < 0.05). Size-selective harvest may be driving earlier maturation and declines in size, but the evidence is not conclusive, and additional factors, such as ocean conditions or competitive interactions with other species of salmon, may also be responsible. Regardless of the cause, these wide-spread phenotypic shifts influence fecundity and population abundance, and ultimately may put populations and associated fisheries at risk of decline.	[Lewis, Bert; Grant, W. Stewart; Hamazaki, Toshihide] Alaska Dept Fish & Game, Commercial Fisheries Div, Anchorage, AK 99518 USA; [Brenner, Richard E.] Alaska Dept Fish & Game, Commercial Fisheries Div, Juneau, AK USA	Alaska Department of Fish & Game; Alaska Department of Fish & Game	Lewis, B (corresponding author), Alaska Dept Fish & Game, Commercial Fisheries Div, 333 Raspberry Rd, Anchorage, AK 99518 USA.	bert.lewis@alaska.gov			Alaska Department of Fish and Game, Anchorage, Alaska	Alaska Department of Fish and Game, Anchorage, Alaska	This work was supported by the Alaska Department of Fish and Game, Anchorage, Alaska.	Alaska Department of Fish and Game Chinook salmon research team, 2013, ADF G SPEC PUBL, V13-01; Audzijonyte A, 2013, EVOL APPL, V6, P585, DOI 10.1111/eva.12044; Beamish RJ, 1999, CAN J FISH AQUAT SCI, V56, P516, DOI 10.1139/cjfas-56-3-516; Bell J, 2012, 1286 FDS AL DEP FISH; BERRIGAN D, 1994, OIKOS, V70, P474, DOI 10.2307/3545787; Bigler BS, 1996, CAN J FISH AQUAT SCI, V53, P455, DOI 10.1139/cjfas-53-2-455; Brodersen AR, 2013, 3A1307 AL DEP FISH G; Bromaghin JF, 2011, NAT RESOUR MODEL, V24, P1, DOI 10.1111/j.1939-7445.2010.00077.x; Bue BG, 2012, FISHERY DATA SERIES, V12-49; Calduch-Verdiell N, 2014, CAN J FISH AQUAT SCI, V71, P1113, DOI 10.1139/cjfas-2014-0034; COCHRANE D, 1949, J AM STAT ASSOC, V44, P32, DOI 10.2307/2280349; Conover DO, 2009, EVOL APPL, V2, P276, DOI 10.1111/j.1752-4571.2009.00079.x; Crozier LG, 2014, EVOL APPL, V7, P68, DOI 10.1111/eva.12135; Eldridge WH, 2010, ECOL APPL, V20, P1936, DOI 10.1890/09-1186.1; Eskelin T, 2013, FISHERY DATA SERIES, V13-63; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Fleischman SJ, 2013, CAN J FISH AQUAT SCI, V70, P401, DOI 10.1139/cjfas-2012-0112; Francis Robert C., 1994, Fisheries Oceanography, V3, P279, DOI 10.1111/j.1365-2419.1994.tb00105.x; Fukuwaka MA, 2008, EVOL APPL, V1, P376, DOI 10.1111/j.1752-4571.2008.00029.x; Gargett AE, 1997, FISH OCEANOGR, V6, P109, DOI 10.1046/j.1365-2419.1997.00033.x; Groot C., 1991, PACIFIC SALMON LIFE; HANKIN DG, 1993, CAN J FISH AQUAT SCI, V50, P347, DOI 10.1139/f93-040; Hard JJ, 2008, EVOL APPL, V1, P388, DOI 10.1111/j.1752-4571.2008.00020.x; Hare S. R., 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P357; Healey M.C., 1991, PACIFIC SALMON LIFE, P313; HEALEY MC, 1984, CAN J FISH AQUAT SCI, V41, P476, DOI 10.1139/f84-057; HEATH DD, 1994, HEREDITY, V72, P146, DOI 10.1038/hdy.1994.21; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; Helle John H., 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P245; Hilborn R, 2000, T AM FISH SOC, V129, P333, DOI 10.1577/1548-8659(2000)129<0333:AROTHP>2.0.CO;2; Irvine JR, 2011, ICES J MAR SCI, V68, P1122, DOI 10.1093/icesjms/fsq199; Joint Technical Committee of the Yukon River US/Canada Panel, 2006, 3A0607 AL DEP FISH G; Jonsson B, 2013, J ANIM ECOL, V82, P201, DOI 10.1111/j.1365-2656.2012.02022.x; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kendall NW, 2014, EVOL APPL, V7, P313, DOI 10.1111/eva.12123; Kendall NW, 2011, T AM FISH SOC, V140, P611, DOI 10.1080/00028487.2011.585575; Kendall NW, 2009, EVOL APPL, V2, P523, DOI 10.1111/j.1752-4571.2009.00086.x; Kinnison MT, 2011, HEREDITY, V106, P448, DOI 10.1038/hdy.2010.162; Kovach RP, 2013, EVOL APPL, V6, P795, DOI 10.1111/eva.12066; Krueger C., 2013, ARCTIC YUKON KUSKOKW; Levin PS, 2001, P ROY SOC B-BIOL SCI, V268, P1153, DOI 10.1098/rspb.2001.1634; Litzow MA, 2014, PROG OCEANOGR, V120, P110, DOI 10.1016/j.pocean.2013.08.003; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Morita K, 2005, CAN J FISH AQUAT SCI, V62, P2752, DOI 10.1139/F05-182; Morita K, 2007, MAR ECOL PROG SER, V335, P289, DOI 10.3354/meps335289; Moss JH, 2009, DEEP-SEA RES PT II, V56, P2553, DOI 10.1016/j.dsr2.2009.03.005; Nicholas J. W, 1988, 881 OR DEP FISH WILD; PARKER RR, 1959, J FISH RES BOARD CAN, V16, P721, DOI 10.1139/f59-052; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quinn TP, 2011, T AM FISH SOC, V140, P45, DOI 10.1080/00028487.2010.550244; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Rand PS, 2012, ENVIRON BIOL FISH, V94, P343, DOI 10.1007/s10641-012-9988-2; Ricker W.E., 1980, CAN TECH REP FISH AQ, V944, P1; RICKER WE, 1981, CAN J FISH AQUAT SCI, V38, P1636, DOI 10.1139/f81-213; Roni Philip, 1995, North American Journal of Fisheries Management, V15, P325, DOI 10.1577/1548-8675(1995)015<0325:GVISAA>2.3.CO;2; Ruggerone GT, 2012, ENVIRON BIOL FISH, V94, P149, DOI 10.1007/s10641-011-9856-5; Ruggerone GT, 2010, MAR COAST FISH, V2, P306, DOI 10.1577/C09-054.1; Ruggerone GT, 2004, REV FISH BIOL FISHER, V14, P371, DOI 10.1007/s11160-004-6927-0; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Shearer K, 2006, AQUACULTURE, V252, P545, DOI 10.1016/j.aquaculture.2005.06.027; Silverstein JT, 1998, CAN J FISH AQUAT SCI, V55, P2376, DOI 10.1139/cjfas-55-11-2376; Tobias T. M., 1994, 2A9436 AL DEP FISH G; Vollestad LA, 2004, T AM FISH SOC, V133, P495, DOI 10.1577/T03-033.1; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wells BK, 2008, FISH OCEANOGR, V17, P101, DOI 10.1111/j.1365-2419.2008.00467.x; Wertheimer AC, 2004, REV FISH BIOL FISHER, V14, P321, DOI 10.1007/s11160-004-2942-4; Zar JH, 1999, BIOSTATISTICAL ANAL	67	45	47	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130184	10.1371/journal.pone.0130184	http://dx.doi.org/10.1371/journal.pone.0130184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090990	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000094
J	Pieperhoff, MS; Pall, GS; Jimenez-Ruiz, E; Das, S; Melatti, C; Gow, M; Wong, EH; Heng, J; Muller, S; Blackman, MJ; Meissner, M				Pieperhoff, Manuela S.; Pall, Gurman S.; Jimenez-Ruiz, Elena; Das, Sujaan; Melatti, Carmen; Gow, Matthew; Wong, Eleanor H.; Heng, Joanne; Mueller, Sylke; Blackman, Michael J.; Meissner, Markus			Conditional U1 Gene Silencing in Toxoplasma gondii	PLOS ONE			English	Article							MALARIA PARASITES; SELECTABLE MARKER; CRE RECOMBINASE; PROTEIN; EXPRESSION; TRANSFORMATION; REPLACEMENTS; BIOGENESIS; DISSECTION; DYNAMIN	The functional characterisation of essential genes in apicomplexan parasites, such as Toxoplasma gondii or Plasmodium falciparum, relies on conditional mutagenesis systems. Here we present a novel strategy based on U1 snRNP-mediated gene silencing. U1 snRNP is critical in pre-mRNA splicing by defining the exon-intron boundaries. When a U1 recognition site is placed into the 3'-terminal exon or adjacent to the termination codon, pre-mRNA is cleaved at the 3'-end and degraded, leading to an efficient knockdown of the gene of interest (GOI). Here we describe a simple method that combines endogenous tagging with DiCre-mediated positioning of U1 recognition sites adjacent to the termination codon of the GOI which leads to a conditional knockdown of the GOI upon rapamycin-induction. Specific knockdown mutants of the reporter gene GFP and several endogenous genes of T. gondii including the clathrin heavy chain gene 1 (chc1), the vacuolar protein sorting gene 26 (vps26), and the dynamin-related protein C gene (drpC) were silenced using this approach and demonstrate the potential of this technology. We also discuss advantages and disadvantages of this method in comparison to other technologies in more detail.	[Pieperhoff, Manuela S.; Pall, Gurman S.; Jimenez-Ruiz, Elena; Melatti, Carmen; Gow, Matthew; Wong, Eleanor H.; Heng, Joanne; Meissner, Markus] Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Das, Sujaan; Blackman, Michael J.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Mueller, Sylke] Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Glasgow; MRC National Institute for Medical Research; University of Glasgow	Blackman, MJ (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, Mill Hill, London NW7 1AA, England.	mblackm@nimr.mrc.ac.uk; Markus.Meissner@glasgow.ac.uk		Meissner, Markus/0000-0002-5341-5969; Jimenez-Ruiz, Elena/0000-0003-2695-0947	ERC-Starting grant [ERC-2012-StG 309255-EndoTox]; Wellcome Trust [087582/Z/08/Z, 085349]; Medical Research Council [MC_U117532063] Funding Source: researchfish; The Francis Crick Institute [10043] Funding Source: researchfish; MRC [MC_U117532063] Funding Source: UKRI	ERC-Starting grant(European Research Council (ERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an ERC-Starting grant (ERC-2012-StG 309255-EndoTox) and the Wellcome Trust 087582/Z/08/Z) Senior Fellowship for MM. The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (085349).	Abad X, 2008, NUCLEIC ACIDS RES, V36, P2338, DOI 10.1093/nar/gkn068; ACHBAROU A, 1991, MOL BIOCHEM PARASIT, V47, P223, DOI 10.1016/0166-6851(91)90182-6; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Beckley SA, 2001, MOL CELL BIOL, V21, P2815, DOI 10.1128/MCB.21.8.2815-2825.2001; Breinich MS, 2009, CURR BIOL, V19, P277, DOI 10.1016/j.cub.2009.01.039; Chen AL, 2015, MBIO, V6, DOI 10.1128/mBio.02357-14; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Ding M, 2000, J CELL SCI, V113, P2409; Donald RGK, 1998, MOL BIOCHEM PARASIT, V91, P295, DOI 10.1016/S0166-6851(97)00210-7; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2013, TRAFFIC, V14, P895, DOI 10.1111/tra.12081; Goraczniak R, 2009, NAT BIOTECHNOL, V27, P257, DOI 10.1038/nbt.1525; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jean L, 2003, J BIOL CHEM, V278, P28572, DOI 10.1074/jbc.M303827200; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Messina M, 1996, MOL BIOCHEM PARASIT, V81, P247, DOI 10.1016/0166-6851(96)02711-9; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Pieperhoff MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077620; Pino P, 2013, MOL MICROBIOL, V88, P650, DOI 10.1111/mmi.12232; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rugarabamu G, 2015, MOL MICROBIOL, V97, P244, DOI 10.1111/mmi.13021; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; Starnes GL, 2006, J BIOL CHEM, V281, P30745, DOI 10.1074/jbc.M606523200; Suarez C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003811; Tawk L, 2013, J BIOL CHEM, V288, P33336, DOI 10.1074/jbc.M113.513234; Vagner S, 2000, RNA, V6, P178, DOI 10.1017/S1355838200991854; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	41	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130356	10.1371/journal.pone.0130356	http://dx.doi.org/10.1371/journal.pone.0130356			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090798	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000356835000106
J	Richard, M; Herfst, S; van den Brand, JMA; Lexmond, P; Bestebroer, TM; Rimmelzwaan, GF; Koopmans, M; Kuiken, T; Fouchier, RAM				Richard, Mathilde; Herfst, Sander; van den Brand, Judith M. A.; Lexmond, Pascal; Bestebroer, Theo M.; Rimmelzwaan, Guus F.; Koopmans, Marion; Kuiken, Thijs; Fouchier, Ron A. M.			Low Virulence and Lack of Airborne Transmission of the Dutch Highly Pathogenic Avian Influenza Virus H5N8 in Ferrets	PLOS ONE			English	Article							RECEPTOR-BINDING SPECIFICITY; CHINA; PROTEIN; MICE	Highly pathogenic avian influenza (HPAI) H5N8 viruses that emerged in poultry in East Asia spread to Europe and North America by late 2014. Here we show that the European HPAI H5N8 viruses differ from the Korean and Japanese HPAI H5N8 viruses by several amino acids and that a Dutch HPAI H5N8 virus had low virulence and was not transmitted via the airborne route in ferrets. The virus did not cross-react with sera raised against pre-pandemic H5 vaccine strains. This data is useful for public health risk assessments.	[Richard, Mathilde; Herfst, Sander; van den Brand, Judith M. A.; Lexmond, Pascal; Bestebroer, Theo M.; Rimmelzwaan, Guus F.; Koopmans, Marion; Kuiken, Thijs; Fouchier, Ron A. M.] Erasmus MC, Postgrad Sch Mol Med, Dept Virosci, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Richard, M (corresponding author), Erasmus MC, Postgrad Sch Mol Med, Dept Virosci, Rotterdam, Netherlands.	m.richard@erasmusmc.nl	Fouchier, Ron A/A-1911-2014; Koopmans, Marion/Y-9170-2019; Richard, Mathilde/F-5461-2017	Fouchier, Ron A/0000-0001-8095-2869; Koopmans, Marion/0000-0002-5204-2312; Richard, Mathilde/0000-0003-0240-9312; Herfst, Sander/0000-0001-9866-8903; Kuiken, Thijs/0000-0001-5501-9049	Dutch Ministry of Economic Affairs; NIAID/NIH [HHSN272201400008C]; Framework Seven Program ANTIGONE [278976]; Horizon Program COMPARE of the European Union [643476]; EU FP7 grant ADITEC [280873]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Framework Seven Program ANTIGONE; Horizon Program COMPARE of the European Union; EU FP7 grant ADITEC	This research was supported by The Dutch Ministry of Economic Affairs, NIAID/NIH contract HHSN272201400008C, Framework Seven Program ANTIGONE (278976), Horizon 2020 Program COMPARE (643476) of the European Union and the EU FP7 grant ADITEC (280873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fan SF, 2009, VIROLOGY, V384, P28, DOI 10.1016/j.virol.2008.11.044; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Gu M, 2014, VET MICROBIOL, V174, P309, DOI 10.1016/j.vetmic.2014.09.029; Guan Y, 2013, VIRUS RES, V178, P35, DOI 10.1016/j.virusres.2013.05.012; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Jeong J, 2014, VET MICROBIOL, V173, P249, DOI 10.1016/j.vetmic.2014.08.002; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kim YI, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.75; Koel BF, 2014, MBIO, V5, DOI 10.1128/mBio.01070-14; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Lan Y, 2010, ANTIVIR THER, V15, P853, DOI 10.3851/IMP1656; Lee YJ, 2014, EMERG INFECT DIS, V20, P1087, DOI 10.3201/eid2006.140233; Li QH, 2014, VET RES, V45, DOI 10.1186/s13567-014-0127-2; Liu CG, 2013, VET MICROBIOL, V167, P296, DOI 10.1016/j.vetmic.2013.09.004; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Prevention CfDCa, 2012, H5N1 GEN CHANG INV 2; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richard M, 2014, FUTURE VIROL, V9, P513, DOI 10.2217/fvl.14.30; Rijksoverheid TN, VOGELGRIEP TER AAR 2; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; Spesock A, 2011, J VIROL, V85, P7048, DOI 10.1128/JVI.00417-11; Verhagen JH, 2015, SCIENCE, V347, P616, DOI 10.1126/science.aaa6724; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Wong FYK, 2015, EMERG INFECT DIS, V21, P511, DOI 10.3201/eid2103.141488; World Health Organization, 2014, ANT GEN CHAR ZOON IN; World Health Organization, EV INFL A H5 HAEM WH; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zhao G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046183; Zhao KK, 2013, VET MICROBIOL, V163, P351, DOI 10.1016/j.vetmic.2012.12.025; Zhou B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067616	31	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129827	10.1371/journal.pone.0129827	http://dx.doi.org/10.1371/journal.pone.0129827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090682	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000063
J	Habib, MR; Mohamed, AH; Osman, GY; El-Din, ATS; Mossalem, HS; Delgado, N; Torres, G; Rolon-Martinez, S; Miller, MW; Croll, RP				Habib, Mohamed R.; Mohamed, Azza H.; Osman, Gamalat Y.; El-Din, Ahmed T. Sharaf; Mossalem, Hanan S.; Delgado, Nadia; Torres, Grace; Rolon-Martinez, Solymar; Miller, Mark W.; Croll, Roger P.			Histamine Immunoreactive Elements in the Central and Peripheral Nervous Systems of the Snail, Biomphalaria spp., Intermediate Host for Schistosoma mansoni	PLOS ONE			English	Article							HUMAN BLOOD FLUKE; CEPHALIC SENSORY ORGANS; SEROTONIN IMMUNOREACTIVITY; POSTEMBRYONIC DEVELOPMENT; HYMENOLEPIS-DIMINUTA; TYROSINE-HYDROXYLASE; LYMNAEA-STAGNALIS; HUMAN PARASITE; APLYSIA; NEURONS	Histamine appears to be an important transmitter throughout the Animal Kingdom. Gastropods, in particular, have been used in numerous studies establishing potential roles for this biogenic amine in the nervous system and showing its involvement in the generation of diverse behaviours. And yet, the distribution of histamine has only previously been described in a small number of molluscan species. The present study examined the localization of histamine-like immunoreactivity in the central and peripheral nervous systems of pulmonate snails of the genus Biomphalaria. This investigation demonstrates immunoreactive cells throughout the buccal, cerebral, pedal, left parietal and visceral ganglia, indicative of diverse regulatory functions in Biomphalaria. Immunoreactivity was also present in statocyst hair cells, supporting a role for histamine in graviception. In the periphery, dense innervation by immunoreactive fibers was observed in the anterior foot, perioral zone, and other regions of the body wall. This study thus shows that histamine is an abundant transmitter in these snails and its distribution suggest involvement in numerous neural circuits. In addition to providing novel subjects for comparative studies of histaminegic neurons in gastropods, Biomphalaria is also the major intermediate host for the digenetic trematode parasite, which causes human schistosomiasis. The study therefore provides a foundation for understanding potential roles for histamine in interactions between the snail hosts and their trematode parasites.	[Habib, Mohamed R.; El-Din, Ahmed T. Sharaf; Mossalem, Hanan S.] Theodor Bilharz Res Inst, Med Malacol Lab, Giza, Egypt; [Habib, Mohamed R.; Croll, Roger P.] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Mohamed, Azza H.; Osman, Gamalat Y.] Menoufia Univ, Fac Sci, Dept Zool, Shibin Al Kawm, Egypt; [Delgado, Nadia; Torres, Grace; Rolon-Martinez, Solymar; Miller, Mark W.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00936 USA; [Delgado, Nadia; Torres, Grace; Rolon-Martinez, Solymar; Miller, Mark W.] Univ Puerto Rico, Dept Anat & Neurobiol, San Juan, PR 00936 USA	Egyptian Knowledge Bank (EKB); Theodor Bilharz Research Institute (TBRI); Dalhousie University; Egyptian Knowledge Bank (EKB); Menofia University; University of Puerto Rico; University of Puerto Rico	Croll, RP (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada.	roger.croll@dal.ca	Mossalem, Hanan/A-7347-2019; Habib, Mohamed R/U-6585-2017; Croll, Roger P/E-2011-2011; Croll, Roger/K-9473-2019	Mossalem, Hanan/0000-0001-7030-0891; Habib, Mohamed R/0000-0003-0820-9290; Croll, Roger/0000-0002-9846-0923; Mohamed, Azza/0000-0002-0770-7194; Rolon-Martinez, Solymar/0000-0002-4653-9568	Natural Sciences and Research Council (Canada) [38863]; National Institutes of Health (USA) [RCMI MD007600]; NIGMS MBRS [GM-087200]; National Science Foundation (USA) [DBI-0115825, DBI-0932955, HRD-1137725]; Ministry of Higher Education and Scientific Research (Egypt): Partnership and Ownership Initiative [ParOwn 0911]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM087200, P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH048190] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	Natural Sciences and Research Council (Canada); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS MBRS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation (USA)(National Science Foundation (NSF)); Ministry of Higher Education and Scientific Research (Egypt): Partnership and Ownership Initiative(Ministry of Higher Education & Scientific Research (MHESR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Natural Sciences and Research Council (Canada): Discovery Grant 38863 to RPC; National Institutes of Health (USA): RCMI MD007600, NIGMS MBRS: GM-087200 to MWM; National Science Foundation (USA): DBI-0115825, DBI-0932955, and HRD-1137725 to MWM; Ministry of Higher Education and Scientific Research (Egypt): Partnership and Ownership Initiative (ParOwn 0911) to MRH. Neither sponsors nor funders had any role in the design or execution of this study.	BAUDOIN M, 1975, EVOLUTION, V29, P335, DOI [10.2307/2407221, 10.1111/j.1558-5646.1975.tb00213.x]; Bayne CJ, 2009, MOL BIOCHEM PARASIT, V165, P8, DOI 10.1016/j.molbiopara.2009.01.005; BENJAMIN PR, 1981, COMP BIOCHEM PHYS A, V70, P293, DOI 10.1016/0300-9629(81)90182-1; BERRY MS, 1973, NATURE-NEW BIOL, V242, P250, DOI 10.1038/newbio242250a0; BERRY MS, 1975, J PHYSIOL-LONDON, V251, pP2; Boyle JP, 2005, J PARASITOL, V91, P542, DOI 10.1645/GE-432R; Boyle JP, 2003, J COMP PHYSIOL A, V189, P631, DOI 10.1007/s00359-003-0429-8; Boyle JP, 2002, COMP BIOCHEM PHYS A, V132, P411, DOI 10.1016/S1095-6433(02)00091-0; Boyle JP, 2000, EXP PARASITOL, V94, P217, DOI 10.1006/expr.2000.4500; Braubach O.R., 2004, J GRAVITATIONAL PHYS, V11, P57; Brown DS, 1980, FRESHWATER SNAILS OF; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; BUCKETT KJ, 1990, J NEUROPHYSIOL, V63, P1426, DOI 10.1152/jn.1990.63.6.1426; BUCKETT KJ, 1990, J NEUROPHYSIOL, V63, P1436, DOI 10.1152/jn.1990.63.6.1436; Bulloch A.G.M., 1995, Experientia Supplementum (Basel), V72, P89; CARPENTER DO, 1975, NATURE, V254, P343, DOI 10.1038/254343a0; CATTO BA, 1980, AM J TROP MED HYG, V29, P886, DOI 10.4269/ajtmh.1980.29.886; CHIANG PK, 1974, J PARASITOL, V60, P264, DOI 10.2307/3278462; CHIEL HJ, 1990, TRENDS NEUROSCI, V13, P223, DOI 10.1016/0166-2236(90)90164-6; CROLL RP, 1988, BRAIN RES, V460, P29, DOI 10.1016/0006-8993(88)90427-1; Croll RP, 2003, CELL TISSUE RES, V314, P437, DOI 10.1007/s00441-003-0778-1; Croll RP, 1999, J COMP NEUROL, V404, P297, DOI 10.1002/(SICI)1096-9861(19990215)404:3<297::AID-CNE2>3.0.CO;2-I; CROLL RP, 1989, J COMP NEUROL, V280, P122, DOI 10.1002/cne.902800109; Croll RP, 2001, J COMP NEUROL, V441, P91, DOI 10.1002/cne.1399; Croll RP, 2002, GRAV SPACE BIOL BULL, V16, P57; CULVER T, 1993, ACTA BIOL HUNG, V44, P103; de Jong-Brink M, 2001, PARASITOLOGY, V123, pS129, DOI 10.1017/S0031182001008149; Delgado N, 2012, J COMP NEUROL, V520, P3236, DOI 10.1002/cne.23095; Diaz-Rios M, 2002, J COMP NEUROL, V445, P29, DOI 10.1002/cne.10152; El-Shehabi F, 2010, INT J PARASITOL, V40, P1395, DOI 10.1016/j.ijpara.2010.04.006; ELSTE A, 1990, J NEUROPHYSIOL, V64, P736, DOI 10.1152/jn.1990.64.3.736; ERCOLI N, 1985, EXP PARASITOL, V59, P204, DOI 10.1016/0014-4894(85)90074-8; Eriksson KS, 1996, J COMP NEUROL, V373, P220; Faccioni-Heuser MC, 2004, BRAZ J MED BIOL RES, V37, P1043, DOI 10.1590/S0100-879X2004000700014; GERSCHENFELD HM, 1973, PHYSIOL REV, V53, P1, DOI 10.1152/physrev.1973.53.1.1; GOTOH H, 1982, BRAIN RES, V242, P87, DOI 10.1016/0006-8993(82)90498-X; GOTOW T, 1980, BRAIN RES, V196, P151, DOI 10.1016/0006-8993(80)90723-4; Hamdan FF, 1998, J NEUROCHEM, V71, P1369; Hamdan FF, 2002, MOL BIOCHEM PARASIT, V119, P75, DOI 10.1016/S0166-6851(01)00400-5; Hamdan FF, 1999, J BIOL CHEM, V274, P21746, DOI 10.1074/jbc.274.31.21746; HARRIS SJ, 1995, EXP PHYSIOL, V80, P37, DOI 10.1113/expphysiol.1995.sp003833; HARRIS WG, 1973, IMMUNOLOGY, V24, P567; Hegedus E, 2004, J COMP NEUROL, V475, P391, DOI 10.1002/cne.20171; Hotez P.J., 2008, EMERG INFECT DIS; KARHUNEN T, 1993, J COMP NEUROL, V334, P477, DOI 10.1002/cne.903340311; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Larsen MB, 2011, MOL BIOCHEM PARASIT, V177, P35, DOI 10.1016/j.molbiopara.2011.01.006; LONGLEY RD, 1986, J NEUROBIOL, V17, P339, DOI 10.1002/neu.480170408; LUKOWIAK K, 1993, ACTA BIOL HUNG, V44, P115; Malek EA, 1985, SNAIL HOSTS OF SCHIS; Manger P, 1996, COMP BIOCHEM PHYS A, V114, P227, DOI 10.1016/0300-9629(95)02131-0; Maule AG, 2006, PARASITIC FLATWORMS: MOLECULAR BIOLOGY, BIOCHEMISTRY, IMMUNOLOGY AND PHYSIOLOGY, P369, DOI 10.1079/9780851990279.0369; MCCAMAN RE, 1985, J NEUROPHYSIOL, V53, P1016, DOI 10.1152/jn.1985.53.4.1016; MELLIN TN, 1983, AM J TROP MED HYG, V32, P83, DOI 10.4269/ajtmh.1983.32.83; METTRICK DF, 1963, J PARASITOL, V49, P653, DOI 10.2307/3275779; Nassel DR, 1999, MICROSC RES TECHNIQ, V44, P121, DOI 10.1002/(SICI)1097-0029(19990115/01)44:2/3<121::AID-JEMT6>3.0.CO;2-F; Newcomb JM, 2006, J COMP NEUROL, V499, P485, DOI 10.1002/cne.21111; Ohsuga K, 2000, CELL TISSUE RES, V300, P165, DOI 10.1007/s004410000186; ONO JK, 1980, NEUROSCIENCE, V5, P835, DOI 10.1016/0306-4522(80)90152-9; PAN CT, 1965, AM J TROP MED HYG, V14, P931, DOI 10.4269/ajtmh.1965.14.931; PANULA P, 1988, J HISTOCHEM CYTOCHEM, V36, P259, DOI 10.1177/36.3.3343510; Rao KVN, 2002, J BIOL CHEM, V277, P31207, DOI 10.1074/jbc.M204114200; Ribeiro P, 2005, PARASITOLOGY, V131, pS19; Ribeiro P, 2010, CAN J ZOOL, V88, P1, DOI 10.1139/Z09-126; Rollinson D, 2001, FLUKES AND SNAILS RE; SATTERLIE RA, 1995, J EXP BIOL, V198, P895; SCHOENBE.MJ, 1968, P SOC EXP BIOL MED, V127, P601, DOI 10.3181/00379727-127-32752; Schwartz J-C, 1986, COMPREHENSIVE PHYSIO; SOINILA S, 1990, J COMP NEUROL, V298, P83, DOI 10.1002/cne.902980107; SROZSA K, 1979, AM ZOOL, V19, P117; STEIN C, 1983, COMP BIOCHEM PHYS C, V74, P79, DOI 10.1016/0742-8413(83)90153-6; SUKHDEO MVK, 1984, J PARASITOL, V70, P682, DOI 10.2307/3281750; SYED NI, 1993, J EXP BIOL, V174, P19; THOMPSON SN, 1986, Z PARASITENKD, V72, P417, DOI 10.1007/BF00928752; THORNHILL JA, 1986, PARASITOLOGY, V93, P443, DOI 10.1017/S0031182000081166; Toledo R, 2011, BIOMPHALARIA SNAILS AND LARVAL TREMATODES, P1, DOI 10.1007/978-1-4419-7028-2; TOMOSKY TK, 1974, J PHARMACOL EXP THER, V190, P260; Tunholi-Alves VM, 2011, J INVERTEBR PATHOL, V108, P220, DOI 10.1016/j.jip.2011.08.009; Vallejo D, 2014, J COMP NEUROL, V522, P2532, DOI 10.1002/cne.23548; Weinreich D, 1977, BIOCH CHARACTERISED, P153; Weinreich D, 1976, NEUROBIOLOGY INVERTE, P191; WIKGREN M, 1990, CELL TISSUE RES, V260, P479, DOI 10.1007/BF00297227; World Health Organization, 2011, REPORT NO 115; Wyeth RC, 2011, J COMP NEUROL, V519, P1894, DOI 10.1002/cne.22607; Wyeth RC, 2009, J NEUROSCI METH, V176, P121, DOI 10.1016/j.jneumeth.2008.08.028; YONGE KA, 1992, CAN J ZOOL, V70, P43, DOI 10.1139/z92-007	86	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129800	10.1371/journal.pone.0129800	http://dx.doi.org/10.1371/journal.pone.0129800			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086611	gold, Green Submitted, Green Published			2022-12-26	WOS:000356567500063
J	Hallengren, E; Almgren, P; Engstrom, G; Persson, M; Melander, O				Hallengren, Erik; Almgren, Peter; Engstrom, Gunnar; Persson, Margaretha; Melander, Olle			Analysis of Low Frequency Protein Truncating Stop-Codon Variants and Fasting Concentration of Growth Hormone	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OF-FUNCTION MUTATIONS; GENETIC-VARIATION; RARE; RISK; HERITABILITY; MORTALITY; INSULIN; GLUCOSE; MYO1A	Background The genetic background of Growth Hormone (GH) secretion is not well understood. Mutations giving rise to a stop codon have a high likelihood of affecting protein function. Objectives To analyze likely functional stop codon mutations that are associated with fasting plasma concentration of Growth Hormone. Methods We analyzed stop codon mutations in 5451 individuals in the Malmo Diet and Cancer study by genotyping the Illumina Exome Chip. To enrich for stop codon mutations with likely functional effects on protein function, we focused on those disrupting >80% of the predicted amino acid sequence, which were carried by >= 10 individuals. Such mutations were related to GH concentration, measured with a high sensitivity assay (hs-GH) and, if nominally significant, to GH related phenotypes, using linear regression analysis. Results Two stop codon mutations were associated with the fasting concentration of hs-GH. rs121909305 (NP_005370.1:p.R93*) [Minor Allele Frequency (MAF) = 0.8%] in the Myosin 1A gene (MYO1A) was associated with a 0.36 (95% CI, 0.04 to 0.54; p=0.02) increment of the standardized value of the natural logarithm of hs-GH per 1 minor allele and rs35699176 (NP_067040.1:p.Q100*) in the Zink Finger protein 77 gene (ZNF77) (MAF = 4.8%) was associated with a 0.12 (95% CI, 0.02 to 0.22; p = 0.02) increase of hs-GH. The mutated high hs-GH associated allele of MYO1A was related to lower BMI (beta-coefficient, -0.22; p = 0.05), waist (beta-coefficient, -0.22; p = 0.04), body fat percentage (beta-coefficient, -0.23; p = 0.03) and with higher HDL (beta-coefficient, 0.23; p = 0.04). The ZNF77 stop codon was associated with height (beta-coefficient, 0.11; p = 0.02) but not with cardiometabolic risk factors. Conclusion We here suggest that a stop codon of MYO1A, disrupting 91% of the predicted amino acid sequence, is associated with higher hs-GH and GH-related traits suggesting that MYO1A is involved in GH metabolism and possibly body fat distribution. However, our results are preliminary and need replication in independent populations.	[Hallengren, Erik; Almgren, Peter; Engstrom, Gunnar; Persson, Margaretha; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Hallengren, Erik; Persson, Margaretha; Melander, Olle] Skane Univ Hosp, Dept Internal Med, SE-20502 Malmo, Sweden	Lund University; Lund University; Skane University Hospital	Hallengren, E (corresponding author), Skane Univ Hosp, CRC, Dept Clin Sci, Jan Waldenstroms Gata 35,Bldg 91,Level 12, SE-20502 Malmo, Sweden.	erik.hallengren@med.lu.se		Persson, Margaretha/0000-0001-8188-5792; Melander, Olle/0000-0002-2581-484X	European Research Council [StG-282255]; Swedish Heart and Lung Foundation; Swedish Research Council; Novo Nordisk Foundation; Skane University Hospital; Medical Faculty, Lund University; National Health Services; Albert Pahlsson Research Foundation; Region Skane; King Gustaf V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation	European Research Council(European Research Council (ERC)European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Skane University Hospital; Medical Faculty, Lund University; National Health Services; Albert Pahlsson Research Foundation; Region Skane; King Gustaf V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation	Funding was obtained from the European Research Council (StG-282255) http://erc.europa.eu/, the Swedish Heart and Lung Foundation www.hjart-lungfonden.se/, Swedish Research Council http://www.vr.se, the Novo Nordisk Foundation http://www.novonordiskfonden.dk/en; the Skane University Hospital donation funds www.skane.se/sv/Webbplatser/Skanes-universitetssjukhus/; the Medical Faculty, Lund University http://www.med.lu.se; the governmental funding of clinical research within the National Health Services, the Albert Pahlsson Research Foundation http://pahlssonsstiftelse.se/, Region Skane www.skane.se, the King Gustaf V and Queen Victoria Foundation http://www.kungahuset.se/monarkinhovstaterna/kungligastiftelser/forskning/stiftelserforskning.4.292a62ce13848168ac53ba4.html; and the Marianne and Marcus Wallenberg Foundation https://www.wallenberg.com/mmw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bartke A, 2003, NEUROENDOCRINOLOGY, V78, P210, DOI 10.1159/000073704; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Bjorkegren JLM, 2015, J AM COLL CARDIOL, V65, P830, DOI 10.1016/j.jacc.2014.12.033; Bozzola M, 2003, EUR J ENDOCRINOL, V149, P397, DOI 10.1530/eje.0.1490397; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Donaudy F, 2003, AM J HUM GENET, V72, P1571, DOI 10.1086/375654; Eisenberger T, 2014, HUM MUTAT, V35, P565, DOI 10.1002/humu.22532; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Feng JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065033; Glad CAM, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0723; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Hallengren E, 2014, J AM COLL CARDIOL, V64, P1452, DOI 10.1016/j.jacc.2014.03.063; Hindmarsh PC, 1997, J CLIN ENDOCR METAB, V82, P2172, DOI 10.1210/jc.82.7.2172; Hindorff LA MJ, 2015, CATALOG PUBLISHED GE; HUEBNER K, 1993, HUM GENET, V91, P217, DOI 10.1007/BF00218259; Jaffe CA, 1998, J CLIN INVEST, V102, P153, DOI 10.1172/JCI2908; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lettre G, 2014, J MED GENET, V51, P705, DOI 10.1136/jmedgenet-2014-102437; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Maison P, 1998, BRIT MED J, V316, P1132, DOI 10.1136/bmj.316.7138.1132; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Miller KK, 2005, J CLIN ENDOCR METAB, V90, P768, DOI 10.1210/jc.2004-0894; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Moutsianas L, 2014, BRIEF FUNCT GENOMICS, V13, P362, DOI 10.1093/bfgp/elu012; Mulhall C, 2005, CANCER EPIDEM BIOMAR, V14, P2648, DOI 10.1158/1055-9965.EPI-04-0374; Nievergelt CM, 2014, GENE, V540, P104, DOI 10.1016/j.gene.2014.01.069; Pagani S, 2005, EUR J ENDOCRINOL, V152, P207, DOI 10.1530/eje.1.01827; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosvall M, 2005, ATHEROSCLEROSIS, V179, P325, DOI 10.1016/j.atherosclerosis.2004.10.015; SAINI S, 1991, CLIN ENDOCRINOL, V34, P455, DOI 10.1111/j.1365-2265.1991.tb00325.x; Surya Sowmya, 2006, Pituitary, V9, P121, DOI 10.1007/s11102-006-9079-5; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520	42	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128348	10.1371/journal.pone.0128348	http://dx.doi.org/10.1371/journal.pone.0128348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086970	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500016
J	Labrie, M; Lalonde, S; Najyb, O; Thiery, M; Daneault, C; Des Rosiers, C; Rassart, E; Mounier, C				Labrie, Marilyne; Lalonde, Simon; Najyb, Ouafa; Thiery, Maxime; Daneault, Caroline; Des Rosiers, Chrisitne; Rassart, Eric; Mounier, Catherine			Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPAR gamma and Fatty Acid Uptake	PLOS ONE			English	Article							GENE-EXPRESSION; RECEPTOR-ALPHA; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; BETA-OXIDATION; PROTEIN-KINASE; CIDE PROTEINS; OXIDIZED LDL; MOUSE MODEL; LIVER	Transgenic mice (Tg) overexpressing human apolipoprotein D (H-apoD) in the brain are resistant to neurodegeneration. Despite the use of a neuron-specific promoter to generate the Tg mice, they expressed significant levels of H-apoD in both plasma and liver and they slowly develop hepatic steatosis and insulin resistance. We show here that hepatic PPAR. expression in Tg mice is increased by 2-fold compared to wild type (WT) mice. Consequently, PPAR. target genes Plin2 and Cide A/C are overexpressed, leading to increased lipid droplets formation. Expression of the fatty acid transporter CD36, another PPARgamma target, is also increased in Tg mice associated with elevated fatty acid uptake as measured in primary hepatocytes. Elevated expression of AMPK in the liver of Tg leads to phosphorylation of acetyl CoA carboxylase, indicating a decreased activity of the enzyme. Fatty acid synthase expression is also induced but the hepatic lipogenesis measured in vivo is not significantly different between WT and Tg mice. In addition, expression of carnitine palmitoyl transferase 1, the rate-limiting enzyme of beta-oxidation, is slightly upregulated. Finally, we show that overexpressing H-apoD in HepG2 cells in presence of arachidonic acid (AA), the main apoD ligand, increases the transcriptional activity of PPAR gamma. Supporting the role of apoD in AA transport, we observed enrichment in hepatic AA and a decrease in plasmatic AA concentration. Taken together, our results demonstrate that the hepatic steatosis observed in apoD Tg mice is a consequence of increased PPAR. transcriptional activity by AA leading to increased fatty acid uptake by the liver.	[Labrie, Marilyne; Lalonde, Simon; Najyb, Ouafa; Thiery, Maxime; Rassart, Eric; Mounier, Catherine] Univ Quebec, Ctr Rech BioMed, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Des Rosiers, Chrisitne] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Daneault, Caroline; Des Rosiers, Chrisitne] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada	University of Quebec; University of Quebec Montreal; Universite de Montreal; Universite de Montreal	Mounier, C (corresponding author), Univ Quebec, Ctr Rech BioMed, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada.	mounier.catherine@uqam.ca		Mounier, Catherine/0000-0003-3608-4229; Labrie, Marilyne/0000-0003-3957-5533	Fonds de recherche du Quebec-Nature et Technologie (FRQNT); Natural Sciences and Engineering Research Council of Canada (NSERC)	Fonds de recherche du Quebec-Nature et Technologie (FRQNT); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	SL is a MSc student supported by the Fonds de recherche du Quebec-Nature et Technologie (FRQNT) and by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Ameer F, 2014, METABOLISM; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CABRAL JHM, 1995, FEBS LETT, V366, P53, DOI 10.1016/0014-5793(95)00484-Q; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Cofer S, 1996, GENE, V171, P261, DOI 10.1016/0378-1119(96)00099-6; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DILLEY WG, 1990, BREAST CANCER RES TR, V16, P253, DOI 10.1007/BF01806333; Do Carmo S, 2008, J NEUROSCI, V28, P10330, DOI 10.1523/JNEUROSCI.2644-08.2008; Do Carmo S, 2009, AM J PHYSIOL-ENDOC M, V296, pE802, DOI 10.1152/ajpendo.90725.2008; DRAYNA D, 1986, J BIOL CHEM, V261, P6535; DRAYNA DT, 1987, DNA-J MOLEC CELL BIO, V6, P199, DOI 10.1089/dna.1987.6.199; Feng JW, 2000, J LIPID RES, V41, P688; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Gelinas R, 2011, AM J PHYSIOL-HEART C, V301, pH813, DOI 10.1152/ajpheart.01275.2010; Glass CK, 2000, GENE DEV, V14, P121; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Gormaz JG, 2010, PROG LIPID RES, V49, P407, DOI 10.1016/j.plipres.2010.05.003; Ha J, 1996, P NATL ACAD SCI USA, V93, P11466, DOI 10.1073/pnas.93.21.11466; Hebbachi AM, 2008, J BIOL CHEM, V283, P4866, DOI 10.1074/jbc.M709471200; Jinno Y, 2010, PROSTAG LEUKOTR ESS, V83, P75, DOI 10.1016/j.plefa.2010.05.002; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; LEPAGE G, 1986, J LIPID RES, V27, P114; Li HX, 2010, J ZHEJIANG UNIV-SC B, V11, P784, DOI 10.1631/jzus.B0900401; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Liu ZT, 2001, FASEB J, V15, P1329, DOI 10.1096/fj.00-0530fje; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MCCONATH.WJ, 1973, FEBS LETT, V37, P178, DOI 10.1016/0014-5793(73)80453-3; MCCONATHY WJ, 1976, BIOCHEMISTRY-US, V15, P515, DOI 10.1021/bi00648a010; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Menard SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE1049, DOI 10.1152/ajpendo.00560.2009; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Notarnicola M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-10; Patel RC, 1997, PROTEIN ENG, V10, P621, DOI 10.1093/protein/10.6.621; Peitsch M C, 1990, New Biol, V2, P197; Peng DC, 2008, J PHARMACOL EXP THER, V327, P332, DOI 10.1124/jpet.108.142687; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rodrigue-Way A, 2014, FASEB J, V28, P1910, DOI 10.1096/fj.13-240168; Rogue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018816; Rogue A, 2010, PPAR RES, V2010, DOI 10.1155/2010/325183; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; SEGUIN D, 1995, MOL BRAIN RES, V30, P242, DOI 10.1016/0169-328X(95)00008-G; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3086, DOI 10.1073/pnas.83.10.3086; Suresh S, 1998, J NEUROCHEM, V70, P242; Targett-Adams P, 2005, BBA-GENE STRUCT EXPR, V1728, P95, DOI 10.1016/j.bbaexp.2005.01.017; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Terrisse L, 2001, LIFE SCI, V70, P629, DOI 10.1016/S0024-3205(01)01439-4; Thomas EA, 2003, PROSTAG LEUKOTR ESS, V69, P421, DOI 10.1016/j.plefa.2003.08.014; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Truong TQ, 2000, BBA-MOL CELL BIOL L, V1484, P307, DOI 10.1016/S1388-1981(00)00023-8; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Zeng CH, 1996, P NATL ACAD SCI USA, V93, P6626, DOI 10.1073/pnas.93.13.6626; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	77	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130230	10.1371/journal.pone.0130230	http://dx.doi.org/10.1371/journal.pone.0130230			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083030	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400131
J	Lean, QY; Eri, RD; Fitton, JH; Patel, RP; Gueven, N				Lean, Qi Ying; Eri, Rajaraman D.; Fitton, J. Helen; Patel, Rahul P.; Gueven, Nuri			Fucoidan Extracts Ameliorate Acute Colitis	PLOS ONE			English	Article							MOLECULAR-WEIGHT FUCOIDAN; SODIUM-INDUCED COLITIS; ULCERATIVE-COLITIS; IN-VITRO; SULFATED POLYSACCHARIDE; BROWN-ALGAE; T-CELLS; INFLAMMATION; INHIBITION; MODEL	Inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease, are an important cause of morbidity and impact significantly on quality of life. Overall, current treatments do not sustain a long-term clinical remission and are associated with adverse effects, which highlight the need for new treatment options. Fucoidans are complex sulphated, fucose-rich polysaccharides, found in edible brown algae and are described as having multiple bioactivities including potent anti-inflammatory effects. Therefore, the therapeutic potential of two different fucoidan preparations, fucoidan-polyphenol complex (Maritech Synergy) and depyrogenated fucoidan (DPF) was evaluated in the dextran sulphate sodium (DSS) mouse model of acute colitis. Mice were treated once daily over 7 days with fucoidans via oral (Synergy or DPF) or intraperitoneal administration (DPF). Signs and severity of colitis were monitored daily before colons and spleens were collected for macroscopic evaluation, cytokine measurements and histology. Orally administered Synergy and DPF, but not intraperitoneal DPF treatment, significantly ameliorated symptoms of colitis based on retention of body weight, as well as reduced diarrhoea and faecal blood loss, compared to the untreated colitis group. Colon and spleen weight in mice treated with oral fucoidan was also significantly lower, indicating reduced inflammation and oedema. Histological examination of untreated colitis mice confirmed a massive loss of crypt architecture and goblet cells, infiltration of immune cells and oedema, while all aspects of this pathology were alleviated by oral fucoidan. Importantly, in this model, the macroscopic changes induced by oral fucoidan correlated significantly with substantially decreased production of at least 15 proinflammatory cytokines by the colon tissue. Overall, oral fucoidan preparations significantly reduce the inflammatory pathology associated with DSS-induced colitis and could therefore represent a novel nutraceutical option for the management of IBD.	[Lean, Qi Ying; Patel, Rahul P.; Gueven, Nuri] Univ Tasmania, Sch Med, Pharm, Hobart, Tas, Australia; [Lean, Qi Ying] Univ Teknol MARA, Puncak Alam, Selangor, Malaysia; [Eri, Rajaraman D.] Univ Tasmania, Sch Hlth Sci, Launceston, Tas 7250, Australia; [Fitton, J. Helen] Marinova Pty Ltd, Cambridge, Tas, Australia	University of Tasmania; Universiti Teknologi MARA; University of Tasmania	Gueven, N (corresponding author), Univ Tasmania, Sch Med, Pharm, Hobart, Tas, Australia.	nguven@utas.edu.au	Eri, Rajaraman/AAM-3214-2020; Eri, Raj/AAD-1185-2020; Lean, Qi Ying/G-1680-2019	Eri, Raj/0000-0003-1688-8043; Lean, Qi Ying/0000-0003-0331-8607; Fitton, J Helen/0000-0002-1402-0809; Patel, Rahul/0000-0001-9344-1013; Guven, Nuri/0000-0003-3782-767X	Marinova Pty, Ltd.	Marinova Pty, Ltd.	Marinova Pty, Ltd., provided financial support in the form of salaries for co-author J. Helen Fitton and a research grant for consumables, but did not have any input into the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akobeng AA, 2014, INFLAMM BOWEL DIS, V20, P2132, DOI 10.1097/MIB.0000000000000218; Ale MT, 2011, MAR DRUGS, V9, P2106, DOI 10.3390/md9102106; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Ben-Horin S, 2011, ALIMENT PHARM THER, V33, P987, DOI 10.1111/j.1365-2036.2011.04612.x; Cai Jingmei, 2014, Lab Anim Res, V30, P28, DOI 10.5625/lar.2014.30.1.28; Carvalho ACS, 2014, PANCREAS, V43, P82, DOI 10.1097/MPA.0b013e3182a63b9d; Chassaing B., 2014, CURR PROTOC IMMUNOL, V104; Choi JI, 2010, CHEM-BIOL INTERACT, V183, P249, DOI 10.1016/j.cbi.2009.09.015; Chung HJ, 2010, PHYTOTHER RES, V24, P1078, DOI 10.1002/ptr.3138; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Cui YQ, 2012, CNS NEUROSCI THER, V18, P827, DOI 10.1111/j.1755-5949.2012.00372.x; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; Eri R, 2012, METHODS MOL BIOL, V844, P261, DOI 10.1007/978-1-61779-527-5_19; Ferrante M, 2008, J CROHNS COLITIS, V2, P219, DOI 10.1016/j.crohns.2008.03.004; Fitton JH, 2011, MAR DRUGS, V9, P1731, DOI 10.3390/md9101731; Heinsbroek SEM, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001069; Heitz FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045182; Hlawaty H, 2011, BIOCHEM PHARMACOL, V81, P233, DOI 10.1016/j.bcp.2010.09.021; Ishiguro Y, 1999, J GASTROENTEROL, V34, P66, DOI 10.1007/s005350050218; Jin JO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099396; Juffrie M, 2011, INDONES J BIOTECHNOL, V11, P908; Kim KJ, 2012, FITOTERAPIA, V83, P1628, DOI 10.1016/j.fitote.2012.09.014; Kim KJ, 2010, TOXICOLOGY, V267, P154, DOI 10.1016/j.tox.2009.11.007; Koetzner L, 2010, DIGEST DIS SCI, V55, P1278, DOI 10.1007/s10620-009-0848-7; Kuznetsova TA, 2014, MAR DRUGS, V12, P886, DOI 10.3390/md12020886; Lee SH, 2013, CARBOHYD POLYM, V92, P84, DOI 10.1016/j.carbpol.2012.09.066; Lee SH, 2012, CARBOHYD POLYM, V89, P599, DOI 10.1016/j.carbpol.2012.03.056; Li CM, 2011, FOOD CHEM TOXICOL, V49, P2090, DOI 10.1016/j.fct.2011.05.022; Low D, 2013, DRUG DES DEV THER, V7, P1341, DOI 10.2147/DDDT.S40107; Lutay N, 2011, APPL BIOCHEM BIOTECH, V164, P1, DOI 10.1007/s12010-010-9109-7; Maillard M. H., 2010, INFLAMM BOWEL DIS, P119; Matsumoto S, 2004, CLIN EXP IMMUNOL, V136, P432, DOI 10.1111/j.1365-2249.2004.02462.x; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; Mizuno M, 2009, BIOSCI BIOTECH BIOCH, V73, P2324, DOI 10.1271/bbb.90326; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Park KT, 2011, INFLAMM BOWEL DIS, V17, P1603, DOI 10.1002/ibd.21488; Perse M., 2012, BIOMED RES INT, V2012; Peyrin-Biroulet L, 2008, CLIN GASTROENTEROL H, V6, P644, DOI 10.1016/j.cgh.2008.03.014; Rose WA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-41; Senni K, 2006, ARCH BIOCHEM BIOPHYS, V445, P56, DOI 10.1016/j.abb.2005.11.001; Shintani N, 1997, SCAND J IMMUNOL, V46, P581, DOI 10.1046/j.1365-3083.1997.d01-169.x; Tanoue T, 2008, BIOCHEM BIOPH RES CO, V374, P565, DOI 10.1016/j.bbrc.2008.07.063; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Zhang XW, 2001, SCAND J GASTROENTERO, V36, P270, DOI 10.1080/003655201750074555; Zheng B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095441; Zhu W, 2014, IMMUNOL INVEST, V43, P638, DOI 10.3109/08820139.2014.909456	53	60	63	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128453	10.1371/journal.pone.0128453	http://dx.doi.org/10.1371/journal.pone.0128453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083103	gold, Green Published			2022-12-26	WOS:000356567400051
J	Liu, QQ; Li, WZ; Du, XM; Li, WJ; Zhong, TQ; Tang, Y; Feng, YL; Tao, CM; Xie, Y				Liu, Qianqian; Li, Wenzhang; Du, Xinmiao; Li, Weijing; Zhong, Taiqing; Tang, Yin; Feng, Yulin; Tao, Chuanmin; Xie, Yi			Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; GRAM-NEGATIVE BACILLI; ANTIBIOTIC-RESISTANCE; CLINICAL-FEATURES; IMPACT; OUTCOMES; MORTALITY; THERAPY; EPIDEMIOLOGY; EMERGENCE	Background The increasing prevalence and mortality of multidrug-resistant (MDR) Acinetobacter baumannii complex-associated infections, especially bacteremia, in health care settings poses a great threat to public health. We proceeded to investigate the risk and prognostic factors for MDR A. baumannii complex bacteremia in mainland China. Methods This retrospective study was conducted at West China Hospital from January 2009 to December 2013. Using a computer-assisted microbiology laboratory database, patients with MDR A. baumannii complex bacteremia were included as the case group, while those infected with non-MDR A. baumannii complex were selected as the control group. The clinical data were collected and analyzed. Results There were 241 non-duplicated A. baumannii complex blood isolates identified in our research, with the overall rate of multidrug resistance reaching 75.52% over the past five years. Using multivariate logistic analysis, being in the intensive care unit (ICU) (adjusted odds ratio [aOR], 5.84; 95% confidence interval [CI], 1.67-20.44), increased Pittsburgh bacteremia score (aOR, 6.55; 95% CI, 1.27-33.70) and use of carbapenem (aOR, 8.90; 95% CI, 1.71-46.30) were independent risk factors for MDR acquisition among patients with A. baumannii complex bacteremia. Older age (aOR, 1.02; 95% CI, 1.00-1.04), being post-transplantation (aOR, 5.21; 95% CI, 1.13-24.04), having a higher Pittsburgh bacteremia score (aOR, 2.19; 95% CI, 1.08-4.47) and having a lower level of albumin (aOR, 0.93; 95% CI, 0.88-0.99) were identified as independent risk factors for 30-day mortality in patients with MDR A. baumannii complex bacteremia. Conclusion In conclusion, our research revealed the risk factors associated with acquisition of and mortality from MDR A. baumannii complex bacteremia, which may be used to prioritize infection control practices and prognostic evaluations.	[Liu, Qianqian; Li, Weijing; Zhong, Taiqing; Tao, Chuanmin; Xie, Yi] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan, Peoples R China; [Li, Wenzhang] Chengdu Med Coll, Affiliated Hosp 1, Dept Cardiol, Chengdu, Sichuan, Peoples R China; [Du, Xinmiao; Feng, Yulin] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610064, Sichuan, Peoples R China; [Tang, Yin] Tufts Univ, Sch Dent Med, Div Oral Biol, Boston, MA 02111 USA	Sichuan University; Chengdu Medical College; Sichuan University; Tufts University	Xie, Y (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan, Peoples R China.	chuan112500@126.com	tang, yin/AAR-2123-2021; liu, qian/HDM-2936-2022; tang, yin/GXZ-6989-2022		National Natural Science Foundation of China [81000712]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81000712, URL:http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list).	ANDERSON CF, 1984, MAYO CLIN PROC, V59, P477, DOI 10.1016/S0025-6196(12)60437-6; Anunnatsiri S, 2011, SE ASIAN J TROP MED, V42, P693; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Blot S, 2002, CLIN INFECT DIS, V34, P1600, DOI 10.1086/340616; Chen IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065621; Chow JW, 1999, INT J ANTIMICROB AG, V11, P7, DOI 10.1016/S0924-8579(98)00060-0; CHOW JW, 1991, ANN INTERN MED, V115, P585, DOI 10.7326/0003-4819-115-8-585; Chuang YC, 2011, CLIN INFECT DIS, V52, P352, DOI 10.1093/cid/ciq154; Clinical and Laboratory Standards Institute (CLSI), 2016, M100 PERFORMANCE STA, V26th; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; FLECK A, 1989, P NUTR SOC, V48, P347, DOI 10.1079/PNS19890050; Fukuta Y, 2013, AM J INFECT CONTROL, V41, P1249, DOI 10.1016/j.ajic.2013.04.003; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gbaguidi-Haore H, 2013, J ANTIMICROB CHEMOTH, V68, P461, DOI 10.1093/jac/dks406; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; HILF M, 1989, AM J MED, V87, P540, DOI 10.1016/S0002-9343(89)80611-4; Ho PL, 2010, J HOSP INFECT, V74, P358, DOI 10.1016/j.jhin.2009.10.015; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jacquier H, 2012, MICROB DRUG RESIST, V18, P396, DOI 10.1089/mdr.2011.0195; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; Keen EF, 2010, INFECT CONT HOSP EP, V31, P728, DOI 10.1086/653617; Kim SB, 2014, SCAND J INFECT DIS, V46, P81, DOI 10.3109/00365548.2013.857042; Kim Uh Jin, 2014, Chonnam Med J, V50, P37, DOI 10.4068/cmj.2014.50.2.37; Kim YJ, 2012, J KOREAN MED SCI, V27, P471, DOI 10.3346/jkms.2012.27.5.471; Lee HY, 2014, CRIT CARE MED, V42, P1081, DOI 10.1097/CCM.0000000000000125; Lee JH, 2007, J ANTIMICROB CHEMOTH, V59, P633, DOI 10.1093/jac/dkm007; Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954; Lim SK, 2011, J KOREAN MED SCI, V26, P325, DOI 10.3346/jkms.2011.26.3.325; Liu QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098091; Liu WQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095689, 10.1371/journal.pone.0107975, 10.1371/journal.pone.0103350]; Luo LM, 2013, AM J MED SCI, V345, P361, DOI 10.1097/MAJ.0b013e31825b5443; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Ng TM, 2014, INFECT CONT HOSP EP, V35, P49, DOI 10.1086/674387; Opazo A, 2012, J ANTIMICROB CHEMOTH, V67, P1619, DOI 10.1093/jac/dks087; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Raymond DP, 2003, CRIT CARE MED, V31, P1035, DOI 10.1097/01.CCM.0000060015.77443.31; Steinke D, 2001, CLIN INFECT DIS, V33, pS193, DOI 10.1086/321848; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tsai MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083082; Vernaz N, 2011, J ANTIMICROB CHEMOTH, V66, P928, DOI 10.1093/jac/dkq525; Wilson SJ, 2004, AM J INFECT CONTROL, V32, P342, DOI 10.1016/j.ajic.2004.02.008; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wisplinghoff H, 2000, CLIN INFECT DIS, V31, P690, DOI 10.1086/314040; Zaragoza R, 2003, CLIN MICROBIOL INFEC, V9, P412, DOI 10.1046/j.1469-0691.2003.00656.x	47	26	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130701	10.1371/journal.pone.0130701	http://dx.doi.org/10.1371/journal.pone.0130701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083415	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400156
J	Ma, LJ; Qiao, JX; Kong, XY; Zou, YP; Xu, XM; Chen, XM; Hu, XP				Ma, Lijie; Qiao, Jiaxing; Kong, Xinyu; Zou, Yiping; Xu, Xiangming; Chen, Xianming; Hu, Xiaoping			Effect of Low Temperature and Wheat Winter-Hardiness on Survival of Puccinia striiformis f. sp tritici under Controlled Conditions	PLOS ONE			English	Article							PREDICTING STRIPE RUST; INFECTION; PATHOGEN; EPIDEMIOLOGY; EXPRESSION; SELECTION; GENES	Wheat stripe rust, caused by Puccinia striiformis f. sp. tritici (Pst), is one of the most important diseases of wheat worldwide. Understanding the survival of Pst during the overwintering period is critical for predicting Pst epidemics in the spring. Real-time quantitative PCR (qPCR) methods quantifying Pst DNA and RNA (cDNA) were developed and compared for the ability to quantify viable Pst in leaf tissues. Both qPCR of DNA and RNA can provide reliable measurement of viable Pst in plant tissues prior to the late sporulation stage for which qPCR of DNA gave a much higher estimate of fungal biomass than qPCR of RNA. The percentage of Pst biomass that was viable in detached and attached leaves under low temperatures decreased over time. Pst survived longer on attached leaves than on detached leaves. The survival of Pst in cultivars with strong winter-hardiness at 0 degrees C and -5 degrees C was greater than those with weak winter-hardiness. However, such differences in Pst survival among cultivars were negligible at -10, -15 and -20 degrees C. Results indicated that Pst mycelia inside green leaves can also be killed by low temperatures rather than through death of green leaves under low temperatures. The relationship of Pst survival in attached leaves with temperature and winter-hardiness was well described by logistic models. Further field evaluation is necessary to assess whether inclusion of other factors such as moisture and snow cover could improve the model performance in predicting Pst overwintering potential, and hence the epidemic in spring.	[Ma, Lijie; Qiao, Jiaxing; Kong, Xinyu; Zou, Yiping; Hu, Xiaoping] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Peoples R China; [Xu, Xiangming] East Malling Res, East Malling ME19 6BJ, Kent, England; [Chen, Xianming] Washington State Univ, USDA ARS, Pullman, WA 99164 USA; [Chen, Xianming] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	Northwest A&F University - China; United States Department of Agriculture (USDA); Washington State University; Washington State University	Hu, XP (corresponding author), Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Taicheng Rd 3, Yangling 712100, Peoples R China.	xphu@nwsuaf.edu.cn	Xu, Xiangming/I-3050-2014	Xu, Xiangming/0000-0002-4567-7117	National Key Basic Research Program of China [2013CB127700]; National Natural Science Foundation of China [31071640, 31271985]; 111 Project from Education Ministry of China [B07049]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from Education Ministry of China(Ministry of Education, China - 111 Project)	This work was supported by the National Key Basic Research Program of China (2013CB127700), and the National Natural Science Foundation of China (31071640 and 31271985), and partially supported by the 111 Project from Education Ministry of China (B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1983, MEMBRANE TRANSPORT S, P667; Bruce M, 2014, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00520; Burleigh JR, 1965, THESIS WASHINGTON ST; Chen XM, 2007, AUST J AGR RES, V58, P648, DOI 10.1071/AR07045; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; COAKLEY SM, 1978, PHYTOPATHOLOGY, V68, P207, DOI 10.1094/Phyto-68-207; COAKLEY SM, 1988, PHYTOPATHOLOGY, V78, P543, DOI 10.1094/Phyto-78-543; COAKLEY SM, 1982, PHYTOPATHOLOGY, V72, P1539, DOI 10.1094/Phyto-72-1539; COAKLEY SM, 1981, PHYTOPATHOLOGY, V71, P461, DOI 10.1094/Phyto-71-461; DENNIS JI, 1987, T BRIT MYCOL SOC, V88, P91, DOI 10.1016/S0007-1536(87)80189-4; DENNIS JI, 1987, T BRIT MYCOL SOC, V88, P119, DOI 10.1016/S0007-1536(87)80194-8; Gladders P, 2007, ANN APPL BIOL, V150, P371, DOI 10.1111/j.1744-7348.2007.00131.x; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Li Z.Q., 2002, WHEAT RUSTS CHINA, P1; Li ZQ, 1989, WHEAT RUST THEIR CON; Line RF, 2002, ANNU REV PHYTOPATHOL, V40, P75, DOI 10.1146/annurev.phyto.40.020102.111645; Murray JW, 1996, J CELL BIOL, V135, P1309, DOI 10.1083/jcb.135.5.1309; PARK RF, 1990, PLANT PATHOL, V39, P416, DOI 10.1111/j.1365-3059.1990.tb02517.x; RAPILLY F, 1979, ANNU REV PHYTOPATHOL, V17, P59, DOI 10.1146/annurev.py.17.090179.000423; Saulescu N. N., 2001, APPL PHYSL WHEAT BRE, P111; Scholtz JJ, 2013, PHYSIOL MOL PLANT P, V81, P22, DOI 10.1016/j.pmpp.2012.10.006; Sharma-Poudyal D, 2011, PHYTOPATHOLOGY, V101, P544, DOI 10.1094/PHYTO-08-10-0215; Sharma-Poudyal D, 2014, INT J BIOMETEOROL, V58, P987, DOI 10.1007/s00484-013-0683-6; SHARP EL, 1963, PHYTOPATHOLOGY, V53, P1239; Shen Q., 1962, ACTA PHYTOPHYL SIN, V1, P393; Shi ShouDing, 2005, Acta Phytophylacica Sinica, V32, P29; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Tang CL, 2013, J EXP BOT, V64, P2955, DOI 10.1093/jxb/ert135; Tran VT, 2014, NEW PHYTOL, V202, P565, DOI 10.1111/nph.12671; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Yan JH, 2012, PLANT DIS, V96, P544, DOI 10.1094/PDIS-08-11-0680; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; Yin CT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-626; ZADOKS J. C., 1961, TIJDSCHR PLANTEZIEKTEN, V67, P69, DOI 10.1007/BF01984044; Zeng SM, 2006, PLANT DIS, V90, P980, DOI 10.1094/PD-90-0980; Zhang HC, 2012, PLANT CELL REP, V31, P2121, DOI 10.1007/s00299-012-1322-0; [张淑霞 Zhang Shuxia], 2003, [中国生态农业学报, Chinese journal of eco-agriculture], V11, P38; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203	38	12	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130691	10.1371/journal.pone.0130691	http://dx.doi.org/10.1371/journal.pone.0130691			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083371	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400154
J	Omrane, I; Medimegh, I; Baroudi, O; Ayari, H; Bedhiafi, W; Stambouli, N; Ferchichi, M; Kourda, N; Bignon, YJ; Uhrhammer, N; Mezlini, A; Bougatef, K; Benammar-Elgaaied, A				Omrane, Ines; Medimegh, Imen; Baroudi, Olfa; Ayari, Hager; Bedhiafi, Walid; Stambouli, Nejla; Ferchichi, Marwa; Kourda, Nadia; Bignon, Yves-Jean; Uhrhammer, Nancy; Mezlini, Amel; Bougatef, Karim; Benammar-Elgaaied, Amel			Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy	PLOS ONE			English	Article							CROHNS-DISEASE; SIGNIFICANT ASSOCIATION; GENETIC POLYMORPHISMS; PROMOTES ANGIOGENESIS; IMMUNE SURVEILLANCE; NOD2/CARD15 GENE; CELLS; RISK; LUNG; VARIANTS	IL23/IL17 pathway plays an important role in the development of inflammatory bowel diseases (IBD). In general, the genes encoding the cytokines are genetically polymorphic and polymorphisms in genes IL23R and IL17 have been proved to be associated with its susceptibility to inflammatory diseases as well as cancer including colorectal cancer. Moreover, it has been shown that these interleukins are involved in anti-tumor or pro-tumor effects of various cancers. Previously, we showed that there is a significant association between IL17A, IL17F and IL23R polymorphisms as well as the occurrence of colorectal cancer and the clinical features of the disease. The purpose of the present work is to investigate an association between IL17A, IL17F and IL23R polymorphisms in 102 Tunisian patients with colorectal cancer treatment. The association was analyzed by statistical tools. We found that patients with mutated genotypes of IL17A G197A SNP could be a risk factor for the inefficiency of chemotherapy and radiotherapy. Unlike IL17F variant, patients with wild type genotypes require surgery and adjuvant chemotherapy. On the one hand, we found no evidence that supports a significant association between IL23R polymorphism and the combined genotypes of these three genes and the colorectal cancer treatment. On the other hand, we showed that there is an important interaction between IL17A/IL17F polymorphisms and the stage of the disease as well as its treatment. Finally, patients with IL17F wild type genotype highlighted that there is a valid longer OS without all treatments and with radiotherapy and a neoadjuvant chemotherapy. In contrast, we observed that there are no relationships between IL17A, IL23R and the survival of these patients neither with nor without the treatment. Our results suggest that polymorphisms in IL17A and IL17F genes may be a predictive source of colorectal cancer therapy type. Therefore, IL17F may serve as an independent prognostic factor for overall survival in patients with colorectal cancer.	[Omrane, Ines; Medimegh, Imen; Baroudi, Olfa; Ayari, Hager; Bedhiafi, Walid; Stambouli, Nejla; Ferchichi, Marwa; Bougatef, Karim; Benammar-Elgaaied, Amel] Univ Tunis El Manar, Fac Sci Tunis, Lab Genet Immunol & Human Pathol, Tunis, Tunisia; [Kourda, Nadia] Charles Nicolle Hosp, Lab Anat & Cytopathol, Tunis, Tunisia; [Bignon, Yves-Jean; Uhrhammer, Nancy] Ctr Jean Perrin, Lab Diagnost & Mol Genet, Clermont Ferrand, France; [Mezlini, Amel] Inst Salah Azaiez, Dept Med Oncol, Tunis, Tunisia	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite de Tunis-El-Manar; Hopital Charles Nicolle; UNICANCER; Centre Jean Perrin; Universite de Tunis-El-Manar; Institut Salah Azaiez	Omrane, I (corresponding author), Univ Tunis El Manar, Fac Sci Tunis, Lab Genet Immunol & Human Pathol, Tunis, Tunisia.	inesomrane@hotmail.fr	, bignon/Y-3243-2019; Elgaaied, Amel Ben Ammar/AAL-1183-2020; BOUGATEF, karim/AAM-4385-2021; stambouli, NEJLA/GNW-5303-2022; stambouli, NEJLA nejla/AAO-6434-2021	BOUGATEF, karim/0000-0001-9461-2515; stambouli, NEJLA/0000-0001-7688-5210; stambouli, NEJLA nejla/0000-0001-7688-5210				Alvarez-Lobos M, 2005, ANN SURG, V242, P693, DOI 10.1097/01.sla.0000186173.14696.ea; Apetoh L, 2008, CANCER RES, V68, P4026, DOI 10.1158/0008-5472.CAN-08-0427; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Barreiro M., 2005, Rev. esp. enferm. dig., V97, P547, DOI 10.4321/s1130-01082005000800002; Buning C, 2004, ALIMENT PHARM THER, V19, P1073, DOI 10.1111/j.1365-2036.2004.01967.x; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Chen JJ, 2010, MOL CARCINOGEN, V49, P862, DOI 10.1002/mc.20661; Chen JH, 2010, J CLIN IMMUNOL, V30, P539, DOI 10.1007/s10875-010-9391-8; Chen X, 2013, LUNG CANC AMSTERDAM, V69, P348; Chung YC, 2006, ANTICANCER RES, V26, P3905; Cochaud S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03456; de Jong K P, 2002, Ned Tijdschr Geneeskd, V146, P196; Diep CB, 2003, J CLIN ONCOL, V21, P820, DOI 10.1200/JCO.2003.05.190; Gallagher G, 1997, TISSUE ANTIGENS, V50, P47, DOI 10.1111/j.1399-0039.1997.tb02833.x; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032126; Hitre E, 2005, PHARMACOGENET GENOM, V15, P723, DOI 10.1097/01.fpc.0000175598.42141.59; Hsu CP, 2006, ANTICANCER RES, V26, P4607; Huber AK, 2008, J CLIN ENDOCR METAB, V93, P1077, DOI 10.1210/jc.2007-2190; Kawaguchi M, 2004, J ALLERGY CLIN IMMUN, V114, P1265, DOI 10.1016/j.jaci.2004.10.019; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Laghi L, 2005, ALIMENT PHARM THER, V22, P557, DOI 10.1111/j.1365-2036.2005.02629.x; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; McLean LP, 2013, IMMUNOTHERAPY-UK, V5, P923, DOI 10.2217/imt.13.87; Mumm JB, 2008, ONCOGENE, V27, P5913, DOI 10.1038/onc.2008.275; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Omrane I, 2014, TUMOR BIOL, V35, P6627, DOI 10.1007/s13277-014-1890-4; Omrane I, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0954-z; Omrane I, 2014, IMMUNOL LETT, V158, P189, DOI 10.1016/j.imlet.2014.01.002; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Reppert S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1609; Russell RK, 2005, INFLAMM BOWEL DIS, V11, P955, DOI 10.1097/01.MIB.0000183423.38037.f3; Schmidt EGW, 2013, INFLAMM BOWEL DIS, V19, P1567, DOI 10.1097/MIB.0b013e318286fa1c; Schroth W, 2009, JAMA-J AM MED ASSOC, V302, P1429, DOI 10.1001/jama.2009.1420; Slattery ML, 2007, CANCER CAUSE CONTROL, V18, P1095, DOI 10.1007/s10552-007-9049-x; Su D, 2007, LUNG CANCER, V56, P281, DOI 10.1016/j.lungcan.2006.12.002; Suzuki H, 2012, ONCOL LETT, V4, P199, DOI 10.3892/ol.2012.739; Tahara T, 2009, INT J MOL MED, V24, P563, DOI 10.3892/ijmm_00000266; Tong Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034959; Wilkening S, 2008, CARCINOGENESIS, V29, P1202, DOI 10.1093/carcin/bgn101; Wu D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/436307; Yu PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044380; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang XF, 2013, INFLAMM RES, V62, P743, DOI 10.1007/s00011-013-0629-9; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307; Zhou Bin, 2013, Mol Carcinog, V52, P871, DOI 10.1002/mc.21928	53	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128911	10.1371/journal.pone.0128911	http://dx.doi.org/10.1371/journal.pone.0128911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083022	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400071
J	Siu, A; Volotskova, O; Cheng, XQ; Khalsa, SS; Bian, K; Murad, F; Keidar, M; Sherman, JH				Siu, Alan; Volotskova, Olga; Cheng, Xiaoqian; Khalsa, Siri S.; Bian, Ka; Murad, Ferid; Keidar, Michael; Sherman, Jonathan H.			Differential Effects of Cold Atmospheric Plasma in the Treatment of Malignant Glioma	PLOS ONE			English	Article							ADJUVANT TEMOZOLOMIDE; IONIZING-RADIATION; DISCHARGE PLASMA; GLIOBLASTOMA; RESISTANCE; BARRIER; CELLS; CHEMOTHERAPY; RADIOTHERAPY; CONCOMITANT	Objective Cold atmospheric plasma (CAP) has recently been shown to selectively target cancer cells with minimal effects on normal cells. We systematically assessed the effects of CAP in the treatment of glioblastoma. Methods Three glioma cell lines, normal astrocytes, and endothelial cell lines were treated with CAP. The effects of CAP were then characterized for viability, cytotoxicity/apoptosis, and cell cycle effects. Statistical significance was determined with student's t-test. Results CAP treatment decreases viability of glioma cells in a dose dependent manner, with the ID50 between 90-120 seconds for all glioma cell lines. Treatment with CAP for more than 120 seconds resulted in viability less than 35% at 24-hours posttreatment, with a steady decline to less than 20% at 72-hours. In contrast, the effect of CAP on the viability of NHA and HUVEC was minimal, and importantly not significant at 90 to 120 seconds, with up to 85% of the cells remained viable at 72-hours post-treatment. CAP treatment produces both cytotoxic and apoptotic effects with some variability between cell lines. CAP treatment resulted in a G2/M-phase cell cycle pause in all three cell lines. Conclusions This preliminary study determined a multi-focal effect of CAP on glioma cells in vitro, which was not observed in the non-tumor cell lines. The decreased viability depended on the treatment duration and cell line, but overall was explained by the induction of cytotoxicity, apoptosis, and G2/M pause. Future studies will aim at further characterization with more complex pre-clinical models.	[Siu, Alan; Sherman, Jonathan H.] George Washington Univ, Dept Neurol Surg, Washington, DC 20052 USA; [Volotskova, Olga; Cheng, Xiaoqian; Keidar, Michael] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC USA; [Khalsa, Siri S.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Bian, Ka; Murad, Ferid] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC USA	George Washington University; George Washington University; George Washington University; George Washington University	Sherman, JH (corresponding author), George Washington Univ, Dept Neurol Surg, Washington, DC 20052 USA.	jsherman@mfa.gwu.edu		Cheng, Xiaoqian/0000-0002-2544-4260				Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Badie B, 1999, CANCER GENE THER, V6, P155, DOI 10.1038/sj.cgt.7700009; Blaydes JP, 2000, ONCOGENE, V19, P3829, DOI 10.1038/sj.onc.1203773; Bleau AM, 2009, CELL CYCLE, V8, P2936; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cohen MH, 2009, ONCOLOGIST, V14, P1131, DOI 10.1634/theoncologist.2009-0121; Daeschlein G, 2012, J HOSP INFECT, V81, P177, DOI 10.1016/j.jhin.2012.02.012; Daeschlein G, 2012, J DTSCH DERMATOL GES, V10, P509, DOI 10.1111/j.1610-0387.2012.07857.x; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; GASPAR LE, 1992, INT J RADIAT ONCOL, V24, P55, DOI 10.1016/0360-3016(92)91021-E; GENTNER NE, 1978, MOL GEN GENET, V164, P31, DOI 10.1007/BF00267595; Iseki S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694928; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Janigro D, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-72; Johannessen TCA, 2012, EXPERT REV ANTICANC, V12, P635, DOI [10.1586/era.12.37, 10.1586/ERA.12.37]; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kammerer R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021834; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kieft IE, 2005, IEEE T PLASMA SCI, V33, P771, DOI 10.1109/TPS.2005.844528; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim D., 2008, 13 INT C BIOM ENG, V23, P355; Kim GC, 2009, J KOREAN PHYS SOC, V54, P628, DOI 10.3938/jkps.54.628; Kim JY, 2011, BIOSENS BIOELECTRON, V28, P333, DOI 10.1016/j.bios.2011.07.039; Kim T, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3402768; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Klampfl TG, 2012, APPL ENVIRON MICROB, V78, P5077, DOI 10.1128/AEM.00583-12; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; LITTLE JB, 1968, NEW ENGL J MED, V278, P369, DOI 10.1056/NEJM196802152780705; Lupu Andreea-Roxana, 2009, Roum Arch Microbiol Immunol, V68, P136; Moore HM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009241; Ng K, 2012, J NEURO-ONCOL, V107, P1, DOI 10.1007/s11060-011-0714-2; Rahn R O, 1973, Photophysiology, V8, P231; Ratovitski EA, 2014, PLASMA PROCESS POLYM, V11, P1128, DOI 10.1002/ppap.201400071; Shashurin A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3389496; Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223; Shashurin A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3153143; Sinek J, 2004, BIOMED MICRODEVICES, V6, P297, DOI 10.1023/B:BMMD.0000048562.29657.64; Stoffels E, 2008, PLASMA PROCESS POLYM, V5, P599, DOI 10.1002/ppap.200800028; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Volotskova O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00636; Volotskova O, 2011, PLASMA MED, V1, P85, DOI [DOI 10.1615/PlasmaMed.v1.i1.70, DOI 10.1615/PLASMAMED.V1.I1.70]; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; WITKIN EM, 1969, ANNU REV MICROBIOL, V23, P487, DOI 10.1146/annurev.mi.23.100169.002415; Yonson S, 2006, J PHYS D APPL PHYS, V39, P3508, DOI 10.1088/0022-3727/39/16/S08; Yu Yang, 2012, Front Biosci (Elite Ed), V4, P1528; Zhang XH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959735	53	48	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0126313	10.1371/journal.pone.0126313	http://dx.doi.org/10.1371/journal.pone.0126313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083405	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400005
J	Ainai, A; Hasegawa, H; Obuchi, M; Odagiri, T; Ujike, M; Shirakura, M; Nobusawa, E; Tashiro, M; Asanuma, H				Ainai, Akira; Hasegawa, Hideki; Obuchi, Masatsugu; Odagiri, Takato; Ujike, Makoto; Shirakura, Masayuki; Nobusawa, Eri; Tashiro, Masato; Asanuma, Hideki			Host Adaptation and the Alteration of Viral Properties of the First Influenza A/H1N1pdm09 Virus Isolated in Japan	PLOS ONE			English	Article							AMINO-ACID; ESTABLISHED LINE; PANDEMIC H1N1; PLAQUE-ASSAY; A VIRUSES; VACCINES; DETERMINANT; EVOLUTION; SWINE; MDCK	A/Narita/1/2009 (A/N) was the first H1N1 virus from the 2009 pandemic (H1pdm) to be isolated in Japan. To better understand and predict the possible development of this virus strain, the effect of passaging A/N was investigated in Madin-Darby canine kidney cells, chicken eggs and mice. A/N that had been continuously passaged in cells, eggs, or mice obtained the ability to grow efficiently in each host. Moreover, A/N grown in mice had both a high level of pathogenicity in mice and an increased growth rate in cells and eggs. Changes in growth and pathogenicity were accompanied by amino acid substitutions in viral hemagglutinin (HA) and PB2. In addition, the adapted viruses exhibited a reduced ability to react with ferret antisera against A/N. In conclusion, prolonged passaging allowed influenza A/N to adapt to different hosts, as indicated by a high increase in proliferative capacity that was accompanied by an antigenic alteration leading to amino acid substitutions.	[Ainai, Akira; Obuchi, Masatsugu; Odagiri, Takato; Ujike, Makoto; Shirakura, Masayuki; Nobusawa, Eri; Tashiro, Masato; Asanuma, Hideki] Natl Inst Infect Dis, Influenza Virus Res Ctr, Musashimurayama, Tokyo 2080011, Japan; [Ainai, Akira; Hasegawa, Hideki; Asanuma, Hideki] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Ujike, Makoto] Nippon Vet & Life Sci Univ, Dept Vet Med, Musashino, Tokyo 1808602, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Nippon Veterinary & Life Science University	Asanuma, H (corresponding author), Natl Inst Infect Dis, Influenza Virus Res Ctr, Gakuen 4-7-1, Musashimurayama, Tokyo 2080011, Japan.	asanuma@nih.go.jp	Hasegawa, Hideki/C-7978-2014; Ujike, Makoto/W-3508-2019	Ujike, Makoto/0000-0002-7145-7126	Health and Labour Sciences Research Grant [08-16]; Grants-in-Aid for Scientific Research [25286062] Funding Source: KAKEN	Health and Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Health and Labour Sciences Research Grant (ID: 08-16).	Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Centers for Disease Control and Prevention, 2012, CELL BAS FLU VACC; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI 10.1586/ERV.09.31; European Centre for Disease Prevention and Control and the Community Network of Reference Laboratories for Human Influenza in Europe, 2011, INFL VIR CHAR; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; KATZ JM, 1992, J GEN VIROL, V73, P1159, DOI 10.1099/0022-1317-73-5-1159; Lakspere T, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01004-13; Minor PD, 2010, CLIN INFECT DIS, V50, P560, DOI 10.1086/650171; Minor PD, 2009, VACCINE, V27, P2907, DOI 10.1016/j.vaccine.2009.02.064; National Institute of Technology and Evaluation and ational Institute of Infectious Diseases in Japan, 2009, NITE NIID PROT SEQ I; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reynales H, 2012, VACCINE, V30, P6436, DOI 10.1016/j.vaccine.2012.08.005; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Shimada T, 2009, EUROSURVEILLANCE, V14; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; TAMURA SI, 1992, J IMMUNOL, V149, P981; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Wang W, 2010, VIROLOGY, V407, P374, DOI 10.1016/j.virol.2010.08.027; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2009, AV CAND REASS VACC V; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130208	10.1371/journal.pone.0130208	http://dx.doi.org/10.1371/journal.pone.0130208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079133	gold, Green Published, Green Submitted			2022-12-26	WOS:000356542300040
J	Zhu, S; Guo, X; Keyes, LR; Yang, HC; Ge, XN				Zhu, Shu; Guo, Xin; Keyes, Lisa R.; Yang, Hanchun; Ge, Xinna			Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in Mice	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; ATTENUATED MENGO-VIRUS; MOUTH-DISEASE VIRUS; GENETIC STABILITY; IMMUNE-RESPONSE; POLIOVIRUS; VECTOR; INFECTION; PROTEIN; PIGS	Encephalomyocarditis virus (EMCV) is capable of infecting a wide range of species and the infection can cause myocarditis and reproductive failure in pigs as well as febrile illness in human beings. In this study, we introduced the entire ORF5 of the porcine reproductive and respiratory syndrome virus (PRRSV) or the neutralization epitope regions in the E2 gene of the classical swine fever virus (CSFV), into the genome of a stably attenuated EMCV strain, T1100I. The resultant viable recombinant viruses, CvBJC3m/I-Delta GP5 and CvBJC3m/I-E2, respectively expressed partial PRRSV envelope protein GP5 or CSFV neutralization epitope A1A2 along with EMCV proteins. These heterologous proteins fused to the N-terminal of the nonstructural leader protein could be recognized by anti-GP5 or anti-E2 antibody. We also tested the immunogenicity of these fusion proteins by immunizing BALB/c mice with the recombinant viruses. The immunized animals elicited neutralizing antibodies against PRRSV and CSFV. Our results suggest that EMCV can be engineered as an expression vector and serve as a tool in the development of novel live vaccines in various animal species.	[Zhu, Shu; Guo, Xin; Yang, Hanchun; Ge, Xinna] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100193, Peoples R China; [Zhu, Shu; Guo, Xin; Yang, Hanchun; Ge, Xinna] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Keyes, Lisa R.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; State University System of Florida; University of Florida	Yang, HC (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100193, Peoples R China.	yanghanchun1@cau.edu.cn; gexn@cau.edu.cn			National Natural Science Foundation of China [30700589]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 30700589) [http://www.nsfc.gov.cn/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMEYER R, 1994, P NATL ACAD SCI USA, V91, P9775, DOI 10.1073/pnas.91.21.9775; ALTMEYER R, 1995, J VIROL, V69, P3193, DOI 10.1128/JVI.69.5.3193-3196.1995; ANDINO R, 1994, SCIENCE, V265, P1448, DOI 10.1126/science.8073288; Binder JJ, 2003, VIROLOGY, V312, P481, DOI 10.1016/S0042-6822(03)00245-9; BURKE KL, 1988, NATURE, V332, P81, DOI 10.1038/332081a0; Canelli E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-64; Dvorak CMT, 2001, VIROLOGY, V290, P261, DOI 10.1006/viro.2001.1193; EVANS DJ, 1989, NATURE, V339, P385, DOI 10.1038/339385a0; Faaberg KS, 2006, VIRAL IMMUNOL, V19, P294, DOI 10.1089/vim.2006.19.294; Ge X, 2010, VET REC, V166, P145, DOI 10.1136/vr.b4766; GIRARD M, 1995, BIOLOGICALS, V23, P165, DOI 10.1006/biol.1995.0027; Hammoumi S, 2006, ARCH VIROL, V151, P1783, DOI 10.1007/s00705-006-0746-7; Hato SV, 2010, CELL MICROBIOL, V12, P310, DOI 10.1111/j.1462-5822.2009.01395.x; Jia H, 2008, ANTIVIR RES, V79, P95, DOI 10.1016/j.antiviral.2007.12.003; Kheyar A, 2005, VACCINE, V23, P4016, DOI 10.1016/j.vaccine.2005.03.012; KITSON JDA, 1991, J VIROL, V65, P3068, DOI 10.1128/JVI.65.6.3068-3075.1991; KOENEN F, 1994, VET MICROBIOL, V39, P111, DOI 10.1016/0378-1135(94)90091-4; LaRue R, 2003, J VIROL, V77, P9136, DOI 10.1128/JVI.77.17.9136-9146.2003; Lee SG, 2002, J VIROL, V76, P1649, DOI 10.1128/JVI.76.4.1649-1662.2002; Liu H, 2013, GENOME ANNOUNC, V1, P12; MARTIN A, 1988, EMBO J, V7, P2839, DOI 10.1002/j.1460-2075.1988.tb03140.x; Masek-Hammerman K, 2012, VET PATHOL, V49, P386, DOI 10.1177/0300985811409254; MURNANE TG, 1960, SCIENCE, V131, P498, DOI 10.1126/science.131.3399.498; MURRAY MG, 1988, P NATL ACAD SCI USA, V85, P3203, DOI 10.1073/pnas.85.9.3203; Nam HM, 2013, ARCH VIROL, V158, P1275, DOI 10.1007/s00705-013-1612-z; Petty RV, 2014, J VIROL, V88, P13503, DOI 10.1128/JVI.02148-14; Qiu HJ, 2005, VET IMMUNOL IMMUNOP, V106, P309, DOI 10.1016/j.vetimm.2005.03.008; Ricour C, 2009, J VIROL, V83, P11223, DOI 10.1128/JVI.00829-09; Robinson SR, 2013, VET MICROBIOL, V164, P281, DOI 10.1016/j.vetmic.2013.03.006; Van der Ryst E, 1998, RES VIROLOGY, V149, P5, DOI 10.1016/S0923-2516(97)86896-3; Yeo DSY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-248; ZHANG L, 1995, J VIROL, V69, P3171, DOI 10.1128/JVI.69.5.3171-3175.1995; Zhu S, 2011, SCI CHINA LIFE SCI, V54, P535, DOI 10.1007/s11427-011-4172-z	33	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129729	10.1371/journal.pone.0129729	http://dx.doi.org/10.1371/journal.pone.0129729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076449	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900097
J	Chang, HY; Liao, CY; Su, GC; Lin, SW; Wang, HW; Chi, P				Chang, Hao-Yen; Liao, Chia-Yu; Su, Guan-Chin; Lin, Sheng-Wei; Wang, Hong-Wei; Chi, Peter			Functional Relationship of ATP Hydrolysis, Presynaptic Filament Stability, and Homologous DNA Pairing Activity of the Human Meiotic Recombinase DMC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALKER-B MOTIF; HUMAN RAD51 PROTEIN; NUCLEOTIDE-BINDING; CHROMOSOME SYNAPSIS; PROMOTES; HOP2-MND1; HSDMC1	DMC1 and RAD51 are conserved recombinases that catalyze homologous recombination. DMC1 and RAD51 share similar properties in DNA binding, DNA-stimulated ATP hydrolysis, and catalysis of homologousDNAstrand exchange. Alarge body of evidence indicates that attenuation ofATPhydrolysis leads to stabilization of the RAD51-ssDNA presynaptic filament and enhancement ofDNAstrand exchange. However, the functional relationship of ATPase activity, presynaptic filament stability, and DMC1-mediated homologous DNA strand exchange has remained largely unexplored. To address this important question, we have constructed several mutant variants of human DMC1and characterized them biochemically to gain mechanistic insights. Two mutations, K132R and D223N, that change key residues in the WalkerAandBnucleotide-binding motifs ablate ATP binding and renderDMC1inactive. On the other hand, the nucleotide-binding cap D317K mutant binds ATP normally but shows significantly attenuated ATPase activity and, accordingly, forms a highly stable presynaptic filament. Surprisingly, unlike RAD51, presynaptic filament stabilization achieved via ATP hydrolysis attenuation does not lead to any enhancement of DMC1-catalyzed homologous DNA pairing and strand exchange. This conclusion is further supported by examining wild-type DMC1 with non-hydrolyzable ATP analogues. Thus, our results reveal an important mechanistic difference between RAD51 and DMC1.	[Chang, Hao-Yen; Liao, Chia-Yu; Su, Guan-Chin; Chi, Peter] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Lin, Sheng-Wei; Chi, Peter] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Wang, Hong-Wei] Tsinghua Univ, Minist Educ, Key Lab Prot Sci,Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci,Ctr Struct Bio, Beijing 100084, Peoples R China	National Taiwan University; Academia Sinica - Taiwan; Tsinghua University	Chi, P (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	peterhchi@ntu.edu.tw	Lin, Sheng-Wei/G-8142-2015; Chi, Peter/AAI-1580-2019; Huang, Wenchi/F-3981-2010	Lin, Sheng-Wei/0000-0001-7777-2090; Chi, Peter/0000-0001-9229-8729; Huang, Wenchi/0000-0001-5556-1460; Chang, Hao-Yen/0000-0001-5677-816X	Academia Sinica; National Taiwan University [NTU-ICRP-103R7560-6, NTU-CDP-103R7848, NTU-ERP-104R8955-3]; Ministry of Science and Technology [MOST 102-2628-B-002-044-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Taiwan University(National Taiwan University); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Academia Sinica, National Taiwan University (Grants NTU-ICRP-103R7560-6, NTU-CDP-103R7848, and NTU-ERP-104R8955-3), and Ministry of Science and Technology (MOST 102-2628-B-002-044-MY3). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Amunugama R, 2012, J BIOL CHEM, V287, P8724, DOI 10.1074/jbc.M111.239426; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bugreev DV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5198; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Chiraniya A, 2013, GENES-BASEL, V4, P134, DOI 10.3390/genes4020134; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Cole F, 2012, ANN NY ACAD SCI, V1267, P95, DOI 10.1111/j.1749-6632.2012.06595.x; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fung CW, 2006, MOL CELL BIOL, V26, P9544, DOI 10.1128/MCB.00599-06; Gupta RC, 2001, P NATL ACAD SCI USA, V98, P8433, DOI 10.1073/pnas.121005298; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hong S, 2013, MOL CELL, V51, P440, DOI 10.1016/j.molcel.2013.08.008; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lao JP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003978; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Rai V, 2006, BIOCHEMISTRY-US, V45, P14726, DOI 10.1021/bi061535t; Rossi MJ, 2011, P NATL ACAD SCI USA, V108, P6432, DOI 10.1073/pnas.1016072108; Sehorn MG, 2004, CELL CYCLE, V3, P1375, DOI 10.4161/cc.3.11.1364; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Sharma D, 2013, DNA REPAIR, V12, P53, DOI 10.1016/j.dnarep.2012.10.005; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Stratford FLL, 2007, BIOCHEM J, V401, P581, DOI 10.1042/BJ20060968; Su GC, 2014, NUCLEIC ACIDS RES, V42, P349, DOI 10.1093/nar/gkt879; Tombline G, 2002, J BIOL CHEM, V277, P14426, DOI 10.1074/jbc.M109916200; Tsai SP, 2012, NUCLEIC ACIDS RES, V40, P6558, DOI 10.1093/nar/gks305; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yu X, 2010, J MOL BIOL, V401, P544, DOI 10.1016/j.jmb.2010.06.049; Zhao WX, 2014, NUCLEIC ACIDS RES, V42, P906, DOI 10.1093/nar/gkt924	41	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19863	19873		10.1074/jbc.M115.666289	http://dx.doi.org/10.1074/jbc.M115.666289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088134	Green Published, hybrid			2022-12-26	WOS:000359364600042
J	Bartlett, PJ; Metzger, W; Gaspers, LD; Thomas, AP				Bartlett, Paula J.; Metzger, Walson; Gaspers, Lawrence D.; Thomas, Andrew P.			Differential Regulation of Multiple Steps in Inositol 1,4,5-Trisphosphate Signaling by Protein Kinase C Shapes Hormone-stimulated Ca2+ Oscillations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC CALCIUM OSCILLATIONS; PHOSPHORYLATION; RECEPTOR; WAVES; FREQUENCY; MODEL; IP3; ACTIVATION; DIACYLGLYCEROL; PHENYLEPHRINE	How Ca2+ oscillations are generated and fine-tuned to yield versatile downstream responses remains to be elucidated. In hepatocytes, G protein-coupled receptor-linked Ca2+ oscillations report signal strength via frequency, whereas Ca2+ spike amplitude and wave velocity remain constant. IP3 uncaging also triggers oscillatory Ca2+ release, but, in contrast to hormones, Ca2+ spike amplitude, width, and wave velocity were dependent on [IP3] and were not perturbed by phospholipase C (PLC) inhibition. These data indicate that oscillations elicited by IP3 uncaging are driven by the biphasic regulation of the IP3 receptor by Ca2+, and, unlike hormone-dependent responses, do not require PLC. Removal of extracellular Ca2+ did not perturb Ca2+ oscillations elicited by IP3 uncaging, indicating that reloading of endoplasmic reticulum stores via plasma membrane Ca2+ influx does not entrain the signal. Activation and inhibition of PKC attenuated hormone-induced Ca2+ oscillations but had no effect on Ca2+ increases induced by uncaging IP3. Importantly, PKC activation and inhibition differentially affected Ca2+ spike frequencies and kinetics. PKC activation amplifies negative feedback loops at the level of G protein-coupled receptor PLC activity and/or IP3 metabolism to attenuate IP3 levels and suppress the generation of Ca2+ oscillations. Inhibition of PKC relieves negative feedback regulation of IP3 accumulation and, thereby, shifts Ca2+ oscillations toward sustained responses or dramatically prolonged spikes. PKC down-regulation attenuates phenylephrine-induced Ca2+ wave velocity, whereas responses to IP3 uncaging are enhanced. The ability to assess Ca2+ responses in the absence of PLC activity indicates that IP3 receptor modulation by PKC regulates Ca2+ release and wave velocity.	[Bartlett, Paula J.; Metzger, Walson; Gaspers, Lawrence D.; Thomas, Andrew P.] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Thomas, AP (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA.	andrew.thomas@rutgers.edu	Gaspers, Lawrence/W-8766-2019; Regan, Clinton/E-6250-2012	Gaspers, Lawrence/0000-0002-5620-3283; Thomas, Andrew/0000-0002-9026-7467	National Institutes of Health [DK082954, AI099277]; Thomas P. Infusion Endowed Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas P. Infusion Endowed Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK082954 and AI099277 (to A. P. T.). This work was also supported by the Thomas P. Infusion Endowed Chair (to A. P. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; BANNO Y, 1994, J BIOL CHEM, V269, P15846; Bartlett PJ, 2014, CELL CALCIUM, V55, P306, DOI 10.1016/j.ceca.2014.02.007; Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIE CP, 1995, CELL CALCIUM, V18, P232, DOI 10.1016/0143-4160(95)90068-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bootman MD, 1996, BIOCHEM J, V314, P347, DOI 10.1042/bj3140347; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; Brini M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004168; Collazos A, 2006, MOL CELL BIOL, V26, P2247, DOI 10.1128/MCB.26.6.2247-2261.2006; CONNOLLY TM, 1986, CELL, V46, P951, DOI 10.1016/0092-8674(86)90077-2; Dakin K, 2007, CELL CALCIUM, V42, P291, DOI 10.1016/j.ceca.2006.12.003; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dupont G, 1997, CELL CALCIUM, V22, P321, DOI 10.1016/S0143-4160(97)90017-8; Dupont G, 2011, COLD SPRING HARB PER, V3; Dupont G, 2011, BIOCHIMIE, V93, P2132, DOI 10.1016/j.biochi.2011.09.010; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fraiman D, 2004, CELL CALCIUM, V35, P403, DOI 10.1016/j.ceca.2003.10.004; Gaspers LD, 2014, CELL REP, V9, P1209, DOI 10.1016/j.celrep.2014.10.033; Gaspers LD, 2005, CELL CALCIUM, V38, P329, DOI 10.1016/j.ceca.2005.06.009; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P586, DOI 10.1038/nrm1152; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Kim JK, 2011, CELL SIGNAL, V23, P1022, DOI 10.1016/j.cellsig.2011.01.017; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Nash MS, 2001, NATURE, V413, P381, DOI 10.1038/35096643; NATHANSON MH, 1995, AM J PHYSIOL-GASTR L, V269, pG167, DOI 10.1152/ajpgi.1995.269.1.G167; NATHANSON MH, 1994, AM J PHYSIOL, V267, pG338, DOI 10.1152/ajpgi.1994.267.3.G338; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Robb-Gaspers LD, 1998, BBA-BIOENERGETICS, V1366, P17, DOI 10.1016/S0005-2728(98)00118-2; ROBBGASPERS LD, 1995, J BIOL CHEM, V270, P8102, DOI 10.1074/jbc.270.14.8102; ROONEY TA, 1990, J BIOL CHEM, V265, P10792; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; ROONEY TA, 1991, J BIOL CHEM, V266, P12272; ROONEY TA, 1991, PHARMACOL THERAPEUT, V49, P223, DOI 10.1016/0163-7258(91)90056-R; Salazar C, 2008, BIOPHYS J, V94, P1203, DOI 10.1529/biophysj.107.113084; SANCHEZBUENO A, 1990, BIOCHEM J, V268, P627, DOI 10.1042/bj2680627; Shin DM, 2001, J BIOL CHEM, V276, P44146, DOI 10.1074/jbc.M105203200; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Sneyd J, 2006, P NATL ACAD SCI USA, V103, P1675, DOI 10.1073/pnas.0506135103; Strassheim D, 2000, J BIOL CHEM, V275, P39767, DOI 10.1074/jbc.M007775200; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; THOMAS AP, 1991, CELL CALCIUM, V12, P111, DOI 10.1016/0143-4160(91)90013-5; Thurley K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005237; Thurley K, 2011, P NATL ACAD SCI USA, V108, P427, DOI 10.1073/pnas.1008435108; Tordjmann T, 1998, EMBO J, V17, P4695, DOI 10.1093/emboj/17.16.4695; Uchino M, 2004, J BIOL CHEM, V279, P2254, DOI 10.1074/jbc.M309894200; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Woodring PJ, 1997, J BIOL CHEM, V272, P30447, DOI 10.1074/jbc.272.48.30447; Yamasaki-Mann M, 2011, CELL CALCIUM, V50, P36, DOI 10.1016/j.ceca.2011.04.008; Young KW, 2003, J BIOL CHEM, V278, P20753, DOI 10.1074/jbc.M211555200; Zhu LP, 2011, J CELL SCI, V124, P2591, DOI 10.1242/jcs.082727	62	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18519	18533		10.1074/jbc.M115.657767	http://dx.doi.org/10.1074/jbc.M115.657767			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26078455	Green Published, hybrid			2022-12-26	WOS:000358512100024
J	Birse, KDM; Cole, AL; Hirbod, T; McKinnon, L; Ball, TB; Westmacott, GR; Kimani, J; Plummer, F; Cole, AM; Burgener, A; Broliden, K				Birse, Kenzie D. M.; Cole, Amy L.; Hirbod, Taha; McKinnon, Lyle; Ball, Terry B.; Westmacott, Garrett R.; Kimani, Joshua; Plummer, Frank; Cole, Alexander M.; Burgener, Adam; Broliden, Kristina			Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; IMMUNOGLOBULIN-A; THIOREDOXIN; INFECTION; MUCOSAL; TRACT; ACQUISITION; RESISTANCE; IMMUNITY; S100A11	Objective Cationic proteins found in cervicovaginal secretions (CVS) are known to contribute to the early antiviral immune response against HIV-infection in vitro. We here aimed to define additional antiviral factors that are over-expressed in CVS from female sex workers at high risk of infection. Methods CVS were collected from Kenyan HIV-seronegative (n = 34) and HIV-seropositive (n = 12) female sex workers, and were compared with those from HIV-seronegative low-risk women (n = 12). The highly exposed seronegative (HESN) sex workers were further divided into those with less (n = 22) or more (n = 12) than three years of documented sex work. Cationic protein-depleted CVS were assessed for HIV-neutralizing activity by a PBMC-based HIV-neutralizing assay, and then characterized by proteomics. Results HIV neutralizing activity was detected in all unprocessed CVS, however only CVS from the female sex worker groups maintained its HIV neutralizing activity after cationic protein-depletion. Differentially abundant proteins were identified in the cationic protein-depleted secretions including 26, 42, and 11 in the HESN>3yr, HESN<3yr, and HIV-positive groups, respectively. Gene ontology placed these proteins into functional categories including proteolysis, oxidation-reduction, and epidermal development. The proteins identified in this study include proteins previously associated with the HESN phenotype in other cohorts as well as novel proteins not yet associated with anti-HIV activities. Conclusion While cationic proteins appear to contribute to the majority of the intrinsic HIV neutralizing activity in the CVS of low-risk women, a broader range of non-cationic proteins were associated with HIV neutralizing activity in HESN and HIV-positive female sex workers. These results indicate that novel protein factors found in CVS of women with high-risk sexual practices may have inherent antiviral activity, or are involved in other aspects of anti-HIV host defense, and warrant further exploration into their mode of action.	[Birse, Kenzie D. M.; Ball, Terry B.; Plummer, Frank; Burgener, Adam] Publ Hlth Agcy Canada, JC Wilt Infect Dis Res Ctr, Natl Lab HIV Immunol, Prote Unit, Winnipeg, MB, Canada; [Birse, Kenzie D. M.; Ball, Terry B.; Plummer, Frank; Burgener, Adam] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Cole, Amy L.; Cole, Alexander M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Hirbod, Taha; Burgener, Adam; Broliden, Kristina] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Dept Med Solna,Infect Dis Unit, Stockholm, Sweden; [McKinnon, Lyle] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa, Doris Duke Med Res Inst, Congella, South Africa; [Westmacott, Garrett R.; Plummer, Frank] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Ball, Terry B.; Kimani, Joshua; Plummer, Frank] Univ Nairobi, Kenyatta Natl Hosp, Dept Med Microbiol, Nairobi, Kenya	Public Health Agency of Canada; University of Manitoba; State University System of Florida; University of Central Florida; Karolinska Institutet; Karolinska University Hospital; University of Kwazulu Natal; Public Health Agency of Canada; Kenyatta National Hospital; University of Nairobi	Birse, KDM (corresponding author), Publ Hlth Agcy Canada, JC Wilt Infect Dis Res Ctr, Natl Lab HIV Immunol, Prote Unit, Winnipeg, MB, Canada.	ummogkk@myumanitoba.ca		McKinnon, Lyle/0000-0002-7157-0700	Swedish Research Council; National Institutes of Health [A1082693]	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Swedish Research Council http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html (KB, TH) and the National Institutes of Health A1082693 http://www.nih.gov/ (AMC).	Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; Broliden K, 2010, J INFECT DIS, V202, pS351, DOI 10.1086/655964; Burgener A, 2011, J PROTEOME RES, V10, P5139, DOI 10.1021/pr200596r; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Burgener A, 2013, J VIROL, V87, P5141, DOI 10.1128/JVI.03347-12; Chappell CA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.041; Choi RY, 2012, AIDS, V26, P2155, DOI 10.1097/QAD.0b013e328359b99b; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; Doerflinger SY, 2014, J INFECT DIS, V209, P1989, DOI 10.1093/infdis/jiu004; Embree JE, 2000, AIDS, V14, P2535, DOI 10.1097/00002030-200011100-00016; Findlay EG, 2013, BIODRUGS, V27, P479, DOI 10.1007/s40259-013-0039-0; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Hattori F, 2014, BRIT J DERMATOL, V171, P742, DOI 10.1111/bjd.13125; Hirbod T, 2008, AIDS, V22, P727, DOI 10.1097/QAD.0b013e3282f56b64; Hirbod T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004416; Hocini H, 2000, CLIN DIAGN LAB IMMUN, V7, P515, DOI 10.1128/CDLI.7.3.515-518.2000; Iqbal SM, 2009, AIDS, V23, P1669, DOI 10.1097/QAD.0b013e32832ea643; Jasinghe VJ, 2013, BIORESEARCH OPEN ACC, V2, P128, DOI 10.1089/biores.2012.0275; Jendrysik MA, 2005, J INFECT DIS, V192, P630, DOI 10.1086/432071; Kouno T, 2008, J PEPT SCI, V14, P1129, DOI 10.1002/psc.1050; Laneve P, 2008, J BIOL CHEM, V283, P34712, DOI 10.1074/jbc.M805759200; Morizane S, 2012, J DERMATOL, V39, P225, DOI 10.1111/j.1346-8138.2011.01483.x; Morrison C, 2014, JAIDS-J ACQ IMM DEF, V66, P109, DOI 10.1097/QAI.0000000000000103; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P15143, DOI 10.1073/pnas.191498798; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; NEWMAN GW, 1994, J EXP MED, V180, P359, DOI 10.1084/jem.180.1.359; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; Patel MV, 2013, AM J REPROD IMMUNOL, V69, P463, DOI 10.1111/aji.12078; Qin LZ, 2003, VIROLOGY, V308, P225, DOI [10.1016/S0042-6822(02)00088-0, 10.1016/S0042-3822(02)00088-0]; Rahman S, 2013, AM J REPROD IMMUNOL, V69, P64, DOI 10.1111/aji.12014; Sakaguchi M, 2011, AMINO ACIDS, V41, P797, DOI 10.1007/s00726-010-0747-4; Schenk H, 1996, J IMMUNOL, V156, P765; Shaw JLV, 2007, J PROTEOME RES, V6, P2859, DOI 10.1021/pr0701658; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wahl S M, 1997, Oral Dis, V3 Suppl 1, pS64; Wira CR, 2014, AM J REPROD IMMUNOL; Yao XD, 2014, MUCOSAL IMMUNOL, V7, P268, DOI 10.1038/mi.2013.44; Zhou J, 2013, MOL CELL BIOCHEM, V377, P75, DOI 10.1007/s11010-013-1572-3	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130404	10.1371/journal.pone.0130404	http://dx.doi.org/10.1371/journal.pone.0130404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090884	Green Published, gold			2022-12-26	WOS:000356835000114
J	Fenwick, PS; Macedo, P; Kilty, IC; Barnes, PJ; Donnelly, LE				Fenwick, Peter S.; Macedo, Patricia; Kilty, Iain C.; Barnes, Peter J.; Donnelly, Louise E.			Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; INDUCED SPUTUM; CXCR3 LIGANDS; SMOOTH-MUSCLE; TNF-ALPHA; EXPRESSION; CHEMOKINES; ACTIVATION; SMOKERS	Background CD8(+) T-cells are located in the small airways of COPD patients and may contribute to pathophysiology. CD8(+) cells express the chemokine receptor, CXCR3 that binds CXCL9, CXCL10 and CXCL11, which are elevated in the airways of COPD patients. These chemokines are released from airway epithelial cells via activation of receptor associated Janus kinases (JAK). This study compared the efficacy of two structurally dissimilar pan-JAK inhibitors, PF956980 and PF1367550, and the glucocorticosteroid dexamethasone, in BEAS-2B and human primary airway epithelial cells from COPD patients and control subjects. Methods Cells were stimulated with either IFN gamma alone or with TNF alpha, and release of CXCL9, CXCL10 and CXCL11 measured by ELISA and expression of CXCL9, CXCL10 and CXCL11 by qPCR. Activation of JAK signalling was assessed by STAT1 phosphorylation and DNA binding. Results There were no differences in the levels of release of CXCL9, CXCL10 and CXCL11 from primary airway epithelial cells from any of the subjects or following stimulation with either IFN gamma alone or with TNF alpha. Dexamethasone did not inhibit CXCR3 chemokine release from stimulated BEAS-2B or primary airway epithelial cells. However, both JAK inhibitors suppressed this response with PF1367550 being similar to 50-65-fold more potent than PF956980. The response of cells from COPD patients did not differ from controls with similar responses regardless of whether inhibitors were added prophylactically or concomitant with stimuli. These effects were mediated by JAK inhibition as both compounds suppressed STAT1 phosphorylation and DNA-binding of STAT1 and gene transcription. Conclusions These data suggest that the novel JAK inhibitor, PF1367550, is more potent than PF956980 and that JAK pathway inhibition in airway epithelium could provide an alternative anti-inflammatory approach for glucocorticosteroid-resistant diseases including COPD.	[Fenwick, Peter S.; Macedo, Patricia; Barnes, Peter J.; Donnelly, Louise E.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis, London, England; [Kilty, Iain C.] Pfizer Inc, Cambridge, MA USA	Imperial College London; Pfizer	Donnelly, LE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis, London, England.	l.donnelly@imperial.ac.uk		Barnes, Peter/0000-0002-5122-4018; Donnelly, Louise/0000-0002-0753-5425	NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London; Pfizer Inc.; National Institute for Health Research [NF-SI-0611-10148] Funding Source: researchfish	NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London(General Electric); Pfizer Inc.(Pfizer); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London and Pfizer Inc. The funders provided the molecules under assessment. However, the funders had no role in study design, data collection and analysis, or decision to publish.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; BURNETT D, 1987, LANCET, V2, P1043; Catley MC, 2006, MOL PHARMACOL, V70, P697, DOI 10.1124/mol.106.023150; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Chrysofakis G, 2004, CHEST, V125, P71, DOI 10.1378/chest.125.1.71; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Coe JWD, 2013, INVENTORINDAZOLES201; Costa C, 2008, CHEST, V133, P26, DOI 10.1378/chest.07-0393; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; Culpitt SV, 2005, RESP MED, V99, P703, DOI 10.1016/j.rmed.2004.10.022; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hardaker EL, 2004, FASEB J, V18, P191, DOI 10.1096/fj.03-0170fje; Hsu L, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/283617; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Meinke A, 1996, MOL CELL BIOL, V16, P6937; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Pechkovsky DV, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-75; Quint JK, 2010, CHEST, V137, P812, DOI 10.1378/chest.09-1541; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; SAETTA M, 1993, AM REV RESPIR DIS, V147, P301, DOI 10.1164/ajrccm/147.2.301; Saetta M, 2002, AM J RESP CRIT CARE, V165, P1404, DOI 10.1164/rccm.2107139; Sauty A, 1999, J IMMUNOL, V162, P3549; Siena L, 2011, RESP MED, V105, P1491, DOI 10.1016/j.rmed.2011.04.014; Steele AJ, 2010, BLOOD, V116, P4569, DOI 10.1182/blood-2009-09-245811; Tudhope SJ, 2007, J IMMUNOL, V179, P6237, DOI 10.4049/jimmunol.179.9.6237; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Vyas D, 2013, ANN PHARMACOTHER, V47, P1524, DOI 10.1177/1060028013512790; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Warwick G, 2013, RESPIROLOGY, V18, P874, DOI 10.1111/resp.12089; Yang CH, 2007, J IMMUNOL, V178, P986, DOI 10.4049/jimmunol.178.2.986	40	40	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128757	10.1371/journal.pone.0128757	http://dx.doi.org/10.1371/journal.pone.0128757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090665	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835000028
J	Guo, QY; Mather, JP; Yang, P; Boden, M; Mather, PT				Guo, Qiongyu; Mather, Jason P.; Yang, Pine; Boden, Mark; Mather, Patrick T.			Fabrication of Polymeric Coatings with Controlled Microtopographies Using an Electrospraying Technique	PLOS ONE			English	Article							THERMOPLASTIC POLYURETHANES; SURFACE-MORPHOLOGY; STENT COATINGS; ELUTING STENT; DRUG-RELEASE; IMPLANTS; DEGRADATION; TOPOGRAPHY; OSTEOBLAST; ROUGHNESS	Surface topography of medical implants provides an important biophysical cue on guiding cellular functions at the cell-implant interface. However, few techniques are available to produce polymeric coatings with controlled microtopographies onto surgical implants, especially onto implant devices of small dimension and with complex structures such as drug-eluting stents. Therefore, the main objective of this study was to develop a new strategy to fabricate polymeric coatings using an electrospraying technique based on the uniqueness of this technique in that it can be used to produce a mist of charged droplets with a precise control of their shape and dimension. We hypothesized that this technique would allow facile manipulation of coating morphology by controlling the shape and dimension of electrosprayed droplets. More specifically, we employed the electrospraying technique to coat a layer of biodegradable polyurethane with tailored microtopographies onto commercial coronary stents. The topography of such stent coatings was modulated by controlling the ratio of round to stretched droplets or the ratio of round to crumped droplets under high electric field before deposition. The shape of electrosprayed droplets was governed by the stability of these charged droplets right after ejection or during their flight in the air. Using the electrospraying technique, we achieved conformal polymeric coatings with tailored microtopographies onto conductive surgical implants. The approach offers potential for controlling the surface topography of surgical implant devices to modulate their integration with surrounding tissues.	[Guo, Qiongyu] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA; [Guo, Qiongyu; Mather, Jason P.; Yang, Pine; Mather, Patrick T.] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13210 USA; [Mather, Jason P.; Yang, Pine; Mather, Patrick T.] Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY USA; [Boden, Mark] Boston Sci Corp, Marlborough, MA USA	Case Western Reserve University; Syracuse University; Syracuse University; Boston Scientific	Mather, PT (corresponding author), Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13210 USA.	ptmather@syr.edu	Guo, Qiongyu/J-3118-2014	Guo, Qiongyu/0000-0002-1916-9100	Boston Scientific Corporation	Boston Scientific Corporation(Boston Scientific)	The authors received funding from Boston Scientific Corporation for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.bostonscientific.com/en-US/home.html. The funder provided support in the form of a salary for author MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; de Jonge LT, 2009, ADV FUNCT MATER, V19, P755, DOI 10.1002/adfm.200800819; deJuan L, 1997, J COLLOID INTERF SCI, V186, P280, DOI 10.1006/jcis.1996.4654; Duft D, 2003, NATURE, V421, P128, DOI 10.1038/421128a; Fuchs T, 2008, EUR J TRAUMA EMERG S, V34, P60, DOI 10.1007/s00068-006-6110-5; Gittens RA, 2013, ACTA BIOMATER, V9, P6268, DOI 10.1016/j.actbio.2012.12.002; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Gu XZ, 2011, BIOMACROMOLECULES, V12, P3066, DOI 10.1021/bm2006938; Guo Qiongyu, 2012, Results Pharma Sci, V2, P66, DOI 10.1016/j.rinphs.2012.09.002; Guo QY, 2009, J CONTROL RELEASE, V137, P224, DOI 10.1016/j.jconrel.2009.04.016; Hu H, 2006, J PHYS CHEM B, V110, P7090, DOI 10.1021/jp0609232; Huang Y, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045003; Huitron-Rattinger E, 2013, POLYMER, V54, P3350, DOI 10.1016/j.polymer.2013.04.015; Ijsebaert JC, 2001, J APPL PHYSIOL, V91, P2735, DOI 10.1152/jappl.2001.91.6.2735; Jaworek A, 2008, J ELECTROSTAT, V66, P197, DOI 10.1016/j.elstat.2007.10.001; Jaworek A, 2007, POWDER TECHNOL, V176, P18, DOI 10.1016/j.powtec.2007.01.035; Jaworek A, 1999, J AEROSOL SCI, V30, P873, DOI 10.1016/S0021-8502(98)00787-3; Knight PT, 2008, BIOMACROMOLECULES, V9, P2458, DOI 10.1021/bm8004935; Knight PT, 2010, J BIOMED MATER RES A, V94A, P333, DOI 10.1002/jbm.a.32806; Knoll W, 2010, ADV POLYM SCI, V224, P87, DOI 10.1007/12_2009_27; Kumbar SG, 2007, J BIOMED MATER RES B, V81B, P91, DOI 10.1002/jbm.b.30641; Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092106; Liu YL, 2010, J R SOC INTERFACE, V7, pS631, DOI 10.1098/rsif.2010.0115.focus; Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3; Nath SD, 2013, INT J PHARMACEUT, V443, P87, DOI 10.1016/j.ijpharm.2012.12.037; Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079; Nikolov AD, 2002, ADV COLLOID INTERFAC, V96, P325, DOI 10.1016/S0001-8686(01)00087-2; Oliveira DP, 2014, J BIOMED MATER RES A, V102, P1816, DOI 10.1002/jbm.a.34855; Puskas JE, 2009, WIRES NANOMED NANOBI, V1, P451, DOI 10.1002/wnan.38; Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934; TANG K, 1994, PHYS FLUIDS, V6, P2317, DOI 10.1063/1.868182; TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151; Tseng LF, 2013, ACTA BIOMATER, V9, P8790, DOI 10.1016/j.actbio.2013.06.043; Uematsu I, 2004, J COLLOID INTERF SCI, V269, P336, DOI 10.1016/j.jcis.2003.08.069; van der Hoeven BL, 2005, INT J CARDIOL, V99, P9, DOI 10.1016/j.ijcard.2004.01.021; Weh L, 2004, MACROMOL MATER ENG, V289, P227, DOI 10.1002/mame.200300262; Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237; Yohe ST, 2013, CHEM COMMUN, V49, P804, DOI 10.1039/c2cc38012a; Yu DG, 2013, RSC ADV, V3, P4652, DOI 10.1039/c3ra40334c	41	24	25	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129960	10.1371/journal.pone.0129960	http://dx.doi.org/10.1371/journal.pone.0129960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090663	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000077
J	Martinson, EO; Hackett, JD; Machado, CA; Arnold, AE				Martinson, Ellen O.; Hackett, Jeremiah D.; Machado, Carlos A.; Arnold, A. Elizabeth			Metatranscriptome Analysis of Fig Flowers Provides Insights into Potential Mechanisms for Mutualism Stability and Gall Induction	PLOS ONE			English	Article							CHALCONE SYNTHASE; RNA-SEQ; WASP; EVOLUTION; EXPRESSION; HOST; OVIPOSITION; ACCUMULATION; COEVOLUTION; ACTIVATION	A striking property of the mutualism between figs and their pollinating wasps is that wasps consistently oviposit in the inner flowers of the fig syconium, which develop into galls that house developing larvae. Wasps typically do not use the outer ring of flowers, which develop into seeds. To better understand differences between gall and seed flowers, we used a metatranscriptomic approach to analyze eukaryotic gene expression within fig flowers at the time of oviposition choice and early gall development. Consistent with the unbeatable seed hypothesis, we found significant differences in gene expression between gall- and seed flowers in receptive syconia prior to oviposition. In particular, transcripts assigned to flavonoids and carbohydrate metabolism were significantly up-regulated in gall flowers relative to seed flowers. In response to oviposition, gall flowers significantly up-regulated the expression of chalcone synthase, which previously has been connected to gall formation in other plants. We propose several genes encoding proteins with signal peptides or associations with venom of other Hymenoptera as candidate genes for gall initiation or growth. This study simultaneously evaluates the gene expression profile of both mutualistic partners in a plant-insect mutualism and provides insight into a possible stability mechanism in the ancient fig-fig wasp association.	[Martinson, Ellen O.; Hackett, Jeremiah D.; Arnold, A. Elizabeth] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Machado, Carlos A.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ USA	University of Arizona; University System of Maryland; University of Maryland College Park; University of Arizona	Martinson, EO (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	e.martinson@rochester.edu	Machado, Carlos A/B-8855-2009	Machado, Carlos A/0000-0003-1546-7415; Martinson, Ellen/0000-0001-9757-6679	National Science Foundation [IOB-062492]; NSF; Smithsonian Institute	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Smithsonian Institute(Smithsonian Institution)	We gratefully acknowledge the National Science Foundation (www.nsf.gov/) for supporting this research (IOB-062492 to AEA and an NSF Graduate Research Fellowship to EOM), as well as the Smithsonian Institute (www.si.edu/ Predoctoral Fellowship to EOM).	ABOUZAID MM, 1993, BIOCHEM SYST ECOL, V21, P415, DOI 10.1016/0305-1978(93)90099-D; Anstett MC, 2001, OIKOS, V95, P476, DOI 10.1034/j.1600-0706.2001.950313.x; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barbehenn RV, 2002, J CHEM ECOL, V28, P1329, DOI 10.1023/A:1016288201110; Beninger CW, 1997, BIOCHEM SYST ECOL, V25, P505, DOI 10.1016/S0305-1978(97)00034-3; Brent AE, 2007, SCIENCE, V315, P1841, DOI 10.1126/science.1137528; BRONSTEIN JL, 1988, ECOLOGY, V69, P1298, DOI 10.2307/1941287; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Bronstein JL, 2009, J ECOL, V97, P1160, DOI 10.1111/j.1365-2745.2009.01566.x; BULL JJ, 1991, J THEOR BIOL, V149, P63, DOI 10.1016/S0022-5193(05)80072-4; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; de Graaf DC, 2010, INSECT MOL BIOL, V19, P11, DOI 10.1111/j.1365-2583.2009.00914.x; Dunn DW, 2008, J ANIM ECOL, V77, P927, DOI 10.1111/j.1365-2656.2008.01416.x; Ersoy N, 2007, U ZIRAAT FAKULTESI D SDU ZIRAAT FAKULTESI, V2, P22; FEENY P, 1988, PHYTOCHEMISTRY, V27, P3439, DOI 10.1016/0031-9422(88)80745-3; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Grandi G., 1929, Bollettino del Laboratorio di Entomologia Bologna, V2, P1; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Gutierrez-Gonzalez JJ, 2010, PLANT CELL PHYSIOL, V51, P936, DOI 10.1093/pcp/pcq065; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Herre EA, 1997, P ROY SOC B-BIOL SCI, V264, P1501, DOI 10.1098/rspb.1997.0208; HERRE EA, 1989, EXPERIENTIA, V45, P637, DOI 10.1007/BF01975680; Herre EA, 1995, PARASITOLOGY, V111, pS179, DOI 10.1017/S0031182000075880; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; Holland JN, 2004, P ROY SOC B-BIOL SCI, V271, P1807, DOI 10.1098/rspb.2004.2789; HONDA K, 1990, J CHEM ECOL, V16, P325, DOI 10.1007/BF01021768; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hutangura P, 1999, AUST J PLANT PHYSIOL, V26, P221, DOI 10.1071/PP98157; Jander KC, 2010, P R SOC B; Jousselin E, 2003, OECOLOGIA, V134, P381, DOI 10.1007/s00442-002-1116-0; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Leigh E. G., 1996, ECOLOGY TROPICAL FOR; Leigh Egbert Giles Jr, 1995, Ecologie, V26, P131; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; Machado CA, 2001, P ROY SOC B-BIOL SCI, V268, P685, DOI 10.1098/rspb.2000.1418; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mani M.S., 1992, BIOL INSECT INDUCED, P3; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martinson EO, 2012, MICROB ECOL, V64, P1073, DOI 10.1007/s00248-012-0079-x; Nason JD, 1996, J BIOGEOGR, V23, P501, DOI 10.1111/j.1365-2699.1996.tb00012.x; Nefdt RJC, 1996, J ANIM ECOL, V65, P170, DOI 10.2307/5720; Neuhauser C, 2004, ECOL MODEL, V177, P337, DOI 10.1016/j.ecolmodel.2004.02.010; NISHIDA R, 1987, CELL MOL LIFE SCI, V43, P342; Pasold S, 2010, MOL PLANT PATHOL, V11, P545, DOI [10.1111/J.1364-3703.2010.00628.X, 10.1111/j.1364-3703.2010.00628.x]; Peiren N, 2006, FEBS LETT, V580, P4895, DOI 10.1016/j.febslet.2006.08.005; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Price DRG, 2009, INSECT MOL BIOL, V18, P195, DOI 10.1111/j.1365-2583.2009.00864.x; ROESSINGH P, 1991, PHYSIOL ENTOMOL, V16, P485, DOI 10.1111/j.1365-3032.1991.tb00588.x; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; RYDER TB, 1987, MOL GEN GENET, V210, P219, DOI 10.1007/BF00325687; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schwalm K, 2003, PLANTA, V218, P163, DOI 10.1007/s00425-003-1104-6; Simmonds MSJ, 2003, PHYTOCHEMISTRY, V64, P21, DOI 10.1016/S0031-9422(03)00293-0; Simmonds MSJ, 2001, PHYTOCHEMISTRY, V56, P245, DOI 10.1016/S0031-9422(00)00453-2; STRID A, 1994, PHOTOSYNTH RES, V39, P475, DOI 10.1007/BF00014600; VERKERKE W, 1986, P K NED AKAD C BIOL, V89, P443; Verkerke W, 1988, P K NED AKAD WETENSC, P443; Wang H, 2013, OIKOS, V122, P533, DOI 10.1111/j.1600-0706.2012.20463.x; Wasson AP, 2006, PLANT CELL, V18, P1617, DOI 10.1105/tpc.105.038232; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; WEST SA, 1994, P ROY SOC B-BIOL SCI, V258, P67, DOI 10.1098/rspb.1994.0143; Xiao JH, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r141; YOSHIOKA K, 1995, J JPN SOC FOOD SCI, V42, P219	71	17	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130745	10.1371/journal.pone.0130745	http://dx.doi.org/10.1371/journal.pone.0130745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090817	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000148
J	Siddiqui, MR; Mayanil, CS; Kim, KS; Tomita, T				Siddiqui, M. Rizwan; Mayanil, Chandra S.; Kim, Kwang Sik; Tomita, Tadanori			Angiopoietin-1 Regulates Brain Endothelial Permeability through PTPN-2 Mediated Tyrosine Dephosphorylation of Occludin	PLOS ONE			English	Article							TIGHT JUNCTION TRAFFICKING; IN-VIVO; CEREBRAL-ISCHEMIA; CELL-CELL; BARRIER; PHOSPHORYLATION; ZO-1; TIE2; COMPLEXES; PREVENTS	Objective Blood brain barrier (BBB) breakdown and increased endothelial permeability is a hallmark of neuro-vascular inflammation. Angiopoietin-1 (Ang-1), a Tie-2 receptor agonist ligand, is known to modulate barrier function of endothelial cells; however the molecular mechanisms related to Ang-1 mediated repair of Tight Junctions (TJs) in brain endothelium still remain elusive. In this study, we investigated a novel role of non-receptor protein tyrosine phosphatase N-2 (PTPN-2) in Ang-1 mediated stabilization of tight junction proteins. Method and Result To study the barrier protective mechanism of Ang-1, we challenged human brain microvascular endothelial cells in-vitro, with a potent inflammatory mediator thrombin. By using confocal microscopy and transwell permeability assay, we show that pretreatment of brain endothelial cells with Ang-1 diminish thrombin mediated disruption of TJs and increase in endothelial permeability. We also found that Ang-1 inhibits thrombin induced tyrosine phosphorylation of Occludin and promote Occludin interaction with Zona Occludens-1 (ZO-1) to stabilize TJs. Interestingly, our study revealed that depletion of PTPN-2 by siRNAs abolishes Ang-1 ability to promote tyrosine dephosphorylation of Occludin, resulting Occludin disassociation from ZO-1 and endothelial hyperpermeability. Summary Collectively, our findings suggest that in brain endothelial cells blocking PTPN-2 mediated tyrosine phosphorylation of Occludin is a novel mechanism to maintain BBB function, and may offer a key therapeutic strategy for neuro-inflammatory disorders associated with BBB disruption.	[Siddiqui, M. Rizwan; Mayanil, Chandra S.; Tomita, Tadanori] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Neurosurg, Chicago, IL 60611 USA; [Mayanil, Chandra S.; Tomita, Tadanori] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Kim, Kwang Sik] Johns Hopkins Univ, Sch Med, Div Pediat Infect Dis, Baltimore, MD USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Johns Hopkins University	Siddiqui, MR (corresponding author), Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Neurosurg, Chicago, IL 60611 USA.	msiddiqui@luriechildrens.org; ttomita@luriechildrens.org			Practice Plan Faculty Development Program Fund by Ann & Robert H. Lurie Children's Hospital of Chicago	Practice Plan Faculty Development Program Fund by Ann & Robert H. Lurie Children's Hospital of Chicago	This work was supported by Faculty Practice Plan Faculty Development Program Fund by Ann & Robert H. Lurie Children's Hospital of Chicago.	Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Chen T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05531; Coulombe G, 2013, MOL CELL BIOL, V33, P2275, DOI 10.1128/MCB.00043-13; Cristante E, 2013, P NATL ACAD SCI USA, V110, P832, DOI 10.1073/pnas.1209362110; Cui X, 2015, STROKE, V46, P827, DOI 10.1161/STROKEAHA.114.007145; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Heinonen KM, 2004, BLOOD, V103, P3457, DOI 10.1182/blood-2003-09-3153; Hua Y, 2003, ACT NEUR S, V86, P503; Kago T, 2006, BIOCHEM BIOPH RES CO, V339, P1197, DOI 10.1016/j.bbrc.2005.11.133; Kale G, 2003, BIOCHEM BIOPH RES CO, V302, P324, DOI 10.1016/S0006-291X(03)00167-0; Li HJ, 2014, J CELL SCI, V127, P3269, DOI 10.1242/jcs.145193; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Mattila E, 2008, J CELL SCI, V121, P3570, DOI 10.1242/jcs.031898; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Penrose HM, 2013, J BIOL CHEM, V288, P32651, DOI 10.1074/jbc.M113.475962; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Scharl M, 2009, GASTROENTEROLOGY, V137, P2030, DOI 10.1053/j.gastro.2009.07.078; Sharshar T, 2007, INTENS CARE MED, V33, P798, DOI 10.1007/s00134-007-0598-y; Siddiqui MR, 2011, J CELL BIOL, V193, P841, DOI 10.1083/jcb.201012129; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tash BR, 2012, P NATL ACAD SCI USA, V109, P10855, DOI 10.1073/pnas.1121390109; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Yamamoto M, 2008, AM J PATHOL, V172, P521, DOI 10.2353/ajpath.2008.070076	37	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130857	10.1371/journal.pone.0130857	http://dx.doi.org/10.1371/journal.pone.0130857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090670	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000152
J	Wang, DC; Zhang, GL; Zhao, MS; Pan, XZ; Zhao, YG; Li, DC; Macmillan, B				Wang, De-Cai; Zhang, Gan-Lin; Zhao, Ming-Song; Pan, Xian-Zhang; Zhao, Yu-Guo; Li, De-Cheng; Macmillan, Bob			Retrieval and Mapping of Soil Texture Based on Land Surface Diurnal Temperature Range Data from MODIS	PLOS ONE			English	Article							BRIGHTNESS TEMPERATURE; PHYSICAL-PROPERTIES; CLASSIFICATION; SATELLITE; MOISTURE	Numerous studies have investigated the direct retrieval of soil properties, including soil texture, using remotely sensed images. However, few have considered how soil properties influence dynamic changes in remote images or how soil processes affect the characteristics of the spectrum. This study investigated a new method for mapping regional soil texture based on the hypothesis that the rate of change of land surface temperature is related to soil texture, given the assumption of similar starting soil moisture conditions. The study area was a typical flat area in the Yangtze-Huai River Plain, East China. We used the widely available land surface temperature product of MODIS as the main data source. We analyzed the relationships between the content of different particle soil size fractions at the soil surface and land surface day temperature, night temperature and diurnal temperature range (DTR) during three selected time periods. These periods occurred after rainfalls and between the previous harvest and the subsequent autumn sowing in 2004, 2007 and 2008. Then, linear regression models were developed between the land surface DTR and sand (> 0.05 mm), clay (< 0.001 mm) and physical clay (< 0.01 mm) contents. The models for each day were used to estimate soil texture. The spatial distribution of soil texture from the studied area was mapped based on the model with the minimum RMSE. A validation dataset produced error estimates for the predicted maps of sand, clay and physical clay, expressed as RMSE of 10.69%, 4.57%, and 12.99%, respectively. The absolute error of the predictions is largely influenced by variations in land cover. Additionally, the maps produced by the models illustrate the natural spatial continuity of soil texture. This study demonstrates the potential for digitally mapping regional soil texture variations in flat areas using readily available MODIS data.	[Wang, De-Cai; Zhang, Gan-Lin; Zhao, Ming-Song; Pan, Xian-Zhang; Zhao, Yu-Guo; Li, De-Cheng] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Wang, De-Cai] Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China; [Zhao, Ming-Song] Anhui Univ Sci & Technol, Inst Surveying & Mapping, Huainan, Anhui, Peoples R China; [Macmillan, Bob] ISRIC World Soil Informat, NL-6700 AJ Wageningen, Netherlands	Chinese Academy of Sciences; Institute of Soil Science, CAS; Henan Agricultural University; Anhui University of Science & Technology	Zhang, GL (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	glzhang@issas.ac.cn	Pan, Xianzhang/F-1623-2016; Zhang, Gan-Lin/V-9261-2017; Li, Decheng/L-7383-2019	Pan, Xianzhang/0000-0001-5713-9132; Zhang, Gan-Lin/0000-0002-6189-5018; 	Natural Science Foundation of China [41130530, 41201210]; International Science & Technology Cooperation Project of China [2010DFB24140]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Project of China	The study was financially supported by the Natural Science Foundation of China (Grant No. 41130530; Grant No. 41201210), and the International Science & Technology Cooperation Project of China (2010DFB24140).	Cai G, 2007, INT J REMOTE SENS, V28, P3567, DOI 10.1080/01431160601034886; Chang DH, 2003, IEEE T GEOSCI REMOTE, V41, P664, DOI 10.1109/TGRS.2003.809935; Chang DH, 2000, REMOTE SENS ENVIRON, V74, P534, DOI 10.1016/S0034-4257(00)00144-9; CHEN HL, 1999, REMOTE SENSING TECHN, V14, P55; Crivelenti RC, 2009, PESQUI AGROPECU BRAS, V44, P1707, DOI 10.1590/S0100-204X2009001200021; Dematte JAM, 2007, INT J REMOTE SENS, V28, P3813, DOI 10.1080/01431160601121469; Gao MF, 2008, SENSORS-BASEL, V8, P4687, DOI 10.3390/s8084687; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Guoliang T., 1997, J REMOTE SENS, V1, P24; Henderson BL, 2005, GEODERMA, V124, P383, DOI 10.1016/j.geoderma.2004.06.007; HUDSON BD, 1992, SOIL SCI SOC AM J, V56, P836, DOI 10.2136/sssaj1992.03615995005600030027x; Iqbal J, 2005, SOIL SCI SOC AM J, V69, P1338, DOI 10.2136/sssaj2004.0154; [李星敏 Li Xingmin], 2005, [干旱地区农业研究, Agricultural Research in the Arid Areas], V23, P54; Li Yi, 2003, Transactions of the Chinese Society of Agricultural Engineering, V19, P62; Liu F, 2012, GEODERMA, V171, P44, DOI 10.1016/j.geoderma.2011.05.007; Lopez-Granados F, 2005, EUR J AGRON, V23, P279, DOI 10.1016/j.eja.2004.12.003; Maselli F, 2008, INT J REMOTE SENS, V29, P5555, DOI 10.1080/01431160802029651; Mattikalli NM, 1998, WATER RESOUR RES, V34, P2289, DOI 10.1029/98WR00553; Mattikalli NM, 1995, P SOC PHOTO-OPT INS, V2585, P89, DOI 10.1117/12.227172; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; McBratney AB, 2000, GEODERMA, V97, P293, DOI 10.1016/S0016-7061(00)00043-4; McKenzie NJ, 1999, GEODERMA, V89, P67, DOI 10.1016/S0016-7061(98)00137-2; Mora-Vallejo A, 2008, CATENA, V76, P44, DOI 10.1016/j.catena.2008.09.008; Nanni MR, 2006, SOIL SCI SOC AM J, V70, P393, DOI 10.2136/sssaj2003.0285; Oberthur T, 1999, EUR J SOIL SCI, V50, P457, DOI 10.1046/j.1365-2389.1999.00255.x; Qi F, 2006, GEODERMA, V136, P774, DOI 10.1016/j.geoderma.2006.06.001; Santanello JA, 2007, REMOTE SENS ENVIRON, V110, P79, DOI 10.1016/j.rse.2007.02.007; Shi X, 2004, SOIL SCI SOC AM J, V68, P885, DOI 10.2136/sssaj2004.0885; Soil Survey Office of Jiangsu Province, 1996, SOIL SPEC JIANGS PRO; Thompson JA, 2006, GEODERMA, V133, P57, DOI 10.1016/j.geoderma.2006.03.037; Wang DC, 2012, PEDOSPHERE, V22, P394, DOI 10.1016/S1002-0160(12)60025-3; Zhai YS, 2006, COMPUT ELECTRON AGR, V54, P53, DOI 10.1016/j.compag.2006.08.001; Zhu AX, 2010, SOIL SCI SOC AM J, V74, P861, DOI 10.2136/sssaj2008.0411; Zhu AX, 2010, GEODERMA, V155, P164, DOI 10.1016/j.geoderma.2009.05.024; 刘振华, 2006, [中国科学. D辑, 地球科学, Science in China. D], V36, P552	35	20	21	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129977	10.1371/journal.pone.0129977	http://dx.doi.org/10.1371/journal.pone.0129977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090852	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000079
J	Dolcino, M; Ottria, A; Barbieri, A; Patuzzo, G; Tinazzi, E; Argentino, G; Beri, R; Lunardi, C; Puccetti, A				Dolcino, Marzia; Ottria, Andrea; Barbieri, Alessandro; Patuzzo, Giuseppe; Tinazzi, Elisa; Argentino, Giuseppe; Beri, Ruggero; Lunardi, Claudio; Puccetti, Antonio			Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis	PLOS ONE			English	Article							FC-GAMMA-RIIB; RHEUMATOID-ARTHRITIS; OSTEOBLAST DIFFERENTIATION; INFLAMMATORY RESPONSE; INTERFERON SIGNATURE; BETA-CATENIN; MULTIPLE-SCLEROSIS; BONE-FORMATION; MESSENGER-RNA; PROTEIN	Background Psoriatic arthritis (PsA) is an inflammatory arthritis whose pathogenesis is poorly understood; it is characterized by bone erosions and new bone formation. The diagnosis of PsA is mainly clinical and diagnostic biomarkers are not yet available. The aim of this work was to clarify some aspects of the disease pathogenesis and to identify specific gene signatures in paired peripheral blood cells (PBC) and synovial biopsies of patients with PsA. Moreover, we tried to identify biomarkers that can be used in clinical practice. Methods PBC and synovial biopsies of 10 patients with PsA were used to study gene expression using Affymetrix arrays. The expression values were validated by Q-PCR, FACS analysis and by the detection of soluble mediators. Results Synovial biopsies of patients showed a modulation of approximately 200 genes when compared to the biopsies of healthy donors. Among the differentially expressed genes we observed the upregulation of Th17 related genes and of type I interferon (IFN) inducible genes. FACS analysis confirmed the Th17 polarization. Moreover, the synovial trascriptome shows gene clusters (bone remodeling, angiogenesis and inflammation) involved in the pathogenesis of PsA. Interestingly 90 genes are modulated in both compartments (PBC and synovium) suggesting that signature pathways in PBC mirror those of the inflamed synovium. Finally the osteoactivin gene was upregulared in both PBC and synovial biopsies and this finding was confirmed by the detection of high levels of osteoactivin in PsA sera but not in other inflammatory arthritides. Conclusions We describe the first analysis of the trancriptome in paired synovial tissue and PBC of patients with PsA. This study strengthens the hypothesis that PsA is of autoimmune origin since the coactivity of IFN and Th17 pathways is typical of autoimmunity. Finally these findings have allowed the identification of a possible disease biomarker, osteoactivin, easily detectable in PsA serum.	[Dolcino, Marzia; Puccetti, Antonio] Inst G Gaslini, Genoa, Italy; [Barbieri, Alessandro; Patuzzo, Giuseppe; Tinazzi, Elisa; Argentino, Giuseppe; Beri, Ruggero; Lunardi, Claudio] Univ Verona, I-37100 Verona, Italy; [Ottria, Andrea; Puccetti, Antonio] Univ Genoa, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona; University of Genoa	Puccetti, A (corresponding author), Inst G Gaslini, Genoa, Italy.	antonio.puccetti@unige.it	Tinazzi, Elisa/AAB-9450-2020	Ottria, Andrea/0000-0001-8722-3968; PATUZZO, Giuseppe/0000-0001-8011-0004; Argentino, Giuseppe/0000-0002-4747-4655				Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Abdelmagid SM, 2014, AM J PATHOL, V184, P697, DOI 10.1016/j.ajpath.2013.11.031; Abdelmagid SM, 2010, J CELL BIOCHEM, V111, P295, DOI 10.1002/jcb.22702; Al-Alwan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027339; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Alves RDAM, 2010, J PROTEOME RES, V9, P4688, DOI 10.1021/pr100400d; Ambrosi A, 2012, EUR J IMMUNOL, V42, P2274, DOI 10.1002/eji.201242653; Anandarajah A, 2013, CLIN REV ALLERG IMMU, V44, P157, DOI 10.1007/s12016-012-8304-4; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Batliwalla FM, 2005, GENES IMMUN, V6, P388, DOI 10.1038/sj.gene.6364209; Benjamin M, 2007, ARTHRITIS RHEUM, V56, P224, DOI 10.1002/art.22290; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Boncela J, 2011, J BIOL CHEM, V286, P43164, DOI 10.1074/jbc.M111.245647; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Braum Oliver, 2012, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V11, P221; Brkic Z, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4499; Bundschu K, 2005, J BIOL CHEM, V280, P28572, DOI 10.1074/jbc.M503640200; Butt C, 2005, ANN RHEUM DIS, V64, P114; Cai CK, 2012, ONCOL REP, V28, P1764, DOI 10.3892/or.2012.1995; Caignard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053881; Canete JD, 2007, ANN RHEUM DIS, V66, P720, DOI 10.1136/ard.2006.062042; Chang SK, 2010, IMMUNOL REV, V233, P256, DOI 10.1111/j.0105-2896.2009.00854.x; Charoenwattanasatien R, 2012, BIOCHEM GENET, V50, P990, DOI 10.1007/s10528-012-9538-9; Chatterjee M, 2012, J BIOL CHEM, V287, DOI [10.1074/jbc.M112.415067, 10.1074/jbc.M111.272179]; Chatterjee M, 2012, J IMMUNOL, V188, P1206, DOI 10.4049/jimmunol.1102773; Chen T, 2009, PROTEINS, V77, P209, DOI 10.1002/prot.22432; Cheung CL, 2009, HUM MOL GENET, V18, P679, DOI 10.1093/hmg/ddn397; Chimenti MS, 2013, AUTOIMMUN REV, V12, P599, DOI 10.1016/j.autrev.2012.10.002; Costa D, 2013, J CELL PHYSIOL, V228, P2210, DOI 10.1002/jcp.24391; Crow Mary K, 2010, Arthritis Res Ther, V12 Suppl 1, pS5, DOI 10.1186/ar2886; Dolcino M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/198956; Dolcino M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115424; Dolcino M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097571; Duarte GV, 2012, BEST PRACT RES CL RH, V26, P147, DOI 10.1016/j.berh.2012.01.003; E XQ, 2012, SCAND J RHEUMATOL, V41, P413, DOI 10.3109/03009742.2012.696135; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Eder L, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0316-4; Eto N, 2009, AM J PATHOL, V174, P1553, DOI 10.2353/ajpath.2009.080190; Fan JB, 2009, TISSUE ENG PART B-RE, V15, P75, DOI 10.1089/ten.teb.2008.0586; Fan LY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4112; Fearon Ursula, 2007, V135, P343; Fujikawa K, 2000, ANTICANCER RES, V20, P1927; Gao J, 2011, J CELL BIOCHEM, V112, P1844, DOI 10.1002/jcb.23106; Garlanda C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00396; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Gordon JAR, 2010, MOL CELL BIOL, V30, P3531, DOI 10.1128/MCB.00889-09; Gordon RA, 2012, ARTHRITIS RHEUM-US, V64, P3119, DOI 10.1002/art.34544; Guang W, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00105; Gunther C, 2012, J INVEST DERMATOL, V132, P626, DOI 10.1038/jid.2011.371; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Han SW, 2013, CARDIOVASC RES, V98, P73, DOI 10.1093/cvr/cvt019; Hemdan NY, 2010, AUTOIMMUN REV, V9, P785, DOI 10.1016/j.autrev.2010.07.003; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hirvonen M, 2012, J HISTOCHEM CYTOCHEM, V60, P537, DOI 10.1369/0022155412448069; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Hossain MN, 2006, BIOCHEM BIOPH RES CO, V351, P645, DOI 10.1016/j.bbrc.2006.10.112; Hsieh JL, 2010, J ORTHOP RES, V28, P1300, DOI 10.1002/jor.21134; Huang HW, 2011, RHEUMATOLOGY, V50, P1045, DOI 10.1093/rheumatology/keq440; Ishikawa M, 2012, ARTHRITIS RHEUM-US, V64, P1024, DOI 10.1002/art.33452; Iwamoto T, 2008, FEBS J, V275, P4448, DOI 10.1111/j.1742-4658.2008.06580.x; Jackson TA, 2010, J IMMUNOL, V185, P7405, DOI 10.4049/jimmunol.1002305; Jain A, 2005, P NATL ACAD SCI USA, V102, P11858, DOI 10.1073/pnas.0502113102; Jeong CY, 2012, ONCOL REP, V28, P1283, DOI 10.3892/or.2012.1922; Jones GW, 2013, ANN RHEUM DIS, V72, P1738, DOI 10.1136/annrheumdis-2013-203771; Joyce-Shaikh B, 2010, J EXP MED, V207, P579, DOI 10.1084/jem.20090516; Kaleta B, 2014, ARCH IMMUNOL THER EX; Kane D, 2004, J RHEUMATOL, V31, P1274; Kikuta J, 2013, RHEUMATOLOGY, V52, P226, DOI 10.1093/rheumatology/kes259; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kim Chang H., 2009, Inflammation & Allergy Drug Targets, V8, P221; Kitamoto S, 2012, ONCOGENE; Konig A, 2000, VIRCHOWS ARCH, V436, P449, DOI 10.1007/s004280050472; Korb-Pap A, 2012, ANN RHEUM DIS, V71, P1004, DOI 10.1136/annrheumdis-2011-200386; Korendowych Eleanor, 2005, Curr Rheumatol Rep, V7, P306, DOI 10.1007/s11926-005-0041-8; Kruithof E, 2005, ARTHRITIS RES THER, V7, pR569, DOI 10.1186/ar1698; LAFLEUR M, 1987, J BIOL CHEM, V262, P2111; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee A, 2013, ARTHRITIS RHEUM-US, V65, P928, DOI 10.1002/art.37853; Li FH, 2005, J BONE MINER RES, V20, P1161, DOI 10.1359/JBMR.050207; Li HL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/953462; Li W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019313; Li Y, 2010, MOL IMMUNOL, V47, P2467, DOI 10.1016/j.molimm.2010.06.007; Lin NY, 2013, AUTOPHAGY, V9, P1253, DOI 10.4161/auto.25467; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logar DB, 2007, J BONE MINER METAB, V25, P219, DOI 10.1007/s00774-007-0753-0; Lu YJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3304; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Magnusson SE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2206; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Maria NI, 2013, ANN RHEUM DIS; Mathews S, 2012, DIFFERENTIATION, V84, P185, DOI 10.1016/j.diff.2012.05.001; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Mavropoulos A, 2013, AUTOIMMUN REV, V12, P580, DOI 10.1016/j.autrev.2012.10.019; McGonagle D, 2002, ANN RHEUM DIS, V61, P534, DOI 10.1136/ard.61.6.534; McGonagle D, 2011, ANN RHEUM DIS, V70, pI71, DOI 10.1136/ard.2010.144097; McGonagle DG, 2012, DERMATOLOGY, V225, P100, DOI 10.1159/000341536; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; McQueen F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1934; Mease P, 2013, CURR OPIN RHEUMATOL, V25, P287, DOI 10.1097/BOR.0b013e32835fd8d5; Mensah Kofi A, 2008, Curr Rheumatol Rep, V10, P311, DOI 10.1007/s11926-008-0050-5; Mentink A, 2013, BIOMATERIALS, V34, P4592, DOI 10.1016/j.biomaterials.2013.03.001; Miao CG, 2013, CELL SIGNAL, V25, P2069, DOI 10.1016/j.cellsig.2013.04.002; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Morimoto J, 2010, CURR DRUG TARGETS, V11, P494, DOI 10.2174/138945010790980321; Moschella F, 2013, CLIN CANCER RES, V19, P4249, DOI 10.1158/1078-0432.CCR-12-3666; Nakki A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-50; Nissen-Meyer LSH, 2007, J CELL SCI, V120, P2785, DOI 10.1242/jcs.003855; O'Connor BP, 2008, IMMUNOL RES, V41, P217, DOI 10.1007/s12026-008-8026-0; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Oh MJ, 2008, BIOCHEM BIOPH RES CO, V375, P430, DOI 10.1016/j.bbrc.2008.08.040; Olivieri I, 2014, NAT REV RHEUMATOL; Park J. S., 2013, ANN RHEUM DIS; Patterson AM, 2008, ANN RHEUM DIS, V67, P592, DOI 10.1136/ard.2006.063875; Patterson EI, 2013, J VIROL METHODS, V189, P118, DOI 10.1016/j.jviromet.2013.01.020; Pollock RA, 2015, J INVEST DERMATOL, V135, P620, DOI 10.1038/jid.2014.414; Power PF, 2013, J ORTHOP RES, V31, P493, DOI 10.1002/jor.22227; Qu N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/968549; Rahimi H, 2012, CURR RHEUMATOL REP, V14, P349, DOI 10.1007/s11926-012-0259-1; Rahman P, 2005, ANN RHEUM DIS, V64, P1370, DOI 10.1136/ard.2004.031765; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; Ramonda R, 2013, EXP BIOL MED, V238, P1431, DOI 10.1177/1535370213506435; Raterman HG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3819; Raychaudhuri SP, 2014, J AUTOIMMUN, V48-49, P128, DOI 10.1016/j.jaut.2014.01.015; Ritchlin CT, 2005, CURR OPIN RHEUMATOL, V17, P406, DOI 10.1097/01.bor.0000167752.93543.76; Robinson H, 2009, J RHEUMATOL, V36, P14, DOI 10.3899/jrheum.090212; Rodig SJ, 2010, HAEMATOL-HEMATOL J, V95, P2056, DOI 10.3324/haematol.2010.025767; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Ruiz- Heiland G, 2013, ANN RHEUM DIS; Russolillo A, 2013, RHEUMATOLOGY, V52, P62, DOI 10.1093/rheumatology/kes242; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Sherlock JP, 2014, MOL IMMUNOL, V57, P38, DOI 10.1016/j.molimm.2013.06.010; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Smith KGC, 2010, NAT REV IMMUNOL, V10, P674, DOI 10.1038/nri2762; Song CZ, 2012, INFLAMM RES, V61, P1219, DOI 10.1007/s00011-012-0519-6; Staudt LM, 2002, ANNU REV MED, V53, P303, DOI 10.1146/annurev.med.53.082901.103941; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; Strehl C, 2014, J LEUKOCYTE BIOL, V95, P233, DOI 10.1189/jlb.1212627; Su KH, 2007, J IMMUNOL, V178, P3272, DOI 10.4049/jimmunol.178.5.3272; Suzuki E, 2014, AUTOIMMUN REV, V13, P496, DOI 10.1016/j.autrev.2014.01.050; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Talhouk RS, 2013, EXP CELL RES, V319, P3065, DOI 10.1016/j.yexcr.2013.10.002; Tanaka M, 2008, CLIN EXP IMMUNOL, V154, P38, DOI 10.1111/j.1365-2249.2008.03733.x; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Thurlings RM, 2010, ARTHRITIS RHEUM-US, V62, P3607, DOI 10.1002/art.27702; Tinazzi E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3069; Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578; Toyoshima Y, 2004, J BIOL CHEM, V279, P25898, DOI 10.1074/jbc.M400661200; Trouw LA, 2012, AUTOIMMUN REV, V12, P318, DOI 10.1016/j.autrev.2012.05.007; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; van Vliet SJ, 2008, TRENDS IMMUNOL, V29, P83, DOI 10.1016/j.it.2007.10.010; Veale DJ, 2005, ANN RHEUM DIS, V64, P26, DOI 10.1136/ard.2004.031740; Venkateswaran A, 2013, INVEST NEW DRUG, V31, P535, DOI 10.1007/s10637-012-9884-9; Vessichelli M, 2012, J BIOL CHEM, V287, P13722, DOI 10.1074/jbc.M111.304436; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024967; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Wang RX, 2012, J BIOL CHEM, V287, P36012, DOI 10.1074/jbc.M112.390625; Weng LH, 2012, ARTHRITIS RHEUM-US, V64, P3267, DOI 10.1002/art.34602; Wu XFS, 2012, P NATL ACAD SCI USA, V109, pE2101, DOI 10.1073/pnas.1209397109; Xu K, 2013, INFLAMM RES, V62, P229, DOI 10.1007/s00011-012-0572-1; Xu LL, 2012, HEPATOLOGY, V55, P1985, DOI 10.1002/hep.25560; Yamamoto Toshiyuki, 2013, ISRN Dermatol, V2013, P630620, DOI 10.1155/2013/630620; Yammani RR, 2012, BBA-MOL BASIS DIS, V1822, P600, DOI 10.1016/j.bbadis.2012.01.006; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543; Zanotti S, 2011, J BIOL CHEM, V286, P2648, DOI 10.1074/jbc.M110.183038; Zhuo JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043594	175	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128262	10.1371/journal.pone.0128262	http://dx.doi.org/10.1371/journal.pone.0128262			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086874	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500015
J	Ewing, VL; Tolhurst, R; Kapinda, A; SanJoaquin, M; Terlouw, DJ; Richards, E; Lalloo, DG				Ewing, Victoria L.; Tolhurst, Rachel; Kapinda, Andrew; SanJoaquin, Miguel; Terlouw, Dianne J.; Richards, Esther; Lalloo, David G.			Understanding Interpretations of and Responses to Childhood Fever in the Chikhwawa District of Malawi	PLOS ONE			English	Article							HEALTH-SEEKING BEHAVIOR; MALARIA CONTROL; FEBRILE ILLNESS; ECONOMIC COSTS; RURAL MALAWI; KNOWLEDGE; PERCEPTIONS; CHILDREN; TANZANIA; NDIRANDE	Background Universal access to, and community uptake of malaria prevention and treatment strategies are critical to achieving current targets for malaria reduction. Each step in the treatment-seeking pathway must be considered in order to establish where opportunities for successful engagement and treatment occur. We describe local classifications of childhood febrile illnesses, present an overview of treatment-seeking, beginning with recognition of illness, and suggest how interventions could be used to target the barriers experienced. Methods Qualitative data were collected between September 2010 and February 2011. A total of 12 Focus Group Discussions and 22 Critical Incident Interviews were conducted with primary caregivers who had reported a recent febrile episode for one of their children. Findings and Conclusion The phrase 'kutentha thupi', or 'hot body' was used to describe fever, the most frequently mentioned causes of which were malungo(translated as 'malaria'), mauka, nyankhwa and (m)tsempho. Differentiating the cause was challenging because these illnesses were described as having many similar non-specific symptoms, despite considerable differences in the perceived mechanisms of illness. Malungo was widely understood to be caused by mosquitoes. Commonly described symptoms included: fever, weakness, vomiting, diarrhoea and coughing. These symptoms matched well with the biomedical definition of malaria, although they also overlapped with symptoms of other illnesses in both the biomedical model and local illness classifications. In addition, malungo was used interchangeably to describe malaria and fever in general. Caregivers engaged in a three-phased approach to treatment seeking. Phase 1-Assessment; Phase 2-Seeking care outside the home; Phase 3-Evaluation of treatment response. Within this paper, the three-phased approach is explored to identify potential interventions to target barriers to appropriate treatment. Community engagement and health promotion, the provision of antimalarials at community level and better training health workers in the causes and treatment of non-malarial febrile illnesses may improve access to appropriate treatment and outcomes.	[Ewing, Victoria L.; Kapinda, Andrew; Terlouw, Dianne J.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Ewing, Victoria L.; Tolhurst, Rachel; Terlouw, Dianne J.; Richards, Esther; Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [SanJoaquin, Miguel] World Bank, Phnom Penh, Cambodia	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; The World Bank	Ewing, VL (corresponding author), Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	ewingvl@gmail.com	Dusabe-Richards, Esther/R-4329-2017	Dusabe-Richards, Esther/0000-0003-3568-9023; Lalloo, David/0000-0001-7680-2200; Terlouw, Anja/0000-0001-5327-8995; Tolhurst, Rachel/0000-0002-3005-6641	ACT Consortium [ITGB-5150]; Bill and Melinda Gates Foundation	ACT Consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This publication is supported by the ACT Consortium (Grant ID = ITGB-5150, http://www.actconsortium.org/), which is funded through a grant from the Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; Aubel J, 2004, SOC SCI MED, V59, P945, DOI 10.1016/j.socscimed.2003.11.044; Barbour R., 2007, DOING FOCUS GROUPS; Bisika T, 2009, MALAWI MED J, V21, P59; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Chibwana AI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-219; Chuma J, 2008, US AG INT DEV UNPUB; Chuma J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-243; Chuma JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-76; Ewing VL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-32; HEGGENHOUGEN K, 2003, UNDP WORLD BANK WHO; HELITZERALLEN DL, 1992, HEALTH EDUC QUART, V19, P41, DOI 10.1177/109019819201900104; Kamat VR, 2006, SOC SCI MED, V62, P2945, DOI 10.1016/j.socscimed.2005.11.042; Kizito J, 2012, MALARIA J, V11, DOI [10.1186/PREACCEPT-2317562776368437, 10.1186/1475-2875-11-55]; Launiala A, 2010, MED ANTHROPOL Q, V24, P399, DOI 10.1111/j.1548-1387.2010.01111.x; Lichtenstein B, 2005, SOC SCI MED, V60, P701, DOI 10.1016/j.socscimed.2004.06.021; LIPOWSKY R, 1992, SOC SCI MED, V34, P625, DOI 10.1016/0277-9536(92)90190-2; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; McCombie SC, 2002, HEALTH POLICY PLANN, V17, P333, DOI 10.1093/heapol/17.4.333; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; Molyneux CS, 2002, J BIOSOC SCI, V34, P109, DOI 10.1017/S0021932002001098; Mota REM, 2009, AM J TROP MED HYG, V81, P935, DOI 10.4269/ajtmh.2009.08-0361; Muela S H, 1998, Anthropol Med, V5, P43, DOI 10.1080/13648470.1998.9964548; Muela SH, 2002, SOC SCI MED, V55, P403; Mumba M, 2003, TROP MED INT HEALTH, V8, P544, DOI 10.1046/j.1365-3156.2003.01064.x; Muula AS, 2004, TROP DOCT, V34, P187, DOI 10.1177/004947550403400327; Muula AS, 2004, TROP DOCT, V34, P90, DOI 10.1177/004947550403400210; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; NSO, 2005, INT HOUS SURV 2004 2; NSO, MAL NAT MAL IND SURV; Patton M. Q., 1990, QUALITATIVE EVALUATI; RBM, 2008, GLOB MAL ACT PLAN RO; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Ribera JM, 2011, MED ANTHROPOL Q, V25, P103, DOI 10.1111/j.1548-1387.2010.01139.x; Richie J., 2003, QUALITATIVE RES PRAC; Roca-Feltrer A, 2012, AM J TROP MED HYG, V86, P96, DOI 10.4269/ajtmh.2012.11-0397; Sauerborn R, 1996, SOC SCI MED, V43, P291, DOI 10.1016/0277-9536(95)00375-4; Sauerborn R, 1996, SOC SCI MED, V43, P281, DOI 10.1016/0277-9536(95)00374-6; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-333; Tanner M, 1998, SOC SCI MED, V46, P523, DOI 10.1016/S0277-9536(97)00195-0; Tolhurst R, 2008, MIDWIFERY, V24, P83, DOI 10.1016/j.midw.2006.09.003; Tolhurst R, 2008, SOC SCI MED, V66, P1106, DOI 10.1016/j.socscimed.2007.11.032; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010	45	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0125439	10.1371/journal.pone.0125439	http://dx.doi.org/10.1371/journal.pone.0125439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NT	26087147	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000356567500005
J	Noer, CL; Needham, EK; Wiese, AS; Balsby, TJS; Dabelsteen, T				Noer, Christina Lehmkuhl; Needham, Esther Kjaer; Wiese, Ann-Sophie; Balsby, Thorsten Johannes Skovbjerg; Dabelsteen, Torben			Context Matters: Multiple Novelty Tests Reveal Different Aspects of Shyness-Boldness in Farmed American Mink (Neovison vison)	PLOS ONE			English	Article							BEHAVIORAL SYNDROMES; INDIVIDUAL-DIFFERENCES; COPING STYLES; PERSONALITY; ANIMALS; EVOLUTION; HUMANS; FEAR; PHENOTYPES; SITUATION	Animal personality research is receiving increasing interest from related fields, such as evolutionary personality psychology. By merging the conceptual understanding of personality, the contributions to both fields of research may be enhanced. In this study, we investigate animal personality based on the definition of personality traits as underlying dispositional factors, which are not directly measurable, but which predispose individuals to react through different behavioural patterns. We investigated the shyness-boldness continuum reflected in the consistency of inter-individual variation in behavioural responses towards novelty in 47 farmed American mink (Neovison vison), which were raised in identical housing conditions. Different stages of approach behaviour towards novelty, and how these related within and across contexts, were explored. Our experimental design contained four tests: two novel object tests (non-social contexts) and two novel animated stimuli tests (social contexts). Our results showed consistency in shyness measures across multiple tests, indicating the existence of personality in farmed American mink. It was found that consistency in shyness measures differs across non-social and social contexts, as well as across the various stages in the approach towards novel objects, revealing that different aspects of shyness exist in the farmed American mink. To our knowledge this is the first study to reveal aspects of the shyness-boldness continuum in the American mink. Since the mink were raised in identical housing conditions, inherited factors may have been important in shaping the consistent inter-individual variation. Body weight and sex had no effect on the personality of the mink. Altogether, our results suggest that the shyness-boldness continuum cannot be explained by a simple underlying dispositional factor, but instead encompasses a broader term of hesitating behaviour that might comprise several different personality traits.	[Noer, Christina Lehmkuhl; Needham, Esther Kjaer; Wiese, Ann-Sophie; Dabelsteen, Torben] Univ Copenhagen, Behav Ecol Grp, Sect Ecol & Evolut, Dept Biol, Copenhagen, Denmark; [Noer, Christina Lehmkuhl] Copenhagen Zoo, Res & Conservat, Frederiksberg, Denmark; [Balsby, Thorsten Johannes Skovbjerg] Aarhus Univ, Dept Biosci, Marine Ecol, Aarhus, Denmark	University of Copenhagen; Aarhus University	Noer, CL (corresponding author), Univ Copenhagen, Behav Ecol Grp, Sect Ecol & Evolut, Dept Biol, Copenhagen, Denmark.	cln@zoo.dk		Lehmkuhl Noer, Christina/0000-0001-8303-5759; Balsby, Thorsten J. S./0000-0001-6855-4040	Copenhagen Zoo; Innovation Fund Denmark, Ministry of Higher Education and Science, Denmark [12-122917]	Copenhagen Zoo; Innovation Fund Denmark, Ministry of Higher Education and Science, Denmark	Copenhagen Zoo funded the study by paying for the study animals and partly funding the PhD student CLN (http://www.zoo.dk/BesogZoo.aspx). Innovation Fund Denmark, Ministry of Higher Education and Science, Denmark supported the study by partly funding the PhD student CLN, Grant number: 12-122917 (http://innovationsfonden.dk).	Aron EN, 2012, PERS SOC PSYCHOL REV, V16, P262, DOI 10.1177/1088868311434213; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Buss DM, 2009, PERSPECT PSYCHOL SCI, V4, P359, DOI 10.1111/j.1745-6924.2009.01138.x; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Carter AJ, 2012, ANIM BEHAV, V84, P603, DOI 10.1016/j.anbehav.2012.06.015; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Edelaar P, 2012, BEHAV ECOL, V23, P619, DOI 10.1093/beheco/ars006; Fidell L., 2007, USING MULTIVARIATE S, P607; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Haage M, 2013, BEHAV PROCESS, V100, P103, DOI 10.1016/j.beproc.2013.08.009; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lund A, 1961, MINK OPDRAET NORDISK; MacDonald M, 2013, EXCEL 2013 THE MISSI, P292; Malmkvist J, 2002, ANIM BEHAV, V64, P487, DOI 10.1006/anbe.2002.3058; Manly B.S.J, 1990, MULTIVARIATE STAT ME, P59; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Michalski RL, 2010, PERS INDIV DIFFER, V48, P509, DOI 10.1016/j.paid.2009.10.027; Michelena P, 2009, BEHAV ECOL, V20, P145, DOI 10.1093/beheco/arn126; Montiglio PO, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0343; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; PETER JP, 1979, J MARKETING RES, V16, P6, DOI 10.2307/3150868; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; SVENDSEN GE, 1973, ECOLOGY, V54, P623, DOI 10.2307/1935349; Uher J, 2011, DEV PSYCHOBIOL, V53, P521, DOI 10.1002/dev.20544; van Oers K, 2005, BEHAV ECOL, V16, P716, DOI 10.1093/beheco/ari045; Van Reenen CG, 2005, PHYSIOL BEHAV, V85, P557, DOI 10.1016/j.physbeh.2005.06.015; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	36	16	16	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130474	10.1371/journal.pone.0130474	http://dx.doi.org/10.1371/journal.pone.0130474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087277	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500110
J	Goijman, AP; Conroy, MJ; Bernardos, JN; Zaccagnini, ME				Paula Goijman, Andrea; Conroy, Michael. J.; Nicolas Bernardos, Jaime; Elena Zaccagnini, Maria			Multi-Season Regional Analysis of Multi-Species Occupancy: Implications for Bird Conservation in Agricultural Lands in East-Central Argentina	PLOS ONE			English	Article							BUENOS-AIRES PROVINCE; FARMLAND BIRDS; SPECIES RICHNESS; GRASSLAND BIRDS; BREEDING BIRDS; HABITAT; ABUNDANCE; PATTERNS; FOREST; INTENSIFICATION	Rapid expansion and intensification of agriculture create challenges for the conservation of biodiversity and associated ecosystem services. In Argentina, the total row crop planted area has increased in recent decades with the expansion of soybean cultivation, homogenizing the landscape. In 2003 we started the first long-term, large-scale bird monitoring program in agroecosystems of central Argentina, in portions of the Pampas and Espinal ecoregions. Using data from this program, we evaluated the effect of land use and cover extent on birds between 2003-2012, accounting for imperfect detection probabilities using a Bayesian hierarchical, multi-species and multi-season occupancy model. We tested predictions that species diversity is positively related to habitat heterogeneity, which in intensified agroecosystems is thought to be mediated by food availability; thus the extent of land use and cover is predicted to affect foraging guilds differently. We also infer about ecosystem services provisioning and inform management recommendations for conservation of birds. Overall our results support the predictions. Although many species within each guild responded differently to land use and native forest cover, we identified generalities for most trophic guilds. For example, granivorous gleaners, ground insectivores and omnivores responded negatively to high proportions of soybean, while insectivore gleaners and aerial foragers seemed more tolerant. Habitat heterogeneity would likely benefit most species in an intensified agroecosystem, and can be achieved with a diversity of crops, pastures, and natural areas within the landscape. Although most studied species are insectivores, potentially beneficial for pest control, some guilds such as ground insectivores are poorly represented, suggesting that agricultural intensification reduces ecological functions, which may be recovered through management. Continuation of the bird monitoring program will allow us to continue to inform for conservation of birds in agroecosystems, identify research needed to reduce key uncertainties, and anticipate the effects of changes in agriculture in central Argentina.	[Paula Goijman, Andrea; Elena Zaccagnini, Maria] INTA, CIRN, Inst Recursos Biol, Buenos Aires, DF, Argentina; [Paula Goijman, Andrea; Conroy, Michael. J.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Nicolas Bernardos, Jaime] INTA, EEA Ingn Agr Guillermo Covas, Anguil, La Pampa, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); University System of Georgia; University of Georgia; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Goijman, AP (corresponding author), INTA, CIRN, Inst Recursos Biol, Buenos Aires, DF, Argentina.	goijman.andrea@inta.gob.ar		Goijman, Andrea/0000-0003-3475-9296	INTA Projects [AERN 292241, AERN 292221]; US Fish and Wildlife Service [98210-1-G958]; Western Hemisphere International Office; Neotropical Migratory Bird Conservation Act [2534]	INTA Projects; US Fish and Wildlife Service(US Fish & Wildlife Service); Western Hemisphere International Office; Neotropical Migratory Bird Conservation Act	Funds for this research have been provided by INTA Projects AERN 292241 (former 2624), AERN 292221 (former 2622). Part of the funding for avian field surveys was provided by the US Fish and Wildlife Service (Grant # 98210-1-G958), the Western Hemisphere International Office (1997-2002) and the Neotropical Migratory Bird Conservation Act (2003-2005) (Grant # 2534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen M.A., 2008, ECOL AUSTRAL, V19, P45, DOI DOI 10.1016/J.JPROT.2015.04.029; Alessio Viviana G., 2005, Instituto Superior de Correlacion Geologica (INSUGEO) Miscelanea, V14, P441; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2013, FAOSTAT; Azpiroz AB, 2003, AVES URUGUAY LISTA I, DOI [10.1007/s12185-014-1527-9, DOI 10.1007/S12185-014-1527-9]; Azpiroz AB, 2012, J FIELD ORNITHOL, V83, P217, DOI 10.1111/j.1557-9263.2012.00372.x; Baldi G, 2008, ECOL SOC, V13; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Bianchi A.R., 2010, ATLAS CLIMATICO DIGI; Biondi LM, 2005, ORNITOL NEOTROP, V16, P31; Birdlife International, 2013, IUCN RED LIST BIRDS; Blondel J, 2003, OIKOS, V100, P223, DOI 10.1034/j.1600-0706.2003.12152.x; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Bruggers RL, 1998, INT BIODETER BIODEGR, V42, P173, DOI 10.1016/S0964-8305(98)00046-8; Bucher E.H., 1990, P291; Cabrera AL., 1971, BOLET N SOC ARGENTIN, V14, P1; Camperi AR, 2004, ORNITOL NEOTROP, V15, P299; Canavelli S. B., 2011, BASES DISMINUIR DANO, V64, P49; Canavelli SB, 2014, AGR ECOSYST ENVIRON, V197, P128, DOI 10.1016/j.agee.2014.07.024; Canavelli Sonia B, 2012, Hornero, V27, P89; Carrete M, 2009, BIOL CONSERV, V142, P2002, DOI 10.1016/j.biocon.2009.02.012; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Codesido M, 2008, ORNITOL NEOTROP, V19, P575; Dardanelli S, 2006, DIVERS DISTRIB, V12, P687, DOI [10.1111/j.1472-4642.2006.00266.x, 10.1111/j.1366-9516.2006.00266.x]; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Filloy J, 2007, AGR ECOSYST ENVIRON, V120, P291, DOI 10.1016/j.agee.2006.09.013; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gavier-Pizarro GI, 2012, AGR ECOSYST ENVIRON, V154, P44, DOI 10.1016/j.agee.2011.08.013; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Goijman Andrea P., 2008, Hornero, V23, P67; Goijman AP, 2014, THESIS U GEORGIA ATH; Goldstein MI, 1999, ECOTOXICOLOGY, V8, P201, DOI 10.1023/A:1026496331396; Fischer CMG, 2012, MAMMALIA, V76, P399, DOI 10.1515/mammalia-2011-0113; Greenwood JJD, 2003, SCI TOTAL ENVIRON, V310, P221, DOI 10.1016/S0048-9697(02)00642-3; Guillera-Arroita G, 2011, METHODS ECOL EVOL, V2, P401, DOI 10.1111/j.2041-210X.2011.00089.x; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Jobin B, 2001, AGR ECOSYST ENVIRON, V84, P131, DOI 10.1016/S0167-8809(00)00206-1; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kery M, 2004, BASIC APPL ECOL, V5, P65, DOI 10.1078/1439-1791-00194; Kery M, 2009, ECOLOGY, V90, P1279, DOI 10.1890/07-1794.1; Lopez-Lanus B., 2008, CATEGORIZACION AVES; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MACARTHUR RH, 1964, AM NAT, V98, P387, DOI 10.1086/282334; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; MURTON RK, 1974, CONDOR, V76, P80, DOI 10.2307/1365986; Narosky T., 2010, AVES ARGENTINA URUGU; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Pacifici K, 2014, ECOL EVOL, V4, P877, DOI 10.1002/ece3.976; Panasci TA, 2002, WILSON BULL, V114, P114, DOI 10.1676/0043-5643(2002)114[0114:RHBEIF]2.0.CO;2; Pearman PB, 2002, ECOL MONOGR, V72, P19, DOI 10.1890/0012-9615(2002)072[0019:TSOCSH]2.0.CO;2; Philpott SM, 2009, ECOL APPL, V19, P1858, DOI 10.1890/08-1928.1; Remsen J.V. Jr, 1990, Studies in Avian Biology, P144; Remsen Jr J.V., 2014, CLASSIFICATION BIRD; Robinson RA, 2001, J APPL ECOL, V38, P1059, DOI 10.1046/j.1365-2664.2001.00654.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Ruiz-Gutierrez V, 2010, J APPL ECOL, V47, P621, DOI 10.1111/j.1365-2664.2010.01811.x; Saluso A., 2007, Revista Cientifica Agropecuaria, V11, P153; Di Giacomo AS, 2010, CONDOR, V112, P283, DOI 10.1525/cond.2010.090039; Sauer JR, 2002, ECOLOGY, V83, P1743, DOI 10.2307/3071992; Sauer JR, 2012, N AM BREEDING BIRD S; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Schrag AM, 2009, AGR ECOSYST ENVIRON, V132, P135, DOI 10.1016/j.agee.2009.03.009; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; SIIA, 2013, PRES NAC; Soriano A., 1992, NATURAL GRASSLANDS I, P367; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; THOMPSON J. J., 2009, GAM 2006 QUAIL 6 PER, P111; Thompson JJ, 2013, MONOGRAFIA AVES ARGE, V9, P61; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; Vickery JA, 2009, AGR ECOSYST ENVIRON, V133, P1, DOI 10.1016/j.agee.2009.05.012; Wiens J.A., 1989, ECOLOGY BIRD COMMUNI, V1; Wiens J. A, 1989, ECOLOGY BIRD COMMUNI, V2; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Zaccagnini Marie Elena, 2010, P39; Zaccagnini ME, 2011, VALORACION SERVICIOS, P185; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	83	26	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130874	10.1371/journal.pone.0130874	http://dx.doi.org/10.1371/journal.pone.0130874			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086250	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500138
J	Charmsaz, S; Beckett, K; Smith, FM; Bruedigam, C; Moore, AS; Al-Ejeh, F; Lane, SW; Boyd, AW				Charmsaz, Sara; Beckett, Kirrilee; Smith, Fiona M.; Bruedigam, Claudia; Moore, Andrew S.; Al-Ejeh, Fares; Lane, Steven W.; Boyd, Andrew W.			EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; EPHRIN; RECEPTORS; KINASE; FAMILY; HEK; ACTIVATION; LIGANDS; CLONING	Members of the Eph family of receptor tyrosine kinases and their membrane bound ephrin ligands have been shown to play critical roles in many developmental processes and more recently have been implicated in both normal and pathological processes in post-embryonic tissues. In particular, expression studies of Eph receptors and limited functional studies have demonstrated a role for the Eph/ephrin system in hematopoiesis and leukemogenesis. In particular, EphA2 was reported on hematopoietic stem cells and stromal cells. There are also reports of EphA2 expression in many different types of malignancies including leukemia, however there is a lack of knowledge in understanding the role of EphA2 in hematopoiesis and leukemogenesis. We explored the role of EphA2 in hematopoiesis by analyzing wild type and EphA2 knockout mice. Mature, differentiated cells, progenitors and hematopoietic stem cells derived from knockout and control mice were analyzed and no significant abnormality was detected. These studies showed that EphA2 does not have an obligatory role in normal hematopoiesis. Comparative studies using EphA2-negative MLL-AF9 leukemias derived from EphA2-knockout animals showed that there was no detectable functional role for EphA2 in the initiation or progression of the leukemic process. However, expression of EphA2 in leukemias initiated by MLL-AF9 suggested that this protein might be a possible therapy target in this type of leukemia. We showed that treatment with EphA2 monoclonal antibody IF7 alone had no effect on tumorigenicity and latency of the MLL-AF9 leukemias, while targeting of EphA2 using EphA2 monoclonal antibody with a radioactive payload significantly impaired the leukemic process. Altogether, these results identify EphA2 as a potential radio-therapeutic target in leukemias with MLL translocation.	[Charmsaz, Sara; Beckett, Kirrilee; Smith, Fiona M.; Bruedigam, Claudia; Al-Ejeh, Fares; Lane, Steven W.; Boyd, Andrew W.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Moore, Andrew S.; Lane, Steven W.; Boyd, Andrew W.] Univ Queensland, Brisbane, Qld, Australia; [Moore, Andrew S.] Childrens Hlth Queensland Hosp & Hlth Serv, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Charmsaz, S (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	Sara.Charmsaz@qimrberghofer.edu.au	Bruedigam, Claudia/P-6326-2018; Al-Ejeh, Fares/M-7032-2016; Bruedigam, Claudia/ABC-8681-2020; Moore, Andrew S/I-6275-2012	Bruedigam, Claudia/0000-0002-9580-1446; Al-Ejeh, Fares/0000-0002-1553-0077; Bruedigam, Claudia/0000-0002-9580-1446; Moore, Andrew S/0000-0001-8062-1779	Ph.D scholarship Leukaemia Foundation Australia; Leukaemia Foundation Australia; Conquer Cancer	Ph.D scholarship Leukaemia Foundation Australia; Leukaemia Foundation Australia; Conquer Cancer	This work was funded by Ph.D scholarship Leukaemia Foundation Australia to SC, Leukaemia Foundation Australia to AWB, Ride to Conquer Cancer to AWB and SC.	Al-Ejeh F, 2014, GROWTH FACTORS, V32, P254, DOI 10.3109/08977194.2014.984807; Al-Ejeh F, 2009, NUCL MED BIOL, V36, P395, DOI 10.1016/j.nucmedbio.2009.01.001; Annunziata CM, 2013, INVEST NEW DRUG, V31, P77, DOI 10.1007/s10637-012-9801-2; Bagger FO, 2013, NUCLEIC ACIDS RES, V41, pD1034, DOI 10.1093/nar/gks1021; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; BOYD AW, 1992, J BIOL CHEM, V267, P3262; Bruedigam C, 2014, CELL STEM CELL, V15, P775, DOI 10.1016/j.stem.2014.11.010; Charmsaz S, 2013, J LEUKEMIA; Dottori M, 1999, BLOOD, V94, P2477, DOI 10.1182/blood.V94.7.2477.419k13_2477_2486; Easty DJ, 2011, PIGM CELL MELANOMA R, V24, P446, DOI 10.1111/j.1755-148X.2011.00836.x; EASTY DJ, 1995, INT J CANCER, V60, P129, DOI 10.1002/ijc.2910600119; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Herath NI, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-144; Herath NI, 2012, EUR J CANCER, V48, P753, DOI 10.1016/j.ejca.2011.07.003; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lane SW, 2010, BLOOD, V115, P3489, DOI 10.1182/blood-2009-11-251728; Lazarova P, 2006, INT J IMMUNOPATH PH, V19, P49; Nakanishi H, 2007, P NATL ACAD SCI USA, V104, P14442, DOI 10.1073/pnas.0703211104; Naruse-Nakajima C, 2001, MECH DEVELOP, V102, P95, DOI 10.1016/S0925-4773(01)00290-8; Noberini R, 2009, CANCER CELL, V16, P452, DOI 10.1016/j.ccr.2009.11.008; Oricchio E, 2011, CELL, V147, P554, DOI 10.1016/j.cell.2011.09.035; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rao AV, 2005, CLIN MED RES, V3, P157, DOI 10.3121/cmr.3.3.157; Steube KG, 1999, LEUKEMIA LYMPHOMA, V33, P371, DOI 10.3109/10428199909058438; Ting MJ, 2010, EXP HEMATOL, V38, P1087, DOI 10.1016/j.exphem.2010.07.007; Ting MJ, 2008, OEPN HEMATOLOGY J, V2, P7; WICKS IP, 1992, P NATL ACAD SCI USA, V89, P1611, DOI 10.1073/pnas.89.5.1611	30	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130692	10.1371/journal.pone.0130692	http://dx.doi.org/10.1371/journal.pone.0130692			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083390	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567400155
J	Chen, HY; Yao, K; Chang, XY; Shim, JH; Kim, HG; Malakhova, M; Kim, DJ; Bode, AM; Dong, ZG				Chen, Hanyong; Yao, Ke; Chang, Xiaoyu; Shim, Jung-Hyun; Kim, Hong-Gyum; Malakhova, Margarita; Kim, Dong-Joon; Bode, Ann M.; Dong, Zigang			Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)	PLOS ONE			English	Article							TERMINAL KINASE DOMAIN; (-)-EPIGALLOCATECHIN GALLATE; HISTONE H3; CRYSTAL-STRUCTURE; TEA POLYPHENOLS; CELL-GROWTH; PHOSPHORYLATION; INHIBITION; RECEPTOR; ACTIVATION	The most active anticancer component in green tea is epigallocatechin-3-gallate (EGCG). Protein interaction with EGCG is a critical step for mediating the effects of EGCG on the regulation of various key molecules involved in signal transduction. By using computational docking screening methods for protein identification, we identified a serine/threonine kinase, 90-kDa ribosomal S6 kinase (RSK2), as a novel molecular target of EGCG. RSK2 includes two kinase catalytic domains in the N-terminal (NTD) and the C-terminal (CTD) and RSK2 full activation requires phosphorylation of both terminals. The computer prediction was confirmed by an in vitro kinase assay in which EGCG inhibited RSK2 activity in a dose-dependent manner. Pull-down assay results showed that EGCG could bind with RSK2 at both kinase catalytic domains in vitro and ex vivo. Furthermore, results of an ATP competition assay and a computer-docking model showed that EGCG binds with RSK2 in an ATP-dependent manner. In RSK2(+/+) and RSK2(-/-) murine embryonic fibroblasts, EGCG decreased viability only in the presence of RSK2. EGCG also suppressed epidermal growth factor-induced neoplastic cell transformation by inhibiting phosphorylation of histone H3 at Ser10. Overall, these results indicate that RSK2 is a novel molecular target of EGCG.	[Chen, Hanyong; Yao, Ke; Chang, Xiaoyu; Shim, Jung-Hyun; Kim, Hong-Gyum; Malakhova, Margarita; Kim, Dong-Joon; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu		Shim, Jung-Hyun/0000-0002-4062-4016	National Institutes of Health [CA1661011, CA172457, R37 C081064, CA027502, ES016548]; Hormel Foundation; United Soybean Board; NATIONAL CANCER INSTITUTE [R21CA172457, P01CA027502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; United Soybean Board; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The Hormel Foundation, United Soybean Board, and National Institutes of Health Grants CA1661011, CA172457, R37 C081064, CA027502, and ES016548. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; Choi HS, 2005, CANCER RES, V65, P5818, DOI 10.1158/0008-5472.CAN-05-0197; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Derewenda U, 2013, ACTA CRYSTALLOGR D, V69, P266, DOI 10.1107/S0907444912045520; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dong ZG, 1997, CANCER RES, V57, P4414; Dong ZG, 2006, MOL CARCINOGEN, V45, P416, DOI 10.1002/mc.20220; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Grover A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S20; Hsu KC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003127; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Leone M, 2003, CANCER RES, V63, P8118; Lin JX, 2008, BLOOD, V111, P525, DOI 10.1182/blood-2007-02-072207; LoRusso PM, 2010, CLIN CANCER RES, V16, P1924, DOI 10.1158/1078-0432.CCR-09-1883; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Malakhova M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008044; Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592; Milligan SA, 2009, CLIN CANCER RES, V15, P4885, DOI 10.1158/1078-0432.CCR-09-0109; Okimoto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000528; Ota T, 2002, CANCER RES, V62, P5168; Petrelli A, 2008, CURR MED CHEM, V15, P422; Poteet-Smith CE, 1999, J BIOL CHEM, V274, P22135, DOI 10.1074/jbc.274.32.22135; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schrodinger, 2014, SCHRODINGER SUITE 20; Sheng YQ, 2014, J BIOL CHEM, V289, P28192, DOI 10.1074/jbc.M114.593475; Shim JH, 2008, J BIOL CHEM, V283, P28370, DOI 10.1074/jbc.M802200200; Shim JH, 2010, CANCER PREV RES, V3, P670, DOI 10.1158/1940-6207.CAPR-09-0185; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Suzuki Y, 2001, CANCER LETT, V173, P15, DOI 10.1016/S0304-3835(01)00685-1; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Urusova DV, 2011, CANCER PREV RES, V4, P1366, DOI 10.1158/1940-6207.CAPR-11-0301; Utepbergenov D, 2012, BIOCHEMISTRY-US, V51, P6499, DOI 10.1021/bi300620c; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang DJ, 2006, J CHROMATOGR A, V1119, P277, DOI 10.1016/j.chroma.2005.12.031; Yao K, 2014, CANCER PREV RES, V7, P958, DOI 10.1158/1940-6207.CAPR-14-0126; Zykova TA, 2005, CARCINOGENESIS, V26, P331, DOI 10.1093/carcin/bgh334	47	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130049	10.1371/journal.pone.0130049	http://dx.doi.org/10.1371/journal.pone.0130049			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083344	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400123
J	Fukuda, K; Sugihara, E; Ohta, S; Izuhara, K; Funakoshi, T; Amagai, M; Saya, H				Fukuda, Keitaro; Sugihara, Eiji; Ohta, Shoichiro; Izuhara, Kenji; Funakoshi, Takeru; Amagai, Masayuki; Saya, Hideyuki			Periostin Is a Key Niche Component for Wound Metastasis of Melanoma	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; GROWTH; CELL; ENRICHMENT; REPAIR	Tissue injury promotes metastasis of several human cancers, although factors associated with wound healing that attract circulating tumor cells have remained unknown. Here, we examined the primary and metastatic lesions that appeared 1 month after trauma in a patient with acral lentiginous melanoma. The levels of mRNA for periostin (POSTN), type 1 collagen, and fibronectin were significantly increased in the metastatic lesion relative to the primary lesion. The increase of these extracellular matrix proteins at the wound site was reproduced in a mouse model of wound healing, with the upregulation of Postn mRNA persisting the longest. POSTN was expressed in the region surrounding melanoma cell nests in metastatic lesions of both wounded mice and the patient. POSTN attenuated the cell adhesion and promoted the migration of melanoma cells without affecting their proliferation in vitro. In the mouse model, the wound site as well as subcutaneously injected osteoblasts that secrete large amounts of POSTN invited the metastasis of remotely-transplanted melanoma cells on the sites. Osteoblasts with suppression of POSTN by shRNA showed a greatly reduced ability to promote such metastasis. Our results suggest that POSTN is a key factor in promoting melanoma cell metastasis to wound sites by providing a premetastatic niche.	[Fukuda, Keitaro; Sugihara, Eiji; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Ohta, Shoichiro] Saga Med Sch, Dept Lab Med, Saga, Japan; [Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga, Japan; [Fukuda, Keitaro; Funakoshi, Takeru; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan	Keio University; Saga University; Saga University; Keio University	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan.	hsaya@a5.keio.jp	Saya, Hideyuki/J-4325-2013; Amagai, Masayuki/K-5325-2013; Fukuda, Keitaro/AAP-6121-2020; Funakoshi, Takeru/A-7994-2015	Amagai, Masayuki/0000-0003-3314-7052; Funakoshi, Takeru/0000-0002-8893-4590; Sugihara, Eiji/0000-0002-3233-1045; Saya, Hideyuki/0000-0001-6610-1902; Fukuda, Keitaro/0000-0001-8847-0063	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22130007]; Keio University [02-002-0018]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (HS #22130007) (https://kaken.nii.ac.jp/d/r/80264282) and Keio University Grant-in-Aid for Encouragement of Young Medical Scientists (KF #02-002-0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Elliott CG, 2012, J CELL SCI, V125, P121, DOI 10.1242/jcs.087841; Gao DW, 2014, PATHOL ONCOL RES, V20, P27, DOI 10.1007/s12253-013-9734-x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kikuchi Y, 2014, AM J PATHOL, V184, P859, DOI 10.1016/j.ajpath.2013.11.012; Kim YY, 2008, J DERMATOL, V35, P473, DOI 10.1111/j.1346-8138.2008.00506.x; Kotobuki Y, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12245; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Marenco F, 2009, DERMATOL SURG, V35, P1282, DOI 10.1111/j.1524-4725.2009.01226.x; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Ontsuka K, 2012, EXP DERMATOL, V21, P331, DOI 10.1111/j.1600-0625.2012.01454.x; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Soikkeli J, 2010, AM J PATHOL, V177, P387, DOI 10.2353/ajpath.2010.090748; Stuelten CH, 2008, CANCER RES, V68, P7278, DOI 10.1158/0008-5472.CAN-08-1842; Sugihara E, 2012, ONCOGENE, V31, P2849, DOI 10.1038/onc.2011.462; Terraube V, 2006, J THROMB HAEMOST, V4, P519, DOI 10.1111/j.1538-7836.2005.01770.x; Trefzer U, 1998, J AM ACAD DERMATOL, V38, P997, DOI 10.1016/S0190-9622(98)70166-5; Ulmer A, 2004, CLIN CANCER RES, V10, P531, DOI 10.1158/1078-0432.CCR-0424-03; Yamaguchi Y, 2013, BRIT J DERMATOL, V168, P717, DOI 10.1111/bjd.12117; Yates CC, 2011, CELL MOL LIFE SCI, V68, P1871, DOI 10.1007/s00018-011-0663-0	29	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129704	10.1371/journal.pone.0129704	http://dx.doi.org/10.1371/journal.pone.0129704			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083413	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400105
J	Kolby, JE; Smith, KM; Ramirez, SD; Rabemananjara, F; Pessier, AP; Brunner, JL; Goldberg, CS; Berger, L; Skerratt, LF				Kolby, Jonathan E.; Smith, Kristine M.; Ramirez, Sara D.; Rabemananjara, Falitiana; Pessier, Allan P.; Brunner, Jesse L.; Goldberg, Caren S.; Berger, Lee; Skerratt, Lee F.			Rapid Response to Evaluate the Presence of Amphibian Chytrid Fungus (Batrachochytrium dendrobatidis) and Ranavirus in Wild Amphibian Populations in Madagascar	PLOS ONE			English	Article							BOX TURTLES; CHYTRIDIOMYCOSIS; FROG; SUSCEPTIBILITY; INFECTION; DNA; SURVEILLANCE; PERSISTENCE; PREVALENCE; DISEASE	We performed a rapid response investigation to evaluate the presence and distribution of amphibian pathogens in Madagascar following our identification of amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd) and ranavirus in commercially exported amphibians. This targeted risk-based field surveillance program was conducted from February to April 2014 encompassing 12 regions and 47 survey sites. We simultaneously collected amphibian and environmental samples to increase survey sensitivity and performed sampling both in wilderness areas and commercial amphibian trade facilities. Bd was not detected in any of 508 amphibian skin swabs or 68 water filter samples, suggesting pathogen prevalence was below 0.8%, with 95% confidence during our visit. Ranavirus was detected in 5 of 97 amphibians, including one adult Mantidactylus cowanii and three unidentified larvae from Ranomafana National Park, and one adult Mantidactylus mocquardi from Ankaratra. Ranavirus was also detected in water samples collected from two commercial amphibian export facilities. We also provide the first report of an amphibian mass-mortality event observed in wild amphibians in Madagascar. Although neither Bd nor ranavirus appeared widespread in Madagascar during this investigation, additional health surveys are required to disentangle potential seasonal variations in pathogen abundance and detectability from actual changes in pathogen distribution and rates of spread. Accordingly, our results should be conservatively interpreted until a comparable survey effort during winter months has been performed. It is imperative that biosecurity practices be immediately adopted to limit the unintentional increased spread of disease through the movement of contaminated equipment or direct disposal of contaminated material from wildlife trade facilities. The presence of potentially introduced strains of ranaviruses suggests that Madagascar's reptile species might also be threatened by disease. Standardized population monitoring of key amphibian and reptile species should be established with urgency to enable early detection of potential impacts of disease emergence in this global biodiversity hotspot.	[Kolby, Jonathan E.; Berger, Lee; Skerratt, Lee F.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, One Hlth Res Grp, Townsville, Qld 4811, Australia; [Kolby, Jonathan E.; Smith, Kristine M.] EcoHlth Alliance, New York, NY USA; [Ramirez, Sara D.] Ramapo Coll, Sustainabil Studies Program, Mahwah, NJ USA; [Rabemananjara, Falitiana] IUCN SSC Amphibian Specialist Grp Madagascar, Antananarivo, Madagascar; [Pessier, Allan P.] San Diego Zoo Global, Inst Conservat Res, Amphibian Dis Lab, San Diego, CA USA; [Brunner, Jesse L.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Goldberg, Caren S.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA	James Cook University; EcoHealth Alliance; Ramapo College New Jersey (RCNJ); Washington State University; Washington State University	Kolby, JE (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, One Hlth Res Grp, Townsville, Qld 4811, Australia.	jonathan.kolby@my.jcu.edu.au	Kolby, Jonathan/GWZ-3092-2022; Brunner, Jesse L./B-1692-2013; Kolby, Jonathan/GWV-5557-2022; Goldberg, Caren S/B-4075-2015	Brunner, Jesse L./0000-0003-4894-8274; Berger, Lee/0000-0001-9227-5439; Skerratt, Lee/0000-0003-3471-7512	Columbus Zoo & Aquarium (CCMC Emergency Fund); National Geographic Society [9472-14]; James Cook University Australian Postgraduate Research Scholarship	Columbus Zoo & Aquarium (CCMC Emergency Fund); National Geographic Society(National Geographic Society); James Cook University Australian Postgraduate Research Scholarship	Funding for this project was provided to JEK by the Columbus Zoo & Aquarium (CCMC Emergency Fund) and the National Geographic Society (Committee for Research and Exploration Grant #9472-14). JEK is supported by a James Cook University Australian Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender MC, 2011, J WILDLIFE DIS, V47, P759, DOI 10.7589/0090-3558-47.3.759; Altig R, 2007, HERPETOL CONSERV BIO, V2, P1; Andreone Franco, 2012, Alytes (Paris), V29, P44; Bletz MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08633; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brenes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092476; Bryan LK, 2009, DIS AQUAT ORGAN, V84, P89, DOI 10.3354/dao02036; Cashins SD, 2008, DIS AQUAT ORGAN, V80, P63, DOI 10.3354/dao01919; Chestnut T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106790; Crottini A, 2011, NORTH-WEST J ZOOL, V7, P346; Earl JE, 2014, ECOHEALTH, V11, P581, DOI 10.1007/s10393-014-0950-y; Gervasi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054490; Glaw F, 2007, FIELD GUIDE AMPHIBIA; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; GRANOFF A, 1966, VIROLOGY, V29, P133, DOI 10.1016/0042-6822(66)90203-0; Gray MJ, 2012, DIS AQUAT ORGAN, V99, P1, DOI 10.3354/dao02436; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Grogan LF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004015; Hall EM, MOL ECOL RESOU UNPUB; Hemingway V, 2009, AMPHIBIAN BIOL, V8, P2969; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Hyman OJ, 2012, DIS AQUAT ORGAN, V97, P185, DOI 10.3354/dao02423; Jenkins RKB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100173; Johnson AF, 2014, DIS AQUAT ORGAN, V111, P129, DOI 10.3354/dao02774; Johnson AJ, 2008, J WILDLIFE DIS, V44, P851, DOI 10.7589/0090-3558-44.4.851; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Kolby JE, 2014, NATURE, V509, P563, DOI 10.1038/509563a; Kolby JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089660; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Langhammer PF, 2014, J WILDLIFE DIS, V50, P438, DOI 10.7589/2013-10-268; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; Lotters S., 2011, BIODIVERSITY HOTSPOT, P255; Marschang RE, 2005, J ZOO WILDLIFE MED, V36, P295, DOI 10.1638/04-008.1; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Miller D, 2011, VIRUSES-BASEL, V3, P2351, DOI 10.3390/v3112351; Murray KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061061; Murray KA, 2012, HUM ECOL RISK ASSESS, V18, P200, DOI 10.1080/10807039.2012.632310; Murray KA, 2011, P ROY SOC B-BIOL SCI, V278, P1515, DOI 10.1098/rspb.2010.1872; Nazir J, 2012, DIS AQUAT ORGAN, V98, P177, DOI 10.3354/dao02443; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Perl RGB, 2014, AMPHIBIA-REPTILIA, V35, P197, DOI 10.1163/15685381-00002942; Phillott AD, 2010, DIS AQUAT ORGAN, V92, P175, DOI 10.3354/dao02162; Picco AM, 2007, J WILDLIFE DIS, V43, P286, DOI 10.7589/0090-3558-43.2.286; Price J, 2014, CURR BIOL; Rabemananjara F., 2011, FROGLOG, V97, P33; Rachowicz Lara J., 2002, Herpetological Review, V33, P263; Reiczigel J, 2010, EPIDEMIOL INFECT, V138, P1674, DOI 10.1017/S0950268810000385; Retallick RWR, 2006, DIS AQUAT ORGAN, V72, P77, DOI 10.3354/dao072077; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Searle CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060920; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Speare R, 2004, AUST VET J, V82, P300, DOI 10.1111/j.1751-0813.2004.tb12710.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Symonds EP, 2007, J WILDLIFE DIS, V43, P48, DOI 10.7589/0090-3558-43.1.48; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Voyles J, 2014, HERPETOL CONSERV BIO, V9, P106; Vredenburg VT, 2012, HERPETOLOGY NOTES, V5, P507, DOI DOI 10.1186/1756-0500-5-507; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x; Webb R, 2007, DIS AQUAT ORGAN, V74, P13, DOI 10.3354/dao074013; Weldon C, 2013, ECOHEALTH, V10, P234, DOI 10.1007/s10393-013-0869-8; Weldon Che, 2008, Museo Regionale di Scienze Naturali Monografie (Turin), V45, P95; Whitfield SM, 2012, BIOTROPICA, V44, P779, DOI 10.1111/j.1744-7429.2012.00872.x; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x	66	17	20	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0125330	10.1371/journal.pone.0125330	http://dx.doi.org/10.1371/journal.pone.0125330			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083349	Green Accepted, gold, Green Published			2022-12-26	WOS:000356567400003
J	Lagendijk, DDG; Thaker, M; de Boer, WF; Page, BR; Prins, HHT; Slotow, R				Lagendijk, D. D. Georgette; Thaker, Maria; de Boer, Willem F.; Page, Bruce R.; Prins, Herbert H. T.; Slotow, Rob			Change in Mesoherbivore Browsing Is Mediated by Elephant and Hillslope Position	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; LOXODONTA-AFRICANA; WOODLAND REGENERATION; AEPYCEROS-MELAMPUS; FORAGING BEHAVIOR; EAST-AFRICA; DRY-SEASON; SAVANNA; HERBIVORES; POPULATION	Elephant are considered major drivers of ecosystems, but their effects within small-scale landscape features and on other herbivores still remain unclear. Elephant impact on vegetation has been widely studied in areas where elephant have been present for many years. We therefore examined the combined effect of short-term elephant presence (< 4 years) and hillslope position on tree species assemblages, resource availability, browsing intensity and soil properties. Short-term elephant presence did not affect woody species assemblages, but did affect height distribution, with greater sapling densities in elephant access areas. Overall tree and stem densities were also not affected by elephant. By contrast, slope position affected woody species assemblages, but not height distributions and densities. Variation in species assemblages was statistically best explained by levels of total cations, Zinc, sand and clay. Although elephant and mesoherbivore browsing intensities were unaffected by slope position, we found lower mesoherbivore browsing intensity on crests with high elephant browsing intensity. Thus, elephant appear to indirectly facilitate the survival of saplings, via the displacement of mesoherbivores, providing a window of opportunity for saplings to grow into taller trees. In the short-term, effects of elephant can be minor and in the opposite direction of expectation. In addition, such behavioural displacement promotes recruitment of saplings into larger height classes. The interaction between slope position and elephant effect found here is in contrast with other studies, and illustrates the importance of examining ecosystem complexity as a function of variation in species presence and topography. The absence of a direct effect of elephant on vegetation, but the presence of an effect on mesoherbivore browsing, is relevant for conservation areas especially where both herbivore groups are actively managed.	[Lagendijk, D. D. Georgette; Thaker, Maria; Page, Bruce R.; Prins, Herbert H. T.; Slotow, Rob] Univ KwaZulu Natal, Sch Life Sci, ZA-4000 Durban, South Africa; [Thaker, Maria] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [de Boer, Willem F.; Prins, Herbert H. T.] Wageningen Univ, Resource Ecol Grp, NL-6708 PB Wageningen, Netherlands; [Slotow, Rob] UCL, Dept Genet Evolut & Environm, London, England	University of Kwazulu Natal; Indian Institute of Science (IISC) - Bangalore; Wageningen University & Research; University of London; University College London	Lagendijk, DDG (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Westville Campus,Private Bag,X54001, ZA-4000 Durban, South Africa.	georgette.lagendijk@gmail.com	Slotow, Rob/AAM-9053-2020	Thaker, Maria/0000-0001-6019-2639; Prins, Herbert/0000-0003-1131-5107; Slotow, Rob/0000-0001-9469-1508	Amarula Elephant Research Programme, University of KwaZulu-Natal; South African National Research Foundation [FA2006032300024]	Amarula Elephant Research Programme, University of KwaZulu-Natal; South African National Research Foundation(National Research Foundation - South Africa)	This research was financed by the Amarula Elephant Research Programme, University of KwaZulu-Natal, and the South African National Research Foundation (Grant FA2006032300024 to RS).	Asner GP, 2009, P NATL ACAD SCI USA, V106, P4947, DOI 10.1073/pnas.0810637106; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Babweteera F, 2007, BIOL CONSERV, V134, P40, DOI 10.1016/j.biocon.2006.08.002; BEEKMAN JH, 1989, AFR J ECOL, V27, P129, DOI 10.1111/j.1365-2028.1989.tb00937.x; BELSKY AJ, 1984, AFR J ECOL, V22, P271, DOI 10.1111/j.1365-2028.1984.tb00701.x; Boyes LJ, 2010, PLANT ECOL, V208, P293, DOI 10.1007/s11258-009-9706-0; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coates Palgrave K., 2002, TREES SO AFRICA; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; de Garine-Wichatitsky M, 2004, OECOLOGIA, V141, P66, DOI 10.1007/s00442-004-1630-3; de Knegt HJ, 2010, THESIS WAGENINGEN U; du Toit Johan T., 2003, P292; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; DUTOIT JT, 1990, AFR J ECOL, V28, P55, DOI 10.1111/j.1365-2028.1990.tb01136.x; Ferguson CD, 1997, ENV SURVEY MAN UNPUB; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Grant CC, 2006, BIOL CONSERV, V130, P426, DOI 10.1016/j.biocon.2006.01.004; Holdo RM, 2004, BIOTROPICA; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; Illius AW, 2000, OIKOS, V89, P283, DOI 10.1034/j.1600-0706.2000.890209.x; Jacobs SM, 2007, ECOSYSTEMS, V10, P1231, DOI 10.1007/s10021-007-9092-1; Kalwij JM, 2010, ECOL APPL, V20, P222, DOI 10.1890/09-0541.1; Kerley Graham I.H., 2008, P146; Khomo L, 2011, CATENA, V87, P119, DOI 10.1016/j.catena.2011.05.017; Kinahan AA, 2007, J THERM BIOL, V32, P47, DOI 10.1016/j.jtherbio.2006.09.002; Kirby Taryn, 2008, Acta Zoologica Sinica, V54, P561; Kohi EM, 2011, BIOTROPICA, V43, P711, DOI 10.1111/j.1744-7429.2010.00724.x; Kyalangalilwa B, 2013, BOT J LINN SOC, V172, P500, DOI 10.1111/boj.12047; Lagendijk DDG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017983; Lagendijk G, 2012, BIOTROPICA, V44, P63, DOI 10.1111/j.1744-7429.2011.00776.x; Levick S, 2008, BIOL CONSERV, V141, P489, DOI 10.1016/j.biocon.2007.11.001; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; Macandza VA, 2004, S AFR J WILDL RES, V34, P113; Makhabu SW, 2006, ACTA OECOL, V30, P136, DOI 10.1016/j.actao.2006.02.005; Moe SR, 2009, J APPL ECOL, V46, P223, DOI 10.1111/j.1365-2664.2008.01595.x; Nellemann C, 2002, J TROP ECOL, V18, P835, DOI 10.1017/S0266467402002547; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Peel M, 2007, ECOLOGICAL MONITORIN; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; Prins Herbert H. T., 2008, V23, P129; PRINS HHT, 1993, J ECOL, V81, P305, DOI 10.2307/2261500; PRINS HHT, 1989, BEHAVIOUR, V108, P262, DOI 10.1163/156853989X00330; Rutina LP, 2005, WILDLIFE BIOL, V11, P207, DOI 10.2981/0909-6396(2005)11[207:ELADWC]2.0.CO;2; Selby M.J., 1993, HILLSLOPE MAT PROCES; Shannon G, 2008, J TROP ECOL, V24, P281, DOI 10.1017/S0266467408004951; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; Valeix M, 2007, OECOLOGIA, V153, P739, DOI 10.1007/s00442-007-0764-5; van aarde Rudi, 2008, P84; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Whyte I. J., 1999, Koedoe, V42, P111; Wronski T, 2002, AFR J ECOL, V40, P205, DOI 10.1046/j.1365-2028.2002.00348.x	53	5	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128340	10.1371/journal.pone.0128340	http://dx.doi.org/10.1371/journal.pone.0128340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083248	gold, Green Submitted, Green Published			2022-12-26	WOS:000356567400042
J	Matsuda, O; Hara, M; Tobita, H; Yazaki, K; Nakagawa, T; Shimizu, K; Uemura, A; Utsugi, H				Matsuda, Osamu; Hara, Masashi; Tobita, Hiroyuki; Yazaki, Kenichi; Nakagawa, Toshinori; Shimizu, Kuniyoshi; Uemura, Akira; Utsugi, Hajime			Determination of Seed Soundness in Conifers Cryptomeria japonica and Chamaecyparis obtusa Using Narrow-Multiband Spectral Imaging in the Short-Wavelength Infrared Range	PLOS ONE			English	Article							JAPAN	Regeneration of planted forests of Cryptomeria japonica (sugi) and Chamaecyparis obtuse (hinoki) is the pressing importance to the forest administration in Japan. Low seed germination rate of these species, however, has hampered low-cost production of their seedlings for reforestation. The primary cause of the low germinability has been attributed to highly frequent formation of anatomically unsound seeds, which are indistinguishable from sound germinable seeds by visible observation and other common criteria such as size and weight. To establish a method for sound seed selection in these species, hyperspectral imaging technique was used to identify a wavelength range where reflectance spectra differ clearly between sound and unsound seeds. In sound seeds of both species, reflectance in a narrow waveband centered at 1,730 nm, corresponding to a lipid absorption band in the short-wavelength infrared (SWIR) range, was greatly depressed relative to that in adjacent wavebands on either side. Such depression was absent or less prominent in unsound seeds. Based on these observations, a reflectance index SQI, abbreviated for seed quality index, was formulated using reflectance at three narrow SWIR wavebands so that it represents the extent of the depression. SQI calculated from seed area-averaged reflectance spectra and spatial distribution patterns of pixelwise SQI within each seed area were both proven as reliable criteria for sound seed selection. Enrichment of sound seeds was accompanied by an increase in germination rate of the seed lot. Thus, the methods described are readily applicable toward low-cost seedling production in combination with single seed sowing technology.	[Matsuda, Osamu] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Hara, Masashi] Sumitomo Forestry Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki, Japan; [Tobita, Hiroyuki; Yazaki, Kenichi; Utsugi, Hajime] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Nakagawa, Toshinori; Shimizu, Kuniyoshi] Kyushu Univ, Fac Agr, Dept Agroenvironm Sci, Fukuoka 812, Japan; [Uemura, Akira] Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Sapporo, Hokkaido, Japan	Kyushu University; Novartis; Forestry & Forest Products Research Institute - Japan; Kyushu University; Forestry & Forest Products Research Institute - Japan	Matsuda, O (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	matsuda.osamu.084@m.kyushu-u.ac.jp			Project of the NARO Bio-oriented Technology Research Advancement Institution (Special Scheme to Create Dynamism in Agriculture, Forestry and Fisheries through Deploying Highly Advanced Technology); Kurata Memorial Hitachi Science and Technology Foundation; Kakihara Foundation (Fukuoka, Japan); Sumitomo Forestry Co., Ltd.	Project of the NARO Bio-oriented Technology Research Advancement Institution (Special Scheme to Create Dynamism in Agriculture, Forestry and Fisheries through Deploying Highly Advanced Technology); Kurata Memorial Hitachi Science and Technology Foundation; Kakihara Foundation (Fukuoka, Japan); Sumitomo Forestry Co., Ltd.	This work was supported by grants from the Project of the NARO Bio-oriented Technology Research Advancement Institution (The Special Scheme to Create Dynamism in Agriculture, Forestry and Fisheries through Deploying Highly Advanced Technology) (to OM MH HT HU), the Kurata Memorial Hitachi Science and Technology Foundation (to OM), and the Kakihara Foundation (Fukuoka, Japan) (to OM). Sumitomo Forestry Co., Ltd. provided support in the form of salaries for an author MH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Bellassen V, 2014, NATURE, V506, P153, DOI 10.1038/506153a; Bonner F.T., 2008, AGR HDB, P1223; Cheng SS, 2014, WOOD SCI TECHNOL, V48, P831, DOI 10.1007/s00226-014-0644-1; Fujikake I, 2007, FOREST POLICY ECON, V9, P811, DOI 10.1016/j.forpol.2006.03.009; Grossnickle SC, 2012, NEW FOREST, V43, P711, DOI 10.1007/s11056-012-9336-6; Imaizumi F, 2008, EARTH SURF PROC LAND, V33, P827, DOI 10.1002/esp.1574; ISTA, 1993, SEED SCI TECHNOL, V13, P484; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Liu C, 2005, VIENNA IUFRO WORLD S, V17, P209; Mac Donncadha M, 1997, JAPANESE FORESTRY FO; Matsuda K., 1978, Journal of the Japanese Forestry Society, V60, P1; Matsuda O, 2012, PLANT CELL PHYSIOL, V53, P1154, DOI 10.1093/pcp/pcs043; McGoverin CM, 2011, ANAL BIOANAL CHEM, V401, P2283, DOI 10.1007/s00216-011-5291-x; McLafferty F.W., 2009, WILEY REGISTRY MASS, V9th; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002	15	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128358	10.1371/journal.pone.0128358	http://dx.doi.org/10.1371/journal.pone.0128358			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083366	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400044
J	Morante, JC; Faria, D; Mariano-Neto, E; Rhodes, J				Morante-Filho, Jose Carlos; Faria, Deborah; Mariano-Neto, Eduardo; Rhodes, Jonathan			Birds in Anthropogenic Landscapes: The Responses of Ecological Groups to Forest Loss in the Brazilian Atlantic Forest	PLOS ONE			English	Article							2 CONTRASTING LANDSCAPES; SHADE CACAO PLANTATIONS; HABITAT FRAGMENTATION; RAIN-FOREST; FUNCTIONAL EXTINCTION; RELATIVE IMPORTANCE; SPECIES RESPONSES; SOUTHERN BAHIA; THRESHOLDS; CONSERVATION	Habitat loss is the dominant threat to biodiversity and ecosystem functioning in terrestrial environments. In this study, we used an a priori classification of bird species based on their dependence on native forest habitats (forest-specialist and habitat generalists) and specific food resources (frugivores and insectivores) to evaluate their responses to forest cover reduction in landscapes in the Brazilian Atlantic Forest. From the patch-landscapes approach, we delimited 40 forest sites, and quantified the percentage of native forest within a 2 km radius around the center of each site (from 6 - 85%). At each site, we sampled birds using the point-count method. We used a null model, a generalized linear model and a four-parameter logistic model to evaluate the relationship between richness and abundance of the bird groups and the native forest amount. A piecewise model was then used to determine the threshold value for bird groups that showed nonlinear responses. The richness and abundance of the bird community as a whole were not affected by changes in forest cover in this region. However, a decrease in forest cover had a negative effect on diversity of forest-specialist, frugivorous and insectivorous birds, and a positive effect on generalist birds. The species richness and abundance of all ecological groups were nonlinearly related to forest reduction and showed similar threshold values, i.e., there were abrupt changes in individuals and species numbers when forest amount was less than approximately 50%. Forest sites within landscapes with forest cover that was less than 50% contained a different bird species composition than more extensively forested sites and had fewer forest-specialist species and higher beta-diversity. Our study demonstrated the pervasive effect of forest reduction on bird communities in one of the most important hotspots for bird conservation and shows that many vulnerable species require extensive forest cover to persist.	[Morante-Filho, Jose Carlos; Faria, Deborah] Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Appl Conservat Ecol Lab, Ilheus, BA, Brazil; [Mariano-Neto, Eduardo] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil; [Rhodes, Jonathan] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia; [Rhodes, Jonathan] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia	Universidade Estadual de Santa Cruz; Universidade Federal da Bahia; University of Queensland; University of Queensland	Morante, JC (corresponding author), Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Appl Conservat Ecol Lab, Km16 Salobrinho, Ilheus, BA, Brazil.	jcmfilho9@hotmail.com	Mariano-Neto, Eduardo/F-3441-2010; Filho, Jose Carlos Morante/K-8214-2015; faria, deborah/ABC-2757-2021; Faria, Deborah/F-2879-2010; Rhodes, Jonathan/C-4841-2008	Mariano-Neto, Eduardo/0000-0002-4204-0882; Filho, Jose Carlos Morante/0000-0002-1625-9872; faria, deborah/0000-0002-0375-2887; Faria, Deborah/0000-0002-0375-2887; Rhodes, Jonathan/0000-0001-6746-7412	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [69014416]; Universidade Estadual de Santa Cruz [002011001171]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [462/2012]; CNPq [307221/2012-1]; Australian Research Council Centre of Excellence for Environmental Decisions	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Estadual de Santa Cruz; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council)	This study was possible due to the collaborative work of the REDE SISBIOTA team, with the financial support by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant number 69014416) and Universidade Estadual de Santa Cruz (grant number 002011001171). JCMF thanks the Fundacao de Amparo a Pesquisa do Estado da Bahia for the fellowship (FAPESB, grant number 462/2012). DF received a grant from CNPq (number 307221/2012-1). This study was also supported by funding from the Australian Research Council Centre of Excellence for Environmental Decisions.	ADDICOTT JF, 1987, OIKOS, V49, P340, DOI 10.2307/3565770; Anderson D. R., 2008, MODEL BASED INFERENC; Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; Bibby C. J., 1992, BIRDS CENSUS TECHNIQ; Bolker BM., 2007, ECOLOGICAL MODELS AN; Bolker BM, 2012, BBMLE TOOLS FOR GENE; Bregman TP, 2014, BIOL CONSERV, V169, P372, DOI 10.1016/j.biocon.2013.11.024; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; de Lima RF, 2013, DIVERS DISTRIB, V19, P411, DOI 10.1111/ddi.12015; Develey PF, 2001, CONSERV BIOL, V15, P1416, DOI 10.1046/j.1523-1739.2001.00170.x; Estavillo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082369; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Faria D, 2006, BIODIVERS CONSERV, V15, P587, DOI 10.1007/s10531-005-2089-1; Faria D, 2007, BIODIVERS CONSERV, V16, P2335, DOI 10.1007/s10531-007-9189-z; Ficetola GF, 2009, ECOGRAPHY, V32, P1075, DOI 10.1111/j.1600-0587.2009.05571.x; Firbank L, 2013, AGR ECOSYST ENVIRON, V166, P65, DOI 10.1016/j.agee.2011.11.014; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Rigueira DMG, 2013, BIODIVERS CONSERV, V22, P3141, DOI 10.1007/s10531-013-0575-4; Graham CH, 2001, CONSERV BIOL, V15, P1789, DOI 10.1046/j.1523-1739.2001.00070.x; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; Haffer J., 1974, AVIAN SPECIATION IN; Hampe A, 2008, OECOLOGIA, V156, P137, DOI 10.1007/s00442-008-0979-0; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Huggett AJ, 2005, BIOL CONSERV, V124, P301, DOI 10.1016/j.biocon.2005.01.037; IBGE Instituto Brasileiro de Geografia e Estatistica, 2006, MANUAL TECNICO DE US; King RS, 2011, ECOL APPL, V21, P2833, DOI 10.1890/10-0882.1; Laurance SGW, 2005, BIOTROPICA, V37, P149, DOI 10.1111/j.1744-7429.2005.04099.x; Lima MM, 2014, FOREST ECOL MANAG, V312, P260, DOI 10.1016/j.foreco.2013.09.003; Lindenmayer DB, 2005, BIOL CONSERV, V124, P311, DOI 10.1016/j.biocon.2005.01.038; Lindenmayer DB, 2005, BIOL CONSERV, V124, P351, DOI 10.1016/j.biocon.2005.01.041; Martensen AC, 2008, BIOL CONSERV, V141, P2184, DOI 10.1016/j.biocon.2008.06.008; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Mata JRR, 2006, FIELD GUIDE TO THE B; McCune B, 2002, ANALYSIS OF ECOLOGIC; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; Metzger JP, 2010, SCIENCE, V329, P276, DOI 10.1126/science.329.5989.276-b; Mittermeier RA, 2005, CONSERV BIOL, V19, P601, DOI 10.1111/j.1523-1739.2005.00709.x; Moran C, 2014, CONSERV BIOL, V28, P551, DOI 10.1111/cobi.12236; MORI SA, 1983, BOT REV, V49, P155, DOI 10.1007/BF02861011; Muggeo V.M., 2008, R NEWS, V8, P20; Murphy GEP, 2012, AM NAT, V180, P316, DOI 10.1086/666986; Newbold T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2131; Ochoa-Quintero JM, 2015, CONSERV BIOL, V29, P440, DOI 10.1111/cobi.12446; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Parker Theodore A. Iii, 1996, P113; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro J, 2000, MIXED EFFECTS MODELS; Puttker T, 2015, OIKOS, V124, P206, DOI 10.1111/oik.01018; R Development Core Team RDC, 2013, R A LANGUAGE AND ENV; Remsen Jr J.V., 2014, CLASSIFICATION BIRD; Rhodes JR, 2008, J APPL ECOL, V45, P549, DOI 10.1111/j.1365-2664.2007.01407.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ridgely RS, 2009, FIELD GUIDE TO THE S; Rueda M, 2013, GLOBAL ECOL BIOGEOGR, V22, P1282, DOI 10.1111/geb.12079; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2012, J ORNITHOL, V153, pS153, DOI 10.1007/s10336-012-0869-4; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; SOS Mata Atlantica Instituto Nacional de Pesquisas Espaciais, ATLAS DOS REMANESCEN; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Suarez-Rubio M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067593, 10.1371/journal.pone.0081143]; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Thomas WW, 1998, BIODIVERS CONSERV, V7, P311, DOI 10.1023/A:1008825627656; Tobias J.A., 2013, KEY TOPICS CONSERVAT, P258; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Van Bael SA, 2003, P NATL ACAD SCI USA, V100, P8304, DOI 10.1073/pnas.1431621100; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Villard MA, 2014, J APPL ECOL, V51, P309, DOI 10.1111/1365-2664.12190; Wenny DG, 2011, AUK, V128, P1, DOI 10.1525/auk.2011.10248; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; With KA, 1999, LANDSCAPE ECOL, V14, P73, DOI 10.1023/A:1008030215600; With KA, 2001, BIOL CONSERV, V100, P75, DOI 10.1016/S0006-3207(00)00209-3; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	87	117	123	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128923	10.1371/journal.pone.0128923	http://dx.doi.org/10.1371/journal.pone.0128923			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083245	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400072
J	Park, M; Verhoeven, JE; Cuijpers, P; Reynolds, CF; Penninx, BWJH				Park, Mijung; Verhoeven, Josine E.; Cuijpers, Pim; Reynolds, Charles F., III; Penninx, Brenda W. J. H.			Where You Live May Make You Old: The Association between Perceived Poor Neighborhood Quality and Leukocyte Telomere Length	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; FOLLOW-UP; STRESS; ENVIRONMENT; DISORDER; OBESITY; LEVEL; EPIDEMIOLOGY; DEPRESSION; MORTALITY	Background Strong evidence supports that living in disadvantaged neighborhoods has direct unfavorable impact on mental and physical health. However, whether it also has direct impact on cellular health is largely unknown. Thus we examined whether neighborhood quality was associated with leukocyte telomere length, an indicator of cellular aging. Methods In May 2014, we extracted and analyzed baseline data from the Netherlands Study of Depression and Anxiety (NESDA), a large epidemiological study of individuals age between 18-65 years (n=2902). Telomere length was determined using quantitative polymerase chain reaction. Neighborhood quality was assessed using modified measures of perceived neighborhood disorder, fear of crime, and noise. We used multivariable linear regression models to examine association between perceived neighborhood quality and telomere length with comprehensive adjustment for individual and community characteristics related to socioeconomic and demographic status, urbanization level, mental and physical health, and lifestyle. Results Compared to individuals who reported good neighborhood quality, the mean telomere length of those who reported moderate neighborhood quality was approximately 69 base pair shorter (beta = -69.33, 95% CI: -119.49, -19.17, p = 0.007), and that of those who reported poor neighborhood quality were 174 base pair shorter (beta = -173.80, 95% CI: -298.80, -49.01, p = 0.006). For illustrative purposes, one could extrapolate these outcomes to 8.7 and 11.9 years in chronological age, respectively. Conclusion We have established an association between perceived neighborhood quality and cellular aging over and above a range of individual attributes. Biological aging processes may be impacted by socioeconomic milieu.	[Park, Mijung] Univ Pittsburgh, Dept Hlth & Community Syst, Pittsburgh, PA 15260 USA; [Verhoeven, Josine E.; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Verhoeven, Josine E.; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Reynolds, Charles F., III] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Park, M (corresponding author), Univ Pittsburgh, Dept Hlth & Community Syst, Pittsburgh, PA 15260 USA.	parkm@pitt.edu	Cuijpers, Pim/G-1703-2013; Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672; Park, Mijung/0000-0003-0528-2142	Geestkracht program of Netherlands Organization for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; University Medical Center Groningen; Leiden University Medical Center; NWO-VICI grant [91811602]; Bristol-Myers Squibb; Forest; Pfizer; Lilly; National Institute of Mental Health; National Institute on Aging; National Center for Minority Health Disparities; National Heart Lung and Blood Institute; Center for Medicare and Medicaid Services; Patient Centered Outcomes Research Institute (PCORI); Commonwealth of Pennsylvania; John A Hartford Foundation; National Palliative Care Research Center; Clinical and Translational Science Institute; American Foundation for Suicide Prevention; National Institute of Health [K01NR015101];  [P30 MH90333]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH090333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [K01NR015101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	Geestkracht program of Netherlands Organization for Health Research and Development (Zon-Mw); VU University Medical Center; University Medical Center Groningen; Leiden University Medical Center; NWO-VICI grant(Netherlands Organization for Scientific Research (NWO)); Bristol-Myers Squibb(Bristol-Myers Squibb); Forest; Pfizer(Pfizer); Lilly(Eli Lilly); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Minority Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Medicare and Medicaid Services; Patient Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI); Commonwealth of Pennsylvania; John A Hartford Foundation; National Palliative Care Research Center; Clinical and Translational Science Institute; American Foundation for Suicide Prevention; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by VU University Medical Center, University Medical Center Groningen, Leiden University Medical Center and participating mental health care organizations. Drs. Verhoeven, Penninx and telomere length assaying were supported through an NWO-VICI grant (number 91811602). Dr. Reynolds is supported by P30 MH90333. He also reports receiving pharmaceutical support for NIH-sponsored research studies from Bristol-Myers Squibb, Forest, Pfizer, and Lilly; receiving grants from the National Institute of Mental Health, National Institute on Aging, National Center for Minority Health Disparities, National Heart Lung and Blood Institute, Center for Medicare and Medicaid Services, Patient Centered Outcomes Research Institute (PCORI), the Commonwealth of Pennsylvania, the John A Hartford Foundation, National Palliative Care Research Center, Clinical and Translational Science Institute, and the American Foundation for Suicide Prevention. He is serving on the American Association for Geriatric Psychiatry editorial review board. He has received an honorarium as a speaker from MedScape/WEB MD. He is the co-inventor (Licensed Intellectual Property) of Psychometric analysis of the Pittsburgh Sleep Quality Index (PSQI) PRO10050447 (PI: Buysse). Dr. Park is supported by National Institute of Health (K01NR015101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Aneshensel CS, 2010, ADVANCES IN THE CONCEPTUALIZATION OF THE STRESS PROCESS: ESSAYS IN HONOR OF LEONARD I. PEARLIN, P35, DOI 10.1007/978-1-4419-1021-9_3; [Anonymous], 1990, Med Sci Sports Exerc, V22, P265; BAKER MH, 1983, LAW SOC REV, V17, P319, DOI 10.2307/3053350; Balfour JL, 2002, AM J EPIDEMIOL, V155, P507, DOI 10.1093/aje/155.6.507; Brunton-Smith I, 2011, CRIMINOLOGY, V49, P331, DOI 10.1111/j.1745-9125.2011.00228.x; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chae DH, 2014, AM J PREV MED, V46, P103, DOI 10.1016/j.amepre.2013.10.020; Du M, 2012, AM J EPIDEMIOL; Echeverria SE, 2004, J URBAN HEALTH, V81, P682, DOI 10.1093/jurban/jth151; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Feng J, 2010, HEALTH PLACE, V16, P175, DOI 10.1016/j.healthplace.2009.09.008; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Freedman VA, 2011, AM J PUBLIC HEALTH, V101, P79, DOI 10.2105/AJPH.2009.178640; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Hill TD, 2005, SOC SCI MED, V61, P965, DOI 10.1016/j.socscimed.2004.12.027; Hoen PW, 2013, PSYCHOL MED, V43, P689, DOI 10.1017/S0033291712001766; Hoff S, 2010, MINIMUM AGREED; Latkin CA, 2003, J HEALTH SOC BEHAV, V44, P34, DOI 10.2307/1519814; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; Ludlow AT, 2008, MED SCI SPORT EXER, V40, P1764, DOI 10.1249/MSS.0b013e31817c92aa; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Mainous AG, 2010, AGE AGEING; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Needham BL, 2014, HEALTH PLACE, V28, P167, DOI 10.1016/j.healthplace.2014.04.009; Nussey DH, 2014, METHODS ECOL EVOL, V5, P299, DOI 10.1111/2041-210X.12161; O'Donovan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019687; Pavanello S, 2011, INT J CANCER, V129, P983, DOI 10.1002/ijc.25999; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Robertson T, 2013, EPIDEMIOL REV, V35, P98, DOI 10.1093/epirev/mxs001; Ross CE, 2001, J HEALTH SOC BEHAV, V42, P258, DOI 10.2307/3090214; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Salem, 1986, FEAR CRIME INCIVILIT; Sampson RJ, 2004, SOC PSYCHOL QUART, V67, P319, DOI 10.1177/019027250406700401; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Sapolsky RM, 2004, P NATL ACAD SCI USA, V101, P17323, DOI 10.1073/pnas.0408041101; Seminar S, SOCIAL CAPITAL COMMU; Skogan W. G., 1992, DISORDER DECLINE CRI; STAFFORD MC, 1984, CRIMINOLOGY, V22, P173, DOI 10.1111/j.1745-9125.1984.tb00295.x; Starkweather AR, 2014, NURS RES, V63, P36, DOI 10.1097/NNR.0000000000000009; Steenland K, 2004, AM J EPIDEMIOL, V159, P1047, DOI 10.1093/aje/kwh129; Theall KP, 2013, SOC SCI MED, V85, P50, DOI 10.1016/j.socscimed.2013.02.030; Tomiyama AJ, 2012, PHYSIOL BEHAV, V106, P40, DOI 10.1016/j.physbeh.2011.11.016; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Verhoeven J., 2013, MOL PSYCHIAT; Wen M, 2006, SOC SCI MED, V63, P2575, DOI 10.1016/j.socscimed.2006.06.025; Willeit P, 2011, JAMA-J AM MED ASSOC, V306, P42, DOI 10.1001/jama.2011.901; Woo J, 2009, LANCET, V373, P299, DOI 10.1016/S0140-6736(09)60094-5	54	42	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128460	10.1371/journal.pone.0128460	http://dx.doi.org/10.1371/journal.pone.0128460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NS	26083263	Green Published, gold, Green Accepted			2022-12-26	WOS:000356567400052
J	Ritchie, LE; Taddeo, SS; Weeks, BR; Lima, F; Bloomfield, SA; Azcarate-Peril, MA; Zwart, SR; Smith, SM; Turner, ND				Ritchie, Lauren E.; Taddeo, Stella S.; Weeks, Brad R.; Lima, Florence; Bloomfield, Susan A.; Azcarate-Peril, M. Andrea; Zwart, Sara R.; Smith, Scott M.; Turner, Nancy D.			Space Environmental Factor Impacts upon Murine Colon Microbiota and Mucosal Homeostasis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; IMMUNE-SYSTEM; RADIATION; COLITIS; MODEL; SPACEFLIGHT; IRRADIATION; MICE; SUSCEPTIBILITY	Astronaut intestinal health may be impacted by microgravity, radiation, and diet. The aim of this study was to characterize how high and low linear energy transfer (LET) radiation, microgravity, and elevated dietary iron affect colon microbiota (determined by 16S rDNA pyrosequencing) and colon function. Three independent experiments were conducted to achieve these goals: 1) fractionated low LET. radiation (Cs-137, 3 Gy, RAD), high Fe diet (IRON) (650 mg/kg diet), and a combination of low LET. radiation and high Fe diet (IRON+RAD) in male Sprague-Dawley rats; 2) high LET Si-38 particle exposure (0.050 Gy), 1/6 G partial weight bearing (PWB), and a combination of high (LETSi)-Si-38 particle exposure and PWB in female BalbC/ByJ mice; and 3) 13 d spaceflight in female C57BL/6 mice. Low LET radiation, IRON and spaceflight increased Bacteroidetes and decreased Firmicutes. RAD and IRON+RAD increased Lactobacillales and lowered Clostridiales compared to the control (CON) and IRON treatments. Low LET radiation, IRON, and spaceflight did not significantly affect diversity or richness, or elevate pathogenic genera. Spaceflight increased Clostridiales and decreased Lactobacillales, and similar trends were observed in the experiment using a ground-based model of microgravity, suggesting altered gravity may affect colonic microbiota. Although we noted no differences in colon epithelial injury or inflammation, spaceflight elevated TGF beta gene expression. Microbiota and mucosal characterization in these models is a first step in understanding the impact of the space environment on intestinal health.	[Ritchie, Lauren E.; Turner, Nancy D.] Texas A&M Univ, Intercollegiate Fac Genet, College Stn, TX 77843 USA; [Taddeo, Stella S.; Turner, Nancy D.] Texas A&M Univ, Nutr & Food Sci Dept, College Stn, TX USA; [Weeks, Brad R.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA; [Lima, Florence] Univ Kentucky, Dept Med, Div Nephrol, Lexington, KY 40506 USA; [Bloomfield, Susan A.] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA; [Azcarate-Peril, M. Andrea] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Zwart, Sara R.; Smith, Scott M.] NASA, Lyndon B Johnson Space Ctr, Human Hlth & Performance Directorate, Houston, TX 77058 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Kentucky; Texas A&M University System; Texas A&M University College Station; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Turner, ND (corresponding author), Texas A&M Univ, Intercollegiate Fac Genet, College Stn, TX 77843 USA.	n-turner@tamu.edu	Azcarate-Peril, M. Andrea/AFO-7157-2022; Azcarate-Peril, M. Andrea/ABH-5508-2020; Core, UNC Microbiome/AAB-3304-2022; Azcarate-Peril, M. Andrea/AAA-9056-2022	Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Weeks, Brad/0000-0002-5509-5719; Turner, Nancy/0000-0001-7737-7277	NASA; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK34987]; National Space Biomedical Research Institute [NCC 9-58]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Space Biomedical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the NASA Human Research Program's Human Health Countermeasures Element by a grant to SRZ, SMS, and NDT; a National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases grant (P30 DK34987) to MAAP, and a National Space Biomedical Research Institute grant (NCC 9-58) to NDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter S.J, 2012, INVESTIGATION 6X SCR; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Atlas R.M., 1981, MICROBIAL ECOLOGY FU; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Chopra V, 2006, J TOXICOL ENV HEAL A, V69, P1345, DOI 10.1080/15287390500361792; Cucinotta F.A., 2011, NASA TECHNICAL PAPER, P1, DOI [10.1007/978-3-319-10152-1_84-1, DOI 10.1007/978-3-319-10152-1_84-1]; Cucinotta FA, 2001, RADIAT RES, V156, P460, DOI 10.1667/0033-7587(2001)156[0460:SRACIA]2.0.CO;2; Datta K, 2013, PLOS ONE, V8; Devine AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073140; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Frey Mary Anne, 2009, Aviat Space Environ Med, V80, P575; Ghosh S, 2011, AM J PHYSIOL-GASTR L, V301, pG39, DOI 10.1152/ajpgi.00509.2010; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Gopalakrishnan R, 2010, AVIAT SPACE ENVIR MD, V81, P91, DOI 10.3357/ASEM.2583.2010; Hamilton SA, 2006, J APPL PHYSIOL, V101, P789, DOI 10.1152/japplphysiol.01078.2005; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Horneck G, 2006, SPACE TECHNOLOGY LIB, V18, P291; IJssennagger N, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043260, 10.1371/journal.pone.0049868]; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; Keyak JH, 2009, BONE, V44, P449, DOI 10.1016/j.bone.2008.11.014; Kiang Juliann G, 2010, Adapt Med, V2, P1, DOI 10.4247/AM.2010.ABA004; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P1829, DOI 10.3748/wjg.v12.i12.1829; Lam V, 2012, RADIAT RES, V177, P573, DOI 10.1667/RR2691.1; Lima F, 2014, ENVIRON MOL MUTAGEN, V55, P266, DOI 10.1002/em.21832; Lloyd SA, 2012, BONE, V51, P756, DOI 10.1016/j.bone.2012.07.001; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Macnaughton WK, 2000, ALIMENT PHARM THER, V14, P523; Manichanh C, 2008, AM J GASTROENTEROL, V103, P1754, DOI 10.1111/j.1572-0241.2008.01868.x; MCLAUGHLIN MM, 1964, RADIAT RES, V23, P333, DOI 10.2307/3571614; Menon R, 2013, APPL ENVIRON MICROB, V79, P5763, DOI 10.1128/AEM.01182-13; Morgan JLL, 2014, FASEB J, V28, P1486, DOI 10.1096/fj.13-239418; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Nagalingam NA, 2011, INFLAMM BOWEL DIS, V17, P917, DOI 10.1002/ibd.21462; Ni H, 2011, RADIAT RES, V175, P485, DOI 10.1667/RR2373.1; Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje; Noor Samah O, 2010, BMC Gastroenterol, V10, P134, DOI 10.1186/1471-230X-10-134; Packey CD, 2010, CURR OPIN GASTROEN, V26, P88, DOI 10.1097/MOG.0b013e3283361927; Pecaut MJ, 2010, INT J RADIAT BIOL, V86, P409, DOI 10.3109/09553000903567995; Portess DI, 2007, CANCER RES, V67, P1246, DOI 10.1158/0008-5472.CAN-06-2985; Pouget JP, 2001, EUR J NUCL MED, V28, P541, DOI 10.1007/s002590100484; Prousek J, 2007, PURE APPL CHEM, V79, P2325, DOI 10.1351/pac200779122325; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rosenzweig JA, 2010, APPL MICROBIOL BIOT, V85, P885, DOI 10.1007/s00253-009-2237-8; Rutter MD, 2006, GASTROENTEROLOGY, V130, P1030, DOI 10.1053/j.gastro.2005.12.035; Schepens MAA, 2011, NUTRITION, V27, P590, DOI 10.1016/j.nut.2010.05.002; Sepehri S, 2007, INFLAMM BOWEL DIS, V13, P675, DOI 10.1002/ibd.20101; Sheng HM, 2000, J BIOL CHEM, V275, P6628, DOI 10.1074/jbc.275.9.6628; Smith SM, 2013, PROC FOOD SCI, V2, P27, DOI 10.1016/j.profoo.2013.04.006; Soo I, 2008, CAN J GASTROENTEROL, V22, P237, DOI 10.1155/2008/520383; Sun GS, 2010, NUTRITION, V26, P1163, DOI 10.1016/j.nut.2009.09.018; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Templin T, 2011, INT J RADIAT BIOL, V87, P653, DOI 10.3109/09553002.2010.549537; Vijay-Kumar M, 2007, INFLAMM BOWEL DIS, V13, P856, DOI 10.1002/ibd.20142; Vilela EG, 2008, SCAND J GASTROENTERO, V43, P842, DOI 10.1080/00365520801943354; WIEGEL J, 1989, INT J SYST BACTERIOL, V39, P199, DOI 10.1099/00207713-39-2-199; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923; Yusuf SW, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/317659; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044329	69	39	40	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0125792	10.1371/journal.pone.0125792	http://dx.doi.org/10.1371/journal.pone.0125792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083373	Green Published, gold			2022-12-26	WOS:000356567400004
J	Tabei, K; Satoh, M; Kida, H; Kizaki, M; Sakuma, H; Sakuma, H; Tomimoto, H				Tabei, Ken-ichi; Satoh, Masayuki; Kida, Hirotaka; Kizaki, Moeni; Sakuma, Haruno; Sakuma, Hajime; Tomimoto, Hidekazu			Involvement of the Extrageniculate System in the Perception of Optical Illusions: A Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; MULLER-LYER-ILLUSION; ILLUSORY CONTOURS; FRONTAL-CORTEX; REPRESENTATION; SIZE; MECHANISMS; ATTENTION; RESPONSES; DYNAMICS	Research on the neural processing of optical illusions can provide clues for understanding the neural mechanisms underlying visual perception. Previous studies have shown that some visual areas contribute to the perception of optical illusions such as the Kanizsa triangle and Muller-Lyer figure; however, the neural mechanisms underlying the processing of these and other optical illusions have not been clearly identified. Using functional magnetic resonance imaging (fMRI), we determined which brain regions are active during the perception of optical illusions. For our study, we enrolled 18 participants. The illusory optical stimuli consisted of many kana letters, which are Japanese phonograms. During the shape task, participants stated aloud whether they perceived the shapes of two optical illusions as being the same or not. During the word task, participants read aloud the kana letters in the stimuli. A direct comparison between the shape and word tasks showed activation of the right inferior frontal gyrus, left medial frontal gyrus, and right pulvinar. It is well known that there are two visual pathways, the geniculate and extrageniculate systems, which belong to the higher-level and primary visual systems, respectively. The pulvinar belongs to the latter system, and the findings of the present study suggest that the extrageniculate system is involved in the cognitive processing of optical illusions.	[Tabei, Ken-ichi; Satoh, Masayuki; Kida, Hirotaka; Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Dementia Prevent & Therapeut, Tsu, Mie, Japan; [Tabei, Ken-ichi; Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie, Japan; [Kizaki, Moeni; Sakuma, Haruno] Mie Univ, Fac Med, Tsu, Mie, Japan; [Sakuma, Hajime] Mie Univ, Grad Sch Med, Dept Radiol, Tsu, Mie, Japan	Mie University; Mie University; Mie University; Mie University	Tabei, K (corresponding author), Mie Univ, Grad Sch Med, Dept Dementia Prevent & Therapeut, Tsu, Mie, Japan.	tabei@clin.medic.mie-u.ac.jp		Tabei, Ken-ichi/0000-0002-3969-9184	JSPS; Grants-in-Aid for Scientific Research [25870325] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (B), JSPS.	Baba Y, 2004, ASSENT ILLUSION FIGU; Brighina F, 2003, EUR J NEUROSCI, V17, P2469, DOI 10.1046/j.1460-9568.2003.02679.x; BRINDLEY GS, 1969, J NEUROL NEUROSUR PS, V32, P259, DOI 10.1136/jnnp.32.4.259; Bruno N, 2008, NEUROSCI BIOBEHAV R, V32, P423, DOI 10.1016/j.neubiorev.2007.08.006; Cowey A, 2010, EXP BRAIN RES, V200, P3, DOI 10.1007/s00221-009-1914-2; Daini R, 2002, EXP BRAIN RES, V144, P224, DOI 10.1007/s00221-002-1034-8; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Halgren E, 2003, NEUROIMAGE, V18, P1001, DOI 10.1016/S1053-8119(03)00045-4; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; HIRSCH J, 1995, P NATL ACAD SCI USA, V92, P6469, DOI 10.1073/pnas.92.14.6469; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Kemmotsu N, 2005, COGNITIVE BRAIN RES, V24, P335, DOI 10.1016/j.cogbrainres.2005.02.015; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lyon DC, 2010, NEURON, V65, P270, DOI 10.1016/j.neuron.2010.01.003; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Nieder A, 2002, J COMP PHYSIOL A, V188, P249, DOI 10.1007/s00359-002-0306-x; Pan YX, 2012, J NEUROSCI, V32, P6760, DOI 10.1523/JNEUROSCI.6140-11.2012; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; Ramsden BM, 2001, CEREB CORTEX, V11, P648, DOI 10.1093/cercor/11.7.648; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ritzl A, 2003, NEUROIMAGE, V19, P1567, DOI 10.1016/S1053-8119(03)00180-0; Sasaki Y, 2004, P NATL ACAD SCI USA, V101, P18251, DOI 10.1073/pnas.0406293102; SCHELL GR, 1984, J NEUROSCI, V4, P539; Seghier M, 2000, CEREB CORTEX, V10, P663, DOI 10.1093/cercor/10.7.663; Shapley R, 2008, PERCEPTION, V37, P1471, DOI 10.1068/p5987; Shiina K, 1995, PSYCHOLOGY OF ILLUSI; Sperandio I, 2012, NAT NEUROSCI, V15, P540, DOI 10.1038/nn.3069; Spillmann L, 1995, PERCEPTION, V24, P1333, DOI 10.1068/p241333; STRICK PL, 1973, BRAIN RES, V55, P1, DOI 10.1016/0006-8993(73)90485-X; Talairach J, 1988, CO PLANAR STEREOTAXI; TOBIAS TJ, 1975, BRAIN RES, V83, P191, DOI 10.1016/0006-8993(75)90930-0; Tremblay P, 2006, NEUROIMAGE, V33, P947, DOI 10.1016/j.neuroimage.2006.07.041; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vallar G, 2000, NEUROPSYCHOLOGIA, V38, P1087, DOI 10.1016/S0028-3932(99)00139-6; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; Vossel S, 2009, J COGNITIVE NEUROSCI, V21, P30, DOI 10.1162/jocn.2009.21003; Watt SJ, 2000, EXP BRAIN RES, V135, P411, DOI 10.1007/s002210000545; Weidner R, 2010, CEREB CORTEX, V20, P1586, DOI 10.1093/cercor/bhp217; Weidner R, 2007, CEREB CORTEX, V17, P878, DOI 10.1093/cercor/bhk042; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; Wokke ME, 2013, PSYCHOL SCI, V24, P63, DOI 10.1177/0956797612449175; Zeki S, 2004, CONSCIOUS COGN, V13, P173, DOI 10.1016/j.concog.2003.10.003	49	3	3	12	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128750	10.1371/journal.pone.0128750	http://dx.doi.org/10.1371/journal.pone.0128750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083375	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400064
J	Vogel, J; de Rezende, FF; Rohrbach, S; Zhang, M; Schroder, K				Vogel, Juri; de Rezende, Flavia Figueiredo; Rohrbach, Susanne; Zhang, Min; Schroeder, Katrin			Nox4 Is Dispensable for Exercise Induced Muscle Fibre Switch	PLOS ONE			English	Article							NADPH OXIDASE 4; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; TWITCH MUSCLE; ADAPTATIONS; MASS; AMPK; RAT	Introduction By producing H2O2, the NADPH oxidase Nox4 is involved in differentiation of mesenchymal cells. Exercise alters the composition of slow and fast twitch fibres in skeletal. Here we hypothesized that Nox4 contributes to exercise-induced adaptation such as changes in muscle metabolism or muscle fibre specification and studied this in wildtype and Nox4-/mice. Results Exercise, as induced by voluntary running in a running wheel or forced running on a treadmill induced a switch from fast twitch to intermediate fibres. However the induced muscle fibre switch was similar between Nox4-/- and wildtype mice. The same held true for exercise-induced expression of PGC1 alpha or AMPK activation. Both are increased in response to exercise, but with no difference was observed between wildtype and Nox4-/-mice. Conclusion Thus, exercise-induced muscle fibre switch is Nox4-independent.	[Vogel, Juri; de Rezende, Flavia Figueiredo; Schroeder, Katrin] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, D-60054 Frankfurt, Germany; [Zhang, Min] Kings Coll London, BHF Ctr Excellence, Div Cardiovasc, London, England; [Rohrbach, Susanne] Univ Giessen, Inst Physiol, D-35390 Giessen, Germany	Goethe University Frankfurt; University of London; King's College London; Justus Liebig University Giessen	Schroder, K (corresponding author), Goethe Univ Frankfurt, Inst Cardiovasc Physiol, D-60054 Frankfurt, Germany.	Schroeder@vrc.uni-frankfurt.de	Schröder, Katrin/E-6874-2013; Zhang, Min/AAF-7467-2021	Schröder, Katrin/0000-0002-3099-526X; Zhang, Min/0000-0003-1657-1337	Deutsche Forschungsgemeinschaft (DFG) [SFB815/TP1, SCHR1241/1-1]; Heinrich und Fritz-Riese-Stiftung; British Heart Foundation; British Heart Foundation [PG/12/26/29477] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Heinrich und Fritz-Riese-Stiftung; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (SFB815/TP1 and SCHR1241/1-1 to KS), the Heinrich und Fritz-Riese-Stiftung and the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo ML, 2006, AGEING RES REV, V5, P310, DOI 10.1016/j.arr.2006.05.001; Brandes RP, 2014, FREE RADIC BIOL MED; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Desaphy JF, 2005, NEUROBIOL DIS, V18, P356, DOI 10.1016/j.nbd.2004.09.016; Goettsch C, 2013, J CLIN INVEST, V123, P4731, DOI 10.1172/JCI67603; GORZA L, 1988, J PHYSIOL-LONDON, V402, P627, DOI 10.1113/jphysiol.1988.sp017226; HAGGMARK T, 1981, INT J SPORTS MED, V2, P12, DOI 10.1055/s-2008-1034577; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hostler D, 2001, EUR J APPL PHYSIOL, V86, P112, DOI 10.1007/s004210100495; HOWALD H, 1982, INT J SPORTS MED, V3, P1, DOI 10.1055/s-2008-1026053; KOMI PV, 1977, ACTA PHYSIOL SCAND, V100, P385; Kubis HP, 1997, P NATL ACAD SCI USA, V94, P4205, DOI 10.1073/pnas.94.8.4205; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Miura S, 2013, AM J PHYSIOL-ENDOC M, V305, pE213, DOI 10.1152/ajpendo.00114.2013; NWOYE L, 1981, J MUSCLE RES CELL M, V2, P307, DOI 10.1007/BF00713269; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Powers SK, 2011, FREE RADICAL BIO MED, V51, P942, DOI 10.1016/j.freeradbiomed.2010.12.009; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Sun QA, 2011, P NATL ACAD SCI USA, V108, P16098, DOI 10.1073/pnas.1109546108; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Yuan YA, 2011, MOL CELL BIOCHEM, V348, P77, DOI 10.1007/s11010-010-0640-1	26	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130769	10.1371/journal.pone.0130769	http://dx.doi.org/10.1371/journal.pone.0130769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083642	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400159
J	Zhan, X; Zhang, L; Wang, Z; Jin, ML; Liu, M; Tong, ZH				Zhan, Xi; Zhang, Lei; Wang, Zheng; Jin, Mulan; Liu, Min; Tong, Zhaohui			Reversed Halo Sign: Presents in Different Pulmonary Diseases	PLOS ONE			English	Article							HIGH-RESOLUTION CT; ORGANIZING PNEUMONIA; TUBERCULOSIS; FEATURES	Objective To observe the incidence of reversed halo sign in different pulmonary diseases and the pathological correspondence of reversed halo sign. Methods Retrospectively studied the high resolution computer tomography scans of all the patients who were admitted in our department with abnormal pulmonary imaging, from 1st of January 2011 to 31st of December 2013, and all the cases with reversed halo sign on the high resolution computer tomography were collected. Clinical data such as pathological findings and confirmed diagnosis of the patients with reversed halo sign on the high resolution computer tomography scan were collected and summarized. Results Of 1546 abnormal High resolution computer tomography scans 108 had a reverse halo sign present, including 108 cases were observed with reversed halo sign in the high resolution computer tomography, including 40 cases of pulmonary tuberculosis, 43 cases of cryptogenic organizing pneumonia, 16 cases of lung cancer, 7 cases of sarcoidosis, and 1 case of pulmonary cryptococcosis, 1 case of granulomatosis with polyangiitis. Reversed halo sign had a higher incidence in granulomatous diseases (16.28%) compared with non-granulomatous diseases (9.97%). Conclusions Reversed halo sign is relatively non specific; it can be observed in different lung diseases, and different phases of diseases; reversed halo sign is more commonly found in granulomatous diseases compared with non-granulomatous diseases, and is most commonly observed in pulmonary tuberculosis among the granulomatous diseases, and in cryptogenic organizing pneumonia among the non-granulomatous diseases.	[Zhan, Xi; Wang, Zheng; Tong, Zhaohui] Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp & Crit Care Med, Beijing 100020, Peoples R China; [Zhan, Xi; Wang, Zheng; Tong, Zhaohui] Beijing Inst Resp Med, Beijing Key Lab Resp & Pulm Circulat, Beijing 100020, Peoples R China; [Zhang, Lei; Liu, Min] Capital Med Univ, Beijing Chao Yang Hosp, Dept Radiol, Beijing 100020, Peoples R China; [Jin, Mulan] Capital Med Univ, Beijing Chao Yang Hosp, Dept Pathol, Beijing 100020, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Zhan, X (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp & Crit Care Med, Beijing 100020, Peoples R China.	zhanxi99@gmail.com; tongzhaohuicy@sina.com						Agarwal R, 2007, BRIT J RADIOL, V80, P849, DOI 10.1259/bjr/61353689; [Anonymous], [No title captured]; Benamore R E, 2007, Br J Radiol, V80, pe162, DOI 10.1259/bjr/46361210; Gasparetto EL, 2005, AM J ROENTGENOL, V184, P1932, DOI 10.2214/ajr.184.6.01841932; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kim SJ, 2003, AM J ROENTGENOL, V180, P1251, DOI 10.2214/ajr.180.5.1801251; Marchiori E, 2010, BRIT J RADIOL, V83, pE58, DOI 10.1259/bjr/22699201; Marchiori E, 2012, CHEST, V141, P1260, DOI 10.1378/chest.11-1050; Marchiori E, 2010, KOREAN J RADIOL, V11, P251, DOI 10.3348/kjr.2010.11.2.251; Voloudaki AE, 1996, ACTA RADIOL, V37, P889; Wahba H, 2008, CLIN INFECT DIS, V46, P1733, DOI 10.1086/587991; Zhan X, 2013, INT J TUBERC LUNG D, V17, P1621, DOI 10.5588/ijtld.13.0300	12	20	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128153	10.1371/journal.pone.0128153	http://dx.doi.org/10.1371/journal.pone.0128153			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083865	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400030
J	Sjostedt, E; Fagerberg, L; Hallstrom, BM; Haggmark, A; Mitsios, N; Nilsson, P; Ponten, F; Hokfelt, T; Uhlen, M; Mulder, J				Sjostedt, Evelina; Fagerberg, Linn; Hallstrom, Bjorn M.; Haggmark, Anna; Mitsios, Nicholas; Nilsson, Peter; Ponten, Fredrik; Hokfelt, Tomas; Uhlen, Mathias; Mulder, Jan			Defining the Human Brain Proteome Using Transcriptomics and Antibody-Based Profiling with a Focus on the Cerebral Cortex	PLOS ONE			English	Article							GENE-EXPRESSION; NONCODING RNA; GLUTAMATE TRANSPORTER; REVEALS 2; LOCALIZATION; CELLS; LONG; GENOME; TOOL; SEQ	The mammalian brain is a complex organ composed of many specialized cells, harboring sets of both common, widely distributed, as well as specialized and discretely localized proteins. Here we focus on the human brain, utilizing transcriptomics and public available Human Protein Atlas (HPA) data to analyze brain-enriched (frontal cortex) polyadenylated messenger RNA and long non-coding RNA and generate a genome-wide draft of global and cellular expression patterns of the brain. Based on transcriptomics analysis of altogether 27 tissues, we have estimated that approximately 3% (n=571) of all protein coding genes and 13% (n=87) of the long non-coding genes expressed in the human brain are enriched, having at least five times higher expression levels in brain as compared to any of the other analyzed peripheral tissues. Based on gene ontology analysis and detailed annotation using antibody-based tissue micro array analysis of the corresponding proteins, we found the majority of brain-enriched protein coding genes to be expressed in astrocytes, oligodendrocytes or in neurons with molecular properties linked to synaptic transmission and brain development. Detailed analysis of the transcripts and the genetic landscape of brainenriched coding and non-coding genes revealed brain-enriched splice variants. Several clusters of neighboring brain-enriched genes were also identified, suggesting regulation of gene expression on the chromatin level. This multi-angle approach uncovered the brainenriched transcriptome and linked genes to cell types and functions, providing novel insights into the molecular foundation of this highly specialized organ.	[Sjostedt, Evelina; Fagerberg, Linn; Hallstrom, Bjorn M.; Haggmark, Anna; Nilsson, Peter; Uhlen, Mathias] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden; [Sjostedt, Evelina; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Mitsios, Nicholas; Hokfelt, Tomas; Mulder, Jan] Karolinska Inst, Dept Neurosci, Sci Life Lab, Stockholm, Sweden	Royal Institute of Technology; Uppsala University; Karolinska Institutet	Mulder, J (corresponding author), Karolinska Inst, Dept Neurosci, Sci Life Lab, Stockholm, Sweden.	jan.mulder@ki.se	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021; Mulder, Jan/AAG-9761-2021; Mulder, Jan/G-3909-2011; Nilsson, Peter/E-4547-2010	Uhlen, Mathias/0000-0002-4858-8056; Mulder, Jan/0000-0003-3717-5018; Nilsson, Peter/0000-0002-4657-8532; Fagerberg, Linn/0000-0003-0198-7137; Sjostedt, Evelina/0000-0002-0327-7377; Mitsios, Nicholas/0000-0001-6243-4953	Knut and Alice Wallenberg Foundation; European Directorate [HEALTH-F4-2008-201648/PROSPECTS]; Swedish research council [VR 4x-2887]; Alzheimerfonden [03-216]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Directorate; Swedish research council(Swedish Research CouncilEuropean Commission); Alzheimerfonden	Funding was provided by: Knut and Alice Wallenberg Foundation (MU, FP, ES, LF, BMH,PN) -https://www.wallenberg.com/kaw/; PROSPECTS, a 7th Framework grant by the European Directorate (grant agreement HEALTH-F4-2008-201648/PROSPECTS, MU, PN)-http://www.prospects-fp7.eu/index.html; Swedish research council (VR 4x-2887, TH)-http://www.vr.se; Alzheimerfonden (grant 03-216, JM)-http://www.alzheimerfonden.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai LQ, 2001, J BIOL CHEM, V276, P36764, DOI 10.1074/jbc.M104578200; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barry G, 2014, MOL PSYCHIATR, V19, P410, DOI 10.1038/mp.2013.196; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Clark BS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00164; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; ELFERINK LA, 1993, J CELL SCI, P75; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Francescatto M, 2014, INT J BIOCHEM CELL B, V54, P331, DOI 10.1016/j.biocel.2014.06.014; Gonchar Y, 2001, J COMP NEUROL, V431, P182, DOI 10.1002/1096-9861(20010305)431:2<182::AID-CNE1064>3.0.CO;2-K; Gremel G, 2015, J GASTROENTEROL, V50, P46, DOI 10.1007/s00535-014-0958-7; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hooper SD, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-123; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kampf C., 2004, CLIN PROTEOM, V1, P285, DOI DOI 10.1385/CP:1:3-4:285; Kampf C, 2014, PROTEOMICS, V14, P2498, DOI 10.1002/pmic.201400201; Kampf C, 2014, FASEB J, V28, P2901, DOI 10.1096/fj.14-250555; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindskog C, 2014, FASEB J, V28, P5184, DOI 10.1096/fj.14-254862; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Mardinoglu A, 2014, J PROTEOME RES, V13, P5106, DOI 10.1021/pr500586e; Milton ID, 1997, MOL BRAIN RES, V52, P17, DOI 10.1016/S0169-328X(97)00233-7; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Nielsen S, 1997, J NEUROSCI, V17, P171; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Ohtsuki S, 2004, BIOL PHARM BULL, V27, P1489, DOI 10.1248/bpb.27.1489; Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011; Paavilainen L, 2010, J HISTOCHEM CYTOCHEM, V58, P237, DOI 10.1369/jhc.2009.954321; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Takano M, 2006, PHARMACOL THERAPEUT, V109, P137, DOI 10.1016/j.pharmthera.2005.06.005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	57	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130028	10.1371/journal.pone.0130028	http://dx.doi.org/10.1371/journal.pone.0130028			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076492	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900125
J	Olmeda, B; Garcia-Alvarez, B; Gomez, MJ; Martinez-Calle, M; Cruz, A; Perez-Gil, J				Olmeda, Barbara; Garcia-Alvarez, Begona; Gomez, Manuel J.; Martinez-Calle, Marta; Cruz, Antonio; Perez-Gil, Jesus			A model for the structure and mechanism of action of pulmonary surfactant protein B	FASEB JOURNAL			English	Article						saposin; air-liquid interface; lipid transport; lung; lipid-protein interaction	SAPOSIN-LIKE PROTEINS; N-TERMINAL SEGMENT; SP-C; LUNG SURFACTANT; SECONDARY STRUCTURE; PHOSPHOLIPID FILMS; CRYSTAL-STRUCTURES; NMR STRUCTURE; CUBIC PHASES; MEMBRANES	Surfactant protein B (SP-B), from the saposin-like family of proteins, is essential to facilitate the formation and proper performance of surface active films at the air-liquid interface of mammalian lungs, and lack of or deficiency in this protein is associated with lethal respiratory failure. Despite its importance, neither a structural model nor a molecular mechanism of SP-B is available. The purpose of the present work was to purify and characterize native SP-B supramolecular assemblies to provide a model supporting structure-function features described for SP-B. Purification of porcine SP-B using detergent-solubilized surfactant reveals the presence of 10 nm ring-shaped particles. These rings, observed by atomic force and electron microscopy, would be assembled by oligomerization of SP-B as a multimer of dimers forming a hydrophobically coated ring at the surface of phospholipid membranes or monolayers. Docking of rings from neighboring membranes would lead to formation of SP-B-based hydrophobic tubes, competent to facilitate the rapid flow of surface active lipids both between membranes and between surfactant membranes and the interface. A similar sequential assembly of dimers, supradimeric oligomers and phospholipid-loaded tubes could explain the activity of other saposins with colipase, cytolysin, or antibiotic activities, offering a common framework to understand the range of functions carried out by saposins.	[Olmeda, Barbara; Garcia-Alvarez, Begona; Martinez-Calle, Marta; Cruz, Antonio; Perez-Gil, Jesus] Univ Complutense, Fac Biol, Dept Bioquim, E-28040 Madrid, Spain; [Gomez, Manuel J.] CSIC, Ctr Astrobiol INTA, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Perez-Gil, J (corresponding author), Univ Complutense, Fac Biol, Dept Bioquim & Biol Mol, Jose Antonio Novais 2, E-28040 Madrid, Spain.	jperezgil@bio.ucm.es	Martínez-Calle, Marta/C-5930-2018; Cruz, Antonio/H-2881-2015; Olmeda, Bárbara/H-1440-2015; Garcia-Alvarez, Begoña/K-1409-2016; Calle, Marta Martínez/H-1451-2015; Gómez, Manuel J/F-8854-2016; Perez-Gil, Jesus/H-3102-2019	Martínez-Calle, Marta/0000-0003-1198-2532; Cruz, Antonio/0000-0002-0465-4111; Olmeda, Bárbara/0000-0001-6004-1603; Garcia-Alvarez, Begoña/0000-0003-3774-1999; Calle, Marta Martínez/0000-0003-1198-2532; Gómez, Manuel J/0000-0002-4111-4835; Perez-Gil, Jesus/0000-0003-3587-7147	Spanish Ministry of Economy [BIO2012-30733]; Regional Government of Madrid [S2013/MlT-2807]	Spanish Ministry of Economy(Spanish Government); Regional Government of Madrid	The authors sincerely thank Prof. Stephen Hall (Oregon Health and Science University, Portland, OR, USA), Prof. Johanna Floros, (Pennsylvania State University at Hershey, Hershey, PA, USA), Prof. Valery Booth (Memorial University of Newfoundland, St. John's, NL, Canada), Prof. Thomas Haller (Medical University of Innsbruck, Innsbruck, Austria), and Prof. Sandra Orgeig (University of South Australia, Adelaide, SA, Australia), for fruitful discussions on the SP-B model. The assistance of Dr. J. Antonio Enriquez (National Center of Cardiovascular Research, Madrid, Spain), with the analysis by blue native electrophoresis of supramolecular protein complexes, is also recognized. The authors are also indebted to Drs. German Rivas, Carlos Alfonso, and Oscar Llorca (Centro de Investigaciones Biologicas, Madrid, Spain), for technical assistance with analytical centrifugation and electron microscopy, respectively. The authors also acknowledge the technical assistance and infrastructure from Centro Nacional de Microscopia Avanzada (Madrid, Spain) during the electron microscopy and AFM experiments. This work has been supported by grants from the Spanish Ministry of Economy (BIO2012-30733) and the Regional Government of Madrid (S2013/MlT-2807).	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; ANDERSSON M, 1995, FEBS LETT, V362, P328, DOI 10.1016/0014-5793(95)00268-E; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banares-Hidalgo A, 2014, BBA-BIOMEMBRANES, V1838, P1738, DOI 10.1016/j.bbamem.2014.03.016; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Bernardinode la Serna J., 2013, FARADAY DISCUSS, V161, P535; Bernardinode la Serna J., 2013, FARADAY DISCUSS, V161, P563; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Bryksa BC, 2011, J BIOL CHEM, V286, P28265, DOI 10.1074/jbc.M111.252619; Bunger H, 2001, PROTEIN EXPRES PURIF, V23, P319, DOI 10.1006/prep.2001.1510; Cabre EJ, 2012, BBA-BIOMEMBRANES, V1818, P1717, DOI 10.1016/j.bbamem.2012.03.008; Cabre EJ, 2009, BIOPHYS J, V97, P768, DOI 10.1016/j.bpj.2009.04.057; Chavarha M, 2013, BIOPHYS J, V104, P594, DOI 10.1016/j.bpj.2012.12.041; Chavarha M, 2012, LANGMUIR, V28, P16596, DOI 10.1021/la3025364; Chavarha M, 2010, BIOPHYS J, V98, P1549, DOI 10.1016/j.bpj.2009.12.4302; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cruz A, 2004, BIOPHYS J, V86, P308, DOI 10.1016/S0006-3495(04)74106-5; Cruz Antonio, 2007, V400, P439; Farver RS, 2010, BIOPHYS J, V99, P1773, DOI 10.1016/j.bpj.2010.06.076; Flach CR, 2003, BIOPHYS J, V85, P340, DOI 10.1016/S0006-3495(03)74478-6; Follows D, 2007, BBA-BIOMEMBRANES, V1768, P228, DOI 10.1016/j.bbamem.2006.10.004; Foster CD, 2003, AM J RESP CELL MOL, V29, P259, DOI 10.1165/rcmb.2002-0149OC; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Hawgood S, 1998, BBA-MOL BASIS DIS, V1408, P150, DOI 10.1016/S0925-4439(98)00064-7; Hawkins CA, 2005, J MOL BIOL, V346, P1381, DOI 10.1016/j.jmb.2004.12.045; Hecht O, 2004, J BIOL CHEM, V279, P17834, DOI 10.1074/jbc.M312978200; Ikegami M, 2002, J APPL PHYSIOL, V93, P505, DOI 10.1152/japplphysiol.01137.2001; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Krol S, 2000, BIOPHYS J, V79, P904, DOI 10.1016/S0006-3495(00)76346-6; Kurutz JW, 2002, BIOCHEMISTRY-US, V41, P9627, DOI 10.1021/bi016077x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Lipp MM, 1996, SCIENCE, V273, P1196, DOI 10.1126/science.273.5279.1196; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mingarro I, 2008, CURR MED CHEM, V15, P393, DOI 10.2174/092986708783497364; MUNFORD RS, 1995, J LIPID RES, V36, P1653; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Olmeda B, 2013, EUR BIOPHYS J BIOPHY, V42, P209, DOI 10.1007/s00249-012-0858-9; Olmeda B, 2010, BBA-BIOMEMBRANES, V1798, P1281, DOI 10.1016/j.bbamem.2010.03.008; Parra E, 2013, BIOPHYS J, V104, P146, DOI 10.1016/j.bpj.2012.11.014; Parra E, 2011, BIOCHEM J, V438, P555, DOI 10.1042/BJ20110681; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; PEREZGIL J, 1993, BIOCHIM BIOPHYS ACTA, V1168, P261, DOI 10.1016/0005-2760(93)90181-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce B, 2005, BIOINFORMATICS, V21, P1472, DOI 10.1093/bioinformatics/bti229; Piknova B, 2002, CURR OPIN STRUC BIOL, V12, P487, DOI 10.1016/S0959-440X(02)00352-4; Popovic K, 2012, P NATL ACAD SCI USA, V109, P2908, DOI 10.1073/pnas.1115743109; Rodriguez-Capote K, 2001, AM J PHYSIOL-LUNG C, V281, pL231, DOI 10.1152/ajplung.2001.281.1.L231; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rugonyi S, 2008, RESP PHYSIOL NEUROBI, V163, P244, DOI 10.1016/j.resp.2008.05.018; Ryan MA, 2005, BIOCHEMISTRY-US, V44, P861, DOI 10.1021/bi0485575; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Schurch D, 2010, BIOPHYS J, V99, P3290, DOI 10.1016/j.bpj.2010.09.039; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Serrano AG, 2006, BIOPHYS J, V90, P238, DOI 10.1529/biophysj.105.073403; Serrano AG, 2005, BIOCHEMISTRY-US, V44, P417, DOI 10.1021/bi048781u; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; VANDENBUSSCHE G, 1992, BIOCHEMISTRY-US, V31, P9169, DOI 10.1021/bi00153a008; Wang YD, 2003, BIOCHEMISTRY-US, V42, P4015, DOI 10.1021/bi027344h; Weaver TE, 1999, BIOL NEONATE, V76, P15, DOI 10.1159/000047041; Wustneck N, 2003, BIOPHYS J, V84, P1940, DOI 10.1016/S0006-3495(03)75002-4; Wustneck R, 2005, ADV COLLOID INTERFAC, V117, P33, DOI 10.1016/j.cis.2005.05.001; Zaltash S, 2000, BBA-BIOMEMBRANES, V1466, P179, DOI 10.1016/S0005-2736(00)00199-1; Zaltash S, 2001, BIOL CHEM, V382, P933, DOI 10.1515/BC.2001.116	72	39	41	1	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4236	4247		10.1096/fj.15-273458	http://dx.doi.org/10.1096/fj.15-273458			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26089319				2022-12-26	WOS:000361367300013
J	Dujardin, M; Madan, V; Montserret, R; Ahuja, P; Huvent, I; Launay, H; Leroy, A; Bartenschlager, R; Penin, F; Lippens, G; Hanoulle, X				Dujardin, Marie; Madan, Vanesa; Montserret, Roland; Ahuja, Puneet; Huvent, Isabelle; Launay, Helene; Leroy, Arnaud; Bartenschlager, Ralf; Penin, Franois; Lippens, Guy; Hanoulle, Xavier			A Proline-Tryptophan Turn in the Intrinsically Disordered Domain 2 of NS5A Protein Is Essential for Hepatitis C Virus RNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOMERASE ACTIVE-SITE; NONSTRUCTURAL PROTEIN; VIRAL-PROTEINS; MEMBRANOUS REPLICATION; PROLYL ISOMERIZATION; CRYSTAL-STRUCTURE; BINDING-SITE; CYCLOPHILIN; 5A; PROPENSITY	Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) and its interaction with the human chaperone cyclophilin A are both targets for highly potent and promising antiviral drugs that are in the late stages of clinical development. Despite its high interest in regards to the development of drugs to counteract the worldwide HCV burden, NS5A is still an enigmatic multifunctional protein poorly characterized at the molecular level. NS5A is required for HCV RNA replication and is involved in viral particle formation and regulation of host pathways. Thus far, no enzymatic activity or precise molecular function has been ascribed to NS5A that is composed of a highly structured domain 1 (D1), as well as two intrinsically disordered domains 2 (D2) and 3 (D3), representing half of the protein. Here, we identify a short structural motif in the disordered NS5A-D2 and report its NMR structure. We show that this structural motif, a minimal Pro(314)-Trp(316) turn, is essential for HCV RNA replication, and its disruption alters the subcellular distribution of NS5A. We demonstrate that this Pro-Trpturn is required for proper interaction with the host cyclophilin A and influences its peptidyl-prolyl cis/trans isomerase activity on residue Pro(314) of NS5A-D2. This work provides a molecular basis for further understanding of the function of the intrinsically disordered domain 2 of HCV NS5A protein. In addition, our work highlights how very small structural motifs present in intrinsically disordered proteins can exert a specific function.	[Dujardin, Marie; Ahuja, Puneet; Huvent, Isabelle; Launay, Helene; Lippens, Guy; Hanoulle, Xavier] CNRS, Unit Glycobiol Structurale & Fonctionnelle, F-59655 Villeneuve Dascq, France; [Dujardin, Marie; Ahuja, Puneet; Huvent, Isabelle; Launay, Helene; Lippens, Guy; Hanoulle, Xavier] Univ Lille 1, F-59655 Villeneuve Dascq, France; [Montserret, Roland; Penin, Franois] CNRS, Bases Mol & Struct Syst Infectieux, IBCP, LabEx Ecofect,UMR 5086, F-69367 Lyon, France; [Montserret, Roland; Penin, Franois] Univ Lyon 1, F-69367 Lyon, France; [Madan, Vanesa; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, D-69120 Heidelberg, Germany; [Leroy, Arnaud] Univ Paris Sud, EA4529 & InstruL2, UFR Pharm, F-92296 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ruprecht Karls University Heidelberg; UDICE-French Research Universities; Universite Paris Saclay	Hanoulle, X (corresponding author), Univ Lille 1, CNRS, Unit Glycobiol Struct & Fonctionnelle, UMR 8576, F-59655 Villeneuve Dascq, France.	xavier.hanoulle@univ-lille1.fr	Hanoulle, Xavier/AAK-7236-2021; HANOULLE, Xavier/HHN-4815-2022; Bartenschlager, Ralf/L-2582-2015	Hanoulle, Xavier/0000-0002-3755-2680; Huvent, Isabelle/0000-0002-7241-0290; Lippens, Guy/0000-0002-8236-0901; Bartenschlager, Ralf/0000-0001-5601-9307; Launay, Helene/0000-0003-0639-2642	French National Agency for Research [ANR-11-JSV8-005]; French National Agency for Research on AIDS and Viral Hepatitis [A02007-2, A02011-2]; Mapping 128 Project [ANR-11-BINF-003]; Deutsche Forschungsgemeinschaft [TRR83, TP13]	French National Agency for Research(French National Research Agency (ANR)); French National Agency for Research on AIDS and Viral Hepatitis(ANRS); Mapping 128 Project; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by French National Agency for Research Grant ANR-11-JSV8-005 and French National Agency for Research on AIDS and Viral Hepatitis Grant A02007-2 and A02011-2. The NMR facility was supported by the European Community, the CNRS (TGIR RMN THC, FR-3050), the Universities of Lille1 and Lille2, the Region Nord-Pas-de-Calais (France), and the Institut Pasteur de Lille. This work was also supported by Mapping 128 Project ANR-11-BINF-003 (to F. P. and R. M.) and Deutsche Forschungsgemeinschaft Grants TRR83 and TP13 (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Postdoctoral Fellowship ANR-11-JSV8-005 from the French National Agency for Research.	Alves C, 2012, FUTURE VIROL, V7, P1183, DOI 10.2217/FVL.12.114; Anderson LJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-329; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Ascher DB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04765; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Barua B, 2008, PROTEIN ENG DES SEL, V21, P171, DOI 10.1093/protein/gzm082; Berger C, 2014, GASTROENTEROLOGY, V147, P1094, DOI 10.1053/j.gastro.2014.07.019; Berger KL, 2011, J VIROL, V85, P8870, DOI 10.1128/JVI.00059-11; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; Brown JW, 2009, J MOL BIOL, V393, P608, DOI 10.1016/j.jmb.2009.08.018; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Casteleijn MG, 2006, BIOCHEMISTRY-US, V45, P15483, DOI 10.1021/bi061683j; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Chung HY, 2014, J VIROL, V88, P11022, DOI 10.1128/JVI.01582-14; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; Fan X, 2014, MOL BIOSYST, V10, P1345, DOI 10.1039/c4mb00027g; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Gallay PA, 2013, DRUG DES DEV THER, V7, P105, DOI 10.2147/DDDT.S30946; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a; Grise H, 2012, J VIROL, V86, P4811, DOI 10.1128/JVI.06641-11; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kursula I, 2004, PROTEIN ENG DES SEL, V17, P375, DOI 10.1093/protein/gzh048; Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456; Lange CM, 2014, EMBO MOL MED, V6, P4, DOI 10.1002/emmm.201303131; Lee SH, 2012, CURR PROTEIN PEPT SC, V13, P34, DOI 10.2174/138920312799277974; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P22, DOI 10.1055/s-0034-1371007; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Reiss S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003359; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Rozovsky S, 2001, J MOL BIOL, V310, P271, DOI 10.1006/jmbi.2001.4673; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Theillet Francois-Xavier, 2013, Intrinsically Disord Proteins, V1, pe24360, DOI 10.4161/idp.24360; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Weininger U, 2009, P NATL ACAD SCI USA, V106, P12335, DOI 10.1073/pnas.0902102106; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118	71	20	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19104	19120		10.1074/jbc.M115.644419	http://dx.doi.org/10.1074/jbc.M115.644419			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085105	hybrid, Green Published			2022-12-26	WOS:000358781100027
J	Yellman, CM; Roeder, GS				Yellman, Christopher M.; Roeder, G. Shirleen			Cdc14 Early Anaphase Release, FEAR, Is Limited to the Nucleus and Dispensable for Efficient Mitotic Exit	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CHROMOSOME SEGREGATION; TRANSCRIPTION FACTOR; CYCLIN DESTRUCTION; SPO12 PROTEIN; POLO KINASE; MEIOSIS-I; M-PHASE	Cdc14 phosphatase is a key regulator of exit from mitosis, acting primarily through antagonism of cyclin-dependent kinase, and is also thought to be important for meiosis. Cdc14 is released from its sequestration site in the nucleolus in two stages, first by the non-essential Cdc Fourteen Early Anaphase Release (FEAR) pathway and later by the essential Mitotic Exit Network (MEN), which drives efficient export of Cdc14 to the cytoplasm. We find that Cdc14 is confined to the nucleus during early mitotic anaphase release, and during its meiosis I release. Proteins whose degradation is directed by Cdc14 as a requirement for mitotic exit (e.g. the B-type cyclin, Clb2), remain stable during mitotic FEAR, a result consistent with Cdc14 being restricted to the nucleus and not participating directly in mitotic exit. Cdc14 released by the FEAR pathway has been proposed to have a wide variety of activities, all of which are thought to promote passage through anaphase. Proposed functions of FEAR include stabilization of anaphase spindles, resolution of the rDNA to allow its segregation, and priming of the MEN so that mitotic exit can occur promptly and efficiently. We tested the model for FEAR functions using the FEAR-deficient mutation net1-6cdk. Our cytological observations indicate that, contrary to the current model, FEAR is fully dispensable for timely progression through a series of anaphase landmarks and mitotic exit, although it is required for timely rDNA segregation. The net1-6cdk mutation suppresses temperature-sensitive mutations in MEN genes, suggesting that rather than activating mitotic exit, FEAR either inhibits the MEN or has no direct effect upon it. One interpretation of this result is that FEAR delays MEN activation to ensure that rDNA segregation occurs before mitotic exit. Our findings clarify the distinction between FEAR and MEN-dependent Cdc14 activities and will help guide emerging quantitative models of this cell cycle transition.	[Yellman, Christopher M.; Roeder, G. Shirleen] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Yellman, Christopher M.; Roeder, G. Shirleen] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Roeder, G. Shirleen] Yale Univ, Dept Genet, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Yellman, CM (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, 2500 Speedway, Austin, TX 78712 USA.	christopher.yellman@gmail.com			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Methods Enzymol, V194, P1; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Bouchoux C, 2011, CELL, V147, P803, DOI 10.1016/j.cell.2011.09.047; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Burke D., 2000, METHODS YEAST GENETI, pxvii; Burke DJ, 2009, GENE DEV, V23, P1613, DOI 10.1101/gad.1826409; Calabria I, 2012, J CELL SCI, V125, P2875, DOI 10.1242/jcs.097865; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Chen CT, 2006, J CELL SCI, V119, P4462, DOI 10.1242/jcs.03220; Clarke DJ, 2008, FRONT BIOSCI-LANDMRK, V13, P6787, DOI 10.2741/3189; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Grether ME, 1999, MOL BIOL CELL, V10, P3689, DOI 10.1091/mbc.10.11.3689; Hancioglu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030810; Havens KA, 2010, GENETICS, V186, P1247, DOI 10.1534/genetics.110.123257; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Hwang WW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000588; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Jones MH, 2011, CELL CYCLE, V10, P3435, DOI 10.4161/cc.10.20.17790; Kamieniecki RJ, 2005, CELL CYCLE, V4, P1093; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; Lu Y, 2009, MOL BIOL CELL, V20, P1576, DOI 10.1091/mbc.E08-10-1042; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Meitinger F, 2010, J CELL SCI, V123, P1851, DOI 10.1242/jcs.063891; Messier V, 2013, CELL, V153, P1080, DOI 10.1016/j.cell.2013.04.035; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; PARKES V, 1992, NUCLEIC ACIDS RES, V20, P5617, DOI 10.1093/nar/20.21.5617; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Queralt E, 2008, J CELL BIOL, V182, P873, DOI 10.1083/jcb.200801054; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003; Rahal R, 2008, CELL CYCLE, V7, P3262, DOI 10.4161/cc.7.20.6852; Richmond D, 2013, MOL BIOL CELL, V24, P566, DOI 10.1091/mbc.E12-07-0552; Robbins JA, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-23; Rock JM, 2009, CURR BIOL, V19, pR1063, DOI 10.1016/j.cub.2009.10.002; Rossio V, 2011, J CELL BIOL, V193, P445, DOI 10.1083/jcb.201101134; Sanchez-Diaz A, 2012, EMBO J, V31, P3620, DOI 10.1038/emboj.2012.224; Shah R, 2001, GENETICS, V159, P965; SHIRAYAMA M, 1994, MOL CELL BIOL, V14, P7476, DOI 10.1128/MCB.14.11.7476; Shou WY, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-4; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Tang XY, 2006, P NATL ACAD SCI USA, V103, P16290, DOI 10.1073/pnas.0607856103; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Tomson BN, 2009, CURR BIOL, V19, P449, DOI 10.1016/j.cub.2009.02.024; TOYN JH, 1993, GENETICS, V135, P963; Toyn JH, 1997, GENETICS, V145, P85; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vinod PK, 2011, J R SOC INTERFACE, V8, P1128, DOI 10.1098/rsif.2010.0649; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Yellman CM, 2006, MOL BIOL CELL, V17, P658, DOI 10.1091/mbc.E05-04-0336; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	73	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128604	10.1371/journal.pone.0128604	http://dx.doi.org/10.1371/journal.pone.0128604			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090959	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000024
J	Arif, M; Opit, G; Mendoza-Yerbafria, A; Dobhal, S; Li, ZH; Kucerova, Z; Ochoa-Corona, FM				Arif, Mohammad; Opit, George; Mendoza-Yerbafria, Abigail; Dobhal, Shefali; Li, Zhihong; Kucerova, Zuzana; Ochoa-Corona, Francisco M.			Array of Synthetic Oligonucleotides to Generate Unique Multi-Target Artificial Positive Controls and Molecular Probe-Based Discrimination of Liposcelis Species	PLOS ONE			English	Article							BOSTRYCHOPHILA BADONNEL PSOCOPTERA; PRODUCT PSOCIDS PSOCOPTERA; PCR ASSAY; IDENTIFICATION; ENTOMOPHILA; PHOSPHINE; EFFICACY; PEST; MORPHOLOGY; SPINOSAD	Several species of the genus Liposcelis are common insect pests that cause serious qualitative and quantitative losses to various stored grains and processed grain products. They also can contaminate foods, transmit pathogenic microorganisms and cause allergies in humans. The common occurrence of multi-species infestations and the fact that it is difficult to identify and discriminate Liposcelis spp. make accurate, rapid detection and discriminatory tools absolutely necessary for confirmation of their identity. In this study, PCR primers and probes specific to different Liposcelis spp. were designed based on nucleotide sequences of the cytochrome oxidase 1 (CO1) gene. Primer sets ObsCo13F/ 13R, PeaCo15F/14R, BosCO7F/7R, BruCo5F/5R, and DecCo11F/11R were used to specifically detect Liposcelis obscura Broadhead, Liposcelis pearmani Lienhard, Liposcelis bostrychophila Badonnel, Liposcelis brunnea Motschulsky and Liposcelis decolor (Pearman) in multiplex endpoint PCRs, which amplified products of 438-, 351-, 191-, 140-, and 87-bp, respectively. In multiplex TaqMan qPCR assays, orange, yellow, red, crimson and green channels corresponding to reporter dyes 6-ROXN, HEX, Cy5, Quasar705 and 6-FAM specifically detected L. obscura, L. brunnea, L. bostrychophila, L. pearmani and L. decolor, respectively. All developed primer and probe sets allowed specific amplification of corresponding targeted Liposcelis species. The development of multiplex endpoint PCR and multiplex TaqMan qPCR will greatly facilitate psocid identification and their management. The use of APCs will streamline and standardize PCR assays. APC will also provide the opportunity to have all positive controls in a single tube, which reduces maintenance cost and labor, but increases the accuracy and reliability of the assays. These novel methods from our study will have applications in pest management, biosecurity, quarantine, food safety, and routine diagnostics.	[Arif, Mohammad; Mendoza-Yerbafria, Abigail; Dobhal, Shefali; Ochoa-Corona, Francisco M.] Oklahoma State Univ, Noble Res Ctr 127, Natl Inst Microbial Forens & Food & Agr Biosecur, Stillwater, OK 74078 USA; [Arif, Mohammad; Opit, George; Mendoza-Yerbafria, Abigail; Dobhal, Shefali; Ochoa-Corona, Francisco M.] Oklahoma State Univ, Noble Res Ctr 127, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; [Li, Zhihong] China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100193, Peoples R China; [Kucerova, Zuzana] Crop Res Inst, Prague 16106 6, Czech Republic	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; China Agricultural University; Czech Crop Research Institute (CRI)	Opit, G (corresponding author), Oklahoma State Univ, Noble Res Ctr 127, Natl Inst Microbial Forens & Food & Agr Biosecur, Stillwater, OK 74078 USA.	george.opit@okstate.edu; ochoaco@okstate.edu	Arif, Mohammad/M-5755-2013	Arif, Mohammad/0000-0002-5887-2050; Ochoa-Corona, Francisco/0000-0002-4112-8209	Oklahoma Agricultural Experiment Station, Oklahoma State University [OKL02695, OKL02773]	Oklahoma Agricultural Experiment Station, Oklahoma State University	This work was funded by Oklahoma Agricultural Experiment Station, Oklahoma State University (project numbers OKL02695 and OKL02773).	Arif M, 2014, APPL ENVIRON MICROB, V80, P320, DOI 10.1128/AEM.02340-13; Arif M, 2013, MOL BIOTECHNOL, V55, P17, DOI 10.1007/s12033-012-9617-5; Arif M, 2013, APPL ENVIRON MICROB, V79, P2312, DOI 10.1128/AEM.03239-12; Arif M, 2012, J STORED PROD RES, V49, P184, DOI 10.1016/j.jspr.2012.02.001; Athanassiou CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102867; Athanassiou CG, 2011, J PEST SCI, V84, P61, DOI 10.1007/s10340-010-0326-1; BAI XG, 1997, J CHIN CEREALS OILS, V12, P1; Beckett SJ, 2003, J STORED PROD RES, V39, P103, DOI 10.1016/S0022-474X(02)00026-7; Caasi DRJ, 2013, J MICROBIOL METH, V95, P229, DOI 10.1016/j.mimet.2013.08.017; Dobhal S, 2015, ANN APPL BIOL, V166, P286, DOI 10.1111/aab.12182; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gautam SG, 2010, J ECON ENTOMOL, V103, P1920, DOI 10.1603/EC10127; Kalinovic I., 2006, Proceedings of the 9th International Working Conference on Stored-Product Protection, ABRAPOS, Passo Fundo, RS, Brazil, 15-18 October 2006, P1087; Kavallieratos NG, 2011, J FOOD PROTECT, V74, P1288, DOI 10.4315/0362-028X.JFP-10-575; Kucerova Z, 2002, EUR J ENTOMOL, V99, P491, DOI 10.14411/eje.2002.066; Kucerova Z, 2009, J STORED PROD RES, V45, P54, DOI 10.1016/j.jspr.2008.08.002; Kucerova Zuzana, 2002, Plant Protection Science, V38, P103; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li ZH, 2011, J STORED PROD RES, V47, P168, DOI 10.1016/j.jspr.2010.10.005; Li ZhiHong, 2012, African Journal of Biotechnology, V11, P15460; LIENHARD C, 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P117; Lienhard C., 2002, PSOCOPTERA INSECTA W, P745; McFarlane. J. A, 1982, Tropical Stored Products Information, P3; Nayak M. K., 2006, Proceedings of the 9th International Working Conference on Stored-Product Protection, ABRAPOS, Passo Fundo, RS, Brazil, 15-18 October 2006, P1061; Nayak MK, 2008, PEST MANAG SCI, V64, P971, DOI 10.1002/ps.1586; Nayak MK, 2007, PEST MANAG SCI, V63, P104, DOI 10.1002/ps.1313; Nayak MK, 1998, J ECON ENTOMOL, V91, P1208, DOI 10.1093/jee/91.5.1208; Nayak MK, 2003, PEST MANAG SCI, V59, P1191, DOI 10.1002/ps.753; OBR S, 1978, ACTA ENTOMOL BOHEMOS, V75, P226; Opit G. P., 2011, IOBC/WPRS Bulletin, V69, P111; Opit GP, 2009, J ECON ENTOMOL, V102, P1369, DOI 10.1603/029.102.0365; Phillips TW, 2010, ANNU REV ENTOMOL, V55, P375, DOI 10.1146/annurev.ento.54.110807.090451; Ping OY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081647; Qin M, 2008, EUR J ENTOMOL, V105, P713, DOI 10.14411/eje.2008.097; Rees D, 2003, ADVANCES IN STORED PRODUCT PROTECTION, P59, DOI 10.1079/9780851996912.0059; Rees D., 2004, INSECTS STORED PRODU; Rozen S, 2000, Methods Mol Biol, V132, P365; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Trematerra P, 2011, FOOD CONTROL, V22, P1021, DOI 10.1016/j.foodcont.2010.11.026; TURNER B, 1991, International Pest Control, V33, P153; Turner BD, 1996, P 2 INT C INS PESTS, P609; Wang JJ, 1999, INT J PEST MANAGE, V45, P75, DOI 10.1080/096708799228085; Wilcox TP, 1997, MOL PHYLOGENET EVOL, V7, P208, DOI 10.1006/mpev.1996.0388; Yang QQ, 2013, J STORED PROD RES, V54, P1, DOI 10.1016/j.jspr.2013.03.005; Yang QQ, 2013, J ECON ENTOMOL, V106, P419, DOI 10.1603/EC12163; Yang QQ, 2012, J STORED PROD RES, V48, P120, DOI 10.1016/j.jspr.2011.10.007; Zhang DX, 1997, INSECT MOL BIOL, V6, P143, DOI 10.1111/j.1365-2583.1997.tb00082.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	13	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129810	10.1371/journal.pone.0129810	http://dx.doi.org/10.1371/journal.pone.0129810			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086728	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500064
J	Cheng, XE; Qian, ZM; Wang, SH; Jiang, N; Guo, AK; Chen, YQ				Cheng, Xi En; Qian, Zhi-Ming; Wang, Shuo Hong; Jiang, Nan; Guo, Aike; Chen, Yan Qiu			A Novel Method for Tracking Individuals of Fruit Fly Swarms Flying in a Laboratory Flight Arena	PLOS ONE			English	Article							BEHAVIOR; ETHOMICS	The growing interest in studying social behaviours of swarming fruit flies, Drosophila melanogaster, has heightened the need for developing tools that provide quantitative motion data. To achieve such a goal, multi-camera three-dimensional tracking technology is the key experimental gateway. We have developed a novel tracking system for tracking hundreds of fruit flies flying in a confined cubic flight arena. In addition to the proposed tracking algorithm, this work offers additional contributions in three aspects: body detection, orientation estimation, and data validation. To demonstrate the opportunities that the proposed system offers for generating high-throughput quantitative motion data, we conducted experiments on five experimental configurations. We also performed quantitative analysis on the kinematics and the spatial structure and the motion patterns of fruit fly swarms. We found that there exists an asymptotic distance between fruit flies in swarms as the population density increases. Further, we discovered the evidence for repulsive response when the distance between fruit flies approached the asymptotic distance. Overall, the proposed tracking system presents a powerful method for studying flight behaviours of fruit flies in a three-dimensional environment.	[Cheng, Xi En; Qian, Zhi-Ming; Wang, Shuo Hong; Chen, Yan Qiu] Fudan Univ, Sch Comp Sci, Shanghai Key Lab Intelligent Informat Proc, Shanghai, Peoples R China; [Jiang, Nan; Guo, Aike] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China; [Cheng, Xi En] Jingdezhen Ceram Inst, Jingdezhen, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Jingdezhen Ceramic Institute	Guo, AK (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China.	akguo@ion.ac.cn; chenyq@fudan.edu.cn	JIANG, NAN/AHB-1945-2022		National Natural Science Foundation of China [61175036]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB02040100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	The research work presented in this paper is supported by National Natural Science Foundation of China (grant no. 61175036 awarded to YQC) and the Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XDB02040100 awarded to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NAT METHODS, V6, P395, DOI 10.1038/nmeth0609-395; Ardekani R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0547; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Attanasi A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003697; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bergou AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.148101; Betke M, 2007, PROC CVPR IEEE, P192; Blackman S., 1999, DESIGN AND ANALYSIS; Bouguet J-Y, 2010, CAMERA CALIBRATION T; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; Corke P., 2011, INROBOTICVISION; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Fontaine EI, 2009, J EXP BIOL, V212, P1307, DOI 10.1242/jeb.025379; Grover D, 2008, J R SOC INTERFACE, V5, P1181, DOI 10.1098/rsif.2007.1333; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; Kelley DH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01073; Liu Y, 2012, LECT NOTES COMPUT SC, V7575, P730, DOI 10.1007/978-3-642-33765-9_52; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Miller N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048865; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Ramdya P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048381; Reiser M, 2009, NAT METHODS, V6, P413, DOI 10.1038/nmeth0609-413; Schilstra C, 1999, J EXP BIOL, V202, P1481; Shishika D, 2014, SCI REP-UK, V4, DOI 10.1038/srep06318; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Tammero LF, 2002, J EXP BIOL, V205, P327; Tsai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034784; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wu HS, 2011, OPT EXPRESS, V19, P7646, DOI 10.1364/OE.19.007646; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718	37	10	11	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129657	10.1371/journal.pone.0129657	http://dx.doi.org/10.1371/journal.pone.0129657			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083385	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400104
J	Danna, J; Paz-Villagran, V; Gondre, C; Aramaki, M; Kronland-Martinet, R; Ystad, S; Velay, JL				Danna, Jeremy; Paz-Villagran, Vietminh; Gondre, Charles; Aramaki, Mitsuko; Kronland-Martinet, Richard; Ystad, Solvi; Velay, Jean-Luc			"Let Me Hear Your Handwriting!" Evaluating the Movement Fluency from Its Sonification	PLOS ONE			English	Article							CONCURRENT FEEDBACK; PERCEPTION; MOTOR; REPRESENTATION; BIOFEEDBACK; PROFICIENT; CHILDREN; SYSTEM; IMPACT; MUSIC	The quality of handwriting is evaluated from the visual inspection of its legibility and not from the movement that generates the trace. Although handwriting is achieved in silence, adding sounds to handwriting movement might help towards its perception, provided that these sounds are meaningful. This study evaluated the ability to judge handwriting quality from the auditory perception of the underlying sonified movement, without seeing the written trace. In a first experiment, samples of a word written by children with dysgraphia, proficient children writers, and proficient adult writers were collected with a graphic tablet. Then, the pen velocity, the fluency, and the axial pen pressure were sonified in order to create forty-five audio files. In a second experiment, these files were presented to 48 adult listeners who had to mark the underlying unseen handwriting. In order to evaluate the relevance of the sonification strategy, two experimental conditions were compared. In a first 'implicit' condition, the listeners made their judgment without any knowledge of the mapping between the sounds and the handwriting variables. In a second 'explicit' condition, they knew what the sonified variables corresponded to and the evaluation criteria. Results showed that, under the implicit condition, two thirds of the listeners marked the three groups of writers differently. In the explicit condition, all listeners marked the dysgraphic handwriting lower than that of the two other groups. In a third experiment, the scores given from the auditory evaluation were compared to the scores given by 16 other adults from the visual evaluation of the trace. Results revealed that auditory evaluation was more relevant than the visual evaluation for evaluating a dysgraphic handwriting. Handwriting sonification might therefore be a relevant tool allowing a therapist to complete the visual assessment of the written trace by an auditory control of the handwriting movement quality.	[Danna, Jeremy; Paz-Villagran, Vietminh; Velay, Jean-Luc] Aix Marseille Univ, CNRS, FR FR 3512 3C, Lab Neurosci Cognit,LNC,UMR 7291, F-13331 Marseille 3, France; [Gondre, Charles; Aramaki, Mitsuko; Kronland-Martinet, Richard; Ystad, Solvi] Aix Marseille Univ, Cent Marseille, UPR 7051, Lab Mecan & Acoust,LMA,CNRS, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite	Danna, J (corresponding author), Aix Marseille Univ, CNRS, FR FR 3512 3C, Lab Neurosci Cognit,LNC,UMR 7291, F-13331 Marseille 3, France.	jeremy.danna@univ-amu.fr	Kronland-Martinet, Richard/M-3095-2016; Ystad, Sølvi/AAN-4517-2020	Kronland-Martinet, Richard/0000-0002-7325-4920; Ystad, Sølvi/0000-0001-9022-9690	Labex Brain & Language Research Institute (BLRI) [ANR-11-LABX-0036]; French government [ANR-11-IDEX-0001-02, ANR-10-CORD-0003]	Labex Brain & Language Research Institute (BLRI); French government	This work, carried out within the Labex Brain & Language Research Institute (BLRI, ANR-11-LABX-0036, http://www.blri.fr/), has benefited from support from the French government, managed by the French National Agency for Research (ANR), under the project title Investments of the Future A*MIDEX (ANR-11-IDEX-0001-02) and under the project METASON CONTINT (ANR-10-CORD-0003, http://metason.cnrs-mrs.fr/).	Aramaki M, 2011, IEEE T AUDIO SPEECH, V19, P301, DOI 10.1109/TASL.2010.2047755; Bangert M, 2001, ANN NY ACAD SCI, V930, P425, DOI 10.1111/j.1749-6632.2001.tb05760.x; Baudry L, 2006, J SPORT SCI, V24, P149, DOI 10.1080/02640410500130979; Baur B, 2009, J HAND THER, V22, P163, DOI 10.1016/j.jht.2008.11.001; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; BINDMAN E, 1977, BRIT J PSYCHIAT, V131, P143, DOI 10.1192/bjp.131.2.143; Bluteau J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001775; Castiello U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012240; Charles M., 2003, BHK ECHELLE EVALUATI; Chartrel E, 2008, LEARN INSTR, V18, P537, DOI 10.1016/j.learninstruc.2007.11.003; Chollet D, 1988, SWIMMING SCI, VV, P389; Danna J, 2013, P 9 INT C PROGR MOT, P118; Danna J., 2014, LNCS, V8905; Danna J, 2015, HUM MOVEMENT SCI, V43, P216, DOI 10.1016/j.humov.2014.12.002; Danna J, 2013, RES DEV DISABIL, V34, P4375, DOI 10.1016/j.ridd.2013.09.012; Dubus G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096018; Effenberg AO, 2005, IEEE MULTIMEDIA, V12, P53, DOI 10.1109/MMUL.2005.31; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Hamstra-Bletz L, 1987, CONCISE EVALUATION S, DOI [10.2466/10.15.PMS.120v15x5, DOI 10.2466/10.15.PMS.120V15X5]; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Hermann Thomas, 2011, SONIFICATION HDB; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; INCE LP, 1986, J BEHAV THER EXP PSY, V17, P95, DOI 10.1016/0005-7916(86)90044-3; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Konttinen M, 2004, J SPORT EXERCISE PSY, V26, P306, DOI 10.1123/jsep.26.2.306; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Meulenbroek R. G., 1986, GRAPHONOMICS CONT RE, V37, P71, DOI [10.1016/S0166-4115(09)60073-X, DOI 10.1016/S0166-4115(09)60073-X]; Meulenbroek R. G., 1988, ADV PSYCHOL, V55, P273, DOI [10.1016/S0166-4115(08)60627-5, DOI 10.1016/S0166-4115(08)60627-5]; Paz-Villagran V. V.-A., 2013, P INT S COMP MUS MUL, P200; Paz-Villagran V, 2014, HUM MOVEMENT SCI, V33, P381, DOI 10.1016/j.humov.2013.11.005; Plimmer B, 2011, ACM T COMPUT-HUM INT, V18, DOI 10.1145/1993060.1993067; PORTIER SJ, 1992, HUM MOVEMENT SCI, V11, P563, DOI 10.1016/0167-9457(92)90016-5; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; REAVLEY W, 1975, J BEHAV THER EXP PSY, V6, P335, DOI 10.1016/0005-7916(75)90074-9; Rosenblum S, 2003, AM J OCCUP THER, V57, P129, DOI 10.5014/ajot.57.2.129; Rosenblum S, 2003, EDUC PSYCHOL REV, V15, P41, DOI 10.1023/A:1021371425220; Rosenblum S, 2013, J NEUROL, V260, P2357, DOI 10.1007/s00415-013-6996-x; Schmitz G, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-32; Sigrist R, 2013, PSYCHON B REV, V20, P21, DOI 10.3758/s13423-012-0333-8; Sigrist R, 2011, PRESENCE-TELEOP VIRT, V20, P15, DOI 10.1162/pres_a_00032; SmitsEngelsman BCM, 1997, J EXP CHILD PSYCHOL, V67, P164, DOI 10.1006/jecp.1997.2400; Thoret E, 2014, J EXP PSYCHOL HUMAN, V40, P983, DOI 10.1037/a0035441; VANGALEN GP, 1993, ACTA PSYCHOL, V82, P161, DOI 10.1016/0001-6918(93)90010-O; VIVIANI P, 1982, NEUROSCIENCE, V7, P431, DOI 10.1016/0306-4522(82)90277-9; VIVIANI P, 1991, J EXP PSYCHOL HUMAN, V17, P198, DOI 10.1037/0096-1523.17.1.198; Vogt K, 2010, LECT NOTES COMPUT SC, V5954, P103; Young W, 2013, J EXP PSYCHOL HUMAN, V39, P464, DOI 10.1037/a0029402; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	50	12	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128388	10.1371/journal.pone.0128388	http://dx.doi.org/10.1371/journal.pone.0128388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NS	26083384	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400045
J	Klammer, M; Dybowski, JN; Hoffmann, D; Schaab, C				Klammer, Martin; Dybowski, J. Nikolaj; Hoffmann, Daniel; Schaab, Christoph			Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib	PLOS ONE			English	Article							MULTIOBJECTIVE OPTIMIZATION; SIGNALING PATHWAYS; MASS-SPECTROMETRY; CANCER; SELECTION; INVASION; KINASE; SRC; SENSITIVITY; EXPRESSION	Multivariate biomarkers that can predict the effectiveness of targeted therapy in individual patients are highly desired. Previous biomarker discovery studies have largely focused on the identification of single biomarker signatures, aimed at maximizing prediction accuracy. Here, we present a different approach that identifies multiple biomarkers by simultaneously optimizing their predictive power, number of features, and proximity to the drug target in a protein-protein interaction network. To this end, we incorporated NSGA-II, a fast and elitist multi-objective optimization algorithm that is based on the principle of Pareto optimality, into the biomarker discovery workflow. The method was applied to quantitative phosphoproteome data of 19 non-small cell lung cancer (NSCLC) cell lines from a previous biomarker study. The algorithm successfully identified a total of 77 candidate biomarker signatures predicting response to treatment with dasatinib. Through filtering and similarity clustering, this set was trimmed to four final biomarker signatures, which then were validated on an independent set of breast cancer cell lines. All four candidates reached the same good prediction accuracy (83%) as the originally published biomarker. Although the newly discovered signatures were diverse in their composition and in their size, the central protein of the originally published signature - integrin beta 4 (ITGB4) - was also present in all four Pareto signatures, confirming its pivotal role in predicting dasatinib response in NSCLC cell lines. In summary, the method presented here allows for a robust and simultaneous identification of multiple multivariate biomarkers that are optimized for prediction performance, size, and relevance.	[Klammer, Martin; Dybowski, J. Nikolaj; Schaab, Christoph] Evotec Munchen GmbH, Dept Bioinformat, Klopferspitz 19a, D-82152 Martinsried, Germany; [Hoffmann, Daniel] Univ Duisburg Essen, Ctr Med Biotechnol, D-45141 Essen, Germany; [Schaab, Christoph] Max Plack Inst Biochem, D-82152 Martinsried, Germany	Evotec; University of Duisburg Essen	Schaab, C (corresponding author), Evotec Munchen GmbH, Dept Bioinformat, Klopferspitz 19a, D-82152 Martinsried, Germany.	christoph.schaab@evotec.com	Hoffmann, Daniel/P-5624-2019; Hoffmann, Daniel/B-1314-2018	Hoffmann, Daniel/0000-0003-2973-7869; Hoffmann, Daniel/0000-0003-2973-7869	Federal German Ministry of Education and Research [0315011]; Evotec (Munchen) GmbH	Federal German Ministry of Education and Research; Evotec (Munchen) GmbH	This work is based on a project supported by the Federal German Ministry of Education and Research (0315011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Evotec (Munchen) GmbH provided support in the form of salaries for authors MK, JND, and CS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Andersen JN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001065; Beume N, 2007, EUR J OPER RES, V181, P1653, DOI 10.1016/j.ejor.2006.08.008; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Buettner R, 2008, MOL CANCER RES, V6, P1766, DOI 10.1158/1541-7786.MCR-08-0169; Chung BM, 2009, ONCOGENE, V28, P1821, DOI 10.1038/onc.2009.31; Coello CAC, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.1597059; Corne D. W., 2000, Parallel Problem Solving from Nature PPSN VI. 6th International Conference. Proceedings (Lecture Notes in Computer Science Vol.1917), P839; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Cun YP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-69; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Deng XT, 2007, CANCER INFORM, V3, P183; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Dutta U, 2008, CANCER RES, V68, P8779, DOI 10.1158/0008-5472.CAN-08-2125; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gronwald W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-109; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Keilhauer EC, 2015, MOL CELL PROTEOMICS, V14, P120, DOI 10.1074/mcp.M114.041012; Klammer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104504; Klammer M, 2012, MOL CELL PROTEOMICS, V11, P651, DOI 10.1074/mcp.M111.016410; Knowles J., 1999, P 1999 C EV COMP CEC, V1, P98, DOI DOI 10.1109/CEC.1999.781913; Konak A, 2006, RELIAB ENG SYST SAFE, V91, P992, DOI 10.1016/j.ress.2005.11.018; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Nicolaou Christos A, 2013, Drug Discov Today Technol, V10, pe427, DOI 10.1016/j.ddtec.2013.02.001; Nicolaou CA, 2009, J CHEM INF MODEL, V49, P295, DOI 10.1021/ci800308h; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Passeron T, 2011, EXP DERMATOL, V20, P1030, DOI 10.1111/j.1600-0625.2011.01385.x; Rajapakse JC, 2013, IEEE ACM T COMPUT BI, V10, P87, DOI 10.1109/TCBB.2013.1; Roy J, 2014, BRIEF BIOINFORM, V15, P612, DOI 10.1093/bib/bbs083; Schaab C, 2014, LEUKEMIA, V28, P716, DOI 10.1038/leu.2013.347; Schaab C, 2011, METHODS MOL BIOL, V696, P41, DOI 10.1007/978-1-60761-987-1_3; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Tagliabue E, 1998, CLIN CANCER RES, V4, P407; VANWAES C, 1991, CANCER RES, V51, P2395; Winter C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002511; Xue B, 2013, IEEE T CYBERNETICS, V43, P1656, DOI 10.1109/TSMCB.2012.2227469; Zhu YN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S21; Zitzler Eckart, 2001, P IEEE C EV METH DES	43	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128542	10.1371/journal.pone.0128542	http://dx.doi.org/10.1371/journal.pone.0128542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083411	Green Published, gold			2022-12-26	WOS:000356567400055
J	Pradhan, P; Fischer, G; van Velthuizen, H; Reusser, DE; Kropp, JP				Pradhan, Prajal; Fischer, Guenther; van Velthuizen, Harrij; Reusser, Dominik E.; Kropp, Juergen P.			Closing Yield Gaps: How Sustainable Can We Be?	PLOS ONE			English	Article							CLIMATE-CHANGE	Global food production needs to be increased by 60-110% between 2005 and 2050 to meet growing food and feed demand. Intensification and/or expansion of agriculture are the two main options available to meet the growing crop demands. Land conversion to expand cultivated land increases GHG emissions and impacts biodiversity and ecosystem services. Closing yield gaps to attain potential yields may be a viable option to increase the global crop production. Traditional methods of agricultural intensification often have negative externalities. Therefore, there is a need to explore location-specific methods of sustainable agricultural intensification. We identified regions where the achievement of potential crop calorie production on currently cultivated land will meet the present and future food demand based on scenario analyses considering population growth and changes in dietary habits. By closing yield gaps in the current irrigated and rain-fed cultivated land, about 24% and 80% more crop calories can respectively be produced compared to 2000. Most countries will reach food self-sufficiency or improve their current food self-sufficiency levels if potential crop production levels are achieved. As a novel approach, we defined specific input and agricultural management strategies required to achieve the potential production by overcoming biophysical and socioeconomic constraints causing yield gaps. The management strategies include: fertilizers, pesticides, advanced soil management, land improvement, management strategies coping with weather induced yield variability, and improving market accessibility. Finally, we estimated the required fertilizers (N, P2O5, and K2O) to attain the potential yields. Globally, N-fertilizer application needs to increase by 45-73%, P2O5-fertilizer by 22-46%, and K2O-fertilizer by 2-3 times compared to the year 2010 to attain potential crop production. The sustainability of such agricultural intensification largely depends on the way management strategies for closing yield gaps are chosen and implemented.	[Pradhan, Prajal; Reusser, Dominik E.; Kropp, Juergen P.] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Pradhan, Prajal; Fischer, Guenther; van Velthuizen, Harrij] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Kropp, Juergen P.] Univ Potsdam, Dept Geo & Environm Sci, Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung; International Institute for Applied Systems Analysis (IIASA); University of Potsdam	Pradhan, P (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.	pradhan@pik-potsdam.de	Pradhan, Prajal/ABE-2912-2020; Kropp, Juergen/D-8220-2012	Pradhan, Prajal/0000-0003-0491-5489; Kropp, Juergen/0000-0001-7791-3420	IIASA's German National Member Organization; Federal Ministry for Education and Research of Germany [03IS2191B]; European Climate-KIC; Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany	IIASA's German National Member Organization; Federal Ministry for Education and Research of Germany; European Climate-KIC; Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany	The authors acknowledge the financial support from the IIASA's German National Member Organization who supported this work within IIASA's YSSP Program, Federal Ministry for Education and Research of Germany who provided support under the framework of the PROGRESS Initiative (Grant No. 03IS2191B), the European Climate-KIC for providing a scholarship, and the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany who supported this work within the framework of the International Climate Protection Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, WORLD AGRICULTURE TO; Bruinsma J., 2011, Looking ahead in world food and agriculture: perspectives to 2050, P233; Burney JA, 2010, P NATL ACAD SCI USA, V107, P12052, DOI 10.1073/pnas.0914216107; Cassidy ES, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034015; CIESIN/IFPRI/CIAT, 2011, GLOBAL RURAL URBAN M; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; FAO, 2012, FAOSTAT FAO STATISTI; FAO. Food and Agriculture Organization of the United Nations, 2001, PAST NEW MILL; Fischer G., 2011, Looking ahead in world food and agriculture: perspectives to 2050, P95; Fischer T. R., 2011, Looking ahead in world food and agriculture: perspectives to 2050, P389; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization of the UN [FAO], 2013, CLIMATE SMART AGRICU; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; IIASA/FAO, 2012, GLOBAL AGRO ECOLOGIC; Kovats RS, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1267; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu JG, 2010, P NATL ACAD SCI USA, V107, P8035, DOI 10.1073/pnas.0913658107; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Mihelcic JR, 2011, CHEMOSPHERE, V84, P832, DOI 10.1016/j.chemosphere.2011.02.046; Molden D, 2007, WATER FOOD WATER LIF, P279; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Mueller L, 2010, AGRON SUSTAIN DEV, V30, P601, DOI 10.1051/agro/2009057; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Nelson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014327; Nelson G. C, 2013, P NATL ACAD SCI USA; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Parsa S, 2014, P NATL ACAD SCI USA, V111, P3889, DOI 10.1073/pnas.1312693111; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Potter P, 2010, EARTH INTERACT, V14, DOI 10.1175/2009EI288.1; Pradhan P, 2014, ENVIRON SCI TECHNOL, V48, P9463, DOI 10.1021/es5005939; Pradhan P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044044; Pradhan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062228; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rounsevell MDA, 2005, AGR ECOSYST ENVIRON, V107, P117, DOI 10.1016/j.agee.2004.12.002; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Swindale LD, 1981, FOOD CLIMATE INTERAC, P139; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; United Nations, 2011, WORLD POPULATION PRO; van Wart J, 2013, FIELD CROP RES, V143, P44, DOI 10.1016/j.fcr.2012.11.023; Verburg PH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034019	46	144	145	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129487	10.1371/journal.pone.0129487	http://dx.doi.org/10.1371/journal.pone.0129487			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083456	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400097
J	Schott, M; Klein, B; Vilcinskas, A				Schott, Matthias; Klein, Birgit; Vilcinskas, Andreas			Detection of Illicit Drugs by Trained Honeybees (Apis mellifera)	PLOS ONE			English	Article							BIOSENSORS; VOLATILES; SYSTEM	Illegal drugs exacerbate global social challenges such as substance addiction, mental health issues and violent crime. Police and customs officials often rely on specially-trained sniffer dogs, which act as sensitive biological detectors to find concealed illegal drugs. However, the dog "alert" is no longer sufficient evidence to allow a search without a warrant or additional probable cause because cannabis has been legalized in two US states and is decriminalized in many others. Retraining dogs to recognize a narrower spectrum of drugs is difficult and training new dogs is time consuming, yet there are no analytical devices with the portability and sensitivity necessary to detect substance-specific chemical signatures. This means there is currently no substitute for sniffer dogs. Here we describe an insect screening procedure showing that the western honeybee (Apis mellifera) can sense volatiles associated with pure samples of heroin and cocaine. We developed a portable electroantennographic device for the on-site measurement of volatile perception by these insects, and found a positive correlation between honeybee antennal responses and the concentration of specific drugs in test samples. Furthermore, we tested the ability of honeybees to learn the scent of heroin and trained them to show a reliable behavioral response in the presence of a highly-diluted scent of pure heroin. Trained honeybees could therefore be used to complement or replace the role of sniffer dogs as part of an automated drug detection system. Insects are highly sensitive to volatile compounds and provide an untapped resource for the development of biosensors. Automated conditioning as presented in this study could be developed as a platform for the practical detection of illicit drugs using insect-based sensors.	[Schott, Matthias; Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany; [Schott, Matthias; Vilcinskas, Andreas] Fraunhofer Inst Mol Biol & Appl Ecol IME, Dept Bioresources, Giessen, Germany; [Klein, Birgit] Forens Inst, Sect Narcot Chem, State Off Criminal Investigat Hessen, Wiesbaden, Germany	Justus Liebig University Giessen; Fraunhofer Gesellschaft	Vilcinskas, A (corresponding author), Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany.	andreas.vilcinskas@agrar.uni-giessen.de		Schott, Matthias/0000-0002-3034-9305	Hessen State Ministry of Higher Education, Research and the Arts (HMWK) via LOEWE research focus "AmbiProbe"; LOEWE center for Insect Biotechnology and Bioressources	Hessen State Ministry of Higher Education, Research and the Arts (HMWK) via LOEWE research focus "AmbiProbe"; LOEWE center for Insect Biotechnology and Bioressources	This research was funded by the Hessen State Ministry of Higher Education, Research and the Arts (HMWK) via the LOEWE research focus "AmbiProbe" to AV and the LOEWE center for Insect Biotechnology and Bioressources to AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERS RP, 1992, CHEM SENSES, V17, P191, DOI 10.1093/chemse/17.2.191; [Anonymous], WORLD DRUG REP 2014; Behrends A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00015; Coffman K, 2012, WASHINGTON 1 STATES; Davis PJ, 2007, Great Britain patent, Patent No. 237504; Frederickx C, 2011, BIOTECHNOL AGRON SOC, V15, P449; HANSSON BS, 1990, J CHEM ECOL, V16, P1887, DOI 10.1007/BF01020502; HOLM S, 1979, SCAND J STAT, V6, P65; Kirkerud NH, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00029; LAWRENCE AH, 1984, CAN J CHEM, V62, P1886, DOI 10.1139/v84-323; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leitch O, 2013, FORENSIC SCI INT, V232, P92, DOI 10.1016/j.forsciint.2013.07.004; Lent DD, 2004, J EXP BIOL, V207, P369, DOI 10.1242/jeb.00736; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Michel R, 2014, PHEROMONES GEN ODOR, P23; Missbach C, 2014, ELIFE, V3, DOI 10.7554/eLife.02115; Oldham J, 2013, DRUG SNIFFING DOGS P; Park KC, 2002, J INSECT PHYSIOL, V48, P1139, DOI 10.1016/S0022-1910(02)00207-X; Rains GC, 2008, TRENDS BIOTECHNOL, V26, P288, DOI 10.1016/j.tibtech.2008.02.007; Room R, 2014, ADDICTION, V109, P345, DOI 10.1111/add.12355; Schott M, 2013, ADV BIOCHEM ENG BIOT, V136, P101, DOI 10.1007/10_2013_210; Schott M, 2013, ANAL BIOANAL CHEM, V405, P7457, DOI 10.1007/s00216-013-7196-3; United Nations Office on Drugs and Crime, 2012, WORLD DRUG REP 2012	23	15	15	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128528	10.1371/journal.pone.0128528	http://dx.doi.org/10.1371/journal.pone.0128528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083377	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400054
J	Goebes, P; Bruelheide, H; Hardtle, W; Krober, W; Kuhn, P; Li, Y; Seitz, S; von Oheimb, G; Scholten, T				Goebes, Philipp; Bruelheide, Helge; Haerdtle, Werner; Kroeber, Wenzel; Kuehn, Peter; Li, Ying; Seitz, Steffen; von Oheimb, Goddert; Scholten, Thomas			Species-Specific Effects on Throughfall Kinetic Energy in Subtropical Forest Plantations Are Related to Leaf Traits and Tree Architecture	PLOS ONE			English	Article							DROP SIZE DISTRIBUTIONS; SOIL-EROSION; RAINFALL INTERCEPTION; RAINDROP IMPACT; CANOPY; PLANT; STEMFLOW; CHINA; BIODIVERSITY; SAPLINGS	Soil erosion is a key threat to many ecosystems, especially in subtropical China where high erosion rates occur. While the mechanisms that induce soil erosion on agricultural land are well understood, soil erosion processes in forests have rarely been studied. Throughfall kinetic energy (TKE) is influenced in manifold ways and often determined by the tree's leaf and architectural traits. We investigated the role of species identity in mono-specific stands on TKE by asking to what extent TKE is species-specific and which leaf and architectural traits account for variation in TKE. We measured TKE of 11 different tree species planted in monocultures in a biodiversity-ecosystem-functioning experiment in subtropical China, using sand-filled splash cups during five natural rainfall events in summer 2013. In addition, 14 leaf and tree architectural traits were measured and linked to TKE. Our results showed that TKE was highly species-specific. Highest TKE was found below Choerospondias axillaris and Sapindus saponaria, while Schima superba showed lowest TKE. These species-specific effects were mediated by leaf habit, leaf area (LA), leaf pinnation, leaf margin, stem diameter at ground level (GD), crown base height (CBH), tree height, number of branches and leaf area index (LAI) as biotic factors and throughfall as abiotic factor. Among these, leaf habit, tree height and LA showed the highest effect sizes on TKE and can be considered as major drivers of TKE. TKE was positively influenced by LA, GD, CBH, tree height, LAI, and throughfall amount while it was negatively influenced by the number of branches. TKE was lower in evergreen, simple leaved and dentate leaved than in deciduous, pinnated or entire leaved species. Our results clearly showed that soil erosion in forest plantations can be mitigated by the appropriate choice of tree species.	[Goebes, Philipp; Kuehn, Peter; Seitz, Steffen; Scholten, Thomas] Univ Tubingen, Inst Geog, Dept Geosci, Chair Soil Sci & Geomorphol, D-72070 Tubingen, Germany; [Bruelheide, Helge; Kroeber, Wenzel] Univ Halle Wittenberg, D-06108 Halle, Germany; [Bruelheide, Helge] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Haerdtle, Werner; Li, Ying] Univ Luneburg, Fac Sustainabil, Inst Ecol, D-21335 Luneburg, Germany; [von Oheimb, Goddert] Tech Univ Dresden, Inst Gen Ecol & Environm Protect, D-01737 Tharandt, Germany	Eberhard Karls University of Tubingen; Martin Luther University Halle Wittenberg; Leuphana University Luneburg; Technische Universitat Dresden	Goebes, P (corresponding author), Univ Tubingen, Inst Geog, Dept Geosci, Chair Soil Sci & Geomorphol, Rumelinstr 19-23, D-72070 Tubingen, Germany.	philipp.goebes@uni-tuebingen.de	von Oheimb, Goddert/O-9483-2015; Seitz, Steffen/B-7627-2016; Haerdtle, Werner/B-2568-2016; Scholten, Thomas/E-4024-2012; Kühn, Peter/A-9146-2009; Bruelheide, Helge/G-3907-2013	von Oheimb, Goddert/0000-0001-7408-425X; Seitz, Steffen/0000-0003-4911-3906; Scholten, Thomas/0000-0002-4875-2602; Kühn, Peter/0000-0002-4417-5633; Bruelheide, Helge/0000-0003-3135-0356; Goebes, Philipp/0000-0001-8264-9070; Hardtle, Werner/0000-0002-5599-5792	German Research Foundation [DFG FOR 891/1, DFG FOR 891/2]; Sino-German Centre for Research Promotion in Beijing [GZ 524, GZ 592, GZ 698, GZ 699, GZ 785]; University of Tubingen	German Research Foundation(German Research Foundation (DFG)); Sino-German Centre for Research Promotion in Beijing; University of Tubingen	The authors gratefully acknowledge funding by the German Research Foundation, (DFG FOR 891/1 and 2). Travel grants and summer schools were granted through the Sino-German Centre for Research Promotion in Beijing, (GZ 524,592,698,699 and 785). Support was also received from the Open Access Publishing Fund of the University of Tubingen.	AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Andre F, 2011, J HYDROL, V400, P244, DOI 10.1016/j.jhydrol.2011.01.037; ASTON AR, 1979, J HYDROL, V42, P383, DOI 10.1016/0022-1694(79)90057-X; Bates B., 2013, [lme4: linear mixed-effects models using S4 classes, R package version 0.999375-39]; Bauhus J., 2010, ECOSYSTEM GOODS SERV; BRANDT CJ, 1989, CATENA, V16, P507, DOI 10.1016/0341-8162(89)90032-5; BRANDT J, 1988, J BIOGEOGR, V15, P41, DOI 10.2307/2845044; Bruelheide H, 2014, METHODS ECOL EVOL, V5, P74, DOI 10.1111/2041-210X.12126; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Bugmann H, 1996, J VEG SCI, V7, P359, DOI 10.2307/3236279; Butler D, 2009, ASREML ASREML FITS L; Cao Y, 2008, LAND DEGRAD DEV, V19, P321, DOI 10.1002/ldr.812; Dixon RK, 1995, WATER AIR SOIL POLL, V85, P101, DOI 10.1007/BF00483692; Foot K, 2005, EARTH SURF PROC LAND, V30, P1509, DOI 10.1002/esp.1207; Geissler C, 2012, CATENA, V91, P85, DOI 10.1016/j.catena.2010.10.009; Geissler C, 2012, AGR FOREST METEOROL, V156, P31, DOI 10.1016/j.agrformet.2011.12.005; Geissler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049618; Geissler C, 2010, J EARTH SCI-CHINA, V21, P897, DOI 10.1007/s12583-010-0132-y; GIVNISH T J, 1978, P351; Gomez JA, 2001, AGR WATER MANAGE, V49, P65, DOI 10.1016/S0378-3774(00)00116-5; GUNN R, 1949, J METEOROL, V6, P243, DOI 10.1175/1520-0469(1949)006<0243:TTVOFF>2.0.CO;2; Guo JianFen, 2006, Journal of Northeast Forestry University, V34, P49; HALL RL, 1993, J GEOPHYS RES-ATMOS, V98, P18465, DOI 10.1029/93JD01498; HERWITZ SR, 1987, EARTH SURF PROC LAND, V12, P425, DOI 10.1002/esp.3290120408; Hill RD, 1998, JOHN; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; Krober W, 2015, PLANT BIOLOGY, V17, P373, DOI 10.1111/plb.12250; Krober W, 2014, TREES-STRUCT FUNCT, V28, P901, DOI 10.1007/s00468-014-1004-3; Krober W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035742; Kundela A., 2009, THESIS U ZURICH; Lal R, 1998, SOIL TILL RES, V48, P103, DOI 10.1016/S0167-1987(98)00109-3; Levia DF, 2006, PROG PHYS GEOG, V30, P605, DOI 10.1177/0309133306071145; Li Y, 2014, FOREST ECOL MANAG, V327, P118, DOI 10.1016/j.foreco.2014.04.039; Loescher HW, 2002, J TROP ECOL, V18, P397, DOI 10.1017/S0266467402002274; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; MOSLEY MP, 1982, EARTH SURF PROC LAND, V7, P103, DOI 10.1002/esp.3290070204; Nanko K, 2004, J FOREST RES-JPN, V9, P157, DOI 10.1007/s10310-003-0067-6; Nanko K, 2006, J HYDROL, V329, P422, DOI 10.1016/j.jhydrol.2006.02.036; Nanko K, 2013, AGR FOREST METEOROL, V169, P74, DOI 10.1016/j.agrformet.2012.09.018; Nanko K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033010; Park A, 2008, FOREST ECOL MANAG, V255, P1915, DOI 10.1016/j.foreco.2007.12.025; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pimentel David, 2006, Environment Development and Sustainability, V8, P119, DOI 10.1007/s10668-005-1262-8; R Core Team, 2021, R LANGUAGE ENV STAT; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; RENARD KG, 1994, J HYDROL, V157, P287, DOI 10.1016/0022-1694(94)90110-4; Scholten T, 2011, J PLANT NUTR SOIL SC, V174, P596, DOI 10.1002/jpln.201000349; Staelens J, 2008, HYDROL PROCESS, V22, P33, DOI 10.1002/hyp.6610; Tanaka N, 2015, INT J BIOMETEOROL, V59, P1145, DOI 10.1007/s00484-014-0926-1; VIS M, 1986, EARTH SURF PROC LAND, V11, P591, DOI 10.1002/esp.3290110603; Wang K, 2005, PEDOSPHERE, V15, P620; Wei LH, 2007, AGR WATER MANAGE, V94, P54, DOI 10.1016/j.agwat.2007.08.007; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Xu XL, 2009, ECOL RES, V24, P37, DOI 10.1007/s11284-008-0479-z; Yang XF, 2013, EUR J FOREST RES, V132, P593, DOI 10.1007/s10342-013-0696-z; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135; Zuur Alain F., 2009, P1	57	33	34	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0128084	10.1371/journal.pone.0128084	http://dx.doi.org/10.1371/journal.pone.0128084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079260	gold, Green Submitted, Green Published			2022-12-26	WOS:000356542300008
J	Liu, HW; Luo, LX; Liang, CQ; Jiang, N; Liu, PF; Li, JQ				Liu, H. W.; Luo, L. X.; Liang, C. Q.; Jiang, N.; Liu, P. F.; Li, J. Q.			High-Throughput Sequencing Identifies Novel and Conserved Cucumber (Cucumis sativus L.) microRNAs in Response to Cucumber Green Mottle Mosaic Virus Infection	PLOS ONE			English	Article							BZIP TRANSCRIPTION FACTORS; SMALL RNAS; GENE-EXPRESSION; PLANT MICRORNA; PROTEIN; TOMATO; SEED; RESISTANCE; TOBACCO; GENOME	Seedlings of Cucumis sativus L. (cv. 'Zhongnong 16') were artificially inoculated with Cucumber green mottle mosaic virus (CGMMV) at the three-true-leaf stage. Leaf and flower samples were collected at different time points post-inoculation (10, 30 and 50 d), and processed by high throughput sequencing analysis to identify candidate miRNA sequences. Bioinformatic analysis using screening criteria, and secondary structure prediction, indicated that 8 novel and 23 known miRNAs (including 15 miRNAs described for the first time in vivo) were produced by cucumber plants in response to CGMMV infection. Moreover, gene expression profiles (p-value <0.01) validated the expression of 3 of the novel miRNAs and 3 of the putative candidate miRNAs and identified a further 82 conserved miRNAs in CGMMV-infected cucumbers. Gene ontology (GO) analysis revealed that the predicted target genes of these 88 miRNAs, which were screened using the psRNATarget and miRanda algorithms, were involved in three functional categories: 2265 in molecular function, 1362 as cellular components and 276 in biological process. The subsequent Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed that the predicted target genes were frequently involved in metabolic processes (166 pathways) and genetic information processes (40 pathways) and to a lesser degree the biosynthesis of secondary metabolites (12 pathways). These results could provide useful clues to help elucidate host-pathogen interactions in CGMMV and cucumber, as well as for the screening of resistance genes.	[Liu, H. W.; Luo, L. X.; Liang, C. Q.; Jiang, N.; Liu, P. F.; Li, J. Q.] China Agr Univ, Dept Plant Pathol, Key Lab Plant Pathol, Beijing 100094, Peoples R China; [Liu, H. W.; Luo, L. X.; Liang, C. Q.; Jiang, N.; Liu, P. F.; Li, J. Q.] Beijing Engn Res Ctr Seed & Plant Hlth, Beijing Key Lab Seed Dis Testing & Control, Beijing, Peoples R China; [Liu, H. W.] ARS, Mol Plant Pathol Lab, US Dept, Beltsville, MD USA	China Agricultural University	Li, JQ (corresponding author), China Agr Univ, Dept Plant Pathol, Key Lab Plant Pathol, Beijing 100094, Peoples R China.	lijq231@cau.edu.cn			National Science Foundation of China (NSFC) [31371910]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]; Special Fund for Agroscientific Research in the Public Interest of China [201303028]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Special Fund for Agroscientific Research in the Public Interest of China	This work was supported by the National Science Foundation of China (NSFC) project (Grant No. 31371910), the Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT1042) and the Special Fund for Agroscientific Research in the Public Interest of China (Grant No. 201303028). All the funding was received by Dr. Jianqiang Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge C, 2009, FEBS J, V276, P1177, DOI 10.1111/j.1742-4658.2009.06875.x; Alvaro LPQ, 2010, BMC PLANT BIOL, V10, P138, DOI [10.1186/1471-2229-10-138, DOI 10.1186/1471-2229-10-138]; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; ANTIGNUS Y, 1990, PHYTOPARASITICA, V18, P50, DOI 10.1007/BF02980826; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Baker C, 2013, CUCUMBER GREEN MOTTL; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Cho SH, 2012, PLANT CELL, V24, P4837, DOI 10.1105/tpc.112.103176; Choi GugSeoun, 2001, Plant Pathology Journal, V17, P243; Chung KM, 2007, PLANT BIOTECHNOL-NAR, V24, P307, DOI 10.5511/plantbiotechnology.24.307; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; DrogeLaser W, 1997, EMBO J, V16, P726, DOI 10.1093/emboj/16.4.726; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Foyer CH, 2001, TRENDS PLANT SCI, V6, P486, DOI 10.1016/S1360-1385(01)02086-6; Fu CX, 2012, PLANT BIOTECHNOL J, V10, P443, DOI 10.1111/j.1467-7652.2011.00677.x; Gachon C, 2004, PLANT MOL BIOL, V54, P137, DOI 10.1023/B:PLAN.0000028775.58537.fe; Garcia-Masa J, 2012, PNAS, V109, P11882; Grant-Downton R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-643; Gu XingFang, 2005, Acta Horticulturae Sinica, V32, P762; Correa LGG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002944; Guo ChengJin, 2011, Frontiers of Agriculture in China, V5, P291, DOI 10.1007/s11703-011-1067-5; Hammerschmidt R, 1999, PHYSIOL MOL PLANT P, V55, P77, DOI 10.1006/pmpp.1999.0215; Hannoufa A, 2015, GEN M; Herbette S, 2005, BBA-GEN SUBJECTS, V1724, P108, DOI 10.1016/j.bbagen.2005.04.018; Hollings M, 1975, CMI AAB DESCRIPTIONS; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KOMURO Y., 1971, Japan Agricultural Research Quarterly, V6, P41; Laliberte JF, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00203; Langlois-Meurinne M, 2005, PLANT PHYSIOL, V139, P1890, DOI 10.1104/pp.105.067223; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082445; Li CH, 2014, PHYSIOL PLANTARUM, V151, P406, DOI 10.1111/ppl.12122; Liu HW, 2014, PLANT PATHOL, V63, P72, DOI 10.1111/ppa.12065; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moreno IM, 2004, J GEN VIROL, V85, P749, DOI 10.1099/vir.0.19540-0; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pitrat M., 1999, Acta Horticulturae, P21; Prade RA, 1999, BIOTECHNOL GENET ENG, V16, P361, DOI 10.1080/02648725.1999.10647984; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Raisley B, 2004, DEV BIOL, V265, P433, DOI 10.1016/j.ydbio.2003.09.035; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Reingold V., 2013, New Disease Reports, V28, P11, DOI 10.5197/j.2044-0588.2013.028.011; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Riyahi TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027311; Rottiers V, 2011, COLD SH Q B, V76, P225, DOI 10.1101/sqb.2011.76.011049; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Schommer C, 2014, MOL PLANT, V7, P1533, DOI 10.1093/mp/ssu084; Simon-Buela L, 1999, MOL PLANT MICROBE IN, V12, P112, DOI 10.1094/MPMI.1999.12.2.112; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Uzarowska A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-15; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2014, J EXP BOT, V65, P4723, DOI 10.1093/jxb/eru246; Wei S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-169; Wellmer F, 2014, J EXP BOT, V65, P1, DOI 10.1093/jxb/ert385; Wu HuiJie, 2011, Scientia Agricultura Sinica, V44, P1527; Yan YS, 2011, MOL PLANT, V4, P190, DOI 10.1093/mp/ssq066; Yang YO, 1996, P NATL ACAD SCI USA, V93, P14972, DOI 10.1073/pnas.93.25.14972; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4	88	23	25	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129002	10.1371/journal.pone.0129002	http://dx.doi.org/10.1371/journal.pone.0129002			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076360	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900042
J	McElroy, A; Hiraide, R; Bexfield, N; Jalal, H; Brownlie, J; Goodfellow, I; Caddy, SL				McElroy, Aoife; Hiraide, Rintaro; Bexfield, Nick; Jalal, Hamid; Brownlie, Joe; Goodfellow, Ian; Caddy, Sarah L.			Detection of Hepatitis E Virus Antibodies in Dogs in the United Kingdom	PLOS ONE			English	Article							BLOOD-DONORS; GENOTYPES 1; INFECTION; PREVALENCE; SWINE; STRAINS; VETERINARIANS; PATHOGENESIS; REPLICATION; PARTICLES	Hepatitis E virus (HEV) genotypes 3 and 4 are zoonotic pathogens, with pigs predominantly implicated in disease transmission. The rapid rise in human cases in developed countries over the past decade indicates a change in epidemiology of HEV, and it has been suggested that additional animal species may be involved in transmission of infection. Multiple studies have identified contact with dogs as a risk factor for HEV infection in industrialised nations, and a low seroprevalence to HEV has previously been reported in dogs in low-income countries. In this study we aimed to evaluate the possibility that dogs are susceptible to HEV, and determine the frequency with which this occurs. Serum samples from UK dogs with and without hepatitis were screened for HEV-specific antibodies, and canine liver and stool samples were analysed by qPCR for the presence of HEV RNA. We describe evidence to show HEV infection occurs at low levels in dogs in the UK, but the strain of origin is undetermined. The low seroprevalence level of HEV in dogs implies the risk of zoonotic disease transmission is likely to be limited, but further investigations will be required to determine if HEV-infected dogs can transmit HEV to man.	[McElroy, Aoife; Hiraide, Rintaro; Goodfellow, Ian; Caddy, Sarah L.] Univ Cambridge, Addenbrookes Hosp, Div Virol, Dept Pathol, Cambridge CB2 2QQ, England; [Bexfield, Nick] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England; [Jalal, Hamid] Addenbrookes Hosp, Publ Hlth Lab Cambridge, Publ Hlth England, Cambridge CB2 2QQ, England; [Brownlie, Joe] Royal Vet Coll, Dept Pathol & Pathogen Biol, Hatfield AL9 7TA, Herts, England; [Caddy, Sarah L.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Virol Sect, London W2 1NY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Public Health England; University of Cambridge; University of London; University of London Royal Veterinary College; Imperial College London	Goodfellow, I (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Virol, Dept Pathol, Hills Rd, Cambridge CB2 2QQ, England.	ig299@cam.ac.uk; slc50@cam.ac.uk	Caddy, Sarah/AAG-9891-2019	Caddy, Sarah/0000-0002-9790-7420; Goodfellow, Ian/0000-0002-9483-510X; Bexfield, Nicholas/0000-0001-6830-8296	Wellcome Trust [WT088619MA, WT097997MA]; Medical Research Council; Medical Research Council [1110704] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Vacation Scholarship to AM, Wellcome Trust Research Training Fellowship to NB (Ref: WT088619MA), Wellcome Trust Senior Fellowship to IG (Ref: WT097997MA) (http://www.wellcome.ac.uk/), and a PhD studentship from the Medical Research Council to SC (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P223, DOI 10.1046/j.1365-2893.2001.00290.x; Arankalle VA, 1999, J GEN VIROL, V80, P1691, DOI 10.1099/0022-1317-80-7-1691; Arends JE, 2014, J CLIN VIROL, V59, P81, DOI 10.1016/j.jcv.2013.11.013; Asher L, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-74; Baechlein C, 2013, BERL MUNCH TIERARZTL, V126, P25, DOI 10.2376/0005-9366-126-25; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Banks M, 2004, EMERG INFECT DIS, V10, P953, DOI 10.3201/eid1005.030908; Bexfield NH, 2014, J VIRAL HEPATITIS, V21, P223, DOI 10.1111/jvh.12150; Bexfield NH, 2011, VET REC, V169, P415, DOI 10.1136/vr.d4665; Billam P, 2005, J VIROL, V79, P3429, DOI 10.1128/JVI.79.6.3429-3437.2005; Boomkens SY, 2005, VET MICROBIOL, V108, P49, DOI 10.1016/j.vetmic.2005.03.003; Borgen K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-61; Caddy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081596; Dong C, 2011, J CLIN MICROBIOL, V49, P4164, DOI 10.1128/JCM.05481-11; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; Gallian P, 2014, EMERG INFECT DIS, V20, P1914, DOI 10.3201/eid2011.140516; Geng Jia-bao, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P47; GRAY JJ, 1993, J CLIN MICROBIOL, V31, P1022, DOI 10.1128/JCM.31.4.1022-1025.1993; Guu TSY, 2009, P NATL ACAD SCI USA, V106, P12992, DOI 10.1073/pnas.0904848106; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Harvala H, 2014, J CLIN VIROL, V59, P184, DOI 10.1016/j.jcv.2014.01.001; Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Lewis HC, 2008, EMERG INFECT DIS, V14, P2003; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Liang HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098068; Liu JF, 2009, SCAND J INFECT DIS, V41, P291, DOI 10.1080/00365540902767031; Ma HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009160; McCreary C, 2008, VET REC, V163, P261, DOI 10.1136/vr.163.9.261; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Mesquita JR, 2014, J MED VIROL, V86, P954, DOI 10.1002/jmv.23927; Mochizuki M, 2006, VET REC, V159, P853; Poldervaart JH, 2009, J VET INTERN MED, V23, P72, DOI 10.1111/j.1939-1676.2008.0215.x; Sanford BJ, 2013, TRANSBOUND EMERG DIS, V60, P538, DOI 10.1111/tbed.12001; Sauleda S, 2014, TRANSFUSION, DOI [10.1111/trf.12929.10.1111/trf.12929, DOI 10.1111/TRF.12929.10.1111/TRF.12929]; Schielke A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-58; Shukla P, 2012, J VIROL, V86, P5697, DOI 10.1128/JVI.00146-12; Takahashi M, 2010, J CLIN MICROBIOL, V48, P1112, DOI 10.1128/JCM.02002-09; Takeda H, 2010, VOX SANG, V99, P307, DOI 10.1111/j.1423-0410.2010.01362.x; Vitral CL, 2005, MEM I OSWALDO CRUZ, V100, P117, DOI 10.1590/S0074-02762005000200003; Wang S, 2013, VIRUS RES, V176, P101, DOI 10.1016/j.virusres.2013.05.013; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Xing L, 2011, J VIROL, V85, P1117, DOI 10.1128/JVI.00657-10; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x; Zhuang WC, 2014, INT J INFECT DIS, V26, P9, DOI 10.1016/j.ijid.2014.04.022	50	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128703	10.1371/journal.pone.0128703	http://dx.doi.org/10.1371/journal.pone.0128703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076364	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900024
J	Metzler-Zebeli, BU; Eberspacher, E; Grull, D; Kowalczyk, L; Molnar, T; Zebeli, Q				Metzler-Zebeli, Barbara U.; Eberspaecher, Eva; Gruell, Dietmar; Kowalczyk, Lidia; Molnar, Timea; Zebeli, Qendrim			Enzymatically Modified Starch Ameliorates Postprandial Serum Triglycerides and Lipid Metabolome in Growing Pigs	PLOS ONE			English	Article							RESISTANT STARCH; PROTEIN-SYNTHESIS; LEUCINE SUPPLEMENTATION; NUTRIENT ABSORPTION; SKELETAL-MUSCLE; NEONATAL PIGS; PLASMA; CHOLESTEROL; OXIDATION; AMYLOSE	Developing host digestion-resistant starches to promote human health is of great research interest. Chemically modified starches (CMS) are widely used in processed foods and although the modification of the starch molecule allows specific reduction in digestibility, the metabolic effects of CMS have been less well described. This short-term study evaluated the impact of enzymatically modified starch (EMS) on fasting and postprandial profiles of blood glucose, insulin and lipids, and serum metabolome in growing pigs. Eight jugular-vein catheterized pigs (initial body weight, 37.4 kg; 4 months of age) were fed 2 diets containing 72% purified starch (EMS or waxy corn starch (control)) in a cross-over design for 7 days. On day 8, an 8-hour meal tolerance test (MTT) was performed with serial blood samplings. Besides biochemical analysis, serum was analysed for 201 metabolites through targeted mass spectrometry-based metabolomic approaches. Pigs fed the EMS diet showed increased (P<0.05) immediate serum insulin and plasma glucose response compared to pigs fed the control diet; however, area-under-the-curves for insulin and glucose were not different among diets. Results from MTT indicated reduced postprandial serum triglycerides with EMS versus control diet (P<0.05). Likewise, serum metabolome profiling identified characteristic changes in glycerophospholipid, lysophospholipids, sphingomyelins and amino acid metabolome profiles with EMS diet compared to control diet. Results showed rapid adaptations of blood metabolites to dietary starch shifts within 7 days. In conclusion, EMS ingestion showed potential to attenuate postprandial raise in serum lipids and suggested constant alteration in the synthesis or breakdown of sphingolipids and phospholipids which might be a health benefit of EMS consumption. Because serum insulin was not lowered, more research is warranted to reveal possible underlying mechanisms behind the observed changes in the profile of serum lipid metabolome in response to EMS consumption.	[Metzler-Zebeli, Barbara U.] Univ Vet Med Vienna, Univ Clin Swine, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Eberspaecher, Eva; Kowalczyk, Lidia] Univ Vet Med Vienna, Dept Compan Anim & Horses, Anaesthesiol & Perioperat Intens Care, Vienna, Austria; [Gruell, Dietmar; Molnar, Timea] Agrana Res & Innovat Ctr GmbH, Tulln, Austria; [Zebeli, Qendrim] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Metzler-Zebeli, BU (corresponding author), Univ Vet Med Vienna, Univ Clin Swine, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	barbara.metzler@vetmeduni.ac.at			Austrian Research Promotion Agency (FFG) [836447]; Agrana Research & Innovation Center GmbH	Austrian Research Promotion Agency (FFG); Agrana Research & Innovation Center GmbH	This work was supported by the Austrian Research Promotion Agency (FFG), BRIDGE project No. 836447 - 'Healthy Carbohydrates' to QZ (www.ffg.at/en/bridge), and the Agrana Research & Innovation Center GmbH provided support in the form of salaries for authors DG and TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tamimi EK, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/651063; Bird AR, 2004, BRIT J NUTR, V92, P607, DOI 10.1079/BJN20041248; Birt DF, 2013, ADV NUTR, V4, P587, DOI 10.3945/an.113.004325; Brites CM, 2011, NUTR RES, V31, P302, DOI 10.1016/j.nutres.2011.02.001; da Silva CS, 2014, ANIMAL, V8, P1917, DOI 10.1017/S1751731114001840; den Besten G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107392; den Besten G, 2013, AM J PHYSIOL-GASTR L, V305, pG900, DOI 10.1152/ajpgi.00265.2013; Deng J, 2010, J ANIM PHYSIOL AN N, V94, P220, DOI 10.1111/j.1439-0396.2008.00902.x; Dunn WB, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/011001; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Garlick PJ, 2005, J NUTR, V135, p1553S, DOI 10.1093/jn/135.6.1553S; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gootenberg DB, 2011, J ANIM SCI, V89, P1531, DOI 10.2527/jas.2010-3371; Granfeldt Y, 2006, EUR J CLIN NUTR, V60, P104, DOI 10.1038/sj.ejcn.1602273; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Han KH, 2005, BRIT J NUTR, V94, P902, DOI 10.1079/BJN20051598; Haub MD, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/230501; He QH, 2011, J PROTEOME RES, V10, P5214, DOI 10.1021/pr200688u; Hooda S, 2009, J ANIM SCI, V87, P2013, DOI 10.2527/jas.2008-1423; Ishikawa M, 2013, BIOL PHARM BULL, V36, P682; Iverson Jennifer F, 2013, J Amino Acids, V2013, P964637, DOI 10.1155/2013/964637; Lattimer JM, 2010, NUTRIENTS, V2, P1266, DOI 10.3390/nu2121266; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; Metzler-Zebeli BU, 2014, METABOLOMIC IN PRESS; Michal G, 1999, BIOCH PATHWAYS ATLAS; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; Nugent AP, 2005, NUTR BULL, V30, P27, DOI 10.1111/j.1467-3010.2005.00481.x; Nutrient Research Council, 2012, NUTRIENT REQUIREMENT; Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715; Regmi PR, 2011, J NUTR, V141, P398, DOI 10.3945/jn.110.132449; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Shimano H, 2002, VITAM HORM, V65, P167, DOI 10.1016/S0083-6729(02)65064-2; Shimotoyodome A, 2010, AM J PHYSIOL-ENDOC M, V298, pE652, DOI 10.1152/ajpendo.00468.2009; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Singh J, 2010, TRENDS FOOD SCI TECH, V21, P168, DOI 10.1016/j.tifs.2009.12.001; Suryawan A, 2012, PEDIATR RES, V71, P324, DOI 10.1038/pr.2011.79; TAGLIABUE A, 1995, AM J CLIN NUTR, V61, P1070, DOI 10.1093/ajcn/61.5.1070; Then C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078430; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Torrazza RM, 2010, J NUTR, V140, P2145, DOI 10.3945/jn.110.128421; VDLUFA, 2007, METHODENBUCH; Wahl S, 2012, OBESITY FACTS, V5, P660, DOI 10.1159/000343204; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43	45	15	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130553	10.1371/journal.pone.0130553	http://dx.doi.org/10.1371/journal.pone.0130553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076487	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900179
J	Zou, L; Yli-Halla, M; Stoddard, FL; Makela, PSA				Zou, Ling; Yli-Halla, Markku; Stoddard, Frederick L.; Makela, Pirjo S. A.			Effects of Break Crops on Yield and Grain Protein Concentration of Barley in a Boreal Climate	PLOS ONE			English	Article							SOIL MINERAL NITROGEN; ORGANIC-MATTER; CATCH CROPS; ALLELOPATHY; GERMINATION; LEGUMES; LOSSES	Rotation with dicotyledonous crops to break cereal monoculture has proven to be beneficial to successive cereals. In two fields where the soil had been subjected to prolonged, continuous cereal production, two 3-year rotation trials were established. In the first year, faba bean, turnip rape and barley were grown, as first crops, in large blocks and their residues tilled into the soil after harvest. In the following year, barley, buckwheat, caraway, faba bean, hemp and white lupin were sown, as second crops, in each block and incorporated either at flowering stage (except barley) or after harvest. In the third year, barley was grown in all plots and its yield and grain protein concentration were determined. Mineral N in the plough layer was determined two months after incorporation of crops and again before sowing barley in the following year. The effect of faba bean and turnip rape on improving barley yields and grain protein concentration was still detectable two years after they were grown. The yield response of barley was not sensitive to the growth stage of second crops when they were incorporated, but was to different second crops, showing clear benefits averaging 6-7% after white lupin, faba bean and hemp but no benefit from caraway or buckwheat. The effect of increased N in the plough layer derived from rotation crops on barley yields was minor. Incorporation of plants at flowering stage slightly increased third-year barley grain protein concentration but posed a great potential for N loss compared with incorporation of crop residues after harvest, showing the value of either delayed incorporation or using catch crops.	[Zou, Ling; Stoddard, Frederick L.; Makela, Pirjo S. A.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Yli-Halla, Markku] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland	University of Helsinki; University of Helsinki	Zou, L (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	ling.zou@helsinki.fi	Stoddard, Frederick/E-6436-2015; Mäkelä, Pirjo/N-7863-2013	Stoddard, Frederick/0000-0002-8097-5750; Mäkelä, Pirjo/0000-0002-8757-6015; Yli-Halla, Markku/0000-0002-8062-7019	Maj and Tor Nessling Foundation; Finnish Cultural foundation; Olvi foundation; Niemi Foundation	Maj and Tor Nessling Foundation; Finnish Cultural foundation(Finnish Cultural FoundationFinnish IT center for science); Olvi foundation; Niemi Foundation	This work was supported by Maj and Tor Nessling Foundation (http://www.nessling.fi/en/), Finnish Cultural foundation (https://www.skr.fi/en), Olvi foundation (http://www.olvisaatio.fi/web/olvisaatio/) and the Niemi Foundation (http://www.aurora-tietokanta.fi/foundation/details/id/336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcand MM, 2013, PLANT SOIL, V371, P67, DOI 10.1007/s11104-013-1626-z; Azirak S, 2008, ACTA AGR SCAND B-S P, V58, P88, DOI 10.1080/09064710701228353; Campiglia E, 2014, SOIL TILL RES, V139, P1, DOI 10.1016/j.still.2014.01.003; Chen YH, 2012, BIOL RES, V45, P171, DOI 10.4067/S0716-97602012000200009; DALAL RC, 1987, AUST J SOIL RES, V25, P83, DOI 10.1071/SR9870083; FAO, 2006, WORLD SOIL RES REP; Felipe M., 2012, STAT PROCEDURES AGR; Hamza MA, 2007, SOIL TILL RES, V82, P121; Hauggaard-Nielsen H, 2009, NUTR CYCL AGROECOSYS, V84, P281, DOI 10.1007/s10705-008-9242-7; Heikinkeimo M., 1992, STAT SOIL TEMPERATUR, V22, P75; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; INAM B, 1989, Pakistan Journal of Scientific and Industrial Research, V32, P617; Johnston AE, 2009, ADV AGRON, V101, P1, DOI 10.1016/S0065-2113(08)00801-8; Kaul H. P., 2004, Bodenkultur, V55, P95; Kirkegaard J, 2008, FIELD CROP RES, V107, P185, DOI 10.1016/j.fcr.2008.02.010; Kraljevic D, 2007, CEREAL RES COMMUN, V35, P665, DOI 10.1556/CRC.35.2007.2.125; Kramberger B, 2009, EUR J AGRON, V31, P103, DOI 10.1016/j.eja.2009.05.006; LINDEN B, 1992, SWED J AGR RES, V22, P3; LOVETT JV, 1991, BIOL AGRIC HORTIC, V8, P89, DOI 10.1080/01448765.1991.9754583; Macias FA, 2007, PEST MANAG SCI, V63, P327, DOI 10.1002/ps.1342; Mandal N, 2013, FIELD CROP RES, V154, P178, DOI 10.1016/j.fcr.2013.08.007; Meier U., 2001, GROWTH STAGES MONO D; Ministry of Agriculture and Forestry of Finland, 2010, CER PROD; Miransari M, 2012, COMMUN SOIL SCI PLAN, V43, P799, DOI 10.1080/00103624.2012.648357; Neumann G, 2000, ANN BOT-LONDON, V85, P909, DOI 10.1006/anbo.2000.1135; Paasonen-Kivekas M, 2005, AGR FOOD SCI, V14, P57, DOI 10.2137/1459606054224174; Peoples MB, 2009, SYMBIOSIS, V48, P1, DOI 10.1007/BF03179980; Pietikainen J, 2005, FEMS MICROBIOL ECOL, V52, P49, DOI 10.1016/j.femsec.2004.10.002; R Core Team, 2020, R LANG ENV STAT COMP; Salo T, 2006, AGR ECOSYST ENVIRON, V113, P98, DOI 10.1016/j.agee.2005.09.002; St Luce M, 2013, CAN J SOIL SCI, V93, P607, DOI [10.4141/CJSS2013-005, 10.4141/cjss2013-005]; Stenberg M, 1999, SOIL TILL RES, V50, P115, DOI 10.1016/S0167-1987(98)00197-4; Tekauz A., 2003, DIS FIELD CROPS CANA, P30; Thorup-Kristensen K, 2010, SOIL USE MANAGE, V26, P27, DOI 10.1111/j.1475-2743.2009.00255.x; Turtola E, 1998, AGR FOOD SCI FINLAND, V7, P569, DOI 10.23986/afsci.5614; Valkama E, 2013, AGR ECOSYST ENVIRON, V164, P1, DOI 10.1016/j.agee.2012.09.010; Weinert TL, 2002, AGRON J, V94, P365, DOI 10.2134/agronj2002.0365; WINK M, 1983, PLANTA, V158, P365, DOI 10.1007/BF00397339; YLARANTA T, 1993, AGR SCI FINLAND, V2, P281, DOI 10.23986/afsci.72651; Zou L, 2014, ALLELOPATHY J, V33, P227	40	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130765	10.1371/journal.pone.0130765	http://dx.doi.org/10.1371/journal.pone.0130765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076452	Green Submitted, Green Published, gold			2022-12-26	WOS:000356329900187
J	Nguyen, S; Leija, C; Kinch, L; Regmi, S; Li, Q; Grishin, NV; Phillips, MA				Suong Nguyen; Leija, Chrisopher; Kinch, Lisa; Regmi, Sandesh; Li, Qiong; Grishin, Nick V.; Phillips, Margaret A.			Deoxyhypusine Modification of Eukaryotic Translation Initiation Factor 5A (eIF5A) Is Essential for Trypanosoma brucei Growth and for Expression of Polyprolyl-containing Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; BLOOD-STREAM FORMS; FACTOR EF-P; SACCHAROMYCES-CEREVISIAE; HYPUSINE MODIFICATION; POLYAMINE METABOLISM; ACTIN CYTOSKELETON; CELL-GROWTH; HOMOLOG; YEAST	The eukaryotic protozoan parasite Trypanosoma brucei is the causative agent of human African trypanosomiasis. Polyamine biosynthesis is essential in T. brucei, and the polyamine spermidine is required for synthesis of a novel cofactor called trypanothione and for deoxyhypusine modification of eukaryotic translation initiation factor 5A (eIF5A). eIF5A promotes translation of proteins containing polyprolyl tracts in mammals and yeast. To evaluate the function of eIF5A in T. brucei, we used RNA interference (RNAi) to knock down eIF5A levels and found that it is essential for T. brucei growth. The RNAi-induced growth defect was complemented by expression of wild-type human eIF5A but not by a Lys-50 mutant that blocks modification by deoxyhypusine. Bioinformatics analysis showed that 15% of the T. brucei proteome contains 3 or more consecutive prolines and that actin-related proteins and cysteine proteases were highly enriched in the group. Steady-state protein levels of representative proteins containing 9 consecutive prolines that are involved in actin assembly (formin and CAP/Srv2p) were significantly reduced by knockdown of eIF5A. Several T. brucei polyprolyl proteins are involved in flagellar assembly. Knockdown of TbeIF5A led to abnormal cell morphologies and detached flagella, suggesting that eIF5A is important for translation of proteins needed for these processes. Potential specialized functions for eIF5A in T. brucei in translation of variable surface glycoproteins were also uncovered. Inhibitors of deoxyhypusination would be expected to cause a pleomorphic effect on multiple cell processes, suggesting that deoxyhypusine/hypusine biosynthesis could be a promising drug target in not just T. brucei but in other eukaryotic pathogens.	[Suong Nguyen; Leija, Chrisopher; Regmi, Sandesh; Li, Qiong; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Kinch, Lisa; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys & Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Phillips, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	margaret.phillips@UTSouthwestern.edu	Regan, Clinton/E-6250-2012	Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [2R37 AI034432, GM007062, GM094575]; Welch Foundation [I-1257, I-1505]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575, T32GM007062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R37 AI034432 (to M. A. P.), GM007062 (to C. L.), and GM094575 (to N. V. G.). This work was also supported by Welch Foundation Grants I-1257 (to M. A. P.) and I-1505 (to N. V. G.). The authors declare that they have no conflicts of interest with the content of this article.	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Barrett MP, 2010, CURR OPIN INFECT DIS, V23, P603, DOI 10.1097/QCO.0b013e32833f9fd0; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chawla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033138; Chawla B, 2010, J BIOL CHEM, V285, P453, DOI 10.1074/jbc.M109.048850; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; Freeman NL, 2000, CELL MOTIL CYTOSKEL, V45, P106, DOI 10.1002/(SICI)1097-0169(200002)45:2<106::AID-CM3>3.0.CO;2-3; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hall JPJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003502; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacobs RT, 2011, CURR TOP MED CHEM, V11, P1255; Kalidas S, 2011, MOL BIOCHEM PARASIT, V178, P51, DOI 10.1016/j.molbiopara.2011.03.002; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Li T, 2014, GENETICS, V197, P1191, DOI 10.1534/genetics.114.166926; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; Mirey G, 2005, BIOCHEM SOC T, V33, P1247, DOI 10.1042/BST0331247; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; PARK MH, 1993, TRENDS BIOCHEM SCI, V18, P475, DOI 10.1016/0968-0004(93)90010-K; Patel PH, 2009, J CELL BIOL, V185, P1181, DOI 10.1083/jcb.200904161; Pegg AE, 2007, BIOCHEM SOC T, V35, P295, DOI 10.1042/BST0350295; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pratt C, 2014, EUKARYOT CELL, V13, P614, DOI 10.1128/EC.00015-14; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Rossi D, 2014, WIRES RNA, V5, P209, DOI 10.1002/wrna.1211; Santos CC, 2007, MOL MICROBIOL, V66, P991, DOI 10.1111/j.1365-2958.2007.05970.x; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Sugimoto A, 2004, DIFFERENTIATION, V72, P81, DOI 10.1111/j.1432-0436.2004.07202004.x; Sun SY, 2013, J CELL SCI, V126, P520, DOI 10.1242/jcs.113621; Nguyen S, 2013, J BIOL CHEM, V288, P15256, DOI 10.1074/jbc.M113.461137; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; WHO, 2014, TRYP HUM AFR SLEEP S; Willert E, 2012, TRENDS PARASITOL, V28, P66, DOI 10.1016/j.pt.2011.11.001; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	49	20	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19987	19998		10.1074/jbc.M115.656785	http://dx.doi.org/10.1074/jbc.M115.656785			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26082486	Green Published, hybrid			2022-12-26	WOS:000359364600053
J	Nielsen, LG; Folkestad, L; Brodersen, JB; Brabrand, M				Nielsen, Louise Gramstrup; Folkestad, Lars; Brodersen, Jacob Broder; Brabrand, Mikkel			Inter-Observer Agreement in Measuring Respiratory Rate	PLOS ONE			English	Article							EARLY WARNING SCORE	Background Respiratory rate (RR) is an important vital sign which is strongly correlated with in-hospital mortality. At the same time, RR is the most likely vital sign to be omitted when assessing a patient. We believe that one reason for this could be the difficulty in measure the RR, since it is not read off a monitor, but counted manually. Also there is the possibility of assessment bias and the inter-observer reliability becomes important. We therefore set out to investigate how the nursing staff counting the actual number of respirations per minute would agree with the nursing staff using a predefined ordinal scale. Methods For this prospective study, we recorded five videos of a young healthy man breathing approximately 5, 10, 15, 30 and 60 times per minute. The videos were shown in a random order to a suitable sample of the nursing staff. The participants were randomized into two groups; one to count the exact number of breaths per minute, and one to use a predefined ordinal scale. Results Comparing the exact number of breaths per minute, the Intra Class Coefficient (ICC) was 0.99 (95% CI: 0.97-1.00). Comparing the RR using the predefined scale, the overall Kappa Fleiss Coefficient was 0.75. Conclusions The inter-observer agreement was high when comparing the use of the actual number of breaths per minute and substantial when comparing the use of the predefined scale. This is the largest inter-observer study on RR to date. However, further studies on the use of scaled comparisons of RR are needed.	[Nielsen, Louise Gramstrup] Sygehus Lillebaelt, Dept Anaesthesiol, Vejle, Denmark; [Folkestad, Lars] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Brodersen, Jacob Broder; Brabrand, Mikkel] Sydvestjysk Sygehus, Dept Med, Esbjerg, Denmark; [Brodersen, Jacob Broder] Sydvestjysk Sygehus, Dept Emergency Med, Esbjerg, Denmark	University of Southern Denmark; Odense University Hospital	Folkestad, L (corresponding author), Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark.	lfolkestad@health.sdu.dk	Folkestad, Lars/X-5774-2019; Folkestad, Lars/K-3181-2015; Brabrand, Mikkel/F-7276-2011	Folkestad, Lars/0000-0001-6266-6439; Folkestad, Lars/0000-0001-6266-6439; Brabrand, Mikkel/0000-0002-3340-8251; Brodersen, Jacob Broder/0000-0003-2530-7554				Brabrand M, 2011, EUR J EMERG MED, V18, P46, DOI 10.1097/MEJ.0b013e32833b4fba; Cretikos M, 2007, RESUSCITATION, V73, P62, DOI 10.1016/j.resuscitation.2006.08.020; Cretikos MA, 2008, MED J AUSTRALIA, V188, P657; Edwards SM, 2001, CLIN MED, V1, P85, DOI 10.7861/clinmedicine.1-1-85; FIESELMANN JF, 1993, J GEN INTERN MED, V8, P354, DOI 10.1007/BF02600071; Goldhill DR, 2005, ANAESTHESIA, V60, P547, DOI 10.1111/j.1365-2044.2005.04186.x; Hillman K, 2005, LANCET, V365, P2091; Leuvan Chris H Van, 2008, Crit Care Resusc, V10, P111; Lim WS, 2002, RESP MED, V96, P31, DOI 10.1053/rmed.2001.1203; Liu LL, 2004, PEDIATR PULM, V37, P243, DOI 10.1002/ppul.10425; Subbe CP, 2003, ANAESTHESIA, V58, P797, DOI 10.1046/j.1365-2044.2003.03258.x; Worster A, 2003, EUR J EMERG MED, V10, P108, DOI 10.1097/00063110-200306000-00008	12	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129493	10.1371/journal.pone.0129493	http://dx.doi.org/10.1371/journal.pone.0129493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090961	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000045
J	Otani, H; Yamamoto, H; Takaoka, M; Sakaguchi, M; Soh, J; Jida, M; Ueno, T; Kubo, T; Asano, H; Tsukuda, K; Kiura, K; Hatakeyama, S; Kawahara, E; Naomoto, Y; Miyoshi, S; Toyooka, S				Otani, Hiroki; Yamamoto, Hiromasa; Takaoka, Munenori; Sakaguchi, Masakiyo; Soh, Junichi; Jida, Masaru; Ueno, Tsuyoshi; Kubo, Takafumi; Asano, Hiroaki; Tsukuda, Kazunori; Kiura, Katsuyuki; Hatakeyama, Shinji; Kawahara, Eiji; Naomoto, Yoshio; Miyoshi, Shinichiro; Toyooka, Shinichi			TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; FACTOR-I RECEPTOR; PROSPECTIVE PHASE-II; GEFITINIB-RESISTANCE; ACQUIRED-RESISTANCE; CLINICAL SPECIMENS; GENE-MUTATIONS; GROWTH; SENSITIVITY; LINES	TAE226, a bis-anilino pyrimidine compound, has been developed as an inhibitor of focal adhesion kinase (FAK) and insulin-like growth factor-I receptor (IGF-IR). In this study, we investigated the effect of TAE226 on non-small-cell lung cancer (NSCLC), especially focusing on the EGFR mutational status. TAE226 was more effective against cells with mutant EGFR, including the T790M mutant, than against cells with wild-type one. TAE226 preferentially inhibited phospho-EGFR and its downstream signaling mediators in the cells with mutant EGFR than in those with wild-type one. Phosphorylation of FAK and IGF-IR was not inhibited at the concentration at which the proliferation of EGFR-mutant cells was inhibited. Results of the in vitro binding assay indicated significant differences in the affinity for TAE226 between the wild-type and L858R (or delE746_A750) mutant, and the reduced affinity of ATP to the L858R (or delE746_A750) mutant resulted in good responsiveness of the L858R (or delE746_A750) mutant cells to TAE226. Of interest, the L858R/T790M or delE746_A750/T790M mutant enhanced the binding affinity for TAE226 compared with the L858R or delE746_A750 mutant, resulting in the effectiveness of TAE226 against T790M mutant cells despite the T790M mutation restoring the ATP affinity for the mutant EGFR close to that for the wild-type. TAE226 also showed higher affinity of about 15-fold for the L858R/T790M mutant than for the wild-type one by kinetic interaction analysis. The antitumor effect against EGFR-mutant tumors including T790M mutation was confirmed in mouse models without any significant toxicity. In summary, we showed that TAE226 inhibited the activation of mutant EGFR and exhibited anti-proliferative activity against NSCLCs carrying EGFR mutations, including T790M mutation.	[Otani, Hiroki; Yamamoto, Hiromasa; Soh, Junichi; Jida, Masaru; Ueno, Tsuyoshi; Kubo, Takafumi; Asano, Hiroaki; Tsukuda, Kazunori; Miyoshi, Shinichiro; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama 7008558, Japan; [Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Okayama 7008558, Japan; [Sakaguchi, Masakiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008558, Japan; [Kiura, Katsuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama 7008558, Japan; [Takaoka, Munenori; Naomoto, Yoshio] Kawasaki Med Sch, Dept Gen Surg, Okayama 7008505, Japan; [Hatakeyama, Shinji] Novartis Pharmaceut, Novartis Inst BioMed Res Basel, Musculoskeletal Dis Area, Basel, Switzerland; [Kawahara, Eiji] Novartis Pharma KK, Dept Oncol Dev Med Affairs, Dept Med Sci Liaison, Tokyo 1060031, Japan	Okayama University; Okayama University; Okayama University; Okayama University; Kawasaki Medical School; Novartis; Novartis	Toyooka, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama 7008558, Japan.	toyooka@md.okayama-u.ac.jp	KIURA, Katsuyuki/B-1991-2011; Tsukuda, Kazunori/AAY-2985-2020; Soh, Junichi/AAV-1053-2020; Soh, Junichi/AAT-7095-2021; Hatakeyama, Shinji/I-8873-2019; Sakaguchi, Masakiyo/B-2280-2011	Soh, Junichi/0000-0001-8532-7915; Soh, Junichi/0000-0001-8532-7915; Hatakeyama, Shinji/0000-0002-0166-2773; Kiura, Katsuyuki/0000-0002-9172-9379; Tsukuda, Kazunori/0000-0001-6293-1693	Ministry of Education, Culture, Sports, Science and Technology of Japan [18790993]; Novartis Pharma AG	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novartis Pharma AG	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number: 18790993 to ST), http://www.mext.go.jp/english/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novartis Pharma AG provided support in the form of salaries for authors SH and EK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BROWER M, 1986, CANCER RES, V46, P798; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Fong T, 2008, J THORAC ONCOL, V3, P303, DOI 10.1097/JTO.0b013e3181645477; Fujishita T, 2003, ONCOLOGY-BASEL, V64, P399, DOI 10.1159/000070299; Fukui T, 2008, GEN THORAC CARDIOVAS, V56, P97, DOI 10.1007/s11748-007-0193-8; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; GAZDAR AF, 1986, CANCER RES, V46, P6011; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Gridelli C, 2007, ONCOLOGIST, V12, P840, DOI 10.1634/theoncologist.12-7-840; Guerreiro AS, 2006, DRUG NEWS PERSPECT, V19, P261, DOI 10.1358/dnp.2006.19.5.985933; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Hehlgans S, 2009, RADIOTHER ONCOL, V92, P371, DOI 10.1016/j.radonc.2009.08.001; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Klebe G, 1997, J RECEPT SIGNAL TR R, V17, P459, DOI 10.3109/10799899709036621; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Lietha D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003800; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Neumann L, 2011, METHOD ENZYMOL, V493, P299, DOI 10.1016/B978-0-12-381274-2.00012-1; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Phelps RM, 1996, J CELL BIOCHEM, P32; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Schneider EV, 2013, P NATL ACAD SCI USA, V110, P8081, DOI 10.1073/pnas.1305378110; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Suehisa H, 2007, J CLIN ONCOL, V25, P3952, DOI 10.1200/JCO.2007.11.8646; Tamura K, 2008, BRIT J CANCER, V98, P907, DOI 10.1038/sj.bjc.6604249; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Toyooka S, 2005, NEW ENGL J MED, V352, P2136; Uchida A, 2007, CANCER SCI, V98, P357, DOI 10.1111/j.1349-7006.2007.00387.x; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Watanabe N, 2008, CLIN CANCER RES, V14, P4631, DOI 10.1158/1078-0432.CCR-07-4755; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105	45	7	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129838	10.1371/journal.pone.0129838	http://dx.doi.org/10.1371/journal.pone.0129838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090892	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000065
J	Thebault, S; Waters, P; Snape, MD; Cottrell, D; Darin, N; Hallbook, T; Huutoniemi, A; Partinen, M; Pollard, AJ; Vincent, A				Thebault, Simon; Waters, Patrick; Snape, Matthew D.; Cottrell, Dominic; Darin, Niklas; Hallbook, Tove; Huutoniemi, Anne; Partinen, Markku; Pollard, Andrew J.; Vincent, Angela			Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination	PLOS ONE			English	Article							HYPOCRETIN NEURONS	Type 1 narcolepsy is caused by deficiency of hypothalamic orexin/hypocretin. An autoimmune basis is suspected, but no specific antibodies, either causative or as biomarkers, have been identified. However, the AS03 adjuvanted split virion H1N1 (H1N1-AS03) vaccine, created to protect against the 2009 Pandemic, has been implicated as a trigger of narcolepsy particularly in children. Sera and CSFs from 13 H1N1-AS03-vaccinated patients (12 children, 1 young adult) with type 1 narcolepsy were tested for autoantibodies to known neuronal antigens including the N-methyl-D-aspartate receptor (NMDAR) and contactin-associated protein 2 (CASPR2), both associated with encephalopathies that include disordered sleep, to rodent brain tissue including the lateral hypothalamus, and to live hippocampal neurons in culture. When sufficient sample was available, CSF levels of melanin-concentrating hormone (MCH) were measured. Sera from 44 H1N1-ASO3-vaccinated children without narcolepsy were also examined. None of these patients' CSFs or sera was positive for NMDAR or CASPR2 antibodies or binding to neurons; 4/13 sera bound to orexin-neurons in rat brain tissue, but also to other neurons. MCH levels were a marginally raised (n = 8; p = 0.054) in orexin-deficient narcolepsy patients compared with orexin-normal children (n = 6). In the 44 H1N1-AS03-vaccinated healthy children, there was no rise in total IgG levels or in CASPR2 or NMDAR antibodies three weeks following vaccination. In conclusion, there were no narcolepsy-specific autoantibodies identified in type 1 narcolepsy sera or CSFs, and no evidence for a general increase in immune reactivity following H1N1-AS03 vaccination in the healthy children. Antibodies to other neuronal specific membrane targets, with their potential for directing use of immunotherapies, are still an important goal for future research.	[Thebault, Simon; Waters, Patrick; Vincent, Angela] Univ Oxford, Nuffield Dept Clin Neurosci, Neuroimmunol Grp, Oxford, England; [Snape, Matthew D.; Pollard, Andrew J.] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Snape, Matthew D.; Pollard, Andrew J.] Oxford Univ Hosp Trust, NIHR Oxford Biomed Ctr, Oxford, England; [Cottrell, Dominic] Univ London Imperial Coll Sci Technol & Med, London, England; [Darin, Niklas; Hallbook, Tove] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Paediat, Gothenburg, Sweden; [Huutoniemi, Anne; Partinen, Markku] Finnish Narcolepsy Res Ctr, Helsinki Sleep Clin, Helsinki, Finland; [Partinen, Markku] Univ Helsinki, Dept Clin Neurosci, Helsinki, Finland	University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; Imperial College London; University of Gothenburg; University of Helsinki	Vincent, A (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Neuroimmunol Grp, Oxford, England.	angela.vincent@ndcn.ox.ac.uk	Thebault, Simon/W-3320-2019; Darin, Niklas/AAL-6345-2020; Waters, Patrick/Y-3753-2019; Vincent, Angela/AAE-7310-2019; Waters, Patrick/AAF-2658-2019	Thebault, Simon/0000-0003-0395-3395; Waters, Patrick/0000-0003-4142-2667; Waters, Patrick/0000-0003-4142-2667; Partinen, Markku/0000-0002-8182-9368; Snape, Matthew/0000-0003-0531-5426	DJC Educational Fund; Oxford NIHR Biomedical Research Centre; NIHR Health Technology Assessment Programme; National Institute for Health Research [10/111/01] Funding Source: researchfish	DJC Educational Fund; Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	There was no specific funding for this work. ST was sponsored by the DJC Educational Fund. General support was from the Oxford NIHR Biomedical Research Centre, which provides salary support to MDS. The original H1N1 vaccine study was funded by NIHR Health Technology Assessment Programme. AJP is a Jenner Institute Investigator.	American Academy of Sleep Medicine (AASM), 2014, INT CLASS SLEEP DIS, Vthird; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bergman P, 2014, P NATL ACAD SCI USA, V111, pE3735, DOI 10.1073/pnas.1412189111; Dalal J, 2013, GENE DEV, V27, P565, DOI 10.1101/gad.207654.112; Dauvilliers Y, 2013, BRAIN, V136, P2486, DOI 10.1093/brain/awt187; Dauvilliers Y, 2010, SLEEP, V33, P1428, DOI 10.1093/sleep/33.11.1428; Finnish National Institute of Health and Welfare, 2010, NIH WELF REC DISC PA; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; HUBLIN C, 1994, ANN NEUROL, V35, P709, DOI 10.1002/ana.410350612; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; LANGDON N, 1984, LANCET, V2, P1178; MCLAUGHLIN BJ, 1974, BRAIN RES, V76, P377, DOI 10.1016/0006-8993(74)90815-4; MIGNOT E, 1995, ADV NEUROIMMUNOL, V5, P23, DOI 10.1016/0960-5428(94)00043-N; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Peyron C, 2011, SLEEP MED, V12, P768, DOI 10.1016/j.sleep.2011.04.002; Scammell TE, 2006, SLEEP, V29, P601, DOI 10.1093/sleep/29.5.601; Swedish Medical Products Agency (MPA) M.P.A, 2010, MPA INV REP NARC PAT; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5; Waddington CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2649; Westphal C., 1877, ARCH PSYCHIAT NERVEN, V7, P631; Zandi MS, 2015, J NEUROL NEUROSUR PS, V86, P708, DOI 10.1136/jnnp-2014-308736	25	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129555	10.1371/journal.pone.0129555	http://dx.doi.org/10.1371/journal.pone.0129555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090827	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000050
J	Caughlin, S; Hepburn, JD; Park, DH; Jurcic, K; Yeung, KKC; Cechetto, DF; Whitehead, SN				Caughlin, Sarah; Hepburn, Jeffrey D.; Park, Dae Hee; Jurcic, Kristina; Yeung, Ken K. -C.; Cechetto, David F.; Whitehead, Shawn N.			Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of A beta Toxicity and Stroke	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; AMYLOID TOXICITY; BRAIN; MOUSE; LOCALIZATION; SECTIONS; DEMENTIA; DISEASE	The aging brain is often characterized by the presence of multiple comorbidities resulting in synergistic damaging effects in the brain as demonstrated through the interaction of Alzheimer's disease (AD) and stroke. Gangliosides, a family of membrane lipids enriched in the central nervous system, may have a mechanistic role in mediating the brain's response to injury as their expression is altered in a number of disease and injury states. Matrix-Assisted Laser Desorption Ionization (MALDI) Imaging Mass Spectrometry (IMS) was used to study the expression of A-series ganglioside species GD1a, GM1, GM2, and GM3 to determine alteration of their expression profiles in the presence of beta-amyloid (A beta) toxicity in addition to ischemic injury. To model a stroke, rats received a unilateral striatal injection of endothelin-1 (ET-1) (stroke alone group). To model A beta toxicity, rats received intracerebralventricular (icv) injections of the toxic 25-35 fragment of the A beta peptide (A beta alone group). To model the combination of A beta toxicity with stroke, rats received both the unilateral ET-1 injection and the bilateral icv injections of A beta(25-35) (combined A beta/ET-1 group). By 3 d, a significant increase in the simple ganglioside species GM2 was observed in the ischemic brain region of rats who received a stroke (ET-1), with or without A beta. By 21 d, GM2 levels only remained elevated in the combined A beta/ET-1 group. GM3 levels however demonstrated a different pattern of expression. By 3 d GM3 was elevated in the ischemic brain region only in the combined A beta/ET-1 group. By 21 d, GM3 was elevated in the ischemic brain region in both stroke alone and A beta/ET-1 groups. Overall, results indicate that the accumulation of simple ganglioside species GM2 and GM3 may be indicative of a mechanism of interaction between AD and stroke.	[Caughlin, Sarah; Hepburn, Jeffrey D.; Park, Dae Hee; Cechetto, David F.; Whitehead, Shawn N.] Western Univ, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Jurcic, Kristina; Yeung, Ken K. -C.] Western Univ, Dept Chem, London, ON N6A 5C1, Canada; [Jurcic, Kristina; Yeung, Ken K. -C.] Western Univ, Dept Biochem, London, ON N6A 5C1, Canada; [Whitehead, Shawn N.] Univ Western Ontario, Dept Clin Neurol Sci, London Hlth Sci Ctr, London, ON N6A 5A5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario)	Whitehead, SN (corresponding author), Western Univ, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.	shawn.whitehead@schulich.uwo.ca	Whitehead, Shawn/E-3772-2016; Yeung, Ken/AFN-0535-2022	Whitehead, Shawn/0000-0003-4728-8067; Yeung, Ken/0000-0001-6933-2941	Canadian Health Research Institute Operating Grant [287308]; National Science and Engineering Research Council Discovery Grant [268505, 250020]; Canadian Health Research Institute Emerging Team Grant [101925]; CIHR strategic training initiative in vascular biology	Canadian Health Research Institute Operating Grant; National Science and Engineering Research Council Discovery Grant; Canadian Health Research Institute Emerging Team Grant; CIHR strategic training initiative in vascular biology	This study was supported by the Canadian Health Research Institute Operating Grant (287308) to SNW; National Science and Engineering Research Council Discovery Grant (268505) to SNW; National Science and Engineering Research Council Discovery Grant (to KY 250020); Canadian Health Research Institute Emerging Team Grant to DFC and SNW (101925); SC received a graduate scholarship from the CIHR strategic training initiative in vascular biology.	Abate LE, 2006, J NEUROCHEM, V98, P1973, DOI 10.1111/j.1471-4159.2006.04097.x; Amtul Z, 2014, NEUROBIOL AGING, DOI [10.1016/j.neurobiolaging, DOI 10.1016/J.NEUROBIOLAGING]; ANDO S, 1978, ANAL BIOCHEM, V89, P437, DOI 10.1016/0003-2697(78)90373-1; Angel PM, 2012, ANAL CHEM, V84, P1557, DOI 10.1021/ac202383m; Barrier L, 2007, NEUROBIOL AGING, V28, P1863, DOI 10.1016/j.neurobiolaging.2006.08.002; Bley AE, 2011, PEDIATRICS, V128, pE1233, DOI 10.1542/peds.2011-0078; Cechetto David F, 2008, Expert Rev Neurother, V8, P743, DOI 10.1586/14737175.8.5.743; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; Desplats PA, 2007, NEUROBIOL DIS, V27, P265, DOI 10.1016/j.nbd.2007.05.003; DIMARTINO A, 1993, NEUROCHEM RES, V18, P907, DOI 10.1007/BF00998276; Jin YP, 2008, NEUROLOGY, V70, P9, DOI 10.1212/01.wnl.0000284609.77385.03; Jiwa NS, 2010, J NEUROCHEM, V115, P814, DOI 10.1111/j.1471-4159.2010.06958.x; Johnston JM, 2000, NEUROEPIDEMIOLOGY, V19, P320, DOI 10.1159/000026271; KOTANI M, 1994, GLYCOBIOLOGY, V4, P855, DOI 10.1093/glycob/4.6.855; Kreutz F, 2011, NEUROCHEM INT, V59, P648, DOI 10.1016/j.neuint.2011.06.007; Lietz CB, 2013, ADV DRUG DELIVER REV, V65, P1074, DOI 10.1016/j.addr.2013.04.009; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Nakatsuji Y, 2001, EXP NEUROL, V168, P290, DOI 10.1006/exnr.2000.7602; Prokazova NV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P235, DOI 10.1134/S0006297909030018; Richards AL, 2012, J LIPID RES, V53, P1390, DOI 10.1194/jlr.D019711; Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024; Sekigawa A, 2011, ALZHEIMERS DISEASE P, DOI [10.5772/21624, DOI 10.5772/21624]; Seyfried TN, 2010, J ONCOL, V2010, DOI 10.1155/2010/961243; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; Stoeckli M, 2007, J AM SOC MASS SPECTR, V18, P1921, DOI 10.1016/j.jasms.2007.08.005; SVENNERHOLM L, 1994, J NEUROCHEM, V62, P1039; Whitehead S, 2005, STROKE, V36, P1782, DOI 10.1161/01.STR.0000173405.02425.d6; Whitehead SN, 2007, STROKE, V38, P3245, DOI 10.1161/STROKEAHA.107.492660; Whitehead SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020808; Whitehead SN, 2005, STROKE, V36, P107, DOI 10.1161/01.STR.0000149627.30763.f9; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Yamamoto A, 1996, J NEUROCHEM, V66, P26; Yu RK, 2010, FEBS LETT, V584, P1694, DOI 10.1016/j.febslet.2009.08.026; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200	36	31	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130364	10.1371/journal.pone.0130364	http://dx.doi.org/10.1371/journal.pone.0130364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086081	Green Submitted, gold, Green Published			2022-12-26	WOS:000356567500098
J	Liu, M; Zhong, QD; Cheng, YR; Li, SH; Fang, S; Pu, CE; Yuan, HW; Shen, SF				Liu, Mark; Zhong, Quen-Dian; Cheng, Yi-Ru; Li, Shou-Hsien; Fang, Shu; Pu, Chang-En; Yuan, Hsiao-Wei; Shen, Sheng-Feng			The Genetic Relatedness in Groups of Joint-Nesting Taiwan Yuhinas: Low Genetic Relatedness with Preferences for Male Kin	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; CUCKOO GUIRA-GUIRA; SOCIAL-BEHAVIOR; MICROSATELLITE LOCI; EVOLUTIONARY ROUTES; REPRODUCTIVE SKEW; COMPUTER-PROGRAM; DIRECT BENEFITS; PATTERNS; SELECTION	The relative importance of direct and indirect fitness and, thus, the role of kinship in the evolution of social behavior is much debated. Studying the genetic relatedness of interacting individuals is crucial to improving our understanding of these issues. Here, we used a seven-year data set to study the genetic structure of the Taiwan yuhina (Yuhina brunneciceps), a joint-nesting passerine. Ten microsatellite loci were used to investigate the pair-wised relatedness among yuhina breeding group members. We found that the average genetic relatedness between same-sex group members was very low (0.069 for male dyads and 0.016 for female dyads). There was also a low ratio of closely-related kin (r>0.25) in the cooperative breeding groups of yuhinas (21.59% and 9.68% for male and female dyads, respectively). However, the relatedness of male dyads within breeding groups was significantly higher than female dyads. Our results suggest that yuhina cooperation is maintained primarily by direct fitness benefits to individuals; however, kin selection might play a role in partner choice for male yuhinas. Our study also highlights an important, but often neglected, question: Why do animals form non-kin groups, if kin are available? We use biological market theory to propose an explanation for group formation of unrelated Taiwan yuhinas.	[Liu, Mark; Zhong, Quen-Dian; Cheng, Yi-Ru; Fang, Shu; Shen, Sheng-Feng] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Zhong, Quen-Dian; Yuan, Hsiao-Wei] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan; [Li, Shou-Hsien] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Pu, Chang-En] Minist Justice, Sci & Tech Res Ctr Invest Bur, Hsin Tien, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan Normal University	Yuan, HW (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	hwyuan@ntu.edu.tw; shensf@sinica.edu.tw	Shen, Sheng-Feng/R-1177-2019	Shen, Sheng-Feng/0000-0002-0631-6343; YUAN, HSIAO-WEI/0000-0002-1540-9584	National Science Council of Taiwan; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was funded by National Science Council of Taiwan (to S.-F.S. and H.-W.Y.) and Academia Sinica (to S.-F.S.).	Aviles L, 2004, AM NAT, V164, P132, DOI 10.1086/422263; Baglione V, 2003, SCIENCE, V300, P1947, DOI 10.1126/science.1082429; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Brouwer L, 2005, BEHAV ECOL, V16, P667, DOI 10.1093/beheco/ari042; Brown JL, 1987, HELPING AND COMMUNAL; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cockburn A, 2011, CURR BIOL, V21, pR195, DOI 10.1016/j.cub.2011.01.044; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Gompper ME, 1998, MOL ECOL, V7, P157, DOI 10.1046/j.1365-294x.1998.00325.x; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hatchwell BJ, 2000, ANIM BEHAV, V59, P1079, DOI 10.1006/anbe.2000.1394; Haydock J, 2003, AM NAT, V162, P277, DOI 10.1086/376888; Haydock J, 2002, P NATL ACAD SCI USA, V99, P7178, DOI 10.1073/pnas.102624199; Huang YJ, 2004, MOL ECOL NOTES, V4, P170, DOI 10.1111/j.1471-8286.2004.00605.x; Hughes C, 1998, ECOLOGY, V79, P383, DOI 10.1890/0012-9658(1998)079[0383:IMTWFM]2.0.CO;2; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Johnstone RA, 2008, J EVOLUTION BIOL, V21, P879, DOI 10.1111/j.1420-9101.2008.01505.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Koenig WD, 1998, AM NAT, V151, P243, DOI 10.1086/286115; Koford R.R., 1990, P333, DOI 10.1017/CBO9780511752452.012; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Lee PF, 2005, ZOOL STUD, V44, P497; Lefebvre D, 2003, BEHAV ECOL SOCIOBIOL, V53, P402, DOI 10.1007/s00265-002-0578-8; Leimar O, 2010, PHILOS T R SOC B, V365, P2619, DOI 10.1098/rstb.2010.0116; Lima MR, 2011, AUK, V128, P475, DOI 10.1525/auk.2011.10234; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; MACEDO RH, 1992, AUK, V109, P786, DOI 10.2307/4088153; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Manly BFJ, 1997, RANDOMIZATION BOOTST; Matocq MD, 2004, BEHAV ECOL, V15, P647, DOI 10.1093/beheco/arh056; NOE R, 1991, ETHOLOGY, V87, P97; Noe Ronald, 2001, P93, DOI 10.1017/CBO9780511752421.008; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Pemberton JM, 2008, P ROY SOC B-BIOL SCI, V275, P613, DOI 10.1098/rspb.2007.1531; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Radespiel L, 2003, ANIM BEHAV, V65, P709, DOI 10.1006/anbe.2003.2121; Reeve Hudson Kern, 1998, P118; REYER HU, 1980, BEHAV ECOL SOCIOBIOL, V6, P219, DOI 10.1007/BF00569203; Richardson DS, 2002, EVOLUTION, V56, P2313; Riehl C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2245; Riehl C, 2011, P ROY SOC B-BIOL SCI, V278, P1728, DOI 10.1098/rspb.2010.1752; Ross KG, 2001, MOL ECOL, V10, P265, DOI 10.1046/j.1365-294x.2001.01191.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; RStudio, 2012, INTEGRATED DEVELOPME; Rubenstein DR, 2011, P NATL ACAD SCI USA, V108, P10816, DOI 10.1073/pnas.1100303108; Schwacke L, 2005, RERAT RELATEDNESS ES; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Shen S-F, 2002, THE ECOLOGY OF COOPE; Shen SF, AMERICAN NATURALIST; Sherman PT, 1995, AUK, V112, P296, DOI 10.2307/4088718; Vehrencamp Sandra L., 2004, P177, DOI 10.1017/CBO9780511606816.012; Vehrencamp SL, 2000, BEHAV ECOL, V11, P334, DOI 10.1093/beheco/11.3.334; VEHRENCAMP SL, 1986, ANIM BEHAV, V34, P347, DOI 10.1016/S0003-3472(86)80103-8; Wang MT, 2005, MOL ECOL NOTES, V5, P439, DOI 10.1111/j.1471-8286.2005.00955.x; Yeung C, 2004, MOL ECOL NOTES, V4, P420, DOI 10.1111/j.1471-8286.2004.00671.x; Yuan HW, 2006, WILSON J ORNITHOL, V118, P558, DOI 10.1676/05-809.1; Yuan HW, 2005, WILSON BULL, V117, P306, DOI 10.1676/04-072.1; Yuan HW, 2004, CONDOR, V106, P862, DOI 10.1650/7520	70	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0127341	10.1371/journal.pone.0127341	http://dx.doi.org/10.1371/journal.pone.0127341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086267	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500008
J	Subudhi, PK; De Leon, T; Singh, PK; Parco, A; Cohn, MA; Sasaki, T				Subudhi, Prasanta K.; De Leon, Teresa; Singh, Pradeep K.; Parco, Arnold; Cohn, Marc A.; Sasaki, Takuji			A Chromosome Segment Substitution Library of Weedy Rice for Genetic Dissection of Complex Agronomic and Domestication Traits	PLOS ONE			English	Article							ORYZA-SATIVA; INTROGRESSION LINES; SEED DORMANCY; GREEN-REVOLUTION; RED RICE; LOCI; IDENTIFICATION; POPULATION; CROSS; RUFIPOGON	Chromosome segment substitution lines (CSSLs) are a powerful alternative for locating quantitative trait loci (QTL), analyzing gene interactions, and providing starting materials for map-based cloning projects. We report the development and characterization of a CSSL library of a U.S. weedy rice accession 'PSRR-1' with genome-wide coverage in an adapted rice cultivar 'Bengal' background. The majority of the CSSLs carried a single defined weedy rice segment with an average introgression segment of 2.8% of the donor genome. QTL mapping results for several agronomic and domestication traits from the CSSL population were compared with those obtained from two recombinant inbred line (RIL) populations involving the same weedy rice accession. There was congruence of major effect QTLs between both types of populations, but new and additional QTLs were detected in the CSSL population. Although, three major effect QTLs for plant height were detected on chromosomes 1, 4, and 8 in the CSSL population, the latter two escaped detection in both RIL populations. Since this was observed for many traits, epistasis may play a major role for the phenotypic variation observed in weedy rice. High levels of shattering and seed dormancy in weedy rice might result from an accumulation of many small effect QTLs. Several CSSLs with desirable agronomic traits (e.g. longer panicles, longer grains, and higher seed weight) identified in this study could be useful for rice breeding. Since weedy rice is a reservoir of genes for many weedy and agronomic attributes, the CSSL library will serve as a valuable resource to discover latent genetic diversity for improving crop productivity and understanding the plant domestication process through cloning and characterization of the underlying genes.	[Subudhi, Prasanta K.; De Leon, Teresa; Singh, Pradeep K.; Parco, Arnold] Louisiana State Univ, Sch Plant Environm & Soil Sci, Ctr Agr, Baton Rouge, LA 70803 USA; [Cohn, Marc A.] Louisiana State Univ, Dept Plant Pathol & Crop Physiol, Ctr Agr, Baton Rouge, LA 70803 USA; [Sasaki, Takuji] Tokyo Univ Agr, Tokyo, Japan	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Tokyo University of Agriculture	Subudhi, PK (corresponding author), Louisiana State Univ, Sch Plant Environm & Soil Sci, Ctr Agr, Baton Rouge, LA 70803 USA.	psubudhi@agcenter.lsu.edu		Singh, Pawan/0000-0003-4610-3120	United States Department of Agriculture-National Institute of Food and Agriculture [2006-35320-16555]	United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	United States Department of Agriculture-National Institute of Food and Agriculture (Grant #2006-35320-16555) provided funding for this work.	Ahn SN, 2002, RICE GENET NEWSL, V19, P12; Ali ML, 2010, RICE, V3, P218, DOI 10.1007/s12284-010-9058-3; Arbelaez JD, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0276-7; Ashikari M, 2006, TRENDS PLANT SCI, V11, P344, DOI 10.1016/j.tplants.2006.05.008; BRAR DS, 2003, MONOGRAPH GENUS ORYZ, P283; Bres-Patry C, 2001, THEOR APPL GENET, V102, P118, DOI 10.1007/s001220051626; Cai HW, 2002, THEOR APPL GENET, V104, P1217, DOI 10.1007/s00122-001-0819-7; Deen R., 2010, RICE GENET NEWSL, V25, P70; Doust AN, 2014, P NATL ACAD SCI USA, V111, P6178, DOI 10.1073/pnas.1308940110; Ebitani T, 2005, BREEDING SCI, V55, P65, DOI 10.1270/jsbbs.55.65; Eshed Y, 1992, THEOR APPL GENET, V83, P1027, DOI 10.1007/BF00232968; ESHED Y, 1995, GENETICS, V141, P1147; Furuta T, 2014, BREEDING SCI, V63, P468, DOI 10.1270/jsbbs.63.468; Gu XY, 2007, THEOR APPL GENET, V114, P745, DOI 10.1007/s00122-006-0475-z; Gu XY, 2004, GENETICS, V166, P1503, DOI 10.1534/genetics.166.3.1503; Guo SB, 2013, RICE SCI, V20, P95, DOI 10.1016/S1672-6308(13)60111-0; Imai I, 2013, MOL BREEDING, V32, P101, DOI 10.1007/s11032-013-9855-7; Jeung JU, 2003, RICE GENET NEWSL, V20, P92; Jin FX, 2011, BREEDING SCI, V61, P69, DOI 10.1270/jsbbs.61.69; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kubo T, 2002, BREEDING SCI, V52, P319, DOI 10.1270/jsbbs.52.319; Lee F. N., 2000, Research Series - Arkansas Agricultural Experiment Station, P94; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li M, 2011, THEOR APPL GENET, V123, P411, DOI 10.1007/s00122-011-1593-9; Linscombe SD, 1999, LSU AGR CTR PUBL, V2321; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Moncada P, 2001, THEOR APPL GENET, V102, P41, DOI 10.1007/s001220051616; OKA HI, 1988, ORIGIN CULTIVATED RI, P107; Onishi K, 2007, GENOME, V50, P757, DOI 10.1139/G07-051; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; PATERSON AH, 1990, GENETICS, V124, P735; Paterson AH, 2002, NEW PHYTOL, V154, P591, DOI 10.1046/j.1469-8137.2002.00420.x; Prada D, 2004, THEOR APPL GENET, V109, P62, DOI 10.1007/s00122-004-1608-x; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; SAS Institute Inc, 2006, BASE SAS 9 1 3 PROCE; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; SOBRIZAL, 2002, RICE GENET NEWSL, V19, P40; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Subudhi PK, 2014, J HERED, V105, P276, DOI 10.1093/jhered/est089; Subudhi PK, 2012, CROP SCI, V52, P2564, DOI 10.2135/cropsci2012.04.0228; Sugimoto K, 2010, P NATL ACAD SCI USA, V107, P5792, DOI 10.1073/pnas.0911965107; Tai T., 1990, PLANT MOL BIOL REP, V8, P297, DOI [10.1007/BF02668766, DOI 10.1007/BF02668766]; Takai T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0295-2; Tan LB, 2007, J INTEGR PLANT BIOL, V49, P871, DOI 10.1111/j.1744-7909.2007.00497.x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tian F, 2006, THEOR APPL GENET, V112, P570, DOI 10.1007/s00122-005-0165-2; Vaughan LK, 2001, WEED SCI, V49, P468, DOI 10.1614/0043-1745(2001)049[0468:IARRFI]2.0.CO;2; Wang S., 2011, WINDOWS QTL CARTOGRA; Xiao JH, 1996, NATURE, V384, P223, DOI 10.1038/384223a0; Xiong LX, 1999, THEOR APPL GENET, V98, P243, DOI 10.1007/s001220051064; Yasui, 2001, RICE GENET NEWSL, V18, P57; Yasui, 2004, RICE GENET NEWSL, V21, P64; YOUNG ND, 1989, THEOR APPL GENET, V77, P95, DOI 10.1007/BF00292322; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590; Zhang FT, 2014, EUPHYTICA, V200, P1, DOI 10.1007/s10681-014-1121-5	55	23	23	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130650	10.1371/journal.pone.0130650	http://dx.doi.org/10.1371/journal.pone.0130650			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086245	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500125
J	Tao, H; Chang, GJ; Xu, TL; Zhao, HJ; Zhang, K; Shen, XZ				Tao, Hui; Chang, Guangjun; Xu, Tianle; Zhao, Huajian; Zhang, Kai; Shen, Xiangzhen			Feeding a High Concentrate Diet Down-Regulates Expression of ACACA, LPL and SCD and Modifies Milk Composition in Lactating Goats	PLOS ONE			English	Article							SUBACUTE RUMINAL ACIDOSIS; CONJUGATED LINOLEIC-ACID; DAIRY-COWS; FATTY-ACIDS; TRANSCRIPTION FACTORS; DIFFERENT TISSUES; RUMEN; GRAIN; LIPOPOLYSACCHARIDE; FERMENTATION	High concentrate diets are fed to early and mid-lactation stages dairy ruminants to meet the energy demands for high milk production in modern milk industry. The present study evaluated the effects of a high concentrate diet on milk fat and milk composition, especially, cis-9, trans-11 CLA content in milk and gene expression of lactating goats. Eight mid-lactating goats with rumen fistula were randomly assigned into a high concentrate diet (HCD) group and low concentrate diet (LCD) group. High concentrate diet feeding significantly increased lipopolysaccharides (LPS) in plasma and decreased milk fat content, vaccenic acid (VA) and cis-9, trans-11CLA in milk of the lactating goats. The mRNA expression levels of sterol regulatory element binding protein B 1c (SREBP1c), lipoprotein lipase (LPL), fatty acid synthetase (FASN) and acetyl-CoA carboxylase a (ACACA, ACC alpha) involving in lipid metabolism were analyzed, and ACACA and LPL all decreased in their expression level in the mammary glands of goats fed a high concentrate diet. DNA methylation rate of stearoyl-CoA desaturase (SCD) was elevated and decreased, and SCD mRNA and protein expression was reduced significantly in the mammary glands of goats fed a high concentrate diet. In conclusion, feeding a high concentrate diet to lactating goats decreases milk fat and reduced expression of SCD in the mammary gland, which finally induced cis-9, trans-11 CLA content in milk.	[Tao, Hui; Chang, Guangjun; Xu, Tianle; Zhao, Huajian; Zhang, Kai; Shen, Xiangzhen] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Shen, XZ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China.	xzshen@njau.edu.cn			National Basic Research Program of China [2011CB100802]; National Natural Science Foundation of China [31172371, 30371040]; Federal Ministry of Food, Agriculture and Consumer Protection of Germany; Ministry of Agriculture of China [30/2008-2009]; Priority Academic Program Development of Jinagsu Higher Education Institutions	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Federal Ministry of Food, Agriculture and Consumer Protection of Germany; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Priority Academic Program Development of Jinagsu Higher Education Institutions	This study was supported by the National Basic Research Program of China (2011CB100802), National Natural Science Foundation of China (31172371; 30371040), the Federal Ministry of Food, Agriculture and Consumer Protection of Germany, the Ministry of Agriculture of China (Grant No. 30/2008-2009), and the Priority Academic Program Development of Jinagsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM S, 1983, LIPIDS, V18, P820, DOI 10.1007/BF02534642; Allred JB, 2004, LIPIDS, V35, P371; Angulo J, 2012, J SCI FOOD AGR, V92, P2968, DOI 10.1002/jsfa.5709; Bargo F, 2006, ANIM FEED SCI TECH, V125, P17, DOI 10.1016/j.anifeedsci.2005.05.010; Bauman DE, 2006, ADV DAIRY CHEM, V3, P93; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Chilliard Y, 2000, ANN ZOOTECH, V49, P181, DOI 10.1051/animres:2000117; Chirala SS, 2004, LIPIDS, V39, P1045, DOI 10.1007/s11745-004-1329-9; Chouinard PY, 1999, J NUTR, V129, P1579, DOI 10.1093/jn/129.8.1579; Colman E, 2013, J DAIRY SCI, V96, P4100, DOI 10.3168/jds.2012-6109; Connor WE, 2007, AM J CLIN NUTR S, V7, P171; Dannenberger D, 2007, J AGR FOOD CHEM, V55, P452, DOI 10.1021/jf061793x; Dong HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082850; DOREAU M, 1994, ANIM FEED SCI TECH, V45, P379, DOI 10.1016/0377-8401(94)90039-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Griinari JM, 2000, J NUTR, V130, P2285, DOI 10.1093/jn/130.9.2285; Guo YQ, 2013, ARCH ANIM NUTR, V67, P433, DOI 10.1080/1745039X.2013.842038; HAMADA T, 1968, J DAIRY SCI, V51, P228, DOI 10.3168/jds.S0022-0302(68)86962-0; Herdmann A, 2010, J AGR FOOD CHEM, V58, P8314, DOI 10.1021/jf101145y; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9; Jump DB, 2010, BIOCHEM PHARMACOL, V81, P649, DOI [10.1016/j.bcp.2010.12.014, DOI 10.1016/J.BCP.2010.12.014]; Keating AF, 2005, MAMM GENOME, V16, P184, DOI 10.1007/s00335-004-2325-0; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Kim EJ, 2008, J NUTR, V138, P889, DOI 10.1093/jn/138.5.889; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Li S, 2012, J DAIRY SCI, V95, P294, DOI 10.3168/jds.2011-4447; Lock AL, 2004, LIPIDS, V39, P1197, DOI 10.1007/s11745-004-1348-6; Ma L, 2014, J DAIRY SCI, V97, P5001, DOI 10.3168/jds.2013-7555; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; OPSTVEDT J, 1967, J DAIRY SCI, V50, P108, DOI 10.3168/jds.S0022-0302(67)87366-1; Palmquist D. L., 2006, ADV DAIRY CHEM, V2, P43; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plaizier JC, 2008, VET J, V176, P21, DOI 10.1016/j.tvjl.2007.12.016; Plaizier JC, 2004, J DAIRY SCI, V87, P2495, DOI 10.3168/jds.S0022-0302(04)73374-3; Ratnayake WMN, 2009, ANN NUTR METAB, V55, P8, DOI 10.1159/000228994; Rudolph MC, 2007, J MAMMARY GLAND BIOL, V12, P269, DOI 10.1007/s10911-007-9061-5; Seymour WM, 2005, ANIM FEED SCI TECH, V119, P155, DOI 10.1016/j.anifeedsci.2004.10.001; Shen XZ, 2007, LIPIDS, V42, P1093, DOI 10.1007/s11745-007-3115-8; Shimano H, 2002, VITAM HORM, V65, P167, DOI 10.1016/S0083-6729(02)65064-2; SHIRLEY JE, 1973, J DAIRY SCI, V56, P569, DOI 10.3168/jds.S0022-0302(73)85220-8; Steele MA, 2012, J DAIRY SCI, V95, P6072, DOI 10.3168/jds.2011-4864; Storm AC, 2012, J DAIRY SCI, V95, P2919, DOI 10.3168/jds.2011-4239; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Tagang A, 2011, AFR J BIOTECHNOL, V9, P6229; Thomson NA, 2003, P N Z SOC ANIM PROD, P25; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Xu TL, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0360-6	51	12	15	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130525	10.1371/journal.pone.0130525	http://dx.doi.org/10.1371/journal.pone.0130525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086219	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500112
J	Teramura, H; Sasaki, K; Oshima, T; Aikawa, S; Matsuda, F; Okamoto, M; Shirai, T; Kawaguchi, H; Ogino, C; Yamasaki, M; Kikuchi, J; Kondo, A				Teramura, Hiroshi; Sasaki, Kengo; Oshima, Tomoko; Aikawa, Shimpei; Matsuda, Fumio; Okamoto, Mami; Shirai, Tomokazu; Kawaguchi, Hideo; Ogino, Chiaki; Yamasaki, Masanori; Kikuchi, Jun; Kondo, Akihiko			Changes in Lignin and Polysaccharide Components in 13 Cultivars of Rice Straw following Dilute Acid Pretreatment as Studied by Solution-State 2D H-1-C-13 NMR	PLOS ONE			English	Article							ENZYMATIC SACCHARIFICATION; LIGNOCELLULOSIC BIOMASS; CROSS-LINKS; CELL-WALL; HYDROLYSIS; RELEASE	A renewable raw material, rice straw is pretreated for biorefinery usage. Solution-state two-dimensional (2D) H-1-(13) C hetero-nuclear single quantum coherence (HSQC) nuclear magnetic resonance (NMR) spectroscopy, was used to analyze 13 cultivars of rice straw before and after dilute acid pretreatment, to characterize general changes in the lignin and polysaccharide components. Intensities of most (15 of 16) peaks related to lignin aromatic regions, such as p-coumarate, guaiacyl, syringyl, p-hydroxyphenyl, and cinnamyl alcohol, and methoxyl, increased or remained unchanged after pretreatment. In contrast, intensities of most (11 of 13) peaks related to lignin aliphatic linkages or ferulate decreased. Decreased heterogeneity in the intensities of three peaks related to cellulose components in acid-insoluble residues resulted in similar glucose yield (0.45-0.59 g/g-dry biomass). Starch-derived components showed positive correlations (r = 0.71 to 0.96) with glucose, 5-hydroxymethyl-furfural (5-HMF), and formate concentrations in the liquid hydrolysates, and negative correlations (r = -0.95 to -0.97) with xylose concentration and acid-insoluble residue yield. These results showed the fate of lignin and polysaccharide components by pretreatment, suggesting that lignin aromatic regions and cellulose components were retained in the acid insoluble residues and starch-derived components were transformed into glucose, 5-HMF, and formate in the liquid hydrolysate.	[Teramura, Hiroshi; Oshima, Tomoko; Aikawa, Shimpei; Kawaguchi, Hideo; Ogino, Chiaki; Kondo, Akihiko] Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, Kobe, Hyogo 657, Japan; [Sasaki, Kengo] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 657, Japan; [Matsuda, Fumio] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka, Japan; [Matsuda, Fumio; Shirai, Tomokazu; Kikuchi, Jun; Kondo, Akihiko] RIKEN, Biomass Engn Program, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Okamoto, Mami; Yamasaki, Masanori] Kobe Univ, Grad Sch Agr Sci, Food Resources Educ & Res Ctr, Kasai, Hyogo, Japan; [Kikuchi, Jun] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Kikuchi, Jun] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 232, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kikuchi, Jun] Nagoya Univ, Sch Agr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Kobe University; Kobe University; Osaka University; RIKEN; Kobe University; RIKEN; Yokohama City University; Nagoya University; Nagoya University	Kondo, A (corresponding author), Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, Rokkodaicho, Kobe, Hyogo 657, Japan.	akondo@kobe-u.ac.jp	Shirai, Tomokazu/C-7986-2017; Kawaguchi, Hideo/J-5553-2018; Aikawa, Shimpei/A-6512-2014; Kikuchi, Jun/O-4725-2019; Kondo, Akihiko/A-2130-2015; Ogino, Chiaki/G-9932-2014; Yamasaki, Masanori/C-5193-2018; Kikuchi, Jun/M-5512-2015; Sasaki, Kengo/O-6739-2018	Kawaguchi, Hideo/0000-0002-5189-9509; Kikuchi, Jun/0000-0002-6809-394X; Ogino, Chiaki/0000-0002-8906-7724; Yamasaki, Masanori/0000-0001-7759-3965; Kikuchi, Jun/0000-0002-6809-394X; Sasaki, Kengo/0000-0002-5764-1429; Aikawa, Shimpei/0000-0001-9202-0225	Ministry of Education, Culture, Sports, Science and Technology, Japan, through NC-CARP Project; Ministry of Education, Culture, Sports, Science and Technology, through Japan Innovative Bioproduction Kobe	Ministry of Education, Culture, Sports, Science and Technology, Japan, through NC-CARP Project; Ministry of Education, Culture, Sports, Science and Technology, through Japan Innovative Bioproduction Kobe	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan, through the NC-CARP Project, http://nc-carp.org/, and the Ministry of Education, Culture, Sports, Science and Technology, through the Japan Innovative Bioproduction Kobe, http://www.org.kobeu.ac.jp/bioproduction/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai-Sanoh Y, 2011, BIOSCI BIOTECH BIOCH, V75, P1104, DOI 10.1271/bbb.110009; Bartolome B, 1997, APPL ENVIRON MICROB, V63, P208; Binod P, 2010, BIORESOURCE TECHNOL, V101, P4767, DOI 10.1016/j.biortech.2009.10.079; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen WH, 2011, BIORESOURCE TECHNOL, V102, P2916, DOI 10.1016/j.biortech.2010.11.052; Chylla RA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-45; del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Hou XD, 2012, BIOTECHNOL BIOENG, V109, P2484, DOI 10.1002/bit.24522; Hsu TC, 2010, BIORESOURCE TECHNOL, V101, P4907, DOI 10.1016/j.biortech.2009.10.009; IIYAMA K, 1990, PHYTOCHEMISTRY, V29, P733, DOI 10.1016/0031-9422(90)80009-6; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; Karimi K, 2006, BIOMASS BIOENERG, V30, P247, DOI 10.1016/j.biombioe.2005.11.015; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; Komatsu T, 2013, ANAL CHEM, V85, P8857, DOI 10.1021/ac402197h; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; Matsuda F, 2011, BIOSCI BIOTECH BIOCH, V75, P1603, DOI 10.1271/bbb.110082; Meng XZ, 2013, BIORESOURCE TECHNOL, V144, P467, DOI 10.1016/j.biortech.2013.06.091; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Ogura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066919; Okushita K, 2012, POLYM J, V44, P895, DOI 10.1038/pj.2012.82; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Rahimi A, 2014, NATURE, V515, P249, DOI 10.1038/nature13867; RALPH J, 1992, J CHEM SOC PERK T 1, P2961, DOI 10.1039/p19920002961; RALPH J, 1995, CARBOHYD RES, V275, P167, DOI 10.1016/0008-6215(95)00237-N; Redding AP, 2011, BIORESOURCE TECHNOL, V102, P1415, DOI 10.1016/j.biortech.2010.09.053; Rencoret J, 2011, PLANT PHYSIOL, V155, P667, DOI 10.1104/pp.110.167254; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Samuel R, 2010, APPL BIOCHEM BIOTECH, V162, P62, DOI 10.1007/s12010-009-8749-y; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Teramura H, 2013, BIORESOURCE TECHNOL, V149, P520, DOI 10.1016/j.biortech.2013.09.109; Watanabe T, 2012, PLANT BIOTECHNOL-NAR, V29, P163, DOI 10.5511/plantbiotechnology.12.0222a; Wei WQ, 2012, BIORESOURCE TECHNOL, V110, P302, DOI 10.1016/j.biortech.2012.01.003; Yamamura M, 2013, PLANT BIOTECHNOL-NAR, V30, P25, DOI 10.5511/plantbiotechnology.12.1127a; Yi Zheng, 2009, International Journal of Agricultural and Biological Engineering, V2, P51, DOI 10.3965/j.issn.1934-6344.2009.03.051-068; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u	37	20	21	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128417	10.1371/journal.pone.0128417	http://dx.doi.org/10.1371/journal.pone.0128417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083431	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400047
J	Zhang, LF; Selao, TT; Selstam, E; Norling, B				Zhang, Lifang; Selao, Tiago Toscano; Selstam, Eva; Norling, Birgitta			Subcellular Localization of Carotenoid Biosynthesis in Synechocystis sp PCC 6803	PLOS ONE			English	Article							ENERGY-DISSIPATION; LYCOPENE CYCLASE; PLASMA-MEMBRANE; PHOTOSYSTEM-II; SP PCC-6803; CYANOBACTERIUM; PROTEIN; MYXOXANTHOPHYLL; PATHWAY; COMPLEX	The biosynthesis pathway of carotenoids in cyanobacteria is partly described. However, the subcellular localization of individual steps is so far unknown. Carotenoid analysis of different membrane subfractions in Synechocystis sp. PCC6803 shows that "light" plasma membranes have a high carotenoid/protein ratio, when compared to "heavier" plasma membranes or thylakoids. The localization of CrtQ and CrtO, two well-defined carotenoid synthesis pathway enzymes in Synechocystis, was studied by epitope tagging and western blots. Both enzymes are locally more abundant in plasma membranes than in thylakoids, implying that the plasma membrane has higher synthesis rates of beta-carotene precursor molecules and echinenone.	[Zhang, Lifang; Selao, Tiago Toscano; Norling, Birgitta] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Selstam, Eva] Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, Umea, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Umea University	Norling, B (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	ibnorling@ntu.edu.sg	Selao, Tiago/AAX-4709-2021		Nanyang Technological University (Singapore) [M4080306]; Carl Tryggers Stiftelse [CTS 08:354]	Nanyang Technological University (Singapore)(Nanyang Technological University); Carl Tryggers Stiftelse	This work was supported by grant M4080306 to BN from Nanyang Technological University (Singapore, www.ntu.edu.sg), and grant CTS 08:354 to ES from Carl Tryggers Stiftelse (www.carltryggersstiftelse.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baniulis D, 2009, J BIOL CHEM, V284, P9861, DOI 10.1074/jbc.M809196200; Bautista JA, 2005, J BIOL CHEM, V280, P38839, DOI 10.1074/jbc.M504953200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boehm M, 2009, J BACTERIOL, V191, P6425, DOI 10.1128/JB.00644-09; Bond SR, 2012, NUCLEIC ACIDS RES, V40, pW209, DOI 10.1093/nar/gks396; Breitenbach J, 1998, PLANT MOL BIOL, V36, P725, DOI 10.1023/A:1005997405431; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Cogdell RJ, 2000, PHILOS T ROY SOC B, V355, P1345, DOI 10.1098/rstb.2000.0696; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Domonkos I, 2009, PLANT CELL PHYSIOL, V50, P374, DOI 10.1093/pcp/pcn204; Eaton-Rye JJ, 2011, METHODS MOL BIOL, V684, P295, DOI [10.1007/978.1.60761.925.3_22, 10.1007/978-1-60761-925-3_22]; FernandezGonzalez B, 1997, J BIOL CHEM, V272, P9728; Grotjohann I, 2005, PHOTOSYNTH RES, V85, P51, DOI 10.1007/s11120-005-1440-4; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Guskov A, 2010, CHEMPHYSCHEM, V11, P1160, DOI 10.1002/cphc.200900901; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; Krubasik P, 2000, MOL GEN GENET, V263, P423, DOI 10.1007/s004380051186; Lagarde D, 1999, FEBS LETT, V454, P247, DOI 10.1016/S0014-5793(99)00817-0; Lopez AB, 2008, PHYSIOL PLANTARUM, V133, P190, DOI 10.1111/j.1399-3054.2008.01058.x; Maresca JA, 2008, PHOTOSYNTH RES, V97, P121, DOI 10.1007/s11120-008-9312-3; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; MARTINEZFEREZ I, 1994, BBA-GENE STRUCT EXPR, V1218, P145, DOI 10.1016/0167-4781(94)90003-5; Masamoto K, 2004, PLANT CELL PHYSIOL, V45, P1325, DOI 10.1093/pcp/pch144; Masamoto K, 1997, J PLANT PHYSIOL, V151, P257, DOI 10.1016/S0176-1617(97)80250-7; Miller SR, 2002, ARCH MICROBIOL, V177, P392, DOI 10.1007/s00203-002-0404-8; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; Mohamed HE, 2006, J BACTERIOL, V188, P3337, DOI 10.1128/JB.188.9.3337-3344.2006; Mohamed HE, 2005, J BACTERIOL, V187, P6883, DOI 10.1128/JB.187.20.6883-6892.2005; Peramuna Anantha, 2015, Life-Basel, V5, P1111, DOI 10.3390/life5021111; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Punginelli C, 2009, BBA-BIOENERGETICS, V1787, P280, DOI 10.1016/j.bbabio.2009.01.011; Rexroth S, 2011, PLANT CELL, V23, P2379, DOI 10.1105/tpc.111.085779; Schafer L, 2005, J PHOTOCH PHOTOBIO B, V78, P195, DOI 10.1016/j.jphotobiol.2004.11.007; Selao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088153; Sozer O, 2010, PLANT CELL PHYSIOL, V51, P823, DOI 10.1093/pcp/pcq031; Steiger S, 1999, J PHOTOCH PHOTOBIO B, V52, P14, DOI 10.1016/S1011-1344(99)00094-9; Stickforth P, 2003, ARCH MICROBIOL, V179, P409, DOI 10.1007/s00203-003-0545-4; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; Takaichi S, 2006, PLANT CELL PHYSIOL, V47, P211, DOI 10.1093/pcp/pci236; Takaichi S, 2005, PLANT CELL PHYSIOL, V46, P497, DOI 10.1093/pcp/pci049; Takaichi S, 2001, PLANT CELL PHYSIOL, V42, P756, DOI 10.1093/pcp/pce098; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Volkmer T, 2007, J BIOL CHEM, V282, P3730, DOI 10.1074/jbc.M604948200; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson A, 2010, J BIOL CHEM, V285, P18364, DOI 10.1074/jbc.M110.115709; Zhu YH, 2010, ARCH BIOCHEM BIOPHYS, V504, P86, DOI 10.1016/j.abb.2010.07.007	46	18	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130904	10.1371/journal.pone.0130904	http://dx.doi.org/10.1371/journal.pone.0130904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083372	Green Published, gold			2022-12-26	WOS:000356567400164
J	Choi, SA; Lee, JY; Kwon, SE; Wang, KC; Phi, JH; Choi, JW; Jin, X; Lim, JY; Kim, H; Kim, SK				Choi, Seung Ah; Lee, Ji Yeoun; Kwon, Sung Eun; Wang, Kyu-Chang; Phi, Ji Hoon; Choi, Jung Won; Jin, Xiong; Lim, Ja Yun; Kim, Hyunggee; Kim, Seung-Ki			Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells	PLOS ONE			English	Article							CANCER; GLIOBLASTOMA; IDENTIFICATION; RECEPTORS; EXOSOMES; GLIOMAS; MICE	In neuro-oncology, the biology of neural stem cells (NSCs) has been pursued in two ways: as tumor-initiating cells (TICs) and as a potential cell-based vehicle for gene therapy. NSCs as well as mesenchymal stem cells (MSCs) have been reported to possess tumor tropism capacities. However, there is little data on the migratory capacity of MSCs toward brain tumor-initiating cells (BTICs). This study focuses on the ability of human adipose tissue derived MSCs (hAT-MSCs) to target BTICs and their crosstalk in the microenvironment. BTICs were isolated from three different types of brain tumors. The migration capacities of hAT-MSCs toward BTICs were examined using an in vitro migration assay and in vivo bioluminescence imaging analysis. To investigate the crosstalk between hAT-MSCs and BTICs, we analyzed the mRNA expression patterns of cyto-chemokine receptors by RT-qPCR and the protein level of their ligands in co-cultured medium. The candidate cyto-chemokine receptors were selectively inhibited using siRNAs. Both in vitro and in vivo experiments showed that hAT-MSCs possess migratory abilities to target BTICs isolated from medulloblastoma, atypical teratoid/rhabdoid tumors (AT/RT) and glioblastoma. Different types of cyto-chemokines are involved in the crosstalk between hAT-MSCs and BTICs (medulloblastoma and AT/RT: CXCR4/SDF-1, CCR5/RANTES, IL6R/IL-6 and IL8R/IL8; glioblastoma: CXCR4/SDF-1, IL6R/IL-6, IL8R/IL-8 and IGF1R/IGF-1). Our findings demonstrated the migratory ability of hAT-MSCs for BTICs, implying the potential use of MSCs as a delivery vehicle for gene therapy. This study also confirmed the expression of hAT-MSCs cytokine receptors and the BTIC ligands that play roles in their crosstalk.	[Choi, Seung Ah; Lee, Ji Yeoun; Wang, Kyu-Chang; Phi, Ji Hoon; Choi, Jung Won; Kim, Seung-Ki] Seoul Natl Univ, Coll Med, Childrens Hosp, Div Pediat Neurosurg,Pediat Clin Neurosci Ctr, Seoul, South Korea; [Choi, Seung Ah; Wang, Kyu-Chang; Phi, Ji Hoon; Choi, Jung Won; Kim, Seung-Ki] Seoul Natl Univ, Canc Hosp, Adolescent Canc Ctr, Seoul, South Korea; [Lee, Ji Yeoun] Seoul Natl Univ, Dept Anat, Coll Med, Seoul, South Korea; [Kwon, Sung Eun] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Jin, Xiong; Lim, Ja Yun; Kim, Hyunggee] Korea Univ, Sch Life Sci & Biotechnol, Cell Growth Regulat Lab, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); University of Pennsylvania; Korea University	Kim, SK (corresponding author), Seoul Natl Univ, Coll Med, Childrens Hosp, Div Pediat Neurosurg,Pediat Clin Neurosci Ctr, Seoul, South Korea.	nsthomas@snu.ac.kr	Kim, Hyunggee/F-2673-2013; Jin, Xiong/I-7609-2015	Kim, Hyunggee/0000-0002-4738-0990; Jin, Xiong/0000-0001-9252-1441	National Research Foundation of Korea (NRF) - Korean government (MEST) [2012011770]; Seoul National University Hospital Research Fund [3020140270]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Seoul National University Hospital Research Fund	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2012011770) and the Seoul National University Hospital Research Fund (3020140270, http://bri.snuh.org).	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Altaner C, 2014, INT J CANCER, V134, P1458, DOI 10.1002/ijc.28455; Altanerova V, 2012, INT J CANCER, V130, P2455, DOI 10.1002/ijc.26278; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Choi SA, 2014, EUR J CANCER, V50, P137, DOI 10.1016/j.ejca.2013.09.004; Choi SA, 2012, CANCER LETT, V324, P221, DOI 10.1016/j.canlet.2012.05.026; Choi SA, 2012, EUR J CANCER, V48, P129, DOI 10.1016/j.ejca.2011.04.033; Choi SA, 2011, NEURO-ONCOLOGY, V13, P61, DOI 10.1093/neuonc/noq147; Corrado C, 2014, CANCER LETT, V348, P71, DOI 10.1016/j.canlet.2014.03.009; Fang XG, 2014, STEM CELLS, V32, P2033, DOI 10.1002/stem.1730; Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.521; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kan I, 2005, CURR DRUG TARGETS, V6, P31, DOI 10.2174/1389450053344902; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Koyama Y, 2007, NEOPLASIA, V9, P1021, DOI 10.1593/neo.07787; Lee DH, 2009, CLIN CANCER RES, V15, P4925, DOI 10.1158/1078-0432.CCR-08-3076; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Leo AJ, 2006, CELLS TISSUES ORGANS, V183, P112, DOI 10.1159/000095985; Lim SH, 2011, CANCER GENE THER, V18, P817, DOI 10.1038/cgt.2011.52; Malik Babar, 2012, Front Biosci (Elite Ed), V4, P2142; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakano I., 2006, PEDIAT RES, V59; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Studeny M, 2002, CANCER RES, V62, P3603; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479	36	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129292	10.1371/journal.pone.0129292	http://dx.doi.org/10.1371/journal.pone.0129292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076490	gold, Green Published			2022-12-26	WOS:000356329900062
J	Chola, L; McGee, S; Tugendhaft, A; Buchmann, E; Hofman, K				Chola, Lumbwe; McGee, Shelley; Tugendhaft, Aviva; Buchmann, Eckhart; Hofman, Karen			Scaling Up Family Planning to Reduce Maternal and Child Mortality: The Potential Costs and Benefits of Modern Contraceptive Use in South Africa	PLOS ONE			English	Article							PROXIMATE DETERMINANTS; MOTHERS; BABIES; HEALTH; LIVES; FERTILITY; FRAMEWORK; INFANT; ACCESS	Introduction Family planning contributes significantly to the prevention of maternal and child mortality. However, many women still do not use modern contraception and the numbers of unintended pregnancies, abortions and subsequent deaths are high. In this paper, we estimate the service delivery costs of scaling up modern contraception, and the potential impact on maternal, newborn and child survival in South Africa. Methods The Family Planning model in Spectrum was used to project the impact of modern contraception on pregnancies, abortions and births in South Africa (2015-2030). The contraceptive prevalence rate (CPR) was increased annually by 0.68 percentage points. The Lives Saved Tool was used to estimate maternal and child deaths, with coverage of essential maternal and child health interventions increasing by 5% annually. A scenario analysis was done to test impacts when: the change in CPR was 0.1% annually; and intervention coverage increased linearly to 99% in 2030. Results If CPR increased by 0.68% annually, the number of pregnancies would reduce from 1.3 million in 2014 to one million in 2030. Unintended pregnancies, abortions and births decrease by approximately 20%. Family planning can avert approximately 7,000 newborn and child and 600 maternal deaths. The total annual costs of providing modern contraception in 2030 are estimated to be US$33 million and the cost per user of modern contraception is US$7 per year. The incremental cost per life year gained is US$40 for children and US$1,000 for mothers. Conclusion Maternal and child mortality remain high in South Africa, and scaling up family planning together with optimal maternal, newborn and child care is crucial. A huge impact can be made on maternal and child mortality, with a minimal investment per user of modern contraception.	[Chola, Lumbwe; McGee, Shelley; Tugendhaft, Aviva; Hofman, Karen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, PRICELESS MRC Wits Rural Publ Hlth & Hlth Transit, Johannesburg, South Africa; [Buchmann, Eckhart] Univ Witwatersrand, Fac Hlth Sci, Dept Obstet & Gynaecol, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Hofman, K (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, PRICELESS MRC Wits Rural Publ Hlth & Hlth Transit, Johannesburg, South Africa.	karen.hofman@wits.ac.za	Chola, Lumbwe/AFX-3377-2022	Chola, Lumbwe/0000-0001-6488-2813; HOFMAN, KAREN/0000-0001-9512-7220				[Anonymous], 2013, STAT WORLD CHILDR CH; Baumgartner JN, 2007, INT FAM PLAN PERSPEC, V33, P66, DOI 10.1363/3306607; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bradshaw D., 2014, RAPID MORTALITY SURV; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Canudas-Romo V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086694; Cates W, 2010, CONTRACEPTION, V81, P460, DOI 10.1016/j.contraception.2010.01.002; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Collumbien M., 2004, COMP QUANTIFICATION, P1255; Culwell KR, 2010, INT J GYNECOL OBSTET, V110, pS13, DOI 10.1016/j.ijgo.2010.04.003; DaVanzo J, 2008, POP STUD-J DEMOG, V62, P131, DOI 10.1080/00324720802022089; Fabic MS, 2015, LANCET, V385, P1928, DOI 10.1016/S0140-6736(14)61055-2; FP2020, 2013, PROGR REPORT 2012 20; Halperin DT, 2009, AIDS, V23, pS123, DOI 10.1097/01.aids.0000363785.73450.5a; Health Systems Trust, 2013, TERM PREGN DURB; Lebese RT, 2013, HEALTH SA GESONDHEID, V18, DOI 10.4102/hsag.v18i1.654; National Department of Health, 2007, S AFR DEM HLTH SURV; National Department of Health, 2012, NAT CONTR FERT PLANN; NCCEMD, 2012, 5 NCCEMD NDOH; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Petruney T, 2014, B WORLD HEALTH ORGAN, V92, P548, DOI 10.2471/BLT.14.142893; Pillay-van Wyk V, 2013, LANCET, V381, pS113; Prata N, 2009, PHILOS T R SOC B, V364, P3093, DOI 10.1098/rstb.2009.0172; Richter MS, 2005, HLTH SA GESONDHEID, V10, P61, DOI DOI 10.4102/HSAG.V10I2.195; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Singh S, 2012, ADDING IT COSTS BENE; Singh S, 2009, ADDING IT COSTS BENE; SINGH Susheela, 2009, ABORTION WORLDWIDE D; Stats S, 2014, MORTALITY CAUSES DEA; Stats SA, 2013, MID YEAR POPULATION; Stats SA, 2013, MILLENNIUM DEV GOALS; Stover J, 1998, STUD FAMILY PLANN, V29, P255, DOI 10.2307/172272; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; Tathiah N, 2013, DISTRICT HLTH BAROME; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD FERT REP 2012; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; Willan W, 2013, REV TEENAGE PREGNANC; Wood K, 2006, REPROD HEALTH MATTER, V14, P109, DOI 10.1016/S0968-8080(06)27231-8; World Health Organization, 2003, GUID COST EFF AN; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	41	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130077	10.1371/journal.pone.0130077	http://dx.doi.org/10.1371/journal.pone.0130077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076482	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900134
J	Colby-Milley, J; Cavanagh, C; Jego, S; Breitner, JCS; Quirion, R; Adamantidis, A				Colby-Milley, Jessica; Cavanagh, Chelsea; Jego, Sonia; Breitner, John C. S.; Quirion, Remi; Adamantidis, Antoine			Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; LOCUS-CERULEUS; DAYTIME SLEEPINESS; DEMENTIA; NEURONS; DISTURBANCES; MILD; NOREPINEPHRINE; EEG; ARCHITECTURE	In addition to cognitive decline, individuals affected by Alzheimer's disease (AD) can experience important neuropsychiatric symptoms including sleep disturbances. We characterized the sleep-wake cycle in the TgCRND8 mouse model of AD, which overexpresses a mutant human form of amyloid precursor protein resulting in high levels of beta-amyloid and plaque formation by 3 months of age. Polysomnographic recordings in freely-moving mice were conducted to study sleep-wake cycle architecture at 3, 7 and 11 months of age and corresponding levels of beta-amyloid in brain regions regulating sleep-wake states were measured. At all ages, TgCRND8 mice showed increased wakefulness and reduced non-rapid eye movement (NREM) sleep during the resting and active phases. Increased wakefulness in TgCRND8 mice was accompanied by a shift in the waking power spectrum towards fast frequency oscillations in the beta (14-20 Hz) and low gamma range (20-50 Hz). Given the phenotype of hyperarousal observed in TgCRND8 mice, the role of noradrenergic transmission in the promotion of arousal, and previous work reporting an early disruption of the noradrenergic system in TgCRND8, we tested the effects of the alpha-1-adrenoreceptor antagonist, prazosin, on sleep-wake patterns in TgCRND8 and non-transgenic (NTg) mice. We found that a lower dose (2 mg/kg) of prazosin increased NREM sleep in NTg but not in TgCRND8 mice, whereas a higher dose (5 mg/kg) increased NREM sleep in both genotypes, suggesting altered sensitivity to noradrenergic blockade in TgCRND8 mice. Collectively our results demonstrate that amyloidosis in TgCRND8 mice is associated with sleep-wake cycle dysfunction, characterized by hyperarousal, validating this model as a tool towards understanding the relationship between beta-amyloid overproduction and disrupted sleep-wake patterns in AD.	[Colby-Milley, Jessica; Cavanagh, Chelsea; Jego, Sonia; Breitner, John C. S.; Quirion, Remi; Adamantidis, Antoine] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada; [Adamantidis, Antoine] Univ Bern, Univ Hosp Bern, Dept Neurol, Inselspital, CH-3010 Bern, Switzerland	McGill University; University of Bern; University Hospital of Bern	Adamantidis, A (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada.	antoine.adamantidis@dkf.unibe.ch		Adamantidis, Antoine/0000-0003-2531-5175	Canadian Insitutes for Health Research (CIHR); Stop-AD Centre of the Douglas Institute; Human Frontier Science Program; Douglas Foundation; McGill University; Canadian Fund for Innovation (CFI); Canadian Research Chair (CRC Tier 2); Natural Science and Engineering Council of Canada (NSERC); University of Bern (Switzerland); Inselspital; CIHR	Canadian Insitutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Stop-AD Centre of the Douglas Institute; Human Frontier Science Program(Human Frontier Science Program); Douglas Foundation; McGill University; Canadian Fund for Innovation (CFI)(Canada Foundation for Innovation); Canadian Research Chair (CRC Tier 2); Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Bern (Switzerland); Inselspital; CIHR(Canadian Institutes of Health Research (CIHR))	Financial support for this study was granted by the Canadian Insitutes for Health Research (CIHR) to RQ and the Stop-AD Centre of the Douglas Institute to JCM. JCM and AA are supported by the Human Frontier Science Program, the Douglas Foundation, McGill University, Canadian Fund for Innovation (CFI), Canadian Research Chair (CRC Tier 2), CIHR and the Natural Science and Engineering Council of Canada (NSERC), the Inselspital and the University of Bern (Switzerland).	Adamantidis A, 2008, EUR J NEUROSCI, V27, P1793, DOI 10.1111/j.1460-9568.2008.06129.x; Berridge CW, 2012, SLEEP MED REV, V16, P187, DOI 10.1016/j.smrv.2011.12.003; Bonanni E, 2005, J SLEEP RES, V14, P311, DOI 10.1111/j.1365-2869.2005.00462.x; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; BORBELY AA, 1992, J SLEEP RES, V1, P63, DOI 10.1111/j.1365-2869.1992.tb00013.x; Brian D., 1996, CLIN GERONTOLOGIST, V16, P35; Broese M, 2012, PHARMACOPSYCHIATRY, V45, P209, DOI 10.1055/s-0031-1299728; CHANPALAY V, 1989, J COMP NEUROL, V287, P373, DOI 10.1002/cne.902870308; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Clement O, 2011, SLEEP, V34, P419, DOI 10.1093/sleep/34.4.419; Elrod R, 1997, AM J PSYCHIAT, V154, P25; Espana RA, 2011, SLEEP, V34, P845, DOI 10.5665/SLEEP.1112; EVANS LK, 1987, J AM GERIATR SOC, V35, P101, DOI 10.1111/j.1532-5415.1987.tb01337.x; Francis BM, 2012, NEUROPSYCHOPHARMACOL, V37, P1934, DOI 10.1038/npp.2012.40; Gary Aston-Jones PD, 2007, BRAIN NOREPINEPHRINE; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Hasan S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.010; Herrmann N, 2004, J NEUROPSYCH CLIN N, V16, P261, DOI 10.1176/appi.neuropsych.16.3.261; Hita-Yanez E, 2013, SLEEP, V36, P1327, DOI 10.5665/sleep.2956; Hoogendijk WJG, 1999, ANN NEUROL, V45, P82, DOI 10.1002/1531-8249(199901)45:1<82::AID-ART14>3.0.CO;2-T; Huitron-Resendiz S, 2002, BRAIN RES, V928, P126, DOI 10.1016/S0006-8993(01)03373-X; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; JONES BE, 1993, PROG BRAIN RES, V98, P61; JOUVET M., 1960, JOUR PHYSIOL [PARIS], V52, P130; Ju YES, 2013, JAMA NEUROL, V70, P587, DOI 10.1001/jamaneurol.2013.2334; Jyoti A, 2010, J ALZHEIMERS DIS, V22, P873, DOI 10.3233/JAD-2010-100879; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Lee JH, 2007, AM J GERIAT PSYCHIAT, V15, P620, DOI 10.1097/JGP.0b013e3180381521; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Lyketsos Constantine G, 2011, Alzheimers Dement, V7, P532, DOI 10.1016/j.jalz.2011.05.2410; MANN DM, 1982, J NEUROL NEUROSUR PS, V45, P113, DOI 10.1136/jnnp.45.2.113; McCurry SM, 1999, J GERIATR PSYCH NEUR, V12, P53, DOI 10.1177/089198879901200203; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Platt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027068; PRINZ PN, 1982, NEUROBIOL AGING, V3, P361, DOI 10.1016/0197-4580(82)90024-0; PRINZ PN, 1982, J AM GERIATR SOC, V30, P86, DOI 10.1111/j.1532-5415.1982.tb01279.x; RASKIND MA, 1984, ARCH GEN PSYCHIAT, V41, P343; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Rothman SM, 2013, BRAIN RES, V1529, P200, DOI 10.1016/j.brainres.2013.07.010; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sethi M, 2015, NEUROSCIENCE, V290, P80, DOI 10.1016/j.neuroscience.2015.01.035; Spira AP, 2013, JAMA NEUROL, V70, P1537, DOI 10.1001/jamaneurol.2013.4258; STERIADE M, 1991, P NATL ACAD SCI USA, V88, P4396, DOI 10.1073/pnas.88.10.4396; Stern AL, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-014-0777-6; Sterniczuk R, 2013, CURR ALZHEIMER RES, V10, P767, DOI 10.2174/15672050113109990134; Sterniczuk R, 2010, BRAIN RES, V1348, P139, DOI 10.1016/j.brainres.2010.05.013; Szot P, 2007, NEUROSCIENCE, V146, P471, DOI 10.1016/j.neuroscience.2007.01.031; Szot P, 2006, J NEUROSCI, V26, P467, DOI 10.1523/JNEUROSCI.4265-05.2006; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; Toth LA, 2013, COMPARATIVE MED, V63, P91; Tractenberg RE, 2003, J SLEEP RES, V12, P331, DOI 10.1046/j.0962-1105.2003.00374.x; Vecchierini MF, 2010, PSYCHOL NEUROPSYCHIA, V8, P15, DOI 10.1684/pnv.2010.0203; Vitiello M V, 1989, Clin Geriatr Med, V5, P289; Vitiello MV, 1997, J GERONTOL A-BIOL, V52, pM189, DOI 10.1093/gerona/52A.4.M189; VITIELLO MV, 1990, J GERONTOL, V45, pM131, DOI 10.1093/geronj/45.4.M131; VITIELLO MV, 1992, NEUROLOGY, V42, P83; VITIELLO MV, 1984, BIOL PSYCHIAT, V19, P721; Vitiello MV, 2001, CNS DRUGS, V15, P777, DOI 10.2165/00023210-200115100-00004; Volicer L, 2001, AM J PSYCHIAT, V158, P704, DOI 10.1176/appi.ajp.158.5.704; Wisor JP, 2005, NEUROSCIENCE, V131, P375, DOI 10.1016/j.neuroscience.2004.11.018; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Zhang B, 2005, AM J PATHOL, V167, P1361, DOI 10.1016/S0002-9440(10)61223-0	68	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130177	10.1371/journal.pone.0130177	http://dx.doi.org/10.1371/journal.pone.0130177			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076358	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900150
J	Cotero, VE; Kimm, SY; Siclovan, TM; Zhang, R; Kim, EM; Matsumoto, K; Gondo, T; Scardino, PT; Yazdanfar, S; Laudone, VP; Hehir, CAT				Cotero, Victoria E.; Kimm, Simon Y.; Siclovan, Tiberiu M.; Zhang, Rong; Kim, Evgenia M.; Matsumoto, Kazuhiro; Gondo, Tatsuo; Scardino, Peter T.; Yazdanfar, Siavash; Laudone, Vincent P.; Hehir, Cristina A. Tan			Improved Intraoperative Visualization of Nerves through a Myelin-Binding Fluorophore and Dual-Mode Laparoscopic Imaging	PLOS ONE			English	Article							CORONARY-ARTERY-BYPASS; LYMPH-NODE DISSECTION; GUIDED SURGERY; BREAST-CANCER; RISK-FACTORS; INJURY; PAIN; IDENTIFICATION; MORBIDITY; CARCINOMA	The ability to visualize and spare nerves during surgery is critical for avoiding chronic morbidity, pain, and loss of function. Visualization of such critical anatomic structures is even more challenging during minimal access procedures because the small incisions limit visibility. In this study, we focus on improving imaging of nerves through the use of a new small molecule fluorophore, GE3126, used in conjunction with our dual-mode (color and fluorescence) laparoscopic imaging instrument. GE3126 has higher aqueous solubility, improved pharmacokinetics, and reduced non-specific adipose tissue fluorescence compared to previous myelin-binding fluorophores. Dosing and kinetics were initially optimized in mice. A non-clinical modified Irwin study in rats, performed to assess the potential of GE3126 to induce nervous system injuries, showed the absence of major adverse reactions. Real-time intraoperative imaging was performed in a porcine model. Compared to white light imaging, nerve visibility was enhanced under fluorescence guidance, especially for small diameter nerves obscured by fascia, blood vessels, or adipose tissue. In the porcine model, nerve visualization was observed rapidly, within 5 to 10 minutes post-intravenous injection and the nerve fluorescence signal was maintained for up to 80 minutes. The use of GE3126, coupled with practical implementation of an imaging instrument may be an important step forward in preventing nerve damage in the operating room.	[Cotero, Victoria E.; Siclovan, Tiberiu M.; Zhang, Rong; Kim, Evgenia M.; Yazdanfar, Siavash; Hehir, Cristina A. Tan] GE Global Res, Diagnost Imaging & Biomed Technol, Niskayuna, NY 12309 USA; [Kimm, Simon Y.; Matsumoto, Kazuhiro; Gondo, Tatsuo; Scardino, Peter T.; Laudone, Vincent P.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA	General Electric; Memorial Sloan Kettering Cancer Center	Hehir, CAT (corresponding author), GE Global Res, Diagnost Imaging & Biomed Technol, Niskayuna, NY 12309 USA.	tanhehir@ge.com	Yazdanfar, Siavash/A-9013-2009	Yazdanfar, Siavash/0000-0003-2768-6199	National Institutes of Health [R01-EB-022872]; GE Global Research; Sidney Kimmel Center for Prostate and Urologic Cancers; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE Global Research(General Electric); Sidney Kimmel Center for Prostate and Urologic Cancers; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by a grant from the National Institutes of Health, under award number R01-EB-022872 (CTH), by GE Global Research, and by the Sidney Kimmel Center for Prostate and Urologic Cancers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, conclusions or other recommendations expressed herein are those of the authors and do not necessarily reflect the views of the funders.	[Anonymous], 2011, GUIDE CARE USE LAB A; Baima J, 2008, CURR REV MUSCULOSKE, V1, P147, DOI 10.1007/s12178-008-9023-6; Bajaj A, 2013, J HISTOCHEM CYTOCHEM, V61, P19, DOI 10.1369/0022155412467353; Bizzarri F, 2001, TEX HEART I J, V28, P315; Canbaz Suat, 2004, BMC Surg, V4, P2, DOI 10.1186/1471-2482-4-2; Carpenter JS, 1999, CANCER PRACT, V7, P66, DOI 10.1046/j.1523-5394.1999.07208.x; Charoenkwan K, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.09.027; Costello AJ, 2004, BJU INT, V94, P1071, DOI 10.1111/j.1464-410X.2004.05106.x; Cotero VE, 2012, MOL IMAGING BIOL, V14, P708, DOI 10.1007/s11307-012-0555-1; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gibbs SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073493; Gibbs-Strauss SL, 2011, MOL IMAGING, V10, P91, DOI 10.2310/7290.2010.00026; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Gray D, 2012, PROC SPIE, V8214, DOI 10.1117/12.905757; Gray DC, 2012, BIOMED OPT EXPRESS, V3, P1880, DOI 10.1364/BOE.3.001880; GUINN GA, 1990, TEX HEART I J, V17, P48; Gustafson TP, 2012, MEDCHEMCOMM, V3, P685, DOI 10.1039/c2md00297c; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Katz MG, 1998, ANN THORAC SURG, V65, P32, DOI 10.1016/S0003-4975(97)00915-6; Keereweer S, 2011, MOL IMAGING BIOL, V13, P199, DOI 10.1007/s11307-010-0373-2; KOKATNUR MG, 1979, AM J CLIN NUTR, V32, P2198, DOI 10.1093/ajcn/32.11.2198; Kretschmer T, 2009, NEUROSURG CLIN N AM, V20, P73, DOI 10.1016/j.nec.2008.07.025; London J, 1996, ANN ROY COLL SURG, V78, P146; Macdonald L, 2005, BRIT J CANCER, V92, P225, DOI 10.1038/sj.bjc.6602304; Marien TP, 2008, BJU INT, V102, P1581, DOI 10.1111/j.1464-410X.2008.07921.x; Markman J, MERCK MANUAL2014; Ntziachristos V., 2010, J BIOMED OPT, V15, DOI DOI 10.1117/1.3523364; Park MH, 2014, THERANOSTICS, V4, P823, DOI 10.7150/thno.8696; Penson DF, 2008, J UROLOGY, V179, pS40, DOI 10.1016/j.juro.2008.03.136; Pogue BW, 2010, IEEE J SEL TOP QUANT, V16, P493, DOI 10.1109/JSTQE.2009.2034541; Poleshuck EL, 2006, J PAIN, V7, P626, DOI 10.1016/j.jpain.2006.02.007; Rehman J, 1999, BJU INT, V84, P305; Roux S, 2001, CURR PROTOC PHARM; Schellingerhout D, 2009, MOL IMAGING, V8, P319, DOI 10.2310/7290.2009.00029; Schrenk P, 2000, CANCER, V88, P608, DOI 10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K; Sevick-Muraca E. M., 2008, J BIOMED OPT, V13, DOI DOI 10.1117/1.2953185; Tagaya N, 2011, WORLD J SURG, V35, P154, DOI 10.1007/s00268-010-0811-y; Takenaka A, 2005, UROLOGY, V65, P136, DOI 10.1016/j.urology.2004.08.028; Tobis S, 2011, J UROLOGY, V186, P47, DOI 10.1016/j.juro.2011.02.2701; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Vaz C, 2012, VASCULAR SURG; Warmuth MA, 1998, CANCER, V83, P1362, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1362::AID-CNCR13>3.0.CO;2-2; Whitney MA, 2011, NAT BIOTECHNOL, V29, P352, DOI 10.1038/nbt.1764; Wilbourn AJ, 1998, NEUROL CLIN, V16, P55, DOI 10.1016/S0733-8619(05)70367-4; Yuan X, 2007, DRUGS PHARM SCI, V172, P303	45	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130276	10.1371/journal.pone.0130276	http://dx.doi.org/10.1371/journal.pone.0130276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076448	Green Submitted, gold, Green Published			2022-12-26	WOS:000356329900160
J	He, M; Zheng, B; Zhang, Y; Zhang, XH; Wang, C; Yang, Z; Sun, Y; Wu, XL; Wen, JK				He, Ming; Zheng, Bin; Zhang, Yu; Zhang, Xin-Hua; Wang, Chang; Yang, Zhan; Sun, Yan; Wu, Xiao-Li; Wen, Jin-Kun			KLF4 mediates the link between TGF-beta 1-induced gene transcription and H3 acetylation in vascular smooth muscle cells	FASEB JOURNAL			English	Article						p300; PTEN; p38 MAPK; p21 promoter; phosphorylation	TUMOR-SUPPRESSOR PTEN; HISTONE ACETYLATION; EXPRESSION; INHIBITION; PATHWAY; PROTEIN; PHOSPHORYLATION; RECRUITMENT; CHROMATIN; PROMOTER	Transcriptional activation by transcription factors is coupled with histone acetylation and chromatin remodeling. However, the relationship between TGF-beta 1-induced gene transcription by Kruppel-like factor (KLF)-4 and histone acetylation remains unknown. In our study, KLF4 overexpression or knockdown, respectively increased or decreased H3 acetylation and p300 occupancy, which is concentrated in the region containing TGF-beta 1 control elements (TCEs) of the genes by TGF-beta 1 regulation during vascular smooth muscle cell (VSMC) differentiation. Coimmunoprecipitation and glutathione S-transferase pull-down assays showed that phosphatase and tensin homolog (PTEN) formed a complex with KLF4 to inhibit the phosphorylation of the latter in basal conditions. After TGF-beta 1 signaling activation, PTEN was phosphorylated by p38 MAPK or PI3K/Akt signaling, phosphorylated PTEN lost its ability to dephosphorylate KLF4, and the cofactors interacting with KLF4 switched from PTEN to p300. Then, KLF4-p300 complexes were recruited toKLF4-binding sites of the gene promoter of VSMCs, to acetylate histone H3 and activate transcription. In addition, phosphorylated KLF4 enhanced p300 histone acetyltransferase (HAT) activity via the p38 MAPK pathway, which may be responsible for H3 acetylation. Taken together, the results of our study reveal a novel mechanism whereby KLF4 mediates the link between TGF-beta 1-induced gene transcription activation and H3 acetylation during VSMC differentiation.	[He, Ming; Zheng, Bin; Zhang, Yu; Zhang, Xin-Hua; Wang, Chang; Yang, Zhan; Sun, Yan; Wu, Xiao-Li; Wen, Jin-Kun] Hebei Med Univ, China Adm Educ, Key Lab Neural & Vasc Biol, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [He, Ming] Hebei Univ Chinese Med, Inst Chinese Integrat Med, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei University of Chinese Medicine	Wen, JK (corresponding author), Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Dept Biochem & Mol Biol, 361 Zhongshan East Rd, Shijiazhuang 050017, Peoples R China.	wjk@hebmu.edu.cn	Yang, Zhan/GQG-9995-2022	Yang, Zhan/0000-0001-7191-2910; Wen, Jinkun/0000-0002-8453-4549	National Basic Research Program of China [2012CB518601]; Natural Science Foundation of China [31271396, 31271244, 31301136]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB518601 and Natural Science Foundation of China Grants 31271396, 31271244, and 31301136. The authors declare no conflicts of interest.	Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Choi HJ, 2006, GLYCOBIOLOGY, V16, P573, DOI 10.1093/glycob/cwj105; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Fukuda Hiroki, 2006, Briefings in Functional Genomics & Proteomics, V5, P190, DOI 10.1093/bfgp/ell032; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; He JM, 2010, BIOCHEM BIOPH RES CO, V397, P513, DOI 10.1016/j.bbrc.2010.05.146; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Li ZG, 2014, MOL CELL BIOL, V34, P3642, DOI 10.1128/MCB.00814-14; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Nemenoff RA, 2011, ARTERIOSCL THROM VAS, V31, P1300, DOI 10.1161/ATVBAHA.111.223701; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Seay U, 2005, J PHARMACOL EXP THER, V315, P1005, DOI 10.1124/jpet.105.091249; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Spin JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014301; Stiehl DP, 2007, CANCER RES, V67, P2256, DOI 10.1158/0008-5472.CAN-06-3985; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Williamson I, 2011, DEV CELL, V21, P17, DOI 10.1016/j.devcel.2011.06.008; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Wygrecka M, 2012, AM J RESP CELL MOL, V47, P614, DOI 10.1165/rcmb.2012-0097OC; Yu K, 2011, CARDIOVASC RES, V90, P464, DOI 10.1093/cvr/cvr017; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zhang XH, 2012, ARTERIOSCL THROM VAS, V32, P1015, DOI 10.1161/ATVBAHA.111.244962; Zheng B, 2011, CELL RES, V21, P1487, DOI 10.1038/cr.2011.34	34	37	38	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					4059	4070		10.1096/fj.15-272658	http://dx.doi.org/10.1096/fj.15-272658			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26082460				2022-12-26	WOS:000359915600039
J	Sakanaka, A; Kuboniwa, M; Takeuchi, H; Hashino, E; Amano, A				Sakanaka, Akito; Kuboniwa, Masae; Takeuchi, Hiroki; Hashino, Ei; Amano, Atsuo			Arginine-Ornithine Antiporter ArcD Controls Arginine Metabolism and Interspecies Biofilm Development of Streptococcus gordonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biofilm; cell metabolism; metabolic regulation; metabolomics; Streptococcus; symbiosis; Fusobacterium; arginine metabolism; cross-feeding; ornithine export	ORAL MICROBIAL COMMUNITY; HUMAN DENTAL PLAQUE; FUSOBACTERIUM-NUCLEATUM; PORPHYROMONAS-GINGIVALIS; PSEUDOMONAS-AERUGINOSA; ACTINOMYCES-NAESLUNDII; MULTISPECIES BIOFILM; BIOLOGICAL FITNESS; DEIMINASE OPERON; MEMBRANE-PROTEIN	Background: Arginine and its derivatives are key factors for inter-bacterial communication in periodontal microflora. Results: ArcD-mediated export of ornithine by oral commensal Streptococcus gordonii facilitates biofilm development of Fusobacterium nucleatum. Conclusion: Ornithine cross-feeding from S. gordonii to F. nucleatum mediates dental biofilm maturation. Significance: This is the first report of metabolic cross-feeding between S. gordonii and F. nucleatum. Arginine is utilized by the oral inhabitant Streptococcus gordonii as a substrate of the arginine deiminase system (ADS), eventually producing ATP and NH3, the latter of which is responsible for microbial resistance to pH stress. S. gordonii expresses a putative arginine-ornithine antiporter (ArcD) whose function has not been investigated despite relevance to the ADS and potential influence on inter-bacterial communication with periodontal pathogens that utilize amino acids as a main energy source. Here, we generated an S. gordonii arcD mutant to explore the role of ArcD in physiological homeostasis and bacterial cross-feeding. First, we confirmed that S. gordonii ArcD plays crucial roles for mediating arginine uptake and promoting bacterial growth, particularly under arginine-limited conditions. Next, metabolomic profiling and transcriptional analysis of the arcD mutant revealed that deletion of this gene caused intracellular accumulation of ornithine leading to malfunction of the ADS and suppression of de novo arginine biosynthesis. The mutant strain also showed increased susceptibility to low pH stress due to reduced production of ammonia. Finally, accumulation of Fusobacterium nucleatum was found to be significantly decreased in biofilm formed by the arcD mutant as compared with the wild-type strain, although ornithine supplementation restored fusobacterium biovolume in dual-species biofilms with the arcD mutant and also enhanced single species biofilm development by F. nucleatum. Our results are the first direct evidence showing that S. gordonii ArcD modulates not only alkali and energy production but also interspecies interaction with F. nucleatum, thus initiating a middle stage of periodontopathic biofilm formation, by metabolic cross-feeding.	[Sakanaka, Akito; Kuboniwa, Masae; Takeuchi, Hiroki; Hashino, Ei; Amano, Atsuo] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka 5650871, Japan; [Kuboniwa, Masae] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Japan Science & Technology Agency (JST)	Kuboniwa, M (corresponding author), Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka 5650871, Japan.	kuboniwa@dent.osaka-u.ac.jp		Kuboniwa, Masae/0000-0002-3332-2431; Sakanaka, Akito/0000-0001-9733-6886	CREST from Japan Science and Technology Agency; Japan Society for the Promotion of Science [262530940, 245931500]; Osaka University Graduate School of Dentistry; Grants-in-Aid for Scientific Research [15K20642] Funding Source: KAKEN	CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka University Graduate School of Dentistry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST from the Japan Science and Technology Agency, Grants-in-aid (A) 262530940 and (C) 245931500 from the Japan Society for the Promotion of Science, and the "Challenge to Intractable Oral Diseases" Project of Osaka University Graduate School of Dentistry. The authors declare that they have no conflicts of interest with the contents of this article.	Biyikoglu B, 2012, ANAEROBE, V18, P459, DOI 10.1016/j.anaerobe.2012.06.003; BOURDINEAUD JP, 1993, J BIOL CHEM, V268, P5417; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Catenazzi MCE, 2014, MOL MICROBIOL, V93, P346, DOI 10.1111/mmi.12664; Christopher AB, 2010, MICROBIOL-SGM, V156, P3469, DOI 10.1099/mic.0.042671-0; CLARK WB, 1989, INFECT IMMUN, V57, P3003, DOI 10.1128/IAI.57.10.3003-3008.1989; Cugini C, 2013, MICROBIOL-SGM, V159, P275, DOI 10.1099/mic.0.062695-0; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Dong YQ, 2004, J BACTERIOL, V186, P2511, DOI 10.1128/JB.186.8.2511-2514.2004; Dong YQ, 2002, APPL ENVIRON MICROB, V68, P5549, DOI 10.1128/AEM.68.11.5549-5553.2002; DRIESSEN AJM, 1987, P NATL ACAD SCI USA, V84, P6093, DOI 10.1073/pnas.84.17.6093; Fukui K, 2011, J BIOTECHNOL, V154, P25, DOI 10.1016/j.jbiotec.2011.03.010; Fulde M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00107; Fulde M, 2011, MICROBIOL-SGM, V157, P572, DOI 10.1099/mic.0.043067-0; GHARBIA SE, 1991, ORAL MICROBIOL IMMUN, V6, P264, DOI 10.1111/j.1399-302X.1991.tb00489.x; Griswold A, 2004, APPL ENVIRON MICROB, V70, P1321, DOI 10.1128/AEM.70.3.1321-1327.2004; Gupta R, 2013, INFECT IMMUN, V81, P3903, DOI 10.1128/IAI.00778-13; Hashino E, 2013, MOL ORAL MICROBIOL, V28, P435, DOI 10.1111/omi.12037; Hendrickson EL, 2014, MICROBIOLOGYOPEN, V3, P729, DOI 10.1002/mbo3.204; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; HIGHAM SM, 1989, ARCH ORAL BIOL, V34, P329, DOI 10.1016/0003-9969(89)90105-2; Jakubovics NS, 2008, J BACTERIOL, V190, P3646, DOI 10.1128/JB.00088-08; Jakubovics NS, 2015, MOL MICROBIOL, V97, P281, DOI 10.1111/mmi.13023; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kaplan CW, 2009, MOL MICROBIOL, V71, P35, DOI 10.1111/j.1365-2958.2008.06503.x; Kloosterman TG, 2011, J BIOL CHEM, V286, P44594, DOI 10.1074/jbc.M111.295832; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3194, DOI 10.1128/IAI.57.10.3194-3203.1989; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Kuboniwa M, 2010, PERIODONTOL 2000, V52, P38, DOI 10.1111/j.1600-0757.2009.00311.x; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-98; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Li Y, 2014, ISME J, V8, P1879, DOI 10.1038/ismej.2014.28; Liu YL, 2012, INT J ORAL SCI, V4, P135, DOI 10.1038/ijos.2012.54; Liu YL, 2008, APPL ENVIRON MICROB, V74, P5023, DOI 10.1128/AEM.00556-08; Liu YL, 2009, J BACTERIOL, V191, P7353, DOI 10.1128/JB.01053-09; LUTHI E, 1990, GENE, V87, P37, DOI 10.1016/0378-1119(90)90493-B; Mouz N, 1996, P NATL ACAD SCI USA, V93, P9414, DOI 10.1073/pnas.93.18.9414; Nascimento MM, 2014, MOL ORAL MICROBIOL, V29, P45, DOI 10.1111/omi.12044; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Rogers AH, 1998, ANAEROBE, V4, P111, DOI 10.1006/anae.1997.0140; Rosen G, 2006, FEMS MICROBIOL LETT, V256, P304, DOI 10.1111/j.1574-6968.2006.00131.x; Ruhl S, 2004, J DENT RES, V83, P505, DOI 10.1177/154405910408300614; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; VANWUYCKHUYSE BC, 1995, J DENT RES, V74, P686, DOI 10.1177/00220345950740021001; VERHOOGT HJC, 1992, J BACTERIOL, V174, P1568, DOI 10.1128/jb.174.5.1568-1573.1992; Wang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056131; Whitmore SE, 2011, MOL MICROBIOL, V81, P305, DOI 10.1111/j.1365-2958.2011.07707.x; Wimmer F, 2008, FEBS LETT, V582, P3771, DOI 10.1016/j.febslet.2008.10.004; Yamamoto H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-51; Yoneda S, 2013, MOL ORAL MICROBIOL, V28, P354, DOI 10.1111/omi.12029; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60	62	38	40	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21185	21198		10.1074/jbc.M115.644401	http://dx.doi.org/10.1074/jbc.M115.644401			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26085091	Green Published, hybrid			2022-12-26	WOS:000360637600001
J	Steneberg, P; Sykaras, AG; Backlund, F; Straseviciene, J; Soderstrom, I; Edlund, H				Steneberg, Par; Sykaras, Alexandros G.; Backlund, Fredrik; Straseviciene, Jurate; Soderstrom, Ingegerd; Edlund, Helena			Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; BASAL-STATE HYPERINSULINEMIA; HEALTHY NORMOGLYCEMIC ADULTS; DIET-INDUCED OBESITY; PPAR-GAMMA; LIVER-DISEASE; MONOACYLGLYCEROL ACYLTRANSFERASE; UP-REGULATION; MOUSE MODEL; LIPID-ACCUMULATION	Hepatosteatosis is associated with the development of both hepatic insulin resistance and Type 2 diabetes. Hepatic expression of Cd36, a fatty acid transporter, is enhanced in obese and diabetic murine models and human nonalcoholic fatty liver disease, and thus it correlates with hyperinsulinemia, steatosis, and insulin resistance. Here, we have explored the effect of hyperinsulinemia on hepatic Cd36 expression, development of hepatosteatosis, insulin resistance, and dysglycemia. A 3-week sucrose-enriched diet was sufficient to provoke hyperinsulinemia, hepatosteatosis, hepatic insulin resistance, and dysglycemia in CBA/J mice. The development of hepatic steatosis and insulin resistance in CBA/J mice on a sucrose-enriched diet was paralleled by increased hepatic expression of the transcription factor Ppar gamma and its target gene Cd36 whereas that of genes implicated in lipogenesis, fatty acid oxidation, and VLDL secretion was unaltered. Additionally, we demonstrate that insulin, in a Ppar gamma-dependent manner, is sufficient to directly increase Cd36 expression in perfused livers and isolated hepatocytes. Mouse strains that display low insulin levels, i.e. C57BL6/J, and/or lack hepatic Ppar gamma, i.e. C3H/HeN, do not develop hepatic steatosis, insulin resistance, or dysglycemia on a sucrose-enriched diet, suggesting that elevated insulin levels, via enhanced CD36 expression, provoke fatty liver development that in turn leads to hepatic insulin resistance and dysglycemia. Thus, our data provide evidence for a direct role for hyperinsulinemia in stimulating hepatic Cd36 expression and thus the development of hepatosteatosis, hepatic insulin resistance, and dysglycemia.	[Steneberg, Par; Sykaras, Alexandros G.; Backlund, Fredrik; Straseviciene, Jurate; Edlund, Helena] Umea Univ, Umea Ctr Mol Med, SE-90187 Umea, Sweden; [Soderstrom, Ingegerd] Umea Univ, Dept Publ Hlth & Clin Med, SE-90187 Umea, Sweden	Umea University; Umea University	Edlund, H (corresponding author), Umea Univ, Umea Ctr Mol Med, SE-90187 Umea, Sweden.	helena.edlund@umu.se	Sykaras, Alexandros/AAO-1565-2020	Sykaras, Alexandros/0000-0002-2972-0138; Edlund, Helena/0000-0002-3553-7348	Strategic Research Program in Diabetes at Umea University; Swedish Research Council [521-2010-3618]; Knut and Alice Wallenberg Foundation [KAW 2010.0033, KAW 2012.0060]	Strategic Research Program in Diabetes at Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Strategic Research Program in Diabetes at Umea University, by Grants 521-2010-3618 from the Swedish Research Council, and by Grants KAW 2010.0033 and KAW 2012.0060 from The Knut and Alice Wallenberg Foundation. H. E. is a co-founder, shareholder, and consultant of the unlisted biotech company Betagenon AB. Par Steneberg, Alexandros Sykaras, Fredrik Backlund, Jurate Straseviciene, and Ingegerd Soderstrom have no conflicts of interest with the contents of this article.	Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Buque X, 2012, AM J PHYSIOL-ENDOC M, V303, pE504, DOI 10.1152/ajpendo.00653.2011; Buque X, 2010, J LIPID RES, V51, P500, DOI 10.1194/jlr.M001966; Chabowski A, 2004, AM J PHYSIOL-ENDOC M, V287, pE781, DOI 10.1152/ajpendo.00573.2003; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen JL, 2014, J LIPID RES, V55, P32, DOI 10.1194/jlr.M039453; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Corpeleijn E, 2008, J PHYSIOL PHARMACOL, V59, P77; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Dankner R, 2012, DIABETES-METAB RES, V28, P618, DOI 10.1002/dmrr.2322; Dankner R, 2009, DIABETES CARE, V32, P1464, DOI 10.2337/dc09-0153; Degrace P, 2006, J LIPID RES, V47, P2647, DOI 10.1194/jlr.M600140-JLR200; Edvardsson U, 2006, BIOCHEM BIOPH RES CO, V340, P111, DOI 10.1016/j.bbrc.2005.12.008; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hames KC, 2014, DIABETES, V63, P3606, DOI 10.2337/db14-0369; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Lee JE, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-29; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109; Liu Q, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-42; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Memon RA, 1999, DIABETES, V48, P121, DOI 10.2337/diabetes.48.1.121; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Nilsson SK, 2012, BBA-MOL CELL BIOL L, V1821, P1370, DOI 10.1016/j.bbalip.2012.06.003; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Rhee EJ, 2011, AM J MED, V124, P69, DOI 10.1016/j.amjmed.2010.08.012; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	50	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19034	19043		10.1074/jbc.M115.640292	http://dx.doi.org/10.1074/jbc.M115.640292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26085100	hybrid, Green Published			2022-12-26	WOS:000358781100021
J	Labbe, C; Ogaki, K; Lorenzo-Betancor, O; Carrasquillo, MM; Heckman, MG; McCarthy, A; Soto-Ortolaza, AI; Walton, RL; Lynch, T; Siuda, J; Opala, G; Krygowska-Wajs, A; Barcikowska, M; Czyzewski, K; Dickson, DW; Uitti, RJ; Wszolek, ZK; Ross, OA				Labbe, Catherine; Ogaki, Kotaro; Lorenzo-Betancor, Oswaldo; Carrasquillo, Minerva M.; Heckman, Michael G.; McCarthy, Allan; Soto-Ortolaza, Alexandra I.; Walton, Ronald L.; Lynch, Timothy; Siuda, Joanna; Opala, Grzegorz; Krygowska-Wajs, Anna; Barcikowska, Maria; Czyzewski, Krzysztof; Dickson, Dennis W.; Uitti, Ryan J.; Wszolek, Zbigniew K.; Ross, Owen A.			Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson's Disease Locus	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; SUSCEPTIBILITY; METAANALYSIS; BROWSER; SPAK	Genome-wide association studies (GWAS) in Parkinson's disease (PD) have identified over 20 genomic regions associated with disease risk. Many of these loci include several candidate genes making it difficult to pinpoint the causal gene. The locus on chromosome 2q24.3 encompasses three genes: B3GALT1, STK39, and CERS6. In order to identify if the causal variants are simple missense changes, we sequenced all 31 exons of these three genes in 187 patients with PD. We identified 13 exonic variants including four non-synonymous and three insertion/deletion variants (indels). These non-synonymous variants and rs2102808, the GWAS tag SNP, were genotyped in three independent series consisting of a total of 1976 patients and 1596 controls. Our results show that the seven identified 2q24.3 coding variants are not independently responsible for the GWAS association signal at the locus; however, there is a haplotype, which contains both rs2102808 and a STK39 exon 1 6bp indel variant, that is significantly associated with PD risk (Odds Ratio [OR] = 1.35, 95% CI: 1.11-1.64, P = 0.003). This haplotype is more associated than each of the two variants independently (OR = 1.23, P = 0.005 and 1.10, P = 0.10, respectively). Our findings suggest that the risk variant is likely located in a non-coding region. Additional sequencing of the locus including promoter and regulatory regions will be needed to pinpoint the association at this locus that leads to an increased risk to PD.	[Labbe, Catherine; Ogaki, Kotaro; Lorenzo-Betancor, Oswaldo; Carrasquillo, Minerva M.; Soto-Ortolaza, Alexandra I.; Walton, Ronald L.; Ross, Owen A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Heckman, Michael G.] Mayo Clin, Biostat Sect, Jacksonville, FL 32224 USA; [McCarthy, Allan; Lynch, Timothy] Univ Coll Dublin, Mater Misericordiae Univ Hosp, Dublin Neurol Inst, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Siuda, Joanna; Opala, Grzegorz] Med Univ Silesia, Dept Neurol, Katowice, Poland; [Krygowska-Wajs, Anna] Jagiellonian Univ, Dept Neurol, Krakow, Poland; [Barcikowska, Maria] Polish Acad Sci, Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland; [Czyzewski, Krzysztof] Cent Hosp, Minist Interior & Adm, Dept Neurol, Warsaw, Poland; [Dickson, Dennis W.; Uitti, Ryan J.; Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Dickson, Dennis W.] Mayo Clin, Dept Pathol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mater Misericordiae University Hospital; University College Dublin; Medical University Silesia; Jagiellonian University; Polish Academy of Sciences; Mayo Clinic; Mayo Clinic	Ross, OA (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	ross.owen@mayo.edu	Lynch, Timothy/M-1316-2019; Lorenzo-Betancor, Oswaldo/J-2753-2019; Siuda, Joanna/H-9967-2018; Wszolek, Zbigniew K./AAB-1431-2019	Lorenzo-Betancor, Oswaldo/0000-0002-5607-8363; Siuda, Joanna/0000-0002-0340-660X; Ross, Owen/0000-0003-4813-756X; Barcikowska, Maria/0000-0001-5657-9670	Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50) [NS072187]; NINDS [R01 NS078086]; Michael J. Fox Foundation; FRSQ postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078086, P50NS072187] Funding Source: NIH RePORTER	Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; FRSQ postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by a Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50 #NS072187), NINDS R01 NS078086 (www.nih.gov), Michael J. Fox Foundation, and a gift from Carl Edward Bolch, Jr., and Susan Bass Bolch awarded to OAR. CL is the recipient of a FRSQ postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonifati Vincenzo, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS23, DOI 10.1016/S1353-8020(13)70009-9; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; Geng Y, 2010, BEHAV BRAIN RES, V208, P377, DOI 10.1016/j.bbr.2009.12.005; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Labbe C, 2014, CURR GENOMICS, V15, P2, DOI 10.2174/1389202914666131210212745; Labbe C, 2013, PARKINSONISM RELAT D, V19, P755, DOI 10.1016/j.parkreldis.2013.03.005; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Liu XM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-104; N Li, 2013, TUMOR BIOL, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0079211; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Pihlstrom L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.019; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353; Soto-Ortolaza Alexandra I, 2013, Am J Neurodegener Dis, V2, P287; Spatola Marianna, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS35, DOI 10.1016/S1353-8020(13)70011-7; Wang YQ, 2014, NEUROSCI LETT, V566, P206, DOI 10.1016/j.neulet.2014.03.007; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	23	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128586	10.1371/journal.pone.0128586	http://dx.doi.org/10.1371/journal.pone.0128586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090850	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000023
J	Rajecky, M; Sebrlova, K; Mravec, F; Taborsky, P				Rajecky, Michal; Sebrlova, Kristyna; Mravec, Filip; Taborsky, Petr			Influence of Solvent Polarity and DNA-Binding on Spectral Properties of Quaternary Benzo[c]phenanthridine Alkaloids	PLOS ONE			English	Article							BENZOPHENANTHRIDINE ALKALOIDS; ISOQUINOLINE ALKALOIDS; NITROGEN HETEROCYCLES; PSEUDOBASE FORMATION; SMALL MOLECULES; SANGUINARINE; CHELERYTHRINE; SANGUILUTINE; PAPAVERACEAE; FLUORESCENCE	Quaternary benzo[c]phenanthridine alkaloids are secondary metabolites of the plant families Papaveraceae, Rutaceae, and Ranunculaceae with anti-inflammatory, antifungal, antimicrobial and anticancer activities. Their spectral changes induced by the environment could be used to understand their interaction with biomolecules as well as for analytical purposes. Spectral shifts, quantum yield and changes in lifetime are presented for the free form of alkaloids in solvents of different polarity and for alkaloids bound to DNA. Quantum yields range from 0.098 to 0.345 for the alkanolamine form and are below 0.033 for the iminium form. Rise of fluorescence lifetimes (from 2-5 ns to 3-10 ns) and fluorescence intensity are observed after binding of the iminium form to the DNA for most studied alkaloids. The alkanolamine form does not bind to DNA. Acid-base equilibrium constant of macarpine is determined to be 8.2-8.3. Macarpine is found to have the highest increase of fluorescence upon DNA binding, even under unfavourable pH conditions. This is probably a result of its unique methoxy substitution at C-12 a characteristic not shared with other studied alkaloids. Association constant for macarpine-DNA interaction is 700000 M-1.	[Rajecky, Michal; Taborsky, Petr] Masaryk Univ, CEITEC, Brno, Czech Republic; [Sebrlova, Kristyna] Masaryk Univ, Fac Med, Dept Biochem, Brno, Czech Republic; [Mravec, Filip] Brno Univ Technol, Fac Chem, Mat Res Ctr, CS-61090 Brno, Czech Republic; [Taborsky, Petr] Masaryk Univ, Fac Sci, Dept Chem, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Brno University of Technology; Masaryk University Brno	Taborsky, P (corresponding author), Masaryk Univ, CEITEC, Brno, Czech Republic.	taborak@email.cz	Mravec, Filip/G-7170-2015	Mravec, Filip/0000-0001-6114-4751; Rajecky, Michal/0000-0002-0865-4012	Ministry of Education, Youth and Sports of the Czech Republic [KONTAKT II LH12176]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Funding was provided by the Ministry of Education, Youth and Sports of the Czech Republic (KONTAKT II LH12176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absolinova H, 2010, CENT EUR J CHEM, V8, P626, DOI 10.2478/s11532-010-0038-7; Absolinova H, 2009, CENT EUR J CHEM, V7, P876, DOI 10.2478/s11532-009-0079-y; Adhikari A, 2008, J MOL STRUCT, V889, P54, DOI 10.1016/j.molstruc.2008.01.016; Bai LP, 2008, CHEMBIOCHEM, V9, P2583, DOI 10.1002/cbic.200800256; Bai LP, 2008, ANAL BIOANAL CHEM, V392, P709, DOI 10.1007/s00216-008-2302-7; Bai LP, 2006, BIOORGAN MED CHEM, V14, P5439, DOI 10.1016/j.bmc.2006.05.012; Berberan-Santos, 2013, MOL FLUORESCENCE PRI; Bhadra K, 2007, BBA-GEN SUBJECTS, V1770, P1071, DOI 10.1016/j.bbagen.2007.03.001; BUNTING JW, 1973, CAN J CHEM, V51, P1965, DOI 10.1139/v73-294; BUNTING JW, 1972, CAN J CHEMISTRY, V50, P917, DOI 10.1139/v72-143; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; DOSTAL J, 1990, COLLECT CZECH CHEM C, V55, P2840, DOI 10.1135/cccc19902840; Gregorova J, 2010, FITOTERAPIA, V81, P565, DOI 10.1016/j.fitote.2010.01.020; Gu Q, 2009, ANAL CHEM, V81, P420, DOI 10.1021/ac801676j; Haynes W.M., 2013, CRC HDB CHEM PHYS RE; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hossain M, 2011, PLOS ONE, V6, P12, DOI DOI 10.1371/J0URNAL.P0NE.0018333; ISHIKAWA T, 1995, TETRAHEDRON, V51, P8447, DOI 10.1016/0040-4020(95)00460-P; Islam M, 2007, BIOPHYS CHEM, V125, P508, DOI 10.1016/j.bpc.2006.11.001; Janovska M, 2010, PHYS CHEM CHEM PHYS, V12, P11335, DOI 10.1039/b925828k; Janovska M, 2009, ANAL BIOANAL CHEM, V395, P235, DOI 10.1007/s00216-009-2903-9; KOVAR J, 1986, COLLECT CZECH CHEM C, V51, P2626, DOI 10.1135/cccc19862626; KOVAR J, 1985, COLLECT CZECH CHEM C, V50, P1312, DOI 10.1135/cccc19851312; Kumar GS, 1997, J PHOTOCH PHOTOBIO A, V111, P51, DOI 10.1016/S1010-6030(97)00246-3; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Maiti M, 2007, MED RES REV, V27, P649, DOI 10.1002/med.20087; MELHUISH WH, 1961, J PHYS CHEM-US, V65, P229, DOI 10.1021/j100820a009; MONGAY C, 1974, ANN CHIM-ROME, V64, P409; Motevich IG, 2010, J APPL SPECTROSC+, V77, P394, DOI 10.1007/s10812-010-9344-2; Pencikova K, 2011, MOLECULES, V16, P3391, DOI 10.3390/molecules16043391; Qu XG, 2000, METHOD ENZYMOL, V321, P353; Rybakova S, 2013, CHEM PAP, V67, P568, DOI 10.2478/s11696-013-0340-x; SEN A, 1994, BIOCHEM PHARMACOL, V48, P2097, DOI 10.1016/0006-2952(94)90510-X; Slaninova I, 2001, CELL BIOL TOXICOL, V17, P51, DOI 10.1023/A:1010907231602; Slaninova I, 2007, CYTOM PART A, V71A, P700, DOI 10.1002/cyto.a.20423; Slaninova I, 2014, PHYTOCHEM REV, V13, P51, DOI 10.1007/s11101-013-9290-8; SLAVIK J, 1955, COLLECT CZECH CHEM C, V20, P356, DOI 10.1135/cccc19550356; SLAVIK J, 1968, COLLECT CZECH CHEM C, V33, P1619, DOI 10.1135/cccc19681619; SLAVIK J, 1965, COLLECT CZECH CHEM C, V30, P887, DOI 10.1135/cccc19650887; Slunska Z, 2010, TOXICOL IN VITRO, V24, P697, DOI 10.1016/j.tiv.2010.01.012; Suchomelova J, 2007, J PHARMACEUT BIOMED, V44, P283, DOI 10.1016/j.jpba.2007.02.005; Urbanova J, 2009, ANAL BIOANAL CHEM, V394, P997, DOI 10.1007/s00216-009-2601-7; Zdarilova A, 2006, CHEM LISTY, V100, P30	44	8	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129925	10.1371/journal.pone.0129925	http://dx.doi.org/10.1371/journal.pone.0129925			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091027	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000073
J	Zhang, W; Cho, SY; Xiang, G; Min, KJ; Yu, Q; Jin, JO				Zhang, Wei; Cho, Si-Young; Xiang, Gao; Min, Kyung-Jin; Yu, Qing; Jin, Jun-O			Ginseng Berry Extract Promotes Maturation of Mouse Dendritic Cells	PLOS ONE			English	Article							IMMUNE-RESPONSES; T-CELLS; LIPOPOLYSACCHARIDES; POLYSACCHARIDES; ANTIGEN; VACCINE; RG1	Ginseng extract has been shown to possess certain anti-virus, anti-tumor and immune-activating effects. However, the immunostimulatory effect of ginseng berry extract (GB) has been less well characterized. In this study, we investigated the effect of GB on the activation of mouse dendritic cells (DCs) in vitro and in vivo. GB treatment induced up-regulation of co-stimulatory molecules in bone marrow-derived DCs (BMDCs). Interestingly, GB induced a higher degree of co-stimulatory molecule up-regulation than ginseng root extract (GR) at the same concentrations. Moreover, in vivo administration of GB promoted up-regulation of CD86, MHC class I and MHC class II and production of IL-6, IL-12 and TNF-alpha in spleen DCs. GB also promoted the generation of Th1 and Tc1 cells. Furthermore, Toll like receptor 4 (TLR4) and myeloid differentiation primary response 88 (MyD88) signaling pathway were essential for DC activation induced by GB. In addition, GB strongly prompted the proliferation of ovalbumin (OVA)-specific CD4 and CD8 T cells. Finally, GB induced DC activation in tumor-bearing mice and the combination of OVA and GB treatment inhibited B16-OVA tumor cell growth in C57BL/6 mice. These results demonstrate that GB is a novel tumor therapeutic vaccine adjuvant by promoting DC and T cell activation.	[Zhang, Wei; Jin, Jun-O] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Cho, Si-Young] AmorePacific Corp, R&D Unit, Yongin, Gyeonggi Do, South Korea; [Xiang, Gao] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Min, Kyung-Jin] Inha Univ, Dept Biol Sci, Inchon, South Korea; [Yu, Qing] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA	Fudan University; Nanjing University; Inha University; Harvard University; Forsyth Institute	Jin, JO (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	Junojin1@gmail.com	yu, qing/HGC-4611-2022; Min, Kyung-Jin/AAG-5774-2020; Jin, Jun-O/G-2998-2014	Min, Kyung-Jin/0000-0001-5829-6842; Jin, Jun-O/0000-0003-4216-8111	Research fund for International Young Scientists from National Natural Science Foundation of China [81450110090]; AmorePacific Corporation	Research fund for International Young Scientists from National Natural Science Foundation of China; AmorePacific Corporation	This study was supported by Research fund for International Young Scientists from National Natural Science Foundation of China (81450110090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AmorePacific Corporation provided support in the form of salary for author Si-Young Cho and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Blumenthal M., 2001, ADV NURSE PRACTITION, V9, P33; Byeon SE, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/732860; Calzas C, 2013, INFECT IMMUN, V81, P3106, DOI 10.1128/IAI.00113-13; Chen LW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-48; Cho KS, 2013, ASIAN J ANDROL, V15, P503, DOI 10.1038/aja.2013.49; Choi YD, 2013, INT J IMPOT RES, V25, P45, DOI 10.1038/ijir.2012.45; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Dey L, 2003, PHYTOMEDICINE, V10, P600, DOI 10.1078/094471103322331908; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Inagawa H, 2011, ANTICANCER RES, V31, P2431; Jin JO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099396; Jin JO, 2009, BLOOD, V113, P5839, DOI 10.1182/blood-2008-10-184796; Kim CK, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/490301; KIMURA M, 1981, J PHARMACOBIO-DYNAM, V4, P410, DOI 10.1248/bpb1978.4.410; Lee JS, 2014, INT J MOL MED, V34, P183, DOI 10.3892/ijmm.2014.1750; Lin CY, 2013, MAR DRUGS, V11, P1336, DOI 10.3390/md11041336; MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111; Ochi A, 2012, J EXP MED, V209, P1671, DOI 10.1084/jem.20111706; Oketani K, 2001, EUR J PHARMACOL, V427, P159, DOI 10.1016/S0014-2999(01)01234-1; Park EY, 2012, J GINSENG RES, V36, P153, DOI 10.5142/jgr.2012.36.2.153; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Ramberg JE, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-54; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Su F, 2012, VACCINE, V30, P4106, DOI 10.1016/j.vaccine.2012.03.052; Tran TL, 2014, BIOORGAN MED CHEM, V22, P499, DOI 10.1016/j.bmc.2013.11.002; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wang Y, 2014, INT IMMUNOPHARMACOL, V23, P77, DOI 10.1016/j.intimp.2014.07.028; Wang ZZ, 2013, INT J BIOL MACROMOL, V53, P93, DOI 10.1016/j.ijbiomac.2012.11.009; Zhai LJ, 2011, VACCINE, V29, P5007, DOI 10.1016/j.vaccine.2011.04.097; Zhang GY, 2013, INT J BIOL MACROMOL, V53, P1, DOI 10.1016/j.ijbiomac.2012.10.031; Zhang W, 2014, MAR DRUGS, V12, P4148, DOI 10.3390/md12074148; Zhao BS, 2014, MOLECULES, V19, P16925, DOI 10.3390/molecules191016925; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	36	23	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130926	10.1371/journal.pone.0130926	http://dx.doi.org/10.1371/journal.pone.0130926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090808	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000160
J	Arukwe, A; Rosbak, R; Adeogun, AO; Langberg, HA; Venter, A; Myburgh, J; Botha, C; Benedetti, M; Regoli, F				Arukwe, Augustine; Rosbak, Randi; Adeogun, Aina O.; Langberg, Hakon A.; Venter, Annette; Myburgh, Jan; Botha, Christo; Benedetti, Maura; Regoli, Francesco			Biotransformation and Oxidative Stress Responses in Captive Nile Crocodile (Crocodylus niloticus) Exposed to Organic Contaminants from the Natural Environment in South Africa	PLOS ONE			English	Article							SALMON SALMO-SALAR; ALLIGATORS ALLIGATOR-MISSISSIPPIENSIS; WASTE-WATER CONTAMINANTS; KRUGER-NATIONAL-PARK; AMERICAN ALLIGATORS; REPRODUCTIVE-CYCLE; TRACE-ELEMENTS; RAT-LIVER; CYTOCHROME-P450; INDUCTION	In the present study, the biotransformation and oxidative stress responses in relation to chemical burden in the liver of male and female Nile crocodiles-Crocodylus niloticus-from a commercial crocodile farm passively exposed to various anthropogenic aquatic pollutants was investigated. In general, the data showed that male crocodiles consistently produced higher biotransformation and oxidative stress responses compared to females. Relationships between these responses and concentrations of aliphatic hydrocarbons and polycyclic aromatic hydrocarbons (PAHs) were also observed. Specifically, the catalytic assays for EROD and BROD (not PROD and MROD) showed sex-differences between male and female crocodiles and paralleled immunochemically determined CYP1A and CYP3A protein levels; the relatively similar levels of PAHs in both sexes suggest an estrogen-mediated reduction of this pathway in females. The antioxidant system exhibited higher levels in male crocodiles with slight or significant higher values for catalase (CAT), glutathione reductase (GR), glutathione peroxidases-H2O2 (GPx-H2O2), glutathione peroxidases-Cu (GPx-Cu), total antioxidant capacity towards peroxyl radicals (TOSC-ROO) and hydroxyl radicals (TOSC-HO), total glutathione (GSH) and malondialdehyde (MDA). On the other hand, the activities of acyl-CoA oxidase (AOX) and glutathione S-transferases (GST) were significantly higher in females. Principal component analysis (PCA) produced significant groupings that revealed correlative relationships (both positive and negative) between biotransformation/oxidative stress variables and liver PAHs and aliphatic hydrocarbon burden. The overall results suggest that these captive pre-slaughter crocodiles exhibited adverse exposure responses to anthropogenic aquatic contaminants with potentially relevant effects on key cellular pathways, and these responses may be established as relevant species biomarkers of exposure and effects in this endangered species.	[Arukwe, Augustine; Rosbak, Randi; Langberg, Hakon A.] Norwegian Univ Sci & Technol, NTNU, Dept Biol, N-7491 Trondheim, Norway; [Adeogun, Aina O.] Univ Ibadan, Dept Zool, Ibadan, Nigeria; [Venter, Annette; Myburgh, Jan; Botha, Christo] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa; [Benedetti, Maura; Regoli, Francesco] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy	Norwegian University of Science & Technology (NTNU); University of Ibadan; University of Pretoria; Marche Polytechnic University	Arukwe, A (corresponding author), Norwegian Univ Sci & Technol, NTNU, Dept Biol, N-7491 Trondheim, Norway.	arukwe@bio.ntnu.no	Botha, Christo/ABD-1162-2020; Benedetti, Maura/K-5399-2016; Arukwe, Augustine/ABD-4927-2020; Regoli, Francesco/K-2719-2018; Arukwe, Augustine/H-8497-2014; Langberg, Håkon/ABH-3090-2020	Benedetti, Maura/0000-0003-0803-3846; Arukwe, Augustine/0000-0002-2134-4799; Regoli, Francesco/0000-0001-6084-6188; Langberg, Håkon/0000-0002-6186-6962; Botha, Christo/0000-0003-1535-9270	National Research Foundation of South Africa; Norwegian Research Council	National Research Foundation of South Africa(National Research Foundation - South Africa); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work is based upon research supported by the National Research Foundation of South Africa (CB and JM) and the Norwegian Research Council (AA).	Almli B, 2005, SCI TOTAL ENVIRON, V337, P75, DOI 10.1016/j.scitotenv.2004.06.019; ANDERSSON T, 1992, AQUAT TOXICOL, V24, P1, DOI 10.1016/0166-445X(92)90014-E; Arukwe A, 1997, ENVIRON TOXICOL CHEM, V16, P2576, DOI [10.1897/1551-5028(1997)016&lt;2576:XASBEI&gt;2.3.CO;2, 10.1002/etc.5620161220]; Arukwe A, 2000, AQUAT TOXICOL, V49, P159, DOI 10.1016/S0166-445X(99)00083-1; Arukwe A, 1997, J EXP ZOOL, V277, P313, DOI 10.1002/(SICI)1097-010X(19970301)277:4&lt;313::AID-JEZ5&gt;3.0.CO;2-S; BINDOLI A, 1988, FREE RADICAL BIO MED, V5, P247, DOI 10.1016/0891-5849(88)90018-4; BLUME H, 1984, XENOBIOTICA, V14, P463, DOI 10.3109/00498258409151433; Bouwman H, 2014, ECOTOX ENVIRON SAFE, V104, P393, DOI 10.1016/j.ecoenv.2013.12.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKE MD, 1994, BIOCHEM PHARMACOL, V48, P923, DOI 10.1016/0006-2952(94)90363-8; CELANDER M, 1989, MAR ENVIRON RES, V28, P9, DOI 10.1016/0141-1136(89)90175-X; CHAN Z, 1995, ENVIRON TOXICOL CHEM, V14, P597, DOI 10.1002/etc.5620140407; Clark D., 2010, MOL BIOL; Croom E, 2012, PROG MOL BIOL TRANSL, V112, P31, DOI 10.1016/B978-0-12-415813-9.00003-9; Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4; Ertl RP, 1998, COMP BIOCHEM PHYS C, V121, P85, DOI 10.1016/S0742-8413(98)10032-4; FARBER JL, 1994, ENVIRON HEALTH PERSP, V102, P17, DOI 10.2307/3432207; Furtado OV, 2007, COMP BIOCHEM PHYS C, V146, P241, DOI 10.1016/j.cbpc.2006.11.017; Galloway TS, 2004, ENVIRON SCI TECHNOL, V38, P1723, DOI 10.1021/es030570+; Giuliani ME, 2013, AQUAT TOXICOL, V134, P120, DOI 10.1016/j.aquatox.2013.03.012; Giuliani ME, 2011, AQUAT TOXICOL, V134-135, P120, DOI [10.1016/j.aquatox.2011.01.006, DOI 10.1016/J.AQUATOX.2011.01.006]; GOKSOYR A, 1992, AQUAT TOXICOL, V22, P287, DOI 10.1016/0166-445X(92)90046-P; Gunderson MP, 2004, CHEMOSPHERE, V56, P335, DOI 10.1016/j.chemosphere.2004.01.020; HAASCH ML, 1994, BIOCHEM PHARMACOL, V47, P893, DOI 10.1016/0006-2952(94)90490-1; Hasselberg Linda, 2005, Comp Hepatol, V4, P2, DOI 10.1186/1476-5926-4-2; Hermes-Lima M, 2012, COMP BIOCHEM PHYS A, V163, P189, DOI 10.1016/j.cbpa.2012.06.006; Horai S, 2014, CHEMOSPHERE, V108, P159, DOI 10.1016/j.chemosphere.2014.01.031; JEWELL CSE, 1989, COMP BIOCHEM PHYS B, V92, P329, DOI 10.1016/0305-0491(89)90287-3; Kamat JP, 2000, TOXICOLOGY, V155, P55, DOI 10.1016/S0300-483X(00)00277-8; KLOTZ AV, 1986, ARCH BIOCHEM BIOPHYS, V249, P326, DOI 10.1016/0003-9861(86)90009-3; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; LARSEN HE, 1992, FISH PHYSIOL BIOCHEM, V10, P291, DOI 10.1007/BF00004478; Lech J J, 1984, Natl Cancer Inst Monogr, V65, P355; Lohmann R, 2007, ENVIRON POLLUT, V150, P150, DOI 10.1016/j.envpol.2007.06.051; Lushchak VI, 2001, AM J PHYSIOL-REG I, V280, pR100, DOI 10.1152/ajpregu.2001.280.1.R100; Miranda CL, 1991, BIOCHEM BIOPH RES CO, V1776, P558; Navas JM, 2000, AQUAT TOXICOL, V51, P79, DOI 10.1016/S0166-445X(00)00100-4; Neff J.M., 2002, BIOACCUMULATION MARI, P241; Oberholster PJ, 2008, ENVIRON POLLUT, V156, P184, DOI 10.1016/j.envpol.2007.12.028; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; POOLEY AC, 1976, SCI AM, V234, P114, DOI 10.1038/scientificamerican0476-114; Quattrochi LC, 2001, DRUG METAB DISPOS, V29, P615; Rauschenberger RH, 2009, J AQUAT ANIM HEALTH, V21, P249, DOI 10.1577/H07-051.1; Regoli F, 2014, MAR ENVIRON RES, V96, P92, DOI 10.1016/j.marenvres.2013.09.016; Regoli F, 2014, MAR ENVIRON RES, V93, P106, DOI 10.1016/j.marenvres.2013.07.006; Ripp SL, 2002, DRUG METAB DISPOS, V30, P570, DOI 10.1124/dmd.30.5.570; Ronis MJ, 2006, EXP BIOL MED, V231, P60; Sepulveda MS, 2004, J WILDLIFE DIS, V40, P782, DOI 10.7589/0090-3558-40.4.782; Skarydova L, 2012, DRUG METAB REV, V44, P173, DOI 10.3109/03602532.2011.638304; Sparling DW, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P1, DOI 10.1201/EBK1420064162; Stegeman J. J., 1993, CYTOCHROME P450 HDB, V105, P279; Stegeman John J., 1994, P87; Storey KB, 1996, BRAZ J MED BIOL RES, V29, P1715; Swanepoel D, 2000, ONDERSTEPOORT J VET, V67, P141; Taysse L, 1998, B ENVIRON CONTAM TOX, V60, P300, DOI 10.1007/s001289900625; Testa B, 2012, DRUG DISCOV TODAY, V17, P549, DOI 10.1016/j.drudis.2012.01.017; UENG TH, 1993, TOXICOL APPL PHARM, V119, P66, DOI 10.1006/taap.1993.1045; WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023; Wu T, 2014, CHEMOSPHERE, V110, P23, DOI 10.1016/j.chemosphere.2014.03.015; Zhou Z, 2014, ENVIRON SCI TECHNOL, V48, P1343, DOI 10.1021/es404185m; ZIMNIAK P, 1993, HDB EXPT PHARM, V105, P125	62	23	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130002	10.1371/journal.pone.0130002	http://dx.doi.org/10.1371/journal.pone.0130002			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086370	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500074
J	Thomsen, MS; Zwart, R; Ursu, D; Jensen, MM; Pinborg, LH; Gilmour, G; Wu, J; Sher, E; Mikkelsen, JD				Thomsen, Morten Skott; Zwart, Ruud; Ursu, Daniel; Jensen, Majbrit Myrup; Pinborg, Lars Hageman; Gilmour, Gary; Wu, Jie; Sher, Emanuele; Mikkelsen, Jens Damsgaard			alpha 7 and beta 2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties	PLOS ONE			English	Article							CHOLINERGIC NEURONS; ALZHEIMERS-DISEASE; SCHIZOPHRENIA; BUNGAROTOXIN; ANTIBODIES; BINDING; GENE; ASSOCIATION; SUITABILITY; ACTIVATION	The existence of alpha 7 beta 2 nicotinic acetylcholine receptors (nAChRs) has recently been demonstrated in both the rodent and human brain. Since alpha 7-containing nAChRs are promising drug targets for schizophrenia and Alzheimer's disease, it is critical to determine whether alpha 7 beta 2 nAChRs are present in the human brain, in which brain areas, and whether they differ functionally from alpha 7 nAChR homomers. We used alpha-bungarotoxin to affinity purify alpha 7-containing nAChRs from surgically excised human temporal cortex, and found that alpha 7 subunits co-purify with beta 2 subunits, indicating the presence of alpha 7 beta 2 nAChRs in the human brain. We validated these results by demonstrating co-purification of beta 2 from wild-type, but not alpha 7 or beta 2 knock-out mice. The pharmacology and kinetics of human alpha 7 beta 2 nAChRs differed significantly from that of alpha 7 homomers in response to nAChR agonists when expressed in Xenopus oocytes and HEK293 cells. Notably, alpha 7 beta 2 heteromers expressed in HEK293 cells display markedly slower rise and decay phases. These results demonstrate that alpha 7 subunits in the human brain form heteromeric complexes with beta 2 subunits, and that human alpha 7 beta 2 nAChR heteromers respond to nAChR agonists with a unique pharmacology and kinetic profile. alpha 7 beta 2 nAChRs thus represent an alternative mechanism for the reported clinical efficacy of alpha 7 nAChR ligands.	[Thomsen, Morten Skott; Jensen, Majbrit Myrup; Pinborg, Lars Hageman; Mikkelsen, Jens Damsgaard] Rigshosp, Univ Copenhagen Hosp, Neurobiol Res Unit, DK-2100 Copenhagen, Denmark; [Zwart, Ruud; Ursu, Daniel; Gilmour, Gary; Sher, Emanuele] Eli Lilly & Co Ltd, Lilly Res Ctr, Erl Wood Manor, England; [Pinborg, Lars Hageman] Rigshosp, Univ Copenhagen Hosp, Epilepsy Clin, DK-2100 Copenhagen, Denmark; [Wu, Jie] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ USA	Rigshospitalet; University of Copenhagen; Eli Lilly; Rigshospitalet; University of Copenhagen; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Mikkelsen, JD (corresponding author), Rigshosp, Univ Copenhagen Hosp, Neurobiol Res Unit, DK-2100 Copenhagen, Denmark.	jdm@nru.dk		Pinborg, Lars Hageman/0000-0001-9024-7936	Danish Strategic Research Council (COGNITO); Lundbeck Foundation; Eli Lilly and Company through the Lilly Research Award Program; Eli Lilly and Company	Danish Strategic Research Council (COGNITO); Lundbeck Foundation(Lundbeckfonden); Eli Lilly and Company through the Lilly Research Award Program; Eli Lilly and Company(Eli Lilly)	This work was supported by the Danish Strategic Research Council (COGNITO, JDM), the Lundbeck Foundation (JDM), Eli Lilly and Company through the Lilly Research Award Program (JDM). The funder Eli Lilly and Company provided support in the form of salaries for authors RZ, DU, GG & ES, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Azam L, 2003, NEUROSCIENCE, V119, P965, DOI 10.1016/S0306-4522(03)00220-3; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Brooks JM, 2012, NEUROPSYCHOPHARMACOL, V37, P2476, DOI 10.1038/npp.2012.106; Carson R, 2008, J MED GENET, V45, P244, DOI 10.1136/jmg.2007.052704; Carson R, 2008, NEUROMOL MED, V10, P377, DOI 10.1007/s12017-008-8048-8; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Criado M, 2012, J NEUROCHEM, V123, P504, DOI 10.1111/j.1471-4159.2012.07931.x; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gill JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055047; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Herber DL, 2004, J HISTOCHEM CYTOCHEM, V52, P1367, DOI 10.1369/jhc.4A6319.2004; Khiroug SS, 2002, J PHYSIOL-LONDON, V540, P425, DOI 10.1113/jphysiol.2001.013847; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Lendvai B, 2013, BRAIN RES BULL, V93, P86, DOI 10.1016/j.brainresbull.2012.11.003; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Liu Q, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-155; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; Moretti M, 2014, MOL PHARMACOL, V86, P306, DOI 10.1124/mol.114.093377; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Mowrey DD, 2013, J BIOL CHEM, V288, P35793, DOI 10.1074/jbc.M113.508333; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; Palma E, 1999, J BIOL CHEM, V274, P18335, DOI 10.1074/jbc.274.26.18335; Papke RL, 2009, COMB CHEM HIGH T SCR, V12, P38, DOI 10.2174/138620709787047975; Rommel FR, 2015, J HISTOCHEM CYTOCHEM, V63, P329, DOI 10.1369/0022155415575028; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Thomsen MS, 2012, CURR DRUG TARGETS, V13, P707, DOI 10.2174/138945012800399035; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Thomsen MS, 2009, NEUROPHARMACOLOGY, V56, P1001, DOI 10.1016/j.neuropharm.2009.02.003; Thomsen MS, 2014, BRAIN STRUCT FUNCT, V219, P1923, DOI 10.1007/s00429-013-0611-x; Zaborszky L, 2015, CEREB CORTEX, V25, P118, DOI 10.1093/cercor/bht210; Zwart R, 2002, NEUROPHARMACOLOGY, V43, P374, DOI 10.1016/S0028-3908(02)00094-1; Zwart R, 2014, EUR J PHARMACOL, V726, P77, DOI 10.1016/j.ejphar.2014.01.031	37	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130572	10.1371/journal.pone.0130572	http://dx.doi.org/10.1371/journal.pone.0130572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086615	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500115
J	Chardwiriyapreecha, S; Manabe, K; Iwaki, T; Kawano-Kawada, M; Sekito, T; Lunprom, S; Akiyama, K; Takegawa, K; Kakinuma, Y				Chardwiriyapreecha, Soracom; Manabe, Kunio; Iwaki, Tomoko; Kawano-Kawada, Miyuki; Sekito, Takayuki; Lunprom, Siriporn; Akiyama, Koichi; Takegawa, Kaoru; Kakinuma, Yoshimi			Functional Expression and Characterization of Schizosaccharomyces pombe Avt3p as a Vacuolar Amino Acid Exporter in Saccharomyces cerevisiae	PLOS ONE			English	Article							MEMBRANE-VESICLES; ACTIVE-TRANSPORT; PLASMA-MEMBRANE; FISSION; PROTEINS; HOMOLOG; FUSION; FAMILY; GENES; POOLS	In Saccharomyces cerevisiae, Avt3p and Avt4p mediate the extrusion of several amino acids from the vacuolar lumen into the cytosol. SpAvt3p of Schizosaccharomyces pombe, a homologue of these vacuolar amino acid transporters, has been indicated to be involved in spore formation. In this study, we confirmed that GFP-SpAvt3p localized to the vacuolar membrane in S. pombe. The amounts of various amino acids increased significantly in the vacuolar pool of avt3 Delta cells, but decreased in that of avt3(+)-overexpressing avt3. cells. These results suggest that SpAvt3p participates in the vacuolar compartmentalization of amino acids in S. pombe. To examine the export activity of SpAvt3p, we expressed the avt3(+) gene in S. cerevisiae cells. We found that the heterologously overproduced GFP-SpAvt3p localized to the vacuolar membrane in S. cerevisiae. Using the vacuolar membrane vesicles isolated from avt3+-overexpressing S. cerevisiae cells, we detected the export activities of alanine and tyrosine in an ATP-dependent manner. These activities were inhibited by the addition of a V-ATPase inhibitor, concanamycin A, thereby suggesting that the activity of SpAvt3p is dependent on a proton electrochemical gradient generated by the action of V-ATPase. In addition, the amounts of various amino acids in the vacuolar pools of S. cerevisiae cells were decreased by the overproduction of SpAvt3p, which indicated that SpAvt3p was functional in S. cerevisiae cells. Thus, SpAvt3p is a vacuolar transporter that is involved in the export of amino acids from S. pombe vacuoles.	[Chardwiriyapreecha, Soracom; Manabe, Kunio; Iwaki, Tomoko; Kawano-Kawada, Miyuki; Sekito, Takayuki; Lunprom, Siriporn; Akiyama, Koichi; Kakinuma, Yoshimi] Ehime Univ, Fac Agr, Lab Mol Physiol & Genet, Matsuyama, Ehime 790, Japan; [Kawano-Kawada, Miyuki; Lunprom, Siriporn; Akiyama, Koichi] Ehime Univ, Adv Res Support Ctr ADRES, Matsuyama, Ehime, Japan; [Takegawa, Kaoru] Kyushu Univ, Fac Agr, Appl Microbiol Lab, Fukuoka 812, Japan	Ehime University; Ehime University; Kyushu University	Kakinuma, Y (corresponding author), Ehime Univ, Fac Agr, Lab Mol Physiol & Genet, Matsuyama, Ehime 790, Japan.	ykaki@agr.ehime-u.ac.jp		KAWANO-KAWADA, Miyuki/0000-0002-1168-9291	Japan Society for the Promotion of Science [15H04486, 15K07396]; Public Foundation of Elizabeth Arnold-Fuji; Grants-in-Aid for Scientific Research [15K07396] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Public Foundation of Elizabeth Arnold-Fuji; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported partly by a Grant-in-Aid from the Japan Society for the Promotion of Science under a JSPS Postdoctoral Fellowship for Foreign Researchers (to S.C., http://www.jsps.go.jp/english/e-fellow/), the Public Foundation of Elizabeth Arnold-Fuji (to M.K-K., http://www.hoovers.com/company-information/cs/company-profile.ELIZABETH_ARNOLD_FUJI_ZAIDAN_PUBLIC_INTEREST_FOUNDATION.2896b931aa3892c4.html), and JSPS KAKENHI (https://www.jsps.go.jp/english/e-grants/) Grant Numbers 15H04486 (to Y.K.) and 15K07396 (to T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; Amberg DC., 2005, METHODS YEAST GENETI; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Chahomchuen T, 2009, J GEN APPL MICROBIOL, V55, P409, DOI 10.2323/jgam.55.409; Chardwiriyapreecha S, 2008, FEBS LETT, V582, P2225, DOI 10.1016/j.febslet.2008.05.017; Chardwiriyapreecha S, 2010, FEBS LETT, V584, P2339, DOI 10.1016/j.febslet.2010.04.012; Chardwiriyapreecha S, 2009, BIOSCI BIOTECH BIOCH, V73, P2090, DOI 10.1271/bbb.90319; Fujita Y, 2004, BIOSCI BIOTECH BIOCH, V68, P306, DOI 10.1271/bbb.68.306; Gachet Y, 2005, J CELL SCI, V118, P5525, DOI 10.1242/jcs.02656; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; Kashiwazaki J, 2009, TRAFFIC, V10, P912, DOI 10.1111/j.1600-0854.2009.00907.x; Kim Y, 2003, P NATL ACAD SCI USA, V100, P15458, DOI 10.1073/pnas.2136651100; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morita T, 2004, YEAST, V21, P613, DOI 10.1002/yea.1104; Mukaiyama H, 2010, FEBS LETT, V584, P1327, DOI 10.1016/j.febslet.2009.12.037; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nakase M, 2012, MICROBIOL-SGM, V158, P659, DOI 10.1099/mic.0.053389-0; OHSUMI Y, 1988, J BACTERIOL, V170, P2676, DOI 10.1128/jb.170.6.2676-2682.1988; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pongcharoen P, 2013, BIOSCI BIOTECH BIOCH, V77, P1988, DOI 10.1271/bbb.130387; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; SATO T, 1984, J BIOL CHEM, V259, P1505; Sekito T, 2008, IUBMB LIFE, V60, P519, DOI 10.1002/iub.92; Sekito T, 2014, BIOSCI BIOTECH BIOCH, V78, P1199, DOI 10.1080/09168451.2014.918489; Sekito T, 2014, BIOSCI BIOTECH BIOCH, V78, P969, DOI 10.1080/09168451.2014.910095; Shimazu M, 2005, J BIOL CHEM, V280, P4851, DOI 10.1074/jbc.M412617200; Sugimoto N, 2011, BIOSCI BIOTECH BIOCH, V75, P385, DOI 10.1271/bbb.100747; Sugimoto N, 2010, BIOSCI BIOTECH BIOCH, V74, P2166, DOI 10.1271/bbb.100627; Tone J, 2015, BIOSCI BIOTECH BIOCH, V79, P782, DOI 10.1080/09168451.2014.998621; Uemura T, 2004, BIOCHEM BIOPH RES CO, V315, P1082, DOI 10.1016/j.bbrc.2004.01.162; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WIEMKEN A, 1974, ARCH MICROBIOL, V101, P45, DOI 10.1007/BF00455924; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479	43	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130542	10.1371/journal.pone.0130542	http://dx.doi.org/10.1371/journal.pone.0130542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083598	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400148
J	Gozzi, GJ; Pires, ADA; Valdameri, G; Rocha, MEM; Martinez, GR; Noleto, GR; Acco, A; de Souza, CEA; Echevarria, A; dos Reis, CM; Di Pietro, A; Cadena, SMSC				Gozzi, Gustavo Jabor; Andrade Pires, Amanda do Rocio; Valdameri, Glaucio; Merlin Rocha, Maria Eliane; Martinez, Glaucia Regina; Noleto, Guilhermina Rodrigues; Acco, Alexandra; Alves de Souza, Carlos Eduardo; Echevarria, Aurea; dos Reis, Camilla Moretto; Di Pietro, Attilio; Suter Correia Cadena, Silvia Maria			Selective Cytotoxicity of 1,3,4-Thiadiazolium Mesoionic Derivatives on Hepatocarcinoma Cells (HepG2)	PLOS ONE			English	Article							HUMAN HEPATOMA HEPG2; ENERGY-LINKED FUNCTIONS; COMPOUND MI-D; MULTIDRUG-RESISTANCE; OXIDATIVE STRESS; IN-VITRO; APOPTOSIS; ACID; TRANSPORTER; EXPRESSION	In this work, we evaluated the cytotoxicity of mesoionic 4-phenyl-5-(2-Y, 4-X or 4-X-cinnamoyl)-1,3,4-thiadiazolium-2-phenylamine chloride derivatives (MI-J: X=OH, Y=H; MI-D: X=NO2, Y=H; MI-4F: X=F, Y=H; MI-2,4diF: X=Y=F) on human hepatocellular carcinoma (HepG2), and non-tumor cells (rat hepatocytes) for comparison. MI-J, M-4F and MI-2,4diF reduced HepG2 viability by similar to 50% at 25 mu M after 24-h treatment, whereas MI-D required a 50 mu M concentration, as shown by 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide assays. The cytotoxicity was confirmed with lactate dehydrogenase assay, of which activity was increased by 55, 24 and 16% for MI-J, MI-4F and MI-2,4diF respectively (at 25 mu M after 24 h). To identify the death pathway related to cytotoxicity, the HepG2 cells treated by mesoionic compounds were labeled with both annexin V and PI, and analyzed by flow cytometry. All compounds increased the number of doubly-stained cells at 25 mu M after 24 h: by 76% for MI-J, 25% for MI-4F and MI-2,4diF, and 11% for MI-D. It was also verified that increased DNA fragmentation occurred upon MI-J, MI-4F and MI-2,4diF treatments (by 12%, 9% and 8%, respectively, at 25 mu M after 24 h). These compounds were only weakly, or not at all, transported by the main multidrug transporters, P-glycoprotein, ABCG2 and MRP1, and were able to slightly inhibit their drug-transport activity. It may be concluded that 1,3,4-thiadiazolium compounds, especially the hydroxy derivative MI-J, constitute promising candidates for future investigations on in-vivo treatment of hepatocellular carcinoma.	[Gozzi, Gustavo Jabor; Andrade Pires, Amanda do Rocio; Valdameri, Glaucio; Merlin Rocha, Maria Eliane; Martinez, Glaucia Regina; Noleto, Guilhermina Rodrigues; Suter Correia Cadena, Silvia Maria] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil; [Acco, Alexandra; Alves de Souza, Carlos Eduardo] Univ Fed Parana, Dept Farmacol, BR-80060000 Curitiba, Parana, Brazil; [Echevarria, Aurea; dos Reis, Camilla Moretto] Univ Fed Rural Rio de Janeiro, Dept Quim, Rio De Janeiro, Brazil; [Di Pietro, Attilio] Univ Lyon 1, Equipe Labellisee Ligue 2014, BMSSI UMR CNRS 5086, IBCP, F-69365 Lyon, France	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Cadena, SMSC (corresponding author), Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil.	silvia.cadena@ufpr.br	NOLETO, GUILHERMINA R/J-5304-2015; Valdameri, Glaucio/A-8909-2013; Valdameri, Glaucio/G-8354-2017; Echevarria, Aurea/J-2694-2015; Valdameri, Glaucio/ABA-4792-2021; Cadena, Silvia MSC/C-2702-2013; Martinez, Glaucia Regina/I-3110-2016	NOLETO, GUILHERMINA R/0000-0001-6170-5272; Valdameri, Glaucio/0000-0003-1882-1512; Valdameri, Glaucio/0000-0003-1882-1512; Echevarria, Aurea/0000-0002-7330-676X; Valdameri, Glaucio/0000-0003-1882-1512; Cadena, Silvia MSC/0000-0003-4661-8458; Martinez, Glaucia Regina/0000-0002-2628-4406; MERLIN ROCHA, MARIA ELIANE/0000-0001-6790-9196	Brazilian research funding agency CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico); Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Brazilian research funding agency French National League against Cancer (Equipe Labellisee); CNRS; University of Lyon 1 [UMR5086]; Brazilian Agency (CNPq) [245762/2012-4]; Instituto do Milenio: Redoxoma, INCT de Processos Redox em Biomedicina-Redoxoma	Brazilian research funding agency CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico); Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Brazilian research funding agency French National League against Cancer (Equipe Labellisee); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lyon 1; Brazilian Agency (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto do Milenio: Redoxoma, INCT de Processos Redox em Biomedicina-Redoxoma	This study was supported by the Brazilian research funding agencies CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), and the French National League against Cancer (Equipe Labellisee 2014), CNRS and University of Lyon 1 (UMR5086). G.J.G. was supported by a sandwich Ph.D. fellowship from the Brazilian Agency (CNPq) (process numbers 245762/2012-4). G.R.M. also received financial support from the Instituto do Milenio: Redoxoma, INCT de Processos Redox em Biomedicina-Redoxoma.	Pires ADA, 2011, CHEM-BIOL INTERACT, V189, P17, DOI 10.1016/j.cbi.2010.09.030; Pires ADA, 2010, CHEM-BIOL INTERACT, V186, P1, DOI 10.1016/j.cbi.2010.04.001; Archana, 2004, BIOORGAN MED CHEM, V12, P1257, DOI 10.1016/j.bmc.2003.08.035; Balasubramaniyan V, 2007, BBA-GEN SUBJECTS, V1770, P1136, DOI 10.1016/j.bbagen.2007.04.009; Borght SV, 2008, LIVER INT, V28, P1370, DOI 10.1111/j.1478-3231.2008.01889.x; Bracht A., 2003, METODOS LABORATORIO, Vfirst, P275; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brito AF, 2014, MOL DIAGN THER; Cadena SMSC, 2002, CELL BIOCHEM FUNCT, V20, P31, DOI 10.1002/cbf.932; Cadena SMSC, 1998, FEBS LETT, V440, P46, DOI 10.1016/S0014-5793(98)01427-6; Carvalho SA, 2004, BIOORG MED CHEM LETT, V14, P5967, DOI 10.1016/j.bmcl.2004.10.007; Castaneda F, 2000, J CANCER RES CLIN, V126, P503, DOI 10.1007/s004320000119; Chandrakantha B, 2014, EUR J MED CHEM, V71, P316, DOI 10.1016/j.ejmech.2013.10.056; Cheng JW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0381-y; Cheung CSF, 2007, CANCER LETT, V253, P224, DOI 10.1016/j.canlet.2007.01.025; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; dos Santos ACS, 2001, MAGN RESON CHEM, V39, P182; Douglas RS, 1995, J IMMUNOL METHODS, V188, P219, DOI 10.1016/0022-1759(95)00216-2; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FDA, 2012, DRUG INT STUD STUD D; Grynberg N, 1997, ANTI-CANCER DRUG, V8, P88, DOI 10.1097/00001813-199701000-00012; Hall MD, 2009, TRENDS PHARMACOL SCI, V30, P546, DOI 10.1016/j.tips.2009.07.003; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hossain MA, 2012, INT J ONCOL, V40, P1298, DOI 10.3892/ijo.2011.1304; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jubie S, 2012, EUR J MED CHEM, V54, P931, DOI 10.1016/j.ejmech.2012.06.025; Khan I, 2010, EUR J MED CHEM, V45, P5200, DOI 10.1016/j.ejmech.2010.08.034; Kratz F, 2008, CHEMMEDCHEM, V3, P20, DOI 10.1002/cmdc.200700159; Kumar H, 2008, EUR J MED CHEM, V43, P2688, DOI 10.1016/j.ejmech.2008.01.039; Liu ZH, 2009, TOXICOL LETT, V187, P131, DOI 10.1016/j.toxlet.2009.02.012; Loong HH, 2014, ONCOTARGETS THER, V7, P575, DOI 10.2147/OTT.S46019; Martinez L, 2014, FEBS J, V281, P673, DOI 10.1111/febs.12613; Noguchi K, 2014, PHARMACOGN PERS MED, V7, P53, DOI 10.2147/PGPM.S38295; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Padhya KT, 2013, CURR OPIN GASTROEN, V29, P285, DOI 10.1097/MOG.0b013e32835ff1cf; Patterson Jr MK, 1973, TISSUE CULTURE METHO, P406; Raychaudhuri S, 2010, WORLD J CLIN ONCOL, V1, P24, DOI 10.5306/wjco.v1.i1.24; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Reataza M, 2014, FRONT MED; Reilly TP, 1998, BIOCHEM PHARMACOL, V55, P803, DOI 10.1016/S0006-2952(97)00547-9; Rieger Aja M, 2011, J Vis Exp, DOI 10.3791/2597; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Senff-Ribeiro A, 2004, BRIT J CANCER, V91, P297, DOI 10.1038/sj.bjc.6601946; Senff-Ribeiro A, 2004, ANTI-CANCER DRUG, V15, P269, DOI 10.1097/00001813-200403000-00012; Senff-Ribeiro A, 2003, MELANOMA RES, V13, P465, DOI 10.1097/00008390-200310000-00005; Seo S, 2007, CLIN CANCER RES, V13, P427, DOI 10.1158/1078-0432.CCR-06-1357; Shi JL, 2014, J HEPATOCELL CARCINO, V1, P1, DOI 10.2147/JHC.S44537; Stacy AE, 2013, MOL PHARMACOL, V84, P655, DOI 10.1124/mol.113.088609; Sukowati CHC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-160; Takahashi S, 2002, NEUROCHEM INT, V40, P441, DOI 10.1016/S0197-0186(01)00097-3; Tian Z, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-237; Uchibori K, 2012, INT J ONCOL, V40, P1005, DOI 10.3892/ijo.2011.1300; Uhl P, 2014, INT J MOL SCI, V15, P7500, DOI 10.3390/ijms15057500; Valdameri G, 2012, J MED CHEM, V55, P966, DOI 10.1021/jm201404w; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wu X, 2014, MOL CANC RES; Xiang QF, 2011, CELL ONCOL, V34, P33, DOI 10.1007/s13402-010-0003-7; Zheng LH, 2008, CANCER LETT, V272, P102, DOI 10.1016/j.canlet.2008.06.029; Zhu XH, 2010, CHEM BIOL DRUG DES, V76, P330, DOI 10.1111/j.1747-0285.2010.01017.x	61	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130046	10.1371/journal.pone.0130046	http://dx.doi.org/10.1371/journal.pone.0130046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083249	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400122
J	Guigueno, MF; MacDougall-Shackleton, SA; Sherry, DF				Guigueno, Melanie F.; MacDougall-Shackleton, Scott A.; Sherry, David F.			Sex Differences in Spatial Memory in Brown-Headed Cowbirds: Males Outperform Females on a Touchscreen Task	PLOS ONE			English	Article							EVOLUTION; COGNITION; ABILITY; INFORMATION; HIPPOCAMPUS; PEROMYSCUS; EXPRESSION; HYPOTHESIS; SELECTION; LOCATION	Spatial cognition in females and males can differ in species in which there are sex-specific patterns in the use of space. Brown-headed cowbirds are brood parasites that show a reversal of sex-typical space use often seen in mammals. Female cowbirds, search for, revisit and parasitize hosts nests, have a larger hippocampus than males and have better memory than males for a rewarded location in an open spatial environment. In the current study, we tested female and male cowbirds in breeding and non-breeding conditions on a touchscreen delayed-match-to-sample task using both spatial and colour stimuli. Our goal was to determine whether sex differences in spatial memory in cowbirds generalizes to all spatial tasks or is task-dependant. Both sexes performed better on the spatial than on the colour touchscreen task. On the spatial task, breeding males outperformed breeding females. On the colour task, females and males did not differ, but females performed better in breeding condition than in non-breeding condition. Although female cowbirds were observed to outperform males on a previous larger-scale spatial task, males performed better than females on a task testing spatial memory in the cowbirds' immediate visual field. Spatial abilities in cowbirds can favour males or females depending on the type of spatial task, as has been observed in mammals, including humans.	[Guigueno, Melanie F.; MacDougall-Shackleton, Scott A.; Sherry, David F.] Univ Western Ontario, Dept Biol, London, ON, Canada; [MacDougall-Shackleton, Scott A.; Sherry, David F.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Guigueno, Melanie F.; MacDougall-Shackleton, Scott A.; Sherry, David F.] Univ Western Ontario, Adv Facil Avian Res, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Guigueno, MF (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	mguiguen@uwo.ca	Sherry, David F/B-2551-2014; MacDougall-Shackleton, Scott A/C-6622-2008	Sherry, David F/0000-0001-6623-2232; MacDougall-Shackleton, Scott A/0000-0001-8518-765X	Natural Sciences and Engineering Research Council of Canada [217381, 105542]; American Ornithologists' Union	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); American Ornithologists' Union	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grants 217381 to S.A.M-S. and 105542 to D.F.S (http://www.nserc-crsng.gc.ca/index_eng.asp) Natural Sciences and Engineering Research Council of Canada Doctoral Postgraduate Scholarship to M.F.G. It was also supported by a research award from American Ornithologists' Union to M.F.G. (http://www.aou.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astie Andrea Alejandra, 1998, Animal Cognition, V1, P77, DOI 10.1007/s100710050011; Bailey DJ, 2013, ENDOCRINOLOGY, V154, P4707, DOI 10.1210/en.2013-1684; Balda R. P., 1997, CURR ORNITHOL, V13, P333; Bettis TJ, 2013, ANIM COGN, V16, P873, DOI 10.1007/s10071-013-0619-x; BRODBECK DR, 1995, J EXP PSYCHOL ANIM B, V21, P64, DOI 10.1037/0097-7403.21.1.64; Burns JG, 2011, P ROY SOC B-BIOL SCI, V278, P923, DOI 10.1098/rspb.2010.2488; Cole EF, 2012, CURR BIOL, V22, P1808, DOI 10.1016/j.cub.2012.07.051; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; DUFOUR KW, 1991, CAN J ZOOL, V69, P2686, DOI 10.1139/z91-377; Fernandez-Juricic E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058985; Galea LAM, 1996, J EXP BIOL, V199, P195; Gates JE, 1998, ECOL APPL, V8, P27, DOI 10.1890/1051-0761(1998)008[0027:CBITCA]2.0.CO;2; GAULIN SJC, 1989, ANIM BEHAV, V37, P322, DOI 10.1016/0003-3472(89)90121-8; GAULIN SJC, 1986, AM NAT, V127, P74, DOI 10.1086/284468; GAULIN SJC, 1990, J COMP PSYCHOL, V104, P88, DOI 10.1037/0735-7036.104.1.88; Gonzalez-Gomez PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090165; Guigueno MF, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0026; Guigueno MF, 2011, ANIM BEHAV, V81, P211, DOI 10.1016/j.anbehav.2010.10.005; Hampson E., 2008, SEX DIFFERENCES BRAI, P311; Hasenstaub A, 2010, P NATL ACAD SCI USA, V107, P12329, DOI 10.1073/pnas.0914886107; Healy SD, 2012, CURR BIOL, V22, pR840, DOI 10.1016/j.cub.2012.08.032; Herborn K, 2011, ANIM COGN, V14, P269, DOI 10.1007/s10071-010-0360-7; Hodgson ZG, 2005, ANIM COGN, V8, P211, DOI 10.1007/s10071-004-0249-4; Hodgson ZG, 2008, J COMP PHYSIOL A, V194, P963, DOI 10.1007/s00359-008-0369-4; JACOBS LF, 1990, P NATL ACAD SCI USA, V87, P6349, DOI 10.1073/pnas.87.16.6349; Jasarevic E, 2012, ANIM BEHAV, V84, P1141, DOI 10.1016/j.anbehav.2012.08.015; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; Jozet-Alves C, 2008, P ROY SOC B-BIOL SCI, V275, P2049, DOI 10.1098/rspb.2008.0501; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lowther PE., 1993, THE BIRDS OF NORTH A; McCarter RA, 2012, EXPERIMENTOR SOFTWAR; McGraw KJ, 2002, J EXP BIOL, V205, P3747; McGregor A, 1999, ANIM BEHAV, V58, P727, DOI 10.1006/anbe.1999.1190; Newman AEM, 2008, GEN COMP ENDOCR, V155, P503, DOI 10.1016/j.ygcen.2007.08.007; NORMAN RF, 1975, AUK, V92, P610, DOI 10.2307/4084631; Oberlander JG, 2004, HORM BEHAV, V45, P250, DOI 10.1016/j.yhbeh.2003.12.003; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Postma A, 2004, BRAIN COGNITION, V54, P24, DOI 10.1016/S0278-2626(03)00238-0; Pravosudov VV, 2013, ANNU REV ECOL EVOL S, V44, P173, DOI 10.1146/annurev-ecolsys-110512-135904; Reboreda JC, 1996, NEUROREPORT, V7, P505, DOI 10.1097/00001756-199601310-00031; Rodriguez CA, 2011, LEARN BEHAV, V39, P324, DOI 10.3758/s13420-011-0027-5; Rothstein S.I., 1986, Current Ornithology, V3, P127; Saldanha CJ, 2004, J COMP NEUROL, V469, P522, DOI 10.1002/cne.11035; Sherry DF, 2006, ANNU REV PSYCHOL, V57, P167, DOI 10.1146/annurev.psych.56.091103.070324; SHERRY DF, 1993, P NATL ACAD SCI USA, V90, P7839, DOI 10.1073/pnas.90.16.7839; SHERRY DF, 1987, PSYCHOL REV, V94, P439, DOI 10.1037/0033-295X.94.4.439; SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R; Shettleworth Sara J., 1998, P65, DOI 10.1016/B978-012077030-4/50055-6; Silverman I, 2000, EVOL HUM BEHAV, V21, P201, DOI 10.1016/S1090-5138(00)00036-2; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Sulikowski D, 2010, BEHAVIOUR, V147, P1461, DOI 10.1163/000579510X521564; Tello-Ramos MC, 2014, ANIM BEHAV, V93, P129, DOI 10.1016/j.anbehav.2014.04.036; Voyer D, 2007, PSYCHON B REV, V14, P23, DOI 10.3758/BF03194024; Washburn BE, 2007, CONDOR, V109, P181, DOI 10.1650/0010-5422(2007)109[181:UACAEI]2.0.CO;2; White DJ, 2009, PSYCHOL SCI, V20, P1140, DOI 10.1111/j.1467-9280.2009.02418.x; WILLIAMS CL, 1990, BEHAV NEUROSCI, V104, P84, DOI 10.1037/0735-7044.104.1.84; WILLIAMS CL, 1991, PSYCHONEUROENDOCRINO, V16, P155, DOI 10.1016/0306-4530(91)90076-6; Woolfenden BE, 2003, ANIM BEHAV, V66, P95, DOI 10.1006/anbe.2003.2181; Wyman MJ, 2013, J EVOLUTION BIOL, V26, P2070, DOI 10.1111/jeb.12188	59	25	25	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128302	10.1371/journal.pone.0128302	http://dx.doi.org/10.1371/journal.pone.0128302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083573	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400038
J	Nakano, S; Tsukimura, T; Togawa, T; Ohashi, T; Kobayashi, M; Takayama, K; Kobayashi, Y; Abiko, H; Satou, M; Nakahata, T; Warnock, DG; Sakuraba, H; Shibasaki, F				Nakano, Sachie; Tsukimura, Takahiro; Togawa, Tadayasu; Ohashi, Toya; Kobayashi, Masahisa; Takayama, Katsuyoshi; Kobayashi, Yukuharu; Abiko, Hiroshi; Satou, Masatsugu; Nakahata, Tohru; Warnock, David G.; Sakuraba, Hitoshi; Shibasaki, Futoshi			Rapid Immunochromatographic Detection of Serum Anti-alpha-Galactosidase A Antibodies in Fabry Patients after Enzyme Replacement Therapy	PLOS ONE			English	Article							AGALSIDASE-ALPHA; DISEASE; EFFICACY; STORAGE; SAFETY; TRIAL; BETA	We developed an immunochromatography-based assay for detecting antibodies against recombinant alpha-galactosidase A proteins in serum. The evaluation of 29 serum samples from Fabry patients, who had received enzyme replacement therapy with agalsidase alpha and/or agalsidase beta, was performed by means of this assay method, and the results clearly revealed that the patients exhibited the same level of antibodies against both agalsidase alpha and agalsidase beta, regardless of the species of recombinant alpha-galactosidase A used for enzyme replacement therapy. A conventional enzyme-linked immunosorbent assay supported the results. Considering these, enzyme replacement therapy with agalsidase alpha or agalsidase beta would generate antibodies against the common epitopes in both agalsidase alpha and agalsidase beta. Most of the patients who showed immunopositive reaction exhibited classic Fabry phenotype and harbored gene mutations affecting biosynthesis of alpha-galactosidase A. As immunochromatography is a handy and simple assay system which can be available at bedside, this assay method would be extremely useful for quick evaluation or first screening of serum antibodies against agalsidase alpha or agalsidase beta in Fabry disease with enzyme replacement therapy.	[Nakano, Sachie; Shibasaki, Futoshi] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, Tokyo 1568506, Japan; [Nakano, Sachie] Synthera Technol Co Ltd, Bunkyo Ku, Tokyo 1130021, Japan; [Tsukimura, Takahiro; Togawa, Tadayasu] Meiji Pharmaceut Univ, Dept Funct Bioanal, Tokyo 2048588, Japan; [Ohashi, Toya] Jikei Univ, Sch Med, Inst DNA Med, Dept Gene Therapy,Minato Ku, Tokyo 1058461, Japan; [Kobayashi, Masahisa] Jikei Univ, Sch Med, Dept Pediat, Minato Ku, Tokyo 1058461, Japan; [Takayama, Katsuyoshi; Kobayashi, Yukuharu] ADTEC Co Ltd, Usa City, Oita 8790471, Japan; [Abiko, Hiroshi] Nihonkai Gen Hosp, Sakata, Yamagata 9988501, Japan; [Satou, Masatsugu] Koujin Kai Kimachi Hosp, Aoba Ku, Sendai, Miyagi 9800801, Japan; [Nakahata, Tohru] Mutsu Gen Hosp, Mutsu, Aomori 0358601, Japan; [Warnock, David G.] Univ Alabama Birmingham, Sch Med, Div Nephrol, Birmingham, AL 35249 USA; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo 2048588, Japan	Tokyo Metropolitan Institute of Medical Science; Meiji Pharmaceutical University; Jikei University; Jikei University; University of Alabama System; University of Alabama Birmingham; Meiji Pharmaceutical University	Shibasaki, F (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	shibasaki-ft@igakuken.or.jp		Ohashi, Toya/0000-0002-9932-0631	Japan Society for the Promotion of Science KAKENHI [23659314, 25860399]; Tokyo Metropolitan Government; Program for Research on Intractable Diseases of Health and Labor Science Research [H22-Nanchi-Ippan-002]; Program for the Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation [09-15]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyo Metropolitan Government(Tokyo Metropolitan Government); Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation	This work was supported by grants from the Japan Society for the Promotion of Science KAKENHI, grant numbers 23659314 (F.S.), and 25860399 (T.T.), and by some part of the special grant from Tokyo Metropolitan Government; the Program for Research on Intractable Diseases of Health and Labor Science Research (ID: H22-Nanchi-Ippan-002, H.S.); the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (ID: 09-15, H.S.). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deegan PB, 2012, J INHERIT METAB DIS, V35, P227, DOI 10.1007/s10545-011-9400-y; Desnick RJ, 2001, METABOLIC MOL BASES, V8, P3733; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Ohashi T, 2007, MOL GENET METAB, V92, P271, DOI 10.1016/j.ymgme.2007.06.013; Ries M, 2006, PEDIATRICS, V118, P924, DOI 10.1542/peds.2005-2895; Rombach SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047805; Sakai-Tagawa Y, 2010, J CLIN MICROBIOL, V48, P2872, DOI 10.1128/JCM.00439-10; Sakurai A, 2012, VIRUSES-BASEL, V4, P1235, DOI 10.3390/v4081235; Sasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050670; Schellekens H, 2008, CLIN THER, V30, pS50, DOI 10.1016/S0149-2918(08)80041-0; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Tondel C, 2013, J AM SOC NEPHROL, V24, P137, DOI 10.1681/ASN.2012030316; Tsukimura T, 2014, MOLEC GENET METAB RE, V1, P288, DOI 10.1016/j.ymgmr.2014.07.005; Vedder AC, 2008, MOL GENET METAB, V94, P319, DOI 10.1016/j.ymgme.2008.03.003; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366	21	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128351	10.1371/journal.pone.0128351	http://dx.doi.org/10.1371/journal.pone.0128351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083343	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400043
J	Yin, ZH; Cui, ZG; Guan, P; Li, XL; Wu, W; Ren, YW; He, QC; Zhou, BS				Yin, Zhihua; Cui, Zhigang; Guan, Peng; Li, Xuelian; Wu, Wei; Ren, Yangwu; He, Qincheng; Zhou, Baosen			Interaction between Polymorphisms in Pre-MiRNA Genes and Cooking Oil Fume Exposure on the Risk of Lung Cancer in Chinese Non-Smoking Female Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; AIR-POLLUTION; NEVER SMOKERS; MICRORNAS; WOMEN; ADENOCARCINOMA; EXPRESSION; XRCC1	Background Both genetic polymorphisms and environmental risk factors play important roles in the development of human chronic diseases including lung cancer. This is the first case-control study of interaction between polymorphisms in pre-miRNA genes and cooking oil fume exposure on the risk of lung cancer. Methods A hospital-based case-control study of 258 cases and 310 controls was conducted. Six polymorphisms in miRNAs were determined by Taqman allelic discrimination method. The gene-environment interactions were assessed on both additive and multiplicative scale. The statistical analyses were performed mostly with SPSS. Results The combination of the risk genotypes of five miRNA SNPs (miR-146a rs2910164, miR-196a2 rs11614913, miR-608 rs4919510, miR-27a rs895819 and miR-423 rs6505162) with risk factor (cooking oil fume exposure) contributed to a significantly higher risk of lung cancer, and the corresponding ORs (95% confidence intervals) were 1.91 (1.04-3.52), 1.94 (1.16-3.25), 2.06 (1.22-3.49), 1.76 (1.03-2.98) and 2.13 (1.29-3.51). The individuals with both risk genotypes of miRNA SNPs and exposure to risk factor (cooking oil fumes) were in a higher risk of lung cancer than persons with only one of the two risk factors (ORs were 1.91, 1.05 and 1.41 for miR-146a rs2910164, ORs were 1.94, 1.23 and 1.34 for miR-196a2 rs11614913, ORs were 2.06, 1.41 and 1.68 for miR-608 rs4919510, ORs were 1.76, 0.82 and 1.07 for miR-27a rs895819, and ORs were 2.13, 1.15 and 1.02 for miR-423 rs6505162, respectively). All the measures of biological interaction indicate that there were not indeed biological interactions between the six SNPs of miRNAs and exposure to cooking oil fumes on an additive scale. Logistic models suggested that the gene-environment interactions were not statistically significant on a multiplicative scale. Conclusions The interactions between miRNA SNPs and cooking oil fume exposure suggested by ORs of different combination were not statistically significant.	[Yin, Zhihua; Guan, Peng; Li, Xuelian; Wu, Wei; Ren, Yangwu; He, Qincheng; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110013, Peoples R China; [Yin, Zhihua; Guan, Peng; Li, Xuelian; Wu, Wei; Ren, Yangwu; Zhou, Baosen] Univ Liaoning Prov, Key Lab Canc Etiol & Intervent, Shenyang 110013, Peoples R China; [Cui, Zhigang] China Med Univ, Shenyang 110013, Peoples R China	China Medical University; China Medical University	Zhou, BS (corresponding author), China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110013, Peoples R China.	bszhou@mail.cmu.edu.cn	Guan, Peng/GWM-9170-2022		National Natural Science Foundation of China [81102194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 81102194). ZY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Couraud S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/j.ejca.2012.03.007; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Granville CA, 2005, AM J RESP CELL MOL, V32, P169, DOI 10.1165/rcmb.F290; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Jeon HS, 2014, GENE, V534, P66, DOI 10.1016/j.gene.2013.10.014; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Ko YC, 2000, AM J EPIDEMIOL, V151, P140, DOI 10.1093/oxfordjournals.aje.a010181; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li MC, 2008, LUNG CANCER, V62, P145, DOI 10.1016/j.lungcan.2008.03.002; Ma Xj, 2008, Biomed Imaging Interv J, V4, pe39, DOI 10.2349/biij.4.3.e39; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Pallis AG, 2013, CRIT REV ONCOL HEMAT, V88, P494, DOI 10.1016/j.critrevonc.2013.06.011; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Saikia BJ, 2014, ASIAN PAC J CANCER P, V15, P1993, DOI 10.7314/APJCP.2014.15.5.1993; Seow WJ, 2014, CHIN J CANCER, V33, P471, DOI 10.5732/cjc.014.10132; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Tung YH, 2001, ENVIRON RES, V87, P47, DOI 10.1006/enrs.2001.4272; Wang G, 2014, TUMOR BIOL, V35, P2693, DOI 10.1007/s13277-013-1355-1; Wang XR, 2009, ANN ONCOL, V20, P746, DOI 10.1093/annonc/mdn699; Wu C, 2002, J CHINA PUBLIC HLTH, V18, P137; Yin ZH, 2013, ASIAN PAC J CANCER P, V14, P6519, DOI 10.7314/APJCP.2013.14.11.6519; Yin ZH, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0114-5; Yin ZH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-153; Yu ITS, 2006, CANCER RES, V66, P4961, DOI 10.1158/0008-5472.CAN-05-2932; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; [张晖 Zhang Hui], 2002, 卫生研究, V31, P238; Zhou BS, 2000, ONCOL REP, V7, P1253	35	38	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128572	10.1371/journal.pone.0128572	http://dx.doi.org/10.1371/journal.pone.0128572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083623	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400058
J	Baker, CP; Kulkarni, B; Radhakrishna, KV; Charyulu, MS; Gregson, J; Matsuzaki, M; Taylor, AE; Prabhakaran, D; Mamidi, RS; Wells, J; Wilkinson, I; McEniery, C; Yasmin; Smith, GD; Ben-Shlomo, Y; Kuper, H; Kinra, S				Baker, Christopher Paul; Kulkarni, Bharati; Radhakrishna, K. V.; Charyulu, M. S.; Gregson, John; Matsuzaki, Mika; Taylor, Amy E.; Prabhakaran, Dorairaj; Mamidi, Raja Sriswan; Wells, Jonathan; Wilkinson, Ian; McEniery, Carmel; Yasmin; Smith, George Davey; Ben-Shlomo, Yoav; Kuper, Hannah; Kinra, Sanjay			Is the Association between Vitamin D and Cardiovascular Disease Risk Confounded by Obesity? Evidence from the Andhra Pradesh Children and Parents Study (APCAPS)	PLOS ONE			English	Article							MENDELIAN RANDOMIZATION; PARATHYROID-HORMONE; 25-HYDROXYVITAMIN D; D DEFICIENCY; OLDER MEN; PREVALENCE; MORTALITY; METAANALYSIS; OUTCOMES; INDIANS	Background Evidence of an association between serum vitamin D and cardiovascular disease risk is inconsistent and comes predominantly from studies in high-income settings. We assessed the association between serum levels of 25-hydroxyvitamin D-3 (25(OH) D) and cardiovascular disease risk factors in a population of young Indian adults. Methods Cross-sectional analyses of data from APCAPS (Andhra Pradesh Children and Parents Study); a prospective birth cohort study in rural south India. Participants were 1038 (40.3% females) adults aged 18-24 years. Main outcome measures were blood pressures, fasting serum lipids (cholesterols and triglycerides), fasting glucose, insulin, measures of arterial stiffness (aortic augmentation index and aortic pulse wave velocity (aPWV)), carotid intima-media thickness, body mass index (BMI) and body fat (dual X-ray absorptiometry). Results Vitamin D deficiency (<= 20ng/ml) was observed in 41.1% of this lean (mean BMI: 19.5) and active (mean minutes of moderate or vigorous physical activity per day: 186) population. Vitamin D deficiency was associated with higher median body fat in both males (15.9% body fat in vitamin D deficient males vs. 14.6% in non-deficient males, p<0.05) and females (29.1% body fat in vitamin D deficient females vs. 27.8% in non-deficient females, p<0.05) but no associations were observed between vitamin D deficiency and mean BMI or median fat mass index (FMI). Except a weak inverse association with fasting insulin in males, there was no clear association between serum vitamin D levels and cardiovascular disease risk factors in fully adjusted models. Conclusions We did not find clear evidence for an association between serum vitamin D levels and cardiovascular disease risk factors. Our results, consistent with the limited evidence from randomised trials of vitamin D supplementation and Mendelian randomisation experiments, suggest that the postulated link between serum vitamin D and cardiovascular disease may be non-causal. Instead, it may be attributable to confounding by lifestyle factors such as obesity and physical inactivity which may provide more fruitful targets for cardiovascular disease prevention.	[Baker, Christopher Paul; Gregson, John; Matsuzaki, Mika; Kinra, Sanjay] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Kulkarni, Bharati; Radhakrishna, K. V.; Charyulu, M. S.; Mamidi, Raja Sriswan] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Taylor, Amy E.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Wells, Jonathan] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London, England; [Wilkinson, Ian; McEniery, Carmel; Yasmin] Univ Cambridge, Div Expt Med & Immunotherapeut, Cambridge, England; [Smith, George Davey; Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Kuper, Hannah] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); University of Bristol; University of London; University College London; University of Cambridge; University of Bristol; University of London; London School of Hygiene & Tropical Medicine	Baker, CP (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England.	chris.baker@lshtm.ac.uk	Davey Smith, George/A-7407-2013; Ben-Shlomo, Yoav/ABD-2004-2021; Mamidi, Raja/AAG-4801-2019; Prabhakaran, Dorairaj/B-4147-2011; Kulkarni, Bharati/ABB-3188-2020; Wells, Jonathan/A-4604-2009	Davey Smith, George/0000-0002-1407-8314; Ben-Shlomo, Yoav/0000-0001-6648-3007; Prabhakaran, Dorairaj/0000-0002-3172-834X; Kulkarni, Bharati/0000-0003-0636-318X; wilkinson, ian/0000-0001-6598-9399; Wells, Jonathan/0000-0003-0411-8025; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Bhogadi, Santhi/0000-0002-7713-8804	Indian Council of Medical Research; US Agency for International Development; Royal College of Physicians, United Kingdom; Wellcome Trust (United Kingdom) [083707]; MRC [MC_UU_12013/1] Funding Source: UKRI; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); US Agency for International Development(United States Agency for International Development (USAID)); Royal College of Physicians, United Kingdom; Wellcome Trust (United Kingdom)(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The Hyderabad Nutrition Trial was funded jointly by the Indian Council of Medical Research and the US Agency for International Development. The first follow-up study (2003-2005) was funded by a personal fellowship to SK (Eden Fellowship in Paediatrics, granted by the Royal College of Physicians, United Kingdom), and the second follow-up study (2009-2010) was funded by the Wellcome Trust (United Kingdom) (Grant: 083707; Principal Investigator: HK). The National Institute of Nutrition (Indian Council of Medical Research) provided infrastructural support.	Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Afzal S, 2014, LANCET DIABETES ENDO, V2, P298, DOI 10.1016/S2213-8587(13)70200-6; Annuzzi G, 2012, CURR ATHEROSCLER REP, V14, P525, DOI 10.1007/s11883-012-0281-9; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bolland MJ, 2010, AM J CLIN NUTR, V91, P82, DOI 10.3945/ajcn.2009.28424; Cawthon PM, 2010, J CLIN ENDOCR METAB, V95, P4625, DOI 10.1210/jc.2010-0638; CLEMENS TL, 1982, LANCET, V1, P74; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goswami R, 2000, AM J CLIN NUTR, V72, P472; Grandi NC, 2010, PREV MED, V51, P228, DOI 10.1016/j.ypmed.2010.06.013; Gunta SS, 2013, NAT REV NEPHROL, V9, P337, DOI 10.1038/nrneph.2013.74; Harinarayan CV, 2007, AM J CLIN NUTR, V85, P1062, DOI 10.1093/ajcn/85.4.1062; Harvey NC, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4695; Hickson SS, 2009, HYPERTENS RES, V32, P1079, DOI 10.1038/hr.2009.154; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kienreich K, 2013, NUTRIENTS, V5, P3005, DOI 10.3390/nu5083005; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; Kinra S, 2014, INT J EPIDEMIOL, V43, P1417, DOI 10.1093/ije/dyt128; Macro IIfPSIaO, 2000, NAT FAM HLTH SURV NF; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477, DOI 10.1093/ajcn/82.2.477; Miettinen ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100235; Parker J, 2010, MATURITAS, V65, P225, DOI 10.1016/j.maturitas.2009.12.013; Pilz S, 2011, CLIN ENDOCRINOL, V75, P575, DOI 10.1111/j.1365-2265.2011.04147.x; Pilz S, 2009, CLIN ENDOCRINOL, V71, P666, DOI 10.1111/j.1365-2265.2009.03548.x; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; Scragg R, 1992, Ann Epidemiol, V2, P697; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Sokol SI, 2011, CARDIOL REV, V19, P192, DOI 10.1097/CRD.0b013e31821da9a5; Sullivan R, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-13; Taylor AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051042; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Vupputuri MR, 2006, AM J CLIN NUTR, V83, P1411; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Zargar AH, 2007, POSTGRAD MED J, V83, P713, DOI 10.1136/pgmj.2007.059113	40	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129468	10.1371/journal.pone.0129468	http://dx.doi.org/10.1371/journal.pone.0129468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079685	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000356542300023
J	Sommerauer, M; Graf, C; Schafer, N; Huber, G; Schneider, P; Wuthrich, R; Schmid, C; Steinert, H				Sommerauer, Michael; Graf, Carmen; Schaefer, Niklaus; Huber, Gerhard; Schneider, Paul; Wuethrich, Rudolf; Schmid, Christoph; Steinert, Hans			Sensitivity and Specificity of Dual-Isotope Tc-99m-Tetrofosmin and I-123 Sodium Iodide Single Photon Emission Computed Tomography (SPECT) in Hyperparathyroidism	PLOS ONE			English	Article							PARATHYROID SCINTIGRAPHY; SECONDARY HYPERPARATHYROIDISM; TC-99M-SESTAMIBI SPECT/CT; PHASE TC-99M-SESTAMIBI; C-11-METHIONINE PET/CT; SUBTRACTION SPECT; SESTAMIBI; SURGERY; I-123/TC-99M-SESTAMIBI; EXPLORATIONS	Purpose Despite recommendations for Tc-99m-tetrofosmin dual tracer imaging for hyperparathyroidism in current guidelines, no report was published on dual-isotope Tc-99m-tetrofosmin and I-123 sodium iodide single-photon-emission-computed-tomography (SPECT). We evaluated diagnostic accuracy and the impact of preoperative SPECT on the surgical procedures and disease outcomes. Methods Analysis of 70 consecutive patients with primary hyperparathyroidism and 20 consecutive patients with tertiary hyperparathyroidism. Imaging findings were correlated with surgical results. Concomitant thyroid disease, pre- and postoperative laboratory measurements, histopathological results, type and duration of surgery were assessed. Results In primary hyperparathyroidism, SPECT had a sensitivity of 80% and a positive predictive value of 93% in patient-based analysis. Specificity was 99% in lesion-based analysis. Patients with positive SPECT elicit higher levels of parathyroid hormone and higher weight of resected parathyroids than SPECT-negative patients. Duration of parathyroid surgery was on average, approximately 40 minutes shorter in SPECT-positive than in SPECT-negative patients (89 +/- 46 vs. 129 +/- 41 minutes, p=0.006); 86% of SPECT-positive and 50% of SPECT-negative patients had minimal invasive surgery (p = 0.021). SPECT had lower sensitivity (60%) in patients with tertiary hyperparathyroidism; however, 90% of these patients had multiple lesions and all of these patients had bilateral lesions. Conclusion Dual-isotope SPECT with Tc-99m-tetrofosmin and I-123 sodium iodide has a high diagnostic value in patients with primary hyperparathyroidism and allows for saving of operation time. Higher levels of parathyroid hormone and higher glandular weight facilitated detection of parathyroid lesion. Diagnostic accuracy of preoperative imaging was lower in patients with tertiary hyperparathyroidism.	[Sommerauer, Michael; Graf, Carmen; Schaefer, Niklaus; Steinert, Hans] Univ Zurich Hosp, Dept Nucl Med, CH-8091 Zurich, Switzerland; [Huber, Gerhard] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland; [Schneider, Paul] Univ Zurich Hosp, Dept Gen Visceral & Transplant Surg, CH-8091 Zurich, Switzerland; [Wuethrich, Rudolf] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Schmid, Christoph] Univ Zurich Hosp, Div Endocrinol & Diabetol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Sommerauer, M (corresponding author), Univ Zurich Hosp, Dept Nucl Med, Ramistr 100, CH-8091 Zurich, Switzerland.	michael.sommerauer@usz.ch		Schmid, Christoph/0000-0003-2080-4439; Schaefer, Niklaus/0000-0002-9732-7696				Ciappuccini R, 2012, CLIN NUCL MED, V37, P223, DOI 10.1097/RLU.0b013e31823362e5; Dewberry LK, 2014, AM SURGEON, V80, P646; Fahy BN, 2002, ARCH SURG-CHICAGO, V137, P917, DOI 10.1001/archsurg.137.8.917; Fjeld JG, 1997, J NUCL MED, V38, P831; Gayed IW, 2005, J NUCL MED, V46, P248; Harris L, 2008, HEAD NECK-J SCI SPEC, V30, P509, DOI 10.1002/hed.20727; Hassler S, 2014, CLIN NUCL MED, V39, P32, DOI 10.1097/RLU.0000000000000272; Hindie E, 2000, ARCH SURG-CHICAGO, V135, P1461, DOI 10.1001/archsurg.135.12.1461; Hindie E, 1999, LANCET, V353, P2200, DOI 10.1016/S0140-6736(98)09089-8; Hindie E, 2009, EUR J NUCL MED MOL I, V36, P1201, DOI 10.1007/s00259-009-1131-z; Lavely WC, 2007, J NUCL MED, V48, P1084, DOI 10.2967/jnumed.107.040428; Leslie WD, 2002, EUR J NUCL MED MOL I, V29, P1566, DOI 10.1007/s00259-002-0944-9; Mihai R, 2009, LANGENBECK ARCH SURG, V394, P765, DOI 10.1007/s00423-009-0534-4; Neumann DR, 2008, J NUCL MED, V49, P2012, DOI 10.2967/jnumed.108.054858; Neumann DR, 1997, AM J ROENTGENOL, V169, P1671, DOI 10.2214/ajr.169.6.9393188; Neumann DR, 1998, J CLIN ENDOCR METAB, V83, P3867, DOI 10.1210/jc.83.11.3867; Pattou F, 1998, BRIT J SURG, V85, P1605; Quak E, 2013, J CLIN ENDOCR METAB, V98, P3111, DOI 10.1210/jc.2013-2084; Rink T, 2002, J NUCL MED, V43, P1175; Schalin-Jantti C, 2013, J NUCL MED, V54, P739, DOI 10.2967/jnumed.112.109561; Schmidt MC, 2011, CLIN NUCL MED, V36, P1153, DOI 10.1097/RLU.0b013e31823360ee; Solorzano CC, 2008, ARCH SURG-CHICAGO, V143, P659, DOI 10.1001/archsurg.143.7.659; Swanson TW, 2010, AM J SURG, V199, P614, DOI 10.1016/j.amjsurg.2010.02.001; Taieb D, 2012, CLIN NUCL MED, V37, P568, DOI 10.1097/RLU.0b013e318251e408; Torney MVU, 2012, SURG ENDOSC, V26, P2579, DOI 10.1007/s00464-012-2236-1; Tunninen Virpi, 2013, Int J Mol Imaging, V2013, P921260, DOI 10.1155/2013/921260; Udelsman R, 2002, ANN SURG, V235, P665, DOI 10.1097/00000658-200205000-00008; Udelsman R, 2000, ANN SURG, V232, P331, DOI 10.1097/00000658-200009000-00005; UDEN P, 1992, WORLD J SURG, V16, P791, DOI 10.1007/BF02067389; Ugur O, 2006, OTOLARYNG HEAD NECK, V134, P316, DOI 10.1016/j.otohns.2005.08.010	30	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129194	10.1371/journal.pone.0129194	http://dx.doi.org/10.1371/journal.pone.0129194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079132	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000356542300018
J	van der Meer, S; Jacquemyn, H				van der Meer, Sascha; Jacquemyn, Hans			Genetic Diversity and Spatial Genetic Structure of the Grassland Perennial Saxifraga granulata along Two River Systems	PLOS ONE			English	Article							RIPARIAN PLANT; POPULATION; PATTERNS; FLOW; DIFFERENTIATION; METAPOPULATION; EXTINCTION; CONSERVATION; CONSEQUENCES; DISPERSAL	Due to changes in land use, the natural habitats of an increasing number of plant species have become more and more fragmented. In landscapes that consist of patches of suitable habitat, the frequency and extent of long-distance seed dispersal can be expected to be an important factor determining local genetic diversity and regional population structure of the remaining populations. In plant species that are restricted to riparian habitats, rivers can be expected to have a strong impact on the dynamics and spatial genetic structure of populations as they may enable long-distance seed dispersal and thus maintain gene flow between fragmented populations. In this study, we used polymorphic microsatellite markers to investigate the genetic diversity and the spatial genetic structure of 28 populations of Saxifraga granulata along two rivers in central Belgium. We hypothesized that rivers might be essential for gene flow among increasingly isolated populations of this species. Genetic diversity was high (H-S = 0.68), which to a certain extent can be explained by the octoploid nature of S. granulata in the study area. Populations along the Dijle and Demer rivers were also highly differentiated (G ''(ST) = 0.269 and 0.164 and D-EST = 0.190 and 0.124, respectively) and showed significant isolation-by-distance, indicating moderate levels of gene flow primarily between populations that are geographically close to each other. Along the river Demer population genetic diversity was higher upstream than downstream, suggesting that seed dispersal via the water was not the primary mode of dispersal. Overall, these results indicate that despite increasing fragmentation populations along both rivers were highly genetically diverse. The high ploidy level and longevity of S. granulata have most likely buffered negative effects of fragmentation on genetic diversity and the spatial genetic structure of populations in riparian grasslands.	[van der Meer, Sascha; Jacquemyn, Hans] Katholieke Univ Leuven, Lab Plant Conservat & Populat Biol, Heverlee, Belgium	KU Leuven	van der Meer, S (corresponding author), Katholieke Univ Leuven, Lab Plant Conservat & Populat Biol, Kasteelpark Arenberg 31 Bus 02435, Heverlee, Belgium.	sascha.vandermeer@bio.kuleuven.be	Jacquemyn, Hans/AAC-4875-2019	Jacquemyn, Hans/0000-0001-9600-5794	Fonds Wetenschappelijk onderzoek project [11G1715N]; European Research Council ERC starting grant [260601 - MYCASOR]	Fonds Wetenschappelijk onderzoek project; European Research Council ERC starting grant(European Research Council (ERC))	This work was supported by the Fonds Wetenschappelijk onderzoek project 11G1715N to SM (http://www.fwo.be/), and the European Research Council ERC starting grant 260601 - MYCASOR to HJ (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 1998, MOL ECOL, V7, P1371, DOI 10.1046/j.1365-294x.1998.00485.x; Andersson S, 1996, HEREDITY, V77, P217, DOI 10.1038/hdy.1996.127; Bauwens W, 1985, WATER, V23, P125; Breckpot M, 2013, CONTROL ENG PRACT, V21, P1776, DOI 10.1016/j.conengprac.2013.08.008; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; De Becker P, 1999, APPL VEG SCI, V2, P215, DOI 10.2307/1478985; De Becker P, 2013, ADVIES BETREFFENDE V; De Becker P, 2006, ATLAS FLORA VLAADERE, P799; De Silva HN, 2005, HEREDITY, V95, P327, DOI 10.1038/sj.hdy.6800728; De Vries H, 2006, WAARNEMINGEN; DeWoody J, 2004, CONSERV GENET, V5, P603, DOI 10.1007/s10592-004-1985-3; HANSEN JEL, 1994, NORD J BOT, V14, P257, DOI 10.1111/j.1756-1051.1994.tb00597.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Higgins SI, 2002, J ECOL, V90, P616, DOI 10.1046/j.1365-2745.2002.00694.x; Honnay O, 2009, J ECOL, V97, P131, DOI 10.1111/j.1365-2745.2008.01452.x; Honnay O, 2010, J BIOGEOGR, V37, P1730, DOI 10.1111/j.1365-2699.2010.02331.x; Imbert E, 2003, J ECOL, V91, P447, DOI 10.1046/j.1365-2745.2003.00772.x; INBO, 2006, ROD LIJST HOG PLANT; James EA, 2013, FRESHWATER BIOL, V58, P2102, DOI 10.1111/fwb.12194; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2012, TUTORIAL SPATIAL ANA; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kudoh H, 1997, AM J BOT, V84, P1285, DOI 10.2307/2446054; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; LANDE R, 1992, EVOLUTION, V46, P381, DOI 10.1111/j.1558-5646.1992.tb02046.x; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Liu YF, 2006, AM J BOT, V93, P206, DOI 10.3732/ajb.93.2.206; Lundqvist E, 2001, HEREDITAS, V135, P75, DOI 10.1111/j.1601-5223.2001.00075.x; Markwith SH, 2007, AM J BOT, V94, P151, DOI 10.3732/ajb.94.2.151; MARSDENJONES EM, 1947, J GENET, V48, P206, DOI 10.1007/BF02989381; Meirmans PG, 2013, HEREDITY, V110, P131, DOI 10.1038/hdy.2012.80; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; MOODY ME, 1993, GENETICS, V134, P649; Munzbergova Z, 2013, PLANT BIOLOGY, V15, P195, DOI 10.1111/j.1438-8677.2012.00601.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NILSSON C, 1989, ECOLOGY, V70, P77, DOI 10.2307/1938414; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Pollux BJA, 2007, MOL ECOL, V16, P313, DOI 10.1111/j.1365-294X.2006.03146.x; Prentis PJ, 2008, FRESHWATER BIOL, V53, P973, DOI 10.1111/j.1365-2427.2008.01953.x; QGIS Development Team, 2009, QGIS GEOGR INF SYST; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RITLAND K, 1989, CAN J BOT, V67, P2017, DOI 10.1139/b89-255; Russell JR, 1999, MOL ECOL, V8, P199, DOI 10.1046/j.1365-294X.1999.00551.x; Schleuning M, 2011, J ECOL, V99, P373, DOI 10.1111/j.1365-2745.2010.01775.x; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smulders MJM, 2008, FOREST ECOL MANAG, V255, P1388, DOI 10.1016/j.foreco.2007.10.063; Soons MB, 2008, J ECOL, V96, P619, DOI 10.1111/j.1365-2745.2008.01372.x; Tero N, 2003, MOL ECOL, V12, P2073, DOI 10.1046/j.1365-294X.2003.01898.x; Trapnell DW, 2011, J HERED, V102, P473, DOI 10.1093/jhered/esr045; van der Meer S, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400040; Van Looy K, 2006, J BIOGEOGR, V33, P1615, DOI 10.1111/j.1365-2699.2006.01536.x; Van Looy K, 2009, BIOL CONSERV, V142, P870, DOI 10.1016/j.biocon.2008.12.006; Walisch TJ, 2012, AM J BOT, V99, P1300, DOI 10.3732/ajb.1100479; Ward JV, 1998, BIOL CONSERV, V83, P269, DOI 10.1016/S0006-3207(97)00083-9; Werth S, 2014, FRESHWATER BIOL, V59, P2502, DOI 10.1111/fwb.12449; Werth S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099400; Wetzel RG, 2001, MORPHOLOGY FLOW RIVE, VThird, P18; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	64	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130463	10.1371/journal.pone.0130463	http://dx.doi.org/10.1371/journal.pone.0130463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079603	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300044
J	Bouman, AC; ten Cate-Hoek, AJ; Ramaekers, BLT; Joore, MA				Bouman, A. C.; ten Cate-Hoek, A. J.; Ramaekers, B. L. T.; Joore, M. A.			Sample Size Estimation for Non-Inferiority Trials: Frequentist Approach versus Decision Theory Approach	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; RANDOMIZED CONTROLLED-TRIALS; POSTTHROMBOTIC SYNDROME; INFORMATION ANALYSIS; VENOUS THROMBOSIS; EXPECTED VALUE; COMPRESSION STOCKINGS; PULMONARY-EMBOLISM; ECONOMIC BURDEN; CLINICAL-TRIALS	Background Non-inferiority trials are performed when the main therapeutic effect of the new therapy is expected to be not unacceptably worse than that of the standard therapy, and the new therapy is expected to have advantages over the standard therapy in costs or other (health) consequences. These advantages however are not included in the classic frequentist approach of sample size calculation for non-inferiority trials. In contrast, the decision theory approach of sample size calculation does include these factors. The objective of this study is to compare the conceptual and practical aspects of the frequentist approach and decision theory approach of sample size calculation for non-inferiority trials, thereby demonstrating that the decision theory approach is more appropriate for sample size calculation of non-inferiority trials. Methods The frequentist approach and decision theory approach of sample size calculation for non-inferiority trials are compared and applied to a case of a non-inferiority trial on individually tailored duration of elastic compression stocking therapy compared to two years elastic compression stocking therapy for the prevention of post thrombotic syndrome after deep vein thrombosis. Results The two approaches differ substantially in conceptual background, analytical approach, and input requirements. The sample size calculated according to the frequentist approach yielded 788 patients, using a power of 80% and a one-sided significance level of 5%. The decision theory approach indicated that the optimal sample size was 500 patients, with a net value of (sic)92 million. Conclusions This study demonstrates and explains the differences between the classic frequentist approach and the decision theory approach of sample size calculation for non-inferiority trials. We argue that the decision theory approach of sample size estimation is most suitable for sample size calculation of non-inferiority trials.	[Bouman, A. C.; Ramaekers, B. L. T.; Joore, M. A.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment KEMT, NL-6200 MD Maastricht, Netherlands; [Bouman, A. C.; ten Cate-Hoek, A. J.] Maastricht Univ, Med Ctr, Lab Thrombosis & Hemostasis, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University	Bouman, AC (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment KEMT, NL-6200 MD Maastricht, Netherlands.	annemieke.bouman@maastrichtuniversity.nl		Ramaekers, Bram/0000-0001-5785-9228; Joore, Manuela/0000-0002-5649-6768	Zorgonderzoek Nederland/Medische Wetenschappen (ZonMW) the Netherlands [171102007]	Zorgonderzoek Nederland/Medische Wetenschappen (ZonMW) the Netherlands	AB, AtC, and MJ received funding from Zorgonderzoek Nederland/Medische Wetenschappen (ZonMW) (http://www.zonmw.nl/nl/) the Netherlands grant number 171102007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; [Anonymous], 2006, STAT MED, V25, P1628; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Blattler W, 1999, Wien Med Wochenschr, V149, P61; Boivin A, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.034835; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Briggs A, 2006, DECISION MODELLING H; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2012, LANCET, V379, P123, DOI 10.1016/S0140-6736(11)61505-5; Buxton MJ, 2006, PHARMACOECONOMICS, V24, P1133, DOI 10.2165/00019053-200624110-00009; Caprini JA, 2003, VALUE HEALTH, V6, P59, DOI 10.1046/j.1524-4733.2003.00204.x; Casparie A F, 1998, Ned Tijdschr Geneeskd, V142, P2075; Claxton K, 1996, HEALTH ECON, V5, P513, DOI 10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO;2-9; Claxton K, 2013, CHE RESEARCH PAPER 8; DETSKY AS, 1985, J CHRON DIS, V38, P753, DOI 10.1016/0021-9681(85)90118-3; Eckermann S, 2007, HEALTH ECON, V16, P195, DOI 10.1002/hec.1161; Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012; Gelderblom GJ, 2005, KOUSEN UITTREKHULPMI; Grutters JPC, 2011, ONCOLOGIST, V16, P1752, DOI 10.1634/theoncologist.2011-0029; Julious SA, 2011, STAT METHODS MED RES, V20, P595, DOI 10.1177/0962280210378945; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kent S, 2013, INT J TECHNOL ASSESS, V29, P435, DOI 10.1017/S0266462313000433; KIND P, 1999, 172 U YORK CTR HLTH; Koerkamp BG, 2008, RADIOLOGY, V246, P420, DOI [10.1148/radiol.2462070093, 10.1148/radio1.2462070093]; Koerkamp BG, 2010, VALUE HEALTH, V13, P242, DOI 10.1111/j.1524-4733.2009.00656.x; Krahn M, 2008, JAMA-J AM MED ASSOC, V300, P436, DOI 10.1001/jama.300.4.436; Laster LL, 2006, STAT MED, V25, P1115, DOI 10.1002/sim.2476; Laster LL, 2003, STAT MED, V22, P187, DOI 10.1002/sim.1137; Lindley DV, 1997, J ROY STAT SOC D-STA, V46, P129; MacDougall DA, 2006, AM J HEALTH-SYST PH, V63, pS5, DOI 10.2146/ajhp060388; McKenna C, 2011, MED DECIS MAKING, V31, P853, DOI 10.1177/0272989X11399921; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Oostenbrink JB, 2002, PHARMACOECONOMICS, V20, P443, DOI 10.2165/00019053-200220070-00002; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Ramacciotti E, 2006, THROMB RES, V118, P699, DOI 10.1016/j.thromres.2005.12.005; Retel VP, 2013, VALUE HEALTH, V16, P720, DOI 10.1016/j.jval.2013.04.013; Roberts M, 2012, VALUE HEALTH, V15, P804, DOI 10.1016/j.jval.2012.06.016; Rothmann Mark D, 2003, J Biopharm Stat, V13, P565, DOI 10.1081/BIP-120022775; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Smith RD, 2005, HEALTH POLICY, V74, P77, DOI 10.1016/j.healthpol.2004.12.009; Soonawala D, 2010, INT J EPIDEMIOL, V39, P1567, DOI 10.1093/ije/dyq136; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; ten Cate-Hoek AJ, 2009, J THROMB HAEMOST, V7, P2042, DOI 10.1111/j.1538-7836.2009.03627.x; Ten Cate-Hoek AJ, 2014, BMJ OPEN; ten Cate-Hoek AJ, 2010, J VASC SURG, V52, P132, DOI 10.1016/j.jvs.2010.01.089; Thariani R, 2013, J COMP EFFECT RES, V2, P325, DOI [10.2217/CER.13.15, 10.2217/cer.13.15]; Welton NJ, 2011, RHEUMATOLOGY, V50, piv19, DOI 10.1093/rheumatology/ker242; Willan AR, 2007, CLIN TRIALS, V4, P279, DOI 10.1177/1740774507079237; Zorgverzekeringen Cv, 2004, HANDLEIDING KOSTENON	52	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130531	10.1371/journal.pone.0130531	http://dx.doi.org/10.1371/journal.pone.0130531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6HU	26076354	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900177
J	Li, SH; Wang, QX; Sun, P; Li, Q; Yang, ZY; Shi, M; Wei, W; Guo, RP				Li Shaohua; Wang Qiaoxuan; Sun Peng; Li Qing; Yang Zhongyuan; Shi Ming; Wei Wei; Guo Rongping			Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis	PLOS ONE			English	Article							ARTERIAL INFUSION CHEMOTHERAPY; LONG-TERM OUTCOMES; MAJOR PORTAL-VEIN; NATURAL-HISTORY; PROGNOSTIC-FACTORS; RESECTION; SURVIVAL; EFFICACY; INVASION; CHEMOEMBOLIZATION	Background Portal/hepatic vein tumor thrombosis (PVTT/HVTT) in hepatocellular carcinoma (HCC) is a sign of advanced stage disease and is associated with poor prognosis. This study investigated the surgical outcomes of patients with HCC and PVTT/HVTT to determine the most appropriate surgical treatment strategy for these patients. Materials and Methods The study population included 77 HCC patients from January 2004 to June 2009 who underwent hepatectomy in our department and were diagnosed with PVTT/HVTT based on pathological examination. The patients were divided into two groups: in group 1, PVTT/HVTT was located in the hepatic resection area and removed with the tumor en bloc (38 cases); in group 2, PVTT/x HVTT was beyond the resection line and removed by suction or thrombectomy (39 cases). Concerning the factor of surgical margins, the patients were further divided into four subgroups: group 1A: patients in group 1 with surgical margins <= 1 cm (28 cases); group 1B: patients in group 1 with surgical margins >1 cm (9 cases); group 2A: patients in group 2 with surgical margins <= 1 cm (28 cases); and group 2B: patients in group 2 with surgical margins >1 cm (9 cases). Results Most of the characteristics of groups 1 and 2 were similar. Patients in group 2 had significantly higher median blood loss (p=0.002) and higher blood transfusion rate (p=0.002) during the operation, which were not considered prognostic factors (p=0.323 and 0.571, respectively). The median overall survival (OS) duration in group 1 was significantly longer than that in group 2 (14.3 vs. 10.4 months, p=0.047). The median OS durations in groups 1A, 1B, 2A, and 2B were 14.3, 42.7, 7.5, and 18.0 months, respectively, which were significantly different (p=0.018). Conclusions When PVTT/HVTT is located in the hepatic resection area and removed with the tumor en bloc, the median OS duration is longer. Based on this finding, widening the surgical margins when technically possible may increase OS.	[Li Shaohua; Shi Ming; Wei Wei; Guo Rongping] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Li Shaohua; Wang Qiaoxuan; Sun Peng; Li Qing; Yang Zhongyuan; Shi Ming; Wei Wei; Guo Rongping] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Wang Qiaoxuan] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun Peng] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesia, Guangzhou 510275, Guangdong, Peoples R China; [Li Qing] Sun Yat Sen Univ, Ctr Canc, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China; [Yang Zhongyuan] Sun Yat Sen Univ, Ctr Canc, Dept Head & Neck Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wei, W (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China.	weiwei@sysucc.org.cn; guorp@sysucc.org.cn		Guo, Rongping/0000-0003-2799-3463	Science and Technology Planning Project of Guangdong Province [2013B021800159]; Guangzhou Municipal Science and Technology Project of China [2012J4100078]	Science and Technology Planning Project of Guangdong Province; Guangzhou Municipal Science and Technology Project of China	This study was supported by Science and Technology Planning Project of Guangdong Province (No. 2013B021800159) and Guangzhou Municipal Science and Technology Project of China (No. 2012J4100078).	Aldrighetti L, 2009, ANN SURG ONCOL, V16, P1254, DOI 10.1245/s10434-009-0383-y; Amitrano L, 2004, J HEPATOL, V40, P736, DOI 10.1016/j.jhep.2004.01.001; Ando E, 2002, CANCER-AM CANCER SOC, V95, P588, DOI 10.1002/cncr.10694; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; CALVET X, 1990, J HEPATOL, V10, P311, DOI 10.1016/0168-8278(90)90138-H; Chen JS, 2012, J SURG RES, V175, P243, DOI 10.1016/j.jss.2011.03.072; Chen XP, 2006, ANN SURG ONCOL, V13, P940, DOI 10.1245/ASO.2006.08.007; Cheong JY, 2005, HEPATOL RES, V32, P127, DOI 10.1016/j.hepres.2005.01.015; Chok KSH, 2014, WORLD J SURG, V38, P490, DOI 10.1007/s00268-013-2290-4; CHUNG JW, 1995, AM J ROENTGENOL, V165, P315, DOI 10.2214/ajr.165.2.7618547; COHEN J, 1992, AM J MED, V92, P173, DOI 10.1016/0002-9343(92)90109-O; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Eshkenazy Rony, 2014, Hepatobiliary Surg Nutr, V3, P303, DOI 10.3978/j.issn.2304-3881.2014.09.08; Fan J, 2005, WORLD J GASTROENTERO, V11, P1215, DOI 10.3748/wjg.v11.i8.1215; Fatourou Evangelia M, 2014, Hepatobiliary Surg Nutr, V3, P415, DOI 10.3978/j.issn.2304-3881.2014.07.01; Georgiades CS, 2005, J VASC INTERV RADIOL, V16, P1653, DOI 10.1097/01.RVI.0000182185.47500.7A; Ikai I, 2006, J AM COLL SURGEONS, V202, P431, DOI 10.1016/j.jamcollsurg.2005.11.012; Itamoto T, 2002, J SURG ONCOL, V80, P143, DOI 10.1002/jso.10116; Kauffmann Rondi, 2014, Hepatobiliary Surg Nutr, V3, P238, DOI 10.3978/j.issn.2304-3881.2014.09.01; Kim JM, 2013, WORLD J SURG ONCOL, V11; Le Treut YP, 2006, J GASTROINTEST SURG, V10, P855, DOI 10.1016/j.gassur.2005.12.011; Lin CS, 2006, JPN J CLIN ONCOL, V36, P212, DOI 10.1093/jjco/hyl006; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Minagawa M, 2001, ANN SURG, V233, P379, DOI 10.1097/00000658-200103000-00012; Minagawa M, 2006, WORLD J GASTROENTERO, V12, P7561, DOI 10.3748/wjg.v12.i47.7561; Niguma T, 2005, J HEPATO-BILIARY-PAN, V12, P249, DOI 10.1007/s00534-004-0969-5; NONAMI T, 1992, HEPATOLOGY, V16, P1195, DOI 10.1016/0270-9139(92)90014-Z; Ohkubo T, 2000, J AM COLL SURGEONS, V191, P657, DOI 10.1016/S1072-7515(00)00740-7; OKADA S, 1992, HEPATOLOGY, V16, P112, DOI 10.1002/hep.1840160119; Ota H, 2005, BRIT J CANCER, V93, P557, DOI 10.1038/sj.bjc.6602742; Pawarode A, 1998, AM J CLIN ONCOL-CANC, V21, P386, DOI 10.1097/00000421-199808000-00014; Pawlik TM, 2005, SURGERY, V137, P403, DOI 10.1016/j.surg.2004.12.012; Peng BG, 2009, AM J SURG, V198, P313, DOI 10.1016/j.amjsurg.2008.09.026; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; RAOUL JL, 1994, J NUCL MED, V35, P1782; Salem R, 2010, GASTROENTEROLOGY, V138, P52, DOI 10.1053/j.gastro.2009.09.006; Sangro B, 2011, HEPATOLOGY, V54, P868, DOI 10.1002/hep.24451; Shi J, 2011, J HEPATO-BIL-PAN SCI, V18, P74, DOI 10.1007/s00534-010-0314-0; Song DS, 2014, J GASTROENTEROL; Takizawa D, 2007, DIGEST DIS SCI, V52, P3290, DOI 10.1007/s10620-007-9808-2; Tarantino L, 2006, ABDOM IMAGING, V31, P537, DOI 10.1007/s00261-005-0150-x; VILANA R, 1993, AM J ROENTGENOL, V160, P1285, DOI 10.2214/ajr.160.6.8388621; YAMADA R, 1983, RADIOLOGY, V148, P397, DOI 10.1148/radiology.148.2.6306721; Zeng ZC, 2005, INT J RADIAT ONCOL, V61, P432, DOI 10.1016/j.ijrobp.2004.05.025	45	35	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0130021	10.1371/journal.pone.0130021	http://dx.doi.org/10.1371/journal.pone.0130021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076461	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900124
J	Liu, JHK; Mansouri, K; Weinreb, RN				Liu, John H. K.; Mansouri, Kaweh; Weinreb, Robert N.			Estimation of 24-Hour Intraocular Pressure Peak Timing and Variation Using a Contact Lens Sensor	PLOS ONE			English	Article							PRIMARY OPEN-ANGLE; 20-4-HOUR PATTERN; GLAUCOMA PATIENTS; HEALTHY-SUBJECTS; RHYTHM; POSITION; EYES	Purpose To compare estimates of 24-hour intraocular pressure (IOP) peak timing and variation obtained using a contact lens sensor (CLS) and using a pneumatonometer. Methods Laboratory data collected from 30 healthy volunteers (ages, 20-66 years) in a randomized, controlled clinical trial were analyzed. Participants were housed for 24 hours in a sleep laboratory. One randomly selected right or left eye was fitted with a CLS that monitored circumferential curvature in the corneoscleral region related to the change of IOP. Electronic output signals of 30 seconds were averaged and recorded every 5 minutes. In the contralateral eye, habitual IOP measurements were taken using a pneumatonometer once every two hours. Simulated 24-hour rhythms in both eyes were determined by cosinor fitting. Simulated peak timings (acrophases) and simulated data variations (amplitudes) were compared between the paired eyes. Results Bilateral change patterns of average 24-hour data for the group were in parallel. The simulated peak timing in the CLS fitted eye occurred at 4: 44 AM +/- 210 min (mean +/- SD) and the IOP peak timing in the contralateral eye at 4: 11 AM +/- 120 min (P=0.256, Wilcoxon signed-rank test). There was no significant correlation between the simulated data variations in the paired eyes (P=0.820, linear regression). Conclusions The 24-hour CLS data showed a simulated peak timing close to the 24-hour IOP peak timing obtained using the pneumatonometer. However, the simulated variations of 24-hour data in the paired eyes were not correlated. Estimated 24-hour IOP rhythms using the two devices should not be considered interchangeable.	[Liu, John H. K.; Mansouri, Kaweh; Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Mansouri, Kaweh] Univ Hosp Geneva, Div Ophthalmol, Glaucoma Sect, Geneva, Switzerland	University of California System; University of California San Diego; University of Geneva	Liu, JHK (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA.	joliu@ucsd.edu			Sensimed AG, Lausanne, Switzerland	Sensimed AG, Lausanne, Switzerland	This study utilized data from a clinical trial sponsored by Sensimed AG, Lausanne, Switzerland (JHKL). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnifili L, 2015, ACTA OPHTHALMOL, V93, pE14, DOI 10.1111/aos.12408; Aptel F, 2014, JAMA OPHTHALMOL, V132, P1232, DOI 10.1001/jamaophthalmol.2014.1761; Bagga H, 2009, CURR OPIN OPHTHALMOL, V20, P79, DOI 10.1097/ICU.0b013e32831eef4f; Barkana Y, 2006, ARCH OPHTHALMOL-CHIC, V124, P793, DOI 10.1001/archopht.124.6.793; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Currie BD, 2011, J GLAUCOMA, V20, P465, DOI 10.1097/IJG.0b013e3181f46324; De Smedt S, 2012, J GLAUCOMA, V21, P539, DOI 10.1097/IJG.0b013e31821dac43; Faschinger C, 2013, JAMA OPHTHALMOL, V131, P696, DOI 10.1001/jamaophthalmol.2013.2874; Freiberg FJ, 2012, ACTA OPHTHALMOL, V90, pE534, DOI 10.1111/j.1755-3768.2012.02495.x; Grippo TM, 2013, INVEST OPHTH VIS SCI, V54, P512, DOI 10.1167/iovs.12-10709; Hubanova R, 2014, ACTA OPHTHALMOL, V92, pE119, DOI 10.1111/aos.12241; Kida T, 2006, INVEST OPHTH VIS SCI, V47, P4422, DOI 10.1167/iovs.06-0507; Lee YR, 2012, INVEST OPHTH VIS SCI, V53, P881, DOI 10.1167/iovs.11-7846; Leonardi M, 2004, INVEST OPHTH VIS SCI, V45, P3113, DOI 10.1167/iovs.04-0015; Leonardi M, 2009, ACTA OPHTHALMOL, V87, P433, DOI 10.1111/j.1755-3768.2008.01404.x; Liu H, 2011, ARCH OPHTHALMOL-CHIC, V129, P269, DOI 10.1001/archophthalmol.2011.4; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666; Liu JHK, 1998, INVEST OPHTH VIS SCI, V39, P2707; Liu JHK, 1999, INVEST OPHTH VIS SCI, V40, P2912; Liu JHK, 2014, INVEST OPHTH VIS SCI, V55, P7398, DOI 10.1167/iovs.14-14464; Liu JHK, 2011, BRIT J OPHTHALMOL, V95, P599, DOI 10.1136/bjo.2010.199737; Lorenz K, 2013, J GLAUCOMA, V22, P311, DOI 10.1097/IJG.0b013e318241b874; Malihi M, 2012, OPHTHALMOLOGY, V119, P987, DOI 10.1016/j.ophtha.2011.11.024; Mansouri K, 2008, BRIT J OPHTHALMOL, V92, P332, DOI 10.1136/bjo.2007.123042; Mansouri K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125530; Mansouri K, 2012, INVEST OPHTH VIS SCI, V53, P8050, DOI 10.1167/iovs.12-10569; Mansouri K, 2012, ARCH OPHTHALMOL-CHIC, V130, P1534, DOI [10.1001/archophthalmol.2012.2280, 10.1001/jamaophthalmol.2013.1350]; Mansouri K, 2012, INVEST OPHTH VIS SCI, V53, P112, DOI 10.1167/iovs.11-8763; Mansouri K, 2011, BRIT J OPHTHALMOL, V95, P627, DOI 10.1136/bjo.2010.192922; Mottet B, 2013, JAMA OPHTHALMOL, V131, P1507, DOI 10.1001/jamaophthalmol.2013.5297; Mottet B, 2012, INVEST OPHTH VIS SCI, V53, P8186, DOI 10.1167/iovs.12-10877; Pajic B, 2011, CURR EYE RES, V36, P1129, DOI 10.3109/02713683.2011.608240; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Quaranta L, 2013, SURV OPHTHALMOL, V58, P26, DOI 10.1016/j.survophthal.2012.05.003; Sit AJ, 2009, J GLAUCOMA, V18, P272, DOI 10.1097/IJG.0b013e3181862490; Sultan MB, 2009, SURV OPHTHALMOL, V54, P643, DOI 10.1016/j.survophthal.2009.05.001; Todani A, 2011, INVEST OPHTH VIS SCI, V52, P9573, DOI 10.1167/iovs.11-7878; Tojo N, 2014, GRAEF ARCH CLIN EXP, V252, P1463, DOI 10.1007/s00417-014-2666-7; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Zar JH., 2010, BIOSTAT ANAL, V5th	40	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129529	10.1371/journal.pone.0129529	http://dx.doi.org/10.1371/journal.pone.0129529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076472	Green Published, gold			2022-12-26	WOS:000356329900080
J	Sheth, SA; Iavarone, AT; Liebeskind, DS; Won, SJ; Swanson, RA				Sheth, Sunil A.; Iavarone, Anthony T.; Liebeskind, David S.; Won, Seok Joon; Swanson, Raymond A.			Targeted Lipid Profiling Discovers Plasma Biomarkers of Acute Brain Injury	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INFARCT VOLUME; WHITE-MATTER; SPHINGOLIPIDS; INTERVENTION; ASSOCIATION; GUIDELINES; PROGNOSIS	Prior efforts to identify a blood biomarker of brain injury have relied almost exclusively on proteins; however their low levels at early time points and poor correlation with injury severity have been limiting. Lipids, on the other hand, are the most abundant molecules in the brain and readily cross the blood-brain barrier. We previously showed that certain sphingolipid (SL) species are highly specific to the brain. Here we examined the feasibility of using SLs as biomarkers for acute brain injury. A rat model of traumatic brain injury (TBI) and a mouse model of stroke were used to identify candidate SL species though our mass-spectrometry based lipid profiling approach. Plasma samples collected after TBI in the rat showed large increases in many circulating SLs following injury, and larger lesions produced proportionately larger increases. Plasma samples collected 24 hours after stroke in mice similarly revealed a large increase in many SLs. We constructed an SL score (sum of the two SL species showing the largest relative increases in the mouse stroke model) and then evaluated the diagnostic value of this score on a small sample of patients (n = 14) who presented with acute stroke symptoms. Patients with true stroke had significantly higher SL scores than patients found to have non-stroke causes of their symptoms. The SL score correlated with the volume of ischemic brain tissue. These results demonstrate the feasibility of using lipid biomarkers to diagnose brain injury. Future studies will be needed to further characterize the diagnostic utility of this approach and to transition to an assay method applicable to clinical settings.	[Sheth, Sunil A.; Liebeskind, David S.] Univ Calif Los Angeles, Comprehens Stroke Ctr, Los Angeles, CA 90095 USA; [Sheth, Sunil A.; Liebeskind, David S.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Chem Mass Spectrometry Facil QB3, Berkeley, CA 94720 USA; [Won, Seok Joon; Swanson, Raymond A.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Neurol & Rehabil Serv, San Francisco, CA 94143 USA; [Won, Seok Joon; Swanson, Raymond A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Sheth, SA (corresponding author), Univ Calif Los Angeles, Comprehens Stroke Ctr, Los Angeles, CA 90095 USA.	ssheth@post.harvard.edu			NIH [NS041421]; Department of Defense (RAS) [W81XWH-13-2-0091]; Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081149, R01NS041421] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (RAS); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the NIH (NS041421), Department of Defense (RAS, grant W81XWH-13-2-0091) and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Adibhatla RM, 2006, AAPS J, V8, pE314; Ahmad O, 2012, CEREBROVASC DIS, V33, P47, DOI 10.1159/000332810; Anand N, 2005, CEREBROVASC DIS; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dassan P, 2009, CEREBROVASC DIS, V27, P295, DOI 10.1159/000199468; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Jain M, 2014, AM J PHYSIOL-ENDOC M, V306, pE854, DOI 10.1152/ajpendo.00371.2013; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kuntz M, 2014, J CEREBR BLOOD F MET, V34, P95, DOI 10.1038/jcbfm.2013.169; Laskowitz DT, 2009, STROKE, V40, P77, DOI 10.1161/STROKEAHA.108.516377; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Nicoli F, 2014, NEURORADIOLOGY, V56, P117, DOI 10.1007/s00234-013-1310-2; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; O'Brien J. S, 1965, J LIPID RES; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; ROUSER G, 1965, J AM OIL CHEM SOC, V42, P404, DOI 10.1007/BF02635576; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752; Won SJ, 2011, ANN NEUROL, V70, P583, DOI 10.1002/ana.22538; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	38	39	40	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129735	10.1371/journal.pone.0129735	http://dx.doi.org/10.1371/journal.pone.0129735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076478	gold, Green Published			2022-12-26	WOS:000356329900098
J	Cordeiro, TN; Garcia, J; Bernado, P; Millet, O; Pons, M				Cordeiro, Tiago N.; Garcia, Jesus; Bernado, Pau; Millet, Oscar; Pons, Miquel			A Three-protein Charge Zipper Stabilizes a Complex Modulating Bacterial Gene Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrostatics; gene silencing; nuclear magnetic resonance (NMR); protein dynamic; protein-protein interaction; horizontal gene transfer; charge zipper complexes; nucleoid-associated proteins	PARAMAGNETIC RELAXATION ENHANCEMENT; HORIZONTALLY ACQUIRED DNA; HHA-LIKE PROTEINS; H-NS; ESCHERICHIA-COLI; BIOLOGICAL MACROMOLECULES; CHEMICAL-EXCHANGE; BIOFILM FORMATION; EXPRESSION; YMOA	Background: The complex between Hha and H-NS selective represses genes in Enterobacteria acquired by horizontal transfer. Results: A structural model for the regulatory complex is described. Conclusion: A charge zipper formed by interdigitation of residues from three proteins stabilizes the complex. Significance: Charge zippers provide selectivity to electrostatic protein complexes. Understanding selective gene silencing may help fighting antibiotic resistance. The Hha/YmoA nucleoid-associated proteins help selectively silence horizontally acquired genetic material, including pathogenicity and antibiotic resistance genes and their maintenance in the absence of selective pressure. Members of the Hha family contribute to gene silencing by binding to the N-terminal dimerization domain of H-NS and modifying its selectivity. Hha-like proteins and the H-NS N-terminal domain are unusually rich in charged residues, and their interaction is mostly electrostatic-driven but, nonetheless, highly selective. The NMR-based structural model of the complex between Hha/YmoA and the H-NS N-terminal dimerization domain reveals that the origin of the selectivity is the formation of a three-protein charge zipper with interdigitated complementary charged residues from Hha and the two units of the H-NS dimer. The free form of YmoA shows collective microsecond-millisecond dynamics that can by measured by NMR relaxation dispersion experiments and shows a linear dependence with the salt concentration. The number of residues sensing the collective dynamics and the population of the minor form increased in the presence of H-NS. Additionally, a single residue mutation in YmoA (D43N) abolished H-NS binding and the dynamics of the apo-form, suggesting the dynamics and binding are functionally related.	[Cordeiro, Tiago N.; Pons, Miquel] Univ Barcelona, Dept Organ Chem, Biomol NMR Lab, E-08028 Barcelona, Spain; [Cordeiro, Tiago N.; Bernado, Pau] Univ Montpellier 1 & 2, CNRS UMR 5048, INSERM, Ctr Biochim Struct,U1054, F-34092 Montpellier, France; [Garcia, Jesus] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Millet, Oscar] Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Elexalde Derio 48160, Spain	University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIC bioGUNE	Millet, O (corresponding author), Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Parque Cient Tecnol Bizkaia Bldg 801A, Elexalde Derio 48160, Spain.	omillet@cicbiogune.es; mpons@ub.edu	Cordeiro, Tiago N/E-9842-2012; Millet, Oscar/F-9696-2011; pons, miquel/C-8657-2011	Cordeiro, Tiago N/0000-0003-2663-3220; Millet, Oscar/0000-0001-8748-4105; pons, miquel/0000-0002-0586-8322; Garcia, Jesus/0000-0003-2961-9790; Bernado, Pau/0000-0001-7395-5922	Spanish Ministry of Economy and Competitivity [BIO2010-15683, BIO2013-45793R, CTQ2012-32183]; Generalitat de Catalunya [2009SGR1352]; European Commission (BioNMR) [261863]; Department of Industry, Tourism, and Trade of Government of the Autonomous Community of Basque Country	Spanish Ministry of Economy and Competitivity(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Commission (BioNMR)(European CommissionEuropean Commission Joint Research Centre); Department of Industry, Tourism, and Trade of Government of the Autonomous Community of Basque Country	This work was supported by the Spanish Ministry of Economy and Competitivity (BIO2010-15683, BIO2013-45793R, and CTQ2012-32183), the Generalitat de Catalunya (2009SGR1352), the European Commission (BioNMR, contract 261863), and by the Department of Industry, Tourism, and Trade of the Government of the Autonomous Community of the Basque Country. The authors declare that they have no conflicts of interest with the contents of this article.	Ali SS, 2013, J BIOL CHEM, V288, P13356, DOI 10.1074/jbc.M113.455378; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Aznar S, 2013, MICROBIOL-SGM, V159, P545, DOI 10.1099/mic.0.062448-0; Balsalobre C, 1996, MICROBIOL-SGM, V142, P1841, DOI 10.1099/13500872-142-7-1841; Banos RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000513; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Cordeiro TN, 2008, FEBS LETT, V582, P3139, DOI 10.1016/j.febslet.2008.07.037; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; CORNELIS GR, 1991, MOL MICROBIOL, V5, P1023, DOI 10.1111/j.1365-2958.1991.tb01875.x; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; de Alba CF, 2011, FEBS LETT, V585, P1765, DOI 10.1016/j.febslet.2011.05.024; Fernandez-de-Alba C, 2013, J MOL BIOL, V425, P2347, DOI 10.1016/j.jmb.2013.03.006; Gabdoulline RR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-373; Garcia J, 2005, BIOCHEM J, V388, P755, DOI 10.1042/BJ20050002; Garcia J, 2006, J MOL BIOL, V359, P679, DOI 10.1016/j.jmb.2006.03.059; Garcia J, 2009, FEBS LETT, V583, P2911, DOI 10.1016/j.febslet.2009.07.054; Garcia-Contreras R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002394; Hong SH, 2010, MICROB BIOTECHNOL, V3, P717, DOI 10.1111/j.1751-7915.2010.00220.x; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kieslich CA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002840; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Madrid C, 2007, J BACTERIOL, V189, P265, DOI 10.1128/JB.01124-06; McFeeters RL, 2007, BIOCHEMISTRY-US, V46, P13975, DOI 10.1021/bi701210j; MIKULSKIS AV, 1994, MOL MICROBIOL, V11, P77, DOI 10.1111/j.1365-2958.1994.tb00291.x; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; NIETO JM, 1991, MOL MICROBIOL, V5, P1285, DOI 10.1111/j.1365-2958.1991.tb01902.x; Nieto JM, 2002, J BACTERIOL, V184, P629, DOI 10.1128/JB.184.3.629-635.2002; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Paytubi S, 2011, CENT EUR J BIOL, V6, P879, DOI 10.2478/s11535-011-0071-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renault M, 2013, FEBS J, V280, P2916, DOI 10.1111/febs.12297; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Sharma VK, 2013, APPL ENVIRON MICROB, V79, P2384, DOI 10.1128/AEM.02998-12; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Takeda Toshiharu, 2011, Int J Evol Biol, V2011, P685015, DOI 10.4061/2011/685015; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Walther TH, 2013, CELL, V152, P316, DOI 10.1016/j.cell.2012.12.017; World Health Organization, 2014, ANT RES GLOB REP SUR; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Zhou HX, 2001, BIOPOLYMERS, V59, P427, DOI 10.1002/1097-0282(200111)59:6<427::AID-BIP1047>3.0.CO;2-7	53	13	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21200	21212		10.1074/jbc.M114.630400	http://dx.doi.org/10.1074/jbc.M114.630400			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26085102	Green Published, hybrid			2022-12-26	WOS:000360637600002
J	Haji-Ghassemi, O; Muller-Loennies, S; Rodriguez, T; Brade, L; Kosma, P; Brade, H; Evans, SV				Haji-Ghassemi, Omid; Mueller-Loennies, Sven; Rodriguez, Teresa; Brade, Lore; Kosma, Paul; Brade, Helmut; Evans, Stephen V.			Structural Basis for Antibody Recognition of Lipid A INSIGHTS TO POLYSPECIFICITY TOWARD SINGLE-STRANDED DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; FAB FRAGMENT; CRYSTAL-STRUCTURE; SEVERE SEPSIS; V-J; BINDING; SPECIFICITY; LPS; LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN	Septic shock is a leading cause of death, and it results from an inflammatory cascade triggered by the presence of microbial products in the blood. Certain LPS from Gram-negative bacteria are very potent inducers and are responsible for a high percentage of septic shock cases. Despite decades of research, mAbs specific for lipid A (the endotoxic principle of LPS) have not been successfully developed into a clinical treatment for sepsis. To understand the molecular basis for the observed inability to translate in vitro specificity for lipid A into clinical potential, the structures of antigen-binding fragments of mAbs S1-15 and A6 have been determined both in complex with lipid A carbohydrate backbone and in the unliganded form. The two antibodies have separate germ line origins that generate two markedly different combining-site pockets that are complementary both in shape and charge to the antigen. mAb A6 binds lipid A through both variable light and heavy chain residues, whereas S1-15 utilizes exclusively the variable heavy chain. Both antibodies bind lipid A such that the GlcN-O6 attachment point for the core oligosaccharide is buried in the combining site, which explains the lack of LPS recognition. Longstanding reports of polyspecificity of anti-lipid A antibodies toward single-stranded DNA combined with observed homology of S1-15 and A6 and the reports of several single-stranded DNA-specific mAbs prompted the determination of the structure of S1-15 in complex with single-stranded DNA fragments, which may provide clues about the genesis of autoimmune diseases such as systemic lupus erythematosus, thyroiditis, and rheumatic autoimmune diseases.	[Haji-Ghassemi, Omid; Rodriguez, Teresa; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 3P6, Canada; [Mueller-Loennies, Sven; Brade, Lore; Brade, Helmut] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Kosma, Paul] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria	University of Victoria; Forschungszentrum Borstel; University of Natural Resources & Life Sciences, Vienna	Muller-Loennies, S (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Parkallee 22, D-23845 Borstel, Germany.	sml@fz-borstel.de; svevans@uvic.ca	Kosma, Paul/Y-7443-2019; Martín, Teresa Rodríguez/GZL-1938-2022	Kosma, Paul/0000-0001-5342-7161; Haji-Ghassemi, Omid/0000-0003-0116-005X; Evans, Stephen/0000-0002-0366-4027	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We gratefully acknowledge the technical assistance of Ute Agge, Veronika Susott, and Christine Schneider at the Research Center Borstel, Germany. Research described in this paper was performed at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; APPELMELK BJ, 1988, J MED MICROBIOL, V26, P107, DOI 10.1099/00222615-26-2-107; Blackler R. J., 2012, ANTICARBOHYDRATE ANT, P75; Blackler RJ, 2011, BIOCHEMISTRY-US, V50, P3357, DOI 10.1021/bi101886v; BRADE L, 1985, INFECT IMMUN, V48, P776, DOI 10.1128/IAI.48.3.776-781.1985; BRADE L, 1993, INFECT IMMUN, V61, P4514, DOI 10.1128/IAI.61.10.4514-4517.1993; Brade L, 1997, INFECT IMMUN, V65, P3961, DOI 10.1128/IAI.65.9.3961-3965.1997; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Brooks CL, 2008, J MOL BIOL, V377, P450, DOI 10.1016/j.jmb.2008.01.018; Buttenschoen K, 2010, LANGENBECK ARCH SURG, V395, P597, DOI 10.1007/s00423-010-0658-6; Cross AS, 2014, VIRULENCE, V5, P219, DOI 10.4161/viru.25965; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; DENG SJ, 1994, J BIOL CHEM, V269, P9533; DIPADOVA FE, 1993, INFECT IMMUN, V61, P3863, DOI 10.1128/IAI.61.9.3863-3872.1993; ElSamalouti VT, 1997, EUR J BIOCHEM, V250, P418, DOI 10.1111/j.1432-1033.1997.0418a.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; FUJIHARA Y, 1993, J INFECT DIS, V168, P1429, DOI 10.1093/infdis/168.6.1429; GALANOS C, 1971, EUR J BIOCHEM, V24, P116; Gomery K, 2012, P NATL ACAD SCI USA, V109, P20877, DOI 10.1073/pnas.1209253109; Helmerhorst EJ, 1998, INFECT IMMUN, V66, P870, DOI 10.1128/IAI.66.2.870-873.1998; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; Hold GL, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P371, DOI 10.1007/978-3-7091-0733-1_12; Holst O, 2007, FEMS MICROBIOL LETT, V271, P3, DOI 10.1111/j.1574-6968.2007.00708.x; Ianaro A, 2009, MINI-REV MED CHEM, V9, P306, DOI 10.2174/1389557510909030306; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; IZUI S, 1977, J IMMUNOL, V119, P2157; KABURAKI J, 1992, Keio Journal of Medicine, V41, P10; Kaminski MJ, 1999, J BIOL CHEM, V274, P5597, DOI 10.1074/jbc.274.9.5597; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Krishnan MR, 1996, J IMMUNOL, V157, P2430; KUHN HM, 1993, INFECTION, V21, P179, DOI 10.1007/BF01710544; KUHN HM, 1992, INFECT IMMUN, V60, P2201, DOI 10.1128/IAI.60.6.2201-2210.1992; Li Joan, 2011, Hosp Pract (1995), V39, P99, DOI 10.3810/hp.2011.08.585; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; MOL CD, 1994, J BIOL CHEM, V269, P3615; MOL CD, 1994, J BIOL CHEM, V269, P3605; MONESTIER M, 1987, J EXP MED, V166, P1109, DOI 10.1084/jem.166.4.1109; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Muller-Loennies S, 2007, INT J MED MICROBIOL, V297, P321, DOI 10.1016/j.ijmm.2007.04.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Pedro ABP, 2006, EXP CLIN ENDOCR DIAB, V114, P35, DOI 10.1055/s-2005-873005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POKKULURI PR, 1994, J MOL BIOL, V243, P283, DOI 10.1006/jmbi.1994.1654; Pollack M, 1997, J IMMUNOL, V159, P3519; RATHBUN GA, 1988, J MOL BIOL, V202, P383, DOI 10.1016/0022-2836(88)90272-0; Ravirajan CT, 2001, RHEUMATOLOGY, V40, P1405, DOI 10.1093/rheumatology/40.12.1405; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; ROBERTSON CR, 1992, CLIN EXP RHEUMATOL, V10, P589; Rynkiewicz MJ, 2012, BIOCHEMISTRY-US, V51, P5684, DOI 10.1021/bi201711m; SCHULZEGAHMEN U, 1993, J MOL BIOL, V234, P1098, DOI 10.1006/jmbi.1993.1663; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; Spellerberg M, 1995, ANN NY ACAD SCI, V764, P427; SUMAZAKI R, 1986, CLIN EXP IMMUNOL, V66, P103; Tanner JJ, 2001, J MOL BIOL, V314, P807, DOI 10.1006/jmbi.2001.5178; TILLMAN DM, 1992, J EXP MED, V176, P761, DOI 10.1084/jem.176.3.761; TORMO J, 1992, PROTEIN SCI, V1, P1154, DOI 10.1002/pro.5560010909; Vranken W, 2002, BIOCHEMISTRY-US, V41, P8570, DOI 10.1021/bi012169a; Vulliez-Le Normand B, 2008, P NATL ACAD SCI USA, V105, P9976, DOI 10.1073/pnas.0801711105; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	65	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19629	19640		10.1074/jbc.M115.657874	http://dx.doi.org/10.1074/jbc.M115.657874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26085093	Green Published, hybrid			2022-12-26	WOS:000359364600024
J	Mehrazarin, S; Chen, W; Oh, JE; Liu, ZX; Kang, KL; Yi, JK; Kim, RH; Shin, KH; Park, NH; Kang, MK				Mehrazarin, Shebli; Chen, Wei; Oh, Ju-Eun; Liu, Zi X.; Kang, Kyung L.; Yi, Jin K.; Kim, Reuben H.; Shin, Ki-Hyuk; Park, No-Hee; Kang, Mo K.			The p63 Gene Is Regulated by Grainyhead-like 2 (GRHL2) through Reciprocal Feedback and Determines the Epithelial Phenotype in Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ORAL KERATINOCYTES; MESENCHYMAL TRANSITION; STEM-CELLS; DIFFERENTIATION; ZEB1; SUPPRESSION; ACTIVATION; SENESCENCE; REPRESSION; MIGRATION	In this study, we investigated the effects of p63 modulation in epithelial plasticity in human keratinocytes. The p63 isoforms Delta Np63 alpha, Delta Np63 beta, and Delta Np63 gamma were ectopically expressed in normal human epidermal keratinocytes (NHEKs). The epithelial or mesenchymal state was determined by morphological changes and altered expression of various markers, e.g. fibronectin, E-Cadherin, and keratin 14. Overexpression of Delta Np63 alpha and Delta Np63 beta but not Delta Np63 gamma isoforms led to morphological changes consistent with epithelial-mesenchymal transition (EMT). However, only Delta Np63 alpha overexpression was able to maintain the morphological changes and molecular phenotype consistent with EMT. Interestingly, knockdown of all p63 isoforms by transfection of p63 siRNA also led to the EMT phenotype, further confirming the role of p63 in regulating the epithelial phenotype in NHEKs. EMT in NHKs accompanied loss of Grainyhead-Like 2 (GHRL2) and miR-200 family gene expression, both of which play crucial roles in determining the epithelial phenotype. Modulation of GRHL2 in NHKs also led to congruent changes in p63 expression. ChIP revealed direct GRHL2 binding to the p63 promoter. GRHL2 knockdown in NHK led to impaired binding of GRHL2 and changes in the histone marks consistent with p63 gene silencing. These data indicate the presence of a reciprocal feedback regulation between p63 and GRHL2 in NHEKs to regulate epithelial plasticity.	[Mehrazarin, Shebli; Chen, Wei; Oh, Ju-Eun; Liu, Zi X.; Kang, Kyung L.; Yi, Jin K.; Kim, Reuben H.; Shin, Ki-Hyuk; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA; [Kim, Reuben H.; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Park, No-Hee] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kang, Kyung L.; Yi, Jin K.; Park, No-Hee] Kyung Hee Univ, Sch Dent, Seoul 130701, South Korea	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kyung Hee University	Kang, MK (corresponding author), Univ Calif Los Angeles, Ctr Hlth Sci, Sch Dent, Rm 43-009,10833 Conte Ave, Los Angeles, CA 90024 USA.	mkang@dentistry.ucla.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01DE18295, K02DE18959, R56DE024593]; Jack Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K02DE018959, R56DE024593, R03DE024259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jack Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE18295, K02DE18959, and R56DE024593. This work was also supported by the Jack Weichman Endowed Fund (to M. K. K.). The authors declare no conflict of interest with the content of this article.	Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Chen W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.190; Chen W, 2010, J BIOL CHEM, V285, P40852, DOI 10.1074/jbc.M110.103812; Cieply B, 2013, CANCER RES, V73, P6299, DOI 10.1158/0008-5472.CAN-12-4082; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Grille SJ, 2003, CANCER RES, V63, P2172; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Kang MK, 2000, EXP CELL RES, V258, P288, DOI 10.1006/excr.2000.4943; Kang MK, 2004, J CELL PHYSIOL, V199, P364, DOI 10.1002/jcp.10410; Kang MK, 1998, CELL GROWTH DIFFER, V9, P85; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Oh JE, 2011, J BIOL CHEM, V286, P38757, DOI 10.1074/jbc.M111.244939; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Varma S, 2012, J BIOL CHEM, V287, P37282, DOI 10.1074/jbc.M112.408401; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xiang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050781; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	28	25	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19999	20008		10.1074/jbc.M115.659144	http://dx.doi.org/10.1074/jbc.M115.659144			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26085095	Green Published, hybrid			2022-12-26	WOS:000359364600054
J	Ganie, AH; Ahmad, A; Pandey, R; Aref, IM; Yousuf, PY; Ahmad, S; Iqbal, M				Ganie, Arshid Hussain; Ahmad, Altaf; Pandey, Renu; Aref, Ibrahim M.; Yousuf, Peerzada Yasir; Ahmad, Sayeed; Iqbal, Muhammad			Metabolite Profiling of Low-P Tolerant and Low-P Sensitive Maize Genotypes under Phosphorus Starvation and Restoration Conditions	PLOS ONE			English	Article							PHOSPHATE; ARABIDOPSIS; EXPRESSION; STRESS; ROOTS; L.; DEPRIVATION; RAFFINOSE; RESPONSES; FRUCTANS	Background Maize (Zea mays L.) is one of the most widely cultivated crop plants. Unavoidable economic and environmental problems associated with the excessive use of phosphatic fertilizers demands its better management. The solution lies in improving the phosphorus (P) use efficiency to sustain productivity even at low P levels. Untargeted metabolomic profiling of contrasting genotypes provides a snap shot of whole metabolome which differs under specific conditions. This information provides an understanding of the mechanisms underlying tolerance to P stress and the approach for increasing P-use-efficiency. Methodology/Principal Findings A comparative metabolite-profiling approach based on gas chromatography-mass spectrometry (GC/MS) was applied to investigate the effect of P starvation and its restoration in low-P sensitive (HM-4) and low-P tolerant (PEHM-2) maize genotypes. A comparison of the metabolite profiles of contrasting genotypes in response to P-deficiency revealed distinct differences among low-P sensitive and tolerant genotypes. Another set of these genotypes were grown under P-restoration condition and sampled at different time intervals (3, 5 and 10 days) to investigate if the changes in metabolite profile under P-deficiency was restored. Significant variations in the metabolite pools of these genotypes were observed under P-deficiency which were genotype specific. Out of 180 distinct analytes, 91 were identified. Phosphorus-starvation resulted in accumulation of di- and trisaccharides and metabolites of ammonium metabolism, specifically in leaves, but decreased the levels of phosphate-containing metabolites and organic acids. A sharp increase in the concentrations of glutamine,asparagine, serine and glycine was observed in both shoots and roots under low-P condition. Conclusion The new insights generated on the maize metabolome in resposne to P-starvation and restoration would be useful towards improvement of the P-use efficiency in maize.	[Ganie, Arshid Hussain; Yousuf, Peerzada Yasir; Iqbal, Muhammad] Hamdard Univ, Dept Bot, Fac Sci, New Delhi 110062, India; [Ahmad, Altaf] Aligarh Muslim Univ, Dept Bot, Aligarh 202002, Uttar Pradesh, India; [Pandey, Renu] Indian Agr Res Inst, Div Plant Physiol, New Delhi 110012, India; [Aref, Ibrahim M.] King Saud Univ, Dept Plant Prod, Coll Food & Agr Sci, Riyadh 11451, Saudi Arabia; [Ahmad, Sayeed] Jamia Hamdard, Fac Pharm, Dept Pharmacognosy & Pharmaceut Chem, New Delhi 110062, India	Jamia Hamdard University; Aligarh Muslim University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; King Saud University; Jamia Hamdard University	Iqbal, M (corresponding author), Hamdard Univ, Dept Bot, Fac Sci, New Delhi 110062, India.	iqbalg5@yahoo.co.in	Ahmad, Sayeed/N-1359-2013; AHMAD, ALTAF/AAE-9371-2020; Yousuf, Peerzada Yasir/AAK-8950-2020; Pandey, Renu/AES-7797-2022	Ahmad, Sayeed/0000-0003-1573-152X; AHMAD, ALTAF/0000-0003-4099-7338; Pandey, Renu/0000-0002-9244-8579; Yousuf, Peerzada Yasir/0000-0002-1273-9158	Department of Biotechnology, Ministry of Science & Technology, Government of India	Department of Biotechnology, Ministry of Science & Technology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Ministry of Science & Technology, Government of India.	Amiard V, 2003, PLANT PHYSIOL, V132, P2218, DOI 10.1104/pp.103.022335; Batjes NH, 1997, SOIL USE MANAGE, V13, P9, DOI 10.1111/j.1475-2743.1997.tb00550.x; Bieleski R. L., 1983, Inorganic plant nutrition, P422; Bollard EG, 1970, BIOCH FRUIT THEIR PR, V1; Ciereszko I, 2000, J PLANT PHYSIOL, V156, P640, DOI 10.1016/S0176-1617(00)80225-4; Djanaguiraman M, 2014, ENVIRON EXP BOT, V100, P43, DOI 10.1016/j.envexpbot.2013.11.013; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Fairhurst T., 1999, Agroforestry Forum, V9, P2; FAO, 2008, FOR LONG TERM GLOB F; HENDRY GAF, 1993, NEW PHYTOL, V123, P3; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; Hewitt MM, 2005, PLANT PHYSIOL BIOCH, V43, P91, DOI 10.1016/j.plaphy.2005.01.003; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Khoshgoftarmanesh AH, 2012, J GEOCHEM EXPLOR, V121, P49, DOI 10.1016/j.gexplo.2012.06.002; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; KRAJEWSKIBERTRAND MA, 1992, CHEM PHYS LIPIDS, V63, P235, DOI 10.1016/0009-3084(92)90039-R; Li KP, 2007, PROTEOMICS, V7, P1501, DOI 10.1002/pmic.200600960; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Murrell TS, 2006, PHOSPH DYN SOIL PLAN; Nanamori M, 2004, PLANT CELL PHYSIOL, V45, P460, DOI 10.1093/pcp/pch056; Neumann G, 1999, PLANT SOIL, V211, P121, DOI 10.1023/A:1004380832118; Nikiforova VJ, 2005, PLANT PHYSIOL, V138, P304, DOI 10.1104/pp.104.053793; Nilsson L, 2007, PLANT CELL ENVIRON, V30, P1499, DOI 10.1111/j.1365-3040.2007.01734.x; Panikulangara TJ, 2004, PLANT PHYSIOL, V136, P3148, DOI 10.1104/pp.104.042606; Pearse SJ, 2006, NEW PHYTOL, V169, P515, DOI 10.1111/j.1469-8137.2005.01614.x; Perez-Clemente RM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/654120; Plaxton W.C., 2004, ENCY PLANT CROP SCI, P976, DOI DOI 10.1081/E-EPCS-120010648; Roessner U, 2006, PLANT PHYSIOL, V142, P1087, DOI 10.1104/pp.106.084053; RYCHTER AM, 1994, PHYSIOL PLANTARUM, V91, P383, DOI 10.1111/j.1399-3054.1994.tb02964.x; SANCHEZ PA, 1981, ADV AGRON, V34, P279, DOI 10.1016/S0065-2113(08)60889-5; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; SCHULER I, 1990, BIOCHIM BIOPHYS ACTA, V1028, P82, DOI 10.1016/0005-2736(90)90268-S; Shih CY, 1996, PLANT PHYSIOL, V111, P721, DOI 10.1104/pp.111.3.721; Wingler A, 2000, PHILOS T R SOC B, V355, P1517, DOI 10.1098/rstb.2000.0712; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yamamoto YT, 1997, PLANT PHYSIOL, V115, P1397, DOI 10.1104/pp.115.4.1397	39	57	60	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129520	10.1371/journal.pone.0129520	http://dx.doi.org/10.1371/journal.pone.0129520			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090681	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000049
J	Gong, X; Lin, C; Cheng, J; Su, JS; Zhao, H; Liu, TL; Wen, XJ; Zhao, P				Gong, Xue; Lin, Chao; Cheng, Jian; Su, Jiansheng; Zhao, Hang; Liu, Tianlin; Wen, Xuejun; Zhao, Peng			Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing	PLOS ONE			English	Article							IN-VITRO EVALUATION; CELL-CULTURE; CHEMOTHERAPEUTIC DRUGS; GENE-EXPRESSION; CANCER; RESISTANCE; MODEL; CHEMORESISTANCE; ARCHITECTURE; PENETRATION	Three dimensional multicellular aggregate, also referred to as cell spheroid or microtissue, is an indispensable tool for in vitro evaluating antitumor activity and drug efficacy. Compared with classical cellular monolayer, multicellular tumor spheroid (MCTS) offers a more rational platform to predict in vivo drug efficacy and toxicity. Nevertheless, traditional processing methods such as plastic dish culture with nonadhesive surfaces are regularly time-consuming, laborious and difficult to provide uniform-sized spheroids, thus causing poor reproducibility of experimental data and impeding high-throughput drug screening. In order to provide a robust and effective platform for in vitro drug evaluation, we present an agarose scaffold prepared with the template containing uniform-sized micro-wells in commercially available cell culture plates. The agarose scaffold allows for good adjustment of MCTS size and large-scale production of MCTS. Transparent agarose scaffold also allows for monitoring of spheroid formation under an optical microscopy. The formation of MCTS from MCF-7 cells was prepared using different-size-well templates and systematically investigated in terms of spheroid growth curve, circularity, and cell viability. The doxorubicin cytotoxicity against MCF-7 spheroid and MCF-7 monolayer cells was compared. The drug penetration behavior, cell cycle distribution, cell apoptosis, and gene expression were also evaluated in MCF-7 spheroid. The findings of this study indicate that, compared with cellular monolayer, MCTS provides a valuable platform for the assessment of therapeutic candidates in an in vivo-mimic microenvironment, and thus has great potential for use in drug discovery and tumor biology research.	[Gong, Xue; Su, Jiansheng; Zhao, Hang; Liu, Tianlin] Tongji Univ, Sch Stomatol, Dept Prosthodont, Lab Oral Biomed Sci & Translat Med, Shanghai 200092, Peoples R China; [Lin, Chao; Cheng, Jian; Wen, Xuejun; Zhao, Peng] Tongji Univ, Sch Med, Inst Biomed Engn & Nano Sci, Shanghai 200092, Peoples R China; [Wen, Xuejun] Virginia Commonwealth Univ, Inst Engn & Med, Dept Chem & Life Sci Engn, Richmond, VA USA	Tongji University; Tongji University; Virginia Commonwealth University	Su, JS (corresponding author), Tongji Univ, Sch Stomatol, Dept Prosthodont, Lab Oral Biomed Sci & Translat Med, Shanghai 200092, Peoples R China.	sjs@tongji.edu.cn; zp@tongji.edu.cn	Zhao, Peng/HDO-7507-2022		Ministry of Science and Technology of China [2014CB964600, 2012CB966300]; National Natural Science Funds of China [81271369, 81371949]; Shanghai Municipal Natural Science Foundation [13ZR1443600]; Shanghai Municipal Science and Technology Foundation [13411951201, 114119a3700]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; Shanghai Municipal Science and Technology Foundation	This work was funded by the following grants: the Ministry of Science and Technology of China (Grant Nos. 2014CB964600 and 2012CB966300), the National Natural Science Funds of China (Grant No. 81271369 and Grant No. 81371949), the Shanghai Municipal Natural Science Foundation (Grant No. 13ZR1443600), and the Shanghai Municipal Science and Technology Foundation (Grant No. 13411951201 and Grant No. 114119a3700).	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alves CS, 2009, J BIOL CHEM, V284, P1177, DOI 10.1074/jbc.M805144200; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Bryce NS, 2009, CHEM COMMUN, P2673, DOI 10.1039/b902415h; Charoen KM, 2014, BIOMATERIALS, V35, P2264, DOI 10.1016/j.biomaterials.2013.11.038; Dean DM, 2007, FASEB J, V21, P4005, DOI 10.1096/fj.07-8710com; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Dong Y, 2010, CANCER RES, V70, P2624, DOI 10.1158/0008-5472.CAN-09-3415; Doublier S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-4; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Frankel A, 1997, CANCER RES, V57, P2388; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Goodman TT, 2007, INT J NANOMED, V2, P265; Goodman TT, 2008, BIOCONJUGATE CHEM, V19, P1951, DOI 10.1021/bc800233a; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Hakanson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040141; Hall MD, 2004, BIOCHEM PHARMACOL, V67, P17, DOI 10.1016/j.bcp.2003.07.016; Hamilton G, 1998, CANCER LETT, V131, P29, DOI 10.1016/S0304-3835(98)00198-0; Hardelauf H, 2011, LAB CHIP, V11, P419, DOI 10.1039/c0lc00089b; Harmey JH, 2002, BIOESSAYS, V24, P280, DOI 10.1002/bies.10043; Ho WY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044640, DOI 10.1371/J0URNAL.P0NE.0044640]; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Karlsson H, 2012, EXP CELL RES, V318, P1577, DOI 10.1016/j.yexcr.2012.03.026; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kim JW, 2011, ANTICANCER RES, V31, P3237; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Makhija S, 1999, INT J ONCOL, V14, P515; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nakayama K, 2002, CANCER LETT, V176, P215, DOI 10.1016/S0304-3835(01)00762-5; Nigro P, 2007, LIFE SCI, V81, P873, DOI 10.1016/j.lfs.2007.07.010; Nyberg SL, 2005, LIVER TRANSPLANT, V11, P901, DOI 10.1002/lt.20446; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Schmidt DS, 2004, EXP CELL RES, V297, P329, DOI 10.1016/j.yexcr.2004.02.023; Song H, 2004, TISSUE ENG, V10, P1266, DOI 10.1089/1076327041887673; Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043; VAITHILINGAM IS, 1991, J NEURO-ONCOL, V10, P203, DOI 10.1007/BF00177532; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang X, 2013, BIOMATERIALS, V34, P4667, DOI 10.1016/j.biomaterials.2013.03.008; Whatley BR, 2014, J BIOMED MATER RES A, V102, P1537, DOI 10.1002/jbm.a.34797; Yang J, 2002, BIOMATERIALS, V23, P471, DOI 10.1016/S0142-9612(01)00129-6; Yang X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059147, DOI 10.1371/J0URNAL.P0NE.0059147]	53	197	202	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130348	10.1371/journal.pone.0130348	http://dx.doi.org/10.1371/journal.pone.0130348			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090664	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000105
J	Kamiya, K; Asato, H; Shimizu, K; Kobashi, H; Igarashi, A				Kamiya, Kazutaka; Asato, Hitomi; Shimizu, Kimiya; Kobashi, Hidenaga; Igarashi, Akihito			Effect of Intraocular Forward Scattering and Corneal Higher-Order Aberrations on Visual Acuity after Descemet's Stripping Automated Endothelial Keratoplasty	PLOS ONE			English	Article							PENETRATING KERATOPLASTY; GRAFT THICKNESS; LIGHT SCATTER; ANTERIOR; SURFACE; VISION; DYSTROPHY; LAMELLAR; DSAEK; HAZE	Purpose To assess the relationship of intraocular forward scattering and corneal higher-order aberrations (HOAs) with best spectacle corrected visual acuity (BSCVA) after Descemet's stripping automated endothelial keratoplasty (DSAEK), and to compare these parameters between DSAEK and non-Descemet's stripping automated endothelial keratoplasty (n-DSAEK) groups. Methods This retrospective study enrolled thirty eyes of 30 consecutive patients who underwent standard DSAEK, and who underwent successful phacoemulsification with intraocular lens implantation before DSAEK. The mean age at the time of surgery was 71.7 +/- 10.4 years. We quantitatively evaluated the objective scattering index (OSI) using the double-pass instrument (OQAS II, Visiometrics) and corneal HOAs using Hartmann-Shack aberrometry (KR-9000PW, Topcon) 3 months postoperatively. Results The mean OSI, corneal HOAs, and logMAR BSCVA 3 months after DSAEK were 7.91 +/- 3.58, 0.43 +/- 0.27 mu m, and 0.32 +/- 0.25, respectively. We found a significant correlation between the OSI and logMAR BSCVA (Spearman correlation coefficient r = 0.714, p < 0.001), but no significant association between corneal HOAs and logMAR BSCVA 3 months postoperatively (r = 0.209, p = 0.267). We found no significant differences in any postoperative parameters between the DSAEK and n-DSAEK groups (p > 0.05). Conclusions Our pilot study demonstrated that the postoperative corrected visual acuity was significantly correlated with intraocular forward scattering, but not with corneal HOAs in post-DSAEK eyes, suggesting that intraocular forward scattering plays a more essential role in postoperative visual performance than corneal aberrations after DSAEK. The detailed visual performance, such as HOAs and intraocular scattering, after n-DSAEK appears to be essentially equivalent to that after DSAEK.	[Kamiya, Kazutaka; Asato, Hitomi; Shimizu, Kimiya; Kobashi, Hidenaga; Igarashi, Akihito] Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan	Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan.	kamiyak-tky@umin.ac.jp						Arnalich-Montiel F, 2013, GRAEF ARCH CLIN EXP, V251, P2575, DOI 10.1007/s00417-013-2460-y; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Chamberlain W, 2012, CORNEA, V31, P6, DOI 10.1097/ICO.0b013e3182151df2; Dickman MM, 2013, JAMA OPHTHALMOL, V131, P737, DOI 10.1001/jamaophthalmol.2013.73; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Heinzelmann S, 2014, ACTA OPHTHALMOL, V92, pE1, DOI 10.1111/aos.12217; Hindman HB, 2013, CORNEA, V32, P1567, DOI 10.1097/ICO.0b013e3182a9b182; Koh S, 2012, AM J OPHTHALMOL, V153, P284, DOI 10.1016/j.ajo.2011.06.027; Muftuoglu O, 2010, OPHTHALMOLOGY, V117, P878, DOI 10.1016/j.ophtha.2010.02.001; Pantanelli SM, 2012, INVEST OPHTH VIS SCI, V53, P4797, DOI 10.1167/iovs.12-10003; Patel SV, 2008, AM J OPHTHALMOL, V145, P97, DOI 10.1016/j.ajo.2007.09.002; Patel SV, 2012, OPHTHALMOLOGY, V119, P1522, DOI 10.1016/j.ophtha.2012.01.038; Patel SV, 2009, ARCH OPHTHALMOL-CHIC, V127, P153, DOI 10.1001/archophthalmol.2008.581; Patel SV, 2008, AM J OPHTHALMOL, V146, P913, DOI 10.1016/j.ajo.2008.07.018; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2007, CURR OPIN OPHTHALMOL, V18, P290, DOI 10.1097/ICU.0b013e3281a4775b; Seery LS, 2011, AM J OPHTHALMOL, V152, P910, DOI 10.1016/j.ajo.2011.05.003; Tung CI, 2012, CORNEA, V31, P108, DOI [10.1097/ICO.0b013e31821ea667, 10.1097/ICO.0b013e318269c9cd]; Yamaguchi T, 2011, INVEST OPHTH VIS SCI, V52, P6222, DOI 10.1167/iovs.11-7647; Yamaguchi TD, 2009, J CATARACT REFR SURG, V35, P688, DOI 10.1016/j.jcrs.2008.11.062	20	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0131110	10.1371/journal.pone.0131110	http://dx.doi.org/10.1371/journal.pone.0131110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090889	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000168
J	Lindam, A; Kendall, BJ; Thrift, AP; Macdonald, GA; O'Brien, S; Lagergren, J; Whiteman, DC				Lindam, Anna; Kendall, Bradley J.; Thrift, Aaron P.; Macdonald, Graeme A.; O'Brien, Suzanne; Lagergren, Jesper; Whiteman, David C.			Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett's Esophagus in a Population-Based Case-Control Study	PLOS ONE			English	Article							ADENOCARCINOMA; OBESITY; DISEASE; SEVERITY; PRESSURE; COHORT	Background Gastroesophageal reflux is overrepresented in people with obstructive sleep apnea (OSA) and it has been suggested that OSA worsens gastroesophageal reflux symptoms. Aggravated reflux might lead to an increased risk of Barrett's esophagus. Aim To assess the association between sleep apnea symptoms and Barrett's esophagus. Methods Included in a case-control study in Brisbane, Australia were 237 patients with histologically confirmed Barrett's esophagus and 247 population controls. The controls were randomly selected from the electoral roll and frequency-matched to the cases by age and sex. Information on OSA symptoms (excessive daytime sleepiness and sleep related apnea symptoms), gastroesophageal reflux symptoms and anthropometric measures were collected through interviews and written questionnaires. Multivariable logistic regression provided odds ratios (OR) and 95% confidence intervals (CI), adjusted for potential confounding by BMI and gastroesophageal reflux. Results The prevalence of Barrett's esophagus was higher among people with excessive daytime sleepiness than those without (24% vs. 18%; p-value 0.1142) and in participants with sleep-related apnea symptoms (20% vs. 13%; p-value 0.1730). However, there were non-significantly increased ORs of Barrett's esophagus among people with excessive daytimesleepiness (OR 1.42, 95% CI 0.90-2.34) and sleep related apnea symptoms (OR 1.32, 95% CI 0.74-2.36) when adjusting for age, sex and BMI. After further adjustment for gastroesophageal reflux symptoms, the point ORs were no longer increased (OR 1.02, 95% CI 0.61-1.70 for daytime sleepiness and OR 0.72, 95% CI 0.38-1.38 for sleep related apnea symptoms). Conclusions Symptoms of OSA are possibly associated with an increased risk of Barrett's esophagus, an association that appears to be mediated entirely by gastroesophageal reflux.	[Lindam, Anna; Lagergren, Jesper] Karolinska Inst, Dept Mol Med & Surg, Upper GI Surg, Stockholm, Sweden; [Lindam, Anna; Kendall, Bradley J.; Thrift, Aaron P.; O'Brien, Suzanne; Whiteman, David C.] QIMR Berghofer Med Res Inst, Canc Control Lab, Brisbane, Qld, Australia; [Macdonald, Graeme A.] Univ Queensland, Sch Med, Dept Med, Brisbane, Qld, Australia; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London, England	Karolinska Institutet; QIMR Berghofer Medical Research Institute; University of Queensland; University of London; King's College London	Lindam, A (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Upper GI Surg, Stockholm, Sweden.	anna.lindam@ki.se	Kendall, Bradley/AAZ-7941-2021; Whiteman, David C/P-2728-2014; Kendall, Bradley/AAZ-7937-2021; Macdonald, Graeme A/K-4167-2013	Kendall, Bradley/0000-0002-6471-2918; Whiteman, David C/0000-0003-2563-9559; Macdonald, Graeme A/0000-0003-0929-110X; Lindam, Anna/0000-0002-6230-0354	Queensland Cancer Fund; Queensland Government Smart State Fund; National Cancer Institute [RO1 CA 001833]; Swedish Research Council for Health, Working Life and Welfare (FORTE) [NR 2012-1457]; Bengt Ihres Fond from the Swedish Society of Medicine [SLS-252121]; Cancer Council NSW STREP grant [08-04]; Australian Research Council; NATIONAL CANCER INSTITUTE [R01CA001833] Funding Source: NIH RePORTER	Queensland Cancer Fund; Queensland Government Smart State Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Research Council for Health, Working Life and Welfare (FORTE); Bengt Ihres Fond from the Swedish Society of Medicine; Cancer Council NSW STREP grant(Cancer Council New South Wales); Australian Research Council(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by grants by the Queensland Cancer Fund and Queensland Government Smart State Fund. The Study of Digestive Health (SDH) was funded by the National Cancer Institute (Grant RO1 CA 001833). The funding bodies played no role in the design or conduct of the study; the collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript. AL was funded by travel grants from the Swedish Research Council for Health, Working Life and Welfare (FORTE) NR 2012-1457 and Bengt Ihres Fond from the Swedish Society of Medicine no: SLS-252121. APT was supported by the Cancer Council NSW STREP grant 08-04. DCW is funded by a Future Fellowship from the Australian Research Council.	Coleman HG, 2011, EUR J EPIDEMIOL, V26, P739, DOI 10.1007/s10654-011-9596-z; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Cummings LC, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-82; Green BT, 2003, ARCH INTERN MED, V163, P41, DOI 10.1001/archinte.163.1.41; Ing Alvin J., 2000, American Journal of Medicine, V108, p120S; Jansson C, 2009, CLIN GASTROENTEROL H, V7, P960, DOI 10.1016/j.cgh.2009.03.007; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jung Hye-Kyung, 2010, J Neurogastroenterol Motil, V16, P22, DOI 10.5056/jnm.2010.16.1.22; Kendall BJ, 2008, GUT, V57, P448, DOI 10.1136/gut.2007.131243; Kendall BJ, 2006, AM J GASTROENTEROL, V101, P1178, DOI 10.1111/j.1572-0241.2006.00548.x; Kendall BJ, 2013, INT J CANCER, V132, P2192, DOI 10.1002/ijc.27887; Kendzerska T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001599; Kim HN, 2005, ALIMENT PHARM THER, V21, P1127, DOI 10.1111/j.1365-2036.2005.02447.x; Kuribayashi S, 2010, CHEST, V137, P769, DOI 10.1378/chest.09-0913; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lee Won, 2008, Expert Rev Respir Med, V2, P349, DOI 10.1586/17476348.2.3.349; Leggett C, 2012, GASTROENTEROLOGY, V142, pS751; Leggett CL, 2014, CLIN GASTROENTEROL H, V12, P583, DOI 10.1016/j.cgh.2013.08.043; MAISLIN G, 1995, SLEEP, V18, P158, DOI 10.1093/sleep/18.3.158; Mannarino MR, 2012, EUR J INTERN MED, V23, P586, DOI 10.1016/j.ejim.2012.05.013; Morse CA, 2004, CLIN GASTROENTEROL H, V2, P761, DOI 10.1016/S1542-3565(04)00347-7; Qaseem A, 2013, ANN INTERN MED; Shaheen NJ, 2005, GASTROENTEROLOGY, V128, P1554, DOI 10.1053/j.gastro.2005.03.032; Shepherd KL, 2011, J SLEEP RES, V20, P241, DOI 10.1111/j.1365-2869.2010.00843.x; Smith KJ, 2005, CANCER EPIDEM BIOMAR, V14, P2481, DOI 10.1158/1055-9965.EPI-05-0370; Thrift AP, 2012, ANN ONCOL, V23, P3155, DOI 10.1093/annonc/mds181; Vgontzas Alexandros N., 2008, Archives of Physiology and Biochemistry, V114, P211, DOI [10.1080/13813450802364627, 10.1080/13813450802364627 ]; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Zamagni M, 1996, CHEST, V109, P651, DOI 10.1378/chest.109.3.651	31	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129836	10.1371/journal.pone.0129836	http://dx.doi.org/10.1371/journal.pone.0129836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090820	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835000064
J	Yasamut, U; Tongmuang, N; Yenchitsomanus, PT; Junking, M; Noisakran, S; Puttikhunt, C; Chu, JJH; Limjindaporn, T				Yasamut, Umpa; Tongmuang, Nopprarat; Yenchitsomanus, Pa-Thai; Junking, Mutita; Noisakran, Sansanee; Puttikhunt, Chunya; Chu, Justin Jang Hann; Limjindaporn, Thawornchai			Adaptor Protein 1A Facilitates Dengue Virus Replication	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; ENVELOPE PROTEIN; 3-DIMENSIONAL ARCHITECTURE; MONOCLONAL-ANTIBODIES; SORTING SIGNALS; INFECTION; AP-1; BINDING; IDENTIFICATION; DETERMINANTS	Rearrangement of membrane structure induced by dengue virus (DENV) is essential for replication, and requires host cellular machinery. Adaptor protein complex (AP)-1 is a host component, which can be recruited to components required for membrane rearrangement. Therefore, dysfunction of AP-1 may affect membrane organization, thereby decreasing replication of virus in infected cells. In the present study, AP-1-dependent traffic inhibitor inhibited DENV protein expression and virion production. We further clarified the role of AP-1A in the life cycle of DENV by RNA interference. AP-1A was not involved in DENV entry into cells. However, it facilitated DENV RNA replication. Viral RNA level was reduced significantly in Huh7 cells transfected with AP-1A small interfering RNA (siRNA) compared with control siRNA. Transfection of naked DENV viral RNA into Huh7 cells transfected with AP-1A siRNA resulted in less viral RNA and virion production than transfection into Huh7 cells transfected with control siRNA. Huh7 cells transfected with AP-1A siRNA showed greater modification of membrane structures and fewer vesicular packets compared with cells transfected with control siRNA. Therefore, AP-1A may partly control DENV-induced rearrangement of membrane structures required for viral replication.	[Yasamut, Umpa; Tongmuang, Nopprarat; Yenchitsomanus, Pa-Thai; Junking, Mutita] Mahidol Univ, Siriraj Hosp, Fac Med, Div Mol Med,Dept Res & Dev, Bangkok 10700, Thailand; [Yasamut, Umpa] Mahidol Univ, Siriraj Hosp, Fac Med, Grad Program Immunol,Dept Immunol, Bangkok 10700, Thailand; [Noisakran, Sansanee; Puttikhunt, Chunya] Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol Dev Agcy, Med Biotechnol Unit, Bangkok, Thailand; [Chu, Justin Jang Hann] Natl Univ Singapore, Natl Univ Hlth Syst, Lab Mol RNA Virol & Antiviral Strategies, Yong Loo Lin Sch Med,Dept Microbiol, Singapore 117548, Singapore; [Limjindaporn, Thawornchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok 10700, Thailand	Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National University of Singapore; Mahidol University	Limjindaporn, T (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok 10700, Thailand.	thawornchai.lim@mahidol.ac.th	Noisakran, Sansanee/H-5186-2011; Yasamut, Umpa/ADS-2101-2022; Chu, Justin Jang Hann/ABA-8297-2021; Junking, Mutita/GOG-8176-2022	Noisakran, Sansanee/0000-0002-9336-3331; Yasamut, Umpa/0000-0001-9169-7285; Chu, Justin Jang Hann/0000-0002-1673-6819; Tongmuang, Nopprarat/0000-0002-6669-0847	Thailand Research Fund [RSA5780012]	Thailand Research Fund(Thailand Research Fund (TRF))	This work is supported by Thailand Research Fund (RSA5780012) to TL. UY is the RGJ-Ph.D. student (PHD/0259/2552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01813; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020; Baust T, 2006, P NATL ACAD SCI USA, V103, P3159, DOI 10.1073/pnas.0511062103; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Duncan MC, 2007, P NATL ACAD SCI USA, V104, P6235, DOI 10.1073/pnas.0607773104; Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Gan YB, 2002, NAT CELL BIOL, V4, P605, DOI 10.1038/ncb827; Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guo YJ, 2012, J CELL SCI, V125, P1706, DOI 10.1242/jcs.093203; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Hung SL, 1999, VIROLOGY, V257, P156, DOI 10.1006/viro.1999.9633; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Jirakanjanakit N, 1997, T ROY SOC TROP MED H, V91, P614, DOI 10.1016/S0035-9203(97)90050-X; Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14; KANASEKI T, 1969, J CELL BIOL, V42, P202, DOI 10.1083/jcb.42.1.202; Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Lee YR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-65; Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070; Lin YL, 2002, ANTIVIR RES, V56, P93, DOI 10.1016/S0166-3542(02)00095-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nakatsu F, 2014, MEMBRANES, V4, P747, DOI 10.3390/membranes4040747; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Noisakran S, 2008, BIOCHEM BIOPH RES CO, V372, P67, DOI 10.1016/j.bbrc.2008.04.165; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Peng T, 2009, CAN J MICROBIOL, V55, P139, DOI [10.1139/W08-107, 10.1139/w08-107]; Puttikhunt C, 2003, J VIROL METHODS, V109, P55, DOI 10.1016/S0166-0934(03)00045-4; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sawasdee N, 2010, BIOCHEM BIOPH RES CO, V401, P85, DOI 10.1016/j.bbrc.2010.09.015; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Tang WC, 2014, J VIROL, V88, P6793, DOI 10.1128/JVI.00045-14; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007	63	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130065	10.1371/journal.pone.0130065	http://dx.doi.org/10.1371/journal.pone.0130065			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090672	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000084
J	Giustiniani, J; Gabriel, D; Nicolier, M; Monnin, J; Haffen, E				Giustiniani, Julie; Gabriel, Damien; Nicolier, Magali; Monnin, Julie; Haffen, Emmanuel			Neural Correlates of Successful and Unsuccessful Strategical Mechanisms Involved in Uncertain Decision-Making	PLOS ONE			English	Article							IOWA GAMBLING TASK; VENTROMEDIAL PREFRONTAL CORTEX; SOMATIC MARKER HYPOTHESIS; MEDIAL FRONTAL-CORTEX; FUTURE CONSEQUENCES; PROBLEM GAMBLERS; SEX-DIFFERENCES; FRENCH VERSION; BAD OUTCOMES; REWARD	The ability to develop successful long-term strategies in uncertain situations relies on complex neural mechanisms. Although lesion studies have shown some of the mechanisms involved, it is still unknown why some healthy subjects are able to make the right decision whereas others are not. The aim of our study was to investigate neurophysiological differences underlying this ability to develop a successful strategy in a group of healthy subjects playing a monetary card game called the Iowa Gambling Task (IGT). In this task, subjects have to win and earn money by choosing between four decks of cards, two were advantageous in the long term and two disadvantageous. Twenty healthy right-handed subjects performed the IGT while their cerebral activity was recorded by electroencephalography. Based on their behavioral performances, two groups of subjects could clearly be distinguished: one who selected the good decks and thus succeeded in developing a Favorable strategy (9 subjects) and one who remained Undecided (11 subjects). No neural difference was found between each group before the selection of a deck, but in both groups a greater negativity was found emerging from the right superior frontal gyrus 600 ms before a disadvantageous selection. During the processing of the feedback, an attenuation of the P200 and P300 waveforms was found for the Undecided group, and a P300 originating from the medial frontal gyrus was found in response to a loss only in the Favorable group. Our results suggest that undecided subjects are hyposensitive to the valence of the cards during gambling, which affects the feedback processing.	[Giustiniani, Julie; Nicolier, Magali; Monnin, Julie; Haffen, Emmanuel] Univ Hosp, Dept Clin Psychiat, Besancon, France; [Gabriel, Damien; Nicolier, Magali; Monnin, Julie; Haffen, Emmanuel] Univ Franche Comte, Neurosci Lab, EA 481, F-25030 Besancon, France; [Giustiniani, Julie; Gabriel, Damien; Nicolier, Magali; Monnin, Julie; Haffen, Emmanuel] Univ Hosp, INSERM, CIC 1431, Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon	Gabriel, D (corresponding author), Univ Franche Comte, Neurosci Lab, EA 481, F-25030 Besancon, France.	dgabriel@chu-besancon.fr	haffen, emmanuel/R-2765-2017	haffen, emmanuel/0000-0002-4091-518X; giustiniani, julie/0000-0003-0208-6306; nicolier, magali/0000-0001-5135-5109; gabriel, damien/0000-0001-5413-3640	French Ministry of Health (PHRC) [2009-A00806-51]	French Ministry of Health (PHRC)	This study was supported by a grant from the French Ministry of Health (PHRC no2009-A00806-51, 2009). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asp E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00086; Bagneux V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081498; Beamesderfer A, 1974, PSYCHOL MEASUREMENT, P267; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2005, TRENDS COGN SCI, V9, P159, DOI 10.1016/j.tics.2005.02.002; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bianchin M, 2011, BRAIN COGNITION, V75, P273, DOI 10.1016/j.bandc.2011.01.005; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Bland AR, 2011, BRAIN RES, V1417, P55, DOI 10.1016/j.brainres.2011.08.031; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Bouvard M, 2009, QUESTIONNAIRES ECHEL; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Cavedini P, 2002, NEUROPSYCHOLOGIA, V40, P205, DOI 10.1016/S0028-3932(01)00077-X; Cavedini P, 2004, PSYCHIAT RES, V127, P259, DOI 10.1016/j.psychres.2004.03.012; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Chiu YC, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-13; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Collective E, 2008, JEUX HASARD ARGENT C; COLLET L, 1986, Encephale, V12, P77; Cui JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00776; Cunningham WA, 2005, COGN AFFECT BEHAV NE, V5, P202, DOI 10.3758/CABN.5.2.202; Derntl B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00352; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Ferdinand NK, 2013, BIOL PSYCHOL, V94, P235, DOI 10.1016/j.biopsycho.2013.07.006; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Horovitz SG, 2002, MAGN RESON IMAGING, V20, P319, DOI 10.1016/S0730-725X(02)00496-4; John O, 1991, BIG 5 INVENTORY VERS; Jollant F, 2007, J AFFECT DISORDERS, V99, P59, DOI 10.1016/j.jad.2006.07.022; Lejoyeux M., 2009, ABREGES ADDICTOLOGIE; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Lin CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-72; Mapelli D, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00684; Meyer G, 2000, BIOL PSYCHIAT, V48, P948, DOI 10.1016/S0006-3223(00)00888-X; Meyer G, 2004, PSYCHONEUROENDOCRINO, V29, P1272, DOI 10.1016/j.psyneuen.2004.03.005; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Miedl SF, 2010, PSYCHIAT RES-NEUROIM, V181, P165, DOI 10.1016/j.pscychresns.2009.11.008; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nieuwenhuis S, 2007, CEREB CORTEX, V17, P1570, DOI 10.1093/cercor/bhl068; Oberg SAK, 2011, NEUROPSYCHOLOGIA, V49, P3768, DOI 10.1016/j.neuropsychologia.2011.09.037; Ohgami Y, 2006, PSYCHOPHYSIOLOGY, V43, P227, DOI 10.1111/j.1469-8986.2006.00396.x; Overman WH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00935; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PERRIN F, 1987, IEEE T BIO-MED ENG, V34, P283, DOI 10.1109/TBME.1987.326089; Plaisant O, 2005, ANN MED-PSYCHOL, V163, P161, DOI 10.1016/j.amp.2005.02.002; Plaisant O, 2010, ANN MED-PSYCHOL, V168, P97, DOI 10.1016/j.amp.2009.09.003; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Poiezzi D, 2008, BEHAV BRAIN RES, V187, P116, DOI 10.1016/j.bbr.2007.09.001; Polezzi D, 2010, NEUROIMAGE, V49, P1886, DOI 10.1016/j.neuroimage.2009.08.068; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Qin JG, 2009, NEUROPSYCHOLOGIA, V47, P397, DOI 10.1016/j.neuropsychologia.2008.09.010; Reavis R, 2001, BEHAV NEUROSCI, V115, P196, DOI 10.1037//0735-7044.115.1.196; Reynaud M, 2002, USAGES NOCIFS SUBSTA; Rigoni D, 2010, BRAIN RES BULL, V81, P445, DOI 10.1016/j.brainresbull.2009.12.003; Rogers RD, 2011, NEUROPSYCHOPHARMACOL, V36, P114, DOI 10.1038/npp.2010.165; Schuermann B, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00204; Singh V, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00944; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; van Honk J, 2003, NEUROREPORT, V14, P1993, DOI 10.1097/00001756-200310270-00023; Wang Y, 2014, NEUROREPORT, V25, P110, DOI 10.1097/WNR.0000000000000077; Xu LJ, 2009, BRAIN RES, V1261, P65, DOI 10.1016/j.brainres.2008.12.061; Yao SN, 1999, ENCEPHALE, V25, P429; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	79	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130871	10.1371/journal.pone.0130871	http://dx.doi.org/10.1371/journal.pone.0130871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NT	26086196	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500137
J	Mollet, P; Kery, M; Gardner, B; Pasinelli, G; Royle, JA				Mollet, Pierre; Kery, Marc; Gardner, Beth; Pasinelli, Gilberto; Royle, J. Andrew			Estimating Population Size for Capercaillie (Tetrao urogallus L.) with Spatial Capture-Recapture Models Based on Genotypes from One Field Sample	PLOS ONE			English	Article							ESTIMATING ANIMAL ABUNDANCE; MATING SYSTEMS; ORGANIZATION; EVOLUTION; FRAMEWORK; INFERENCE; WINBUGS; DENSITY; ADULT; SEX	We conducted a survey of an endangered and cryptic forest grouse, the capercaillie Tetrao urogallus, based on droppings collected on two sampling occasions in eight forest fragments in central Switzerland in early spring 2009. We used genetic analyses to sex and individually identify birds. We estimated sex-dependent detection probabilities and population size using a modern spatial capture-recapture (SCR) model for the data from pooled surveys. A total of 127 capercaillie genotypes were identified (77 males, 46 females, and 4 of unknown sex). The SCR model yielded atotal population size estimate (posterior mean) of 137.3 capercaillies (posterior sd 4.2, 95% CRI 130-147). The observed sex ratio was skewed towards males (0.63). The posterior mean of the sex ratio under the SCR model was 0.58 (posterior sd 0.02, 95% CRI 0.54-0.61), suggesting a male-biased sex ratio in our study area. A subsampling simulation study indicated that a reduced sampling effort representing 75% of the actual detections would still yield practically acceptable estimates of total size and sex ratio in our population. Hence, field work and financial effort could be reduced without compromising accuracy when the SCR model is used to estimate key population parameters of cryptic species.	[Mollet, Pierre; Kery, Marc; Pasinelli, Gilberto] Swiss Ornithol Inst, CH-6204 Sempach, Switzerland; [Gardner, Beth] N Carolina State Univ, Raleigh, NC 27695 USA; [Royle, J. Andrew] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA	Swiss Ornithological Institute; University of North Carolina; North Carolina State University; United States Department of the Interior; United States Geological Survey	Mollet, P (corresponding author), Swiss Ornithol Inst, Seerose 1, CH-6204 Sempach, Switzerland.	pierre.mollet@vogelwarte.ch		Royle, Jeffrey/0000-0003-3135-2167	Swiss federal office for the environment; Stiftung Naturland; Ausbildungsstiftung fur den Kanton Schwyz und den Bezirk Gaster	Swiss federal office for the environment; Stiftung Naturland; Ausbildungsstiftung fur den Kanton Schwyz und den Bezirk Gaster	Swiss federal office for the environment (http://www.bafu.admin.ch/); Stiftung Naturland (http://www.naturland.ch/); Ausbildungsstiftung fur den Kanton Schwyz und den Bezirk Gaster (Kanton St. Gallen) (No Webpage). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Bollmann K, 2005, FOREST ECOL MANAG, V215, P307, DOI 10.1016/j.foreco.2005.05.019; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borchers D.L., 2002, ESTIMATING ANIMAL AB; Borchers D, 2012, J ORNITHOL, V152, pS435, DOI 10.1007/s10336-010-0583-z; CURRY RL, 1989, J ANIM ECOL, V58, P441, DOI 10.2307/4841; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Efford Murry, 2004, Oikos, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; GILKS WR, 1994, J R STAT SOC D-STAT, V43, P169, DOI DOI 10.2307/2348941; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hjorth I., 1970, VILTREVY, V7, P183; Illian J, 2008, STAT ANAL MODELLING; Jacob G, 2010, CONSERV GENET, V11, P33, DOI 10.1007/s10592-008-9794-8; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller V., 2010, ROTE LISTE BRUTVOGEL; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2011, CONSERV BIOL, V25, P356, DOI 10.1111/j.1523-1739.2010.01616.x; Linden Harto, 1996, Finnish Game Research, V49, P4; Lukacs PM, 2005, MOL ECOL, V14, P3909, DOI 10.1111/j.1365-294X.2005.02717.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Marti C., 1986, Ornithologische Beobachter, V83, P67; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Mollet Pierre, 2003, Ornithologische Beobachter, V100, P67; Moran-Luis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099799; OTIS DL, 1978, WILDLIFE MONOGR, P1; Piertney SB, 2001, MOL ECOL NOTES, V1, P303, DOI 10.1046/j.1471-8278.2001.00118.x; Rajala P., 1974, Riistatieteellisia Julk, V35, P1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2007, J COMPUT GRAPH STAT, V16, P67, DOI 10.1198/106186007X181425; Royle JA, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00148.1; Royle JA, 2011, METHODS ECOL EVOL, V2, P602, DOI 10.1111/j.2041-210X.2011.00116.x; Royle J. Andrew, 2012, Journal of Ornithology, V152, pS521, DOI 10.1007/s10336-010-0619-4; Royle JA, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P163, DOI 10.1007/978-4-431-99495-4_10; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, SPATIAL CAPTURE RECA; Russell RE, 2012, J WILDLIFE MANAGE, V76, P1551, DOI 10.1002/jwmg.412; Schwarz CJ, 1999, STAT SCI, V14, P427; Segelbacher G, 2000, MOL ECOL, V9, P1934, DOI 10.1046/j.1365-294x.2000.0090111934.x; Segelbacher G, 2002, MOL ECOL NOTES, V2, P367, DOI 10.1046/j.1471-8286.2002.00180.x; Storch I, 1997, WILDLIFE BIOL, V3, P149, DOI 10.2981/wlb.1997.019; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Thompson CM, 2012, J WILDLIFE MANAGE, V76, P863, DOI 10.1002/jwmg.317; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WEGGE P, 1987, AUK, V104, P481, DOI 10.2307/4087547; WILEY RH, 1974, Q REV BIOL, V49, P201, DOI 10.1086/408083; Williams BK, 2002, ANAL MANAGEMENT ANIM; WITTENBERGER JF, 1978, CONDOR, V80, P126, DOI 10.2307/1367912	55	25	28	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129020	10.1371/journal.pone.0129020	http://dx.doi.org/10.1371/journal.pone.0129020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087321	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500032
J	Vassell, R; He, Y; Vennakalanti, P; Dey, AK; Zhuang, M; Wang, W; Sun, Y; Biron-Sorek, Z; Srivastava, IK; LaBranche, CC; Montefiori, DC; Barnett, SW; Weiss, CD				Vassell, Russell; He, Yong; Vennakalanti, Prasad; Dey, Antu K.; Zhuang, Min; Wang, Wei; Sun, Yide; Biron-Sorek, Zohar; Srivastava, Indresh K.; LaBranche, Celia C.; Montefiori, David C.; Barnett, Susan W.; Weiss, Carol D.			Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODY; CELL-CELL FUSION; TYPE-1 GP41; VACCINE DESIGN; POTENT NEUTRALIZATION; ANTIGENIC PROPERTIES; LENTIVIRAL VECTOR; EPITOPE-SCAFFOLDS	The membrane proximal external region (MPER) of the gp41 subunit of the HIV-1 envelope glycoprotein (Env) contains determinants for broadly neutralizing antibodies and has remained an important focus of vaccine design. However, creating an immunogen that elicits broadly neutralizing antibodies to this region has proven difficult in part due to the relative inaccessibility of the MPER in the native conformation of Env. Here, we describe the antigenicity and immunogenicity of a panel of oligomeric gp41 immunogens designed to model a fusion-intermediate conformation of Env in order to enhance MPER exposure in a relevant conformation. The immunogens contain segments of the gp41 N- and C-heptad repeats to mimic a trapped intermediate, followed by the MPER, with variations that include different N-heptad lengths, insertion of extra epitopes, and varying C-termini. These well-characterized immunogens were evaluated in two different immunization protocols involving gp41 and gp140 proteins, gp41 and gp160 DNA primes, and different immunization schedules and adjuvants. We found that the immunogens designed to reduce extension of helical structure into the MPER elicited the highest MPER antibody binding titers, but these antibodies lacked neutralizing activity. The gp41 protein immunogens also elicited higher MPER titers than the gp140 protein immunogen. In prime-boost studies, the best MPER responses were seen in the groups that received DNA priming with gp41 vectors followed by gp41 protein boosts. Finally, although titers to the entire protein immunogen were similar in the two immunization protocols, MPER-specific titers differed, suggesting that the immunization route, schedule, dose, or adjuvant may differentially influence MPER immunogenicity. These findings inform the design of future MPER immunogens and immunization protocols.	[Vassell, Russell; He, Yong; Vennakalanti, Prasad; Zhuang, Min; Wang, Wei; Weiss, Carol D.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Dey, Antu K.; Sun, Yide; Biron-Sorek, Zohar; Srivastava, Indresh K.; Barnett, Susan W.] Novartis Vaccines & Diagnost, Cambridge, MA USA; [Zhuang, Min] Harbin Med Univ, Dept Microbiol, Heilongjiang, Peoples R China; [LaBranche, Celia C.; Montefiori, David C.] Duke Med Ctr, Dept Surg, Durham, NC USA	US Food & Drug Administration (FDA); Novartis; Harbin Medical University; Duke University	Weiss, CD (corresponding author), US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	carol.weiss@fda.hhs.gov	Weiss, Carol D./F-6438-2011	Weiss, Carol D./0000-0002-9965-1289; Prasad, VVSP/0000-0002-2029-1525; Dey, Antu/0000-0001-7438-9379	National Institutes of Health, National Institute of Allergy and Infectious Diseases [P01 AI066287, RFA/PA PAR03-094]; Novartis Vaccines and Diagnostics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066287] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Novartis Vaccines and Diagnostics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health, National Institute of Allergy and Infectious Diseases grant P01 AI066287 to SWB responsive to RFA/PA PAR03-094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FDA institutional funds to CDW: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors clarify that Novartis Vaccines and Diagnostics provided support in the form of salaries for authors AKD, YS, ZB-S, IKS and SWB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; BRODSKY MH, 1990, J IMMUNOL, V144, P3078; Buonaguro L, 2013, EXPERT REV VACCINES, V12, P119, DOI [10.1586/erv.12.152, 10.1586/ERV.12.152]; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cavacini LA, 2002, AIDS, V16, P2409, DOI 10.1097/00002030-200212060-00005; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; Chen W, 2008, AIDS RES HUM RETROV, V24, P11; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; Finnegan CM, 2002, J VIROL, V76, P12123, DOI 10.1128/JVI.76.23.12123-12134.2002; Finnegan CM, 2001, J VIROL, V75, P11096, DOI 10.1128/JVI.75.22.11096-11105.2001; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; He Y, 2007, J INFECT DIS, V196, P1026, DOI 10.1086/520936; Hinz A, 2009, VIROLOGY, V390, P221, DOI 10.1016/j.virol.2009.05.015; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Kim M, 2013, J BIOL CHEM, V288, P31888, DOI 10.1074/jbc.M113.494609; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Koff WC, 2012, VACCINE, V30, P4310, DOI 10.1016/j.vaccine.2011.11.014; Krebs SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113463; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lian Y, 2005, J VIROL, V79, P13338, DOI 10.1128/JVI.79.21.13338-13349.2005; Lu M, 1999, J VIROL, V73, P4433, DOI 10.1128/JVI.73.5.4433-4438.1999; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2014, J VIROL, V88, P2426, DOI 10.1128/JVI.02837-13; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Phogat S, 2008, VIROLOGY, V373, P72, DOI 10.1016/j.virol.2007.11.005; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P147, DOI 10.1016/j.jim.2014.02.013; SATTENTAU QJ, 1995, VIROLOGY, V206, P713, DOI 10.1016/S0042-6822(95)80094-8; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WANG JR, 2011, ELECTRON J QUAL THEO, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018233; WILD C, 1995, AIDS RES HUM RETROV, V11, P323, DOI 10.1089/aid.1995.11.323; Wingfield PT, 1997, PROTEIN SCI, V6, P1653, DOI 10.1002/pro.5560060806; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zhuang M, 2012, J BIOL CHEM, V287, P8297, DOI 10.1074/jbc.M111.324483; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	97	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128562	10.1371/journal.pone.0128562	http://dx.doi.org/10.1371/journal.pone.0128562			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087072	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500017
J	Burke, A; Nahin, RL; Stussman, BJ				Burke, Adam; Nahin, Richard L.; Stussman, Barbara J.			Limited Health Knowledge as a Reason for Non-Use of Four Common Complementary Health Practices	PLOS ONE			English	Article							LOW-BACK-PAIN; UNITED-STATES; ALTERNATIVE MEDICINE; CHRONIC DISEASE; LITERACY; ASSOCIATION; INCOME; ADULTS; INTERVENTIONS; EPIDEMIOLOGY	Background Complementary health practices are an important element of health/healthcare seeking behavior among adults in the United States. Reasons for use include medical need, prevention and wellness promotion, and cultural relevance. Survey studies published over the past several decades have provided important information on the use of complementary health practices, such as acupuncture and yoga. A review of the literature, however, reveals an absence of studies looking specifically at who does not use these approaches, and why not. Methods To explore this issue two samples were created using data from the 2007 National Health Interview Survey Complementary and Alternative Medicine supplement. Of particular interest was the relationship between lack of health knowledge, as a reason for non-use, and key independent variables. The first sample was comprised of individuals who had never used any of four common complementary health practices - acupuncture, chiropractic, natural products, and yoga. The second was a subset of those same non-users who had also reported low back pain, the most frequently cited health concern related to use of complementary therapies. Results A hypothesized association between lack of health knowledge, lower educational attainment, and other key socioeconomic indicators was supported in the findings. Although it was hypothesized that low back pain would be associated with greater information seeking, regardless of level of education, that hypothesis was not supported. Conclusion Lack of knowledge was found to affect utilization of common complementary health practices, regardless of the potentially motivating presence of back pain. Disparities in the utilization of complementary medicine, related to educational attainment and other socioeconomic factors, may negatively affect quality of care for many Americans. Creative approaches are needed to help reduce inequities in understanding and improve access to care for underserved populations.	[Burke, Adam] San Francisco State Univ, Inst Holist Hlth Studies, Dept Hlth Educ, San Francisco, CA 94132 USA; [Nahin, Richard L.; Stussman, Barbara J.] NIH, Natl Ctr Complementary & Integrat Hlth, Bethesda, MD USA	California State University System; San Francisco State University; National Institutes of Health (NIH) - USA	Burke, A (corresponding author), San Francisco State Univ, Inst Holist Hlth Studies, Dept Hlth Educ, San Francisco, CA 94132 USA.	aburke@sfsu.edu						ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; [Anonymous], 2014, CHIR SERV; Bains SS, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-138; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Barnes Patricia M, 2004, Adv Data, P1; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Benjamin-Garner Ruby, 2002, Ethnicity and Disease, V12, P124; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Burke A, 2012, ENCY LIFESTYLE MED H, P706; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cui Y, 2012, J ALTERN COMPLEM MED, V18, P844, DOI 10.1089/acm.2011.0363; Daley A, 2006, CLIMACTERIC, V9, P336, DOI 10.1080/13697130600864074; Deyo RA, 2015, PHYS THER, V95, P159, DOI 10.2522/ptj.2015.95.2.e1; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; Dunn K M, 2004, Eura Medicophys, V40, P9; Garcia Tamyra Carroll, 2010, NCHS Data Brief, P1; Gardiner P, 2013, J HEALTH COMMUN, V18, P290, DOI 10.1080/10810730.2013.830663; Gazmararian JA, 2003, PATIENT EDUC COUNS, V51, P267, DOI 10.1016/S0738-3991(02)00239-2; Goff DC, 1998, ARCH INTERN MED, V158, P2329, DOI 10.1001/archinte.158.21.2329; Gray Carolyn M, 2002, Eff Clin Pract, V5, P17; Homayoon B, 2013, AM J CLIN ONCOL-CANC, V36, P167, DOI 10.1097/COC.0b013e3182439068; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Institute of Medicine, 2004, HLTH LITERACY PRESCR; Kutner M, 2006, 2006483 NCES; Long SK, 2009, EMERGENCY DEP VISITS; Macabasco-O'Connell A, 2011, J GEN INTERN MED, V26, P979, DOI 10.1007/s11606-011-1668-y; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P35; Marmot M, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.2.31; Martin LT, 2009, J GEN INTERN MED, V24, P1211, DOI 10.1007/s11606-009-1105-7; McIntosh Aileen, 2003, Health Expect, V6, P19, DOI 10.1046/j.1369-6513.2003.00197.x; Mosher HJ, 2012, J HEALTH COMMUN, V17, P241, DOI 10.1080/10810730.2012.712611; Muir KW, 2012, PATIENT EDUC COUNS, V87, P160, DOI 10.1016/j.pec.2011.09.009; Muller A, 2002, BRIT MED J, V324, P23, DOI 10.1136/bmj.324.7328.23; Nahin RL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-217; Nahin RL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-220; National Center for Health Statistics, 2012, HLTH US 2011 SPEC FE; Ni HY, 2002, MED CARE, V40, P353, DOI 10.1097/00005650-200204000-00011; Rahman M, 2012, J AM COLL NUTR, V31, P397, DOI 10.1080/07315724.2012.10720465; Research Triangle Institute, 2009, SUDAAN REL 10 0 1; Robinson AR, 2002, PREV MED, V34, P51, DOI 10.1006/pmed.2001.0950; Rogers RG, 2013, POPUL RES POLICY REV, V32, P325, DOI 10.1007/s11113-013-9268-7; Saper RB, 2004, ALTERN THER HEALTH M, V10, P44; SAS Institute, 2008, SAS REL 10 0 1; Savoia E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-328; Saydah SH, 2006, J ALTERN COMPLEM MED, V12, P805, DOI 10.1089/acm.2006.12.805; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Schoenborn Charlotte A, 2010, Vital Health Stat 10, P1; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Tindle HA, 2005, ALTERN THER HEALTH M, V11, P42; Viswanath K, 2006, EXAMINING HLTH DISPA, P215; Weiss B, 2007, HLTH LIT PATIENT SAF; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Wolf MS, 2005, ARCH INTERN MED, V165, P1946, DOI 10.1001/archinte.165.17.1946; Zhang Y, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/710750	54	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129336	10.1371/journal.pone.0129336	http://dx.doi.org/10.1371/journal.pone.0129336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NS	26083564	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400088
J	Sumpf, M; Jentschke, S; Koelsch, S				Sumpf, Maria; Jentschke, Sebastian; Koelsch, Stefan			Effects of Aesthetic Chills on a Cardiac Signature of Emotionality	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; T-WAVE ALTERNANS; PANIC DISORDER; MUSIC; DEPRESSION; NEUROFEEDBACK; STRESS; MARKER	Background Previous studies have shown that a cardiac signature of emotionality (referred to as E-K, which can be computed from the standard 12 lead electrocardiogram, ECG), predicts inter-individual differences in the tendency to experience and express positive emotion. Here, we investigated whether E-K values can be transiently modulated during stimulation with participant-selected music pieces and film scenes that elicit strongly positive emotion. Methodology/Principal Findings The phenomenon of aesthetic chills, as indicated by measurable piloerection on the forearm, was used to accurately locate moments of peak emotional responses during stimulation. From 58 healthy participants, continuous E-K values, heart rate, and respiratory frequency were recorded during stimulation with film scenes and music pieces, and were related to the aesthetic chills. E-K values, as well as heart rate, increased significantly during moments of peak positive emotion accompanied by piloerection. Conclusions/Significance These results are the first to provide evidence for an influence of momentary psychological state on a cardiac signature of emotional personality (as reflected in E-K values). The possibility to modulate ECG amplitude signatures via stimulation with emotionally significant music pieces and film scenes opens up new perspectives for the use of emotional peak experiences in the therapy of disorders characterized by flattened emotionality, such as depression or schizoid personality disorder.	[Sumpf, Maria; Jentschke, Sebastian; Koelsch, Stefan] Free Univ Berlin, Cluster Languages Emot, Berlin, Germany	Free University of Berlin	Koelsch, S (corresponding author), Free Univ Berlin, Cluster Languages Emot, Berlin, Germany.	koelsch@cbs.mpg.de	Koelsch, Stefan/AAV-1556-2020; Jentschke, Sebastian/C-1618-2008	Jentschke, Sebastian/0000-0003-2576-5432; Koelsch, Stefan/0000-0002-8714-3404	German Federal Ministry of Education and Research (BMBF)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was funded by the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour JA, 2004, BASIC AND CLINICAL N; Baehr E., 2001, J NEUROTHER, V4, P11, DOI [10.1300/J184v04n04_03, DOI 10.1300/J184V04N04_03]; Bailon R, 2006, IEEE T BIO-MED ENG, V53, P1273, DOI 10.1109/TBME.2006.871888; Benedek M, 2011, BIOL PSYCHOL, V86, P320, DOI 10.1016/j.biopsycho.2010.12.012; Benedek M, 2010, PSYCHOPHYSIOLOGY, V47, P989, DOI 10.1111/j.1469-8986.2010.01003.x; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bloomfield DM, 2004, CIRCULATION, V110, P1885, DOI 10.1161/01.CIR.0000143160.14610.53; Brattico E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00308; Cacioppo J.T., 2000, HDB EMOTIONS, P173, DOI DOI 10.1017/CBO9780511546396.025; Camm AJ, 1996, CIRCULATION, V93, P1043; Carney RM, 2001, CIRCULATION, V104, P2024, DOI 10.1161/hc4201.097834; Chechetto D, 2004, BASIC CLIN NEUROCARD, P220; Costa PT, 1992, PSYCHOLOGICAL ASSESS; Craig DG, 2005, MUSIC SCI, V9, P273, DOI 10.1177/102986490500900207; Friedman BH, 1998, J PSYCHOSOM RES, V44, P133, DOI 10.1016/S0022-3999(97)00202-X; GOLDSTEIN A, 1980, PHYSIOL PSYCHOL, V8, P126; Gray MA, 2012, EMOTION, V12, P180, DOI 10.1037/a0025083; Grewe O, 2007, MUSIC PERCEPT, V24, P297, DOI 10.1525/MP.2007.24.3.297; Grewe O, 2011, PSYCHOL MUSIC, V39, P220, DOI 10.1177/0305735610362950; Grewe O, 2009, ANN NY ACAD SCI, V1169, P351, DOI 10.1111/j.1749-6632.2009.04783.x; Guhn M, 2007, MUSIC PERCEPT, V24, P473, DOI 10.1525/MP.2007.24.5.473; HAKKI AH, 1984, J AM COLL CARDIOL, V3, P1155, DOI 10.1016/S0735-1097(84)80172-2; Hammond DC, 2005, J ADULT DEV, V12, P131, DOI 10.1007/s10804-005-7029-5; Hammond DC., 2000, J NEUROTHER, V4, P45, DOI [10.1300/J184v04n02_06, DOI 10.1300/J184V04N02_06]; Hohnloser SH, 1998, J CARDIOVASC ELECTR, V9, P1258, DOI 10.1111/j.1540-8167.1998.tb00101.x; Kaernbach C., 2015, PHYSICS OF LIFE REVI; Koelsch S, 2007, EUR J NEUROSCI, V26, P3328, DOI 10.1111/j.1460-9568.2007.05889.x; Koelsch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077196; Koelsch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031441; Konecni VJ, 2007, AM J PSYCHOL, V120, P619, DOI 10.2307/20445428; Korner A., 2008, Z FUER MEDIZINISCHE, V17, P133; McCrae RR, 2007, MOTIV EMOTION, V31, P5, DOI 10.1007/s11031-007-9053-1; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; Nagel F, 2008, MUSIC SCI, V12, P101, DOI 10.1177/102986490801200106; Panksepp J, 1995, MUSIC PERCEPT, V13, P171; Raymond J, 2005, COGNITIVE BRAIN RES, V23, P287, DOI 10.1016/j.cogbrainres.2004.10.023; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Rosenfeld JP, 2000, CLIN ELECTROENCEPHAL, V31, P7, DOI 10.1177/155005940003100106; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Scherer K. R., 2001, MUSIC EMOTION THEORY, DOI DOI 10.1016/j.jsams.2011.06.003; Shiota MN, 2011, EMOTION AND THE BODY, P83; Silvia PJ, 2011, PSYCHOL AESTHET CREA, V5, P208, DOI 10.1037/a0021914; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Taruffi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110490; TAYLOR GJ, 1992, PSYCHOTHER PSYCHOSOM, V57, P34, DOI 10.1159/000288571; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Yeragani VK, 2000, PSYCHIAT RES, V93, P225, DOI 10.1016/S0165-1781(00)00119-0; Yeragani VK, 2002, BIOL PSYCHIAT, V51, P733, DOI 10.1016/S0006-3223(01)01347-6; YERAGANI VK, 1993, PSYCHIAT RES, V46, P89, DOI 10.1016/0165-1781(93)90011-5; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	52	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130117	10.1371/journal.pone.0130117	http://dx.doi.org/10.1371/journal.pone.0130117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083383	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400125
J	Bhowmik, AK; Schafer, RB				Bhowmik, Avit Kumar; Schaefer, Ralf B.			Large Scale Relationship between Aquatic Insect Traits and Climate	PLOS ONE			English	Article							MACROINVERTEBRATE COMMUNITIES; STREAM MACROINVERTEBRATES; PATTERNS; INVERTEBRATES; VULNERABILITY; SENSITIVITY; EVOLUTION; IMPACTS; ECOLOGY; OXYGEN	Climate is the predominant environmental driver of freshwater assemblage pattern on large spatial scales, and traits of freshwater organisms have shown considerable potential to identify impacts of climate change. Although several studies suggest traits that may indicate vulnerability to climate change, the empirical relationship between freshwater assemblage trait composition and climate has been rarely examined on large scales. We compared the responses of the assumed climate-associated traits from six grouping features to 35 bioclimatic indices (similar to 18 km resolution) for five insect orders (Diptera, Ephemeroptera, Odonata, Plecoptera and Trichoptera), evaluated their potential for changing distribution pattern under future climate change and identified the most influential bioclimatic indices. The data comprised 782 species and 395 genera sampled in 4,752 stream sites during 2006 and 2007 in Germany (similar to 357,000 km(2) spatial extent). We quantified the variability and spatial autocorrelation in the traits and orders that are associated with the combined and individual bioclimatic indices. Traits of temperature preference grouping feature that are the products of several other underlying climate-associated traits, and the insect order Ephemeroptera exhibited the strongest response to the bioclimatic indices as well as the highest potential for changing distribution pattern. Regarding individual traits, insects in general and ephemeropterans preferring very cold temperature showed the highest response, and the insects preferring cold and trichopterans preferring moderate temperature showed the highest potential for changing distribution. We showed that the seasonal radiation and moisture are the most influential bioclimatic aspects, and thus changes in these aspects may affect the most responsive traits and orders and drive a change in their spatial distribution pattern. Our findings support the development of trait-based metrics to predict and detect climate-related changes of freshwater assemblages.	[Bhowmik, Avit Kumar; Schaefer, Ralf B.] Univ Koblenz Landau, Inst Environm Sci, Quantitat Landscape Ecol, Landau In Der Pfalz, Germany	University of Koblenz & Landau	Bhowmik, AK (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Quantitat Landscape Ecol, Landau In Der Pfalz, Germany.	bhowmik@uni-landau.de	Bhowmik, Avit/C-4820-2013; Bhowmik, Avit/AEW-6934-2022; Schaefer, Ralf/E-1926-2011	Bhowmik, Avit/0000-0002-7137-0741; Schaefer, Ralf/0000-0003-3510-1701				AQEM CONSORTIUM, 2002, MAN APPL AQ SYST COM; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Biss R, 2006, 29824777 UMW BUND UM, P1; Bivand RS, 2008, USE R, P1; Bonada N, 2007, GLOBAL CHANGE BIOL, V13, P1658, DOI 10.1111/j.1365-2486.2007.01375.x; Bonada N, 2012, J BIOGEOGR, V39, P56, DOI 10.1111/j.1365-2699.2011.02562.x; Brittain JE., 2008, INT ADV ECOLOGY ZOOG, P1, DOI DOI 10.1525/CALIFORNIA/9780520098688.003.0001; Conti L, 2014, HYDROBIOLOGIA, V721, P297, DOI 10.1007/s10750-013-1690-7; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Department of Applied Zoology/Hydrobiology University Duisburg- Essen Germany (DZHUDE), 2008, DEV TEST INT ASS SYS; Deutscher Wetterdienst (DW), 2014, WEATH CLIM DTSCH WET; Doledec S, 2006, J N AM BENTHOL SOC, V25, P44, DOI 10.1899/0887-3593(2006)25[44:COSAFA]2.0.CO;2; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; Domisch S, 2011, FRESHWATER BIOL, V56, P2009, DOI 10.1111/j.1365-2427.2011.02631.x; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; Floury M, 2013, GLOBAL CHANGE BIOL, V19, P1085, DOI 10.1111/gcb.12124; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Harrison JF, 2010, P ROY SOC B-BIOL SCI, V277, P1937, DOI 10.1098/rspb.2010.0001; Heino J, 2013, FRESHWATER BIOL, V58, P1539, DOI 10.1111/fwb.12164; Hering D, 2009, AQUAT SCI, V71, P3, DOI 10.1007/s00027-009-9159-5; Hershkovitz Y, 2015, ECOL INDIC, V50, P150, DOI 10.1016/j.ecolind.2014.10.023; Hijmans R.J., 2010, RASTER GEOGRAPHIC AN; Kotiaho JS, 2005, P NATL ACAD SCI USA, V102, P1963, DOI 10.1073/pnas.0406718102; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Lancaster J, 2010, RIVER RES APPL, V26, P921, DOI 10.1002/rra.1425; Lancaster J, 2010, RIVER RES APPL, V26, P385, DOI 10.1002/rra.1274; Larsen S, 2010, BIOL CONSERV, V143, P2638, DOI 10.1016/j.biocon.2010.07.006; Lawrence JE, 2010, J N AM BENTHOL SOC, V29, P1424, DOI 10.1899/09-178.1; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lewin-Koh N., 2011, MAPTOOLS TOOLS READI; Ministry of Economy Trade and Industry, 2020, ENV MANAGEMENT ACCOU; Mlambo MC, 2014, BIODIVERS CONSERV, V23, P781, DOI 10.1007/s10531-014-0618-5; Nishii R, 2013, ENVIRON ECOL STAT, V20, P315, DOI 10.1007/s10651-012-0227-y; Oksanen J., 2007, COMMUN ECOL PACK, P631; Ospina R, 2012, COMPUT STAT DATA AN, V56, P1609, DOI 10.1016/j.csda.2011.10.005; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Poff NL, 2010, J N AM BENTHOL SOC, V29, P1441, DOI 10.1899/10-030.1; R Core Team, 2021, R LANGUAGE ENV STAT; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rolauffs P, 2003, UMWELTBUNDESAMT TEXT, P1; Sandin L, 2014, CURR ZOOL, V60, P221, DOI 10.1093/czoolo/60.2.221; Schmera D, 2015, FRESHW SCI, V34, P823, DOI 10.1086/681623; Schmera D, 2014, FRESHWATER BIOL, V59, P1551, DOI 10.1111/fwb.12369; Schmidt-Kloiber A, 2004, HYDROBIOLOGIA, V516, P269, DOI 10.1023/B:HYDR.0000025270.10807.10; Schmidt-Kloiber A, 2015, ECOL INDIC, V53, P271, DOI 10.1016/j.ecolind.2015.02.007; Stamp JD, 2010, J N AM BENTHOL SOC, V29, P1410, DOI 10.1899/10-003.1; Statzner B, 2010, FRESHWATER BIOL, V55, P80, DOI 10.1111/j.1365-2427.2009.02369.x; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; de Figueroa JMT, 2010, BIODIVERS CONSERV, V19, P1269, DOI 10.1007/s10531-009-9753-9; Usseglio-Polatera P, 2000, HYDROBIOLOGIA, V422, P153, DOI 10.1023/A:1017042921298; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Verberk WCEP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0473; Verberk WCEP, 2013, FUNCT ECOL, V27, P1275, DOI 10.1111/1365-2435.12152; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; Zeuss D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4874	62	15	14	5	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0130025	10.1371/journal.pone.0130025	http://dx.doi.org/10.1371/journal.pone.0130025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080074	Green Published, Green Submitted, gold			2022-12-26	WOS:000356542300038
J	Koenig, P; Lee, CV; Sanowar, S; Wu, P; Stinson, J; Harris, SF; Fuh, G				Koenig, Patrick; Lee, Chingwei V.; Sanowar, Sarah; Wu, Ping; Stinson, Jeremy; Harris, Seth F.; Fuh, Germaine			Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; 2-IN-ONE ANTIBODY; MATURATION; BINDING; CONFORMATIONS; LIBRARIES; STRATEGY; DISPLAY; DOMAIN; VEGF	The development of dual targeting antibodies promises therapies with improved efficacy over mono-specific antibodies. Here, we engineered a Two-in-One VEGF/angiopoietin 2 antibody with dual action Fab (DAF) as a potential therapeutic for neovascular age-related macular degeneration. Crystal structures of the VEGF/angiopoietin 2 DAF in complex with its two antigens showed highly overlapping binding sites. To achieve sufficient affinity of the DAF to block both angiogenic factors, we turned to deep mutational scanning in the complementarity determining regions (CDRs). By mutating all three CDRs of each antibody chain simultaneously, we were able not only to identify affinity improving single mutations but also mutation pairs from different CDRs that synergistically improve both binding functions. Furthermore, insights into the cooperativity between mutations allowed us to identify fold-stabilizing mutations in the CDRs. The data obtained from deep mutational scanning reveal that the majority of the 52 CDR residues are utilized differently for the two antigen binding function and permit, for the first time, the engineering of several DAF variants with subnanomolar affinity against two structurally unrelated antigens. The improved variants show similar blocking activity of receptor binding as the high affinity mono-specific antibodies against these two proteins, demonstrating the feasibility of generating a dual specificity binding surface with comparable properties to individual high affinity mono-specific antibodies.	[Koenig, Patrick; Lee, Chingwei V.; Sanowar, Sarah; Fuh, Germaine] Genentech Res & Early Dev, Dept Antibody Engn, San Francisco, CA 94080 USA; [Stinson, Jeremy] Genentech Res & Early Dev, Dept Mol Biol, San Francisco, CA 94080 USA; [Wu, Ping; Harris, Seth F.] Genentech Res & Early Dev, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Fuh, G (corresponding author), Genentech Res & Early Dev, Dept Antibody Engn, San Francisco, CA 94080 USA.	gml@gene.com			Genentech, Inc., a member of the Roche Group	Genentech, Inc., a member of the Roche Group	All authors are paid employees of Genentech, Inc., a member of the Roche Group, and are inventors of a patent application based on the work described herein.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; Bostrom Jenny, 2009, V525, P353, DOI 10.1007/978-1-59745-554-1_19; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Bricogne G., 2011, BUSTER; Campagne MV, 2014, J PATHOL, V232, P151, DOI 10.1002/path.4266; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Cauerhff A, 2004, P NATL ACAD SCI USA, V101, P3539, DOI 10.1073/pnas.0400060101; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Christinger HW, 1996, PROTEINS, V26, P353, DOI 10.1002/(SICI)1097-0134(199611)26:3<353::AID-PROT9>3.0.CO;2-E; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Forsyth CM, 2013, MABS-AUSTIN, V5, P523, DOI 10.4161/mabs.24979; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Fujino Y, 2012, BIOCHEM BIOPH RES CO, V428, P395, DOI 10.1016/j.bbrc.2012.10.066; Hotzel I, 2012, MABS-AUSTIN, V4, P753, DOI 10.4161/mabs.22189; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee CV, 2006, BLOOD, V108, P3103, DOI 10.1182/blood-2006-03-011031; Lee CV, 2014, MABS-AUSTIN, V6, P622, DOI 10.4161/mabs.28483; Lee CV, 2004, J IMMUNOL METHODS, V284, P119, DOI 10.1016/j.jim.2003.11.001; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Li B, 2014, MABS-AUSTIN, V6, P437, DOI 10.4161/mabs.27875; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Morea V, 1998, J MOL BIOL, V275, P269, DOI 10.1006/jmbi.1997.1442; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; R Core Team, 2021, R LANGUAGE ENV STAT; Rajpal A, 2005, P NATL ACAD SCI USA, V102, P8466, DOI 10.1073/pnas.0503543102; Rennel ES, 2011, MICROCIRCULATION, V18, P598, DOI 10.1111/j.1549-8719.2011.00120.x; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rosenfeld Philip J, 2006, Ophthalmol Clin North Am, V19, P361; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Skinner MM, 1996, P NATL ACAD SCI USA, V93, P10753, DOI 10.1073/pnas.93.20.10753; Thurston G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006650; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu HR, 1998, P NATL ACAD SCI USA, V95, P6037, DOI 10.1073/pnas.95.11.6037	50	28	33	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21773	21786		10.1074/jbc.M115.662783	http://dx.doi.org/10.1074/jbc.M115.662783			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26088137	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000360968500001
J	Louzolo, A; Kalckert, A; Petrovic, P				Louzolo, Anais; Kalckert, Andreas; Petrovic, Predrag			When Passive Feels Active - Delusion-Proneness Alters Self-Recognition in the Moving Rubber Hand Illusion	PLOS ONE			English	Article							SENSORY PREDICTION; PSYCHOSIS; AGENCY; BODY; IDEATION; HALLUCINATIONS; SCHIZOPHRENIA; OWNERSHIP; MOVEMENT; KETAMINE	Psychotic patients have problems with bodily self-recognition such as the experience of self-produced actions (sense of agency) and the perception of the body as their own (sense of ownership). While it has been shown that such impairments in psychotic patients can be explained by hypersalient processing of external sensory input it has also been suggested that they lack normal efference copy in voluntary action. However, it is not known how problems with motor predictions like efference copy contribute to impaired sense of agency and ownership in psychosis or psychosis-related states. We used a rubber hand illusion based on finger movements and measured sense of agency and ownership to compute a bodily self-recognition score in delusion-proneness (indexed by Peters' Delusion Inventory - PDI). A group of healthy subjects (n=71) experienced active movements (involving motor predictions) or passive movements (lacking motor predictions). We observed a highly significant correlation between delusion-proneness and self-recognition in the passive conditions, while no such effect was observed in the active conditions. This was seen for both ownership and agency scores. The result suggests that delusion-proneness is associated with hypersalient external input in passive conditions, resulting in an abnormal experience of the illusion. We hypothesize that this effect is not present in the active condition because deficient motor predictions counteract hypersalience in psychosis proneness.	[Louzolo, Anais; Petrovic, Predrag] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Kalckert, Andreas] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Kalckert, A (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	andreas.kalckert@gmail.com	Petrovic, Predrag/AAS-6736-2020; Kalckert, Andreas/I-2385-2019	Petrovic, Predrag/0000-0002-5536-945X; Kalckert, Andreas/0000-0003-2498-9135	James S. McDonnell Foundation; Swedish Research Council; Soderberska Stiftelsen; Vetenskapsradet [DR:2013-7826]; Karolinska Institutet	James S. McDonnell Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberska Stiftelsen; Vetenskapsradet(Swedish Research Council); Karolinska Institutet(Karolinska Institutet)	This study was funded by the James S. McDonnell Foundation, the Swedish Research Council and Soderberska Stiftelsen (A.K.) and by Vetenskapsradet (DR:2013-7826) and Karolinska Institutet (A.L. and P.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MA, 2011, PSYCHOPHARMACOLOGY, V217, P39, DOI 10.1007/s00213-011-2255-y; Balzan RP, 2013, J NERV MENT DIS, V201, P319, DOI 10.1097/NMD.0b013e318288e229; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Braun N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111967; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2009, PSYCHOPHARMACOLOGY, V206, P515, DOI 10.1007/s00213-009-1561-0; Corlett PR, 2006, ARCH GEN PSYCHIAT, V63, P611, DOI 10.1001/archpsyc.63.6.611; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; David N, 2008, CONSCIOUS COGN, V17, P523, DOI 10.1016/j.concog.2008.03.004; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Ferri F, 2014, SCHIZOPHR RES, V152, P51, DOI 10.1016/j.schres.2013.06.026; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; Frith C, 2005, CR BIOL, V328, P169, DOI 10.1016/j.crvi.2004.10.012; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Germine L, 2013, PSYCHIAT RES, V207, P45, DOI 10.1016/j.psychres.2012.11.022; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; Hur JW, 2014, SCHIZOPHR RES, V152, P58, DOI 10.1016/j.schres.2013.08.042; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Jeannerod M, 2009, EXP BRAIN RES, V192, P527, DOI 10.1007/s00221-008-1533-3; Kalckert A, 2012, FRONT HUM NEUROSCI, P6; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Morgan HL, 2011, BIOL PSYCHIAT, V69, P35, DOI 10.1016/j.biopsych.2010.07.032; Parnas J, 2005, SCHIZOPHR B, P1; Peled A, 2000, BIOL PSYCHIAT, V48, P1105, DOI 10.1016/S0006-3223(00)00947-1; Peters E, 2004, SCHIZOPHRENIA BULL, V30, P1005, DOI 10.1093/oxfordjournals.schbul.a007116; Peters ER, 1999, SCHIZOPHRENIA BULL, V25, P553, DOI 10.1093/oxfordjournals.schbul.a033401; Schmack K, 2013, J NEUROSCI, V33, P13701, DOI 10.1523/JNEUROSCI.1778-13.2013; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Synofzik M, 2010, BRAIN, V133, P262, DOI 10.1093/brain/awp291; Teufel C, 2010, NEUROPSYCHOLOGIA, V48, P4169, DOI 10.1016/j.neuropsychologia.2010.10.024; Thakkar KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027089; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Voss M, 2010, BRAIN, V133, P3104, DOI 10.1093/brain/awq152; Waters FAV, 2010, SCHIZOPHRENIA BULL, V36, P510, DOI 10.1093/schbul/sbn112; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	50	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128549	10.1371/journal.pone.0128549	http://dx.doi.org/10.1371/journal.pone.0128549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26090797	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000356835000022
J	Farooqui, H; Jit, M; Heymann, DL; Zodpey, S				Farooqui, Habib; Jit, Mark; Heymann, David L.; Zodpey, Sanjay			Burden of Severe Pneumonia, Pneumococcal Pneumonia and Pneumonia Deaths in Indian States: Modelling Based Estimates	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD PNEUMONIA; CONJUGATE VACCINE; CHILDREN; DISEASE; TRIAL; EPIDEMIOLOGY; SURVEILLANCE; INFECTION; MORTALITY	The burden of severe pneumonia in terms of morbidity and mortality is unknown in India especially at sub-national level. In this context, we aimed to estimate the number of severe pneumonia episodes, pneumococcal pneumonia episodes and pneumonia deaths in children younger than 5 years in 2010. We adapted and parameterized a mathematical model based on the epidemiological concept of potential impact fraction developed CHERG for this analysis. The key parameters that determine the distribution of severe pneumonia episode across Indian states were state-specific under-5 population, state-specific prevalence of selected definite pneumonia risk factors and meta-estimates of relative risks for each of these risk factors. We applied the incidence estimates and attributable fraction of risk factors to population estimates for 2010 of each Indian state. We then estimated the number of pneumococcal pneumonia cases by applying the vaccine probe methodology to an existing trial. We estimated mortality due to severe pneumonia and pneumococcal pneumonia by combining incidence estimates with case fatality ratios from multi-centric hospital-based studies. Our results suggest that in 2010, 3.6 million (3.3-3.9 million) episodes of severe pneumonia and 0.35 million (0.31-0.40 million) all cause pneumonia deaths occurred in children younger than 5 years in India. The states that merit special mention include Uttar Pradesh where 18.1% children reside but contribute 24% of pneumonia cases and 26% pneumonia deaths, Bihar (11.3% children, 16% cases, 22% deaths) Madhya Pradesh (6.6% children, 9% cases, 12% deaths), and Rajasthan (6.6% children, 8% cases, 11% deaths). Further, we estimated that 0.56 million (0.49-0.64 million) severe episodes of pneumococcal pneumonia and 105 thousand (92-119 thousand) pneumococcal deaths occurred in India. The top contributors to India's pneumococcal pneumonia burden were Uttar Pradesh, Bihar, Madhya Pradesh and Rajasthan in that order. Our results highlight the need to improve access to care and increase coverage and equity of pneumonia preventing vaccines in states with high pneumonia burden.	[Farooqui, Habib; Zodpey, Sanjay] Publ Hlth Fdn India, New Delhi, India; [Jit, Mark; Heymann, David L.] London Sch Hyg & Trop Med, London WC1, England; [Jit, Mark] Publ Hlth England, Modelling & Econ Unit, London, England	Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine; Public Health England	Farooqui, H (corresponding author), Publ Hlth Fdn India, New Delhi, India.	drhabibhasan@gmail.com	Farooqui, Habib/AAD-8818-2021; Jit, Mark/HDM-7797-2022	Farooqui, Habib/0000-0002-3081-2929; Jit, Mark/0000-0001-6658-8255	Wellcome Trust Capacity Strengthening Strategic Award; consortium of UK universities	Wellcome Trust Capacity Strengthening Strategic Award(Wellcome Trust); consortium of UK universities	This work was supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of UK universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CENS IND 2011 NEW DE; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Broor S, 2001, Indian Pediatr, V38, P1361; Broor S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000491; Gladstone BP, 2010, J TROP PEDIATRICS, V56, P221, DOI 10.1093/tropej/fmp116; Gupta M, 2010, INDIAN J MED RES, V131, P649; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Kim M, 2004, J HEALTH POPUL NUTR, P257; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kumar C, 2013, J PUBLIC HEALTH-UK, V35, P598, DOI 10.1093/pubmed/fds108; Kumar S, 2014, PNEUMONIA, V3, P36, DOI [10.1186/2047-2994-3-36, DOI 10.1186/2047-2994-3-36]; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; Madsen HO, 2009, TROP MED INT HEALTH, V14, P1315, DOI 10.1111/j.1365-3156.2009.02374.x; Manoharan A., 2013, SURVEILLANCE INVASIV; Mathew JL, 2011, INDIAN PEDIATR, V48, P191, DOI 10.1007/s13312-011-0051-8; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Russel F, 2011, GLOBAL REV DISTRIBUT; Thomas K, 1999, LANCET, V353, P1216, DOI 10.1016/S0140-6736(98)07228-6; UN Web Services Section Information DoP, 2014, UN MILL DEV GOALS 20; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Zodpey S, 2015, INDIAN J PU IN PRESS	28	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129191	10.1371/journal.pone.0129191	http://dx.doi.org/10.1371/journal.pone.0129191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086700	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000356567500038
J	Forin-Wiart, MA; Hubert, P; Sirguey, P; Poulle, ML				Forin-Wiart, Marie-Amelie; Hubert, Pauline; Sirguey, Pascal; Poulle, Marie-Lazarine			Performance and Accuracy of Lightweight and Low-Cost GPS Data Loggers According to Antenna Positions, Fix Intervals, Habitats and Animal Movements	PLOS ONE			English	Article							RADIO-COLLAR PERFORMANCE; SYSTEM COLLARS; TELEMETRY; BIAS; ORIENTATION; SELECTION; BEHAVIOR; ECOLOGY; ISSUES	Recently developed low-cost Global Positioning System (GPS) data loggers are promising tools for wildlife research because of their affordability for low-budget projects and ability to simultaneously track a greater number of individuals compared with expensive built-in wildlife GPS. However, the reliability of these devices must be carefully examined because they were not developed to track wildlife. This study aimed to assess the performance and accuracy of commercially available GPS data loggers for the first time using the same methods applied to test built-in wildlife GPS. The effects of antenna position, fix interval and habitat on the fix-success rate (FSR) and location error (LE) of CatLog data loggers were investigated in stationary tests, whereas the effects of animal movements on these errors were investigated in motion tests. The units operated well and presented consistent performance and accuracy over time in stationary tests, and the FSR was good for all antenna positions and fix intervals. However, the LE was affected by the GPS antenna and fix interval. Furthermore, completely or partially obstructed habitats reduced the FSR by up to 80% in households and increased the LE. Movement across habitats had no effect on the FSR, whereas forest habitat influenced the LE. Finally, the mean FSR (0.90 +/- 0.26) and LE (15.4 +/- 10.1 m) values from low-cost GPS data loggers were comparable to those of built-in wildlife GPS collars (71.6% of fixes with LE < 10 m for motion tests), thus confirming their suitability for use in wildlife studies.	[Forin-Wiart, Marie-Amelie; Poulle, Marie-Lazarine] Univ Reims, SFR Cap Sante, PROTAL EA3800, Reims, France; [Forin-Wiart, Marie-Amelie; Hubert, Pauline; Poulle, Marie-Lazarine] Univ Reims, CERFE, Boult Aux Bois, France; [Sirguey, Pascal] Univ Otago, Natl Sch Surveying, Dunedin, New Zealand	Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; University of Otago	Forin-Wiart, MA (corresponding author), Univ Reims, SFR Cap Sante, PROTAL EA3800, Reims, France.	ma.forinw@hotmail.fr	Poulle, Marie-Lazarine/X-9919-2019; FORIN-WIART, Marie-Amélie/AAO-9706-2020	FORIN-WIART, Marie-Amélie/0000-0002-1996-1907	Region Champagne-Ardenne; Conseil Regional de Champagne-Ardenne [D201011937]; Conseil General des Ardennes	Region Champagne-Ardenne(Region Grand-Est); Conseil Regional de Champagne-Ardenne(Region Grand-Est); Conseil General des Ardennes	This work was supported by an operating grant from the Region Champagne-Ardenne. MAFW was funded by a PhD grant from the Conseil Regional de Champagne-Ardenne (grant number D201011937, https://www.cr-champagne-ardenne.fr/) and the Conseil General des Ardennes (www.cg08.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068496; Allan BM, 2013, WILDLIFE RES, V40, P345, DOI 10.1071/WR13069; Belant JL, 2009, NORTHEAST NAT, V16, P577, DOI 10.1656/045.016.n407; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Bourgoin G, 2009, EUR J WILDLIFE RES, V55, P603, DOI 10.1007/s10344-009-0284-1; Brendel C, 2012, MAMMAL NOTES MAMMAL, P1; Buerkert A, 2009, COMPUT ELECTRON AGR, V65, P85, DOI 10.1016/j.compag.2008.07.010; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Cargnelutti B, 2007, J WILDLIFE MANAGE, V71, P1380, DOI 10.2193/2006-257; Coelho CM, 2007, APPL ANIM BEHAV SCI, V105, P259, DOI 10.1016/j.applanim.2006.04.024; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2003, J WILDLIFE MANAGE, V67, P858, DOI 10.2307/3802693; Dean B, 2013, J R SOC INTERFACE, V10, DOI [10.1098/rsif.2012.0570, 10.1098/rsif.2013.0279]; DeCesare NJ, 2005, WILDLIFE SOC B, V33, P935, DOI 10.2193/0091-7648(2005)33[935:EOFCOG]2.0.CO;2; Dennis T.E., 2010, Wildlife Biology in Practice, V6, P14; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Ferreira JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025970; Forin-Wiart M-A, 2014, THESIS U REIMS CHAMP; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Glasby L, 2013, EUR J WILDLIFE RES, V59, P915, DOI 10.1007/s10344-013-0770-3; Gloor S, 2001, MAMM BIOL, V66, P155; Gompper ME, 2002, BIOSCIENCE, V52, P185, DOI 10.1641/0006-3568(2002)052[0185:TCITSE]2.0.CO;2; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hansen MC, 2008, J WILDLIFE MANAGE, V72, P518, DOI 10.2193/2006-493; Hebblewhite M, 2007, J WILDLIFE MANAGE, V71, P2026, DOI 10.2193/2006-238; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hoffmann IE, 2003, MAMM BIOL, V68, P205, DOI 10.1078/1616-5047-00086; Horn JA, 2011, J WILDLIFE MANAGE, V75, P1177, DOI 10.1002/jwmg.145; Hubert P, 2011, LANDSCAPE URBAN PLAN, V103, P34, DOI 10.1016/j.landurbplan.2011.05.010; Hulbert IAR, 2001, J APPL ECOL, V38, P869, DOI 10.1046/j.1365-2664.2001.00624.x; Humphries NE, 2013, METHODS ECOL EVOL, V4, P930, DOI 10.1111/2041-210X.12096; Jiang Z, 2008, ECOL RES, V23, P581, DOI 10.1007/s11284-007-0412-x; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Mattisson J, 2010, J WILDLIFE MANAGE, V74, P557, DOI 10.2193/2009-157; Parsons MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110984; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Quaglietta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029235; RCoreTeam, 2014, R LANG ENV STAT COMP; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; Recio MR, 2010, NZ J ECOLOGY, V34, P114; Reid Neil, 2010, Conservation Evidence, V7, P32; Rodgers Arthur R., 2001, P79, DOI 10.1016/B978-012497781-5/50005-0; Rose E, 2006, BEHAV ECOL SOCIOBIOL, V60, P242, DOI 10.1007/s00265-006-0162-8; Sager-Fradkin KA, 2007, J WILDLIFE MANAGE, V71, P1298, DOI 10.2193/2006-367; Sirguey P, 2009, REMOTE SENS ENVIRON, V113, P160, DOI 10.1016/j.rse.2008.09.008; Soutullo A, 2007, J WILDLIFE MANAGE, V71, P1010, DOI 10.2193/2006-042; Stothard JR, 2011, T ROY SOC TROP MED H, V105, P500, DOI 10.1016/j.trstmh.2011.05.007; Swanepoel LH, 2010, S AFR J WILDL RES, V40, P10, DOI 10.3957/056.040.0111; Thomas RL, 2014, URBAN ECOSYST, V17, P911, DOI 10.1007/s11252-014-0360-5; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Urbano F, 2010, PHILOS T R SOC B, V365, P2177, DOI 10.1098/rstb.2010.0081; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Vazquez-Prokopec GM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-68; Villepique JT, 2008, CALIF FISH GAME, V94, P155; Webb SL, 2013, WILDLIFE BIOL, V19, P257, DOI 10.2981/12-038; Wells AG, 2011, REMOTE SENS-BASEL, V3, P435, DOI 10.3390/rs3030435; Williams DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048439; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	63	38	39	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129271	10.1371/journal.pone.0129271	http://dx.doi.org/10.1371/journal.pone.0129271			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086958	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500042
J	Marais, A; Faure, C; Mustafayev, E; Candresse, T				Marais, Armelle; Faure, Chantal; Mustafayev, Eldar; Candresse, Thierry			Characterization of New Isolates of Apricot vein clearing-associated virus and of a New Prunus-Infecting Virus: Evidence for Recombination as a Driving Force in Betaflexiviridae Evolution	PLOS ONE			English	Article							COMPLETE GENOME; NUCLEOTIDE-SEQUENCE; GENETIC DIVERSITY; MOTTLE VIRUS; CARLAVIRUS; CHERRY; IDENTIFICATION; FLEXIVIRIDAE; VARIABILITY; REVEALS	Double stranded RNAs from Prunus samples gathered from various surveys were analyzed by a deep-sequencing approach. Contig annotations revealed the presence of a potential new viral species in an Azerbaijani almond tree (Prunus amygdalus) and its genome sequence was completed. Its genomic organization is similar to that of the recently described Apricot vein clearing associated virus (AVCaV) for which two new isolates were also characterized, in a similar fashion, from two Japanese plums (Prunus salicina) from a French germplasm collection. The amino acid identity values between the four proteins encoded by the genome of the new virus have identity levels with those of AVCaV which fall clearly outside the species demarcation criteria. The new virus should therefore be considered as a new species for which the name of Caucasus prunus virus (CPrV) has been proposed. Phylogenetic relationships and nucleotide comparisons suggested that together with AVCaV, CPrV could define a new genus ( proposed name: Prunevirus) in the family Betaflexiviridae. A molecular test targeting both members of the new genus was developed, allowing the detection of additional AVCaV isolates, and therefore extending the known geographical distribution and the host range of AVCaV. Moreover, the phylogenetic trees reconstructed with the amino acid sequences of replicase, movement and coat proteins of representative Betaflexiviridae members suggest that Citrus leaf blotch virus (CLBV, type member of the genus Citrivirus) may have evolved from a recombination event involving a Prunevirus, further highlighting the importance of recombination as a driving force in Betaflexiviridae evolution. The sequences reported in the present manuscript have been deposited in the GenBank database under accession numbers KM507061-KM504070.	[Marais, Armelle; Faure, Chantal; Candresse, Thierry] INRA, BFP, UMR 1332, Villenave Dornon, France; [Marais, Armelle; Faure, Chantal; Candresse, Thierry] Univ Bordeaux, BFP, UMR 1332, Villenave Dornon, France; [Mustafayev, Eldar] Azerbaijan Natl Acad Sci, Genet Resource Inst, Baku, Azerbaijan	INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Azerbaijan National Academy of Sciences (ANAS); Azerbaijan Institute of Genetic Resources	Marais, A (corresponding author), INRA, BFP, UMR 1332, Villenave Dornon, France.	amarais@bordeaux.inra.fr	Mustafayev, Eldar/T-4827-2019	Candresse, Thierry/0000-0001-9757-1835; Marais, Armelle/0000-0003-2482-1543				Abou Ghanem-Sabanadzovic N, 2013, ARCH VIROL, V158, P445, DOI 10.1007/s00705-012-1484-7; Adams M. J., 2012, VIRUS TAXONOMY, P920, DOI DOI 10.1016/B978-0-12-384684-6.00078-1; Al Rwahnih M, 2012, J VIROL, V86, P9545, DOI 10.1128/JVI.01444-12; Alabi OJ, 2014, PHYTOPATHOLOGY, V104, P548, DOI 10.1094/PHYTO-06-13-0179-R; Barba M, 2014, VIRUSES-BASEL, V6, P106, DOI 10.3390/v6010106; Blouin AG, 2012, ARCH VIROL, V157, P713, DOI 10.1007/s00705-011-1219-1; Candresse T, 2013, PHYTOPATHOLOGY, V103, P293, DOI 10.1094/PHYTO-10-12-0275-R; Chavan RR, 2013, ARCH VIROL, V158, P1679, DOI 10.1007/s00705-013-1654-2; De Souza J, 2013, ARCH VIROL, V158, P1393, DOI 10.1007/s00705-013-1614-x; Elbeaino T, 2014, VIRUS RES, V181, P1, DOI 10.1016/j.virusres.2013.12.030; Foissac X, 2005, PHYTOPATHOLOGY, V95, P617, DOI 10.1094/PHYTO-95-0617; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Gibbs A, 2010, ANNU REV PHYTOPATHOL, V48, P205, DOI 10.1146/annurev-phyto-073009-114404; Glasa M, 2014, ARCH VIROL, V159, P2103, DOI 10.1007/s00705-014-2031-5; Hatlestad GJ, 2011, ARCH VIROL, V156, P2109, DOI 10.1007/s00705-011-1101-1; Howell WE, 2011, VIRUS VIRUS LIKE DIS, P259; Ito T, 2013, J GEN VIROL, V94, P1917, DOI 10.1099/vir.0.054445-0; James D, 2013, ARCH VIROL, V158, P1877, DOI 10.1007/s00705-013-1678-7; James D, 2014, ARCH VIROL, V159, P2463, DOI 10.1007/s00705-014-2075-6; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395; Marais A, 2012, PLANT PATHOL, V61, P195, DOI 10.1111/j.1365-3059.2011.02488.x; Marais A, 2015, PHYTOPATHOLOGY, V105, P135, DOI 10.1094/PHYTO-04-14-0125-R; Marais A, 2014, PHYTOPATHOLOGY, V104, P660, DOI 10.1094/PHYTO-08-13-0229-R; Martelli GP, 2007, ANNU REV PHYTOPATHOL, V45, P73, DOI 10.1146/annurev.phyto.45.062806.094401; Massart S, 2014, VIRUS RES, V188, P90, DOI 10.1016/j.virusres.2014.03.029; Prabha K, 2013, INDIAN J VIROL, V24, P157, DOI 10.1007/s13337-013-0133-4; Rubino L, 2012, ARCH VIROL, V157, P1629, DOI 10.1007/s00705-012-1342-7; Rubio L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00151; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Singh L, 2012, ARCH VIROL, V157, P531, DOI 10.1007/s00705-011-1190-x; Studholme D. J., 2011, ANNU REV PHYTOPATHOL, V49, P141; Sztuba-Solinska J, 2011, ANNU REV PHYTOPATHOL, V49, P415, DOI 10.1146/annurev-phyto-072910-095351; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang J, 2010, ARCH VIROL, V155, P7, DOI 10.1007/s00705-009-0541-3; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; Teycheney PY, 2005, ARCH VIROL, V150, P1715, DOI 10.1007/s00705-005-0567-0; Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0; Villamor DEV, 2013, PHYTOPATHOLOGY, V103, P1287, DOI 10.1094/PHYTO-05-13-0140-R; Vives MC, 2001, VIROLOGY, V287, P225, DOI 10.1006/viro.2001.1040; Wylie SJ, 2012, ARCH VIROL, V157, P1471, DOI 10.1007/s00705-012-1319-6; Yoon JY, 2014, PLANT PATHOLOGY J, V30, P195, DOI 10.5423/PPJ.NT.02.2014.0015; Youssef F, 2011, VIRUS RES, V155, P440, DOI 10.1016/j.virusres.2010.11.013; Zanardo LG, 2014, ARCH VIROL, V159, P727, DOI 10.1007/s00705-013-1879-0; Zhou ZS, 2006, J GEN VIROL, V87, P2387, DOI 10.1099/vir.0.81893-0	46	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129469	10.1371/journal.pone.0129469	http://dx.doi.org/10.1371/journal.pone.0129469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086395	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500048
J	Ronda, MCM; Dijkhorst-Oei, LT; Rutten, GEHM				Ronda, Maaike C. M.; Dijkhorst-Oei, Lioe-Ting; Rutten, Guy E. H. M.			Patients' Experiences with and Attitudes towards a Diabetes Patient Web Portal	PLOS ONE			English	Article							PILOT RANDOMIZED-TRIAL; COLLABORATIVE CARE; DIGITAL DIVIDE; HEALTH RECORD; MANAGEMENT; DISTRESS; VALIDITY; BARRIERS; ADOPTION; SUPPORT	Objective 'A diabetes patient web portal allows patients to access their personal health record and may improve diabetes outcomes; however, patients' adoption is slow. We aimed to get insight into patients' experiences with a web portal to understand how the portal is being used, how patients perceive the content of the portal and to assess whether redesign of the portal might be needed. Materials and Methods A survey among 1500 patients with type 1 and type 2 diabetes with a login to a patient portal. Setting: 62 primary care practices and one outpatient hospital clinic, using a combined patient portal. We compared patients who requested a login but never used it or once ('early quitters') with patients who used it at least two times ('persistent users'). Results 632 patients (42.1%) returned the questionnaire. Their mean age was 59.7 years, 63.1% was male and 81.8% had type 2 diabetes. 413 (65.3%) people were persistent users and 34.7% early quitters. In the multivariable analysis, insulin use (OR2.07; 95% CI[1.18-3.62]), experiencing more frequently hyperglycemic episodes (OR1.30; 95% CI[1.14-1.49]) and better diabetes knowledge (OR1.02, 95% CI[1.01-1.03]) do increase the odds of being a persistent user. Persistent users perceived the usefulness of the patient portal significantly more favorable. However, they also more decisively declared that the patient portal is not helpful in supporting life style changes. Early quitters felt significantly more items not applicable in their situation compared to persistent users. Both persistent users (69.8%) and early quitters (58.8%) would prefer a reminder function for scheduled visits. About 60% of both groups wanted information about medication and side-effects in their portal. Conclusions The diabetes patient web portal might be improved significantly by taking into account the patients' experiences and attitudes. We propose creating separate portals for patients on insulin or not.	[Ronda, Maaike C. M.; Rutten, Guy E. H. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Dijkhorst-Oei, Lioe-Ting] Meander Med Ctr, Dept Internal Med, Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; Meander Medisch Centrum	Ronda, MCM (corresponding author), Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	m.c.m.ronda@umcutrecht.nl			Diabetes Fund, The Netherlands Organization for Scientific Research in Diabetes [2010.13.1369]	Diabetes Fund, The Netherlands Organization for Scientific Research in Diabetes	This study was supported by the Diabetes Fund, The Netherlands Organization for Scientific Research in Diabetes (grant 2010.13.1369). Website: http://www.diabetesfonds.nl/overzicht/vooronderzoekers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante DJ, 2014, DIABETES TECHNOL THE, V16, P784, DOI 10.1089/dia.2014.0078; Bond GE, 2007, DIABETES TECHNOL THE, V9, P52, DOI 10.1089/dia.2006.0057; Bradley C., 1994, HDB PSYCHOL DIABETES, P111; Britto MT, 2009, J AM MED INFORM ASSN, V16, P660, DOI 10.1197/jamia.M3154; Byczkowski TL, 2014, HEALTH INFORM J, V20, P151, DOI 10.1177/1460458213489054; Campmans-Kuijpers MJ, 2015, DIABETES CARE, V38, P285, DOI 10.2337/dc14-1860; Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706; Geppert Cynthia, 2014, AJOB Empir Bioeth, V5, P14; Goel MS, 2011, J AM MED INFORM ASSN, V18, pI8, DOI 10.1136/amiajnl-2011-000473; Greenhalgh T, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5814; Hess R, 2007, TELEMED J E-HEALTH, V13, P509, DOI 10.1089/tmj.2006.0089; Holbrook A, 2009, CAN MED ASSOC J, V181, P37, DOI 10.1503/cmaj.081272; McCarrier KP, 2009, DIABETES TECHNOL THE, V11, P211, DOI 10.1089/dia.2008.0063; McMahon GT, 2005, DIABETES CARE, V28, P1624, DOI 10.2337/diacare.28.7.1624; Osborn CY, 2013, J MED INTERNET RES, V15, P204, DOI 10.2196/jmir.2589; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Pyper C, 2004, BRIT J GEN PRACT, V54, P38; Ralston JD, 2009, DIABETES CARE, V32, P234, DOI 10.2337/dc08-1220; Ralston JD, 2004, BMJ, V328; Ronda MCM, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3457; Ronda MCM, 2013, DIABETES TECHNOL THE, V15, P556, DOI 10.1089/dia.2013.0023; Ronda MC, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.f4c78, DOI 10.5061/DRYAD.F4C78]; Sarkar U, 2011, J AM MED INFORM ASSN, V18, P318, DOI [10.1136/jamia.2010.006015, 10.1136/amiajnl.2010.006015]; Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157; Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305; Struijs JN, 2011, NEW ENGL J MED, V364, P990, DOI 10.1056/NEJMp1011849; Struijs JN, 2009, EXPERIMENTEREN MET D; van der Bijl J, 1999, J ADV NURS, V30, P352, DOI 10.1046/j.1365-2648.1999.01077.x; Weppner WG, 2010, DIABETES CARE, V33, P2314, DOI 10.2337/dc10-1124; Woods SS, 2013, J MED INTERNET RES, V15, P182, DOI 10.2196/jmir.2356; Yamin CK, 2011, ARCH INTERN MED, V171, P568, DOI 10.1001/archinternmed.2011.34; Zickmund SL, 2008, J GEN INTERN MED, V23, P20, DOI 10.1007/s11606-007-0273-6	32	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129403	10.1371/journal.pone.0129403	http://dx.doi.org/10.1371/journal.pone.0129403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NT	26086272	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500047
J	Su, FM; Liu, DH; Chen, JF; Yu, SF; Chiu, WC; Hsu, CY; Ko, CH; Tsai, CC; Cheng, TT				Su, Fu-Mei; Liu, Dung-Huan; Chen, Jia-Feng; Yu, Shan-Fu; Chiu, Wen-Chan; Hsu, Chung-Yuan; Ko, Chi-Hua; Tsai, Ching-Chou; Cheng, Tien-Tsai			Development and Validation of an Osteoporosis Self-Assessment Tool for Taiwan (OSTAi) Postmenopausal Women-A Sub-Study of the Taiwan OsteoPorosis Survey (TOPS)	PLOS ONE			English	Article							BONE-MINERAL DENSITY; INCREASED RISK; FACILITATE IDENTIFICATION; BODY-SIZE; PERFORMANCE; FRACTURES; SELECTION; INDEXES; OSIRIS; MEN	Background To develop an OSTAi tool and compare this with the National Osteoporosis Foundation recommendations in 2013 (NOF 2013) for bone mineral density (BMD) testing among Taiwan postmenopausal women. Methods Taiwan Osteoporosis Association (TOA) conducted a nationwide BMD survey by a bus installed with a dual energy X-ray absorptiometry (DXA) between 2008 and 2011. All of the participants completed questionnaire, which included demographics and risk factors of osteoporotic fracture in FRAX tool. We used the database to analyze potential risk factors for osteoporosis and followed the model by Koh et al. to develop a risk index via multiple variable regression analysis and item reduction. We used the index values to set up a simple algorithm (namely OSTAi) to identify those who need BMD measurement. Receiver operating characteristic (ROC) curve and the area under the curve (AUC) was used to compare the sensitivity/specificity analysis of this model with that of recommendations by NOF 2013. Results A total of 12,175 Taiwan postmenopausal women enrolled in this survey. The index value was derived by age and body weight of the participants according to weighted odds of each risk factor and the selected cutoff value was set at "-1". There are 6393 (52.5%) participants whose index value is below "-1" and whose risk of osteoporosis was 57.5% (3674/6393). The AUC for OSTAi and NOF 2013 were 0.739 (95% confidence interval (CI), 0.728-0.749, P<0.001) and 0.618 (95% CI, 0.606-0.630, P<0.001), respectively. The sensitivity and specificity of OSTAi, at the selected cutoff value of -1, and NOF 2013 to identify osteoporosis were 73.1%, 62.0% and 78.3%, 45.7%, respectively. Conclusions As OSTA for Asian populations, OSTAi is an useful tool to identify Taiwan postmenopausal women with osteoporosis, In comparison with NOF 2013, OSTAi may be an easier and better tool for referral to BMD measurement by DXA in this area.	[Su, Fu-Mei; Chen, Jia-Feng; Yu, Shan-Fu; Chiu, Wen-Chan; Hsu, Chung-Yuan; Ko, Chi-Hua; Cheng, Tien-Tsai] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Rheumatol Allergy & Immunol, Kaohsiung, Taiwan; [Liu, Dung-Huan] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Yu, Shan-Fu; Tsai, Ching-Chou; Cheng, Tien-Tsai] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Tsai, Ching-Chou] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Cheng, TT (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Rheumatol Allergy & Immunol, Kaohsiung, Taiwan.	tiantsai@ms2.hinet.net			Chang Gung Memorial Hospital [CMRPG8D0651]; Merck Sharp & Dohme Pharmaceutical Company	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Merck Sharp & Dohme Pharmaceutical Company	The author (TTC) received the funding for this work by grant CMRPG8D0651 from Chang Gung Memorial Hospital (https://www.cgmh.org.tw/) who were responsible for collection, input and procession of the data and for the publication associated fee of this article. The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The Taiwan Osteoporosis Association (TOA) conducted the nationwide circuit program for BMD measurements, sponsored by Merck Sharp & Dohme Pharmaceutical Company. A bus installed with a DXA machine, a well trained nurse, and an International Society of Clinical Densitometry (ISCD) certified radiology technician was sponsored by Merck Sharp & Dohme Pharmaceutical Company. The Taiwan Osteoporosis Association and Merck Sharp & Dohme Pharmaceutical Company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AO, 2002, AM FAM PHYSICIAN, V66, P1430; Black DM, 1998, BONE, V23, pS605; BURGER H, 1994, BONE MINER, V25, P1, DOI 10.1016/S0169-6009(08)80203-6; Cadarette SM, 2000, CAN MED ASSOC J, V162, P1289; Chan SP, 2006, OSTEOPOROSIS INT, V17, P1182, DOI 10.1007/s00198-005-0051-4; Chan SP, 2003, BONE, V32, pS176; Chang SF, 2014, J CLIN NURS, V23, P2628, DOI 10.1111/jocn.12483; Chie WC, 2004, OSTEOPOROSIS INT, V15, P998, DOI 10.1007/s00198-004-1651-0; Dargent-Molina P, 2000, OSTEOPOROSIS INT, V11, P881, DOI 10.1007/s001980070048; EDELSTEIN SL, 1993, AM J EPIDEMIOL, V138, P160, DOI 10.1093/oxfordjournals.aje.a116842; Fujiwara S, 2001, CURR THER RES CLIN E, V62, P586, DOI 10.1016/S0011-393X(01)80065-5; Geater Sarayut, 2004, Journal of the Medical Association of Thailand, V87, P1286; Geusens P, 2002, MAYO CLIN PROC, V77, P629, DOI 10.4065/77.7.629; Hwang JS, 2014, J BONE MINER METAB, V32, P10, DOI 10.1007/s00774-013-0495-0; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Koh LKH, 2001, OSTEOPOROSIS INT, V12, P699, DOI 10.1007/s001980170070; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Li-Yu JT, 2005, OSTEOPOROSIS INT, V16, P1789, DOI 10.1007/s00198-005-1929-x; Lin MH, 2010, AGEING RES REV, V9, pS23, DOI 10.1016/j.arr.2010.07.004; Lydick E, 1998, AM J MANAG CARE, V4, P37; Margolis KL, 2000, ANN INTERN MED, V133, P123, DOI 10.7326/0003-4819-133-2-200007180-00011; Michaelsson K, 1996, OSTEOPOROSIS INT, V6, P120, DOI 10.1007/BF01623934; Muslim DAJ, 2012, MALAYS ORTHOP J, V6, P35, DOI 10.5704/MOJ.1203.011; NOF, 2013, CLIN GUID PREV TREAT; Park HM, 2003, J CLIN DENSITOM, V6, P247, DOI 10.1385/JCD:6:3:247; Rubin KH, 2013, BONE, V56, P16, DOI 10.1016/j.bone.2013.05.002; Salaffi F, 2005, CLIN RHEUMATOL, V24, P203, DOI 10.1007/s10067-004-1014-4; Sarav FD, 2013, J OSTEOPOROS, V2013, DOI 10.1155/2013/150154; Sedrine WB, 2002, GYNECOL ENDOCRINOL, V16, P245; Sherchan B, 2014, NEPAL ORTHOPAEDIC AS, V3, P20; The Taiwanese Osteoporosis Association (TOA), 2012, CLIN PRACT GUID PREV; Tu SH, 2011, ASIA PAC J CLIN NUTR, V20, P225; Weinstein L, 2000, AM J OBSTET GYNECOL, V183, P547, DOI 10.1067/mob.2000.106594; World Health Organization, 1994, WHO STUD GROUP M HEL; Yang Y, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-271	36	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130716	10.1371/journal.pone.0130716	http://dx.doi.org/10.1371/journal.pone.0130716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086766	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500130
J	Achari, C; Winslow, S; Larsson, C				Achari, Chandrani; Winslow, Sofia; Larsson, Christer			Down Regulation of CLDND1 Induces Apoptosis in Breast Cancer Cells	PLOS ONE			English	Article							EXPRESSION CONFERS RESISTANCE; TIGHT JUNCTIONS; CARCINOMA-CELLS; TUMOR-GROWTH; COLON-CANCER; CLAUDIN-1; PROTEINS; COMPONENTS; PATHWAY; STRANDS	Identification of targets for apoptosis induction is important to provide novel therapeutic approaches in breast cancer. Our earlier studies showed that down regulation of protein kinase C delta (PKC delta) induces death in breast cancer cells. In this study we set out to identify previously unrecognized apoptosis regulators in breast cancer cells. To identify candidates, global expression analysis with microarray was performed after down regulation of PKC delta in the basal-like breast cancer cell lines MDA-MB-231, MDA-MB-468 and BT-549. Genes that were down regulated in all cell lines were further studied for survival-supporting effects. The claudin-like CLDND1 was singled out since several independent siRNAs targeting CLDND1 induced cell death in several cell lines. The cell death induced by CLDND1 knockdown was caspase-dependent, suggesting induction of apoptosis. Nuclear fragmentation, cleavage of caspase-3 and PARP and release of cytochrome C from the mitochondria upon CLDND1 depletion demonstrated involvement of the intrinsic apoptotic pathway. Inhibition of MEK1/2 and JNK further potentiated the cell death induction by CLDND1 knockdown. However, CLDND1 down regulation augmented ERK1/2 phosphorylation, which thereby may protect against the apoptosis inducing effects of CLDND1 down regulation. A concomitant inhibition of MEK1/2 suppresses the ERK1/2 phosphorylation and markedly potentiates the cell death following CLDND1 siRNA treatment. There is today little information on the function of CLDND1. These data provide novel information on CLDND1 and highlight it as a novel survival factor in basal-like breast cancer cell lines.	[Achari, Chandrani; Winslow, Sofia; Larsson, Christer] Lund Univ, Translat Canc Res, Dept Lab Med, Lund, Sweden	Lund University	Larsson, C (corresponding author), Lund Univ, Translat Canc Res, Dept Lab Med, Lund, Sweden.	Christer.Larsson@med.lu.se			Swedish Research Council; Swedish Cancer Society; Gunnar Nilsson foundation; Malmo University Hospital research funds	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson foundation; Malmo University Hospital research funds	This work was funded by the Swedish Research Council (www.vr.se), The Swedish Cancer Society (www.cancerfonden.se), The Gunnar Nilsson foundation (ww.cancerstiftelsen.com), and Malmo University Hospital research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-548; Anderson JM, 1993, CURR OPIN CELL BIOL, V5, P772, DOI 10.1016/0955-0674(93)90024-K; Blanchard AA, 2009, VIRCHOWS ARCH, V454, P647, DOI 10.1007/s00428-009-0770-6; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Cerimele F, 2005, P NATL ACAD SCI USA, V102, P175, DOI 10.1073/pnas.0408381102; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Escudero-Esparza A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-43; Fayein NA, 2002, GENE, V289, P119, DOI 10.1016/S0378-1119(02)00507-3; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Hoggard J, 2013, CANCER SCI, V104, P611, DOI 10.1111/cas.12135; Huang YH, 2009, P NATL ACAD SCI USA, V106, P3426, DOI 10.1073/pnas.0813348106; Jessen KA, 2005, MOL CANCER THER, V4, P761, DOI 10.1158/1535-7163.MCT-04-0333; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Lanigan F, 2009, INT J CANCER, V124, P2088, DOI 10.1002/ijc.24159; Lee JW, 2010, INT J CANCER, V126, P1353, DOI 10.1002/ijc.24857; Liu Y, 2012, TUMOR BIOL, V33, P2307, DOI 10.1007/s13277-012-0493-1; Lonne GK, 2009, J BIOL CHEM, V284, P33456, DOI 10.1074/jbc.M109.036186; Lu Z, 2011, EXP CELL RES, V317, P1935, DOI 10.1016/j.yexcr.2011.05.019; Martin TA, 2011, METHODS MOL BIOL, V762, P383, DOI 10.1007/978-1-61779-185-7_28; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Osanai M, 2007, CANCER SCI, V98, P1557, DOI 10.1111/j.1349-7006.2007.00569.x; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Shang XY, 2012, NEOPLASIA, V14, P974, DOI 10.1593/neo.12942; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Singh AB, 2012, CARCINOGENESIS, V33, P2538, DOI 10.1093/carcin/bgs275; Soini Y, 2005, HISTOPATHOLOGY, V46, P551, DOI 10.1111/j.1365-2559.2005.02127.x; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Wang W, 2010, MOL MED REP, V3, P845, DOI 10.3892/mmr.2010.334; Yoon CH, 2010, J BIOL CHEM, V285, P226, DOI 10.1074/jbc.M109.054189	41	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130300	10.1371/journal.pone.0130300	http://dx.doi.org/10.1371/journal.pone.0130300			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083392	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400135
J	Miki, K; Honma, S; Ebara, S; Kumamoto, K; Murakami, S; Wakisaka, S				Miki, Koji; Honma, Shiho; Ebara, Satomi; Kumamoto, Kenzo; Murakami, Shinya; Wakisaka, Satoshi			Changes in the Distribution of Periodontal Nerve Fibers during Dentition Transition in the Cat	PLOS ONE			English	Article							NEUROFILAMENT PROTEIN; S-100 PROTEIN; RUFFINI ENDINGS; RAT INCISOR; POSTNATAL-DEVELOPMENT; SENSORY INNERVATION; LIGAMENT; TEETH; MORPHOLOGY; MECHANORECEPTORS	The periodontal ligament has a rich sensory nerve supply which originates from the trigeminal ganglion and trigeminal mesencephalic nucleus. Although various types of mechanoreceptors have been reported in the periodontal ligament, the Ruffini ending is an essential one. It is unknown whether the distribution of periodontal nerve fibers in deciduous teeth is identical to that in permanent teeth or not. Moreover, morphological changes in the distribution of periodontal nerve fibers during resorption of deciduous teeth and eruption of successional permanent teeth in diphyodont animals have not been reported in detail. Therefore, in this study, we examined changes in the distribution of periodontal nerve fibers in the cat during changes in dentition (i.e., deciduous, mixed and permanent dentition) by immunohistochemistry of protein gene product 9.5. During deciduous dentition, periodontal nerve fibers were concentrated at the apical portion, and sparsely distributed in the periodontal ligament of deciduous molars. During mixed dentition, the periodontal nerve fibers of deciduous molars showed degenerative profiles during resorption. In permanent dentition, the periodontal nerve fibers of permanent premolars, the successors of deciduous molars, increased in number. Similar to permanent premolars, the periodontal nerve fibers of permanent molars, having no predecessors, increased in number, and were densely present in the apical portion. The present results indicate that the distribution of periodontal nerve fibers in deciduous dentition is almost identical to that in permanent dentition although the number of periodontal nerve fibers in deciduous dentition was low. The sparse distribution of periodontal nerve fibers in deciduous dentition agrees with clinical evidence that children are less sensitive to tooth stimulation than adults.	[Miki, Koji; Honma, Shiho; Wakisaka, Satoshi] Osaka Univ, Grad Sch Dent, Dept Oral Anat & Dev Biol, Osaka, Japan; [Miki, Koji; Murakami, Shinya] Osaka Univ, Grad Sch Dent, Dept Periodontol, Osaka, Japan; [Honma, Shiho] Baika Womens Univ, Fac Nursing & Hlth Care, Dept Oral Hlth Sci, Osaka, Japan; [Ebara, Satomi; Kumamoto, Kenzo] Meiji Univ Integrat Med, Dept Anat, Kyoto, Japan	Osaka University; Osaka University	Honma, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral Anat & Dev Biol, Osaka, Japan.	s-honma@baika.ac.jp	Ebara, Satomi/GRJ-0914-2022	Miki, Koji/0000-0003-2824-9038; Murakami, Shinya/0000-0002-5230-452X	Japan Society for the Promotion of Science [24792324, 26861811, 24592762]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Young Scientists (B) Grant Number 24792324, and 26861811 to KM and Grant-in-Aid for Scientific Research (C) Grant Number 24592762 to SH. http://kaken.nii.ac.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEERTSEN W, 1974, ARCH ORAL BIOL, V19, P1099, DOI 10.1016/0003-9969(74)90236-2; Brenan A, 1986, BRAIN RES, V384, P250; BYERS MR, 1986, J COMP NEUROL, V250, P181, DOI 10.1002/cne.902500205; BYERS MR, 1989, J COMP NEUROL, V279, P117, DOI 10.1002/cne.902790110; BYERS MR, 1985, J COMP NEUROL, V231, P500, DOI 10.1002/cne.902310408; Byers MR, 1997, ACTA MED DENT HELV, V2, P116; Chantha KJ, 2002, ARCH HISTOL CYTOL, V65, P233; Egan CA, 1996, J ANAT, V188, P623; HOLLAND GR, 1987, EXP NEUROL, V98, P489, DOI 10.1016/0014-4886(87)90258-5; ITOH K, 1976, ARCH HISTOL JAPON, V39, P379, DOI 10.1679/aohc1950.39.379; LAMBRICHTS I, 1992, J PERIODONTAL RES, V27, P191, DOI 10.1111/j.1600-0765.1992.tb01668.x; LINDEN RWA, 1994, ANAT EMBRYOL, V190, P127; LISNEY SJW, 1978, J PHYSIOL-LONDON, V279, P509, DOI 10.1113/jphysiol.1978.sp012359; LOESCHER AR, 1991, ANAT REC, V230, P57, DOI 10.1002/ar.1092300107; MAEDA T, 1987, ARCH HISTOL JAPON, V50, P437, DOI 10.1679/aohc.50.437; MAEDA T, 1987, CELL TISSUE RES, V249, P13, DOI 10.1007/BF00215413; MAEDA T, 1990, ARCH HISTOL CYTOL, V53, P259, DOI 10.1679/aohc.53.259; Maeda T, 1999, CRIT REV ORAL BIOL M, V10, P307, DOI 10.1177/10454411990100030401; Millar J, 1989, J ANAT, V167, P117; NAKAKURAOHSHIMA K, 1995, J COMP NEUROL, V362, P551, DOI 10.1002/cne.903620409; NAKAKURAOHSHIMA K, 1993, ARCH HISTOL CYTOL, V56, P385, DOI 10.1679/aohc.56.385; SATO O, 1992, ARCH HISTOL CYTOL, V55, P21, DOI 10.1679/aohc.55.21; SATO O, 1989, ACTA ANAT, V134, P94; SATO O, 1988, CELL TISSUE RES, V251, P13, DOI 10.1007/BF00215442; Shi L, 2006, ARCH ORAL BIOL, V51, P681, DOI 10.1016/j.archoralbio.2006.02.006; Tadokoro O, 1998, EUR J ORAL SCI, V106, P519, DOI 10.1111/j.1600-0722.1998.tb02216.x; Wakisaka S, 2000, ARCH HISTOL CYTOL, V63, P91, DOI 10.1679/aohc.63.91; WESTRUM LE, 1979, EXP NEUROL, V65, P169, DOI 10.1016/0014-4886(79)90257-7	28	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129826	10.1371/journal.pone.0129826	http://dx.doi.org/10.1371/journal.pone.0129826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083023	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400111
J	Tokuhara, Y; Kurano, M; Shimamoto, S; Igarashi, K; Nojiri, T; Kobayashi, T; Masuda, A; Ikeda, H; Nagamatsu, T; Fujii, T; Aoki, J; Yatomi, Y				Tokuhara, Yasunori; Kurano, Makoto; Shimamoto, Satoshi; Igarashi, Koji; Nojiri, Takahiro; Kobayashi, Tamaki; Masuda, Akiko; Ikeda, Hitoshi; Nagamatsu, Takeshi; Fujii, Tomoyuki; Aoki, Junken; Yatomi, Yutaka			A New Enzyme Immunoassay for the Quantitative Determination of Classical Autotaxins (ATX alpha, ATX beta, and ATX gamma) and Novel Autotaxins (ATX delta and ATX epsilon)	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; BIOCHEMICAL-CHARACTERIZATION; LYSOPHOSPHOLIPASE-D; MOTILITY; IDENTIFICATION; EXPRESSION; PROTEIN; CANCER; DIFFERENTIATION; ACTIVATION	Background Autotaxin (ATX) is a secreted enzyme that converts lysophosphatidylcholine to lysophosphatidic acid, a potent bioactive lipid mediator, through its lysophospholipase D activity. Although five alternative splicing isoforms of ATX have been identified as ATX alpha, ATX beta, ATX gamma, ATX delta, and ATX epsilon and the expression patterns of each isoform differ among several tissues, the clinical significance of each isoform remains to be elucidated. Methods Anti-ATX beta and anti-ATX delta monoclonal antibodies were produced by immunization with recombinant human ATX beta and ATX delta expressed using a baculovirus system, respectively. We then developed enzyme immunoassays to measure (ATX alpha, ATX beta, and ATX gamma) the serum concentrations of "classical ATX" (ATX alpha, ATX beta, and ATX gamma) and "novel ATX" (ATX delta and ATX epsilon) antigens and evaluated the usefulness of these assays using human serum samples. Results The with-run and between-run precision, interference, detection limit, and linearity studies for the present assay were well validated. In healthy subjects, the serum concentrations of classical ATX and novel ATX were significantly (P < 0.01) higher in women than in men, while the ratios of classical ATX or novel ATX to total ATX were not different between women and men. The concentrations of both classical ATX and novel ATX in normal pregnant subjects and patients with chronic liver diseases or follicular lymphoma were significantly higher than those in healthy subjects, while the ratio of both ATX isoforms to total ATX did not vary among these groups. Conclusions We have developed a new enzyme immunoassay to determine the concentrations of classical ATX and novel ATX in human serum. These assays may be helpful for elucidating the distinct functional roles of each ATX isoform, which are largely unknown at present.	[Tokuhara, Yasunori; Nojiri, Takahiro; Kobayashi, Tamaki; Yatomi, Yutaka] Tokyo Univ Hosp, Dept Clin Lab, Tokyo 113, Japan; [Tokuhara, Yasunori; Kurano, Makoto; Masuda, Akiko; Ikeda, Hitoshi; Aoki, Junken; Yatomi, Yutaka] Japan Sci & Technol Corp JST, CREST, Saitama, Japan; [Tokuhara, Yasunori] Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, Takamatsu, Kagawa, Japan; [Kurano, Makoto; Masuda, Akiko; Ikeda, Hitoshi; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Grad Sch Med, Tokyo, Japan; [Nagamatsu, Takeshi; Fujii, Tomoyuki] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Shimamoto, Satoshi; Igarashi, Koji] TOSOH Corp, AIA Res Grp, Reagent Dev Dept, Biosci Div, Ayase, Kanagawa, Japan; [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Biochem, Sendai, Miyagi 980, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Tosoh Corporation; Tohoku University	Yatomi, Y (corresponding author), Tokyo Univ Hosp, Dept Clin Lab, Tokyo 113, Japan.	yatoyuta-tky@umin.ac.jp	Nagamatsu, Takeshi/AAH-1402-2019; Igarashi, Koji/AAC-5332-2020; Nagamatsu, Takeshi/AAC-5201-2021	Igarashi, Koji/0000-0002-5007-7079; Nagamatsu, Takeshi/0000-0003-1480-5785; Yatomi, Yutaka/0000-0003-1719-4297; Tokuhara, Yasunori/0000-0002-8322-2543; Aoki, Junken/0000-0001-9435-1896	JSPS KAKENHI [22249017, 25253040]; CREST from JST; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST from JST(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 22249017 and 25253040 (Y.Y.) and CREST from JST.	Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Giganti A, 2008, J BIOL CHEM, V283, P7776, DOI 10.1074/jbc.M708705200; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hashimoto T, 2012, J BIOCHEM, V151, P89, DOI 10.1093/jb/mvr126; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Lee HY, 1996, BIOCHEM BIOPH RES CO, V218, P714, DOI 10.1006/bbrc.1996.0127; Masuda A, 2008, BRIT J HAEMATOL, V143, P60, DOI 10.1111/j.1365-2141.2008.07325.x; Masuda A, 2011, CLIN CHIM ACTA, V412, P1944, DOI 10.1016/j.cca.2011.06.039; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar Wouter H., 1994, Trends in Cell Biology, V4, P213, DOI 10.1016/0962-8924(94)90144-9; Nakai Y, 2011, CLIN BIOCHEM, V44, P576, DOI 10.1016/j.clinbiochem.2011.03.128; Nakamura K, 2008, CLIN CHIM ACTA, V388, P51, DOI 10.1016/j.cca.2007.10.005; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Stracke ML, 1997, ADV ENZYME REGUL, V37, P135, DOI 10.1016/S0065-2571(96)00017-9; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; TOKUMURA A, 1995, PROG LIPID RES, V34, P151, DOI 10.1016/0163-7827(95)00001-G; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667	23	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130074	10.1371/journal.pone.0130074	http://dx.doi.org/10.1371/journal.pone.0130074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083365	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400124
J	Zhao, XB; Wang, AY; Walter, V; Patel, NM; Eberhard, DA; Hayward, MC; Salazar, AH; Jo, H; Soloway, MG; Wilkerson, MD; Parker, JS; Yin, XY; Zhang, GS; Siegel, MB; Rosson, GB; Earp, HS; Sharpless, NE; Gulley, ML; Weck, KE; Hayes, DN; Moschos, SJ				Zhao, Xiaobei; Wang, Anyou; Walter, Vonn; Patel, Nirali M.; Eberhard, David A.; Hayward, Michele C.; Salazar, Ashley H.; Jo, Heejoon; Soloway, Matthew G.; Wilkerson, Matthew D.; Parker, Joel S.; Yin, Xiaoying; Zhang, Guosheng; Siegel, Marni B.; Rosson, Gary B.; Earp, H. Shelton, III; Sharpless, Norman E.; Gulley, Margaret L.; Weck, Karen E.; Hayes, D. Neil; Moschos, Stergios J.			Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; MUTATIONS; KRAS; ACCURATE; LANDSCAPE; REARRANGEMENT; VALIDATION; DATABASE; VARIANTS; FORMAT	The recent FDA approval of the MiSeqDx platform provides a unique opportunity to develop targeted next generation sequencing (NGS) panels for human disease, including cancer. We have developed a scalable, targeted panel-based assay termed UNCseq, which involves a NGS panel of over 200 cancer-associated genes and a standardized downstream bioinformatics pipeline for detection of single nucleotide variations (SNV) as well as small insertions and deletions (indel). In addition, we developed a novel algorithm, NGScopy, designed for samples with sparse sequencing coverage to detect large-scale copy number variations (CNV), similar to human SNP Array 6.0 as well as small-scale intragenic CNV. Overall, we applied this assay to 100 snap-frozen lung cancer specimens lacking same-patient germline DNA (07-0120 tissue cohort) and validated our results against Sanger sequencing, SNP Array, and our recently published integrated DNA-seq/RNA-seq assay, UNCqeR, where RNA-seq of same-patient tumor specimens confirmed SNV detected by DNA-seq, if RNA-seq coverage depth was adequate. In addition, we applied the UNCseq assay on an independent lung cancer tumor tissue collection with available same-patient germline DNA (11-1115 tissue cohort) and confirmed mutations using assays performed in a CLIA-certified laboratory. We conclude that UNCseq can identify SNV, indel, and CNV in tumor specimens lacking germline DNA in a cost-efficient fashion.	[Zhao, Xiaobei; Wang, Anyou; Walter, Vonn; Patel, Nirali M.; Eberhard, David A.; Hayward, Michele C.; Salazar, Ashley H.; Jo, Heejoon; Soloway, Matthew G.; Wilkerson, Matthew D.; Parker, Joel S.; Yin, Xiaoying; Zhang, Guosheng; Rosson, Gary B.; Earp, H. Shelton, III; Sharpless, Norman E.; Gulley, Margaret L.; Weck, Karen E.; Hayes, D. Neil; Moschos, Stergios J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Patel, Nirali M.; Eberhard, David A.; Gulley, Margaret L.; Weck, Karen E.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Siegel, Marni B.; Rosson, Gary B.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Wilkerson, Matthew D.; Sharpless, Norman E.; Hayes, D. Neil] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Earp, H. Shelton, III; Sharpless, Norman E.; Hayes, D. Neil; Moschos, Stergios J.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Earp, H. Shelton, III] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Jo, Heejoon] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Moschos, SJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	moschos@med.unc.edu	Walter, Vonn/AAI-3450-2021; Parker, Joel/AAG-1108-2019; W, Andrew/ABE-8298-2020	Walter, Vonn/0000-0001-6114-6714; W, Andrew/0000-0002-4981-3606; Patel, Nirali/0000-0002-2683-4789; McClure, Marni/0000-0002-0807-4368; Sharpless, Norman/0000-0001-7078-9455	NCI Cancer Clinical Investigator Team Leadership Award; University Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA163896, T32CA071341] Funding Source: NIH RePORTER	NCI Cancer Clinical Investigator Team Leadership Award; University Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the NCI Cancer Clinical Investigator Team Leadership Award (SJM) and the University Cancer Research Fund.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Altimari A, 2013, ONCOTARGETS THER, V6, P1057, DOI 10.2147/OTT.S42369; Anderson SM, 2011, EXPERT REV MOL DIAGN, V11, P635, DOI [10.1586/erm.11.42, 10.1586/ERM.11.42]; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chiogna M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-61; Choudhary A, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0062-0; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foreman Ann Katherine M, 2013, N C Med J, V74, P500; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Garralda E, 2014, CLIN CANCER RES, V20, P2476, DOI 10.1158/1078-0432.CCR-13-3047; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Guo Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/915636; Hagemann IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/cncr.29089; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iwakawa R, 2013, GENE CHROMOSOME CANC, V52, P802, DOI 10.1002/gcc.22076; Jayaraman SS, 2014, J INVEST DERMATOL, V134, P213, DOI 10.1038/jid.2013.276; Jeck WR, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12238; Jour G, 2014, HUM PATHOL, V45, P1563, DOI 10.1016/j.humpath.2014.04.012; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; Lee SE, 2015, MODERN PATHOL, V28, P468, DOI 10.1038/modpathol.2014.107; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004144; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marioni JC, 2006, BIOINFORMATICS, V22, P1144, DOI 10.1093/bioinformatics/btl089; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nair KR, 1940, SANKHYA, V4, P551; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh RR, 2014, BRIT J CANCER, V111, P2014, DOI 10.1038/bjc.2014.518; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tembe WD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-824; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wilkerson MD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku489; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Yi ES, 2012, MOL DIAGN THER, V16, P143, DOI 10.2165/11632830-000000000-00000; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	61	28	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129280	10.1371/journal.pone.0129280	http://dx.doi.org/10.1371/journal.pone.0129280			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076459	Green Published, gold, Green Submitted			2022-12-26	WOS:000356329900061
J	Escobar-Ramirez, A; Vercoutter-Edouart, AS; Mortuaire, M; Huvent, I; Hardiville, S; Hoedt, E; Lefebvre, T; Pierce, A				Escobar-Ramirez, Adelma; Vercoutter-Edouart, Anne-Sophie; Mortuaire, Marlene; Huvent, Isabelle; Hardiville, Stephan; Hoedt, Esthelle; Lefebvre, Tony; Pierce, Annick			Modification by SUMOylation Controls Both the Transcriptional Activity and the Stability of Delta-Lactoferrin	PLOS ONE			English	Article							O-GLCNAC; SUMO-1 MODIFICATION; MESSENGER-RNA; COVALENT MODIFICATION; PROTEIN MODIFICATION; SIRT1 DEACETYLASE; MODIFIER-1 SUMO-1; BREAST-CANCER; P53 ACTIVITY; MOTIF	Delta-lactoferrin is a transcription factor, the expression of which is downregulated or silenced in case of breast cancer. It possesses antitumoral activities and when it is re-introduced in mammary epithelial cancer cell lines, provokes antiproliferative effects. It is posttranslationally modified and our earlier investigations showed that the O-GlcNAcylation/phosphorylation interplay plays a major role in the regulation of both its stability and transcriptional activity. Here, we report the covalent modification of delta-lactoferrin with the small ubiquitin-like modifier SUMO-1. Mutational and reporter gene analyses identified five different lysine residues at K13, K308, K361, K379 and K391 as SUMO acceptor sites. The SUMOylation deficient M5S mutant displayed enhanced transactivation capacity on a delta-lactoferrin responsive promoter, suggesting that SUMO-1 negatively regulates the transactivation function of delta-lactoferrin. K13, K308 and K379 are the main SUMO sites and among them, K308, which is located in a SUMOylation consensus motif of the NDSM-like type, is a key SUMO site involved in repression of delta-lactoferrin transcriptional activity. K13 and K379 are both targeted by other posttranslational modifications. We demonstrated that K13 is the main acetylation site and that favoring acetylation at K13 reduced SUMOylation and increased delta-lactoferrin transcriptional activity. K379, which is either ubiquitinated or SUMOylated, is a pivotal site for the control of delta-lactoferrin stability. We showed that SUMOylation competes with ubiquitination and protects delta-lactoferrin from degradation by positively regulating its stability. Collectively, our results indicate that multi-SUMOylation occurs on delta-lactoferrin to repress its transcriptional activity. Reciprocal occupancy of K13 by either SUMO-1 or an acetyl group may contribute to the establishment of finely regulated mechanisms to control delta-lactoferrin transcriptional activity. Moreover, competition between SUMOylation and ubiquitination at K379 coordinately regulates the stability of delta-lactoferrin toward proteolysis. Therefore SUMOylation of delta-lactoferrin is a novel mechanism controlling both its activity and stability.	[Escobar-Ramirez, Adelma; Vercoutter-Edouart, Anne-Sophie; Mortuaire, Marlene; Huvent, Isabelle; Hardiville, Stephan; Hoedt, Esthelle; Lefebvre, Tony; Pierce, Annick] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, CNRS, UMR 8576,FR3688,FRABio, Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Pierce, A (corresponding author), Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, CNRS, UMR 8576,FR3688,FRABio, Villeneuve Dascq, France.	annick.pierce@univ-lille1.fr	Lefebvre, Tony/AAW-9169-2021; Lefebvre, Tony/AAZ-1724-2021	Lefebvre, Tony/0000-0001-9883-2240; Vercoutter-Edouart, Anne-Sophie/0000-0002-3243-7122; Hardiville, Stephan/0000-0002-3554-277X; Huvent, Isabelle/0000-0002-7241-0290	Centre National de la Recherche Scientifique; Unite Mixte de Recherche [8576]; Institut Federatif de Recherche [147]; Universite des Sciences et Technologies de Lille I; Comite du Nord de la Ligue Nationale contre le Cancer	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Unite Mixte de Recherche; Institut Federatif de Recherche; Universite des Sciences et Technologies de Lille I; Comite du Nord de la Ligue Nationale contre le Cancer	This investigation was supported in part by the Centre National de la Recherche Scientifique, the Unite Mixte de Recherche 8576, the Institut Federatif de Recherche no 147, the Universite des Sciences et Technologies de Lille I, the Comite du Nord de la Ligue Nationale contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aillet F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051672; Baker HM, 2012, BIOCHEM CELL BIOL, V90, P320, DOI [10.1139/O11-071, 10.1139/o11-071]; Benaissa M, 2005, INT J CANCER, V114, P299, DOI 10.1002/ijc.20728; Benayoun BA, 2009, TRENDS CELL BIOL, V19, P189, DOI 10.1016/j.tcb.2009.02.003; Breton M, 2004, BIOMETALS, V17, P325, DOI 10.1023/B:BIOM.0000027712.81056.13; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fu Y, 2007, J CELL BIOCHEM, V102, P704, DOI 10.1002/jcb.21323; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hardiville S, 2014, BIOMETALS, V27, P875, DOI 10.1007/s10534-014-9744-5; Hardiville S, 2010, J BIOL CHEM, V285, P19205, DOI 10.1074/jbc.M109.080572; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hoedt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104563; Hoedt E, 2010, BIOMETALS, V23, P441, DOI 10.1007/s10534-010-9305-5; Hsieh YL, 2013, EMBO J, V32, P791, DOI 10.1038/emboj.2013.5; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055338; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu DX, 2003, BIOCHEM BIOPH RES CO, V301, P472, DOI 10.1016/S0006-291X(02)03077-2; Mariller C, 2007, FEBS J, V274, P2038, DOI 10.1111/j.1742-4658.2007.05747.x; Mariller C, 2012, BIOCHEM CELL BIOL, V90, P307, DOI [10.1139/O11-070, 10.1139/o11-070]; Mariller C, 2009, BIOCHIMIE, V91, P109, DOI 10.1016/j.biochi.2008.07.009; MASSON PL, 1969, J EXP MED, V130, P643, DOI 10.1084/jem.130.3.643; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Miteva M, 2010, SUBCELL BIOCHEM, V54, P195, DOI 10.1007/978-1-4419-6676-6_16; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; PANELLA TJ, 1991, CANCER RES, V51, P3037; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Qian M, 2009, PLOS ONE, V6, DOI [10.1371/journal.pone.0019001, DOI 10.1371/JOURNAL.PONE.0019001]; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Siebert PD, 1997, P NATL ACAD SCI USA, V94, P2198, DOI 10.1073/pnas.94.6.2198; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Teng C, 2004, BIOMETALS, V17, P317, DOI 10.1023/B:BIOM.0000027711.13818.8a; Urvalek AM, 2011, AM J TRANSL RES, V3, P121; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Watts FZ, 2013, CHROMOSOMA, V122, P451, DOI 10.1007/s00412-013-0422-0; Xue Y, 2006, PAIL PREDICTION ACET; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yonashiro R, 2009, MOL BIOL CELL, V20, P4524, DOI 10.1091/mbc.E09-02-0112; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	70	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129965	10.1371/journal.pone.0129965	http://dx.doi.org/10.1371/journal.pone.0129965			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090800	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000078
J	Yang, CX; Pan, HP; Liu, Y; Zhou, XG				Yang, Chunxiao; Pan, Huipeng; Liu, Yong; Zhou, Xuguo			Temperature and Development Impacts on Housekeeping Gene Expression in Cowpea Aphid, Aphis craccivora (Hemiptera: Aphidiae)	PLOS ONE			English	Article							REAL-TIME PCR; VALIDATION; HOMOPTERA; SELECTION; TISSUES; KOCH	Quantitative real-time PCR (qRT-PCR) is a powerful technique to quantify gene expression. To standardize gene expression studies and obtain more accurate qRT-PCR analysis, normalization relative to consistently expressed housekeeping genes (HKGs) is required. In this study, ten candidate HKGs including elongation factor 1 alpha (EF1A), ribosomal protein L11(RPL11), ribosomal protein L14(RPL14), ribosomal protein S8(RPS8), ribosomal protein S23(RPS23), NADH-ubiquinone oxidoreductase(NADH), vacuolar-type H+-ATPase (ATPase), heat shock protein 70(HSP70), 18S ribosomal RNA(18S), and 12S ribosomal RNA(12S) from the cowpea aphid, Aphis craccivora Koch were selected. Four algorithms, geNorm, Normfinder, BestKeeper, and the Delta C-t method were employed to evaluate the expression profiles of these HKGs as endogenous controls across different developmental stages and temperature regimes. Based on RefFinder, which integrates all four analytical algorithms to compare and rank the candidate HKGs, RPS8, RPL14, and RPL11 were the three most stable HKGs across different developmental stages and temperature conditions. This study is the first step to establish a standardized qRT-PCR analysis in A. craccivora following the MIQE guideline. Results from this study lay a foundation for the genomics and functional genomics research in this sap-sucking insect pest with substantial economic impact.	[Yang, Chunxiao; Liu, Yong] Hunan Acad Agr Sci, Inst Plant Protect, Changsha, Hunan, Peoples R China; [Yang, Chunxiao; Pan, Huipeng; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Hunan Academy of Agricultural Sciences; University of Kentucky	Liu, Y (corresponding author), Hunan Acad Agr Sci, Inst Plant Protect, Changsha, Hunan, Peoples R China.	haoasliu@163.com; xuguozhou@uky.edu			University of Kentucky; USDA BRAG grant [3048108827]; Special Fund for Agroscience Research in the Public Interest [201303028]	University of Kentucky; USDA BRAG grant; Special Fund for Agroscience Research in the Public Interest	This research was supported by a start-up fund from the University of Kentucky to XGZ, a grant from USDA BRAG grant (Award Agreement No.: 3048108827) to XGZ, and a Special Fund for Agroscience Research in the Public Interest (Award Agreement No.: 201303028) to YL. The granting agencies have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agunbiade TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079929; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Annan IB, 2000, ANN ENTOMOL SOC AM, V93, P133, DOI 10.1603/0013-8746(2000)093[0133:SPABAC]2.0.CO;2; Bansal R, 2012, J ECON ENTOMOL, V105, P1432, DOI 10.1603/EC12095; BERG GN, 1984, AUST J ZOOL, V32, P345, DOI 10.1071/ZO9840345; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cameron RC, 2013, APIDOLOGIE, V44, P357, DOI 10.1007/s13592-012-0187-0; Chen CY, 2013, B ENTOMOL RES, V103, P406, DOI 10.1017/S0007485312000867; Chen CY, 2009, SYMBIOSIS, V49, P53, DOI 10.1007/s13199-009-0011-4; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Kamphuis LG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-101; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Liang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087514; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Obopile M, 2010, J PEST SCI, V83, P9, DOI 10.1007/s10340-009-0262-0; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Sainsbury F, 2010, ANNU REV PHYTOPATHOL, V48, P437, DOI 10.1146/annurev-phyto-073009-114242; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Wu KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097038; Yang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120833; Yang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110454; YANG CX, 2014, PEERJ PREPRINTS, V2, pV6621; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	34	36	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130593	10.1371/journal.pone.0130593	http://dx.doi.org/10.1371/journal.pone.0130593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090683	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000133
J	Cimini, E; Agrati, C; D'Offizi, G; Vlassi, C; Casetti, R; Sacchi, A; Lionetti, R; Bordoni, V; Tumino, N; Scognamiglio, P; Martini, F				Cimini, Eleonora; Agrati, Chiara; D'Offizi, Gianpiero; Vlassi, Chrysoula; Casetti, Rita; Sacchi, Alessandra; Lionetti, Raffaella; Bordoni, Veronica; Tumino, Nicola; Scognamiglio, Paola; Martini, Federico			Primary and Chronic HIV Infection Differently Modulates Mucosal V delta 1 and V delta 2 T-Cells Differentiation Profile and Effector Functions	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; GAMMA-DELTA; DENDRITIC CELLS; GASTROINTESTINAL-TRACT; LYMPHOCYTES; DEPLETION; RECEPTOR; ANERGY; REPLICATION; EXPRESSION	Gut-associated immune system has been identified as a major battlefield during the early phases of HIV infection. Upsilon delta T-cells, deeply affected in number and function after HIV infection, are able to act as a first line of defence against invading pathogens by producing antiviral soluble factors and by killing infected cells. Despite the relevant role in mucosal immunity, few data are available on gut-associated Upsilon delta T-cells during HIV infection. Aim of this work was to evaluate how primary (P-HIV) and chronic (C-HIV) HIV infection affects differentiation profile and functionality of circulating and gut-associated V delta 1 and V delta 2 T-cells. In particular, circulating and mucosal cells were isolated from respectively whole blood and residual gut samples from HIV-infected subjects with primary and chronic infection and from healthy donors (HD). Differentiation profile and functionality were analyzed by multiparametric flow cytometry. P-HIV and C-HIV were characterized by an increase in the frequency of effector V delta 1-T cells both in circulating and mucosal compartments. Moreover, during P-HIV mucosal V delta 1 T-cells expressed high levels of CD107a, suggesting a good effector cytotoxic capability of these cells in the early phase of infection that was lost in C-HIV. P-HIV induced an increase in circulating effector V delta 2 T-cells in comparison to C-HIV and HD. Notably, P-HIV as well as HD were characterized by the ability of mucosal V delta 2 T-cells to spontaneously produce IFN-Upsilon that was lost in C-HIV. Altogether, our data showed for the first time a functional capability of mucosal V delta 1 and V delta 2 T-cells during P-HIV that was lost in C-HIV, suggesting exhaustion mechanisms induced by persistent stimulation.	[Cimini, Eleonora; Agrati, Chiara; Casetti, Rita; Sacchi, Alessandra; Bordoni, Veronica; Tumino, Nicola; Martini, Federico] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, I-00149 Rome, Italy; [Agrati, Chiara] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Virol Lab, I-00149 Rome, Italy; [D'Offizi, Gianpiero; Vlassi, Chrysoula; Lionetti, Raffaella] IRCCS, Natl Inst Infect Dis, Clin Dept, I-00149 Rome, Italy; IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Gastrointestinal Endoscopy Unit, I-00149 Rome, Italy; [Scognamiglio, Paola] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Epidemiol Unit, I-00149 Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Agrati, C (corresponding author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Via Portuense 292, I-00149 Rome, Italy.	chiara.agrati@inmi.it	Scognamiglio, Paola/B-4754-2017; Casetti, Rita/K-8631-2016; bordoni, veronica/K-8614-2016; Sacchi, Alessandra/K-7782-2016; Tumino, Nicola/Y-4761-2019; Cimini, Eleonora/K-8878-2016; Agrati, Chiara/K-8806-2016	Scognamiglio, Paola/0000-0002-7938-6457; Casetti, Rita/0000-0002-7574-8780; bordoni, veronica/0000-0002-1747-2245; Sacchi, Alessandra/0000-0003-4964-386X; Tumino, Nicola/0000-0003-3773-8829; Cimini, Eleonora/0000-0002-2659-0868; Agrati, Chiara/0000-0002-5252-0927	Italian Ministry of Health (Ricerca Corrente)	Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy)	This study was funded by grants from the Italian Ministry of Health (Ricerca Corrente). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2011, AIDS REV, V13, P3; Agrati C, 2009, J IMMUNOL, V182, P522, DOI 10.4049/jimmunol.182.1.522; AUTRAN B, 1989, CLIN EXP IMMUNOL, V75, P206; Benlahrech A, 2012, CLIN EXP IMMUNOL, V170, P212, DOI 10.1111/j.1365-2249.2012.04647.x; BOULLIER S, 1995, J IMMUNOL, V154, P1418; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Chung NPY, 2012, J IMMUNOL, V189, P5257, DOI 10.4049/jimmunol.1201905; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; DAVODEAU F, 1993, SCIENCE, V260, P1800, DOI 10.1126/science.8390096; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Enders PJ, 2003, AIDS RES HUM RETROV, V19, P21, DOI 10.1089/08892220360473934; FALINI B, 1989, J IMMUNOL, V143, P2480; FARSTAD IN, 1993, SCAND J IMMUNOL, V38, P451, DOI 10.1111/j.1365-3083.1993.tb02587.x; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; He H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019607; Hofer U, 2009, SEMIN IMMUNOPATHOL, V31, P257, DOI 10.1007/s00281-009-0158-3; Kuroda H, 2012, GASTRIC CANCER, V15, P433, DOI 10.1007/s10120-011-0138-x; Martini F, 2000, IMMUNOLOGY, V100, P481, DOI 10.1046/j.1365-2567.2000.00068.x; Martini F, 2002, J INFECT DIS, V186, P847, DOI 10.1086/342410; Martino A, 2007, CURR MOL MED, V7, P658, DOI 10.2174/156652407782564345; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Meresse B, 2009, SEMIN IMMUNOL, V21, P121, DOI 10.1016/j.smim.2009.01.002; Milush JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-158; MODLIN RL, 1989, NATURE, V339, P544, DOI 10.1038/339544a0; Nilssen DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029066; Nilssen DE, 1996, J VIROL, V70, P3545, DOI 10.1128/JVI.70.6.3545-3550.1996; Poccia F, 1999, J INFECT DIS, V180, P858, DOI 10.1086/314925; Poccia F, 1998, INT J MOL MED, V1, P409; Poccia F, 1996, J IMMUNOL, V157, P449; Poccia F., 2002, Current Molecular Medicine (Hilversum), V2, P769, DOI 10.2174/1566524023361880; Poggi A, 2004, BLOOD, V103, P2205, DOI 10.1182/blood-2003-08-2928; Poles MA, 2003, J VIROL, V77, P10456, DOI 10.1128/JVI.77.19.10456-10467.2003; Sacchi A, 2009, J INFECT DIS, V199, P432, DOI 10.1086/596047; Shacklett Barbara L, 2010, Curr Infect Dis Rep, V12, P19, DOI 10.1007/s11908-009-0072-9; UYEMURA K, 1991, CURR TOP MICROBIOL, V173, P203; VECCHI M, 1992, GASTROENTEROLOGY, V102, P1499, DOI 10.1016/0016-5085(92)91707-B	39	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129771	10.1371/journal.pone.0129771	http://dx.doi.org/10.1371/journal.pone.0129771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086523	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500062
J	Crewe, TL; Taylor, PD; Lepage, D				Crewe, Tara L.; Taylor, Philip D.; Lepage, Denis			Modeling Systematic Change in Stopover Duration Does Not Improve Bias in Trends Estimated from Migration Counts	PLOS ONE			English	Article							POPULATION TRENDS; WESTERN SANDPIPERS; RIVER DELTA; BIRDS; PATTERNS; WIND; SITE	The use of counts of unmarked migrating animals to monitor long term population trends assumes independence of daily counts and a constant rate of detection. However, migratory stopovers often last days or weeks, violating the assumption of count independence. Further, a systematic change in stopover duration will result in a change in the probability of detecting individuals once, but also in the probability of detecting individuals on more than one sampling occasion. We tested how variation in stopover duration influenced accuracy and precision of population trends by simulating migration count data with known constant rate of population change and by allowing daily probability of survival (an index of stopover duration) to remain constant, or to vary randomly, cyclically, or increase linearly over time by various levels. Using simulated datasets with a systematic increase in stopover duration, we also tested whether any resulting bias in population trend could be reduced by modeling the underlying source of variation in detection, or by subsampling data to every three or five days to reduce the incidence of recounting. Mean bias in population trend did not differ significantly from zero when stopover duration remained constant or varied randomly over time, but bias and the detection of false trends increased significantly with a systematic increase in stopover duration. Importantly, an increase in stopover duration over time resulted in a compounding effect on counts due to the increased probability of detection and of recounting on subsequent sampling occasions. Under this scenario, bias in population trend could not be modeled using a covariate for stopover duration alone. Rather, to improve inference drawn about long term population change using counts of unmarked migrants, analyses must include a covariate for stopover duration, as well as incorporate sampling modifications (e.g., subsampling) to reduce the probability that individuals will be detected on more than one occasion.	[Crewe, Tara L.] Western Univ, Dept Biol, London, ON, Canada; [Taylor, Philip D.] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada; [Lepage, Denis] Bird Studies Canada, Natl Data Ctr, Port Rowan, ON, Canada	Western University (University of Western Ontario); Acadia University	Crewe, TL (corresponding author), Western Univ, Dept Biol, London, ON, Canada.	tcrewe2@uwo.ca			National Science and Engineering Research Council (NSERC); NSERC; two-term Mitacs Accelerate grant; Bird Studies Canada	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); two-term Mitacs Accelerate grant; Bird Studies Canada	This work was funded by a National Science and Engineering Research Council (NSERC; http://www.nserc-crsng.gc.ca/index_eng.asp) Post-Graduate Scholarship (PGS-B) to TC, a two-term Mitacs Accelerate grant (https://www.mitacs.ca/en/programs/accelerate) to TC and PT in partnership with Bird Studies Canada (DL), and an NSERC Discovery Grant to PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Ballard G, 2003, CONDOR, V105, P737, DOI 10.1650/7131; Bart J, 2004, J WILDLIFE MANAGE, V68, P611, DOI 10.2193/0022-541X(2004)068[0611:GASFET]2.0.CO;2; Berthiaume E, 2009, CONDOR, V111, P43, DOI 10.1525/cond.2009.080081; Bildstein KL, 2008, UNION SERIES ORNITHO, V3; Bishop MA, 2000, J FIELD ORNITHOL, V71, P627, DOI 10.1648/0273-8570-71.4.627; Blancher PJ, 2009, FOREST CHRON, V85, P184, DOI 10.5558/tfc85184-2; Brattstrom O, 2008, ANIM BEHAV, V76, P335, DOI 10.1016/j.anbehav.2008.02.011; Buler JJ, 2014, CONDOR, V116, P357, DOI 10.1650/CONDOR-13-162.1; Calvert AM, 2009, GLOBAL CHANGE BIOL, V15, P744, DOI 10.1111/j.1365-2486.2008.01733.x; Crewe TL, 2008, 1 CAN MIGR MON NETW, P69; Drever MC, 2014, J FIELD ORNITHOL, V85, P10, DOI 10.1111/jofo.12045; Dunn Erica H., 2005, U S Forest Service General Technical Report PSW, V191, P712; Environment Canada, 2012, N AM BREED BIRD SURV; Farmer CJ, 2007, AUK, V124, P1047, DOI 10.1642/0004-8038(2007)124[1047:DPTIMB]2.0.CO;2; Findlay KP, 2011, AFR J MAR SCI, V33, P375, DOI 10.2989/1814232X.2011.637345; Francis CM, 1998, BIRD POPULATIONS, V4, P37; Gibbs D, 2006, J KANSAS ENTOMOL SOC, V79, P156, DOI 10.2317/0504.06.1; Harrison N. M., 2000, Ringing and Migration, V20, P1; Hochachka WM, 2008, J ORNITHOL, V149, P375, DOI 10.1007/s10336-008-0282-1; Hussell David J.T., 2005, North American Bird Bander, V30, P6; Hussell DJT, 1998, RECOMMENDED METHODS, P1; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; Kery M, 2004, BASIC APPL ECOL, V5, P65, DOI 10.1078/1439-1791-00194; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Long Point Bird Observatory, 2011, CAN MIGR MON NETW DA; Martino S, 2010, IMPLEMENTING APPROXI; Nichols JD, 2009, ENVIRON ECOL STAT SE, V3, P201, DOI 10.1007/978-0-387-78151-8_9; Osenkowski JE, 2012, CONDOR, V114, P470, DOI 10.1525/cond.2012.110169; R Core Team, 2021, R LANGUAGE ENV STAT; RICH TD, 2004, PARTNERS FLIGHT N AM; Robinson WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044976; Rue H., 2014, INLA FUNCTIONS WHICH; RUSSELL RW, 1994, CONSERV BIOL, V8, P483, DOI 10.1046/j.1523-1739.1994.08020483.x; Sanders CE, 2014, CONDOR, V116, P371, DOI 10.1650/CONDOR-13-098.1; Schaub M, 2004, ANIM BEHAV, V67, P229, DOI 10.1016/j.anbehav.2003.03.011; Schaub M, 2001, ECOLOGY, V82, P852, DOI 10.2307/2680203; Schaub M, 2008, BEHAV ECOL, V19, P657, DOI 10.1093/beheco/arn023; Schmidt JH, 2013, BIOL CONSERV, V160, P130, DOI 10.1016/j.biocon.2013.01.007; Taylor PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027054; Vardanis Y, 2011, BIOL LETTERS, V7, P502, DOI 10.1098/rsbl.2010.1180; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713	45	8	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130137	10.1371/journal.pone.0130137	http://dx.doi.org/10.1371/journal.pone.0130137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086796	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500079
J	Ivars, K; Nelson, N; Theodorsson, A; Theodorsson, E; Strom, JO; Morelius, E				Ivars, Katrin; Nelson, Nina; Theodorsson, Annette; Theodorsson, Elvar; Strom, Jakob O.; Morelius, Evalotte			Development of Salivary Cortisol Circadian Rhythm and Reference Intervals in Full-Term Infants	PLOS ONE			English	Article							PSYCHIATRIC-SYMPTOMS; PRETERM INFANTS; EMERGENCE; CHILDREN; STRESS; SLEEP; LIFE; AGE	Background Cortisol concentrations in plasma display a circadian rhythm in adults and children older than one year. Earlier studies report divergent results regarding when cortisol circadian rhythm is established. The present study aims to investigate at what age infants develop a circadian rhythm, as well as the possible influences of behavioral regularity and daily life trauma on when the rhythm is established. Furthermore, we determine age-related reference intervals for cortisol concentrations in saliva during the first year of life. Methods 130 healthy full-term infants were included in a prospective, longitudinal study with saliva sampling on two consecutive days, in the morning (07:30-09:30), noon (10:00-12:00) and evening (19:30-21:30), each month from birth until the infant was twelve months old. Information about development of behavioral regularity and potential exposure to trauma was obtained from the parents through the Baby Behavior Questionnaire and the Life Incidence of Traumatic Events checklist. Results A significant group-level circadian rhythm of salivary cortisol secretion was established at one month, and remained throughout the first year of life, although there was considerable individual variability. No correlation was found between development of cortisol circadian rhythm and the results from either the Baby Behavior Questionnaire or the Life Incidence of Traumatic Events checklist. The study presents salivary cortisol reference intervals for infants during the first twelve months of life. Conclusions Cortisol circadian rhythm in infants is already established by one month of age, earlier than previous studies have shown. The current study also provides first year age-related reference intervals for salivary cortisol levels in healthy, full-term infants.	[Ivars, Katrin; Nelson, Nina] Linkoping Univ, Fac Hlth Sci, Div Pediat, Dept Clin & Expt Med, Linkoping, Sweden; [Nelson, Nina] Gothenburg Univ, Dept Pediat, Inst Clin Sci, S-41124 Gothenburg, Sweden; [Theodorsson, Annette] Linkoping Univ, Dept Clin & Expt Med, Fac Hlth Sci,Reg Ostergotland, Div Neurosci,Dept Neurosurg,Anaesthet Operat & Sp, Linkoping, Sweden; [Theodorsson, Elvar; Strom, Jakob O.] Linkoping Univ, Ctr Diagnost, Div Microbiol & Mol Med,Reg Ostergotland, Dept Clin & Expt Med,Fac Hlth Sci,Dept Clin Chem, Linkoping, Sweden; [Morelius, Evalotte] Linkoping Univ, Fac Hlth Sci, Div Hlth Act & Care, Dept Social & Welf Studies, Linkoping, Sweden	Linkoping University; University of Gothenburg; Linkoping University; Linkoping University; Linkoping University	Theodorsson, E (corresponding author), Linkoping Univ, Ctr Diagnost, Div Microbiol & Mol Med,Reg Ostergotland, Dept Clin & Expt Med,Fac Hlth Sci,Dept Clin Chem, Linkoping, Sweden.	elvar.theodorsson@liu.se	Mörelius, Evalotte/AAH-8407-2021; Theodorsson, Elvar/H-2096-2011	Mörelius, Evalotte/0000-0002-3256-5407; Theodorsson, Elvar/0000-0003-0756-7723; Strom, Jakob/0000-0002-6681-0546	County Council of Ostergotland, Sweden; Medical Research Council of Southeast Sweden, FORSS	County Council of Ostergotland, Sweden; Medical Research Council of Southeast Sweden, FORSS	This study was supported by the County Council of Ostergotland, Sweden, and Medical Research Council of Southeast Sweden, FORSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini SRR, 2000, CLIN ENDOCRINOL, V52, P423, DOI 10.1111/j.1365-2265.2000.tb00561.x; Clements AD, 1998, PSYCHONEUROENDOCRINO, V23, P613; Custodio RJ, 2007, CLIN ENDOCRINOL, V66, P192, DOI 10.1111/j.1365-2265.2006.02706.x; de Weerth C, 2003, EARLY HUM DEV, V73, P39, DOI 10.1016/S0378-3782(03)00074-4; GIANNAKOULOPOULOS X, 1994, LANCET, V344, P77, DOI 10.1016/S0140-6736(94)91279-3; Greenwald R, 1999, RES SOCIAL WORK PRAC, V9, P61, DOI 10.1177/104973159900900105; Gustafsson PE, 2010, NORD J PSYCHIAT, V64, P27, DOI 10.3109/08039480903265314; Gustafsson PE, 2009, AM J ORTHOPSYCHIAT, V79, P387, DOI 10.1037/a0016559; HAGEKULL B, 1985, SCAND J PSYCHOL, V26, P110, DOI 10.1111/j.1467-9450.1985.tb01148.x; Ivars K, 2012, ACTA PAEDIATR, V101, P1206, DOI 10.1111/apa.12001; KIESS W, 1995, PEDIATR RES, V37, P502, DOI 10.1203/00006450-199504000-00020; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kristenson M., 2011, ROLE SALIVA CORTISOL; LEWIS M, 1995, CHILD DEV, V66, P657, DOI 10.1111/j.1467-8624.1995.tb00896.x; Morelius E, 2006, SCAND J CLIN LAB INV, V66, P15, DOI 10.1080/00365510500402166; Morelius E, 2004, SCAND J CLIN LAB INV, V64, P113, DOI 10.1080/00365510410004452; PRICE DA, 1983, ARCH DIS CHILD, V58, P454, DOI 10.1136/adc.58.6.454; Santiago LB, 1996, CLIN ENDOCRINOL, V44, P157, DOI 10.1046/j.1365-2265.1996.645466.x; SPANGLER G, 1991, EARLY HUM DEV, V25, P197, DOI 10.1016/0378-3782(91)90116-K; STAHL F, 1979, ENDOKRINOLOGIE, V74, P243; Tollenaar MS, 2010, EARLY HUM DEV, V86, P13, DOI 10.1016/j.earlhumdev.2009.12.003; Yehuda R, 1998, PSYCHIAT CLIN N AM, V21, P359, DOI 10.1016/S0193-953X(05)70010-1	22	43	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129502	10.1371/journal.pone.0129502	http://dx.doi.org/10.1371/journal.pone.0129502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086734	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500051
J	He, YJ; Meng, ZW; Jia, Q; Hu, F; He, XH; Tan, J; Zhang, GZ; Li, X; Zhang, JP; Zhang, Q; Liu, L; Zhao, LL; Li, J; Wang, YL; Qian, YM; Hou, SL; Liu, H; Wang, S; Wang, RF; Zheng, W; Hu, TP; Liu, N; Upadhyaya, A; Liu, Y				He, Yajing; Meng, Zhaowei; Jia, Qiang; Hu, Fang; He, Xianghui; Tan, Jian; Zhang, Guizhi; Li, Xue; Zhang, Jianping; Zhang, Qing; Liu, Li; Zhao, Lili; Li, Jing; Wang, Yuling; Qian, Yumei; Hou, Shuling; Liu, Hua; Wang, Sheng; Wang, Renfei; Zheng, Wei; Hu, Tianpeng; Liu, Na; Upadhyaya, Arun; Liu, Yang			Sleep Quality of Patients with Differentiated Thyroid Cancer	PLOS ONE			English	Article							OF-LIFE; CONTROLLED-TRIAL; PROSTATE-CANCER; BREAST; DISTURBANCES; PREVALENCE; INSOMNIA; MULTICENTER; THERAPY; FATIGUE	Objective We aimed to measure prevalence of sleep disturbance in patients with differentiated thyroid cancer (DTC) by calculating Pittsburgh Sleep Quality Index (PSQI), and compare these data with patients with benign thyroid nodules or normal participants. Methods Three groups of patients participated in this cross-sectional study. In the first group, 162 patients with DTC received total thyroidectomy, and then 131I therapy. The second group consisted of 84 patients with benign thyroid nodules, who received partial thyroidectomy. The third group was 78 normal healthy control cases. PSQI was used to assess the sleep quality. Inter-group differences were analyzed by Kruskal-Wallis test or independent samples T test.. 2 test was also used to check prevalence differences of poor sleep quality among the groups. Differences of PSQI score and poor sleep quality prevalence before and after 131I therapy in the same group of DTC participants were analyzed by paired T test and Mcnemar's test. Results Higher PSQI score (7.59 +/- 4.21) and higher rate of poor sleep quality (54.32%) were shown in DTC patients than in any other group. After 131I therapy, PSQI score and prevalence of poor sleep quality in DTC patients increased significantly to 8.78 +/- 4.72 and 70.99%. Then DTC patients were divided into two subgroups based on their metastatic status. DTC patients with metastasis (87/162 cases, 53.70%) had significantly higher PSQI score (10.87 +/- 5.18) and higher prevalence of poor sleep quality (79.31%). Conclusion DTC patients suffer from sleep disturbance, 131I therapy and awareness of metastatic status could worsen sleep problem. Psychological fear of cancer, nuclear medicine therapy and metastasis could be one major underlying reason. Longitude and interventional studies are necessary for further investigations.	[He, Yajing; Meng, Zhaowei; Jia, Qiang; Tan, Jian; Zhang, Guizhi; Li, Xue; Zhang, Jianping; Zhao, Lili; Li, Jing; Wang, Yuling; Qian, Yumei; Hou, Shuling; Liu, Hua; Wang, Sheng; Wang, Renfei; Zheng, Wei; Hu, Tianpeng; Liu, Na; Upadhyaya, Arun; Liu, Yang] Tianjin Med Univ, Gen Hosp, Dept Nucl Med, Tianjin, Peoples R China; [Hu, Fang; He, Xianghui] Tianjin Med Univ, Gen Hosp, Dept Gen Surg, Tianjin, Peoples R China; [Zhang, Qing; Liu, Li] Tianjin Med Univ, Gen Hosp, Dept Hlth Management, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Meng, ZW (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Nucl Med, Tianjin, Peoples R China.	jamesmencius@163.com; tanposta@163.com	Zheng, Wei/AAB-4413-2021; Linong, Ji/AAB-6543-2020; Meng, Zhaowei/AAE-4732-2022	Zheng, Wei/0000-0003-1206-9243; 	National Key Clinical Specialty Project; Tianjin Medical University General Hospital New Century Excellent Talent Program; Young and Middle-aged Innovative Talent Training Program from Tianjin Education Committee; Talent Fostering Program (the 131 Project) from Tianjin Education Committee, Tianjin Human Resources and Social Security Bureau	National Key Clinical Specialty Project; Tianjin Medical University General Hospital New Century Excellent Talent Program; Young and Middle-aged Innovative Talent Training Program from Tianjin Education Committee; Talent Fostering Program (the 131 Project) from Tianjin Education Committee, Tianjin Human Resources and Social Security Bureau	This investigation was supported by the National Key Clinical Specialty Project (awarded to the Departments of Nuclear Medicine and Radiology). This study was also supported by Tianjin Medical University General Hospital New Century Excellent Talent Program; Young and Middle-aged Innovative Talent Training Program from Tianjin Education Committee; and Talent Fostering Program (the 131 Project) from Tianjin Education Committee, Tianjin Human Resources and Social Security Bureau (awarded to Zhaowei Meng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Becze Elisa, 2009, ONS Connect, V24, P22; Berger AM, 2007, PSYCHO-ONCOLOGY, V16, P401, DOI 10.1002/pon.1079; Berger AM, 2009, J CLIN ONCOL, V27, P6033, DOI 10.1200/JCO.2008.20.8306; Berger AM, 2009, ONCOL NURS FORUM, V36, P401, DOI 10.1188/09.ONF.E165-E177; Berger AM, 2009, PSYCHO-ONCOLOGY, V18, P634, DOI 10.1002/pon.1438; Buysse D J, 1989, Psychiatry Res, V28, P193; Chen WY, 2014, BREAST CANCER RES TR, V145, P381, DOI 10.1007/s10549-014-2944-4; Colagiuri B, 2011, J PAIN SYMPTOM MANAG, V42, P710, DOI 10.1016/j.jpainsymman.2011.02.012; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Courneya KS, 2014, BREAST CANCER RES TR, V144, P361, DOI 10.1007/s10549-014-2883-0; Dahiya S, 2013, CLEV CLIN J MED, V80, P722, DOI 10.3949/ccjm.80a.12170; Do Rosario PWS, 2004, CLIN NUCL MED, V29, P795, DOI 10.1097/00003072-200412000-00005; Garrett K, 2011, J PAIN SYMPTOM MANAG, V42, P239, DOI 10.1016/j.jpainsymman.2010.11.010; Gooneratne NS, 2007, LUNG CANCER, V58, P403, DOI 10.1016/j.lungcan.2007.07.011; Joffe H, 2010, MENOPAUSE, V17, P908, DOI 10.1097/gme.0b013e3181dbee1b; Kouvaraki MA, 2003, SURGERY, V134, P946, DOI 10.1016/S0039-6060(03)00424-0; Liu LQ, 2008, PSYCHIAT ANN, V38, P627, DOI 10.3928/00485713-20080901-01; Meng ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033597; Mercadante S, 2004, SUPPORT CARE CANCER, V12, P355, DOI 10.1007/s00520-004-0623-4; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Mustian KM, 2013, J CLIN ONCOL, V31, P3233, DOI 10.1200/JCO.2012.43.7707; Phillips KM, 2012, SUPPORT CARE CANCER, V20, P357, DOI 10.1007/s00520-011-1106-z; Roscoe JA, 2007, ONCOLOGIST, V12, P35, DOI 10.1634/theoncologist.12-S1-35; Savard J, 2005, PSYCHO-ONCOLOGY, V14, P147, DOI 10.1002/pon.830; Savard J, 2001, SLEEP, V24, P583, DOI 10.1093/sleep/24.5.583; Savard J, 2001, J CLIN ONCOL, V19, P895, DOI 10.1200/JCO.2001.19.3.895; Savard J, 2009, SLEEP, V32, P1155, DOI 10.1093/sleep/32.9.1155; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Thomas KS, 2010, PSYCHO-ONCOLOGY, V19, P767, DOI 10.1002/pon.1639; Tian J, 2015, SUPPORT CARE CANCER, V23, P1401, DOI 10.1007/s00520-014-2493-8; Wong KK, 2008, AM J ROENTGENOL, V191, P1785, DOI 10.2214/AJR.08.1218	31	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130634	10.1371/journal.pone.0130634	http://dx.doi.org/10.1371/journal.pone.0130634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083787	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400150
J	Lopez-Alfaro, C; Coogan, SCP; Robbins, CT; Fortin, JK; Nielsen, SE				Lopez-Alfaro, Claudia; Coogan, Sean C. P.; Robbins, Charles T.; Fortin, Jennifer K.; Nielsen, Scott E.			Assessing Nutritional Parameters of Brown Bear Diets among Ecosystems Gives Insight into Differences among Populations	PLOS ONE			English	Article							AMERICAN BLACK BEARS; GRIZZLY URSUS-ARCTOS; WEST-CENTRAL ALBERTA; CUTTHROAT TROUT; ECONOMIC-SYSTEMS; FOOD-HABITS; BODY-MASS; CONSERVATION; ECOLOGY; ENERGY	Food habit studies are among the first steps used to understand wildlife-habitat relationships. However, these studies are in themselves insufficient to understand differences in population productivity and life histories, because they do not provide a direct measure of the energetic value or nutritional composition of the complete diet. Here, we developed a dynamic model integrating food habits and nutritional information to assess nutritional parameters of brown bear (Ursus arctos) diets among three interior ecosystems of North America. Specifically, we estimate the average amount of digestible energy and protein (per kilogram fresh diet) content in the diet and across the active season by bears living in western Alberta, the Flathead River (FR) drainage of southeast British Columbia, and the Greater Yellowstone Ecosystem (GYE). As well, we estimate the proportion of energy and protein in the diet contributed by different food items, thereby highlighting important food resources in each ecosystem. Bear diets in Alberta had the lowest levels of digestible protein and energy through all seasons, which might help explain the low reproductive rates of this population. The FR diet had protein levels similar to the recent male diet in the GYE during spring, but energy levels were lower during late summer and fall. Historic and recent diets in GYE had the most energy and protein, which is consistent with their larger body sizes and higher population productivity. However, a recent decrease in consumption of trout (Oncorhynchus clarki), whitebark pine nuts (Pinus albicaulis), and ungulates, particularly elk (Cervus elaphus), in GYE bears has decreased the energy and protein content of their diet. The patterns observed suggest that bear body size and population densities are influenced by seasonal availability of protein an energy, likely due in part to nutritional influences on mass gain and reproductive success.	[Lopez-Alfaro, Claudia; Coogan, Sean C. P.; Nielsen, Scott E.] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; [Lopez-Alfaro, Claudia] Univ Chile, Dept Ciencias Ambientales & Recursos Nat Renovabl, Santiago, Chile; [Coogan, Sean C. P.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Coogan, Sean C. P.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Robbins, Charles T.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Robbins, Charles T.; Fortin, Jennifer K.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	University of Alberta; Universidad de Chile; University of Sydney; University of Sydney; Washington State University; Washington State University	Lopez-Alfaro, C (corresponding author), Univ Alberta, Dept Renewable Resources, 751 GSB, Edmonton, AB T6G 2H1, Canada.	lopez@ualberta.ca	Nielsen, Scott/O-7482-2019; Lopez, Claudia/GPX-5995-2022; Nielsen, Scott/C-2842-2013	Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630	Natural Sciences and Engineering Council (NSERC); Alberta Innovates Bio Solutions	Natural Sciences and Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Bio Solutions	This project was partially funded by the Natural Sciences and Engineering Council (NSERC) and Alberta Innovates Bio Solutions.	[Anonymous], 1987, BEARS BIOL MANAG; ASRD ACA, 2010, STAT GRIZZL BEAR URS; Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Barboza PS, 2009, INTEGRATIVE WILDLIFE, Vxviii; Bojarska K, 2013, URSUS, V24, P13, DOI 10.2192/URSUS-D-12-00017.1; Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x; Boulanger J, 2013, WILDLIFE BIOL, V19, P274, DOI 10.2981/12-088; Cheung PCK, 1997, J SCI FOOD AGR, V73, P255, DOI [10.1002/(SICI)1097-0010(199702)73:2<255::AID-JSFA723>3.0.CO;2-U, 10.1002/(SICI)1097-0010(199702)73:2&lt;255::AID-JSFA723&gt;3.0.CO;2-U]; Coogan SCP, 2012, THESIS U ALBERTA EDM; Coogan SCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097968; Coogan Sean C.P., 2012, ISRN Ecology, P1; Costanza R, 1998, ECOL MODEL, V112, P81, DOI 10.1016/S0304-3800(98)00073-8; Costanza R, 2001, ECOL MODEL, V143, P1, DOI 10.1016/S0304-3800(01)00358-1; Dobson AP, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002025; Eberhardt LL, 2007, J WILDLIFE MANAGE, V71, P594, DOI 10.2193/2005-770; Edwards MA, 2011, OECOLOGIA, V165, P877, DOI 10.1007/s00442-010-1869-9; Efford MG, 2013, METHODS ECOL EVOL, V4, P629, DOI 10.1111/2041-210X.12049; Erlenbach JA, 2014, J MAMMAL, V95, P160, DOI 10.1644/13-MAMM-A-161; Farley SD, 1995, CAN J ZOOL, V73, P2216, DOI 10.1139/z95-262; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Ferguson SH, 2000, ECOGRAPHY, V23, P193, DOI 10.1034/j.1600-0587.2000.230205.x; FOGEL R, 1978, Northwest Science, V52, P1; Fortin JK, 2013, J WILDLIFE MANAGE, V77, P270, DOI 10.1002/jwmg.483; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Group GYWPMW, 2010, MON WHIT PIN GREAT Y, P63; Haroldson MA, 2010, WHITEBARK PINE CONE; Haroldson Mark A., 2008, Yellowstone Science, V16, P13; Herfindal I, 2006, OECOLOGIA, V150, P213, DOI 10.1007/s00442-006-0519-8; Hewitt DG, 1996, WILDLIFE SOC B, V24, P547; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hilderbrand GV, 1999, CAN J ZOOL, V77, P1623, DOI 10.1139/cjz-77-10-1623; Homyack JA, 2010, WILDLIFE RES, V37, P332, DOI 10.1071/WR08093; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Koel TM, 2005, FISHERIES, V30, P10, DOI 10.1577/1548-8446(2005)30[10:NLTRIY]2.0.CO;2; Koel TM, 2006, J AQUAT ANIM HEALTH, V18, P157, DOI 10.1577/H05-031.1; Lopez-Alfaro C, 2013, ECOL MODEL, V270, P1, DOI 10.1016/j.ecolmode1.2013.09.002; MATTSON DJ, 1991, CAN J ZOOL, V69, P1619, DOI 10.1139/z91-226; MATTSON DJ, 1992, J MAMMAL, V73, P422, DOI 10.2307/1382078; Mattson DJ, 2004, COEFFICIENTS PRODUCT; McDonald PT, 2008, ECOL MODEL, V215, P276, DOI 10.1016/j.ecolmodel.2008.03.021; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; MCLELLAN BN, 1989, CAN J ZOOL, V67, P1861, DOI 10.1139/z89-265; McLellan BN, 2008, IUCN RED LIST OF THR; Mealey S.P., 1975, NATURAL FOOD HABITS; Middleton AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0870; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Nielsen SE, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-31; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P67, DOI 10.1016/j.foreco.2004.04.015; Noyce KV, 1997, CAN J ZOOL, V75, P1671, DOI 10.1139/z97-794; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Proctor MF, 2002, URSUS, V13, P153; Proctor M, 2010, URSUS, V21, P169, DOI 10.2192/1537-6176-21.2.169; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; Raubenheimer D, 2011, ECOL MONOGR, V81, P407, DOI 10.1890/10-1707.1; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Richmond B, 2001, INTRO SYSTEMS THINKI; Ripple WJ, 2014, J ANIM ECOL, V83, P223, DOI 10.1111/1365-2656.12123; Robbins CT, 2007, OIKOS, V116, P1675, DOI 10.1111/j.0030-1299.2007.16140.x; Robbins CT, 2012, J MAMMAL, V93, P540, DOI 10.1644/11-MAMM-A-155.1; Robbins CT, 2004, URSUS, V15, P161, DOI 10.2192/1537-6176(2004)015<0161:NEOUAR>2.0.CO;2; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Rode KD, 2000, CAN J ZOOL, V78, P1640, DOI 10.1139/cjz-78-9-1640; Schwartz CC, 2006, WILDLIFE MONOGR, V161, P9; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Schwartz CC, 2014, J WILDLIFE MANAGE, V78, P68, DOI 10.1002/jwmg.633; Servheen C, 2013, 22 INT C BEAR RES MA; Shafer ABA, 2014, EVOL APPL, V7, P301, DOI 10.1111/eva.12122; Simpson SJ, 2002, J EXP BIOL, V205, P121; Stringham SF, 1990, BEARS THEIR BIOL MAN, V8, P433, DOI DOI 10.2307/3872948; Swenson JE, 1999, CAN J ZOOL, V77, P551, DOI 10.1139/cjz-77-4-551; Swenson JE, 2007, OECOLOGIA, V153, P37, DOI 10.1007/s00442-007-0715-1; Team IGBS, 2011, YELL GRIZZL BEAR INV; Teisberg JE, 2014, J WILDLIFE MANAGE, V78, P369, DOI 10.1002/jwmg.667; US Department of Agriculture, NAT NUTR DAT STAND R; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005	84	33	33	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128088	10.1371/journal.pone.0128088	http://dx.doi.org/10.1371/journal.pone.0128088			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083536	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400027
J	Murakami, H; Katsunuma, R; Oba, K; Terasawa, Y; Motomura, Y; Mishima, K; Moriguchi, Y				Murakami, Hiroki; Katsunuma, Ruri; Oba, Kentaro; Terasawa, Yuri; Motomura, Yuki; Mishima, Kazuo; Moriguchi, Yoshiya			Neural Networks for Mindfulness and Emotion Suppression	PLOS ONE			English	Article							STRESS REDUCTION MBSR; DISPOSITIONAL MINDFULNESS; PREFRONTAL CORTEX; RESPONSES; MEDITATION; INTERVENTION; POLYMORPHISM; STIMULATION; ASSOCIATION; VARIABILITY	Mindfulness, an attentive non-judgmental focus on "here and now" experiences, has been incorporated into various cognitive behavioral therapy approaches and beneficial effects have been demonstrated. Recently, mindfulness has also been identified as a potentially effective emotion regulation strategy. On the other hand, emotion suppression, which refers to trying to avoid or escape from experiencing and being aware of one's own emotions, has been identified as a potentially maladaptive strategy. Previous studies suggest that both strategies can decrease affective responses to emotional stimuli. They would, however, be expected to provide regulation through different top-down modulation systems. The present study was aimed at elucidating the different neural systems underlying emotion regulation via mindfulness and emotion suppression approaches. Twenty-one healthy participants used the two types of strategy in response to emotional visual stimuli while functional magnetic resonance imaging was conducted. Both strategies attenuated amygdala responses to emotional triggers, but the pathways to regulation differed across the two. A mindful approach appears to regulate amygdala functioning via functional connectivity from the medial prefrontal cortex, while suppression uses connectivity with other regions, including the dorsolateral prefrontal cortex. Thus, the two types of emotion regulation recruit different top-down modulation processes localized at prefrontal areas. These different pathways are discussed.	[Murakami, Hiroki] Tokyo Metropolitan Inst Med Sci, Integrated Neurosci Res Project, Tokyo 113, Japan; [Katsunuma, Ruri; Oba, Kentaro; Terasawa, Yuri; Motomura, Yuki; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Kodaira, Tokyo, Japan; [Moriguchi, Yoshiya] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Kodaira, Tokyo, Japan; [Moriguchi, Yoshiya] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma, Japan	Tokyo Metropolitan Institute of Medical Science; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Gunma University	Moriguchi, Y (corresponding author), Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Kodaira, Tokyo, Japan.	ymoriguchi@gunma-u.ac.jp	Terasawa, Yuri/HGA-1834-2022	Terasawa, Yuri/0000-0002-2812-0544; MISHIMA, KAZUO/0000-0003-1182-1181	JSPS KAKENHI [25780438]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25780438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anticevic A, 2013, BIOL PSYCHIAT, V73, P565, DOI 10.1016/j.biopsych.2012.07.031; Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; Aue T, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00194, 10.3389/fnhum.2013.00418]; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Bokde ALW, 2005, COGNITIVE BRAIN RES, V25, P701, DOI 10.1016/j.cogbrainres.2005.09.016; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Campbell-Sills L, 2006, BEHAV RES THER, V44, P1251, DOI 10.1016/j.brat.2005.10.001; Carlson LE, 2007, BRAIN BEHAV IMMUN, V21, P1038, DOI 10.1016/j.bbi.2007.04.002; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Creswell JD, 2007, PSYCHOSOM MED, V69, P560, DOI 10.1097/PSY.0b013e3180f6171f; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Das P, 2005, NEUROIMAGE, V26, P141, DOI 10.1016/j.neuroimage.2005.01.049; Erk S, 2010, J NEUROSCI, V30, P15726, DOI 10.1523/JNEUROSCI.1856-10.2010; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fairclough SH, 2004, BIOL PSYCHOL, V66, P177, DOI 10.1016/j.biopsycho.2003.10.001; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; Gianaros PJ, 2004, PSYCHOPHYSIOLOGY, V41, P521, DOI 10.1111/1469-8986.2004.00179.x; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Goldin PR, 2010, EMOTION, V10, P83, DOI 10.1037/a0018441; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hayes AM, 2004, CLIN PSYCHOL-SCI PR, V11, P255, DOI 10.1093/clipsy/bph080; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Hirano S, 1997, EXP BRAIN RES, V113, P75, DOI 10.1007/BF02454143; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lang PJ, 1995, INT AFFECTIVE PICTUR; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Murakami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046377; Murakami H, 2010, INT J PSYCHOPHYSIOL, V77, P21, DOI 10.1016/j.ijpsycho.2010.03.012; Murakami H, 2009, NEUROREPORT, V20, P414, DOI 10.1097/WNR.0b013e328325a910; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Renaud P, 1997, INT J PSYCHOPHYSIOL, V27, P87, DOI 10.1016/S0167-8760(97)00049-4; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Tang YY, 2013, SOC COGN AFFECT NEUR, V8, P1, DOI 10.1093/scan/nss104; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Vrticka P, 2011, NEUROPSYCHOLOGIA, V49, P1067, DOI 10.1016/j.neuropsychologia.2011.02.020; Way BM, 2010, EMOTION, V10, P12, DOI 10.1037/a0018312; Xiao ZW, 2005, HUM BRAIN MAPP, V25, P212, DOI 10.1002/hbm.20105	55	28	29	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128005	10.1371/journal.pone.0128005	http://dx.doi.org/10.1371/journal.pone.0128005			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083379	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400024
J	Pei, ZL; Jiang, XH; Yang, Z; Ren, XG; Gong, H; Reeves, M; Sheng, JX; Wang, Y; Pan, ZS; Liu, FY; Wu, JG; Lu, SW				Pei, Zenglin; Jiang, Xiaohong; Yang, Zhu; Ren, Xiaoguang; Gong, Hao; Reeves, Michael; Sheng, Jingxue; Wang, Yu; Pan, Zishu; Liu, Fenyong; Wu, Jianguo; Lu, Sangwei			Oral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral Infection	PLOS ONE			English	Article							IMMUNE-RESPONSES; III SECRETION; DNA VACCINES; ENTERICA; TYPHIMURIUM; SYSTEM; NUCLEOPROTEIN; REPLICATION; INHIBITION; STABILITY	Attenuated strains of invasive enteric bacteria, such as Salmonella, represent promising gene delivery agents for nucleic acid-based vaccines as they can be administrated orally. In this study, we constructed a novel attenuated strain of Salmonella for the delivery and expression of the hemagglutinin (HA) and neuraminidase (NA) of a highly pathogenic H5N1 influenza virus. We showed that the constructed Salmonella strain exhibited efficient gene transfer activity for HA and NA expression and little cytotoxicity and pathogenicity in mice. Using BALB/c mice as the model, we evaluated the immune responses and protection induced by the constructed Salmonella-based vaccine. Our study showed that the Salmonella-based vaccine induced significant production of anti-HA serum IgG and mucosal IgA, and of anti-HA interferon-gamma producing T cells in orally vaccinated mice. Furthermore, mice orally vaccinated with the Salmonella vaccine expressing viral HA and NA proteins were completely protected from lethal challenge of highly pathogenic H5N1 as well as H1N1 influenza viruses while none of the animals treated with the Salmonella vaccine carrying the empty expression vector with no viral antigen expression was protected. These results suggest that the Salmonella-based vaccine elicits strong antigen-specific humoral and cellular immune responses and provides effective immune protection against multiple strains of influenza viruses. Furthermore, our study demonstrates the feasibility of developing novel attenuated Salmonella strains as new oral vaccine vectors against influenza viruses.	[Pei, Zenglin; Ren, Xiaoguang; Pan, Zishu; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Jiang, Xiaohong; Gong, Hao; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Yang, Zhu; Wang, Yu] Taizhou Inst Virol, Taizhou, Jiangsu, Peoples R China; [Yang, Zhu; Wang, Yu] Jiangsu Affynigen Biotechnol Inc, Taizhou, Jiangsu, Peoples R China; [Reeves, Michael; Sheng, Jingxue; Liu, Fenyong] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, FY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liu_fy@berkeley.edu; jwu@whu.edu.cn; sangwei@berkeley.edu		Wu, Jianguo/0000-0002-8326-2895	National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 31230005, 812111146]; National Mega Project on Major Drug Development [2009ZX09103-678]; National Small Business Innovation and Research (SBIR) Program of China; Technology R & D Program of Jiangsu Province, China [BG20077035, BG2008662]; NIH [RO1-AI041927, RO1-AI091536, RO1-DE014842]; Chancellor's Graduate Fellowship; University of California at Berkeley; Graduate Division of University of California at Berkeley; Jiangsu Affynigen Biotechnologies, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041927, R01AI091536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025462, R01DE023935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Drug Development; National Small Business Innovation and Research (SBIR) Program of China; Technology R & D Program of Jiangsu Province, China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chancellor's Graduate Fellowship; University of California at Berkeley; Graduate Division of University of California at Berkeley; Jiangsu Affynigen Biotechnologies, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by grants from National Basic Research Program of China (973 Program; No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, 31230005, and 812111146), National Mega Project on Major Drug Development (2009ZX09103-678), National Small Business Innovation and Research (SBIR) Program of China, the Technology R & D Program of Jiangsu Province, China (BG20077035 and BG2008662), and NIH (RO1-AI041927, RO1-AI091536, and RO1-DE014842). MR was partially supported by a Chancellor's Graduate Fellowship and a Hellman Family Graduate Fellowship from University of California at Berkeley. MR and JS were also partially supported by a block grant from the Graduate Division of University of California at Berkeley. Jiangsu Affynigen Biotechnologies, Inc provided support in the form of salaries for authors Zhu Yang and Yu Wang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2007, FIELDS VIROLOGY; Ashraf S, 2011, VACCINE, V29, P3990, DOI 10.1016/j.vaccine.2011.03.066; Atkins HS, 2006, VACCINE, V24, P2710, DOI 10.1016/j.vaccine.2005.12.046; Babiuk LA, 2003, VACCINE, V21, P649, DOI 10.1016/S0264-410X(02)00574-1; Bai Y, 2011, P NATL ACAD SCI USA, V108, P3222, DOI 10.1073/pnas.1014975108; Bai Y, 2010, P NATL ACAD SCI USA, V107, P7269, DOI 10.1073/pnas.0912813107; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Brumell JH, 2002, INFECT IMMUN, V70, P3264, DOI 10.1128/IAI.70.6.3264-3270.2002; CARDENAS L, 1992, CLIN MICROBIOL REV, V5, P328; Cheminay C, 2008, INT J MED MICROBIOL, V298, P87, DOI 10.1016/j.ijmm.2007.08.006; Chen JR, 2011, TRENDS BIOTECHNOL, V29, P426, DOI 10.1016/j.tibtech.2011.04.007; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng YP, 1997, J IMMUNOL, V158, P1507; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; Gu H, 2010, J APPL MICROBIOL, V108, P1145, DOI 10.1111/j.1365-2672.2009.04520.x; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jagger BW, 2010, MBIO, V1, DOI 10.1128/mBio.00067-10; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Jiang XH, 2012, P NATL ACAD SCI USA, V109, P13070, DOI 10.1073/pnas.1201620109; Kong W, 2012, P NATL ACAD SCI USA, V109, P19414, DOI 10.1073/pnas.1217554109; LEVINE MM, 1987, J CLIN INVEST, V79, P888, DOI 10.1172/JCI112899; Li XH, 2009, DIAGN MICR INFEC DIS, V65, P261, DOI 10.1016/j.diagmicrobio.2009.07.016; Liljebjelke KA, 2010, VACCINE, V28, P4430, DOI 10.1016/j.vaccine.2010.04.009; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Lu S, 2002, INFECT IMMUN, V70, P451, DOI 10.1128/IAI.70.2.451-461.2002; Luo MC, 2011, VACCINE, V29, P2561, DOI 10.1016/j.vaccine.2011.01.060; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Paglia P, 2000, GENE THER, V7, P1725, DOI 10.1038/sj.gt.3301290; Park KS, 2009, VIROLOGY, V395, P182, DOI 10.1016/j.virol.2009.09.018; Paterson GK, 2010, HUM VACCINES, V6, P379, DOI 10.4161/hv.6.5.10755; Prabakaran M, 2010, J VIROL, V84, P11822, DOI 10.1128/JVI.00891-10; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song MS, 2009, VACCINE, V27, P3145, DOI 10.1016/j.vaccine.2009.03.061; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tao P, 2009, VIRAL IMMUNOL, V22, P273, DOI 10.1089/vim.2009.0017; TITE JP, 1990, IMMUNOLOGY, V70, P540; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Wu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042363; Xie H, 2009, J INFECT DIS, V200, P1874, DOI 10.1086/648405; Xu K, 2011, VIRAL IMMUNOL, V24, P45, DOI 10.1089/vim.2010.0056; Yang N, 2008, CANCER BIOL THER, V7, P147; Yang Zhu, 2013, Virologica Sinica, V28, P24, DOI 10.1007/s12250-013-3290-0	53	13	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129276	10.1371/journal.pone.0129276	http://dx.doi.org/10.1371/journal.pone.0129276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083421	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400086
J	Steinberg, F; Kalicinski, M; Dalecki, M; Bock, O				Steinberg, Fabian; Kalicinski, Michael; Dalecki, Marc; Bock, Otmar			Human Performance in a Realistic Instrument-Control Task during Short-Term Microgravity	PLOS ONE			English	Article							GRASPING MOVEMENTS; SENSORIMOTOR COORDINATION; ARM MOVEMENTS; STRESS; SPACEFLIGHT; ACCURACY; EXPOSURE; CONTEXT; DEMAND; SKILLS	Previous studies have documented the detrimental effects of microgravity on human sensorimotor skills. While that work dealt with simple, laboratory-type skills, we now evaluate the effects of microgravity on a complex, realistic instrument-control skill. Twelve participants controlled a simulated power plant during the short-term microgravity intervals of parabolic flight as well as during level flight. To this end they watched multiple displays, made strategic decisions and used multiple actuators to maximize their virtual earnings from the power plant. We quantified control efficiency as the participants' net earnings (revenue minus expenses), motor performance as hand kinematics and dynamics, and stress as cortisol level, self-assessed mood and self-assessed workload. We found that compared to normal gravity, control efficiency substantially decreased in microgravity, hand velocity slowed down, and cortisol level and perceived physical strain increased, but other stress and motor scores didn't change. Furthermore, control efficiency was not correlated with motor and stress scores. From this we conclude that realistic instrument control was degraded in short-term microgravity. This degradation can't be explained by the motor and/or stress indicators under study, and microgravity affected motor performance differently in our complex, realistic skill than in the simple, laboratory-type skills of earlier studies.	[Steinberg, Fabian; Kalicinski, Michael; Dalecki, Marc; Bock, Otmar] German Sport Univ Cologne, Inst Physiol & Anat, Cologne, Germany; [Steinberg, Fabian] Johannes Gutenberg Univ Mainz, Inst Sport Sci, D-55122 Mainz, Germany; [Dalecki, Marc] York Univ, Ctr Vis Res, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	German Sport University Cologne; Johannes Gutenberg University of Mainz; York University - Canada	Steinberg, F (corresponding author), German Sport Univ Cologne, Inst Physiol & Anat, Cologne, Germany.	Fabian.steinberg@uni-mainz.de		Steinberg, Fabian/0000-0001-8313-0529	Deutsches Zentrum fur Luft- und Raumfahrt [50WB1224]	Deutsches Zentrum fur Luft- und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR))	This work was funded by Deutsches Zentrum fur Luft- und Raumfahrt (grant number 50WB1224) (URL: www.dlr.de); OB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger M, 1997, AVIAT SPACE ENVIR MD, V68, P781; Bock O, 1998, BRAIN RES REV, V28, P155, DOI 10.1016/S0165-0173(98)00035-6; Bock O, 1996, AVIAT SPACE ENVIR MD, V67, P1185; BOCK O, 1992, AVIAT SPACE ENVIR MD, V63, P994; Bock O, 2003, AVIAT SPACE ENVIR MD, V74, P1256; Bock O, 2001, AVIAT SPACE ENVIR MD, V72, P877; Bock O, 2003, NEUROLAB SPACELAB MI, P83; Bock O, 2013, HUM MOVEMENT SCI, V32, P249, DOI 10.1016/j.humov.2012.12.009; Bock O, 2010, AVIAT SPACE ENVIR MD, V81, P819, DOI 10.3357/ASEM.2608.2010; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; De la Torre Gabriel G., 2014, Life-Basel, V4, P281, DOI 10.3390/life4030281; Foley P, 2010, NEUROSCI BIOBEHAV R, V35, P91, DOI 10.1016/j.neubiorev.2010.01.010; Fowler B, 2000, HUM FACTORS, V42, P318, DOI 10.1518/001872000779656507; Hancock PA, 1998, ERGONOMICS, V41, P1169, DOI 10.1080/001401398186469; Hockey G, 1996, ADV SPACE BIOL MED, P309; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Johannes B, 2003, Aviakosm Ekolog Med, V37, P6; Jungling S, 2002, AVIAT SPACE ENVIR MD, V73, P430; Kanas N, 2008, SPACE TECHNOL LIB, V22, P15, DOI 10.1007/978-1-4020-6770-9_2; Kleinert J, 2006, Z SPORTPSYCHOL, V13, P156, DOI 10.1026/1612-5010.13.4.156; Kornilova LN, 1997, J VESTIBUL RES-EQUIL, V7, P429, DOI 10.1016/S0957-4271(96)00184-X; Lackner JR, 1996, CURR OPIN NEUROBIOL, V6, P744, DOI 10.1016/S0959-4388(96)80023-7; Macho L, 2003, ADV SPACE RES, V31, P1605, DOI 10.1016/S0273-1177(03)00097-8; Manzey D, 1995, HUM FACTORS, V37, P667, DOI 10.1518/001872095778995599; Manzey D, 1998, BRAIN RES REV, V28, P215, DOI 10.1016/S0165-0173(98)00041-1; Manzey D, 2000, ERGONOMICS, V43, P589, DOI 10.1080/001401300184279; Metz GA, 2007, REV NEUROSCIENCE, V18, P209; Papaxanthis C, 2005, NEUROSCIENCE, V135, P371, DOI 10.1016/j.neuroscience.2005.06.063; Rafiq A, 2005, AVIAT SPACE ENVIR MD, V76, P385; Rafiq A, 2006, AVIAT SPACE ENVIR MD, V77, P852; Schneider S, 2009, STRESS, V12, P336, DOI 10.1080/10253890802499175; Sherman CR, 2002, J TRAVEL MED, V9, P251; Steinberg F, 2013, AVIAT SPACE ENVIR MD, V84, P467, DOI 10.3357/ASEM.3348.2013; Steinberg F, 2013, EXP BRAIN RES, V225, P387, DOI 10.1007/s00221-012-3379-y; Verheyden B, 2005, EUR J APPL PHYSIOL, V95, P557, DOI 10.1007/s00421-005-0016-5	36	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128992	10.1371/journal.pone.0128992	http://dx.doi.org/10.1371/journal.pone.0128992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083473	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400076
J	Tomomura, M; Suzuki, R; Shirataki, Y; Sakagami, H; Tamura, N; Tomomura, A				Tomomura, Mineko; Suzuki, Ryuichiro; Shirataki, Yoshiaki; Sakagami, Hiroshi; Tamura, Nobuaki; Tomomura, Akito			Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-kappa B/NFATc1 Signaling	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CALCIUM-DECREASING FACTOR; RECEPTOR ACTIVATOR; LIGAND RANKL; NFATC1; LIPOPOLYSACCHARIDE; TRAF6; OSTEOPOROSIS; SUPPRESSION	Rhinacanthin C is a naphthoquinone ester with anti-inflammatory activity, found in Rhinacanthus nasutus (L) Kurz (Acanthaceae). We found that rhinacanthin C inhibited osteoclast differentiation stimulated by the receptor activator of nuclear factor-kappa B ligand (RANKL) in mouse bone marrow macrophage cultures, although the precise molecular mechanisms underlying this phenomenon are unclear. In this study, we investigated the inhibitory mechanisms of rhinacanthin C in osteoclastogenesis. Rhinacanthin C suppressed RANKL-induced nuclear factor of activated T cells c1 (NFATc1) expression. Phosphorylation of ERK, JNK, and NF-kappa B, but not p38, was inhibited by rhinacanthin C, which also inhibited RANKL-stimulated TRAF6-TAK1 complex formation. Thus, the anti-osteoclastogenic effect of rhinacanthin C is mediated by a cascade of inhibition of RANKL-induced TRAF6-TAK1 association followed by activation of MAPKs/NF-kappa B; this leads to suppression of c-Fos and NFATc1, which regulate transcription of genes associated with osteoclast differentiation. In vivo, rhinacanthin C also reduced RANKL-induced osteoclast formation and bone resorption in mouse calvaria. Rhinacanthin C also suppressed LPS-stimulated osteoclastogenesis and bone resorption in vitro and in vivo. Rhinacanthin C may provide a novel therapy for abnormal bone lysis that occurs during inflammatory bone resorption.	[Tomomura, Mineko; Sakagami, Hiroshi] Meikai Univ, Sch Dent, Meikai Pharmaco Med Lab MPL, Sakado, Saitama 35002, Japan; [Tomomura, Mineko; Tomomura, Akito] Meikai Univ, Sch Dent, Dept Oral Biol & Tissue Engn, Div Biochem, Sakado, Saitama 35002, Japan; [Suzuki, Ryuichiro; Shirataki, Yoshiaki] Josai Univ, Fac Pharmaceut Sci, Lab Pharmacognosy & Nat Med, Sakado, Saitama 35002, Japan; [Sakagami, Hiroshi] Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Pharmacol, Sakado, Saitama 35002, Japan; [Tamura, Nobuaki] Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Oral & Maxillofacial Surg 1, Sakado, Saitama 35002, Japan	Meikai University; Meikai University; Josai University; Meikai University; Meikai University	Tomomura, M (corresponding author), Meikai Univ, Sch Dent, Meikai Pharmaco Med Lab MPL, Sakado, Saitama 35002, Japan.	mineko-t@dent.meikai.ac.jp		Sakagami, Hiroshi/0000-0001-8001-2121	Japan Society for the promotion of Science [25462898]	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS Grant-in-Aid for Scientific Research (25462898 to MT) from the Japan Society for the promotion of Science (http://www.JSPS.go.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or operation of the manuscript.	Abu-Amer Y, 2013, OSTEOPOROSIS INT, V24, P2377, DOI 10.1007/s00198-013-2313-x; AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Braun T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3380; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chiou WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089159; Gotoh A, 2004, BIOL PHARM BULL, V27, P1070, DOI 10.1248/bpb.27.1070; Hasegawa H, 2010, J BIOL CHEM, V285, P25448, DOI 10.1074/jbc.M109.068742; Horii H, 2013, ANTICANCER RES, V33, P453; Horii H, 2011, IN VIVO, V25, P367; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Lee MS, 2009, J IMMUNOL, V183, P3390, DOI 10.4049/jimmunol.0804314; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Mormann M, 2008, MOL IMMUNOL, V45, P3330, DOI 10.1016/j.molimm.2008.04.022; Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996; Sakuma Y, 2000, INFECT IMMUN, V68, P6819, DOI 10.1128/IAI.68.12.6819-6825.2000; Sendl A, 1996, J NAT PROD, V59, P808, DOI 10.1021/np9601871; Siripong P, 2006, BIOL PHARM BULL, V29, P2279, DOI 10.1248/bpb.29.2279; Siriwatanametanon N, 2010, J ETHNOPHARMACOL, V130, P196, DOI 10.1016/j.jep.2010.04.036; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tewtrakul S, 2009, PHYTOMEDICINE, V16, P929, DOI 10.1016/j.phymed.2009.03.010; Tomomura M, 2012, J BIOL CHEM, V287, P17963, DOI 10.1074/jbc.M112.358796; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wei ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059171; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yen ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038048; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	38	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130174	10.1371/journal.pone.0130174	http://dx.doi.org/10.1371/journal.pone.0130174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083531	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567400128
J	Zheng, JD; Gui, X; Cao, Q; Yang, RR; Yan, YJ; Deng, LP; Lio, J				Zheng, Jinding; Gui, Xien; Cao, Qian; Yang, Rongrong; Yan, Yajun; Deng, Liping; Lio, Jonathan			A Clinical Study of Acquired Immunodeficiency Syndrome Associated Penicillium Marneffei Infection from a NonEndemic Area in China	PLOS ONE			English	Article							FUNGAL-INFECTIONS	Objective To investigate the clinical characteristics, diagnosis, treatment and prognosis of penicilliosis among the patients with acquired immunodeficiency syndrome (AIDS) in non-endemic areas of China, and then to discuss its incubation period and the diagnostic performance of serum galactomannan test for penicilliosis. Methods Medical records and travel histories of penicilliosis patients in Zhongnan hospital from January 2006 to December 2013, and the interval from when the patients left the endemic area to the onset of the disease was analyzed. Serum galactomannan levels of penicilliosis patients and AIDS patients with fever were measured by the Platelia Aspergillus Enzyme Immunoassay Kit. Results A total of 47 AIDS-associated penicilliosis were confirmed by fungal culture, which accounted for 4.8% of 981 AIDS-related admissions. The sensitivity and specificity of serum galactomannan test for penicilliosis were 95.8%(23/24) and 90.9%(30/33), respectively, (cutoff index = 1.0). Two independent predictors for early mortality (death within 12 weeks) of the patients (21.3%, 10/47) were a delayed diagnosis and no treatment with antifungal therapy. Among 14 patients who became ill after leaving endemic areas, ten patients presented with the onset symptoms within 12 months (from 11 days to 360 days). We found a patient living with asymptomatic P. marneffei fungemia who had not received any antifungal therapy until 18 months' follow up. Conclusions The co-infection of P. marneffei and HIV was not uncommon in the non-endemic areas of penicilliosis in China. There exists a latent form of infection for P. marneffei. The incubation period of penicilliosis may be quite different from one patient to another. In AIDS patients, the serum galactomannan test has utility for the diagnosis of penicilliosis. When patients with penicilliosis/AIDS were diagnosed early and treated with standardized antifungal therapy and combined antiretroviral therapy, their prognosis improved.	[Zheng, Jinding; Gui, Xien; Cao, Qian; Yang, Rongrong; Yan, Yajun; Deng, Liping] Wuhan Univ, Zhongnan Hosp, Dept Infect Dis, Wuhan 430072, Hubei, Peoples R China; [Lio, Jonathan] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Wuhan University; University of Chicago	Gui, X (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Infect Dis, Wuhan 430072, Hubei, Peoples R China.	ZNACT@126.com		Deng, Liping/0000-0002-4897-7721; Lio, Jonathan/0000-0002-3723-2767				Armstrong-James D, 2014, TRENDS MICROBIOL, V22, P120, DOI 10.1016/j.tim.2014.01.001; Bulterys PL, 2013, CLIN INFECT DIS, V56, P1273, DOI 10.1093/cid/cit058; Cao CW, 2011, EMERG INFECT DIS, V17, P209, DOI 10.3201/eid1702.100718; Chariyalertsak S, 1997, CLIN INFECT DIS, V24, P1080, DOI 10.1086/513649; Dalle F, 2005, J CLIN MICROBIOL, V43, P2929, DOI 10.1128/JCM.43.6.2929-2931.2005; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hu YX, 2013, MYCOPATHOLOGIA, V175, P57, DOI 10.1007/s11046-012-9577-0; Huang Li-fen, 2010, Zhonghua Nei Ke Za Zhi, V49, P653; Huang YT, 2007, J CLIN MICROBIOL, V45, P2858, DOI 10.1128/JCM.00050-07; Jung JY, 2012, J KOREAN MED SCI, V27, P697, DOI 10.3346/jkms.2012.27.6.697; Larsson M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-24; Nguyen K, 2006, J AM ACAD DERMATOL, V54, P730, DOI 10.1016/j.jaad.2005.06.041; Rimek D, 1999, MYCOSES, V42, P25, DOI 10.1111/j.1439-0507.1999.tb00008.x; Sun HY, 2006, JPN J INFECT DIS, V59, P311; SUPPARATPINYO K, 1993, ANTIMICROB AGENTS CH, V37, P2407, DOI 10.1128/AAC.37.11.2407; Thuy L, 2011, CLIN INFECT DIS, V52, P945, DOI 10.1093/cid/cir028; Uehara Masae, 2008, Nihon Ishinkin Gakkai Zasshi, V49, P205, DOI 10.3314/jjmm.49.205; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Wang TKF, 2007, INT J INFECT DIS, V11, P280, DOI 10.1016/j.ijid.2006.04.004; Wu T. C., 2008, Hong Kong Medical Journal, V14, P103	21	29	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0130376	10.1371/journal.pone.0130376	http://dx.doi.org/10.1371/journal.pone.0130376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083736	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400140
J	Aarstad, HH; Vintermyr, OK; Ulvestad, E; Kross, K; Heimdal, JH; Aarstad, HJ				Aarstad, Helene Hersvik; Vintermyr, Olav Karsten; Ulvestad, Elling; Kross, Kenneth; Heimdal, John Helge; Aarstad, Hans Jorgen			In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; HUMAN-PAPILLOMAVIRUS; PROGNOSTIC MARKER; CANCER PATIENTS; LUNG-CANCER; INFLAMMATION; HPV; PHOSPHORYLATION; EXPRESSION; PROFILE	The study was performed in order to determine whether peripheral blood monocyte in vitro function, and lymphocyte in vivo activation at diagnosis, was associated with HPV tumor infection status and 15-year survival in head and neck squamous cell carcinoma (HNSCC) patients. Sixty-five patients from a consecutive cohort of newly diagnosed HNSCCs, together with 18 control patients, were included in the study. Monocyte responsiveness was assessed by measuring monocyte in vitro interleukin (IL)-6 secretions after 24 hours of LPS stimulation in cultures with a serum-free medium. T lymphocyte activation was determined as the fraction of CD71-positive cells on CD3-positive cells by flow cytometry, whereas HPV infection was determined by PCR on formalin-fixed paraffin-embedded (FFPE) tumor tissue. Disease-specific survivals and overall survivals were determined 15 years following inclusion. HPV-positive HNSCC patients had a lower monocyte LPS-stimulated IL-6 response. A high LPS-stimulated monocyte IL-6 response predicted a decreased survival rate (P=0.019). A high percentage of CD71-positive T lymphocytes also predicted an impaired prognosis (P=0.021). The predictive power of IL-6 monocyte LPS-stimulated responses was retained when adjusted for age, gender and TNM stage of the patients. The monocyte and T lymphocyte survival predictions were independent of each other. The survival was particularly low with a combined high activated monocyte and T lymphocyte status. In a multivariate analysis, IL-6 secretion and the percentage of CD71-positive T lymphocytes both uniquely predicted survival independent of HPV infection status. It is postulated that the natural and adaptive immune systems are separately and additionally linked to the clinical aggressiveness of HNSCCs.	[Aarstad, Helene Hersvik; Vintermyr, Olav Karsten; Heimdal, John Helge; Aarstad, Hans Jorgen] Univ Bergen, Fac Med & Dent, Dept Clin Med, Bergen, Norway; [Aarstad, Helene Hersvik; Heimdal, John Helge; Aarstad, Hans Jorgen] Haukeland Hosp, Dept Otolaryngol Head & Neck Surg, N-5021 Bergen, Norway; [Vintermyr, Olav Karsten] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Ulvestad, Elling] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Ulvestad, Elling] Univ Bergen, Fac Med & Dent, Dept Clin Sci, Bergen, Norway; [Kross, Kenneth] Maastricht Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-6200 MD Maastricht, Netherlands	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Maastricht University	Aarstad, HJ (corresponding author), Univ Bergen, Fac Med & Dent, Dept Clin Med, Bergen, Norway.	hans.aarstad@uib.no			Norwegian Cancer Society	Norwegian Cancer Society(Norwegian Cancer Society)	The laboratories were in general supported by the Norwegian Cancer Society.	Aarstad HJ, 2006, ACTA OTO-LARYNGOL, V126, P1326, DOI 10.1080/00016480600702092; Aarstad HJ, 2015, APMIS; Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Andersen AS, 2014, INT J CANCER, V134, P2755, DOI 10.1002/ijc.28411; Ang KK, 2012, SEMIN RADIAT ONCOL, V22, P128, DOI 10.1016/j.semradonc.2011.12.004; Blitzer GC, 2014, INT J RADIAT ONCOL, V88, P761, DOI 10.1016/j.ijrobp.2013.08.029; Chang CH, 2013, INT J CANCER, V132, P1977, DOI 10.1002/ijc.27892; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Cho WCS, 2011, EXPERT OPIN THER TAR, V15, P1127, DOI 10.1517/14728222.2011.599801; Costa NL, 2013, ORAL ONCOL, V49, P216, DOI 10.1016/j.oraloncology.2012.09.012; Davidson HC, 2009, ORAL ONCOL, V45, P747, DOI 10.1016/j.oraloncology.2009.02.009; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Feller L, 2013, ORAL ONCOL, V49, P887, DOI 10.1016/j.oraloncology.2013.07.003; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Heimdal JH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-34; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hong SH, 2000, FASEB J, V14, P1499, DOI 10.1096/fj.99-0802com; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Kipanyula MJ, 2013, CELL SIGNAL, V25, P403, DOI 10.1016/j.cellsig.2012.10.014; Kross KW, 2008, SCAND J IMMUNOL, V67, P392, DOI 10.1111/j.1365-3083.2008.02072.x; Kross KW, 2010, EUR ARCH OTO-RHINO-L, V267, P335, DOI 10.1007/s00405-009-1153-y; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Ljokjel B, 2014, ACTA OTO-LARYNGOL, V134, P1, DOI [10.3109/00016489.2013.840922, DOI 10.3109/00016489.2013.840922]; Ljokjel B, 2014, ACTA OTO-LARYNGOL, V134, P636, DOI 10.3109/00016489.2014.886336; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Millrud CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051120; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Olsnes C, 2011, SCAND J IMMUNOL, V74, P114, DOI 10.1111/j.1365-3083.2011.02555.x; Olsnes C, 2013, APMIS, V121, P299, DOI 10.1111/j.1600-0463.2012.02969.x; Reddy M, 2004, J IMMUNOL METHODS, V293, P127, DOI 10.1016/j.jim.2004.07.006; Shipkova M, 2012, CLIN CHIM ACTA, V413, P1338, DOI 10.1016/j.cca.2011.11.006; Starska K, 2011, FOLIA HISTOCHEM CYTO, V49, P593, DOI 10.5603/FHC.2011.0082; Tartour E, 2001, LANCET, V357, P1263, DOI 10.1016/S0140-6736(00)04420-2; Vermeer DW, 2013, INT J CANCER, V133, P120, DOI 10.1002/ijc.28015; Ward MJ, 2014, BRIT J CANCER, V110, P489, DOI 10.1038/bjc.2013.639; Whiteside TL, 2005, CANCER METAST REV, V24, P95, DOI 10.1007/s10555-005-5050-6	37	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129724	10.1371/journal.pone.0129724	http://dx.doi.org/10.1371/journal.pone.0129724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079381	gold, Green Submitted, Green Published			2022-12-26	WOS:000356542300031
J	Aguado-Fraile, E; Ramos, E; Conde, E; Rodriguez, M; Martin-Gomez, L; Lietor, A; Candela, A; Ponte, B; Liano, F; Garcia-Bermejo, ML				Aguado-Fraile, Elia; Ramos, Edurne; Conde, Elisa; Rodriguez, Macarena; Martin-Gomez, Laura; Lietor, Aurora; Candela, Angel; Ponte, Belen; Liano, Fernando; Laura Garcia-Bermejo, Maria			A Pilot Study Identifying a Set of microRNAs As Precise Diagnostic Biomarkers of Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; DEFINITION; EXPRESSION; URINE	In the last decade, Acute Kidney Injury (AKI) diagnosis and therapy have not notably improved probably due to delay in the diagnosis, among other issues. Precocity and accuracy should be critical parameters in novel AKI biomarker discovery. microRNAs are key regulators of cell responses to many stimuli and they can be secreted to the extracellular environment. Therefore, they can be detected in body fluids and are emerging as novel disease biomarkers. We aimed to identify and validate serum miRNAs useful for AKI diagnosis and management. Using qRT-PCR arrays in serum samples, we determined miRNAs differentially expressed between AKI patients and healthy controls. Statistical and target prediction analysis allowed us to identify a panel of 10 serum miRNAs. This set was further validated, by qRT-PCR, in two independent cohorts of patients with relevant morbi-mortality related to AKI: Intensive Care Units (ICU) and Cardiac Surgery (CS). Statistical correlations with patient clinical parameter were performed. Our results demonstrated that the 10 selected miRNAs (miR-101-3p, miR-127-3p, miR-210-3p, miR-126-3p, miR-26b-5p, miR-29a-3p, miR-146a-5p, miR-27a-3p, miR-93-3p and miR-10a-5p) were diagnostic biomarkers of AKI in ICU patients, exhibiting areas under the curve close to 1 in ROC analysis. Outstandingly, serum miRNAs estimated before CS predicted AKI development later on, thus becoming biomarkers to predict AKI predisposition. Moreover, after surgery, the expression of the miRNAs was modulated days before serum creatinine increased, demonstrating early diagnostic value. In summary, we have identified a set of serum miRNAs as AKI biomarkers useful in clinical practice, since they demonstrate early detection and high diagnostic value and they recognize patients at risk.	[Aguado-Fraile, Elia; Ramos, Edurne; Conde, Elisa; Rodriguez, Macarena; Martin-Gomez, Laura; Laura Garcia-Bermejo, Maria] IRYCIS, miRNAs Based Biomarkers & Therapeut Targets Unit, Madrid, Spain; [Lietor, Aurora] Univ Hosp Ramon y Cajal, Dept Intens Med, Madrid, Spain; [Candela, Angel] Univ Hosp Ramon y Cajal, Dept Anesthesia & Reanimat, Madrid, Spain; [Ponte, Belen] Univ Hosp Geneve, Dept Internal Med, Geneva, Switzerland; [Liano, Fernando] Univ Hosp Ramon y Cajal, IRYCIS, Dept Nephrol, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; University of Geneva; Hospital Universitario Ramon y Cajal	Garcia-Bermejo, ML (corresponding author), IRYCIS, miRNAs Based Biomarkers & Therapeut Targets Unit, Madrid, Spain.	garciabermejo@gmail.com	García-Bermejo, María Laura/E-1542-2015; rodriguez, macarena/E-8790-2018; MORENO, ELISA CONDE/H-7853-2017; Conde-Moreno, Elisa/AAG-2295-2021	García-Bermejo, María Laura/0000-0002-8167-2276; rodriguez, macarena/0000-0003-3499-5926; MORENO, ELISA CONDE/0000-0002-3751-9602; Conde-Moreno, Elisa/0000-0002-3751-9602; Ramos, Edurne/0000-0001-5388-0281	Instituto de Salud Carlos III (ISCIII) [FIS PS09/02183, PS12/00094]; Comunidad de MAdrid-Consorcio de Investigacion en Fracaso Renal Agudo (CAM-CIFRA) [S2010/BMD-2378]; CAM-CIFRA [S2010/BMD-2378]; Eusebio Martin Escudero Foundation Fellowship; Red de Investigacion Renal (REDINREN) [RD12/0021/0020]; ISCIII [CA11/00491]	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de MAdrid-Consorcio de Investigacion en Fracaso Renal Agudo (CAM-CIFRA); CAM-CIFRA; Eusebio Martin Escudero Foundation Fellowship; Red de Investigacion Renal (REDINREN); ISCIII(Instituto de Salud Carlos III)	This work was supported by grants FIS PS09/02183 and PS12/00094 by Instituto de Salud Carlos III (ISCIII) and Comunidad de MAdrid-Consorcio de Investigacion en Fracaso Renal Agudo (CAM-CIFRA, S2010/BMD-2378). EAF was supported by CAM-CIFRA (S2010/BMD-2378) and is currently funded by Eusebio Martin Escudero Foundation Fellowship, ER was funded by Red de Investigacion Renal (REDINREN, RD12/0021/0020), MR was recipient of contract from ISCIII (CA11/00491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Fraile E, 2013, NEFROLOGIA, V33, P826, DOI 10.3265/Nefrologia.pre2013.Aug.12198; Aguado-Fraile E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044305; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1569, DOI 10.1093/ndt/gfn009; Bellinger MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093297; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Devarajan P, 2014, NEPHRON CLIN PRACT, V127, P176, DOI 10.1159/000363206; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Haase M, 2010, CONTRIB NEPHROL, V165, P33, DOI 10.1159/000313742; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee CG, 2014, KIDNEY INT, V86, P943, DOI 10.1038/ki.2014.117; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Mariscalco G, 2011, ANN THORAC SURG, V92, P1539, DOI 10.1016/j.athoracsur.2011.04.123; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Saikumar J, 2014, CLIN CHEM, V60, P1158, DOI 10.1373/clinchem.2013.216044; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; Sirota JC, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/328120; Soto K, 2010, CLIN J AM SOC NEPHRO, V5, P1745, DOI 10.2215/CJN.00690110; Srisawat N, 2011, CURR OPIN CRIT CARE, V17, P548, DOI 10.1097/MCC.0b013e32834cd349; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Trionfini P, 2015, NAT REV NEPHROL, V11, P23, DOI 10.1038/nrneph.2014.202; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang G, 2011, DIS MARKERS, V30, P171, DOI [10.3233/DMA-2011-0766, 10.1155/2011/304852]	36	91	98	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0127175	10.1371/journal.pone.0127175	http://dx.doi.org/10.1371/journal.pone.0127175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079930	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300003
J	Baumer, N; Baumer, S; Haak, M; Koschmieder, S; Schonig, K; Berdel, WE; Muller-Tidow, C				Baeumer, Nicole; Baeumer, Sebastian; Haak, Miriam; Koschmieder, Steffen; Schoenig, Kai; Berdel, Wolfgang E.; Mueller-Tidow, Carsten			A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; HEMATOPOIETIC STEM-CELLS; PML-RAR-ALPHA; A1-CDK2 COMPLEX; MOUSE MODEL; EXPRESSION; CANCER; OVEREXPRESSION; PROLIFERATION	The quest for novel therapeutic targets in acute myeloid leukemia (AML) is still ongoing. One of such targets, cyclin A1, was shown to be overexpressed in AML including AML stem cells. However, the function of cyclin A1 in AML is largely unknown, and the data on its impact on patients' survival remain controversial. Therefore, we developed a transgenic mouse model of stem cell-directed inducible cyclin A1 overexpression and crossed these mice with PML-RAR alpha-knockin mice, which develop an AML M3-like phenotype. To observe the effects of cyclin A1 loss-of-function, we also crossed PML-RAR alpha-knockin mice to cyclin A1-knockout mice. Neither overexpression nor loss of cyclin A1 significantly altered leuke-mogenesis in PML-RAR alpha-knockin mice. These findings imply that upregulation of cyclin A1 is not essential for leukemogenesis. Our data suggest that cyclin A1 does not represent a suitable target for AML therapy.	[Baeumer, Nicole; Baeumer, Sebastian; Haak, Miriam; Berdel, Wolfgang E.; Mueller-Tidow, Carsten] Univ Munster, Dept Med A, Hematol Oncol, D-48149 Munster, Germany; [Haak, Miriam] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Koschmieder, Steffen] Rhein Westfal TH Aachen, Fac Med, Dept Med, Hematol Oncol Hemostaseol & SCT, Aachen, Germany; [Schoenig, Kai] Heidelberg Univ, Dept Mol Biol, Cent Inst Mental Hlth, Mannheim, Germany; [Mueller-Tidow, Carsten] Univ Halle Wittenberg, Dept Med 4, Hematol & Oncol, D-06108 Halle, Germany	University of Munster; Miltenyi Biotec; RWTH Aachen University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg	Baumer, N (corresponding author), Univ Munster, Dept Med A, Hematol Oncol, D-48149 Munster, Germany.	nbaeumer@uni-muenster.de; Carsten.Mueller-Tidow@UK-Halle.de	Müller-Tidow, Carsten/O-7207-2018; Baeumer, Sebastian/GYU-0544-2022	Müller-Tidow, Carsten/0000-0002-7166-5232; Koschmieder, Steffen/0000-0002-1011-8171	Deutsche Forschungsgemeinschaft [Mu 1328/2-3]; Deutsche Krebshilfe [10-1539-Mu3]; Miltenyi Biotec GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Miltenyi Biotec GmbH	This study was supported by grants from the Deutsche Forschungsgemeinschaft (Mu 1328/2-3; www.dfg.de) and the Deutsche Krebshilfe (10-1539-Mu3; www.krebshilfe.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Miltenyi Biotec GmbH provided support in the form of salary for author "MH," but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Baumer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094993; Baumer N, 2011, J BIOL CHEM, V286, P28210, DOI 10.1074/jbc.M110.203471; Bruyere C, 2013, CURR OPIN CELL BIOL, V25, P772, DOI 10.1016/j.ceb.2013.08.004; Diederichs S, 2005, INT J CANCER, V116, P207, DOI 10.1002/ijc.21034; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Ekberg J, 2005, EUR J HAEMATOL, V75, P106, DOI 10.1111/j.1600-0609.2005.00473.x; Gopinathan L, 2014, CANCER RES, V74, P3870, DOI 10.1158/0008-5472.CAN-13-3440; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hebestreit K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039148; Holm C, 2006, LEUKEMIA RES, V30, P254, DOI 10.1016/j.leukres.2005.07.010; Iida H, 1997, BLOOD, V90, P3707, DOI 10.1182/blood.V90.9.3707; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kelly LM, 2002, P NATL ACAD SCI USA, V99, P8283, DOI 10.1073/pnas.122233699; Khaja ASS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072210; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Liao C, 2001, P NATL ACAD SCI USA, V98, P6853, DOI 10.1073/pnas.121540098; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Liu Y, 2013, MOL CELL BIOCHEM, V384, P221, DOI 10.1007/s11010-013-1801-9; Muller C, 2000, BLOOD, V96, P3894, DOI 10.1182/blood.V96.12.3894.h8003894_3894_3899; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Munari E, 2015, HISTOPATHOLOGY, V66, P262, DOI 10.1111/his.12499; Ochsenreither S, 2012, BLOOD, V119, P5492, DOI 10.1182/blood-2011-07-365890; Schemionek M, 2010, BLOOD, V115, P3185, DOI 10.1182/blood-2009-04-215376; Schonig K, 2011, TRANSGENIC RES, V20, P709, DOI 10.1007/s11248-010-9427-0; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; van der Meer T, 2004, REPRODUCTION, V127, P503, DOI 10.1530/rep.1.00131; Vukman KV, 2014, BIOPROTOCOL, V4, pe1052; Wegiel B, 2008, JNCI-J NATL CANCER I, V100, P1022, DOI 10.1093/jnci/djn214; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Yang R, 1999, BLOOD, V93, P2067; Yu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006445	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129147	10.1371/journal.pone.0129147	http://dx.doi.org/10.1371/journal.pone.0129147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080083	Green Published, gold			2022-12-26	WOS:000356542300017
J	Ducken, DR; Brown, WC; Alperin, DC; Brayton, KA; Reif, KE; Turse, JE; Palmer, GH; Noh, SM				Ducken, Deirdre R.; Brown, Wendy C.; Alperin, Debra C.; Brayton, Kelly A.; Reif, Kathryn E.; Turse, Joshua E.; Palmer, Guy H.; Noh, Susan M.			Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein	PLOS ONE			English	Article							MAMMALIAN HOST-CELLS; MAJOR SURFACE PROTEIN-2; BOOPHILUS-MICROPLUS; VACCINE DEVELOPMENT; IMMUNOGENICITY; IMMUNITY; IDENTIFICATION; INFECTION; SUPERINFECTION; TRANSMISSION	Anaplasma marginale is a tick-borne rickettsial pathogen of cattle with a worldwide distribution. Currently a safe and efficacious vaccine is unavailable. Outer membrane protein (OMP) extracts or a defined surface protein complex reproducibly induce protective immunity. However, there are several knowledge gaps limiting progress in vaccine development. First, are these OMPs conserved among the diversity of A. marginale strains circulating in endemic regions? Second, are the most highly conserved outer membrane proteins in the immunogens recognized by immunized and protected animals? Lastly, can this subset of OMPs recognized by antibody from protected vaccinates and conserved among strains recapitulate the protection of outer membrane vaccines? To address the first goal, genes encoding OMPs AM202, AM368, AM854, AM936, AM1041, and AM1096, major subdominant components of the outer membrane, were cloned and sequenced from geographically diverse strains and isolates. AM202, AM936, AM854, and AM1096 share 99.9 to 100% amino acid identity. AM1041 has 97.1 to 100% and AM368 has 98.3 to 99.9% amino acid identity. While all four of the most highly conserved OMPs were recognized by IgG from animals immunized with outer membranes, linked surface protein complexes, or unlinked surface protein complexes and shown to be protected from challenge, the highest titers and consistent recognition among vaccinates were to AM854 and AM936. Consequently, animals were immunized with recombinant AM854 and AM936 and challenged. Recombinant vaccinates and purified outer membrane vaccinates had similar IgG and IgG2 responses to both proteins. However, the recombinant vaccinates developed higher bacteremia after challenge as compared to adjuvant-only controls and outer membrane vaccinates. These results provide the first evidence that vaccination with specific antigens may exacerbate disease. Progressing from the protective capacity of outer membrane formulations to recombinant vaccines requires testing of additional antigens, optimization of the vaccine formulation and a better understanding of the protective immune response.	[Ducken, Deirdre R.; Noh, Susan M.] USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Ducken, Deirdre R.; Brown, Wendy C.; Alperin, Debra C.; Brayton, Kelly A.; Reif, Kathryn E.; Turse, Joshua E.; Noh, Susan M.] Washington State Univ, Dept Vet Microbiol & Pathol, Program Vector Borne Dis, Pullman, WA 99164 USA; [Brayton, Kelly A.; Noh, Susan M.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University; Washington State University	Noh, SM (corresponding author), USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA.	snoh@vetmed.wsu.edu	, 0000-0001-7041-1823/B-9144-2014	, 0000-0001-7041-1823/0000-0001-7041-1823	United States Department of Agriculture-Agricultural Research Service [5348-32000-033-00D, 5348-3200-033-03S]; National Institutes of Health [R37 AI44005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044005, T32AI007025] Funding Source: NIH RePORTER	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States Department of Agriculture-Agricultural Research Service grant 5348-32000-033-00D, United States Department of Agriculture-Agricultural Research Service cooperative agreement 5348-3200-033-03S, and National Institutes of Health R37 AI44005.	Abbott JR, 2004, INFECT IMMUN, V72, P7360, DOI 10.1128/IAI.72.12.7360-7366.2004; Agnes JT, 2011, INFECT IMMUN, V79, P1311, DOI 10.1128/IAI.01174-10; Albarrak SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046372; Ayalew S, 2011, CLIN VACCINE IMMUNOL, V18, P2067, DOI 10.1128/CVI.05332-11; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Bock RE, 2003, VET PARASITOL, V118, P121, DOI 10.1016/j.vetpar.2003.08.011; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brown WC, 1998, INFECT IMMUN, V66, P5406, DOI 10.1128/IAI.66.11.5406-5413.1998; Couzin-Frankel J, 2013, SCIENCE, V342, P68, DOI 10.1126/science.342.6154.68; Dark MJ, 2011, VACCINE, V29, P4923, DOI 10.1016/j.vaccine.2011.04.131; Dark MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-16; de Echaide ST, 1998, J CLIN MICROBIOL, V36, P777, DOI 10.1128/JCM.36.3.777-782.1998; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Kahlon A, 2013, INFECT IMMUN, V81, P65, DOI 10.1128/IAI.00932-12; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Knight J, 2003, NATURE, V422, P554, DOI 10.1038/422554a; KUTTLER KL, 1984, VET MICROBIOL, V9, P181, DOI 10.1016/0378-1135(84)90033-6; Little SF, 2011, FEMS IMMUNOL MED MIC, V62, P11, DOI 10.1111/j.1574-695X.2011.00782.x; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; MANSON LA, 1991, IMMUNOL TODAY, V12, P352, DOI 10.1016/0167-5699(91)90065-2; Miltiadou D, 2003, TISSUE ANTIGENS, V62, P55, DOI 10.1034/j.1399-0039.2003.00080.x; Mudenda L, 2014, INT J PARASITOL, V44, P1029, DOI 10.1016/j.ijpara.2014.07.003; Nelson HS, 2007, J ALLERGY CLIN IMMUN, V119, P769, DOI 10.1016/j.jaci.2007.01.036; Noh SM, 2008, INFECT IMMUN, V76, P2219, DOI 10.1128/IAI.00008-08; Noh SM, 2006, INFECT IMMUN, V74, P3471, DOI 10.1128/IAI.01843-05; Noh SM, 2013, CLIN VACCINE IMMUNOL, V20, P651, DOI 10.1128/CVI.00600-12; Noh SM, 2010, VACCINE, V28, P3741, DOI 10.1016/j.vaccine.2010.02.067; Ojogun N, 2012, INFECT IMMUN, V80, P3748, DOI 10.1128/IAI.00654-12; PALMER GH, 1995, VET PARASITOL, V57, P233, DOI 10.1016/0304-4017(94)03123-E; Palmer GH, 2012, FEMS IMMUNOL MED MIC, V64, P115, DOI 10.1111/j.1574-695X.2011.00878.x; PIPANO E, 1995, VET PARASITOL, V57, P213, DOI 10.1016/0304-4017(94)03122-D; POTGIETER FT, 1983, ONDERSTEPOORT J VET, V50, P29; Ramabu SS, 2010, INFECT IMMUN, V78, P3047, DOI 10.1128/IAI.00300-10; Ren CC, 2014, APPL MICROBIOL BIOT, V98, P6353, DOI 10.1007/s00253-014-5678-7; Rodriguez JL, 2005, GENE, V361, P127, DOI 10.1016/j.gene.2005.06.038; RODRIGUEZ M, 1995, VET PARASITOL, V57, P339, DOI 10.1016/0304-4017(94)00678-6; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Seidman D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004669; Seidman D, 2014, CELL MICROBIOL, V16, P1133, DOI 10.1111/cmi.12286; Shkap V, 2009, VET MICROBIOL, V134, P254, DOI 10.1016/j.vetmic.2008.08.004; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takeshima SN, 2011, TISSUE ANTIGENS, V78, P208, DOI 10.1111/j.1399-0039.2011.01708.x; TEBELE N, 1991, INFECT IMMUN, V59, P3199, DOI 10.1128/IAI.59.9.3199-3204.1991; Telford JL, 2008, CELL HOST MICROBE, V3, P408, DOI 10.1016/j.chom.2008.05.004; Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10; Ueti MW, 2012, INFECT IMMUN, V80, P2354, DOI 10.1128/IAI.00341-12; Weiser JN, 2003, P NATL ACAD SCI USA, V100, P4215, DOI 10.1073/pnas.0637469100	48	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0129309	10.1371/journal.pone.0129309	http://dx.doi.org/10.1371/journal.pone.0129309			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26079491	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300021
J	Fousteri, G; Jofra, T; Di Fonte, R; Battaglia, M				Fousteri, Georgia; Jofra, Tatiana; Di Fonte, Roberta; Battaglia, Manuela			Combination of an Antigen-Specific Therapy and an Immunomodulatory Treatment to Simultaneous Block Recurrent Autoimmunity and Alloreactivity in Non-Obese Diabetic Mice	PLOS ONE			English	Article							TRANSPLANTATION TOLERANCE INDUCTION; ALLOGENEIC ISLET TRANSPLANTATION; T-CELL COSTIMULATION; PANCREAS TRANSPLANTATION; NOD MICE; GRAFT-SURVIVAL; PRONE MICE; TYPE-1; IMMUNOSUPPRESSION; RESPONSES	Restoration of endogenous insulin production by islet transplantation is considered a curative option for patients with type 1 diabetes. However, recurrent autoimmunity and alloreactivity cause graft rejection hindering successful transplantation. Here we tested whether transplant tolerance to allogeneic islets could be achieved in non-obese diabetic (NOD) mice by simultaneously tackling autoimmunity via antigen-specific immunization, and alloreactivity via granulocyte colony stimulating factor (G-CSF) and rapamycin (RAPA) treatment. Immunization with insB(9-23) peptide alone or in combination with two islet peptides (IGRP(206-214) and GAD(524-543)) in incomplete Freund's adjuvant (IFA) were tested for promoting syngeneic pancreatic islet engraftment in spontaneously diabetic NOD mice. Treatment with G-CSF/RAPA alone or in combination with insB(9-23)/IFA was examined for promoting allogeneic islet engraftment in the same mouse model. InsB(9-23)/IFA immunization significantly prolonged syngeneic pancreatic islet survival in NOD mice by a mechanism that necessitated the presence of CD4(+)CD25(+)T regulatory (Treg) cells, while combination of three islet epitopes was less efficacious in controlling recurrent autoimmunity. G-CSF/RAPA treatment was unable to reverse T1D or control recurrent autoimmunity but significantly prolonged islet allograft survival in NOD mice. Blockade of interleukin-10 (IL-10) during G-CSF/RAPA treatment resulted in allograft rejection suggesting that IL-10-producing cells were fundamental to achieve transplant tolerance. G-CSF/RAPA treatment combined with insB(9-23)/IFA did not further increase the survival of allogeneic islets. Thus, insB(9-23)/IFA immunization controls recurrent autoimmunity and G-CSF/RAPA treatment limits alloreactivity, however their combination does not further promote allogeneic pancreatic islet engraftment in NOD mice.	[Fousteri, Georgia; Jofra, Tatiana; Di Fonte, Roberta; Battaglia, Manuela] Ist Sci San Raffaele, IRCCS, DRI, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Fousteri, G (corresponding author), Ist Sci San Raffaele, IRCCS, DRI, Via Olgettina 58, I-20132 Milan, Italy.	fousteri.georgia@hsr.it; battaglia.manuela@hsr.it	Di Fonte, Roberta/AAC-5886-2020; Jofra, Tatiana/AAN-4727-2020; Fousteri, Georgia/B-1226-2012	Di Fonte, Roberta/0000-0002-8541-686X; Jofra, Tatiana/0000-0003-2825-155X; Battaglia, Manuela/0000-0003-4535-3152; Fousteri, Georgia/0000-0001-7745-7517	Juvenile Diabetes Research Foundation (JDRF) [10-2012-204]; Telethon-JDRF [JT-01]	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Telethon-JDRF(Juvenile Diabetes Research Foundation)	This work was supported by grants: Juvenile Diabetes Research Foundation (JDRF) advanced postdoctoral fellowship (10-2012-204) to G. Fousteri and Telethon-JDRF (JT-01) career development award to M. Battaglia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JRF, 2013, CURR DIABETES REP, V13, P704, DOI 10.1007/s11892-013-0399-3; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bresson D, 2009, DIABETES CARE, V32, P1753, DOI 10.2337/dc09-0373; Burke GW, 2011, CURR DIABETES REP, V11, P413, DOI 10.1007/s11892-011-0206-y; Chujo D, 2012, CELL TRANSPLANT, V21, P2783, DOI 10.3727/096368912X654993; Coppieters KT, 2013, CLIN IMMUNOL, V149, P345, DOI 10.1016/j.clim.2013.02.002; Fousteri G, 2010, DIABETOLOGIA, V53, P1958, DOI 10.1007/s00125-010-1777-x; Fousteri G, 2007, ADV EXP MED BIOL, V601, P313; Fousteri G, 2010, DIABETES, V59, P3148, DOI 10.2337/db10-0561; Fousteri G, 2009, J AUTOIMMUN, V32, P70, DOI 10.1016/j.jaut.2008.12.001; Gagliani N, 2013, AM J TRANSPLANT, V13, P1963, DOI 10.1111/ajt.12333; Gagliani N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028434; Gruessner RWG, 2013, NAT REV ENDOCRINOL, V9, P555, DOI 10.1038/nrendo.2013.138; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; Kimelman M, 2013, CURR OPIN ORGAN TRAN, V18, P76, DOI 10.1097/MOT.0b013e32835c6eda; Kirk AD, 2006, TRANSPLANTATION, V82, P593, DOI 10.1097/01.tp.0000234905.56926.7f; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Larsen CP, 2006, AM J TRANSPLANT, V6, P876, DOI 10.1111/j.1600-6143.2006.01259.x; Laughlin E, 2008, CLIN IMMUNOL, V128, P23, DOI 10.1016/j.clim.2008.03.459; Lutterotti A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006168; Makhlouf L, 2002, DIABETES, V51, P3202, DOI 10.2337/diabetes.51.11.3202; Markees TG, 1999, DIABETES, V48, P967, DOI 10.2337/diabetes.48.5.967; Molano RD, 2001, DIABETES, V50, P270, DOI 10.2337/diabetes.50.2.270; Monti P, 2008, J CLIN INVEST, V118, P1806, DOI 10.1172/JCI35197; Olcott AP, 2005, J IMMUNOL, V175, P1991, DOI 10.4049/jimmunol.175.3.1991; Orlando G, 2014, DIABETES, V63, P1433, DOI 10.2337/db13-1742; Peakman M, 2010, DIABETES, V59, P2087, DOI 10.2337/db10-0630; Pearson T, 2003, ANN NY ACAD SCI, V1005, P148, DOI 10.1196/annals.1288.016; Pearson T, 2003, DIABETES, V52, P321, DOI 10.2337/diabetes.52.2.321; Ramesh A, 2013, CURR DIABETES REV, V9, P294, DOI 10.2174/15733998113099990063; Ravanan R, 2007, CLIN EXP IMMUNOL, V148, P368, DOI 10.1111/j.1365-2249.2007.03358.x; Rayat GR, 2000, TRANSPLANTATION, V70, P976, DOI 10.1097/00007890-200009270-00016; Roep BO, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007781; Rossini AA, 2001, TRANSPLANTATION, V72, pS43; Ryden AKE, 2014, HUM VACC IMMUNOTHER, V10, P838, DOI 10.4161/hv.26890; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shapiro A M James, 2012, Rev Diabet Stud, V9, P385, DOI 10.1900/RDS.2012.9.385; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Stegall MD, 1996, TRANSPLANTATION, V61, P1272, DOI 10.1097/00007890-199604270-00027; Stratta RJ, 2014, EXPERT REV CLIN IMMU, V10, P117, DOI 10.1586/1744666X.2014.853616; Tian J, 2002, J IMMUNOL, V169, P6564, DOI 10.4049/jimmunol.169.11.6564; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; van de Linde Pieter, 2005, Am J Ther, V12, P573, DOI 10.1097/01.mjt.0000178768.44987.cb; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183	47	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2015	10	6							e0127631	10.1371/journal.pone.0127631	http://dx.doi.org/10.1371/journal.pone.0127631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9EB	26080071	Green Published, gold, Green Submitted			2022-12-26	WOS:000356542300005
J	Bae, S; Lim, YH; Kashima, S; Yorifuji, T; Honda, Y; Kim, H; Hong, YC				Bae, Sanghyuk; Lim, Youn-Hee; Kashima, Saori; Yorifuji, Takashi; Honda, Yasushi; Kim, Ho; Hong, Yun-Chul			Non-Linear Concentration-Response Relationships between Ambient Ozone and Daily Mortality	PLOS ONE			English	Article							TIME-SERIES ANALYSES; AIR-POLLUTION; PARTICULATE MATTER; EXPOSURE; HEALTH; ASSOCIATIONS; METAANALYSIS; COMMUNITIES; POPULATIONS; PROJECT	Background Ambient ozone (O-3) concentration has been reported to be significantly associated with mortality. However, linearity of the relationships and the presence of a threshold has been controversial. Objectives The aim of the present study was to examine the concentration-response relationship and threshold of the association between ambient O-3 concentration and non-accidental mortality in 13 Japanese and Korean cities from 2000 to 2009. Methods We selected Japanese and Korean cities which have population of over 1 million. We constructed Poisson regression models adjusting daily mean temperature, daily mean PM10, humidity, time trend, season, year, day of the week, holidays and yearly population. The association between O-3 concentration and mortality was examined using linear, spline and linear-threshold models. The thresholds were estimated for each city, by constructing linear-threshold models. We also examined the city-combined association using a generalized additive mixed model. Results The mean O-3 concentration did not differ greatly between Korea and Japan, which were 26.2 ppb and 24.2 ppb, respectively. Seven out of 13 cities showed better fits for the spline model compared with the linear model, supporting a non-linear relationships between O-3 concentration and mortality. All of the 7 cities showed J or U shaped associations suggesting the existence of thresholds. The range of city-specific thresholds was from 11 to 34 ppb. The city-combined analysis also showed a non-linear association with a threshold around 30-40 ppb. Conclusion We have observed non-linear concentration-response relationship with thresholds between daily mean ambient O-3 concentration and daily number of non-accidental death in Japanese and Korean cities.	[Bae, Sanghyuk] Seoul Natl Univ Hosp, Publ Hlth Med Serv, Seoul 110744, South Korea; [Bae, Sanghyuk; Lim, Youn-Hee; Hong, Yun-Chul] Seoul Natl Univ, Ctr Environm Hlth, Coll Med, Seoul, South Korea; [Kashima, Saori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Yorifuji, Takashi] Okayama Univ, Dept Human Ecol, Grad Sch Environm & Life Sci, Okayama, Japan; [Honda, Yasushi] Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, Tsukuba, Ibaraki, Japan; [Kim, Ho] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Epidemiol & Biostat, Seoul, South Korea; [Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hong, Yun-Chul] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hiroshima University; Okayama University; University of Tsukuba; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hong, YC (corresponding author), Seoul Natl Univ, Ctr Environm Hlth, Coll Med, Seoul, South Korea.	ychong1@snu.ac.kr	Kim, Ho/AAS-2402-2021; Bae, Sanghyuk/AAQ-6635-2020; Kashima, Saori/B-4524-2010; Hong, Yun-Chul/J-5725-2012	Kim, Ho/0000-0001-7472-3752; Bae, Sanghyuk/0000-0002-4995-6543; Kashima, Saori/0000-0002-3401-8191; Lim, Youn-Hee/0000-0002-1290-5814				Akaike H., 1976, MATH SCI, V14, P5; Anderson HR, 1996, BMJ-BRIT MED J, V312, P665; [Anonymous], 2014, STAT KOR; Atkinson RW, 2012, ENVIRON HEALTH PERSP, V120, P1411, DOI 10.1289/ehp.1104108; BALMES JR, 1993, ENVIRON HEALTH PERSP, V101, P219, DOI 10.2307/3431683; Bell ML, 2006, ENVIRON HEALTH PERSP, V114, P532, DOI 10.1289/ehp.8816; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Brauer M, 2002, RISK ANAL, V22, P1183, DOI 10.1111/1539-6924.00282; Canty A, 2014, BOOT BOOTSTRAP FUNCT; Chen R, 2014, AM J EPIDEMIOLOGY; Goldberg MS, 2001, AM J EPIDEMIOL, V154, P817, DOI 10.1093/aje/154.9.817; Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC; Hazucha MJ, 2007, ATMOS ENVIRON, V41, P4559, DOI 10.1016/j.atmosenv.2007.03.052; Hong YC, 1999, J KOREAN MED SCI, V14, P239, DOI 10.3346/jkms.1999.14.3.239; Hunova I, 2013, INT ARCH OCC ENV HEA, V86, P89, DOI 10.1007/s00420-012-0751-y; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Kim SY, 2004, ENVIRON RES, V94, P113, DOI 10.1016/j.envres.2003.09.006; Lim Y.H, 2013, HEAT HLTH EFFECTS AI; McDonnell WF, 2012, INHAL TOXICOL, V24, P619, DOI 10.3109/08958378.2012.705919; Moolgavkar SH, 2013, ENVIRON HEALTH PERSP, V121, P73, DOI 10.1289/ehp.1104507; Ren C, 2008, ENVIRON INT, V34, P451, DOI 10.1016/j.envint.2007.10.001; Samoli E, 2005, ENVIRON HEALTH PERSP, V113, P88, DOI 10.1289/ehp.7387; Simpson R, 2000, J EXPO ANAL ENV EPID, V10, P488, DOI 10.1038/sj.jea.7500137; Simpson R, 2005, AUST NZ J PUBL HEAL, V29, P205, DOI 10.1111/j.1467-842X.2005.tb00758.x; Smith RL, 2009, INHAL TOXICOL; Statistics Bureau, 2014, STAT JAP; Stylianou M, 2009, ENVIRON POLLUT, V157, P2216, DOI 10.1016/j.envpol.2009.04.011; U.S. EPA, 2013, EPA600R20012; Urch B, 2010, INHAL TOXICOL, V22, P210, DOI 10.3109/08958370903173666; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Watkinson WP, 2001, ENVIRON HEALTH PERSP, V109, P539, DOI 10.2307/3454666; WHO, 2006, REPORT WORKING GROUP; Williams ML, 2014, AIR QUAL ATMOS HLTH, V7, P407, DOI 10.1007/s11869-014-0249-8; Wood S., 2013, GAMM4 GEN ADDITIVE M; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; WOODWARD A, 1995, J EPIDEMIOL COMMUN H, V49, P401, DOI 10.1136/jech.49.4.401; Yang Z, 2005, DRUG DISCOV TODAY DI, V2, P71	39	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129423	10.1371/journal.pone.0129423	http://dx.doi.org/10.1371/journal.pone.0129423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076447	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900070
J	Toyama, Y; Tanizawa, K; Kubo, T; Chihara, Y; Harada, Y; Murase, K; Azuma, M; Hamada, S; Hitomi, T; Handa, T; Oga, T; Chiba, T; Mishima, M; Chin, K				Toyama, Yoshiro; Tanizawa, Kiminobu; Kubo, Takeshi; Chihara, Yuichi; Harada, Yuka; Murase, Kimihiko; Azuma, Masanori; Hamada, Satoshi; Hitomi, Takefumi; Handa, Tomohiro; Oga, Toru; Chiba, Tsutomu; Mishima, Michiaki; Chin, Kazuo			Impact of Obstructive Sleep Apnea on Liver Fat Accumulation According to Sex and Visceral Obesity	PLOS ONE			English	Article							CHRONIC INTERMITTENT HYPOXIA; POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR RISK-FACTORS; NONALCOHOLIC STEATOHEPATITIS; HEART-FAILURE; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEPATIC STEATOSIS; DISEASE; CT	Rationale Associations between obstructive sleep apnea (OSA) and liver fat accumulation have been frequently investigated because both morbidities are common. Visceral fat was reported to be closely related to OSA and liver fat accumulation. Recently, sex differences in the association between OSA and mortality have gained much attention. Objectives To investigate the associations among OSA, liver fat accumulation as determined by computed tomography, and visceral fat area and their sex differences. Methods Studied were 188 males and 62 females who consecutively underwent polysomnography and computed tomography. Results Although the apnea-hypopnea index was positively correlated with liver fat accumulation in the total males, none of the OSA-related factors was independently associated with liver fat accumulation in either the total male or female participants in the multivariate analyses. When performing subanalyses using a specific definition for Japanese of obesity or visceral obesity (body mass index (BMI) >= 25 kg/m(2) or visceral fat area >= 100 cm(2)), in only males without visceral obesity, percent sleep time with oxygen saturation <90%, in addition to BMI, insulin resistance, and serum triglyceride values, was independently correlated with liver fat accumulation (R-2 = 15.1%, P<0.001). In males, percent sleep time of oxygen saturation <90% was also a determining factor for alanine aminotransferase values regardless of visceral fat area. In contrast, OSA was not associated with liver fat accumulation or alanine aminotransferase values in females whether or not visceral obesity was absent. Conclusions Sex differences in the visceral fat-dependent impact of OSA on liver fat accumulation existed. Although the mechanisms are not known and ethnic differences may exist in addition to the specific criteria of visceral obesity in Japan, the treatment of male patients with OSA might be favorable from the viewpoint of preventing liver fat accumulation and liver dysfunction even in patients without obvious visceral fat accumulation.	[Toyama, Yoshiro; Murase, Kimihiko; Azuma, Masanori; Hamada, Satoshi; Handa, Tomohiro; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Tanizawa, Kiminobu; Oga, Toru; Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan; [Kubo, Takeshi] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Chihara, Yuichi] Otsu Red Cross Hosp, Dept Resp Med, Shiga, Japan; [Harada, Yuka] Kansai Elect Power Hosp, Dept Resp Med, Osaka, Japan; [Hitomi, Takefumi] Kyoto Univ, Dept Clin Lab, Grad Sch Med, Kyoto, Japan; [Chiba, Tsutomu] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Chin, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan.	chink@kuhp.kyoto-u.ac.jp	Tanizawa, Kiminobu/GPC-4728-2022; Chihara, Yuichi/AAK-3397-2020	Tanizawa, Kiminobu/0000-0002-5719-0744	Japanese Ministry of Education, Culture, Sports, Science and Technology; Philips-Respironics; Teijin Pharma; Fukuda Denshi	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Philips-Respironics; Teijin Pharma; Fukuda Denshi	This work was partly supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology and Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan. The Department of Respiratory Care and Sleep Control Medicine is funded by endowments from Philips-Respironics, Teijin Pharma, and Fukuda Denshi to Kyoto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Barcelo A, 2011, EUR RESPIR J, V37, P1418, DOI 10.1183/09031936.00050410; Campos GM, 2008, HEPATOLOGY, V47, P1916, DOI 10.1002/hep.22241; Chihara Y, 2013, EUR RESPIR J, V42, P1563, DOI 10.1183/09031936.00133512; Chin K, 2003, AM J MED, V114, P370, DOI 10.1016/S0002-9343(02)01570-X; Chin KZ, 1999, CIRCULATION, V100, P706, DOI 10.1161/01.CIR.100.7.706; Corey KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062504; Daltro C, 2010, OBES SURG, V20, P1536, DOI 10.1007/s11695-010-0212-1; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Eguchi M, 2007, HYPERTENS RES, V30, P315, DOI 10.1291/hypres.30.315; Finelli C, 2012, J GASTROINTEST LIVER, V21, P207; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Harada Yuka, 2014, Ann Am Thorac Soc, V11, P383, DOI 10.1513/AnnalsATS.201306-182OC; Harsch IA, 2004, AM J RESP CRIT CARE, V169, P156, DOI 10.1164/rccm.200302-206OC; Hashimoto E, 2011, J GASTROENTEROL, V46, P63, DOI 10.1007/s00535-010-0311-8; Hiuge-Shimizu A, 2012, ANN MED, V44, P82, DOI 10.3109/07853890.2010.526138; Hoyos CM, 2012, THORAX, V67, P1081, DOI 10.1136/thoraxjnl-2011-201420; Iber C., 2007, AASM MANUAL SCORING; Iwasaki M, 2004, TRANSPLANTATION, V78, P1501, DOI 10.1097/01.TP.0000140499.23683.0D; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Jouet P, 2007, OBES SURG, V17, P478, DOI 10.1007/s11695-007-9085-3; Jun JC, 2011, SLEEP, V34, P1207, DOI 10.5665/SLEEP.1240; Kashihara H, 2009, CIRC J, V73, P1881, DOI 10.1253/circj.CJ-09-0183; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Kodama Y, 2007, AM J ROENTGENOL, V188, P1307, DOI 10.2214/AJR.06.0992; Li JG, 2005, J APPL PHYSIOL, V99, P1643, DOI 10.1152/japplphysiol.00522.2005; Li JG, 2005, CIRC RES, V97, P698, DOI 10.1161/01.RES.0000183879.60089.a9; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; Ministry of Health Labor and Welfare of Japan, 2014, SUMM NAT HLTH NUTR S; Ministry of Health Labour and Welfare, 2008, SUMM NAT HLTH NUTR S; Minville C, 2014, CHEST, V145, P525, DOI 10.1378/chest.13-0938; Mishra P, 2008, LIVER INT, V28, P1080, DOI 10.1111/j.1478-3231.2008.01822.x; Murase Kimihiko, 2014, Ann Am Thorac Soc, V11, P375, DOI 10.1513/AnnalsATS.201306-144OC; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Polotsky VY, 2009, AM J RESP CRIT CARE, V179, P228, DOI 10.1164/rccm.200804-608OC; Poynard T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030325; Punjabi NM, 2008, AM J RESP CRIT CARE, V177, P1150, DOI 10.1164/rccm.200712-1884OC; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Ryo M, 2014, INTERNAL MED, V53, P299, DOI 10.2169/internalmedicine.53.9476; Savransky V, 2008, CIRC RES, V103, P1173, DOI 10.1161/CIRCRESAHA.108.178533; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Shinohara E, 1997, J INTERN MED, V241, P11, DOI 10.1046/j.1365-2796.1997.63889000.x; Tachikawa R, 2014, AM J CARDIOL, V114, P618, DOI 10.1016/j.amjcard.2014.05.044; Tanne F, 2005, HEPATOLOGY, V41, P1290, DOI 10.1002/hep.20725; Tatsumi K, 2005, HEPATOL RES, V33, P100, DOI 10.1016/j.hepres.2005.09.014; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Xu JW, 2012, MOL BIOL REP, V39, P8177, DOI 10.1007/s11033-012-1665-1; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	54	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0129513	10.1371/journal.pone.0129513	http://dx.doi.org/10.1371/journal.pone.0129513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076443	gold, Green Published, Green Submitted			2022-12-26	WOS:000356329900079
J	Whiting, JL; Nygren, PJ; Tunquist, BJ; Langeberg, LK; Seternes, OM; Scott, JD				Whiting, Jennifer L.; Nygren, Patrick J.; Tunquist, Brian J.; Langeberg, Lorene K.; Seternes, Ole-Morten; Scott, John D.			Protein Kinase A Opposes the Phosphorylation-dependent Recruitment of Glycogen Synthase Kinase 3 beta to A-kinase Anchoring Protein 220	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT; SIGNALING COMPLEX; PKA; AKAP; SPECIFICITY; BINDING; INACTIVATION; MECHANISM; MOTIFS; RI	The proximity of an enzyme to its substrate can influence rate and magnitude of catalysis. A-kinase anchoring protein 220 (AKAP220) is a multivalent anchoring protein that can sequester a variety of signal transduction enzymes. These include protein kinase A (PKA) and glycogen synthase kinase 3 beta (GSK3 beta). Using a combination of molecular and cellular approaches we show that GSK3 beta phosphorylation of Thr-1132 on AKAP220 initiates recruitment of this kinase into the enzyme scaffold. We also find that AKAP220 anchors GSK3 beta and its substrate beta-catenin in membrane ruffles. Interestingly, GSK3 beta can be released from the multienzyme complex in response to PKA phosphorylation on serine 9, which suppresses GSK3 beta activity. The signaling scaffold may enhance this regulatory mechanism, as AKAP220 has the capacity to anchor two PKA holoenzymes. Site 1 on AKAP220 (residues 610-623) preferentially interacts with RII, whereas site 2 (residues 1633-1646) exhibits a dual specificity for RI and RII. In vitro affinity measurements revealed that site 2 on AKAP220 binds RII with similar to 10-fold higher affinity than site 1. Occupancy of both R subunit binding sites on AKAP220 could provide a mechanism to amplify local cAMP responses and enable cross-talk between PKA and GSK3 beta.	[Whiting, Jennifer L.; Nygren, Patrick J.; Langeberg, Lorene K.; Seternes, Ole-Morten; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Tunquist, Brian J.] Array BioPharma Inc, Translat Oncol, Boulder, CO 80301 USA; [Seternes, Ole-Morten] Univ Tromso, Arctic Univ Norway, Dept Pharm, N-9037 Tromso, Norway	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Pfizer; Array BioPharma; UiT The Arctic University of Tromso	Scott, JD (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA.	scottjdw@uw.edu	Regan, Clinton/E-6250-2012; Seternes, Ole Morten/M-9520-2019	Seternes, Ole Morten/0000-0001-8537-3612	National Institutes of Health [DK105542, DK054441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105542, P30DK017047, P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK105542 and DK054441.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Asirvatham AL, 2004, J IMMUNOL, V173, P4806, DOI 10.4049/jimmunol.173.8.4806; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Burgers PP, 2015, BIOCHEMISTRY-US, V54, P11, DOI 10.1021/bi500721a; Burgers PP, 2012, J BIOL CHEM, V287, P43789, DOI 10.1074/jbc.M112.395970; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; CARR DW, 1991, J BIOL CHEM, V266, P14188; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Day ME, 2011, J CELL BIOL, V193, P347, DOI 10.1083/jcb.201010034; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gold MG, 2013, J BIOL CHEM, V288, P17111, DOI 10.1074/jbc.M112.447326; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Hinke SA, 2012, EMBO J, V31, P3991, DOI 10.1038/emboj.2012.244; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Kritzer MD, 2014, CIRC-HEART FAIL, V7, P663, DOI 10.1161/CIRCHEARTFAILURE.114.001266; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Logue Jeremy S, 2011, Small GTPases, V2, P173; Logue JS, 2011, J BIOL CHEM, V286, P39269, DOI 10.1074/jbc.M111.277756; Logue JS, 2011, J BIOL CHEM, V286, P22113, DOI 10.1074/jbc.M111.232660; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Prince JT, 2010, MOL CELL, V37, P455, DOI 10.1016/j.molcel.2010.02.010; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Schillace RV, 2001, J BIOL CHEM, V276, P12128, DOI 10.1074/jbc.M010398200; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Smith FD, 2011, BIOCHEM J, V438, P103, DOI 10.1042/BJ20110720; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Wong W, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000026	59	15	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19445	19457		10.1074/jbc.M115.654822	http://dx.doi.org/10.1074/jbc.M115.654822			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26088133	Green Published, hybrid			2022-12-26	WOS:000359364600005
J	Xue, JF; Zhou, AD; Tan, C; Wu, YM; Lee, HT; Li, WL; Xie, KP; Huang, SY				Xue, Jianfei; Zhou, Aidong; Tan, Christina; Wu, Yamei; Lee, Hsueh-Te; Li, Wenliang; Xie, Keping; Huang, Suyun			Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG PATHWAY; GENE-EXPRESSION; FOXM1; TARGET; GLI1; SUPPRESSOR	The transcription factors glioma-associated oncogene homolog 1 (GLI1), a primary marker of Hedgehog pathway activation, and Forkhead box M1 (FOXM1) are aberrantly activated in a wide range of malignancies, including glioma. However, the mechanism of nuclear localization of GLI1 and whether FOXM1 regulates the Hedgehog signaling pathway are poorly understood. Here we found that FOXM1 promotes nuclear import of GLI1 in glioblastoma multiforme cells and thus increases the expression of its target genes. Conversely, knockdown of FOXM1 expression with FOXM1 siRNA abrogated its nuclear import and inhibited the expression of its target genes. Also, genetic deletion of FOXM1 in mouse embryonic fibroblasts abolished nuclear localization of GLI1. We observed that FOXM1 directly binds to the importin-7 (IPO7) promoter and increases its promoter activity. IPO7 interacted with GLI1, leading to enhanced nuclear import of GLI1. Depletion of IPO7 by IPO7 siRNA reduced nuclear accumulation of GLI1. In addition, FOXM1 induced nuclear import of GLI1 by promoting IPO7 expression. Moreover, the FOXM1/IPO7/GLI1 axis promoted cell proliferation, migration, and invasion in vitro. Finally, expression of FOXM1 was markedly correlated with that of GLI1 in human glioblastoma specimens. These data suggest that FOXM1 and GLI1 form a positive feedback loop that contributes to glioblastoma development. Furthermore, our study revealed a mechanism that controls nuclear import of GLI1 in glioblastoma multiforme cells.	[Xue, Jianfei; Zhou, Aidong; Tan, Christina; Wu, Yamei; Lee, Hsueh-Te; Huang, Suyun] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Li, Wenliang] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin 300060, Peoples R China; [Li, Wenliang] Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China; [Xie, Keping] Univ Texas Houston, Grad Sch Biomed Sci, Dept Gastroenterol Hepatol, Houston, TX 77030 USA; [Xie, Keping] Univ Texas Houston, Grad Sch Biomed Sci, Dept Nutr, Houston, TX 77030 USA; [Xie, Keping; Huang, Suyun] Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Xue, JF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Unit 1004,1515 Holcombe Blvd, Houston, TX 77030 USA.	jfxue09@gmail.com		Zhou, Aidong/0000-0001-8389-9522	National Institutes of Health NCI [R01CA157933, R01CA182684, R01CA152309, P50CA127001, P30CA016672]; NATIONAL CANCER INSTITUTE [R01CA182684, R01CA152309, P30CA016672, P50CA127001, R01CA157933] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health NCI Grants R01CA157933, R01CA182684, R01CA152309, P50CA127001, and P30CA016672 (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Fernandez M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00030; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Cai YQ, 2013, J BIOL CHEM, V288, P22527, DOI 10.1074/jbc.M113.455089; Carpenter RL, 2012, DISCOV MED, V13, P105; Carr JR, 2012, CELL REP, V1, P715, DOI 10.1016/j.celrep.2012.05.005; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Chi SM, 2012, CELL SIGNAL, V24, P1222, DOI 10.1016/j.cellsig.2012.02.004; Dai BB, 2013, J BIOL CHEM, V288, P1634, DOI 10.1074/jbc.M112.379362; Deng WT, 2015, J CELL SCI, V128, P1123, DOI 10.1242/jcs.162164; Gai XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084551; Golomb L, 2012, MOL CELL, V45, P222, DOI 10.1016/j.molcel.2011.11.022; Infante P, 2015, EMBO J, V34, P200, DOI 10.15252/embj.201489213; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kim K, 2010, BIOCHEM J, V427, P413, DOI 10.1042/BJ20091445; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Li X, 2015, ONCOGENE, V34, P1619, DOI 10.1038/onc.2014.98; Li Y, 2012, FUTURE ONCOL, V8, P223, DOI [10.2217/FON.12.1, 10.2217/fon.12.1]; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Pandolfi S, 2013, ONCOGENE, V32, P4737, DOI 10.1038/onc.2012.502; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; POWERS MA, 1994, CELL, V79, P931, DOI 10.1016/0092-8674(94)90024-8; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Szczepny A, 2014, BIOCHEM J, V461, P469, DOI 10.1042/BJ20130709; Teh MT, 2002, CANCER RES, V62, P4773; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang IC, 2012, MOL CELL BIOL, V32, P3838, DOI 10.1128/MCB.00355-12; Xue JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7156; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016	33	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18662	18670		10.1074/jbc.M115.662882	http://dx.doi.org/10.1074/jbc.M115.662882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26085085	hybrid, Green Published			2022-12-26	WOS:000358512100035
J	Ribeiro, SC; Figueiredo, AE; Barretti, P; Pecoits, R; de Moraes, TP				Ribeiro, Silvia Carreira; Figueiredo, Ana Elizabeth; Barretti, Pasqual; Pecoits-Filho, Roberto; de Moraes, Thyago Proenca		Ctr Contributed BRAZPD II Stud	Low Serum Potassium Levels Increase the Infectious-Caused Mortality in Peritoneal Dialysis Patients: A Propensity-Matched Score Study	PLOS ONE			English	Article							HYPOKALEMIA; RISK	Background and Objectives Hypokalemia has been consistently associated with high mortality rate in peritoneal dialysis. However, studies investigating if hypokalemia is acting as a surrogate marker of comorbidities or has a direct effect in the risk for mortality have not been studied. Thus, the aim of this study was to analyze the effect of hypokalemia on overall and cause-specific mortality. Design, Setting, Participants and Measurements This is an analysis of BRAZPD II, a nationwide prospective cohort study. All patients on PD for longer than 90 days with measured serum potassium levels were used to verify the association of hypokalemia with overall and cause-specific mortality using a propensity match score to reduce selection bias. In addition, competing risks were also taken into account for the analysis of cause-specific mortality. Results There was a U-shaped relationship between time-averaged serum potassium and all-cause mortality of PD patients. Cardiovascular disease was the main cause of death in the normokalemic group with 133 events (41.8%) followed by PD-non related infections, n=105 (33.0%). Hypokalemia was associated with a 49% increased risk for CV mortality after adjustments for covariates and the presence of competing risks (SHR 1.49; CI95% 1.01-2.21). In contrast, in the group of patients with K < 3.5mEq/L, PD-non related infections were the main cause of death with 43 events (44.3%) followed by cardiovascular disease (n=36; 37.1%). For PD-non related infections the SHR was 2.19 (CI95% 1.52-3.14) while for peritonitis was SHR 1.09 (CI95% 0.47-2.49). Conclusions Hypokalemia had a significant impact on overall, cardiovascular and infectious mortality even after adjustments for competing risks. The causative nature of this association suggested by our study raises the need for intervention studies looking at the effect of potassium supplementation on clinical outcomes of PD patients.	[Ribeiro, Silvia Carreira; Pecoits-Filho, Roberto; de Moraes, Thyago Proenca] Pontificia Univ Catolica Parana PUCPR, Sch Med, Curitiba, Parana, Brazil; [Figueiredo, Ana Elizabeth] Pontificia Univ Catolica Rio Grande Sul PUCRS, Grad Program Med & Hlth Sci, Porto Alegre, RS, Brazil; [Barretti, Pasqual] UNESP, Sch Med, Botucatu, SP, Brazil	Pontificia Universidade Catolica do Parana; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Estadual Paulista	de Moraes, TP (corresponding author), Pontificia Univ Catolica Parana PUCPR, Sch Med, Curitiba, Parana, Brazil.	thyago.moraes@pucpr.br	Figueiredo, Ana/GWU-6748-2022; de Moraes, Thyago Proenca/M-9400-2014; Barretti, Pasqual/K-4156-2012; Pecoits-Filho, Roberto/K-7986-2013; Barretti, Pasqual/AAK-7934-2021; Figueiredo, Ana Elizabeth/C-2137-2013	de Moraes, Thyago Proenca/0000-0002-2983-3968; Barretti, Pasqual/0000-0003-4979-4836; Pecoits-Filho, Roberto/0000-0002-0255-6710; Barretti, Pasqual/0000-0003-4979-4836; Figueiredo, Ana Elizabeth/0000-0002-8555-8649	Baxter Healthcare	Baxter Healthcare	This study was funded by Baxter Healthcare. The sponsor had no participation in the study design, data analysis or preparation of the manuscript.	Ahmed A, 2007, EUR HEART J, V28, P1334, DOI 10.1093/eurheartj/ehm091; Chuang YW, 2009, NEPHROL DIAL TRANSPL, V24, P1603, DOI 10.1093/ndt/gfn709; Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FITZOVICH DE, 1991, J AM COLL CARDIOL, V18, P1105, DOI 10.1016/0735-1097(91)90774-4; Ho DE., 2011, J STAT SOFTW, V42, P1, DOI DOI 10.18637/JSS.V042.I08; Jung Ji Yong, 2009, Electrolyte Blood Press, V7, P73, DOI 10.5049/EBP.2009.7.2.73; Khan AN, 1996, PERITON DIALYSIS INT, V16, P652; Kwan BCH, 2012, NAT REV NEPHROL, V8, P501, DOI 10.1038/nrneph.2012.159; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Ming KW, 2000, BIOMETRICS, V56, P118, DOI 10.1111/j.0006-341X.2000.00118.x; Szeto CC, 2005, AM J KIDNEY DIS, V46, P128, DOI 10.1053/j.ajkd.2005.03.015; Torlen K, 2012, CLIN J AM SOC NEPHRO, V7, P1272, DOI 10.2215/CJN.00960112; TPd Moraes, 2014, PERITONEAL DIALYSIS; Tziviskou Effie, 2003, International Urology and Nephrology, V35, P429, DOI 10.1023/B:UROL.0000022867.93739.03; Verduijn M, 2011, NEPHROL DIAL TRANSPL, V26, P56, DOI 10.1093/ndt/gfq661; Xu QD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086750	17	27	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0127453	10.1371/journal.pone.0127453	http://dx.doi.org/10.1371/journal.pone.0127453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091005	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000010
J	Yang, M; Tan, L; Xu, YY; Zhao, YH; Cheng, F; Ye, SM; Jiang, WX				Yang, Mei; Tan, Ling; Xu, Yuanyuan; Zhao, Yihui; Cheng, Fei; Ye, Shaoming; Jiang, Weixin			Effect of Low pH and Aluminum Toxicity on the Photosynthetic Characteristics of Different Fast-Growing Eucalyptus Vegetatively Propagated Clones	PLOS ONE			English	Article							ANATOMICAL CHANGES; MINERAL-NUTRITION; ORGANIC-ACIDS; GAS-EXCHANGE; AL TOLERANCE; SEEDLINGS; STRESS; GROWTH; RESISTANCE; SOILS	Knowing how acid soils and aluminum in soils may limit the growth of Eucalyptus trees in plantations is important because these plantations grow in many tropical and subtropical regions. Seedlings of four vegetatively propagated Eucalyptus clones, E. grandis x E. urophylla 'GLGU9'(G9), E. grandis x E. urophylla 'GLGU12'(G12), E. urophylla x E. camaldulensis 'GLUC3'(G3) and E. urophylla 'GLU4'(G4), were subjected to liquid culture with Hoagland nutrient solution for 40 days, then treated with four different treatments of acid and aluminum for 1 day. The four treatments used either pH 3.0 or 4.0 with or without added aluminum (4.4 mM) in all possible combinations; a control used no added aluminum at pH 4.8. Subsequently, the photosynthetic parameters and morphology of leaves from eucalypt seedlings were determined and observed. The results showed that the tested chlorophyll content, net photosynthetic rate, transpiration rate and water use efficiency were apparently inhibited by aluminum. Under uniform Al concentration (4.4 mM), the Al-induced limitation to photosynthetic parameters increased with pH, indicating acid stimulation to Al toxicity. Among all treatments, the most significant reduction was found in the combination of pH 3.0 and 4.4 mM Al. The photosynthetic and transpiration rates showed similar trends with G9 > G12 > G3 > G4, suggesting that G9 and G12 had higher Al-tolerance than other two clones. Microscopic observation revealed changes in leaf morphology when exposed to Al stress; for example, a reduced thickness of leaf epidermis and palisade tissue, the descendant palisade tissue/spongy tissue ratio and leaf tissue looseness. Overall, the acid and aluminum stress exerted negative effects on the photosynthetic activity of eucalypt seedlings, but the differences in tolerance to Al toxicity between the clones were favorable, offering potential to improve Eucalyptus plantation productivity by selecting Al tolerant clones.	[Yang, Mei; Tan, Ling; Xu, Yuanyuan; Zhao, Yihui; Cheng, Fei; Ye, Shaoming; Jiang, Weixin] Guangxi Univ, Coll Forestry, Nanning 530004, Guangxi, Peoples R China; [Yang, Mei; Tan, Ling; Ye, Shaoming] Guangxi Univ, Key Lab Natl Forestry, Bur Fast Growing Wood Breeding Cent South China, Nanning 530004, Guangxi, Peoples R China; [Yang, Mei; Tan, Ling; Ye, Shaoming] Guangxi Coll, Nanning, Guangxi, Peoples R China; [Yang, Mei; Tan, Ling; Ye, Shaoming] Univ Key Lab Forestry Sci & Engn, Nanning, Guangxi, Peoples R China	Guangxi University; Guangxi University	Yang, M (corresponding author), Guangxi Univ, Coll Forestry, Nanning 530004, Guangxi, Peoples R China.	fjyangmei@126.com		YANG, MEI/0000-0001-6420-115X	National Natural Science Foundation of China [31070560]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	MY received funding from the National Natural Science Foundation of China (31070560) for this work (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla M. M., 2008, Australian Journal of Basic and Applied Sciences, V2, P549; Ali B, 2008, ENVIRON EXP BOT, V62, P153, DOI 10.1016/j.envexpbot.2007.07.014; Ali S, 2011, BIOL PLANTARUM, V55, P291, DOI 10.1007/s10535-011-0041-7; Alvarez E, 2005, FOREST ECOL MANAG, V211, P227, DOI 10.1016/j.foreco.2005.02.044; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Balakrishnan K, 2000, PHOTOSYNTHETICA, V38, P477, DOI 10.1023/A:1010958512210; Brunner I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00172; Cao H., 1992, ACTA ECOL SIN, V12, P239; Chen LS, 2005, TREE PHYSIOL, V25, P317, DOI 10.1093/treephys/25.3.317; Darko E, 2004, PLANT SCI, V166, P583, DOI 10.1016/j.plantsci.2003.10.023; de Almeida NM, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1732-4; de Jesus DD, 2013, COMMUN SOIL SCI PLAN, V44, P3423, DOI 10.1080/00103624.2013.847453; Delhaize E, 2012, TRENDS PLANT SCI, V17, P341, DOI 10.1016/j.tplants.2012.02.008; George E, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P409, DOI 10.1016/B978-0-12-384905-2.00017-0; Gomes MP, 2011, SCI AGR, V68, P566, DOI 10.1590/S0103-90162011000500009; HAMMEL JE, 1985, SOIL SCI SOC AM J, V49, P1508, DOI 10.2136/sssaj1985.03615995004900060035x; Inostroza-Blancheteau C, 2012, MOL BIOL REP, V39, P2069, DOI 10.1007/s11033-011-0954-4; Jones D.L., 2003, ENCY APPL PLANT SCI, P656; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; KRUGER E, 1989, J EXP BOT, V40, P659, DOI 10.1093/jxb/40.6.659; Lazarevic B, 2014, POTATO RES, V57, P33, DOI 10.1007/s11540-014-9251-7; Li Jun-yu, 2012, Yingyong Shengtai Xuebao, V23, P45; Li YaMin, 2011, Medicinal Plant, V2, P5; Liao XY, 2015, ACTA PHYSIOL PLANT, V37, P1; LIBERT B, 1987, J AGR FOOD CHEM, V35, P926, DOI 10.1021/jf00078a019; Lopez-Cesati J., 2001, APPL PHYSL WHEAT BRE, P172; Martins N, 2013, ACTA PHYSIOL PLANT, V35, P615, DOI 10.1007/s11738-012-1102-z; MCQUATTIE CJ, 1993, CAN J FOREST RES, V23, P1375, DOI 10.1139/x93-174; Meriga B, 2004, J PLANT PHYSIOL, V161, P63, DOI 10.1078/0176-1617-01156; Mihailovic N, 2008, PHOTOSYNTHETICA, V46, P476, DOI 10.1007/s11099-008-0082-0; Mitchell A. D., 2009, Tasforests, V18, P131; Moustakas M, 1996, PLANT PHYSIOL BIOCH, V34, P553; Mukhopadyay M, 2012, BIOMETALS, V25, P1141, DOI 10.1007/s10534-012-9576-0; Neves J. C. L., 1982, Revista Arvore, V6, P1; Nguyen NT, 2003, TREE PHYSIOL, V23, P1041, DOI 10.1093/treephys/23.15.1041; Nunes-Nesi A, 2014, TRENDS PLANT SCI, V19, P399, DOI 10.1016/j.tplants.2013.12.006; Panda SK, 2009, PLANT SIGNAL BEHAV, V4, P592, DOI 10.4161/psb.4.7.8903; Peixoto PHP, 2002, J PLANT NUTR, V25, P821, DOI 10.1081/PLN-120002962; Pereira WE, 2000, J PLANT PHYSIOL, V157, P513, DOI 10.1016/S0176-1617(00)80106-6; Qian P, 2014, J PLANT GROWTH REGUL, V33, P526, DOI 10.1007/s00344-013-9402-0; Ribeiro MAQ, 2013, J PLANT NUTR, V36, P1161, DOI 10.1080/01904167.2013.766889; Ridolfi M, 2000, ANN FOREST SCI, V57, P209; ROY AK, 1988, BOT REV, V54, P145, DOI 10.1007/BF02858527; [阮少宁 RUAN Shaoning], 2011, [四川农业大学学报, Journal of Sichuan Agricultural University], V29, P173; Ryan PR, 2011, J EXP BOT, V62, P9, DOI 10.1093/jxb/erq272; Samac DA, 2003, PLANT CELL TISS ORG, V75, P189, DOI 10.1023/A:1025843829545; Sierra J, 2003, PLANT SOIL, V252, P215, DOI 10.1023/A:1024713127053; Silva IR, 2004, TREE PHYSIOL, V24, P1267, DOI 10.1093/treephys/24.11.1267; SIMON L, 1994, J PLANT NUTR, V17, P307, DOI 10.1080/01904169409364729; Smirnov OE, 2014, MOD PHYTOL, V6, P15; Sridhar BBM, 2005, ENVIRON EXP BOT, V54, P131, DOI 10.1016/j.envexpbot.2004.06.011; Tahara K, 2008, PLANT SOIL, V302, P175, DOI 10.1007/s11104-007-9464-5; Tahara K, 2014, PLANT PHYSIOL, V164, P683, DOI 10.1104/pp.113.222885; Wang Hong, 1999, CHINESE B BOT, V16, P245; WAVARE RA, 1983, INDIAN J BIOCHEM BIO, V20, P301; Xiao X, 2004, CHINESE J TROPICAL C, V26, P63; Xu YuFeng, 2005, Journal of Maize Sciences, V13, P79; Yamamoto Y, 2002, PLANT PHYSIOL, V128, P63, DOI 10.1104/pp.010417; Yang Mei, 2012, Southwest China Journal of Agricultural Sciences, V25, P1061; Yang Mei, 2011, Scientia Silvae Sinicae, V47, P181, DOI 10.1360/012010-582; Yang Mei, 2011, Plant Nutrition and Fertilizer Science, V17, P195; [杨敏文 Yang Minwen], 2002, [光谱实验室, Spectrolabo], V19, P478; Yang Z.D., 1996, GUANGXI SCI, V3, P30; Ying Xiaofang, 2005, Yingyong Shengtai Xuebao, V16, P166; Zhang HH, 2013, MODERN AGR SCI TECHN, V16, P141; Zhang XB, 2007, BOT STUD, V48, P435; Zhao FJ, 2000, PLANT CELL ENVIRON, V23, P507, DOI 10.1046/j.1365-3040.2000.00569.x	68	62	69	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130963	10.1371/journal.pone.0130963	http://dx.doi.org/10.1371/journal.pone.0130963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26090998	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000162
J	Faggi, F; Codenotti, S; Poliani, PL; Cominelli, M; Chiarelli, N; Colombi, M; Vezzoli, M; Monti, E; Bono, F; Tulipano, G; Fiorentini, C; Zanola, A; Lo, HP; Parton, RG; Keller, C; Fanzani, A				Faggi, Fiorella; Codenotti, Silvia; Poliani, Pietro Luigi; Cominelli, Manuela; Chiarelli, Nicola; Colombi, Marina; Vezzoli, Marika; Monti, Eugenio; Bono, Federica; Tulipano, Giovanni; Fiorentini, Chiara; Zanola, Alessandra; Lo, Harriet P.; Parton, Robert G.; Keller, Charles; Fanzani, Alessandro			MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line	PLOS ONE			English	Article							COILED-COIL PROTEIN; ALVEOLAR RHABDOMYOSARCOMA; MUTANT CAVEOLIN-3; MICE; GENE; DYSTROPHIN; MUTATIONS; SKELETAL; GROWTH; MODEL	The purpose of this study was to investigate whether MURC/cavin-4, a plasma membrane and Z-line associated protein exhibiting an overlapping distribution with Caveolin-3 (Cav-3) in heart and muscle tissues, may be expressed and play a role in rhabdomyosarcoma (RMS), an aggressive myogenic tumor affecting childhood. We found MURC/cavin-4 to be expressed, often concurrently with Cav-3, in mouse and human RMS, as demonstrated through in silico analysis of gene datasets and immunohistochemical analysis of tumor samples. In vitro expression studies carried out using human cell lines and primary mouse tumor cultures showed that expression levels of both MURC/cavin-4 and Cav-3, while being low or undetectable during cell proliferation, became robustly increased during myogenic differentiation, as detected via semi-quantitative RT-PCR and immunoblotting analysis. Furthermore, confocal microscopy analysis performed on human RD and RH30 cell lines confirmed that MURC/cavin-4 mostly marks differentiated cell elements, colocalizing at the cell surface with Cav-3 and labeling myosin heavy chain (MHC) expressing cells. Finally, MURC/cavin-4 silencing prevented the differentiation in the RD cell line, leading to morphological cell impairment characterized by depletion of myogenin, Cav-3 and MHC protein levels. Overall, our data suggest that MURC/cavin-4, especially in combination with Cav-3, may play a consistent role in the differentiation process of RMS.	[Faggi, Fiorella; Codenotti, Silvia; Poliani, Pietro Luigi; Cominelli, Manuela; Chiarelli, Nicola; Colombi, Marina; Vezzoli, Marika; Monti, Eugenio; Bono, Federica; Tulipano, Giovanni; Fiorentini, Chiara; Zanola, Alessandra; Fanzani, Alessandro] Univ Brescia, Dept Mol & Translat Med, I-25123 Brescia, Italy; [Faggi, Fiorella; Codenotti, Silvia; Fanzani, Alessandro] IIM, Rome, Italy; [Lo, Harriet P.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Keller, Charles] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Keller, Charles] Childrens Canc Therapy Dev Inst, Ft Collins, CO USA	University of Brescia; University of Queensland; Oregon Health & Science University	Fanzani, A (corresponding author), Univ Brescia, Dept Mol & Translat Med, Viale Europa 11, I-25123 Brescia, Italy.	alessandro.fanzani@unibs.it	Cominelli, Manuela/J-9988-2016; Chiarelli, Nicola/T-4923-2019; Lo, Harriet P/D-2052-2017; POLIANI, Pietro Luigi/E-8145-2010; Parton, Robert/C-5673-2009	Cominelli, Manuela/0000-0002-4520-6104; Lo, Harriet P/0000-0002-3998-6132; BONO, Federica/0000-0001-9716-5327; MONTI, Eugenio/0000-0002-4742-7445; Keller, Charles/0000-0003-2505-7487; Chiarelli, Nicola/0000-0002-1760-5079; POLIANI, Pietro Luigi/0000-0002-5662-8978; FANZANI, Alessandro/0000-0001-7475-2668; Parton, Robert/0000-0002-7494-5248; Vezzoli, Marika/0000-0002-0424-4235	Fondazione Cariplo grant; Grant NEDD - Network Enabled Drug Design, Regione Lombardia; University of Brescia research fund; NHMRC program grant	Fondazione Cariplo grant(Fondazione Cariplo); Grant NEDD - Network Enabled Drug Design, Regione Lombardia; University of Brescia research fund; NHMRC program grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Fondazione Cariplo grant to E.M., Grant NEDD - Network Enabled Drug Design, Regione Lombardia to E.M. and University of Brescia research fund (ex 60%) to A.F., E.M. and S.M. RGP is a fellow of the National Health and Medical Research Council (NHMRC) of Australia and is supported by a NHMRC program grant.	Anderson John, 1999, Neoplasia (New York), V1, P340, DOI 10.1038/sj.neo.7900052; Ariotti N, 2013, CELL, V154, DOI 10.1016/j.cell.2013.07.009; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Blum JM, 2013, CELL REP, V5, P933, DOI 10.1016/j.celrep.2013.10.020; Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; Chadda R, 2008, CELL, V132, P23, DOI 10.1016/j.cell.2007.12.021; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Davicioni E, 2010, J CLIN ONCOL, V28, P1240, DOI 10.1200/JCO.2008.21.1268; Dias P, 2000, AM J PATHOL, V156, P399, DOI 10.1016/S0002-9440(10)64743-8; Faggi F, 2015, LAB INVEST, V95, P585, DOI 10.1038/labinvest.2015.45; Faggi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084618; Fanzani A, 2013, TRENDS MOL MED, V19, P546, DOI 10.1016/j.molmed.2013.07.001; Fernandez K, 2010, AM J PATHOL, V176, P416, DOI 10.2353/ajpath.2010.090405; Finckenstein FG, 2008, ONCOGENE, V27, P2004, DOI 10.1038/sj.onc.1210835; Fine SW, 2005, APPL IMMUNOHISTO M M, V13, P231, DOI 10.1097/00129039-200509000-00003; Gazzerro E, 2010, EUR J HUM GENET, V18, P137, DOI 10.1038/ejhg.2009.103; Guenther MK, 2013, CANCER LETT, V337, P200, DOI 10.1016/j.canlet.2013.05.010; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Hettmer S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a025650; Hettmer S, 2011, P NATL ACAD SCI USA, V108, P20002, DOI 10.1073/pnas.1111733108; Hnasko Robert, 2003, Mol Interv, V3, P445, DOI 10.1124/mi.3.8.445; Hosur V, 2012, CANCER GENET-NY, V205, P232, DOI 10.1016/j.cancergen.2012.03.005; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Keller C, 2013, FEBS J, V280, P4323, DOI 10.1111/febs.12421; Kikuchi K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004107; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; LOLLINI PL, 1991, INVAS METAST, V11, P116; Mackall CL, 2002, CANCER CELL, V2, P175, DOI 10.1016/S1535-6108(02)00132-0; Marampon F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-31; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Marshall AD, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-25; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Missiaglia E, 2012, J CLIN ONCOL, V30, P1670, DOI 10.1200/JCO.2011.38.5591; Nabi IR, 2009, NAT CELL BIOL, V11, P789, DOI 10.1038/ncb0709-789; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Ogata T, 2014, P NATL ACAD SCI USA, V111, P3811, DOI 10.1073/pnas.1315359111; Ognjanovic S, 2009, CANCER-AM CANCER SOC, V115, P4218, DOI 10.1002/cncr.24465; Ohsawa Y, 2004, HUM MOL GENET, V13, P151, DOI 10.1093/hmg/ddh014; Ohsawa Y, 2006, J CLIN INVEST, V116, P2924, DOI 10.1172/JCI28520; Ohsawa Y, 2012, LAB INVEST, V92, P1100, DOI 10.1038/labinvest.2012.78; Parham DM, 2013, ADV ANAT PATHOL, V20, P387, DOI 10.1097/PAP.0b013e3182a92d0d; Parham DM, 2012, PEDIATR DEVEL PATHOL, V15, P211, DOI 10.2350/10-12-0953-PB.1; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rossi S, 2011, J CELL MOL MED, V15, P2553, DOI 10.1111/j.1582-4934.2011.01364.x; Rossi S, 2011, EUR J CANCER, V47, P761, DOI 10.1016/j.ejca.2010.10.018; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Schmidt WM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002042; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Skapek SX, 2013, PEDIATR BLOOD CANCER, V60, P1411, DOI 10.1002/pbc.24532; Smythe GM, 2003, J CELL SCI, V116, P4739, DOI 10.1242/jcs.00806; SNEATH PHA, 1957, J GEN MICROBIOL, V17, P201, DOI 10.1099/00221287-17-1-201; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Stoppani E, 2011, BBA-MOL BASIS DIS, V1812, P468, DOI 10.1016/j.bbadis.2010.12.005; STRATTON MR, 1989, CANCER RES, V49, P6324; Sunada Y, 2001, HUM MOL GENET, V10, P173, DOI 10.1093/hmg/10.3.173; Tagawa M, 2008, AM J PHYSIOL-CELL PH, V295, pC490, DOI 10.1152/ajpcell.00188.2008; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Taylor AC, 2000, MED PEDIATR ONCOL, V35, P96, DOI 10.1002/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Wang C, 2012, J DENT RES, V91, P341, DOI 10.1177/0022034511421490; Wang YX, 2014, NAT GENET, V46, P601, DOI 10.1038/ng.2974; Way M, 1996, FEBS LETT, V378, P101, DOI 10.1016/0014-5793(96)82884-5; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; Yang ZH, 2009, GENE DEV, V23, P694, DOI 10.1101/gad.1765109	84	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130287	10.1371/journal.pone.0130287	http://dx.doi.org/10.1371/journal.pone.0130287			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086601	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500089
J	Kernan, C; Chow, PP; Christianson, RJ; Huang, J				Kernan, Chase; Chow, Philicia P.; Christianson, Rebecca J.; Huang, Jean			Experimental and Computational Investigation of Biofilm Formation by Rhodopseudomonas palustris Growth under Two Metabolic Modes	PLOS ONE			English	Article							WASTE-WATER TREATMENT; PHOTOTROPHIC BIOFILMS; LIGHT; PHOTOSYNTHESIS; HYDROGEN; REMOVAL	We examined biofilms formed by the metabolically versatile bacterium Rhodopseudomonas palustris grown via different metabolic modes. R. palustris was grown in flow cell chambers with identical medium conditions either in the presence or absence of light and oxygen. In the absence of oxygen and the presence of light, R. palustris grew and formed biofilms photoheterotrophically, and in the presence of oxygen and the absence of light, R. palustris grew and formed biofilms heterotrophically. We used confocal laser scanning microscopy and image analysis software to quantitatively analyze and compare R. palustris biofilm formation over time in these two metabolic modes. We describe quantifiable differences in structure between the biofilms formed by the bacterium grown heterotrophically and those grown photoheterotrophically. We developed a computational model to explore ways in which biotic and abiotic parameters could drive the observed biofilm architectures, as well as a random-forest machine-learning algorithm based on structural differences that was able to identify growth conditions from the confocal imaging of the biofilms with 87% accuracy. Insight into the structure of phototrophic biofilms and conditions that influence biofilm formation is relevant for understanding the generation of biofilm structures with different properties, and for optimizing applications with phototrophic bacteria growing in the biofilm state.	[Kernan, Chase; Chow, Philicia P.; Christianson, Rebecca J.; Huang, Jean] Franklin W Olin Coll Engn, Needham, MA 02492 USA	Franklin W. Olin College of Engineering	Christianson, RJ (corresponding author), Franklin W Olin Coll Engn, Needham, MA 02492 USA.	rebecca.christianson@olin.edu			National Science Foundation, Physics of Living Systems [PHY-1205985, BES-0619373]	National Science Foundation, Physics of Living Systems	This work was supported by the National Science Foundation, Physics of Living Systems, grant numbers PHY-1205985 and BES-0619373. www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1208, DOI 10.1128/AAC.36.6.1208; Barranguet C, 2002, ENVIRON TOXICOL CHEM, V21, P1955, DOI 10.1002/etc.5620210925; Boessmann M, 2004, WATER SCI TECHNOL, V49, P371, DOI 10.2166/wst.2004.0884; Brading M. G., 1995, MICROBIAL BIOFILMS, P46; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Characklis WG, 1990, BIOFILMS, P3; Chen MJ, 2005, COLLOID SURFACE B, V43, P61, DOI 10.1016/j.colsurfb.2005.04.004; Davis TA, 2004, ACM T MATH SOFTWARE, V30, P196, DOI 10.1145/992200.992206; Di Pippo F, 2012, J APPL PHYCOL, V24, P211, DOI 10.1007/s10811-011-9669-0; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Edwards SJ, 2013, APPL MICROBIOL BIOT, V97, P9909, DOI 10.1007/s00253-013-5216-z; Gosse JL, 2007, BIOTECHNOL PROGR, V23, P124, DOI 10.1021/bp060254+; Guzzon A, 2008, WATER RES, V42, P4357, DOI 10.1016/j.watres.2008.07.029; Hermanowicz SW, 1999, WATER SCI TECHNOL, V39, P107, DOI 10.2166/wst.1999.0339; Hermanowicz SW, 2001, MATH BIOSCI, V169, P1, DOI 10.1016/S0025-5564(00)00049-3; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Liao Q, 2012, INT J HYDROGEN ENERG, V37, P15607, DOI 10.1016/j.ijhydene.2012.03.056; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; Moller S, 1997, APPL ENVIRON MICROB, V63, P2432, DOI 10.1128/AEM.63.6.2432-2438.1997; Morikawa M, 2006, J BIOSCI BIOENG, V101, P1, DOI 10.1263/jbb.101.1; Ohl AL, 2004, WATER SCI TECHNOL, V49, P345, DOI 10.2166/wst.2004.0877; Ortega-Morales B.O., 2004, BIOFILMS, V1, P79, DOI [DOI 10.1017/S1479050504001188, 10.1017/S1479050504001188]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pereira MO, 2002, BIOTECHNOL BIOENG, V78, P164, DOI 10.1002/bit.10189; Picioreanu C, 1997, BIOTECHNOL BIOENG, V58, P100; Prince RC, 2005, CRIT REV MICROBIOL, V31, P19, DOI 10.1080/10408410590912961; Rey FE, 2010, MOL MICROBIOL, V75, P1007, DOI 10.1111/j.1365-2958.2009.07037.x; Roeselers G, 2008, J APPL PHYCOL, V20, P227, DOI 10.1007/s10811-007-9223-2; Sarti A, 2006, CHEMOSPHERE, V62, P1437, DOI 10.1016/j.chemosphere.2005.06.007; Schumacher G, 2003, WATER SCI TECHNOL, V47, P195, DOI 10.2166/wst.2003.0605; Sternberg Claus, 2006, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b02s00; Stoodley P, 1999, J APPL MICROBIOL, V85, p19S, DOI 10.1111/j.1365-2672.1998.tb05279.x; Tang YN, 2013, WATER RES, V47, P5729, DOI 10.1016/j.watres.2013.06.055; VerBerkmoes NC, 2006, J PROTEOME RES, V5, P287, DOI 10.1021/pr0503230; Vymazal J, 2001, WATER SCI TECHNOL, V44, P211, DOI 10.2166/wst.2001.0831; Wang Q, 2010, SOLID STATE COMMUN, V150, P1009, DOI 10.1016/j.ssc.2010.01.021; Wang YJ, 2011, BIORESOURCE TECHNOL, V102, P6902, DOI 10.1016/j.biortech.2011.04.026; Wuertz S, 2004, WATER SCI TECHNOL, V49, P327, DOI 10.2166/wst.2004.0873; Ylla I, 2009, FEMS MICROBIOL ECOL, V69, P27, DOI 10.1111/j.1574-6941.2009.00689.x; Zippel B, 2005, WATER SCI TECHNOL, V52, P203, DOI 10.2166/wst.2005.0202	43	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129354	10.1371/journal.pone.0129354	http://dx.doi.org/10.1371/journal.pone.0129354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087200	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500044
J	Lei, Y; Pereira, JA; Quach, S; Bettinger, JA; Kwong, JC; Corace, K; Garber, G; Feinberg, Y; Guay, M				Lei, Yang; Pereira, Jennifer A.; Quach, Susan; Bettinger, Julie A.; Kwong, Jeffrey C.; Corace, Kimberly; Garber, Gary; Feinberg, Yael; Guay, Maryse		Public Hlth Agcy Canada Canadian I	Examining Perceptions about Mandatory Influenza Vaccination of Healthcare Workers through Online Comments on News Stories	PLOS ONE			English	Article							SEASONAL INFLUENZA; INFORMATION; VACCINES; SYSTEM; POLICY	Background The aim of this study was to understand online public perceptions of the debate surrounding the choice of annual influenza vaccinations or wearing masks as a condition of employment for healthcare workers, such as the one enacted in British Columbia in August 2012. Methods Four national and 82 local (British Columbia) Canadian online news sites were searched for articles posted between August 2012 and May 2013 containing the words "healthcare workers" and "mandatory influenza vaccinations/immunizations" or "mandatory flu shots and healthcare workers." We included articles from sources that predominantly concerned our topic of interest and that generated reader comments. Two researchers coded the unedited comments using thematic analysis, categorizing codes to allow themes to emerge. In addition to themes, the comments were categorized by: 1) sentiment towards influenza vaccines; 2) support for mandatory vaccination policies; 3) citing of reference materials or statistics; 4) self-identified health-care worker status; and 5) sharing of a personal story. Results 1163 comments made by 648 commenters responding to 36 articles were analyzed. Popular themes included concerns about freedom of choice, vaccine effectiveness, patient safety, and distrust in government, public health, and the pharmaceutical industry. Almost half (48%) of commenters expressed a negative sentiment toward the influenza vaccine, 28% were positive, 20% were neutral, and 4% expressed mixed sentiment. Of those who commented on the policy, 75% did not support the condition to work policy, while 25% were in favour. Of the commenters, 11% self-identified as healthcare workers, 13% shared personal stories, and 18% cited a reference or statistic. Interpretation The perception of the influenza vaccine in the comment sections of online news sites is fairly poor. Public health agencies should consider including online forums, comment sections, and social media sites as part of their communication channels to correct misinformation regarding the benefits of HCW influenza immunization and the effectiveness of the vaccine.	[Lei, Yang; Pereira, Jennifer A.; Quach, Susan; Kwong, Jeffrey C.; Garber, Gary; Feinberg, Yael] Publ Hlth Ontario, Toronto, ON, Canada; [Lei, Yang; Garber, Gary; Feinberg, Yael] Univ Toronto, Fac Med, Toronto, ON, Canada; [Bettinger, Julie A.] Vaccine Evaluat Ctr, Vancouver, BC, Canada; [Bettinger, Julie A.] British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada; [Bettinger, Julie A.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Kwong, Jeffrey C.] Univ Hlth Network, Toronto, ON, Canada; [Corace, Kimberly; Garber, Gary] Ottawa Hosp, Ottawa, ON, Canada; [Corace, Kimberly; Garber, Gary] Univ Ottawa, Ottawa, ON, Canada; [Corace, Kimberly; Feinberg, Yael] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada; [Guay, Maryse] Univ Sherbrooke, Dept Sci Sante Communautaire, Longueuil, PQ, Canada; [Guay, Maryse] Inst Natl Sante publ Quebec, Longueuil, PQ, Canada; [Guay, Maryse] Hop Charles LeMoyne, Ctr Rech, Longueuil, PQ, Canada; [Guay, Maryse] Agence Sante & Serv Sociaux Monteregie, Ctr Rech, Longueuil, PQ, Canada	University of Toronto; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Sherbrooke; Institut national de sante publique du Quebec (INSPQ); University of Sherbrooke	Guay, M (corresponding author), Univ Sherbrooke, Dept Sci Sante Communautaire, Longueuil, PQ, Canada.	maryse.guay.agence16@ssss.gouv.qc.ca	McGeer, Allison/AAB-6885-2020	McGeer, Allison/0000-0001-5647-6137; Lei, Yang/0000-0003-4105-6353; Bettinger, Julie/0000-0002-2118-4174				Awali RA, 2014, AM J INFECT CONTROL, V42, P649, DOI 10.1016/j.ajic.2014.02.025; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Betsch C, 2011, MED DECIS MAKING, V31, P742, DOI 10.1177/0272989X11400419; Coe K, 2014, J COMMUN, V64, P658, DOI 10.1111/jcom.12104; Corace K, 2013, AM J INFECT CONTROL, V41, P679, DOI 10.1016/j.ajic.2013.01.014; Flegel K, 2012, CAN MED ASSOC J, V184, P1873, DOI 10.1503/cmaj.121679; Gardam M, 2013, CAN MED ASSOC J, V185, P639, DOI 10.1503/cmaj.122074; Gesser-Edelsburg A, 2014, AM J INFECT CONTROL, V42, P829, DOI 10.1016/j.ajic.2014.04.012; Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; Gruben V, 2014, CAN MED ASSOC J, V186, P1076, DOI 10.1503/cmaj.140035; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Huynh S, 2012, AM J INFECT CONTROL, V40, P771, DOI 10.1016/j.ajic.2011.10.011; Immunize BC, 2014, INFLUENZA CONTROL PR; Knox Shawn, 2014, GLOBAL NEWS     0709; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Larson HJ, 2013, LANCET INFECT DIS, V13, P606, DOI 10.1016/S1473-3099(13)70108-7; Lehmann BA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-407; Miller BL, 2011, VACCINE, V29, P9398, DOI 10.1016/j.vaccine.2011.09.047; Moskosky S. B., 2011, Morbidity and Mortality Weekly Report, V60, P1; National Advisory Committee on Immunization, 2011, CAN COMMUN DIS REP, V37; Newspaper Audience Databank Inc, NADBANK 2013 STUD; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pereira JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064072; Peter C, 2014, J MEDIA PSYCHOL-GER, V26, P19, DOI 10.1027/1864-1105/a000103; Poland GA, 2005, VACCINE, V23, P2251, DOI 10.1016/j.vaccine.2005.01.043; Prematunge C, 2014, VACCINE, V32, P7128, DOI 10.1016/j.vaccine.2014.10.023; Prematunge C, 2012, VACCINE, V30, P4733, DOI 10.1016/j.vaccine.2012.05.018; Quach S, 2013, AM J INFECT CONTROL, V41, P1017, DOI 10.1016/j.ajic.2013.05.016; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210; Rowe G, 2008, HEALTH RISK SOC, V10, P361, DOI 10.1080/13698570802166456; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Toronto Public Health, 2011, INFL IMM RAT HEALTHC, P1; Walther JB, 2010, HUM COMMUN RES, V36, P469, DOI 10.1111/j.1468-2958.2010.01384.x; Wellington-Dufferin-Guelph Public Health, 2011, WELL DUFF GUELPH 201; Wheelock A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113503; Winston L, 2014, VACCINE, V32, P4786, DOI 10.1016/j.vaccine.2014.06.001; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018	39	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129993	10.1371/journal.pone.0129993	http://dx.doi.org/10.1371/journal.pone.0129993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK9NT	26086194	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500072
J	Li, LY; Adamkiewicz, G; Zhang, YP; Spengler, JD; Qu, F; Sundell, J				Li, Linyan; Adamkiewicz, Gary; Zhang, Yinping; Spengler, John D.; Qu, Fang; Sundell, Jan			Effect of Traffic Exposure on Sick Building Syndrome Symptoms among Parents/Grandparents of Preschool Children in Beijing, China	PLOS ONE			English	Article							MULTIFAMILY RESIDENTIAL BUILDINGS; FINE PARTICULATE MATTER; US OFFICE BUILDINGS; LONG-TERM EXPOSURE; AIR-POLLUTION; RISK-FACTORS; PSYCHOSOCIAL FACTORS; SBS-SYMPTOMS; INDOOR; ROAD	Introduction Sick building syndrome (SBS) includes general, mucosal and skin symptoms. It is typically associated with an individual's place of work or residence. The aim of this study was to explore the effect of traffic exposure on SBS symptoms in Beijing, China. Methods From January to May, 2011, recruitment occurred at kindergartens in 11 districts in Beijing. Self-administered questionnaires were distributed by teachers to legal guardians of children and then returned to teachers. The questionnaire asked them to recall the presence of 12 SBS symptoms from the previous three months. Living near a highway or main road (within 200 meters) was used as a proxy for traffic exposure. Multivariable logistic regression was used to test the association between traffic exposure and a higher number of SBS symptoms, controlling for key covariates. Results There were 5487 valid questionnaires (65.0% response rate). Univariate analysis showed that living near a main road or highway (OR = 1.40), female gender (OR = 1.44), and environmental tobacco smoking (ETS) (OR = 1.13) were significant risk factors for general symptoms. Grandparent's generation (OR = 0.32) and home ownership (owner vs. renter) (OR = 0.89) were significant protective factors. The adjusted odds ratio (aOR) for the association between living close to a highway and general symptoms remained significant in the multivariable model (aOR = 1.39; 95% CI = 1.21: 1.59). ORs and aORs were similar for mucosal and skin symptoms. Conclusions This study found traffic exposure to be significantly associated with SBS symptoms. This finding is consistent with current literature that indicates an association between adverse health effects and living near highway or main road.	[Li, Linyan; Adamkiewicz, Gary; Spengler, John D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Zhang, Yinping; Qu, Fang; Sundell, Jan] Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Tsinghua University	Li, LY (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	linyan.li@mail.harvard.edu	Zhang, Yinping/B-5187-2012	Zhang, Yinping/0000-0001-9175-7890; Li, Linyan/0000-0001-5736-2115	Natural Science Foundation of China [51136002]; Charoen Pokphand Group (through the Health And Places Initiative); Charoen Pokphand Group	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Charoen Pokphand Group (through the Health And Places Initiative); Charoen Pokphand Group	This work was supported by Natural Science Foundation of China (51136002) and Charoen Pokphand Group (through the Health And Places Initiative, a joint project between the Harvard TH Chan School of Public Health and the Harvard University Graduate School of Design). Support from Charoen Pokphand Group was used to complete the analysis of these data and preparation of the manuscript. However, the Charoen Pokphand Group did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkiewicz G, 2014, AM J PUBLIC HEALTH, V104, P1650, DOI 10.2105/AJPH.2013.301253; [Anonymous], 2008, TRAFFIC RELATED AIR; [Anonymous], 1993, INDOOR AIR, DOI DOI 10.1111/j.1600-0668.1993.00024.x; Apte MG, 2000, INDOOR AIR, V10, P246, DOI 10.1034/j.1600-0668.2000.010004246.x; Baxter LK, 2007, ATMOS ENVIRON, V41, P6561, DOI 10.1016/j.atmosenv.2007.04.027; Baxter LK, 2010, J EXPO SCI ENV EPID, V20, P101, DOI 10.1038/jes.2009.5; Baxter LK, 2008, ATMOS ENVIRON, V42, P9080, DOI 10.1016/j.atmosenv.2008.09.023; Beelen R, 2009, OCCUP ENVIRON MED, V66, P243, DOI 10.1136/oem.2008.042358; Bendokiene I, 2011, NOISE HEALTH, V13, P371, DOI 10.4103/1463-1741.90288; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Brasche S, 2001, INDOOR AIR, V11, P217, DOI 10.1034/j.1600-0668.2001.110402.x; Brauer C, 2006, INT ARCH OCC ENV HEA, V79, P453, DOI 10.1007/s00420-005-0074-3; Brunekreef B, 2009, RES REP HLTH EFF I, V139, P5; Bui DS, 2013, RESPIROLOGY, V18, P1101, DOI 10.1111/resp.12108; Delfino RJ, 2014, EPIDEMIOLOGY, V25, P48, DOI 10.1097/EDE.0000000000000016; Engvall K, 2005, INDOOR AIR, V15, P120, DOI 10.1111/j.1600-0668.2004.00325.x; Engvall K, 2001, INT ARCH OCC ENV HEA, V74, P270, DOI 10.1007/s004200000218; Engvall K, 2000, INDOOR AIR, V10, P101; FRANCK C, 1993, INT ARCH OCC ENV HEA, V65, P65, DOI 10.1007/BF00586061; Garshick E, 2003, EPIDEMIOLOGY, V14, P728, DOI 10.1097/01.ede.0000082045.50073.66; Guo P, 2013, INT J ENV RES PUB HE, V10, P1489, DOI 10.3390/ijerph10041489; GYNTELBERG F, 1994, INDOOR AIR, V4, P223, DOI 10.1111/j.1600-0668.1994.00003.x; Hart JE, 2011, AM J RESP CRIT CARE, V183, P73, DOI 10.1164/rccm.200912-1903OC; Hume KI, 2012, NOISE HEALTH, V14, P297, DOI 10.4103/1463-1741.104897; John D., 2001, INDOOR AIR QUALITY H; Kinman G, 2008, STRESS HEALTH, V24, P165, DOI 10.1002/smi.1175; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Li XH, 2012, ENVIRON SCI POLLUT R, V19, P1375, DOI 10.1007/s11356-011-0718-7; Lipsett MJ, 2011, AM J RESP CRIT CARE, V184, P828, DOI 10.1164/rccm.201012-2082OC; Meijer A, 2006, INT J LIFE CYCLE ASS, V11, P64, DOI 10.1065/lca2006.04.013; Mendell MJ, 2008, INDOOR AIR, V18, P301, DOI 10.1111/j.1600-0668.2008.00531.x; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mizoue T, 2001, AM J EPIDEMIOL, V154, P803, DOI 10.1093/aje/154.9.803; Nafstad P, 2004, ENVIRON HEALTH PERSP, V112, P610, DOI 10.1289/ehp.6684; NAKAI S, 1995, J EXPO ANAL ENV EPID, V5, P125; Ndrepepa A, 2011, NOISE HEALTH, V13, P251, DOI 10.4103/1463-1741.80163; Ooi PL, 1998, OCCUP ENVIRON MED, V55, P188, DOI 10.1136/oem.55.3.188; Ooi PL, 1996, LANCET, V347, P841, DOI 10.1016/S0140-6736(96)90927-7; Ooi PL, 1997, INT J EPIDEMIOL, V26, P1243, DOI 10.1093/ije/26.6.1243; Perez L, 2013, EUR RESPIR J, V42, P594, DOI 10.1183/09031936.00031112; Puett RC, 2008, AM J EPIDEMIOL, V168, P1161, DOI 10.1093/aje/kwn232; Qu F, 2013, CHINESE SCI BULL, V58, P4190, DOI 10.1007/s11434-013-5790-6; Roorda-Knape MC, 1998, ATMOS ENVIRON, V32, P1921, DOI 10.1016/S1352-2310(97)00496-2; Runeson R, 2006, INDOOR AIR, V16, P445, DOI 10.1111/j.1600-0668.2006.00438.x; STENBERG B, 1995, SOC SCI MED, V40, P491, DOI 10.1016/0277-9536(94)E0104-Z; Stenerg B, 1993, INDOOR AIR, V3, P71, DOI [DOI 10.1111/j.1600-0668.1993.t01-2-00002.x, 10.1111/j.1600-0668.1993.t01-2-00002.x, DOI 10.11II/J.1600-0668.1993.T01-2-00002.X]; SUNDELL J, 1994, ENVIRON INT, V20, P239, DOI 10.1016/0160-4120(94)90141-4; Sundell J, 2011, INDOOR AIR, V21, P191, DOI 10.1111/j.1600-0668.2010.00703.x; Todaka E, 2012, TOXICOL LETT, V211, pS94, DOI 10.1016/j.toxlet.2012.03.354; USEPA, 2009, SICK BUILD SYNDR; Wang C, 2012, ENVIRON POLLUT, V171, P234, DOI 10.1016/j.envpol.2012.07.041; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072385; Wargocki P, 2000, INDOOR AIR, V10, P222, DOI 10.1034/j.1600-0668.2000.010004222.x; Wargocki P, 2002, INDOOR AIR, V12, P74, DOI 10.1034/j.1600-0668.2002.01101.x; WHO, 1983, IND AIR POLL EXP HLT; Wong SK, 2009, HABITAT INT, V33, P463, DOI 10.1016/j.habitatint.2009.03.001; Zhang YP, 2013, CHINESE SCI BULL, V58, P4182, DOI 10.1007/s11434-013-5914-z; Zhao ZH, 2008, ENVIRON HEALTH PERSP, V116, P90, DOI 10.1289/ehp.10576; Zhu YF, 2002, J AIR WASTE MANAGE, V52, P1032, DOI 10.1080/10473289.2002.10470842; [No title captured], DOI DOI 10.4103/1463-1741.99864	60	15	15	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128767	10.1371/journal.pone.0128767	http://dx.doi.org/10.1371/journal.pone.0128767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086248	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567500021
J	Nishida, H; Ikegami, A; Kaneko, C; Kakuma, H; Nishi, H; Tanaka, N; Aoyama, M; Usami, M; Okimura, Y				Nishida, Hikaru; Ikegami, Ayaka; Kaneko, Chiaki; Kakuma, Hitomi; Nishi, Hisano; Tanaka, Noriko; Aoyama, Michiko; Usami, Makoto; Okimura, Yasuhiko			Dexamethasone and BCAA Failed to Modulate Muscle Mass and mTOR Signaling in GH-Deficient Rats	PLOS ONE			English	Article							GROWTH-FACTOR-I; CHAIN AMINO-ACIDS; MESSENGER-RIBONUCLEIC-ACID; SKELETAL-MUSCLE; IGF-I; GLUCOCORTICOID-RECEPTOR; HYPOPHYSECTOMIZED RATS; METABOLIC PARAMETERS; MYOSTATIN GENE; UP-REGULATION	Branched-chain amino acids (BCAAs) and IGF-I, the secretion of which is stimulated by growth hormone (GH), prevent muscle atrophy. mTOR plays a pivotal role in the protective actions of BCAA and IGF-1. The pathway by which BCAA activates mTOR is different from that of IGF-1, which suggests that BCAA and GH work independently. We tried to examine whether BCAA exerts a protective effect against dexamethasone (Dex)-induced muscle atrophy independently of GH using GH-deficient spontaneous dwarf rats (SDRs). Unexpectedly, Dex did not induce muscle atrophy assessed by the measurement of cross-sectional area (CSA) of the muscle fibers and did not increase atrogin-1, MuRF1 and REDD1 expressions, which are activated during protein degradation. Glucocorticoid (GR) mRNA levels were higher in SDRs compared to GH-treated SDRs, indicating that the low expression of GR is not the reason of the defect of Dex's action in SDRs. BCAA did not stimulate the phosphorylation of p70S6K or 4E-BP1, which stimulate protein synthesis. BCAA did not decrease the mRNA level of atrogin-1 or MuRF1. These findings suggested that Dex failed to modulate muscle mass and that BCAA was unable to activate mTOR in SDRs because these phosphorylations of p70S6K and 4E-BP1 and the reductions of these mRNAs are regulated by mTOR. In contrast, after GH supplementation, these responses to Dex were normalized and muscle fiber CSA was decreased by Dex. BCAA prevented the Dex-induced decrease in CSA. BCAA increased the phosphorylation of p70S6K and decreased the Dex-induced elevations of atrogin-1 and Bnip3 mRNAs. However, the amount of mTORC1 components including mTOR was not decreased in the SDRs compared to the normal rats. These findings suggest that GH increases mTORC1 activity but not its content to recover the action of BCAA in SDRs and that GH is required for actions of Dex and BCAA in muscles.	[Nishida, Hikaru; Ikegami, Ayaka; Kaneko, Chiaki; Kakuma, Hitomi; Nishi, Hisano; Tanaka, Noriko; Okimura, Yasuhiko] Kobe Womens Univ, Grad Sch Life Sci, Dept Nutr & Food Sci, Kobe, Hyogo, Japan; [Aoyama, Michiko; Usami, Makoto] Kobe Univ, Grad Sch Hlth Sci, Div Nutr & Metab, Kobe, Hyogo 657, Japan	Kobe University	Okimura, Y (corresponding author), Kobe Womens Univ, Grad Sch Life Sci, Dept Nutr & Food Sci, Kobe, Hyogo, Japan.	y-okimura@suma.kobe-wu.ac.jp			Japanese Ministry of Education, Science, Sports, and Culture; Japanese Ministry of Health [26500021]	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health	This study is supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture, and grants from the Japanese Ministry of Health (# 26500021, YO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aversa Z, 2012, BIOCHEM BIOPH RES CO, V423, P739, DOI 10.1016/j.bbrc.2012.06.029; AYLING CM, 1989, J ENDOCRINOL, V123, P429, DOI 10.1677/joe.0.1230429; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Britto FA, 2014, AM J PHYSIOL-ENDOC M, V307, pE983, DOI 10.1152/ajpendo.00234.2014; Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099; Chikani V, 2014, J MOL ENDOCRINOL, V52, pR107, DOI 10.1530/JME-13-0208; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DEKHUIJZEN PNR, 1995, J APPL PHYSIOL, V78, P629, DOI 10.1152/jappl.1995.78.2.629; Dominick G, 2015, ENDOCRINOLOGY, V156, P565, DOI 10.1210/en.2014-1690; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Gazzaneo MC, 2011, PEDIATR RES, V70, P253, DOI 10.1203/PDR.0b013e3182276cfa; Herningtyas EH, 2008, BBA-GEN SUBJECTS, V1780, P1115, DOI 10.1016/j.bbagen.2008.06.004; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jesinkey SR, 2014, J PHARMACOL EXP THER, V351, P663, DOI 10.1124/jpet.114.217380; Kamegai J, 1998, ENDOCRINOLOGY, V139, P3554, DOI 10.1210/en.139.8.3554; Kim H, 2005, ENDOCRINOLOGY, V146, P1772, DOI 10.1210/en.2004-0906; Lang CH, 2010, AM J PHYSIOL-ENDOC M, V298, pE1283, DOI 10.1152/ajpendo.00676.2009; LEWIS MI, 1992, J APPL PHYSIOL, V72, P293, DOI 10.1152/jappl.1992.72.1.293; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; LOUGHNA PT, 1994, BIOCHEM BIOPH RES CO, V198, P97, DOI 10.1006/bbrc.1994.1014; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; Maki T, 2012, NUTR RES, V32, P676, DOI 10.1016/j.nutres.2012.07.005; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Nordstrom SM, 2011, MOL ENDOCRINOL, V25, P1223, DOI 10.1210/me.2011-0047; Qin WP, 2014, BIOCHEM BIOPH RES CO, V450, P979, DOI 10.1016/j.bbrc.2014.06.080; Rizzoli R, 2013, CALCIFIED TISSUE INT, V93, P101, DOI 10.1007/s00223-013-9758-y; Roef G, 2012, EUR J ENDOCRINOL, V167, P719, DOI 10.1530/EJE-12-0447; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Suzuki T, 2011, ACTA BIOCH BIOPH SIN, V43, P671, DOI 10.1093/abbs/gmr066; TRONCOSO R, 2014, CELL CYCLE, P13; Troncoso R, 2014, CELL CYCLE, V13, P2281, DOI 10.4161/cc.29272; Van Balkom RHH, 1998, J APPL PHYSIOL, V84, P1492, DOI 10.1152/jappl.1998.84.5.1492; vanBalkom RHH, 1996, EUR RESPIR J, V9, P1217, DOI 10.1183/09031936.96.09061217; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Weber JD, 2012, CELL CYCLE, V11, P236, DOI 10.4161/cc.11.2.19022; Wu Y, 2010, ENDOCRINOLOGY, V151, P1050, DOI 10.1210/en.2009-0530; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yamamoto D, 2010, MUSCLE NERVE, V41, P819, DOI 10.1002/mus.21621; Zhao WD, 2008, J STEROID BIOCHEM, V110, P125, DOI 10.1016/j.jsbmb.2008.03.024	51	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0128805	10.1371/journal.pone.0128805	http://dx.doi.org/10.1371/journal.pone.0128805			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086773	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567500026
J	Rui, B; Yi, Y; Shen, T; Zheng, MJ; Zhou, WW; Du, HL; Fan, YD; Wang, YK; Zhang, ZD; Xu, SS; Liu, ZJ; Wen, H; Xie, XY				Rui, Bin; Yi, Yin; Shen, Tie; Zheng, Meijuan; Zhou, Wenwei; Du, Honglin; Fan, Yadong; Wang, Yongkang; Zhang, Zhengdong; Xu, Shengsheng; Liu, Zhijie; Wen, Han; Xie, Xiaoyao			Elementary Flux Mode Analysis Revealed Cyclization Pathway as a Powerful Way for NADPH Regeneration of Central Carbon Metabolism	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; OXIDATIVE STRESS; ESCHERICHIA-COLI; THERMODYNAMIC ANALYSIS; NONENZYMATIC FORMATION; GENE-EXPRESSION; ENZYME; NETWORKS; AVAILABILITY; MITOCHONDRIA	NADPH regeneration capacity is attracting growing research attention due to its important role in resisting oxidative stress. Besides, NADPH availability has been regarded as a limiting factor in production of industrially valuable compounds. The central carbon metabolism carries the carbon skeleton flux supporting the operation of NADPH-regenerating enzyme and offers flexibility in coping with NADPH demand for varied intracellular environment. To acquire an insightful understanding of its NADPH regeneration capacity, the elementary mode method was employed to compute all elementary flux modes (EFMs) of a network representative of central carbon metabolism. Based on the metabolic flux distributions of these modes, a cluster analysis of EFMs with high NADPH regeneration rate was conducted using the self-organizing map clustering algorithm. The clustering results were used to study the relationship between the flux of total NADPH regeneration and the flux in each NADPH producing enzyme. The results identified several reaction combinations supporting high NADPH regeneration, which are proven to be feasible in cells via thermodynamic analysis and coincident with a great deal of previous experimental report. Meanwhile, the reaction combinations showed some common characteristics: there were one or two decarboxylation oxidation reactions in the combinations that produced NADPH and the combination constitution included certain gluconeogenesis pathways. These findings suggested cyclization pathways as a powerful way for NADPH regeneration capacity of bacterial central carbon metabolism.	[Rui, Bin; Fan, Yadong; Wang, Yongkang; Xu, Shengsheng; Wen, Han] Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China; [Shen, Tie; Zhou, Wenwei; Du, Honglin; Zhang, Zhengdong; Liu, Zhijie; Xie, Xiaoyao] Guizhou Normal Univ, Key Lab Informat & Comp Sci, Guiyang, Guizhou Provinc, Peoples R China; [Yi, Yin] Guizhou Normal Univ, Key Lab Plant Physiol & Dev Regulat, Guiyang, Guizhou Provinc, Peoples R China; [Zheng, Meijuan] Guizhou Acad Testing & Anal, Guiyang, Peoples R China	Anhui Agricultural University; Guizhou Normal University; Guizhou Normal University	Wen, H (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China.	swhx12@ahau.edu.cn; xys@gznu.edu.cn	zhang, zheng/HCH-9684-2022		Chinese National Natural Science Foundation [31200626, 31460233, 31372402]; Biology Key Subject Construction of Anhui [2014SKQJ017]; Programme for Changjiang Scholars and the Innovative Research Teams at the University [PCSIRT-1227]; Initial Fund for the Key Laboratory of Guizhou Province [2011-4005]; Guizhou Lianhe Foundation [LKS(2012)22]; Initial Fund for collaborative Innovation Center of Guizhou Province [[2014]04]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Biology Key Subject Construction of Anhui; Programme for Changjiang Scholars and the Innovative Research Teams at the University; Initial Fund for the Key Laboratory of Guizhou Province; Guizhou Lianhe Foundation; Initial Fund for collaborative Innovation Center of Guizhou Province	This work was supported by the Chinese National Natural Science Foundation (grant 31200626, 31460233, 31372402), the Biology Key Subject Construction of Anhui (2014SKQJ017), the Programme for Changjiang Scholars and the Innovative Research Teams at the University (PCSIRT-1227), the Initial Fund for the Key Laboratory of Guizhou Province (Grant no. 2011-4005), the Guizhou Lianhe Foundation, LKS(2012)22, the Initial Fund for collaborative Innovation Center of Guizhou Province ([2014]04).	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088368; Brookes PS, 2006, FREE RADICAL BIO MED, V41, P41, DOI 10.1016/j.freeradbiomed.2006.03.019; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; Chemler JA, 2010, METAB ENG, V12, P96, DOI 10.1016/j.ymben.2009.07.003; de Figueiredo LF, 2011, BIOCHEM J, V439, P341, DOI 10.1042/BJ20110320; Dghim AA, 2013, PHYSIOL PLANTARUM, V148, P36, DOI 10.1111/j.1399-3054.2012.01686.x; Fedotcheva NI, 2006, FREE RADICAL BIO MED, V41, P56, DOI 10.1016/j.freeradbiomed.2006.02.012; Hanke T, 2013, APPL ENVIRON MICROB, V79, P2336, DOI 10.1128/AEM.03414-12; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784; Jiang LY, 2013, J IND MICROBIOL BIOT, V40, P1143, DOI 10.1007/s10295-013-1306-2; Jol SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002415; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Klamt S, 2003, TRENDS BIOTECHNOL, V21, P64, DOI 10.1016/S0167-7799(02)00034-3; Li X, 2008, FREE RADICAL BIO MED, V44, P1465, DOI 10.1016/j.freeradbiomed.2008.01.004; Lien SK, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0148-0; Martinez I, 2008, METAB ENG, V10, P352, DOI 10.1016/j.ymben.2008.09.001; MAVROVOUNIOTIS ML, 1991, J BIOL CHEM, V266, P14440; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Schwarz R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-135; Shen T, 2013, MOL BIOSYST, V9, P121, DOI 10.1039/c2mb25285f; Siedler S, 2013, APPL MICROBIOL BIOT, V97, P143, DOI 10.1007/s00253-012-4314-7; Siedler S, 2012, APPL MICROBIOL BIOT, V93, P1459, DOI 10.1007/s00253-011-3626-3; Siedler S, 2011, APPL MICROBIOL BIOT, V92, P929, DOI 10.1007/s00253-011-3374-4; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Suga H, 2013, APPL MICROBIOL BIOT, V97, P1669, DOI 10.1007/s00253-012-4298-3; Supek F, 2004, BIOINFORMATICS, V20, P2329, DOI 10.1093/bioinformatics/bth238; von Kamp A, 2006, BIOINFORMATICS, V22, P1930, DOI 10.1093/bioinformatics/btl267; Wiback SJ, 2002, BIOPHYS J, V83, P808, DOI 10.1016/S0006-3495(02)75210-7; Wu JL, 2008, PHYSIOL RES, V57, P261, DOI 10.33549/physiolres.931161; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309	45	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0129837	10.1371/journal.pone.0129837	http://dx.doi.org/10.1371/journal.pone.0129837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086807	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500066
J	Schurmann, C; Gremse, F; Jo, H; Kiessling, F; Brandes, RP				Schuurmann, Christoph; Gremse, Felix; Jo, Hanjoong; Kiessling, Fabian; Brandes, Ralf P.			Micro-CT Technique Is Well Suited for Documentation of Remodeling Processes in Murine Carotid Arteries	PLOS ONE			English	Article							ATHEROSCLEROSIS; FLOW; SHRINKAGE; MODEL	Background The pathomechanisms of atherosclerosis and vascular remodelling are under intense research. Only a few in vivo tools to study these processes longitudinally in animal experiments are available. Here, we evaluated the potential of micro-CT technology. Methods Lumen areas of the common carotid arteries (CCA) in the ApoE(-/-) partial carotid artery ligation mouse model were compared between in vivo and ex vivo micro-CT technique and serial histology in a total of 28 animals. AuroVist-15 nm nanoparticles were used as in vivo blood pool contrast agent in a Skyscan 1176 micro-CT at resolution of 18 mu meter voxel size and a mean x-ray dose of 0.5 Gy. For ex vivo imaging, animals were perfused with MicroFil and imaged at 9 mu meter voxel size. Lumen area was evaluated at postoperative days 7, 14, and 28 first by micro-CT followed by histology. Results In vivo micro-CT and histology revealed lumen loss starting at day 14. The lumen profile highly correlated (r = 0.79, P < 0.0001) between this two methods but absolute lumen values obtained by histology were lower than those obtained by micro-CT. Comparison of in vivo and ex vivo micro-CT imaging revealed excellent correlation (r = 0.83, P < 0.01). Post mortem micro-CT yielded a higher resolution than in vivo micro-CT but there was no statistical difference of lumen measurements in the partial carotid artery ligation model. Conclusion These data demonstrate that in vivo micro-CT is a feasible and accurate technique with low animal stress to image remodeling processes in the murine carotid artery.	[Schuurmann, Christoph; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Fachbereich Med, Frankfurt, Germany; [Gremse, Felix; Kiessling, Fabian] Rhein Westfal TH Aachen, Univ Clin Aachen, Expt Mol Imaging, Aachen, Germany; [Jo, Hanjoong] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Jo, Hanjoong] Emory Univ, Atlanta, GA 30322 USA; [Schuurmann, Christoph; Brandes, Ralf P.] German Ctr Cardiovasc Res DZHK, Frankfurt, Germany	Goethe University Frankfurt; RWTH Aachen University; RWTH Aachen University Hospital; University System of Georgia; Georgia Institute of Technology; Emory University; German Centre for Cardiovascular Research	Schurmann, C (corresponding author), Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Fachbereich Med, Theodor Stern Kai 7, Frankfurt, Germany.	schuermann@vrc.uni-frankfurt.de	Kiessling, Fabian/Y-2417-2019; Brandes, Ralf P/L-3058-2017; Jo, Hanjoong/L-6216-2019	Kiessling, Fabian/0000-0002-7341-0399; Brandes, Ralf P/0000-0002-8035-0048; Jo, Hanjoong/0000-0003-1833-372X; Schurmann, Christoph/0000-0003-1530-1378	Goethe-University; DFG [SFB 815, SFB 834]; German Center for Cardiovascular Research (DZHK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095070, R01HL119798] Funding Source: NIH RePORTER	Goethe-University; DFG(German Research Foundation (DFG)); German Center for Cardiovascular Research (DZHK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Goethe-University, the DFG Excellence Cluster 147 ECCPS - excellence cluster cardio-pulmonary system and the German Center for Cardiovascular Research (DZHK) and the DFG collaborative research centers SFB 815 (TP A1) and SFB 834 (TP A2) to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartling SH, 2007, CURR MED IMAGING, V3, P45, DOI 10.2174/157340507779940327; Dunn J, 2014, J CLIN INVEST, V124, P3187, DOI 10.1172/JCI74792; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Gaens ME, 2013, RADIOLOGY, V266, P271, DOI 10.1148/radiol.12120499; Hainfeld JF, 2006, BRIT J RADIOL, V79, P248, DOI 10.1259/bjr/13169882; KRATKY RG, 1984, ATHEROSCLEROSIS, V51, P339, DOI 10.1016/0021-9150(84)90182-5; Liehn EA, 2011, J AM COLL CARDIOL, V58, P2415, DOI 10.1016/j.jacc.2011.08.033; Loqman MY, 2010, EUR CELLS MATER, V19, P214, DOI 10.22203/eCM.v019a21; Nam D., 2010, J VIS EXP, V2010, P1861, DOI DOI 10.3791/1861; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Shin IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073451; Son DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4000; Sullivan CJ, 2002, ARTERIOSCL THROM VAS, V22, P1100, DOI 10.1161/01.ATV.0000023230.17493.E3; Vandeghinste B, 2011, MOL IMAGING BIOL, V13, P78, DOI 10.1007/s11307-010-0335-8; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0	15	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130374	10.1371/journal.pone.0130374	http://dx.doi.org/10.1371/journal.pone.0130374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086218	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500099
J	Volpato, H; Desoti, VC; Valdez, RH; Ueda-Nakamura, T; Silva, SD; Sarragiotto, MH; Nakamura, CV				Volpato, Helito; Desoti, Vania Cristina; Valdez, Rodrigo Hinojosa; Ueda-Nakamura, Tania; Silva, Sueli de Oliveira; Sarragiotto, Maria Helena; Nakamura, Celso Vataru			Mitochondrial Dysfunction Induced by N-Butyl-1-(4-Dimethylamino)Phenyl-1,2,3,4-Tetrahydro-beta-Carboline-3-Carboxamide Is Required for Cell Death of Trypanosoma cruzi	PLOS ONE			English	Article							IN-VITRO; CHAGAS-DISEASE; BIOLOGICAL-ACTIVITY; APOPTOSIS; CHEMOTHERAPY	Background Chagas' disease is caused by the protozoan Trypanosoma cruziand affects thousands of people worldwide. The available treatments are unsatisfactory, and new drugs must be developed. Our group recently reported the trypanocidal activity of the synthetic compound N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxamide (C4), but the mechanism of action of this compound was unclear. Methodology/Principal Findings We investigated the mechanism of action of C4 against epimastigote and trypomastigote forms of T. cruzi. The results showed alterations in mitochondrial membrane potential, alterations in cell membrane integrity, an increase in the formation of reactive oxygen species, phosphatidylserine exposure, a reduction of cell volume, DNA fragmentation, and the formation of lipid inclusions. Conclusion/Significance These finding suggest that mitochondria are a target of C4, the dysfunction of which can lead to different pathways of cell death.	[Volpato, Helito; Nakamura, Celso Vataru] Univ Estadual Maringa, Programa Posgrad Ciencias Biol Biol Celular & Mol, Maringa, Parana, Brazil; [Desoti, Vania Cristina; Ueda-Nakamura, Tania; Silva, Sueli de Oliveira; Nakamura, Celso Vataru] Univ Estadual Maringa, Programa Posgrad Ciencias Farmaceut, Maringa, Parana, Brazil; [Valdez, Rodrigo Hinojosa] Inst Fed Parana, Dept Farmacia, Palmas, Parana, Brazil; [Sarragiotto, Maria Helena] Univ Estadual Maringa, Dept Quim, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Instituto Federal do Parana; Universidade Estadual de Maringa	Nakamura, CV (corresponding author), Univ Estadual Maringa, Programa Posgrad Ciencias Biol Biol Celular & Mol, Maringa, Parana, Brazil.	cvnakamura@uem.br	Lautenschlager, Sueli OS/P-2164-2017; Ueda-Nakamura, Tania/P-8250-2015; Sarragiotto, Maria Helena/ABH-6675-2020; Volpato, Hélito/AAI-8483-2021; Desoti, Vania/AAC-6414-2020; Nakamura, Celso Vataru/AAA-5620-2019	Lautenschlager, Sueli OS/0000-0001-9303-0804; Ueda-Nakamura, Tania/0000-0001-5057-3518; Sarragiotto, Maria Helena/0000-0003-3861-502X; Volpato, Helito/0000-0003-1241-8052; DESOTI, VANIA/0000-0002-2087-5248; Nakamura, Celso Vataru/0000-0002-9911-7369	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP); Programa de Pos-Graduacao em Ciencias Biologicas; Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM) da Universidade Estadual de Maringa	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Programa de Pos-Graduacao em Ciencias Biologicas; Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM) da Universidade Estadual de Maringa	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (FINEP), Programa de Pos-Graduacao em Ciencias Biologicas and Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM) da Universidade Estadual de Maringa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 1 WHO REP NEGL TROP; Arambage SC, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-32; Britta EA, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0236-0; Cao R, 2005, EUR J MED CHEM, V40, P991, DOI 10.1016/j.ejmech.2005.04.008; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P549, DOI 10.1590/S0074-02762009000400002; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; de Macedo-Silva ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083247; Gomes FOD, 2012, PARASITOL RES, V111, P2361, DOI 10.1007/s00436-012-3091-7; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Fernandes MP, 2010, J BIOENERG BIOMEMBR, V42, P69, DOI 10.1007/s10863-010-9268-9; Jimenez-Ruiz A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-104; Kaczanowski S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-44; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lazarin-Bidoia D, 2013, FREE RADICAL BIO MED, V60, P17, DOI 10.1016/j.freeradbiomed.2013.01.008; Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167; Luo Y, 1996, PHOTOCHEM PHOTOBIOL, V63, P528, DOI 10.1111/j.1751-1097.1996.tb03079.x; Mandelker L, 2008, VET CLIN N AM-SMALL, V38, P1, DOI 10.1016/j.cvsm.2007.10.005; Matsuo AL, 2010, ANTIMICROB AGENTS CH, V54, P3318, DOI 10.1128/AAC.00323-10; Formagio ASN, 2008, BIOORGAN MED CHEM, V16, P9660, DOI 10.1016/j.bmc.2008.10.008; Formagio ASN, 2009, EUR J MED CHEM, V44, P4695, DOI 10.1016/j.ejmech.2009.07.005; Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281; Godinho JLP, 2013, EXP PARASITOL, V135, P153, DOI 10.1016/j.exppara.2013.06.015; Skulachev VP, 1996, FEBS LETT, V397, P7, DOI 10.1016/0014-5793(96)00989-1; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Valdez RH, 2012, ANTIMICROB AGENTS CH, V56, P507, DOI 10.1128/AAC.05575-11; Valdez RH, 2009, ACTA TROP, V110, P7, DOI 10.1016/j.actatropica.2008.11.008; Volpato H, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/874367; World Health Organization, 2015, CHAG DIS AM TRYP; Yahya M., 2013, Research Journal of Parasitology, V8, P14	29	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130652	10.1371/journal.pone.0130652	http://dx.doi.org/10.1371/journal.pone.0130652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26086449	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567500127
J	Wu, PS; Yen, JH; Kou, MC; Wu, MJ				Wu, Pei-Shan; Yen, Jui-Hung; Kou, Mei-Chun; Wu, Ming-Jiuan			Luteolin and Apigenin Attenuate 4-Hydroxy-2-Nonenal-Mediated Cell Death through Modulation of UPR, Nrf2-ARE and MAPK Pathways in PC12 Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HEME OXYGENASE-1 EXPRESSION; LIPID-PEROXIDATION PRODUCT; GLUTAMATE CYSTEINE LIGASE; FACTOR-KAPPA-B; OXIDATIVE STRESS; PROTEIN-KINASE; ER STRESS; CYSTINE/GLUTAMATE ANTIPORTER; ACTIVATE AUTOPHAGY	Luteolin and apigenin are dietary flavones and exhibit a broad spectrum of biological activities including antioxidant, anti-inflammatory, anti-cancer and neuroprotective effects. The lipid peroxidation product 4-hydroxy-2-nonenal (4-HNE) has been implicated as a causative agent in the development of neurodegenerative disorders. This study investigates the cytoprotective effects of luteolin and apigenin against 4-HNE-mediated cytotoxicity in neuronal-like catecholaminergic PC12 cells. Both flavones restored cell viability and repressed caspase-3 and PARP-1 activation in 4-HNE-treated cells. Luteolin also mitigated 4-HNE-mediated LC3 conversion and reactive oxygen species (ROS) production. Luteolin and apigenin up-regulated 4-HNE-mediated unfolded protein response (UPR), leading to an increase in endoplasmic reticulum chaperone GRP78 and decrease in the expression of UPR-targeted pro-apoptotic genes. They also induced the expression of Nrf2-targeted HO-1 and xCT in the absence of 4-HNE, but counteracted their expression in the presence of 4-HNE. Moreover, we found that JNK and p38 MAPK inhibitors significantly antagonized the increase in cell viability induced by luteolin and apigenin. Consistently, enhanced phosphorylation of JNK and p38 MAPK was observed in luteolin-and apigenin-treated cells. In conclusion, this result shows that luteolin and apigenin activate MAPK and Nrf2 signaling, which elicit adaptive cellular stress response pathways, restore 4-HNE-induced ER homeostasis and inhibit cytotoxicity. Luteolin exerts a stronger cytoprotective effect than apigenin possibly due to its higher MAPK, Nrf2 and UPR activation, and ROS scavenging activity.	[Wu, Pei-Shan; Kou, Mei-Chun; Wu, Ming-Jiuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan 717, Taiwan; [Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien 970, Taiwan	Chia Nan University of Pharmacy & Science; Tzu Chi University	Wu, MJ (corresponding author), Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan 717, Taiwan.	imwu@mail.cnu.edu.tw			Ministry of Science and Technology, Taiwan [NSC 102-2320-B-041-003-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Authors were supported by grant NSC 102-2320-B-041-003-MY3 from Ministry of Science and Technology, Taiwan (http://www.most.gov.tw/mp.aspx?mp=7). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2000, J BIOL CHEM, V275, P27694; Andreadi CK, 2006, MOL PHARMACOL, V69, P1033, DOI 10.1124/mol.105.018374; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Butterfield DA, 2010, BBA-MOL CELL BIOL L, V1801, P924, DOI 10.1016/j.bbalip.2010.02.005; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen ZH, 2006, IUBMB LIFE, V58, P372, DOI 10.1080/15216540600686896; Cheng HY, 2010, PHYTOTHER RES, V24, pS102, DOI 10.1002/ptr.2940; Chian S, 2014, BIOCHEM BIOPH RES CO, V447, P602, DOI 10.1016/j.bbrc.2014.04.039; Csala M, 2015, BBA-MOL BASIS DIS, V1852, P826, DOI 10.1016/j.bbadis.2015.01.015; D'Amours D, 2001, J CELL SCI, V114, P3771; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; GORDON PB, 1995, J BIOL CHEM, V270, P5830, DOI 10.1074/jbc.270.11.5830; Gresa-Arribas N, 2010, J NEUROCHEM, V115, P526, DOI 10.1111/j.1471-4159.2010.06952.x; Guo DJ, 2013, PHARM BIOL, V51, P190, DOI 10.3109/13880209.2012.716852; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Haberzettl P, 2013, REDOX BIOL, V1, P56, DOI 10.1016/j.redox.2012.10.003; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hill BG, 2008, BIOCHEM J, V410, P525, DOI 10.1042/BJ20071063; Hu LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097880; Huang CS, 2013, ARCH TOXICOL, V87, P167, DOI 10.1007/s00204-012-0913-4; Ishisaka M, 2011, BIOL PHARM BULL, V34, P1481, DOI 10.1248/bpb.34.1481; Jang YJ, 2011, J PHARMACOL EXP THER, V337, P747, DOI 10.1124/jpet.110.176925; Ju W, 2007, MOL PHARMACOL, V71, P1381, DOI 10.1124/mol.106.032185; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanadaswami C, 2005, IN VIVO, V19, P895; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x; Lin LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043304; Lin MH, 2014, TOXICOLOGY, V315, P24, DOI 10.1016/j.tox.2013.11.007; Lin YP, 2012, PHYTOCHEMISTRY, V84, P102, DOI 10.1016/j.phytochem.2012.07.020; Liu R, 2011, J ALZHEIMERS DIS, V24, P85, DOI 10.3233/JAD-2010-101593; Liu W, 2000, J CELL SCI, V113, P635; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; Pavlica S, 2010, LIFE SCI, V86, P79, DOI 10.1016/j.lfs.2009.10.017; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pedrosa R, 2002, BRIT J PHARMACOL, V137, P1305, DOI 10.1038/sj.bjp.0704982; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Raza H, 2008, TOXICOL APPL PHARM, V226, P161, DOI 10.1016/j.taap.2007.09.002; Rendeiro C, 2012, P NUTR SOC, V71, P246, DOI 10.1017/S0029665112000146; Rezai-Zadeh K, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-41; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Schipper HM, 2000, EXP GERONTOL, V35, P821, DOI 10.1016/S0531-5565(00)00148-0; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shenvi SV, 2009, PHARMACOL RES, V60, P229, DOI 10.1016/j.phrs.2009.06.003; Su JD, 2012, FREE RADICAL BIO MED, V52, P126, DOI 10.1016/j.freeradbiomed.2011.10.002; Tang XW, 2011, FREE RADICAL BIO MED, V50, P1599, DOI 10.1016/j.freeradbiomed.2011.03.008; Ullery JC, 2012, BBA-BIOMEMBRANES, V1818, P2424, DOI 10.1016/j.bbamem.2012.04.014; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Vauzour D, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/914273; Vladykovskaya E, 2012, J BIOL CHEM, V287, P11398, DOI 10.1074/jbc.M111.320416; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; West JD, 2005, CHEM RES TOXICOL, V18, P1642, DOI 10.1021/tx050211n; Wu RP, 2010, P NATL ACAD SCI USA, V107, P7479, DOI 10.1073/pnas.1002890107; Xu HG, 2014, ONCOGENE; Xu J, 2014, FREE RADIC BIOL MED; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Xu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029169; Yang F, 2009, NEUROSCI LETT, V454, P203, DOI 10.1016/j.neulet.2009.03.027; Zarkovic Kamelija, 2003, Molecular Aspects of Medicine, V24, P293, DOI 10.1016/S0098-2997(03)00024-4; Zhang TS, 2014, ARCH BIOCHEM BIOPHYS, V557, P36, DOI 10.1016/j.abb.2014.05.023; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070663; Zhao L, 2011, MOLECULES, V16, P4005, DOI 10.3390/molecules16054005; Zhu Q, 2011, MOL NUTR FOOD RES, V55, P1375, DOI 10.1002/mnfr.201100149; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	83	42	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2015	10	6							e0130599	10.1371/journal.pone.0130599	http://dx.doi.org/10.1371/journal.pone.0130599			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NT	26087007	gold, Green Published, Green Submitted			2022-12-26	WOS:000356567500120
J	Ciampaglia, GL; Shiralkar, P; Rocha, LM; Bollen, J; Menczer, F; Flammini, A				Ciampaglia, Giovanni Luca; Shiralkar, Prashant; Rocha, Luis M.; Bollen, Johan; Menczer, Filippo; Flammini, Alessandro			Computational Fact Checking from Knowledge Networks	PLOS ONE			English	Article							MISINFORMATION	Traditional fact checking by expert journalists cannot keep up with the enormous volume of information that is now generated online. Computational fact checking may significantly enhance our ability to evaluate the veracity of dubious information. Here we show that the complexities of human fact checking can be approximated quite well by finding the shortest path between concept nodes under properly defined semantic proximity metrics on knowledge graphs. Framed as a network problem this approach is feasible with efficient computational techniques. We evaluate this approach by examining tens of thousands of claims related to history, entertainment, geography, and biographical information using a public knowledge graph extracted from Wikipedia. Statements independently known to be true consistently receive higher support via our method than do false ones. These findings represent a significant step toward scalable computational fact-checking methods that may one day mitigate the spread of harmful misinformation.	[Ciampaglia, Giovanni Luca; Shiralkar, Prashant; Rocha, Luis M.; Bollen, Johan; Menczer, Filippo; Flammini, Alessandro] Indiana Univ, Ctr Complex Networks & Syst Res, Bloomington, IN 47405 USA; [Rocha, Luis M.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Indiana University System; Indiana University Bloomington; Instituto Gulbenkian de Ciencia	Ciampaglia, GL (corresponding author), Indiana Univ, Ctr Complex Networks & Syst Res, Bloomington, IN 47405 USA.	gciampag@indiana.edu	Shiralkar, Prashant/U-3056-2019		Swiss National Science Foundation [142353]; Lilly Endowment; James S. McDonnell Foundation; National Science Foundation [CCF-1101743]; Department of Defense [W911NF-12-1-0037]; Division of Computing and Communication Foundations [1101743] Funding Source: National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lilly Endowment; James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported in part by the Swiss National Science Foundation (fellowship 142353, http://snf.ch), the Lilly Endowment (http://www.lillyendowment.org/), the James S. McDonnell Foundation (https://www.jsmf.org/), the National Science Foundation (grant CCF-1101743, http://www.nsf.gov/), and Department of Defense (grant W911NF-12-1-0037, http://www.darpa.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Aiello LM, 2012, ACM T WEB, V6, DOI 10.1145/2180861.2180866; Auer S, 2007, LECT NOTES COMPUT SC, V4825, P722, DOI 10.1007/978-3-540-76298-0_52; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; Bishop Christopher M., 2006, PATTERN RECOGNITION; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Capitan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043694; Castillo C., 2011, P 20 INT C WORLD WID, P675, DOI [DOI 10.1145/1963405.1963500, 10.1145/1963405.1963500]; Cohen S, 2011, COMMUN ACM, V54, P66, DOI 10.1145/2001269.2001288; Conover M. D., 2011, 5 INT AAAI C WEBL SO, DOI DOI 10.1021/JA202932E; Cranor LF, 1998, COMMUN ACM, V41, P74, DOI 10.1145/280324.280336; DeDeo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075818; Dong XL, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P601, DOI 10.1145/2623330.2623623; Etzioni O, 2008, COMMUN ACM, V51, P68, DOI 10.1145/1409360.1409378; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finn S, 2014, P COMP JOURN C; Flanagin AJ, 2000, JOURNALISM MASS COMM, V77, P515, DOI 10.1177/107769900007700304; Friggeri Adrien, 2014, 8 INT AAAI C WEBL SO; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Gupta A, 2014, P 6 INT C SOC INF SC; Jagatic TN, 2007, COMMUN ACM, V50, P94, DOI 10.1145/1290958.1290968; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Lao N., 2011, P 2011 C EMP METH NA, DOI DOI 10.5555/2145432.2145494; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Luper S, 2012, STANFORD ENCY PHILOS; Markines B, 2009, 20TH ACM CONFERENCE ON HYPERTEXT AND HYPERMEDIA (HYPERTEXT 2009), P347; Mendoza M., 2010, P 1 WORKSH SOC MED A, V10, P71, DOI DOI 10.1145/1964858.1964869; Nickel M., 2015, ARXIV150300759; Niu F, 2012, INT J SEMANT WEB INF, V8, P42, DOI 10.4018/jswis.2012070103; Nyhan B, 2013, MED CARE, V51, P127, DOI 10.1097/MLR.0b013e318279486b; Orr D, 2013, 50 000 LESSONS ON HO; Masucci AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017333; Poole KeithT.., 2007, IDEOLOGY C POLITICAL; Priedhorsky R, 2007, GROUP'07: PROCEEDINGS OF THE 2007 INTERNATIONAL ACM CONFERENCE ON SUPPORTING GROUP WORK, P259; Ratkiewicz J., 2011, PROC 20 INT C COMPAN, P297, DOI [10.1.1.646.5073, 10.1145/1963192.1963301, DOI 10.1145/1963192.1963301]; Resnick P., 2014, P COMP JOURN C, V5; Rieh SY, 2007, ANNU REV INFORM SCI, V41, P307, DOI 10.1002/aris.2007.1440410114; Simas T, 2014, NETWORK SCI IN PRESS; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Wilner T., 2014, COLUMBIA JOURNALISM; Wu Y, 2014, P VLDB ENDOWMENT, V7	43	119	125	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128193	10.1371/journal.pone.0128193	http://dx.doi.org/10.1371/journal.pone.0128193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083336	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400033
J	Fokam, J; Elat, JBN; Billong, SC; Kembou, E; Nkwescheu, AS; Obam, NM; Essiane, A; Torimiro, JN; Ekanmian, GK; Ndjolo, A; Shiro, KS; Bissek, ACZK				Fokam, Joseph; Elat, Jean-Bosco N.; Billong, Serge C.; Kembou, Etienne; Nkwescheu, Armand S.; Obam, Nicolas M.; Essiane, Andre; Torimiro, Judith N.; Ekanmian, Gatien K.; Ndjolo, Alexis; Shiro, Koulla S.; Bissek, Anne C. Z-K.			Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL TREATMENT; VIRAL LOAD; THERAPY; ADHERENCE; NAIVE	Background The majority (>95%) of new HIV infection occurs in resource-limited settings, and Cameroon is still experiencing a generalized epidemic with similar to 122,638 patients receiving antiretroviral therapy (ART). A detrimental outcome in scaling-up ART is the emergence HIV drug resistance (HIVDR), suggesting the need for pragmatic approaches in sustaining a successful ART performance. Methods A survey was conducted in 15 ART sites of the Centre and Littoral regions of Cameroon in 2013 (10 urban versus 05 rural settings; 8 at tertiary/secondary versus 7 at primary healthcare levels), evaluating HIVDR-early warning indicators (EWIs) as-per the 2012 revised World Health Organization's guidelines: EWI1 (on-time pill pick-up), EWI2 (retention in care), EWI3 (no pharmacy stock-outs), EWI4 (dispensing practices), EWI5 (virological suppression). Poor performance was interpreted as potential HIVDR. Results Only 33.3% (4/12) of sites reached the desirable performance for "on-time pill pick-up" (57.1% urban versus 0% rural; p<0.0001) besides 25% (3/12) with fair performance. 69.2% (9/13) reached the desirable performance for "retention in care" (77.8% urban versus 50% rural; p=0.01) beside 7.7% (1/13) with fair performance. Only 14.4% (2/13) reached the desirable performance of "no pharmacy stock-outs" (11.1% urban versus 25% rural; p=0.02). All 15 sites reached the desirable performance of 0% "dispensing mono- or dual-therapy". Data were unavailable to evaluate "virological suppression" due to limited access to viral load testing (min-max: <1%-15%). Potential HIVDR was higher in rural (57.9%) compared to urban (27.8%) settings, p=0.02; and at primary (57.9%) compared to secondary/tertiary (33.3%) healthcare levels, p=0.09. Conclusions Delayed pill pick-up and pharmacy stock-outs are major factors favoring HIVDR emergence, with higher risks in rural settings and at primary healthcare. Retention in care appears acceptable in general while ART dispensing practices are standard. There is need to support patient-adherence to pharmacy appointments while reinforcing the national drug supply system.	[Fokam, Joseph; Torimiro, Judith N.; Ndjolo, Alexis] Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon; [Fokam, Joseph; Billong, Serge C.; Nkwescheu, Armand S.; Essiane, Andre; Torimiro, Judith N.; Ndjolo, Alexis; Shiro, Koulla S.; Bissek, Anne C. Z-K.] Univ Yaounde I, FMBS, Yaounde, Cameroon; [Fokam, Joseph] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Fokam, Joseph; Elat, Jean-Bosco N.; Billong, Serge C.; Kembou, Etienne; Nkwescheu, Armand S.; Obam, Nicolas M.; Essiane, Andre; Torimiro, Judith N.; Bissek, Anne C. Z-K.] Minist Publ Hlth, Natl HIV Drug Resistance Surveillance & Prevent W, Yaounde, Cameroon; [Elat, Jean-Bosco N.; Billong, Serge C.] Minist Publ Hlth, Natl AIDS Control Comm, Yaounde, Cameroon; [Kembou, Etienne] WHO, Afro, Country Off, Yaounde, Cameroon; [Bissek, Anne C. Z-K.] Minist Publ Hlth, Div Operat Hlth Res, Yaounde, Cameroon; [Ekanmian, Gatien K.] United Nations Program HIV AIDS UNAIDS, Yaounde, Cameroon; [Shiro, Koulla S.] Minist Publ Hlth, Gen Secretariat, Yaounde, Cameroon; [Shiro, Koulla S.] Agence Natl Rech SIDA & Hepatites Virales ANRS, Yaounde, Cameroon	University of Yaounde I; University of Rome Tor Vergata; World Health Organization	Fokam, J (corresponding author), Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon.	josephfokam@gmail.com			World Health Organization (WHO)	World Health Organization (WHO)(World Health Organization)	The World Health Organization (WHO) supported this work, through technical and financial assistance allocated to the Division of Operational Health Research of the Ministry of Public Health in Cameroon.	Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Billong SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072680; Billong SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036777; Boyer S, 2013, LANCET INFECT DIS, V13, P577, DOI 10.1016/S1473-3099(13)70073-2; Bureau Central des Recensement et des Etudes des Populations Republique du Cameroun, 2010, 3 REC GEN POP HAB; Comite Nationale de Lutte contre le SIDA, 2014, RAPP EV FIL ACT PVVI; Fokam J, 2011, ARCH VIROL, V156, P1235, DOI 10.1007/s00705-011-0982-3; Fokam J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-308; Fokam J, 2011, PEDIATR INFECT DIS J, V30, P1062, DOI 10.1097/INF.0b013e31822db54c; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Jonas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100539; Kouanfack C, 2009, CLIN INFECT DIS, V48, P1318, DOI 10.1086/597779; Marcellin F, 2008, TROP MED INT HEALTH, V13, P1470, DOI 10.1111/j.1365-3156.2008.02170.x; Ministere de la Sante Publique Cameroun, 2010, DIR NAT PRIS CHARG A; Murtagh M.M., 2013, CURRENT TECHNOLOGIES; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Republique du Cameroun Institut National de la Statistique, 2011, RAPP 2011 ENQ DEM SA; Santoro MM, 2013, ANTIVIR THER, V18, P867, DOI 10.3851/IMP2531; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Sigaloff KCE, 2012, CLIN INFECT DIS, V54, pS294, DOI 10.1093/cid/cir1015; UNAIDS, 2014, GLOB REP UNAIDS REP; UNAIDS, 2011, POL DECL HIV AIDS IN; WHO, 2010, ANT THER HIV INF AD; *WHO UNAIDS, 2003, WHO UNAIDS GLOB IN P; World Health Organization, 2010, HIV DRUG RES EARL WA; World Health Organization, 2014, ANT RES GLOB REP SUR; World Health Organization, 2014, POL BRIEF CONS GUID; World Health Organization, 2011, EARL WARN IND ADV PA; World Health Organization (WHO), 2012, HIV DRUG RES REP	30	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129210	10.1371/journal.pone.0129210	http://dx.doi.org/10.1371/journal.pone.0129210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083364	Green Published, gold, Green Submitted			2022-12-26	WOS:000356567400084
J	Garvas, M; Testen, A; Umek, P; Gloter, A; Koklic, T; Strancar, J				Garvas, Maja; Testen, Anze; Umek, Polona; Gloter, Alexandre; Koklic, Tilen; Strancar, Janez			Protein Corona Prevents TiO2 Phototoxicity	PLOS ONE			English	Article							NANOPARTICLES; NANOTUBES; KERATINOCYTES; APOPTOSIS	Background & Aim TiO2 nanoparticles have generally low toxicity in the in vitro systems although some toxicity is expected to originate in the TiO2-associated photo-generated radical production, which can however be modulated by the radical trapping ability of the serum proteins. To explore the role of serum proteins in the phototoxicity of the TiO2 nanoparticles we measure viability of the exposed cells depending on the nanoparticle and serum protein concentrations. Methods & Results Fluorescence and spin trapping EPR spectroscopy reveal that the ratio between the nanoparticle and protein concentrations determines the amount of the nanoparticles' surface which is not covered by the serum proteins and is proportional to the amount of photoinduced radicals. Phototoxicity thus becomes substantial only at the protein concentration being too low to completely coat the nanotubes' surface. Conclusion These results imply that TiO2 nanoparticles should be applied with ligands such as proteins when phototoxic effects are not desired - for example in cosmetics industry. On the other hand, the nanoparticles should be used in serum free medium or any other ligand free medium, when phototoxic effects are desired - as for efficient photodynamic cancer therapy.	[Garvas, Maja; Umek, Polona; Koklic, Tilen; Strancar, Janez] Jozef Stefan Inst, Ljubljana, Slovenia; [Garvas, Maja] Jozef Stefan Int Postgrad Sch, Ljubljana, Slovenia; [Testen, Anze; Umek, Polona; Koklic, Tilen; Strancar, Janez] NAMASTE Ctr Excellence, Ljubljana, Slovenia; [Gloter, Alexandre] Univ Paris 11, Phys Solides Lab, CNRS, UMR 8502, F-91405 Orsay, France	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Koklic, T (corresponding author), Jozef Stefan Inst, Ljubljana, Slovenia.	tilen.koklic@ijs.si; Janez.strancar@ijs.si	GLOTER, Alexandre/F-7130-2017; Gloter, Alexandre/ABE-2539-2020	Gloter, Alexandre/0000-0002-4813-3799	Eksperimentalna biofizika kompleksnih sistemov [JS P1-0060]; JS Napredni Biomateriali	Eksperimentalna biofizika kompleksnih sistemov; JS Napredni Biomateriali	This study was supported by JS P1-0060 Eksperimentalna biofizika kompleksnih sistemov (https://www.arrs.gov.si/en/novo.asp), JS Napredni Biomateriali (http://www.conamaste.si/slo/BioMateriali.php).	Adams GE, 1977, FREE RADICALS BIOL P; Allouni ZE, 2009, COLLOID SURFACE B, V68, P83, DOI 10.1016/j.colsurfb.2008.09.014; Bell IR, 2014, DOSE-RESPONSE, V12, P202, DOI 10.2203/dose-response.13-025.Bell; CAI RX, 1992, CANCER RES, V52, P2346; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Chen XB, 2006, J NANOSCI NANOTECHNO, V6, P906, DOI 10.1166/jnn.2006.160; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Deng LX, 2009, CATAL LETT, V129, P513, DOI 10.1007/s10562-008-9834-5; FINKELSTEIN E, 1980, ARCH BIOCHEM BIOPHYS, V200, P1, DOI 10.1016/0003-9861(80)90323-9; Fujishima A., 2000, J PHOTOCHEM PHOTOB C, V1, P1, DOI [10.1016/s1389-5567(00)00002-2, DOI 10.1016/S1389-5567(00)00002-2]; Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108; Jurkovic P, 2003, EUR J PHARM BIOPHARM, V56, P59, DOI 10.1016/S0939-6411(03)00062-6; Kocbek P, 2010, SMALL, V6, P1908, DOI 10.1002/smll.201000032; Lagopati N, 2014, INT J NANOMED, V9, P3219, DOI 10.2147/IJN.S62972; Magrez A, 2009, ACS NANO, V3, P2274, DOI 10.1021/nn9002067; Marucco A, 2013, J PHYS CONF SER, V429, DOI 10.1088/1742-6596/429/1/012014; Meena R, 2015, APPL BIOCHEM BIOTECH, V175, P825, DOI 10.1007/s12010-014-1299-y; Meena R, 2012, APPL BIOCHEM BIOTECH, V167, P791, DOI 10.1007/s12010-012-9699-3; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26; SORIANI M, 1994, ARCH BIOCHEM BIOPHYS, V312, P180, DOI 10.1006/abbi.1994.1297; Sund J, 2011, ACS NANO, V5, P4300, DOI 10.1021/nn101492k; Tenuta T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025556; Umek P, 2005, CHEM MATER, V17, P5945, DOI 10.1021/cm050928w; Umek P, 2007, J NANOSCI NANOTECHNO, V7, P3502, DOI 10.1166/jnn.2007.838; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; Xiong SJ, 2013, ARCH TOXICOL, V87, P99, DOI 10.1007/s00204-012-0912-5; Yin JJ, 2012, TOXICOL APPL PHARM, V263, P81, DOI 10.1016/j.taap.2012.06.001	28	27	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0129577	10.1371/journal.pone.0129577	http://dx.doi.org/10.1371/journal.pone.0129577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083725	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400100
J	Marsolier-Kergoat, MC; Palacio, P; Berthonaud, V; Maksud, F; Stafford, T; Begouen, R; Elalouf, JM				Marsolier-Kergoat, Marie-Claude; Palacio, Pauline; Berthonaud, Veronique; Maksud, Frederic; Stafford, Thomas; Begouen, Robert; Elalouf, Jean-Marc			Hunting the Extinct Steppe Bison (Bison priscus) Mitochondrial Genome in the Trois-Freres Paleolithic Painted Cave	PLOS ONE			English	Article							SEQUENCE; ALIGNMENT; WISENT; DAMAGE	Despite the abundance of fossil remains for the extinct steppe bison (Bison priscus), an animal that was painted and engraved in numerous European Paleolithic caves, a complete mitochondrial genome sequence has never been obtained for this species. In the present study we collected bone samples from a sector of the Trois-Freres Paleolithic cave (Ariege, France) that formerly functioned as a pitfall and was sealed before the end of the Pleistocene. Screening the DNA content of the samples collected from the ground surface revealed their contamination by Bos DNA. However, a 19,000-year-old rib collected on a rock apart the pathway delineated for modern visitors was devoid of such contaminants and reproducibly yielded Bison priscus DNA. High-throughput shotgun sequencing combined with conventional PCR analysis of the rib DNA extract enabled to reconstruct a complete mitochondrial genome sequence of 16,318 bp for the extinct steppe bison with a 10.4-fold coverage. Phylogenetic analyses robustly established the position of the Bison priscus mitochondrial genome as basal to the clade delineated by the genomes of the modern American Bison bison. The extinct steppe bison sequence, which exhibits 93 specific polymorphisms as compared to the published Bison bison mitochondrial genomes, provides an additional resource for the study of Bovinae specimens. Moreover this study of ancient DNA delineates a new research pathway for the analysis of the Magdalenian Trois-Freres cave.	[Marsolier-Kergoat, Marie-Claude; Palacio, Pauline; Berthonaud, Veronique; Elalouf, Jean-Marc] CEA Saclay, iBiTec S SBiGeM, F-91191 Gif Sur Yvette, France; [Marsolier-Kergoat, Marie-Claude; Palacio, Pauline; Elalouf, Jean-Marc] Musee Homme Paris, Dept Hommes Nat & Soc, Ecoanthropol & Ethnobiol, CNRS UMR7206, F-75016 Paris, France; [Maksud, Frederic] Serv Reg Archeol, F-31080 Toulouse 6, France; [Stafford, Thomas] Univ Aarhus, Dept Phys & Astron, AMS Dating Ctr 14C, DK-8000 Aarhus C, Denmark; [Begouen, Robert] Assoc Louis Begouen, Lab Prehist Pujol, F-09200 Montesquieu Avantes, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Aarhus University	Elalouf, JM (corresponding author), CEA Saclay, iBiTec S SBiGeM, F-91191 Gif Sur Yvette, France.	jean-marc.elalouf@cea.fr	Elalouf, Jean-Marc/C-4351-2014	Elalouf, Jean-Marc/0000-0003-0151-6423	CEA Saclay [LOC1043ELALO]	CEA Saclay(French Atomic Energy Commission)	This work was supported by CEA Saclay, LOC1043ELALO, to Dr. Jean-Marc Elalouf. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Begouen H, 1936, BERICHTE INT GESELLS, V3, P295; Begouen H, 1912, CR HEBD ACAD SCI, P532; Begouen H, 1958, CAVERNES VOLP TROIS; Begouen R., 2014, CAVERNE TROIS FRERES; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bon C, 2012, P ROY SOC B-BIOL SCI, V279, P2825, DOI 10.1098/rspb.2012.0358; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chung H, 2013, OPEN J GENETICS, V3, P12, DOI [10.4236/ojgen.2013.31003, DOI 10.4236/OJGEN.2013.31003]; Der Sarkissian C, 2014, MOL ECOL, V23, P1780, DOI 10.1111/mec.12690; Douglas KC, 2011, MITOCHONDRION, V11, P166, DOI 10.1016/j.mito.2010.09.005; Edwards CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009255; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; KurtUn B., 1968, PLEISTOCENE MAMMALS; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Llamas B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030226; Paule M.R., 1998, TRANSCRIPTION RIBOSO, P1; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verkaar ELC, 2004, MOL BIOL EVOL, V21, P1165, DOI 10.1093/molbev/msh064; VOGEL JS, 1984, NUCL INSTRUM METH B, V5, P289, DOI 10.1016/0168-583X(84)90529-9; Zeyland J, 2012, J APPL GENET, V53, P317, DOI 10.1007/s13353-012-0090-4	27	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128267	10.1371/journal.pone.0128267	http://dx.doi.org/10.1371/journal.pone.0128267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083419	Green Published, Green Submitted, gold			2022-12-26	WOS:000356567400036
J	Ruane, S; Torres-Carvajal, O; Burbrink, FT				Ruane, Sara; Torres-Carvajal, Omar; Burbrink, Frank T.			Independent Demographic Responses to Climate Change among Temperate and Tropical Milksnakes (Colubridae: Genus Lampropeltis)	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; LATE-PLEISTOCENE; NORTH-AMERICA; HISTORICAL DEMOGRAPHY; GENETIC CONSEQUENCES; POPULATION-GENETICS; POLLEN RECORD; SOUTH-AMERICA; ICE AGES; PHYLOGEOGRAPHY	The effects of Late Quaternary climate change have been examined for many temperate New World taxa, but the impact of Pleistocene glacial cycles on Neotropical taxa is less well understood, specifically with respect to changes in population demography. Here, we examine historical demographic trends for six species of milksnake with representatives in both the temperate and tropical Americas to determine if species share responses to climate change as a taxon or by area (i.e., temperate versus tropical environments). Using a multilocus dataset, we test for the demographic signature of population expansion and decline using non-genealogical summary statistics, as well as coalescent-based methods. In addition, we determine whether range sizes are correlated with effective population sizes for milksnakes. Results indicate that there are no identifiable trends with respect to demographic response based on location, and that species responded to changing climates independently, with tropical taxa showing greater instability. There is also no correlation between range size and effective population size, with the largest population size belonging to the species with the smallest geographic distribution. Our study highlights the importance of not generalizing the demographic histories of taxa by region and further illustrates that the New World tropics may not have been a stable refuge during the Pleistocene.	[Ruane, Sara; Burbrink, Frank T.] CUNY Coll Staten Isl, Dept Biol, Staten Isl, NY 10314 USA; [Ruane, Sara; Burbrink, Frank T.] CUNY, Grad Ctr, New York, NY 10016 USA; [Torres-Carvajal, Omar] Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Ecuador	City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; Pontificia Universidad Catolica del Ecuador	Ruane, S (corresponding author), Amer Museum Nat Hist, Dept Herpetol, Cent Pk West 79th St, New York, NY 10024 USA.	sruane@amnh.org	Torres-Carvajal, Omar/I-1977-2019	Torres-Carvajal, Omar/0000-0003-0041-9250	American Museum of Natural History (Theodore Roosevelt Memorial Fund); Graduate Women in Science (Vanessa Notchev Fund); Explorer's Club; CUNY-PSC; National Science Foundation Grant [CNS-0958379, CNS-0855217, DEB-0613802]; Secretaria de Educacion Superior, Ciencia y Tecnologia (SENESCYT); City University of New York High Performance Computing Center; Direct For Biological Sciences [1632956] Funding Source: National Science Foundation	American Museum of Natural History (Theodore Roosevelt Memorial Fund); Graduate Women in Science (Vanessa Notchev Fund); Explorer's Club; CUNY-PSC; National Science Foundation Grant(National Science Foundation (NSF)); Secretaria de Educacion Superior, Ciencia y Tecnologia (SENESCYT); City University of New York High Performance Computing Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in part, by the American Museum of Natural History (Theodore Roosevelt Memorial Fund); Graduate Women in Science (Vanessa Notchev Fund); The Explorer's Club; and CUNY-PSC. This research was also supported, in part, under National Science Foundation Grants (CNS-0958379, CNS-0855217); Secretaria de Educacion Superior, Ciencia y Tecnologia (SENESCYT); The City University of New York High Performance Computing Center; and for tissue samples loaned from the University of Texas at Arlington, support was granted by National Science Foundation Grant (DEB-0613802) to J.A. Campbell.	ANDREWS JT, 1978, ANNU REV EARTH PL SC, V6, P205, DOI 10.1146/annurev.ea.06.050178.001225; [Anonymous], 2014, TRACER V1 6; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Becerra JX, 2005, P NATL ACAD SCI USA, V102, P10919, DOI 10.1073/pnas.0409127102; BEECHER WJ, 1955, ECOLOGY, V36, P23, DOI 10.2307/1931426; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; BRADBURY JP, 1989, QUATERNARY SCI REV, V8, P75, DOI 10.1016/0277-3791(89)90022-X; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; BROECKER WS, 1986, QUATERNARY RES, V26, P121, DOI 10.1016/0033-5894(86)90087-6; Burbrink FT, 2008, MOL PHYLOGENET EVOL, V47, P274, DOI 10.1016/j.ympev.2007.10.020; Bush MB, 2009, DEV PALEOENVIRON RES, V14, P113, DOI 10.1007/978-90-481-2672-9_5; BUSH MB, 1990, J VEG SCI, V1, P105, DOI 10.2307/3236060; Bush MB, 2002, PALAEOGEOGR PALAEOCL, V177, P5, DOI 10.1016/S0031-0182(01)00348-0; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Campbell JA, 1999, AMPHIBIANS REPTILES, P400; Cheviron ZA, 2005, MOL PHYLOGENET EVOL, V36, P338, DOI 10.1016/j.ympev.2005.01.015; CLAPPERTON CM, 1993, PALAEOGEOGR PALAEOCL, V101, P189, DOI 10.1016/0031-0182(93)90012-8; CLIMAP C, 1981, GEOL SOC AM MAP C MC, V36, P1; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Daza JM, 2009, MOL PHYLOGENET EVOL, V53, P653, DOI 10.1016/j.ympev.2009.07.022; Deevey ES, 1944, AM ANTIQUITY, V10, P135, DOI 10.2307/275110; DELCOURT PA, 1983, QUATERNARY RES, V19, P265, DOI 10.1016/0033-5894(83)90010-8; Devitt TJ, 2006, MOL ECOL, V15, P4387, DOI 10.1111/j.1365-294X.2006.03015.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duplessy JC, 2007, SCIENCE, V316, P89, DOI 10.1126/science.1138582; Dyke A.S., 1987, GEOGR PHYS QUATERNAI, V2, P237, DOI [10.7202/032681ar, DOI 10.7202/032681AR]; Edwards SV, 2000, EVOLUTION, V54, P1839; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; Ernst C.H., 2003, SNAKES US CANADA; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; FU YX, 1993, GENETICS, V133, P693; Galtier N, 2000, GENETICS, V155, P981; Gaston KJ, 1998, TRENDS ECOL EVOL, V13, P70, DOI 10.1016/S0169-5347(97)01236-6; Gaston KJ, 1996, OIKOS, V76, P211, DOI 10.2307/3546192; Guiher TJ, 2008, MOL PHYLOGENET EVOL, V48, P543, DOI 10.1016/j.ympev.2008.04.008; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Harding RM, 1998, NEW USES NEW PHYLOGE, P15; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; HORN S P, 1990, Climate Research, V1, P81, DOI 10.3354/cr001081; Hudson R.R., 1990, OXF SURV EVOL BIOL, V7, P44; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Johnson NK, 2004, EVOLUTION, V58, P1122; King MG, 2009, MOL ECOL, V18, P4256, DOI 10.1111/j.1365-294X.2009.04280.x; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Koscinski D, 2008, MOL ECOL, V17, P2012, DOI 10.1111/j.1365-294X.2008.03733.x; Kronauer DJC, 2005, MOL PHYLOGENET EVOL, V34, P431, DOI 10.1016/j.ympev.2004.10.009; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Kuhner MK, 1998, GENETICS, V149, P429; Lachniet MS, 2002, GEOL SOC AM BULL, V114, P547, DOI 10.1130/0016-7606(2002)114<0547:LQGOCR>2.0.CO;2; Lavergne S, ANN REV ECOL EVOL SY, V41, P321; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; LEYDEN BW, 1984, P NATL ACAD SCI-BIOL, V81, P4856, DOI 10.1073/pnas.81.15.4856; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Light JE, 2013, J MAMM EVOL, V20, P129, DOI 10.1007/s10914-012-9193-2; LYLE MW, 1992, NATURE, V355, P812, DOI 10.1038/355812a0; Mapelli FJ, 2012, J ZOOL, V286, P48, DOI 10.1111/j.1469-7998.2011.00849.x; MARTIN PS, 1957, ECOLOGY, V38, P468, DOI 10.2307/1929892; MARUYAMA T, 1984, GENETICS, V108, P745; Mengel R. M., 1964, Living Bird, V1964, P9; Metcalfe SE, 2000, QUATERNARY SCI REV, V19, P699, DOI 10.1016/S0277-3791(99)00022-0; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Myers EA, 2013, J HERPETOL, V47, P432, DOI 10.1670/12-104; Neigel Joseph E., 1996, P329; Nogues-Bravo D, 2010, EVOLUTION, V64, P2442, DOI 10.1111/j.1558-5646.2010.01009.x; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Pielou E.C., 1979, BIOGEOGRAPHY; Pielou EC, 1991, ICE AGE RETURN LIFE; Piperno DR, 2003, QUATERNARY RES, V59, P79, DOI 10.1016/S0033-5894(02)00021-2; Pulgarin-R PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040412; Pyron RA, 2009, MOL PHYLOGENET EVOL, V52, P524, DOI 10.1016/j.ympev.2009.02.008; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAND AL, 1948, EVOLUTION, V2, P314, DOI 10.2307/2405522; RIND D, 1985, QUATERNARY RES, V24, P1, DOI 10.1016/0033-5894(85)90080-8; Rogers AR, 1996, MOL BIOL EVOL, V13, P895, DOI 10.1093/molbev/13.7.895; Ruane S, 2014, SYST BIOL, V63, P231, DOI 10.1093/sysbio/syt099; Rull V, 2006, MOL ECOL, V15, P4257, DOI 10.1111/j.1365-294X.2006.03052.x; Russell DA, 2009, BIOL REV, V84, P173, DOI 10.1111/j.1469-185X.2008.00069.x; Schmidt D, 2002, EFFECT POPULATION HI, DOI [10.1002/hed.21649, DOI 10.1002/HED.21649]; SIMPSON BB, 1978, ANNU REV ECOL SYST, V9, P497, DOI 10.1146/annurev.es.09.110178.002433; SLATKIN M, 1991, GENETICS, V129, P555; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; Suarez-Atilano M, 2014, J BIOGEOGR, V41, P2371, DOI 10.1111/jbi.12372; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Thompson LG, 2000, J QUATERNARY SCI, V15, P377, DOI 10.1002/1099-1417(200005)15:4<377::AID-JQS542>3.0.CO;2-L; Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x; van der Hammen T, 2000, QUATERNARY SCI REV, V19, P725, DOI 10.1016/S0277-3791(99)00024-4; VUILLEUMIER SB, 1971, SCIENCE, V173, P771, DOI 10.1126/science.173.3999.771; Wang IJ, 2008, MOL PHYLOGENET EVOL, V47, P992, DOI 10.1016/j.ympev.2008.02.021; Webb RS, 1997, NATURE, V385, P695, DOI 10.1038/385695a0; Werler JE, 2000, TECAS SNAKES IDENTIF; Williams K.L., 1988, SYSTEMATICS NATURAL; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288; Zarza E, 2008, MOL ECOL, V17, P3259, DOI 10.1111/j.1365-294X.2008.03826.x	112	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0128543	10.1371/journal.pone.0128543	http://dx.doi.org/10.1371/journal.pone.0128543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083467	Green Published, gold			2022-12-26	WOS:000356567400056
J	Taylor, JW; Long, M; Ashley, E; Denning, A; Gout, B; Hansen, K; Huws, T; Jennings, L; Quinn, S; Sarkies, P; Wojtowicz, A; Newton, PM				Taylor, Joseph W.; Long, Marie; Ashley, Elizabeth; Denning, Alex; Gout, Beatrice; Hansen, Kayleigh; Huws, Thomas; Jennings, Leifa; Quinn, Sinead; Sarkies, Patrick; Wojtowicz, Alex; Newton, Philip M.			When Medical News Comes from Press Releases-A Case Study of Pancreatic Cancer and Processed Meat	PLOS ONE			English	Article							CONSUMPTION; RISK; METAANALYSIS; NUTRITION; STORIES; RED	The media have a key role in communicating advances in medicine to the general public, yet the accuracy of medical journalism is an under-researched area. This project adapted an established monitoring instrument to analyse all identified news reports (n = 312) on a single medical research paper: a meta-analysis published in the British Journal of Cancer which showed a modest link between processed meat consumption and pancreatic cancer. Our most significant finding was that three sources (the journal press release, a story on the BBC News website and a story appearing on the 'NHS Choices' website) appeared to account for the content of over 85% of the news stories which covered the meta analysis, with many of them being verbatim or moderately edited copies and most not citing their source. The quality of these 3 primary sources varied from excellent (NHS Choices, 10 of 11 criteria addressed) to weak (journal press release, 5 of 11 criteria addressed), and this variance was reflected in the accuracy of stories derived from them. Some of the methods used in the original meta-analysis, and a proposed mechanistic explanation for the findings, were challenged in a subsequent commentary also published in the British Journal of Cancer, but this discourse was poorly reflected in the media coverage of the story.	[Taylor, Joseph W.; Long, Marie; Ashley, Elizabeth; Denning, Alex; Gout, Beatrice; Hansen, Kayleigh; Huws, Thomas; Jennings, Leifa; Quinn, Sinead; Sarkies, Patrick; Wojtowicz, Alex; Newton, Philip M.] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales	Swansea University	Newton, PM (corresponding author), Swansea Univ, Coll Med, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	p.newton@swansea.ac.uk		Newton, Philip/0000-0002-5272-7979				[Anonymous], 2014, BRIT J CANC AIMS SCO; Ashwell DJ, 2016, PUBLIC UNDERST SCI, V25, P379, DOI 10.1177/0963662514556144; Basu AJ, 2008, PUBLIC HEALTH NUTR, V11, P1124, DOI 10.1017/S1368980007001565; Brechman J, 2009, SCI COMMUN, V30, P453, DOI 10.1177/1075547009332649; British Broadcasting Corporation, 2015, BBC ED GUID SECT 4 I; Cameron AM, 2013, AM J TRANSPLANT, V13, P2059, DOI 10.1111/ajt.12312; Clarke JN, 2006, SOC SCI MED, V62, P2591, DOI 10.1016/j.socscimed.2005.11.021; Cooper BEJ, 2012, PUBLIC UNDERST SCI, V21, P664, DOI 10.1177/0963662511401782; de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; Goldacre B., 2014, BMJ-BRIT MED J, V348, pg2868, DOI [10.1136/bmj.g2868, DOI 10.1136/BMJ.G2868]; Hawkes N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5346; Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131; House of Commons Science and Technology Committee, 2014, COMM CLIM SCI; IpsosMORI, 2011, PUBL ATT SCI; Jones SC, 2008, ASIA PAC J CLIN NUTR, V17, P317; Katan MB, 2009, AM J CLIN NUTR, V90, P11, DOI 10.3945/ajcn.2009.28014; Lai WYY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006103; Larsson SC, 2012, BRIT J CANCER, V106, P603, DOI 10.1038/bjc.2011.585; Lightsey D, 2012, BRIT J CANCER, V107, P754, DOI 10.1038/bjc.2012.111; MCCARTNEY M, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G2868; Nason G.J., 2014, BJU INT, DOI 10.1111/bju.12840; Nyhan B., 2015, COLUMBIA JOURNALISM; Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178; Phillipov M, 2012, AUSTRALAS MED J, V5, P593, DOI 10.4066/AMJ.2012.1460; Purcell K., 2010, UNDERSTANDING PARTIC; Rohrmann S, 2013, INT J CANCER, V132, P617, DOI 10.1002/ijc.27637; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwitzer G, 2005, PLOS MED, V2, P576, DOI 10.1371/journal.pmed.0020215; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Smith DE, 2005, MED J AUSTRALIA, V183, P190, DOI 10.5694/j.1326-5377.2005.tb06992.x; Sumner P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7015; Wells J, 2001, ANN INTERN MED, V135, P1029, DOI 10.7326/0003-4819-135-12-200112180-00006; Williams A., 2009, MAPPING FIELD SPECIA; Williamson JML, 2010, ANN ROY COLL SURG, V92, P537, DOI 10.1308/003588410X12771863936044; Wilson A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000323; Wilson A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004831; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; Yadamsuren B., 2010, P AM SOC INFORM SCI, V47, P1, DOI [10.1002/meet.14504701237, DOI 10.1002/MEET.14504701237]; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308	39	17	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2015	10	6							e0127848	10.1371/journal.pone.0127848	http://dx.doi.org/10.1371/journal.pone.0127848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK9NS	26083640	Green Submitted, Green Published, gold			2022-12-26	WOS:000356567400020
J	Ullmann, AJ; Russell, TM; Dolan, MC; Williams, M; Hojgaard, A; Weiner, ZP; Johnson, BJB				Ullmann, Amy J.; Russell, Theresa M.; Dolan, Marc C.; Williams, Martin; Hojgaard, Andrias; Weiner, Zachary P.; Johnson, Barbara J. B.			Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice	PLOS ONE			English	Article							ORIENTIA-TSUTSUGAMUSHI; 47-KILODALTON ANTIGEN; DISEASE; PROTEINS	Borrelia burgdorferi synthesizes an HtrA protease (BbHtrA) which is a surface-exposed, conserved protein within Lyme disease spirochetes with activity toward CheX and BmpD of Borrelia spp, as well as aggrecan, fibronectin and proteoglycans found in skin, joints and neural tissues of vertebrates. An antibody response against BbHtrA is observed in Lyme disease patients and in experimentally infected laboratory mice and rabbits. Given the surface location of BbHtrA on B. burgdorferi and its ability to elicit an antibody response in infected hosts, we explored recombinant BbHtrA as a potential vaccine candidate in a mouse model of tick-transmitted Lyme disease. We immunized mice with two forms of BbHtrA: the proteolytically active native form and BbHtrA ablated of activity by a serine to alanine mutation at amino acid 226 (BbHtrA(S226A)). Although inoculation with either BbHtrA or BbHtrA(S226A) produced high-titer antibody responses in C3H/HeJ mice, neither antigen was successful in protecting mice from B. burgdorferi challenge. These results indicate that the search for novel vaccine candidates against Lyme borreliosis remains a challenge.	[Ullmann, Amy J.; Russell, Theresa M.; Dolan, Marc C.; Williams, Martin; Hojgaard, Andrias; Weiner, Zachary P.; Johnson, Barbara J. B.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Bacterial Dis Branch, Ft Collins, CO 80521 USA	Centers for Disease Control & Prevention - USA	Ullmann, AJ (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Bacterial Dis Branch, Ft Collins, CO 80521 USA.	aff1@cdc.gov			federal government	federal government	All authors are government employees and the research was funded by the federal government.	Bartolini E, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20181; Centers for Disease Control and Prevention, 2014, MMWR Morb Mortal Wkly Rep, V63, P702; Chen HW, 2009, INFECT IMMUN, V77, P2311, DOI 10.1128/IAI.01298-08; Coleman JL, 2013, MOL MICROBIOL, V88, P619, DOI 10.1111/mmi.12213; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Finco O, 2011, P NATL ACAD SCI USA, V108, P9969, DOI 10.1073/pnas.1101756108; He P, 2015, HUM VACC IMMUNOTHER, V11, P477, DOI 10.1080/21645515.2014.1004026; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; HogenEsch H, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00406; Hojgaard A, 2014, TICKS TICK-BORNE DIS, V5, P349, DOI 10.1016/j.ttbdis.2013.12.001; Kung F, 2013, FUTURE MICROBIOL, V8, P41, DOI [10.2217/FMB.12.121, 10.2217/fmb.12.121]; Loosmore SM, 1998, INFECT IMMUN, V66, P899, DOI 10.1128/IAI.66.3.899-906.1998; Masuzawa T, 2004, JPN J INFECT DIS, V57, P229; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; PIESMAN J, 1993, J MED ENTOMOL, V30, P199, DOI 10.1093/jmedent/30.1.199; Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2; Russell TM, 2013, MOL MICROBIOL, V90, P241, DOI 10.1111/mmi.12377; Russell TM, 2013, MOL MICROBIOL, V90, P228, DOI 10.1111/mmi.12276; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Willyard C, 2014, NAT MED, V20, P698, DOI 10.1038/nm0714-698; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Yu YF, 2005, AM J TROP MED HYG, V72, P458, DOI 10.4269/ajtmh.2005.72.458	27	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2015	10	6							e0128868	10.1371/journal.pone.0128868	http://dx.doi.org/10.1371/journal.pone.0128868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6HU	26076465	Green Published, Green Submitted, gold			2022-12-26	WOS:000356329900034
